dls_datetime,drug_link,drug_synonym_type,drug_synonym
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Code name:,AZD 4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Code name:,AZD-4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Code name:,AZD4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Synonym:,11-beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Synonym:,11b-HSD1 inhibitor AZD4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Synonym:,11bHSD1 inhibitor AZD4017
2020-10-14T03:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017,Synonym:,11β-HSD1 inhibitor AZD4017
2020-09-18T01:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11c-topotecan,NA,NA
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Chemical structure:,2-(3-{l-carboxy-5-[3-(4-iodo-phenyl)-ureido]-pentyl}-ureido)-pentanedioic acid
2020-09-18T01:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095,Synonym:,iodine I 123 IMP-1095
2020-10-14T05:14:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/13-deoxydoxorubicin,Synonym:,13-deoxydoxorubicin
2020-09-18T01:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/14c-bms-275183,NA,NA
2020-09-18T01:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/16-16-dimethyl-prostaglandin-e2,Abbreviation:,dmPGE2
2020-10-14T03:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/1616-dimethyl-prostaglandin-e2,Abbreviation:,dmPGE2
2020-10-14T03:21:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/17beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Chemical structure:,(4-(2-hydroxy-2-methylpropyl)piperidin-1-yl)(5-methoxy-1H-indol-2-yl)methanone
2020-10-14T03:21:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/17beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP 9521
2020-10-14T03:21:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/17beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP9521
2020-10-14T03:21:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/17beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Synonym:,17βHSD5 inhibitor ASP9521
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,(18)F-FAC
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Abbreviation:,F-AC
2020-09-18T01:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate,Synonym:,fluorine F 18 fluoroacetate
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Chemical structure:,9-(4-18F-fluoro-3-[hydroxymethyl]butyl)guanine
2020-09-18T01:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg,Synonym:,reporter probe 18F-FHBG
2020-09-18T06:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoroazomycin-arabinoside,Abbreviation:,18F-FAZA
2020-09-18T06:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoroazomycin-arabinoside,Synonym:,18F-fluoroazomycin arabinoside
2020-09-18T01:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoromisonidazole,Abbreviation:,18F-FMISO
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,(18)F-FB-mini-PEG-E[c(RGDyK)](2)
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,[18F] FPRGD2
2020-09-18T01:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer,Abbreviation:,18F-FPRGD2
2020-09-18T01:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-substance-p-antagonist-receptor-quantifier,Abbreviation:,[18F]SPA-RQ
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Chemical structure:,[18F]-2-(5-fluoro-pentyl)-2-methyl-malonic-acid
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Foreign brand name:,[18F]-ApoSense
2020-09-18T01:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10,Synonym:,Fluorine F 18 ML-10
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18]F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAc
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,[18F]FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Abbreviation:,18F-FAC
2020-09-18T01:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac,Chemical structure:,1-(2′-deoxy-2′-[18F]fluoroarabinofuranosyl) cytosine
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Chemical structure:,2’-deoxy-2’-18F-fluoro-5-methyl-beta-L-arabinofuranosylcytosine
2020-09-18T01:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac,Synonym:,L-fluorine F 18-FMAC
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Abbreviation:,ODSH
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX 01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX-01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,CX01
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX-100
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Code name:,PGX100
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,O-desulfated heparin
2020-09-18T01:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin,Synonym:,PGX-ODSH
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Chemical structure:,1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil
2020-09-18T01:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine,Synonym:,FAU
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Code name:,SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2-FF containing SGN-2FF
2020-09-18T01:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff,Synonym:,2FF-containing SGN-2FF
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,[18F] FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PEG3-RGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FP-PRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,18F-FPPRGD2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Abbreviation:,PEG3-E[c(RGDyk)]2
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Code name:,104150
2020-09-18T01:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide,Synonym:,fluorine 18 ((18)F) FPPRGD2
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Foreign brand name:,Liproca
2020-09-18T01:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot,Synonym:,2-hydroxyflutamide controlled-release formulation
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2-OHOA
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Abbreviation:,2OHOA
2020-09-18T01:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid,Foreign brand name:,Minerval
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Abbreviation:,2ME2
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Chemical structure:,"(17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol"
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-ME
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,Synonym:,2-Methoxy Estradiol
2020-09-18T01:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol,US brand name:,Panzem
2020-09-18T01:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2g-1-tcr-retroviral-vector-transduced-lymphocytes,NA,NA
2020-10-14T05:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2p132,Code name:,CCRIS 7640
2020-10-14T05:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2p132,Code name:,EINECS 232-371-1
2020-10-14T05:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2p132,Synonym:,Allium sativum extract
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,Synonym:,nicotine conjugate vaccine
2020-09-18T01:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine,US brand name:,NicVax
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Abbreviation:,ECyd
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Chemical structure:,1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine
2020-09-18T01:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine,Code name:,TAS-106
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Abbreviation:,DAU
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Chemical structure:,"2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl4-hydroxy-1-(beta-D-ribopentofuranosyl)-2-pyridone"
2020-09-18T01:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine,Synonym:,deazauridine
2020-09-18T01:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/34-methylenedioxymethamphetamine,Abbreviation:,MDMA
2020-09-18T08:31:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/39298,US brand name:,Synthroid
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX RAD
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Code name:,PLX-R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLacental eXpanded-R18
2020-09-18T01:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18,Synonym:,PLX-R18 cells
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Code name:,BAY 85-8050
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Code name:,BAY 858050
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Synonym:,(2S)-2-amino-4-[F-18]-fluoro pentanedioic acid
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Synonym:,[F-18]BAY 85-8050
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Synonym:,4-[(18)F]fluoro L-glutamic acid
2020-10-14T03:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid,Synonym:,fluorine F 18-BAY 85-8050
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Abbreviation:,IDOX
2020-09-18T01:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin,Synonym:,iododoxorubicin
2020-09-18T01:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-nitroestrone-3-methyl-ether,Synonym:,4-Nitroestrone
2020-09-18T01:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-peptide-melanoma-vaccine,NA,NA
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,T-dCyd
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Abbreviation:,TdCyd
2020-09-18T01:13:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine,Synonym:,4'-thio-2'-deoxycytidine
2020-09-18T07:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/476335,Synonym:,G9 209-2M
2020-09-18T07:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/476335,Synonym:,gp100:209-217(210M)
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,4H11-28z/fIL-12/EFGRt+ T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous 4H11-28z/fIL-12/EFGRt+ genetically-modified T cells
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T01:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes,Synonym:,autologous MUC16ecto-targeting EGFR-secreting T lymphocytes
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4S-GD2-CAR-T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2 T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,4SCAR-GD2-modified T cells
2020-09-18T01:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes,Synonym:,GD2-specific 4th generation chimeric antigen receptor-modified T Cells
2020-09-18T01:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-18ffluorouracil,NA,NA
2020-10-14T03:20:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-aza-4-thio-2-deoxycytidine,Abbreviation:,5-Aza-TdCyd
2020-10-14T03:20:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-aza-4-thio-2-deoxycytidine,Abbreviation:,Aza-TdC
2020-10-14T03:20:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-aza-4-thio-2-deoxycytidine,Abbreviation:,Aza-TdCyd
2020-10-14T03:20:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-aza-4-thio-2-deoxycytidine,Chemical structure:,5-aza-4-thio-2-deoxycytidine
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCC colon heptapeptide
2020-09-18T01:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide,Synonym:,KCCFPAQ-GGGSK-(5-FITC)-NH2
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Chemical structure:,Ala1-Ser2-Tyr3-Asn4-Tyr5-Asp6-Ala7-Gly8- Gly9-Gly10-Ser11-Lys12 (5-FITC) -NH213
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,5-FITC-labeled 7-AA peptide
2020-09-18T01:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide,Synonym:,GI heptapeptide
2020-09-18T01:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluoro-2-deoxycytidine,Abbreviation:,FdCyd
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Abbreviation:,low-dose 5-FU/SA
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Code name:,LAS 41005
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Foreign brand name:,Actikerall
2020-09-18T01:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution,Synonym:,low-dose 5-fluorouracil/salicylic acid
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Code name:,TAK 954
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Code name:,TAK-954
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Code name:,TAK954
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Code name:,TD-8954
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Synonym:,serotonin 4 receptor agonist TAK-954
2020-10-14T03:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954,Synonym:,serotonin agonist TAK-954
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Entonox
2020-09-18T01:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix,Foreign brand name:,Kalinox 170 bar
2020-09-18T01:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/531923,US brand name:,Zovirax
2020-09-18T01:57:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/539100,US brand name:,HyperAcute-Lung Cancer Vaccine
2020-09-18T04:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560190,NA,NA
2020-09-18T04:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560192,NA,NA
2020-09-18T06:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/561774,US brand name:,PEDIARIX
2020-09-18T10:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/571184,Foreign brand name:,ApoCell
2020-09-18T01:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/580835,Foreign brand name:,AlloStim
2020-09-18T05:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155,US brand name:,PHC
2020-09-18T05:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155,US brand name:,Prostate Health Cocktail
2020-09-18T11:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/599024,Code name:,AGS-003
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Abbreviation:,6-AZUR
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Chemical structure:,"1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl2-beta-D-ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine riboside6-azauracil-.beta.-D-riboside"
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,6-azauracil riboside
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,azauridine
2020-09-18T01:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine,Synonym:,riboazauracil
2020-10-14T03:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-melanoma-helper-peptide-vaccine,Abbreviation:,6MHP
2020-10-14T03:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-melanoma-helper-peptide-vaccine,Synonym:,6MHP vaccine
2020-09-18T05:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/612154,NA,NA
2020-09-18T01:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/61cu-atsm,NA,NA
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-CAR-engineered autologous PBLs
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,anti-Her-2-chimeric antigen receptor-engineered autologous peripheral blood lymphocytes
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,CART-HER-2 cells
2020-09-18T02:39:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766,Synonym:,HER-2 CAR-expressing autologous T-lymphocytes
2020-10-14T03:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/630382,NA,NA
2020-09-18T03:55:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632702,US brand name:,Aquacel AG with Hydrofiber
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BP-GMAX-CD1
2020-09-18T04:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422,Code name:,BPX-101
2020-09-18T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642488,Synonym:,autologous CD133-positive brain tumor stem cell mRNA-pulsed autologous dendritic cell vaccine
2020-09-18T04:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642644,NA,NA
2020-09-18T04:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642645,NA,NA
2020-09-18T04:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/643475,Synonym:,autologous TGF beta-resistant HER2/EBV-CTLs
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Code name:,BAY 858050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,(2S)-2-amino-4-[F-18]-fluoro pentanedioic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,[F-18]BAY 85-8050
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,4-[(18)F]fluoro L-glutamic acid
2020-09-18T01:12:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979,Synonym:,fluorine F 18-BAY 85-8050
2020-09-18T07:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653980,NA,NA
2020-09-18T09:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/665369,Code name:,MB-6
2020-09-18T09:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/665369,Synonym:,"oligomeric proanthocyanidins/green tea,/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule"
2020-09-18T05:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666096,Abbreviation:,tetwtCEA DNA
2020-09-18T04:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666847,Foreign brand name:,Homeodent
2020-09-18T07:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/667444,NA,NA
2020-09-18T07:39:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/667445,NA,NA
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Code name:,GRm13Z40-2
2020-09-18T01:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180,Synonym:,cytotoxic T lymphocytes GRm13Z40-2
2020-09-18T08:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/669230,Foreign brand name:,femMED BREAST HEALTH
2020-09-18T10:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/669661,Abbreviation:,oxaliplatin-encapsulated Tf-conjugated NGPE liposome
2020-09-18T10:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/669661,Code name:,MBP-426
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI 613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Code name:,CPI-613
2020-09-18T01:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid,Synonym:,alpha-lipoic acid analogue CPI-613
2020-09-18T09:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/681902,Abbreviation:,NSCLC tumor Ag-loaded Dex
2020-09-18T09:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/681902,Abbreviation:,NSCLC tumor antigen-loaded Dex
2020-09-18T09:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/681902,Synonym:,non-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Chemical structure:,"ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-α-D-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-α-D-mannopyranosyl-N15-methyl-"
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,A-A-1
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,BI397
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,"MDL 63,397"
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,Code name:,VER001
2020-09-18T05:52:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691,US brand name:,Zeven
2020-09-18T10:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/685700,NA,NA
2020-09-18T07:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/688700,Synonym:,hyperpolarized 13C-pyruvate
2020-09-18T07:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/688700,Synonym:,hyperpolarized pyruvate (13C)
2020-09-18T04:13:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/693322,Synonym:,autologous CD8+ PBL sensitized To Drosophila cell-presented melanoma peptides
2020-09-18T07:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524,Code name:,IMM 101
2020-09-18T07:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524,Code name:,IMM-101
2020-09-18T07:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524,Code name:,IMM101
2020-09-18T07:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524,Synonym:,heat-killed mycobacterial product IMM-101
2020-09-18T07:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524,Synonym:,heat-killed Mycobacterium obuense NCTC 13365 IMM-101
2020-09-18T11:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/698993,Synonym:,recombinant Bordetella pertussis adenylate cyclase toxin coupled to tyrosinase.A2 epitope YMDGTMSQV vaccine
2020-09-18T10:01:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/699229,Code name:,DC-006
2020-09-18T10:01:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/699229,Code name:,DC-006 vaccine
2020-09-18T01:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-cyanoquinocarcinol,Code name:,DX-52-1
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Chemical structure:,"8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo[a, g]cyclonona[cde] trinden-1-one, 2,3,9,10,11, 12-hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)"
2020-09-18T01:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine,Code name:,UCN-01
2020-09-18T01:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/708408,US brand name:,Alkagin
2020-09-18T07:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/715580,Foreign brand name:,Procure
2020-09-18T04:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717605,Foreign brand name:,Neoviderm
2020-09-18T01:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717909,Synonym:,allogeneic CD19CAR-TCM cells
2020-09-18T01:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/727131,NA,NA
2020-09-18T08:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/730576,Synonym:,lentivirus-transduced hematopoietic progenitor cells
2020-09-18T09:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/732671,Abbreviation:,mesothelin-specific CAR-engineered PBLs
2020-09-18T09:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/732671,Synonym:,anti-mesothelin CAR PBL
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Code name:,INXN-3001/1001
2020-09-18T01:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561,Synonym:,DC-RTS-IL-12
2020-09-18T12:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735790,Foreign brand name:,Samital granules
2020-09-18T12:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735790,Synonym:,V. myrtillus/M. cordata/E. angustfolia granules
2020-10-14T04:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735852,Foreign brand name:,CVac
2020-09-18T01:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735883,Synonym:,AdVTMM2-transduced dendritic cell vaccine
2020-09-18T07:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/736258,US brand name:,Goodbelly Probiotic
2020-09-18T03:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/739744,NA,NA
2020-09-18T08:23:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/741869,NA,NA
2020-09-18T09:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409,Synonym:,PEG-Asc
2020-09-18T09:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409,US brand name:,Moviprep
2020-09-18T09:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409,US brand name:,Plenvu
2020-09-18T07:18:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745403,Abbreviation:,GGTI-I
2020-09-18T07:18:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745403,Code name:,PTX-100
2020-09-18T07:18:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745403,Synonym:,GGTase-I inhibitor
2020-09-18T13:14:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745657,Synonym:,89Zr-DFO-MSTP2109A
2020-09-18T13:14:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745657,Synonym:,89Zr-DFO-vandortuzumab vedotin
2020-09-18T13:14:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745657,Synonym:,zirconium Zr 89 DFO-MSTP2109A
2020-09-18T07:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748730,Code name:,2B3-101
2020-09-18T01:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748904,Code name:,BPX-201
2020-09-18T08:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/750374,Foreign brand name:,GeniusVac-Mel4
2020-09-18T01:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751302,NA,NA
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Abbreviation:,IL-15N72D/IL-15Ra-Fc
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Code name:,ALT 803
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Code name:,ALT803
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Code name:,N 803
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Code name:,N-803
2020-09-18T11:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380,Synonym:,IL-15N72D:IL-15RaSu/Fc fusion complex
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,FMC63-28Z CAR-transduced allogeneic T lymphocytes
2020-09-18T02:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864,Synonym:,MSGV1-FMC63-28Z anti-CD19 CAR-transduced allogeneic T lymphocytes
2020-09-18T04:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/753553,NA,NA
2020-09-18T04:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754007,Synonym:,GVAX colorectal cancer vaccine
2020-09-18T08:39:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754227,Code name:,ADU-623
2020-09-18T10:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755346,Synonym:,Replens
2020-09-18T04:14:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755477,Code name:,CT7/MAGE-A3/WT1 mRNA-electroporated LCs
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous lymphocytes cotransduced with genes encoding IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,autologous PBL cotransduced with retroviral vectors encoding inducible IL-12 and anti-NY-ESO-1 TCR
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12 plus anti-ESO-1 TCR PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous PBL
2020-09-18T04:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595,Synonym:,inducible IL-12/Anti-NY-ESO-1 TCR-expressing autologous peripheral blood lymphocytes
2020-09-18T01:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756037,NA,NA
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,Abbreviation:,HAR
2020-09-18T01:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792,US brand name:,HyperAcute™ Renal
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,ACT-PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Code name:,PFK-158
2020-09-18T01:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225,Synonym:,PFKFB3 Inhibitor PFK-158
2020-09-18T06:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757880,Synonym:,tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
2020-09-18T06:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757880,Synonym:,αDC1-TBVA vaccine
2020-09-18T04:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/758035,Foreign brand name:,Lactibiane Tolerance
2020-09-18T12:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579,Code name:,ABBV 399
2020-09-18T12:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579,Code name:,ABBV-399
2020-09-18T12:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579,Code name:,ABT 399
2020-09-18T12:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579,Code name:,ABT-399
2020-09-18T12:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579,Synonym:,ABT-700-VCMMAE
2020-09-18T07:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/760677,Synonym:,anti-MAGE-A3-DP4 TCR PBL
2020-10-14T03:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606,Abbreviation:,GD2Bi-a ATC
2020-10-14T03:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606,Abbreviation:,Hu3F8Bi-armed ATC
2020-10-14T03:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606,Synonym:,anti-CD3 x hu3F8 bispecific antibody-armed ATC
2020-10-14T03:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606,Synonym:,OKT3/humanized 3F8 bispecific antibody-activated T lymphocytes
2020-09-18T11:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761688,Code name:,APVAC2
2020-09-18T04:20:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/762213,Synonym:,anti-MAGE-A3 HLA-A*01-restricted TCR-gene engineered lymphocytes
2020-09-18T07:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/763113,Synonym:,autologous IL13(EQ)BBzeta/CD19t+ TCM-enriched T cells
2020-09-18T11:19:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/766088,Synonym:,RNA anti-CD19 CAR T cells
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CD171 CAR+ T cells
2020-09-18T04:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199,Synonym:,CE7R CAR T cells
2020-09-18T02:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767368,Synonym:,anti-CD22-CAR m971-BBz cells
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Code name:,L-DOS47
2020-09-18T02:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359,Synonym:,immunoconjugate L-DOS47
2020-09-18T08:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770190,Code name:,ADXS31-164
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,allogeneic mesothelioma tumor lysate-pulsed autologous DC vaccine
2020-09-18T01:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460,Synonym:,MesoCancerVac
2020-09-18T05:09:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770796,US brand name:,Nutrison
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Code name:,MVI-118
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,AR LBD-encoding plasmid DNA vaccine MVI-118
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR
2020-09-18T02:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098,Synonym:,pTVG-AR vaccine
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Foreign brand name:,Pediacel
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Synonym:,DTaP-IPV-Hib
2020-09-18T06:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556,Synonym:,DTaP(5)-IPV-Hib
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Code name:,BTCT 4465A
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Code name:,BTCT-4465A
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Code name:,RG 7828
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Code name:,RG7828
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody BTCT4465A
2020-09-18T09:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847,Synonym:,CD20/CD3 BiMAb BTCT4465A
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Code name:,INO-3112
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Code name:,MEDI0457
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Synonym:,INO-3112 vaccine
2020-09-18T06:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854,Synonym:,VGX-3100 plus INO-9012
2020-09-18T09:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776267,Code name:,ICT-107
2020-09-18T09:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776267,Synonym:,multi-glioblastoma-peptide-pulsed autologous DC vaccine ICT-107
2020-09-18T09:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776267,Synonym:,multi-glioblastoma-peptide-targeting autologous DC vaccine ICT-107
2020-09-18T10:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776756,Foreign brand name:,Albis
2020-09-18T10:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776756,Synonym:,ranitidine hydrochloride/bismuth potassium citrate/sucralfate
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,"autologous T lymphocytes expressing NY-ESO-1-specific, enhanced TCRs"
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1/C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESO-1C259T
2020-09-18T04:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841,Synonym:,NY-ESOc259T
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 CARs-expressing tandem TCR-zeta/4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,autologous T lymphocytes expressing CD22 chimeric antigen receptors expressing tandem TCR-zeta and 4-1BB
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRzeta/4-1BB CART22 cells
2020-09-18T02:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843,Synonym:,TCRζ/4-1BB CART22 cells
2020-09-18T08:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777270,Code name:,ADU-214
2020-09-18T08:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777270,Code name:,JNJ-64041757
2020-09-18T08:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777270,Synonym:,LADD Listeria monocytogenes JNJ-64041757
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-DC-CTL
2020-09-18T04:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274,Synonym:,MUC1-gene-DC-CTL
2020-09-18T04:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777275,Synonym:,MUC1-peptide-DC-CTL
2020-10-20T13:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777759,Code name:,MBG 453
2020-10-20T13:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777759,Code name:,MBG453
2020-10-20T13:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777759,Synonym:,anti-TIM-3 monoclonal antibody MBG453
2020-10-20T13:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777759,Synonym:,anti-TIM3 checkpoint inhibitor MBG453
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-ERBB2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T cells
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,anti-HER2 antibody expressing pluripotent killer T lymphocytes
2020-09-18T02:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383,Synonym:,PIK-HER2
2020-09-18T08:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778386,Code name:,JCAR017
2020-09-18T08:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778386,Synonym:,anti-CD19-CAR genetically engineered autologous T lymphocytes JCAR017
2020-09-18T08:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778386,Synonym:,autologous anti-CD19-EGFRt-4-1BB-zeta-modified CAR CD8+ and CD4+ T lymphocytes JCAR017
2020-09-18T08:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778386,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes JCAR017
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Code name:,PIK-PD-1
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PD-1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T cells
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-PDCD1 antibody expressing pluripotent killer T lymphocytes
2020-09-18T03:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444,Synonym:,anti-programmed cell death protein 1 antibody expressing pluripotent killer T cells
2020-09-18T07:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778524,Foreign brand name:,LactoFos
2020-09-18T07:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778524,Synonym:,fructooligosaccharide/L. paracasei/L. rhamnosus/L. acidophilus/B. lactis probiotic supplement
2020-09-18T09:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780143,Chemical structure:,"2-pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-"
2020-09-18T09:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780143,Code name:,FT-2102
2020-09-18T09:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780143,Code name:,FT2102
2020-09-18T09:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780143,Synonym:,IDH1-R132 inhibitor FT-2102
2020-11-03T11:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780220,Code name:,INCB 057643
2020-11-03T11:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780220,Code name:,INCB057643
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Code name:,JCAR014
2020-09-18T04:07:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ CM T lymphocytes JCAR014
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-functional short hairpin RNA EWS/FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-functional shRNA EWS-FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 type 1 lipoplex
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 Type 1 LP
2020-09-18T04:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967,Synonym:,pbi-shRNA EWS/FLI1 type 1 LPX
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Code name:,IMU-131
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Synonym:,HER-Vaxx
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Synonym:,HER-Vaxx peptide vaccine
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Synonym:,IMU-131 vaccine
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Synonym:,MU-131 HER2/Neu peptide vaccine
2020-10-14T05:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063,Synonym:,P467-CRM197/Montanide vaccine IMU-131
2020-09-18T08:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782403,Synonym:,lentivirus vector CCR5 shRNA/TRIM5alpha/TAR decoy-transduced autologous CD34-positive HPCs
2020-09-18T12:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782595,Abbreviation:,autologous DC1-CTL
2020-09-18T12:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782595,Synonym:,DC1-induced antigen-specific autologous CTLs
2020-09-18T12:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782595,Synonym:,type-1 polarized DC-induced antigen-specific autologous CTLs
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Code name:,ISA201
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Foreign brand name:,Hespecta
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Synonym:,HPV E six peptide conjugated To amplivant
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Synonym:,HPV E6 peptides-amplivant
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Synonym:,HPV16 peptides AMPLIVANT vaccine
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Synonym:,SLP HPV16 E6/amplivant vaccine ISA201
2020-09-18T11:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216,Synonym:,SLP-amplivant ISA201
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR-087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Code name:,ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,anti-ACTR viral vector-transduced autologous T lymphocytes ACTR087
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,CD16-41BB-CD3zeta ACTR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,viral ATCR autologous T cells
2020-09-18T02:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523,Synonym:,virally-delivered antibody-coupled TCR ACTR087
2020-09-18T09:35:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784730,NA,NA
2020-09-18T04:35:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785056,Code name:,NKTR-214
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Code name:,INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 agonist antibody INCAGN01949
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,anti-OX40 monoclonal antibody INCAGN0194
2020-09-18T01:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256,Synonym:,monoclonal antibody INCAGN01949
2020-09-18T07:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785876,Code name:,BVAC-C
2020-09-18T07:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785876,Synonym:,autologous lymphocyte/Tumor antigen gene vaccine BVAC-C
2020-10-14T04:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786186,Synonym:,autologous NY-ESOc259T GSK3377794
2020-10-14T04:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786186,Synonym:,genetically engineered NY-ESO-1/LAGE-1 specific (c259) T cells GSK3377794
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Abbreviation:,MAGEA10c796 T
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous genetically-modified T cells MAGEA10c796
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE A10c796 T cells
2020-09-18T04:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272,Synonym:,autologous MAGE-A10-specific HLA-A2-restricted TCR c796 gene-engineered lymphocytes
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Code name:,huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,anti-CD19-CAR genetically-engineered autologous T lymphocytes huJCAR014
2020-09-18T04:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,BB 21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb-21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Code name:,bb21217
2020-09-18T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258,Synonym:,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing memory T cells bb21217
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-antigen presenting cells
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous CD19t T-APC
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing CD19t
2020-09-18T04:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464,Synonym:,autologous T-cell antigen presenting cells expressing truncated CD19
2020-09-18T02:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791831,Code name:,PRS-343
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Abbreviation:,autologous iC9-CARCD19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,ATL-iC9-CAR-CD19
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CAR19 T cells
2020-09-18T04:18:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844,Synonym:,autologous iC9-CARCD19 T cells
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,gamma-retroviral MSGV1 139 scFv EGFRvIII CAR gene-modified autologous T lymphocytes
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGv1-EGFRvIII-CAR autologous T cells
2020-09-18T04:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887,Synonym:,MSGV1-EGFRvIII-specific CAR-transduced autologous T lymphocytes
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG-596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Code name:,AMG596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,anti-EGFRvIII x anti-CD3 bi-specific T-cell engager AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,bispecific BITE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,BiTE antibody AMG 596
2020-09-18T02:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074,Synonym:,EGFRvIII specific BiTE antibody AMG 596
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX 2853
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX-2853
2020-09-18T04:49:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077,Code name:,PLX2853
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Abbreviation:,EBV-CTLs
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Code name:,ATA 129
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Code name:,ATA129
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Synonym:,allogeneic EBV-specific CTLs ATA129
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Synonym:,allogeneic EBV-specific cytotoxic T lymphocytes
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,Synonym:,CTLs ATA129
2020-09-18T11:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147,US brand name:,Tab-cel
2020-09-18T12:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792148,Code name:,VBP 926
2020-09-18T12:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792148,Code name:,VBP-926
2020-09-18T12:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792148,Synonym:,VBP-926 solution
2020-09-18T09:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149,Code name:,PCM 075
2020-09-18T09:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149,Code name:,PCM-075
2020-09-18T09:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149,Synonym:,PLK-1 inhibitor PCM-075
2020-09-18T09:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149,Synonym:,PLK1 inhibitor PCM-075
2020-09-18T09:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149,Synonym:,Polo-like kinase 1 inhibitor PCM-075
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN 632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN-632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Code name:,IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,antibody-drug conjugate IMGN632
2020-09-18T02:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150,Synonym:,CD123-targeted ADC IMGN632
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN 2001
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Code name:,INXN-2001
2020-09-18T01:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151,Synonym:,adaoviral-rheoswitch therapeutic system-human interleukin 12
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Code name:,VBI 1901
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Code name:,VBI-1901
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Synonym:,enveloped virus-like particles CMV gB-pp65 plus GM-CSF VBI-1901
2020-09-18T06:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152,Synonym:,VBI-1901 vaccine
2020-09-18T07:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792153,Code name:,BNZ-1
2020-09-18T07:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792153,Code name:,BNZ132-1-40
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Code name:,MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,bispecific DART protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,dual-affinity retargeting protein MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 bispecific DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART molecule MGD013
2020-09-18T03:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154,Synonym:,PD-1 x LAG-3 DART protein MGD013
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Code name:,CC 92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Code name:,CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,CELMoD CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,cereblon E3 ligase modulation drug CC-92480
2020-09-18T05:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155,Synonym:,cereblon modulator CC-92480
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI 1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,HTI-1066
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Code name:,SHR-A1403
2020-09-18T02:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156,Synonym:,ADC HTI-1066
2020-09-18T06:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792157,Abbreviation:,18F-TFB
2020-09-18T06:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792157,Synonym:,18F-tetrafluoroborate
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1 breast cancer cell line vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR-1-GM vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,Synonym:,SV-BR1-GM breast cancer vaccine
2020-09-18T01:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158,US brand name:,Bria-IMT
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Abbreviation:,IV NEPA FDC
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,fosnetupitant-palonosetron HCl
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,fosnetupitant/palonosetron HCl combination
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,pro-netupitant/palonosetron HCl
2020-09-18T07:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159,Synonym:,pronetupitant/palonosetron HCl
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS 986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Code name:,BMS986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-ICOS BMS-986226
2020-09-18T02:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161,Synonym:,anti-inducible T-cell co-stimulator BMS-986226
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS 986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS-986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Code name:,BMS986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Synonym:,CTLA-4 probody BMS-986249
2020-09-18T05:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162,Synonym:,protease-activated anti-CTLA-4 antibody prodrug BMS-986249
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA 201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA-201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Code name:,IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,ACTengine IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,autologous T-cell receptor-engineered T cells IMA201
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 autologous T lymphocytes
2020-09-18T04:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163,Synonym:,IMA201 T cells
2020-09-18T07:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164,Code name:,ALN AS1
2020-09-18T07:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164,Code name:,ALN-AS1
2020-09-18T07:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164,Synonym:,ESC-GalNAc-siRNA conjugate ALN-AS1
2020-09-18T07:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164,Synonym:,RNA interference therapeutic ALN-AS1
2020-09-18T07:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164,Synonym:,RNAi ALN-AS1
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY 1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY-1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Code name:,BAY1895344
2020-09-18T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166,Synonym:,ATR inhibitor BAY1895344
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Code name:,UCART123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,allogeneic engineered T cells expressing anti-CD123 chimeric antigen receptor
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,UCART123 T cells
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cell 123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal chimeric antigen receptor T cells targeting CD123
2020-09-18T01:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167,Synonym:,universal TALEN gene-edited CART123 cells
2020-09-18T07:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792168,Code name:,TAS 0728
2020-09-18T07:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792168,Code name:,TAS-0728
2020-09-18T07:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792168,Code name:,TAS0728
2020-09-18T07:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792168,Code name:,TPC-107
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM 112
2020-09-18T02:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169,Code name:,CJM112
2020-09-18T09:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792256,Code name:,mRNA 4157
2020-09-18T09:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792256,Code name:,mRNA-4157
2020-09-18T09:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792256,Synonym:,mRNA-based PCV mRNA-4157
2020-09-18T09:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792256,Synonym:,PCV mRNA-4157
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb 18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb-18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Code name:,XmAb18087
2020-09-18T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257,Synonym:,anti-SSTR2 x anti-CD3 monoclonal antibody XmAb18087
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Code name:,SOR007
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Synonym:,nanopac ointment
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Synonym:,nanoparticle paclitaxel SOR007
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Synonym:,SOR007 ointment
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Synonym:,topical manoparticle paclitaxel ointment
2020-09-18T09:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258,Synonym:,uncoated nanoparticle paclitaxel ointment
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF 06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Code name:,PF06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,anti-CD3/anti-BCMA bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,B-cell maturation antigen-CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA x CD3 bispecific antibody PF-06863135
2020-09-18T02:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267,Synonym:,BCMA-CD3 bispecific Ab PF-06863135
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Code name:,CGX 1321
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Code name:,CGX-1321
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Code name:,CGX1321
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Synonym:,PORCN inhibitor CGX1321
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Synonym:,WNT inhibitor CGX1321
2020-09-18T10:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268,Synonym:,Wnt signaling inhibitor CGX1321
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Code name:,ABBV 621
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Code name:,ABBV-621
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Code name:,APG880
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Synonym:,HERA ligand ABBV-621
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Synonym:,hexavalent TRAIL receptor agonist ABBV-621
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Synonym:,TRAIL-Fc protein ABBV-621
2020-09-18T12:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269,Synonym:,TRAIL-receptor agonist fusion protein ABBV-621
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR 439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR-439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Code name:,SAR439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-TGFb SAR-439459
2020-09-18T03:50:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270,Synonym:,anti-transforming growth factor-beta mAb SAR439459
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous PBLs expressing mutated neoantigen-specific T-cell receptors
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,autologous peripheral blood lymphocytes retrovirally-transduced with TCRs targeting neoantigens
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,individual patient TCR-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-reactive TCRs-transduced autologous PBLs
2020-09-18T04:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330,Synonym:,neoantigen-specific TCRs gene-transduced autologous PBLs
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Code name:,NLA101
2020-09-18T01:55:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373,Synonym:,allogeneic UCB-derived hematopoietic stem and progenitor cells NLA101
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG-673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Code name:,AMG673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,anti-CD33 x anti-CD3 BiTE AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,BiTE antibody AMG 673
2020-09-18T02:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 673
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG-757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Code name:,AMG757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,anti-DLL3 x anti-CD3 BiTE AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,BiTE antibody AMG 757
2020-09-18T02:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376,Synonym:,DLL3/CD3-directed bispecific T-cell engager antibody AMG 757
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG-701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Code name:,AMG701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,bispecific T-cell engager antibody AMG 701
2020-09-18T02:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377,Synonym:,BiTE antibody AMG 701
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,ADC SC-007
2020-09-18T02:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378,Code name:,SC-007
2020-09-18T11:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792379,Code name:,GDC-9545
2020-09-18T11:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792379,Synonym:,selective estrogen receptor degrader GDC-9545
2020-09-18T11:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792379,Synonym:,selective estrogen receptor downregulator GDC-9545
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Code name:,RG7882
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,ADC DMUC4064A
2020-09-18T02:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380,Synonym:,THIOMAB-drug conjugate DMUC4064A
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Code name:,DNT-UHN-1
2020-09-18T01:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387,Synonym:,allogeneic DNT cells
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST 16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Code name:,TAEST16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,anti-NY-ESO-1 TCR transduced autologous T cells TAEST16001
2020-09-18T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389,Synonym:,NY-ESO-1 antigen specific affinity-enhanced TCR transduced autologous T cells
2020-09-18T04:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792459,Synonym:,autologous PD-1 antibody expressing mesothelin specific CAR-T cells
2020-09-18T09:27:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792460,Code name:,DS 1001
2020-09-18T09:27:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792460,Code name:,DS-1001
2020-09-18T09:27:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792460,Code name:,DS-1001b
2020-09-18T09:27:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792460,Synonym:,mutant isocitrate dehydrogenase type 1 inhibitor DS-1001
2020-09-18T07:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461,Synonym:,GD2-CAR NKT cells
2020-09-18T07:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461,Synonym:,GD2-CAR-expressing autologous natural killer T cells
2020-09-18T07:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461,Synonym:,GINAKIT cells
2020-09-18T07:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461,Synonym:,GINAKIT-cells
2020-09-18T07:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461,Synonym:,iC9-GD2.CD28.OX40.zeta natural killer T cells
2020-09-18T13:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792463,Code name:,RA 101495
2020-09-18T13:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792463,Code name:,RA101495
2020-09-18T13:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792463,Synonym:,C5 inhibitor RA101495
2020-09-18T13:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792463,Synonym:,complement C5 inhibitor RA101495
2020-09-18T09:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792465,US brand name:,Nutri-jelly
2020-09-18T09:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792466,Synonym:,semisolid food gel with PEITC
2020-09-18T09:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792466,US brand name:,Nutri-jelly with PEITC
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM 207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM-207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Code name:,ODM207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Synonym:,BET inhibitor ODM-207
2020-09-18T04:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467,Synonym:,bromodomain and extraterminal domain protein inhibitor ODM-207
2020-09-18T09:58:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792473,Abbreviation:,OMJ
2020-09-18T09:58:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792473,Synonym:,gel-based artificial saliva
2020-09-18T08:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792474,Code name:,TH1579
2020-09-18T08:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792474,Synonym:,Karolinska MTH1 inhibitor TH1579
2020-09-18T08:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792474,Synonym:,Karolinska NUDT1 inhibitor TH1579
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA 117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA-117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Code name:,MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,anti-CLEC12A x CD3 bispecific antibody MCLA117
2020-09-18T02:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475,Synonym:,bispecific antibody MCLA-117
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ 64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Code name:,JNJ64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 bispecific antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,GPRC5D/CD3 duobody antibody JNJ-64407564
2020-09-18T02:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477,Synonym:,humanized GPRC5D x CD3 duobody antibody JNJ-64407564
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Abbreviation:,SVP-R
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Code name:,SEL 110
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Code name:,SEL-110
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Code name:,SEL110
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Synonym:,SVP-rapa
2020-09-18T11:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481,Synonym:,SVP-rapamycin
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH-125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Code name:,JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous anti-BCMA CAR-T cells JCARH 125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA 41BBz CAR-T cells JCARH-125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR-T cells JCARH125
2020-09-18T04:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482,Synonym:,autologous BCMA-specific CAR4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH 125
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR-1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Code name:,GBR1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38 x anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,anti-CD38/anti-CD3 bispecific monoclonal antibody GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,BEAT GBR 1342
2020-09-18T02:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483,Synonym:,CD38xCD3 BsAb GBR 1342
2020-09-18T09:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489,Code name:,TG 6002
2020-09-18T09:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489,Code name:,TG-6002
2020-09-18T09:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489,Code name:,TG6002
2020-09-18T09:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489,Synonym:,oncolytic FCU1-expressing TK-RR-deleted vaccinia virus TG6002
2020-09-18T09:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489,Synonym:,vaccinia virus TG6002
2020-09-18T08:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792490,Chemical structure:,"2-propen-1-one, 3-(5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-, (E)-3-dimethylallyl-4,4'-dihydroxy-6-methoxychalcone"
2020-09-18T11:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792492,Code name:,CD 11301
2020-09-18T11:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792492,Code name:,CD11301
2020-09-18T11:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792492,Synonym:,CD11301 topical gel
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT 1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Code name:,XMT1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b ADC XMT-1536
2020-09-18T02:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1536
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT 1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Code name:,XMT1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,anti-NaPi2b MoAb XMT-1535
2020-09-18T02:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494,Synonym:,MoAb XMT-1535
2020-09-18T09:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792496,Code name:,V 3X
2020-09-18T09:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792496,Code name:,V3-X
2020-09-18T09:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792496,Synonym:,CA19-9 oral vaccine V3-X
2020-09-18T09:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792496,Synonym:,V3-X vaccine
2020-09-18T08:48:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792497,Synonym:,177Lu-PSMA-617
2020-09-18T10:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792500,Synonym:,PD-L1 peptide
2020-09-18T10:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792501,Synonym:,PD-1 knockout EBV-CTLs
2020-09-18T10:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792501,Synonym:,PD-1 knockout EBV-reactive CTLs
2020-09-18T10:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792501,Synonym:,PD-1 knockout Epstein-Barr virus-cytotoxic T lymphocytes
2020-09-18T08:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503,Chemical structure:,N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
2020-09-18T08:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503,Code name:,GNS-1480
2020-09-18T08:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503,Code name:,YH 25448
2020-09-18T08:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503,Code name:,YH-25448
2020-09-18T08:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503,Code name:,YH25448
2020-09-18T08:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792504,Synonym:,L. reuteri probiotic
2020-09-18T08:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792504,Synonym:,Lactobacillus reuteri probiotic
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR a/b T cell-depleted PBSCs
2020-09-18T01:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505,Synonym:,allogeneic TCR alpha/beta T cell-depleted PBSCs
2020-09-18T04:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792517,Synonym:,NY-ESO-1 T Cell receptor genetically modified autologous T cells
2020-09-18T10:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792518,Synonym:,IO103/IO102 peptide vaccine
2020-09-18T10:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792518,Synonym:,PD-L1/IDO peptide
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD 100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD-100
2020-09-18T03:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520,Code name:,BCD100
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Code name:,4SCAR19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4S-CAR-T19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,4SCAR19 cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous anti-CD19 CAR-T cells 4SCAR19
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19- scFv/CD28/CD137/CD27/CD3z-iCasp9 4SCAR-19 T cells
2020-09-18T04:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521,Synonym:,autologous CD19-scFv/CD28/CD137/CD27/CD3z-iCasp9 CAR-T cells
2020-09-18T07:31:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792522,Code name:,CKD 581
2020-09-18T07:31:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792522,Code name:,CKD-581
2020-09-18T07:31:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792522,Code name:,CKD581
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,AC 013773
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP-32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,CEP32496
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX 105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX-105
2020-09-18T01:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523,Code name:,RXDX105
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Code name:,ACH-0144471
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Code name:,ACH-4471
2020-09-18T05:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524,Synonym:,FD inhibitor ACH-4471
2020-09-18T07:18:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792527,Code name:,CBT 501
2020-09-18T07:18:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792527,Code name:,CBT-501
2020-09-18T07:18:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792527,Code name:,CBT501
2020-09-18T07:18:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792527,Code name:,GB-226
2020-09-18T11:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792528,Code name:,TLD 1411
2020-09-18T11:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792528,Code name:,TLD-1411
2020-09-18T11:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792528,Code name:,TLD1411
2020-09-18T11:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792528,Synonym:,PS TLD1411
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,autologous CART-meso
2020-09-18T04:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529,Synonym:,Hu-CART meso cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,allogeneic iC9/CAR19/IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,CAR-CD19-CD28-zeta-2A-iCasp9-IL15-transduced CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR-CD19-CD28-zeta-2A/IL-15 CB-NK cells
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,iC9/CAR19/IL15-transduced CB-NKs
2020-09-18T01:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530,Synonym:,UCB-derived CAR-CD19-CD28-zeta-2A-iCasp9-IL15 engineered NK cells
2020-09-18T02:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792531,Abbreviation:,ACC
2020-09-18T05:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792532,Synonym:,[14 C]-pevonedistat
2020-09-18T05:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792532,Synonym:,carbon C 14-pevonedistat
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Code name:,CON-4619
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,Synonym:,aurixim antibody conjugate
2020-09-18T04:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533,US brand name:,Aurixim
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9 targeting HPV16/18 E6 and E7 genes
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1 plus CRISPR/Cas9-HPV18 E6/ E7T2
2020-09-18T05:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1;CRISPR/Cas9-HPV18 E6/ E7T2
2020-09-18T11:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535,Synonym:,plasmid HPV16/18 E6E7-targeting TALEN
2020-09-18T11:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535,Synonym:,TALEN-HPV16 E6/E7;TALEN-HPV18 E6/E7
2020-09-18T11:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535,Synonym:,TALEN-HPV16 E6/E7/TALEN-HPV18 E6/E7
2020-09-18T11:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535,Synonym:,TALEN-HPV16 E6/E7/TALEN-HPV18 E6/E7 plasmid
2020-09-18T11:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535,Synonym:,TALEN-mediated HPV16/18 E6/7 editing
2020-09-18T13:14:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792536,Synonym:,89Zr-ABT806
2020-09-18T13:14:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792536,Synonym:,89Zr-labeled ABT-806
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous AML/DC fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous DC/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,autologous dendritic cell/AML fusion vaccine
2020-09-18T04:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537,Synonym:,DC/AML fusion cell vaccine
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Abbreviation:,Z-CTLs
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,autologous CAR-T Cells Targeting PD-L1 and CD80/CD86
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield CTLs
2020-09-18T04:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541,Synonym:,Zeushield cytotoxic T lymphocytes
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous cMET redirected CAR-T cells
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,autologous mRNA CART-cMET
2020-09-18T04:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542,Synonym:,cMET CAR-mRNA-electroporated autologous T lymphocytes
2020-09-18T12:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792543,Code name:,BI-CON-02
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD 115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD-115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Code name:,BCD115
2020-09-18T05:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544,Synonym:,CDK8/19 inhibitor BCD 115
2020-09-18T11:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792545,Code name:,MK-4621
2020-09-18T11:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792545,Code name:,RGT 100
2020-09-18T11:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792545,Code name:,RGT-100
2020-09-18T11:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792545,Code name:,RGT100
2020-09-18T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792546,Synonym:,89Zr-labeled pembrolizumab
2020-09-18T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792546,Synonym:,89Zr-pembrolizumab
2020-09-18T09:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792548,Synonym:,neo-MASCT
2020-09-18T09:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792548,Synonym:,neo-multiple TAA-loaded DC vaccine
2020-09-18T09:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792548,Synonym:,neoantigen-loaded dendritic cell vaccine
2020-09-18T07:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549,Chemical structure:,"2-pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-, (2E)-2-butenedioate (2:1)"
2020-09-18T07:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549,Code name:,ASP2215 hemifumarate
2020-09-18T07:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549,Synonym:,gilteritinib hemifumarate
2020-09-18T07:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549,US brand name:,Xospata
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic CIML NK cells
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic CIML NKs
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,allogeneic cytokine-induced memory-like NK cell
2020-09-18T06:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552,Synonym:,CIML-NK cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,autologous EGFRt/BCMA-41BBz CAR T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,B-cell maturation antigen-targeted EGFRt/BCMA-41BBz CAR-modified T cells
2020-09-18T04:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554,Synonym:,EGFRt/BCMA-41BBz CAR T cell
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled WFA
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled WFL
2020-09-18T06:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555,Synonym:,fluorescein-labeled Wisteria floribunda lectin
2020-09-18T07:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792557,Code name:,OBE2109
2020-09-18T07:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792557,Synonym:,GnRH receptor antagonist OBE2109
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV 368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Code name:,ABBV368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,agonistic anti-OX40 monoclonal antibody ABBV-368
2020-09-18T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559,Synonym:,anti-OX40 agonistic monoclonal antibody ABBV-368
2020-09-18T04:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792560,Foreign brand name:,ProBion Clinica
2020-09-18T04:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792560,Synonym:,B. lactis/L. acidophilus/inulin probiotic supplement
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,[68Ga] HBED-CC-PHENOXY-PSMA
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,[68Ga]P16-093
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,Ga-68 P16-093
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,Ga-68 PSMA-093
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,Ga-68 PSMA-93
2020-09-18T07:12:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561,Synonym:,gallium-68-P16 093
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Chemical structure:,"(R)-4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]nonan-1-yl)-2-fluoro-N-methylbenzamide"
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC 113 B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC-10013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-0013B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC1-13B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Code name:,ONC113B
2020-09-18T02:05:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562,Synonym:,AR antagonist ONC1-0013B
2020-09-18T07:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792571,Code name:,RO 7082859
2020-09-18T07:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792571,Code name:,RO7082859
2020-09-18T07:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792571,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody RO7082859
2020-09-18T07:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792571,Synonym:,anti-CD20/CD3 bispecific monoclonal antibody RO7082859
2020-09-18T10:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792572,Synonym:,AMX513 dicaprate
2020-09-18T10:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792572,Synonym:,AMXT 1501 dicaprate
2020-09-18T10:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792572,Synonym:,AMXT-1501 dicaprate
2020-09-18T04:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792573,Code name:,APG 1252
2020-09-18T04:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792573,Code name:,APG-1252
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Code name:,SH003
2020-09-18T04:00:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574,Synonym:,Am/Ag/Tk herbal extract SH003
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5-specific CAR-28 zeta CAR T lymphocytes
2020-09-18T04:13:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575,Synonym:,autologous CD5.CAR/28zeta CAR T cells
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Chemical structure:,"1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-"
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,Code name:,UCB34714
2020-09-18T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577,US brand name:,Briviact
2020-09-18T07:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792625,Code name:,MP 0274
2020-09-18T07:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792625,Code name:,MP0274
2020-09-18T07:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792625,Synonym:,DARPin MP0274
2020-09-18T07:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792625,Synonym:,HER2-targeting DARPin drug MP0274
2020-09-18T07:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792626,Synonym:,HBV antigen peptides/HepG2 cell protein lysate-activated DCs
2020-09-18T07:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792626,Synonym:,HBV antigen peptides/HepG2 cell protein lysate-activated dendritic cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFbRDN T cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,autologous CART-PSMA-TGFβRDN cells
2020-09-18T04:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627,Synonym:,PSMA-specific/TGFb-resistant CAR-modified autologous T cells
2020-09-18T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792628,Code name:,MEDI 5083
2020-09-18T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792628,Code name:,MEDI5083
2020-09-18T05:03:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792629,Synonym:,11C-JNJ-63779586
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Code name:,LCAR-B38M
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous anti-BCMA CAR-T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,autologous bi-epitope CAR T cells JNJ-68284528
2020-09-18T04:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630,Synonym:,LCAR-B38M-transduced CAR-T cells JNJ-68284528
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17-producing CD8+ T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic IL-17+ CD8 T cells
2020-09-18T01:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631,Synonym:,allogeneic Tc17 cells
2020-09-18T04:32:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792633,Synonym:,bacillus Calmette-Guerin Tokyo-172 strain vaccine
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA donor T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,anti-MiHA T cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,GLIDE T lymphocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide derived expansion against MiHAs cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,guided lymphocyte immunopeptide-derived expansion cells
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA T lympocytes
2020-09-18T02:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634,Synonym:,MiHA-specific T cells
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,AK 01 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,aurora kinase A inhibitor LY3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY 3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY-3295668 erbumine
2020-09-18T04:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635,Synonym:,LY3295668 erbumine
2020-09-18T12:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792636,Chemical structure:,"(8S,11R,13S,14S,17S)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one"
2020-09-18T12:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792636,Code name:,BAY 1002670
2020-09-18T12:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792636,Code name:,BAY-1002670
2020-09-18T12:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792636,Code name:,BAY1002670
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA CAR4-1BBz T cells
2020-09-18T04:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637,Synonym:,autologous anti-BCMA:TCRz-4-1-BB CAR-T cells
2020-09-18T12:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792638,Synonym:,therapeutic iNK T cells
2020-09-18T12:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792638,Synonym:,therapeutic iNKT
2020-09-18T12:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792638,Synonym:,therapeutic iNKT cells
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Code name:,AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,ADC AVID100
2020-09-18T02:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639,Synonym:,antibody-drug conjugate AVID100
2020-09-18T06:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792640,Synonym:,18F-Al-NOTA-MATBBN
2020-09-18T05:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792646,Code name:,LY-3143921 hydrate
2020-09-18T05:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792646,Code name:,LY3143921 hydrate
2020-09-18T09:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792648,Code name:,IT-141
2020-09-18T09:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792648,Code name:,IT141
2020-09-18T09:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792648,Synonym:,nanoparticle SN-38 formulation IT141
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ B3139
2020-09-18T01:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652,Code name:,TQ-B3139
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Code name:,AZD 4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Code name:,AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,ASO AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,cEt KRAS ASO AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,generation 2.5 drug AZD4785
2020-09-18T05:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660,Synonym:,IONIS-KRAS-2.5Rx
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD 4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD-4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Code name:,AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11-beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11b-HSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11bHSD1 inhibitor AZD4017
2020-09-18T01:10:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667,Synonym:,11β-HSD1 inhibitor AZD4017
2020-09-18T06:33:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792670,Synonym:,EPS8 peptide-specific DCs
2020-09-18T12:25:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792678,Code name:,DFD-07
2020-09-18T12:25:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792678,Code name:,DFD07
2020-09-18T12:25:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792678,Synonym:,celecoxib cream
2020-09-18T12:25:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792678,Synonym:,celecoxib topical
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY 1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY-1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Code name:,BAY1161116
2020-09-18T02:05:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679,Synonym:,AR antagonist BAY 1161116
2020-09-18T02:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792680,NA,NA
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Code name:,PAN 301-1
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Code name:,PAN-301-1
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Code name:,SNS 301
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Code name:,SNS-301
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Code name:,SNS301
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Synonym:,bacteriophage cancer vaccine SNS-301
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Synonym:,HAAH-1/2/3 lambda phage vaccine SNS-301
2020-09-18T07:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681,Synonym:,nanoparticle HAAH vaccine SNS-301
2020-09-18T08:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683,Synonym:,PEG-based hydrogel tissue marker
2020-09-18T08:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683,Synonym:,radiopaque polymer hydrogel imaging agent
2020-09-18T08:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683,US brand name:,TraceIT
2020-09-18T08:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683,US brand name:,TraceIT Hydrogel
2020-09-18T08:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683,US brand name:,TraceIT Tissue Marker
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Code name:,4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4S-CD38-CAR-T cell
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,4SCAR38 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38 CAR-T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,anti-CD38-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR38
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-4SCAR-expressing T lymphocytes
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684,Synonym:,CD38-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Code name:,4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4S-CD22-CAR-T cell
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,4SCAR22 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22 CAR-T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,anti-CD22-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR22
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-4SCAR-expressing T lymphocytes
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685,Synonym:,CD22-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Code name:,4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4S-CD20-CAR-T cell
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,4SCAR20 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20 CAR-T cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,anti-CD20-CD28-CD137-CD27-CD3z-iCasp9 CAR T-cells 4SCAR20
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-4SCAR-expressing T lymphocytes
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686,Synonym:,CD20-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Code name:,4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4S-CD123-CAR-T cell
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,4SCAR123 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123 CAR-T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,anti-CD123-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR123
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-4SCAR-expressing T lymphocytes
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-09-18T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687,Synonym:,CD123-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T09:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792688,Code name:,LXI-15029
2020-09-18T09:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792688,Code name:,LXI15029
2020-09-18T09:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792688,Code name:,SCC-31
2020-09-18T09:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792698,Code name:,CT-053-PTSA
2020-09-18T09:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792698,Code name:,CT053PTSA
2020-09-18T09:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792698,Synonym:,CT-053 tosylate
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous anti-CD33 CAR-T cells
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous anti-CD33 chimeric antigen receptor T cells
2020-09-18T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699,Synonym:,autologous CD33-CAR-T cells
2020-09-18T10:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792706,Code name:,HMPL 689
2020-09-18T10:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792706,Code name:,HMPL-689
2020-09-18T10:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792706,Code name:,HMPL689
2020-09-18T10:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792706,Synonym:,PI3K-d inhibitor HMPL 689
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB 1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB-1003
2020-09-18T01:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707,Code name:,PLB1003
2020-09-18T10:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792708,Code name:,YS ON 001
2020-09-18T10:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792708,Code name:,YS-ON-001
2020-09-18T10:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792708,Synonym:,poly IC/inactivated RV-V YS-ON-001
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,HTI-1088
2020-09-18T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709,Code name:,SHR-1316
2020-09-18T05:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710,Code name:,S-16257
2020-09-18T05:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710,US brand name:,Corlanor
2020-09-18T11:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792711,Code name:,PCUR 101
2020-09-18T11:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792711,Code name:,PCUR-101
2020-09-18T11:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792711,Code name:,PCUR101
2020-09-18T09:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792712,Code name:,JNJ-38877618
2020-09-18T09:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792712,Code name:,OMO-1
2020-09-18T09:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792712,Code name:,OMO1
2020-09-18T11:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792713,Code name:,ABX-1431
2020-09-18T11:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792713,Synonym:,MGLL inhibitor ABX-1431
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Code name:,"SFVeE6,7"
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Code name:,Vvax-001
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Code name:,Vvax001
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Synonym:,HPV E6/7 Semliki Forest virus based cancer vaccine
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Synonym:,"rSFVeE6,7"
2020-09-18T07:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714,Synonym:,Vvax001 therapeutic cancer vaccine
2020-09-18T12:33:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792732,Synonym:,triclosan/copolymer/fluoride dentifrice
2020-09-18T08:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792733,Foreign brand name:,Rozana
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,anti-CD3/MUC1-armed PD-1 inhibitor-induced CIK cells
2020-09-18T02:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734,Synonym:,PD-1 activated CIK armed with anti-CD3/Anti-MUC1 bispecific antibody
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Chemical structure:,Gln-Arg-His-Lys-Pro-Arg-Glu-Gly-Gly-Gly-Ser-Lys(Cy5)-NH2
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Code name:,QRH-882260
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Synonym:,fluorescence peptide QRH-882260
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Synonym:,fluorescently-labeled peptide QRH-882260
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Synonym:,QRH-882260 Cy-5-labeled heptapeptide
2020-09-18T07:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736,Synonym:,QRHKPRE-GGGSK-(Cy5)-NH2
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Code name:,A-101
2020-09-18T01:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737,Synonym:,A-101 solution
2020-09-18T08:38:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792738,Chemical structure:,N26-(hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
2020-09-18T08:38:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792738,Code name:,NN2211
2020-09-18T08:38:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792738,US brand name:,Victoza
2020-09-18T08:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792743,Code name:,LIK 066
2020-09-18T08:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792743,Code name:,LIK-066
2020-09-18T08:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792743,Code name:,LIK066
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Code name:,BMS-986310
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Code name:,ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,PGE2 receptor antagonist ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,prostaglandin E2 receptor antagonist ONO-4578
2020-09-18T06:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745,Synonym:,selective PGE2 receptor 4 antagonist ONO-4578
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Code name:,TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,anti-CD19-CAR T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,autologous anti-CD19 chimeric antigen receptor T cells TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CAR19 T lymphocytes TBI-1501
2020-09-18T04:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746,Synonym:,CD19-CAR-T TBI-1501
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD 19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Code name:,BinD19
2020-09-18T04:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748,Synonym:,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T cells BinD19
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Code name:,BI 754111
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti LAG-3 MoAb
2020-09-18T02:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749,Synonym:,anti-LAG-3 monoclonal antibody
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,C. albicans test antigen injection
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,Synonym:,Candida albicans skin test antigen
2020-09-18T04:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750,US brand name:,Candin
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,SAN 007
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,VIR 003
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Code name:,VIR 007
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Synonym:,EISO cream
2020-09-18T06:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786,Synonym:,Santalum album oil cream
2020-09-18T05:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792787,Synonym:,CMV/EBV/ADV/BKV-specific CTLs
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Code name:,CT041
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous anti-Claudin18.2 CAR-T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,autologous CAR-CLD18.2 T cells
2020-09-18T04:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788,Synonym:,Claudin18.2-redirected autologous T cells
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Code name:,HMPL 453
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Code name:,HMPL-453
2020-09-18T06:49:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789,Synonym:,FGFR inhibitor HMPL-453
2020-09-18T12:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793,Acronym:,VERB
2020-09-18T12:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793,Code name:,BTG-002814
2020-09-18T12:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793,Synonym:,vandetanib-eluting radiopaque embolic beads
2020-09-18T12:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793,Synonym:,VERB BTG-002814
2020-09-18T12:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793,Synonym:,VTB-loaded beads
2020-09-18T08:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792794,Code name:,KSP-910638G
2020-09-18T08:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792794,Synonym:,KSP heptapeptide
2020-09-18T08:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792794,Synonym:,KSP-910638G heptapeptide
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Chemical structure:,(2-(((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX 682
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX-682
2020-09-18T05:46:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795,Code name:,SX682
2020-09-18T07:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792847,Code name:,CNTO 1959
2020-09-18T07:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792847,US brand name:,Tremfya
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Abbreviation:,18F-αvβ6-BP
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Synonym:,18F-alphavbeta6-binding peptide
2020-09-18T06:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848,Synonym:,18F-aVb6-binding-peptide
2020-09-18T08:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792849,Code name:,NLG 802
2020-09-18T08:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792849,Code name:,NLG-802
2020-09-18T08:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792849,Code name:,NLG802
2020-09-18T08:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792849,Synonym:,IDO1 inhibitor NLG802
2020-09-18T07:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792850,Synonym:,68Ga-NOTA-RM26
2020-09-18T07:48:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792851,Synonym:,hydrocortisone sodium succinate mixed with aluminum phosphate gel
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Code name:,V3 P
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Code name:,V3-P
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Code name:,V3P
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Synonym:,cancer vaccine V3-P
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Synonym:,oral tableted therapeutic vaccine V3-P
2020-09-18T09:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852,Synonym:,V3-P cancer vaccine
2020-09-18T11:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862,Code name:,CV 8102
2020-09-18T11:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862,Code name:,CV-8102
2020-09-18T11:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862,Code name:,CV8102
2020-09-18T11:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862,Synonym:,RNA-based adjuvant CV8102
2020-09-18T11:19:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862,US brand name:,RNAdjuvant
2020-09-18T08:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792864,Synonym:,L. rhamnosus and L. reuteri probiotic supplement
2020-09-18T08:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792864,US brand name:,RepHresh Pro-B
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Foreign brand name:,Forfivo XL
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl controlled-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion HCl extended release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,Synonym:,bupropion hydrochloride extended-release
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Aplenzin
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin SR
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Wellbutrin XL
2020-09-18T03:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878,US brand name:,Zyban
2020-09-18T11:39:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793013,Code name:,BI 891065
2020-09-18T08:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793029,NA,NA
2020-09-18T10:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793030,Chemical structure:,"3',4',5,7-tetrahydroxyflavone-encapsulated polymer nanoparticles"
2020-09-18T10:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793030,Synonym:,nano-luteolin
2020-09-18T10:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793030,Synonym:,nanoluteolin
2020-09-18T10:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793030,Synonym:,nanoparticle-based luteolin
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO 2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,AUTO2
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Code name:,SUB-96123
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells (AUTO2) targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,APRIL CAR T cells targeting BCMA and TACI
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous APRIL CAR T cells
2020-09-18T04:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032,Synonym:,autologous CAR T product AUTO2
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,allogeneic NY-ESO-1-c259 T cells
2020-09-18T01:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046,Synonym:,NY-ESO-1 c259 T cells
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Code name:,ETBX-021
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,"Ad5 [E1-, E2b-]-HER2/neu vaccine"
2020-09-18T01:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072,Synonym:,adenovirus type 5 E1/E2b-deleted HER2/neu vaccine ETBX-021
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,anti-PD-1/PD-L1-antibodies-expressing
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous anti-PD-1/anti-PD-L1 antibodies-expressing anti-EGFRvIII CAR T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous EGFRvIII-4SCAR-IgT
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,autologous GBM-specific CAR-T cells
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,EGFRvIII-4SCAR-IgT cells-producing PD1 and PD-L1 antibodies
2020-09-18T04:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086,Synonym:,PD-1/PD-L1 antibody-producing T cells (IgT)
2020-09-18T05:33:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793087,Code name:,CBT-101
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8-positive T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous HCC antigens-specific CD8+ T lymphocytes
2020-09-18T04:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088,Synonym:,autologous specific HCC antigens CD8+ T cells
2020-09-18T02:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793089,Code name:,YS110
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK 1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK-1308
2020-09-18T02:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094,Code name:,MK1308
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Code name:,SHR 7390
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Code name:,SHR-7390
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Code name:,SHR7390
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Synonym:,MAP2K inhibitor SHR 7390
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Synonym:,MAPK kinase inhibitor SHR 7390
2020-09-18T09:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097,Synonym:,MEKi SHR 7390
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing meso-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous anti-CTLA-4/PD-1 antibodies-expressing mesothelin-targeted CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing mesothelin-CAR-T cells
2020-09-18T04:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113,Synonym:,autologous CTLA4/PD-1-targeting antibodies-expressing mesothelin-CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-CTLA-4/PD-1-expressing EGFR-CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous anti-PD-1/CTLA4-targeting antibodies-expressing EGFR-specific CAR-T cells
2020-09-18T04:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing EGFR-CAR-T cells
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,autologous human OC-IgT cells
2020-09-18T04:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116,Synonym:,OC-IgT cells
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DC vaccine
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-DCs
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,autologous TSA-loaded dendritic cells
2020-09-18T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117,Synonym:,tumor specific antigen-loaded autologous dendritic cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Abbreviation:,4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous 4S-FRa-CAR-T cells
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,autologous anti-FRa-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,chimeric antigen receptor T cells 4SCAR-FRa
2020-09-18T04:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118,Synonym:,FRa-specific 4th generation CART cells
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous 4S-PSMA-CAR-T cells
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,autologous anti-PSMA-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,chimeric antigen receptor T cells 4SCAR-PSMA
2020-09-18T04:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119,Synonym:,PSMA-specific 4th generation CART cells
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Abbreviation:,CAMB
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Code name:,MAT2203
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,cochleate lipid-crystal nano-particles-containing amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,cochleate-amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,lipid-crystal nano-particle formulation of amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,lipid-crystal nanoparticle-based amphotericin B formulation
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,nano-cochleated-particles containing amphotericin B
2020-09-18T06:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120,Synonym:,oral encochleated amphotericin B
2020-09-18T05:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793122,Abbreviation:,CB
2020-09-18T05:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793122,Chemical structure:,"14,15b-epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate5b,20(22)-bufadienolide-14,15b-epoxy-3b,5a,16b-triol 16-acetate5-beta-bufa-20,22-dienolide, 14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-, 16-acetate"
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BJD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BJHD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,BSJPD
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Abbreviation:,JPBS
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Synonym:,Jianpi Bushen
2020-09-18T04:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123,Synonym:,Jianpi-Bushen decoction
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3 zumab
2020-09-18T03:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124,Synonym:,PRL3-zumab
2020-09-18T11:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793126,Code name:,C188-9
2020-09-18T11:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793126,Synonym:,STAT3 inhibitor XIII
2020-09-18T09:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793127,Synonym:,T 1101 tosylate
2020-09-18T09:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793127,Synonym:,T1101 tosylate
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,anti-CD19/CD20/CD22/CD30 chimeric antigen receptor-T cells
2020-09-18T02:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132,Synonym:,CAR-T CD19/CD20/CD22/CD30
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous anti-HPV-16 E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous E6 TCR T cells
2020-09-18T04:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136,Synonym:,autologous HPV-16 E6 TCR T cells
2020-09-18T11:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793139,Code name:,RV 001
2020-09-18T11:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793139,Code name:,RV 001V
2020-09-18T11:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793139,Code name:,RV001V
2020-09-18T11:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793139,Synonym:,RV001 vaccine
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Code name:,IC 2000
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Code name:,IC2000
2020-09-18T07:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140,Synonym:,IC2000 fluorescence imaging agent
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Chemical structure:,3-(4-fluorophenyl)-2-(4-hydroxyphenoxy)benzo[b]thiophen-6-ol
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Code name:,TTC 352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Code name:,TTC-352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Synonym:,ERa partial agonist TTC-352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Synonym:,selective estrogen mimic TTC-352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Synonym:,selective estrogen modulator TTC-352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Synonym:,SEM TTC-352
2020-09-18T11:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141,Synonym:,ShERPA TTC-352
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI-1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,ABI1968
2020-09-18T01:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142,Code name:,HTI 1968
2020-09-18T12:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793143,Code name:,IMA970A
2020-09-18T12:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793143,Synonym:,HCC vaccine IMA970A
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Chemical structure:,"(R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one"
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Code name:,AZD 5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Code name:,AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,BET inhibitor AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,bivalent BET bromodomain inhibitor AZD5153
2020-09-18T04:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144,Synonym:,BRD4/BET bromodomain antagonist AZD5153
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Code name:,NIR 178
2020-09-18T01:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151,Synonym:,A2AR antagonist NIR178
2020-09-18T04:22:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793152,Synonym:,autologous iPD1 CD19 eCAR T cells
2020-09-18T07:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793153,Code name:,HTI-1090
2020-09-18T07:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793153,Code name:,SHR9146
2020-09-18T07:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793153,Synonym:,HTI 1090
2020-09-18T12:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793156,Code name:,AM-001
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK 301
2020-09-18T03:45:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157,Code name:,CK-301
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Code name:,161533
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Synonym:,CD16/IL-15/CD33 161533 tri-specific killer engagers
2020-09-18T05:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158,Synonym:,CD16/IL15/CD33 TriKE
2020-09-18T11:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793169,Chemical structure:,"1H-pyrrole-3-methanamine, 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1)"
2020-09-18T11:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793169,Code name:,TAK-438
2020-09-18T11:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793169,US brand name:,Takecab
2020-09-18T04:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793170,Code name:,CC 90010
2020-09-18T04:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793170,Code name:,CC-90010
2020-09-18T07:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793171,Code name:,CHO H01
2020-09-18T07:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793171,Code name:,CHO-H01
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Code name:,PEN 866
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Code name:,PEN-866
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Code name:,PEN866
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Code name:,STA-12-8666
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Code name:,STA-8666
2020-09-18T07:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183,Synonym:,HDC SN-38
2020-09-18T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793184,Synonym:,autologous Muc1/CD33/CD38/CD56/CD123-specific gene-engineered CAR-T cells
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,AJT-240
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,SK 1403
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Code name:,SK1403
2020-09-18T04:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192,Synonym:,CaSR agonist SK 1403
2020-09-18T07:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793193,Code name:,T27
2020-09-18T07:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793193,Synonym:,HPV16-targeting TALEN T27
2020-09-18T07:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793194,Code name:,T512
2020-09-18T07:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793194,Synonym:,HPV16-targeting TALEN T512
2020-09-18T05:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793386,Synonym:,[64Cu]-DOTA-alendronate
2020-09-18T05:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793386,Synonym:,64Cu-DOTA-alendronate
2020-09-18T08:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793409,Synonym:,177Lu-PSMA-R2
2020-09-18T08:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793409,Synonym:,177LuPSMA-R2
2020-09-18T08:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793409,Synonym:,Lu177-PSMA-R2
2020-09-18T08:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793409,Synonym:,lutetium-177 PSMA-R2
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb 20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Code name:,XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,anti-PD-1/anti-CTLA-4 XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 bispecific antibody XmAb20717
2020-09-18T03:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor XmAb20717
2020-09-18T10:23:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793411,Synonym:,TSMA-based SLP vaccine
2020-09-18T10:23:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793411,Synonym:,TSMA-based synthetic long peptide vaccine
2020-09-18T10:23:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793411,Synonym:,tumor specific mutant antigen-based synthetic long peptide vaccine
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,allogeneic CB-derived ex vivo-expanded NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,CB-derived expanded allogeneic NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,UCB-derived expanded allogeneic NK cells
2020-09-18T05:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416,Synonym:,umbilical cord blood-derived expanded allogeneic natural killer cells
2020-09-18T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425,US brand name:,Doptelet
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus Specific CTLs
2020-09-18T01:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439,Synonym:,most closely HLA-matched third-party donor adenovirus-specific T cells
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX 1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Code name:,CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,agonist CD40 antibody CDX-1140
2020-09-18T02:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440,Synonym:,anti-CD40 agonistic monoclonal antibody CDX-1140
2020-09-18T11:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793441,Code name:,G1T48
2020-09-18T11:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793441,Synonym:,selective estrogen receptor downregulator G1T48
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym 023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym-023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Code name:,Sym023
2020-09-18T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443,Synonym:,anti-TIM3 monoclonal antibody Sym023
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Chemical structure:,"N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide"
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,CEP 40783
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,CEP-40783
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,CEP40783
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,RXDX 106
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,RXDX-106
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Code name:,RXDX106
2020-09-18T12:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447,Synonym:,TYRO3/AXL/MER/c-Met inhibitor RXDX-106
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG 119
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG-119
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Code name:,AMG119
2020-09-18T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448,Synonym:,AMG 119 CAR-T cells
2020-09-18T12:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793449,Abbreviation:,TetMYB
2020-09-18T12:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793449,Synonym:,DNA vaccine TetMYB
2020-09-18T12:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793449,Synonym:,DNA-based TetMYB vaccine
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM 009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Code name:,LZM-009
2020-09-18T03:44:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463,Synonym:,LZM009
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL 813
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL-813
2020-09-18T06:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471,Code name:,HMPL813
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV 321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Code name:,ABBV321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,ADC ABBV-321
2020-09-18T02:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472,Synonym:,anti-EGFR/PBD ADC ABBV-321
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,Synonym:,carbidopa levodopa
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,Synonym:,carbidopa-levodopa
2020-09-18T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473,US brand name:,Sinemet
2020-09-18T11:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793484,Code name:,SAR 439859
2020-09-18T11:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793484,Code name:,SAR-439859
2020-09-18T11:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793484,Synonym:,selective estrogen receptor degrader SAR439859
2020-09-18T11:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793484,Synonym:,selective estrogen receptor downregulator SAR439859
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Code name:,FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 bispecific antibody FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,LAG-3/PD-L1 Mab2 FS118
2020-09-18T02:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522,Synonym:,Mab2 FS118
2020-09-18T11:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524,Code name:,TTI 622
2020-09-18T11:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524,Code name:,TTI-622
2020-09-18T11:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524,Code name:,TTI622
2020-09-18T11:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524,Synonym:,SIRPa-IgG4 Fc
2020-09-18T11:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524,Synonym:,SIRPa-IgG4 Fc TTI-622
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-09-18T04:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525,Synonym:,autologous CD3zeta-4-1BB-expressing CART-19 cells
2020-09-18T10:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793526,Code name:,MTX 110
2020-09-18T10:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793526,Code name:,MTX-110
2020-09-18T10:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793526,Code name:,MTX110
2020-09-18T06:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527,Synonym:,Venlafaxine HCl ER
2020-09-18T06:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527,US brand name:,Effexor XR
2020-09-18T07:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793540,Code name:,TAR 200
2020-09-18T07:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793540,Code name:,TAR-200
2020-09-18T07:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793540,US brand name:,GemRIS
2020-09-18T11:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793552,Code name:,ISA 101b
2020-09-18T11:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793552,Code name:,ISA-101b
2020-09-18T11:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793552,Code name:,ISA101b
2020-09-18T11:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793552,Synonym:,HPV16 E6/E7-SLP ISA101b
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-EGFRt T cells
2020-09-18T04:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561,Synonym:,CD19-CD8CD28zCAR-specific-mbIL15-HER1t T lymphocytes
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX 2843
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX-2843
2020-09-18T06:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562,Code name:,MRX2843
2020-09-18T05:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793585,Synonym:,CD137L-DC-EBV-VAX
2020-09-18T05:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793585,Synonym:,CD137L/Epstein-Barr virus-targeting autologous DC vaccine
2020-09-18T07:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586,Code name:,ALT-P7
2020-09-18T07:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586,Code name:,HER2ALT-P7
2020-09-18T07:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586,Synonym:,ADC ALT-P7
2020-09-18T07:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586,Synonym:,HM2-MMAE
2020-09-18T07:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586,Synonym:,HM2/MMAE ADC ALT-P7
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Code name:,PZ01
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous CD19-specific CAR-T cells PZ01
2020-09-18T04:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588,Synonym:,autologous PZ01 CAR-T cells
2020-09-18T08:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793591,Code name:,BI 1356 BS
2020-09-18T08:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793591,Code name:,BI-1356
2020-09-18T08:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793591,US brand name:,Tradjenta
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Chemical structure:,"benzeneacetic acid, 4-((3S)-3-(((1R)-1-(1-naphthalenyl)ethyl)amino)-1-pyrrolidinyl)-"
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Code name:,KHK7580
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Code name:,MT-4580
2020-09-18T06:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594,Foreign brand name:,Orkedia
2020-09-18T03:57:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793609,US brand name:,R-Gene 10
2020-09-18T12:34:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793610,US brand name:,Vastarel MR
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated T lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated TIL
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CISH-inactivated tumor-infiltrating lymphocytes
2020-09-18T04:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668,Synonym:,autologous CRISPR/Cas 9-CISH knockout TILs
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,GX-I7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,NT-I7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ 107
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ-107
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Code name:,TJ107
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,Hyleukin-7
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,Il-7 hybrid Fc
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,IL-7-hyFc
2020-09-18T06:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669,Synonym:,rhIL-7-hyFc
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Code name:,PF 06873600
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Code name:,PF-06873600
2020-09-18T05:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673,Synonym:,CDK inhibitor PF-06873600
2020-09-18T08:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793674,Synonym:,111In-HuJ591
2020-09-18T08:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793674,Synonym:,111In-J591
2020-09-18T08:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793674,Synonym:,In111-J591
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Code name:,MDR 101
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Code name:,MDR-101
2020-09-18T06:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675,Synonym:,donor-derived CD34+ HPCs/CD3+ T cells MDR-101
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Abbreviation:,225Ac-J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 MOAB J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,Ac 225 monoclonal antibody J591
2020-09-18T01:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676,Synonym:,actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591
2020-09-18T09:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793677,NA,NA
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF 1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Code name:,PBF1129
2020-09-18T01:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680,Synonym:,A2BR Antagonist PBF-1129
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS 1062a
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Code name:,DS-1062
2020-09-18T03:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720,Synonym:,ADC DS-1062a
2020-09-18T11:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793774,Code name:,DSP 0337
2020-09-18T11:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793774,Code name:,DSP-0337
2020-09-18T11:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793774,Synonym:,cancer stemness inhibitor DSP-0337
2020-09-18T11:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793774,Synonym:,napabucasin prodrug DSP-0337
2020-09-18T10:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779,Code name:,IM 156
2020-09-18T10:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779,Code name:,IM-156
2020-09-18T10:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779,Code name:,IM156
2020-09-18T10:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779,Synonym:,mitochondrial oxidative phosphorylation inhibitor IM156
2020-09-18T10:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779,Synonym:,OxPhos inhibitor IM156
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Chemical structure:,"butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-"
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,ABT-620
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,NBI 56418
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,Code name:,NBI-56418
2020-09-18T06:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786,US brand name:,Orilissa
2020-09-18T09:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793840,Code name:,1024 DS
2020-09-18T09:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793840,Code name:,1024-DS
2020-09-18T09:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793840,Synonym:,zatuximab
2020-09-18T07:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842,Code name:,IMX 101
2020-09-18T07:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842,Code name:,IMX-101
2020-09-18T07:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842,Code name:,IMX101
2020-09-18T07:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842,Synonym:,H. pylori therapeutic vaccine IMX101
2020-09-18T07:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842,Synonym:,IMX101 vaccine
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Chemical structure:,"2-hydroxy-6-((2-(1-(propan-2-yl)-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydebenzaldehyde, 2-hydroxy-6-((2-(1-(1-methylethyl)-1H-pyrazol-5-yl)-3-pyridinyl)methoxy)-"
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Code name:,GBT 440
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Code name:,GBT-440
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Code name:,GBT440
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Code name:,GTx 011
2020-09-18T12:59:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847,Code name:,GTx-011
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Chemical structure:,"immunoglobulin G1, anti-(human epidermal growth factor receptor extracellular domain III) (human-Mus musculus monoclonal 992 DS heavy chain), disulfide with human-Mus musculus monoclonal 992 DS light chain, dimer"
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992 DS
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992-DS
2020-09-18T07:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850,Code name:,992DS
2020-09-18T07:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793859,Code name:,LAM 003
2020-09-18T07:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793859,Code name:,LAM-003
2020-09-18T07:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793859,Code name:,LAM003
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS 1205c
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS-1205c
2020-09-18T04:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863,Code name:,DS1205c
2020-09-18T11:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793864,Synonym:,related donor Ad-specific CTLs
2020-09-18T09:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793891,Code name:,CAN 04
2020-09-18T09:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793891,Code name:,CAN-04
2020-09-18T09:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793891,Code name:,CAN04
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP-2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,ASP2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL 2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL-2397
2020-09-18T02:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892,Code name:,VL2397
2020-09-18T11:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793893,Synonym:,autologous CD8+ SLC45A2-specific T lymphocytes
2020-09-18T11:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793893,Synonym:,autologous SLC45A2-specific CTLs
2020-09-18T11:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793893,Synonym:,autologous SLC45A2-specific cytotoxic T lymphocytes
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Code name:,SEA-BCMA
2020-09-18T02:11:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894,Synonym:,Anti-BCMA Afucosylated Monoclonal Antibody SEA-BCMA
2020-09-18T08:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793899,NA,NA
2020-09-18T08:41:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793901,Code name:,ADXS NEO
2020-09-18T08:41:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793901,Code name:,ADXS-NEO
2020-09-18T08:41:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793901,Synonym:,neoepitope-based Immunotherapeutic ADXS-NEO
2020-09-18T05:10:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793902,Code name:,E 7386
2020-09-18T05:10:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793902,Code name:,E7386
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD 4573
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD-4573
2020-09-18T05:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903,Code name:,AZD4573
2020-09-18T07:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914,Synonym:,ledipasvir and sofosbuvir
2020-09-18T07:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914,Synonym:,ledipasvir-sofosbuvir
2020-09-18T07:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914,Synonym:,ledipasvir/sofosbuvir
2020-09-18T07:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914,Synonym:,ledipasvir/sofosbuvir tablet
2020-09-18T07:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914,US brand name:,Harvoni
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK 104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK-104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Code name:,AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD-1 x CTLA-4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,anti-PD1/anti-CTLA4 bispecific antibody AK104
2020-09-18T03:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor AK104
2020-09-18T09:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793931,Synonym:,milled flax/sesame/pumpkin seed mix
2020-09-18T09:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793931,Synonym:,milled mix of flax/sesame/pumpkin seeds in sour milk
2020-09-18T09:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793931,Synonym:,milled sesame/pumpkin/flax seed mixture
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS 006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS-006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Code name:,CLS006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Synonym:,furosemide topical gel CLS 006
2020-09-18T07:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933,Synonym:,furosemide topical gel CLS-006
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized GCB
2020-09-18T01:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934,Synonym:,aerosolized gemcitabine
2020-09-18T02:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793935,NA,NA
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Code name:,IMCnyeso
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,bispecific NY-ESO-1- and LAGE-1A-specific TCR/anti-CD3
2020-09-18T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936,Synonym:,HLA- A*0201-restricted NY-ESO-1- and LAGE-1A-specific soluble TCR/anti-CD3 bispecific molecule
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN 4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN-4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Code name:,REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16/CD3-directed bispecific T-cell engager antibody REGN4018
2020-09-18T02:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937,Synonym:,MUC16xCD3 bispecific T-cell engager REGN4018
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB 081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB 81776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB-081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB-81776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB081776
2020-09-18T04:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938,Code name:,INCB81776
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK 6072
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK-6072
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,Code name:,MK6072
2020-09-18T04:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939,US brand name:,Zinplava
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM 076
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM-076
2020-09-18T05:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940,Code name:,QBM076
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY 2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY-2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Code name:,BAY2402234
2020-09-18T06:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941,Synonym:,DHODH inhibitor BAY2402234
2020-09-18T10:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943,Abbreviation:,rATG
2020-09-18T10:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943,Synonym:,anti-thymocyte globulin rabbit
2020-09-18T10:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943,Synonym:,rabbit antithymocyte globulin
2020-09-18T10:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943,Synonym:,rabbit ATG
2020-09-18T10:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943,Synonym:,thymoglobulin
2020-09-18T11:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944,Code name:,IW 1701
2020-09-18T11:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944,Code name:,IW-1701
2020-09-18T11:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944,Code name:,IW1701
2020-09-18T11:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944,Synonym:,sGC stimulator IW-1701
2020-09-18T11:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944,Synonym:,stimulator of soluble guanylate cyclase IW-1701
2020-09-18T12:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793945,Code name:,VMD 928
2020-09-18T12:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793945,Code name:,VMD-928
2020-09-18T12:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793945,Code name:,VMD928
2020-09-18T12:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793945,Synonym:,NTRK1 inhibitor VMD-928
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZN e4
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZN-e4
2020-09-18T06:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946,Code name:,ZNe4
2020-09-18T08:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793947,Code name:,AG 270
2020-09-18T08:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793947,Code name:,AG-270
2020-09-18T08:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793947,Code name:,AG270
2020-09-18T08:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793948,NA,NA
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BEL X HG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BEL-X-HG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Code name:,BELXHG
2020-09-18T04:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949,Synonym:,botanical agent BEL X HG
2020-09-18T12:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793955,Synonym:,glycerol tricaprin
2020-09-18T12:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793955,Synonym:,glycerol tridecanoate
2020-09-18T12:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793955,Synonym:,tricapric glyceride
2020-09-18T12:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793955,Synonym:,tridecanoin
2020-09-18T11:30:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793979,Code name:,H3B 6545
2020-09-18T11:30:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793979,Code name:,H3B-6545
2020-09-18T11:30:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793979,Synonym:,SERCA H3B-6545
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Code name:,NPt
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Code name:,NPt-Ca
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,NPt nanomaterial
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,NPt nanoparticles
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,platinum acetylacetonate nanomaterial
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,platinum-titania nanoparticles
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,Pt(acac)2/F-TiO2
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,Pt(acac)2/F-TiO2 nanoparticles
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,Pt(acac)2/titanium dioxide
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,sol-gel NPt nanomaterial
2020-09-18T10:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980,Synonym:,sol-gel NPt nanoparticles
2020-09-18T07:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007,Chemical structure:,1-methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide
2020-09-18T07:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007,US brand name:,Sancuso
2020-09-18T07:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007,US brand name:,Sustol
2020-09-18T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014,Code name:,SUN 131
2020-09-18T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014,Code name:,SUN-131
2020-09-18T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014,Code name:,SUN131
2020-09-18T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014,Synonym:,SUN-131 TDS
2020-09-18T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014,Synonym:,triamcinolone acetonide transdermal patch SUN-131
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA 128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA-128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Code name:,MCLA128
2020-09-18T02:38:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043,Synonym:,anti-HER2 x anti-HER3 bispecific monoclonal antibody MCLA-128
2020-09-18T08:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794044,US brand name:,Optiray
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Abbreviation:,CPHPC
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Chemical structure:,(2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Code name:,CPHPC
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Code name:,GSK 2315698
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Code name:,GSK-2315698
2020-09-18T09:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046,Code name:,GSK2315698
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK 2398852
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK-2398852
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Code name:,GSK2398852
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Synonym:,anti-SAP mAb
2020-09-18T06:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047,Synonym:,anti-SAP monoclonal antibody
2020-09-18T09:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794048,Synonym:,KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes
2020-09-18T09:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794048,Synonym:,MSC-derived exosomes with KrasG12D siRNA
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG-562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Code name:,AMG562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,BiTE antibody AMG 562
2020-09-18T02:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049,Synonym:,CD19/CD3-directed bispecific T-cell engager antibody AMG 562
2020-09-18T06:42:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051,Synonym:,oxycodone ER microsphere capsule
2020-09-18T06:42:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051,US brand name:,Xtampza ER
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA 202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA-202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Code name:,IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,ACTengine IMA202
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T cells
2020-09-18T04:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052,Synonym:,IMA202 T-cell product
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Code name:,GEN 1029
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Code name:,GEN1029
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,HexaBody-DR5-01/DR5-05
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,HexaBody-DR5/DR5
2020-09-18T06:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053,Synonym:,Hx-DR5-01/05
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC 1907206
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC 206
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC-1907206
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC-206
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC1907206
2020-09-18T09:13:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054,Code name:,ETC206
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI 888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI-888
2020-09-18T02:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060,Code name:,OBI888
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR 112
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR-112
2020-09-18T06:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067,Code name:,DBPR112
2020-09-18T08:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794068,Code name:,PPF11
2020-09-18T08:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794068,Synonym:,111-indium CP04
2020-09-18T08:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794068,Synonym:,111In-CP04
2020-09-18T08:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794068,Synonym:,indium In 111 CP04
2020-09-18T05:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794070,Foreign brand name:,Gelaspan
2020-09-18T05:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794070,Synonym:,colloidal succinylated gelatine plasma substitute
2020-09-18T11:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071,Code name:,CORT 125281
2020-09-18T11:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071,Code name:,CORT-125281
2020-09-18T11:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071,Code name:,CORT125281
2020-09-18T11:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071,Synonym:,glucocorticoid receptor antagonist CORT125281
2020-09-18T11:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071,Synonym:,selective GR antagonist CORT125134
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Code name:,MDA-TILs
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous TILs
2020-09-18T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072,Synonym:,MDA autologous tumor-infiltrating lymphocytes
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX 2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Code name:,CX2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,anti-CD71 Probody/vcMMAE drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,antibody prodrug-drug conjugate CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,CD71-directed probody therapeutic CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC CX-2029
2020-09-18T02:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073,Synonym:,PDC-targeting CD71 CX-2029
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,eATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Abbreviation:,hATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,anti-thymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,antithymocyte globulin equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,ATG equine
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,equine ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,horse ATG
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,Synonym:,"lymphocyte immune globulin, anti-thymocyte globulin equine"
2020-09-18T04:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074,US brand name:,Atgam
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Abbreviation:,R-IVAC
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Abbreviation:,RIVAC
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Synonym:,R-IVAC regimen
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Synonym:,rituximab + ifosfamide + cytarabine + etoposide
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Synonym:,rituximab-ifosfamide-cytarabine-etoposide
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Synonym:,rituximab/ifosfamide/cytarabine/etoposide
2020-09-18T11:19:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075,Synonym:,rituximab/ifosphamide/VP-16/ARA-C
2020-09-18T12:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794076,Code name:,DSP 0509
2020-09-18T12:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794076,Code name:,DSP-0509
2020-09-18T12:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794076,Code name:,DSP0509
2020-09-18T12:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794076,Synonym:,TLR7 agonist DSP-0509
2020-09-18T11:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078,Abbreviation:,fusion protein rHSA/GCSF
2020-09-18T11:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078,Abbreviation:,rHSA/G-CSF
2020-09-18T11:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078,Synonym:,human serum albumin GCSF
2020-09-18T11:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078,Synonym:,recombinant human serum albumin/granulocyte colony-stimulating factor fusion protein
2020-09-18T11:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078,Synonym:,rHSA/GCSF fusion protein
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX 6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX-6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,SNDX6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Code name:,UCB6352
2020-09-18T02:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081,Synonym:,anti-M-CSFR monoclonal antibody SNDX-6352
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,[18F]-azafol
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,3'-Aza-2'-[(18)F]fluorofolic acid
2020-09-18T06:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120,Synonym:,fluorine F 18 azafol
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,ammonia oxidizing bacteria-containing probiotic Mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AO bacteria-containing mist
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,AOB-based probiotic sprayt
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic solution
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,Synonym:,topical probiotic spray
2020-09-18T03:53:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123,US brand name:,AO+ Mist
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,BIW-8405
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,KHK-4563
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Code name:,MEDI-563
2020-09-18T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137,Synonym:,"anti-CD125 humanized monoclonal antibody, IgG1-kappa"
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV GBM 1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Code name:,AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous dendritic cells loaded with autologous tumor associated antigens
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,autologous TAAs-loaded autologous DCs AV-GBM-1
2020-09-18T04:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138,Synonym:,neoantigen-loaded autologous dendritic cells AV-GBM-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 TCR-expressing CRISPR-edited (TCR and PD-1) T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NY-ESO-1 transgenic TCR-expressing endogenous TCR-PD-1 gene-edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,autologous NYCE T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1 TCR-PD-1-CRISPR-gene-edited autologous T lymphocytes
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR-edited endogenous TCR and PD-1
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR edited T cells
2020-09-18T04:22:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140,Synonym:,NY-ESO-1-redirected CRISPR-TCRendo/PD1-edited T cells
2020-09-18T10:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794141,Chemical structure:,"3',5'-dimethoxy-4-stilbenol (SY); 3,5-dimethoxy-4'-hydroxystilbenephenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (E)-trans-3,5-dimethoxy-4-hydroxystilbene"
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,activated veto cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,activated veto T cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto CD8-positive T cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto cell
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto cells
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto-enhanced CTL
2020-09-18T05:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144,Synonym:,veto-enhanced cytotoxic T cell
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,GVAX allogeneic irradiated pancreatic tumor cell vaccine
2020-09-18T01:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145,Synonym:,irradiated allogeneic GM-CSF-secreting pancreatic tumor cell vaccine
2020-09-18T11:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794147,Code name:,RGX 202
2020-09-18T11:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794147,Code name:,RGX-202
2020-09-18T11:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794147,Code name:,RGX-202-01
2020-09-18T11:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794147,Code name:,RGX202
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,coffee bean extract
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,green coffee bean extract
2020-09-18T05:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158,Synonym:,green coffee beans extract
2020-09-18T09:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794159,Code name:,ECI 006
2020-09-18T09:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794159,Code name:,ECI-006
2020-09-18T09:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794159,Code name:,ECI006
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301 38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Code name:,CCT301-38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous anti-AXL CAR-T Cells CCT30138
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,autologous CAR-T cells targeting AXL CCT301-38
2020-09-18T04:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160,Synonym:,CCT30138 CAR-T cells
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301 59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Code name:,CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous anti-ROR2 CAR-T cells CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CAR-T cells targeting ROR2 CCT301-59
2020-09-18T04:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161,Synonym:,autologous CCT301-59 CAR-T cells
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI 1018
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI-1018
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Code name:,PolyPEPI1018
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Synonym:,PolyPEPI1018 CRC peptide vaccine
2020-09-18T05:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166,Synonym:,PolyPEPI1018 CRC vaccine
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,5-Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdC
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Abbreviation:,Aza-TdCyd
2020-09-18T01:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175,Chemical structure:,5-aza-4-thio-2-deoxycytidine
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Chemical structure:,"D-leucine, D-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-cysteinyl-L-alpha-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4->12),(7->15)-bis(disulfide)"
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP 333
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP-333
2020-09-18T06:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176,Code name:,SP333
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Abbreviation:,6MHP
2020-09-18T01:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177,Synonym:,6MHP vaccine
2020-09-18T08:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794178,Synonym:,magnesium-based BVF
2020-09-18T08:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794178,US brand name:,Osteocrete
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL 006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,FL006
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX 0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX-0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Code name:,WX0593
2020-09-18T01:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180,Synonym:,FL-006
2020-09-18T12:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794184,Synonym:,autologous Tcm cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous HER2(EQ)BBζ/CD19t+ Tcm cells
2020-09-18T04:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190,Synonym:,autologous memory enriched HER2(EQ)BBzeta/CD19t+-expressing T cells
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,allogeneic CARCIK-CD19 cells
2020-09-18T01:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267,Synonym:,transposon-manipulated allogeneic CARCIK-CD19 cells
2020-09-18T08:43:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794285,US brand name:,Lovaza
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI 7711
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI-7711
2020-09-18T06:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290,Code name:,BPI7711
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted PBSCs
2020-09-18T01:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297,Synonym:,allogeneic CD34+E- T-cell depleted peripheral blood stem cells
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Chemical structure:,"pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, 3,3'-(1,3-phenylenebis(sulfonyl))bis(N-(diphenylmethyl)decahydro-5-(((2S)-2-(methylamino)-1-oxopropyl)amino)-6-oxo-, (5S,5'S,8S,8'S,10aR,10'ar)-"
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Code name:,APG 1387
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Code name:,APG1387
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Code name:,SM-1387
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Synonym:,IAP antagonist APG-1387
2020-11-03T11:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301,Synonym:,SMAC mimetic APG-1387
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX 3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Code name:,TBX-3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous PBMCs TBX-3400
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,autologous TBX-4000-treated human PBMCs
2020-09-18T04:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318,Synonym:,TBX-3400 cells
2020-09-18T07:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794320,Abbreviation:,68Ga-Sgc8
2020-09-18T07:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794320,Synonym:,[68Ga]-Sgc8
2020-09-18T07:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794320,Synonym:,68Ga-labeled ssDNA aptamer Sgc8
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Abbreviation:,MMDT
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Synonym:,Bakumondo-to
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Synonym:,Maekgeuron granules
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Synonym:,Mai-men-dong-tang
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Synonym:,Ophiopogonis tuber/Pinelliae tuber/Glycyrrhizae radix/Zizyphi fructus/Ginseng radix/oryzae semen herbal formulation
2020-09-18T08:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323,Synonym:,TJ-29
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,anti-HER2-CAR-CD28zeta NK-92 cells
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,anti-HER2-CAR-engineered NK-92/5.28.z cells
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,HER2.taNK
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,HER2.taNK cells
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,NK-92/5.28.z
2020-09-18T07:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325,Synonym:,NK-92/5.28.z cells
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX 110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX-110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Code name:,IMX110
2020-09-18T05:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327,Synonym:,Stat3/NF-kB/poly-tyrosine kinase inhibitor/doxorubicin-encapsulating nanoparticle IMX-110
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,177 Lu-DOTA-EB-TATE
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,177Lu-DOTA-EB-TATE
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,177Lu-DOTA0-EB-Tyr3-octreotate
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,lutetium Lu 177 DOTA(0)-EB-Tyr(3)-octreotate
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,lutetium Lu 177-DOTA-EB-Tyr3-octreotate
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,"lutetium-177-1, 4, 7, 10-tetra-azacyclododecane-1, 4, 7, 10-tetraacetic acid-Evans blue-octreotate"
2020-09-18T08:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348,Synonym:,lutetium-177-DOTA-EB-TATE
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS 1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS-1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,CS1001
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP 3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WBP-3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Code name:,WPB3155
2020-09-18T03:46:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350,Synonym:,anti-PD-L1 monoclonal antibody WBP 3155
2020-09-18T07:18:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794351,NA,NA
2020-09-18T11:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794352,Code name:,GNS 561
2020-09-18T11:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794352,Code name:,GNS-561
2020-09-18T11:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794352,Code name:,GNS561
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,ADC SC-005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC 005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC-005
2020-09-18T02:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353,Code name:,SC005
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,IDX 1197
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,IDX-1197
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,IDX1197
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,NOV 1401
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,NOV-1401
2020-09-18T10:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354,Code name:,NOV1401
2020-09-18T10:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794356,Synonym:,PD-L2 peptide plus Montanide ISA-51 vaccine
2020-09-18T10:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794356,Synonym:,PD-L2 peptide plus Montanide vaccine
2020-09-18T10:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794356,Synonym:,programmed death ligand 2 peptide vaccine
2020-09-18T10:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794357,Synonym:,PD-L1/PD-L2 peptide plus Montanide ISA-51 vaccine
2020-09-18T10:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794357,Synonym:,PD-L1/PD-L2 peptide plus Montanide vaccine
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGN CD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Code name:,SGNCD48A
2020-09-18T02:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392,Synonym:,Anti-CD48 ADC SGN-CD48A
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET 190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Code name:,ET190L1
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM)
2020-09-18T04:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393,Synonym:,ET190L1-ARTEMIS (TM) T Cells
2020-09-18T09:34:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407,Code name:,HS 196
2020-09-18T09:34:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407,Code name:,HS-196
2020-09-18T09:34:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407,Code name:,HS196
2020-09-18T09:34:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407,Synonym:,HSP90 inhibitor-linked NIR probe HS-196
2020-09-18T09:34:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407,Synonym:,NIR-tethered Hsp90 inhibitor HS-196
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,[68Ga]-NeoB
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,68Ga-DOTA-NeoBOMB1
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,68Ga-NeoB
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,gallium Ga 68 NeoBOMB1
2020-09-18T07:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408,Synonym:,gallium-68 DOTA-NeoBOMB1
2020-09-18T07:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794409,Synonym:,68Ga-PSMA-R2
2020-09-18T07:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794409,Synonym:,68GaPSMA-R2
2020-09-18T07:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794409,Synonym:,gallium Ga 68 PSMA-R2
2020-09-18T07:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794409,Synonym:,gallium-68 PSMA-R2
2020-09-18T11:29:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794410,Code name:,SP 2577
2020-09-18T11:29:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794410,Code name:,SP-2577
2020-09-18T11:29:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794410,Code name:,SP2577
2020-09-18T11:29:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794410,Synonym:,LSD1 inhibitor SP-2577
2020-09-18T11:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794411,Code name:,AMG 510
2020-09-18T11:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794411,Code name:,AMG510
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB A333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGB-A333
2020-09-18T03:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412,Code name:,BGBA333
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Chemical structure:,"[(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid"
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,APX3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E 3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Code name:,E3330
2020-09-18T03:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415,Synonym:,APE1/Ref-1 Inhibitor APX3330
2020-09-18T10:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794436,Synonym:,P. vivax-infected RBCs
2020-09-18T10:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794436,Synonym:,P. vivax-infected red blood cells
2020-09-18T10:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794436,Synonym:,Plasmodium vivax RBC immunotherapy agent
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT 7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT-7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,CT7001
2020-09-18T05:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642,Code name:,ICEC0942
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted PBSCs
2020-09-18T01:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648,Synonym:,allogeneic CD34+E- T-cell-depleted peripheral blood stem cells
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,darleukin and fibromun
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,darleukin/fibromun
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19-IL2 and L19-TNF-alpha
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19-IL2/L19-TNF-alpha
2020-09-18T05:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649,Synonym:,L19IL2/L19TNF
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Code name:,CAM 101
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Code name:,CAM-101
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Code name:,CAM101
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Synonym:,FD hPL CAM-101
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Synonym:,ophthalmic fibrinogen-depleted allogeneic standardized human platelet lysate
2020-09-18T12:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650,Synonym:,topical fibrinogen-depleted human platelet lysate
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIE cells
2020-09-18T04:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651,Synonym:,autologous CC-EIEs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Abbreviation:,OC-CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous OC-CTLs
2020-09-18T04:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654,Synonym:,autologous ovarian cancer-specific CTLs
2020-09-18T12:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794657,NA,NA
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Code name:,ABBV 744
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Code name:,ABBV-744
2020-09-18T04:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664,Synonym:,BD2-selective BET inhibitor ABBV-744
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ 602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ-602
2020-09-18T02:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677,Code name:,CPGJ602
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,CBM 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,CBM588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Code name:,MIYAIRI 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum CBM 588 probiotic strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum MIYAIRI strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum MIYAIRI strain CBM 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,C. butyricum strain MIYAIRI 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,Clostridium butyricum MIYAIRI 588
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,Clostridium butyricum MIYAIRI 588 probiotic strain
2020-09-18T05:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751,Synonym:,MIYAIRI 588 strain of C. butyricum
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR 029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR-029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Code name:,JWCAR029
2020-09-18T04:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777,Synonym:,autologous anti-CD19 CAR T cells JWCAR029
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,Chemical structure:,"1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride"
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Cepacol
2020-09-18T05:19:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778,US brand name:,Dyclone
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK 105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK-105
2020-09-18T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779,Code name:,AK105
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30-CD28zeta-CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLCAR.CD30.CCR4 cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,ATLs co-expressing CD30-CARCD28zeta and CCR4
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,CCR4-CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781,Synonym:,SFG.CCR4-CAR.CD30 autologous T lymphocytess
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATL-expressing CD30-CAR-CD28zeta
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30 cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,ATLCAR.CD30-CD28zeta cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,autologous CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,CAR-CD30-28zeta-specific autologous T cells
2020-09-18T04:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782,Synonym:,SFG.CAR.CD30 autologous T lymphocytes
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARP1-targeted probe
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,[18F]PARPi imaging agent
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F fluorinated PARP1-targeted probe
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F-1(2H)phthalazinone-based PARPi imaging agent
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,18F-radiolabeled 1(2H)phthalazinone PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,fluorine F 18 PARPi
2020-09-18T06:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783,Synonym:,fluorine F 18 poly(ADP-ribose) polymerase inhibitor
2020-09-18T12:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794786,Synonym:,Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 disulfide)
2020-09-18T12:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794786,Synonym:,N-(N-(N-glycylglycyl)glycyl)-8-L-lysinevasopressin
2020-09-18T12:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794786,Synonym:,terlipressinum
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Abbreviation:,autologous HPV-CTLs
2020-09-18T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787,Synonym:,autologous HPV-specific immune lymphocytes
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Abbreviation:,allogeneic HPV-CTLs
2020-09-18T01:53:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788,Synonym:,allogeneic HPV-specific immune lymphocytes
2020-09-18T10:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794790,Synonym:,qilisheng
2020-09-18T10:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794790,Synonym:,qilisheng solution
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE 585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Code name:,KITE585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-T cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous genetically-modified anti-BCMA CAR-transduced T Cells KITE-585
2020-09-18T04:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792,Synonym:,autologous T Cells KITE-585
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous AFP-CAR-transduced T cells ET1402L1
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous ET1402L1-CAR-T cells
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,autologous T cells transduced with ET1402L1-CAR
2020-09-18T04:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793,Synonym:,ET1402L1-CAR-T cells
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPX POM
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPX-POM
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Code name:,CPXPOM
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Synonym:,ciclopirox prodrug
2020-09-18T05:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795,Synonym:,CPX prodrug
2020-09-18T07:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796,Synonym:,acacia gum solution
2020-09-18T07:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796,Synonym:,Acacia senegal
2020-09-18T07:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796,Synonym:,Acacia senegal solution
2020-09-18T07:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796,Synonym:,acacia solution
2020-09-18T07:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796,Synonym:,gum acacia solution
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Code name:,IM19
2020-09-18T04:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869,Synonym:,autologous CD19-specific CAR-T cells IM19
2020-09-18T08:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794871,Code name:,AU 4948
2020-09-18T08:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794871,Code name:,CA 4948
2020-09-18T08:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794871,Code name:,CA-4948
2020-09-18T08:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794871,Synonym:,interleukin-1 receptor-associated kinase 4 inhibitor CA-4948
2020-09-18T09:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872,Code name:,BOS 172722
2020-09-18T09:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872,Code name:,BOS172722
2020-09-18T09:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872,Synonym:,monopolar spindle 1 inhibitor BOS172722
2020-09-18T09:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872,Synonym:,TTK inhibitor BOS172722
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,autologous CD19/CD22CAR-HER2t-EGFRt-expressing T lymphocytes
2020-09-18T04:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873,Synonym:,bispecific anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-09-18T07:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875,Code name:,VHH1
2020-09-18T07:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875,Synonym:,68Ga-HER2-nanobody VHH1
2020-09-18T07:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875,Synonym:,68Ga-NOTA-2Rs15d
2020-09-18T07:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875,Synonym:,68Ga-NOTA-anti-HER2 VHH1
2020-09-18T07:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875,Synonym:,gallium Ga 68-NOTA-anti-HER2-VHH1
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B 001
2020-09-18T02:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877,Code name:,B001
2020-09-18T07:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794878,Code name:,APX001
2020-09-18T07:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794878,Code name:,E1211
2020-09-18T07:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794878,Synonym:,prodrug APX001
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Code name:,G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Code name:,SKI-G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,FLT3 kinase inhibitor SKI-G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,FLT3 tyrosine kinase inhibitor SKI-G-801
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,G-749 HCl salt
2020-09-18T06:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986,Synonym:,G749 hydrochloride
2020-09-18T07:53:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794987,Code name:,LY3381916
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Code name:,MCY-M11
2020-09-18T04:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988,Synonym:,anti-mesothelin mRNA-transfected autologous PBMCs MCY-M11
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX 029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX-029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Code name:,ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,ERK inhibitor ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor ASTX029
2020-09-18T06:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989,Synonym:,extracellular signal-regulated kinase inhibitor ASTX029
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT 602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Code name:,ADCT602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,ADC ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,anti-CD22/PBD ADC ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,antibody-drug conjugate ADCT-602
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,epratuzumab-cys-SG3249
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,hLL2-cys-PBD
2020-09-18T06:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990,Synonym:,hLL2-cys-SG3249
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Code name:,BA 3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Code name:,BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,ADC BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,anti-ROR2 CAB ADC
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,antibody-drug conjugate BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,CAB anti-ROR2 ADC BA3021
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,CAB-ROR2-ADC
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,conditionally active biologic anti-ROR2 antibody-drug conjugate
2020-09-18T04:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991,Synonym:,ROR2-targeted ADC BA3021
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Code name:,FCARH143
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,autologous anti-BCMA-CAR CD4+/CD8+ cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA CAR-CD4+/CD8+ T cells
2020-09-18T04:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992,Synonym:,BCMA-specific CAR-expressing CD4+/CD8+ T lymphocytes
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14 C]-TAK-659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK 659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK-659
2020-09-18T05:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993,Synonym:,[14C]TAK659
2020-09-18T12:28:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794995,Synonym:,autologous TTRNA mRNA-loaded lymphocyte transfer cells
2020-09-18T12:28:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794995,Synonym:,TTRNA-xALT
2020-09-18T12:28:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794995,Synonym:,TTRNA-xALT cells
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Androtardyl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testinon
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,Foreign brand name:,Testo-Enant
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Andro LA
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Delatestryl
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Everone
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Primosteston
2020-09-18T02:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022,US brand name:,Testate
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM-333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Code name:,GEM333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/anti-CD3 bispecific antibody GEM 333
2020-09-18T02:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023,Synonym:,anti-CD33/CD3 antibody GEM 333
2020-09-18T08:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795024,Code name:,CS 3006
2020-09-18T08:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795024,Code name:,CS-3006
2020-09-18T08:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795024,Code name:,CS3006
2020-09-18T08:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795024,Synonym:,MAPK kinase inhibitor CS3006
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,[18F]AlF-NOTA-neurotensin
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,"[18F]aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,18F-AlF-NOTA-neurotensin
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,18F-AlF-NOTA-NT
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,"18F-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-09-18T06:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028,Synonym:,fluorine F 18-Al-NOTA-neurotensin
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Abbreviation:,BBD
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Abbreviation:,BD
2020-09-18T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030,Synonym:,babao dan
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA 150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA-150
2020-09-18T02:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105,Code name:,FPA150
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF 231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF-231
2020-09-18T02:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110,Code name:,SRF231
2020-09-18T12:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118,Code name:,BAY 2287411
2020-09-18T12:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118,Code name:,BAY2287411
2020-09-18T12:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118,Synonym:,thorium Th 227-antibody-chelator conjugate BAY2287411
2020-09-18T12:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118,Synonym:,thorium-227-labeled anetumab
2020-09-18T12:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118,Synonym:,thorium-227-labeled antibody-chelator conjugate BAY2287411
2020-09-18T09:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795263,Code name:,EDP 1503
2020-09-18T09:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795263,Code name:,EDP-1503
2020-09-18T09:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795263,Code name:,EDP1503
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB 2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB-2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Code name:,MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,anti-PDL1 monoclonal antibody MSB2311
2020-09-18T03:46:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264,Synonym:,humanized anti-PD-L1 monoclonal antibody MSB2311
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Code name:,DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-MA ADC DHES0815A
2020-09-18T02:38:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265,Synonym:,anti-HER2/PBD-monoamide ADC DHES0815A
2020-09-18T09:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795266,Code name:,BMS 986299
2020-09-18T09:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795266,Code name:,BMS-986299
2020-09-18T09:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795266,Code name:,BMS986299
2020-09-18T09:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795266,Synonym:,NLR family pyrin-domain-containing 3 agonist BMS-986299
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Chemical structure:,"4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide"
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN 1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN-1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Code name:,FN1501
2020-09-18T05:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267,Synonym:,CDK/FLT3 inhibitor FN-1501
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG 1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG-1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Code name:,MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous anti-PRAME-TCR-expressing T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous PRAME TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,autologous TCR-modified T cells MDG1011
2020-09-18T04:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276,Synonym:,PRAME-TCR gene-modified autologous T cells MDG1011
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV 19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV-19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Code name:,hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,anti-VEGF MAb hPV19
2020-09-18T03:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278,Synonym:,MAb hPV19
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T lymphocytes
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,Hu-CART-meso cells
2020-09-18T04:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279,Synonym:,mesothelin-specific CAR-T cells
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA 3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA-3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Code name:,BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,ADC BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,CAB anti-AXL ADC BA3011
2020-09-18T05:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303,Synonym:,CAB-AXL-ADC BA3011
2020-09-18T13:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795318,Code name:,INO 5401
2020-09-18T13:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795318,Code name:,INO5401
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVAC-B
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Code name:,BVACB
2020-09-18T04:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331,Synonym:,HER2/neu-specific autologous B-cell/monocyte vaccine BVAC-B
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,complement C5-inhibitor rEV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant EV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant OmCI
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,recombinant Ornithodoros moubata complement inhibitor
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,Synonym:,rEV576
2020-09-18T05:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332,US brand name:,Coversin
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV 111
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV-111
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Code name:,PRV111
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Synonym:,cisplatin drug-loaded patch
2020-09-18T05:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340,Synonym:,cisplatin transmucosal system
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA 150
2020-09-18T02:10:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341,Code name:,FPA150
2020-09-18T04:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795343,Synonym:,autologous HER2 CAR/EGFRt-expressing CD4+ and CD8+ T cells
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB S6 500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVB-S6-500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Code name:,AVBS6500
2020-09-18T02:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349,Synonym:,AXL Fc fusion protein AVB-S6-500
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF 06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF-06936308
2020-09-18T01:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350,Code name:,PF06936308
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous TriCAR-T-CD19 cells
2020-09-18T04:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364,Synonym:,autologous trifunctional anti-CD19 CAR T cells
2020-09-18T07:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366,Synonym:,IgM-enriched immunoglobulin
2020-09-18T07:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366,Synonym:,immunoglobulin GMA
2020-09-18T07:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366,Synonym:,immunoglobulin M-enriched immunoglobulins
2020-09-18T07:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366,Synonym:,ivIgGMA
2020-09-18T07:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366,Synonym:,pentaglobin
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX 06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX-06
2020-09-18T03:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367,Code name:,HLX06
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP 022
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP-022
2020-09-18T04:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368,Code name:,ICP022
2020-09-18T05:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795369,Foreign brand name:,Ialuril
2020-09-18T05:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795369,Foreign brand name:,Ialuril Soft Gels
2020-09-18T10:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795373,Code name:,MS 553
2020-09-18T10:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795373,Code name:,MS-553
2020-09-18T10:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795373,Synonym:,PKC-b inhibitor MS-553
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,alkylglycerol and rosemary capsules
2020-09-18T01:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374,Synonym:,rosemary/alkylglycerol dietary supplement
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC 1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC-1
2020-09-18T02:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377,Code name:,MSC1
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI 2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Code name:,MEDI-2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,anti-BCMA ADC MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Anti-BCMA/PBD MEDI2228
2020-09-18T02:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378,Synonym:,Antibody-drug Conjugate MEDI2228
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym 022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym-022
2020-09-18T02:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379,Code name:,Sym022
2020-09-18T12:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795388,Code name:,BDB 001
2020-09-18T12:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795388,Code name:,BDB-001
2020-09-18T12:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795388,Code name:,BDB001
2020-09-18T12:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795388,Synonym:,Toll-like receptor agonist BDB001
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,CC 93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Code name:,EM901
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,anti-BCMA/CD3 bispecific antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA x CD3 T Cell-engaging antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA/CD3 T-cell bi-specific antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMAxCD3 BiTE antibody CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,BCMAxCD3 TCB CC-93269
2020-09-18T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389,Synonym:,bi-specific antibody CC-93269
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV pp65-LAMP mRNA-loaded DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous CMV-pp65-flLamp DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous flLAMP-pp65-DCs
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DC vaccine
2020-09-18T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394,Synonym:,autologous pp65-flLAMP DCs
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI 006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI-006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPI006
2020-09-18T02:24:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397,Code name:,CPX-006
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA 201
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA-201
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Code name:,CXA201
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,Synonym:,ceftolozane/tazobactam
2020-09-18T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424,US brand name:,Zerbaxa
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Code name:,AB 110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Code name:,AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,AB-110 cell product
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,CD34-positive Enriched HPCs Mixed with Engineered Human ECs AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,CD34+ Cord-Blood Derived Hematopoietic Stem Cells Co-Cultured and Co-Infused with Genetically Modified Endothelial Cells AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,Cord Blood-derived HPCs Co-cultured and Expanded with E-CEL UVEC Cells AB-110
2020-09-18T06:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426,Synonym:,Genetically-modified Endothelial Cells Plus Expanded Cord Blood Hematopoietic Stem Cells AB-110
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX 0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Code name:,ALX0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,anti-RSV protein F nanobody ALX-0171
2020-09-18T03:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427,Synonym:,RSV-specific nanobody ALX-0171
2020-09-18T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795428,Synonym:,89Zr-labeled panitumumab
2020-09-18T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795428,Synonym:,89Zr-panitumumab
2020-09-18T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795428,Synonym:,zirconium Zr 89 panitumumab
2020-09-18T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795428,Synonym:,Zr 89-panitumumab
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Code name:,ETBX-071
2020-09-18T01:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436,Synonym:,Adenoviral PSA Prostate Cancer Vaccine ETBX-071
2020-09-18T13:14:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795437,Synonym:,(89)Zr-daratumumab
2020-09-18T13:14:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795437,Synonym:,89Zr-DFO-daratumumab
2020-09-18T13:14:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795437,Synonym:,zirconium Zr 89 DFO-daratumumab
2020-09-18T13:14:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795437,Synonym:,Zr 89-DFO-daratumumab
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous aDC1-induced CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous CTLs sensitized ex-vivo with autologous TAA-loaded alphaDC1
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous natural killer-like cytotoxic lymphocytes
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,autologous NK-like CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in vitro DC-sensitized CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,in-vitro DC-sensitized autologous CTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,therapeutic nCTLs
2020-09-18T04:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451,Synonym:,tumor neo-antigen-specific nCTLs
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous anti-CD38 A2 CAR2 T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 CAR T cells
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CAR2 anti-CD38 A2 T lymphocytes
2020-09-18T04:07:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452,Synonym:,autologous CD38-A2 CAR2-expressing T lymphocytes
2020-09-18T07:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795503,Synonym:,ginseng/lingzhi mushroom/Cordyceps sinensis/rose supplement
2020-09-18T07:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795503,Synonym:,Shen-Ling-Cao
2020-09-18T07:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795503,Synonym:,Shenlingcao oral liquid
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Code name:,NEO 201
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Code name:,NEO-201
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Code name:,NEO201
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Synonym:,h16C3
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Synonym:,h16C3 antibody
2020-09-18T09:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513,Synonym:,neoantigen-targeting antibody NEO-201
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Abbreviation:,CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA 4-1BBz CAR T cells CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,autologous BCMA-specific CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA
2020-09-18T04:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542,Synonym:,CART-BCMA cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 CAR-T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,anti-CD19 Humanized scFv TCRz-41BB-CAR lentiviral vector-transduced autologous T lymphocytes
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells huCART19
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,CTL119 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 cells
2020-09-18T04:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543,Synonym:,huCART19 T lymphocytes
2020-09-18T11:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795544,Code name:,TAK 981
2020-09-18T11:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795544,Code name:,TAK-981
2020-09-18T11:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795544,Code name:,TAK981
2020-09-18T10:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554,Synonym:,allogeneic HLA-matched virus-specific T cell lines
2020-09-18T10:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554,Synonym:,allogeneic HLA-matched VSTs
2020-09-18T10:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554,Synonym:,allogeneic partially HLA-matched AdV/CMV/EBV-specific T cells
2020-09-18T10:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554,Synonym:,partially HLA-matched adenovirus/cytomegalovirus/Epstein-Barr virus-specific allogeneic cytotoxic T lymphocytes
2020-09-18T10:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554,Synonym:,partially HLA-matched AdV/CMV/EBV-specific allogeneic T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Code name:,CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 CAR T cells CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous anti-CD22 scFv CAR 4-1BB-TCRz-expressing T lymphocytes CART22-65s
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s T cells
2020-09-18T04:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556,Synonym:,autologous CART22-65s-expressing T cells
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG 2575
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG-2575
2020-09-18T04:32:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558,Code name:,APG2575
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Code name:,MSB0011359C
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,anti-PD-L1/TGFbetaRII fusion protein M7824
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,anti-PDL1/TGFb Trap MSB0011359C
2020-09-18T04:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582,Synonym:,M7824
2020-09-18T07:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795583,Foreign brand name:,Prisma
2020-09-18T07:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795583,Synonym:,mesoglycan
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Code name:,NUC 3373
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Code name:,NUC-3373
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Code name:,NUC3373
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Synonym:,5-FU analog prodrug NUC-3373
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Synonym:,nucleotide analog NUC-3373
2020-09-18T09:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584,Synonym:,phosphoramidate-FUDR-MP prodrug NUC-3373
2020-09-18T10:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599,Code name:,NKTR 262
2020-09-18T10:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599,Code name:,NKTR262
2020-09-18T10:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599,Synonym:,TLR 7/8 agonist NKTR-262
2020-09-18T10:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599,Synonym:,TLR7/TLR8 agonist NKTR-262
2020-09-18T10:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599,Synonym:,Toll-like receptor 7/8 agonist NKTR-262
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Code name:,BST 236
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Code name:,BST-236
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,Ara-C asparagine conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,asparagine Ara-C conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,asparagine cytarabine conjugate
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,astarabine
2020-09-18T05:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601,Synonym:,cytarabine asparagine conjugate
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Chemical structure:,"Ethanaminium, 2,2'-((1,4-Dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-)"
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,Synonym:,Suxamethonium Chloride
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Anectine
2020-09-18T02:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677,US brand name:,Quelicin
2020-09-18T11:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795682,Code name:,HLX 10
2020-09-18T11:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795682,Code name:,HLX10
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Code name:,FH-MCVA2TCR
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T04:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693,Synonym:,FH-MCVA2TCR autologous CD8+ and CD4+ T cells transduced with TCR A2-MCC1
2020-09-18T12:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795694,Synonym:,IT-Tavo-EP
2020-09-18T12:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795694,Synonym:,plasmid IL-12 pUMVC3-hIL-12-NGVL3
2020-09-18T12:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795694,Synonym:,tavo
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG-427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Code name:,AMG427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,anti-FLT3 x anti-CD3 BiTE AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,BiTE antibody AMG 427
2020-09-18T02:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695,Synonym:,FLT3/CD3-directed bispecific T-cell engager antibody AMG 427
2020-09-18T13:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696,Synonym:,89Zr-cRGDY
2020-09-18T13:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dot nanoparticles
2020-09-18T13:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles
2020-09-18T13:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dots
2020-09-18T13:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696,Synonym:,Zr 89-DFO-cRGDY PEG-Cy5-C' dots
2020-09-18T08:57:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795697,Code name:,AMG 397
2020-09-18T08:57:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795697,Code name:,AMG-397
2020-09-18T08:57:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795697,Code name:,AMG397
2020-09-18T08:57:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795697,Synonym:,myeloid cell leukemia 1 inhibitor AMG 397
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA co-formulated with rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,DARA/rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab + rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab with rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab-rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,daratumumab/rHuPH20 co-formulation
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,darzalex/rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,HuMax-CD38-rHuPH20
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,Synonym:,recombinant human hyaluronidase mixed with daratumumab
2020-09-18T05:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698,US brand name:,Darzalex Faspro
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,ASP 1948
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,ASP-1948
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,ASP1948
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,PTZ 329
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,PTZ-329
2020-09-18T09:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699,Code name:,PTZ329
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,OBI3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH 3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Code name:,TH3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,AKR1C3-activated prodrug TH-3424
2020-09-18T01:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700,Synonym:,aldo-keto reductase 1c3-activated prodrug OBI-3424
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD 135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD-135
2020-09-18T03:45:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701,Code name:,BCD135
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,[11C] osimertinib
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,[11C]AZD9291
2020-09-18T05:03:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702,Synonym:,11C-osimertinib
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF 06821497
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF-06821497
2020-09-18T06:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703,Code name:,PF06821497
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM 208
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM-208
2020-09-18T05:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704,Code name:,ODM208
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK 079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Code name:,TAK-079
2020-09-18T02:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705,Synonym:,anti-CD38 MAb TAK-079
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP 023
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP-023
2020-09-18T06:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707,Code name:,LNP023
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT 502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT-502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,CBT502
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB 2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB-2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Code name:,TQB2450
2020-09-18T03:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708,Synonym:,anti-PD-L1 monoclonal antibody TQB2450
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Code name:,ECT-001
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Code name:,UM171
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,ECT-001 expanded UCB
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,ECT-001 expanded umbilical cord blood
2020-09-18T06:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709,Synonym:,UM171 expanded cord blood
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-a
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,antitumor B KAC-α
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,ATB-KAC-alpha
2020-09-18T03:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710,Synonym:,Chinese herbal mixture antitumor B KAC-a
2020-09-18T11:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711,Chemical structure:,1-[4-chloro-3(trifluoromethyl)phenyl-3-[3-(4-cyanophenoxy)] urea
2020-09-18T11:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711,Code name:,SC 43
2020-09-18T11:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711,Code name:,SC-43
2020-09-18T11:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711,Code name:,SC43
2020-09-18T11:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711,Synonym:,SC-43 oral solution
2020-09-18T12:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712,Chemical structure:,"9,10-anthracenedione, 2,7-bis(((3R,5S)-3,5-dimethyl-1-piperidinyl)sulfonyl)-, 9,10-dioxime, rel-"
2020-09-18T12:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712,Code name:,BC 2059
2020-09-18T12:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712,Code name:,BC-2059
2020-09-18T12:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712,Code name:,BC2059
2020-09-18T12:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712,Synonym:,tegatrabetan
2020-09-18T07:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795713,Code name:,E 7130
2020-09-18T07:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795713,Code name:,E-7130
2020-09-18T07:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795713,Code name:,E7130
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,188Re-etidronate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,188Re-HEDP
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re 188 etidronic acid
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re 188 hydroxyethylidene diphosphonate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re-188 etidronate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re-188 HEDP
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re-188 hydroxyethylidene diphosphonate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,Re-188etidronate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,rhenium Re 188-HEDP
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,rhenium Re-188 hydroxyethylidene diphosphonate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,rhenium-188 etidronate
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,rhenium-188 HEDP
2020-09-18T11:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714,Synonym:,rhenium-188-HEDP
2020-09-18T09:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795715,Code name:,RiMO-301
2020-09-18T07:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795718,Code name:,SCC 244
2020-09-18T07:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795718,Code name:,SCC-244
2020-09-18T07:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795718,Code name:,SCC244
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS 986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Code name:,BMS-986258
2020-09-18T03:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721,Synonym:,anti-TIM3 antibody BMS-986258
2020-09-18T10:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795722,Code name:,RXC 004
2020-09-18T10:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795722,Code name:,RXC-004
2020-09-18T10:41:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795722,Code name:,RXC004
2020-09-18T04:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723,Code name:,ACZ885
2020-09-18T04:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723,US brand name:,Ilaris
2020-09-18T10:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724,Abbreviation:,PTS
2020-09-18T10:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724,Code name:,PTS 100
2020-09-18T10:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724,Code name:,PTS-100
2020-09-18T10:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724,Code name:,PTS100
2020-09-18T10:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724,Synonym:,p-toluenesulfonamide
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,ARG-6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC-4017
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,BTRC4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Code name:,RG6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017A
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody RG 6194
2020-09-18T02:38:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725,Synonym:,anti-HER2/anti-CD3 bispecific monoclonal antibody 4017A
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Code name:,Descartes-08
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,anti-BCMA-CAR-mRNA-transfected autologous CD8+ T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8-positive T cells
2020-09-18T04:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T cells
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK 164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK-164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Code name:,TAK164
2020-09-18T02:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729,Synonym:,anti-GCC ADC TAK-164
2020-09-18T08:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795735,Code name:,BI 907828
2020-09-18T08:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795735,Code name:,BI-907828
2020-09-18T08:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795735,Code name:,BI907828
2020-09-18T07:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795737,Code name:,LY 01005
2020-09-18T07:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795737,Code name:,LY-01005
2020-09-18T07:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795737,Code name:,LY01005
2020-09-18T07:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795737,Synonym:,goserelin acetate extended-release microspheres
2020-09-18T04:22:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795738,NA,NA
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Chemical structure:,"(9-beta,10-alpha)-pregna-4,6-diene-3,20-dioneretro-6-dehydroprogesterone"
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,didrogesterone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,hydrogestrone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,Synonym:,isopregnenone
2020-09-18T06:16:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783,US brand name:,Duphaston
2020-09-18T04:33:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795784,Synonym:,BCMA-CD19 cCAR T cells
2020-09-18T04:33:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795784,Synonym:,BCMA-CD19 cCAR-T cells
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Code name:,D-0316
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Code name:,D0316
2020-09-18T06:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785,Synonym:,D 0316
2020-09-18T08:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795786,Code name:,AZD 4205
2020-09-18T08:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795786,Code name:,AZD-4205
2020-09-18T08:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795786,Code name:,AZD4205
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN 003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN-003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Code name:,ASLAN003
2020-09-18T06:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787,Synonym:,DHODH inhibitor ASLAN003
2020-09-18T08:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795802,Code name:,KRT 232
2020-09-18T08:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795802,Code name:,KRT-232
2020-09-18T08:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795802,Code name:,KRT232
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR 46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR-46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Code name:,FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,anti-CD46 ADC FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,antibody-drug conjugate FOR46
2020-09-18T02:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803,Synonym:,CD46-ADC FOR46
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI 1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Code name:,BI1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,anti-hFcγRIIB monoclonal antibody BI-1206
2020-09-18T02:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804,Synonym:,hFcgammaRIIB mAb BI-1206
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T cells
2020-09-18T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
2020-09-18T13:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795823,Synonym:,therapeutic young autologous TILs
2020-09-18T13:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795823,Synonym:,young autologous TIL
2020-09-18T13:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795823,Synonym:,young autologous TILs
2020-09-18T13:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795823,Synonym:,young autologous tumor infiltrating lymphocytes
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A 166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A-166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Code name:,A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,ADC A166
2020-09-18T02:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827,Synonym:,anti-HER2 ADC A166
2020-09-18T07:54:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795828,Synonym:,IL13 [EQ]BBzeta/truncated CD19[t]+ naive and memory T cells
2020-09-18T07:54:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795828,Synonym:,IL13 [EQ]BBzeta/truncated CD19[t]+ TN/MEM cells
2020-09-18T07:54:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795828,Synonym:,IL13Ra2-specific-hinge-optimized-4-1BB-CAR/truncated CD19-expressing autologous TN/MEM lymphocytes
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,ascorbate injection
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,ascorbic acid injection
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,HD ascorbate
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,HD P-AscH-
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,high-dose ascorbate
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,high-dose ascorbic acid
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,high-dose parenteral ascorbate
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,high-dose vitamin C
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,intravenous ascorbate
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,intravenous high-dose ascorbate
2020-09-18T10:24:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829,Synonym:,IV ascorbate
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY 1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY-1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Code name:,BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-ILDR2 inhibitor BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,anti-immunoglobulin-like domain containing receptor 2 MoAb BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,ILDR2 function-blocking antibody BAY1905254
2020-09-18T02:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831,Synonym:,immune checkpoint inhibitor BAY1905254
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Abbreviation:,MNA-D
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,doxorubicin-coated patches
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,doxorubicin-loaded patches
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,micro-needle array doxorubicin
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,microneedle applicator-doxorubicin
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,microneedle array doxorubicin
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,MNA-D patches
2020-09-18T09:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832,Synonym:,MNA-doxorubicin
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Code name:,HPN 424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Code name:,HPN-424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Code name:,HPN424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Synonym:,anti-PSMA/CD3 TriTAC HPN424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Synonym:,PSMA/CD3 TriTAC HPN424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Synonym:,PSMA/CD3-specific TriTAC HPN424
2020-09-18T10:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833,Synonym:,TriTAC HPN424
2020-09-18T11:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834,Code name:,RX 108
2020-09-18T11:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834,Code name:,RX-108
2020-09-18T11:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834,Code name:,RX108
2020-09-18T11:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834,Synonym:,Na+/K+-ATPase inhibitor RX108
2020-09-18T11:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834,Synonym:,sodium-potassium pump inhibitor RX108
2020-09-18T11:18:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795835,Code name:,GSK 3145095
2020-09-18T11:18:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795835,Code name:,GSK-3145095
2020-09-18T11:18:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795835,Code name:,GSK3145095
2020-09-18T11:18:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795835,Synonym:,receptor-interacting serine/threonine-protein kinase 1 inhibitor GSK3145095
2020-09-18T10:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795836,Code name:,GSK 3368715
2020-09-18T10:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795836,Code name:,GSK-3368715
2020-09-18T10:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795836,Code name:,GSK3368715
2020-09-18T10:46:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795836,Synonym:,protein arginine methyltransferase 1 inhibitor GSK3368715
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4 LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,64Cu-PEG4-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,copper Cu 64-LLP2A
2020-09-18T05:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462,Synonym:,Cu[64]-CB-TE1A1P-PEG4-LLP2A
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM 701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM-701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Code name:,COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,anti-poliovirus receptor-related immunoglobulin COM701
2020-09-18T03:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463,Synonym:,PVRIG inhibitor COM701
2020-09-18T07:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796464,Code name:,9 ING 41
2020-09-18T07:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796464,Code name:,9-ING-41
2020-09-18T07:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796464,Code name:,9ING41
2020-09-18T07:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796464,Synonym:,glycogen synthase kinase-3 inhibitor 9-ING-41
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,CAT-02-106
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH 222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Code name:,TRPH222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22 antibody-drug conjugate TRPH-222
2020-09-18T02:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465,Synonym:,anti-CD22-4AP ADC TRPH-222
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-K-RAS G12D mTCR-transduced autologous PBLs
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR autologous PBL
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,anti-KRAS G12D mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467,Synonym:,autologous PBL transduced with anti-KRAS G12D mTCR
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Code name:,C188-9
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Code name:,TTI 101
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Code name:,TTI-101
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Code name:,TTI101
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Synonym:,STAT3 inhibitor C188-9
2020-09-18T11:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468,Synonym:,STAT3 inhibitor XIII
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Code name:,GRTC901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,Synonym:,adenoviral TSNA priming vaccine GRT-C901
2020-09-18T01:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478,US brand name:,priming cancer vaccine GRT-C901
2020-09-18T09:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480,Code name:,GRT R902
2020-09-18T09:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480,Code name:,GRT-R902
2020-09-18T09:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480,Code name:,GRTR902
2020-09-18T09:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480,Synonym:,boosting cancer vaccine GRT-R902
2020-09-18T09:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480,Synonym:,mRNA-based TSNA boosting vaccine GRT-R902
2020-09-18T07:45:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796481,Synonym:,human anti-CD30 CAR-expressing autologous T-cells
2020-09-18T07:45:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796481,Synonym:,human anti-CD30scFv CAR-expressing autologous T-lymphocytes
2020-09-18T08:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487,Synonym:,amino acid renal protectant solution
2020-09-18T08:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487,Synonym:,amino acid solution-containing L-lysine and L-arginine
2020-09-18T08:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487,Synonym:,intravenous L-lysine/L-arginine-containing amino acid solution
2020-09-18T08:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487,Synonym:,L-lysine/L-arginine AA solution
2020-09-18T08:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487,Synonym:,radioprotective amino acid solution
2020-09-18T10:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492,Code name:,AG 348
2020-09-18T10:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492,Code name:,AG-348
2020-09-18T10:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492,Code name:,AG348
2020-09-18T10:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492,Synonym:,PK-R activator AG-348
2020-09-18T10:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492,Synonym:,red cell pyruvate kinase activator AG-348
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX 109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX-109
2020-09-18T02:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494,Code name:,INBRX109
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC 318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC-318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Code name:,NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-S15 mAb NC318
2020-09-18T03:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496,Synonym:,anti-Siglec-15 monoclonal antibody NC318
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY 3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY-3415244
2020-09-18T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576,Code name:,LY3415244
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Abbreviation:,6R-MTHF
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Chemical structure:,"(6R)-5,10-methylenetetrahydrofolate[6R] 5,10-methylenetetrahydrofolate[6R]-5,10-methylene-tetrahydrofolate6R-5,10-methyleneTHF6R-methylene THFmethylenetetrahydrofolic acid, L-(+)-"
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,Synonym:,6R-5-10-methylenetetrahydrofolate
2020-09-18T03:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585,US brand name:,Modufolin
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806 specific CAR T cells
2020-09-18T04:13:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590,Synonym:,autologous EGFR806-specific CAR T cells
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous CD4+/CD8+ T cells expressing EGFR806-specific CAR/EGFRt and CD19-specific CAR/HER2tG
2020-09-18T04:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591,Synonym:,autologous EGFR806/CD19-specific CAR T cells
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous anti-CLL1/anti-CD33 CARs-expressing T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T cells
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,autologous CLL1-CD33 cCAR T lymphocytes
2020-09-18T04:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670,Synonym:,CLL1-CD33 cCAR T cells
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG-160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Code name:,AMG160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,anti-PSMA/CD3 bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,BITE AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,half-life extended bispecific T-cell engager antibody AMG 160
2020-09-18T03:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695,Synonym:,HLE-BiTE AMG 160
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI 16350
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI-16350
2020-09-18T05:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716,Code name:,BPI16350
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR SILK cells
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK
2020-09-18T01:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718,Synonym:,allogeneic CD19-TriCAR-T/SILK cells
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX 4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX-4014
2020-09-18T03:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722,Code name:,JTX4014
2020-09-18T06:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796741,Abbreviation:,18F-ASIS
2020-09-18T12:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796746,Foreign brand name:,OmnImmune
2020-09-18T12:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796746,Synonym:,ex-vivo expanded allogeneic gd T lymphocytes
2020-09-18T12:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796746,Synonym:,"therapeutic ex vivo-expanded allogeneic gamma, delta T cells"
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Abbreviation:,EBViNT
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV latent membrane protein-2a-specific Eutil autologous blood-derived T lymphocytes
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV-induced natural T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV-induced T lymphocytes
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBV/LMP-2A-specific CD8 T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBViNT cell
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,EBViNT cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,Epstein-Barr virus induced natural T cells
2020-09-18T06:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750,Synonym:,Eutil autologous T lymphocytes
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF 999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF-999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Code name:,PBF999
2020-09-18T01:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763,Synonym:,A2A/PDE-10 inhibitor PBF-999
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB A425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGB-A425
2020-09-18T03:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770,Code name:,BGBA425
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX 475
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX-475
2020-09-18T05:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,Code name:,FLX475
2020-09-18T08:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796788,Foreign brand name:,Symprove
2020-09-18T08:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796788,Synonym:,Lactobacillus acidophilus/Lactobacillus plantarum/Lactobacillus rhamnosus/Enterococcus faecium aqueous probiotic supplement
2020-09-18T08:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796788,Synonym:,Lactobacillus rhamnosus/L. acidophilus/L. plantarum/Enterococcus faecium aqueous probiotic
2020-09-18T08:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796788,Synonym:,Symprove liquid probiotic
2020-09-18T13:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796790,Abbreviation:,XML
2020-09-18T08:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796791,Code name:,MRTX 849
2020-09-18T08:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796791,Code name:,MRTX-849
2020-09-18T08:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796791,Code name:,MRTX849
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC 95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC-95251
2020-09-18T03:49:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792,Code name:,CC95251
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ADC1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR 1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR-1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Code name:,ATOR1015
2020-09-18T02:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793,Synonym:,CTLA-4 x OX40 bispecific antibody ATOR-1015
2020-09-18T07:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796798,Abbreviation:,IBD
2020-09-18T07:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796798,Chemical structure:,"3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine"
2020-09-18T07:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796798,Code name:,MN-166
2020-09-18T12:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796799,Code name:,MIV 818
2020-09-18T12:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796799,Code name:,MIV-818
2020-09-18T12:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796799,Code name:,MIV818
2020-09-18T12:36:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796799,Synonym:,troxacitabine prodrug MIV-818
2020-09-18T09:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796802,Code name:,CPI 100
2020-09-18T09:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796802,Code name:,CPI-100
2020-09-18T09:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796802,Code name:,CPI100
2020-09-18T09:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796802,Synonym:,NCP nanoparticles CPI-100
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV 155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV-155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Code name:,ABBV155
2020-09-18T02:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806,Synonym:,ADC ABBV-155
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Code name:,IFx-Hu2.0
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Foreign brand name:,ImmuneFx
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Synonym:,autologous cancer cell-transfected with plasmid DNA encoding for Emm55 Streptococcal antigen IFx-Hu2.0
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Synonym:,pDNA autologous cancer cell vaccine IFx-Hu2.0
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Synonym:,plasmid DNA autologous cancer vaccine IFx-Hu2.0
2020-09-18T10:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807,Synonym:,plasmid DNA vaccine encoding S. pyogenes Emm55 protein
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO 436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO-436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Code name:,APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,anti-CD123 x anti-CD3 bispecific antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,bispecific anti-CD123 x anti-CD3 antibody APVO436
2020-09-18T02:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808,Synonym:,CD123 x CD3 targeting bispecific antibody APVO436
2020-09-18T08:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809,Code name:,BC 819
2020-09-18T08:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809,Code name:,BC-819
2020-09-18T08:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809,Code name:,BC819
2020-09-18T08:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809,Synonym:,diphtheria-toxin-A-H19
2020-09-18T08:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809,Synonym:,dT-A-H19
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-selected T lymphocytes
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic HAdV antigen-specific T cells
2020-09-18T01:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810,Synonym:,allogeneic human adenovirus-specific T lymphocytes
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic CMV-specific antigen-selected T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T cells
2020-09-18T01:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T lymphocytes
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,anti-CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted autologous CD8+/CD34t+ T cells
2020-09-18T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813,Synonym:,autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T lymphocytes
2020-09-18T08:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816,Code name:,mRNA 2752
2020-09-18T08:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816,Code name:,mRNA-2752
2020-09-18T08:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816,Code name:,mRNA2752
2020-09-18T08:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816,Synonym:,lipid nanoparticle-encapsulated mRNAs encoding human OX40L/IL-23/IL-36gamma mRNA-2752
2020-09-18T08:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816,Synonym:,lipid nanoparticle-encapsulated OX40L/IL-23/IL-36gamma mRNAs mRNA-2752
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56-enriched donor cells
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56-enriched donor lymphocytes
2020-09-18T05:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843,Synonym:,CD56+/CD3+ donor cells
2020-09-18T08:47:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889,Synonym:,177Lu-3BP-227
2020-09-18T08:47:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889,Synonym:,177Lu-DOTA-3BP-227
2020-09-18T08:47:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889,Synonym:,177Lu-DOTA-IPN01087
2020-09-18T08:47:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889,Synonym:,177Lu-IPN01087
2020-09-18T08:47:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889,Synonym:,lutetium Lu 177 DOTA-3BP-227
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN 046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN-046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Code name:,KN046
2020-09-18T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892,Synonym:,anti-PD-L1 x CTLA-4 bispecific antibody KN046
2020-09-18T09:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796893,Synonym:,PSV-2
2020-09-18T09:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796893,Synonym:,PSV2
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted allogeneic T cells
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted allogeneic T lymphocytes
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,CD45RA-depleted donor T cells
2020-09-18T05:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920,Synonym:,donor CD45RA-depleted (memory) T cells
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,"allogeneic alpha, beta TCR/CD19-depleted HPCs"
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,allogeneic TCRab/CD19-depleted hematopoietic stem cells
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCR alpha/beta/CD19-depleted HPCs
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCR alpha/beta+/CD19+ depleted ematopoietic progenitor cells
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCR alpha/beta+/CD19+ depleted HPCs
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCRab-/CD19-depleted allogeneic hematopoietic progenitor cells
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCRab-/CD19-depleted hematopoietic progenitor cells
2020-09-18T12:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921,Synonym:,TCRab+/CD19+-depleted haploidentical donor HPCs
2020-09-18T09:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922,Code name:,SB 240563
2020-09-18T09:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922,Code name:,SB-240563
2020-09-18T09:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922,Code name:,SB240563
2020-09-18T09:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922,Foreign brand name:,Bosatria
2020-09-18T09:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922,US brand name:,Nucala
2020-09-18T10:36:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796923,Synonym:,chitosan
2020-09-18T10:36:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796923,Synonym:,deacetylchitin
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,anti-NY-ESO-1 mTCR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,autologous anti-NY-ESO-1 Murine TCR retroviral vector-transduced peripheral blood lymphocytes
2020-09-18T04:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924,Synonym:,NY-ESO-1-specific mTCR retroviral vector-transduced autologous PBLs
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Code name:,BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous BCL11A-edited CD34+ hematopoietic stem/progenitor cells
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34-positive BCL11A-disrupted HPCs BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,autologous CD34+ hematopoietic stem cells BIVV003
2020-09-18T04:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965,Synonym:,HSPCs BIVV003
2020-09-18T12:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796966,Synonym:,VPA-expanded cord blood stem cells
2020-09-18T12:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796966,Synonym:,VPA-expanded UCB stem cells
2020-09-18T12:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796966,Synonym:,VPA-expanded UCB-derived CD34-positive cells
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb 23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb-23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Code name:,XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,anti-PD1/anti-ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T03:45:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973,Synonym:,PD1 x ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,EAGD T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,EAGD T lymphocytes
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded and activated gamma delta T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded and activated gamma/delta T cells
2020-09-18T06:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975,Synonym:,expanded/activated gamma/delta T cells
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,[68Ga]CBP-8
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,[68Ga]CBP8
2020-09-18T07:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976,Synonym:,gallium-68 NODAGA-CBP8
2020-09-18T11:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796977,Synonym:,blue-green algae supplement
2020-09-18T11:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796977,Synonym:,spirulina-based supplement
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,BOS 172738
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,BOS-172738
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,BOS172738
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,DS 5010
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,DS-5010
2020-09-18T11:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992,Code name:,DS5010
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Chemical structure:,1-((2-fluoro-6-[18F]fluorophenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,18F-DASA-23
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,F18-labeled PKM2 inhibitor DASA-23
2020-09-18T06:55:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994,Synonym:,F18-labeled pyruvate kinase M2 inhibitor DASA-23
2020-09-18T05:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797004,Synonym:,Cinnamomum aromaticum bark capsules
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG 1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG-1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Code name:,TG1501
2020-09-18T03:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005,Synonym:,anti-PDL1 monoclonal antibody TG-1501
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC 1119
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC-1119
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Code name:,HC1119
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,D3-ENT
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,enzalutamide deuterated
2020-09-18T06:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006,Synonym:,N-trideuteromethyl enzalutamide
2020-09-18T11:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797007,Abbreviation:,rb-bFGF
2020-09-18T04:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797026,Synonym:,Ribes nigrum L. juice
2020-09-18T11:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797048,Code name:,GZ17 6.02
2020-09-18T11:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797048,Code name:,GZ17-6.02
2020-09-18T11:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797048,Code name:,GZ176.02
2020-09-18T11:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797048,Synonym:,synthetic Arum palaestinum derivative GZ17-6.02
2020-09-18T05:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797050,Synonym:,cetuximab-loaded polymeric nanoparticles decorated with octreotide
2020-09-18T05:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797050,Synonym:,polymeric nanoparticles loaded with cetuximab and decorated with octreotide
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,autologous CD19CAR-CD28tm/4-1BBzeta-T2A-EGFRt CART cells
2020-09-18T04:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052,Synonym:,SCRI-huCAR19v1
2020-09-18T12:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797053,Code name:,CK 0801
2020-09-18T12:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797053,Code name:,CK-0801
2020-09-18T12:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797053,Code name:,CK0801
2020-09-18T12:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797053,Synonym:,UCB-derived CD4+CD25+ Tregs CK0801
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Chemical structure:,"2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt"
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,Code name:,NPC-06
2020-09-18T05:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055,US brand name:,Cerebyx
2020-09-18T11:34:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797077,US brand name:,Shingrix
2020-09-18T11:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797080,Synonym:,recombinant VSV-expressing IFN-b and TYRP1
2020-09-18T11:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797080,Synonym:,recombinant VSV-IFNbetaTYRP1
2020-09-18T11:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797080,Synonym:,VSV-IFN-b/TYRP1
2020-09-18T11:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797080,Synonym:,VSV-IFNbetaTYRP1
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,JNJ 63623872
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,JNJ-63623872
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,JNJ63623872
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,VX 787
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,VX-787
2020-09-18T10:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081,Code name:,VX787
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T cells
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/anti-BCMA CAR T lymphocytes
2020-09-18T02:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082,Synonym:,anti-CD38/BCMA CAR T cells
2020-09-18T04:14:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797088,Synonym:,autologous CAR19 T cells carrying cytoplasmic activated PD-1
2020-09-18T07:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797089,Foreign brand name:,Ocoxin-Viusid
2020-09-18T07:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797089,Foreign brand name:,Ocoxin/Viusid
2020-09-18T07:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797089,Synonym:,Ocoxin and Viusid
2020-09-18T07:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797089,Synonym:,oral antioxidant solution
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,6B11 anti-idiotype minibody-pulsed DCs induced autologous CTLs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11-OCIK
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs exposed to 6B11mini-ovarian-cytokine-induced-killer cells
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous CTLs induced with 6B11 anti-idiotype minibody-pulsed DCs
2020-09-18T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090,Synonym:,autologous cytotoxic T cells induced by autologous dendritic cells loaded with 6B11 anti-idiotype minibody
2020-09-18T02:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797091,Synonym:,EGFR-IL12-CAR-T cells
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Chemical structure:,"5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine"
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,CH 5132799
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,CH-5132799
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,MEN 1611
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,MEN-1611
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,MEN1611
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,PA 799
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,PA-799
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Code name:,PA799
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Synonym:,alpha-selective PI3K inhibitor MEN1611
2020-09-18T10:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093,Synonym:,PI3Kalpha inhibitor MEN1611
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC 1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC-1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Code name:,CLIC1901
2020-09-18T04:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095,Synonym:,autologous CLIC-1901 CAR-T cells
2020-09-18T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797097,US brand name:,Boost Breeze
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,anti-mesothelin CAR T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,anti-mesothelin CAR-transduced CRISPR-Cas9-edited T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9 mediated PD-1 and TCR gene-knocked-out mesothelin-directed CAR-T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9-mediated anti-mesothelin CAR T cells
2020-09-18T05:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099,Synonym:,CRISPR-Cas9-mediated gene-edited anti-mesothelin CAR-T cells
2020-09-18T07:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111,Synonym:,trastuzumab and hyaluronidase
2020-09-18T07:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111,Synonym:,trastuzumab and recombinant human hyaluronidase PH20
2020-09-18T07:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111,Synonym:,trastuzumab and rHuPH20
2020-09-18T07:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111,Synonym:,trastuzumab-hyaluronidase-oysk
2020-09-18T07:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111,US brand name:,Herceptin Hylecta
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB 086550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB 86550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB-086550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB-86550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB086550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Code name:,INCB86550
2020-09-18T10:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120,Synonym:,PD-1 ligand 1 inhibitor INCB086550
2020-09-18T11:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797123,Code name:,CVD908ssb-TXSVN
2020-09-18T11:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797123,Code name:,TXSVN
2020-09-18T11:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797123,Synonym:,Salmonella-based survivin vaccine CVD908ssb-TXSVN
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN 5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN-5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Code name:,REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,anti-BCMA x anti-CD3 BiTE REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,bispecific BCMA x CD3 T-cell engaging antibody REGN5458
2020-09-18T02:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141,Synonym:,BiTE antibody REGN5458
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD 019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD-019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Code name:,MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,bispecific DART protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,dual-affinity retargeting protein MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 bispecific DART molecule MGD019
2020-09-18T03:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Chemical structure:,8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX 464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX-464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Code name:,ABX464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Synonym:,CBC 80/20 binder ABX-464
2020-09-18T05:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148,Synonym:,Rev inhibitor ABX-464
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI 101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI-101
2020-09-18T03:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150,Code name:,IBI101
2020-09-18T10:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797151,Code name:,YY 20394
2020-09-18T10:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797151,Code name:,YY-20394
2020-09-18T10:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797151,Code name:,YY20394
2020-09-18T10:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797151,Synonym:,PI3Kdelta inhibitor YY-20394
2020-09-18T12:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797157,Synonym:,99mTc-ABH2
2020-09-18T12:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797157,Synonym:,HER2-targeting 99mTc-labeled affibody
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,autologous anti-PSCA(dCH2)BBz-CAR T cells
2020-09-18T04:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158,Synonym:,PSCA(dCH2)BBzeta-CAR T cells
2020-09-18T12:22:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159,Code name:,AST 008
2020-09-18T12:22:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159,Code name:,AST-008
2020-09-18T12:22:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159,Code name:,AST008
2020-09-18T12:22:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159,Synonym:,SNA AST-008
2020-09-18T12:22:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159,Synonym:,toll-like receptor 9 activator AST-008
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS 101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS-101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Code name:,VLS101
2020-09-18T03:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160,Synonym:,anti-ROR1 antibody-drug conjugate VLS-101
2020-09-18T08:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163,Synonym:,MG1-E6/E7
2020-09-18T08:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163,Synonym:,MG1-E6E7
2020-09-18T08:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163,Synonym:,MG1-expressing mutant HPV E6/E7
2020-09-18T08:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163,Synonym:,oncolytic MG1 virus-encoding E6E7
2020-09-18T08:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163,Synonym:,oncolytic virus MG1-E6E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,Ad-E6E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-expressing mutant HPV E6/E7
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenoviral-HPV E6E7 vaccine
2020-09-18T01:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169,Synonym:,adenovirus vaccine expressing mutant HPV E6 and E7
2020-09-18T08:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797172,Synonym:,177Lu-DOTA-azide-CTT1403
2020-09-18T08:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797172,Synonym:,177Lu-DOTA-N3-CTT1403
2020-09-18T08:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797172,Synonym:,lutetium Lu 177 DOTA-azide-CTT1403
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO 002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Code name:,STRO002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRa ADC STRO-002
2020-09-18T02:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174,Synonym:,anti-FolRalpha ADC STRO-002
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S 65487
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S-65487
2020-09-18T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175,Code name:,S65487
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,aethoxysklerol
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,dodecylnonaoxyethylene glycol monoether
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,Synonym:,Laureth-9
2020-09-18T03:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212,US brand name:,Asclera
2020-09-18T10:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797213,NA,NA
2020-09-18T06:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797223,Abbreviation:,MAG-EPA
2020-09-18T06:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797223,Synonym:,monoglyceride eicosapentaenoic acid
2020-09-18T12:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797224,Code name:,VERU 111
2020-09-18T12:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797224,Code name:,VERU-111
2020-09-18T12:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797224,Code name:,VERU111
2020-09-18T13:14:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797339,Code name:,89Zr˗DFO˗REGN3504
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,[225Ac]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX 01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX-01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Code name:,FPX01
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,[Ac-225]-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,225Ac-FPI-1434
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-FPI-1397-FPI-1175
2020-09-18T01:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340,Synonym:,actinium Ac 225-labeled FPI-1434
2020-09-18T08:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797341,Code name:,[111In]-FPI-1547
2020-09-18T08:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797341,Synonym:,indium In 111-FPI-1397-FPI-1175
2020-09-18T08:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797341,Synonym:,indium In 111-labeled FPI-1547
2020-09-18T09:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350,Abbreviation:,RP1
2020-09-18T09:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350,Synonym:,genetically-modified HSV-1 oncolytic immunotherapeutic RP1
2020-09-18T09:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350,Synonym:,HSV-1 engineered RP1
2020-09-18T09:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350,Synonym:,HSV-1 oncolytic viral strain RP1
2020-09-18T09:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350,Synonym:,HSV-1 RP1
2020-09-18T09:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797351,Abbreviation:,NR
2020-09-18T09:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797351,US brand name:,Niagen
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB 01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Code name:,EMB01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-cMET/EGFR bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,anti-EGFR/anti-c-Met bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,bispecific antibody EMB-01
2020-09-18T02:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352,Synonym:,FIT-013a
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Code name:,TRQ15-01
2020-09-18T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353,Synonym:,IL-15 loaded autologous T lymphocytes TRQ15-01
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITC-E2) CAR T lymphocytes
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,anti-FL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,antiFL(FITCE2) CAR expressing T cells
2020-09-18T02:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354,Synonym:,fluorescein-specific (FITC-E2)-CAR T cells
2020-09-18T10:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797355,Code name:,PF 06939999
2020-09-18T10:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797355,Code name:,PF-06939999
2020-09-18T10:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797355,Code name:,PF06939999
2020-09-18T10:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797355,Synonym:,PRMT5 inhibitor PF-06939999
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG 636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG-636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Code name:,AG636
2020-09-18T06:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356,Synonym:,DHODH inhibitor AG-636
2020-09-18T10:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797357,Synonym:,histone-arginine N-methyltransferase PRMT1 inhibitor
2020-09-18T10:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797357,Synonym:,interferon receptor 1-bound protein 4 inhibitor
2020-09-18T10:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797357,Synonym:,protein arginine N-methyltransferase 1 inhibitor
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV 930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV-930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,NZV930
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF 373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF-373
2020-09-18T02:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358,Code name:,SRF373
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BA058
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,Code name:,BIM-44058
2020-09-18T01:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359,US brand name:,Tymlos
2020-09-18T01:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797360,US brand name:,3M Cavilon Advanced Skin Protectant
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Chemical structure:,"4-[4-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy}-3-methylphenyl)piperazin-1-yl]-N-(4-fluorophenyl)benzamide"
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC 945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC-945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Code name:,PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,inhaled antifungal PC945
2020-09-18T02:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368,Synonym:,triazole antifungal PC945
2020-09-18T10:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797373,Foreign brand name:,SELG-ESSE
2020-09-18T10:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797373,Synonym:,macrogol 4000-based oral osmotic laxative
2020-09-18T10:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797373,Synonym:,PEG4000/simethicone/sodium sulphate/sodium bicarbonate/electrolytes
2020-09-18T10:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797373,Synonym:,powder-for-oral-solution containing PEG4000/simethicone/sodium sulphate/sodium bicarbonate/electrolytes
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR 2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR-2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Code name:,SHR2554
2020-09-18T06:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374,Synonym:,enhancer of Zeste homolog 2 inhibitor SHR2554
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO 305
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO-305
2020-09-18T04:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383,Code name:,LOXO305
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT 8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT-8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,MT8633
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR 1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR-1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Code name:,TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,anti-c-Met ADC TR1801
2020-09-18T02:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392,Synonym:,TR1801-ADC
2020-09-18T09:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797393,Synonym:,CAd-VEC
2020-09-18T09:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797393,Synonym:,CAdVEC
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Abbreviation:,HER2.CAR AdVST
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-AdVST
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified Ad-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified adenovirus-specific CTLs
2020-09-18T04:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396,Synonym:,HER2-CAR-modified autologous AdVSTs
2020-09-18T09:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797410,Synonym:,V3 myoma
2020-09-18T09:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797410,Synonym:,V3 myoma vaccine
2020-09-18T09:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797410,Synonym:,V3-myoma
2020-09-18T09:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797410,Synonym:,V3-myoma vaccine
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU 104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU-104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Code name:,ISU104
2020-09-18T02:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411,Synonym:,anti-HER3 antibody ISU104
2020-09-18T12:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797412,Code name:,BSG 001
2020-09-18T12:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797412,Code name:,BSG-001
2020-09-18T12:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797412,Code name:,BSG001
2020-09-18T12:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797412,Synonym:,syngenon
2020-09-18T10:23:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797413,Code name:,YE-NEO-001
2020-09-18T08:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414,Code name:,ONM 100
2020-09-18T08:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414,Code name:,ONM-100
2020-09-18T08:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414,Code name:,ONM100
2020-09-18T08:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414,Synonym:,ICG-labeled polymeric micelles ONM-100
2020-09-18T08:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414,Synonym:,pH-activated ICG tracer ONM-100
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous pp65-shLAMP-1 DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65 mRNA-pulsed DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DC vaccine
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,autologous shLAMP-1-pp65-DCs
2020-09-18T04:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472,Synonym:,pp65-shLAMP-1 mRNA DCs
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN 1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN-1181
2020-09-18T02:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474,Code name:,AGEN1181
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Code name:,PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,allogeneic anti-CD19-CAR T lymphocytes PBCAR0191
2020-09-18T01:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475,Synonym:,anti-CD19-CAR allogeneic T cells PBCAR0191
2020-09-18T08:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797482,Synonym:,124I-M5A
2020-09-18T08:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797482,Synonym:,iodine I 124 anti-CEA monoclonal antibody M5A
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing NKTs
2020-09-18T04:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483,Synonym:,G28z.15 NKTs
2020-09-18T09:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797484,Synonym:,NeoVax RCC vaccine
2020-09-18T09:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797484,Synonym:,NeoVax renal cell carcinoma vaccine
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU 300
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU-300
2020-09-18T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485,Code name:,OCU300
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T cells
2020-09-18T04:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486,Synonym:,iC9.GD2.CAR.IL-15 T-cells
2020-09-18T08:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797487,Synonym:,[177Lu]-NeoB
2020-09-18T08:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797487,Synonym:,177Lu-NeoB
2020-09-18T08:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797487,Synonym:,lutetium 177-NeoB
2020-09-18T08:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797487,Synonym:,lutetium Lu 177 DOTA-NeoBOMB1
2020-09-18T05:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797547,Synonym:,64Cu-d(LGTFLKC)
2020-09-18T05:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797547,Synonym:,64Cu-DOTA-ECL1i
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP 1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP-1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,ASP1951
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ 522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ-522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Code name:,PTZ522
2020-09-18T02:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644,Synonym:,anti-GITR agonistic monoclonal antibody PTZ-522
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK 2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK-2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Code name:,VK2019
2020-09-18T06:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645,Synonym:,Epstein-Barr nuclear antigen 1 inhibitor VK-2019
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Code name:,EB 001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Code name:,EB001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,BoNT/E EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,botulinum EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,botulinum type E EB-001
2020-09-18T04:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646,Synonym:,toxin E EB-001
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ 4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ-4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ004309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJ4309
2020-09-18T02:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647,Code name:,TJD5
2020-09-18T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797648,Synonym:,[11C]martinostat
2020-09-18T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797648,Synonym:,martinostat C-11
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY 1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY-1834942
2020-09-18T02:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774,Code name:,BAY1834942
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR 1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR-1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Code name:,SHR1603
2020-09-18T02:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797,Synonym:,OA3-targeted antineoplastic agent SHR-1603
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB 928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB-928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Code name:,AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,A2AR/A2BR antagonist AB928
2020-09-18T01:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798,Synonym:,dual A2AR/A2BR antagonist AB928
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO 176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO-176
2020-09-18T02:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803,Code name:,AO176
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG 350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG-350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Code name:,NG350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Synonym:,oncolytic adenoviral vector expressing anti-CD40 antibody NG-350A
2020-09-18T06:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804,Synonym:,oncolytic adenoviral vector-expressing anti-CD40 agonistic antibody NG-350A
2020-09-18T13:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797805,Code name:,AB 122
2020-09-18T13:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797805,Code name:,AB-122
2020-09-18T13:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797805,Code name:,AB122
2020-09-18T13:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797805,Synonym:,anti-PD-1 monoclonal antibody AB122
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT 014
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT-014
2020-09-18T04:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806,Code name:,LUT014
2020-09-18T12:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797809,Code name:,GP 2250
2020-09-18T12:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797809,Code name:,GP-2250
2020-09-18T12:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797809,Code name:,GP2250
2020-09-18T12:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797809,Synonym:,substance 2250
2020-09-18T09:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797813,Synonym:,MA leaf oil
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb 22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb-22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Code name:,XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,anti-CTLA-4/anti-LAG-3 bispecific monoclonal antibody XmAb22841
2020-09-18T02:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814,Synonym:,CTLA-4xLAG-3 bispecific antibody XmAb22841
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Chemical structure:,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol"
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,A 313
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Arovit
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avibon
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Avitol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Axerol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Biovit-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ido A 50
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Idrurto A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Ledovit A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Micelle A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Mulsal A Megadosis
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Rinocusi Vitaminico
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vitaminoftalmina
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Foreign brand name:,Vogan
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,anti-infective vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,antixerophthalmic vitamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophthol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Axerophtholum
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Biosterol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Lard-Factor
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Oleovitamin A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Ophthalamin
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A alcohol
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A USP
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,vitamin A1
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,Synonym:,Vitaminum A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Aquasol A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Del-Vi-A
2020-09-18T03:55:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839,US brand name:,Pedi-Vit-A
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Chemical structure:,"2-((1R,4R)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol"
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,SGI 9481
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,SGI-9481
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,SGI9481
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,TP 3654
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,TP-3654
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Code name:,TP3654
2020-09-18T10:31:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841,Synonym:,PIM inhibitor TP-3654
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK 4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Code name:,MK4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-leukocyte immunoglobulin-like receptor 2 monoclonal antibody MK-4830
2020-09-18T02:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844,Synonym:,anti-LIR2 monoclonal antibody MK-4830
2020-09-18T11:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797845,Code name:,JAB 3068
2020-09-18T11:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797845,Code name:,JAB-3068
2020-09-18T11:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797845,Code name:,JAB3068
2020-09-18T11:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797845,Synonym:,PTPN11 inhibitor JAB-3068
2020-09-18T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797846,Synonym:,CALR exon 9 mutant peptide vaccine With Montanide ISA-51
2020-09-18T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797846,Synonym:,CALRLong36 peptide vaccine/Montanide ISA-51
2020-09-18T10:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797847,Code name:,CCS 1477
2020-09-18T10:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797847,Code name:,CCS-1477
2020-09-18T10:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797847,Code name:,CCS1477
2020-09-18T10:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797847,Synonym:,p300 HAT/CREB binding protein inhibitor CCS1477
2020-09-18T10:02:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797863,Code name:,DNX 2440
2020-09-18T10:02:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797863,Code name:,DNX-2440
2020-09-18T10:02:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797863,Code name:,DNX2440
2020-09-18T10:02:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797863,Synonym:,oncolytic adenovirus armed with OX40L DNX-2440
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,autologous BCMA-specific CAR T-cells IM21
2020-09-18T04:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877,Synonym:,IM21 CAR-T cells
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG 146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG-146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG0146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG280146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Code name:,HG280146-P1
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Synonym:,class I/IIb HDACi HG146
2020-09-18T07:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880,Synonym:,HDAC I/IIb selective inhibitor HG146
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched autologous T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,autologous anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched T lymphocytes
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1 CAR-T cells
2020-09-18T04:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881,Synonym:,CS1-CAR T lymphocytes
2020-09-18T04:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797882,Synonym:,Bushen Culuan TCM decoction
2020-09-18T04:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797882,Synonym:,Bushen Culuan traditional Chinese medicine decoction
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO 7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO-7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Code name:,RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1 x TIM-3 bispecific antibody RO7121661
2020-09-18T03:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892,Synonym:,anti-PD-1/anti-TIM-3 bispecific antibody RO7121661
2020-09-18T06:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797893,NA,NA
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG 106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG-106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Code name:,ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,4-1BB-directed agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,anti-4-1BB agonistic monoclonal antibody ADG106
2020-09-18T02:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894,Synonym:,CD137-directed agonistic monoclonal antibody ADG106
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Chemical structure:,"cis-4-(para-hydroxyphenyl)-7,4′-dihydroxy-3′,5′-dimethoxy-8-methylisoflavan"
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRX E 002 1
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRX-E-002-1
2020-09-18T05:00:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919,Code name:,TRXE0021
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN 4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN-4659
2020-09-18T02:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920,Code name:,REGN4659
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Abbreviation:,BM-hMSC-D24
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,Ad5-DNX-2401-infected allogeneic bone marrow mesenchymal stem cells
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,Ad5-DNX-2401-infected allogeneic bone marrow MSCs
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,allogeneic BM-hMSC-D24
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,allogeneic BM-hMSC-delta-24-RGD
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,allogeneic bone marrow mesenchymal stem cells loaded with DNX-2401
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,allogeneic bone marrow mesenchymal stem cells loaded with oncolytic adenovirus DNX-2401
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,allogeneic bone marrow mesenchymal stem cells loaded with tasadenoturev
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,BM-hMSC-delta-24-RGD
2020-09-18T12:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921,Synonym:,oncolytic adenovirus Ad5-DNX-2401-infected allogeneic bone marrow mesenchymal stem cells
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Code name:,MK-8742/MK-5172
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,elbasvir-grazoprevir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,grazoprevir-elbasvir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,Synonym:,grazoprevir/elbasvir
2020-09-18T06:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922,US brand name:,Zepatier
2020-09-18T10:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797958,Code name:,CX 188
2020-09-18T10:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797958,Code name:,CX-188
2020-09-18T10:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797958,Code name:,CX188
2020-09-18T10:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797958,Synonym:,anti-PD-1 probody CX-188
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX 008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX-008
2020-09-18T03:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959,Code name:,HX008
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Code name:,AVID 200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Code name:,AVID-200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Code name:,AVID200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Synonym:,TGF-beta 1/3 inhibitor AVID200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Synonym:,TGFb inhibitor AVID200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Synonym:,TGFbeta ligand trap AVID200
2020-09-18T12:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961,Synonym:,TGFbeta-neutralizing agent AVID200
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST 17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST-17
2020-09-18T01:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962,Code name:,GAST17
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,ER galantamine hydrobromide
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,galantamine hydrobromide ER
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,Synonym:,galantamine hydrobromide extended release
2020-09-18T06:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963,US brand name:,Razadyne ER
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG 6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG-6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RG6123
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO 7172508
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO-7172508
2020-09-18T05:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964,Code name:,RO7172508
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell and CD19+ B-cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
2020-09-18T01:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965,Synonym:,alpha/beta T-cell/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE 439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Code name:,KITE439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7 T-cell receptor engineered T cells KITE-439
2020-09-18T04:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966,Synonym:,HPV16 E7-specific HLA-A*02:01-restricted TCR gene engineered autologous T lymphocytes KITE-439
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,ES101
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX 105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Code name:,INBRX105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,anti-PD-L1/CD137 bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x 41BB bispecific antibody INBRX-105
2020-09-18T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967,Synonym:,PDL1 x CD137 bispecific antibody INBRX-105
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,ADCT601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB 601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Code name:,BGB601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,ADC ADCT-601
2020-09-18T02:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273,Synonym:,anti-AXL/PBD ADC ADCT-601
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH 395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH-395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Code name:,NJH395
2020-09-18T02:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283,Synonym:,anti-HER2 ISAC NJH395
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM 010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Code name:,SCM010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose derived stem cells SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,adipose-derived expanded MSCs SCM-010
2020-09-18T01:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284,Synonym:,ADSCs SCM-010
2020-09-18T07:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798288,NA,NA
2020-09-18T08:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798315,Code name:,JNJ 67856633
2020-09-18T08:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798315,Code name:,JNJ-67856633
2020-09-18T08:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798315,Code name:,JNJ67856633
2020-09-18T08:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798315,Synonym:,mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitor JNJ-67856633
2020-09-18T12:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798316,Code name:,PF 06952229
2020-09-18T12:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798316,Code name:,PF-06952229
2020-09-18T12:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798316,Code name:,PF06952229
2020-09-18T12:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798316,Synonym:,TGFbR1 inhibitor PF-06952229
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx 0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx-0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Code name:,MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,E. gallinarum MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,gut microbiota-derived strain MRx0518
2020-09-18T06:29:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317,Synonym:,strain MRx0518
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,allogeneic cord blood-derived CMV/AdV/EBV/BKV-specific CTLs
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,cord blood-derived CMV/AdV/EBV/BKV-specific T cells
2020-09-18T05:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318,Synonym:,UCB-derived CMV/AdV/EBV/BKV-specific T cells
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,bispecific T-cell engager antibody SAR440234
2020-09-18T02:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327,Synonym:,CD123xCD3 bispecific T-cell engager SAR440234
2020-09-18T07:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328,Abbreviation:,GLE/PIB
2020-09-18T07:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328,Code name:,ABT-493/ABT-530
2020-09-18T07:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328,Synonym:,glecaprevir and pibrentasvir
2020-09-18T07:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328,Synonym:,glecaprevir-pibrentasvir
2020-09-18T07:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328,US brand name:,Mavyret
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN 1508052
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN A1
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN-1508052
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN-A1
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN1508052
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DN1508052-01
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Code name:,DNA1
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Synonym:,TLR8 agonist DN-A1
2020-09-18T12:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329,Synonym:,TLR8 agonist DN1508052-01
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,autologous CRISPR-edited CD7-targeting CAR-CD28zeta T cells
2020-09-18T04:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380,Synonym:,CD7.CAR/28zeta CAR CRISPR-edited T cells
2020-09-18T03:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798381,Synonym:,ARG-1 peptide vaccine
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT 774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT-774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Code name:,ACT774312
2020-09-18T05:45:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382,Synonym:,prostaglandin D2 receptor 2 antagonist ACT-774312
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous anti-CD19/20 bispecific CAR-CD28-BBz-EGFRt+-expressing Tn/mem cells
2020-09-18T04:06:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415,Synonym:,autologous Anti-CD19/20 CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing naive and memory T lymphocytes
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Chemical structure:,"2,6-piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-"
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC 122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC-122
2020-09-18T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417,Code name:,CC122
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO 647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO-647
2020-09-18T02:23:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418,Code name:,ALLO647
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV 110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Code name:,ARV110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,androgen receptor PROTAC degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR PROTAC ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,AR-targeted PROTAC protein degrader ARV-110
2020-09-18T02:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419,Synonym:,PROTAC protein degrader ARV-110
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN 3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN-3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Code name:,PRGN3006
2020-09-18T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420,Synonym:,autologous CAR T cells PRGN-3006
2020-09-18T09:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798423,Code name:,MET 4
2020-09-18T09:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798423,Code name:,MET-4
2020-09-18T09:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798423,Code name:,MET4
2020-09-18T08:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798427,Code name:,MEDI 1191
2020-09-18T08:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798427,Code name:,MEDI-1191
2020-09-18T08:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798427,Code name:,MEDI1191
2020-09-18T08:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798427,Synonym:,LNP encapsulated human IL-12A/IL-12B mRNAs MEDI-1191
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA 2013
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA-203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Code name:,IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,ACTengine IMA203
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T cells
2020-09-18T04:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429,Synonym:,IMA203 T-cell product
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG 404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG-404
2020-09-18T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431,Code name:,AMG404
2020-09-18T09:25:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798432,Code name:,XL 092
2020-09-18T09:25:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798432,Code name:,XL-092
2020-09-18T09:25:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798432,Code name:,XL092
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV-011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,ABBV011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC 011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC-011
2020-09-18T02:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433,Code name:,SC011
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-CS1 CAR-expressing T cells
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,anti-SLAMF7 CAR-expressing T lymphocytes
2020-09-18T04:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436,Synonym:,autologous anti-SLAMF7 CAR T cells
2020-09-18T09:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798437,Code name:,ASP 9801
2020-09-18T09:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798437,Code name:,ASP-9801
2020-09-18T09:54:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798437,Code name:,ASP9801
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM 95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM-95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Code name:,BCM95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 (R) CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,BCM-95 CG curcumin extract
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,bio-enhanced BCM-95 CG curcumin
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,Synonym:,curcumin BCM-95CG
2020-09-18T04:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439,US brand name:,Biocurcumax
2020-09-18T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798440,Code name:,GS 5816
2020-09-18T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798440,Code name:,GS-5816
2020-09-18T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798440,Code name:,GS5816
2020-09-18T12:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798441,Code name:,GS 9857
2020-09-18T12:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798441,Code name:,GS-9857
2020-09-18T12:59:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798441,Code name:,GS9857
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS 001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS-001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Code name:,SLS001
2020-09-18T07:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450,Synonym:,WT-1 analog peptide vaccine SLS-001
2020-09-18T08:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798451,Code name:,PF 06651600
2020-09-18T08:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798451,Code name:,PF-06651600
2020-09-18T08:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798451,Code name:,PF06651600
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Chemical structure:,"((S)-2,2-difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone"
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF 06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF-06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF-841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Code name:,PF06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Synonym:,TYK2/JAK1 inhibitor PF-06700841
2020-09-18T04:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452,Synonym:,UNII 3X8387Q25N
2020-09-18T07:17:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798453,Synonym:,NeoTCR-P1
2020-09-18T07:17:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798453,Synonym:,NeoTCR-P1 T cells
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GM-CSF-secreting multiple myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic GVAX myeloma vaccine
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,allogeneic myeloma vaccine with GM-CSF-secreting K562 cells
2020-09-18T01:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454,Synonym:,GVAX allogeneic myeloma vaccine
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL 279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL-279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Code name:,SL279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,agonist redirected checkpoint fusion protein SL-279252
2020-09-18T03:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455,Synonym:,PD1-Fc-OX40L ARC fusion protein
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS 003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS-003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Code name:,CLS003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Synonym:,digoxin-furosemide topical gel CLS003
2020-09-18T07:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476,Synonym:,ICVT product CLS003
2020-09-18T10:37:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798478,Code name:,PCC 100
2020-09-18T10:37:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798478,Code name:,PCC-100
2020-09-18T10:37:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798478,Code name:,PCC100
2020-09-18T08:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798593,Code name:,CPI 818
2020-09-18T08:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798593,Code name:,CPI-818
2020-09-18T08:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798593,Code name:,CPI818
2020-09-18T08:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798593,Synonym:,interleukin-2 inducible T-cell kinase inhibitor CPI-818
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX 471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX-471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Code name:,CTX471
2020-09-18T02:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594,Synonym:,anti-4-1BB agonistic monoclonal antibody CTX-471
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ADC ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW-49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Code name:,ZW49
2020-09-18T02:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595,Synonym:,anti-HER2 bispecific ADC ZW49
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Abbreviation:,IBX
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,MK 3118
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,MK-3118
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,MK3118
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,SCY 078
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,SCY-078
2020-09-18T07:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632,Code name:,SCY078
2020-09-18T09:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633,Code name:,V 941
2020-09-18T09:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633,Code name:,V941
2020-09-18T09:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633,Synonym:,mRNA 5671
2020-09-18T09:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633,Synonym:,mRNA-5671
2020-09-18T09:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633,Synonym:,mRNA-5671 vaccine
2020-09-18T09:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798634,Synonym:,allogeneic MOv19 CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-09-18T09:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798634,Synonym:,anti-folate receptor alpha-CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes
2020-09-18T09:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798634,Synonym:,MOv19-CAR-CD3zeta-4-1BB-expressing allogeneic T cells
2020-09-18T05:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798635,Synonym:,"2,2,4,4-2H cholate"
2020-09-18T05:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798636,Synonym:,24-13C cholate
2020-09-18T05:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798636,Synonym:,carbon C 13 cholic acid
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB 205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB-205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Code name:,AB205
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Synonym:,AB-205 cell product
2020-09-18T06:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637,Synonym:,engineered HUVEC AB-205
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET 140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET-140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Code name:,ET140202
2020-09-18T04:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638,Synonym:,ET140202 autologous T cells
2020-09-18T04:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798639,NA,NA
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STI A1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,STIA1014
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB 001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB-001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Code name:,ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,anti-PDL1 monoclonal antibody ZKAB001
2020-09-18T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649,Synonym:,STI-A1014
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Code name:,SKF 62979
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Bilutac
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,Synonym:,Proftril
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Albenza
2020-09-18T01:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650,US brand name:,Zentel
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU 1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU-1604
2020-09-18T02:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657,Code name:,ADU1604
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LCARB4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Code name:,LLCAR B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,autologous LCAR-B4822M CAR T cells
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,BCMA-specific CAR-expressing T lymphocytes LCAR-B4822M
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M CAR T lymphocytes
2020-09-18T04:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658,Synonym:,LCAR-B4822M-02 cells
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous CD138-specific CAR T lymphocytes
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-sepcific CAR T cells
2020-09-18T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous anti-c-Met/PD-L1 CAR T cells
2020-09-18T04:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662,Synonym:,autologous c-Met/PD-L1-specific CAR T lymphocytes
2020-09-18T09:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798664,Code name:,APL 1202
2020-09-18T09:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798664,Code name:,APL-1202
2020-09-18T09:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798664,Code name:,APL1202
2020-09-18T09:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798664,Synonym:,methionine aminopeptidase type II inhibitor APL-1202
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI 1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI-1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,EBI1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR 1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR-1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,SHR1459
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG 1701
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG-1701
2020-09-18T04:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666,Code name:,TG1701
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH 5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,IPH5401
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Code name:,NN 8210
2020-09-18T02:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695,Synonym:,anti-C5aR-215
2020-09-18T10:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798703,Code name:,iNeo-Vac-P01
2020-09-18T04:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798704,Synonym:,autologous -peptide-pulsed mDC3/8 KRAS vaccine
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ 67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ-67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Code name:,JNJ67571244
2020-09-18T02:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705,Synonym:,anti-CD33/anti-CD3 bispecific antibody JNJ-67571244
2020-09-18T10:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706,Code name:,CYC 140
2020-09-18T10:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706,Code name:,CYC-140
2020-09-18T10:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706,Code name:,CYC140
2020-09-18T10:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706,Synonym:,PLK-1 inhibitor CYC140
2020-09-18T10:35:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706,Synonym:,polo-like kinase 1 inhibitor CYC140
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX 1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Code name:,LX1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Foreign brand name:,Lymfactin
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,AdAptVEGF-C adenoviral vector LX-1101
2020-09-18T01:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716,Synonym:,VEGFC-expressing gene therapeutic LX-1101
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Code name:,C 134
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Code name:,C-134
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Code name:,C134
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Synonym:,C134-HSV-1
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Synonym:,IRS-1 HSV C134
2020-09-18T09:53:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723,Synonym:,oHSV C134
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F 520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F-520
2020-09-18T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724,Code name:,F520
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,CCCR-modified NK92
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,CCCR-NK92 cells
2020-09-18T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735,Synonym:,chimeric co-stimulatory converting receptor-modified NK92 cells
2020-09-18T10:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798738,Code name:,PRT 543
2020-09-18T10:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798738,Code name:,PRT-543
2020-09-18T10:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798738,Code name:,PRT543
2020-09-18T10:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798738,Synonym:,PRMT5 inhibitor PRT543
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Code name:,TT00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,AK A/B inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,multi-kinase inhibitor TT-00420
2020-09-18T04:03:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739,Synonym:,TT 00420
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR 313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR-313
2020-09-18T03:49:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741,Code name:,QR313
2020-09-18T07:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798742,Code name:,CUE 101
2020-09-18T07:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798742,Code name:,CUE-101
2020-09-18T07:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798742,Code name:,CUE101
2020-09-18T07:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798742,Synonym:,anti-HPV16 E7 fusion protein CUE-101
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN 668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN-668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,REGN668
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR 231893
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR-231893
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,Code name:,SAR231893
2020-09-18T06:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743,US brand name:,Dupixent
2020-09-18T10:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748,Code name:,DFP 14927
2020-09-18T10:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748,Code name:,DFP-14927
2020-09-18T10:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748,Code name:,DFP14927
2020-09-18T10:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748,Synonym:,PEGylated DFP-10917
2020-09-18T10:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748,Synonym:,polymeric nucleoside analogue DFP-14927
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAA-T
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Abbreviation:,TAATs
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,autologous tumor antigen-associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived multi-antigen associated cytotoxic T lymphocytes
2020-09-18T04:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753,Synonym:,patient-derived WT1/PRAME/survivin-specific T lymphocytes
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN 02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN-02390
2020-09-18T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754,Code name:,INCAGN02390
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR lentiviral vector-transduced autologous T cells
2020-09-18T04:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757,Synonym:,GPA-TriMAR-T cells
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YT-E001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Code name:,YTE001
2020-09-18T04:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763,Synonym:,autologous EBV-specific TCR T cells YT-E001
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Chemical structure:,"(2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid ethyl ester"
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU 377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU-377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,Code name:,AHU377
2020-09-18T06:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813,US brand name:,Entresto
2020-09-18T07:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798818,Code name:,ORIC 101
2020-09-18T07:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798818,Code name:,ORIC-101
2020-09-18T07:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798818,Code name:,ORIC101
2020-09-18T07:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798818,Synonym:,GR antagonist ORIC-101
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY 1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY-1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Code name:,KY1044
2020-09-18T02:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819,Synonym:,anti-ICOS antibody KY1044
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN 026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN-026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Code name:,KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,anti-HER2 heterodimeric antibody KN026
2020-09-18T02:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820,Synonym:,HER2 bispecific antibody KN026
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Code name:,CG 806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Code name:,CG-026806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Code name:,CG-806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Code name:,CG’806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Code name:,CG806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Synonym:,FLT3/BTK inhibitor CG 806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Synonym:,pan-FLT3/BTK multi-kinase inhibitor CG 806
2020-09-18T10:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821,Synonym:,pan-FLT3/pan-BTK inhibitor CG-806
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP 105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP-105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Code name:,ICP105
2020-09-18T06:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826,Synonym:,FGFR4 antagonist ICP-105
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Foreign brand name:,Bifico
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Synonym:,B. longum/L. acidophilus/E. faecalis probiotic supplement
2020-09-18T04:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827,Synonym:,Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis supplement
2020-09-18T11:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798916,Code name:,RMC 4630
2020-09-18T11:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798916,Code name:,RMC4630
2020-09-18T11:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798916,Synonym:,PTPN11 inhibitor RMC-4630
2020-09-18T11:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798916,Synonym:,SAR442720
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO 3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO-3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Code name:,AUTO3
2020-09-18T04:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924,Synonym:,anti-CD19/CD22 CAR autologous T lymphocytes AUTO3
2020-09-18T10:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926,Code name:,THOR 707
2020-09-18T10:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926,Code name:,THOR-707
2020-09-18T10:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926,Code name:,THOR707
2020-09-18T10:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926,Synonym:,IL-2 variant THOR-707
2020-09-18T10:18:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926,Synonym:,pegylated recombinant IL-2 variant THOR-707
2020-09-18T08:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798929,Synonym:,111In-labeled autologous CMV-pp65-LAMP mRNA loaded dendritic cells
2020-09-18T08:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798929,Synonym:,111In-labeled pp65-LAMP mRNA-loaded mature autologous DCs
2020-09-18T08:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798929,Synonym:,indium In 111-CMV pp65-LAMP mRNA-pulsed autologous DCs
2020-09-18T08:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798929,Synonym:,indium In 111-labeled CMV pp65 peptide-pulsed autologous DCs
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT 5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Code name:,MT5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,ETB targeting HER2 MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,HER2-targeted ETB MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,immunotoxin MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,recombinant fusion protein MT-5111
2020-09-18T06:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930,Synonym:,targeted engineered toxin body MT-5111
2020-09-18T12:53:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798939,Code name:,MK-7690
2020-09-18T12:53:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798939,Code name:,SCH 417690
2020-09-18T12:53:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798939,Code name:,SCH-D
2020-09-18T12:53:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798939,Code name:,SCH417690
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Abbreviation:,DMSA
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Chemical structure:,"Butanedioic Acid, 2,3-Dimercapto-, (2R,3S)-rel-"
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,Synonym:,"Meso 2, 3-Dimercaptosuccinic Acid"
2020-09-18T05:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947,US brand name:,Chemet
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH 902
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH-902
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Code name:,KH902
2020-09-18T05:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956,Synonym:,UNII: 1P05PW62F3
2020-09-18T09:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966,Code name:,TPX 0022
2020-09-18T09:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966,Code name:,TPX-0022
2020-09-18T09:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966,Code name:,TPX0022
2020-09-18T09:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966,Synonym:,MET/Src/CSF1R tyrosine kinase inhibitor TPX-0022
2020-09-18T09:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966,Synonym:,multikinase inhibitor TPX-0022
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX 030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX-030
2020-09-18T02:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967,Code name:,TTX030
2020-09-18T09:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968,Code name:,OT 82
2020-09-18T09:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968,Code name:,OT-82
2020-09-18T09:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968,Code name:,OT82
2020-09-18T09:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968,Synonym:,NAMPTi OT-82
2020-09-18T09:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968,Synonym:,nicotinamide phosphoribosyl transferase inhibitor OT-82
2020-09-18T12:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969,Foreign brand name:,Cantharone
2020-09-18T12:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969,Synonym:,cantharidin
2020-09-18T12:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969,Synonym:,topical cantharidin
2020-09-18T12:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969,Synonym:,topical cantharidine
2020-09-18T12:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969,Synonym:,VP-102
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN 3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN-3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,Code name:,GEN3013
2020-09-18T02:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973,US brand name:,DuoBody-CD3xCD20
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway targeted immunization agent
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway targeted immunotherapy agent
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF pathway-targeted immunotherapeutic
2020-09-18T06:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974,Synonym:,EGF-PTI
2020-09-18T08:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798989,Code name:,ASTX 295
2020-09-18T08:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798989,Code name:,ASTX-295
2020-09-18T08:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798989,Code name:,ASTX295
2020-09-18T08:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798989,Synonym:,MDM2 inhibitor ASTX295
2020-09-18T13:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798990,Synonym:,WT1/PRAME/survivin-specific CTLs
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+ and CD19+ cell-depleted allogeneic PBSCs derived from an unrelated or partially matched donor
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+ T-cell-depleted/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells
2020-09-18T05:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991,Synonym:,CD3+/CD19+ cell-depleted unrelated or partially matched donor-derived allogeneic PBSCs
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB 205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB-205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Code name:,PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/anti-CTLA-4 monoclonal antibody mixture PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD-1/CTLA-4 MabPair PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,anti-PD1/CTLA4 antibodies PSB205
2020-09-18T03:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992,Synonym:,bifunctional MabPair product PSB205
2020-09-18T06:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798993,Synonym:,ModraDoc006/r
2020-09-18T06:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798993,Synonym:,oral docetaxel/ritonavir
2020-09-18T09:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071,Synonym:,sterile nanoparticle-based paclitaxel suspension
2020-09-18T09:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071,Synonym:,sterile nanoparticulate paclitaxel
2020-09-18T09:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071,Synonym:,submicron particle paclitaxel
2020-09-18T09:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071,Synonym:,submicron particle paclitaxel formulation
2020-09-18T09:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071,US brand name:,Nanopac
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN 5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN-5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Code name:,REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMA/anti-CD28 bispecific antibody REGN5678
2020-09-18T03:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093,Synonym:,anti-PSMAxCD28 antibody REGN5678
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Code name:,HPN 536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Code name:,HPN-536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Code name:,HPN536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Code name:,MSLN-specific TriTAC HPN536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Synonym:,mesothelin-targeting T-cell engager HPN536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Synonym:,mesothelin/CD3e-specific TriTAC HPN536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Synonym:,MSLN/CD3e TriTAC HPN536
2020-09-18T09:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094,Synonym:,TriTAC HPN536
2020-09-18T07:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799095,Code name:,PTG 300
2020-09-18T07:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799095,Code name:,PTG-300
2020-09-18T07:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799095,Code name:,PTG300
2020-09-18T07:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799095,Synonym:,hepcidin agonist PTG-300
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK 954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TAK954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Code name:,TD-8954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin 4 receptor agonist TAK-954
2020-09-18T01:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096,Synonym:,serotonin agonist TAK-954
2020-09-18T07:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799097,Synonym:,GHR antisense oligonucleotide IONIS-GHR-LRx
2020-09-18T07:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799097,Synonym:,IONIS-GHR-LRx
2020-09-18T07:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799097,Synonym:,LICA drug IONIS-GHR-LRx
2020-09-18T07:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799097,Synonym:,ligand-conjugated antisense drug IONIS-GHR-LRx
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,GAd-209-FSP
2020-09-18T01:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098,Synonym:,great ape adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,ADP-A2M4CD8
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified MAGE-A4 C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous genetically-modified melanoma antigen A4 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous MAGE-A4 C1032 TCR-modified CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,autologous TCR-transduced MAGE-A4 C1032 CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4 SPEAR CD8alpha T cells
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 CD8alpha T lymphocytes
2020-09-18T04:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099,Synonym:,SPEAR T-cell ADP-A2M4CD8
2020-09-18T10:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799112,Code name:,JNJ 64619178
2020-09-18T10:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799112,Code name:,JNJ-64619178
2020-09-18T10:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799112,Code name:,JNJ64619178
2020-09-18T10:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799112,Synonym:,protein arginine methyltransferase 5 inhibitor JNJ-64619178
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX 07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX-07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Code name:,HLX07
2020-09-18T02:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130,Synonym:,cetuximab biobetter HLX07
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY 1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY-1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY-A
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107G
2020-09-18T05:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135,Code name:,BEY1107P
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A 167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A-167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KL-A167
2020-09-18T03:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136,Code name:,KLA167
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CF367
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CF367-C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CFH367 C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,CFH367-C
2020-09-18T04:44:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197,Code name:,PY-1
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,[18F]AlF-cysVar3 pHLIP
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,18F-AlF-Var3 pHLIP
2020-09-18T06:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307,Synonym:,fluorine F 18-cys-Var3 pHLIP
2020-09-18T13:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799309,Synonym:,89Zr-labeled TAK-164
2020-09-18T13:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799309,Synonym:,89Zr-TAK-164
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Code name:,RGI 2001
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Code name:,RGI-2001
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Code name:,RGI2001
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Synonym:,liposomal alpha-GalCer
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Synonym:,liposomal KRN-7000
2020-09-18T08:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312,Synonym:,liposomal RGI-7000
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Chemical structure:,"urea, N-[4-[4-amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N'-[2-fluoro-5-(trifluoromethyl)phenyl]-"
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Code name:,ACTB-1003
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Code name:,EDP317
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Code name:,EOC 317
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Code name:,EOC-317
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Code name:,EOC317
2020-09-18T09:26:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401,Synonym:,MMKI EOC317
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Code name:,docetaxel-loaded PM
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Foreign brand name:,Nanoxel-M
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Foreign brand name:,NanoxelM
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-loaded PMs
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-loaded polymeric micelles
2020-09-18T06:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405,Synonym:,docetaxel-PM
2020-09-18T10:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799414,Code name:,SHC 014748M
2020-09-18T10:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799414,Code name:,SHC-014748M
2020-09-18T10:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799414,Code name:,SHC014748M
2020-09-18T10:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799414,Synonym:,PI3Kd Inhibitor SHC014748M
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX 20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX-20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Code name:,HLX20
2020-09-18T03:46:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415,Synonym:,PD-L1-targeting Monoclonal Antibody HLX20
2020-09-18T07:12:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799422,Abbreviation:,68Ga-THP-PSMA
2020-09-18T07:12:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799422,Synonym:,gallium Ga 68-labeled THP-PSMA
2020-09-18T07:12:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799422,Synonym:,gallium Ga 68-tris(hydroxypyridinone)-prostate-specific membrane antigen
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Code name:,CA 102N
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Code name:,CA102N
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Synonym:,HA-Nim Conjugate CA102N
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Synonym:,HA-Nimesulide
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Synonym:,Hyaluronic Acid Nimesulide-NH2 Bioconjugate
2020-09-18T09:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428,Synonym:,Nim-HA Conjugate
2020-09-18T11:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799429,Code name:,AZD 9833
2020-09-18T11:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799429,Code name:,AZD9833
2020-09-18T11:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799429,Synonym:,SERD AZD9833
2020-09-18T13:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799435,Synonym:,Xiaoai Jiedu recipe
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Code name:,KO 539
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Code name:,KO-539
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Code name:,KO539
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Synonym:,menin-KMT2A inhibitor KO 539
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Synonym:,menin-mixed lineage leukemia protein-protein interaction inhibitor KO 539
2020-09-18T09:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439,Synonym:,menin-MLL inhibitor KO-539
2020-09-18T08:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799443,Code name:,JAB 3312
2020-09-18T08:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799443,Code name:,JAB-3312
2020-09-18T08:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799443,Code name:,JAB3312
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM 120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM-120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Code name:,NGM120
2020-09-18T02:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444,Synonym:,GFRAL antagonistic monoclonal antibody NGM120
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Chemical structure:,"(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridineuridine, 2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydro-, (4R)"
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Code name:,E7727
2020-09-18T05:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445,Synonym:,CDA inhibitor E7727
2020-09-18T08:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799446,NA,NA
2020-09-18T09:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799448,Synonym:,Marrow Infiltrating Lymphocytes-Non-Small Cell Lung Cancer
2020-09-18T09:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799448,Synonym:,MILs-NSCLC
2020-09-18T09:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799448,Synonym:,NSCLC-specific MILs
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Foreign brand name:,Mikei Red Reishi Essence EX
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Synonym:,concentrated Ganoderma lucidum extract
2020-09-18T05:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459,Synonym:,concentrated red Reishi mushroom extract
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO 4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO-4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Code name:,AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,anti-TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,RQR8/TRBC1 CAR T cells AUTO4
2020-09-18T03:51:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460,Synonym:,TRBC1-targeting CAR T cells AUTO4
2020-09-18T09:15:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799500,Code name:,WO 2085
2020-09-18T09:15:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799500,Code name:,WO-2085
2020-09-18T09:15:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799500,Code name:,WO2085
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Code name:,Cal-1
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 lentiviral vector sh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LV-expressing sh5/C46 Cal-1
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,anti-HIV-1 LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,Cal-1 vector
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46
2020-09-18T02:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502,Synonym:,LVsh5/C46 vector
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI 134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Code name:,AGI134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,aGal AGI-134
2020-09-18T01:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503,Synonym:,anti-alpha Gal immunotherapeutic AGI-134
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP 1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP-1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Code name:,HQP1351
2020-09-18T04:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639,Synonym:,multi-kinase inhibitor HQP1351
2020-09-18T11:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640,Code name:,SHR 9549
2020-09-18T11:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640,Code name:,SHR-9549
2020-09-18T11:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640,Code name:,SHR9549
2020-09-18T11:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640,Synonym:,selective estrogen receptor degrader SHR9549
2020-09-18T11:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640,Synonym:,selective estrogen receptor downregulator SHR9549
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Code name:,XLCART001
2020-09-18T02:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644,Synonym:,CD19-specific CAR-T cells XLCART001
2020-09-18T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799646,Foreign brand name:,Aqualief
2020-09-18T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799646,Synonym:,oral mucoadhesive tablet
2020-09-18T05:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799647,NA,NA
2020-09-18T08:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799658,Code name:,BI 905677
2020-09-18T08:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799658,Code name:,BI-905677
2020-09-18T08:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799658,Code name:,BI905677
2020-09-18T08:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799658,Synonym:,anti-LRP5/6 nanobody BI 905677
2020-09-18T07:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799659,Synonym:,68Ga-PSMA-617
2020-09-18T07:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799659,Synonym:,gallium-68 PSMA-617
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP 1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP-1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Code name:,TP1287
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate
2020-09-18T01:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663,Synonym:,alvocidib phosphate TP-1287
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG 0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG-0418
2020-09-18T01:49:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671,Code name:,ZG0418
2020-09-18T06:31:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799672,Abbreviation:,EDP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Chemical structure:,"Sm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylene)phosphonic acidSm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayltetrakis(methylene)tetrakisphosphonic acid"
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,153 Sm-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,153Sm-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,Synonym:,Sm-153-DOTMP
2020-09-18T05:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673,US brand name:,CycloSam
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY 2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY-2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Code name:,BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR antagonist BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,AhR inhibitor BAY2416964
2020-09-18T03:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706,Synonym:,aryl hydrocarbon receptor inhibitor BAY2416964
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB 383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Code name:,TNB383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-BsAb TNB-383B
2020-09-18T02:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707,Synonym:,anti-BCMA x aCD3 T-cell engaging bispecific antibody TNB-383B
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Abbreviation:,hADM
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Synonym:,D-ADM
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,Synonym:,human ADM
2020-09-18T05:59:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709,US brand name:,DermACELL
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM 2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM-2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Code name:,IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific CD20xCD3 IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,bispecific IgM antibody IGM2323
2020-09-18T02:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710,Synonym:,IgM pentamer IGM2323
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN 437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN-437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN-437c
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Code name:,FCN437
2020-09-18T05:16:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711,Synonym:,cyclin-dependent kinase 4/6 inhibitor FCN-437
2020-09-18T06:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799712,Abbreviation:,DS
2020-09-18T06:05:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799712,Synonym:,digestive starch
2020-09-18T06:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799713,Synonym:,flax lignan
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM 43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM-43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Code name:,HM43239
2020-09-18T06:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742,Synonym:,FMS-like tyrosine kinase 3 inhibitor HM43239
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ PBMC HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Code name:,SQZ-PBMC-HPV
2020-09-18T02:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743,Synonym:,APCs expressing HPV16 E6/E7 SQZ-PBMC-HPV
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG-199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Code name:,AMG199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17 x anti-CD3 BiTE AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,anti-MUC17/CD3 bispecific antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,BiTE antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17/CD3-directed bispecific T-cell engager antibody AMG 199
2020-09-18T02:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758,Synonym:,MUC17xCD3 bispecific T-cell engager AMG 199
2020-09-18T10:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799759,Synonym:,KRAS peptide vaccine
2020-09-18T10:41:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799759,Synonym:,pooled mutant KRAS peptide vaccine
2020-09-18T08:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799760,Code name:,HS 130
2020-09-18T08:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799760,Code name:,HS-130
2020-09-18T08:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799760,Code name:,HS130
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Code name:,EO 2401
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Code name:,EO-2401
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Code name:,EO2401
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Synonym:,cancer vaccine EO2401
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Synonym:,microbial-derived peptide vaccine EO2401
2020-09-18T09:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761,Synonym:,microbiome-derived therapeutic cancer vaccine EO2401
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,[211At]OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,211At-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine 211-labeled anti-CD38 monoclonal antibody OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine At 211 anti-CD38 MoAb OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,astatine-211-OKT10-B10
2020-09-18T04:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762,Synonym:,At211-OKT10-B10
2020-09-18T09:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799763,Code name:,H2NVAC
2020-09-18T09:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799763,Synonym:,HER2 peptide vaccine H2NVAC
2020-09-18T09:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799763,Synonym:,HER2 specific helper T-cell epitope vaccine H2NVAC
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV 471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Code name:,ARV471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,ER alpha PROTAC protein degrader ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,estrogen receptor alpha PROTAC protein degrader ARV-471
2020-09-18T06:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764,Synonym:,PROTAC protein degrader ARV-471
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,anti-TnMUC1-CAR-expressing autologous T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous anti-TnMUC1-CAR-expressing T lymphocytes
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous CART-TnMUC1 cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous Tn-MUC1-specific CAR T cells
2020-09-18T04:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771,Synonym:,autologous TnMUC1-targeted genetically-modified CAR T cells
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL 200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL-200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Code name:,CSL200
2020-09-18T04:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772,Synonym:,human gamma-globinG16D/short-hairpin RNA734-transduced CD34-positive cells CSL200
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB 102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Code name:,MB102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,anti CD123-CAR/CD28-CD3zeta-EGFRt-expressing autologous T lymphocytes MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,autologous CD123CAR-CD28-CD3zeta/EGFRt+ T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123-CD28-CD3zeta.EGFRt+ autologous T cells MB-102
2020-09-18T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773,Synonym:,CD123CAR-CD28-CD3zeta-EGFRt lentiviral-transduced autologous T lymphocytes MB-102
2020-09-18T10:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799774,Code name:,CYT 0851
2020-09-18T10:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799774,Code name:,CYT-0851
2020-09-18T10:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799774,Code name:,CYT0851
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Code name:,JNJ 53718678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Code name:,JNJ-53718678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Code name:,JNJ-678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Code name:,JNJ-8678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Code name:,JNJ53718678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Synonym:,respiratory syncytial virus fusion protein inhibitor JNJ-53718678
2020-09-18T11:23:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775,Synonym:,RSV F protein inhibitor JNJ-53718678
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Code name:,MEDI 5395
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Code name:,MEDI-5395
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Code name:,MEDI5395
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Synonym:,oncolytic NDV MEDI5395
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Synonym:,recNDV(GM-CSF)
2020-09-18T09:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776,Synonym:,recombinant NDV expressing GM-CSF
2020-09-18T08:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799793,Synonym:,111In-DOTA-h11B6
2020-09-18T08:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799793,Synonym:,indium-111 radiolabeled h11B6
2020-09-18T01:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796,US brand name:,Alantel
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Foreign brand name:,Salovum
2020-09-18T03:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798,Synonym:,AF-enriched egg yolk powder supplement
2020-09-18T11:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799807,Code name:,PMD 026
2020-09-18T11:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799807,Code name:,PMD-026
2020-09-18T11:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799807,Code name:,PMD026
2020-09-18T11:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799807,Synonym:,RSK inhibitor PMD-026
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG 1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG-1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Code name:,TG1801
2020-09-18T02:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809,Synonym:,bispecific monoclonal antibody TG-1801
2020-09-18T07:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799811,Abbreviation:,EPA-FFA
2020-09-18T07:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799811,Synonym:,eicosapentaenoic acid-free fatty acid
2020-09-18T07:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836,Chemical structure:,immunoglobulin G1 anti-(human interleukin-23) humanized mouse monoclonal gamma1 heavy chain (219-214')-disulfide with humanized mouse monoclonal kappa light chain dimer (225-225'':228-228'')-bisdisulfide
2020-09-18T07:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836,Code name:,MK-3222
2020-09-18T07:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836,Synonym:,"immunoglobulin G1, anti-(human interleukin 23) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer"
2020-09-18T07:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836,US brand name:,Iluyma
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Code name:,BI 1701963
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Code name:,BI-1701963
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Code name:,BI1701963
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Synonym:,PPI Inhibitor BI 1701963
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Synonym:,protein-protein interaction inhibitor BI 1701963
2020-09-18T10:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903,Synonym:,SOS1:KRAS interaction inhibitor BI 1701963
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG 116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG-116
2020-09-18T02:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904,Code name:,ADG116
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL 62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL-62
2020-09-18T02:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905,Code name:,MIL62
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Code name:,E 7766
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Code name:,E-7766
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Code name:,E7766
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Code name:,MBSA E7766
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Synonym:,stimulator of interferon genes agonist E7766
2020-09-18T08:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924,Synonym:,Sting agonist E7766
2020-09-18T08:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799933,Code name:,FF 10850
2020-09-18T08:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799933,Code name:,FF-10850
2020-09-18T08:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799933,Code name:,FF10850
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT 053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT-053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Code name:,CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,anti-BCMA-CAR-41BB-CD3zeta-expressing T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,BCMA Car-T (CT053)
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CAR-BCMA T cells CT053
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T
2020-09-18T04:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961,Synonym:,CT053 CAR-BCMA T cells
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX 110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX-110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX101
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Code name:,CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR CRISPR-edited T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic anti-CD19 CAR-T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9 gene-editing CD19-directed CAR T cells CTX110
2020-09-18T01:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962,Synonym:,allogeneic CRISPR-Cas9-engineered anti-CD19 CAR T cells CTX110
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Code name:,GRT C903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Code name:,GRT-C903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Code name:,GRTC903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Synonym:,priming cancer vaccine GRT-C903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Synonym:,priming vaccine GRT-C903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Synonym:,shared neoantigen cancer vaccine prime GRT-C903
2020-09-18T09:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972,Synonym:,shared neoantigen priming cancer vaccine GRT-C903
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Code name:,GRT R904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Code name:,GRT-R904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Code name:,GRTR904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Synonym:,boosting cancer vaccine GRT-R904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Synonym:,boosting vaccine GRT-R904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Synonym:,Shared Neoantigen Boosting Cancer Vaccine GRT-R904
2020-09-18T09:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974,Synonym:,shared neoantigen cancer vaccine boost GRT-R904
2020-09-18T09:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799975,Code name:,SER 401
2020-09-18T09:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799975,Code name:,SER-401
2020-09-18T09:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799975,Code name:,SER401
2020-09-18T09:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799975,Synonym:,microbiome-based therapeutic SER-401
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,[18F]-C-SNAT4
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,18F C SNAT4
2020-09-18T06:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978,Synonym:,18F-C-SNAT4
2020-09-18T07:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799979,Synonym:,68Ga-FAPi-46
2020-09-18T07:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799979,Synonym:,gallium-68-FAPi-46
2020-09-18T11:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799980,Code name:,SB 11285 (CN); SB-11285 (CN); SB11285
2020-09-18T11:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799980,Code name:,SB-11285
2020-09-18T11:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799980,Code name:,SB11285
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,CLN 081
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,CLN-081
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,CLN081
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,TAS 6417
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,TAS-6417
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Code name:,TAS6417
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Synonym:,EGFR mutant-specific inhibitor CLN-081
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Synonym:,mutation-specific EGFR TKI TAS6417
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Synonym:,pan- EGFR inhibitor CLN-081
2020-09-18T10:09:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981,Synonym:,pan-mutation-selective EGFR tyrosine kinase Inhibitor CLN-081
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,anti-CD3/CD7-RTA immunotoxin
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,Synonym:,CD3/CD7-ricin A IT
2020-09-18T02:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985,US brand name:,T-Guard
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,ADC OBT076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,Anti-CD205
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN 1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN-1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,MEN1309
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT 076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT-076
2020-09-18T02:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986,Code name:,OBT076
2020-09-18T06:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799987,Chemical structure:,"4,4'-(15,20-diphenyl-7,8(or 12,13 or 17,18)-dihydro-21H,23H-porphine-5,10-diyl)bisbenzenesulfonic acid, mixture of three isomers A, B and C (25%,50%,25%)"
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB 1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB-1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Code name:,GB1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Synonym:,integrin alpha-M agonist GB1275
2020-09-18T05:11:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988,Synonym:,integrin CD11b agonist GB1275
2020-09-18T07:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799989,Code name:,IPN 60090
2020-09-18T07:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799989,Code name:,IPN-60090
2020-09-18T07:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799989,Code name:,IPN60090
2020-09-18T12:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799990,Code name:,ATP 128
2020-09-18T12:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799990,Code name:,ATP-128
2020-09-18T12:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799990,Code name:,ATP128
2020-09-18T12:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799990,Synonym:,Z12-multiE/TLR agonist domain ATP128
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS 8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS-8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Code name:,LNS8801
2020-09-18T07:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991,Synonym:,GPER agonist LNS8801
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Chemical structure:,(4-(2-hydroxy-2-methylpropyl)piperidin-1-yl)(5-methoxy-1H-indol-2-yl)methanone
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP 9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Code name:,ASP9521
2020-09-18T01:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521,Synonym:,17βHSD5 inhibitor ASP9521
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,Foreign brand name:,Bag Balm
2020-09-18T01:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment,US brand name:,Bag Balm
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Code name:,CTM-N2D
2020-09-18T01:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069,Synonym:,allogeneic NKG2DL-targeting CAR-gd T cells
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ 3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ-3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQ3370
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQL70-SQP33
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Code name:,SQL70/SQP33
2020-09-18T06:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071,Synonym:,doxorubicin prodrug SQP33/prodrug-activating biomaterial SQL70
2020-09-18T07:33:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800073,NA,NA
2020-09-18T07:12:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800117,Code name:,AP 002
2020-09-18T07:12:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800117,Code name:,AP-002
2020-09-18T07:12:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800117,Code name:,AP002
2020-09-18T11:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800118,Code name:,IMSA 101
2020-09-18T11:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800118,Code name:,IMSA-101
2020-09-18T11:49:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800118,Code name:,IMSA101
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN 5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN-5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Code name:,REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA x anti-CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-BCMA/CD3 bispecific antibody REGN5459
2020-09-18T02:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119,Synonym:,anti-CD3/anti-BCMA bispecific antibody REGN5459
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI-999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Code name:,OBI999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,anti-globo H/MMAE ADC OBI 999
2020-09-18T02:35:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120,Synonym:,OBI-888/MMAE ADC OBI-999
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART CS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCART-CS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Code name:,UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogeneic TALEN gene-edited CAR T cells UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,allogenic engineered T cells expressing anti- CS1 CAR UCARTCS1A
2020-09-18T01:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121,Synonym:,UCARTCS1A cells
2020-09-18T10:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122,Code name:,NKTR 255
2020-09-18T10:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122,Code name:,NKTR-255
2020-09-18T10:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122,Code name:,NKTR255
2020-09-18T10:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122,Synonym:,IL-15 receptor agonist NKTR-255
2020-09-18T10:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122,Synonym:,long-acting polymer-engineered IL-15 conjugate NKTR-255
2020-09-18T07:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800123,Synonym:,bupropion immediate release
2020-09-18T07:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800123,Synonym:,IR bupropion
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV 151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV-151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ABBV151
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX 115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX-115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Code name:,ARGX115
2020-09-18T02:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125,Synonym:,anti-glycoprotein A repetitions predominant monoclonal antibody ABBV-151
2020-09-18T08:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800126,Code name:,HH1
2020-09-18T08:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800126,Synonym:,anti-CD37 monoclonal antibody HH1
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120-34
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL 120-34A
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL-120
2020-09-18T05:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129,Code name:,SEL120
2020-09-18T11:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800130,Code name:,GSK 3745417
2020-09-18T11:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800130,Code name:,GSK-3745417
2020-09-18T11:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800130,Code name:,GSK3745417
2020-09-18T11:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800130,Synonym:,stimulator of interferon genes agonist GSK3745417
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34-positive PBSCs
2020-09-18T04:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131,Synonym:,autologous CD34+ PBSCs
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,autologous CAR-19/CAR-20-T cells Hu1928-Hu20BB
2020-09-18T02:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198,Synonym:,Hu1928-Hu20BB
2020-09-18T09:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199,Code name:,SNDX 5613
2020-09-18T09:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199,Code name:,SNDX-5613
2020-09-18T09:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199,Code name:,SNDX5613
2020-09-18T09:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199,Synonym:,menin-mixed lineage leukemia protein-protein interaction inhibitor SNDX-5613
2020-09-18T09:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199,Synonym:,menin-MLL inhibitor SNDX-5613
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD 0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD-0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Code name:,WSD0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Synonym:,BBB penetrable EGFR/EGFRvIII inhibitor WSD0922-FU
2020-09-18T06:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200,Synonym:,EGFR mutant inhibitor WSD0922-FU
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO 715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Code name:,ALLO715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,ALLO-715 cells
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,alloCAR T ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,anti-BCMA allogeneic CAR T cells ALLO-715
2020-09-18T01:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201,Synonym:,BCMA allogeneic CAR T cells ALLO-715
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,(64Cu)-labeled PSMA-targeting -PEG Cy5.5-C' dots
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dots
2020-09-18T05:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203,Synonym:,64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,Synonym:,fermented soy
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,Synonym:,fermented soy extract
2020-09-18T06:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204,US brand name:,Q-Can Plus
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Abbreviation:,BXM
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Chemical structure:,"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate"
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,Synonym:,"carbonic acid, (((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl ester"
2020-09-18T04:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205,US brand name:,Xofluza
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI 0209
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI-0209
2020-09-18T06:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217,Code name:,CPI0209
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB 680
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB-680
2020-09-18T05:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218,Code name:,AB680
2020-09-18T06:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800220,Synonym:,18F-BMS-986229
2020-09-18T06:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800220,Synonym:,fluorine F 18-labeled BMS-986229
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF 07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Code name:,PF07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-CD3 x anti-GUCY2C bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,anti-GUCY2C/anti-CD3 bispecific antibody PF-07062119
2020-09-18T02:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221,Synonym:,T-cell bispecific antibody PF-07062119
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,BNT 131
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,BNT-131
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,BNT131
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,SAR 441000
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,SAR-441000
2020-09-18T07:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230,Code name:,SAR441000
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR 442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR-442085
2020-09-18T02:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231,Code name:,SAR442085
2020-09-18T12:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800232,Code name:,LHC 165
2020-09-18T12:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800232,Code name:,LHC-165
2020-09-18T12:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800232,Code name:,LHC165
2020-09-18T12:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800233,Synonym:,[U-13C]glutamine
2020-09-18T12:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800233,Synonym:,U-13C-Gln
2020-09-18T12:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800233,Synonym:,U-13C-glutamine
2020-09-18T12:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800234,Synonym:,[U-13C]lactate
2020-09-18T12:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800234,Synonym:,U-13C-lactate
2020-09-18T12:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800235,Synonym:,[U-13C]fructose
2020-09-18T12:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800235,Synonym:,U-13C-fructose
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,ADC SKB264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB 264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB-264
2020-09-18T03:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236,Code name:,SKB264
2020-09-18T08:21:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800237,Code name:,LY 3499446
2020-09-18T08:21:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800237,Code name:,LY-3499446
2020-09-18T08:21:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800237,Code name:,LY3499446
2020-09-18T08:21:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800237,Synonym:,KRAS-G12C inhibitor LY3499446
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM 4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM-4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Code name:,CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,CRAC inhibitor CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,orai Ca2+ channel inhibitor CM4620
2020-09-18T04:57:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239,Synonym:,orai1 inhibitor CM4620
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Code name:,JZP 458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Code name:,JZP-458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Code name:,JZP458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Code name:,PF743
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Synonym:,crisantaspase biobetter JZP-458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Synonym:,RC-P JZP-458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Synonym:,recombinant Asparaginase erwinia chrysanthemi JZP-458
2020-09-18T11:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241,Synonym:,recombinant crisantaspase JZP-458
2020-09-18T07:12:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800242,Synonym:,68Ga-PSMA-11-gadoxetate
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Abbreviation:,18F-PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Abbreviation:,F-18-PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,[18F]-PSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,18FPSMA-1007
2020-09-18T06:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312,Synonym:,fluorine-18 PSMA-1007
2020-09-18T12:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800313,Code name:,BNT 411
2020-09-18T12:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800313,Code name:,BNT-411
2020-09-18T12:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800313,Code name:,BNT411
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX 009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX-009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Code name:,HX009
2020-09-18T03:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318,Synonym:,anti-PD1/CD47 bi-specific antibody fusion protein HX009
2020-09-18T11:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800319,Code name:,LX 039
2020-09-18T11:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800319,Code name:,LX-039
2020-09-18T11:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800319,Code name:,LX039
2020-09-18T11:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800319,Synonym:,SERD LX-039
2020-09-18T09:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800320,Code name:,ORCA 010
2020-09-18T09:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800320,Code name:,ORCA-010
2020-09-18T09:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800320,Code name:,ORCA010
2020-09-18T09:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800320,Synonym:,modified Ad5 ORCA-010
2020-09-18T08:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800350,Code name:,CX 1003
2020-09-18T08:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800350,Code name:,CX-1003
2020-09-18T08:19:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800350,Code name:,CX1003
2020-09-18T12:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351,Code name:,CX 1106
2020-09-18T12:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351,Code name:,CX-1106
2020-09-18T12:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351,Code name:,CX1106
2020-09-18T12:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351,Synonym:,TS inhibitor CX1106
2020-09-18T12:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351,Synonym:,TSI CX1106
2020-09-18T13:17:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800362,Chemical structure:,"4-((5aR,6S,7S,8R,8aS)-7-((dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile"
2020-09-18T13:17:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800362,Code name:,eFT 226
2020-09-18T13:17:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800362,Code name:,eFT-226
2020-09-18T10:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800369,Code name:,PRT 811
2020-09-18T10:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800369,Code name:,PRT-811
2020-09-18T10:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800369,Code name:,PRT811
2020-09-18T10:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800369,Synonym:,protein arginine methyltransferase 5 inhibitor PRT811
2020-09-18T10:11:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800374,Code name:,IMP 4297
2020-09-18T10:11:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800374,Code name:,IMP-4297
2020-09-18T10:11:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800374,Code name:,IMP4297
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI 110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI-110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Code name:,IBI110
2020-09-18T02:42:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401,Synonym:,anti-LAG-3 monoclonal antibody IBI110
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT 312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT-312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,BNT312
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN 1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN-1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Code name:,GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,anti-CD40/anti-CD137 bispecific agonist monoclonal antibody GEN1042
2020-09-18T02:22:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410,Synonym:,DuoBody-CD40x4-1BB GEN1042
2020-09-18T11:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800414,Synonym:,11-valent recombinant HPV vaccine
2020-09-18T11:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800414,Synonym:,11-valent recombinant human papillomavirus vaccine
2020-09-18T11:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800414,Synonym:,11-valent recombinant human papillomavirus vaccine (Hansenula polymorpha)
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,ARS 3248
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,ARS-3248
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,ARS3248
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,JNJ 74699157
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,JNJ-74699157
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Code name:,JNJ74699157
2020-09-18T08:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416,Synonym:,G12C mutant KRAS protein inhibitor JNJ-74699157
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD 9008
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD-9008
2020-09-18T06:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418,Code name:,DZD9008
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Code name:,TregGraft
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Code name:,TRGFT 201
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Code name:,TRGFT-201
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Code name:,TRGFT201
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Synonym:,partially engineered and enriched Treg donor graft TRGFT-201
2020-09-18T10:12:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419,Synonym:,T-cell-depleted graft with additional infusion of conventional T cells and regulatory T cells
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Code name:,REGN 5093
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Code name:,REGN-5093
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Code name:,REGN5093
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Synonym:,anti-c-Met bispecific antibody REGN5093
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Synonym:,METxMET antibody REGN5093
2020-09-18T09:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420,Synonym:,METxMET bispecific antibody REGN5093
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV 2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV-2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Code name:,IOV2001
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs from ibrutinib-treated CLL patients
2020-09-18T04:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421,Synonym:,autologous PBLs IOV-2001
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN 1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN-1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,AGEN1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS 1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS-1423
2020-09-18T04:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422,Code name:,GS1423
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Code name:,MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,autologous tetravalent DC vaccine MIDRIX4-LUNG
2020-09-18T04:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431,Synonym:,tetravalent autologous dendritic cell vaccine MIDRIX4-LUNG
2020-09-18T10:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800432,NA,NA
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,(18)F-NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,[18F]NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,18F NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,18F-NOS
2020-09-18T06:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445,Synonym:,FNOS
2020-09-18T13:14:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800447,Synonym:,89Zr-DFO-SC16.56
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QC ICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QC-ICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Code name:,6QCICG
2020-09-18T05:09:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448,Synonym:,fluorescently quenched protease substrate probe 6QC-ICG
2020-09-18T10:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800449,Code name:,CB 5339
2020-09-18T10:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800449,Code name:,CB-5339
2020-09-18T10:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800449,Code name:,CB5339
2020-09-18T10:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800450,Synonym:,CB 5339 tosylate
2020-09-18T10:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800450,Synonym:,CB-5339 tosylate
2020-09-18T10:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800450,Synonym:,CB5339 tosylate
2020-09-18T11:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800451,Code name:,SYNB 1891
2020-09-18T11:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800451,Code name:,SYNB-1891
2020-09-18T11:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800451,Code name:,SYNB1891
2020-09-18T11:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800451,Synonym:,STING-expressing Escherichia coli strain SYNB1891
2020-09-18T11:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800468,Code name:,BMS 986301
2020-09-18T11:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800468,Code name:,BMS-986301
2020-09-18T11:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800468,Code name:,BMS986301
2020-09-18T10:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800470,Code name:,PLX 038
2020-09-18T10:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800470,Code name:,PLX-038
2020-09-18T10:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800470,Code name:,PLX038
2020-09-18T10:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800470,Synonym:,pegylated SN-38 PLX038
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,anti-TAG ARC-T cells directed by BCMA bi-valent/TAG SparX protein
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,ARC-T plus anti-BCMA SparX
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,immunotherapeutic combination agent SparX protein plus CART-ddBCMA
2020-09-18T02:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471,Synonym:,TAG-containing SparX /bivalent BCMA-targeted ARC-T cells
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Code name:,HB 201
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Code name:,HB-201
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Code name:,HB201
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Synonym:,arenavirus vector-based vaccine HB-201
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Synonym:,arenavirus vector-based vaccine-expressing HPV 16 E7E6 HB-201
2020-09-18T07:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472,Synonym:,HB-201 cancer vaccine
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,Code name:,SN132D
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,Synonym:,manganese-based macromolecular contrast agent SN132D
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,Synonym:,manganese-containing nanoparticle contrast agent SN132D
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,Synonym:,MRI contrast agent SN132D
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,Synonym:,nanoparticle-based contrast agent with manganese SN132D
2020-09-18T09:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590,US brand name:,SpagoPix
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Code name:,ASP 7517
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Code name:,ASP-7517
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Code name:,ASP7517
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Synonym:,WT1-loaded aAVC immunotherapeutic ASP7517
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Synonym:,WT1-loaded aAVCs ASP7517
2020-09-18T13:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591,Synonym:,WT1-loaded artificial adjuvant vector cells ASP7517
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO 7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO-7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Code name:,RO7227166
2020-09-18T05:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608,Synonym:,CD19-4-1BBL RO7227166
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW 702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW-702
2020-09-18T03:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617,Code name:,CCW702
2020-09-18T08:41:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800618,Code name:,M 3258
2020-09-18T08:41:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800618,Code name:,M-3258
2020-09-18T08:41:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800618,Code name:,M3258
2020-09-18T08:41:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800618,Synonym:,immunoproteasome inhibitor M3258
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT 155
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT-155
2020-09-18T05:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619,Code name:,FPT155
2020-09-18T05:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800675,Chemical structure:,"8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine"
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-24831754-ZAE
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-28431754
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,JNJ-28431754-AAA
2020-09-18T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676,Code name:,TA-7284
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG 201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG-201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Code name:,MTG201
2020-09-18T01:23:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680,Synonym:,Ad5-SGE-REIC/Dkk-3
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,fecal microbiota preparation delivery capsule
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMPCapDE
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT Capsule DE
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT capsule delivery
2020-09-18T06:45:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681,Synonym:,FMT DE capsule
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN 2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN-2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Code name:,AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-4-1BB agonistic monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 agonist monoclonal antibody AGEN2373
2020-09-18T02:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682,Synonym:,anti-CD137 monoclonal antibody AGEN2373
2020-09-18T08:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686,Code name:,CMC 001
2020-09-18T08:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686,Code name:,CMC-001
2020-09-18T08:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686,Code name:,CMC001
2020-09-18T08:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686,Synonym:,manganese-based contrast agent CMC 001
2020-09-18T08:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686,US brand name:,Mangoral
2020-09-18T09:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800687,Chemical structure:,"trans-4-(7-benzyl-4-imino-5,6-diphenylpyrrolo[2,3-d]pyrimidin-3-yl)cyclohexan-1-ol"
2020-09-18T09:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800687,Code name:,ML 246
2020-09-18T09:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800687,Code name:,ML-246
2020-09-18T09:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800687,Code name:,ML246
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,BCAR20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR 20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Code name:,PBCAR-20A
2020-09-18T01:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688,Synonym:,allogeneic anti-CD20 CAR T lymphocytes PBCAR20A
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG 509
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG-509
2020-09-18T04:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690,Code name:,AMG509
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN 101
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN-101
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Code name:,ALPN101
2020-09-18T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691,Synonym:,ICOSL vIgD-Fc
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Chemical structure:,N-oleyl-phosphatidylethanolamine/epigallocatechin gallate
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,N-oleoyl-PE/EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,NOPE plus EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,NOPE-EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,NOPE/EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,OEA-PE/EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,Synonym:,oleoyl ethanolamine-phosphatidylethanolamine plus EGCG
2020-09-18T09:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692,US brand name:,PhosphoLean
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS-004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,JS004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB 004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB-004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Code name:,TAB004
2020-09-18T02:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693,Synonym:,anti-B- and T-lymphocyte attenuator monoclonal antibody TAB004
2020-09-18T02:08:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800694,Abbreviation:,AEO
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Chemical structure:,"7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one"
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD 7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD-7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Code name:,AZD7648
2020-09-18T06:10:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695,Synonym:,DNA-dependent protein kinase inhibitor AZD7648
2020-09-18T05:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800700,Synonym:,skin cleanser with chlorhexidine gluconate
2020-09-18T07:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701,Code name:,M 4112
2020-09-18T07:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701,Code name:,M-4112
2020-09-18T07:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701,Code name:,M4112
2020-09-18T07:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701,Code name:,MS201408-0005
2020-09-18T07:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701,Synonym:,"indoleamine 2,3-dioxygenase-1/tryptophan 2,3-dioxygenase 2 inhibitor M4112"
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG 641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG-641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Code name:,NG641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Synonym:,oncolytic adenoviral vector expressing FAP/CD3 bispecific molecule NG-641
2020-09-18T06:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703,Synonym:,oncolytic adenoviral vector-expressing FAP/CD3 bispecific FAP-TAc NG-641
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,Synonym:,Ethanol-based Intranasal Solution
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,Synonym:,Ethanol-based Nasal Sanitizer
2020-09-18T06:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780,US brand name:,Nozin
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141 V-11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141 V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Code name:,2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,anti-CD40 agonist antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,anti-CD40 agonistic antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,Fc-engineered anti-CD40 agonistic antibody 2141-V11
2020-09-18T06:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787,Synonym:,Fc-enhanced wnti-CD40 wntibody 2141-V11
2020-09-18T11:37:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800788,Code name:,SOMCL-15-290
2020-09-18T08:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800789,Code name:,PAT 1251
2020-09-18T08:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800789,Code name:,PAT1251
2020-09-18T08:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800789,Synonym:,Lysyl Oxidase-like Protein 2 Inhibitor PAT-1251
2020-09-18T10:12:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800790,Code name:,RBN 2397
2020-09-18T10:12:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800790,Code name:,RBN-2397
2020-09-18T10:12:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800790,Code name:,RBN2397
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN 401
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN-401
2020-09-18T05:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797,Code name:,ABN401
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGN CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Code name:,SGNCD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228 Antibody-drug Conjugate SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,Anti-CD228-MMAE ADC SGN-CD228A
2020-09-18T02:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848,Synonym:,anti-melanotransferrin ADC SGN-CD228A
2020-09-18T09:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800851,Code name:,MVA-209-FSP
2020-09-18T09:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800851,Synonym:,Modified Vaccinia Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP
2020-09-18T09:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800851,Synonym:,Modified Vaccinia Virus Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP
2020-09-18T10:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800895,NA,NA
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC 007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC-007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Code name:,GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous anti-CD19-CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,autologous CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,CD19 FasT CAR-T cells GC007F
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasT CAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,FasTCAR-19
2020-09-18T04:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931,Synonym:,GC007F CAR-T cells
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC 022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC-022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Code name:,GC022F
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,bispecific CAR T cells GC022
2020-09-18T04:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937,Synonym:,dual CAR-T cells GC022
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL 001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL-001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Code name:,ATL001
2020-09-18T04:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942,Synonym:,autologous cNeT ATL001
2020-09-18T08:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946,Code name:,BSL PS6
2020-09-18T08:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946,Code name:,BSL_PS6
2020-09-18T08:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946,Code name:,BSLPS6
2020-09-18T08:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946,Synonym:,Lactobacillus supplement BSL_PS6
2020-09-18T08:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946,Synonym:,Lactobacillus-based probiotic BSL_PS6
2020-09-18T13:13:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800947,Code name:,ZED88082A
2020-09-18T13:13:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800947,Synonym:,89Zr anti-CD8 antibody ZED88082A
2020-09-18T13:13:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800947,Synonym:,zirconium Zr 89-labeled anti-CD8 imaging agent ZED88082A
2020-09-18T13:13:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800947,Synonym:,Zr-89 anti-CD8 antibody ZED88082A
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Foreign brand name:,Bi1 Procare
2020-09-18T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949,Synonym:,arginine/nucleotides/omega-3 fatty acids/olive oil polyphenols/antioxidants/L-carnitine nutritional supplement
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Code name:,TPST 1120
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Code name:,TPST-1120
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Code name:,TPST1120
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Synonym:,peroxisome proliferator activated receptor alpha antagonist TPST-1120
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Synonym:,PPARA antagonist TPST-1120
2020-09-18T10:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961,Synonym:,PPARalpha antagonist TPST-1120
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX 930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX-930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,BAX930
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP 655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP-655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,SHP655
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK 755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK-755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Code name:,TAK755
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,rADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant a disintegrin and metalloproteinase with thrombospondin motifs 13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant ADAMTS13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS-13
2020-09-18T03:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172,Synonym:,recombinant human ADAMTS13
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,RLI 15
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,RLI-15
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,RLI15
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,SO C101
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,SO-C101
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Code name:,SOC101
2020-09-18T08:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174,Synonym:,IL-15/IL-15 receptor alpha sushi+ domain fusion protein SO-C101
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Code name:,VAX 014
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Code name:,VAX-014
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Code name:,VAX-IP
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Code name:,VAX014
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Synonym:,rBMCs VAX014
2020-09-18T11:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175,Synonym:,VAX-IP minicells
2020-09-18T12:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801176,Code name:,AG 10
2020-09-18T12:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801176,Code name:,AG-10
2020-09-18T12:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801176,Code name:,AG10
2020-09-18T12:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801176,Synonym:,TTR stabilizer AG10
2020-09-18T08:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177,Code name:,FT 596
2020-09-18T08:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177,Code name:,FT-596
2020-09-18T08:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177,Code name:,FT596
2020-09-18T08:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177,Synonym:,induced pluripotent stem cell-derived CD16/IL-15RF-expressing anti-CD19 CAR-NK cells FT596
2020-09-18T08:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177,Synonym:,iPSC-derived CD16/IL-15RF-expressing anti-CD19 CAR-natural killer cells FT596
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG-910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Code name:,AMG910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific antibody AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific T-cell engager AMG 910
2020-09-18T04:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178,Synonym:,bispecific T-cell engager antibody AMG 910
2020-09-18T11:38:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801179,Code name:,RV 521
2020-09-18T11:38:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801179,Code name:,RV-521
2020-09-18T11:38:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801179,Code name:,RV521
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI 001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI-001
2020-09-18T01:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194,Code name:,NEXI001
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,RO 7310729
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,RO-7310729
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,RO7310729
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,XmAb 24306
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,XmAb-24306
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Code name:,XmAb24306
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Synonym:,IL15/IL15Ra complex-Fc fusion protein XmAb24306
2020-09-18T08:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195,Synonym:,IL15/IL15Ra-Fc fusion protein XmAb24306
2020-09-18T09:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801196,Code name:,M 281
2020-09-18T09:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801196,Code name:,M-281
2020-09-18T09:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801196,Code name:,M281
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Code name:,ARO HIF2
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Code name:,ARO-HIF2
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Code name:,AROHIF2
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Synonym:,RNA interference therapeutic ARO-HIF2
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Synonym:,targeted RNAi molecule ARO-HIF2
2020-09-18T07:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198,Synonym:,TRiM ARO-HIF2
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 DC vaccine
2020-09-18T02:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200,Synonym:,anti-HER2/3 dendritic cell vaccine
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKI O 703
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKI-O-703
2020-09-18T05:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206,Code name:,SKIO703
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM 1310
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM-1310
2020-09-18T04:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208,Code name:,ABM1310
2020-09-18T10:23:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801211,Code name:,GNOS-PVO2
2020-09-18T10:23:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801211,Synonym:,neoantigen vaccine GNOS-PVO2
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY 3475070
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY-3475070
2020-09-18T05:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213,Code name:,LY3475070
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Code name:,IMCF106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,ImmTAC molecule IMC-F106C
2020-09-18T03:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-F106C
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,anti-CD37-CAR-T cells
2020-09-18T02:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227,Synonym:,CAR-37 T cells
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX 189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Code name:,BDTX189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,EGFR/HER2 inhibitor BDTX-189
2020-09-18T01:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228,Synonym:,ErbB mutant-specific inhibitor BDTX-189
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Code name:,PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA CAR T cells PBCAR269A
2020-09-18T01:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229,Synonym:,allogeneic anti-BCMA-CAR T lymphocytes PBCAR269A
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M 1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M-1774
2020-09-18T04:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231,Code name:,M1774
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,AMG-420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI 836909
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Code name:,BI836909
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,bispecific T-cell engager antibody AMG 420
2020-09-18T02:11:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291,Synonym:,BiTE antibody AMG 420
2020-09-18T12:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801296,Chemical structure:,"(2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide"
2020-09-18T08:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307,Code name:,919288G
2020-09-18T08:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307,Synonym:,IRDye800-labeled KSP/QRH dimer
2020-09-18T08:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307,Synonym:,KSP-QRH-E3-IRDye800
2020-09-18T08:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307,Synonym:,KSP/QRH peptide dimer
2020-09-18T08:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307,Synonym:,peptide 919288G
2020-09-18T07:17:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801308,Code name:,bacTRL-IL-12
2020-09-18T07:17:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801308,Synonym:,Bifidobacterium longum encoding IL-12
2020-09-18T07:17:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801308,Synonym:,genetically modified IL-12 transgene-encoding Bifidobacterium longum
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Abbreviation:,67Cu-SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,67Cu-labelled MeCOSar-Tyr3-octreotate
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper 67 SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper Cu 67 TATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,copper Cu 67-SARTATE
2020-09-18T05:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332,Synonym:,Cu-67 SARTATE
2020-09-18T10:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801340,Synonym:,probiotic WeiLeShu
2020-09-18T10:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801340,Synonym:,WeiLeShu
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MB-CART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Code name:,MBCART19.1
2020-09-18T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342,Synonym:,autologous CD19 CAR-transduced CD4/CD8 enriched T cells MB-CART19.1
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Chemical structure:,cortexolone 17alpha-valerate-21-propionate
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB 03 10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB-03-10
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Code name:,CB0310
2020-09-18T02:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352,Synonym:,AR/GR antagonist CB-03-10
2020-09-18T04:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801353,US brand name:,Temferon
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Abbreviation:,OH2
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Code name:,OH 2
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Code name:,OH-2
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Synonym:,HG52/ICP34.5-/ICP47- HSV-2-expressing GM-CSF OH2
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Synonym:,oHSV-2-expressing GM-CSF OH2
2020-09-18T09:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354,Synonym:,oncolytic HSV-2-expressing GM-CSF OH2
2020-09-18T12:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801356,Code name:,YL 13027
2020-09-18T12:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801356,Code name:,YL-13027
2020-09-18T12:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801356,Code name:,YL13027
2020-09-18T12:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801356,Synonym:,YTGFbR1 inhibitor YL-13027
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR 1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR-1702
2020-09-18T03:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357,Code name:,SHR1702
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS 100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS-100850
2020-09-18T01:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361,Code name:,EOS100850
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,anti-MUC1*-CAR-4-1BB-CD3zeta-expressing autologous T lymphocytes
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous HuMNC2-CAR44
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 CAR T cells
2020-09-18T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391,Synonym:,autologous huMNC2-CAR44 T lymphocytes
2020-09-18T10:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392,Synonym:,powdered berry extracts
2020-09-18T10:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392,Synonym:,powdered berry extracts blend
2020-09-18T10:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392,Synonym:,powdered natural berry extracts
2020-09-18T10:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392,Synonym:,powdered NBE
2020-09-18T10:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392,US brand name:,PediaBerry
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR 101801
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR-101801
2020-09-18T06:10:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432,Code name:,BR101801
2020-09-18T08:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801443,Chemical structure:,"D-glucofuranoside, ethyl 3,5,6-tris-O-(phenylmethyl)-, mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide"
2020-09-18T08:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801443,US brand name:,Procto-glyvenol
2020-09-18T09:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801465,Code name:,GEN 001
2020-09-18T09:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801465,Code name:,GEN-001
2020-09-18T09:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801465,Code name:,GEN001
2020-09-18T09:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801465,Synonym:,microbiome-based therapeutic GEN-001
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived MSCs
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic adipose-derived stem/stromal cells
2020-09-18T01:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471,Synonym:,allogeneic mesenchymal stem/stromal cells
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI 318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI-318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Code name:,IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,anti-PD-1/PD-L1 bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,bispecific antibody IBI318
2020-09-18T03:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472,Synonym:,recombinant anti-PD-1/anti-PD-L1 bispecific antibody IBI318
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM 209
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM-209
2020-09-18T05:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473,Code name:,ODM209
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01 CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Code name:,TAC01CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,CD19-targeted T cell antigen coupler TAC01-CD19
2020-09-18T04:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474,Synonym:,TAC01-CD19
2020-09-18T10:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801475,Synonym:,CalliSpheres drug-eluting beads with oxaliplatin
2020-09-18T10:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801475,Synonym:,DEB with oxaliplatin
2020-09-18T10:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801475,Synonym:,deboxa
2020-09-18T10:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801475,Synonym:,drug-eluting beads with oxaliplatin
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/20 bispecific CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous anti-CD19/CD20 bispecific nanobody-derived CAR-T cells
2020-09-18T04:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489,Synonym:,autologous CD19/CD20 bispecific CAR T cells
2020-09-18T05:41:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801490,Synonym:,CB-derived CAR T cells
2020-09-18T05:41:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801490,Synonym:,cord blood CAR T cells
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Chemical structure:,"Al18F-1,4,7-triazacyclononane-1,4,7-triacetate-octreotide"
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,18F-AlF-NOTA-octreotide
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,18F-IMP-466
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,Al18F-OC
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,fluorine F 18-IMP-466
2020-09-18T06:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491,Synonym:,fluorine F 18-NOTA octreotide
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT 8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT-8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Code name:,BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,ADC BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-Trop-2 antibody-drug conjugate BAT8003
2020-09-18T03:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492,Synonym:,anti-TROP2 ADC BAT8003
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,CAR-GPC3 T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,glypican-3-specific CAR T cells
2020-09-18T02:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493,Synonym:,GPC3-targeted CAR autologous T cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Abbreviation:,GRPs
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,allogeneic glial restricted progenitor cells
2020-09-18T01:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494,Synonym:,Q-cells
2020-09-18T08:26:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801495,Code name:,Z 650
2020-09-18T08:26:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801495,Code name:,Z-650
2020-09-18T08:26:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801495,Code name:,Z650
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,anti-CD20 CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,autologous CD20-targeted CAR-transduced CD4/CD8-enriched T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,CD20-targeting CAR T cells MB-CART20.1
2020-09-18T04:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497,Synonym:,MB-CART20.1
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F 0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F-0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Code name:,F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,anti-CD30/DM1 ADC F0002
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,F0002-ADC
2020-09-18T02:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498,Synonym:,FADC F0002
2020-09-18T08:04:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801520,Code name:,ABX 196
2020-09-18T08:04:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801520,Code name:,ABX-196
2020-09-18T08:04:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801520,Code name:,ABX196
2020-09-18T08:04:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801520,Synonym:,invariant NKT cell agonist ABX196
2020-09-18T05:12:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801521,Synonym:,anti-CD22 immunotoxin
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,betaglucin soluble gel
2020-09-18T04:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525,Synonym:,epiglucan gel
2020-09-18T10:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801526,Code name:,XNW 7201
2020-09-18T10:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801526,Code name:,XNW-7201
2020-09-18T10:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801526,Code name:,XNW7201
2020-09-18T10:41:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801526,Synonym:,PORCN inhibitor XNW7201
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,anti-PD1 antibody-activated autologous TILs
2020-09-18T04:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527,Synonym:,autologous anti-PD-1 antibody-activated TILs
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG-553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Code name:,AMG553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous anti-FLT3 CAR T lymphocytes AMG 553
2020-09-18T04:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528,Synonym:,autologous FLT3 CAR-T cells AMG 553
2020-09-18T07:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801530,Code name:,HS 201
2020-09-18T07:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801530,Code name:,HS-201
2020-09-18T07:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801530,Code name:,HS201
2020-09-18T07:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801530,Synonym:,Hsp90 inhibitor-linked verteporfin
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM 125
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM-125
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Code name:,AM125
2020-09-18T04:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531,Synonym:,betahistine dihydrochloride nasal spray
2020-09-18T10:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801534,Code name:,PVX 2
2020-09-18T10:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801534,Code name:,PVX-2
2020-09-18T10:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801534,Code name:,PVX2
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD 217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Code name:,BCD217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA-4/PD-1 monoclonal antibody combination BCD-217
2020-09-18T02:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536,Synonym:,anti-CTLA4/anti-PD1 monoclonal antibody combination BCD-217
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX 22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX-22
2020-09-18T02:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537,Code name:,HLX22
2020-09-18T07:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801582,US brand name:,V-Boost
2020-09-18T07:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801582,US brand name:,V-Boost Immunitor
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG 2449
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG-2449
2020-09-18T06:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583,Code name:,APG2449
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,BNT 311
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN 1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Code name:,GEN-1046
2020-09-18T03:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584,Synonym:,duoBody PD-L1 x 4-1BB GEN1046
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS 03592088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS P088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS-03592088
2020-09-18T06:53:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585,Code name:,NMS03592088
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET 019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET-019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Code name:,ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 AbTCR-expressing T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19 T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,anti-CD19-TCR T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,CD19-targeted T cells ET019003
2020-09-18T02:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620,Synonym:,ET019003-T cells
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Code name:,CHC 2014
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Code name:,CHC-2014
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Code name:,NOV 1601
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Code name:,NOV-1601
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Code name:,NOV1601
2020-09-18T10:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625,Synonym:,TRK inhibitor NOV1601
2020-09-18T09:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801626,Chemical structure:,"2-((4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-4-yl)-N-ethylacetamide monobenzenesulfonate salt"
2020-09-18T09:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801626,Code name:,GSK525762C
2020-09-18T08:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801627,Synonym:,LMP2 antigen-specific TCR T cells
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ 63898081
2020-09-18T03:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628,Code name:,JNJ63898081
2020-09-18T05:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801632,Synonym:,"starch, corn"
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC 99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Code name:,CC99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,CelMod CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,cereblon E3 ubiquitin ligase modulating drug CC-99282
2020-09-18T05:20:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633,Synonym:,cereblon modulator CC-99282
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Code name:,OKI 179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Code name:,OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,class-1/4 HDACi OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDAC inhibitor OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDAC1/4i OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDACi 1/4 OKI-179
2020-09-18T05:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634,Synonym:,HDACi OKI-179
2020-09-18T11:20:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801656,Synonym:,anti-ROBO1 BiCAR-NK/T cells
2020-09-18T11:20:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801656,Synonym:,ROBO1 CAR-NK/T cells
2020-09-18T11:20:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801656,Synonym:,ROBO1-targeted Bi-CAR-NK/T cells
2020-09-18T08:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801657,Code name:,FCN 159
2020-09-18T08:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801657,Code name:,FCN-159
2020-09-18T08:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801657,Code name:,FCN159
2020-09-18T08:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801657,Synonym:,MEK inhibitor FCN-159
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML 03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML-03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Code name:,EML03
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Foreign brand name:,Ectoin
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Synonym:,ectoine mouth wash
2020-09-18T06:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658,Synonym:,ectoine mouth wash EML03
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin-4/anti-FAP CAR-T cells
2020-09-18T04:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659,Synonym:,autologous anti-nectin4/FAP CAR-T cells
2020-09-18T05:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801668,US brand name:,Comtan
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,autologous Anti-CD19/PD-1 bispecific CAR-T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,CD19/PD-1 bispecific CAR T cells
2020-09-18T04:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669,Synonym:,MC-19PD1 CAR-T cells
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ 011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJ-011133
2020-09-18T02:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670,Code name:,TJC4
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY 3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Code name:,LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,anti-PD-1/PD-L1 bispecific antibody LY3434172
2020-09-18T03:45:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671,Synonym:,bispecific antibody LY3434172
2020-09-18T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801675,Chemical structure:,"benzoic acid, 2-ethyl-3-methoxy-, 2-(3,5-dimethylbenzoyl)-2-((1R)-1-(1,1-dimethylethyl)butyl)hydrazide"
2020-09-18T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801675,Code name:,INXN-1001
2020-09-18T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801675,Code name:,RG-115932
2020-09-18T02:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801681,Synonym:,anti-CD7 CAR T lymphocytes
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP 011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP-011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Code name:,PPP011
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Foreign brand name:,Caumz
2020-09-18T05:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683,Synonym:,synthetic CBD PPP011
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC 001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC-001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,IMC001
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI 3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI-3031
2020-09-18T03:46:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687,Code name:,STI3031
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609 A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609-A
2020-09-18T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688,Code name:,609A
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Code name:,FS 1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Code name:,FS-1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Code name:,FS1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Synonym:,ADC FS-1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Synonym:,anti-HER2 ADC FS-1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Synonym:,antibody-drug conjugate FS-1502
2020-09-18T12:31:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696,Synonym:,trastuzumab MMAF
2020-09-18T10:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801697,Code name:,TLD 1433
2020-09-18T10:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801697,Code name:,TLD-1433
2020-09-18T10:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801697,Code name:,TLD1433
2020-09-18T10:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801697,Synonym:,PDC TLD-1433
2020-09-18T10:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801702,Code name:,REGN 3918
2020-09-18T10:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801702,Code name:,REGN-3918
2020-09-18T10:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801702,Code name:,REGN3918
2020-09-18T10:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801702,Synonym:,WHO 10945
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B 003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B-003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Code name:,B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,ADC B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,anti-HER2-DM1 antibody-drug conjugate B003
2020-09-18T02:39:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748,Synonym:,recombinant humanized anti-HER2 monoclonal antibody-MCC-DM1 B003
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Code name:,SGNCD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,ADC SGN-CD47M
2020-09-18T02:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749,Synonym:,anti-CD47 antibody-drug conjugate SGN-CD47M
2020-09-18T09:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801753,Abbreviation:,NMC
2020-09-18T09:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801753,Synonym:,N-methylcantharidimide
2020-09-18T13:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801754,Code name:,Debio 0123
2020-09-18T13:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801754,Code name:,Debio-0123
2020-09-18T13:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801754,Code name:,Debio0123
2020-09-18T13:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801754,Synonym:,Wee1 inhibitor Debio 0123
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Code name:,PDClung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,allogeneic pDCs- expressing lung tumor antigens PDC*lung01
2020-09-18T01:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755,Synonym:,therapeutic cancer vaccine PDC*lung01
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR 055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR-055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Code name:,C-TCR055
2020-09-18T04:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757,Synonym:,autologous AFP-specific TCR-transduced T cells C-TCR055
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes 11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-011
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes-11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Code name:,Descartes11
2020-09-18T04:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760,Synonym:,autologous CD8+ T cells expressing anti-BCMA CAR Descartes-11
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMC C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Code name:,IMCC103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,ImmTAC Molecule IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-C103C
2020-09-18T02:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761,Synonym:,T-cell redirecting bi-specific biologic IMC-C103C
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS 986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS-986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Code name:,BMS986288
2020-09-18T02:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762,Synonym:,probody BMS-986288
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA 121-28
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA-121 28
2020-09-18T06:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763,Code name:,HA121-28
2020-09-18T08:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801764,Code name:,HL 085
2020-09-18T08:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801764,Code name:,HL-085
2020-09-18T08:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801764,Code name:,HL085
2020-09-18T09:34:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801765,Code name:,IP 001
2020-09-18T09:34:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801765,Code name:,IP-001
2020-09-18T09:34:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801765,Code name:,IP001
2020-09-18T09:34:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801765,Synonym:,1% N-dihydro-galacto-chitosan
2020-09-18T07:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801787,Chemical structure:,"(Z)-5-(2-hydroxy-3-(2- (3-methyl-5-oxo-1-(5,6,7,8-tetrahydronaphthalen- 2-yl)-1H-pyrazol-4(5H)-ylidene)hydrazinyl)phenyl) Furan-2-carboxylic acid diethanolamine"
2020-09-18T07:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801787,Synonym:,SHR8735 olamine
2020-09-18T08:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801788,Chemical structure:,MnCl2
2020-09-18T08:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801788,Synonym:,manganese chloride tetrahydrate
2020-09-18T08:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801788,Synonym:,manganum muriaticum
2020-09-18T06:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801791,Synonym:,5-fluoropyrimidine
2020-09-18T05:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801792,Synonym:,[14C]-pamiparib
2020-09-18T05:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801792,Synonym:,14C-pamiparib
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Chemical structure:,"(3S,3'S)-3,3'-dihydroxy-beta,beta-carotene-4,4'-dione"
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Foreign brand name:,Algalif
2020-09-18T04:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793,Synonym:,Astaxanthine
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Code name:,PV-001-DC
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,autologous monocyte-derived lysate pulsed DCs PV-001-DC
2020-09-18T04:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794,Synonym:,PV-001-dendritic cell
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV 001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV-001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Code name:,PV001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Synonym:,dengue virus-1 PV-001-DV
2020-09-18T05:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795,Synonym:,PV-001-dengue virus
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC 391
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC-391
2020-09-18T04:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796,Code name:,SLC391
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,episcleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,SR topotecan episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,sustained-release episcleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,sustained-release topotecan episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,topotecan SR episcleral plaque
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,Synonym:,transscleral topotecan
2020-09-18T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808,US brand name:,Chemoplaque
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC 94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC-94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Code name:,CC94676
2020-09-18T02:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809,Synonym:,AR degrader CC-94676
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,4SCAR-CD44v6 T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,anti-CD44v6 CAR T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,CD44v6 CAR-T cells
2020-09-18T05:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822,Synonym:,CD44v6-specific CAR gene-engineered T cells
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN 1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN-1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Code name:,GEN1044
2020-09-18T02:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833,Synonym:,duobody-CD3x5T4
2020-09-18T12:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801834,Code name:,SH 3051
2020-09-18T12:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801834,Code name:,SH-3051
2020-09-18T12:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801834,Code name:,SH3051
2020-09-18T12:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801834,Synonym:,TGFbR1 inhibitor SH3051
2020-09-18T08:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801838,Code name:,DF 6002
2020-09-18T08:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801838,Code name:,DF-6002
2020-09-18T08:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801838,Code name:,DF6002
2020-09-18T08:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801838,Synonym:,IL12-Fc fusion protein DF6002
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Abbreviation:,(68)Ga-DX600
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Abbreviation:,68Ga-DX600
2020-09-18T07:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839,Synonym:,gallium Ga 68-ACE2 inhibitor DX600
2020-09-18T11:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801840,Code name:,BOLD 100
2020-09-18T11:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801840,Code name:,BOLD-100
2020-09-18T11:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801840,Code name:,BOLD100
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI 7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI-7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Code name:,EPI7386
2020-09-18T02:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842,Synonym:,AR inhibitor EPI-7386
2020-09-18T11:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801843,Code name:,TAK 676
2020-09-18T11:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801843,Code name:,TAK-676
2020-09-18T11:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801843,Code name:,TAK676
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC 100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC-100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Code name:,AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T cells AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,autologous ICAM-1-targeted CAR-T lymphocytes AIC100
2020-09-18T04:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844,Synonym:,CAR-T cells AIC100
2020-09-18T10:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801845,Code name:,ALM 488
2020-09-18T10:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801845,Code name:,ALM-488
2020-09-18T10:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801845,Code name:,ALM488
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER 050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER-050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Code name:,KER050
2020-09-18T01:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849,Synonym:,activin type 2A receptor Fc fusion protein KER-050
2020-09-18T12:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801850,Code name:,TL 895
2020-09-18T12:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801850,Code name:,TL895
2020-09-18T12:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801850,Synonym:,TKI TL-895
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN 044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN-044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Code name:,KN044
2020-09-18T02:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856,Synonym:,anti-CTLA4 antibody fusion protein KN044
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB 3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB-3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Code name:,TQB3804
2020-09-18T06:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857,Synonym:,epidermal growth factor receptor inhibitor TQB3804
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN 6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Code name:,LVGN-6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-4-1BB agonistic monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 agonist monoclonal antibody LVGN6051
2020-09-18T02:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858,Synonym:,anti-CD137 monoclona antibody LVGN6051
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Code name:,JSI 1187
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Code name:,JSI-1187
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Synonym:,ERK Inhibitor JSI-1187
2020-09-18T06:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor JSI-1187
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,68Ga-DOTA-FAPI-04
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,68Ga-FAPi-04
2020-09-18T07:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864,Synonym:,gallium-68-FAPi-04
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM 4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM-4003
2020-09-18T02:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868,Code name:,HBM4003
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI-905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Code name:,BI905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,bi-specific agent BI 905711
2020-09-18T03:51:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873,Synonym:,CDH17-targeting TRAILR2 agonist BI 905711
2020-09-18T10:24:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801876,Synonym:,hyaluronidase-zzxf/pertuzumab/trastuzumab
2020-09-18T10:24:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801876,Synonym:,pertuzumab/trastuzumab/hyaluronidase-zzxf
2020-09-18T10:24:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801876,US brand name:,Phesgo
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Foreign brand name:,Bite
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Synonym:,biotechspiramycin
2020-09-18T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877,Synonym:,shengjimycin
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP 108
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP-108
2020-09-18T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885,Code name:,LP108
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO 7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO-7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Code name:,RO7247669
2020-09-18T03:44:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886,Synonym:,anti-PD1/anti-LAG3 bispecific antibody RO7247669
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC 392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC-392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Code name:,ONC392
2020-09-18T02:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887,Synonym:,anti-CTLA4 monoclonal antibody ONC-392
2020-09-18T07:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897,Code name:,DF 1001
2020-09-18T07:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897,Code name:,DF-1001
2020-09-18T07:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897,Synonym:,HER2 tri-specific NK cell engager DF1001
2020-09-18T07:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897,Synonym:,tri-specific natural killer cell engager DF1001
2020-09-18T07:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897,Synonym:,tri-specific NK cell engager DF1001
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR 1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Code name:,ATOR1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-4-1BB monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 agonist monoclonal antibody ATOR-1017
2020-09-18T02:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898,Synonym:,anti-CD137 monoclonal antibody ATOR-1017
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR 442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR-442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Code name:,SAR442168
2020-09-18T04:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899,Synonym:,Bruton's tyrosine kinase inhibitor SAR442168
2020-09-18T07:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801900,Code name:,TQB 3474
2020-09-18T07:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801900,Code name:,TQB-3474
2020-09-18T07:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801900,Code name:,TQB3474
2020-09-18T07:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801900,Synonym:,heat shock protein 90 inhibitor TQB3474
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS 7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Code name:,DS7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7-H3/DXd ADC DS-7300a
2020-09-18T02:10:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901,Synonym:,anti-B7H3/DXd antibody-drug conjugate DS-7300a
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Chemical structure:,"benzoic Acid, 2-hydroxy-, 2-carboxyphenyl ester"
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Synonym:,o-salicylsalicylic acid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,Synonym:,salicylsalicylic scid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Disalcid
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Mono-Gesic
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Salflex
2020-09-18T06:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902,US brand name:,Salsitab
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,Foreign brand name:,Imvanex
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,Synonym:,modified vaccinia Ankara - Bavarian Nordic smallpox vaccine
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,Synonym:,modified vaccinia Ankara smallpox vaccine
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,Synonym:,MVA smallpox vaccine
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,US brand name:,Imvamune
2020-09-18T07:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908,US brand name:,Jynneos
2020-09-18T09:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801909,NA,NA
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN 004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN-004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Code name:,ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted antibody-drug conjugate ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,5T4-targeted dolaflexin ADC ASN004
2020-09-18T02:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910,Synonym:,anti-5T4 ADC ASN004
2020-09-18T12:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801911,Code name:,VT 30
2020-09-18T12:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801911,Code name:,VT-30
2020-09-18T12:59:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801911,Code name:,VT30
2020-09-18T08:24:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801912,Code name:,NC 410
2020-09-18T08:24:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801912,Code name:,NC-410
2020-09-18T08:24:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801912,Code name:,NC410
2020-09-18T08:24:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801912,Synonym:,leukocyte-associated immunoglobulin-like receptor-2 fusion protein NC410
2020-09-18T12:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801913,Code name:,TQB 3558
2020-09-18T12:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801913,Code name:,TQB-3558
2020-09-18T12:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801913,Code name:,TQB3558
2020-09-18T12:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801913,Synonym:,tropomyosin receptor kinase inhibitor TQB3558
2020-09-18T11:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935,Code name:,SL 172154
2020-09-18T11:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935,Code name:,SL-172154
2020-09-18T11:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935,Code name:,SL172154
2020-09-18T11:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935,Synonym:,CD172a-Fc-CD40L chimeric protein SL-172154
2020-09-18T11:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935,Synonym:,SIRPα-Fc-CD40L SL-172154
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK 102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Code name:,TAK102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,anti-GPC3 CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,CAR T cells TAK-102
2020-09-18T02:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936,Synonym:,glypican-3-specific CAR T cells TAK-102
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO 1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Code name:,AUTO-1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,AUTO1 CAR-T Cells
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous Anti-CD19 Chimeric Antigen Receptor T-lymphocytes AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,Autologous CD19-targeted CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAR T-cells AUTO1
2020-09-18T04:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949,Synonym:,CD19CAT-41BBZ CAR T-cells AUTO1
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Code name:,BT 5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Code name:,BT-5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicycle BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicycle toxin conjugate-targeting EphA2 BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,bicyclic peptide conjugate BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,BTC BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,EphA2-targeting BTC BT5528
2020-09-18T06:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972,Synonym:,EphA2-targeting-MMAE bicycle toxin BT5528
2020-09-18T08:44:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801980,Code name:,SYHA 1807
2020-09-18T08:44:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801980,Code name:,SYHA-1807
2020-09-18T08:44:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801980,Code name:,SYHA1807
2020-09-18T08:44:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801980,Synonym:,lysine-specific demethylase 1 inhibitor SYHA1807
2020-09-18T12:43:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801981,Chemical structure:,(3beta)-3-hydroxyurs-12-en-28-oic acid
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR 442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR-442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Code name:,SAR442257
2020-09-18T02:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010,Synonym:,tri-specific T-cell engager SAR442257
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB 011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB-011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Code name:,AB011
2020-09-18T02:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013,Synonym:,anti-CLDN18.2 monoclonal antibody AB011
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION 251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION-251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Code name:,ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO ION251
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,anti-IRF4 ASO IONIS-IRF4-2.5Rx
2020-09-18T02:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018,Synonym:,IONIS-IRF4-2.5Rx
2020-09-18T07:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021,Code name:,INO 3107
2020-09-18T07:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021,Code name:,INO-3107
2020-09-18T07:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021,Code name:,INO3107
2020-09-18T07:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021,Synonym:,HPV-6/11-targeting immunotherapeutic vaccine INO-3107
2020-09-18T07:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021,Synonym:,HPV6/11-targeted DNA plasmid immunotherapeutic INO-3107
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST 001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST-001
2020-09-18T02:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035,Code name:,TST001
2020-09-18T10:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802036,Code name:,ACA-11
2020-09-18T10:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802036,Code name:,CLNH11
2020-09-18T10:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802036,Synonym:,CLN-IgG
2020-09-18T10:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802036,Synonym:,"immunoglobulin G, anti-(human vimentin) (human monoclonal CLN G11 gamma1-chain), disulfide with human monoclonal CLN G11 kappa-chain, dimer"
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT 1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Code name:,XMT1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1592
2020-09-18T02:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039,Synonym:,NaPi2b-targeted antibody-drug conjugate XMT-1592
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC 98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC-98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Code name:,CC98633
2020-09-18T04:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040,Synonym:,autologous BCMA-targeted NEX-T CAR-T Cells CC-98633
2020-09-18T05:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802041,Synonym:,Chinese herbal compound Dendrobium huoshanense
2020-09-18T05:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802041,Synonym:,D. huoshanense granules
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB 6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB-6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Code name:,UCB6114
2020-09-18T02:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055,Synonym:,anti-GREM1 antibody monoclonal UCB6114
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH 2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH-2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Code name:,HH2853
2020-09-18T06:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064,Synonym:,EZH1 and EZH2 inhibitor HH2853
2020-09-18T12:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802067,US brand name:,Tality
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC 1036
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC-1036
2020-09-18T04:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085,Code name:,KC1036
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP 303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP-303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Code name:,DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,ADC DP303c
2020-09-18T02:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152,Synonym:,antibody-drug conjugate DP303c
2020-09-18T10:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802156,Foreign brand name:,Protoves M1
2020-09-18T10:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802156,Synonym:,protopine and nuciferine supplement
2020-09-18T10:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802156,Synonym:,protopine/nuciferine
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL 304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL-304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,CPL304110
2020-09-18T06:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158,Code name:,PG19
2020-09-18T08:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802160,Synonym:,SF6 lipid microspheres
2020-09-18T08:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802160,Synonym:,sulfur hexafluoride lipid-type A microspheres
2020-09-18T08:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802160,US brand name:,Lumason
2020-09-18T12:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802161,Synonym:,autologous CART-TM4SF1 cells/CART-EpCAM cells
2020-09-18T12:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802161,Synonym:,autologous TM4SF1-targeting CAR T cells and EpCAM-targeting CAR T cells
2020-09-18T12:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802161,Synonym:,TM4SF1-CAR autologous T cells/EpCAM-CAR autologous T cells
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT 8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT-8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Code name:,BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,ADC BAT8001
2020-09-18T02:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162,Synonym:,anti-HER2 ADC BAT8001
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT 4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT-4306F
2020-09-18T02:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165,Code name:,BAT4306F
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous anti-EGFR CAR-transduced CXCR 5-modified T cells
2020-09-18T04:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166,Synonym:,autologous CXCR5-modified anti-EGFR CAR-T cells
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA 101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA-101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Code name:,CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,allogeneic anti-CD19 UCAR-T cells CTA101
2020-09-18T01:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167,Synonym:,universal CD19-directed CAR-T cells CTA101
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD19/CD20-expressing compound CAR-T cells
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD20-CD19 cCAR T cells
2020-09-18T05:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177,Synonym:,CD20-CD19 cCAR-T cells
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,123b-33bcCAR-T cells
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,CD123-CD33 cCAR T cells
2020-09-18T05:11:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178,Synonym:,CD123/CD33-expressing compound CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic anti-BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/CS1 bispecific CAR-T cells
2020-09-18T01:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179,Synonym:,allogeneic BCMA/SLAMF7 bispecific CAR-T cells
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded DCs
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate and mRNA-loaded dendritic cells
2020-09-18T04:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181,Synonym:,autologous pancreatic adenocarcinoma lysate- and mRNA-loaded DC vaccine
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG 6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG-6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO 7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO-7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Code name:,RO7296682
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,anti-CD25 monoclonal antibody RG6292
2020-09-18T02:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183,Synonym:,T-regulatory cell-depleting antibody RO7296682
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B 002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B-002
2020-09-18T02:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228,Code name:,B002
2020-09-18T07:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802229,Synonym:,green propolis in oil supplement
2020-09-18T07:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802229,Synonym:,propolis supplement
2020-09-18T07:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802229,Synonym:,Taiwan green propolis supplement
2020-09-20T01:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235,Code name:,TPIV 100
2020-09-20T01:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235,Code name:,TPIV-100
2020-09-20T01:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235,Code name:,TPIV100
2020-09-20T01:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235,Synonym:,HER2/Neu peptide vaccine TPIV100
2020-09-20T01:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235,Synonym:,peptide vaccine TPIV100
2020-09-18T11:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802254,Code name:,GC 4711
2020-09-18T11:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802254,Code name:,GC-4711
2020-09-18T11:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802254,Synonym:,SOD mimetic GC4711
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTE X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTE-X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Code name:,KTEX19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Synonym:,anti-CD19 autologous CAR-CD28 T cells KTE-X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,Synonym:,autologous anti-CD19 CAR-CD28 T cells KTE-X19
2020-09-18T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259,US brand name:,Tecartus
2020-09-18T11:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802260,Code name:,TPX 0046
2020-09-18T11:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802260,Code name:,TPX0046
2020-09-18T11:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802260,Synonym:,RET/SRC tyrosine kinase inhibitor TPX-0046
2020-09-18T01:57:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802261,Foreign brand name:,Opera
2020-09-18T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802262,Synonym:,BCMA-PD1-CAR T cells
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS 3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS-3002
2020-09-18T04:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263,Code name:,CS3002
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH 2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH-2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,BH2950
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI 315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI-315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Code name:,IBI315
2020-09-18T03:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264,Synonym:,HER2/PD-1 bi-specific antibody BH 2950
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4 CAR T cells
2020-09-18T02:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265,Synonym:,CD4-specific CAR T cells
2020-09-18T08:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273,Code name:,BNT-115
2020-09-18T08:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273,Code name:,W_ova1
2020-09-18T08:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273,Synonym:,liposome-formulated mRNA vaccine W_ova1
2020-09-18T08:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273,Synonym:,mRNA vaccine W_ova1
2020-09-18T08:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273,Synonym:,W_ova1 vaccine
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB 0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB-0254
2020-09-18T03:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274,Code name:,MSB0254
2020-09-18T08:47:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802279,Synonym:,177Lu-DTPA-omburtamab
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX 301
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX-301
2020-09-18T06:10:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300,Code name:,NTX301
2020-09-18T07:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802301,Synonym:,68Ga-NOTA-MMR-VHH2 nanobody
2020-09-18T07:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802301,Synonym:,68GaNOTA-anti-MMR-VHH2
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX 55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX-55
2020-09-18T02:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302,Code name:,HLX55
2020-09-18T07:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802303,Synonym:,[68Ga]-NOTA-hGZP
2020-09-18T07:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802303,Synonym:,68Ga-NOTA-hGZP
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH 0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH 5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH-0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH-5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH0145228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ACH5228
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN 2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN-2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Code name:,ALXN2050
2020-09-18T06:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304,Synonym:,FD inhibitor ALXN2050
2020-09-18T08:58:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802310,NA,NA
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A 018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A-018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Code name:,HZ-A018
2020-09-18T04:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311,Synonym:,Bruton’s tyrosine kinase inhibitor HZ-A-018
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,ADC RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC 88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC-88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Code name:,RC88
2020-09-18T02:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312,Synonym:,anti-mesothelin/MMAE ADC RC88
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA 201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA-201
2020-09-18T04:23:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318,Code name:,RAPA201
2020-09-18T12:23:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321,Code name:,SLN 124
2020-09-18T12:23:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321,Code name:,SLN-124
2020-09-18T12:23:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321,Code name:,SLN124
2020-09-18T12:23:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321,Synonym:,GalNAc-anti-TMPRSS6 siRNA conjugate SLN124
2020-09-18T12:23:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321,Synonym:,RNA interference therapeutic SLN124
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR 20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR-20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Code name:,LUCAR20S
2020-09-18T01:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323,Synonym:,LUCAR-20S CAR-T cells
2020-09-18T07:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802324,Synonym:,human lysozyme goat milk
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB 223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB-223
2020-09-18T03:49:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325,Code name:,GB223
2020-09-18T08:56:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802326,Code name:,ABBV 467
2020-09-18T08:56:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802326,Code name:,ABBV-467
2020-09-18T08:56:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802326,Code name:,ABBV467
2020-09-18T08:56:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802326,Synonym:,myeloid cell leukemia-1 inhibitor ABBV-467
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Abbreviation:,CTL 19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL-19
2020-09-18T01:55:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327,Code name:,CTL19
2020-09-20T01:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802329,Abbreviation:,GMV
2020-09-20T01:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802329,Synonym:,Tag-7 gene-modified inactivated tumor cell vaccine
2020-09-20T01:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802329,Synonym:,Tag-7 GMV
2020-09-20T01:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802329,Synonym:,Tag7 gene-modified inactivated tumor cell vaccine
2020-09-18T07:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802330,Chemical structure:,2-propanol
2020-09-18T07:53:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802330,Synonym:,isopropanol
2020-09-18T10:11:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802331,Code name:,NMS 03305293
2020-09-18T10:11:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802331,Code name:,NMS03305293
2020-09-20T01:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802332,Code name:,K 001
2020-09-20T01:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802332,Code name:,K-001
2020-09-20T01:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802332,Code name:,K001
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Code name:,MA Max 4
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Code name:,MAX 40279
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Code name:,MAX-40279
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Code name:,MAX-40279-01
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Code name:,MAX40279
2020-09-20T01:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333,Synonym:,FLT3/FGFR kinase inhibitor MAX-40279
2020-09-20T01:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802334,Synonym:,MUC-1/WT1 peptide-loaded autologous dendritic cells
2020-09-20T01:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802334,Synonym:,MUC-1/WT1 peptide-primed autologous DCs
2020-09-20T01:28:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802335,Synonym:,68 Ga-NOTA-MAL-Cys39-exendin-4
2020-09-20T01:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802336,Synonym:,vitamin K2-rich cheese
2020-09-20T01:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337,Code name:,ALPN 202
2020-09-20T01:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337,Code name:,ALPN-202
2020-09-20T01:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337,Code name:,ALPN202
2020-09-20T01:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337,Synonym:,CD80 vIgD-Fc fusion protein ALPN-202
2020-09-20T01:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337,Synonym:,CD80-vlgD-Fc ALPN-202
2020-09-20T01:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802338,Synonym:,Bifidobacterium animalis probiotic supplement
2020-09-20T01:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802338,Synonym:,Bifidobacterium animalis ssp. lactis supplement
2020-09-20T01:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802338,Synonym:,Bifidobacterium supplement
2020-09-18T11:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802339,Code name:,LY 3484356
2020-09-18T11:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802339,Code name:,LY3484356
2020-09-18T11:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802339,Synonym:,SERD LY3484356
2020-09-20T01:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802340,Abbreviation:,MASL
2020-09-20T01:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802372,Code name:,RC 98
2020-09-20T01:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802372,Code name:,RC-98
2020-09-20T01:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802372,Code name:,RC98
2020-09-20T01:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802375,Abbreviation:,cRGD-ZW800-1
2020-09-20T01:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802375,Synonym:,cyclo-(RGDyK)-ZW800-1
2020-09-18T09:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476,Code name:,NEXI 002
2020-09-18T09:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476,Code name:,NEXI002
2020-09-18T09:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476,Synonym:,autologous MM-associated antigens specific T cells NEXI-002
2020-09-18T09:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476,Synonym:,NEXI-002 T cells
2020-09-18T09:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476,Synonym:,TAA primed antigen-specific CD8+ T cells NEXI-002
2020-10-21T18:58:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802771,Code name:,TMV 018
2020-10-21T18:58:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802771,Code name:,TMV-018
2020-10-21T18:58:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802771,Code name:,TMV018
2020-09-23T03:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802777,Code name:,GMI 1359
2020-09-23T03:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802777,Code name:,GMI-1359
2020-10-21T18:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802778,Code name:,JMT 103
2020-10-21T18:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802778,Code name:,JMT-103
2020-10-21T18:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802778,Code name:,JMT103
2020-10-21T18:59:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802779,Foreign brand name:,Papilocare gel
2020-10-21T18:59:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802779,Synonym:,papilocare vaginal gel
2020-10-21T18:59:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802780,Synonym:,WT1-H/K-HELP-Survivin-H/K-HELP-MAGE-A4-H ⁄ K-HELP-MUC1-22 peptide-loaded autologous DCs
2020-09-23T03:09:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802781,Chemical structure:,"1-(3-methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride9-(gamma-methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride"
2020-09-23T03:09:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802781,US brand name:,Ludiomil
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Code name:,SYD 1875
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Code name:,SYD-1875
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Code name:,SYD1875
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Synonym:,ADC SYD1875
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Synonym:,anti-5T4 ADC SYD1875
2020-10-23T13:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782,Synonym:,antibody-drug conjugate SYD1875
2020-10-23T13:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802783,Code name:,TY 9591
2020-10-23T13:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802783,Code name:,TY-9591
2020-10-23T13:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802783,Code name:,TY9591
2020-10-23T13:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802783,Synonym:,EGFR tyrosine kinase inhibitor TY-9591
2020-10-23T13:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802784,Code name:,ENB 003
2020-10-23T13:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802784,Code name:,ENB-003
2020-10-23T13:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802784,Code name:,ENB003
2020-10-23T13:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802784,Synonym:,ETBR blocker ENB 003
2020-10-23T13:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785,Synonym:,thrombin gel
2020-10-23T13:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785,Synonym:,thrombin gel matrix
2020-10-23T13:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785,Synonym:,thrombin/gelatin foam hemostat
2020-10-23T13:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785,US brand name:,Thrombi-Gel
2020-10-23T13:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802786,Synonym:,18F-AMBF3-TATE
2020-09-23T03:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787,Code name:,VE 800
2020-09-23T03:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787,Code name:,VE-800
2020-09-23T03:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787,Synonym:,bacterial consortium-based formulation VE800
2020-09-23T03:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787,Synonym:,LBP VE800
2020-09-23T03:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787,Synonym:,live biotherapeutic product VE800
2020-10-23T13:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802792,Code name:,SRF 388
2020-10-23T13:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802792,Code name:,SRF-388
2020-10-23T13:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802792,Code name:,SRF388
2020-10-23T13:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802792,Synonym:,anti-IL-27 blocking antibody SRF388
2020-10-23T13:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802819,Synonym:,autologous quikin-CD19-CART
2020-10-23T13:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802819,Synonym:,CD19-CAR T Cells with PD1 Knockout
2020-09-30T03:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802820,Chemical structure:,"D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)"
2020-09-30T03:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802820,Code name:,BMS-512148-05
2020-09-30T03:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802824,Synonym:,chlorotoxin-CD28-CD3z-CD19t-expressing CAR T cells
2020-10-23T13:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802825,Code name:,BGB A445
2020-10-23T13:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802825,Code name:,BGB-A445
2020-10-23T13:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802825,Code name:,BGBA445
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Code name:,TILT 123
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Code name:,TILT-123
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Code name:,TILT123
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Synonym:,Ad5/3-E2F-d24-hTNFa-IRES-hIL2
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Synonym:,oncolytic adenovirus TILT-123
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Synonym:,TNFalpha/IL-2-coding oncolytic adenovirus TILT-123
2020-10-23T13:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826,Synonym:,TNFalpha/IL2-armed oncolytic adenovirus TILT-123
2020-10-23T13:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802837,Synonym:,autologous anti-CLL-1 CAR T cells
2020-10-23T13:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802837,Synonym:,autologous CLL-1.CAR T cells
2020-10-23T13:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802837,Synonym:,autologous CLL1-specific CAR T lymphocytes
2020-10-23T13:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802837,Synonym:,autologous CLL1-targeted CAR T cells
2020-10-23T13:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802838,Synonym:,autologous LCAR-T2C CAR-T cells
2020-10-23T13:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802838,Synonym:,autologous LCAR-T2C CAR-T lymphocytes
2020-10-23T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802839,Code name:,3D 185
2020-10-23T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802839,Code name:,3D-185
2020-10-23T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802839,Code name:,3D185
2020-10-23T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802839,Code name:,HH185
2020-10-23T13:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802840,Synonym:,ATLCAR.κ.28 cells
2020-10-23T13:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802840,Synonym:,CAR.k.28 cells
2020-10-23T13:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802841,Code name:,GC 4419
2020-10-23T13:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802841,Code name:,GC-4419
2020-10-23T13:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802841,Code name:,GC4419
2020-10-23T13:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802842,Chemical structure:,"11beta,21-dihydroxy-2'-methyl-5'beta-H-pregna-1,4-dieno(17,16-D)oxazole-3,20-dione 21-acetate5'H-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11beta,16beta)-"
2020-10-23T13:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802842,Code name:,MDL 458
2020-10-23T13:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802842,US brand name:,Emflaza
2020-10-23T13:33:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802843,Code name:,GST HG161
2020-10-23T13:33:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802843,Code name:,GST-HG161
2020-10-23T13:33:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802843,Code name:,GSTHG161
2020-10-23T13:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802844,Code name:,RZL 012
2020-10-23T13:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802844,Code name:,RZL-012
2020-10-23T13:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802844,Code name:,RZL012
2020-10-23T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802845,Code name:,ZP 059
2020-10-23T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802845,Code name:,ZP-059
2020-10-23T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802845,Code name:,ZP059
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Code name:,TM 123
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Code name:,TM-123
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Code name:,TM123
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Synonym:,CD123 target module TM123
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Synonym:,CD123-specific TM TM123
2020-10-23T13:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894,Synonym:,recombinant antibody derivative TM123
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Code name:,UniCAR02 T
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Code name:,UniCAR02-T
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Code name:,UniCAR02T
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Synonym:,autologous universal CAR-T cells UniCAR02-T
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Synonym:,UniCAR-T
2020-10-23T13:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895,Synonym:,UniCAR02-T cells
2020-10-23T13:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802902,Code name:,CNCT 19
2020-10-23T13:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802902,Code name:,CNCT-19
2020-10-23T13:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802902,Code name:,CNCT19
2020-10-23T13:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802902,Synonym:,autologous anti-CD19 CAR-T cells CNCT19
2020-10-23T13:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907,Code name:,CC 97540
2020-10-23T13:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907,Code name:,CC-97540
2020-10-23T13:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907,Code name:,CC97540
2020-10-23T13:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907,Synonym:,autologous CD19-targeted CAR T cells CC-97540
2020-10-23T13:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907,Synonym:,autologous CD19-targeted NEX-T CAR T cells CC-97540
2020-10-23T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802908,Code name:,CS 3005
2020-10-23T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802908,Code name:,CS-3005
2020-10-23T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802908,Code name:,CS3005
2020-10-23T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802908,Synonym:,A2AR antagonist CS3005
2020-10-23T13:33:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802912,Chemical structure:,"diethylcarbamodithioic acid, sodium salt"
2020-10-23T13:33:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802912,Synonym:,sodium diethyldithiocarbamate
2020-10-23T13:33:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802912,US brand name:,Imuthiol
2020-10-23T13:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802915,Code name:,ST 001
2020-10-23T13:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802915,Code name:,ST-001
2020-10-23T13:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802915,Code name:,ST001
2020-10-23T13:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802915,Synonym:,nanoFenretinide ST-001
2020-10-23T13:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916,Code name:,GC 012F
2020-10-23T13:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916,Code name:,GC-012F
2020-10-23T13:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916,Code name:,GC012F
2020-10-23T13:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916,Synonym:,autologous anti-BCMA/CD19 dual CAR T cells GC012F
2020-10-23T13:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916,Synonym:,autologous GC012F CAR-T cells
2020-10-23T13:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802918,Code name:,SAF 189s
2020-10-23T13:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802918,Code name:,SAF-189s
2020-10-23T13:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802918,Code name:,SAF189s
2020-10-23T13:33:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802919,Synonym:,fibore
2020-10-23T13:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920,Code name:,JBH 492
2020-10-23T13:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920,Code name:,JBH-492
2020-10-23T13:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920,Code name:,JBH492
2020-10-23T13:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920,Synonym:,anti-CCR7 ADC JBH492
2020-10-23T13:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920,Synonym:,anti-CCR7-DM4 antibody-drug conjugate JBH492
2020-10-23T13:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802926,Code name:,IO 202
2020-10-23T13:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802926,Code name:,IO-202
2020-10-23T13:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802926,Code name:,IO202
2020-10-23T13:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802926,Synonym:,anti-leukocyte immunoglobulin-like receptor B4 monoclonal antibody IO-202
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Code name:,MVR-T3011
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Code name:,T 3011
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Code name:,T-3011
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Code name:,T3011
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Synonym:,oHSV-1-expressing IL-12 and anti-PD-1 antibody T3011
2020-10-23T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928,Synonym:,oncolytic HSV-1-expressing IL-12/anti-PD-1 antibody T3011
2020-10-23T13:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802942,Code name:,ICT 01
2020-10-23T13:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802942,Code name:,ICT-01
2020-10-23T13:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802942,Code name:,ICT01
2020-10-23T13:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802942,Synonym:,anti-BTN3A agonist monoclonal antibody ICT01
2020-10-23T13:33:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802943,Code name:,LYT 100
2020-10-23T13:33:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802943,Code name:,LYT-100
2020-10-23T13:33:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802943,Code name:,LYT100
2020-10-23T13:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803024,Synonym:,TAEK-VAC-HerBy
2020-10-23T13:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803025,Code name:,SCO 101
2020-10-23T13:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803025,Code name:,SCO-101
2020-10-23T13:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803025,Code name:,SCO101
2020-10-06T19:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803026,Synonym:,DnaJ homolog subfamily B member 1/cAMP-dependent protein kinase catalytic subunit apha fusion protein
2020-10-06T19:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803026,Synonym:,HSP40/PKA C-alpha fusion protein
2020-10-23T13:32:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803027,Code name:,P-PSMA 101
2020-10-23T13:32:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803027,Code name:,P-PSMA-101
2020-10-23T13:32:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803027,Code name:,P-PSMA101
2020-10-23T13:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029,Code name:,GNX 102
2020-10-23T13:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029,Code name:,GNX-102
2020-10-23T13:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029,Code name:,GNX102
2020-10-23T13:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029,Synonym:,anti-branched Lewis B/Lewis Y monoclonal antibody GNX102
2020-10-23T13:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029,Synonym:,anti-LeB/LeY monoclonal antibody GNX102
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Code name:,BAY 1817080
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Code name:,BAY-1817080
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Code name:,BAY1817080
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Synonym:,P2X ligand-gated ion channel 3 receptor antagonist BAY 1817080
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Synonym:,P2X purinoceptor 3 antagonist BAY 1817080
2020-10-23T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037,Synonym:,P2X3 receptor antagonist BAY 1817080
2020-10-06T19:28:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803038,Synonym:,triproamylin
2020-10-23T13:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803041,US brand name:,Prosta-Q
2020-11-03T11:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803103,Code name:,IPH 5201
2020-11-03T11:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803103,Code name:,IPH-5201
2020-11-03T11:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803103,Code name:,IPH5201
2020-11-03T11:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105,Code name:,NIZ 985
2020-11-03T11:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105,Code name:,NIZ-985
2020-11-03T11:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105,Code name:,NIZ985
2020-11-03T11:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105,Synonym:,hetIL-15 NIZ985
2020-11-03T11:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105,Synonym:,IL-15/IL-15Ra heterodimer NIZ985
2020-11-03T11:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803106,Abbreviation:,HGWWD
2020-11-03T11:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803106,Synonym:,Huang Qi Gui Zhi Wu Wu decoction
2020-11-03T11:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803108,Code name:,DB 020
2020-11-03T11:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803108,Code name:,DB-020
2020-11-03T11:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803108,Code name:,DB020
2020-11-03T11:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803108,Synonym:,STS formulation DB-020
2020-11-03T11:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109,Code name:,NYH817100
2020-11-03T11:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109,Foreign brand name:,Starvanip
2020-11-03T11:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109,Synonym:,NYH817G and NYH100P
2020-11-03T11:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109,Synonym:,NYH817G plus NYH100P
2020-11-03T11:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109,Synonym:,NYH817G/NYH100P
2020-10-20T13:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803125,Synonym:,allogeneic CD8-positive memory T lymphocytes
2020-11-03T11:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803157,Synonym:,99mTc-HPArk2
2020-11-03T11:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803157,Synonym:,99mTc-labeled HER2 affibody HPArk2
2020-11-03T11:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803157,Synonym:,technetium Tc-99m anti-HER2 antagonist HPArk2
2020-11-03T11:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803159,Synonym:,ESR1 peptide vaccine
2020-11-03T11:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803159,Synonym:,mutated ESR1 peptide vaccine
2020-11-03T11:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161,Code name:,ABBV 184
2020-11-03T11:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161,Code name:,ABBV-184
2020-11-03T11:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161,Code name:,ABBV184
2020-11-03T11:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161,Synonym:,anti-survivin TCR/anti-CD3 bispecific therapeutic ABBV-184
2020-11-03T11:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161,Synonym:,survivin TCR/CD3 bispecific therapeutic ABBV-184
2020-11-03T11:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162,Code name:,HMPL 306
2020-11-03T11:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162,Code name:,HMPL-306
2020-11-03T11:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162,Code name:,HMPL306
2020-11-03T11:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162,Synonym:,IDH1/IDH2 inhibitor HMPL-306
2020-11-03T11:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162,Synonym:,isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 dual inhibitor HMPL-306
2020-11-03T11:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803163,Code name:,ZL 1201
2020-11-03T11:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803163,Code name:,ZL-1201
2020-11-03T11:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803163,Code name:,ZL1201
2020-11-03T11:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803210,NA,NA
2020-11-03T11:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803239,Code name:,AIN457
2020-11-03T11:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803239,US brand name:,Cosentyx
2020-11-03T11:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803259,Code name:,PF 07104091
2020-11-03T11:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803259,Code name:,PF-07104091
2020-11-03T11:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803259,Synonym:,cyclin-dependent kinase 2 inhibitor PF-07104091
2020-09-18T01:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/851b-gel,NA,NA
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,TLR7 agonist 852A
2020-09-18T01:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a,Synonym:,Toll-like receptor agonist 852A
2020-10-14T03:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a-101-topical-solution,Code name:,A-101
2020-10-14T03:21:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a-101-topical-solution,Synonym:,A-101 solution
2020-10-14T03:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a2a-receptor-antagonist-eos100850,Code name:,EOS 100850
2020-10-14T03:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a2a-receptor-antagonist-eos100850,Code name:,EOS-100850
2020-10-14T03:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a2a-receptor-antagonist-eos100850,Code name:,EOS100850
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,Code name:,1592U89
2020-09-18T01:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate,US brand name:,Ziagen
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Foreign brand name:,VaccinOvar
2020-09-18T01:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab,Synonym:,monoclonal antibody ACA125 anti-idiotype vaccine
2020-10-14T03:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abaloparatide,Code name:,BA058
2020-10-14T03:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abaloparatide,Code name:,BIM-44058
2020-10-14T03:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abaloparatide,US brand name:,Tymlos
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,PPI-149
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Code name:,R-3827
2020-09-18T01:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix,Synonym:,Plenaxis
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,BMS-188667
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Code name:,RG2077
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTL A4-Ig B7 Inhibitor
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,CTLA4-Ig
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,Synonym:,cytotoxic T lymphocyte-associated antigen-4
2020-09-18T01:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept,US brand name:,Orencia
2020-09-18T01:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abbv-221,NA,NA
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Chemical structure:,"2-pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)"
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Code name:,LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,Synonym:,CDK4/6 dual inhibitor LY2835219
2020-09-18T01:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib,US brand name:,Verzenio
2020-09-18T01:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat,Code name:,PCI-24781
2020-10-14T03:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat-tosylate,Code name:,PCI-24781
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,Code name:,CB7630
2020-09-18T01:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate,US brand name:,Zytiga
2020-10-14T03:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abituzumab,Code name:,EMD 525797
2020-10-14T03:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abituzumab,Synonym:,anti-human CD51 monoclonal antibody EMD 525797
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,Synonym:,oxiplex/AP gel
2020-09-18T01:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel,US brand name:,Intercoat
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Abbreviation:,HFTP
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,Synonym:,human fibrinogen/thrombin patch
2020-09-18T01:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch,US brand name:,TachoSil
2020-09-18T01:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge,US brand name:,Gelfoam
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Abbreviation:,AMP
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,AMP hemostatic powder
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,Synonym:,Endo-Clot
2020-09-18T01:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder,US brand name:,EndoClot
2020-09-18T01:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-510,NA,NA
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Chemical structure:,N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
2020-09-18T01:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751,Code name:,E7010
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Abbreviation:,BLEO/DOX/DTIC/VBL
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,ABVD
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,Adriamycin-bleomycin-vinblastine-dacarbazine regimen
2020-09-18T01:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen,Synonym:,bleomycin/dacarbazine/doxorubicin/vinblastine
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,ABVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide-prednisone-cyclophosphamide regimen
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC
2020-09-18T01:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen,Synonym:,DBVE-PC regimen
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,ABVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide regimen
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE
2020-09-18T01:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen,Synonym:,DBVE regimen
2020-09-18T01:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-regimen,Synonym:,Adriamycin-cyclophosphamide regimen
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-T
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,AC-Taxol regimen
2020-09-18T01:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen,Synonym:,Adriamycin cyclophosphamide-Taxol regimen
2020-09-18T01:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acadesine,Chemical structure:,5-aminoimidazole-4-carboxamide riboside
2020-09-18T01:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acai-berry-juice,Synonym:,acai juice
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Code name:,ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,Bruton tyrosine kinase inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,Synonym:,BTK inhibitor ACP-196
2020-09-18T01:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib,US brand name:,Calquence
2020-10-14T03:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalisib,Code name:,CAL-120
2020-10-14T03:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalisib,Code name:,GS-9820
2020-10-14T03:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalisib,Synonym:,p110beta/delta PI3K Inhibitor GS-9820
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Chemical structure:,"O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose"
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,Code name:,Bay g 5421
2020-09-18T01:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose,US brand name:,Precose
2020-10-14T03:22:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix,Acronym:,ACDM
2020-10-14T03:22:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix,US brand name:,AlloDerm
2020-10-14T03:22:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix,US brand name:,DermaMatrix
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,Acronym:,ACDM
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,AlloDerm
2020-09-18T01:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix,US brand name:,DermaMatrix
2020-09-18T01:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acenocoumarol,NA,NA
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Abbreviation:,ACMP
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Chemical structure:,N-(4-hydroxyphenyl)acetamide
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,Synonym:,paracetamol
2020-09-18T01:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen,US brand name:,Tylenol
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,"acetic acid, glacial"
2020-09-18T01:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid,Synonym:,glacial acetic acid
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Chemical structure:,1-(p-acetylbenzenesulfonyl)-3-cyclohexylurea3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamideN-(p-acetylbenzenesulfonyl)-N'-cyclohexylureaN-(p-acetylphenylsulfonyl)-N'-cyclohexylurea
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Foreign brand name:,Dimelin
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,Synonym:,Cyclamide
2020-09-18T01:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide,US brand name:,Dymelor
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Abbreviation:,NAC
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Airbron
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Broncholysin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Brunac
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fabrol
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluatox
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucetin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Fluprowit
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Muco Sanigen
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucocedyl
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolator
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucolyticum
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucosolvin
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Mucret
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Neo-Fluimucil
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Parvolex
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Respaire
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Foreign brand name:,Tixair
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,L-Alpha-acetamido-beta-mercaptopropionic Acid
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-Acetyl Cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-3-mercaptoalanine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetyl-L-cysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,Synonym:,N-acetylcysteine
2020-09-18T01:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine,US brand name:,Mucomyst
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Abbreviation:,ASA
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Chemical structure:,2-(acetyloxy)benzoic Acid
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,Synonym:,aspirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Aspergum
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Ecotrin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Empirin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Entericin
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Extren
2020-09-18T01:18:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid,US brand name:,Measurin
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Foreign brand name:,Quintapill
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide capsule
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide tablet
2020-09-18T01:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,Polycap
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Chemical structure:,"(All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid"
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro 10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Code name:,Ro-10-1670
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Foreign brand name:,Neotigason
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,Synonym:,Trimethylmethoxyphenyl-retinoic acid
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Etretin
2020-09-18T01:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin,US brand name:,Soriatane
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,AT-125
2020-09-18T01:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin,Code name:,U-42126
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Abbreviation:,ACM-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Code name:,MA144-A1
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinomycine
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclacinon
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Aclaplastin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Foreign brand name:,Jaclacin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclacinomycin A hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,aclacinomycin-A
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Aclarubicin Hydrochloride
2020-09-18T01:20:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin,Synonym:,Antibiotic MA144-A1
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Chemical structure:,"acetamide, N-methyl-N-[4-[(7-methyl-1H-imidazo[4, 5-f]quinolin-9-yl)amino]phenyl]-, monohydrochloride (9CI)"
2020-09-18T01:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole,Synonym:,acodazole hydrochloride
2020-10-14T13:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoramidis,Code name:,AG 10
2020-10-14T13:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoramidis,Code name:,AG-10
2020-10-14T13:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoramidis,Code name:,AG10
2020-10-14T13:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoramidis,Synonym:,TTR stabilizer AG10
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Abbreviation:,BMF
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,acoustic fluid
2020-09-18T01:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid,Synonym:,brain mimicking fluid
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Abbreviation:,DACA
2020-09-18T01:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide,Code name:,XR5000
2020-10-14T03:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-anti-psma-monoclonal-antibody-j591,Abbreviation:,225Ac-J591
2020-10-14T03:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-anti-psma-monoclonal-antibody-j591,Synonym:,Ac 225 MOAB J591
2020-10-14T03:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-anti-psma-monoclonal-antibody-j591,Synonym:,Ac 225 monoclonal antibody J591
2020-10-14T03:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-anti-psma-monoclonal-antibody-j591,Synonym:,actinium Ac-225 anti-prostate-specific membrane antigen monoclonal antibody J591
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Code name:,[225Ac]-FPI-1434
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Code name:,FPX 01
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Code name:,FPX-01
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Code name:,FPX01
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Synonym:,[Ac-225]-FPI-1434
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Synonym:,225Ac-FPI-1434
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Synonym:,actinium Ac 225-FPI-1397-FPI-1175
2020-10-14T03:22:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434,Synonym:,actinium Ac 225-labeled FPI-1434
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Abbreviation:,225Ac-HuM195
2020-09-18T01:21:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab,Synonym:,actinium-225-labeled humanized anti-CD33 monoclonal antibody HuM195
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,aMIL
2020-09-18T01:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes,Abbreviation:,MIL
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Code name:,STM 434
2020-09-18T01:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434,Synonym:,activin A inhibitor STM 434
2020-10-14T03:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-iia-receptor-fc-fusion-protein-ker-050,Code name:,KER 050
2020-10-14T03:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-iia-receptor-fc-fusion-protein-ker-050,Code name:,KER-050
2020-10-14T03:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-iia-receptor-fc-fusion-protein-ker-050,Code name:,KER050
2020-10-14T03:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-iia-receptor-fc-fusion-protein-ker-050,Synonym:,activin type 2A receptor Fc fusion protein KER-050
2020-10-14T03:23:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclic-nucleoside-phosphonate-prodrug-abi-1968,Code name:,ABI-1968
2020-10-14T03:23:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclic-nucleoside-phosphonate-prodrug-abi-1968,Code name:,ABI1968
2020-10-14T03:23:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclic-nucleoside-phosphonate-prodrug-abi-1968,Code name:,HTI 1968
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,Chemical structure:,"2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one monosodium salt9-[(2-hydroxyethoxy)methyl]guanine monosodium salt"
2020-09-18T01:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium,US brand name:,Zovirax for injection
2020-09-18T01:40:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-flt3l,NA,NA
2020-09-18T01:40:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-tk,NA,NA
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD154 ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,Ad-CD40L ISF35
2020-09-18T01:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35,Synonym:,recombinant adenovirus encoding CD40 ligand ISF35-transduced B lymphocytes
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,Ad-REIC/dickkopf homolog 3
2020-09-18T01:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine,Synonym:,adenovirus-mediated REIC/Dkk-3 secretory protein
2020-10-14T03:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-rts-hil-12,Code name:,INXN 2001
2020-10-14T03:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-rts-hil-12,Code name:,INXN-2001
2020-10-14T03:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-rts-hil-12,Synonym:,adaoviral-rheoswitch therapeutic system-human interleukin 12
2020-09-18T01:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-sig-hmuc-1-ecdcd40l-vaccine,Synonym:,Ad-sig-hMUC1/ecdCD40L adenoviral vector vaccine
2020-09-18T01:22:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-cmv-nis,Synonym:,recombinant type 5 adenovirus carrying the human NIS gene linked to the CMV promotor
2020-10-14T03:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-e1--e2b--her2-neu-vaccine-etbx-021,Code name:,ETBX-021
2020-10-14T03:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-e1--e2b--her2-neu-vaccine-etbx-021,Synonym:,"Ad5 [E1-, E2b-]-HER2/neu vaccine"
2020-10-14T03:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-e1--e2b--her2-neu-vaccine-etbx-021,Synonym:,adenovirus type 5 E1/E2b-deleted HER2/neu vaccine ETBX-021
2020-10-14T03:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-sge-reic-dkk-3-mtg-201,Synonym:,Ad-REIC/dickkopf homolog 3
2020-10-14T03:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-sge-reic-dkk-3-mtg-201,Synonym:,adenovirus-mediated REIC/Dkk-3 secretory protein
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Code name:,autologous DC:AdmS
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,Ad5-survivin-transduced autologous DC vaccine
2020-09-18T01:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine,Synonym:,autologous dendritic cell adenovirus type 5-survivin vaccine
2020-09-18T01:23:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-adp,NA,NA
2020-09-18T01:23:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-hil12,Synonym:,oncolytic adenovirus Ad5-yCD/mutTKSR39rep-hIL12
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Abbreviation:,Ad5CMV-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,INGN-201
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Code name:,RPR/INGN-201
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adeno-p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,Synonym:,Adenovirus p53
2020-09-18T01:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene,US brand name:,ADVEXIN
2020-09-18T01:23:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5f35-lmp1-lmp2-transduced-autologous-dendritic-cells,NA,NA
2020-09-18T01:22:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5sstr-tkrgd,NA,NA
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OBI-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Code name:,OPT-822
2020-09-18T01:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin,Synonym:,Globo H-KLH immunostimulant OPT-822
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Chemical structure:,"immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer"
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,D2E7
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,Code name:,LU200134
2020-09-18T01:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab,US brand name:,Humira
2020-10-14T03:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib,Chemical structure:,"2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one"
2020-10-14T03:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib,Code name:,AZD-1775
2020-10-14T03:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib,Code name:,AZD1775
2020-10-14T03:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib,Code name:,MK-1775
2020-10-14T03:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib,Code name:,MK1775
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Abbreviation:,ARA-C/DNR/VP-16
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,ADE
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,AraC-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine-daunorubicin-etoposide regimen
2020-09-18T01:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen,Synonym:,cytarabine/daunorubicin/etoposide
2020-09-18T01:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adecatumumab,Code name:,MT201
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,Code name:,GS-0840
2020-09-18T01:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil,US brand name:,Hepsera
2020-10-14T03:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928,Code name:,AB 928
2020-10-14T03:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928,Code name:,AB-928
2020-10-14T03:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928,Code name:,AB928
2020-10-14T03:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928,Synonym:,A2AR/A2BR antagonist AB928
2020-10-14T03:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928,Synonym:,dual A2AR/A2BR antagonist AB928
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Code name:,CPI-444
2020-09-18T01:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444,Synonym:,adenosine-A2A receptor-targeting agent CPI-444
2020-10-14T03:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-nir178,Code name:,NIR 178
2020-10-14T03:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-nir178,Synonym:,A2AR antagonist NIR178
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Code name:,PBF-509
2020-09-18T01:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509,Synonym:,A2AR antagonist PBF-509
2020-10-14T03:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-phosphodiesterase-10a-pbf-999,Code name:,PBF 999
2020-10-14T03:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-phosphodiesterase-10a-pbf-999,Code name:,PBF-999
2020-10-14T03:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-phosphodiesterase-10a-pbf-999,Code name:,PBF999
2020-10-14T03:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-phosphodiesterase-10a-pbf-999,Synonym:,A2A/PDE-10 inhibitor PBF-999
2020-10-14T03:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2b-receptor-antagonist-pbf-1129,Code name:,PBF 1129
2020-10-14T03:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2b-receptor-antagonist-pbf-1129,Code name:,PBF1129
2020-10-14T03:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2b-receptor-antagonist-pbf-1129,Synonym:,A2BR Antagonist PBF-1129
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Abbreviation:,Cl-IB-MECA
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Chemical structure:,2-chloro-N6-(3-iodobenzyl)-9-[5-(methylcarbamoyl)--D-ribofuranosyl]adenine
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Code name:,CF102
2020-09-18T01:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102,Synonym:,A3AR agonist CF102
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Code name:,INGN 241
2020-09-18T01:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7,Synonym:,adenovector encoding IL24
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX 051
2020-09-18T01:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051,Code name:,ETBX-051
2020-10-14T03:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-cancer-vaccine-pf-06936308,Code name:,PF 06936308
2020-10-14T03:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-cancer-vaccine-pf-06936308,Code name:,PF-06936308
2020-10-14T03:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-cancer-vaccine-pf-06936308,Code name:,PF06936308
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX 061
2020-09-18T01:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061,Code name:,ETBX-061
2020-10-14T03:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-psa-vaccine-etbx-071,Code name:,ETBX-071
2020-10-14T03:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-psa-vaccine-etbx-071,Synonym:,Adenoviral PSA Prostate Cancer Vaccine ETBX-071
2020-10-14T03:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-gad-209-fsp,Synonym:,GAd-209-FSP
2020-10-14T03:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-gad-209-fsp,Synonym:,great ape adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP
2020-10-14T03:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901,Code name:,GRT C901
2020-10-14T03:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901,Code name:,GRT-C901
2020-10-14T03:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901,Code name:,GRTC901
2020-10-14T03:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901,Synonym:,adenoviral TSNA priming vaccine GRT-C901
2020-10-14T03:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901,US brand name:,priming cancer vaccine GRT-C901
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Abbreviation:,"Ad5[E1-,E2b-]-CEA vaccine"
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Code name:,ETBX-011
2020-09-18T01:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine,Synonym:,"adenoviral vector Ad5 [E1-, E2b-]-CEA vaccine"
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Code name:,LX 1101
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Code name:,LX-1101
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Code name:,LX1101
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Foreign brand name:,Lymfactin
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Synonym:,AdAptVEGF-C adenoviral vector LX-1101
2020-10-14T03:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101,Synonym:,VEGFC-expressing gene therapeutic LX-1101
2020-09-18T01:38:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-5-human-guanylyl-cyclase-c-padre-vaccine,Synonym:,Ad5-hGCC-PADRE vaccine
2020-09-18T01:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-b7-1,NA,NA
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Code name:,Ad/PNP
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,Synonym:,adenovirus encoding purine nucleoside phosphorylase
2020-09-18T01:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp,US brand name:,Gedeptin
2020-09-18T01:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-human-aquaporin-1,Abbreviation:,AdhAQP1
2020-09-18T01:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-rat-her-2-neu,NA,NA
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Abbreviation:,Ad-rhENDO
2020-09-18T01:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin,Code name:,E10A
2020-10-14T03:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7,Synonym:,Ad-E6/E7
2020-10-14T03:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7,Synonym:,Ad-E6E7
2020-10-14T03:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7,Synonym:,adenoviral-expressing mutant HPV E6/E7
2020-10-14T03:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7,Synonym:,adenoviral-HPV E6E7 vaccine
2020-10-14T03:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7,Synonym:,adenovirus vaccine expressing mutant HPV E6 and E7
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,Code name:,M-VM3
2020-09-18T01:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3,US brand name:,Mobilan
2020-09-18T01:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-her2-transduced-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Abbreviation:,Ad.hIL-12
2020-09-18T01:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12,Synonym:,adenovirus-interleukin-12
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Abbreviation:,Ad-RTS-IL-12 plus AL
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,INXN-2001/1001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Code name:,ZIN ATI-001
2020-09-18T01:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex,Synonym:,adenovirus-mediated human interleukin-12 INXN-2001 plus activator ligand INXN-1001
2020-09-18T01:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-p53-transduced-dendritic-cell-vaccine,Abbreviation:,Ad.p53-DC vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,Ad/PSA vaccine
2020-09-18T01:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine,Synonym:,adenovirus/PSA vaccine
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Abbreviation:,ADV
2020-09-18T01:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector,Synonym:,Adenoviral Vector
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Abbreviation:,DC-AdGMCAIX
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,DCs expressing CMCA9 gene
2020-09-18T01:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells,Synonym:,dendritic cells transduced with AdGMCA9 expressing GM-CSF-carbonic anhydrase IX fusion protein
2020-09-18T01:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adh-1,US brand name:,Exherin
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Code name:,SCM 010
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Code name:,SCM-010
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Code name:,SCM010
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Synonym:,adipose derived stem cells SCM-010
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Synonym:,adipose-derived expanded MSCs SCM-010
2020-10-14T03:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010,Synonym:,ADSCs SCM-010
2020-09-18T01:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-regenerative-cells,Acronym:,ADRC
2020-09-18T01:40:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-stromal-vascular-fraction-cells,Synonym:,adipose-derived SVF cells
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Abbreviation:,T-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,PRO132365
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Code name:,RO5304020
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab emtansine
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 antibody-drug conjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 immunoconjugate
2020-09-18T01:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine,US brand name:,Kadcyla
2020-09-18T01:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adozelesin,Code name:,"U-73,975"
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Abbreviation:,CCTROP
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,ACTH
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,acthar
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,adrenocorticotropin
2020-09-18T01:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone,Synonym:,corticotropin
2020-09-18T01:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrtvp-1-transduced-prostate-cancer-cell-based-vaccine,Synonym:,Adenoviral vector-mediated RTVP-1 gene-modified prostate cancer cell-based vaccine
2020-09-18T01:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ae37-peptide-gm-csf-vaccine,NA,NA
2020-09-18T01:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aee788,NA,NA
2020-09-18T01:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aeg35156,US brand name:,GEM640
2020-10-14T03:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-gemcitabine,Synonym:,aerosolized GCB
2020-10-14T03:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-gemcitabine,Synonym:,aerosolized gemcitabine
2020-09-18T01:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-sargramostim,Synonym:,aerosol GM-CSF
2020-09-18T01:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-aldesleukin,Synonym:,aerosolized recombinant IL-2
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Code name:,L9NC
2020-09-18T01:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan,Synonym:,aerosolized liposomal 9-nitrocamptothecin
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Chemical structure:,N-acetyl-L-serinyl-L-tyrosyl-L-seryl-(2S)-2-aminohexanoyl-L-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophanylglycyl-L-lysyl-L-prolyl-L-valinamide
2020-09-18T01:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide,Code name:,CUV1647
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,Code name:,BIBW 2992 MA2
2020-09-18T01:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate,US brand name:,Gilotrif
2020-09-18T01:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afimoxifene,Synonym:,4-Hydroxy-Tamoxifen
2020-09-18T01:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp-gene-hepatocellular-carcinoma-vaccine,NA,NA
2020-09-18T01:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp464,NA,NA
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,Akt inhibitor GSK2110183
2020-09-18T01:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib,Code name:,GSK2110183
2020-09-18T01:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ag-024322,NA,NA
2020-09-18T01:43:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agaricus-blazei-murill-extract,NA,NA
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,CpG 7909
2020-09-18T01:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium,Code name:,PF-3512676
2020-10-14T04:30:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agerafenib,Chemical structure:,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride"
2020-10-14T04:30:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agerafenib,Code name:,AC013773
2020-10-14T04:30:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agerafenib,Code name:,CEP-32496
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,Ad HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,adeno-HSV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Abbreviation:,ADV-tk
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding herpes simplex virus thymidine kinase
2020-09-18T01:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec,Synonym:,adenoviral vector encoding HSV thymidine kinase
2020-09-18T01:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-cd40-monoclonal-antibody-adc-1013,Code name:,ADC-1013
2020-10-14T03:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-incagn01949,Code name:,INCAGN01949
2020-10-14T03:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-incagn01949,Synonym:,anti-OX40 agonist antibody INCAGN01949
2020-10-14T03:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-incagn01949,Synonym:,anti-OX40 monoclonal antibody INCAGN0194
2020-10-14T03:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-incagn01949,Synonym:,monoclonal antibody INCAGN01949
2020-09-18T01:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6383,Code name:,MEDI6383
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Code name:,MEDI6469
2020-09-18T01:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469,Synonym:,agonistic anti-CD134 monoclonal antibody MEDI6469
2020-09-18T01:44:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aim2-1-ht001-1-taf1b-1-frameshift-peptide-vaccine,Abbreviation:,AIM2(-1)/HT001(-1)/TAF1B(-1) FSP vaccine
2020-09-18T01:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ak-3012,NA,NA
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,OBI 3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,OBI-3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,OBI3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,TH 3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,TH-3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Code name:,TH3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Synonym:,AKR1C3-activated prodrug TH-3424
2020-10-14T03:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424,Synonym:,aldo-keto reductase 1c3-activated prodrug OBI-3424
2020-09-18T01:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-bay1125976,Code name:,BAY1125976
2020-10-14T03:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-1/2-treated Tumor Infiltrating Lymphocytes
2020-10-14T03:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-treated TIL
2020-10-14T03:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,AKTi-treated TILs
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,Code name:,RX-0201
2020-09-18T01:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201,US brand name:,Archexin
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,ONC201
2020-09-18T01:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201,Code name:,TIC10
2020-09-18T01:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-arq-092,Code name:,ARQ 092
2020-09-18T05:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-azd5363,Code name:,AZD5363
2020-09-18T05:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-azd5363,Synonym:,Akt inhibitor AZD5363
2020-09-18T01:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-gsk2141795,Code name:,GSK2141795
2020-09-18T01:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-ly2780301,Code name:,LY2780301
2020-09-18T01:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-mk2206,Code name:,MK2206
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Chemical structure:,"2,10-dicarbethoxy-6-methoxy-5,7-dihydro-indolo[2,3-b]carbazole"
2020-09-18T01:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668,Code name:,SRI13668
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-1/2-treated Tumor Infiltrating Lymphocytes
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,Akti-treated TIL
2020-09-18T01:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes,Synonym:,AKTi-treated TILs
2020-10-14T13:01:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alacizumab-pegol,Code name:,CDP 791
2020-10-14T12:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alanosine,Chemical structure:,3-(hydroxynitrosoamino)-L-alanineL-2-amino-3-(hydroxynitrosoamino)propionic acidL-2-amino-3-[(N-nitroso)hydroxylamino]propionic acid
2020-10-14T12:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alanosine,Code name:,SDX-102
2020-10-14T12:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alanosine,Synonym:,alanosine
2020-10-14T12:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alanosine,Synonym:,L-alanosine sodium
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,Chemical structure:,"Carbamic Acid,(5-(Propylthio)-1H-benzimidazol-2-yl)-, Methyl Ester"
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,Code name:,SKF 62979
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,Synonym:,Bilutac
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,Synonym:,Proftril
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,US brand name:,Albenza
2020-10-14T03:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole,US brand name:,Zentel
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP 114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Code name:,BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,albumin-conjugating platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,cisplatin/maleimide-based complex BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,platinum-prodrug BTP-114
2020-09-18T01:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114,Synonym:,prodrug BTP-114
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,Synonym:,salbutamol sulfate
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Proventil
2020-09-18T01:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate,US brand name:,Ventolin
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,absolute ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethanol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,ethyl alcohol
2020-09-18T01:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol,Synonym:,methylcarbinol
2020-10-14T03:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol-free-hypoallergenic-barrier-film-solution,US brand name:,3M Cavilon Advanced Skin Protectant
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Abbreviation:,r-serHuIL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Chemical structure:,125-L-serine-2-133-interleukin 2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human IL-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,Synonym:,recombinant human interleukin-2
2020-09-18T01:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin,US brand name:,Proleukin
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Code name:,INNO-206
2020-09-18T01:46:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin,Synonym:,doxorubicin prodrug INNO-206
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Chemical structure:,"5H-benzo(b)carbazole-3-carbonitrile, 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-"
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF-802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,AF802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RG7853
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,RO5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Code name:,UNII-LIJ4CT1Z3Y
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Foreign brand name:,Alecensa
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,ALK inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,Synonym:,anaplastic lymphoma kinase inhibitor CH5424802
2020-09-18T01:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib,US brand name:,Alecensa
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,Code name:,LFA3TIP
2020-09-18T01:46:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept,US brand name:,Amevive
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Abbreviation:,MoAb CD52
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Foreign brand name:,MabCampath
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,anti-CD52 monoclonal antibody
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody Campath-1H
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,Synonym:,Monoclonal Antibody CD52
2020-09-18T01:46:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab,US brand name:,Campath
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,G-704650
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Code name:,MK-217
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Adronat
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Alendros
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Foreign brand name:,Onclast
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,Synonym:,Alendronic Acid Monosodium Salt Trihydrate
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Binosto
2020-09-18T01:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium,US brand name:,Fosamax
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,Foreign brand name:,Rapifen
2020-09-18T01:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride,US brand name:,Alfenta
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST 2818
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Code name:,AST2818
2020-09-18T01:47:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate,Synonym:,ASK120067
2020-09-18T01:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfuzosin-hydrochloride,US brand name:,Uroxatrol
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,"Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Pancreatic Tumor Cell Vaccine"
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,Synonym:,Alpha-Gal Pancreatic Cancer Vaccine
2020-09-18T01:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l,US brand name:,Hyperacute-Pancreatic Cancer Vaccine
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Chemical structure:,"benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-"
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Code name:,MLN8237
2020-09-18T01:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib,Synonym:,Aurora A kinase inhibitor MLN8237
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Abbreviation:,9-CRA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Acronym:,9-cis-RA
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid"
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,ALRT1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Code name:,LGD1057
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panretyn
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Foreign brand name:,Panrexin
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,Synonym:,9-cis-retinoic acid
2020-09-18T01:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin,US brand name:,Panretin
2020-10-14T03:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-c-met-inhibitor-tq-b3139,Code name:,TQ B3139
2020-10-14T03:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-c-met-inhibitor-tq-b3139,Code name:,TQ-B3139
2020-09-18T01:49:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-inhibitor-cep-37440,Code name:,CEP-37440
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT 707
2020-09-18T01:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707,Code name:,CT-707
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Chemical structure:,"N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine"
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP-3026
2020-09-18T01:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026,Code name:,ASP3026
2020-10-14T03:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-plb-1003,Code name:,PLB 1003
2020-10-14T03:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-plb-1003,Code name:,PLB-1003
2020-10-14T03:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-plb-1003,Code name:,PLB1003
2020-09-18T01:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-ro5424802,Code name:,RO5424802
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Code name:,FL 006
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Code name:,FL006
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Code name:,WX 0593
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Code name:,WX-0593
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Code name:,WX0593
2020-10-14T03:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593,Synonym:,FL-006
2020-09-18T11:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005,Code name:,TPX-0005
2020-09-18T11:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005,Synonym:,ALK/ROS1/NTRK/SRC multi-kinase inhibitor TPX-0005
2020-09-18T11:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005,Synonym:,ALK/ROS1/NTRK/SRC/FAK multikinase inhibitor TPX-0005
2020-09-18T11:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005,Synonym:,multi-kinase inhibitor TPX-0005
2020-09-18T11:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005,Synonym:,multikinase inhibitor TPX-0005
2020-09-18T01:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-trk-inhibitor-tsr-011,Code name:,TSR-011
2020-09-18T12:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk5-inhibitor-tew-7197,Code name:,TEW-7197
2020-09-18T12:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk5-inhibitor-tew-7197,Code name:,TEW7197
2020-09-18T12:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk5-inhibitor-tew-7197,Synonym:,TGFBR1 inhibitor TEW-7197
2020-10-14T03:27:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkotinib,Code name:,ZG 0418
2020-10-14T03:27:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkotinib,Code name:,ZG-0418
2020-10-14T03:27:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkotinib,Code name:,ZG0418
2020-10-14T03:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkylglycerol-rosemary-capsules,Synonym:,alkylglycerol and rosemary capsules
2020-10-14T03:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkylglycerol-rosemary-capsules,Synonym:,rosemary/alkylglycerol dietary supplement
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Abbreviation:,T-allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific TR1 cells Allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,alloantigen-specific type 1 Tregs T-allo10
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,donor-derived host alloantigen-specific IL-10 anergized T cells
2020-09-18T01:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10,Synonym:,T-allo10 cells
2020-09-18T01:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-haploidentical-t-cells-expressing-inducible-caspase-9,Synonym:,iCasp9 allogeneic T cells
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Code name:,ATIR101
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,Synonym:,Theralux-ATIR
2020-09-18T01:49:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101,US brand name:,Allodepleted T-cell ImmunotheRapeutics
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCOne
2020-09-18T01:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine,Code name:,DCP-001
2020-09-18T01:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic adenovirus-specific CTLs
2020-10-14T03:27:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adipose-derived-mesenchymal-stem-cells,US brand name:,Temferon
2020-10-14T03:27:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-aml-antigen-expressing-dendritic-cell-vaccine,Code name:,DCOne
2020-10-14T03:27:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-aml-antigen-expressing-dendritic-cell-vaccine,Code name:,DCP-001
2020-10-14T03:27:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-t-cells-pbcar269a,Code name:,PBCAR269A
2020-10-14T03:27:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-t-cells-pbcar269a,Synonym:,allogeneic anti-BCMA CAR T cells PBCAR269A
2020-10-14T03:27:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-t-cells-pbcar269a,Synonym:,allogeneic anti-BCMA-CAR T lymphocytes PBCAR269A
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Code name:,ALLO 715
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Code name:,ALLO-715
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Code name:,ALLO715
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Synonym:,ALLO-715 cells
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Synonym:,alloCAR T ALLO-715
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Synonym:,anti-BCMA allogeneic CAR T cells ALLO-715
2020-10-14T03:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715,Synonym:,BCMA allogeneic CAR T cells ALLO-715
2020-10-14T03:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-cs1-bispecific-car-t-cells,Synonym:,allogeneic anti-BCMA/SLAMF7 bispecific CAR-T cells
2020-10-14T03:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-cs1-bispecific-car-t-cells,Synonym:,allogeneic BCMA/CS1 bispecific CAR-T cells
2020-10-14T03:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-cs1-bispecific-car-t-cells,Synonym:,allogeneic BCMA/SLAMF7 bispecific CAR-T cells
2020-10-14T03:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-car-t-cells-pbcar0191,Code name:,PBCAR0191
2020-10-14T03:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-car-t-cells-pbcar0191,Synonym:,allogeneic anti-CD19-CAR T lymphocytes PBCAR0191
2020-10-14T03:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-car-t-cells-pbcar0191,Synonym:,anti-CD19-CAR allogeneic T cells PBCAR0191
2020-10-14T03:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101,Code name:,CTA 101
2020-10-14T03:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101,Code name:,CTA-101
2020-10-14T03:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101,Code name:,CTA101
2020-10-14T03:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101,Synonym:,allogeneic anti-CD19 UCAR-T cells CTA101
2020-10-14T03:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101,Synonym:,universal CD19-directed CAR-T cells CTA101
2020-10-14T03:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-lucar-20s,Code name:,LUCAR 20S
2020-10-14T03:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-lucar-20s,Code name:,LUCAR-20S
2020-10-14T03:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-lucar-20s,Code name:,LUCAR20S
2020-10-14T03:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-lucar-20s,Synonym:,LUCAR-20S CAR-T cells
2020-10-14T03:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-pbcar20a,Code name:,BCAR20A
2020-10-14T03:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-pbcar20a,Code name:,PBCAR 20A
2020-10-14T03:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-pbcar20a,Code name:,PBCAR-20A
2020-10-14T03:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-pbcar20a,Synonym:,allogeneic anti-CD20 CAR T lymphocytes PBCAR20A
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Code name:,DPV 001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Code name:,DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Code name:,DPV001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,allogeneic DRibble vaccine DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,dribble cancer vaccine DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,DRibble vaccine DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,dribbles vaccine DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,DRiPs and SLiPs-containing blebs vaccine DPV-001
2020-10-14T03:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001,Synonym:,vaccine DPV-001
2020-09-18T01:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-b71-hla-a1-transfected-tumor-cell-vaccine,NA,NA
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Code name:,UCART123
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Synonym:,allogeneic engineered T cells expressing anti-CD123 chimeric antigen receptor
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Synonym:,UCART123 T cells
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Synonym:,universal chimeric antigen receptor T cell 123
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Synonym:,universal chimeric antigen receptor T cells targeting CD123
2020-10-14T03:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes,Synonym:,universal TALEN gene-edited CART123 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,ALLO-501
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Code name:,S68587
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,TCR/CD52-deficient RQR8+ CD19-CAR+ T cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,UCART19 cells
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal chimeric antigen receptor T cell 19
2020-09-18T01:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes,Synonym:,universal TALEN gene-edited CART19 cells
2020-10-14T03:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19car-transfected-cytokine-induced-killer-cells,Synonym:,allogeneic CARCIK-CD19 cells
2020-10-14T03:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19car-transfected-cytokine-induced-killer-cells,Synonym:,transposon-manipulated allogeneic CARCIK-CD19 cells
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Code name:,FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory natural killer cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive memory NKs cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,adaptive NK cells FATE-NK100
2020-09-18T01:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100,Synonym:,NKG2C/CD57-expressing adaptive memory natural killer cells FATE-NK100
2020-10-14T03:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd8-leukemia-associated-antigens-specific-t-cells-nexi-001,Code name:,NEXI 001
2020-10-14T03:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd8-leukemia-associated-antigens-specific-t-cells-nexi-001,Code name:,NEXI-001
2020-10-14T03:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd8-leukemia-associated-antigens-specific-t-cells-nexi-001,Code name:,NEXI001
2020-09-18T01:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-adv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-10-14T03:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-antigen-specific-cd4-cd8-t-lymphocytes,Synonym:,allogeneic CMV-specific antigen-selected T cells
2020-10-14T03:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-antigen-specific-cd4-cd8-t-lymphocytes,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T cells
2020-10-14T03:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-antigen-specific-cd4-cd8-t-lymphocytes,Synonym:,allogeneic cytomegalovirus-specific CD4+ and CD8+ T lymphocytes
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Code name:,CTX 110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Code name:,CTX-110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Code name:,CTX101
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Code name:,CTX110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Synonym:,allogeneic anti-CD19 CAR CRISPR-edited T cells CTX110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Synonym:,allogeneic anti-CD19 CAR-T cells CTX110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Synonym:,allogeneic CRISPR-Cas9 gene-editing CD19-directed CAR T cells CTX110
2020-10-14T03:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110,Synonym:,allogeneic CRISPR-Cas9-engineered anti-CD19 CAR T cells CTX110
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Code name:,UCART CS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Code name:,UCART-CS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Code name:,UCARTCS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Synonym:,allogeneic gene-edited CAR T cells UCARTCS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Synonym:,allogeneic TALEN gene-edited CAR T cells UCARTCS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Synonym:,allogenic engineered T cells expressing anti- CS1 CAR UCARTCS1A
2020-10-14T03:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a,Synonym:,UCARTCS1A cells
2020-09-18T01:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cytomegalovirus-specific-cytotoxic-t-lymphocytes,Abbreviation:,allogeneic CMV-specific CTLs
2020-09-18T01:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-myeloma-idiotype-vaccine,NA,NA
2020-09-18T01:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-vaccine-combig-dc,Synonym:,COMBIG-DC
2020-10-14T03:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-double-negative-t-cells,Code name:,DNT-UHN-1
2020-10-14T03:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-double-negative-t-cells,Synonym:,allogeneic DNT cells
2020-09-18T01:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV-specific CTL
2020-10-14T03:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-glial-progenitor-cells,Abbreviation:,GRPs
2020-10-14T03:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-glial-progenitor-cells,Synonym:,allogeneic glial restricted progenitor cells
2020-10-14T03:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-glial-progenitor-cells,Synonym:,Q-cells
2020-10-14T03:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-based-myeloma-cell-vaccine,Synonym:,allogeneic GM-CSF-based myeloma cell vaccine
2020-10-14T03:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-based-myeloma-cell-vaccine,Synonym:,allogeneic granulocyte macrophage colony-stimulating factor-transfected myeloma cell vaccine
2020-09-18T01:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine,Abbreviation:,GM-CSF BREAST VAC
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,Synonym:,GM-CSF gene-transfected breast cancer vaccine SV-BR-1-GM
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,Synonym:,SV-BR-1 breast cancer cell line vaccine
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,Synonym:,SV-BR-1-GM
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,Synonym:,SV-BR-1-GM vaccine
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,Synonym:,SV-BR1-GM breast cancer vaccine
2020-10-14T03:29:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm,US brand name:,Bria-IMT
2020-09-18T01:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-lethally-irradiated-whole-melanoma-cell-vaccine,Synonym:,GVAX melanoma vaccine
2020-10-14T03:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-myeloma-vaccine,Synonym:,allogeneic GM-CSF-secreting multiple myeloma vaccine
2020-10-14T03:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-myeloma-vaccine,Synonym:,allogeneic GVAX myeloma vaccine
2020-10-14T03:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-myeloma-vaccine,Synonym:,allogeneic myeloma vaccine with GM-CSF-secreting K562 cells
2020-10-14T03:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-myeloma-vaccine,Synonym:,GVAX allogeneic myeloma vaccine
2020-09-18T01:53:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-1005-pcdna-1-gm-neo,Synonym:,PANC 10.05 pcDNA-1/GM-Neo
2020-09-18T01:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-603-pcdna-1-gm-neo,Synonym:,PANC 6.03 pcDNA-1/GM-Neo
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic GM-CSF-based myeloma cell vaccine
2020-09-18T01:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine,Synonym:,allogeneic granulocyte macrophage colony-stimulating factor-transfected myeloma cell vaccine
2020-10-14T03:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hadv-antigen-specific-t-lymphocytes,Synonym:,allogeneic HAdV antigen-selected T cells
2020-10-14T03:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hadv-antigen-specific-t-lymphocytes,Synonym:,allogeneic HAdV antigen-selected T lymphocytes
2020-10-14T03:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hadv-antigen-specific-t-lymphocytes,Synonym:,allogeneic HAdV antigen-specific T cells
2020-10-14T03:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hadv-antigen-specific-t-lymphocytes,Synonym:,allogeneic human adenovirus-specific T lymphocytes
2020-09-18T01:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hla-a2-4-1bb-ligand-expressing-melanoma-vaccine,NA,NA
2020-10-14T03:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hpv-specific-cytotoxic-t-lymphocytes,Abbreviation:,allogeneic HPV-CTLs
2020-10-14T03:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hpv-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic HPV-specific immune lymphocytes
2020-10-14T03:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-interleukin-17-producing-cd8-positive-t-cells,Synonym:,allogeneic IL-17-producing CD8+ T cells
2020-10-14T03:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-interleukin-17-producing-cd8-positive-t-cells,Synonym:,allogeneic IL-17+ CD8 T cells
2020-10-14T03:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-interleukin-17-producing-cd8-positive-t-cells,Synonym:,allogeneic Tc17 cells
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF 470 vaccine
2020-09-18T01:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470,Synonym:,CSF470 vaccine
2020-09-18T01:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine,Synonym:,allogeneic LMI breast cancer vaccine
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Code name:,LP2307
2020-09-18T01:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307,Synonym:,allogeneic LMI melanoma vaccine LP2307
2020-09-18T01:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-10-14T03:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1-lmp2-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T01:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-melanoma-vaccine-agi-101h,Code name:,AGI-101H
2020-09-18T01:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multipotent-adult-progenitor-cells,US brand name:,MultiStem
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic EBV/CMV/AdV/HHV6/BKV-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic multivirus-specific CTLs
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched virus-specific T cells
2020-09-18T01:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched VST
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Abbreviation:,allogeneic NK cell line MG4101
2020-09-18T01:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101,Code name:,MG4101
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,Code name:,NK-92 cells
2020-09-18T01:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92,US brand name:,haNK
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NK cells
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,allogeneic NAM NKs
2020-09-18T01:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells,Synonym:,donor nicotinamide-expanded natural killer cells
2020-10-14T03:29:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nkg2dl-targeting-car-grafted-gamma-delta-t-cells,Code name:,CTM-N2D
2020-10-14T03:29:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nkg2dl-targeting-car-grafted-gamma-delta-t-cells,Synonym:,allogeneic NKG2DL-targeting CAR-gd T cells
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Code name:,MGN1601
2020-09-18T01:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601,Synonym:,IL-7/GM-CSF/CD80/CD154-encoding synthetic dSLIM-30L1 allogeneic renal cell carcinoma vaccine MGN1601
2020-09-18T11:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-bpx-501,Code name:,BPX-501
2020-09-18T11:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-bpx-501,Synonym:,allogeneic T lymphocytes BPX-501
2020-10-14T03:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-expressing-ny-eso-1-c259-specific-tcr,Synonym:,allogeneic NY-ESO-1-c259 T cells
2020-10-14T03:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-expressing-ny-eso-1-c259-specific-tcr,Synonym:,NY-ESO-1 c259 T cells
2020-10-14T03:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tri-functional-anti-cd19-car-nk-cells,Synonym:,allogeneic CD19-TriCAR SILK cells
2020-10-14T03:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tri-functional-anti-cd19-car-nk-cells,Synonym:,allogeneic CD19-TriCAR-T/SILK
2020-10-14T03:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tri-functional-anti-cd19-car-nk-cells,Synonym:,allogeneic CD19-TriCAR-T/SILK cells
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Abbreviation:,ALLOTCV
2020-09-18T01:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine,Synonym:,Allogenic Cell Vaccine
2020-10-14T03:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-umbilical-cord-blood-derived-hspcs-nla101,Code name:,NLA101
2020-10-14T03:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-umbilical-cord-blood-derived-hspcs-nla101,Synonym:,allogeneic UCB-derived hematopoietic stem and progenitor cells NLA101
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Abbreviation:,4'-HPP
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Chemical structure:,"1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one monosodium salt1H-pyrazolo[3,4-d]pyrimidin-4-ol monosodium salt4-hydroxypyrazolo[3,4-d]pyrimidine"
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW 56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Code name:,BW-56158
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Adenock
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allo-Puren
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allozym
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Allural
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Aloral
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apulonga
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Caplenal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cellidrin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Cosuric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Dabroson
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Gichtex
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hamarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Hexanurat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketanrift
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Ledopur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Lysuron
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Miniplanor
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Monarch
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Nektrohan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Remid
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Riball
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Sigapurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Suspendol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Takanarumin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Uripurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urosin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Urtias
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Foreign brand name:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Alositol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anoprolin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Anzief
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Apurol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bleminol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Bloxanth
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Embarin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Epidropal
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Folligan
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Geapur
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Ketobun-A
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,sodium allopurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urbol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Uricemil
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Urosin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Xanturat
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,Synonym:,Zyloric
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Aloprim
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Lopurin
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zurinol
2020-09-18T01:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium,US brand name:,Zyloprim
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Code name:,ABL001
2020-09-18T03:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001,Synonym:,allosteric Bcr-Abl tyrosine kinase inhibitor ABL001
2020-10-14T03:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189,Code name:,BDTX 189
2020-10-14T03:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189,Code name:,BDTX-189
2020-10-14T03:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189,Code name:,BDTX189
2020-10-14T03:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189,Synonym:,EGFR/HER2 inhibitor BDTX-189
2020-10-14T03:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189,Synonym:,ErbB mutant-specific inhibitor BDTX-189
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Chemical structure:,N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Code name:,Cgp-11637
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,n-muramyldipeptide derivative
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,nor-MDP
2020-09-18T01:56:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide,Synonym:,norMDP
2020-10-14T04:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alobresib,Code name:,GS 5829
2020-10-14T04:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alobresib,Code name:,GS-5829
2020-10-14T04:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alobresib,Code name:,GS5829
2020-10-14T03:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-chamomile-thyme-topical-cream,US brand name:,Alantel
2020-09-18T01:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-gel,NA,NA
2020-09-18T01:56:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alogliptin,Chemical structure:,"benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl]methyl]-"
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Code name:,BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,phosphoinositide 3-kinase inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,Synonym:,PI3K inhibitor BYL719
2020-09-18T01:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib,US brand name:,Piqray
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1AT
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,A1P1
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Abbreviation:,AAT
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha 1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1 antitrypsin
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,Synonym:,alpha-1-antiproteinase
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Aralast
2020-09-18T01:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human,US brand name:,Prolastin-C
2020-09-18T01:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-adenoviral-vector-vaccine,Abbreviation:,AdVhAFP
2020-09-18T01:57:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,AFP peptide-pulsed autologous dendritic cell vaccine
2020-09-18T01:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-plasmid-dna-vaccine,Abbreviation:,phAFP
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Chemical structure:,"N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid"
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX 0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Code name:,ONX-0801
2020-09-18T01:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801,Synonym:,BGC 945
2020-10-14T03:30:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134,Code name:,AGI 134
2020-10-14T03:30:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134,Code name:,AGI-134
2020-10-14T03:30:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134,Code name:,AGI134
2020-10-14T03:30:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134,Synonym:,aGal AGI-134
2020-10-14T03:30:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134,Synonym:,anti-alpha Gal immunotherapeutic AGI-134
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Abbreviation:,GSL alpha-GAL
2020-09-18T01:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids,Synonym:,"galactose(alpha1,3,)galactose glycosphingolipids"
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Abbreviation:,DC-KRN7000
2020-09-18T01:57:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells,Synonym:,KRN7000-pulsed autologous dendritic cells
2020-09-18T01:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid,Synonym:,thioctic acid
2020-10-14T03:30:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement,Abbreviation:,LAPd
2020-10-14T03:30:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement,Synonym:,palladium lipoic complex
2020-10-14T03:30:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement,US brand name:,PolyMVA
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Abbreviation:,LAPd
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,Synonym:,palladium lipoic complex
2020-09-18T01:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva,US brand name:,PolyMVA
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me-4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Abbreviation:,Me4FDG
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Chemical structure:,alpha-methyl-4-[F-18]-fluoro-4-deoxy-d-glucopyranosidealpha-methyl-4-deoxy-4-(18F)fluoro-D-glucopyranoside
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,a-methyl-4[18F]-4-deoxy-D-glucopyranoside
2020-09-18T01:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside,Synonym:,Me-4(18F)DG
2020-09-18T01:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopherol,Chemical structure:,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol"
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Abbreviation:,α-TEA
2020-09-18T01:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid,Chemical structure:,"2,5,7,8-tetramethyl-(2R-(4R,8R,12-trimethyltridecyl) chroman-6-yloxy) acetic acid"
2020-09-18T01:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-type-1-polarized-dendritic-cells,Abbreviation:,alphaDC1
2020-10-14T04:03:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-v-beta-1-inhibitor-atn-161,NA,NA
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Apo-Alpzar
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,Foreign brand name:,Nu-Alpraz
2020-09-18T01:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam,US brand name:,Xanax
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Abbreviation:,PGE1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Chemical structure:,"(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid"
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,Synonym:,prostaglandin E1
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,Caverject
2020-09-18T01:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil,US brand name:,MUSE
2020-10-14T03:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alsevalimab,Code name:,FPA 150
2020-10-14T03:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alsevalimab,Code name:,FPA-150
2020-10-14T03:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alsevalimab,Code name:,FPA150
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Abbreviation:,rt-PA
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,recombinant tissue plasminogen activator
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,Synonym:,t-PA
2020-09-18T01:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase,US brand name:,Activase
2020-09-18T01:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altiratinib,Code name:,DCC-2701
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HMM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Abbreviation:,HXM
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Chemical structure:,"2,4,6-tris(dimethylamino)-s-triazineN,N,N',N',N"",N""-hexamethyl-1,3,5-triazine-2,4,6-triamine"
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,ENT-50852
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,RB-1515
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Code name:,WR-95704
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexastat
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Foreign brand name:,Hexinawas
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hemel
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,Synonym:,Hexaloids
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,Hexalen
2020-09-18T01:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine,US brand name:,hexamethylmelamine
2020-09-18T01:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide,NA,NA
2020-10-14T12:39:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide,Synonym:,aluminum hydroxide/magnesium hydroxide
2020-10-14T12:39:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide,US brand name:,Maalox
2020-10-14T12:39:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide,US brand name:,Mylanta
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Abbreviation:,ALVAC-CEA
2020-09-18T01:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine,Synonym:,ALVAC-CEA
2020-09-18T01:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-eso-1-vaccine,NA,NA
2020-09-18T01:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-hb71,NA,NA
2020-09-18T01:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-mart-1-vaccine,NA,NA
2020-09-18T01:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-therapeutic-vaccine,NA,NA
2020-10-14T03:30:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-vaccine,NA,NA
2020-09-18T01:59:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-ny-eso-1-m-tricom-vaccine,Code name:,vCP2292
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Chemical structure:,"6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide"
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD 9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD-9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,AZD9668
2020-09-18T01:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat,Code name:,MPH-966
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Abbreviation:,17-DMAG HCL
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Chemical structure:,"geldanamycin,17-demethoxy-17-[[2-(dimethylamino)ethyl]amino]-,monohydrochloride"
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,BMS-826476
2020-09-18T01:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride,Code name:,KOS-1022
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,ADL8-2698
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,Code name:,LY-246376
2020-09-18T01:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan,US brand name:,Entereg
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Abbreviation:,FLAVO
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Chemical structure:,"(-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one hydrochloride"
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,HMR 1275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Code name:,L-868275
2020-09-18T01:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib,Synonym:,flavopiridol
2020-10-14T03:31:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride,Abbreviation:,FLAVO
2020-10-14T03:31:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride,Chemical structure:,"(-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one hydrochloride"
2020-10-14T03:31:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride,Code name:,HMR 1275
2020-10-14T03:31:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride,Code name:,L-868275
2020-10-14T03:31:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride,Synonym:,flavopiridol
2020-10-14T03:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287,Code name:,TP 1287
2020-10-14T03:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287,Code name:,TP-1287
2020-10-14T03:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287,Code name:,TP1287
2020-10-14T03:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287,Synonym:,alvocidib phosphate
2020-10-14T03:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287,Synonym:,alvocidib phosphate TP-1287
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,Synonym:,Amantadine HCl
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symadine
2020-09-18T02:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride,US brand name:,Symmetrel
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Code name:,MORAb-009
2020-09-18T02:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab,Synonym:,anti-mesothelin monoclonal antibody MORAb-009
2020-10-14T03:31:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amblyomin-x,NA,NA
2020-10-14T04:34:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amcasertib,Code name:,BBI503
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax ginseng
2020-09-18T02:00:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng,Synonym:,Panax quinquifolius
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,Chemical structure:,"3,4-diaminopyridine"
2020-09-18T02:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine,US brand name:,Firdapse
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Abbreviation:,APAETP
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Chemical structure:,2-[(3-aminopropyl)amino]ethanethiol dihydrogen phosphate ester trihydrateS-(N-(3-aminopropyl)-2-aminoethyl)thiophosphoric acid trihydrateS-2-(3-aminopropylamino)ethylphosphorothioic acid trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR 2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR-2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,WR2721
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Code name:,YM-08310
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Foreign brand name:,Cytofos
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,amifostine trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,aminopropylaminoethylthiophosphoric acid trihydrate
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,ethiofos
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,Synonym:,gammaphos
2020-09-18T02:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine,US brand name:,Ethyol
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41 6551
2020-09-18T02:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution,Code name:,BAY41-6551
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,amino acid/electrolyte-coupled transport supplement
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,Synonym:,proprietary amino acid mixture
2020-09-18T02:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement,US brand name:,Enterade
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,Synonym:,multi-amino acid injection
2020-09-18T02:01:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection,US brand name:,Travasol
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,Potaba
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium p-aminobenzoate
2020-09-18T02:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium,Synonym:,potassium para-aminobenzoate
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Abbreviation:,9-AC
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Chemical structure:,9-amino-20(S)-camptothecin9-amino-20-camptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-camptothecin
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-amino-CPT
2020-09-18T02:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin,Synonym:,9-aminocamptothecin
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminocaproic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,6-aminohexanoic acid
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,Synonym:,epsilon S
2020-09-18T02:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid,US brand name:,Amicar
2020-10-14T03:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminoflavone-prodrug-afp464,NA,NA
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Abbreviation:,5-ALA
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Chemical structure:,5-amino-4-oxopentanoic acidd-amino-levulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolaevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,5-aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,amino-levulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta aminolevulinic acid
2020-09-18T02:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid,Synonym:,delta-aminolevulinic acid
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,5-ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Abbreviation:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Chemical structure:,5-amino-4-oxopentanoic acid HCl5-Amino-4-oxopentanoic Acid Hydrochlorided-Amino-Levulinic Acid HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Foreign brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,ALA HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,amino-levulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,aminolevulinic acid HCl
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,Synonym:,delta-aminolevulinic acid hydrochloride
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Ameluz
2020-09-18T02:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride,US brand name:,Levulan Kerastick
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Chemical structure:,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-Ethanediamine(2:1)"
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,ammophyllin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,Synonym:,theophyline ethylenediamine
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Phyllocontin
2020-09-18T02:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline,US brand name:,Truphylline
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Abbreviation:,APGA
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminofolic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,4-aminopteroylglutamic acid
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopterin aodium
2020-09-18T02:02:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin,Synonym:,aminopteroylglutamic acid
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,A-TD
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Abbreviation:,ATDA
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Chemical structure:,"1,3, 4-Thiadiazol-2-amine (9CI)1,3, 4-Thiadiazole, 2-Amino- (8CI)1,3,4-Thiadiazole, 2-Amino2-Amino-1,3,4-thiadiazole2-Amino-1-thia-3,4-diazole"
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Code name:,FDA 0084
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,2-Aminothiadiazole
2020-09-18T02:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole,Synonym:,Amino 134-Thiadiazole
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Cordarone
2020-09-18T02:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride,US brand name:,Nexterone
2020-09-18T02:02:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amitriptyline-hydrochloride,NA,NA
2020-09-18T02:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-plus-lysate-loaded-autologous-dendritic-cell-vaccine,Synonym:,acute myelogenous leukemia mRNA plus lysate loaded autologous dendritic cell vaccine
2020-10-14T03:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-positive-lysate-loaded-autologous-dendritic-cell-vaccine,Synonym:,acute myelogenous leukemia mRNA plus lysate loaded autologous dendritic cell vaccine
2020-09-18T02:02:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonia-n-13,Synonym:,ammonia-(sup 13)N
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Chemical structure:,"tellurate(1-), trichloro[1,2-ethanediolato(2-)-.kappa.O,.kappa.O']-,ammonium, (SP-5-22)-"
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,AS-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,Code name:,IVX-Q-101
2020-09-18T02:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate,US brand name:,Ossirene
2020-09-18T02:03:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amnion-derived-cellular-cytokine-solution,Abbreviation:,ACCS
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,AMON
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Abbreviation:,BIDA
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Chemical structure:,"1H-benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl)"
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Code name:,M-FA-142
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,amonafide hydrochloride
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,benzisoquinolinedione
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,Synonym:,nafidimide
2020-09-18T02:03:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride,US brand name:,Quinamed
2020-09-18T02:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-l-malate,NA,NA
2020-10-14T03:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amorphous-calcium-carbonate,Abbreviation:,ACC
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,Abbreviation:,AMOX
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Amoxil
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Polymox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Trimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Utimox
2020-09-18T02:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin,US brand name:,Wymox
2020-09-18T02:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin-clavulanate-potassium,US brand name:,Augmentin
2020-09-18T02:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amphotericin-b-deoxycholate,US brand name:,Fungizone
2020-09-18T02:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ampicillin-sodium-sulbactam-sodium,US brand name:,Unasyn
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Abbreviation:,AMR
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Foreign brand name:,Calsed
2020-09-18T02:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride,Synonym:,Amirubicin Hydrochloride
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Abbreviation:,m-AMSA
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Chemical structure:,4'-(9-acridinylamino)methane-sulfon-m-anisidideN-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,CI-880
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Code name:,SN-11841
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amekrin
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Amsidyl
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Foreign brand name:,Lamasine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,acridinyl anisidide
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,Synonym:,Cain's Acridine
2020-09-18T02:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine,US brand name:,Amsa P-D
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC 101
2020-09-18T02:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene,Code name:,TAC-101
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,HPK56
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Code name:,MP470
2020-09-18T02:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib,Synonym:,multitargeted receptor tyrosine kinase inhibitor MP470
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,Foreign brand name:,Thromboreductin
2020-09-18T01:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride,US brand name:,Agrylin
2020-09-18T02:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-prolonged-release-formulation,Synonym:,anagrelide retard
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,IL-1ra
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,Synonym:,interleukin-1 receptor antagonist
2020-09-18T02:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra,US brand name:,Kineret
2020-09-18T02:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anamorelin-hydrochloride,Code name:,RC-1291
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Abbreviation:,ANAS
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Chemical structure:,"2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile)alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile"
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ICI-D1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,Code name:,ZD-1033
2020-09-18T02:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole,US brand name:,Arimidex
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Abbreviation:,TGU
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Chemical structure:,"1,2,4-triglycidylurazol"
2020-09-18T02:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone,Synonym:,triglycidylurazol
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Chemical structure:,"6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R(2alpha,3beta,3a beta,9a beta))"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Code name:,"U-33, 624A"
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Foreign brand name:,Ancid
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,Cyclo-C
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cycloCMP hydrochloride
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine HCL
2020-09-18T02:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride,Synonym:,cyclocytidine hydrochloride
2020-10-14T03:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/andecaliximab,Code name:,GS-5745
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Chemical structure:,"pentamethylchromanol, 2,2,5,7,8-pentamethyl-6"
2020-09-18T02:05:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100,Code name:,APC-100
2020-10-14T03:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-bay-1161116,Code name:,BAY 1161116
2020-10-14T03:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-bay-1161116,Code name:,BAY-1161116
2020-10-14T03:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-bay-1161116,Code name:,BAY1161116
2020-10-14T03:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-bay-1161116,Synonym:,AR antagonist BAY 1161116
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Chemical structure:,"(R)-4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxo-7-oxa-1,3-diazaspiro[4.4]nonan-1-yl)-2-fluoro-N-methylbenzamide"
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC 10013B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC 113 B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC-10013B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC1-0013B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC1-13B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Code name:,ONC113B
2020-10-14T03:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b,Synonym:,AR antagonist ONC1-0013B
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR 3680
2020-09-18T02:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680,Code name:,SHR3680
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS 3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Code name:,TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,androgen receptor inhibitor TAS3681
2020-09-18T02:06:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681,Synonym:,AR antagonist TAS3681
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ -63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ 63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,JNJ63576253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC 253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC-253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Code name:,TRC253
2020-09-18T02:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253,Synonym:,AR antagonist TRC253
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Code name:,AZD5312
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-ARRx
2020-09-18T02:06:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312,Synonym:,ISIS-AZ1Rx
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Code name:,EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist LNA antisense oligonucleotide EZN-4176
2020-09-18T02:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176,Synonym:,androgen receptor mRNA antagonist locked nucleic acid antisense oligonucleotide EZN-4176
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Code name:,ARV 110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Code name:,ARV-110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Code name:,ARV110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Synonym:,androgen receptor PROTAC degrader ARV-110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Synonym:,AR PROTAC ARV-110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Synonym:,AR-targeted PROTAC protein degrader ARV-110
2020-10-14T03:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110,Synonym:,PROTAC protein degrader ARV-110
2020-10-14T03:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-cc-94676,Code name:,CC 94676
2020-10-14T03:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-cc-94676,Code name:,CC-94676
2020-10-14T03:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-cc-94676,Code name:,CC94676
2020-10-14T03:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-cc-94676,Synonym:,AR degrader CC-94676
2020-10-14T03:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10,Chemical structure:,cortexolone 17alpha-valerate-21-propionate
2020-10-14T03:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10,Code name:,CB 03 10
2020-10-14T03:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10,Code name:,CB-03-10
2020-10-14T03:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10,Code name:,CB0310
2020-10-14T03:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10,Synonym:,AR/GR antagonist CB-03-10
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Code name:,EPI-506
2020-09-18T02:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506,Synonym:,AR inhibitor EPI-506
2020-10-14T03:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-7386,Code name:,EPI 7386
2020-10-14T03:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-7386,Code name:,EPI-7386
2020-10-14T03:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-7386,Code name:,EPI7386
2020-10-14T03:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-7386,Synonym:,AR inhibitor EPI-7386
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,Chemical structure:,"17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol"
2020-09-18T02:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235,US brand name:,APOTONE
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Code name:,BAY 94-9343
2020-09-18T02:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine,Synonym:,anti-mesothelin antibody-drug conjugate BAY 94-9343
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,CVX-241
2020-09-18T02:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241,Code name:,PF-05057459
2020-09-18T02:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angelica-sinensis-root-extract,Synonym:,dong quai
2020-09-18T02:07:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-heparanase-inhibitor-pg545,Code name:,PG545
2020-09-18T09:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-gt-111,Code name:,GT-111
2020-09-18T09:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-gt-111,Code name:,VB-111
2020-09-18T09:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-gt-111,Synonym:,angiogenesis inhibitor GT-111
2020-09-18T02:07:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-ji-101,Code name:,JI-101
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,Kringles 1-4 of Plasminogen
2020-09-18T02:07:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin,Synonym:,PLG
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Abbreviation:,DAS
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Code name:,MM 4462
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,Anguidin
2020-09-18T02:08:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine,Synonym:,diacetoxyscirpenol
2020-10-14T03:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anhydrous-enol-oxaloacetate,Abbreviation:,AEO
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Code name:,LY303366
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Foreign brand name:,Eraxis
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,V-echinocandin
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,Synonym:,VER-002
2020-09-18T02:08:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin,US brand name:,Eraxis
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Chemical structure:,"benzenamine, N, N-bis(2-chloroethyl)-(9CI)beta, beta'-dichlorodiethylanilineN,N-bis(2-chloroethyl)anilineN,N-bis(2-chloroethyl)benzenaminephenylbis[2-chloroethylamine]"
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,A 14489
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,CB 1074
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,SK 592
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Code name:,TL 476
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphochin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphocin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,lymphoquin
2020-09-18T02:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard,Synonym:,mesylerythrol
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Abbreviation:,ALTN HCl
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Chemical structure:,"cyclopropanamine, 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-, hydrochloride (1:2)"
2020-09-18T02:08:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride,Synonym:,"1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, dihydrochloride"
2020-10-14T12:35:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annamycin-liposomal,Synonym:,annamycin liposomal
2020-09-18T02:08:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annonaceous-acetogenins,Synonym:,acetogenins
2020-09-18T02:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthocyanin-rich-corn-extract,NA,NA
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Chemical structure:,5-imino-13-deoxydoxoubicin
2020-09-18T02:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150,Code name:,GPX-150
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Code name:,ASN 004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Code name:,ASN-004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Code name:,ASN004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Synonym:,5T4-ADC ASN004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Synonym:,5T4-targeted antibody-drug conjugate ASN004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Synonym:,5T4-targeted dolaflexin ADC ASN004
2020-10-14T03:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004,Synonym:,anti-5T4 ADC ASN004
2020-09-18T02:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-pf-06263507,Code name:,PF-06263507
2020-09-18T02:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a33-monoclonal-antibody-krn330,Code name:,KRN330
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Code name:,PF-04605412
2020-09-18T02:09:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412,Synonym:,anti-alpha5beta1 integrin monoclonal antibody PF-04605412
2020-09-18T02:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-16-monoclonal-antibody-ags-16m18,Code name:,AGS-16M18
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Abbreviation:,anti-AGS-5 Ab-drug conjugate ASG-5ME
2020-09-18T02:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me,Code name:,ASG-5ME
2020-09-18T02:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-8-monoclonal-antibody-ags-8m4,Code name:,AGS-8M4
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Code name:,PF-03446962
2020-09-18T02:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962,Synonym:,anti-activin receptor-like kinase 1 monoclonal antibody PF-03446962
2020-10-14T03:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b,Code name:,TNB 383B
2020-10-14T03:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b,Code name:,TNB-383B
2020-10-14T03:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b,Code name:,TNB383B
2020-10-14T03:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b,Synonym:,anti-BCMA x aCD3 T-BsAb TNB-383B
2020-10-14T03:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b,Synonym:,anti-BCMA x aCD3 T-cell engaging bispecific antibody TNB-383B
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,3C23K
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM102
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Code name:,GM10II
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,anti-AMHR2 monoclonal antibody GM10II
2020-09-18T02:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102,Synonym:,GM102 antibody
2020-09-18T02:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amyloid-monoclonal-antibody-neod001,Code name:,NEOD001
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL 01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL-01
2020-09-18T02:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01,Code name:,SXL01
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Abbreviation:,anti-ANG2 MoAb MEDI-3617
2020-09-18T02:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617,Code name:,MEDI-3617
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Code name:,BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-A proliferation-inducing ligand monoclonal antibody BION-1301
2020-09-18T02:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301,Synonym:,anti-TNFSF13 monoclonal antibody BION-1301
2020-10-14T03:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-fusion-protein-avb-s6-500,Code name:,AVB S6 500
2020-10-14T03:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-fusion-protein-avb-s6-500,Code name:,AVB-S6-500
2020-10-14T03:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-fusion-protein-avb-s6-500,Code name:,AVBS6500
2020-10-14T03:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-fusion-protein-avb-s6-500,Synonym:,AXL Fc fusion protein AVB-S6-500
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Abbreviation:,HuMax-AXL-ADC
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE ADC
2020-09-18T02:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate,Synonym:,anti-AXL/MMAE antibody-drug conjugate
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,ADCT 601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,ADCT-601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,ADCT601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,BGB 601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,BGB-601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Code name:,BGB601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Synonym:,ADC ADCT-601
2020-10-14T03:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601,Synonym:,anti-AXL/PBD ADC ADCT-601
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,anti-B4-BR
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Abbreviation:,MOAB anti-B4-bR
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,anti-B4 blocked ricin
2020-09-18T02:10:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin,Synonym:,monoclonal antibody anti-B4 blocked ricin
2020-09-18T02:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-antibody-ds-5573a,Code name:,DS-5573a
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Code name:,DS 7300
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Code name:,DS 7300a
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Code name:,DS7300
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Code name:,DS7300a
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Synonym:,anti-B7-H3/DXd ADC DS-7300a
2020-10-14T03:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a,Synonym:,anti-B7H3/DXd antibody-drug conjugate DS-7300a
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Code name:,REGN 5459
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Code name:,REGN-5459
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Code name:,REGN5459
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Synonym:,anti-BCMA x anti-CD3 bispecific antibody REGN5459
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Synonym:,anti-BCMA/CD3 bispecific antibody REGN5459
2020-10-14T03:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459,Synonym:,anti-CD3/anti-BCMA bispecific antibody REGN5459
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Abbreviation:,J6M0-mcMMAF
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Code name:,GSK2857916
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,Synonym:,belantamab mafodotin
2020-09-18T04:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916,US brand name:,Blenrep
2020-10-14T03:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-sea-bcma,Code name:,SEA-BCMA
2020-10-14T03:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-sea-bcma,Synonym:,Anti-BCMA Afucosylated Monoclonal Antibody SEA-BCMA
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Code name:,AMG 420
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Code name:,AMG-420
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Code name:,BI 836909
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Code name:,BI836909
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 420
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 420
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Synonym:,bispecific T-cell engager antibody AMG 420
2020-10-14T03:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420,Synonym:,BiTE antibody AMG 420
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Code name:,AMG 701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Code name:,AMG-701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Code name:,AMG701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Synonym:,anti-BCMA x anti-CD3 BiTE AMG 701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody AMG 701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Synonym:,bispecific T-cell engager antibody AMG 701
2020-10-14T03:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701,Synonym:,BiTE antibody AMG 701
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Code name:,REGN 5458
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Code name:,REGN-5458
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Code name:,REGN5458
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Synonym:,anti-BCMA x anti-CD3 BiTE REGN5458
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Synonym:,bispecific BCMA x CD3 T-cell engaging antibody REGN5458
2020-10-14T03:33:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458,Synonym:,BiTE antibody REGN5458
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Code name:,MEDI 2228
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Code name:,MEDI-2228
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Synonym:,ADC MEDI2228
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Synonym:,anti-BCMA ADC MEDI2228
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Synonym:,Anti-BCMA/PBD MEDI2228
2020-10-14T03:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228,Synonym:,Antibody-drug Conjugate MEDI2228
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,JS 004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,JS-004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,JS004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,TAB 004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,TAB-004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Code name:,TAB004
2020-10-14T03:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004,Synonym:,anti-B- and T-lymphocyte attenuator monoclonal antibody TAB004
2020-09-18T02:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-fms-monoclonal-antibody-amg-820,Code name:,AMG 820
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Abbreviation:,anti c-KIT ADC LOP628
2020-09-18T02:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628,Code name:,LOP628
2020-10-14T03:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-cdx-0158,Code name:,KTN0158
2020-09-18T02:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-ktn0158,Code name:,KTN0158
2020-10-14T03:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-hti-1066,Code name:,HTI 1066
2020-10-14T03:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-hti-1066,Code name:,HTI-1066
2020-10-14T03:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-hti-1066,Code name:,SHR-A1403
2020-10-14T03:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-hti-1066,Synonym:,ADC HTI-1066
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,MT 8633
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,MT-8633
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,MT8633
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,TR 1801
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,TR-1801
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Code name:,TR1801
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Synonym:,anti-c-Met ADC TR1801
2020-10-14T03:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801,Synonym:,TR1801-ADC
2020-09-18T02:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-abt-700,Code name:,ABT-700
2020-09-18T02:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-argx-111,Code name:,ARGX-111
2020-10-14T03:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-hlx55,Code name:,HLX 55
2020-10-14T03:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-hlx55,Code name:,HLX-55
2020-10-14T03:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-hlx55,Code name:,HLX55
2020-09-18T02:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-ly2875358,Code name:,LY2875358
2020-09-18T02:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-sait301,Code name:,SAIT301
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Abbreviation:,anti-C4.4a ADC BAY1129980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY112-9980
2020-09-18T02:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980,Code name:,BAY1129980
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Code name:,MVT-5873
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab 5B1
2020-09-18T02:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1,Synonym:,HuMab-5B1
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Abbreviation:,huDs6-DM4
2020-09-18T02:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658,Code name:,SAR566658
2020-09-18T08:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ccr5-monoclonal-antibody-pro-140,Code name:,PRO 140
2020-09-18T08:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ccr5-monoclonal-antibody-pro-140,Code name:,PRO140
2020-09-18T08:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ccr5-monoclonal-antibody-pro-140,Synonym:,anti-CCR5 monoclonal antibody PRO 140
2020-10-14T03:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632,Code name:,IMGN 632
2020-10-14T03:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632,Code name:,IMGN-632
2020-10-14T03:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632,Code name:,IMGN632
2020-10-14T03:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632,Synonym:,antibody-drug conjugate IMGN632
2020-10-14T03:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632,Synonym:,CD123-targeted ADC IMGN632
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Code name:,APVO 436
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Code name:,APVO-436
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Code name:,APVO436
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Synonym:,anti-CD123 x anti-CD3 bispecific antibody APVO436
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Synonym:,bispecific anti-CD123 x anti-CD3 antibody APVO436
2020-10-14T03:35:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436,Synonym:,CD123 x CD3 targeting bispecific antibody APVO436
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Code name:,JNJ-63709178
2020-09-18T02:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178,Synonym:,humanized CD123 x CD3 duobody JNJ-63709178
2020-10-14T03:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bite-antibody-sar440234,Synonym:,bispecific T-cell engager antibody SAR440234
2020-10-14T03:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bite-antibody-sar440234,Synonym:,CD123xCD3 bispecific T-cell engager SAR440234
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,RES234
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Code name:,S80880
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,anti-CD123/CD3 monoclonal antibody MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,CD123 x CD3 DART bi-specific antibody MGD006
2020-09-18T06:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006,Synonym:,CD123 x CD3 dual affinity re-targeting bi-specific antibody MGD006
2020-09-18T02:13:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-monoclonal-antibody-khk2823,Code name:,KHK2823
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Code name:,SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123 ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,anti-CD123-PBD ADC SGN-CD123A
2020-09-18T02:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a,Synonym:,antibody-drug conjugate SGN-CD123A
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Code name:,XmAb14045
2020-09-18T02:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045,Synonym:,anti-CD123/anti-CD3 bispecific antibody XmAb1404
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic anti-CD133 CAR T cells
2020-09-18T02:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes,Synonym:,allogeneic CART133
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Code name:,dCD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,anti-CD133-deimmunized pseudomonas exotoxin A-KDEL fusion protein
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL
2020-09-18T02:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein,Synonym:,deimmunized CD133KDEL toxin
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Code name:,ADG 106
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Code name:,ADG-106
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Code name:,ADG106
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Synonym:,4-1BB-directed agonistic monoclonal antibody ADG106
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Synonym:,anti-4-1BB agonistic monoclonal antibody ADG106
2020-10-14T03:35:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106,Synonym:,CD137-directed agonistic monoclonal antibody ADG106
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Code name:,AGEN 2373
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Code name:,AGEN-2373
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Code name:,AGEN2373
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Synonym:,anti-4-1BB agonistic monoclonal antibody AGEN2373
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Synonym:,anti-CD137 agonist monoclonal antibody AGEN2373
2020-10-14T03:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373,Synonym:,anti-CD137 monoclonal antibody AGEN2373
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Code name:,ATOR 1017
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Code name:,ATOR-1017
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Code name:,ATOR1017
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Synonym:,anti-4-1BB monoclonal antibody ATOR-1017
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Synonym:,anti-CD137 agonist monoclonal antibody ATOR-1017
2020-10-14T03:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017,Synonym:,anti-CD137 monoclonal antibody ATOR-1017
2020-10-14T03:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ctx-471,Code name:,CTX 471
2020-10-14T03:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ctx-471,Code name:,CTX-471
2020-10-14T03:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ctx-471,Code name:,CTX471
2020-10-14T03:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ctx-471,Synonym:,anti-4-1BB agonistic monoclonal antibody CTX-471
2020-10-14T03:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051,Code name:,LVGN 6051
2020-10-14T03:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051,Code name:,LVGN-6051
2020-10-14T03:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051,Synonym:,anti-4-1BB agonistic monoclonal antibody LVGN6051
2020-10-14T03:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051,Synonym:,anti-CD137 agonist monoclonal antibody LVGN6051
2020-10-14T03:35:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051,Synonym:,anti-CD137 monoclona antibody LVGN6051
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,MEN1112
2020-09-18T02:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112,Code name:,OBT357NF
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Code name:,CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,ADC CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,anti-CD166-DM4 CX-2009
2020-09-18T02:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009,Synonym:,PDC CX-2009
2020-10-14T03:36:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-anti-cd22-bispecific-immunotoxin-dt2219arl,Code name:,DT2219ARL
2020-10-14T03:36:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-anti-cd22-bispecific-immunotoxin-dt2219arl,Synonym:,anti-CD19/CD22 BLT DT2219ARL
2020-10-14T13:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b,Code name:,SGN CD19B
2020-10-14T13:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b,Code name:,SGN-CD19B
2020-10-14T13:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,ADC SGN-CD19B
2020-10-14T13:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,PBD-based anti-CD19 ADC SGN-CD19B
2020-10-14T13:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,PBD-based anti-CD19 antibody-drug conjugate SGN-CD19B
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Code name:,ET 019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Code name:,ET-019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Code name:,ET019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Synonym:,anti-CD19 AbTCR-expressing T cells ET019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Synonym:,anti-CD19 T cells ET019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Synonym:,anti-CD19-TCR T cells ET019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Synonym:,CD19-targeted T cells ET019003
2020-10-14T03:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003,Synonym:,ET019003-T cells
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Code name:,NKCARCD19
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Synonym:,anti-CD19 redirected NK cells
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing allogenic NK cells
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor natural killer cells
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor NK cells
2020-10-14T03:36:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Code name:,NKCARCD19
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19 redirected NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing allogenic NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor natural killer cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing donor NK cells
2020-09-18T02:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells,Synonym:,anti-CD19-CAR-CD3zeta-4-1BB-expressing NK cells
2020-09-18T02:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-retroviral-vector-transduced-autologous-t-cells,NA,NA
2020-10-14T03:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-t-cells-xlcart001,Code name:,XLCART001
2020-10-14T03:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-t-cells-xlcart001,Synonym:,CD19-specific CAR-T cells XLCART001
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,anti-CD19/CD20 CAR autologous T lymphocytes
2020-09-18T02:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,autologous CAR-20/19-T cells
2020-10-14T03:36:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-cd22-cd30-car-t-cells,Synonym:,anti-CD19/CD20/CD22/CD30 chimeric antigen receptor-T cells
2020-10-14T03:36:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-cd22-cd30-car-t-cells,Synonym:,CAR-T CD19/CD20/CD22/CD30
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Code name:,DT2219ARL
2020-09-18T02:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl,Synonym:,anti-CD19/CD22 BLT DT2219ARL
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR 15
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Code name:,JCAR015
2020-09-18T02:16:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015,Synonym:,anti-CD19/CD28/zeta modified CAR CD3+ T lymphocytes JCAR015
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Code name:,AMG 562
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Code name:,AMG-562
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Code name:,AMG562
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Synonym:,bispecific T-cell engager antibody AMG 562
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Synonym:,BiTE antibody AMG 562
2020-10-14T03:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562,Synonym:,CD19/CD3-directed bispecific T-cell engager antibody AMG 562
2020-09-18T02:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-tetravalent-antibody-afm11,Code name:,AFM11
2020-09-18T02:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-dm4-immunoconjugate-sar3419,Code name:,SAR3419
2020-09-18T02:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-fully-human-monoclonal-antibody-mdx-1342,Code name:,MDX-1342
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Abbreviation:,anti-CD19 MAb DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Code name:,DI-B4
2020-09-18T02:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4,Synonym:,anti-CD19 MoAb DI-B4
2020-10-14T03:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-mdx-1342,Code name:,MDX-1342
2020-09-18T02:15:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-medi-551,Code name:,MEDI-551
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Code name:,MOR 00208
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Code name:,MOR-00208
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Code name:,MOR00208
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Code name:,XmAb5574
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Synonym:,"immunoglobulin, anti-(human Cd19 antigen) (human-mus musculus monoclonal MOR00208 heavy chain), disulfide with human-mus musculus monoclonal MOR00208 .kappa.-chain, dimer"
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,Synonym:,tafasitamab
2020-09-18T09:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574,US brand name:,Monjuvi
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Code name:,IGM 2323
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Code name:,IGM-2323
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Code name:,IGM2323
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Synonym:,bispecific CD20xCD3 IgM antibody IGM2323
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Synonym:,bispecific IgM antibody IGM2323
2020-10-14T03:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323,Synonym:,IgM pentamer IGM2323
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9 scFv-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,anti-CD20 B9E9-SA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,recombinant anti-CD20 B9E9 scFvSA fusion protein
2020-09-18T02:16:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein,Synonym:,scFv B9E9-streptavidin fusion protein
2020-09-18T02:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,NA,NA
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Code name:,REGN1979
2020-09-18T02:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody REGN1979
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Code name:,XmAb13676
2020-09-18T02:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody XmAb13676
2020-09-18T02:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-engineered-toxin-body-mt-3724,Code name:,MT-3724
2020-10-14T03:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-b001,Code name:,B 001
2020-10-14T03:37:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-b001,Code name:,B001
2020-10-14T03:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-bat4306f,Code name:,BAT 4306F
2020-10-14T03:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-bat4306f,Code name:,BAT-4306F
2020-10-14T03:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-bat4306f,Code name:,BAT4306F
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Code name:,IGN002
2020-09-18T02:17:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002,Synonym:,anti-CD20 monoclonal antibody-IFN-a fusion protein IGN002
2020-10-14T03:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-mil62,Code name:,MIL 62
2020-10-14T03:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-mil62,Code name:,MIL-62
2020-10-14T03:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-mil62,Code name:,MIL62
2020-09-18T02:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-sct400,Code name:,SCT400
2020-09-18T02:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-tl011,Code name:,TL011
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,ADC OBT076
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,Anti-CD205
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,MEN 1309
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,MEN-1309
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,MEN1309
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,OBT 076
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,OBT-076
2020-10-14T03:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076,Code name:,OBT076
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Code name:,CAT-02-106
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Code name:,TRPH 222
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Code name:,TRPH-222
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Code name:,TRPH222
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Synonym:,anti-CD22 antibody-drug conjugate TRPH-222
2020-10-14T03:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222,Synonym:,anti-CD22-4AP ADC TRPH-222
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Abbreviation:,CD22 CAR-T
2020-09-18T02:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes,Synonym:,anti-CD22 CAR-expressing T cells
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Code name:,DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,ADC DCDT2980S
2020-09-18T02:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s,Synonym:,antibody-drug conjugate DCDT2980S
2020-10-14T03:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a,Code name:,SGN CD228A
2020-10-14T03:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a,Code name:,SGNCD228A
2020-10-14T03:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a,Synonym:,Anti-CD228 Antibody-drug Conjugate SGN-CD228A
2020-10-14T03:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a,Synonym:,Anti-CD228-MMAE ADC SGN-CD228A
2020-10-14T03:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a,Synonym:,anti-melanotransferrin ADC SGN-CD228A
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RG 6292
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RG-6292
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RG6292
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RO 7296682
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RO-7296682
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Code name:,RO7296682
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Synonym:,anti-CD25 monoclonal antibody RG6292
2020-10-14T03:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682,Synonym:,T-regulatory cell-depleting antibody RO7296682
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Code name:,ADCT-301
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Synonym:,ADC ADCT-301
2020-09-18T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301,Synonym:,anti-CD25-PBD antibody-drug conjugate ADCT-301
2020-10-14T03:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd26-monoclonal-antibody-ys110,Code name:,YS110
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Code name:,AMG 172
2020-09-18T02:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172,Synonym:,anti-epithelial cell adhesion molecule /anti-CD3 antibody-drug conjugate AMG 172
2020-10-14T03:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-5t4-bispecific-antibody-gen1044,Code name:,GEN 1044
2020-10-14T03:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-5t4-bispecific-antibody-gen1044,Code name:,GEN-1044
2020-10-14T03:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-5t4-bispecific-antibody-gen1044,Code name:,GEN1044
2020-10-14T03:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-5t4-bispecific-antibody-gen1044,Synonym:,duobody-CD3x5T4
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ 64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Code name:,JNJ64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 bispecific antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,BCMA x CD3 duobody antibody JNJ-64007957
2020-09-18T02:18:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957,Synonym:,humanized BCMA/CD3 duobody antibody JNJ-64007957
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Code name:,PF 06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Code name:,PF-06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Code name:,PF06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Synonym:,anti-CD3/anti-BCMA bispecific antibody PF-06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Synonym:,B-cell maturation antigen-CD3 bispecific antibody PF-06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Synonym:,BCMA x CD3 bispecific antibody PF-06863135
2020-10-14T03:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135,Synonym:,BCMA-CD3 bispecific Ab PF-06863135
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Code name:,FBTA05
2020-09-18T02:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05,Synonym:,Bi20
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Code name:,JNJ 64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Code name:,JNJ-64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Code name:,JNJ64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Synonym:,GPRC5D x CD3 bispecific antibody JNJ-64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Synonym:,GPRC5D x CD3 duobody antibody JNJ-64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Synonym:,GPRC5D/CD3 duobody antibody JNJ-64407564
2020-10-14T03:39:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564,Synonym:,humanized GPRC5D x CD3 duobody antibody JNJ-64407564
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Code name:,PF 07062119
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Code name:,PF-07062119
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Code name:,PF07062119
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Synonym:,anti-CD3 x anti-GUCY2C bispecific antibody PF-07062119
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Synonym:,anti-GUCY2C/anti-CD3 bispecific antibody PF-07062119
2020-10-14T03:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119,Synonym:,T-cell bispecific antibody PF-07062119
2020-10-14T03:39:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd38-bispecific-monoclonal-antibody-amg-424,NA,NA
2020-10-14T03:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd7-ricin-toxin-a-immunotoxin,Synonym:,anti-CD3/CD7-RTA immunotoxin
2020-10-14T03:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd7-ricin-toxin-a-immunotoxin,Synonym:,CD3/CD7-ricin A IT
2020-10-14T03:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd7-ricin-toxin-a-immunotoxin,US brand name:,T-Guard
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,GD2Bi-a ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Abbreviation:,Hu3F8Bi-armed ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,anti-CD3 x hu3F8 bispecific antibody-armed ATC
2020-09-18T02:19:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes,Synonym:,OKT3/humanized 3F8 bispecific antibody-activated T lymphocytes
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Abbreviation:,A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,A-dmDT390-bisFv(UCHT1) fusion protein
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,Synonym:,anti-T cell immunotoxin A-dmDT390-bisFv(UCHT1)
2020-09-18T02:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1,US brand name:,Resimmune
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Abbreviation:,anti-CD3 x anti-CD20 bi-armed ATC
2020-09-18T02:18:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells,Synonym:,CD20Bi-armed activated T cells
2020-09-18T02:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-cd16a-monoclonal-antibody-afm13,Code name:,AFM13
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Code name:,F 0002
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Code name:,F-0002
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Code name:,F0002
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Synonym:,anti-CD30/DM1 ADC F0002
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Synonym:,F0002-ADC
2020-10-14T03:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002,Synonym:,FADC F0002
2020-09-18T02:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-mdx-1401,Code name:,MDX-1401
2020-09-18T02:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-xmab2513,Code name:,XmAb2513
2020-10-14T03:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206,Code name:,BI 1206
2020-10-14T03:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206,Code name:,BI-1206
2020-10-14T03:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206,Code name:,BI1206
2020-10-14T03:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206,Synonym:,anti-hFcγRIIB monoclonal antibody BI-1206
2020-10-14T03:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206,Synonym:,hFcgammaRIIB mAb BI-1206
2020-10-14T04:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antibody-drug-conjugate-imgn779,Code name:,IMGN779
2020-10-14T04:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antibody-drug-conjugate-imgn779,Synonym:,ADC IMGN779
2020-10-14T04:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antibody-drug-conjugate-imgn779,Synonym:,anti-CD33 ADC IMGN779
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV 564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV-564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Code name:,AMV564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33 x CD3 tandem diabody AMV-564
2020-09-18T02:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564,Synonym:,CD33/CD3 TandAbs AMV564
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Code name:,GEM 333
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Code name:,GEM-333
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Code name:,GEM333
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Synonym:,anti-CD33 bispecific antibody GEM 333
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Synonym:,anti-CD33/anti-CD3 bispecific antibody GEM 333
2020-10-14T03:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333,Synonym:,anti-CD33/CD3 antibody GEM 333
2020-10-14T03:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-jnj-67571244,Code name:,JNJ 67571244
2020-10-14T03:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-jnj-67571244,Code name:,JNJ-67571244
2020-10-14T03:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-jnj-67571244,Code name:,JNJ67571244
2020-10-14T03:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-jnj-67571244,Synonym:,anti-CD33/anti-CD3 bispecific antibody JNJ-67571244
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Code name:,AMG330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,bispecific T-cell engager antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,BiTE antibody AMG 330
2020-09-18T02:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 33
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Code name:,AMG 673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Code name:,AMG-673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Code name:,AMG673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Synonym:,anti-CD33 x anti-CD3 BiTE AMG 673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Synonym:,bispecific T-cell engager antibody AMG 673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Synonym:,BiTE antibody AMG 673
2020-10-14T03:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673,Synonym:,CD33/CD3-directed bispecific T-cell engager antibody AMG 673
2020-09-18T02:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-bi-836858,Code name:,BI 836858
2020-09-18T02:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-dm4-conjugate-ave9633,Code name:,AVE9633
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Code name:,SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD dimer ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 ADC SGN-CD352A
2020-09-18T02:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a,Synonym:,PBD-based anti-CD352 antibody-drug conjugate SGN-CD352A
2020-09-18T02:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-antibody-drug-conjugate-imgn529,Code name:,IMGN529
2020-10-14T03:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-car-expressing-t-lymphocytes,Synonym:,anti-CD37-CAR T cells
2020-10-14T03:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-car-expressing-t-lymphocytes,Synonym:,anti-CD37-CAR-T cells
2020-10-14T03:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-car-expressing-t-lymphocytes,Synonym:,CAR-37 T cells
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,BI 836826
2020-09-18T02:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826,Code name:,mAb 37.1
2020-10-14T03:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-bcma-car-t-lymphocytes,Synonym:,anti-CD38/anti-BCMA CAR T cells
2020-10-14T03:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-bcma-car-t-lymphocytes,Synonym:,anti-CD38/anti-BCMA CAR T lymphocytes
2020-10-14T03:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-bcma-car-t-lymphocytes,Synonym:,anti-CD38/BCMA CAR T cells
2020-10-14T03:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257,Code name:,SAR 442257
2020-10-14T03:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257,Code name:,SAR-442257
2020-10-14T03:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257,Code name:,SAR442257
2020-10-14T03:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257,Synonym:,tri-specific T-cell engager SAR442257
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Code name:,GBR 1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Code name:,GBR-1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Code name:,GBR1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Synonym:,anti-CD38 x anti-CD3 bispecific monoclonal antibody GBR 1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Synonym:,anti-CD38/anti-CD3 bispecific monoclonal antibody GBR 1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Synonym:,BEAT GBR 1342
2020-10-14T03:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342,Synonym:,CD38xCD3 BsAb GBR 1342
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR03087
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,MOR202
2020-09-18T02:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087,Code name:,TJ202/MOR202
2020-10-14T03:38:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-sar442085,Code name:,SAR 442085
2020-10-14T03:38:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-sar442085,Code name:,SAR-442085
2020-10-14T03:38:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-sar442085,Code name:,SAR442085
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Code name:,TEV-48573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,anti-CD38-targeted IgG4-attenuated interferon alpha TAK-573
2020-09-18T02:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573,Synonym:,CD38-targeted IgG4 fused with attenuated IFNa
2020-10-14T03:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd39-monoclonal-antibody-ttx-030,Code name:,TTX 030
2020-10-14T03:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd39-monoclonal-antibody-ttx-030,Code name:,TTX-030
2020-10-14T03:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd39-monoclonal-antibody-ttx-030,Code name:,TTX030
2020-10-14T03:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd4-car-t-cells,Synonym:,CD4 CAR T cells
2020-10-14T03:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd4-car-t-cells,Synonym:,CD4-specific CAR T cells
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Code name:,ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,agonistic anti-CD40 monoclonal antibody ABBV-927
2020-09-18T02:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927,Synonym:,anti-CD40 monoclonal antibody ABBV-927
2020-10-14T03:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140,Code name:,CDX 1140
2020-10-14T03:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140,Code name:,CDX-1140
2020-10-14T03:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140,Synonym:,agonist CD40 antibody CDX-1140
2020-10-14T03:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140,Synonym:,anti-CD40 agonistic monoclonal antibody CDX-1140
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,BNT 312
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,BNT-312
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,BNT312
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,GEN 1042
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,GEN-1042
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Code name:,GEN1042
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Synonym:,anti-CD40/anti-CD137 bispecific agonist monoclonal antibody GEN1042
2020-10-14T03:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042,Synonym:,DuoBody-CD40x4-1BB GEN1042
2020-09-18T02:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4,Code name:,Chi Lob 7/4
2020-09-18T02:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-sea-cd40,Code name:,SEA-CD40
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS-986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Code name:,BMS986004
2020-09-18T02:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004,Synonym:,Fc-fusion protein BMS986004
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RG 7356
2020-09-18T02:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083,Code name:,RO5429083
2020-10-14T03:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-bc8-monoclonal-antibody-streptavidin-conjugate,Abbreviation:,BC8-SA
2020-10-14T03:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-bc8-monoclonal-antibody-streptavidin-conjugate,Synonym:,anti-CD45 BC8 antibody-streptavidin fusion protein
2020-10-14T03:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-bc8-monoclonal-antibody-streptavidin-conjugate,Synonym:,BC8 scFv4SA fusion protein
2020-09-18T02:22:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody,NA,NA
2020-09-18T02:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-ahn-12,Code name:,AHN-12
2020-09-18T02:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8,Abbreviation:,MOAB BC8
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Abbreviation:,BC8-SA
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,anti-CD45 BC8 antibody-streptavidin fusion protein
2020-09-18T02:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate,Synonym:,BC8 scFv4SA fusion protein
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Code name:,FOR 46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Code name:,FOR-46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Code name:,FOR46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Synonym:,ADC FOR46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Synonym:,anti-CD46 ADC FOR46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Synonym:,antibody-drug conjugate FOR46
2020-10-14T03:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46,Synonym:,CD46-ADC FOR46
2020-10-14T03:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m,Code name:,SGN CD47M
2020-10-14T03:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m,Code name:,SGN-CD47M
2020-10-14T03:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m,Code name:,SGNCD47M
2020-10-14T03:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m,Synonym:,ADC SGN-CD47M
2020-10-14T03:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m,Synonym:,anti-CD47 antibody-drug conjugate SGN-CD47M
2020-10-14T03:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-cd19-bispecific-monoclonal-antibody-tg-1801,Code name:,TG 1801
2020-10-14T03:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-cd19-bispecific-monoclonal-antibody-tg-1801,Code name:,TG-1801
2020-10-14T03:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-cd19-bispecific-monoclonal-antibody-tg-1801,Code name:,TG1801
2020-10-14T03:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-cd19-bispecific-monoclonal-antibody-tg-1801,Synonym:,bispecific monoclonal antibody TG-1801
2020-10-14T03:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-ao-176,Code name:,AO 176
2020-10-14T03:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-ao-176,Code name:,AO-176
2020-10-14T03:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-ao-176,Code name:,AO176
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC 90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Code name:,CC-90002
2020-09-18T02:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002,Synonym:,anti-CD47 Mab CC-90002
2020-09-18T08:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-hu5f9-g4,Code name:,Hu5F9-G4
2020-09-18T08:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-hu5f9-g4,Code name:,ONO-7913
2020-09-18T08:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-hu5f9-g4,Synonym:,anti-CD47 monoclonal antibody Hu5F9-G4
2020-10-14T03:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-shr-1603,Code name:,SHR 1603
2020-10-14T03:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-shr-1603,Code name:,SHR-1603
2020-10-14T03:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-shr-1603,Code name:,SHR1603
2020-10-14T03:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-shr-1603,Synonym:,OA3-targeted antineoplastic agent SHR-1603
2020-10-14T03:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-tjc4,Code name:,TJ 011133
2020-10-14T03:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-tjc4,Code name:,TJ-011133
2020-10-14T03:41:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-tjc4,Code name:,TJC4
2020-10-14T03:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd48-mmae-antibody-drug-conjugate-sgn-cd48a,Code name:,SGN CD48A
2020-10-14T03:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd48-mmae-antibody-drug-conjugate-sgn-cd48a,Code name:,SGNCD48A
2020-10-14T03:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd48-mmae-antibody-drug-conjugate-sgn-cd48a,Synonym:,Anti-CD48 ADC SGN-CD48A
2020-10-14T03:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd52-monoclonal-antibody-allo-647,Code name:,ALLO 647
2020-10-14T03:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd52-monoclonal-antibody-allo-647,Code name:,ALLO-647
2020-10-14T03:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd52-monoclonal-antibody-allo-647,Code name:,ALLO647
2020-10-14T03:41:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd7-car-t-cells,Synonym:,anti-CD7 CAR T lymphocytes
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Abbreviation:,anti-CD70 ADC MDX-1203
2020-09-18T02:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203,Code name:,MDX-1203
2020-09-18T02:24:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-sgn-cd70a,Code name:,SGN-CD70A
2020-09-18T05:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-argx-110,Code name:,ARGX-110
2020-09-18T05:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-argx-110,Synonym:,anti-CD70 monoclonal antibody ARGX-110
2020-09-18T02:24:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-mdx-1411,Code name:,MDX-1411
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Code name:,CX 2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Code name:,CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Code name:,CX2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,anti-CD71 Probody/vcMMAE drug conjugate CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,antibody prodrug-drug conjugate CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,CD71-directed PDC CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,CD71-directed probody therapeutic CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,PDC CX-2029
2020-10-14T03:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029,Synonym:,PDC-targeting CD71 CX-2029
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS 986179
2020-09-18T02:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179,Code name:,BMS-986179
2020-10-14T03:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-cpi-006,Code name:,CPI 006
2020-10-14T03:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-cpi-006,Code name:,CPI-006
2020-10-14T03:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-cpi-006,Code name:,CPI006
2020-10-14T03:41:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-cpi-006,Code name:,CPX-006
2020-09-18T09:50:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-medi9447,Code name:,MEDI9447
2020-09-18T09:50:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-medi9447,Synonym:,anti-CD73 monoclonal antibody MEDI9447
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,NZV 930
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,NZV-930
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,NZV930
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,SRF 373
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,SRF-373
2020-10-14T03:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930,Code name:,SRF373
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ 004309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ 4309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ-004309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ-4309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ004309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJ4309
2020-10-14T03:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309,Code name:,TJD5
2020-09-18T02:24:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd98-monoclonal-antibody-ign523,Code name:,IGN523
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Abbreviation:,CDH6-ADC
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT 288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Code name:,HKT288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,CDH6 ADC HKT288
2020-09-18T02:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288,Synonym:,maytansine-based ADC HKT-288
2020-09-18T02:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-dtpa-in-f6-734-bispecific-antibody,NA,NA
2020-09-18T02:25:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2,Synonym:,anti-CEA x anti-histamine-succinyl-glycine bispecific monoclonal antibody TF2
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,AMG211
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MEDI-565
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Code name:,MT111
2020-09-18T02:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211,Synonym:,anti-CEA BiTE monoclonal antibody MEDI-565
2020-09-18T02:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-car-autologous-t-lymphocytes,Synonym:,autologous anti-CEA CAR-T cells
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RG-7802
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RG7802
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,RO6958688
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Code name:,WHO 10636
2020-09-18T05:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688,Synonym:,anti-CEA/CD3 bispecific antibody RO6958688
2020-09-18T02:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-igcd28tcr-transduced-autologous-t-cells,NA,NA
2020-09-18T02:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-tcr-retroviral-vector-transduced-autologous-lymphocytes,NA,NA
2020-09-18T02:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam1-monoclonal-antibody-cm-24,Code name:,CM-24
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Code name:,SAR408701
2020-09-18T02:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701,Synonym:,ADC SAR408701
2020-10-14T03:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam6-antibody-bay1834942,Code name:,BAY 1834942
2020-10-14T03:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam6-antibody-bay1834942,Code name:,BAY-1834942
2020-10-14T03:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam6-antibody-bay1834942,Code name:,BAY1834942
2020-10-14T03:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-ab011,Code name:,AB 011
2020-10-14T03:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-ab011,Code name:,AB-011
2020-10-14T03:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-ab011,Code name:,AB011
2020-10-14T03:42:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-ab011,Synonym:,anti-CLDN18.2 monoclonal antibody AB011
2020-10-14T03:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-tst001,Code name:,TST 001
2020-10-14T03:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-tst001,Code name:,TST-001
2020-10-14T03:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-tst001,Code name:,TST001
2020-10-14T03:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-asp1650,Code name:,ASP1650
2020-10-14T03:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-asp1650,Code name:,IMAB027
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,ASP1650
2020-09-18T02:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027,Code name:,IMAB027
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,IMC-CS4
2020-09-18T02:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4,Code name:,LY3022855
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD 360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,PD-0360324
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Code name:,"PD-360,324"
2020-09-18T02:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324,Synonym:,anti–M-CSF mAb PD-0360324
2020-10-14T04:03:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1r-monoclonal-antibody-imc-cs4,US brand name:,Ridaura
2020-09-18T10:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctgf-monoclonal-antibody-fg-3019,Abbreviation:,anti-CTGF hmAb FG-3019
2020-09-18T10:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctgf-monoclonal-antibody-fg-3019,Code name:,FG-3019
2020-09-18T10:07:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctgf-monoclonal-antibody-fg-3019,Synonym:,anti-connective tissue growth factor monoclonal antibody FG-3019
2020-10-14T03:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217,Code name:,BCD 217
2020-10-14T03:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217,Code name:,BCD-217
2020-10-14T03:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217,Code name:,BCD217
2020-10-14T03:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217,Synonym:,anti-CTLA-4/PD-1 monoclonal antibody combination BCD-217
2020-10-14T03:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217,Synonym:,anti-CTLA4/anti-PD1 monoclonal antibody combination BCD-217
2020-10-14T03:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841,Code name:,XmAb 22841
2020-10-14T03:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841,Code name:,XmAb-22841
2020-10-14T03:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841,Code name:,XmAb22841
2020-10-14T03:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841,Synonym:,anti-CTLA-4/anti-LAG-3 bispecific monoclonal antibody XmAb22841
2020-10-14T03:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841,Synonym:,CTLA-4xLAG-3 bispecific antibody XmAb22841
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous DC
2020-09-18T02:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous dendritic cells
2020-10-14T03:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adg116,Code name:,ADG 116
2020-10-14T03:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adg116,Code name:,ADG-116
2020-10-14T03:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adg116,Code name:,ADG116
2020-10-14T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adu-1604,Code name:,ADU 1604
2020-10-14T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adu-1604,Code name:,ADU-1604
2020-10-14T03:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adu-1604,Code name:,ADU1604
2020-10-14T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1181,Code name:,AGEN 1181
2020-10-14T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1181,Code name:,AGEN-1181
2020-10-14T03:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1181,Code name:,AGEN1181
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN-1884
2020-09-18T02:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884,Code name:,AGEN1884
2020-10-14T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-hbm4003,Code name:,HBM 4003
2020-10-14T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-hbm4003,Code name:,HBM-4003
2020-10-14T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-hbm4003,Code name:,HBM4003
2020-10-14T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-mk-1308,Code name:,MK 1308
2020-10-14T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-mk-1308,Code name:,MK-1308
2020-10-14T03:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-mk-1308,Code name:,MK1308
2020-10-14T03:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-onc-392,Code name:,ONC 392
2020-10-14T03:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-onc-392,Code name:,ONC-392
2020-10-14T03:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-onc-392,Code name:,ONC392
2020-10-14T03:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-onc-392,Synonym:,anti-CTLA4 monoclonal antibody ONC-392
2020-10-14T03:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-regn4659,Code name:,REGN 4659
2020-10-14T03:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-regn4659,Code name:,REGN-4659
2020-10-14T03:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-regn4659,Code name:,REGN4659
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ADC 1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ADC-1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ADC1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ATOR 1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ATOR-1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Code name:,ATOR1015
2020-10-14T03:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015,Synonym:,CTLA-4 x OX40 bispecific antibody ATOR-1015
2020-10-14T03:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-probody-bms-986288,Code name:,BMS 986288
2020-10-14T03:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-probody-bms-986288,Code name:,BMS-986288
2020-10-14T03:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-probody-bms-986288,Code name:,BMS986288
2020-10-14T03:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-probody-bms-986288,Synonym:,probody BMS-986288
2020-10-14T03:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-antibody-fc-fusion-protein-kn044,Code name:,KN 044
2020-10-14T03:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-antibody-fc-fusion-protein-kn044,Code name:,KN-044
2020-10-14T03:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-antibody-fc-fusion-protein-kn044,Code name:,KN044
2020-10-14T03:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-antibody-fc-fusion-protein-kn044,Synonym:,anti-CTLA4 antibody fusion protein KN044
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Abbreviation:,GITRL/antiCTLA4 RNA DC
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous DC
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous dendritic cell
2020-09-18T02:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine
2020-10-14T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Abbreviation:,GITRL/antiCTLA4 RNA DC
2020-10-14T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous DC
2020-10-14T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb heavy and light chain RNA/GITRL RNA-transfected autologous dendritic cell
2020-10-14T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine
2020-10-14T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous DC
2020-10-14T03:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,anti-CTLA-4 mAb RNA-transfected autologous dendritic cells
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS 986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Code name:,BMS-986218
2020-09-18T02:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218,Synonym:,monoclonal antibody BMS-986218
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF 06747143
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Code name:,PF-06747143
2020-09-18T02:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143,Synonym:,anti-CXCR4 IgG1 antibody PF-06747143
2020-10-14T03:44:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-monoclonal-antibody-trc093,Code name:,D93
2020-10-14T03:44:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-monoclonal-antibody-trc093,Code name:,TRC093
2020-10-14T03:44:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-monoclonal-antibody-trc093,Synonym:,anti-dn collagen monoclonal antibody TRC093
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,D93
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Code name:,TRC093
2020-09-18T02:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093,Synonym:,anti-dn collagen monoclonal antibody TRC093
2020-09-18T02:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk-1-monoclonal-antibody-ly2812176,Code name:,LY2812176
2020-09-18T02:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk1-monoclonal-antibody-bhq880,Code name:,BHQ880
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Code name:,AMG 757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Code name:,AMG-757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Code name:,AMG757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Synonym:,anti-DLL3 x anti-CD3 BiTE AMG 757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Synonym:,bispecific T-cell engager antibody AMG 757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Synonym:,BiTE antibody AMG 757
2020-10-14T03:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757,Synonym:,DLL3/CD3-directed bispecific T-cell engager antibody AMG 757
2020-09-18T02:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-medi0639,Code name:,MEDI0639
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Code name:,REGN421
2020-09-18T02:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421,Synonym:,anti-Delta-like 4 monoclonal antibody REGN421
2020-09-18T02:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-vegf-bispecific-monoclonal-antibody-omp-305b83,Code name:,OMP-305B83
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Code name:,TRA-8
2020-09-18T02:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8,Synonym:,anti-death receptor 5 agonist monoclonal antibody TRA-8
2020-10-14T03:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonistic-monoclonal-antibody-inbrx-109,Code name:,INBRX 109
2020-10-14T03:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonistic-monoclonal-antibody-inbrx-109,Code name:,INBRX-109
2020-10-14T03:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonistic-monoclonal-antibody-inbrx-109,Code name:,INBRX109
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Code name:,MEGF0444A
2020-09-18T02:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a,Synonym:,anti-epidermal growth factor-like domain 7 monoclonal antibody MEGF0444A
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Code name:,EMB 01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Code name:,EMB-01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Code name:,EMB01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Synonym:,anti-cMET/EGFR bispecific antibody EMB-01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Synonym:,anti-EGFR/anti-c-Met bispecific antibody EMB-01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Synonym:,bispecific antibody EMB-01
2020-10-14T03:44:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01,Synonym:,FIT-013a
2020-09-18T02:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-jnj-61186372,Code name:,JNJ-61186372
2020-10-14T03:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-car-transduced-il-12-expressing-t-lymphocytes,Synonym:,EGFR-IL12-CAR-T cells
2020-10-14T03:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-dm1-antibody-drug-conjugate-avid100,Code name:,AVID100
2020-10-14T03:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-dm1-antibody-drug-conjugate-avid100,Synonym:,ADC AVID100
2020-10-14T03:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-dm1-antibody-drug-conjugate-avid100,Synonym:,antibody-drug conjugate AVID100
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Code name:,ABY-029
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,ABY-029 trifluoroacetate salt
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,fluorescently-labeled Anti-EGFR affibody molecule ABY-029
2020-09-18T02:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029,Synonym:,IRDye 800CW maleimide-labeled affibody peptide
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym-013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Code name:,Sym013
2020-09-18T02:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013,Synonym:,pan-HER mAb mixture Sym013
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Code name:,MEHD7945A
2020-09-18T02:30:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a,Synonym:,anti-erbB1/erbB3 monoclonal antibody MEHD7945A
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR mAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,anti-EGFR MoAb ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,ABT-806
2020-09-18T02:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806,Code name:,mAb-806
2020-10-14T03:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-cpgj-602,Code name:,CPGJ 602
2020-10-14T03:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-cpgj-602,Code name:,CPGJ-602
2020-10-14T03:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-cpgj-602,Code name:,CPGJ602
2020-09-18T02:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-gc1118,Code name:,GC1118
2020-09-18T02:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-mm-151,Code name:,MM-151
2020-09-18T02:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-sym004,Code name:,sym004
2020-09-18T02:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-ro5083945,Synonym:,anti-epidermal growth factor receptor GFR monoclonal antibody RO5083945
2020-09-18T02:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-syn004,Code name:,SYN004
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Code name:,IMGN289
2020-09-18T02:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289,Synonym:,anti-EGFR-SMCC-DM1
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Code name:,AMG 595
2020-09-18T02:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595,Synonym:,anti-EGFRvIII-DM1 immunoconjugate AMG 595
2020-09-18T02:31:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-car-transduced-allogeneic-t-lymphocytes,Synonym:,anti-EGFRvIII CAR PG13-139-CD8-CD28BBZ-transduced T lymphocytes
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Code name:,AMG 596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Code name:,AMG-596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Code name:,AMG596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Synonym:,anti-EGFRvIII x anti-CD3 bi-specific T-cell engager AMG 596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Synonym:,bispecific BITE antibody AMG 596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Synonym:,BiTE antibody AMG 596
2020-10-14T03:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596,Synonym:,EGFRvIII specific BiTE antibody AMG 596
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Code name:,MR1-1
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1-1KDEL
2020-09-18T02:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1,Synonym:,MR1scFvPE38KDEL
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Code name:,MOC31-PE
2020-09-18T02:31:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe,Synonym:,anti-epithelial glycoprotein-2 immunotoxin MOC31-PE
2020-09-18T05:08:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endoglin-monoclonal-antibody-trc105,Code name:,TRC105
2020-09-18T02:31:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endosialin-tem1-monoclonal-antibody-morab-004,Code name:,MORAb-004
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Abbreviation:,ADC AGS-16C3F
2020-09-18T02:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f,Code name:,AGS-16C3F
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING 1
2020-09-18T02:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1,Code name:,ING-1
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM 310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Code name:,MM310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 antibody-targeted nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,anti-EphA2 docetaxel-based nanoliposome MM-310
2020-09-18T02:31:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310,Synonym:,EphA2-targeted docetaxel nanoliposome MM-310
2020-09-18T02:31:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-ds-8895a,Code name:,DS-8895a
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Code name:,MEDI-547
2020-09-18T02:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547,Synonym:,1C1-mcMMAF
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Abbreviation:,anti-EphA3 mAb KB004
2020-09-18T02:32:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004,Code name:,KB004
2020-09-18T02:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb2-anti-erbb3-bispecific-monoclonal-antibody-mm-111,Code name:,MM-111
2020-09-18T02:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-anti-igf-1r-bispecific-monoclonal-antibody-mm-141,Code name:,MM-141
2020-10-14T03:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-antibody-isu104,Code name:,ISU 104
2020-10-14T03:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-antibody-isu104,Code name:,ISU-104
2020-10-14T03:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-antibody-isu104,Code name:,ISU104
2020-10-14T03:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-antibody-isu104,Synonym:,anti-HER3 antibody ISU104
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Code name:,AV-203
2020-09-18T02:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203,Synonym:,anti-ErbB3 MoAb AV-203
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,CDX 3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,CDX-3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,CDX3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,KTN 3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,KTN-3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Code name:,KTN3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Synonym:,anti-ErbB3 monoclonal antibody KTN3379
2020-10-14T03:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379,Synonym:,anti-HER3 monoclonal antibody CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,CDX3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN 3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN-3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Code name:,KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-ErbB3 monoclonal antibody KTN3379
2020-09-18T02:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379,Synonym:,anti-HER3 monoclonal antibody CDX-3379
2020-09-18T02:32:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-regn1400,Code name:,REGN1400
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG 7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG-7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RG7461
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO-6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Code name:,RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,aFAP-IL2v RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v FP RO6874281
2020-09-18T02:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281,Synonym:,FAP-IL2v RO6874281
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Code name:,RO7187797
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,anti-FCRH5/CD3 TDB BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 T cell-dependent bispecific antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,FCRH5/CD3 TDB antibody BFCR4350A
2020-09-18T02:32:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a,Synonym:,recombinant anti-FCRH5 × anti-CD3 bi-specific T-cell engager BFCR4350A
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT 001
2020-09-18T02:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001,Code name:,SYNT001
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Code name:,KRN23
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Code name:,UX023
2020-09-18T04:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23,Synonym:,anti-FGF23 IgG1 monoclonal antibody KRN23
2020-09-18T02:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-bay1179470,Code name:,BAY1179470
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY 1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Code name:,BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,ADC BAY1187982
2020-09-18T03:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982,Synonym:,anti-FGFR2 antibody-drug conjugate BAY1187982
2020-09-18T04:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-monoclonal-antibody-fpa144,Code name:,FPA144
2020-09-18T04:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-monoclonal-antibody-fpa144,Synonym:,anti-FGFR2 monoclonal antibody FPA144
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Code name:,LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-FGFR3 ADC LY3076226
2020-09-18T02:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226,Synonym:,anti-fibroblast growth factor receptor 3 antibody-drug conjugate LY3076226
2020-09-18T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-b-701,Code name:,B-701
2020-09-18T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-b-701,Synonym:,anti-FGFR3 monoclonal antibody B-701
2020-09-18T02:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-mfgr1877s,Code name:,MFGR1877S
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3 1784
2020-09-18T02:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784,Code name:,U3-1784
2020-10-14T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flfitc-e2-car-t-cells,Synonym:,anti-FL(FITC-E2) CAR T lymphocytes
2020-10-14T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flfitc-e2-car-t-cells,Synonym:,anti-FL(FITCE2) CAR expressing T cells
2020-10-14T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flfitc-e2-car-t-cells,Synonym:,antiFL(FITCE2) CAR expressing T cells
2020-10-14T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flfitc-e2-car-t-cells,Synonym:,fluorescein-specific (FITC-E2)-CAR T cells
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Code name:,RPI.4610
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,Foreign brand name:,Angiozyme
2020-09-18T02:08:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme,US brand name:,Angiozyme
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Code name:,AMG 427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Code name:,AMG-427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Code name:,AMG427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Synonym:,anti-FLT3 x anti-CD3 BiTE AMG 427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Synonym:,bispecific T-cell engager antibody AMG 427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Synonym:,BiTE antibody AMG 427
2020-10-14T03:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427,Synonym:,FLT3/CD3-directed bispecific T-cell engager antibody AMG 427
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Code name:,4G8-SDIEM
2020-09-18T02:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem,Synonym:,FLYSYN
2020-09-18T02:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-imc-eb10,Code name:,IMC-EB10
2020-10-14T03:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002,Code name:,STRO 002
2020-10-14T03:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002,Code name:,STRO-002
2020-10-14T03:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002,Code name:,STRO002
2020-10-14T03:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002,Synonym:,anti-FolRa ADC STRO-002
2020-10-14T03:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002,Synonym:,anti-FolRalpha ADC STRO-002
2020-09-18T02:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fucosyl-gm1-monoclonal-antibody-bms-986012,Code name:,BMS-986012
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Code name:,BIW-8962
2020-09-18T02:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962,Synonym:,anti-GM2 monoclonal antibody BIW-8962
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ABBV 151
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ABBV-151
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ABBV151
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ARGX 115
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ARGX-115
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Code name:,ARGX115
2020-10-14T03:47:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151,Synonym:,anti-glycoprotein A repetitions predominant monoclonal antibody ABBV-151
2020-09-18T02:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-mln0264,Code name:,MLN0264
2020-10-14T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-tak-164,Code name:,TAK 164
2020-10-14T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-tak-164,Code name:,TAK-164
2020-10-14T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-tak-164,Code name:,TAK164
2020-10-14T03:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-tak-164,Synonym:,anti-GCC ADC TAK-164
2020-09-18T02:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-hu1418k322a,Code name:,hu14.18K322A
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Code name:,MORAb-028
2020-09-18T02:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028,Synonym:,anti-G-28 monoclonal antibody MORAb-028
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF 06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Code name:,PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,anti GD3 ADC PF-06688992
2020-09-18T02:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992,Synonym:,GD3 ADC PF-06688992
2020-10-14T03:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gfral-monoclonal-antibody-ngm120,Code name:,NGM 120
2020-10-14T03:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gfral-monoclonal-antibody-ngm120,Code name:,NGM-120
2020-10-14T03:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gfral-monoclonal-antibody-ngm120,Code name:,NGM120
2020-10-14T03:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gfral-monoclonal-antibody-ngm120,Synonym:,GFRAL antagonistic monoclonal antibody NGM120
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,ASP 1951
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,ASP-1951
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,ASP1951
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,PTZ 522
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,PTZ-522
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Code name:,PTZ522
2020-10-14T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951,Synonym:,anti-GITR agonistic monoclonal antibody PTZ-522
2020-10-14T03:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156,Code name:,BMS 986156
2020-10-14T03:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156,Code name:,BMS-986156
2020-10-14T03:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156,Synonym:,anti-GITR MoAb BMS-986156
2020-10-14T03:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156,Synonym:,GITR agonist BMS-986156
2020-10-14T03:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156,Synonym:,TNFRSF18 agonist BMS-986156
2020-09-18T02:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-incagn01876,Code name:,INCAGN01876
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS 986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Code name:,BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,anti-GITR MoAb BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,GITR agonist BMS-986156
2020-09-18T02:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156,Synonym:,TNFRSF18 agonist BMS-986156
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN 323
2020-09-18T02:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323,Code name:,GWN323
2020-09-18T02:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-mk-4166,Code name:,MK-4166
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Code name:,OBI 999
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Code name:,OBI-999
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Code name:,OBI999
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Synonym:,ADC OBI 999
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Synonym:,anti-globo H/MMAE ADC OBI 999
2020-10-14T03:47:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999,Synonym:,OBI-888/MMAE ADC OBI-999
2020-10-14T03:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-monoclonal-antibody-obi-888,Code name:,OBI 888
2020-10-14T03:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-monoclonal-antibody-obi-888,Code name:,OBI-888
2020-10-14T03:47:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-monoclonal-antibody-obi-888,Code name:,OBI888
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,anti-GPC3-scFvGC33-CAR autologous T lymphocytes
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GAP T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,autologous GPC3-CAR T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor expressed in autologous T cells
2020-09-18T02:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes,Synonym:,glypican 3-specific chimeric antigen receptor-expressing autologous T cells
2020-09-18T02:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gnrh-vaccine-pep223,Code name:,PEP223
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Code name:,MGD007
2020-09-18T02:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007,Synonym:,humanized gpA33 x CD3 DART™ protein MGD007
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,anti-GPC3 CAR autologous T cells
2020-09-18T02:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes,Synonym:,GPC3-targeted CAR autologous T cells
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Code name:,TAK 102
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Code name:,TAK-102
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Code name:,TAK102
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Synonym:,anti-GPC3 CAR T cells TAK-102
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Synonym:,CAR T cells TAK-102
2020-10-14T03:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102,Synonym:,glypican-3-specific CAR T cells TAK-102
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Code name:,GC33
2020-09-18T02:36:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33,Synonym:,anti-glypican 3 monoclonal antibody GC33
2020-10-14T03:48:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gremlin-1-monoclonal-antibody-ucb6114,Code name:,UCB 6114
2020-10-14T03:48:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gremlin-1-monoclonal-antibody-ucb6114,Code name:,UCB-6114
2020-10-14T03:48:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gremlin-1-monoclonal-antibody-ucb6114,Code name:,UCB6114
2020-10-14T03:48:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gremlin-1-monoclonal-antibody-ucb6114,Synonym:,anti-GREM1 antibody monoclonal UCB6114
2020-09-18T02:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-grp78-monoclonal-antibody-pat-sm6,Code name:,PAT-SM6
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI 8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Code name:,MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,anti-influenza A hemagglutinin epitope mAb MEDI8852
2020-09-18T02:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852,Synonym:,pan-influenza A mAb MEDI8852
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Code name:,KHK2866
2020-09-18T02:36:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866,Synonym:,anti-HB-EGF MoAb KHK2866
2020-09-18T02:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hbegf-monoclonal-antibody-u3-1565,Code name:,U3-1565
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 autologous CAR-transduced T cells
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70 CAR autologous PBLs
2020-09-18T02:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls,Synonym:,anti-hCD70-CAR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-09-18T02:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcv-e2-monoclonal-antibody-mbl-hcv1,Synonym:,MBL-HCV1
2020-10-14T03:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026,Code name:,KN 026
2020-10-14T03:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026,Code name:,KN-026
2020-10-14T03:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026,Code name:,KN026
2020-10-14T03:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026,Synonym:,anti-HER2 heterodimeric antibody KN026
2020-10-14T03:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026,Synonym:,HER2 bispecific antibody KN026
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,DS-8201a
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Code name:,WHO 10516
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,Synonym:,trastuzumab deruxtecan
2020-09-18T06:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a,US brand name:,Enhertu
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,ARG-6194
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,BTRC 4017A
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,BTRC-4017
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,BTRC4017A
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,RG 6194
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Code name:,RG6194
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017A
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody RG 6194
2020-10-14T03:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a,Synonym:,anti-HER2/anti-CD3 bispecific monoclonal antibody 4017A
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Code name:,GBR1302
2020-09-18T02:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302,Synonym:,anti-HER2 x anti-CD3 bispecific monoclonal antibody GBR 1302
2020-10-14T03:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-her3-bispecific-monoclonal-antibody-mcla-128,Code name:,MCLA 128
2020-10-14T03:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-her3-bispecific-monoclonal-antibody-mcla-128,Code name:,MCLA-128
2020-10-14T03:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-her3-bispecific-monoclonal-antibody-mcla-128,Code name:,MCLA128
2020-10-14T03:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-her3-bispecific-monoclonal-antibody-mcla-128,Synonym:,anti-HER2 x anti-HER3 bispecific monoclonal antibody MCLA-128
2020-10-14T03:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166,Code name:,A 166
2020-10-14T03:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166,Code name:,A-166
2020-10-14T03:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166,Code name:,A166
2020-10-14T03:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166,Synonym:,ADC A166
2020-10-14T03:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166,Synonym:,anti-HER2 ADC A166
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Code name:,ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,ADC ARX788
2020-09-18T02:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788,Synonym:,anti-HER2 ADC ARX788
2020-10-14T03:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001,Code name:,BAT 8001
2020-10-14T03:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001,Code name:,BAT-8001
2020-10-14T03:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001,Code name:,BAT8001
2020-10-14T03:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001,Synonym:,ADC BAT8001
2020-10-14T03:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001,Synonym:,anti-HER2 ADC BAT8001
2020-10-14T03:48:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c,Code name:,DP 303c
2020-10-14T03:48:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c,Code name:,DP-303c
2020-10-14T03:48:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c,Code name:,DP303c
2020-10-14T03:48:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c,Synonym:,ADC DP303c
2020-10-14T03:48:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c,Synonym:,antibody-drug conjugate DP303c
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI-4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Code name:,MEDI4276
2020-09-18T02:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276,Synonym:,ADC MEDI4276
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Code name:,RC48-ACD
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,ADC RC48
2020-09-18T02:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48,Synonym:,anti-HER2 ADC RC48
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Code name:,XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,ADC XMT-1522
2020-09-18T02:38:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522,Synonym:,anti-HER2 ADC XMT-1522
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Code name:,ZW25
2020-09-18T02:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25,Synonym:,HER2 x HER2 bispecific antibody ZW25
2020-10-14T03:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bispecific-antibody-drug-conjugate-zw49,Code name:,ADC ZW49
2020-10-14T03:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bispecific-antibody-drug-conjugate-zw49,Code name:,ZW-49
2020-10-14T03:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bispecific-antibody-drug-conjugate-zw49,Code name:,ZW49
2020-10-14T03:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bispecific-antibody-drug-conjugate-zw49,Synonym:,anti-HER2 bispecific ADC ZW49
2020-09-18T02:38:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-car-autologous-cmv-specific-cytotoxic-t-lymphocytes,NA,NA
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Code name:,B 003
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Code name:,B-003
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Code name:,B003
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Synonym:,ADC B003
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Synonym:,anti-HER2-DM1 antibody-drug conjugate B003
2020-10-14T03:48:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003,Synonym:,recombinant humanized anti-HER2 monoclonal antibody-MCC-DM1 B003
2020-10-14T03:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her2-bispecific-antibody-zw25,Code name:,ZW25
2020-10-14T03:48:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her2-bispecific-antibody-zw25,Synonym:,HER2 x HER2 bispecific antibody ZW25
2020-10-14T03:49:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her3-dendritic-cell-vaccine,Synonym:,anti-HER2/3 DC vaccine
2020-10-14T03:49:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her3-dendritic-cell-vaccine,Synonym:,anti-HER2/3 dendritic cell vaccine
2020-10-14T03:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-immune-stimulator-antibody-conjugate-njh395,Code name:,NJH 395
2020-10-14T03:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-immune-stimulator-antibody-conjugate-njh395,Code name:,NJH-395
2020-10-14T03:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-immune-stimulator-antibody-conjugate-njh395,Code name:,NJH395
2020-10-14T03:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-immune-stimulator-antibody-conjugate-njh395,Synonym:,anti-HER2 ISAC NJH395
2020-10-14T03:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-b002,Code name:,B 002
2020-10-14T03:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-b002,Code name:,B-002
2020-10-14T03:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-b002,Code name:,B002
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P06
2020-09-18T02:38:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6,Code name:,CT-P6
2020-10-14T03:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-hlx22,Code name:,HLX 22
2020-10-14T03:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-hlx22,Code name:,HLX-22
2020-10-14T03:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-hlx22,Code name:,HLX22
2020-10-14T03:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-pbd-ma-antibody-drug-conjugate-dhes0815a,Code name:,DHES0815A
2020-10-14T03:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-pbd-ma-antibody-drug-conjugate-dhes0815a,Synonym:,ADC DHES0815A
2020-10-14T03:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-pbd-ma-antibody-drug-conjugate-dhes0815a,Synonym:,anti-HER2/PBD-MA ADC DHES0815A
2020-10-14T03:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-pbd-ma-antibody-drug-conjugate-dhes0815a,Synonym:,anti-HER2/PBD-monoamide ADC DHES0815A
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF 06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF-068041033
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Code name:,PF06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-HER2-vcAur0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-HER2 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,anti-NG-Her2-vc0101 ADC PF-06804103
2020-09-18T02:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103,Synonym:,antibody-drug conjugate PF-0680410
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3 1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Code name:,U3-1402a
2020-09-18T02:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402,Synonym:,ADC U3 1402
2020-09-18T02:39:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-gsk2849330,Code name:,GSK2849330
2020-09-18T02:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-ljm716,Code name:,LJM716
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Code name:,TAK-701
2020-09-18T02:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701,Synonym:,anti-hepatocyte growth factor monoclonal antibody TAK-701
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,EZN-2968
2020-09-18T02:39:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968,Code name:,RO7070179
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Code name:,Cal-1
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,anti-HIV-1 lentiviral vector sh5/C46
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,anti-HIV-1 LV-expressing sh5/C46 Cal-1
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,anti-HIV-1 LVsh5/C46
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,Cal-1 vector
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,LVsh5/C46
2020-10-14T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1,Synonym:,LVsh5/C46 vector
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,anti-HLA-A2/NY-ESO1 TCR-transduced autologous T cells
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-HLA-A2/NY-ESO1 TCR-transduced T lymphocytes
2020-09-18T02:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes,Synonym:,autologous HLA-A2/NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Code name:,IMMU-114
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,anti-HLA-DR moAb L243
2020-09-18T02:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114,Synonym:,hL243gamma4P
2020-09-18T02:40:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-chorionic-gonadotropin-vaccine,NA,NA
2020-10-14T04:01:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-cytomegalovirus-monoclonal-antibody-combination-csj-148,Code name:,CSJ148
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR mAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Abbreviation:,anti-huGITR MoAb TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Code name:,TRX518
2020-09-18T02:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518,Synonym:,anti-huGITR monoclonal antibody TRX518
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Code name:,EMD 525797
2020-09-18T02:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797,Synonym:,anti-human CD51 monoclonal antibody EMD 525797
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Code name:,BI-505
2020-09-18T02:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505,Synonym:,anti-intercellular adhesion molecule-1 monoclonal antibody BI-505
2020-09-18T02:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-antibody-gsk3359609,Code name:,GSK3359609
2020-10-14T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226,Code name:,BMS 986226
2020-10-14T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226,Code name:,BMS-986226
2020-10-14T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226,Code name:,BMS986226
2020-10-14T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226,Synonym:,anti-ICOS BMS-986226
2020-10-14T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226,Synonym:,anti-inducible T-cell co-stimulator BMS-986226
2020-09-18T12:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-jtx-2011,Code name:,JTX-2011
2020-09-18T12:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-jtx-2011,Synonym:,anti-ICOS agonist MAb JTX-2011
2020-09-18T12:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-jtx-2011,Synonym:,ICOS agonist monoclonal antibody JTX-2011
2020-10-14T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-ky1044,Code name:,KY 1044
2020-10-14T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-ky1044,Code name:,KY-1044
2020-10-14T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-ky1044,Code name:,KY1044
2020-10-14T03:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-ky1044,Synonym:,anti-ICOS antibody KY1044
2020-09-18T02:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-medi-570,Code name:,MEDI-570
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Code name:,AVE1642
2020-09-18T02:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642,Synonym:,anti-CD122 monoclonal antibody AVE1642
2020-09-18T02:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-recombinant-monoclonal-antibody-biib022,Code name:,BIIB022
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Code name:,MEDI-573
2020-09-18T02:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573,Synonym:,anti-insulin-like growth factor 1/2 monoclonal antibody MEDI-573
2020-09-18T02:40:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-ca-18c3,Code name:,CA-18C3
2020-10-14T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1,Code name:,MABp1
2020-10-14T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1 alpha monoclonal antibody MABp1
2020-10-14T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1amonoclonal antibody
2020-10-14T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1,US brand name:,Xilonix
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Code name:,TNX-650
2020-09-18T02:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650,Synonym:,monoclonal antibody TNX-650
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG 714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Code name:,AMG714
2020-09-18T02:41:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714,Synonym:,HuMab-IL15 AMG 714
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX-258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,QBX258
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694 plus QAX576
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Code name:,VAK694/QAX576
2020-09-18T02:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258,Synonym:,dectrekumab/VAK296
2020-10-14T03:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-bms-986253,Code name:,HuMax-IL8
2020-10-14T03:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-bms-986253,Code name:,MDX 018
2020-10-14T03:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-bms-986253,Code name:,MDX-018
2020-10-14T03:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-bms-986253,Synonym:,BMS-986253
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,HuMax-IL8
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX 018
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Code name:,MDX-018
2020-09-18T02:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8,Synonym:,BMS-986253
2020-10-14T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il17a-monoclonal-antibody-cjm112,Code name:,CJM 112
2020-10-14T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il17a-monoclonal-antibody-cjm112,Code name:,CJM112
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Code name:,BAY 1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Code name:,BAY-1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Code name:,BAY1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Synonym:,anti-ILDR2 inhibitor BAY1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Synonym:,anti-immunoglobulin-like domain containing receptor 2 MoAb BAY1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Synonym:,ILDR2 function-blocking antibody BAY1905254
2020-10-14T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254,Synonym:,immune checkpoint inhibitor BAY1905254
2020-10-14T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830,Code name:,MK 4830
2020-10-14T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830,Code name:,MK-4830
2020-10-14T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830,Code name:,MK4830
2020-10-14T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830,Synonym:,anti-leukocyte immunoglobulin-like receptor 2 monoclonal antibody MK-4830
2020-10-14T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830,Synonym:,anti-LIR2 monoclonal antibody MK-4830
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN 1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN-1007
2020-09-18T02:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007,Code name:,ALXN1007
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Foreign brand name:,Dentoxol
2020-09-18T02:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse,Synonym:,Dentoxol mouthrinse
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Code name:,IMGN388
2020-09-18T02:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388,Synonym:,integrin-targeted immunoconjugate IMGN388
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Code name:,NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-IFN gamma monoclonal antibody NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-IFNg mAb NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,anti-interferon gamma monoclonal antibody NI-0501
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,Synonym:,emapalumab
2020-09-18T06:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501,US brand name:,Gamifant
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Code name:,MABp1
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1 alpha monoclonal antibody MABp1
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,Synonym:,Anti-IL-1amonoclonal antibody
2020-09-18T02:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1,US brand name:,Xilonix
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Code name:,ALD518
2020-09-18T02:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518,Synonym:,anti-IL6 monoclonal antibody ALD518
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Code name:,ION 251
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Code name:,ION-251
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Code name:,ION251
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Synonym:,anti-IRF4 ASO ION251
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Synonym:,anti-IRF4 ASO IONIS-IRF4-2.5Rx
2020-10-14T03:50:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251,Synonym:,IONIS-IRF4-2.5Rx
2020-10-14T03:51:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12d-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-K-RAS G12D mTCR-transduced autologous PBLs
2020-10-14T03:51:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12d-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-KRAS G12D mTCR autologous PBL
2020-10-14T03:51:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12d-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-KRAS G12D mTCR-transduced autologous peripheral blood lymphocytes
2020-10-14T03:51:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12d-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,autologous PBL transduced with anti-KRAS G12D mTCR
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-K-RAS G12V mTCR-transduced autologous PBLs
2020-09-18T02:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-KRAS G12V mTCR-transduced autologous peripheral blood lymphocytes
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,1-7F9
2020-09-18T02:42:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101,Code name:,IPH 2101
2020-10-14T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-iph-2101,Code name:,1-7F9
2020-10-14T03:51:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-iph-2101,Code name:,IPH 2101
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Code name:,IPH4102
2020-09-18T02:42:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102,Synonym:,anti-KIR3DL2 mAb IPH4102
2020-10-14T12:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ksp-anti-vegf-sirnas-aln-vsp02,Code name:,ALN-VSP02
2020-10-14T03:51:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody,Code name:,BI 754111
2020-10-14T03:51:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody,Synonym:,anti LAG-3 MoAb
2020-10-14T03:51:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody,Synonym:,anti-LAG-3 monoclonal antibody
2020-09-18T11:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-bms-986016,Code name:,BMS-986016
2020-09-18T11:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-bms-986016,Code name:,BMS986016
2020-09-18T11:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-bms-986016,Synonym:,anti-LAG-3 monoclonal antibody BMS-986016
2020-10-14T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-ibi-110,Code name:,IBI 110
2020-10-14T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-ibi-110,Code name:,IBI-110
2020-10-14T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-ibi-110,Code name:,IBI110
2020-10-14T03:51:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-ibi-110,Synonym:,anti-LAG-3 monoclonal antibody IBI110
2020-09-18T02:42:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-lag525,Code name:,LAG525
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN 3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Code name:,REGN3767
2020-09-18T02:43:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767,Synonym:,anti-LAG-3 MoAb REGN3767
2020-10-14T03:51:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-sym022,Code name:,Sym 022
2020-10-14T03:51:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-sym022,Code name:,Sym-022
2020-10-14T03:51:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-sym022,Code name:,Sym022
2020-10-14T03:51:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-pd-l1-bispecific-antibody-fs118,Code name:,FS118
2020-10-14T03:51:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-pd-l1-bispecific-antibody-fs118,Synonym:,LAG-3/PD-L1 bispecific antibody FS118
2020-10-14T03:51:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-pd-l1-bispecific-antibody-fs118,Synonym:,LAG-3/PD-L1 Mab2 FS118
2020-10-14T03:51:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-pd-l1-bispecific-antibody-fs118,Synonym:,Mab2 FS118
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK 4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK-4280
2020-09-18T02:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280,Code name:,MK4280
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR 033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Code name:,TSR033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-LAG-3 monoclonal antibody TSR-033
2020-09-18T02:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033,Synonym:,anti-lymphocyte activation gene 3 protein monoclonal antibody TSR-033
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,ADC SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Code name:,SAR428926
2020-09-18T02:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926,Synonym:,anti-LAMP1 ADC SAR428926
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,autologous-derived LeY-targeted CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted autologous CAR-T cells
2020-09-18T02:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes,Synonym:,LeY-targeted CAR-T cells
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC-101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Code name:,BNC101
2020-09-18T02:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101,Synonym:,ET-101
2020-10-14T03:51:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lif-monoclonal-antibody-msc-1,Code name:,MSC 1
2020-10-14T03:51:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lif-monoclonal-antibody-msc-1,Code name:,MSC-1
2020-10-14T03:51:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lif-monoclonal-antibody-msc-1,Code name:,MSC1
2020-09-18T08:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-liv-1-monoclonal-antibody-mmae-conjugate-sgn-liv1a,Code name:,SGN-LIV1A
2020-09-18T08:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-liv-1-monoclonal-antibody-mmae-conjugate-sgn-liv1a,Synonym:,anti-LIV-1 antibody-drug conjugate SGN-LIV1A
2020-09-18T08:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-liv-1-monoclonal-antibody-mmae-conjugate-sgn-liv1a,Synonym:,anti-LIV-1 monoclonal antibody-MMAE conjugate SGN-LIV1A
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,AB0024
2020-09-18T02:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634,Code name:,GS-6624
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Code name:,DLYE5953A
2020-09-18T02:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a,Synonym:,ADC DLYE5953A
2020-10-14T03:52:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-rg-7841,Code name:,DLYE5953A
2020-10-14T03:52:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-rg-7841,Synonym:,ADC DLYE5953A
2020-09-18T02:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-m-csf-monoclonal-antibody-mcs110,Code name:,MCS110
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Code name:,IMC C103C
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Code name:,IMCC103C
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Synonym:,ImmTAC IMC-C103C
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Synonym:,ImmTAC Molecule IMC-C103C
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-C103C
2020-10-14T03:52:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c,Synonym:,T-cell redirecting bi-specific biologic IMC-C103C
2020-09-18T02:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-masp-2-monoclonal-antibody-oms721,Code name:,OMS721
2020-09-18T02:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-antibody-drug-conjugate-bms-986148,Code name:,BMS-986148
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Abbreviation:,CART-meso
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,anti-mesothelin CIR mRNA-electroporated autologous T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-mesothelin mRNA-transfected CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,autologous redirected RNA meso-CIR T cells
2020-09-18T02:44:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes,Synonym:,meso-CART
2020-09-18T02:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-meso-CAR vector-transduced autologous T cells
2020-10-14T03:52:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells,Abbreviation:,CART-meso
2020-10-14T03:52:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells,Synonym:,anti-mesothelin CIR mRNA-electroporated autologous T cells
2020-10-14T03:52:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells,Synonym:,autologous anti-mesothelin mRNA-transfected CIR T cells
2020-10-14T03:52:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells,Synonym:,autologous redirected RNA meso-CIR T cells
2020-10-14T03:52:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells,Synonym:,meso-CART
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,LMB-100
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG 7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG-7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RG7787
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO 6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Code name:,RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-mesothelin recombinant cytolytic fusion protein RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN cFP RO6927005
2020-09-18T02:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN-PE24 cFP LMB-100
2020-09-18T02:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-icasp9m28z-car-transduced-autologous-t-lymphocytes,Synonym:,iCasp9M28z T cells
2020-10-14T03:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88,Code name:,ADC RC88
2020-10-14T03:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88,Code name:,RC 88
2020-10-14T03:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88,Code name:,RC-88
2020-10-14T03:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88,Code name:,RC88
2020-10-14T03:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88,Synonym:,anti-mesothelin/MMAE ADC RC88
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,LMB-100
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,RG 7787
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,RG-7787
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,RG7787
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,RO 6927005
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Code name:,RO6927005
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Synonym:,anti-mesothelin recombinant cytolytic fusion protein RO6927005
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN cFP RO6927005
2020-10-14T03:52:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100,Synonym:,anti-MSLN-PE24 cFP LMB-100
2020-09-18T02:44:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-egfr-monoclonal-antibody-ly3164530,Code name:,LY3164530
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym-015
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Code name:,Sym015
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006-Hu9338
2020-09-18T02:44:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015,Synonym:,Hu9006/Hu9338
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,anti-MiHA donor T lymphocytes
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,anti-MiHA T cells
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,GLIDE
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,GLIDE cells
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,GLIDE T lymphocytes
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,guided lymphocyte immunopeptide derived expansion against MiHAs cells
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,guided lymphocyte immunopeptide-derived expansion cells
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,MiHA T lympocytes
2020-10-14T03:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes,Synonym:,MiHA-specific T cells
2020-09-18T02:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mmp-9-monoclonal-antibody-gs-5745,Code name:,GS-5745
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR T Cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-MUC1 CAR-transduced autologous T cells
2020-09-18T02:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes,Synonym:,anti-mucin1 autologous CAR T cells
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Code name:,REGN 4018
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Code name:,REGN-4018
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Code name:,REGN4018
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Synonym:,bispecific T-cell engager antibody REGN4018
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Synonym:,MUC16/CD3-directed bispecific T-cell engager antibody REGN4018
2020-10-14T03:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018,Synonym:,MUC16xCD3 bispecific T-cell engager REGN4018
2020-10-14T03:52:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-mmae-antibody-drug-conjugate-dmuc4064a,Code name:,DMUC4064A
2020-10-14T03:52:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-mmae-antibody-drug-conjugate-dmuc4064a,Code name:,RG7882
2020-10-14T03:52:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-mmae-antibody-drug-conjugate-dmuc4064a,Synonym:,ADC DMUC4064A
2020-10-14T03:52:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-mmae-antibody-drug-conjugate-dmuc4064a,Synonym:,THIOMAB-drug conjugate DMUC4064A
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Code name:,AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Code name:,AMG-199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Code name:,AMG199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,anti-MUC17 x anti-CD3 BiTE AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,anti-MUC17/CD3 bispecific antibody AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,bispecific T-cell engager antibody AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,BiTE antibody AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,MUC17/CD3-directed bispecific T-cell engager antibody AMG 199
2020-10-14T03:53:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199,Synonym:,MUC17xCD3 bispecific T-cell engager AMG 199
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Code name:,BT-062
2020-09-18T02:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062,Synonym:,maytansinoid-conjugated anti-myeloma monoclonal antibody BT-062
2020-09-18T02:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myostatin-monoclonal-antibody-ly2495655,Code name:,LY2495655
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Code name:,XMT 1592
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Code name:,XMT-1592
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Code name:,XMT1592
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Synonym:,anti-NaPi2b ADC XMT-1592
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1592
2020-10-14T03:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592,Synonym:,NaPi2b-targeted antibody-drug conjugate XMT-1592
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Code name:,DNIB0600A
2020-09-18T02:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a,Synonym:,ADC DNIB0600A
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Code name:,ASG-22CE
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Synonym:,anti-nectin 4 ADC ASG-22CE
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,Synonym:,enfortumab vedotin
2020-09-18T06:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce,US brand name:,Padcev
2020-09-18T02:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-monoclonal-antibody-drug-conjugate-ags-22m6e,Code name:,AGS-22M6E
2020-09-18T02:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-neuropilin-1-monoclonal-antibody-mnrp1685a,Code name:,MNRP1685A
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Code name:,BIL-010t
2020-09-18T02:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t,Synonym:,BSCT 10 % ointment
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,ASP 1948
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,ASP-1948
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,ASP1948
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,PTZ 329
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,PTZ-329
2020-10-14T12:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948,Code name:,PTZ329
2020-09-18T02:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nucleolin-aptamer-as1411,Code name:,AS1411
2020-10-14T03:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso-1-tcr-lv-transduced-autologous-t-cells-taest16001,Code name:,TAEST 16001
2020-10-14T03:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso-1-tcr-lv-transduced-autologous-t-cells-taest16001,Code name:,TAEST16001
2020-10-14T03:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso-1-tcr-lv-transduced-autologous-t-cells-taest16001,Synonym:,anti-NY-ESO-1 TCR transduced autologous T cells TAEST16001
2020-10-14T03:53:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso-1-tcr-lv-transduced-autologous-t-cells-taest16001,Synonym:,NY-ESO-1 antigen specific affinity-enhanced TCR transduced autologous T cells
2020-10-14T03:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-lage-1a-tcr-scfv-anti-cd3-imcnyeso,Code name:,IMCnyeso
2020-10-14T03:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-lage-1a-tcr-scfv-anti-cd3-imcnyeso,Synonym:,bispecific NY-ESO-1- and LAGE-1A-specific TCR/anti-CD3
2020-10-14T03:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-lage-1a-tcr-scfv-anti-cd3-imcnyeso,Synonym:,HLA- A*0201-restricted NY-ESO-1- and LAGE-1A-specific soluble TCR/anti-CD3 bispecific molecule
2020-09-18T03:42:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-tcr-transduced-autologous-cd62l-derived-t-lymphocytes,Synonym:,autologous CD62L+-derived T lymphocytes transduced with NY-ESO-1-specific TCR
2020-10-14T03:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-agonist-monoclonal-antibody-pf-04518600,Code name:,PF-04518600
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS 986178
2020-09-18T03:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178,Code name:,BMS-986178
2020-09-18T03:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-pf-04518600,Code name:,PF-04518600
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-CD134 MoAb
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Abbreviation:,anti-OX40 MoAb
2020-09-18T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody,Synonym:,anti-CD134 monoclonal antibody
2020-10-14T03:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-ibi101,Code name:,IBI 101
2020-10-14T03:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-ibi101,Code name:,IBI-101
2020-10-14T03:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-ibi101,Code name:,IBI101
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI-0562
2020-09-18T03:43:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562,Code name:,MEDI0562
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR Retroviral Vector-Transduced PBL
2020-09-18T03:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes,Synonym:,Anti-p53 TCR-Transduced PBL
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Code name:,MGD 019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Code name:,MGD-019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Code name:,MGD019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Synonym:,bispecific DART protein MGD019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Synonym:,dual-affinity retargeting protein MGD019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Synonym:,PD-1 x CTLA4 bispecific DART molecule MGD019
2020-10-14T03:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019,Synonym:,PD-1 x CTLA4 DART protein MGD019
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,BH 2950
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,BH-2950
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,BH2950
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,IBI 315
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,IBI-315
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Code name:,IBI315
2020-10-14T03:54:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315,Synonym:,HER2/PD-1 bi-specific antibody BH 2950
2020-10-14T03:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-bispecific-antibody-ro7247669,Code name:,RO 7247669
2020-10-14T03:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-bispecific-antibody-ro7247669,Code name:,RO-7247669
2020-10-14T03:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-bispecific-antibody-ro7247669,Code name:,RO7247669
2020-10-14T03:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-bispecific-antibody-ro7247669,Synonym:,anti-PD1/anti-LAG3 bispecific antibody RO7247669
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Code name:,MGD013
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Synonym:,bispecific DART protein MGD013
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Synonym:,dual-affinity retargeting protein MGD013
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Synonym:,PD-1 x LAG-3 bispecific DART molecule MGD013
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Synonym:,PD-1 x LAG-3 DART molecule MGD013
2020-10-14T03:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013,Synonym:,PD-1 x LAG-3 DART protein MGD013
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Code name:,IBI 318
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Code name:,IBI-318
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Code name:,IBI318
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Synonym:,anti-PD-1/PD-L1 bispecific antibody IBI318
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Synonym:,bispecific antibody IBI318
2020-10-14T03:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318,Synonym:,recombinant anti-PD-1/anti-PD-L1 bispecific antibody IBI318
2020-10-14T03:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ly3434172,Code name:,LY 3434172
2020-10-14T03:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ly3434172,Code name:,LY3434172
2020-10-14T03:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ly3434172,Synonym:,anti-PD-1/PD-L1 bispecific antibody LY3434172
2020-10-14T03:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ly3434172,Synonym:,bispecific antibody LY3434172
2020-10-14T03:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-cd47-infusion-protein-hx009,Code name:,HX 009
2020-10-14T03:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-cd47-infusion-protein-hx009,Code name:,HX-009
2020-10-14T03:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-cd47-infusion-protein-hx009,Code name:,HX009
2020-10-14T03:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-cd47-infusion-protein-hx009,Synonym:,anti-PD1/CD47 bi-specific antibody fusion protein HX009
2020-09-18T11:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-checkpoint-inhibitor-pf-06801591,Code name:,PF-06801591
2020-09-18T11:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-checkpoint-inhibitor-pf-06801591,Synonym:,anti-PD-1 PF-06801591
2020-09-18T11:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-checkpoint-inhibitor-pf-06801591,Synonym:,WHO 11161
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Code name:,AK 104
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Code name:,AK-104
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Code name:,AK104
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Synonym:,anti-PD-1 x CTLA-4 bispecific antibody AK104
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Synonym:,anti-PD1/anti-CTLA4 bispecific antibody AK104
2020-10-14T03:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor AK104
2020-09-18T03:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-fusion-protein-amp-224,Code name:,AMP-224
2020-10-14T03:55:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-609a,Code name:,609 A
2020-10-14T03:55:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-609a,Code name:,609-A
2020-10-14T03:55:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-609a,Code name:,609A
2020-10-14T03:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-ak105,Code name:,AK 105
2020-10-14T03:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-ak105,Code name:,AK-105
2020-10-14T03:55:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-ak105,Code name:,AK105
2020-10-14T03:55:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-amg-404,Code name:,AMG 404
2020-10-14T03:55:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-amg-404,Code name:,AMG-404
2020-10-14T03:55:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-amg-404,Code name:,AMG404
2020-09-18T12:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bgb-a317,Code name:,BGB-A317
2020-09-18T12:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bgb-a317,Synonym:,anti-PD-1 monoclonal antibody BGB-A317
2020-09-18T03:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bi-754091,Code name:,BI 754091
2020-10-14T03:55:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-f520,Code name:,F 520
2020-10-14T03:55:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-f520,Code name:,F-520
2020-10-14T03:55:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-f520,Code name:,F520
2020-10-14T13:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-gls-010,Code name:,AB 122
2020-10-14T13:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-gls-010,Code name:,AB-122
2020-10-14T13:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-gls-010,Code name:,AB122
2020-10-14T13:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-gls-010,Synonym:,anti-PD-1 monoclonal antibody AB122
2020-10-14T03:55:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-hx008,Code name:,HX 008
2020-10-14T03:55:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-hx008,Code name:,HX-008
2020-10-14T03:55:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-hx008,Code name:,HX008
2020-09-18T12:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-js001,Code name:,JS001
2020-09-18T12:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-js001,Synonym:,anti-PD-1 monoclonal antibody JS001
2020-09-18T12:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-js001,Synonym:,TAB-001
2020-10-14T03:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-jtx-4014,Code name:,JTX 4014
2020-10-14T03:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-jtx-4014,Code name:,JTX-4014
2020-10-14T03:55:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-jtx-4014,Code name:,JTX4014
2020-10-14T03:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-lzm009,Code name:,LZM 009
2020-10-14T03:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-lzm009,Code name:,LZM-009
2020-10-14T03:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-lzm009,Synonym:,LZM009
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,AMP-514
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Code name:,MEDI0680
2020-09-18T03:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680,Synonym:,antprogrammed cell death 1 monoclonal antibody AMP-514
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA 0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA-0012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,INCMGA00012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA 012
2020-09-18T03:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012,Code name:,MGA012
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Chemical structure:,"immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal REGN2810 heavy chain), disulfide with human monoclonal REGN2810 kappa-chain, dimer"
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Code name:,REGN2810
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Synonym:,anti-PD-1 monoclonal antibody REGN2810
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,Synonym:,cemiplimab
2020-09-18T05:19:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810,US brand name:,Libtayo
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,HR-301210
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,SHR-1210
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Code name:,SHR1210
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Synonym:,AiRuiKa
2020-09-18T04:58:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210,Synonym:,carrizumab
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Code name:,Sym021
2020-09-18T03:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021,Synonym:,anti-PD1 monoclonal antibody Sym021
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,ANB011
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR 042
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR-042
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Code name:,TSR042
2020-09-18T06:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042,Synonym:,"immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer"
2020-10-14T03:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661,Code name:,RO 7121661
2020-10-14T03:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661,Code name:,RO-7121661
2020-10-14T03:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661,Code name:,RO7121661
2020-10-14T03:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661,Synonym:,anti-PD-1 x TIM-3 bispecific antibody RO7121661
2020-10-14T03:56:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661,Synonym:,anti-PD-1/anti-TIM-3 bispecific antibody RO7121661
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Code name:,ES101
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Code name:,INBRX 105
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Code name:,INBRX-105
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Code name:,INBRX105
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Synonym:,anti-PD-L1/CD137 bispecific antibody INBRX-105
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Synonym:,PDL1 x 41BB bispecific antibody INBRX-105
2020-10-14T03:56:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105,Synonym:,PDL1 x CD137 bispecific antibody INBRX-105
2020-10-14T03:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-anti-4-1bb-bispecific-monoclonal-antibody-gen1046,Code name:,BNT 311
2020-10-14T03:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-anti-4-1bb-bispecific-monoclonal-antibody-gen1046,Code name:,GEN 1046
2020-10-14T03:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-anti-4-1bb-bispecific-monoclonal-antibody-gen1046,Code name:,GEN-1046
2020-10-14T03:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-anti-4-1bb-bispecific-monoclonal-antibody-gen1046,Synonym:,duoBody PD-L1 x 4-1BB GEN1046
2020-10-14T03:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-ctla-4-bispecific-antibody-kn046,Code name:,KN 046
2020-10-14T03:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-ctla-4-bispecific-antibody-kn046,Code name:,KN-046
2020-10-14T03:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-ctla-4-bispecific-antibody-kn046,Code name:,KN046
2020-10-14T03:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-ctla-4-bispecific-antibody-kn046,Synonym:,anti-PD-L1 x CTLA-4 bispecific antibody KN046
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,A 167
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,A-167
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,A167
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,KL A167
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,KL-A167
2020-10-14T03:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167,Code name:,KLA167
2020-10-14T03:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-bgb-a333,Code name:,BGB A333
2020-10-14T03:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-bgb-a333,Code name:,BGB-A333
2020-10-14T03:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-bgb-a333,Code name:,BGBA333
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,CBT 502
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,CBT-502
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,CBT502
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,TQB 2450
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,TQB-2450
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Code name:,TQB2450
2020-10-14T03:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502,Synonym:,anti-PD-L1 monoclonal antibody TQB2450
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ 053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ-053
2020-09-18T03:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053,Code name:,FAZ053
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,IMC 001
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,IMC-001
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,IMC001
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,STI 3031
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,STI-3031
2020-10-14T03:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001,Code name:,STI3031
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,anti-PD-L1 MoAb KN035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN 035
2020-09-18T03:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035,Synonym:,KN035
2020-09-18T03:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-mdx-1105,Code name:,MDX-1105
2020-10-14T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311,Code name:,MSB 2311
2020-10-14T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311,Code name:,MSB-2311
2020-10-14T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311,Code name:,MSB2311
2020-10-14T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311,Synonym:,anti-PDL1 monoclonal antibody MSB2311
2020-10-14T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311,Synonym:,humanized anti-PD-L1 monoclonal antibody MSB2311
2020-10-14T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-rc98,Code name:,RC 98
2020-10-14T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-rc98,Code name:,RC-98
2020-10-14T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-rc98,Code name:,RC98
2020-10-14T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-shr-1316,Code name:,HTI-1088
2020-10-14T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-shr-1316,Code name:,SHR-1316
2020-10-14T03:57:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-tg-1501,Code name:,TG 1501
2020-10-14T03:57:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-tg-1501,Code name:,TG-1501
2020-10-14T03:57:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-tg-1501,Code name:,TG1501
2020-10-14T03:57:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-tg-1501,Synonym:,anti-PDL1 monoclonal antibody TG-1501
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Code name:,STI A1014
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Code name:,STIA1014
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Code name:,ZKAB 001
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Code name:,ZKAB-001
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Code name:,ZKAB001
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Synonym:,anti-PDL1 monoclonal antibody ZKAB001
2020-10-14T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001,Synonym:,STI-A1014
2020-10-14T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-tim-3-bispecific-antibody-ly3415244,Code name:,LY 3415244
2020-10-14T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-tim-3-bispecific-antibody-ly3415244,Code name:,LY-3415244
2020-10-14T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-tim-3-bispecific-antibody-ly3415244,Code name:,LY3415244
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Code name:,PSB 205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Code name:,PSB-205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Code name:,PSB205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Synonym:,anti-PD-1/anti-CTLA-4 monoclonal antibody mixture PSB205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Synonym:,anti-PD-1/CTLA-4 MabPair PSB205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Synonym:,anti-PD1/CTLA4 antibodies PSB205
2020-10-14T03:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205,Synonym:,bifunctional MabPair product PSB205
2020-10-14T03:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717,Code name:,XmAb 20717
2020-10-14T03:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717,Code name:,XmAb20717
2020-10-14T03:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717,Synonym:,anti-PD-1/anti-CTLA-4 XmAb20717
2020-10-14T03:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717,Synonym:,PD-1 x CTLA-4 bispecific antibody XmAb20717
2020-10-14T03:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717,Synonym:,PD-1 x CTLA-4 dual checkpoint inhibitor XmAb20717
2020-10-14T03:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104,Code name:,XmAb 23104
2020-10-14T03:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104,Code name:,XmAb-23104
2020-10-14T03:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104,Code name:,XmAb23104
2020-10-14T03:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104,Synonym:,anti-PD1/anti-ICOS bispecific monoclonal antibody XmAb23104
2020-10-14T03:55:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104,Synonym:,PD1 x ICOS bispecific monoclonal antibody XmAb23104
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV 181
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV-181
2020-09-18T04:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181,Code name:,ABBV181
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN 2034
2020-09-18T03:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034,Code name:,AGEN2034
2020-09-18T11:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-ibi308,Code name:,IBI 308
2020-09-18T11:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-ibi308,Code name:,IBI308
2020-09-18T11:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-ibi308,Synonym:,anti-PDCD1 monoclonal antibody IBI308
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ 63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ-63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,JNJ63723283
2020-09-18T05:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283,Code name:,WHO 10757
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Code name:,MEDI-575
2020-09-18T03:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575,Synonym:,anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575
2020-09-18T03:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pgf-monoclonal-antibody-ro5323441,Code name:,RO5323441
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Code name:,Atu027
2020-09-18T03:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027,Synonym:,anti-protein kinase N3 siRNA Atu027
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Code name:,TB-403
2020-09-18T03:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403,Synonym:,anti-placental growth factor monoclonal antibody TB-403
2020-09-18T03:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pr1-hla-a2-monoclonal-antibody-hu8f4,Code name:,Hu8F4
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Code name:,IMC F106C
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Code name:,IMC-F106C
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Code name:,IMCF106C
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Synonym:,ImmTAC IMC-F106C
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Synonym:,ImmTAC molecule IMC-F106C
2020-10-14T03:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c,Synonym:,immune mobilizing monoclonal TCR against cancer IMC-F106C
2020-10-14T03:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prl-3-monoclonal-antibody-prl3-zumab,Synonym:,PRL3 zumab
2020-10-14T03:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prl-3-monoclonal-antibody-prl3-zumab,Synonym:,PRL3-zumab
2020-09-18T03:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prolactin-receptor-antibody-lfa102,Code name:,LFA102
2020-09-18T03:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-fully-human-monoclonal-antibody-ags-1c4d4,Code name:,AGS-PSCA
2020-10-14T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-monoclonal-antibody-ags-1c4d4,Code name:,AGS-PSCA
2020-10-14T03:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678,Code name:,REGN 5678
2020-10-14T03:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678,Code name:,REGN-5678
2020-10-14T03:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678,Code name:,REGN5678
2020-10-14T03:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678,Synonym:,anti-PSMA/anti-CD28 bispecific antibody REGN5678
2020-10-14T03:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678,Synonym:,anti-PSMAxCD28 antibody REGN5678
2020-10-14T03:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-ccw702,Code name:,CCW 702
2020-10-14T03:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-ccw702,Code name:,CCW-702
2020-10-14T03:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-ccw702,Code name:,CCW702
2020-10-14T03:58:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-jnj-63898081,Code name:,JNJ 63898081
2020-10-14T03:58:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-jnj-63898081,Code name:,JNJ63898081
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Code name:,AMG 160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Code name:,AMG-160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Code name:,AMG160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Synonym:,anti-PSMA/CD3 bispecific T-cell engager antibody AMG 160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Synonym:,bispecific T-cell engager antibody AMG 160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Synonym:,BITE AMG 160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Synonym:,half-life extended bispecific T-cell engager antibody AMG 160
2020-10-14T03:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160,Synonym:,HLE-BiTE AMG 160
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,BAY2010112
2020-09-18T03:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112,Code name:,MT112
2020-09-18T03:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-monoclonal-antibody-mor209-es414,Code name:,MOR209/ES414
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201
2020-09-18T03:48:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488,Code name:,MDX1201-A488
2020-10-14T12:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mln591-dm1-immunoconjugate-mln2704,Code name:,MLN591DM1
2020-10-14T12:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mln591-dm1-immunoconjugate-mln2704,Synonym:,DM1-conjugated monoclonal antibody MLN591
2020-10-14T12:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mln591-dm1-immunoconjugate-mln2704,Synonym:,maytansinoid -1 conjugated with MLN591 monoclonal antibody
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Abbreviation:,anti-PSMA-MMAE-ADC
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Code name:,PSMA ADC
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,anti-PSMA monoclonal antibody-monomethylauristatin E conjugate
2020-09-18T03:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate,Synonym:,prostate-specific membrane antigen antibody-drug conjugate
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,ADCT-401
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI 3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI-3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Code name:,MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADC MEDI3726
2020-09-18T03:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726,Synonym:,ADCT 401 ADCT401
2020-10-14T03:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701,Code name:,COM 701
2020-10-14T03:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701,Code name:,COM-701
2020-10-14T03:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701,Code name:,COM701
2020-10-14T03:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701,Synonym:,anti-poliovirus receptor-related immunoglobulin COM701
2020-10-14T03:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701,Synonym:,PVRIG inhibitor COM701
2020-10-14T03:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rankl-monoclonal-antibody-gb-223,Code name:,GB 223
2020-10-14T03:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rankl-monoclonal-antibody-gb-223,Code name:,GB-223
2020-10-14T03:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rankl-monoclonal-antibody-gb-223,Code name:,GB223
2020-10-14T03:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ror1-adc-vls-101,Code name:,VLS 101
2020-10-14T03:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ror1-adc-vls-101,Code name:,VLS-101
2020-10-14T03:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ror1-adc-vls-101,Code name:,VLS101
2020-10-14T03:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ror1-adc-vls-101,Synonym:,anti-ROR1 antibody-drug conjugate VLS-101
2020-09-18T03:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rspo3-monoclonal-antibody-omp-131r10,Code name:,OMP-131R10
2020-10-14T03:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318,Code name:,NC 318
2020-10-14T03:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318,Code name:,NC-318
2020-10-14T03:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318,Code name:,NC318
2020-10-14T03:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318,Synonym:,anti-S15 mAb NC318
2020-10-14T03:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318,Synonym:,anti-Siglec-15 monoclonal antibody NC318
2020-09-18T03:49:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sclu-monoclonal-antibody-ab-16b5,Code name:,AB-16B5
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Code name:,VX15/2503
2020-09-18T03:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503,Synonym:,moAb VX15/2503
2020-10-14T03:59:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sirpa-monoclonal-antibody-cc-95251,Code name:,CC 95251
2020-10-14T03:59:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sirpa-monoclonal-antibody-cc-95251,Code name:,CC-95251
2020-10-14T03:59:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sirpa-monoclonal-antibody-cc-95251,Code name:,CC95251
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Abbreviation:,anti-SLITRK6 ADC AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,AGS15E
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Code name:,ASG-15ME
2020-09-18T03:49:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e,Synonym:,anti-SLITRK6 antibody-drugconjugate AGS15E
2020-09-18T07:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ta-muc1-monoclonal-antibody-pankomab,Synonym:,anti-TA-MUC1 monoclonal antibody PankoMab
2020-09-18T07:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ta-muc1-monoclonal-antibody-pankomab,US brand name:,PankoMab-GEX
2020-09-18T03:50:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tag-72-monoclonal-antibody-cc49-streptavidin-conjugate,Synonym:,CC49-streptavidin
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Code name:,ALT-836
2020-09-18T03:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836,Synonym:,anti-TF moAb ALT-836
2020-09-18T12:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-mmae-conjugate,Foreign brand name:,HuMax-TF-ADC
2020-09-18T12:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-mmae-conjugate,Synonym:,anti-TF monoclonal antibody-MMAE conjugate
2020-09-18T03:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-nis793,Code name:,NIS793
2020-10-14T03:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459,Code name:,SAR 439459
2020-10-14T03:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459,Code name:,SAR-439459
2020-10-14T03:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459,Code name:,SAR439459
2020-10-14T03:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459,Synonym:,anti-TGFb SAR-439459
2020-10-14T03:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459,Synonym:,anti-transforming growth factor-beta mAb SAR439459
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,IMC-TR1
2020-09-18T03:50:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1,Code name:,LY3022859
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Abbreviation:,ATG
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,Synonym:,lymphocyte immune globulin
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,ATGAM
2020-09-18T03:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin,US brand name:,Thymoglobulin
2020-09-18T03:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thyroglobulin-mtcr-transduced-autologous-peripheral-blood-lymphocytes,Synonym:,anti-thyroglobulin mTCR-transduced autologous PBL
2020-09-18T03:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-bms-986207,Code name:,BMS-986207
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP 313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Code name:,OMP-313M32
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT (OMP-313M32)
2020-09-18T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32,Synonym:,anti-TIGIT OMP-313M32
2020-10-14T03:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-antibody-bms-986258,Code name:,BMS 986258
2020-10-14T03:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-antibody-bms-986258,Code name:,BMS-986258
2020-10-14T03:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-antibody-bms-986258,Synonym:,anti-TIM3 antibody BMS-986258
2020-10-14T03:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-bgb-a425,Code name:,BGB A425
2020-10-14T03:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-bgb-a425,Code name:,BGB-A425
2020-10-14T03:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-bgb-a425,Code name:,BGBA425
2020-10-14T03:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-incagn02390,Code name:,INCAGN 02390
2020-10-14T03:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-incagn02390,Code name:,INCAGN-02390
2020-10-14T03:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-incagn02390,Code name:,INCAGN02390
2020-10-14T03:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-sym023,Code name:,Sym 023
2020-10-14T03:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-sym023,Code name:,Sym-023
2020-10-14T03:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-sym023,Code name:,Sym023
2020-10-14T03:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-sym023,Synonym:,anti-TIM3 monoclonal antibody Sym023
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Code name:,TSR-022
2020-09-18T03:51:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022,Synonym:,anti-TIM3 checkpoint inhibitor TSR-022
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY 3321367
2020-09-18T03:51:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367,Code name:,LY3321367
2020-10-14T03:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-shr-1702,Code name:,SHR 1702
2020-10-14T03:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-shr-1702,Code name:,SHR-1702
2020-10-14T03:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-shr-1702,Code name:,SHR1702
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Code name:,MORAb-066
2020-09-18T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066,Synonym:,anti-TF monoclonal antibody MORAb-066
2020-09-18T03:51:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tlr2-monoclonal-antibody-opn-305,Code name:,OPN-305
2020-10-14T04:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711,Code name:,BI 905711
2020-10-14T04:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711,Code name:,BI-905711
2020-10-14T04:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711,Code name:,BI905711
2020-10-14T04:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711,Synonym:,bi-specific agent BI 905711
2020-10-14T04:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711,Synonym:,CDH17-targeting TRAILR2 agonist BI 905711
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Code name:,ALN-TTR02
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,Synonym:,RNAi therapeutic-targeting transthyretin ALN-TTR02
2020-09-18T03:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02,US brand name:,Patisiran
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Code name:,BAT 8003
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Code name:,BAT-8003
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Code name:,BAT8003
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Synonym:,ADC BAT8003
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Synonym:,anti-Trop-2 antibody-drug conjugate BAT8003
2020-10-14T04:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003,Synonym:,anti-TROP2 ADC BAT8003
2020-10-14T04:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-skb264,Code name:,ADC SKB264
2020-10-14T04:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-skb264,Code name:,SKB 264
2020-10-14T04:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-skb264,Code name:,SKB-264
2020-10-14T04:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-skb264,Code name:,SKB264
2020-10-14T04:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-dxd-antibody-drug-conjugate-ds-1062a,Code name:,DS 1062a
2020-10-14T04:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-dxd-antibody-drug-conjugate-ds-1062a,Code name:,DS-1062
2020-10-14T04:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-dxd-antibody-drug-conjugate-ds-1062a,Synonym:,ADC DS-1062a
2020-10-14T04:00:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-rg7212,Code name:,RO5458640
2020-09-18T03:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-ro5458640,Code name:,RO5458640
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Code name:,BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,anti-VEGF/ANG2 BI 836880
2020-09-18T03:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880,Synonym:,bi-specific anti-VEGF/Ang2 nanobody BI 836880
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Code name:,PRS-050-PEG40
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,Synonym:,pegylated anti-VEGF anticalin PRS-050-PEG40
2020-09-18T02:07:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40,US brand name:,Angiocal
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Code name:,VGX-100
2020-09-18T03:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100,Synonym:,VEGF-C mAb VGX-100
2020-10-14T04:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19,Code name:,hPV 19
2020-10-14T04:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19,Code name:,hPV-19
2020-10-14T04:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19,Code name:,hPV19
2020-10-14T04:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19,Synonym:,anti-VEGF MAb hPV19
2020-10-14T04:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19,Synonym:,MAb hPV19
2020-09-18T03:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-car-retroviral-vector-transduced-autologous-t-lymphocytes,Synonym:,anti-VEGFR2 gene engineered CD8+ lymphocytes
2020-10-14T04:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-monoclonal-antibody-msb0254,Code name:,MSB 0254
2020-10-14T04:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-monoclonal-antibody-msb0254,Code name:,MSB-0254
2020-10-14T04:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-monoclonal-antibody-msb0254,Code name:,MSB0254
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Code name:,IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR-3 monoclonal antibody IMC-3C5
2020-09-18T03:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5,Synonym:,anti-VEGFR3 MoAb IMC-3C5
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ 61610588
2020-09-18T03:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588,Code name:,JNJ-61610588
2020-09-18T03:53:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-von-willebrand-factor-nanobody,Synonym:,anti-vWf nanobody
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Code name:,TL-118
2020-09-18T02:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118,Foreign brand name:,Hamsa-1
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Chemical structure:,"N-geranyl-N?-(2-adamantyl) ethane-1,2-diamine"
2020-09-18T02:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109,Code name:,SQ109
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,ABBV 011
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,ABBV-011
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,ABBV011
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,SC 011
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,SC-011
2020-10-14T03:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011,Code name:,SC011
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Code name:,ABBV-085
2020-09-18T02:11:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085,Synonym:,ADC ABBV-085
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV 176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV-176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Code name:,ABBV176
2020-09-18T02:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176,Synonym:,ADC ABBV-176
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Code name:,XMT 1536
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Code name:,XMT-1536
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Code name:,XMT1536
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Synonym:,ADC XMT-1536
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Synonym:,anti-NaPi2b ADC XMT-1536
2020-10-14T03:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536,Synonym:,anti-NaPi2b/auristatin F-HPA ADC XMT-1536
2020-09-18T08:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adct-402,Code name:,ADC ADCT-402
2020-09-18T08:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adct-402,Code name:,ADCT-402
2020-09-18T08:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adct-402,Synonym:,anti-CD19 PBD-conjugate ADCT-402
2020-09-18T08:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adct-402,Synonym:,antibody-drug conjugate ADCT-402
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Code name:,CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC anti-TIM-1-vcMMAE CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,ADC CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,antibody-drug conjugate CDX-014
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vc-MMAE
2020-09-18T02:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014,Synonym:,CR014-vcMMAE
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Code name:,BAY79-4620
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,ADC BAY79-4620
2020-09-18T02:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620,Synonym:,MN-IC
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Code name:,DFRF4539A
2020-09-18T02:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a,Synonym:,ADC DFRF4539A
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI 7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Code name:,MEDI7247
2020-09-18T02:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247,Synonym:,ADC MEDI7247
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,h6M24-vc0101
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF 06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF 7020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF-06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Code name:,PF-7020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Synonym:,ADC PF-06647020
2020-09-18T05:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020,Synonym:,ADC PF-7020
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Code name:,SC-002
2020-09-18T02:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002,Synonym:,ADC SC-002
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC 003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC-003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Code name:,SC003
2020-09-18T02:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003,Synonym:,ADC SC-003
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC 004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC-004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Code name:,SC004
2020-09-18T02:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004,Synonym:,ADC SC-004
2020-10-14T03:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-005,Code name:,ADC SC-005
2020-10-14T03:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-005,Code name:,SC 005
2020-10-14T03:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-005,Code name:,SC-005
2020-10-14T03:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-005,Code name:,SC005
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC 006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC-006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Code name:,SC006
2020-09-18T02:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006,Synonym:,ADC SC-006
2020-10-14T03:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-007,Code name:,ADC SC-007
2020-10-14T03:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-007,Code name:,SC-007
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG-101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,APG101
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN-008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Code name:,CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,CD95-Fc fusion protein CAN008
2020-09-18T02:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008,Synonym:,Fas-Fc fusion protein CAN008
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Code name:,MT-102
2020-09-18T02:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102,Synonym:,anti-catabolic/anabolic transforming agent MT-102
2020-09-18T02:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-f901318,Code name:,F901318
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,ASP 2397
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,ASP-2397
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,ASP2397
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,VL 2397
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,VL-2397
2020-10-14T03:46:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397,Code name:,VL2397
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Chemical structure:,"4-[4-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy}-3-methylphenyl)piperazin-1-yl]-N-(4-fluorophenyl)benzamide"
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Code name:,PC 945
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Code name:,PC-945
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Code name:,PC945
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Synonym:,inhaled antifungal PC945
2020-10-14T03:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945,Synonym:,triazole antifungal PC945
2020-10-14T03:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-presenting-cells-expressing-hpv16-e6-e7-sqz-pbmc-hpv,Code name:,SQZ PBMC HPV
2020-10-14T03:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-presenting-cells-expressing-hpv16-e6-e7-sqz-pbmc-hpv,Code name:,SQZ-PBMC-HPV
2020-10-14T03:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-presenting-cells-expressing-hpv16-e6-e7-sqz-pbmc-hpv,Synonym:,APCs expressing HPV16 E6/E7 SQZ-PBMC-HPV
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Foreign brand name:,IVAC ® Warehouse vaccine
2020-09-18T02:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine,Synonym:,IVAC_W_bre1_uID
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Abbreviation:,FVIII
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Code name:,BAY94-9027
2020-09-18T02:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant,Synonym:,Factor VIII
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502
2020-09-18T02:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502,Code name:,FF-10502-01
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Code name:,SM-88
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Synonym:,racemetyrosine/methoxsalen/phenytoin/sirolimus combination SM88
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Synonym:,SM-88 used with methoxsalen/phenytoin/sirolimus
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Synonym:,SM-88 used with MPS
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Synonym:,SM-88/methoxsalen/phenytoin/sirolimus
2020-09-18T10:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88,Synonym:,tyrosine isomers/phenytoin/methoxsalen/sirolimus
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Chemical structure:,"4(1H)-quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-"
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM 1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM-1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,CVM1118
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX 818
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX-818
2020-09-18T07:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818,Code name:,TRX818
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Abbreviation:,A10
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,Chemical structure:,"3-phenylacetylamino-2, 6-piperidinedionebenzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-"
2020-09-18T02:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10,US brand name:,Atengenal
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Abbreviation:,AS2-1
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,Chemical structure:,"L-glutamine, N2-(phenylacetyl)-, monosodium salt, mixture with sodium benzeneacetate"
2020-09-18T02:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1,US brand name:,Astugenal
2020-09-18T03:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiperspirant-cream-f511,Synonym:,F511 cream
2020-10-14T03:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisecretory-factor-enriched-egg-yolk-powder-supplement,Foreign brand name:,Salovum
2020-10-14T03:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisecretory-factor-enriched-egg-yolk-powder-supplement,Synonym:,AF-enriched egg yolk powder supplement
2020-10-14T05:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-gti-2040,NA,NA
2020-10-14T03:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-qr-313,Code name:,QR 313
2020-10-14T03:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-qr-313,Code name:,QR-313
2020-10-14T03:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-qr-313,Code name:,QR313
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Abbreviation:,ATIII
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Synonym:,antithrombin
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Synonym:,antithrombin III
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Synonym:,antithrombin-III
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Synonym:,AT-III (human)
2020-10-14T13:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii,Synonym:,human AT-III
2020-10-14T04:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antitumor-b-key-active-component-alpha,Synonym:,antitumor B KAC-a
2020-10-14T04:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antitumor-b-key-active-component-alpha,Synonym:,antitumor B KAC-α
2020-10-14T04:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antitumor-b-key-active-component-alpha,Synonym:,ATB-KAC-alpha
2020-10-14T04:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antitumor-b-key-active-component-alpha,Synonym:,Chinese herbal mixture antitumor B KAC-a
2020-09-18T03:53:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiviral-agent-csj148,Code name:,CSJ148
2020-09-18T03:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antrodia-cinnamomea-supplement,Synonym:,OB318
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,BAX 930
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,BAX-930
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,BAX930
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,SHP 655
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,SHP-655
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,SHP655
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,TAK 755
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,TAK-755
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Code name:,TAK755
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,rADAMTS13
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,recombinant a disintegrin and metalloproteinase with a thrombospondin type 1 motif member 13
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,recombinant a disintegrin and metalloproteinase with thrombospondin motifs 13
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,recombinant ADAMTS13
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,recombinant human ADAMTS-13
2020-10-14T04:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa,Synonym:,recombinant human ADAMTS13
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Abbreviation:,AR antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Chemical structure:,"4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide"
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Code name:,JNJ-56021927
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,Synonym:,androgen receptor antagonist ARN-509
2020-09-18T02:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide,US brand name:,Erleada
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Code name:,YN968D1
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Aitan
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Foreign brand name:,Rivoceranib
2020-09-18T02:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib,Synonym:,ATAN
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,ISIS 306053
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Code name:,OGX-427
2020-09-18T03:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen,Synonym:,Hsp27 antisense oligonucleotide OGX-427
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Chemical structure:,"3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol"
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,Code name:,E09
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Eoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Neoquin
2020-09-18T03:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone,US brand name:,Qapzola
2020-09-18T03:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apc8015f,NA,NA
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Chemical structure:,"[(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic Acid"
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Code name:,APX 3330
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Code name:,APX3330
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Code name:,E 3330
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Code name:,E3330
2020-10-14T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330,Synonym:,APE1/Ref-1 Inhibitor APX3330
2020-09-18T03:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apf530,NA,NA
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM 002A
2020-09-18T03:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule,Code name:,LAM-002A
2020-10-14T04:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apitolisib,Code name:,GDC-0980
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,Code name:,BMS-562247-01
2020-09-18T03:54:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban,US brand name:,Eliquis
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MOAB 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Abbreviation:,MoAb Hu1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,1D1O Anti-lymphoma Antibody
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal antibody 1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,Synonym:,Monoclonal Antibody Hu1D10
2020-09-18T03:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab,US brand name:,Remitogen
2020-09-18T03:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apomab,NA,NA
2020-09-18T03:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-bzl101,Code name:,BZL101
2020-09-18T03:54:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-gcs-100,Code name:,GCS-100
2020-09-18T03:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-mpc-2130,Code name:,MPC-2130
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,L-754030
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,MK-0869
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,Code name:,ONO-7436
2020-09-18T03:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant,US brand name:,Emend
2020-09-18T03:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apricoxib,Code name:,TG01
2020-10-14T03:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen,Code name:,CGP 64128A
2020-10-14T03:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen,Code name:,LY900003
2020-10-14T03:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-10-14T03:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen,US brand name:,Affinitac
2020-10-14T03:25:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen,US brand name:,Affinitak
2020-10-14T04:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin,US brand name:,Trasylol
2020-09-18T03:55:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin-bovine,US brand name:,Trasylol
2020-10-14T03:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab,Code name:,BAY1179470
2020-10-14T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin,Code name:,BAY 1187982
2020-10-14T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin,Code name:,BAY1187982
2020-10-14T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin,Synonym:,ADC BAY1187982
2020-10-14T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin,Synonym:,anti-FGFR2 antibody-drug conjugate BAY1187982
2020-09-18T03:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-bms-641988,Code name:,BMS-641988
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY 1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY-1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,BAY1841788
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,ODM 201
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Code name:,ODM-201
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,Synonym:,antiandrogen ODM-201
2020-09-18T05:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201,US brand name:,Nubeqa
2020-10-14T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252,Code name:,SL 279252
2020-10-14T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252,Code name:,SL-279252
2020-10-14T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252,Code name:,SL279252
2020-10-14T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252,Synonym:,agonist redirected checkpoint fusion protein SL-279252
2020-10-14T04:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252,Synonym:,PD1-Fc-OX40L ARC fusion protein
2020-10-14T03:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/archexin,Code name:,RX-0201
2020-10-14T03:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/archexin,US brand name:,Archexin
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,Synonym:,IMMU-4
2020-09-18T03:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab,US brand name:,CEA-Scan
2020-10-14T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin,Abbreviation:,6R-MTHF
2020-10-14T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin,Chemical structure:,"(6R)-5,10-methylenetetrahydrofolate[6R] 5,10-methylenetetrahydrofolate[6R]-5,10-methylene-tetrahydrofolate6R-5,10-methyleneTHF6R-methylene THFmethylenetetrahydrofolic acid, L-(+)-"
2020-10-14T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin,Synonym:,6R-5-10-methylenetetrahydrofolate
2020-10-14T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin,US brand name:,Modufolin
2020-10-14T04:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-1-peptide-vaccine,Synonym:,ARG-1 peptide vaccine
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB-1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,CB1158
2020-09-18T03:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158,Code name:,INCB001158
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Code name:,VX-105
2020-09-18T03:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate,Synonym:,"L-arginine, butanoate (3:4)"
2020-10-14T04:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-hydrochloride,US brand name:,R-Gene 10
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Immun-Aid
2020-09-18T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement,US brand name:,Impact
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,Chemical structure:,(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
2020-09-18T03:57:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil,US brand name:,Nuvigil
2020-09-18T03:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arnebia-indigo-jade-pearl-topical-cream,Acronym:,AIJP
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Abbreviation:,AS2O3
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic (III) Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenic Sesquioxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Acid Anhydride
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,Arsenous Oxide
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,Synonym:,White Arsenic
2020-09-18T03:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide,US brand name:,Trisenox
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Code name:,ORH-2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,arsenic trioxide formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,As2O3 formulation ORH 2014
2020-09-18T03:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014,Synonym:,oral arsenic trioxide formulation
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Code name:,LON002
2020-09-18T03:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray,Synonym:,sublingual artemether spray
2020-09-18T03:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artesunate,Abbreviation:,ART
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke extract
2020-09-18T03:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate,Synonym:,artichoke W.P.C.
2020-09-18T03:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artificial-saliva-spray,Foreign brand name:,Hypozalix spray
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Code name:,BAY 2416964
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Code name:,BAY-2416964
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Code name:,BAY2416964
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Synonym:,AhR antagonist BAY2416964
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Synonym:,AhR inhibitor BAY2416964
2020-10-14T04:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964,Synonym:,aryl hydrocarbon receptor inhibitor BAY2416964
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Chemical structure:,2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]benzo[b]thiophene-6-ol hydrochloride
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Code name:,LY353381.HCl
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,LY353381 Hydrochloride
2020-09-18T03:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride,Synonym:,SERM-3
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Arepanrix
2020-09-18T03:58:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine,Foreign brand name:,Pandemrix
2020-09-18T03:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asaley,Synonym:,Asalex
2020-10-14T04:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asciminib,Code name:,ABL001
2020-10-14T04:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asciminib,Synonym:,allosteric Bcr-Abl tyrosine kinase inhibitor ABL001
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Abbreviation:,VIT C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Chemical structure:,"2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one"
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Foreign brand name:,C-Long
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,C vitamin
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,L-ascorbic acid
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,Synonym:,vitamin C
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Asorbicap
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Ce-Vi-Sol
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cecon
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cenolate
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cetane
2020-09-18T03:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid,US brand name:,Cevalin
2020-10-14T03:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascrinvacumab,Code name:,PF-03446962
2020-10-14T03:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascrinvacumab,Synonym:,anti-activin receptor-like kinase 1 monoclonal antibody PF-03446962
2020-09-18T03:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ashwagandha-root-powder-extract,NA,NA
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,ginseng root
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Korean ginseng
2020-09-18T03:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng,Synonym:,Panax ginseng
2020-09-18T03:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ask1-inhibitor-gs-4997,Code name:,GS-4997
2020-09-18T03:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp4132,NA,NA
2020-09-18T03:59:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp9853,NA,NA
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Code name:,BST 236
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Code name:,BST-236
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Synonym:,Ara-C asparagine conjugate
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Synonym:,asparagine Ara-C conjugate
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Synonym:,asparagine cytarabine conjugate
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Synonym:,astarabine
2020-10-14T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine,Synonym:,cytarabine asparagine conjugate
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Abbreviation:,Lcf-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,MK-965
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Code name:,Re-82-TAD-15
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Kidrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Laspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leucogen
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Leunase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Paronal
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Foreign brand name:,Spectrila
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,ASP-1
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,asparaginase II
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,Colaspase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-ASP
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparaginase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,Synonym:,L-asparagine amidohydrolase
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,Elspar
2020-09-18T04:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase,US brand name:,L-Asnase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Foreign brand name:,Erwinase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,asparaginase-Erwinia
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,crisantaspasum
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,cristantaspase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,Erwinia L-asparginase
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspaasi
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,Synonym:,krisantaspas
2020-09-18T04:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi,US brand name:,Erwinaze
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,Abbreviation:,ASA
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,Chemical structure:,2-(acetyloxy)benzoic Acid
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,Synonym:,aspirin
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Aspergum
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Ecotrin
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Empirin
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Entericin
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Extren
2020-10-14T03:22:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin,US brand name:,Measurin
2020-10-14T03:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin-simvastatin-atenolol-ramipril-thiazide-capsule,Foreign brand name:,Quintapill
2020-10-14T03:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide capsule
2020-10-14T03:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,aspirin/simvastatin/atenolol/ramipril/thiazide tablet
2020-10-14T03:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin-simvastatin-atenolol-ramipril-thiazide-capsule,Synonym:,Polycap
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,[211At]OKT10-B10
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,211At-OKT10-B10
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,astatine 211-labeled anti-CD38 monoclonal antibody OKT10-B10
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,astatine At 211 anti-CD38 MoAb OKT10-B10
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,astatine-211-OKT10-B10
2020-10-14T04:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10,Synonym:,At211-OKT10-B10
2020-10-14T04:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astaxanthin,Chemical structure:,"(3S,3'S)-3,3'-dihydroxy-beta,beta-carotene-4,4'-dione"
2020-10-14T04:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astaxanthin,Foreign brand name:,Algalif
2020-10-14T04:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astaxanthin,Synonym:,Astaxanthine
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Abbreviation:,QSYQT
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,Astragalus membranaceus/Panax ginseng/Atractylodes chinensis Koidz/ Cimicifuga foetida/A. macrocephala Koidz/Alisma orientale Juzep/Citrus reticulata Blanco herbal supplement
2020-09-18T04:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang,Synonym:,QING SHU YI Qi Tang
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Abbreviation:,recombinant MAGE-A3 ASCI GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Code name:,GSK1203486A
2020-09-18T04:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r,Synonym:,recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Chemical structure:,"4-acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino-N,5-dimethyl"
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Code name:,CI-921
2020-09-18T04:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate,Synonym:,amsalog
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Abbreviation:,ASV
2020-09-18T04:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir,Code name:,BMS-650032
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Code name:,APG-101
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Code name:,APG101
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Code name:,CAN-008
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Code name:,CAN008
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Synonym:,CD95-Fc fusion protein CAN008
2020-10-14T03:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept,Synonym:,Fas-Fc fusion protein CAN008
2020-09-18T04:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atamestane,NA,NA
2020-09-18T04:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atenolol,NA,NA
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RG7446
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Code name:,RO5541267
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,Synonym:,anti-PD-L1 monoclonal antibody MPDL3280A
2020-09-18T04:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab,US brand name:,Tecentriq
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Chemical structure:,"N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine"
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Code name:,SK&F106615
2020-09-18T04:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod,Synonym:,azaspirane
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M 3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Code name:,M3541
2020-09-18T04:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541,Synonym:,ataxia telangiectasia mutated kinase inhibitor M 3541
2020-09-18T04:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-kinase-inhibitor-azd0156,Code name:,AZD0156
2020-09-18T04:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atn-161,NA,NA
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,Chemical structure:,(-)-N -methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride(-)-N-methyl-gamma(2-methylphenoxy)benzenepropamine Hydrochloride
2020-09-18T04:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride,US brand name:,Strattera
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Code name:,CI-981
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,Synonym:,atorvastatin calcium trihydrate
2020-09-18T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium,US brand name:,Lipitor
2020-09-18T04:02:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-101,NA,NA
2020-09-18T05:19:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-azd6738,Code name:,AZD6738
2020-09-18T05:19:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-azd6738,Synonym:,ATR kinase inhibitor AZD6738
2020-10-14T04:03:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-bay1895344,Code name:,BAY 1895344
2020-10-14T04:03:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-bay1895344,Code name:,BAY-1895344
2020-10-14T04:03:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-bay1895344,Code name:,BAY1895344
2020-10-14T04:03:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-bay1895344,Synonym:,ATR inhibitor BAY1895344
2020-10-14T04:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-m1774,Code name:,M 1774
2020-10-14T04:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-m1774,Code name:,M-1774
2020-10-14T04:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-m1774,Code name:,M1774
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M 6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,M6620
2020-09-18T04:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970,Code name:,VX-970
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Chemical structure:,"(2R,3R,4S)-4-(1,3-benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid monohydrochloride"
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,(+)-A 127722
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT 627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,Code name:,ABT-627
2020-09-18T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride,US brand name:,Xinlay
2020-09-18T04:02:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atropine-sulfate,NA,NA
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx.5T4 vaccine
2020-09-18T04:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine,Synonym:,ChAdOx1.5T4 vaccine
2020-09-18T04:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-listeria-monocytogenes-crs-100,NA,NA
2020-10-14T04:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/audencel,Code name:,AV0113
2020-10-14T04:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/audencel,Synonym:,autologous DC-based immunotherapeutic AV0113
2020-10-14T04:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/audencel,Synonym:,AV0113 DC-CIT
2020-10-14T04:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/audencel,Synonym:,AV0113 dendritic cell cancer immune therapy
2020-09-18T04:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/auranofin,US brand name:,Ridaura
2020-10-14T04:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668,Synonym:,AK 01 erbumine
2020-10-14T04:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668,Synonym:,aurora kinase A inhibitor LY3295668 erbumine
2020-10-14T04:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668,Synonym:,LY 3295668 erbumine
2020-10-14T04:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668,Synonym:,LY-3295668 erbumine
2020-10-14T04:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668,Synonym:,LY3295668 erbumine
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Code name:,TAS-119
2020-09-18T04:03:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119,Synonym:,TAS-2104
2020-09-18T04:03:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-tyrosine-kinase-inhibitor-enmd-2076,Code name:,ENMD-2076
2020-09-18T04:03:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-c-kinase-inhibitor-gsk1070916a,Code name:,GSK1070916A
2020-09-18T04:03:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-kinase-inhibitor-tak-901,Code name:,TAK-901
2020-10-14T04:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-serine-threonine-kinase-inhibitor-tak-901,Code name:,TAK-901
2020-10-14T04:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420,Code name:,TT-00420
2020-10-14T04:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420,Code name:,TT00420
2020-10-14T04:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420,Synonym:,AK A/B inhibitor TT-00420
2020-10-14T04:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420,Synonym:,multi-kinase inhibitor TT-00420
2020-10-14T04:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420,Synonym:,TT 00420
2020-09-18T04:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-amg-900,NA,NA
2020-09-18T04:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-bi-811283,Code name:,BI 811283
2020-09-18T04:03:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-mln8054,Code name:,MLN8054
2020-09-18T04:04:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-pf-03814735,Code name:,PF-03814735
2020-09-18T04:04:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-sns-314,Code name:,SNS-314
2020-09-18T04:04:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-ttp607,Code name:,TTP607
2020-09-18T04:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-vegfr2-inhibitor-cyc116,Code name:,CYC116
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Code name:,ACTR707
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 cells
2020-09-18T04:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707,Synonym:,ACTR707 T cells
2020-09-18T04:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ad-cd154-transduced-cll-b-cells,Synonym:,autologous Ad-ISF35-transduced CLL B cells
2020-10-14T04:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-afp-specific-t-cell-receptor-transduced-t-cells-c-tcr055,Code name:,C-TCR 055
2020-10-14T04:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-afp-specific-t-cell-receptor-transduced-t-cells-c-tcr055,Code name:,C-TCR-055
2020-10-14T04:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-afp-specific-t-cell-receptor-transduced-t-cells-c-tcr055,Code name:,C-TCR055
2020-10-14T04:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-afp-specific-t-cell-receptor-transduced-t-cells-c-tcr055,Synonym:,autologous AFP-specific TCR-transduced T cells C-TCR055
2020-10-14T04:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-aml-dendritic-cell-fusion-vaccine,Synonym:,autologous AML/DC fusion vaccine
2020-10-14T04:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-aml-dendritic-cell-fusion-vaccine,Synonym:,autologous DC/AML fusion vaccine
2020-10-14T04:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-aml-dendritic-cell-fusion-vaccine,Synonym:,autologous dendritic cell/AML fusion vaccine
2020-10-14T04:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-aml-dendritic-cell-fusion-vaccine,Synonym:,DC/AML fusion cell vaccine
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Code name:,CT 053
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Code name:,CT-053
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Code name:,CT053
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Synonym:,anti-BCMA-CAR-41BB-CD3zeta-expressing T cells CT053
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Synonym:,BCMA Car-T (CT053)
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Synonym:,CAR-BCMA T cells CT053
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Synonym:,CT053 CAR-BCMA T
2020-10-14T04:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053,Synonym:,CT053 CAR-BCMA T cells
2020-10-14T04:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-cd4-cd8-t-lymphocytes-fcarh143,Code name:,FCARH143
2020-10-14T04:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-cd4-cd8-t-lymphocytes-fcarh143,Synonym:,autologous anti-BCMA-CAR CD4+/CD8+ cells
2020-10-14T04:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-cd4-cd8-t-lymphocytes-fcarh143,Synonym:,BCMA CAR-CD4+/CD8+ T cells
2020-10-14T04:04:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-cd4-cd8-t-lymphocytes-fcarh143,Synonym:,BCMA-specific CAR-expressing CD4+/CD8+ T lymphocytes
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Code name:,P-BCMA-101
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous anti-BCMA centyrin-based chimeric antigen receptor-expressing Tscm
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CAR-T cells
2020-09-18T04:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101,Synonym:,autologous P-BCMA-101 CARTyrin-T cells
2020-10-14T04:04:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-mrna-transfected-cd8-t-lymphocytes,Code name:,Descartes-08
2020-10-14T04:04:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-mrna-transfected-cd8-t-lymphocytes,Synonym:,anti-BCMA-CAR-mRNA-transfected autologous CD8+ T cells
2020-10-14T04:04:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-mrna-transfected-cd8-t-lymphocytes,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8-positive T cells
2020-10-14T04:04:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-mrna-transfected-cd8-t-lymphocytes,Synonym:,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T cells
2020-10-14T04:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-t-cells-im21,Synonym:,autologous BCMA-specific CAR T-cells IM21
2020-10-14T04:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-t-cells-im21,Synonym:,IM21 CAR-T cells
2020-10-14T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-tcrz-4-1bb-expressing-t-lymphocytes-cart-bcma,Abbreviation:,CART-BCMA
2020-10-14T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-tcrz-4-1bb-expressing-t-lymphocytes-cart-bcma,Synonym:,autologous BCMA 4-1BBz CAR T cells CART-BCMA
2020-10-14T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-tcrz-4-1bb-expressing-t-lymphocytes-cart-bcma,Synonym:,autologous BCMA-specific CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA
2020-10-14T04:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-tcrz-4-1bb-expressing-t-lymphocytes-cart-bcma,Synonym:,CART-BCMA cells
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Code name:,KITE 585
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Code name:,KITE-585
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Code name:,KITE585
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Synonym:,autologous genetically-modified anti-BCMA CAR-T cells KITE-585
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Synonym:,autologous genetically-modified anti-BCMA CAR-transduced T Cells KITE-585
2020-10-14T04:05:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585,Synonym:,autologous T Cells KITE-585
2020-10-14T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11,Code name:,Descartes 11
2020-10-14T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11,Code name:,Descartes-011
2020-10-14T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11,Code name:,Descartes-11
2020-10-14T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11,Code name:,Descartes11
2020-10-14T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11,Synonym:,autologous CD8+ T cells expressing anti-BCMA CAR Descartes-11
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,autologous RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA Anti-CD123 CAR T Cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,RNA CART123 cells
2020-09-18T04:05:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes,Synonym:,snti-CD123 CAR mRNA-electroporated autologous T lymphocytes
2020-10-14T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells,Synonym:,autologous CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-10-14T04:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells,Synonym:,autologous CD3zeta-4-1BB-expressing CART-19 cells
2020-10-14T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells-pz01,Code name:,PZ01
2020-10-14T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells-pz01,Synonym:,autologous CD19-specific CAR-T cells PZ01
2020-10-14T04:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells-pz01,Synonym:,autologous PZ01 CAR-T cells
2020-09-18T04:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes,Synonym:,autologous anti-CD19-CAR T cells
2020-10-14T04:09:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901,Code name:,CLIC 1901
2020-10-14T04:09:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901,Code name:,CLIC-1901
2020-10-14T04:09:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901,Code name:,CLIC1901
2020-10-14T04:09:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901,Synonym:,autologous CLIC-1901 CAR-T cells
2020-10-14T04:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-im19,Code name:,IM19
2020-10-14T04:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-im19,Synonym:,autologous CD19-specific CAR-T cells IM19
2020-10-14T04:10:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501,Code name:,TBI-1501
2020-10-14T04:10:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501,Synonym:,anti-CD19-CAR T cells TBI-1501
2020-10-14T04:10:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501,Synonym:,autologous anti-CD19 chimeric antigen receptor T cells TBI-1501
2020-10-14T04:10:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501,Synonym:,CAR19 T lymphocytes TBI-1501
2020-10-14T04:10:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501,Synonym:,CD19-CAR-T TBI-1501
2020-10-14T04:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-bind19,Code name:,BinD 19
2020-10-14T04:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-bind19,Code name:,BinD19
2020-10-14T04:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-bind19,Synonym:,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T cells BinD19
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,anti-CD19 CAR-T cells huCART19
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,anti-CD19 Humanized scFv TCRz-41BB-CAR lentiviral vector-transduced autologous T lymphocytes
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells huCART19
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,CTL119
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,CTL119 cells
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,huCART19 cells
2020-10-14T04:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19,Synonym:,huCART19 T lymphocytes
2020-10-14T04:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd20-bispecific-nanobody-based-car-t-cells,Synonym:,autologous anti-CD19/20 bispecific CAR-T cells
2020-10-14T04:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd20-bispecific-nanobody-based-car-t-cells,Synonym:,autologous anti-CD19/CD20 bispecific nanobody-derived CAR-T cells
2020-10-14T04:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd20-bispecific-nanobody-based-car-t-cells,Synonym:,autologous CD19/CD20 bispecific CAR T cells
2020-10-14T04:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd22-car-t-cells-auto3,Code name:,AUTO 3
2020-10-14T04:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd22-car-t-cells-auto3,Code name:,AUTO-3
2020-10-14T04:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd22-car-t-cells-auto3,Code name:,AUTO3
2020-10-14T04:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd22-car-t-cells-auto3,Synonym:,anti-CD19/CD22 CAR autologous T lymphocytes AUTO3
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Code name:,AUTO 1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Code name:,AUTO-1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,AUTO1 CAR-T Cells
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,Autologous Anti-CD19 CAR T-cells AUTO1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,Autologous Anti-CD19 Chimeric Antigen Receptor T-lymphocytes AUTO1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,Autologous CD19-targeted CAR T-cells AUTO1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,CD19CAR T-cells AUTO1
2020-10-14T04:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1,Synonym:,CD19CAT-41BBZ CAR T-cells AUTO1
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Code name:,C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CAR-T cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous anti-CD19 CART cells C-CAR011
2020-09-18T04:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011,Synonym:,autologous CD19-specific CAR-T cells C-CAR011
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Code name:,SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CAR-T cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous anti-CD19 CART cells SJCAR19
2020-09-18T04:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19,Synonym:,autologous CD19-specific CAR-T cells SJCAR19
2020-10-14T04:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1,Code name:,ET 190
2020-10-14T04:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1,Code name:,ET190
2020-10-14T04:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1,Code name:,ET190L1
2020-10-14T04:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1,Synonym:,ET190L1-ARTEMIS (TM)
2020-10-14T04:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1,Synonym:,ET190L1-ARTEMIS (TM) T Cells
2020-10-14T04:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-tac-t-cells-tac01-cd19,Code name:,TAC01 CD19
2020-10-14T04:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-tac-t-cells-tac01-cd19,Code name:,TAC01CD19
2020-10-14T04:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-tac-t-cells-tac01-cd19,Synonym:,CD19-targeted T cell antigen coupler TAC01-CD19
2020-10-14T04:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-tac-t-cells-tac01-cd19,Synonym:,TAC01-CD19
2020-09-18T04:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-4-1bb-cd3zeta-egfrt-expressing-t-lymphocytes,NA,NA
2020-10-14T04:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-her2t-cd22car-egfrt-expressing-t-cells,Synonym:,anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-10-14T04:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-her2t-cd22car-egfrt-expressing-t-cells,Synonym:,autologous CD19/CD22CAR-HER2t-EGFRt-expressing T lymphocytes
2020-10-14T04:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-her2t-cd22car-egfrt-expressing-t-cells,Synonym:,bispecific anti-CD19/CD22CAR-HER2t-EGFRt-expressing autologous T cells
2020-10-14T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd20-car-transduced-cd4-cd8-enriched-t-cells-mb-cart201,Synonym:,anti-CD20 CAR T cells MB-CART20.1
2020-10-14T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd20-car-transduced-cd4-cd8-enriched-t-cells-mb-cart201,Synonym:,autologous CD20-targeted CAR-transduced CD4/CD8-enriched T cells MB-CART20.1
2020-10-14T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd20-car-transduced-cd4-cd8-enriched-t-cells-mb-cart201,Synonym:,CD20-targeting CAR T cells MB-CART20.1
2020-10-14T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd20-car-transduced-cd4-cd8-enriched-t-cells-mb-cart201,Synonym:,MB-CART20.1
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Code name:,CART22-65s
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Synonym:,autologous anti-CD22 CAR T cells CART22-65s
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Synonym:,autologous anti-CD22 scFv CAR 4-1BB-TCRz-expressing T lymphocytes CART22-65s
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Synonym:,autologous CART22-65s cells
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Synonym:,autologous CART22-65s T cells
2020-10-14T04:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s,Synonym:,autologous CART22-65s-expressing T cells
2020-10-14T04:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd38-a2-car2-expressing-t-cells,Synonym:,autologous anti-CD38 A2 CAR2 T cells
2020-10-14T04:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd38-a2-car2-expressing-t-cells,Synonym:,autologous CAR2 anti-CD38 A2 CAR T cells
2020-10-14T04:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd38-a2-car2-expressing-t-cells,Synonym:,autologous CAR2 anti-CD38 A2 T lymphocytes
2020-10-14T04:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd38-a2-car2-expressing-t-cells,Synonym:,autologous CD38-A2 CAR2-expressing T lymphocytes
2020-10-14T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd7-car-28zeta-crispr-edited-t-lymphocytes,Synonym:,autologous CRISPR-edited CD7-targeting CAR-CD28zeta T cells
2020-10-14T04:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd7-car-28zeta-crispr-edited-t-lymphocytes,Synonym:,CD7.CAR/28zeta CAR CRISPR-edited T cells
2020-10-14T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041,Code name:,CT041
2020-10-14T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041,Synonym:,autologous anti-Claudin18.2 CAR-T cells
2020-10-14T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041,Synonym:,autologous CAR-CLD18 T cells
2020-10-14T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041,Synonym:,autologous CAR-CLD18.2 T cells
2020-10-14T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041,Synonym:,Claudin18.2-redirected autologous T cells
2020-10-14T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfr-car-transduced-cxcr-5-modified-t-lymphocytes,Synonym:,autologous anti-EGFR CAR-transduced CXCR 5-modified T cells
2020-10-14T04:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfr-car-transduced-cxcr-5-modified-t-lymphocytes,Synonym:,autologous CXCR5-modified anti-EGFR CAR-T cells
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,anti-PD-1/PD-L1-antibodies-expressing
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,autologous anti-PD-1/anti-PD-L1 antibodies-expressing anti-EGFRvIII CAR T cells
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,autologous EGFRvIII-4SCAR-IgT
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,autologous GBM-specific CAR-T cells
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,EGFRvIII-4SCAR-IgT cells-producing PD1 and PD-L1 antibodies
2020-10-14T04:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells,Synonym:,PD-1/PD-L1 antibody-producing T cells (IgT)
2020-10-14T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553,Code name:,AMG 553
2020-10-14T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553,Code name:,AMG-553
2020-10-14T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553,Code name:,AMG553
2020-10-14T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553,Synonym:,autologous anti-FLT3 CAR T lymphocytes AMG 553
2020-10-14T04:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553,Synonym:,autologous FLT3 CAR-T cells AMG 553
2020-10-14T04:11:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-gd2car-cd28-cd3zeta-il-15-expressing-natural-killer-t-cells,Synonym:,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing NKTs
2020-10-14T04:11:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-gd2car-cd28-cd3zeta-il-15-expressing-natural-killer-t-cells,Synonym:,G28z.15 NKTs
2020-10-14T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a02-afp-tcrm-expressing-t-cells-et140202,Code name:,ET 140202
2020-10-14T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a02-afp-tcrm-expressing-t-cells-et140202,Code name:,ET-140202
2020-10-14T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a02-afp-tcrm-expressing-t-cells-et140202,Code name:,ET140202
2020-10-14T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a02-afp-tcrm-expressing-t-cells-et140202,Synonym:,ET140202 autologous T cells
2020-10-14T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1,Synonym:,autologous AFP-CAR-T cells
2020-10-14T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1,Synonym:,autologous AFP-CAR-transduced T cells ET1402L1
2020-10-14T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1,Synonym:,autologous ET1402L1-CAR-T cells
2020-10-14T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1,Synonym:,autologous T cells transduced with ET1402L1-CAR
2020-10-14T04:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1,Synonym:,ET1402L1-CAR-T cells
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Code name:,AIC 100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Code name:,AIC-100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Code name:,AIC100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Synonym:,autologous ICAM-1-targeted CAR T cells AIC100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Synonym:,autologous ICAM-1-targeted CAR-T cells AIC100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Synonym:,autologous ICAM-1-targeted CAR-T lymphocytes AIC100
2020-10-14T04:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100,Synonym:,CAR-T cells AIC100
2020-10-14T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mesothelin-car-cd3zeta-4-1-bb-expressing-t-cells,Synonym:,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T lymphocytes
2020-10-14T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mesothelin-car-cd3zeta-4-1-bb-expressing-t-cells,Synonym:,Hu-CART-meso cells
2020-10-14T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mesothelin-car-cd3zeta-4-1-bb-expressing-t-cells,Synonym:,mesothelin-specific CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7 CAR-T cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous anti-MG7-CAR T-lymphocytes
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,autologous MG7-CART cells
2020-09-18T04:09:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes,Synonym:,MG7-targeted chimeric antigen receptor T cells
2020-10-14T04:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-car-4-1bb-cd3zeta-expressing-t-lymphocytes,Synonym:,anti-MUC1*-CAR-4-1BB-CD3zeta-expressing autologous T lymphocytes
2020-10-14T04:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-car-4-1bb-cd3zeta-expressing-t-lymphocytes,Synonym:,autologous HuMNC2-CAR44
2020-10-14T04:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-car-4-1bb-cd3zeta-expressing-t-lymphocytes,Synonym:,autologous huMNC2-CAR44 CAR T cells
2020-10-14T04:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-car-4-1bb-cd3zeta-expressing-t-lymphocytes,Synonym:,autologous huMNC2-CAR44 T lymphocytes
2020-10-14T04:12:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-cd33-cd38-cd56-cd123-gene-engineered-car-t-cells,Synonym:,autologous Muc1/CD33/CD38/CD56/CD123-specific gene-engineered CAR-T cells
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,autologous NY-ESOc259T GSK3377794
2020-09-18T04:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes,Synonym:,genetically engineered NY-ESO-1/LAGE-1 specific (c259) T cells GSK3377794
2020-10-14T04:12:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-mtcr-retroviral-vector-transduced-pbls,Synonym:,anti-NY-ESO-1 mTCR retroviral vector-transduced autologous peripheral blood lymphocytes
2020-10-14T04:12:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-mtcr-retroviral-vector-transduced-pbls,Synonym:,autologous anti-NY-ESO-1 Murine TCR retroviral vector-transduced peripheral blood lymphocytes
2020-10-14T04:12:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-mtcr-retroviral-vector-transduced-pbls,Synonym:,NY-ESO-1-specific mTCR retroviral vector-transduced autologous PBLs
2020-10-14T04:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-pd-1-antibody-activated-tumor-infiltrating-lymphocytes,Synonym:,anti-PD1 antibody-activated autologous TILs
2020-10-14T04:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-pd-1-antibody-activated-tumor-infiltrating-lymphocytes,Synonym:,autologous anti-PD-1 antibody-activated TILs
2020-10-14T04:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-t-lymphocytes,Synonym:,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T cells
2020-10-14T04:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-t-lymphocytes,Synonym:,autologous anti-PSCA(dCH2)BBz-CAR T cells
2020-10-14T04:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-t-lymphocytes,Synonym:,PSCA(dCH2)BBzeta-CAR T cells
2020-09-18T04:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-cells,Synonym:,autologous anti-prostate-specific membrane antigen gene-modified T-cells
2020-10-14T04:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-lymphocytes,Synonym:,autologous anti-prostate-specific membrane antigen gene-modified T-cells
2020-10-14T04:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-slamf7-car-expressing-t-cells,Synonym:,anti-CS1 CAR-expressing T cells
2020-10-14T04:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-slamf7-car-expressing-t-cells,Synonym:,anti-SLAMF7 CAR-expressing T lymphocytes
2020-10-14T04:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-slamf7-car-expressing-t-cells,Synonym:,autologous anti-SLAMF7 CAR T cells
2020-10-14T04:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38,Code name:,CCT301 38
2020-10-14T04:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38,Code name:,CCT301-38
2020-10-14T04:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38,Synonym:,autologous anti-AXL CAR-T Cells CCT30138
2020-10-14T04:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38,Synonym:,autologous CAR-T cells targeting AXL CCT301-38
2020-10-14T04:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38,Synonym:,CCT30138 CAR-T cells
2020-10-14T04:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-b-cell-monocyte-presenting-her2-neu-antigen-vaccine-bvac-b,Code name:,BVAC B
2020-10-14T04:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-b-cell-monocyte-presenting-her2-neu-antigen-vaccine-bvac-b,Code name:,BVAC-B
2020-10-14T04:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-b-cell-monocyte-presenting-her2-neu-antigen-vaccine-bvac-b,Code name:,BVACB
2020-10-14T04:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-b-cell-monocyte-presenting-her2-neu-antigen-vaccine-bvac-b,Synonym:,HER2/neu-specific autologous B-cell/monocyte vaccine BVAC-B
2020-10-14T04:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-4-1bbz-targeted-car-t-cells,Synonym:,autologous anti-BCMA CAR4-1BBz T cells
2020-10-14T04:12:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-4-1bbz-targeted-car-t-cells,Synonym:,autologous anti-BCMA:TCRz-4-1-BB CAR-T cells
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Code name:,AUTO 2
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Code name:,AUTO2
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Code name:,SUB-96123
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Synonym:,APRIL CAR T cells (AUTO2) targeting BCMA and TACI
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Synonym:,APRIL CAR T cells targeting BCMA and TACI
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Synonym:,autologous APRIL CAR T cells
2020-10-14T04:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2,Synonym:,autologous CAR T product AUTO2
2020-10-14T04:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-cc-98633,Code name:,CC 98633
2020-10-14T04:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-cc-98633,Code name:,CC-98633
2020-10-14T04:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-cc-98633,Code name:,CC98633
2020-10-14T04:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-cc-98633,Synonym:,autologous BCMA-targeted NEX-T CAR-T Cells CC-98633
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Code name:,LCAR-B4822M
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Code name:,LCARB4822M
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Code name:,LLCAR B4822M
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Synonym:,autologous LCAR-B4822M CAR T cells
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Synonym:,BCMA-specific CAR-expressing T lymphocytes LCAR-B4822M
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Synonym:,LCAR-B4822M CAR T lymphocytes
2020-10-14T04:13:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m,Synonym:,LCAR-B4822M-02 cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,autologous CD34+ HSCs transduced with LentiGlobin BB305
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305 lentiviral vector-transduced autologous CD34+ HSCs
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,LentiGlobin BB305-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,Synonym:,lentiviral b-A(T87Q)-globin-transduced CD34-positive cells
2020-09-18T04:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells,US brand name:,LentiGlobin BB305 Drug Product
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Code name:,GC 022
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Code name:,GC-022
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Code name:,GC022
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Code name:,GC022F
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Synonym:,bispecific CAR T cells GC022
2020-10-14T04:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022,Synonym:,dual CAR-T cells GC022
2020-09-18T04:10:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bone-marrow-derived-cd34-cxcr4-positive-stem-cells-amr-001,Code name:,AMR-001
2020-10-14T04:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-c-met-pd-l1-specific-car-t-cells,Synonym:,autologous anti-c-Met/PD-L1 CAR T cells
2020-10-14T04:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-c-met-pd-l1-specific-car-t-cells,Synonym:,autologous c-Met/PD-L1-specific CAR T lymphocytes
2020-10-14T13:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3005,Code name:,PF 06952229
2020-10-14T13:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3005,Code name:,PF-06952229
2020-10-14T13:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3005,Code name:,PF06952229
2020-10-14T13:28:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3005,Synonym:,TGFbR1 inhibitor PF-06952229
2020-10-14T04:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3006,Code name:,PRGN 3006
2020-10-14T04:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3006,Code name:,PRGN-3006
2020-10-14T04:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3006,Code name:,PRGN3006
2020-10-14T04:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3006,Synonym:,autologous CAR T cells PRGN-3006
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,anti-CD30-CAR/CD28z-CCR4 retroviral vector-transduced autologous T cells
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATLCAR.CD30-CD28zeta-CCR4 cells
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATLCAR.CD30.CCR4 cells
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATLs co-expressing CD30-CARCD28zeta and CCR4
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,autologous CCR4-CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,CCR4-CAR-CD30-28zeta-specific autologous T cells
2020-10-14T04:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,SFG.CCR4-CAR.CD30 autologous T lymphocytess
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Code name:,4SCAR123
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,4S-CD123-CAR-T cell
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,4SCAR123 T cells
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,anti-CD123 CAR-T cells 4SCAR123
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,anti-CD123-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR123
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,CD123-4SCAR-expressing T lymphocytes
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,CD123-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-10-14T04:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123,Synonym:,CD123-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,anti-CD123-CAR/CD28-costimulatory retroviral vector-transduced autologous T lymphocytes
2020-09-18T04:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes,Synonym:,CD123R(EQ)28zeta/EGFRt+ T cells
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Code name:,MB 102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Code name:,MB-102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Code name:,MB102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Synonym:,anti CD123-CAR/CD28-CD3zeta-EGFRt-expressing autologous T lymphocytes MB-102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Synonym:,autologous CD123CAR-CD28-CD3zeta/EGFRt+ T cells MB-102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Synonym:,CD123-CD28-CD3zeta.EGFRt+ autologous T cells MB-102
2020-10-14T04:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102,Synonym:,CD123CAR-CD28-CD3zeta-EGFRt lentiviral-transduced autologous T lymphocytes MB-102
2020-10-14T04:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd138-specific-car-t-cells,Synonym:,autologous CD138-specific CAR T lymphocytes
2020-10-14T04:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd138-specific-car-t-cells,Synonym:,autologous syndecan-1-sepcific CAR T cells
2020-10-14T04:13:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd138-specific-car-t-cells,Synonym:,autologous syndecan-1-specific CAR T lymphocytes
2020-09-18T04:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-28z-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,CAR 19-28z T cells
2020-10-14T04:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-car-expressing-cd4-cd8-t-cells-mb-cart191,Code name:,MB CART19.1
2020-10-14T04:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-car-expressing-cd4-cd8-t-cells-mb-cart191,Code name:,MB-CART19.1
2020-10-14T04:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-car-expressing-cd4-cd8-t-cells-mb-cart191,Code name:,MBCART19.1
2020-10-14T04:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-car-expressing-cd4-cd8-t-cells-mb-cart191,Synonym:,autologous CD19 CAR-transduced CD4/CD8 enriched T cells MB-CART19.1
2020-09-18T04:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd22-chimeric-antigen-receptor-t-cells,Synonym:,autologous CD19/CD22 CAR T cells
2020-10-14T04:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd8-cd28-cd3zeta-car-mbil15-her1t-t-cells,Synonym:,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-EGFRt T cells
2020-10-14T04:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd8-cd28-cd3zeta-car-mbil15-her1t-t-cells,Synonym:,CD19-CD8CD28zCAR-specific-mbIL15-HER1t T lymphocytes
2020-10-14T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-pd-1-bispecific-car-t-cells,Synonym:,autologous Anti-CD19/PD-1 bispecific CAR-T cells
2020-10-14T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-pd-1-bispecific-car-t-cells,Synonym:,CD19/PD-1 bispecific CAR T cells
2020-10-14T04:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-pd-1-bispecific-car-t-cells,Synonym:,MC-19PD1 CAR-T cells
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Code name:,GC 007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Code name:,GC-007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Code name:,GC007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,autologous anti-CD19-CAR-T cells GC007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,autologous CAR-T cells GC007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,CD19 FasT CAR-T cells GC007F
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,FasT CAR-19
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,FasTCAR-19
2020-10-14T04:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f,Synonym:,GC007F CAR-T cells
2020-10-14T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-jwcar029,Code name:,JWCAR 029
2020-10-14T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-jwcar029,Code name:,JWCAR-029
2020-10-14T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-jwcar029,Code name:,JWCAR029
2020-10-14T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-jwcar029,Synonym:,autologous anti-CD19 CAR T cells JWCAR029
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Code name:,4SCAR19
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Synonym:,4S-CAR-T19
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Synonym:,4SCAR19 cells
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Synonym:,autologous anti-CD19 CAR-T cells 4SCAR19
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Synonym:,autologous CD19- scFv/CD28/CD137/CD27/CD3z-iCasp9 4SCAR-19 T cells
2020-10-14T04:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes,Synonym:,autologous CD19-scFv/CD28/CD137/CD27/CD3z-iCasp9 CAR-T cells
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19-CAR-specific/truncated EGFR lentiviral vector-transduced autologous T cells
2020-09-18T04:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells,Synonym:,CD19R:CD28:lentiviral/EGFRt+ T cells
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Code name:,4SCAR22
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,4S-CD22-CAR-T cell
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,4SCAR22 T cells
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,anti-CD22 CAR-T cells 4SCAR22
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,anti-CD22-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR22
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,CD22-4SCAR-expressing T lymphocytes
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,CD22-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-10-14T04:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22,Synonym:,CD22-specific 4th generation chimeric antigen receptor-modified T cells
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,anti-CD30-CAR/CD28z retroviral vector-transduced autologous T cells
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATL-expressing CD30-CAR-CD28zeta
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATLCAR.CD30 cells
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,ATLCAR.CD30-CD28zeta cells
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,autologous CAR-CD19-CD28-zeta-transduced T lymphocytes
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,CAR-CD30-28zeta-specific autologous T cells
2020-10-14T04:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes,Synonym:,SFG.CAR.CD30 autologous T lymphocytes
2020-09-18T04:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-hematopoietic-progenitor-cells,Synonym:,autologous CD34-positive HPCs
2020-10-14T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-peripheral-blood-stem-cells,Synonym:,autologous CD34-positive PBSCs
2020-10-14T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-peripheral-blood-stem-cells,Synonym:,autologous CD34+ PBSCs
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Code name:,4SCAR38
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,4S-CD38-CAR-T cell
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,4SCAR38 T cells
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,anti-CD38 CAR-T cells 4SCAR38
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,anti-CD38-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR38
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,CD38-4SCAR-expressing T lymphocytes
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,CD38-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-10-14T04:14:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38,Synonym:,CD38-specific 4th generation chimeric antigen receptor-modified T cells
2020-10-14T04:14:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd5-specific-car-28-zeta-car-t-cells,Synonym:,autologous CD5-specific CAR-28 zeta CAR T lymphocytes
2020-10-14T04:14:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd5-specific-car-28-zeta-car-t-cells,Synonym:,autologous CD5.CAR/28zeta CAR T cells
2020-09-18T04:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-melanoma-specific-t-cells,Synonym:,autologous melanoma-specific cytotoxic T lymphocytes
2020-10-14T13:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-slc45a2-specific-t-lymphocytes,Synonym:,autologous CD8+ SLC45A2-specific T lymphocytes
2020-10-14T13:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-slc45a2-specific-t-lymphocytes,Synonym:,autologous SLC45A2-specific CTLs
2020-10-14T13:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-slc45a2-specific-t-lymphocytes,Synonym:,autologous SLC45A2-specific cytotoxic T lymphocytes
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific AAV-DC-CTLs
2020-09-18T04:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes,Synonym:,CEA-specific CTLs
2020-10-14T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cervical-cancer-specific-engineered-immune-effector-cells,Synonym:,autologous CC-EIE cells
2020-10-14T04:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cervical-cancer-specific-engineered-immune-effector-cells,Synonym:,autologous CC-EIEs
2020-10-14T04:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cish-inactivated-tils,Synonym:,autologous CISH-inactivated T lymphocytes
2020-10-14T04:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cish-inactivated-tils,Synonym:,autologous CISH-inactivated TIL
2020-10-14T04:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cish-inactivated-tils,Synonym:,autologous CISH-inactivated tumor-infiltrating lymphocytes
2020-10-14T04:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cish-inactivated-tils,Synonym:,autologous CRISPR/Cas 9-CISH knockout TILs
2020-10-14T04:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells,Synonym:,autologous anti-CLL1/anti-CD33 CARs-expressing T lymphocytes
2020-10-14T04:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells,Synonym:,autologous CLL1-CD33 cCAR
2020-10-14T04:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells,Synonym:,autologous CLL1-CD33 cCAR T cells
2020-10-14T04:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells,Synonym:,autologous CLL1-CD33 cCAR T lymphocytes
2020-10-14T04:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells,Synonym:,CLL1-CD33 cCAR T cells
2020-10-14T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-clonal-neoantigen-t-cells-atl001,Code name:,ATL 001
2020-10-14T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-clonal-neoantigen-t-cells-atl001,Code name:,ATL-001
2020-10-14T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-clonal-neoantigen-t-cells-atl001,Code name:,ATL001
2020-10-14T04:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-clonal-neoantigen-t-cells-atl001,Synonym:,autologous cNeT ATL001
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous CMV pp65-LAMP mRNA-loaded DC vaccine
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous CMV-pp65-flLamp DCs
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous flLAMP-pp65 mRNA-pulsed DC vaccine
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous flLAMP-pp65-DC vaccine
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous flLAMP-pp65-DCs
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous pp65-flLAMP DC vaccine
2020-10-14T04:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous pp65-flLAMP DCs
2020-10-14T04:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous pp65-shLAMP-1 DC vaccine
2020-10-14T04:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous shLAMP-1-pp65 mRNA-pulsed DC vaccine
2020-10-14T04:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous shLAMP-1-pp65-DC vaccine
2020-10-14T04:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine,Synonym:,autologous shLAMP-1-pp65-DCs
2020-10-14T04:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine,Synonym:,pp65-shLAMP-1 mRNA DCs
2020-09-18T04:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colon-cancer-cell-vaccine,Synonym:,OncoVAX
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,APDC vaccine
2020-09-18T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous colorectal tumor antigen-pulsed DC vaccine
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-reactive cultured CTLs
2020-09-18T04:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes,Synonym:,autologous AML-specific CTL
2020-09-18T04:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytokine-induced-killer-cells,Foreign brand name:,Immuncell-LC
2020-10-14T04:15:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytoplasmic-activated-pd-1-car-t-cells,Synonym:,autologous CAR19 T cells carrying cytoplasmic activated PD-1
2020-10-14T04:15:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-deep-il-15-primed-t-cells-trq15-01,Code name:,TRQ15-01
2020-10-14T04:15:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-deep-il-15-primed-t-cells-trq15-01,Synonym:,IL-15 loaded autologous T lymphocytes TRQ15-01
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,Ad-CCL21-DC
2020-09-18T04:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine,Abbreviation:,DC-AdCCL21
2020-09-18T04:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-p53-vaccine,NA,NA
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Code name:,IDD-3
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,Synonym:,Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine
2020-09-18T04:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine,US brand name:,Uvidem
2020-09-18T04:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-autologous-tumor-mrna-human-cd40l-vaccine,Synonym:,Autologous Dendritic Cell and Tumor mRNA Human CD40L Vaccine
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Code name:,AV0113
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,autologous DC-based immunotherapeutic AV0113
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 DC-CIT
2020-09-18T04:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113,Synonym:,AV0113 dendritic cell cancer immune therapy
2020-09-18T04:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-tumor-fusion-vaccine,NA,NA
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Code name:,ACT2001
2020-09-18T04:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001,Synonym:,autologous DC vaccine ACT2001
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed DC vaccine
2020-09-18T04:15:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide,Synonym:,autologous MART-1 (26-35) peptide pulsed dendritic cell vaccine
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,Synonym:,autologous DNP-modified ovarian cancer vaccine
2020-09-18T04:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine,US brand name:,OVax
2020-10-14T04:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-e6-t-cell-receptor-genetically-modified-t-cells,Synonym:,autologous anti-HPV-16 E6 TCR T cells
2020-10-14T04:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-e6-t-cell-receptor-genetically-modified-t-cells,Synonym:,autologous E6 TCR T cells
2020-10-14T04:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-e6-t-cell-receptor-genetically-modified-t-cells,Synonym:,autologous HPV-16 E6 TCR T cells
2020-09-18T04:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-ctl-cd19car-zeta,NA,NA
2020-09-18T04:16:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine,NA,NA
2020-10-14T04:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfr-specific-car-t-cells-expressing-anti-pd-1-ctla-4-antibodies,Synonym:,autologous anti-CTLA-4/PD-1-expressing EGFR-CAR-T cells
2020-10-14T04:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfr-specific-car-t-cells-expressing-anti-pd-1-ctla-4-antibodies,Synonym:,autologous anti-PD-1/CTLA4-targeting antibodies-expressing EGFR-specific CAR-T cells
2020-10-14T04:15:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfr-specific-car-t-cells-expressing-anti-pd-1-ctla-4-antibodies,Synonym:,autologous CTLA-4 and PD-1 antibodies expressing EGFR-CAR-T cells
2020-10-14T04:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfrt-bcma-41bbz-targeted-car-t-cells,Synonym:,autologous EGFRt/BCMA-41BBz CAR T cells
2020-10-14T04:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfrt-bcma-41bbz-targeted-car-t-cells,Synonym:,B-cell maturation antigen-targeted EGFRt/BCMA-41BBz CAR-modified T cells
2020-10-14T04:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfrt-bcma-41bbz-targeted-car-t-cells,Synonym:,EGFRt/BCMA-41BBz CAR T cell
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,EBV-specific cytotoxic T lymphocytes
2020-09-18T04:16:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes,Synonym:,Epstein-Barr virus-specific cytotoxic T lymphocytes
2020-09-18T04:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine,Synonym:,autologous EBV-transformed B-lymphoblastoid cell vaccine
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,Code name:,OTI-010
2020-09-18T04:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010,US brand name:,Stromagen
2020-10-14T12:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-follicular-lymphoma-derived-idiotype-vaccine,NA,NA
2020-10-14T04:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra,Abbreviation:,4SCAR-FRa
2020-10-14T04:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra,Synonym:,autologous 4S-FRa-CAR-T cells
2020-10-14T04:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra,Synonym:,autologous anti-FRa-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-FRa
2020-10-14T04:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra,Synonym:,chimeric antigen receptor T cells 4SCAR-FRa
2020-10-14T04:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra,Synonym:,FRa-specific 4th generation CART cells
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,ADP-A2M4CD8
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,autologous genetically-modified MAGE-A4 C1032 CD8alpha T lymphocytes
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,autologous genetically-modified melanoma antigen A4 CD8alpha T cells
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,autologous MAGE-A4 C1032 TCR-modified CD8alpha T cells
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,autologous TCR-transduced MAGE-A4 C1032 CD8alpha T cells
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,MAGE-A4 SPEAR CD8alpha T cells
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 CD8alpha T lymphocytes
2020-10-14T04:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells,Synonym:,SPEAR T-cell ADP-A2M4CD8
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Code name:,ADP-A2M4
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified MAGE-A4 C1032 T lymphocytes
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous genetically-modified melanoma antigen A4 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous MAGE-A4 C1032 TCR-modified T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,autologous TCR-transduced MAGE-A4 C1032 T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 SPEAR T cells
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4 TCR
2020-09-18T04:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells,Synonym:,MAGE-A4-specific TCR gene-transduced C1032 T lymphocytes
2020-09-18T04:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-glioma-cell-lysate,NA,NA
2020-09-18T04:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-breast-cancer-vaccine,NA,NA
2020-10-14T04:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine,Code name:,CG8123
2020-10-14T04:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine,Code name:,CG8123V
2020-10-14T04:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine,Synonym:,autologous GVAX lung cancer vaccine
2020-10-14T04:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine,Synonym:,GVAX autologous lung cancer vaccine
2020-10-14T05:16:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-pancreatic-cancer-vaccine,Synonym:,GM-CSF gene transduced autologous pancreatic cancer vaccine
2020-10-14T04:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gpc3-ny-eso-1-afp-specific-cd8-positive-t-lymphocytes,Synonym:,autologous HCC antigens-specific CD8-positive T lymphocytes
2020-10-14T04:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gpc3-ny-eso-1-afp-specific-cd8-positive-t-lymphocytes,Synonym:,autologous HCC antigens-specific CD8+ T lymphocytes
2020-10-14T04:16:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gpc3-ny-eso-1-afp-specific-cd8-positive-t-lymphocytes,Synonym:,autologous specific HCC antigens CD8+ T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV antigen-specific TCR-redirected T cells
2020-09-18T04:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes,Synonym:,autologous HBV/TCR-T cells
2020-09-18T04:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-heat-shock-protein-70-peptide-vaccine-ag-858,Code name:,AG-858
2020-10-14T04:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes,Abbreviation:,HER2.CAR AdVST
2020-10-14T04:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,HER2-AdVST
2020-10-14T04:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,HER2-CAR-modified Ad-specific CTLs
2020-10-14T04:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,HER2-CAR-modified adenovirus-specific CTLs
2020-10-14T04:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes,Synonym:,HER2-CAR-modified autologous AdVSTs
2020-10-14T04:16:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-specific-egfrt-expressing-cd4-cd8-positive-car-t-cells,Synonym:,autologous HER2 CAR/EGFRt-expressing CD4+ and CD8+ T cells
2020-09-18T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hnscc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,NA,NA
2020-09-18T04:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-16-18-e6-e7-specific-tgf-beta-resistant-t-lymphocytes,Synonym:,HPVST cells
2020-10-14T04:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-specific-cytotoxic-t-lymphocytes,Abbreviation:,autologous HPV-CTLs
2020-10-14T04:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-specific-cytotoxic-t-lymphocytes,Synonym:,autologous HPV-specific immune lymphocytes
2020-10-14T04:16:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-deltangfr-cd19car-cd3zeta-4-1bb-expressing-t-lymphocytes,Synonym:,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T cells
2020-10-14T04:16:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-deltangfr-cd19car-cd3zeta-4-1bb-expressing-t-lymphocytes,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T cells
2020-10-14T04:16:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-deltangfr-cd19car-cd3zeta-4-1bb-expressing-t-lymphocytes,Synonym:,iCasp9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
2020-09-18T04:18:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2-car-expressing-vzv-specific-t-lymphocytes,Synonym:,autologous iC9-GD2-CAR-VZV-CTLs
2020-10-14T04:16:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2car-cd28-cd3zeta-il-15-expressing-t-lymphocytes,Synonym:,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T cells
2020-10-14T04:16:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2car-cd28-cd3zeta-il-15-expressing-t-lymphocytes,Synonym:,iC9.GD2.CAR.IL-15 T-cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous iC9.2A.deltaNGFR.2A.CAR.CD19 T cells
2020-09-18T04:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes,Synonym:,autologous inducible caspase 9-CD19-expressing autologous T lymphocytes
2020-10-14T04:17:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-deltangfr-cd19car-expressing-t-cells,Synonym:,autologous iC9.2A.deltaNGFR.2A.CAR.CD19 T cells
2020-10-14T04:17:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-deltangfr-cd19car-expressing-t-cells,Synonym:,autologous inducible caspase 9-CD19-expressing autologous T lymphocytes
2020-09-18T04:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-il-21-modulated-cd8-mart1-specific-t-cells,NA,NA
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Abbreviation:,Id-KLH
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,autologous immunoglobulin idiotype-keyhole limpet hemocyanin conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,GTOP-99
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,Id-KLH conjugate vaccine
2020-09-18T04:19:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine,Synonym:,recombinant Id-KLH
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Abbreviation:,autologous IKDC
2020-09-18T04:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells,Synonym:,autologous IKDC-like cells
2020-09-18T04:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lmp1--lmp2--specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Foreign brand name:,ALECSAT
2020-09-18T04:19:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells,Synonym:,autologous activated cytotoxic T lymphocytes/natural killer cells
2020-09-18T04:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-cell-lysate-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:19:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-immunoglobulin-derived-scfv-chemokine-dna-vaccine,NA,NA
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE 718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Code name:,KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,autologous anti-MAGE-A3/A6 TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 T cell receptor engineered T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGE-A3/A6 TCR engineered T lymphocytes
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,MAGEA3/A6-targeted TCR-transduced T cells KITE-718
2020-09-18T04:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718,Synonym:,TCR-transduced autologous T cells KITE-718
2020-10-14T04:17:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mdc3-8-kras-vaccine,Synonym:,autologous -peptide-pulsed mDC3/8 KRAS vaccine
2020-10-14T04:17:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mdc3-vaccine,NA,NA
2020-09-18T04:20:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-klh-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T04:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-pulsed-autologous-dendritic-cell-vaccine,Synonym:,TLPLDC vaccine
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,Agenmestencel-T
2020-09-18T04:20:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101,Synonym:,autologous MSC_apceth_101
2020-10-14T04:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-car-t-cells,Synonym:,autologous CART-meso
2020-10-14T04:17:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-car-t-cells,Synonym:,Hu-CART meso cells
2020-10-14T04:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-human-mrna-car-transfected-pbmcs-mcy-m11,Code name:,MCY-M11
2020-10-14T04:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-human-mrna-car-transfected-pbmcs-mcy-m11,Synonym:,anti-mesothelin mRNA-transfected autologous PBMCs MCY-M11
2020-10-14T04:17:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-monocyte-derived-lysate-pulsed-dendritic-cell-vaccine-pv-001-dc,Code name:,PV-001-DC
2020-10-14T04:17:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-monocyte-derived-lysate-pulsed-dendritic-cell-vaccine-pv-001-dc,Synonym:,autologous monocyte-derived lysate pulsed DCs PV-001-DC
2020-10-14T04:17:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-monocyte-derived-lysate-pulsed-dendritic-cell-vaccine-pv-001-dc,Synonym:,PV-001-dendritic cell
2020-10-14T04:17:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mrna-modified-anti-cmet-car-t-cells,Synonym:,autologous cMET redirected CAR-T cells
2020-10-14T04:17:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mrna-modified-anti-cmet-car-t-cells,Synonym:,autologous mRNA CART-cMET
2020-10-14T04:17:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mrna-modified-anti-cmet-car-t-cells,Synonym:,cMET CAR-mRNA-electroporated autologous T lymphocytes
2020-09-18T04:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-muc1-mannan-fusion-protein-pulsed-dendritic-cell-vaccine,Foreign brand name:,CVac
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,autologous aDC1-induced CTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,autologous CTLs sensitized ex-vivo with autologous TAA-loaded alphaDC1
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,autologous natural killer-like cytotoxic lymphocytes
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,autologous nCTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,autologous NK-like CTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,in vitro DC-sensitized CTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,in-vitro DC-sensitized autologous CTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,therapeutic nCTLs
2020-10-14T04:17:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls,Synonym:,tumor neo-antigen-specific nCTLs
2020-10-14T04:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nectin-4-fap-targeted-car-t-cells,Synonym:,autologous anti-nectin-4/anti-FAP CAR-T cells
2020-10-14T04:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nectin-4-fap-targeted-car-t-cells,Synonym:,autologous anti-nectin4/FAP CAR-T cells
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,autologous neuroblastoma lysate/KLH-pulsed DC vaccine
2020-09-18T04:21:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine,Synonym:,keyhole limpet hemocyanin-pulsed dendritic cell vaccine
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,CM CS-1
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,CM-CS-1
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,CYAD-01
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,CYAD-101
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,NKR 2
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Code name:,NKR-2
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous CAR NKG2D
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous CAR-T NKG2D
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous CAR-T NKR-2
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous NKG2D CAR-CD3zeta-DAP10-expressing T cells CYAD-01
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous NKR 2 T cells
2020-10-14T04:17:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01,Synonym:,autologous NKR-2 CAR-T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CM-CS-1
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,CYAD-101
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR 2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Code name:,NKR-2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKG2D
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous CAR-T NKR-2
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKG2D CAR-CD3zeta-DAP10-expressing T cells CYAD-01
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR 2 T cells
2020-09-18T04:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1,Synonym:,autologous NKR-2 CAR-T cells
2020-09-18T04:21:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine,Synonym:,autologous non-small cell lung cancer DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine
2020-09-18T04:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-peptide-specific-dendritic-cell-vaccine,Synonym:,autologous NSCLC peptide-specific DC vaccine
2020-09-18T04:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-cells,NA,NA
2020-10-14T04:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-lymphocytes,NA,NA
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,autologous NY-ESO-1 TCR-expressing CRISPR-edited (TCR and PD-1) T cells
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,autologous NY-ESO-1 transgenic TCR-expressing endogenous TCR-PD-1 gene-edited T cells
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,autologous NYCE cells
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,autologous NYCE T cells
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,NY-ESO-1 TCR-PD-1-CRISPR-gene-edited autologous T lymphocytes
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,NY-ESO-1-redirected autologous T cells with CRISPR-edited endogenous TCR and PD-1
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,NY-ESO-1-redirected CRISPR edited T cells
2020-10-14T04:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells,Synonym:,NY-ESO-1-redirected CRISPR-TCRendo/PD1-edited T cells
2020-10-14T04:18:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-specific-cd8-positive-t-lymphocytes,NA,NA
2020-10-14T04:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-tcr-targeted-t-lymphocytes,Synonym:,NY-ESO-1 T Cell receptor genetically modified autologous T cells
2020-09-18T04:22:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ofa-ilrp-rna-transfected-dendritic-cell-vaccine,Synonym:,oncofetal antigen-immature laminin receptor protein-loaded autologous dendritic cell vaccine
2020-10-14T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-immunogene-modified-t-lymphocytes,Synonym:,autologous human OC-IgT cells
2020-10-14T04:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-immunogene-modified-t-lymphocytes,Synonym:,OC-IgT cells
2020-10-14T04:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-specific-cytotoxic-t-lymphocytes,Abbreviation:,OC-CTLs
2020-10-14T04:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-specific-cytotoxic-t-lymphocytes,Synonym:,autologous OC-CTLs
2020-10-14T04:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-specific-cytotoxic-t-lymphocytes,Synonym:,autologous ovarian cancer-specific CTLs
2020-09-18T04:22:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-tumor-cell-lysate-pulsed-dendritic-cell-vaccine,Synonym:,autologous OC-DC vaccine
2020-09-18T04:22:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-oxidized-ovarian-tumor-cell-lysate-vaccine,Synonym:,autologous OC-L vaccine
2020-10-14T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens,Synonym:,autologous PBLs expressing mutated neoantigen-specific T-cell receptors
2020-10-14T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens,Synonym:,autologous peripheral blood lymphocytes retrovirally-transduced with TCRs targeting neoantigens
2020-10-14T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens,Synonym:,individual patient TCR-transduced autologous PBLs
2020-10-14T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens,Synonym:,neoantigen-reactive TCRs-transduced autologous PBLs
2020-10-14T04:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens,Synonym:,neoantigen-specific TCRs gene-transduced autologous PBLs
2020-10-14T12:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbtl-cd19car-28-zeta,NA,NA
2020-10-14T04:23:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-antibody-expressing-mesothelin-specific-car-t-cells,Synonym:,autologous PD-1 antibody expressing mesothelin specific CAR-T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous chimeric switch receptor PD-1:CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,autologous PD-1-targeted CSR T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,chimeric switch receptor PD1CD28 modified T cells
2020-09-18T04:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes,Synonym:,PD1CD28 CSR T cells
2020-10-14T04:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-l1-cd80-cd86-targeted-car-t-cells,Abbreviation:,Z-CTLs
2020-10-14T04:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-l1-cd80-cd86-targeted-car-t-cells,Synonym:,autologous CAR-T Cells Targeting PD-L1 and CD80/CD86
2020-10-14T04:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-l1-cd80-cd86-targeted-car-t-cells,Synonym:,Zeushield CTLs
2020-10-14T04:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-l1-cd80-cd86-targeted-car-t-cells,Synonym:,Zeushield cytotoxic T lymphocytes
2020-10-14T04:23:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd1-inhibiting-anti-cd19-4-1bb-car-t-cells,Synonym:,autologous iPD1 CD19 eCAR T cells
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Code name:,ALD-451
2020-09-18T04:23:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451,Synonym:,ALD-451 bright cells
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Code name:,MDG 1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Code name:,MDG-1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Code name:,MDG1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Synonym:,autologous anti-PRAME-TCR-expressing T cells MDG1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Synonym:,autologous PRAME TCR-modified T cells MDG1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Synonym:,autologous TCR-modified T cells MDG1011
2020-10-14T04:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011,Synonym:,PRAME-TCR gene-modified autologous T cells MDG1011
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Code name:,BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific CAR T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,autologous PSCA-specific chimeric antigen receptor engineered T cells BPX-601
2020-09-18T04:23:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601,Synonym:,GoCART BPX-601
2020-10-14T04:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma,Synonym:,4SCAR-PSMA
2020-10-14T04:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma,Synonym:,autologous 4S-PSMA-CAR-T cells
2020-10-14T04:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma,Synonym:,autologous anti-PSMA-CD28-CD137-CD27-CD3z-iCasp9 CAR T cells 4SCAR-PSMA
2020-10-14T04:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma,Synonym:,chimeric antigen receptor T cells 4SCAR-PSMA
2020-10-14T04:23:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma,Synonym:,PSMA-specific 4th generation CART cells
2020-10-14T04:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-specific-tgfb-resistant-car-t-cells,Synonym:,autologous CART-PSMA-TGFbRDN T cells
2020-10-14T04:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-specific-tgfb-resistant-car-t-cells,Synonym:,autologous CART-PSMA-TGFβRDN cells
2020-10-14T04:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-specific-tgfb-resistant-car-t-cells,Synonym:,PSMA-specific/TGFb-resistant CAR-modified autologous T cells
2020-10-14T04:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-rapamycin-resistant-th1-tc1-cells-rapa-201,Code name:,RAPA 201
2020-10-14T04:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-rapamycin-resistant-th1-tc1-cells-rapa-201,Code name:,RAPA-201
2020-10-14T04:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-rapamycin-resistant-th1-tc1-cells-rapa-201,Code name:,RAPA201
2020-09-18T04:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-dendritic-cell-vaccine,Abbreviation:,autologous RCC tumor lysate-DC vaccine
2020-10-14T04:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-pulsed-dendritic-cell-vaccine,Abbreviation:,autologous RCC tumor lysate-DC vaccine
2020-10-14T04:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59,Code name:,CCT301 59
2020-10-14T04:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59,Code name:,CCT301-59
2020-10-14T04:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59,Synonym:,autologous anti-ROR2 CAR-T cells CCT301-59
2020-10-14T04:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59,Synonym:,autologous CAR-T cells targeting ROR2 CCT301-59
2020-10-14T04:23:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59,Synonym:,autologous CCT301-59 CAR-T cells
2020-09-18T04:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-cell-lysate,NA,NA
2020-09-18T04:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-lysate-pulsed-dendritic-cell-vaccine,NA,NA
2020-10-14T04:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1,Code name:,AV GBM 1
2020-10-14T04:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1,Code name:,AV-GBM-1
2020-10-14T04:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1,Synonym:,autologous dendritic cells loaded with autologous tumor associated antigens
2020-10-14T04:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1,Synonym:,autologous TAAs-loaded autologous DCs AV-GBM-1
2020-10-14T04:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1,Synonym:,neoantigen-loaded autologous dendritic cells AV-GBM-1
2020-10-14T04:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400,Code name:,TBX 3400
2020-10-14T04:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400,Code name:,TBX-3400
2020-10-14T04:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400,Synonym:,autologous PBMCs TBX-3400
2020-10-14T04:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400,Synonym:,autologous TBX-4000-treated human PBMCs
2020-10-14T04:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400,Synonym:,TBX-3400 cells
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Code name:,IMA 201
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Code name:,IMA-201
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Code name:,IMA201
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Synonym:,ACTengine IMA201
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Synonym:,autologous T-cell receptor-engineered T cells IMA201
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Synonym:,IMA201 autologous T lymphocytes
2020-10-14T04:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201,Synonym:,IMA201 T cells
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Code name:,IMA 202
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Code name:,IMA-202
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Code name:,IMA202
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Synonym:,ACTengine IMA202
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Synonym:,IMA202 T cells
2020-10-14T04:24:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202,Synonym:,IMA202 T-cell product
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Code name:,IMA 2013
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Code name:,IMA-203
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Code name:,IMA203
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Synonym:,ACTengine IMA203
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Synonym:,IMA203 T cells
2020-10-14T04:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203,Synonym:,IMA203 T-cell product
2020-10-14T04:24:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung,Code name:,MIDRIX4-LUNG
2020-10-14T04:24:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung,Synonym:,autologous DC vaccine MIDRIX4-LUNG
2020-10-14T04:24:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung,Synonym:,autologous tetravalent DC vaccine MIDRIX4-LUNG
2020-10-14T04:24:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung,Synonym:,tetravalent autologous dendritic cell vaccine MIDRIX4-LUNG
2020-10-14T04:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tgfbeta-resistant-her2-ebv-specific-cytotoxic-t-lymphocytes,Synonym:,autologous TGF beta-resistant HER2/EBV-CTLs
2020-10-14T04:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes,Synonym:,anti-TnMUC1-CAR-expressing autologous T lymphocytes
2020-10-14T04:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes,Synonym:,autologous anti-TnMUC1-CAR-expressing T lymphocytes
2020-10-14T04:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes,Synonym:,autologous CART-TnMUC1 cells
2020-10-14T04:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes,Synonym:,autologous Tn-MUC1-specific CAR T cells
2020-10-14T04:24:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes,Synonym:,autologous TnMUC1-targeted genetically-modified CAR T cells
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Abbreviation:,autologous TAPA-pulsed DC vaccine KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,autologous tumor-associated peptide antigen-pulsed DC vaccine KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,KiroVAX
2020-09-18T04:25:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine,Synonym:,TAPA loaded DC vaccine
2020-09-18T04:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-proteoliposome-chronic-lymphocytic-leukemia-vaccine,US brand name:,Oncoquest-L vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Abbreviation:,ATCV
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,AC vaccine
2020-09-18T04:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine,Synonym:,Autologous Cell Vaccine
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Code name:,LN-144
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,Synonym:,autologous TIL LN-144
2020-09-18T04:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144,US brand name:,Contego
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Code name:,LN145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous TILs LN-145
2020-09-18T04:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145,Synonym:,autologous tumor-infiltrating lymphocytes LN-145
2020-10-14T04:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-mda-til,Code name:,MDA-TILs
2020-10-14T04:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-mda-til,Synonym:,MDA autologous TILs
2020-10-14T04:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-mda-til,Synonym:,MDA autologous tumor-infiltrating lymphocytes
2020-10-14T04:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells,Synonym:,autologous TSA-DC
2020-10-14T04:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells,Synonym:,autologous TSA-DC vaccine
2020-10-14T04:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells,Synonym:,autologous TSA-DCs
2020-10-14T04:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells,Synonym:,autologous TSA-loaded dendritic cells
2020-10-14T04:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells,Synonym:,tumor specific antigen-loaded autologous dendritic cells
2020-09-18T04:25:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-wt1-tcrc4-gene-transduced-cd8-positive-tcm-tn-lymphocytes,Synonym:,autologous WT1-transduced CD8-positive Tcm/Tn lymphocytes
2020-10-14T04:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide,Chemical structure:,"2,6-piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-"
2020-10-14T04:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide,Code name:,CC 122
2020-10-14T04:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide,Code name:,CC-122
2020-10-14T04:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide,Code name:,CC122
2020-10-14T13:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide-hydrochloride,Code name:,CC-122 hydrochloride
2020-09-18T04:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avanafil,NA,NA
2020-10-14T04:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib,Code name:,BLU-285
2020-10-14T04:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib,Code name:,CS3007
2020-10-14T04:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib,Synonym:,PDGFR alpha/KIT mutant-specific inhibitor BLU-285
2020-10-14T04:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib,US brand name:,Ayvakit
2020-10-14T04:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avatrombopag-maleate,US brand name:,Doptelet
2020-10-14T03:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avdoralimab,Code name:,IPH 5401
2020-10-14T03:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avdoralimab,Code name:,IPH5401
2020-10-14T03:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avdoralimab,Code name:,NN 8210
2020-10-14T03:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avdoralimab,Synonym:,anti-C5aR-215
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Code name:,MSB0010718C
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,Synonym:,anti-PD-L1 monoclonal antibody MSB0010718C
2020-09-18T04:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab,US brand name:,Bavencio
2020-10-14T05:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide,Chemical structure:,"exendin 3, 1-de-L-histidine-2-de-L-serine-3-de-L-aspartic acid-4-deglycine-5-de-L-threonine-6-de-L-phenylalanine-7-de-L-threonine-8-de-L-serine-LYS-ASN-GIY-GIY-PRO-SER-SER-GIY-ALA-PRO-PRO-PRO-SER-NH2"
2020-10-14T05:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide,Synonym:,9-39-exendin 4
2020-10-14T05:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide,Synonym:,ex(9-39)NH2
2020-10-14T05:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide,Synonym:,exendin (9-39)
2020-10-14T05:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide,Synonym:,exendin(9-39)amide
2020-10-14T13:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aviscumine,NA,NA
2020-09-18T04:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avitinib-maleate,Code name:,AC0010MA
2020-09-18T04:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avitinib-maleate,Synonym:,AC0010 maleate
2020-09-18T04:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avn944,NA,NA
2020-10-14T12:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac,Code name:,ADXS11-001
2020-10-14T12:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac,Code name:,Lm-LLO-E7
2020-10-14T12:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac,Synonym:,attenuated live Listeria encoding HPV 16 E7 vaccine ADXS11-001
2020-10-14T12:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac,US brand name:,Lovaxin C
2020-10-14T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab,Code name:,SNDX 6352
2020-10-14T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab,Code name:,SNDX-6352
2020-10-14T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab,Code name:,SNDX6352
2020-10-14T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab,Code name:,UCB6352
2020-10-14T03:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab,Synonym:,anti-M-CSFR monoclonal antibody SNDX-6352
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Code name:,KTE-C19
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,anti-CD19/CD28/CD3zeta CAR gammaretroviral vector-transduced autologous T lymphocytes KTE-C19
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,autologous anti-CD19 CAR-positive T lymphocytes KTE-C19
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,Synonym:,KTE-C19 CAR
2020-09-18T04:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel,US brand name:,Yescarta
2020-09-18T04:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib,Code name:,AG-013736
2020-09-18T04:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib,US brand name:,Inlyta
2020-10-14T04:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl--flt3-vegfr2-inhibitor-kc1036,Code name:,KC 1036
2020-10-14T04:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl--flt3-vegfr2-inhibitor-kc1036,Code name:,KC-1036
2020-10-14T04:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl--flt3-vegfr2-inhibitor-kc1036,Code name:,KC1036
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI 9016
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI-9016
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Code name:,BPI-9016M
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Synonym:,AXL receptor tyrosine kinase/c-MET inhibitor BPI-9016M
2020-09-18T04:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m,Synonym:,AXL/cMET inhibitor BPI-9016M
2020-09-18T04:27:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-bgb324,Code name:,BGB324
2020-10-14T04:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-ds-1205c,Code name:,DS 1205c
2020-10-14T04:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-ds-1205c,Code name:,DS-1205c
2020-10-14T04:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-ds-1205c,Code name:,DS1205c
2020-10-14T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-slc-391,Code name:,SLC 391
2020-10-14T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-slc-391,Code name:,SLC-391
2020-10-14T04:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-slc-391,Code name:,SLC391
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Chemical structure:,"2-((5-chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide"
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP 0903
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP-0903
2020-09-18T04:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903,Code name:,TP0903
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB 081776
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB 81776
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB-081776
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB-81776
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB081776
2020-10-14T04:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776,Code name:,INCB81776
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Code name:,ONO 7475
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Code name:,ONO-7475
2020-09-18T04:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475,Synonym:,Axl/Mer RTK inhibitor ONO-7475
2020-10-14T04:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m,Code name:,BPI 9016
2020-10-14T04:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m,Code name:,BPI-9016
2020-10-14T04:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m,Code name:,BPI-9016M
2020-10-14T04:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m,Synonym:,AXL receptor tyrosine kinase/c-MET inhibitor BPI-9016M
2020-10-14T04:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m,Synonym:,AXL/cMET inhibitor BPI-9016M
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,5-AC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,5-AZC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Abbreviation:,AZA-CR
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Chemical structure:,"4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one"
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Code name:,U-18496
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,5-AC
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,5-azacytidine
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,azacytidine
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,Synonym:,ladakamycin
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,US brand name:,Onureg
2020-09-18T04:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine,US brand name:,Vidaza
2020-09-18T04:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azapicyl,Chemical structure:,1-acetyl-2-picolinoylhydrazine2-acetylhydrazide-2-pyridinecarboxylic acid
2020-09-18T04:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azapicyl,Code name:,P-2292
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Abbreviation:,AZAS
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Abbreviation:,AZS
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Chemical structure:,L-diazoacetate (ester) serineL-serine diazoacetate (ester)O-diazoacetyl-L-serine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,CL-337
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,CN-15757
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Code name:,P-165
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetate (ester) L-Serine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetic acid ester with serine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,diazoacetylserine
2020-09-18T04:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine,Synonym:,serine diazoacetate
2020-09-18T04:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium,Foreign brand name:,Imurel
2020-09-18T04:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium,US brand name:,Imuran
2020-09-18T04:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1,Chemical structure:,"2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone"
2020-09-18T04:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1,Code name:,RH1
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,CP 62993
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,Code name:,XZ-450
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,AzaSite
2020-09-18T04:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin,US brand name:,Zithromax
2020-09-18T04:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azp,Chemical structure:,"1,3-Diaziridino-2,4,6-Triaza-1,3,5,5-Tetraaminomethyl-1,3,5-TriphosphorinN(3)P(3)Az(2)(NHMe)4"
2020-09-18T04:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,Code name:,"SQ 26,776"
2020-09-18T04:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam,US brand name:,Azactam
2020-09-18T04:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin-derived-cell-penetrating-peptide-p28,Abbreviation:,azurin-derived CPP p28
2020-10-14T04:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin50-77-cell-penetrating-peptide-p28,Abbreviation:,azurin-derived CPP p28
2020-09-18T04:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b-raf-vegfr-2-inhibitor-raf265,Code name:,CHIR-265
2020-09-18T04:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b-raf-vegfr-2-inhibitor-raf265,Code name:,RAF265
2020-09-18T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b16alphagal-melanoma-vaccine,US brand name:,Hyperacute Melanoma
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Abbreviation:,B43-PAP
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,anti-CD19 immunotoxin
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,B43 immunotoxin
2020-09-18T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin,Synonym:,B43-pokeweed antiviral protein immunotoxin
2020-09-18T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b7-dc-cross-linking-antibody-rhigm12b7,Abbreviation:,rHIgM12B7
2020-10-14T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b7-dc-crosslinking-antibody-rhigm12b7,Abbreviation:,rHIgM12B7
2020-10-14T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/babaodan-capsule,Abbreviation:,BBD
2020-10-14T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/babaodan-capsule,Abbreviation:,BD
2020-10-14T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/babaodan-capsule,Synonym:,babao dan
2020-09-18T04:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacitracin,Acronym:,BAC
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,Chemical structure:,4-Amino-3-(4-chlorophenyl)-butanoic Acidbeta-(Aminomethyl)-4-chlorobenzenepropanoic acid
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,Code name:,BA34647
2020-09-18T04:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen,US brand name:,Lioresal
2020-09-18T04:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen-amitriptyline-ketamine-gel,Synonym:,BAK Gel
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phi X 174
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phi X174
2020-09-18T04:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174,Synonym:,phiX174
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Code name:,INNO-406
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Code name:,NS-187
2020-09-18T04:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib,Synonym:,dual Bcr-Abl/Lyn tyrosine kinase inhibitor INNO-406
2020-09-18T04:30:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balanced-crystalloid-solution,Synonym:,sodium chloride/sodium gluconate/sodium acetate/potassium chloride/magnesium chloride solution
2020-10-14T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balixafortide,Code name:,POL6326
2020-10-14T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balixafortide,Synonym:,CXCR4 inhibitor POL6326
2020-10-14T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil,Abbreviation:,BXM
2020-10-14T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil,Chemical structure:,"(((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl carbonate"
2020-10-14T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil,Synonym:,"carbonic acid, (((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl methyl ester"
2020-10-14T04:26:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil,US brand name:,Xofluza
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Code name:,CMD-003
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,baltaleucel T
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,Cytorex EBV
2020-09-18T04:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t,Synonym:,Epstein-Barr virus-specific LMP1/LMP2/EBNABARF1-targeting autologous cytotoxic T lymphocytes
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Chemical structure:,"9,10-anthracenedione, 1,4-bis((2-(dimethylamino)ethyl)amino)-5,8-dihydroxy-, N,N'-dioxide"
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Code name:,AQ 4N
2020-09-18T04:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone,Code name:,AQ4N
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Code name:,AZD1152
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Code name:,AZD2811
2020-09-18T04:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib,Synonym:,Aurora kinase inhibitor AZD1152
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Chemical structure:,"(+)-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acidoleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-"
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Code name:,CDDO
2020-09-18T04:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone,Code name:,RTA 401
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Chemical structure:,"3-azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-"
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,INCB 028050
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,INCB028050
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,LY 3009104
2020-09-18T04:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib,Code name:,LY3009104
2020-09-18T04:31:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barium-sulfate,NA,NA
2020-09-18T04:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab,Code name:,SDZ-CHI-621
2020-09-18T04:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab,US brand name:,Simulect
2020-09-18T04:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batabulin-sodium,Chemical structure:,"2-fluoro-1-methoxy-4-(pentafluorophenyl-sulfonamido)benzene, sodium salt2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene"
2020-09-18T04:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batabulin-sodium,Code name:,T138067
2020-09-18T04:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bavituximab,US brand name:,Tarvacin
2020-09-18T04:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bay-56-3722,Code name:,BAY 38-3441
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Chemical structure:,"1H-indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-"
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Code name:,TSE-424
2020-09-18T04:32:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene,Code name:,WAY 140424
2020-09-18T04:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex,Abbreviation:,BC-819/PEI
2020-09-18T04:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex,Abbreviation:,DTA-H19/PEI
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,Synonym:,Bacillus Calmette-Guerin solution
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,Synonym:,BCG intravesical solution
2020-09-18T04:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution,US brand name:,TICE BCG solution
2020-10-14T04:26:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-tokyo-172-strain-vaccine,Synonym:,bacillus Calmette-Guerin Tokyo-172 strain vaccine
2020-09-18T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-vaccine,Synonym:,bacillus Calmette-Guerin vaccine
2020-09-18T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-vaccine,Synonym:,oncotice
2020-10-14T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-apg-2575,Code name:,APG 2575
2020-10-14T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-apg-2575,Code name:,APG-2575
2020-10-14T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-apg-2575,Code name:,APG2575
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,BCL-201
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,BCL201
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,S-55746
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Code name:,S55746
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Synonym:,Servier 1
2020-09-18T04:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201,Synonym:,Servier-1
2020-10-14T04:26:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-lp-108,Code name:,LP 108
2020-10-14T04:26:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-lp-108,Code name:,LP-108
2020-10-14T04:26:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-lp-108,Code name:,LP108
2020-10-14T04:26:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-s65487,Code name:,S 65487
2020-10-14T04:26:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-s65487,Code name:,S-65487
2020-10-14T04:26:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-s65487,Code name:,S65487
2020-10-14T04:27:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-cart-cells-secreting-mutant-pd-1fc-fusion-protein,Synonym:,BCMA-PD1-CAR T cells
2020-10-14T04:27:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-cd19-compound-car-t-cells,Synonym:,BCMA-CD19 cCAR T cells
2020-10-14T04:27:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-cd19-compound-car-t-cells,Synonym:,BCMA-CD19 cCAR-T cells
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Code name:,bb2121
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Synonym:,anti-BCMA-CAR T cells
2020-09-18T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes,Synonym:,anti-BCMA-CAR-transduced T cells
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Code name:,CC 93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Code name:,CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Code name:,EM901
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,anti-BCMA/CD3 bispecific antibody CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,BCMA x CD3 T Cell-engaging antibody CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,BCMA/CD3 T-cell bi-specific antibody CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,BCMA/CD3-directed bispecific T-cell engager antibody CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,BCMAxCD3 BiTE antibody CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,BCMAxCD3 TCB CC-93269
2020-10-14T04:27:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269,Synonym:,bi-specific antibody CC-93269
2020-09-18T04:33:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b2a2-derived-peptide-vaccine,Code name:,CML-VAX B2
2020-09-18T04:33:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b3a2-derived-peptide-vaccine,Code name:,CML-VAX B3
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,K0706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN K706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN-K0706
2020-09-18T04:33:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706,Code name:,SUN-K706
2020-09-18T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-pf-114,Code name:,PF-114
2020-09-18T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-pf-114,Synonym:,Bcr-Abl inhibitor PF-114
2020-10-14T04:27:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kit-akt-erk-inhibitor-hqp1351,Code name:,HQP 1351
2020-10-14T04:27:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kit-akt-erk-inhibitor-hqp1351,Code name:,HQP-1351
2020-10-14T04:27:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kit-akt-erk-inhibitor-hqp1351,Code name:,HQP1351
2020-10-14T04:27:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kit-akt-erk-inhibitor-hqp1351,Synonym:,multi-kinase inhibitor HQP1351
2020-09-18T04:34:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-multipeptide-vaccine,Synonym:,CMLVAX100
2020-09-18T04:34:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-multipeptide-vaccine,Synonym:,p210-B3A2-derived peptide vaccine
2020-10-14T04:27:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-pentapeptide-vaccine,Synonym:,CMLVAX100
2020-10-14T04:27:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-pentapeptide-vaccine,Synonym:,p210-B3A2-derived peptide vaccine
2020-09-18T04:34:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-peptide-vaccine,Synonym:,bcr-abl vaccine
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,BEACOPP
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,bleomycin-etoposide-Adriamycin-cyclophosphamide-Oncovin-procarbazine-prednisone regimen
2020-09-18T04:34:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen,Synonym:,bleomycin/cyclophosphamide/doxorubicin/etoposide/prednisone/procarbazine/vincristine
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Chemical structure:,"5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione, 1,11-dichloro-6-(2-(diethylamino)ethyl)-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-"
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,BMS-181176
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,BMY-27557-14
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Code name:,XL119
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,DEAE-rebeccamycin
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,rebeccamycin analogue
2020-09-18T04:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin,Synonym:,"rebeccamycin analogue, tartrate salt"
2020-10-14T12:52:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclabuvir,Code name:,BMS-791325
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Chemical structure:,"(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione dipropionate"
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,Code name:,SCH-18020W
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beclovent
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Beconase
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qnasl
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Qvar
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vancenase
2020-09-18T04:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate,US brand name:,Vanceril
2020-09-18T04:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beetroot-juice,Synonym:,beet juice
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,BT 5/9
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Code name:,SAND-26
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,Synonym:,murine anti-CD26 BT 5/9
2020-09-18T04:35:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab,US brand name:,Begedina
2020-09-18T04:35:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belagenpumatucel-l,US brand name:,Lucanix
2020-10-14T04:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin,Abbreviation:,J6M0-mcMMAF
2020-10-14T04:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin,Code name:,GSK2857916
2020-10-14T04:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin,Synonym:,belantamab mafodotin
2020-10-14T04:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin,US brand name:,Blenrep
2020-10-14T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belapectin,Code name:,GR-MD-02
2020-10-14T05:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belapectin,Synonym:,galactoarabino-rhamnogalacturonate
2020-09-18T04:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,Benlysta
2020-09-18T04:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab,US brand name:,LymphoStat-B antibody
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD 101
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,Code name:,PXD101
2020-09-18T04:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat,US brand name:,Beleodaq
2020-09-18T04:35:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belotecan-hydrochloride,Code name:,CKD-602
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Chemical structure:,2-[3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy]-N-(1-methylethyl)-acetamide
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,KD 025
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,KD-025
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,KD025
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,SLx 2119
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,SLx-2119
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Code name:,SLx2119
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Synonym:,rho-associated coiled-coil kinase 2 inhibitor KD025
2020-10-14T13:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil,Synonym:,ROCK-II inhibitor KD025
2020-10-14T13:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belvarafenib,Code name:,HM95573
2020-10-14T05:18:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belzutifan,Code name:,PT2977
2020-10-14T05:18:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belzutifan,Synonym:,HIF-2a inhibitor PT2977
2020-10-14T04:27:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemarituzumab,Code name:,FPA144
2020-10-14T04:27:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemarituzumab,Synonym:,anti-FGFR2 monoclonal antibody FPA144
2020-10-14T04:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemcentinib,Code name:,BGB324
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Badyket
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Hibor
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Ivor
2020-09-18T04:35:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,Foreign brand name:,Zibor
2020-10-14T04:27:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bempegaldesleukin,Code name:,NKTR-214
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,Abbreviation:,benazepril HCl
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,Code name:,CGS14824A
2020-09-18T04:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride,US brand name:,Lotensin
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,CEP-40125
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,RXDX 107
2020-09-18T04:36:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107,Code name:,RXDX-107
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Chemical structure:,"2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride"
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Code name:,SDX-105
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Levact
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,Ribomustin
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Foreign brand name:,SyB L-0501
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,bendamustin hydrochloride
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,CEP-18083
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,Synonym:,cytostasan hydrochloride
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Bendeka
2020-09-18T04:36:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride,US brand name:,Treanda
2020-09-18T12:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101,Chemical structure:,7-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)-N-hydroxyheptanamide
2020-09-18T12:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101,Code name:,EDO-S 101
2020-09-18T12:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101,Code name:,EDO-S-101
2020-09-18T12:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101,Code name:,EDO-S101
2020-09-18T12:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101,Synonym:,bendamustine-vorinostat fusion molecule EDO-S101
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Code name:,F-627
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Code name:,F627
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Synonym:,recombinant dimeric G-CSF fusion protein F627
2020-09-18T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim,Synonym:,rh G-CSF Fc fusion protein
2020-10-14T04:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benralizumab,Code name:,BIW-8405
2020-10-14T04:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benralizumab,Code name:,KHK-4563
2020-10-14T04:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benralizumab,Code name:,MEDI-563
2020-10-14T04:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benralizumab,Synonym:,"anti-CD125 humanized monoclonal antibody, IgG1-kappa"
2020-09-18T04:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzaldehyde-dimethane-sulfonate,Code name:,DMS612
2020-09-18T04:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzaldehyde-dimethane-sulfonate,Code name:,NSC 281612
2020-09-18T04:37:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzoylphenylurea,Abbreviation:,BPU
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Foreign brand name:,Tantum
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,Synonym:,benzydamine HCl
2020-09-18T04:37:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride,US brand name:,Difflam
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,BEP
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,bleomycin-etoposide-cisplatin regimen
2020-09-18T04:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen,Synonym:,bleomycin-etoposide-Platinol regimen
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Chemical structure:,"5,6-dihydro-9,10-dimethoxybenzo(G)-1,3-benzodioxolo(5,6-A)quinolizinium chloride"
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberine chloride dihydrate
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberine hydrochloride
2020-09-18T04:37:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride,Synonym:,berberinum chloride
2020-10-14T03:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bermekimab,Code name:,CA-18C3
2020-10-14T03:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bersanlimab,Code name:,BI-505
2020-10-14T03:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bersanlimab,Synonym:,anti-intercellular adhesion molecule-1 monoclonal antibody BI-505
2020-09-18T04:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berubicin-hydrochloride,Code name:,RTA 744
2020-09-18T04:37:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berubicin-hydrochloride,Synonym:,topoisomerase II inhibitor RTA 744
2020-10-14T04:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib,Code name:,M 6620
2020-10-14T04:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib,Code name:,M6620
2020-10-14T04:03:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib,Code name:,VX-970
2020-10-14T04:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207,Code name:,ODM 207
2020-10-14T04:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207,Code name:,ODM-207
2020-10-14T04:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207,Code name:,ODM207
2020-10-14T04:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207,Synonym:,BET inhibitor ODM-207
2020-10-14T04:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207,Synonym:,bromodomain and extraterminal domain protein inhibitor ODM-207
2020-09-18T04:37:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694,Code name:,ZEN-3694
2020-09-18T04:37:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694,Synonym:,BETi ZEN-3694
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Code name:,MK-8628
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Code name:,OTX015
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Synonym:,"BET bromodomain proteins 2, 3, and 4 inhibitor MK-8628"
2020-09-18T04:37:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628,Synonym:,BRD 2/3/4 inhibitor MK-8628
2020-10-14T04:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-abbv-744,Code name:,ABBV 744
2020-10-14T04:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-abbv-744,Code name:,ABBV-744
2020-10-14T04:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-abbv-744,Synonym:,BD2-selective BET inhibitor ABBV-744
2020-09-18T04:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097,Code name:,BAY 1238097
2020-09-18T04:38:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097,Code name:,BAY1238097
2020-09-18T04:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bms-986158,Code name:,BMS-986158
2020-10-14T04:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cc-90010,Code name:,CC 90010
2020-10-14T04:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cc-90010,Code name:,CC-90010
2020-09-18T04:38:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cpi-0610,Code name:,CPI-0610
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,CC-95775
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,FT-1101
2020-09-18T04:38:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101,Code name:,FT1101
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS 5829
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS-5829
2020-09-18T04:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829,Code name:,GS5829
2020-09-18T04:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151,Code name:,GSK 2820151
2020-09-18T04:38:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151,Code name:,GSK2820151
2020-09-18T04:38:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-incb054329,Code name:,INCB054329
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,RG6146
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,RO6870810
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Code name:,TEN-010
2020-09-18T04:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810,Synonym:,bromodomain and extra-terminal protein inhibitor RO6870810
2020-09-18T04:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene,US brand name:,Lumitene
2020-09-18T04:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene,US brand name:,Solatene
2020-09-18T04:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene,Chemical structure:,"1alpha,2beta,4beta)-1-methyl-2,4-bis(methylvinyl)-1-vinylcyclohexane (SN)"
2020-09-18T04:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene,Foreign brand name:,Elemene
2020-09-18T04:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan,Abbreviation:,b-GLUC
2020-09-18T04:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan,US brand name:,Immucell WGP
2020-09-18T04:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-lactobacillus-casei-bifidobacterium-lactis-based-supplement,Foreign brand name:,Citogenex
2020-09-18T04:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-mm-10-001,Code name:,MM-10-001
2020-09-18T04:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement,Abbreviation:,HMB supplement
2020-09-18T04:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement,Synonym:,β-hydroxy-β-methylbutyrate supplement
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Chemical structure:,"3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione"
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Code name:,ARQ 501
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Code name:,ARQ501
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Synonym:,b-lapachone
2020-09-18T04:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone,Synonym:,β-lapachone
2020-09-18T04:39:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone-prodrug-arq-761,Code name:,ARQ 761
2020-09-18T04:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-thioguanine-deoxyriboside,Abbreviation:,B-TGDR
2020-09-18T04:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-thioguanine-deoxyriboside,Abbreviation:,BTG
2020-10-14T04:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betaglucin-gel,Synonym:,betaglucin soluble gel
2020-10-14T04:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betaglucin-gel,Synonym:,epiglucan gel
2020-10-14T04:28:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betahistine-hydrochloride-nasal-spray,Code name:,AM 125
2020-10-14T04:28:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betahistine-hydrochloride-nasal-spray,Code name:,AM-125
2020-10-14T04:28:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betahistine-hydrochloride-nasal-spray,Code name:,AM125
2020-10-14T04:28:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betahistine-hydrochloride-nasal-spray,Synonym:,betahistine dihydrochloride nasal spray
2020-09-18T04:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betamethasone,US brand name:,Celestone
2020-09-18T04:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bethanechol-chloride,Synonym:,"2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-1-propanaminium chloride"
2020-10-14T04:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel,Synonym:,autologous CD34+ HSCs transduced with LentiGlobin BB305
2020-10-14T04:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel,Synonym:,LentiGlobin BB305 lentiviral vector-transduced autologous CD34+ HSCs
2020-10-14T04:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel,Synonym:,LentiGlobin BB305-transduced CD34-positive cells
2020-10-14T04:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel,Synonym:,lentiviral b-A(T87Q)-globin-transduced CD34-positive cells
2020-10-14T04:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel,US brand name:,LentiGlobin BB305 Drug Product
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Acronym:,BA
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Chemical structure:,(3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Code name:,ALS-357
2020-09-18T04:40:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid,Synonym:,Mairin
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Abbreviation:,rhuMab-VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Code name:,HD204
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF humanized monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,anti-VEGF rhuMAb
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BAT1706
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BEVZ92
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar BI 695502
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CBT 124
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar CT-P16
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar FKB238
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar GB-222
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HD204
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar HLX04
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar IBI305
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar LY01008
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MB02
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar MIL60
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar PF-06439535
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar QL 1101
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar RPH-001
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar SCT510
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,bevacizumab biosimilar TRS003
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,"immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMab-VEGF light chain, dimer"
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,recombinant humanized anti-VEGF monoclonal antibody
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,Synonym:,rhuMAb VEGF
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Avastin
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Mvasi
2020-09-18T04:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab,US brand name:,Zirabev
2020-10-14T04:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-carboplatin-paclitaxel-regimen,Synonym:,carboplatin-paclitaxel-bevacizumab regimen
2020-09-18T04:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-irdye-800cw,NA,NA
2020-10-14T05:18:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevifimod,Code name:,PRTX-100
2020-10-14T05:18:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevifimod,Synonym:,SpA PRTX-100
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Chemical structure:,"4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid"
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Code name:,LGD1069
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,Synonym:,3-methyl TTNEB
2020-09-18T04:40:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene,US brand name:,Targretin
2020-10-14T04:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab,Code name:,MK 6072
2020-10-14T04:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab,Code name:,MK-6072
2020-10-14T04:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab,Code name:,MK6072
2020-10-14T04:28:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab,US brand name:,Zinplava
2020-09-18T04:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bf-200-gel-formulation,Code name:,BF-200
2020-09-18T04:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bf-200-gel-formulation,Synonym:,BF-200 ALA
2020-09-18T04:41:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bh3-mimetic-abt-737,Code name:,ABT-737
2020-09-18T04:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-2536,NA,NA
2020-09-18T04:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-functional-alkylating-agent-val-083,Code name:,VAL-083
2020-09-18T04:42:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-functional-alkylating-agent-val-083,Code name:,VAL083
2020-10-14T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gm-csf-expressing-autologous-tumor-cell-vaccine,Synonym:,bi-shRNA-furin and granulocyte macrophage colony stimulating factor augmented autologous tumor cell vaccine
2020-10-14T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gm-csf-expressing-autologous-tumor-cell-vaccine,Synonym:,FANG vaccine
2020-10-14T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gm-csf-expressing-autologous-tumor-cell-vaccine,US brand name:,Vigil
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,Synonym:,bi-shRNA-furin and granulocyte macrophage colony stimulating factor augmented autologous tumor cell vaccine
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,Synonym:,FANG vaccine
2020-09-18T04:43:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine,US brand name:,Vigil
2020-09-18T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bibx-1382,NA,NA
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Abbreviation:,CDX
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Code name:,"ICI 176,334"
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,Foreign brand name:,Cosudex
2020-09-18T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide,US brand name:,Casodex
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Abbreviation:,BB-12/LGG
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Foreign brand name:,PROBIO-FIX INUM
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Bifidobacterium animalis/Lactobacillus rhamnosus probiotic
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Lactobacillus rhamnosus GG/ Bifidobacterium animalis subsp. lactis BB-12
2020-09-18T04:41:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement,Synonym:,Lactobacillus rhamnosus/Bifidobacterium animalis subsp. lactis
2020-10-14T04:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-ssp-lactis-probiotic-supplement,Synonym:,Bifidobacterium animalis probiotic supplement
2020-10-14T04:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-ssp-lactis-probiotic-supplement,Synonym:,Bifidobacterium animalis ssp. lactis supplement
2020-10-14T04:29:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-ssp-lactis-probiotic-supplement,Synonym:,Bifidobacterium supplement
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Code name:,BYM338
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Synonym:,HuCAL-based antibody BYM338
2020-09-18T04:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab,Synonym:,human combinatorial antibody library-based monoclonal antibody BYM338
2020-09-18T04:42:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimatoprost-ophthalmic-solution,NA,NA
2020-10-14T12:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimiralisib,Code name:,PQR-309
2020-10-14T12:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimiralisib,Code name:,PQR309
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Abbreviation:,BCGF
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Abbreviation:,BCSF 1
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Abbreviation:,IL-4
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Abbreviation:,MCGF 2
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Abbreviation:,rhIL-4
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,B Cell Proliferating Factor
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,B-Cell Growth Factor
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,B-Cell Stimulating Factor
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,B-Cell Stimulatory Factor 1
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,Mast Cell Growth Factor-2
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,recombinant human IL-4
2020-10-14T13:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin,Synonym:,T-Cell Growth Factor 2
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,ARRY-162
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,ARRY-438162
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,Code name:,MEK162
2020-09-18T04:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,US brand name:,Mektovi
2020-10-14T04:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bintrafusp-alfa,Code name:,MSB0011359C
2020-10-14T04:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bintrafusp-alfa,Synonym:,anti-PD-L1/TGFbetaRII fusion protein M7824
2020-10-14T04:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bintrafusp-alfa,Synonym:,anti-PDL1/TGFb Trap MSB0011359C
2020-10-14T04:29:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bintrafusp-alfa,Synonym:,M7824
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Code name:,BCM 95CG
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Code name:,BCM-95CG
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Code name:,BCM95CG
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Synonym:,BCM-95 (R) CG
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Synonym:,BCM-95 CG curcumin
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Synonym:,BCM-95 CG curcumin extract
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Synonym:,bio-enhanced BCM-95 CG curcumin
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,Synonym:,curcumin BCM-95CG
2020-10-14T04:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation,US brand name:,Biocurcumax
2020-09-18T04:42:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biomed-101,NA,NA
2020-10-14T04:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib,Code name:,MK-8628
2020-10-14T04:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib,Code name:,OTX015
2020-10-14T04:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib,Synonym:,"BET bromodomain proteins 2, 3, and 4 inhibitor MK-8628"
2020-10-14T04:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib,Synonym:,BRD 2/3/4 inhibitor MK-8628
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,Code name:,VX-710
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,Synonym:,Incel VX-710
2020-09-18T04:43:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate,US brand name:,Incel
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Chemical structure:,"propanamide, N,N'-[(6,6'-difluoro[2,2'-bi-1H-indole]-3,3'-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)-,(2S,2'S)-"
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Code name:,TL32711
2020-09-18T04:43:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant,Synonym:,Smac mimetic TL32711
2020-09-18T04:43:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisacodyl,NA,NA
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Chemical structure:,"9, 10-anthracenedicarboxaldehyde, bis(4, 5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride9,10,Anthracenedicarboxaldehyde dihydrochloride9,10-Anthracenedicarboxaldehyde bis(2-imidazolin-2-yl)hydrazone dihydrochloride"
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Code name:,CL 216942
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Code name:,CL-216942
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Foreign brand name:,Zantrene
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,bisantrene dihydrochloride
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,bisantrene HCL
2020-09-18T04:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride,Synonym:,orange crush
2020-10-14T13:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bischolinetetrathiomolybdate,Code name:,ATN-224
2020-09-18T04:43:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-bi213-monoclonal-antibody-m195,Abbreviation:,Bi213 MOAB M195
2020-09-18T04:43:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-subsalicylate,US brand name:,Pepto-Bismol
2020-09-18T04:43:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisoprolol-fumarate,Chemical structure:,(±)-1-[4-[[2-(1-ethylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate (2:1) (fumarate)
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Abbreviation:,BsAb 2B1
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,"2B1 antibody, bispecific"
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1 Bispecific MAb
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,2B1 Bispecific Murine MAb
2020-09-18T04:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1,Synonym:,MoAb 2B1 Bispecific
2020-09-18T04:44:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-4g7xh22,NA,NA
2020-10-14T04:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-amg-509,Code name:,AMG 509
2020-10-14T04:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-amg-509,Code name:,AMG-509
2020-10-14T04:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-amg-509,Code name:,AMG509
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,AGEN 1423
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,AGEN-1423
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,AGEN1423
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,GS 1423
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,GS-1423
2020-10-14T04:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423,Code name:,GS1423
2020-09-18T04:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx-h210,Code name:,MDX-H210
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Code name:,EMD 82633
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Code name:,MDX-447
2020-09-18T04:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447,Synonym:,BsAb MDX447
2020-10-14T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat,Code name:,CF367
2020-10-14T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat,Code name:,CF367-C
2020-10-14T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat,Code name:,CFH367 C
2020-10-14T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat,Code name:,CFH367-C
2020-10-14T04:29:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat,Code name:,PY-1
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Code name:,AMG 910
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Code name:,AMG-910
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Code name:,AMG910
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Synonym:,bispecific antibody AMG 910
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Synonym:,bispecific T-cell engager AMG 910
2020-10-14T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910,Synonym:,bispecific T-cell engager antibody AMG 910
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Chemical structure:,"(R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one"
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Code name:,AZD 5153
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Code name:,AZD5153
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Synonym:,BET inhibitor AZD5153
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Synonym:,bivalent BET bromodomain inhibitor AZD5153
2020-10-14T04:30:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153,Synonym:,BRD4/BET bromodomain antagonist AZD5153
2020-09-18T04:44:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-hpv16-18-therapeutic-cervical-cancer-vaccine,Foreign brand name:,ProCervix
2020-10-14T05:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizalimogene-ralaplasmid,Code name:,VGX-3100
2020-09-18T04:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizelesin,Chemical structure:,"benzo(1,2-b:4,3-b')dipyrrol-4-ol,6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-,(S-(R*,R*))"
2020-09-18T04:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizelesin,Code name:,U-77779
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Abbreviation:,BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Code name:,CAT-3888
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,Anti-CD22 Recombinant Immunotoxin BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,BL22
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,BL22 Immunotoxin [RFB4(dsFv) - PE38
2020-09-18T04:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin,Synonym:,RFB4(dsFv)-PE38 immunotoxin
2020-09-18T04:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-cohosh,US brand name:,Remifemin
2020-10-14T04:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-currant-juice,Synonym:,Ribes nigrum L. juice
2020-09-18T04:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-raspberry-nectar,Synonym:,BRB nectar
2020-09-18T04:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-tea,NA,NA
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Blanoxan
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleo-cell
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleo-S
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleocin
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Bleolem
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Foreign brand name:,Oil Bleo
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycin sulfas
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycin sulphate
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,bleomycini sulfas
2020-09-18T04:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate,Synonym:,blexane
2020-09-18T04:45:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bli850,NA,NA
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MEDI-538
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Code name:,MT-103
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,anti-CD19/anti-CD3 recombinant bispecific monoclonal antibody MT103
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,Synonym:,bispecific T-cell engager MT103
2020-09-18T04:45:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab,US brand name:,Blincyto
2020-09-18T04:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blue-citrus-based-herbal-capsule,NA,NA
2020-09-18T04:45:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blueberry-powder-supplement,US brand name:,VitaBlue tablet formation
2020-09-18T04:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bmi1-inhibitor-ptc596,Code name:,PTC596
2020-09-18T04:46:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bmi1-inhibitor-ptc596,Synonym:,polycomb ring finger oncogene inhibitor PTC596
2020-09-18T04:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662,Abbreviation:,FTI BMS 214662
2020-09-18T04:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662,Synonym:,farnesyltransferase inhibitor BMS-214662
2020-09-18T04:46:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boanmycin-hydrochloride,Abbreviation:,BAM HCl
2020-09-18T04:46:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boanmycin-hydrochloride,Synonym:,bleomycin A6 hydrochloride
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Chemical structure:,"3-azabicyclo(3.1.0)hexane-2-carboxamide, N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2S)-2-((((1,1- dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6- dimethyl-, (1R,2S,5S)-"
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Code name:,EBP 520
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,Code name:,SCH 503034
2020-09-18T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir,US brand name:,Victrelis
2020-10-14T12:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat,Code name:,IMG 7289
2020-10-14T12:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat,Code name:,IMG-7289
2020-10-14T12:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat,Synonym:,LSD-1 inhibitor IMG-7289
2020-10-14T12:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat,Synonym:,lysine-specific demethylase 1 inhibitor IMG-7289
2020-09-18T04:46:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bone-metastasis-targeting-peptide-11,Acronym:,BMTP-11
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Abbreviation:,PARPi-FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,AZD2281-BODIPY FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,BODIPY-modified olaparib fluorescent imaging agent
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,fluorescent PARP1 inhibitor PARPi-FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,fluorescent PARPi binding imaging agent PARPi-FL
2020-09-18T04:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent,Synonym:,olaparib-BODIPY FL
2020-09-18T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boronophenylalanine-fructose-complex,Abbreviation:,BPA-F
2020-09-18T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boronophenylalanine-fructose-complex,Synonym:,p-Boronophenylalanine-Fructose Complex
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Chemical structure:,[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,LDP 341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,MLN341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Code name:,PS-341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,Synonym:,PS-341
2020-09-18T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib,US brand name:,Velcade
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Chemical structure:,"4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile4-anilino-3-quinolinecarbonitrile4-anilinobenzo(g)quinoline-3-carbonitrile"
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,Code name:,SKI-606
2020-09-18T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib,US brand name:,Bosulif
2020-09-18T04:47:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boswellia-serrata-extract,NA,NA
2020-10-14T04:30:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-bel-x-hg,Code name:,BEL X HG
2020-10-14T04:30:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-bel-x-hg,Code name:,BEL-X-HG
2020-10-14T04:30:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-bel-x-hg,Code name:,BELXHG
2020-10-14T04:30:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-bel-x-hg,Synonym:,botanical agent BEL X HG
2020-09-18T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-leac-102,Code name:,LEAC-102
2020-09-18T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-leac-102,Synonym:,LEAC 102
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB BO 1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB BO1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Code name:,DCB-BO1301
2020-09-18T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301,Synonym:,Zhaohe Cao-based botanical drug DCB-BO1301
2020-09-18T04:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extracts-rinse-izn-6n4,Code name:,IZN-6N4
2020-09-18T04:47:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extracts-rinse-izn-6n4,Synonym:,oral botanical extracts mucositis rinse IZN-6N4
2020-09-18T04:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-lotion-cg428,Code name:,CG428
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Code name:,EB 001
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Code name:,EB001
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Synonym:,BoNT/E EB-001
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Synonym:,botulinum EB-001
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Synonym:,botulinum type E EB-001
2020-10-14T04:30:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001,Synonym:,toxin E EB-001
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Abbreviation:,BTX-A
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,abobotulinumtoxinA
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum A toxin
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum neurotoxin type A
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,botulinum toxin A
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onabotulinumtoxinA
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,Synonym:,onaclostox
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,BOTOX
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Botox cosmetic
2020-09-18T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a,US brand name:,Dysport
2020-09-18T04:48:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bovine-lactoferrin-supplement,Synonym:,bLF supplement
2020-09-18T04:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate,Abbreviation:,BBIC
2020-09-18T04:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate,Acronym:,BBIC
2020-10-14T04:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bozitinib,Code name:,PLB-1001
2020-10-14T04:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bozitinib,Code name:,PLB1001
2020-09-18T04:48:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bp-cx1-platinum-complex-bp-c1,Code name:,BP-C1
2020-09-18T04:48:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-modified-vaccinia-ankara-tricom-vaccine,Abbreviation:,MVA brachyury-TRICOM
2020-09-18T04:48:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-yeast-vaccine-gi-6301,Code name:,GI-6301
2020-09-18T04:49:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-egfr-inhibitor-bgb-283,Code name:,BGB-283
2020-09-18T04:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736,Code name:,AQ 736
2020-09-18T04:48:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736,Code name:,ARQ 736
2020-10-14T04:30:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-lut014,Code name:,LUT 014
2020-10-14T04:30:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-lut014,Code name:,LUT-014
2020-10-14T04:30:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-lut014,Code name:,LUT014
2020-09-18T04:48:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-plx8394,Code name:,PLX8394
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Code name:,PLX3603
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Code name:,RO5212054
2020-09-18T04:48:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054,Synonym:,B-Raf inhibitor RO5212054
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN 003
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN-003
2020-09-18T04:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003,Code name:,ASN003
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Chemical structure:,"1-(3-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride"
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Code name:,AC013773
2020-09-18T04:48:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496,Code name:,CEP-32496
2020-10-14T04:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-abm-1310,Code name:,ABM 1310
2020-10-14T04:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-abm-1310,Code name:,ABM-1310
2020-10-14T04:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-abm-1310,Code name:,ABM1310
2020-10-14T04:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-ro5212054,Code name:,PLX3603
2020-10-14T04:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-ro5212054,Code name:,RO5212054
2020-10-14T04:31:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-ro5212054,Synonym:,B-Raf inhibitor RO5212054
2020-09-18T04:49:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brain-tumor-initiating-cell-vaccine,Synonym:,BTIC vaccine
2020-09-18T04:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/branched-chain-amino-acid-supplement,Abbreviation:,BCAA supplement
2020-09-18T04:49:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brassica-vegetable,NA,NA
2020-10-14T04:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx2853,Code name:,PLX 2853
2020-10-14T04:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx2853,Code name:,PLX-2853
2020-10-14T04:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx2853,Code name:,PLX2853
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX 51107
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX-51107
2020-09-18T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107,Code name:,PLX51107
2020-10-14T12:46:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab,Code name:,SGN-30
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Abbreviation:,cAC10-vcMMAE
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Code name:,SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 ADC SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,anti-CD30 antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,Synonym:,antibody-drug conjugate SGN-35
2020-09-18T01:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin,US brand name:,Adcetris
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Chemical structure:,"((S)-2,2-difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone"
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Code name:,PF 06700841
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Code name:,PF-06700841
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Code name:,PF-841
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Code name:,PF06700841
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Synonym:,TYK2/JAK1 inhibitor PF-06700841
2020-10-14T04:31:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib,Synonym:,UNII 3X8387Q25N
2020-09-18T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brequinar,Chemical structure:,"6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid"
2020-09-18T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brequinar,Synonym:,Bipenquinate
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,Code name:,KTE X19
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,Code name:,KTE-X19
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,Code name:,KTEX19
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,Synonym:,anti-CD19 autologous CAR-CD28 T cells KTE-X19
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,Synonym:,autologous anti-CD19 CAR-CD28 T cells KTE-X19
2020-10-14T04:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel,US brand name:,Tecartus
2020-09-18T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium,Code name:,ON 013105
2020-09-18T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium,Synonym:,cyclin D modulator ON 013105
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Code name:,AP26113
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,Synonym:,dual ALK/EGFR inhibitor AP26113
2020-09-18T01:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib,US brand name:,Alunbrig
2020-09-18T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilacidin-oral-rinse,Synonym:,PMX30063 oral rinse
2020-10-14T13:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant,Code name:,ARN-810
2020-10-14T13:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant,Code name:,GDC-0810
2020-10-14T13:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant,Code name:,RG6046
2020-10-14T13:18:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant,Synonym:,SERD ARN-810
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,Synonym:,"6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1)"
2020-09-18T01:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate,US brand name:,Alphagan
2020-10-14T04:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate-nanoemulsion-ocu-300,Code name:,OCU 300
2020-10-14T04:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate-nanoemulsion-ocu-300,Code name:,OCU-300
2020-10-14T04:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate-nanoemulsion-ocu-300,Code name:,OCU300
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Abbreviation:,BCV
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Abbreviation:,HDP-Cidofovir
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Code name:,CMX001
2020-09-18T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir,Synonym:,hexadecyloxypropyl-cidofovir
2020-09-18T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivanib-alaninate,Code name:,BMS-582664
2020-10-14T04:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivaracetam,Chemical structure:,"1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-"
2020-10-14T04:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivaracetam,Code name:,UCB34714
2020-10-14T04:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivaracetam,US brand name:,Briviact
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,Chemical structure:,(E)-5-(2-Bromovinyl)-2'-deoxy-5'-uridyl phenyl L-methoxyalaninylphosphoramidate
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,Code name:,NB1011
2020-09-18T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate,US brand name:,Thymectacin
2020-09-18T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broad-spectrum-human-papillomavirus-vaccine-v505,Code name:,V505
2020-09-18T04:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-broccoli-seed-extract-supplement,US brand name:,Avmacol
2020-09-18T04:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-extract,NA,NA
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,Bromelase
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,EC 3.4.22.33
2020-09-18T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain,Synonym:,Pineapple Enzyme
2020-10-14T04:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelains,Synonym:,Bromelase
2020-10-14T04:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelains,Synonym:,EC 3.4.22.33
2020-10-14T04:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelains,Synonym:,Pineapple Enzyme
2020-09-18T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate,Chemical structure:,"2-Bromo-alpha-ergocryptine Mesylateergotaman-3´,6´,18-trione, 2-bromo-12´-hydroxy-2´-(1-methylethyl)-5´-(2-methylpropyl)-, (5´a)-mono-methanesulfonate (salt), (5'alpha)-"
2020-09-18T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate,US brand name:,Parlodel
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Abbreviation:,5-BrdU
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Abbreviation:,BrdU
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Chemical structure:,5-bromouracil-2-deoxyriboside
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Synonym:,5-bromodeoxyuridine
2020-09-18T04:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine,Synonym:,broxuridine
2020-09-18T04:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodomain-inhibitor-abbv-075,Code name:,ABBV-075
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Abbreviation:,BVDU
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Chemical structure:,(E)-5-(2-bromovinyl)-2'-deoxyuridine
2020-09-18T04:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine,Code name:,RP101
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Abbreviation:,anti-Notch receptor MoAb OMP-52M51
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Code name:,OMP-52M51
2020-09-18T04:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab,Synonym:,anti-Notch1 monoclonal antibody OMP-52M51
2020-09-18T04:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brostallicin,Code name:,PNU-166196
2020-10-14T04:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine,Abbreviation:,5-BrdU
2020-10-14T04:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine,Abbreviation:,BrdU
2020-10-14T04:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine,Chemical structure:,5-bromouracil-2-deoxyriboside
2020-10-14T04:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine,Synonym:,5-bromodeoxyuridine
2020-10-14T04:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine,Synonym:,broxuridine
2020-09-18T04:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brussels-sprout,NA,NA
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Abbreviation:,BRYO
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Code name:,B705008K112
2020-09-18T04:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1,Synonym:,Bryostatin
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Code name:,ARQ 531
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Code name:,ARQ-531
2020-09-18T04:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531,Synonym:,Bruton's tyrosine kinase inhibitor ARQ 531
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Chemical structure:,"(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide"
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Code name:,BGB-3111
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,Synonym:,BTK-InhB
2020-09-18T04:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111,US brand name:,Brukinsa
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Code name:,AVL-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Code name:,CC-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,Bruton's tyrosine kinase inhibitor AVL-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,Bruton's tyrosine kinase inhibitor CC-292
2020-09-18T04:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292,Synonym:,BTK inhibitor AVL-292
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT 1530
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT-1530
2020-09-18T04:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530,Code name:,CT1530
2020-09-18T04:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12,Code name:,DTRMWXHS 12
2020-09-18T04:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12,Code name:,DTRMWXHS-12
2020-09-18T04:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-gdc-0853,Code name:,GDC-0853
2020-09-18T04:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-gdc-0853,Synonym:,Bruton tyrosine kinase inhibitor GDC-0853
2020-10-14T04:32:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-hz-a-018,Code name:,HZ-A 018
2020-10-14T04:32:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-hz-a-018,Code name:,HZ-A-018
2020-10-14T04:32:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-hz-a-018,Code name:,HZ-A018
2020-10-14T04:32:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-hz-a-018,Synonym:,Bruton’s tyrosine kinase inhibitor HZ-A-018
2020-10-14T04:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-icp-022,Code name:,ICP 022
2020-10-14T04:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-icp-022,Code name:,ICP-022
2020-10-14T04:32:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-icp-022,Code name:,ICP022
2020-10-14T04:32:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-loxo-305,Code name:,LOXO 305
2020-10-14T04:32:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-loxo-305,Code name:,LOXO-305
2020-10-14T04:32:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-loxo-305,Code name:,LOXO305
2020-09-18T04:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-m7583,Code name:,M7583
2020-09-18T04:53:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-m7583,Synonym:,Bruton's tyrosine kinase inhibitor M7583
2020-09-18T12:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-sns-062,Code name:,SNS 062
2020-09-18T12:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-sns-062,Code name:,SNS-062
2020-09-18T12:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-sns-062,Code name:,SNS062
2020-09-18T12:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-sns-062,Synonym:,BTK inhibitor SNS-062
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,EBI 1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,EBI-1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,EBI1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,SHR 1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,SHR-1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,SHR1459
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,TG 1701
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,TG-1701
2020-10-14T04:32:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701,Code name:,TG1701
2020-09-18T04:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol,US brand name:,Symbicort
2020-10-14T04:32:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budigalimab,Code name:,ABBV 181
2020-10-14T04:32:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budigalimab,Code name:,ABBV-181
2020-10-14T04:32:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budigalimab,Code name:,ABBV181
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Chemical structure:,"imidodicarbonimidic diamide, N-butyl-, hydrochloride"
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Synonym:,1-butylbiguanide HCl
2020-09-18T04:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride,Synonym:,N-butylbiguanide HCl
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Code name:,BKM120
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Code name:,PI3K_Inhibitor_BKM120
2020-09-18T04:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib,Synonym:,PI3K inhibitor BKM120
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,Foreign brand name:,Marcain
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,US brand name:,Marcaine
2020-09-18T04:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride,US brand name:,Sensorcaine
2020-09-18T04:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,Synonym:,bupivacaine liposome injectable suspension
2020-09-18T04:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension,US brand name:,Exparel
2020-09-18T04:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buprenorphine-transdermal-matrix-patch,NA,NA
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Chemical structure:,"(+-)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride"
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,Code name:,BW 323U66
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Amfebutamone
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Forfivo XL
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Wellbutrin
2020-09-18T02:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride,US brand name:,Zyban
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,Foreign brand name:,Forfivo XL
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,Synonym:,bupropion HCl controlled-release
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,Synonym:,bupropion HCl extended release
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,Synonym:,bupropion hydrochloride extended-release
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,US brand name:,Aplenzin
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,US brand name:,Wellbutrin SR
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,US brand name:,Wellbutrin XL
2020-10-14T04:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release,US brand name:,Zyban
2020-09-18T04:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor,Chemical structure:,"phosphonic Acid, p-(2-(4-(6-Amino-2-(((trans-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)-4-pyrimidinyl)-1-piperazinyl)ethyl)-"
2020-09-18T04:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor,Code name:,TG-0054
2020-10-14T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burosumab,Code name:,KRN23
2020-10-14T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burosumab,Code name:,UX023
2020-10-14T04:33:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burosumab,Synonym:,anti-FGF23 IgG1 monoclonal antibody KRN23
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Abbreviation:,BSRL
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Chemical structure:,"6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig)D-ser (bu(t))(6) pro(9) NEt LHRH Acetate"
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,HOE 766
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,ICI 123215
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Code name:,S74-6766
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Bigonist
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Profact Depot
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Receptal
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprecur
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Depot
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Foreign brand name:,Suprefact Flakon
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,buserelin acetate
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,Synonym:,busereline
2020-09-18T04:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin,US brand name:,Etilamide
2020-10-14T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-culuan-decoction,Synonym:,Bushen Culuan TCM decoction
2020-10-14T04:33:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-culuan-decoction,Synonym:,Bushen Culuan traditional Chinese medicine decoction
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Abbreviation:,BJD
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Abbreviation:,BJHD
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Abbreviation:,BSJPD
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Abbreviation:,JPBS
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Synonym:,Jianpi Bushen
2020-10-14T04:33:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction,Synonym:,Jianpi-Bushen decoction
2020-09-18T04:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buspirone-hydrochloride,US brand name:,Buspar
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BU
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Abbreviation:,BUS
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Chemical structure:,"1,4-bis(methanesulfonoxy)butane1,4-bitanediol dimethanesulfonate esters1,4-butanediol dimethylsulfonate1,4-di(methanesulfonyloxy)butane1,4-di(methylsulfonyloxy)butane"
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,CB-2041
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,GT-41
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Code name:,WR-19508
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mielucin
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulban
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Misulfan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Foreign brand name:,Mitosan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,BSF
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Bussulfam
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Busulfanum
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,busulphan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,glyzophrol
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,"methanesulfonic acid, tetramethylene ester"
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeleukon
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myeloleukon
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Myelosan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Mylecytan
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,Sulfabutin
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,Synonym:,tetramethylene bis(methanesulfonate)
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Busulfex
2020-09-18T04:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan,US brand name:,Myleran
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Abbreviation:,BuMel
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Synonym:,BuMel regimen
2020-09-18T04:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen,Synonym:,busulfan/melphalan regimen
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Abbreviation:,BSO
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Chemical structure:,"2-amino-4-(S-butylsulfonimidoyl) butanoic acidbutanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-S-(3-amino-3-carboxypropyl)-S-butylsulfoximineS-(n-butyl)homocysteine sulfoximine"
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Synonym:,"d,l-buthionine-s,r-sulfoximine"
2020-09-18T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine,Synonym:,L-buthionine sulfoximine
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,buscopan
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,butylscopolamine
2020-09-18T04:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide,Synonym:,oral hyoscine butylbromide
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Code name:,BXQ-350
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,SapC-DOPS nanovesicles
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,saposin C-dioleoylphosphatidylserine nanovesicles
2020-09-18T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation,Synonym:,saposin C–dioleoylphosphatidylserine complexes
2020-09-18T05:30:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-kit-inhibitor-plx9486,Code name:,PLX9486
2020-10-14T04:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-abn401,Code name:,ABN 401
2020-10-14T04:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-abn401,Code name:,ABN-401
2020-10-14T04:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-abn401,Code name:,ABN401
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL 2846
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL-2846
2020-09-18T05:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846,Code name:,AL2846
2020-09-18T05:33:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-208,Code name:,AMG 208
2020-09-18T05:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337,Code name:,AMG 337
2020-09-18T05:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337,Code name:,AMG337
2020-10-14T04:45:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-cbt-101,Code name:,CBT-101
2020-09-18T05:33:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-hs-10241,Code name:,HS-10241
2020-09-18T05:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-jnj-38877605,Code name:,JNJ-38877605
2020-09-18T05:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-msc2156119j,Code name:,MSC2156119J
2020-09-18T05:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-plb1001,Code name:,PLB-1001
2020-09-18T05:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-plb1001,Code name:,PLB1001
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,G4460
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,INX-3001
2020-09-18T05:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460,Code name:,LR3001
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Code name:,CGP 69846A
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Code name:,CGP69846A
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Code name:,ISIS-5132
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Synonym:,c-RAF Antisense
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Synonym:,ISIS 5132/CGP69846A
2020-10-14T05:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132,Synonym:,RAF-IK Antisense ODN
2020-09-18T05:46:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikdd-liposome,Synonym:,BikDD nanoparticle
2020-09-18T05:46:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikdd-liposome,Synonym:,C-VISA BikDD nanoparticle
2020-10-14T04:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikddliposome,Synonym:,BikDD nanoparticle
2020-10-14T04:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikddliposome,Synonym:,C-VISA BikDD nanoparticle
2020-09-18T04:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c3-targeted-complement-inhibitor-apl-2,Code name:,APL-2
2020-09-18T04:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c3-targeted-complement-inhibitor-apl-2,Code name:,APL2
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Code name:,BA 3021
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Code name:,BA3021
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,ADC BA3021
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,anti-ROR2 CAB ADC
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,antibody-drug conjugate BA3021
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,CAB anti-ROR2 ADC BA3021
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,CAB-ROR2-ADC
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,conditionally active biologic anti-ROR2 antibody-drug conjugate
2020-10-14T04:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021,Synonym:,ROR2-targeted ADC BA3021
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Chemical structure:,"1-hydroxy-7β,10β-dimethoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxycarbonyl]amino}-2-hydroxy-3-phenylpropanoate]"
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Code name:,RPR-116258A
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Code name:,XRP6258
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,Synonym:,taxoid XRP6258
2020-09-18T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel,US brand name:,Jevtana
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Chemical structure:,1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,Code name:,FCE 21336
2020-09-18T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline,US brand name:,Dostinex
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,BMS-986227
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA 008
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA-008
2020-09-18T04:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab,Code name:,FPA008
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Chemical structure:,"butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1)"
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,BMS-907351
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,Code name:,XL184
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cabometyx
2020-09-18T04:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate,US brand name:,Cometriq
2020-09-18T04:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cadazolid,Chemical structure:,"1-Cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-((R)-5-hydroxymethyl-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid"
2020-09-18T04:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cadazolid,Code name:,ACT-179811
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Abbreviation:,CTX/DOX/5-FU
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,CAFFI
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,CDF
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,cyclophosphamide-Adriamycin-fluorouracil regimen
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,cyclophosphamide/doxorubicin/fluorouracil
2020-09-18T04:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen,Synonym:,FAC
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Abbreviation:,CAF
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Chemical structure:,"1,3,7-trimethylxanthine3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione"
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Synonym:,methyltheobromine
2020-09-18T04:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine,Synonym:,theine
2020-09-18T04:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348,Chemical structure:,2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide
2020-09-18T04:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348,Code name:,DTP348
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Code name:,EZN-2285
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,calaspargase pegol
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,SC-PEG E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,Synonym:,succinimidyl carbonate monomethoxypolyethylene glycol E. coli L-asparaginase
2020-09-18T04:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,US brand name:,Asparlas
2020-10-14T04:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl,Code name:,EZN-2285
2020-10-14T04:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl,Synonym:,calaspargase pegol
2020-10-14T04:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl,Synonym:,SC-PEG E. coli L-asparaginase
2020-10-14T04:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl,Synonym:,succinimidyl carbonate monomethoxypolyethylene glycol E. coli L-asparaginase
2020-10-14T04:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl,US brand name:,Asparlas
2020-09-18T04:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,Synonym:,calcipotriol
2020-09-18T04:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene,US brand name:,Dovonex
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Abbreviation:,"1,25(OH)2-D3"
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Abbreviation:,CALTROL
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Chemical structure:,"(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol"
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,Synonym:,"1,25-dihydroxycholecalciferol"
2020-09-18T04:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol,US brand name:,Rocaltrol
2020-09-18T04:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-41-chloride-aqueous-solution,NA,NA
2020-09-18T04:57:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-46-chloride-aqueous-solution,NA,NA
2020-09-18T04:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-aluminosilicate-anti-diarrheal,Abbreviation:,CASAD
2020-09-18T04:56:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-carbonate,Abbreviation:,CaCO3
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride anhydrous
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride dihydrate
2020-09-18T04:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride,Synonym:,calcium chloride hexahydrate
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Abbreviation:,CALCIT
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Chemical structure:,"2-Hydroxy-1,2,3-propanetricarboxylic Acid, Calcium Salt (2:3)"
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Foreign brand name:,Acicontral
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,Synonym:,Tricalcium Citrate
2020-09-18T04:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate,US brand name:,Citracal
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Abbreviation:,CGT
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Chemical structure:,"2,3,4,5-tetrahydroxy-1,6- dioxido-hexane-1,6-dione, calcium"
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,antacidin
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium D-glucarate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium D-saccharate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,calcium saccharate
2020-09-18T04:57:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate,Synonym:,saccharated lime
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Abbreviation:,CALGLUC
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Synonym:,Calcium D-gluconate
2020-09-18T04:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate,Synonym:,Calglucon
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Code name:,CM 4620
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Code name:,CM-4620
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Code name:,CM4620
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Synonym:,CRAC inhibitor CM4620
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Synonym:,orai Ca2+ channel inhibitor CM4620
2020-10-14T04:33:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620,Synonym:,orai1 inhibitor CM4620
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP 4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP-4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Code name:,RP4010
2020-09-18T04:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010,Synonym:,CRAC inhibitor RP4010
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Abbreviation:,CGT
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Chemical structure:,"2,3,4,5-tetrahydroxy-1,6- dioxido-hexane-1,6-dione, calcium"
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Synonym:,antacidin
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Synonym:,calcium D-glucarate
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Synonym:,calcium D-saccharate
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Synonym:,calcium saccharate
2020-10-14T04:33:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate,Synonym:,saccharated lime
2020-10-14T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-sensing-receptor-agonist-sk-1403,Code name:,AJT-240
2020-10-14T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-sensing-receptor-agonist-sk-1403,Code name:,SK 1403
2020-10-14T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-sensing-receptor-agonist-sk-1403,Code name:,SK1403
2020-10-14T04:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-sensing-receptor-agonist-sk-1403,Synonym:,CaSR agonist SK 1403
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Abbreviation:,XHP
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Synonym:,wangbang pharmaceutical Xihuang capsule
2020-09-18T04:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule,Synonym:,Xihuang capsule
2020-09-18T04:58:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calfactant,US brand name:,Infasurf Intratracheal Suspension
2020-10-14T04:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calr-exon-9-mutant-peptide-vaccine-montanide-isa-51,Synonym:,CALR exon 9 mutant peptide vaccine With Montanide ISA-51
2020-10-14T04:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calr-exon-9-mutant-peptide-vaccine-montanide-isa-51,Synonym:,CALRLong36 peptide vaccine/Montanide ISA-51
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,Code name:,"U-22,550"
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,Synonym:,dimethyltestosterone
2020-09-18T04:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone,US brand name:,Methosarb
2020-10-14T04:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camidanlumab-tesirine,Code name:,ADCT-301
2020-10-14T04:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camidanlumab-tesirine,Synonym:,ADC ADCT-301
2020-10-14T04:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camidanlumab-tesirine,Synonym:,anti-CD25-PBD antibody-drug conjugate ADCT-301
2020-09-18T04:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-20s-o-propionate-hydrate,Code name:,CZ48
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,Code name:,TLC388
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,Foreign brand name:,Lipotecan
2020-09-18T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388,US brand name:,Lipotecan
2020-10-14T04:26:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-glycoconjugate-bay-38-3441,Code name:,BAY 38-3441
2020-10-14T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab,Code name:,HR-301210
2020-10-14T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab,Code name:,SHR-1210
2020-10-14T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab,Code name:,SHR1210
2020-10-14T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab,Synonym:,AiRuiKa
2020-10-14T04:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab,Synonym:,carrizumab
2020-10-14T03:32:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camsirubicin,Chemical structure:,5-imino-13-deoxydoxoubicin
2020-10-14T03:32:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camsirubicin,Code name:,GPX-150
2020-10-14T04:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canagliflozin,Code name:,JNJ-24831754-ZAE
2020-10-14T04:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canagliflozin,Code name:,JNJ-28431754
2020-10-14T04:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canagliflozin,Code name:,JNJ-28431754-AAA
2020-10-14T04:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canagliflozin,Code name:,TA-7284
2020-10-14T04:34:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canakinumab,Code name:,ACZ885
2020-10-14T04:34:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canakinumab,US brand name:,Ilaris
2020-09-18T04:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canarypox-hil-12-melanoma-vaccine,Synonym:,ALVAC-hIL-12
2020-09-18T04:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canarypox-hil-12-melanoma-vaccine,Synonym:,ALVAC-hIL-12 melanoma vaccine
2020-09-18T04:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-peptide-vaccine-s-588410,Code name:,S-588410
2020-09-18T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-stemness-kinase-inhibitor-bbi503,Code name:,BBI503
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Atacand
2020-09-18T04:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil,US brand name:,Biopress
2020-10-14T04:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candida-albicans-antigen-injection,Synonym:,C. albicans test antigen injection
2020-10-14T04:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candida-albicans-antigen-injection,Synonym:,Candida albicans skin test antigen
2020-10-14T04:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candida-albicans-antigen-injection,US brand name:,Candin
2020-10-14T04:34:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canerpaturev,Code name:,HF10
2020-10-14T04:34:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canerpaturev,Code name:,Msc 2
2020-10-14T04:34:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canerpaturev,Code name:,TBI-1401
2020-10-14T04:34:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canerpaturev,Synonym:,herpes simplex virus type 1 HF10
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Chemical structure:,N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamideN-[-4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Code name:,CI-1033
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Code name:,PD183805
2020-09-18T04:59:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride,Synonym:,CI-1033/PD183805
2020-09-18T04:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride,Code name:,TLK286
2020-09-18T04:59:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride,US brand name:,TELCYTA
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Abbreviation:,CBD
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Chemical structure:,"1,3-benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-"
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Code name:,GWP42003-P
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,Synonym:,CBD oil
2020-09-18T05:00:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol,US brand name:,Epidiolex
2020-10-14T04:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011,Code name:,PPP 011
2020-10-14T04:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011,Code name:,PPP-011
2020-10-14T04:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011,Code name:,PPP011
2020-10-14T04:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011,Foreign brand name:,Caumz
2020-10-14T04:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011,Synonym:,synthetic CBD PPP011
2020-09-18T05:00:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinol,Chemical structure:,"3-amyl-1-hydroxy-6,6,9-trimethyl-6H-dibenzo(b,d)pyran"
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,Synonym:,Cannabis SR capsule
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR
2020-09-18T04:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule,US brand name:,Cannabics SR capsules
2020-10-14T04:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantrixil,Chemical structure:,"cis-4-(para-hydroxyphenyl)-7,4′-dihydroxy-3′,5′-dimethoxy-8-methylisoflavan"
2020-10-14T04:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantrixil,Code name:,TRX E 002 1
2020-10-14T04:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantrixil,Code name:,TRX-E-002-1
2020-10-14T04:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantrixil,Code name:,TRXE0021
2020-09-18T05:00:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantuzumab-ravtansine,Code name:,HuC242-DM4
2020-09-18T05:00:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantuzumab-ravtansine,Synonym:,maytansinoid DM4-conjugated humanized monoclonal antibody huC242
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Chemical structure:,8-chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Code name:,ABX 464
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Code name:,ABX-464
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Code name:,ABX464
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Synonym:,CBC 80/20 binder ABX-464
2020-10-14T04:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464,Synonym:,Rev inhibitor ABX-464
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Abbreviation:,CAPE
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Chemical structure:,5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,Code name:,Ro 09-1978/000
2020-09-18T05:00:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine,US brand name:,Xeloda
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,capecitabine-methotrexate-vinorelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,Xeloda-methotrexate-navelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,Xeloda/methotrexate/navelbine regimen
2020-09-18T05:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen,Synonym:,XMV regimen
2020-09-18T05:00:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-rapidly-disintegrating-tablet,Synonym:,capecitabine RDT
2020-10-14T04:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capivasertib,Code name:,AZD5363
2020-10-14T04:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capivasertib,Synonym:,Akt inhibitor AZD5363
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX 0681
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX-0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0081
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Code name:,ALX0681
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,Synonym:,caplacizumab
2020-09-18T04:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab,US brand name:,Cablivi
2020-09-18T05:01:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib,Code name:,NVP-INC280-AAA
2020-09-18T05:01:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib,US brand name:,Tabrecta
2020-10-14T04:34:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib-hydrochloride,Code name:,NVP-INC280-AAA
2020-10-14T04:34:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib-hydrochloride,US brand name:,Tabrecta
2020-09-18T05:01:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen,Synonym:,capecitabine-oxaliplatin regimen
2020-09-18T05:01:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen,Synonym:,CAPEOX regimen
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Abbreviation:,CPT
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,Chemical structure:,(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
2020-09-18T05:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril,US brand name:,Capoten
2020-10-14T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/car-t-cells-amg-119,Code name:,AMG 119
2020-10-14T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/car-t-cells-amg-119,Code name:,AMG-119
2020-10-14T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/car-t-cells-amg-119,Code name:,AMG119
2020-10-14T04:36:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/car-t-cells-amg-119,Synonym:,AMG 119 CAR-T cells
2020-09-18T05:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caracemide,Chemical structure:,"acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]-(9CI)N-acetyl-N-(methylcarbamoyloxy)-N'-methylurea"
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,Chemical structure:,"5H-Dibenz(b,f)azepine-5-carboxamide"
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Epitol
2020-09-18T05:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine,US brand name:,Tegretol
2020-10-14T04:35:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbidopa-levodopa,Synonym:,carbidopa levodopa
2020-10-14T04:35:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbidopa-levodopa,Synonym:,carbidopa-levodopa
2020-10-14T04:35:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbidopa-levodopa,US brand name:,Sinemet
2020-09-18T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbogen,Abbreviation:,UN1014
2020-09-18T05:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbohydrate-supplement-drink,Synonym:,carbohydrate drink
2020-09-18T05:06:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-11-acetate,NA,NA
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Abbreviation:,[11C] AMT
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Abbreviation:,11C-AMT
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Synonym:,11C-alpha-methyltryptophan
2020-09-18T05:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan,Synonym:,α-[11C]methyl-L-tryptophan
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Chemical structure:,"Ethanaminium, 2-hydroxy-N,N-dimethyl-N-(methyl-11C)-"
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,11C-choline
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,C-11 choline
2020-09-18T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline,Synonym:,C11 choline
2020-09-18T05:02:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-erlotinib-hydrochloride,Synonym:,C11-erlotinib
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,[11C]-glutamine
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,11C-Gln
2020-09-18T05:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine,Synonym:,11C-glutamine
2020-10-14T04:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-jnj-63779586,Synonym:,11C-JNJ-63779586
2020-10-14T04:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-martinostat,Synonym:,[11C]martinostat
2020-10-14T04:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-martinostat,Synonym:,martinostat C-11
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,[11C]-metformin
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,11C-metformin
2020-09-18T05:03:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin,Synonym:,carbon-11 metformin
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Abbreviation:,(11C)dLop
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Chemical structure:,(11C)N-desmethyl-loperamide
2020-09-18T05:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide,Synonym:,carbon C 11 loperamide hydrochloride
2020-10-14T04:35:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-osimertinib,Synonym:,[11C] osimertinib
2020-10-14T04:35:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-osimertinib,Synonym:,[11C]AZD9291
2020-10-14T04:35:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-osimertinib,Synonym:,11C-osimertinib
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Chemical structure:,"acetamide, N-((2-(methoxy-11C)-phenyl)methyl)-N-(6-phenoxy-3-pyridinyl)-"
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Synonym:,(11C)PBR-28
2020-09-18T05:03:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28,Synonym:,[11C] PBR28
2020-09-18T05:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sarcosine,Synonym:,11C-labeled sarcosine
2020-09-18T05:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sarcosine,Synonym:,11C-sarcosine
2020-09-18T05:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sepantronium-bromide,Synonym:,11C-YM155
2020-09-18T05:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-temozolomide,Synonym:,[11C] temozolomide
2020-09-18T05:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-temozolomide,Synonym:,Carbon C11 Temozolomide
2020-09-18T05:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-acetate,Synonym:,"1,2-13C acetate"
2020-09-18T05:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-acetate,Synonym:,2-13C acetate
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Abbreviation:,[(13)C]-DM
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Abbreviation:,13C-dextromethorphan
2020-09-18T05:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan,Synonym:,Carbon C-13 Dextromethorphan
2020-09-18T05:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-idasanutlin,Synonym:,[13C]-radiolabeled idasanutlin
2020-09-18T05:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-idasanutlin,Synonym:,C13 idasanutlin
2020-09-18T05:04:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-lycopene,Abbreviation:,13C-lycopene
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Chemical structure:,"(+)-2-amino-3-methylbutyric Acid-13C5,15N (SY); L-valine-13C5,15N (SY); L-2-amino-3-methylbutanoic acid-13C5,15N"
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Synonym:,C13 N15 valine
2020-09-18T05:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine,Synonym:,carbonomic
2020-09-18T05:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-octanoate,Synonym:,[13C] octanoate
2020-09-18T05:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-octanoate,Synonym:,13C-octanoate
2020-09-18T05:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytoene,Abbreviation:,13C-PE
2020-09-18T05:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytoene,Synonym:,13C-phytoene
2020-09-18T05:04:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytofluene,Abbreviation:,C13-PF
2020-09-18T05:04:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytofluene,Synonym:,13C-phytofluene
2020-10-14T04:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-sodium-octanoate,Synonym:,[13C] octanoate
2020-10-14T04:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-sodium-octanoate,Synonym:,13C-octanoate
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,[14C] AC0010
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,14C-AC0010
2020-09-18T05:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010,Synonym:,14C-labeled AC0010
2020-09-18T05:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-anlotinib-hydrochloride,Synonym:,[14C] anlotinib hydrochloride
2020-09-18T05:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-anlotinib-hydrochloride,Synonym:,14C-labeled anlotinib hydrochloride
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,[14C]PF-00299804
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,carbon C 14 PF-00299804
2020-09-18T05:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib,Synonym:,carbon C-14 dacomitinib
2020-09-18T05:04:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-eribulin-acetate,Synonym:,14C-eribulin acetate
2020-09-18T05:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-gilteritinib,Synonym:,[14C] ASP2215
2020-09-18T05:04:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-gilteritinib,Synonym:,14C-labeled gilteritinib
2020-10-14T04:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin,Synonym:,[14C]-radiolabeled idasanutlin
2020-10-14T04:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin,Synonym:,C14 idasanutlin
2020-09-18T05:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin-index-term-drug-agent,Synonym:,[14C]-radiolabeled idasanutlin
2020-09-18T05:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin-index-term-drug-agent,Synonym:,C14 idasanutlin
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Chemical structure:,"[14C]--1, 4-(R,S)-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid"
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Synonym:,[14C]-ixazomib
2020-09-18T05:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib,Synonym:,[14C]-MLN9708
2020-10-14T04:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-lenvatinib-mesylate,Abbreviation:,14C-E7080
2020-10-14T04:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-lenvatinib-mesylate,Synonym:,14C lenvatinib mesylate
2020-10-14T04:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-lenvatinib-mesylate,Synonym:,14C-lenvatinib mesylate
2020-09-18T05:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ombrabulin,Abbreviation:,[14C]-AVE8062
2020-09-18T05:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-oxaliplatin,Abbreviation:,[14C] oxaliplatin
2020-10-14T04:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pamiparib,Synonym:,[14C]-pamiparib
2020-10-14T04:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pamiparib,Synonym:,14C-pamiparib
2020-10-14T04:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pevonedistat,Synonym:,[14 C]-pevonedistat
2020-10-14T04:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pevonedistat,Synonym:,carbon C 14-pevonedistat
2020-09-18T05:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-roniciclib,Abbreviation:,[14C]-roniciclib
2020-09-18T05:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-roniciclib,Synonym:,[14C]-BAY1000394
2020-09-18T05:05:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-selumetinib,Abbreviation:,[14C] selumetinib
2020-10-14T04:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-tak-659,Synonym:,[14 C]-TAK-659
2020-10-14T04:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-tak-659,Synonym:,[14C]TAK 659
2020-10-14T04:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-tak-659,Synonym:,[14C]TAK-659
2020-10-14T04:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-tak-659,Synonym:,[14C]TAK659
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,[14C]-LX1606
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,[14C]-telotristat etiprate
2020-09-18T05:05:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate,Synonym:,14C-telotristat etiprate
2020-09-18T05:05:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-vemurafenib,Synonym:,14 C-labeled vemurafenib
2020-10-14T04:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c11-temozolomide,Synonym:,[11C] temozolomide
2020-10-14T04:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c11-temozolomide,Synonym:,Carbon C11 Temozolomide
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,[14C] EGFR inhibitor ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,[14C]ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,14C ASP8273
2020-09-18T05:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273,Synonym:,14C EGFR inhibitor ASP8273
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Abbreviation:,14C-E7080
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Synonym:,14C lenvatinib mesylate
2020-09-18T05:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate,Synonym:,14C-lenvatinib mesylate
2020-09-18T05:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-nanoparticle-based-formulation,Abbreviation:,CNP
2020-09-18T05:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-nanoparticle-based-formulation,Synonym:,carbon nanoparticles
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Abbreviation:,CBDCA
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Code name:,JM-8
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Blastocarb
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carboplat
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbosin
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbosol
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Carbotec
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Displata
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Ercar
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Nealorin
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Novoplatinum
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Paraplatin AQ
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Paraplatine
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Platinwas
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Foreign brand name:,Ribocarbo
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Synonym:,Carboplatin Hexal
2020-09-18T05:06:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin,Synonym:,Carboplatino
2020-10-14T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-etoposide-melphalan-regimen,Synonym:,carboplatin/etoposide/melphalan regimen
2020-10-14T04:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-etoposide-melphalan-regimen,Synonym:,CEM
2020-10-14T04:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen,Synonym:,carbo-Tax regimen
2020-10-14T04:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen,Synonym:,carboplatin-paclitaxel regimen
2020-10-14T04:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen,Synonym:,CaT regimen
2020-10-14T04:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen,Synonym:,PC regimen
2020-09-18T05:06:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-bevacizumab-regimen,Synonym:,carboplatin-paclitaxel-bevacizumab regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,carbo-Tax regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,carboplatin-paclitaxel regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,CaT regimen
2020-09-18T05:06:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen,Synonym:,PC regimen
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Abbreviation:,CAI
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Chemical structure:,"1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl)5-Amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1H-1,2,3-triazole-4-carboxamide"
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Code name:,L651582
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Synonym:,carboxyamido-triazole
2020-09-18T05:06:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole,Synonym:,carboxyaminoimidazole
2020-09-18T05:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate,Abbreviation:,CTO
2020-09-18T05:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate,Chemical structure:,"1,2,3-carboxyamido-triazole orotate"
2020-09-18T05:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxylesterase-expressing-allogeneic-neural-stem-cells,Abbreviation:,hCE1m6-NSC
2020-09-18T05:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxylesterase-expressing-allogeneic-neural-stem-cells,Synonym:,CE-secreting allogeneic NSCs
2020-09-18T05:06:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyphenyl-retinamide,Chemical structure:,4-carboxyphenyl retinamideN-(4-carboxyphenyl)retinamide
2020-09-18T05:06:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyphenyl-retinamide,Synonym:,RII
2020-09-18T05:06:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbutamide,Chemical structure:,1-(4-aminophenyl)sulfonyl-3-butylurea
2020-09-18T05:07:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-expressing-measles-virus,Abbreviation:,MV-CEA
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CAP-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,Carcinoembryonic Antigen Peptide-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,Carcinoembryonic Peptide-1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CEA Peptide 1
2020-09-18T05:06:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1,Synonym:,CEA Peptide 9-mer
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Abbreviation:,CAP-1-6D peptide
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Abbreviation:,CEA PEP 1-6D
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,CEA:571-579 (576D)
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,mCEA Peptide
2020-09-18T05:07:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d,Synonym:,Modified CEA Peptide
2020-09-18T05:07:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d-virus-like-replicon-particles-vaccine,Abbreviation:,CEA(6D) VRP vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Abbreviation:,CEARNAVAC
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,carcinoembryonic antigen RNA-pulsed dendritic cell cancer vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,CEA RNA-pulsed DC cancer vaccine
2020-09-18T05:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine,Synonym:,CEA RNA-pulsed dendritic cell cancer vaccine
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,Chemical structure:,(2S)-N-((1S)-1-benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,Code name:,PR-171
2020-09-18T05:07:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib,US brand name:,Kyprolis
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,Chemical structure:,"1-carbamoylmethyl-3-carbamoyl-1,4-dihydropyridine/5-(aziridin-1-yl)-2,4-dinitrobenzamide"
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,Code name:,EP-0152R/CB1954
2020-09-18T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar,US brand name:,Prolarix
2020-09-18T05:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carlumab,Code name:,CNTO 888
2020-09-18T05:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carlumab,Synonym:,anti-CCL2 human monoclonal antibody CNTO 888
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Abbreviation:,BCNU
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Chemical structure:,"1,3-bis(2-chloroethyl)-1-nitrosourea1,3-bis(beta-chloroethyl)-1-nitrosoureaN,N'-bis(2-chloroethyl)-N-nitrosourea"
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,FDA 0345
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SK 27702
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,SRI 1720
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Code name:,WR-139021
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Becenun
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Carmustinum
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrourean
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Foreign brand name:,Nitrumon
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis-chloronitrosourea
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,bis(chloroethyl) nitrosourea
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,Synonym:,carmustin
2020-09-18T04:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine,US brand name:,BiCNU
2020-09-18T05:08:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant,Synonym:,polifeprosan 20 with carmustine implant
2020-09-18T05:08:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant,US brand name:,Gliadel Wafer
2020-09-18T05:08:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-sustained-release-implant-wafer,Foreign brand name:,CASANT wafer
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,(2S)-2-[(3-amino-1-oxopropyl)Amino]-3-(3H-imidazol-4-Yl)propanoic acid
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,beta-alanyl-L-histidine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,beta-alanylhistidine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,L-carnosine
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,"L-histidine, beta-alanyl-"
2020-09-18T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine,Synonym:,"L-histidine, N-beta-alanyl-"
2020-10-14T04:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine-hibiscus-based-oral-mucoadhesive-tablet,Foreign brand name:,Aqualief
2020-10-14T04:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine-hibiscus-based-oral-mucoadhesive-tablet,Synonym:,oral mucoadhesive tablet
2020-10-14T04:36:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carotuximab,Code name:,TRC105
2020-09-18T05:08:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrageenan-containing-gel,US brand name:,Divine 9 with Carragel
2020-10-14T04:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrimycin,Foreign brand name:,Bite
2020-10-14T04:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrimycin,Synonym:,biotechspiramycin
2020-10-14T04:36:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrimycin,Synonym:,shengjimycin
2020-09-18T05:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrot-ji-lin-ginseng-licorice-root-tangerine-peel-soy-beverage,Foreign brand name:,Nutriall
2020-10-14T04:36:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrot-jilin-ginseng-licorice-root-tangerine-peel-soy-beverage,Foreign brand name:,Nutriall
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Abbreviation:,CMM
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,carminomycin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,carminomycin I
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,Demethyldaunomycin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,Karminomitsin
2020-09-18T05:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin,Synonym:,karminomycin
2020-09-18T05:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol,US brand name:,Coreg
2020-09-18T05:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol-phosphate-extended-release-capsule,US brand name:,Coreg CR
2020-09-18T05:09:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caseinate-protein-isolate,NA,NA
2020-09-18T05:09:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/casopitant-mesylate,Code name:,GW679769
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,"L-743,873"
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,Code name:,MK-0991
2020-09-18T04:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate,US brand name:,Cancidas
2020-09-18T05:09:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-activatable-cy5-fluorescent-imaging-probe-lum015,Code name:,LUM015
2020-10-14T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-cleavable-nir-substrate-probe-6qc-icg,Code name:,6QC ICG
2020-10-14T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-cleavable-nir-substrate-probe-6qc-icg,Code name:,6QC-ICG
2020-10-14T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-cleavable-nir-substrate-probe-6qc-icg,Code name:,6QCICG
2020-10-14T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-cleavable-nir-substrate-probe-6qc-icg,Synonym:,fluorescently quenched protease substrate probe 6QC-ICG
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Code name:,MBT-0206
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Foreign brand name:,EndoTAG-1
2020-09-18T05:09:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel,Foreign brand name:,LipoPac
2020-09-18T05:10:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catumaxomab,Foreign brand name:,Removab
2020-09-18T05:10:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cb10-277,Chemical structure:,"1-p-carboxy-3,3-dimethylphenyltriazine"
2020-09-18T05:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-antagonist-pri-724,Code name:,PRI-724
2020-09-18T05:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-antagonist-pri-724,Synonym:,Wnt signaling pathway inhibitor PRI-724
2020-10-14T04:37:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-modulator-e7386,Code name:,E 7386
2020-10-14T04:37:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-modulator-e7386,Code name:,E7386
2020-09-18T05:10:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-1088,NA,NA
2020-09-18T05:10:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-401,NA,NA
2020-09-18T05:10:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-8490,Code name:,SPC8490
2020-09-18T05:10:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccl21-expressing-h1944-cell-vaccine,Synonym:,recombinant human 6C cytokine-expressing H1944 cell vaccine
2020-09-18T05:10:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-ccx872-b,Code name:,CCX872-B
2020-09-18T05:11:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-pf-04136309,Code name:,PF-04136309
2020-09-18T05:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160,Chemical structure:,"(S)-1-[(1S,2R,4R)-4-isopropyl(methyl)amino)-2-propylcyclohexyl]-3-(6 (trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one"
2020-09-18T05:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160,Code name:,BMS-813160
2020-10-14T04:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr4-inhibitor-flx475,Code name:,FLX 475
2020-10-14T04:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr4-inhibitor-flx475,Code name:,FLX-475
2020-10-14T04:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr4-inhibitor-flx475,Code name:,FLX475
2020-09-18T05:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd-expressing-bifidobacterium-aps001f,Code name:,APS001F
2020-10-14T04:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polyepitope-plasmid-dna-vaccine,Code name:,STEMVAC
2020-10-14T04:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polyepitope-plasmid-dna-vaccine,Synonym:,CD105/Yb-1/SOX2/CDH3/MDM2 plasmid vaccine
2020-10-14T04:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polyepitope-plasmid-dna-vaccine,Synonym:,STEMVAC Th1 polyepitope plasmid-based vaccine
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Code name:,STEMVAC
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Synonym:,CD105/Yb-1/SOX2/CDH3/MDM2 plasmid vaccine
2020-09-18T05:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine,Synonym:,STEMVAC Th1 polyepitope plasmid-based vaccine
2020-10-14T04:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275,Code name:,GB 1275
2020-10-14T04:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275,Code name:,GB-1275
2020-10-14T04:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275,Code name:,GB1275
2020-10-14T04:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275,Synonym:,integrin alpha-M agonist GB1275
2020-10-14T04:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275,Synonym:,integrin CD11b agonist GB1275
2020-10-14T04:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd123-cd33-compound-car-t-cells,Synonym:,123b-33bcCAR-T cells
2020-10-14T04:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd123-cd33-compound-car-t-cells,Synonym:,CD123-CD33 cCAR T cells
2020-10-14T04:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd123-cd33-compound-car-t-cells,Synonym:,CD123/CD33-expressing compound CAR-T cells
2020-09-18T05:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd133-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine,Synonym:,CD-133 dendritic cell vaccine
2020-09-18T05:11:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd133-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine,Synonym:,CD133 DC vaccine
2020-10-14T04:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd137l-epstein-barr-virus-targeting-autologous-dendritic-cell-vaccine,Synonym:,CD137L-DC-EBV-VAX
2020-10-14T04:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd137l-epstein-barr-virus-targeting-autologous-dendritic-cell-vaccine,Synonym:,CD137L/Epstein-Barr virus-targeting autologous DC vaccine
2020-09-18T05:11:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd138car-cd137-tcrzeta-expressing-t-lymphocytes,Synonym:,CART-138 TCR zeta:CD137
2020-10-14T04:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd16-il15-cd33-trispecific-killer-cell-engager,Code name:,161533
2020-10-14T04:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd16-il15-cd33-trispecific-killer-cell-engager,Synonym:,CD16/IL-15/CD33 161533 tri-specific killer engagers
2020-10-14T04:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd16-il15-cd33-trispecific-killer-cell-engager,Synonym:,CD16/IL15/CD33 TriKE
2020-09-18T05:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-cd3-dual-affinity-retargeting-protein-jnj-64052781,Code name:,JNJ-64052781
2020-09-18T05:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-cd3-dual-affinity-retargeting-protein-jnj-64052781,Synonym:,CD19 x CD3 DART protein JNJ-64052781
2020-10-14T04:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-targeted-4-1bb-ligand-ro7227166,Code name:,RO 7227166
2020-10-14T04:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-targeted-4-1bb-ligand-ro7227166,Code name:,RO-7227166
2020-10-14T04:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-targeted-4-1bb-ligand-ro7227166,Code name:,RO7227166
2020-10-14T04:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-targeted-4-1bb-ligand-ro7227166,Synonym:,CD19-4-1BBL RO7227166
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19-CAR-specific/truncated EGFR lentiviral vector-transduced T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R:CD28:lentiviral/EGFRt+ T cells
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/EGFRt+ TCM
2020-09-18T05:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/truncated human EGFR+ central memory T cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zeta/EGFRt+ naive and memory T cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zetaEGFRt+ Tn/mem cells
2020-09-18T05:12:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes,Synonym:,CD19R(EQ)28zetaEGFRt+ Tn/Tmem
2020-09-18T05:12:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Synonym:,allogeneic CD19.CAR/28137zeta T-lymphocytes
2020-09-18T05:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-cd28-expressing-autologous-t-lymphocytes,NA,NA
2020-10-14T04:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocyte-cells,Acronym:,CART-19 cells
2020-09-18T05:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Acronym:,CART-19 cells
2020-09-18T05:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-expressing-autologous-t-lymphocytes,Synonym:,aCD19z T cells
2020-09-18T05:12:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-expressing-autologous-t-lymphocytes,Synonym:,autologousCART-19:TCR cells
2020-10-14T04:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-cd19-compound-car-t-cells,Synonym:,CD19/CD20-expressing compound CAR-T cells
2020-10-14T04:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-cd19-compound-car-t-cells,Synonym:,CD20-CD19 cCAR T cells
2020-10-14T04:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-cd19-compound-car-t-cells,Synonym:,CD20-CD19 cCAR-T cells
2020-09-18T05:12:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-targeted-polypeptide-tru-015,Code name:,TRU-015
2020-10-14T04:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd22-immunotoxin,Synonym:,anti-CD22 immunotoxin
2020-09-18T05:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd24-extracellular-domain-igg1-fc-domain-recombinant-fusion-protein-cd24fc,Abbreviation:,CD24Fc
2020-09-18T05:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd24-extracellular-domain-igg1-fc-domain-recombinant-fusion-protein-cd24fc,Abbreviation:,CD24Fc CD24IgG
2020-10-14T04:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28-icos-antagonist-alpn-101,Code name:,ALPN 101
2020-10-14T04:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28-icos-antagonist-alpn-101,Code name:,ALPN-101
2020-10-14T04:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28-icos-antagonist-alpn-101,Code name:,ALPN101
2020-10-14T04:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28-icos-antagonist-alpn-101,Synonym:,ICOSL vIgD-Fc
2020-09-18T05:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28car-cd137car-expressing-t-lymphocytes,NA,NA
2020-10-14T04:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd3-cd28-costimulated-autologous-t-cells,NA,NA
2020-09-18T05:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd3-cd28-costimulated-vaccine-primed-autologous-t-cells,NA,NA
2020-09-18T05:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd30-car-expressing-autologous-t-lymphocytes,Synonym:,CAR.CD30-expressing autologous T lymphocytes
2020-09-18T05:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd30-car-expressing-autologous-t-lymphocytes,Synonym:,ICAR30 T cells
2020-10-14T04:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-specific-car-lentiviral-vector-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-CD33 CAR-T cells
2020-10-14T04:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-specific-car-lentiviral-vector-transduced-autologous-t-lymphocytes,Synonym:,autologous anti-CD33 chimeric antigen receptor T cells
2020-10-14T04:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-specific-car-lentiviral-vector-transduced-autologous-t-lymphocytes,Synonym:,autologous CD33-CAR-T cells
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Code name:,IMGN779
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Synonym:,ADC IMGN779
2020-09-18T05:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779,Synonym:,anti-CD33 ADC IMGN779
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,anti-CD33 TCR zeta:CD137 CAR T cells
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART-33 TCR zeta:CD137 cells
2020-09-18T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART33 TCR zeta:CD137 cells
2020-10-14T04:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd34-tk75-retroviral-vector-transduced-donor-lymphocytes,NA,NA
2020-09-18T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd34-tk75-transduced-donor-lymphocytes,NA,NA
2020-10-14T04:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd4-cd25-regulatory-t-cells,Synonym:,nTregs
2020-09-18T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-cp-870893,Code name:,"CP-870,893"
2020-09-18T11:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-ro7009789,Code name:,RO7009789
2020-09-18T11:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-ro7009789,Synonym:,CD40 agonist monoclonal antibody RO7009789
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX 005
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX 005M
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX-005M
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,APX005M
2020-09-18T05:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m,Code name:,EPI-0050
2020-10-14T04:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40l-fc-fusion-protein-medi5083,Code name:,MEDI 5083
2020-10-14T04:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40l-fc-fusion-protein-medi5083,Code name:,MEDI5083
2020-09-18T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44-targeted-agent-spl-108,Code name:,SPL 108
2020-09-18T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44-targeted-agent-spl-108,Code name:,SPL-108
2020-10-14T04:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44v6-specific-car-t-cells,Synonym:,4SCAR-CD44v6 T cells
2020-10-14T04:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44v6-specific-car-t-cells,Synonym:,anti-CD44v6 CAR T cells
2020-10-14T04:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44v6-specific-car-t-cells,Synonym:,CD44v6 CAR-T cells
2020-10-14T04:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44v6-specific-car-t-cells,Synonym:,CD44v6-specific CAR gene-engineered T cells
2020-10-14T04:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd45ra-depleted-donor-t-lymphocytes,Synonym:,CD45RA-depleted allogeneic T cells
2020-10-14T04:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd45ra-depleted-donor-t-lymphocytes,Synonym:,CD45RA-depleted allogeneic T lymphocytes
2020-10-14T04:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd45ra-depleted-donor-t-lymphocytes,Synonym:,CD45RA-depleted donor T cells
2020-10-14T04:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd45ra-depleted-donor-t-lymphocytes,Synonym:,donor CD45RA-depleted (memory) T cells
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX 148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX-148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Code name:,ALX148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,CD47/SIRPa-blocking agent ALX148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,lgGl-ALX-148
2020-09-18T05:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148,Synonym:,SIRPa variant ALX148
2020-09-18T05:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd4cd25-regulatory-t-cells,Synonym:,nTregs
2020-10-14T04:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd56-enriched-cd3-positive-donor-lymphocytes,Synonym:,CD56-enriched donor cells
2020-10-14T04:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd56-enriched-cd3-positive-donor-lymphocytes,Synonym:,CD56-enriched donor lymphocytes
2020-10-14T04:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd56-enriched-cd3-positive-donor-lymphocytes,Synonym:,CD56+/CD3+ donor cells
2020-10-14T04:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ab680,Code name:,AB 680
2020-10-14T04:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ab680,Code name:,AB-680
2020-10-14T04:39:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ab680,Code name:,AB680
2020-10-14T04:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ly3475070,Code name:,LY 3475070
2020-10-14T04:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ly3475070,Code name:,LY-3475070
2020-10-14T04:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ly3475070,Code name:,LY3475070
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,CD8+ and CD4+ donor memory T cells-expressing pRRLSIN iC9-HA1 TCR2-RQR-CD8
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,HA-1 TCR CD8+ and CD4+ Tm cells
2020-09-18T05:14:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr,Synonym:,HA-1 TCR T cells
2020-10-14T04:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202,Code name:,ALPN 202
2020-10-14T04:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202,Code name:,ALPN-202
2020-10-14T04:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202,Code name:,ALPN202
2020-10-14T04:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202,Synonym:,CD80 vIgD-Fc fusion protein ALPN-202
2020-10-14T04:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202,Synonym:,CD80-vlgD-Fc ALPN-202
2020-10-14T04:39:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-fpt155,Code name:,FPT 155
2020-10-14T04:39:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-fpt155,Code name:,FPT-155
2020-10-14T04:39:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-fpt155,Code name:,FPT155
2020-10-14T04:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8nkg2d-akt-cell,Synonym:,NKG2D/AKT-expressing CD8-positive T cells
2020-09-18T05:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8nkg2d-akt-cells,Synonym:,NKG2D/AKT-expressing CD8-positive T cells
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,Code name:,ASTX727
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,Synonym:,CDA inhibitor E7727/decitabine combination agent ASTX727
2020-09-18T05:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727,US brand name:,Inqovi
2020-09-18T05:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-inhibitor-tak-931,Code name:,TAK-931
2020-09-18T05:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-inhibitor-tak-931,Synonym:,cell division cycle 7 inhibitor TAK-931
2020-09-18T05:15:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-bms-863233,Code name:,BMS-863233
2020-10-14T04:39:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-ly3143921-hydrate,Code name:,LY-3143921 hydrate
2020-10-14T04:39:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-ly3143921-hydrate,Code name:,LY3143921 hydrate
2020-09-18T05:15:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-nms-1116354,Code name:,NMS-1116354
2020-10-14T04:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519,Code name:,AT7519
2020-10-14T04:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519,Code name:,AT7519M
2020-10-14T04:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519,Synonym:,CDKI AT7519M
2020-10-14T04:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519
2020-10-14T04:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519M
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Code name:,P276
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Code name:,P276-00
2020-09-18T05:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00,Synonym:,cyclin-dependent kinase inhibitor P276
2020-10-14T04:41:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-r547,Code name:,R547
2020-10-14T04:41:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-r547,Synonym:,cyclin-dependent kinase inhibitor R547
2020-09-18T05:15:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032,Code name:,BMS-387032
2020-09-18T05:15:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032,Code name:,SNS-032
2020-10-14T03:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-2-4-inhibitor-ag-024322,NA,NA
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY 1107
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY-1107
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY-A
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY1107
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY1107G
2020-10-14T04:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107,Code name:,BEY1107P
2020-10-14T04:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501,Chemical structure:,"4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide"
2020-10-14T04:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501,Code name:,FN 1501
2020-10-14T04:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501,Code name:,FN-1501
2020-10-14T04:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501,Code name:,FN1501
2020-10-14T04:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501,Synonym:,CDK/FLT3 inhibitor FN-1501
2020-09-18T05:15:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-5-9-inhibitor-cyc065,Code name:,CYC065
2020-09-18T05:15:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-5-9-inhibitor-cyc065,Synonym:,cyclin dependent kinase inhibitor 2/5/9 CYC065
2020-09-18T09:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-trka-inhibitor-pha-848125-ac,Chemical structure:,"N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide"
2020-09-18T09:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-trka-inhibitor-pha-848125-ac,Code name:,PHA-848125 AC
2020-09-18T09:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-trka-inhibitor-pha-848125-ac,Synonym:,CDK2/TRKA inhibitor PHA-848125 AC
2020-10-14T04:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-bpi-16350,Code name:,BPI 16350
2020-10-14T04:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-bpi-16350,Code name:,BPI-16350
2020-10-14T04:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-bpi-16350,Code name:,BPI16350
2020-10-14T04:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-cs3002,Code name:,CS 3002
2020-10-14T04:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-cs3002,Code name:,CS-3002
2020-10-14T04:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-cs3002,Code name:,CS3002
2020-10-14T04:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437,Code name:,FCN 437
2020-10-14T04:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437,Code name:,FCN-437
2020-10-14T04:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437,Code name:,FCN-437c
2020-10-14T04:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437,Code name:,FCN437
2020-10-14T04:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437,Synonym:,cyclin-dependent kinase 4/6 inhibitor FCN-437
2020-09-18T05:16:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-g1t38,Code name:,G1T38
2020-09-18T05:16:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-shr6390,Code name:,SHR6390
2020-09-18T05:15:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-inhibitor-p1446a-05,Code name:,P1446A-05
2020-09-18T05:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk7-inhibitor-sy-1365,Code name:,SY 1365
2020-09-18T05:16:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk7-inhibitor-sy-1365,Code name:,SY-1365
2020-10-14T04:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120,Code name:,SEL 120
2020-10-14T04:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120,Code name:,SEL 120-34
2020-10-14T04:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120,Code name:,SEL 120-34A
2020-10-14T04:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120,Code name:,SEL-120
2020-10-14T04:40:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120,Code name:,SEL120
2020-10-14T04:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk9-inhibitor-azd4573,Code name:,AZD 4573
2020-10-14T04:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk9-inhibitor-azd4573,Code name:,AZD-4573
2020-10-14T04:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk9-inhibitor-azd4573,Code name:,AZD4573
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Code name:,AT7519
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Code name:,AT7519M
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,CDKI AT7519M
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519
2020-09-18T05:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519,Synonym:,cyclin-dependent kinase inhibitor AT7519M
2020-09-18T05:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-r547,Code name:,R547
2020-09-18T05:16:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-r547,Synonym:,cyclin-dependent kinase inhibitor R547
2020-09-18T05:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdks-jak2-flt3-inhibitor-tg02-citrate,Code name:,TG02 citrate
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RG 6123
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RG-6123
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RG6123
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RO 7172508
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RO-7172508
2020-10-14T04:41:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123,Code name:,RO7172508
2020-09-18T05:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome,Abbreviation:,MTL-CEBPA
2020-09-18T05:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome,Code name:,MTL-501
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Chemical structure:,"spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine, 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenyl-, (1alpha,4beta)-"
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT 6005
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT-6005
2020-09-18T05:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol,Code name:,GRT6005
2020-10-14T04:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cedazuridine,Chemical structure:,"(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridineuridine, 2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydro-, (4R)"
2020-10-14T04:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cedazuridine,Code name:,E7727
2020-10-14T04:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cedazuridine,Synonym:,CDA inhibitor E7727
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Chemical structure:,"4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1- yl)propoxy]quinazoline (2Z)-but-2-enedioatequinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1- pyrrolidinyl)propoxy]-, (2Z)-2-butenedioate (1:1)"
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Code name:,AZD2171
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Foreign brand name:,Recentin
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,Synonym:,AZD2171 maleate
2020-09-18T05:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate,US brand name:,Recentin
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Chemical structure:,"(6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt"
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,Code name:,SKF 41558
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Ancef
2020-09-18T02:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium,US brand name:,Kefzol
2020-09-18T05:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride,Chemical structure:,"pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))"
2020-09-18T05:17:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride,US brand name:,Maxipime
2020-09-18T05:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime,Code name:,FK 027
2020-09-18T05:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime,US brand name:,Suprax
2020-09-18T05:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefmetazole-sodium,NA,NA
2020-09-18T05:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefotaxime,US brand name:,Claforan
2020-09-18T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium,Foreign brand name:,Pacetin
2020-09-18T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium,US brand name:,Mefoxin
2020-09-18T05:18:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefpodoxime-proxetil,US brand name:,Vantin
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,CAZ-AVI
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,Synonym:,ceftazidime-avibactam sodium
2020-09-18T04:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium,US brand name:,Avycaz
2020-09-18T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Fortaz
2020-09-18T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium,US brand name:,Tazicef
2020-09-18T05:18:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftobiprole-medocaril,Code name:,BAL5788
2020-10-14T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam,Code name:,CXA 201
2020-10-14T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam,Code name:,CXA-201
2020-10-14T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam,Code name:,CXA201
2020-10-14T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam,Synonym:,ceftolozane/tazobactam
2020-10-14T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam,US brand name:,Zerbaxa
2020-09-18T05:18:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftriaxone-sodium,US brand name:,Rocephin
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Abbreviation:,SC-58635
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Chemical structure:,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Code name:,SC-58635
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,Synonym:,YM 177
2020-09-18T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib,US brand name:,Celebrex
2020-09-18T05:19:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cell-cycle-checkpoint-dna-repair-antagonist-ic83,Code name:,IC83
2020-09-18T05:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cem-regimen,Synonym:,carboplatin/etoposide/melphalan regimen
2020-09-18T05:19:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cem-regimen,Synonym:,CEM
2020-10-14T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab,Chemical structure:,"immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal REGN2810 heavy chain), disulfide with human monoclonal REGN2810 kappa-chain, dimer"
2020-10-14T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab,Code name:,REGN2810
2020-10-14T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab,Synonym:,anti-PD-1 monoclonal antibody REGN2810
2020-10-14T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab,Synonym:,cemiplimab
2020-10-14T04:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab,US brand name:,Libtayo
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Code name:,EL625
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,Synonym:,OL(1)p53
2020-09-18T01:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen,US brand name:,Aezea®
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Code name:,AS703569
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Code name:,R763
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Synonym:,Aurora kinase inhibitor AS703569
2020-09-18T05:19:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib,Synonym:,Aurora kinase Inhibitor R763
2020-09-18T05:19:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceop-regimen,Synonym:,Cyclophosphamide-Epirubicin-Oncovin-Prednisone regimen
2020-09-18T05:19:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceop-regimen,Synonym:,Cyclophosphamide/Epirubicin/Vincristine/Prednisone
2020-09-18T05:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cephalexin,US brand name:,Keflex
2020-10-14T04:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceralasertib,Code name:,AZD6738
2020-10-14T04:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceralasertib,Synonym:,ATR kinase inhibitor AZD6738
2020-09-18T05:20:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide,Chemical structure:,N-Acyl Sphingosine
2020-09-18T05:20:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide,Synonym:,Ceramide (lipids)
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Abbreviation:,CNL
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN 001
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN-001
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Code name:,KN-01
2020-09-18T05:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome,Synonym:,nanoliposomal ceramide
2020-10-14T04:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cerdulatinib,Code name:,PRT062070
2020-10-14T04:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cerdulatinib,Synonym:,Syk-JAK inhibitor PRT062070
2020-10-14T04:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cerdulatinib,Synonym:,Syk/JAK inhibitor PRT062070
2020-10-14T04:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480,Code name:,CC 92480
2020-10-14T04:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480,Code name:,CC-92480
2020-10-14T04:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480,Synonym:,CELMoD CC-92480
2020-10-14T04:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480,Synonym:,cereblon E3 ligase modulation drug CC-92480
2020-10-14T04:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480,Synonym:,cereblon modulator CC-92480
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Code name:,CC 99282
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Code name:,CC-99282
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Code name:,CC99282
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Synonym:,CelMod CC-99282
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Synonym:,cereblon E3 ubiquitin ligase modulating drug CC-99282
2020-10-14T04:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282,Synonym:,cereblon modulator CC-99282
2020-09-18T05:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-modulator-cc-90009,Code name:,CC 90009
2020-09-18T05:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-modulator-cc-90009,Code name:,CC-90009
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RG-7813
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RG7813
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RO-6895882
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Code name:,RO6895882
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Synonym:,CEA-IL-2variant
2020-09-18T05:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin,Synonym:,CEA-IL2v
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Chemical structure:,"2,4-pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-"
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Code name:,LDK 378
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,Code name:,LDK378
2020-09-18T05:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib,US brand name:,Zykadia
2020-09-18T05:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/certolizumab,NA,NA
2020-09-18T05:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-131,Abbreviation:,131-Cs
2020-09-18T05:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-131,Synonym:,cesium Cs-131
2020-09-18T05:21:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-137,NA,NA
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Code name:,AZD 4785
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Code name:,AZD4785
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Synonym:,ASO AZD4785
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Synonym:,cEt KRAS ASO AZD4785
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Synonym:,generation 2.5 drug AZD4785
2020-10-14T04:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785,Synonym:,IONIS-KRAS-2.5Rx
2020-10-14T04:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab,Code name:,JNJ 63723283
2020-10-14T04:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab,Code name:,JNJ-63723283
2020-10-14T04:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab,Code name:,JNJ63723283
2020-10-14T04:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab,Code name:,WHO 10757
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,Chimeric MoAb C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Abbreviation:,MOAB C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Code name:,IMC-C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-EGFR Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Anti-Epidermal Growth Factor Receptor Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,C225 monoclonal antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CDP-1
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar CMAB009
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,cetuximab biosimilar KL 140
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Anti-EGFR Monoclonal Antibody
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,Chimeric Monoclonal Antibody C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,"Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer"
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,Synonym:,monoclonal antibody C225
2020-09-18T05:21:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab,US brand name:,Erbitux
2020-09-18T05:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-ir700-conjugate-rm-1929,Code name:,RM-1929
2020-09-18T05:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-ir700-conjugate-rm-1929,Synonym:,cet-IR700
2020-09-18T05:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800,Synonym:,Cetuximab-IRDye800
2020-09-18T05:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800,Synonym:,Cetuximab-IRDye800CW
2020-10-14T04:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800cw,Synonym:,Cetuximab-IRDye800
2020-10-14T04:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800cw,Synonym:,Cetuximab-IRDye800CW
2020-10-14T04:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-sarotalocan,Code name:,RM-1929
2020-10-14T04:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-sarotalocan,Synonym:,cet-IR700
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Abbreviation:,CEV
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Synonym:,carboplatin-etoposide-vincristine regimen
2020-09-18T05:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen,Synonym:,carboplatin/etoposide/vincristine regimen
2020-10-14T04:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevidoplenib-dimesylate,Code name:,SKI O 703
2020-10-14T04:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevidoplenib-dimesylate,Code name:,SKI-O-703
2020-10-14T04:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevidoplenib-dimesylate,Code name:,SKIO703
2020-09-18T05:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,Code name:,AF-102B
2020-09-18T05:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride,US brand name:,Evoxac
2020-09-18T05:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cfms-tyrosine-kinase-inhibitor-arry-382,Code name:,ARRY-382
2020-09-18T05:22:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chamomile,NA,NA
2020-09-18T05:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-azd7762,Code name:,AZD7762
2020-10-14T13:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-xl844,NA,NA
2020-10-14T05:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chemokine-modulation-therapy,US brand name:,Optiray
2020-09-18T05:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum,Synonym:,chewing gum dosage form
2020-09-18T05:23:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum,Synonym:,chewing gum dose form
2020-10-14T04:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum-dosage-form,Synonym:,chewing gum dosage form
2020-10-14T04:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum-dosage-form,Synonym:,chewing gum dose form
2020-09-18T05:23:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chiauranib,Code name:,CS2164
2020-10-14T04:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-costimulatory-converting-receptor-modified-nk-92-cells,Synonym:,CCCR-modified NK92
2020-10-14T04:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-costimulatory-converting-receptor-modified-nk-92-cells,Synonym:,CCCR-NK92 cells
2020-10-14T04:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-costimulatory-converting-receptor-modified-nk-92-cells,Synonym:,chimeric co-stimulatory converting receptor-modified NK92 cells
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Code name:,11-1F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Code name:,111F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,c11-1F4 mAb
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,chimeric amyloid-reactive monoclonal antibody 111F4
2020-09-18T05:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4,Synonym:,mAb-11-1F4
2020-10-14T04:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101,Code name:,11-1F4
2020-10-14T04:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101,Code name:,111F4
2020-10-14T04:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101,Synonym:,c11-1F4 mAb
2020-10-14T04:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101,Synonym:,chimeric amyloid-reactive monoclonal antibody 111F4
2020-10-14T04:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101,Synonym:,mAb-11-1F4
2020-09-18T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-humanized-anti-cd47-antibody,Synonym:,humanized high-chimeric antibody CD47
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Code name:,LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,Herba Epimedii compound extraction LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,TCM formula LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,TCM LC09
2020-09-18T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09,Synonym:,traditional Chinese medicine formula LC09
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,PHY-906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV 906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV-906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Code name:,YIV906
2020-09-18T05:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906,Synonym:,KD018
2020-09-18T05:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-medicine-yq1,Synonym:,YQ1
2020-09-18T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbs,Abbreviation:,CHIHERB
2020-09-18T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbs,Synonym:,"herbs, Chinese"
2020-09-18T05:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chining-decoction,NA,NA
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Code name:,T-ChOs
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Foreign brand name:,Benecta
2020-09-18T05:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos,Synonym:,therapeutic CHOS
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Chemical structure:,(R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Code name:,CCT245737
2020-09-18T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737,Synonym:,checkpoint kinase 1 inhibitor CCT245737
2020-09-18T05:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0425,Code name:,GDC-0425
2020-09-18T05:24:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0425,Code name:,RG7602
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,ARRY-575
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,GDC-0575
2020-09-18T05:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575,Code name:,RG7741
2020-10-14T04:43:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-mk-8776,Code name:,SCH 900776
2020-09-18T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736,Code name:,PF-0047736
2020-09-18T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736,Code name:,PF-477736
2020-09-18T05:24:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-sch-900776,Code name:,SCH 900776
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Abbreviation:,CHL
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Abbreviation:,CLB
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Code name:,CB-1348
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Code name:,WR-139013
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Alti-chlorambucil
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Chloraminophene
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Foreign brand name:,Linfolysin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorambucilum
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chloraminophen
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Chlorbutin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorbutine
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorbutinum
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chloroambucil
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorobutin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,chlorobutine
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Leukersan
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Leukoran
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,Lympholysin
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,Synonym:,phenylbutyric acid nitrogen mustard
2020-09-18T05:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil,US brand name:,Leukeran
2020-09-18T05:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil-prednisone-regimen,Acronym:,CP regimen
2020-09-18T05:25:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil-prednisone-regimen,Synonym:,CP
2020-09-18T05:25:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine,NA,NA
2020-09-18T05:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,Synonym:,chlorhexidine/ethyl alcohol mouth rinse
2020-09-18T05:25:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash,US brand name:,Chloraprep
2020-09-18T05:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate,US brand name:,Peridex
2020-10-14T04:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate-skin-cleanser,Synonym:,skin cleanser with chlorhexidine gluconate
2020-10-14T04:43:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorine-dioxide-sterilization,NA,NA
2020-09-18T05:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid,Chemical structure:,"5-O-(3,4-dihydroxycinnamoyl)-L-quinic acid"
2020-09-18T05:25:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid,Synonym:,3-caffeoylquinic acid
2020-09-18T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquine,NA,NA
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Abbreviation:,CQS
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Chemical structure:,"benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-"
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Synonym:,chlorosulfaquinoxaline
2020-09-18T05:25:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide,Synonym:,chlorsulfaquinoxaline
2020-10-14T04:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-eq-cd28-cd3zeta-cd19t-expressing-car-t-lymphocytes,Synonym:,chlorotoxin-CD28-CD3z-CD19t-expressing CAR T cells
2020-09-18T05:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-indocyanine-green-imaging-agent-blz-100,Code name:,BLZ-100
2020-09-18T05:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-indocyanine-green-imaging-agent-blz-100,Code name:,CyTP 007
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,CLZ
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,CZT
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Abbreviation:,DCNU
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Synonym:,Chlorozotocyna
2020-09-18T05:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin,Synonym:,D-glucopyranose
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,Chemical structure:,2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,Foreign brand name:,Chlor-PZ
2020-09-18T05:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine,US brand name:,Thorazine
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,Chemical structure:,"4-chloro-4-((propylamino)carbonyl)benzenesulfonamidebenzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-"
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Diabinese
2020-09-18T05:26:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide,US brand name:,Prodiaben
2020-09-18T05:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorzoxazone,US brand name:,Paraflex
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Chemical structure:,"(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol9,10-secocholesta-5,7,10(19)-trien-3-beta-ol9,10-secocholesta-5,7,10(19)-trien-3-ol"
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,Calciol
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,delsterol
2020-09-18T05:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol,Synonym:,Vitamin D3
2020-09-18T05:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol-whey-protein-isolate-epa-dha-based-nutritional-supplement,Foreign brand name:,Nutrifriend 1100
2020-09-18T05:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol-whey-protein-isolate-epa-dha-based-nutritional-supplement,Synonym:,Nutrifriend Cachexia
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Chemical structure:,"1-((3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-3-(3-(methylamino)phenyl)urea"
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Code name:,YF-476
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Code name:,YF476
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Synonym:,CCK-B/gastrin receptor antagonist YF476
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Synonym:,cholecystokin 2 (CCK(2)) receptor antagonist YF476
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Synonym:,cholecystokinin B receptor antagonist YF476
2020-10-14T12:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476,Synonym:,sograzepide
2020-10-14T04:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholic-2244-d4-acid,Synonym:,"2,2,4,4-2H cholate"
2020-10-14T04:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholic-acid-24-13c,Synonym:,24-13C cholate
2020-10-14T04:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholic-acid-24-13c,Synonym:,carbon C 13 cholic acid
2020-09-18T05:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717,Abbreviation:,CHKA inhibitor TCD-717
2020-09-18T05:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717,Synonym:,TCD-717
2020-09-18T05:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate,Synonym:,Trisalicylate
2020-09-18T05:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate,US brand name:,Trilisate
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Acronym:,CHOP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,ACOP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,CAVP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,COPA
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,cyclophosphamide/doxorubicin/prednisone/vincristine
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,VACP
2020-09-18T05:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen,Synonym:,VCAP
2020-09-18T05:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chp-ny-eso-1-peptide-vaccine-imf-001,Code name:,IMF-001
2020-09-18T05:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chp-ny-eso-1-peptide-vaccine-imf-001,Synonym:,cholesterol-bearing hydrophobized pullulan NY-ESO-1 protein
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Chemical structure:,"3B-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin Dolivomycin D, 3B-O-(4-O-Acetyl-2, 6-dideoxy-3-C-methyl-.alpha.-L-arabino-hexopyranosyl)-7-methyl- (9CI)"
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,aburamycin B
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,antibiotic B 599
2020-09-18T05:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3,Synonym:,toyomycin
2020-10-14T04:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab,Code name:,RG-7802
2020-10-14T04:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab,Code name:,RG7802
2020-10-14T04:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab,Code name:,RO6958688
2020-10-14T04:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab,Code name:,WHO 10636
2020-10-14T04:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab,Synonym:,anti-CEA/CD3 bispecific antibody RO6958688
2020-09-18T05:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-lotion,US brand name:,Loprox Lotion
2020-09-18T05:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-oral,NA,NA
2020-10-14T04:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom,Code name:,CPX POM
2020-10-14T04:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom,Code name:,CPX-POM
2020-10-14T04:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom,Code name:,CPXPOM
2020-10-14T04:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom,Synonym:,ciclopirox prodrug
2020-10-14T04:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom,Synonym:,CPX prodrug
2020-09-18T05:27:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidan-herbal-capsule,Synonym:,Zedoary rhizome/Pseudobulbus cremastrae seu pleiones/Yatantzu/Strychni pulveratum/beehive/artificial bezoar/Bombyx mori/Danshen root/Radix astragali/Angelica/camphol alcohol capsule
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Abbreviation:,CDV
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Abbreviation:,HPMPC
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,Chemical structure:,1(3-hydroxy-2-phosphonomethoxypropyl) Cytosine
2020-09-18T05:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir,US brand name:,Vistide
2020-10-14T03:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciforadenant,Code name:,CPI-444
2020-10-14T03:23:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciforadenant,Synonym:,adenosine-A2A receptor-targeting agent CPI-444
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Abbreviation:,EMD 121974
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Chemical structure:,cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl)
2020-09-18T05:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide,Code name:,EMD 121974
2020-10-14T04:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel,Code name:,JNJ-68284528
2020-10-14T04:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel,Code name:,LCAR-B38M
2020-10-14T04:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel,Synonym:,autologous anti-BCMA CAR-T cells JNJ-68284528
2020-10-14T04:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel,Synonym:,autologous bi-epitope CAR T cells JNJ-68284528
2020-10-14T04:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel,Synonym:,LCAR-B38M-transduced CAR-T cells JNJ-68284528
2020-09-18T05:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine,Chemical structure:,N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine
2020-09-18T05:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine,US brand name:,Tagamet
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,Chemical structure:,N-[1(R)-(1-Naphthyl)ethyl]-N-[3-[3-(trifluoromethyl)phenyl]propyl]amine hydrochloride
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,Foreign brand name:,Mimpara
2020-09-18T05:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride,US brand name:,Sensipar
2020-10-14T04:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinnamomum-cassia-capsules,Synonym:,Cinnamomum aromaticum bark capsules
2020-09-18T05:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufagin,Synonym:,cinobufacin
2020-09-18T05:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufagin,Synonym:,cinobufacini
2020-10-14T04:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufotalin,Abbreviation:,CB
2020-10-14T04:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufotalin,Chemical structure:,"14,15b-epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate5b,20(22)-bufadienolide-14,15b-epoxy-3b,5a,16b-triol 16-acetate5-beta-bufa-20,22-dienolide, 14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-, 16-acetate"
2020-10-14T13:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintirorgon,Code name:,LYC-55716
2020-10-14T13:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintirorgon,Code name:,LYC55716
2020-10-14T13:16:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintirorgon,Synonym:,RORg agonist LYC-55716
2020-09-18T05:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox,Abbreviation:,IL13-PE38QQR
2020-09-18T05:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox,Synonym:,Interleukin-13 PE38QQR Immunotoxin|
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Abbreviation:,CPFX
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,Chemical structure:,"1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid"
2020-09-18T05:28:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin,US brand name:,Cipro
2020-09-18T05:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cirmtuzumab,Code name:,UC-961
2020-09-18T05:29:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cis-urocanic-acid,Abbreviation:,cis-UCA
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,Chemical structure:,"(1R,2R)-2-(2-carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene esteratracurium besylate 1R-cis,1R'-cis form"
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,Code name:,51W89
2020-09-18T05:29:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate,US brand name:,Nimbex
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Abbreviation:,CDDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Abbreviation:,DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Chemical structure:,"(SP-4-2)-diamminedichloroplatinumplatinum, diaminedichloro-, cis- (8CI)"
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Abiplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Blastolem
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Briplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Cisplatyl
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Citoplatino
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Citosin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Lederplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Metaplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Neoplatin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Placis
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platamine
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiblastin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiblastin-S
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinex
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinol- AQ
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platinol-AQ VHA Plus
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platiran
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platistin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Foreign brand name:,Platosin
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,CACP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloridoplatinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloro platinum (II)
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-diamminedichloroplatinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cis-dichloroammine Platinum (II)
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinous diamine dichloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum II
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,cis-platinum II diamine dichloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cismaplat
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cisplatina
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,CPDD
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Cysplatyna
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,DDP
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,PDD
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Peyrone's Chloride
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Peyrone's Salt
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,Platinoxan
2020-09-18T05:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin,Synonym:,platinum diamminodichloride
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Abbreviation:,CEG
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Code name:,MPI 5010
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Synonym:,CDDP/epi gel
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,Synonym:,cisplatin/epinephrine gel
2020-09-18T05:29:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant,US brand name:,IntraDose
2020-10-14T05:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-gemcitabine-regimen,Synonym:,gemcitabine/cisplatin regimen
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Code name:,SPI-077
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Code name:,SPI-77
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Synonym:,"Cisplatin, Liposomal"
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Synonym:,STEALTH Cisplatin
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Synonym:,STEALTH Liposomal Cisplatin
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Synonym:,STEALTH Liposomal Encapsulated Cisplatin
2020-10-14T12:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal,Synonym:,STEALTH Liposome Cisplatin
2020-10-14T04:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch,Code name:,PRV 111
2020-10-14T04:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch,Code name:,PRV-111
2020-10-14T04:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch,Code name:,PRV111
2020-10-14T04:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch,Synonym:,cisplatin drug-loaded patch
2020-10-14T04:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch,Synonym:,cisplatin transmucosal system
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Code name:,INT 230-6
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Code name:,INT230-6
2020-09-18T05:29:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6,Synonym:,cisplatin/vinblastine formulation with cell penetration enhancer INT230-6
2020-09-18T05:18:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,Chemical structure:,"(±)-1-(3-dimethylaminopropyl)-1- (4-fluorophenyl)-1,3 dihydroisobenzofuran-5-carbonitrile, HBr"
2020-09-18T05:18:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide,US brand name:,Celexa
2020-10-14T05:16:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citarinostat,Code name:,ACY-241
2020-10-14T05:16:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citarinostat,Synonym:,histone deacetylase inhibitor ACY-241
2020-09-18T05:29:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citatuzumab-bogatox,Code name:,VB6-845
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Abbreviation:,CDP-choline
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Synonym:,cytidine 5'-diphosphocholine
2020-09-18T05:29:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline,Synonym:,cytidine diphosphate choline
2020-10-14T12:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citrulline,Chemical structure:,2-amino-5-(carbamoylamino)pentanoic acid
2020-10-14T12:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citrulline,Synonym:,citrulline
2020-09-18T05:30:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab,Code name:,IMC-A12
2020-09-18T05:30:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab,Synonym:,anti-IGF-1R recombinant monoclonal antibody IMC-A12
2020-09-18T05:30:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ck2-targeting-synthetic-peptide-cigb-300,Code name:,CIGB-300
2020-09-18T05:30:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ck2-targeting-synthetic-peptide-cigb-300,Code name:,P15-tat
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Abbreviation:,2-CdA
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Abbreviation:,2CDA
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Chemical structure:,2-chloro-2-deoxyadenosine2-chlorodeoxyadenosine
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Code name:,RWJ-26251
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Foreign brand name:,Leustat
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Foreign brand name:,Leustatine
2020-09-18T05:30:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine,Synonym:,Cladribina
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Abbreviation:,CLARITH
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Chemical structure:,6-O-Methylerythromycin
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,Synonym:,Abbott-56268
2020-09-18T04:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin,US brand name:,Biaxin
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Code name:,OKI 179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Code name:,OKI-179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Synonym:,class-1/4 HDACi OKI-179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Synonym:,HDAC inhibitor OKI-179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Synonym:,HDAC1/4i OKI-179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Synonym:,HDACi 1/4 OKI-179
2020-10-14T04:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179,Synonym:,HDACi OKI-179
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Code name:,XL147
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Synonym:,PI3K inhibitor XL147
2020-09-18T05:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147,Synonym:,SAR245408
2020-09-18T13:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/claudiximab,Code name:,iMAB362
2020-09-18T13:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/claudiximab,Synonym:,claudiximab
2020-10-14T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clazakizumab,Code name:,ALD518
2020-10-14T03:50:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clazakizumab,Synonym:,anti-IL6 monoclonal antibody ALD518
2020-10-14T04:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine,US brand name:,Cleviprex
2020-09-18T05:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine-butyrate-injectable-emulsion,US brand name:,Cleviprex
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Abbreviation:,L-FMAU
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Chemical structure:,"1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyl-1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)thymine; 2,4(1H,3H)-pyrimidinedione2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil"
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Foreign brand name:,Levovir
2020-09-18T05:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine,Foreign brand name:,Revovir
2020-09-18T05:31:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-hydrocortisone-lotion,NA,NA
2020-09-18T05:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-phosphate,Chemical structure:,7(S)-chloro-7-deoxylincomycin 2-phosphate
2020-09-18T05:31:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-phosphate,Code name:,U 28508
2020-09-18T05:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clino-san-vaginal-lubricant,Foreign brand name:,Clino-San
2020-09-18T05:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clioquinol,Chemical structure:,5–chloro-7–iodo-quinolin-8-ol
2020-09-18T05:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clobetasol-propionate,NA,NA
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Code name:,CL2MDP
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Bonefos
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Clasteon
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Difosfonal
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Loron
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Mebonat
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Foreign brand name:,Ossiten
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Synonym:,"clodronic acid, disodium salt"
2020-09-18T05:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium,Synonym:,disodium dichloromethylene diphosphonate
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Abbreviation:,CAFdA
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,Chemical structure:,2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
2020-09-18T05:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine,US brand name:,Clolar
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Abbreviation:,CFB
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,Chemical structure:,2-(4-chlorophenoxy)-2-methylpropanoic acid ethyl esterethyl 2-(4-chlorophenoxy)-2-methylpropanoateethyl p-chlorophenoxyisobyturate
2020-09-18T04:02:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate,US brand name:,Atromid-S
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,Chemical structure:,"2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine citrate (1:1)"
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Clomid
2020-09-18T05:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate,US brand name:,Serophene
2020-09-18T05:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-containing-mucoadhesive-buccal-tablet,US brand name:,Clonidine Lauriad
2020-09-18T05:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-hydrochloride,US brand name:,Catapres
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,Abbreviation:,CLOBI
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,Synonym:,Plavix
2020-09-18T05:32:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate,US brand name:,Plavix
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Code name:,CBM 588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Code name:,CBM588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Code name:,MIYAIRI 588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,C. butyricum CBM 588 probiotic strain
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,C. butyricum MIYAIRI strain
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,C. butyricum MIYAIRI strain CBM 588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,C. butyricum strain MIYAIRI 588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,Clostridium butyricum MIYAIRI 588
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,Clostridium butyricum MIYAIRI 588 probiotic strain
2020-10-14T04:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain,Synonym:,MIYAIRI 588 strain of C. butyricum
2020-09-18T05:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-containing-probiotic,Synonym:,C. butyricum-containing probiotic
2020-09-18T05:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-novyi-nt-spores,Abbreviation:,C. novyi-NT spores
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,Abbreviation:,CLOT
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,Chemical structure:,1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Gyne-Lotrimin
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Lotrimin
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Mycelex
2020-09-18T05:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole,US brand name:,Mycelex Troche
2020-10-14T04:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clozapine,Chemical structure:,"8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine"
2020-09-18T05:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmet-car-mrna-electroporated-autologous-t-lymphocytes,Synonym:,cMet RNA CAR T cells
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Abbreviation:,CMF
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Abbreviation:,CTX/5-FU/MTX
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Code name:,cyclophosphamide/fluorouracil/methotrexate
2020-09-18T05:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen,Synonym:,cyclophosphamide-methotrexate-fluorouracil regimen
2020-10-14T04:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-ebv-adv-bkv-specific-cytotoxic-t-lymphocytes,Synonym:,CMV/EBV/ADV/BKV-specific CTLs
2020-10-14T04:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-n495-peptide,Abbreviation:,CMV-PEP
2020-09-18T05:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-pp65-peptide,Abbreviation:,CMV-PEP
2020-09-18T05:34:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-a0201-peptide-vaccine,NA,NA
2020-09-18T05:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-gb-plasmid-vaccine-asp0113,Code name:,ASP0113
2020-09-18T05:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-gb-plasmid-vaccine-asp0113,Synonym:,TransVax
2020-09-18T05:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cndo-109-activated-allogeneic-natural-killer-cells,Synonym:,CNDO-109-AANK cells
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Abbreviation:,NGR-hTNF
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Abbreviation:,NGR-TNF
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Synonym:,CNGRC peptide-tumor necrosis factor alpha conjugate
2020-09-18T05:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate,Synonym:,tumor vasculature-targeted tumor necrosis factor alpha
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Abbreviation:,vit B12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,B12 vitamin
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,cobalamin (1+)
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin B-12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin B12
2020-09-18T04:29:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin,Synonym:,vitamin-B12
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,GDC-0973
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,Code name:,XL518
2020-09-18T05:34:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib,US brand name:,Cotellic
2020-10-14T04:00:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobolimab,Code name:,TSR-022
2020-10-14T04:00:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobolimab,Synonym:,anti-TIM3 checkpoint inhibitor TSR-022
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Code name:,MRG-106
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Synonym:,anti-miR-155 oligonucleotide MRG-106
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Synonym:,LNA antimiR-155 MRG-106
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Synonym:,LNA-based antimiR-155 MRG-106
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Synonym:,microRNA-155 antagonist MRG-106
2020-10-14T04:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen,Synonym:,MiR-155 antagonist MRG-106
2020-09-18T05:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocculus-nux-vomica-tabacum-petroleum-extract,Foreign brand name:,Cocculine
2020-09-18T05:35:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocoa-extract,Synonym:,cocoa extract supplement
2020-09-18T05:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codeine-phosphate,Chemical structure:,"morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate"
2020-09-18T05:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codeine-phosphate,Synonym:,tricodein
2020-10-14T03:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codrituzumab,Code name:,GC33
2020-10-14T03:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codrituzumab,Synonym:,anti-glypican 3 monoclonal antibody GC33
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Abbreviation:,Co-Q10
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Chemical structure:,"2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione"
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,coenzyme-Q
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubidecarenone
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubiquinone
2020-09-18T05:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10,Synonym:,Ubiquinone 10
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Code name:,h6M24-vc0101
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Code name:,PF 06647020
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Code name:,PF 7020
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Code name:,PF-06647020
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Code name:,PF-7020
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Synonym:,ADC PF-06647020
2020-10-14T04:45:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin,Synonym:,ADC PF-7020
2020-10-14T04:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffea-arabica-extract,Synonym:,coffee bean extract
2020-10-14T04:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffea-arabica-extract,Synonym:,green coffee bean extract
2020-10-14T04:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffea-arabica-extract,Synonym:,green coffee beans extract
2020-09-18T05:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffee-dietary-supplement,NA,NA
2020-09-18T05:35:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine,Chemical structure:,"(S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide"
2020-10-14T03:22:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine-site-binding-agent-abt-751,Chemical structure:,N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
2020-10-14T03:22:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine-site-binding-agent-abt-751,Code name:,E7010
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free I 131-MIBG
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,cold contaminant-free iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,Synonym:,ultratrace iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131,US brand name:,Azedra
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,Chemical structure:,"1-hexaminium, N,N,N-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and N-2-propenyl-1-decanamine, hydrochlorideGT 31-104HB"
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,CholestaGel
2020-09-18T05:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride,US brand name:,Welchol
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Code name:,W-1929
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colimyscine
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,colistin sodium methanesulfonate
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,Synonym:,pentasodium colistinmethanesulfonate
2020-09-18T05:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium,US brand name:,Coly-Mycin
2020-09-18T05:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/collagen-aloe-vera-vitamin-e-lidocaine-topical-hydrogel,US brand name:,Regenecare
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Code name:,CYT-6091
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound recombinant human tumor necrosis factor
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound rhTNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,Synonym:,colloidal gold-bound TNF
2020-09-18T04:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor,US brand name:,Aurimmune
2020-10-14T04:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-modified-fluid-gelatin-plasma-substitute,Foreign brand name:,Gelaspan
2020-10-14T04:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-modified-fluid-gelatin-plasma-substitute,Synonym:,colloidal succinylated gelatine plasma substitute
2020-09-18T04:26:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream,US brand name:,Aveeno cream
2020-10-14T04:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018,Code name:,PolyPEPI 1018
2020-10-14T04:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018,Code name:,PolyPEPI-1018
2020-10-14T04:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018,Code name:,PolyPEPI1018
2020-10-14T04:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018,Synonym:,PolyPEPI1018 CRC peptide vaccine
2020-10-14T04:46:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018,Synonym:,PolyPEPI1018 CRC vaccine
2020-10-14T13:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-tumor-associated-peptides-vaccine-ima910,Code name:,IMA910
2020-10-14T03:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coltuximab-ravtansine,Code name:,SAR3419
2020-09-18T05:37:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/combretastatin-a1-diphosphate,Code name:,OXi4503
2020-10-14T04:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800,Code name:,VE 800
2020-10-14T04:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800,Code name:,VE-800
2020-10-14T04:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800,Synonym:,bacterial consortium-based formulation VE800
2020-10-14T04:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800,Synonym:,LBP VE800
2020-10-14T04:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800,Synonym:,live biotherapeutic product VE800
2020-09-18T11:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210,Code name:,ALXN 1210
2020-09-18T11:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210,Code name:,ALXN1210
2020-09-18T11:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210,Synonym:,complement C5 inhibitor ALXN1210
2020-09-18T11:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210,US brand name:,Ultomiris
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Abbreviation:,CKI
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Synonym:,KS injection
2020-09-18T05:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection,Synonym:,Yanshu injection
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,CSL solution
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,Hartmann's solution
2020-09-18T05:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution,Synonym:,"sodium chloride, potassium chloride, calcium chloride dihydrate, sodium lactate 60% solution"
2020-09-18T05:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab,Code name:,AMG 655
2020-09-18T05:37:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab,Synonym:,anti-TRAIL receptor 2 monoclonal antibody AMG 655
2020-10-14T04:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conbercept,Code name:,KH 902
2020-10-14T04:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conbercept,Code name:,KH-902
2020-10-14T04:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conbercept,Code name:,KH902
2020-10-14T04:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conbercept,Synonym:,UNII: 1P05PW62F3
2020-09-18T04:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-beet-crystals,US brand name:,BeetElite NeoShot
2020-09-18T05:38:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-fortified-collagen-protein-hydrolysate-liquid-supplement,US brand name:,Pro-Stat 101
2020-10-14T04:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-lingzhi-mushroom-extract,Foreign brand name:,Mikei Red Reishi Essence EX
2020-10-14T04:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-lingzhi-mushroom-extract,Synonym:,concentrated Ganoderma lucidum extract
2020-10-14T04:46:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-lingzhi-mushroom-extract,Synonym:,concentrated red Reishi mushroom extract
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Code name:,BA 3011
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Code name:,BA-3011
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Code name:,BA3011
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Synonym:,ADC BA3011
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Synonym:,CAB anti-AXL ADC BA3011
2020-10-14T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011,Synonym:,CAB-AXL-ADC BA3011
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,Ad5/3-delta24
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,CRAd 3/5-delta
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Abbreviation:,CRAd 5/3-delta24
2020-09-18T05:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24,Synonym:,conditionally replicative adenovirus 3/5-delta
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Abbreviation:,EST
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Code name:,Tag-39
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Conestron
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,Foreign brand name:,Sodestrin
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Femest
2020-09-18T05:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,US brand name:,Premarin
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Abbreviation:,CE/BZA
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,Synonym:,CE/BZA formulation
2020-09-18T05:38:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene,US brand name:,Duavee
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Abbreviation:,CLA
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Chemical structure:,"9,11-octadecadienoic acid"
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-conjugated linoleic acid"
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,Synonym:,"9,11-linoleic acid"
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Clarinol
2020-09-18T05:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid,US brand name:,Pamolyn 300
2020-09-18T05:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contrast-agent-cs-1000,Code name:,CS-1000
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Abbreviation:,Ad-p53
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Abbreviation:,Ad5CMV-p53
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Code name:,INGN-201
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Code name:,RPR/INGN-201
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Synonym:,Adeno-p53
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,Synonym:,Adenovirus p53
2020-10-14T03:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec,US brand name:,ADVEXIN
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Chemical structure:,"5-pyrimidinecarboxamide, 2-amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, hydrochloride (1:2)"
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,BAY-80-6946 dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,Synonym:,copanlisib dihydrochloride
2020-09-18T01:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride,US brand name:,Aliqopa
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Abbreviation:,COPDAC
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/Oncovin/prednisone/dacarbazine regimen
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine sulfate (Oncovin)/prednisone/dacarbazine
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine sulfate/prednisone/dacarbazine
2020-09-18T05:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen,Synonym:,cyclophosphamide/vincristine/prednisone/dacarbazine regimen
2020-09-18T05:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-abv-regimen,Synonym:,COPP-ABV
2020-09-18T05:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-abv-regimen,Synonym:,Cytoxan-Oncovin-procarbazine-prednisone/adriamycin-bleomycin-vinblastine regimen
2020-10-14T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-alternating-with-abv-regimen,Synonym:,COPP-ABV
2020-10-14T04:46:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-alternating-with-abv-regimen,Synonym:,Cytoxan-Oncovin-procarbazine-prednisone/adriamycin-bleomycin-vinblastine regimen
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Abbreviation:,CTX/PCB/PRED/VCR
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Acronym:,COPP
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Synonym:,cyclophosphamide-Oncovin-procarbazine-prednisone regimen
2020-09-18T05:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen,Synonym:,cyclophosphamide/prednisone/procarbazine/vincristine
2020-10-14T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper,Abbreviation:,Cu
2020-10-14T04:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper,Synonym:,copper
2020-10-14T04:47:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-64-cu-dota-daratumumab,Synonym:,64Cu-DOTA-daratumumab
2020-10-14T04:47:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-64-cu-dota-daratumumab,Synonym:,copper Cu 64 daratumumab
2020-09-18T05:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-chloride-formulation,Synonym:,CuCl2 formulation
2020-10-14T03:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-61-atsm,NA,NA
2020-09-18T05:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-atsm,Abbreviation:,62Cu-ATSM
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Abbreviation:,62Cu-ETS
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Synonym:,62Cu-ethylglyoxal bis
2020-09-18T05:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone,Synonym:,62Cu-ethylglyoxal bis(thiosemicarbazone)
2020-09-18T05:39:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ptsm,Abbreviation:,62Cu-PTSM
2020-09-18T05:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-anti-cea-monoclonal-antibody-m5a,Synonym:,64Cu-DOTA-M5A
2020-09-18T05:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-anti-cea-monoclonal-antibody-m5a,Synonym:,Cu 64-M5A
2020-09-18T05:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm,Chemical structure:,Cu-64(II)-diacetyl-bis(N-4-methylthiosemicarbazone)
2020-09-18T05:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm,Synonym:,(64)Cu-ATSM
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,(64)Cu-CB-TE1A1P-PEG4-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4 LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,(64)Cu-labeled CB-TE1A1P-PEG4-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,64Cu-CB-TE1A1P-PEG4-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,64Cu-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,64Cu-PEG4-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,copper Cu 64-LLP2A
2020-10-14T04:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a,Synonym:,Cu[64]-CB-TE1A1P-PEG4-LLP2A
2020-09-18T05:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ae105,Synonym:,64Cu-DOTA-AE105
2020-10-14T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-alendronate,Synonym:,[64Cu]-DOTA-alendronate
2020-10-14T04:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-alendronate,Synonym:,64Cu-DOTA-alendronate
2020-09-18T05:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-anti-her3-monoclonal-antibody-u3-1287,Abbreviation:,64Cu-DOTA-U3-1287
2020-09-18T05:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-anti-her3-monoclonal-antibody-u3-1287,Synonym:,[64Cu]-DOTA-AMG 888
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,64 Cu-DOTA B-Fab
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,64 Cu-DOTA DS6 B-Fab
2020-09-18T05:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab,Synonym:,Cu 64-labeled B-Fab DS6 antibody-like binding protein
2020-09-18T05:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-daratumumab,Synonym:,64Cu-DOTA-daratumumab
2020-09-18T05:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-daratumumab,Synonym:,copper Cu 64 daratumumab
2020-10-14T04:47:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ecl1i,Synonym:,64Cu-d(LGTFLKC)
2020-10-14T04:47:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ecl1i,Synonym:,64Cu-DOTA-ECL1i
2020-09-18T05:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-rituximab,Synonym:,64Cu-DOTA-rituximab
2020-09-18T05:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-trastuzumab,Synonym:,64Cu-DOTA-trastuzumab
2020-10-14T04:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-nota-psmai-peg-cy55-c-dots,Synonym:,(64Cu)-labeled PSMA-targeting -PEG Cy5.5-C' dots
2020-10-14T04:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-nota-psmai-peg-cy55-c-dots,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer
2020-10-14T04:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-nota-psmai-peg-cy55-c-dots,Synonym:,64Cu-NOTA-PSMA-PEG-Cy5.5-C' dots
2020-10-14T04:47:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-nota-psmai-peg-cy55-c-dots,Synonym:,64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots
2020-09-18T05:40:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-plerixafor,Synonym:,64-Cu-plerixafor
2020-09-18T05:40:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-tp3805,Abbreviation:,Cu-64-TP3805
2020-09-18T05:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-trastuzumab,Synonym:,Cu-64 labeled trastuzumab
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Abbreviation:,67Cu-SARTATE
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Synonym:,67Cu-labelled MeCOSar-Tyr3-octreotate
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Synonym:,copper 67 SARTATE
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Synonym:,copper Cu 67 TATE
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Synonym:,copper Cu 67-SARTATE
2020-10-14T04:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate,Synonym:,Cu-67 SARTATE
2020-09-18T05:41:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-gluconate,Synonym:,cupric gluconate
2020-09-18T05:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-supplement,Abbreviation:,Cu
2020-09-18T05:41:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-supplement,Synonym:,copper
2020-10-14T04:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-car-t-cells,Synonym:,CB-derived CAR T cells
2020-10-14T04:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-car-t-cells,Synonym:,cord blood CAR T cells
2020-10-14T04:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-cmv-adv-ebv-bkv-specific-cytotoxic-t-lymphocytes,Synonym:,allogeneic cord blood-derived CMV/AdV/EBV/BKV-specific CTLs
2020-10-14T04:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-cmv-adv-ebv-bkv-specific-cytotoxic-t-lymphocytes,Synonym:,cord blood-derived CMV/AdV/EBV/BKV-specific T cells
2020-10-14T04:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-cmv-adv-ebv-bkv-specific-cytotoxic-t-lymphocytes,Synonym:,UCB-derived CMV/AdV/EBV/BKV-specific T cells
2020-10-14T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-expanded-allogeneic-natural-killer-cells,Synonym:,allogeneic CB-derived ex vivo-expanded NK cells
2020-10-14T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-expanded-allogeneic-natural-killer-cells,Synonym:,CB-derived expanded allogeneic NK cells
2020-10-14T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-expanded-allogeneic-natural-killer-cells,Synonym:,UCB-derived expanded allogeneic NK cells
2020-10-14T04:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-expanded-allogeneic-natural-killer-cells,Synonym:,umbilical cord blood-derived expanded allogeneic natural killer cells
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Abbreviation:,COR
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Chemical structure:,3'-dA-CE Phosphoramidite3-dAdenosine3'-Deoxyadenosine3'-Deoxyadenosine-5'-triphosphate9-Cordyceposidoadenine
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Synonym:,Cordycepine
2020-09-18T05:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin,Synonym:,Kordicepin
2020-09-18T05:42:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coriolus-versicolor-extract,Synonym:,Yunzhi extract
2020-10-14T04:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticoliberin,Synonym:,corticotropin-releasing factor
2020-10-14T04:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticoliberin,Synonym:,CRF
2020-10-14T04:48:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticoliberin,Synonym:,CRH
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,corticoliberin
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,corticorelin
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,hCRF
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,recombinant human corticotropin releasing factor
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,Synonym:,synthetic human corticotropin-releasing factor
2020-09-18T05:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate,US brand name:,Xerecept
2020-10-14T03:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin,Abbreviation:,CCTROP
2020-10-14T03:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin,Synonym:,ACTH
2020-10-14T03:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin,Synonym:,acthar
2020-10-14T03:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin,Synonym:,adrenocorticotropin
2020-10-14T03:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin,Synonym:,corticotropin
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,corticotropin-releasing factor
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,CRF
2020-09-18T05:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone,Synonym:,CRH
2020-09-18T05:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corynebacterium-granulosum-p40,Synonym:,Adjuvant P40
2020-10-14T03:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cosibelimab,Code name:,CK 301
2020-10-14T03:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cosibelimab,Code name:,CK-301
2020-10-14T05:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cositecan,Code name:,BNP1350
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Chemical structure:,"1,2-benzopyrone2H-1-benzopyran-2-one"
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Synonym:,chromen-2-one
2020-09-18T05:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin,Synonym:,tonka bean camphor
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Abbreviation:,CVA21
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V 937
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V-937
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Code name:,V937
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,Foreign brand name:,Cavatak
2020-09-18T05:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21,US brand name:,Cavatak
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,Abbreviation:,CVA21
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,Code name:,V 937
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,Code name:,V-937
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,Code name:,V937
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,Foreign brand name:,Cavatak
2020-10-14T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937,US brand name:,Cavatak
2020-09-18T05:43:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cp-724714,NA,NA
2020-10-14T04:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-28-oligodeoxynucleotide,Abbreviation:,CpG ODN
2020-09-18T05:43:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide,Abbreviation:,CpG ODN
2020-09-18T05:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168,Abbreviation:,CpG ODN GNKG168
2020-09-18T05:43:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168,Code name:,GNKG168
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV 281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV-281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Code name:,DV281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Synonym:,CpG ODN TLR9 agonist DV281
2020-09-18T05:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281,Synonym:,TLR9 agonist DV281
2020-09-18T05:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cr2-fh-fusion-protein-tt30,Code name:,TT30
2020-09-18T05:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cr2-fh-fusion-protein-tt30,Synonym:,recombinant chimeric human fusion protein TT30
2020-09-18T05:43:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate,Chemical structure:,N-(aminoiminomethyl)-N-methylglycine monohydrate
2020-09-18T05:43:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate,Synonym:,creatine supplement
2020-09-18T05:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib,Code name:,CP-868596
2020-09-18T05:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib,Synonym:,PDGFR inhibitor CP-868596
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Chemical structure:,"[1-[2-[5-(3-methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine monobenzenesulfonate4-piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-, benzenesulfonate (1:1)"
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Code name:,"CP-868,596-26"
2020-09-18T05:44:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate,Code name:,CP-86859626
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Chemical structure:,2-(9-oxoacridin-10yl)acetic acidsodium 2-(9-oxoacridin-10yl) acetate
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Foreign brand name:,Virexxa
2020-09-18T05:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium,Synonym:,cridanimod
2020-10-14T04:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-edited-hpv16-18-e6-e7-plasmid,Synonym:,CRISPR/Cas9 targeting HPV16/18 E6 and E7 genes
2020-10-14T04:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-edited-hpv16-18-e6-e7-plasmid,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1 plus CRISPR/Cas9-HPV18 E6/ E7T2
2020-10-14T04:48:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-edited-hpv16-18-e6-e7-plasmid,Synonym:,CRISPR/Cas9-HPV16 E6/E7T1;CRISPR/Cas9-HPV18 E6/ E7T2
2020-10-14T04:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells,Synonym:,anti-mesothelin CAR T cells
2020-10-14T04:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells,Synonym:,anti-mesothelin CAR-transduced CRISPR-Cas9-edited T cells
2020-10-14T04:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells,Synonym:,CRISPR-Cas9 mediated PD-1 and TCR gene-knocked-out mesothelin-directed CAR-T cells
2020-10-14T04:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells,Synonym:,CRISPR-Cas9-mediated anti-mesothelin CAR T cells
2020-10-14T04:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells,Synonym:,CRISPR-Cas9-mediated gene-edited anti-mesothelin CAR-T cells
2020-09-18T05:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab,Code name:,SEG101
2020-09-18T05:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab,Code name:,SelG1
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Chemical structure:,"2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H- pyrazol-4-yl]3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4- yl)pyridin-2-amine"
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Code name:,PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Code name:,PF-2341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,c-met/hepatocyte growth factor receptor tyrosine kinase inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,c-met/HGFR tyrosine kinase inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,Synonym:,MET Tyrosine Kinase Inhibitor PF-02341066
2020-09-18T05:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib,US brand name:,Xalkori
2020-09-18T07:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220,Code name:,CC 220
2020-09-18T07:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220,Code name:,CC-220
2020-09-18T07:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220,Synonym:,CRL4 cereblon E3 ubiquitin ligase modulator CC-220
2020-09-18T07:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220,Synonym:,CRL4(CRBN) E3 ubiquitin ligase modulator CC-220
2020-09-18T07:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220,Synonym:,CRL4CRBN E3 ubiquitin ligase modulator CC-220
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP 303
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,Code name:,SP-303
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Fulyzaq
2020-09-18T05:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer,US brand name:,Virend
2020-09-18T05:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin,Code name:,EPC2407
2020-09-18T05:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin,Synonym:,microtubulin inhibitor EPC2407
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Code name:,PA 101
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Code name:,PA101
2020-09-18T05:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101,Synonym:,sodium cromoglicate inhalant PA101
2020-09-18T05:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crotoxin,NA,NA
2020-10-14T04:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crth2-antagonist-act-774312,Code name:,ACT 774312
2020-10-14T04:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crth2-antagonist-act-774312,Code name:,ACT-774312
2020-10-14T04:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crth2-antagonist-act-774312,Code name:,ACT774312
2020-10-14T04:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crth2-antagonist-act-774312,Synonym:,prostaglandin D2 receptor 2 antagonist ACT-774312
2020-09-18T05:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crystalline-genistein-formulation-axp107-11,Code name:,AXP107-11
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Chemical structure:,"4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide"
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ 945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ-945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Code name:,BLZ945
2020-09-18T05:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945,Synonym:,"4-[2((1R,2R)-2-hydroxycyclohexylamino)-benzothiazol-6-yloxyl]-pyridine- 2-carboxylic acid methylamide"
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC 3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC-3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Code name:,DCC3014
2020-09-18T05:45:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014,Synonym:,CSF-1R inhibitor DCC-3014
2020-10-14T04:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249,Code name:,BMS 986249
2020-10-14T04:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249,Code name:,BMS-986249
2020-10-14T04:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249,Code name:,BMS986249
2020-10-14T04:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249,Synonym:,CTLA-4 probody BMS-986249
2020-10-14T04:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249,Synonym:,protease-activated anti-CTLA-4 antibody prodrug BMS-986249
2020-09-18T05:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctp-37-dt-vaccine,Foreign brand name:,Avicine
2020-09-18T05:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctp-37-dt-vaccine,Synonym:,CTP37-DT
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Abbreviation:,CU
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Chemical structure:,"(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione"
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Code name:,C.I. 75300
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,C.I. Natural Yellow 3
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,Diferuloylmethane
2020-09-18T05:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin,Synonym:,Turmeric Yellow
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,Synonym:,curcumin gel
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,Synonym:,topical curcumin
2020-09-18T05:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel,US brand name:,Psoria-Gold
2020-10-14T04:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-chondroitin-sulfate-hyaluronic-acid-quercetin-soft-gels,Foreign brand name:,Ialuril
2020-10-14T04:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-chondroitin-sulfate-hyaluronic-acid-quercetin-soft-gels,Foreign brand name:,Ialuril Soft Gels
2020-10-14T04:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-doxorubicin-encapsulating-nanoparticle-imx-110,Code name:,IMX 110
2020-10-14T04:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-doxorubicin-encapsulating-nanoparticle-imx-110,Code name:,IMX-110
2020-10-14T04:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-doxorubicin-encapsulating-nanoparticle-imx-110,Code name:,IMX110
2020-10-14T04:48:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-doxorubicin-encapsulating-nanoparticle-imx-110,Synonym:,Stat3/NF-kB/poly-tyrosine kinase inhibitor/doxorubicin-encapsulating nanoparticle IMX-110
2020-10-14T04:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cusatuzumab,Code name:,ARGX-110
2020-10-14T04:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cusatuzumab,Synonym:,anti-CD70 monoclonal antibody ARGX-110
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Code name:,ISIS 112989
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Code name:,OGX-011
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense Clusterin
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense Testosterone-Repressed Prostate Message 2
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,Antisense TRPM-2
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,clusterin antisense oligonucleotide
2020-09-18T05:46:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium,Synonym:,TRPM-2 Antisense
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,CTX/PRED/VCR
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,CVP
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Abbreviation:,VCP
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Synonym:,cyclophosphamide-vincristine-prednisone regimen
2020-09-18T05:46:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen,Synonym:,cyclophosphamide/prednisone/vincristine
2020-09-18T05:46:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069,Code name:,AZD5069
2020-09-18T05:46:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069,Synonym:,CXCR2 antagonist AZD5069
2020-10-14T04:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr1-2-inhibitor-sx-682,Chemical structure:,(2-(((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic acid
2020-10-14T04:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr1-2-inhibitor-sx-682,Code name:,SX 682
2020-10-14T04:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr1-2-inhibitor-sx-682,Code name:,SX-682
2020-10-14T04:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr1-2-inhibitor-sx-682,Code name:,SX682
2020-10-14T04:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr2-antagonist-qbm076,Code name:,QBM 076
2020-10-14T04:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr2-antagonist-qbm076,Code name:,QBM-076
2020-10-14T04:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr2-antagonist-qbm076,Code name:,QBM076
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Code name:,BKT140
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Code name:,BL-8040
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Synonym:,CXCR4 antagonist BKT140
2020-09-18T05:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040,Synonym:,CXCR4 chemokine receptor antagonist BKT140
2020-09-18T05:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311,Code name:,USL311
2020-09-18T05:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311,Synonym:,CXCR4 inhibitor USL311
2020-10-14T04:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-e-selectin-antagonist-gmi-1359,Code name:,GMI 1359
2020-10-14T04:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-e-selectin-antagonist-gmi-1359,Code name:,GMI-1359
2020-09-18T05:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-msx-122,Code name:,MSX-122
2020-09-18T05:47:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-msx-122,Synonym:,CXC chemokine receptor 4 inhibitor MSX-122
2020-09-18T04:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-pol6326,Code name:,POL6326
2020-09-18T04:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-pol6326,Synonym:,CXCR4 inhibitor POL6326
2020-10-14T04:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-q-122,Code name:,MSX-122
2020-10-14T04:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-q-122,Synonym:,CXC chemokine receptor 4 inhibitor MSX-122
2020-09-18T08:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001,Chemical structure:,"(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine"
2020-09-18T08:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001,Code name:,AMD-070
2020-09-18T08:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001,Code name:,AMD-11070
2020-09-18T08:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001,Code name:,X4P 001
2020-09-18T08:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001,Code name:,X4P001
2020-09-18T05:47:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-peptide-antagonist-ly2510924,Code name:,LY2510924
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,Synonym:,vitamin B12
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Berubigen
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Betalin 12
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Calomist
2020-09-18T04:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin,US brand name:,Cobavite
2020-09-18T05:47:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin-dexamethasone-gentamicin-procaine-formulation,Synonym:,cyanocobalamin/dexamethasone/gentamicin/procaine oral formulation
2020-09-18T05:47:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin-dexamethasone-gentamicin-procaine-formulation,Synonym:,quadruple mixture
2020-09-18T05:47:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-b1-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,CCNB1 peptide-pulsed autologous dendritic cell vaccine
2020-10-14T04:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-8-19-inhibitor-bcd-115,Code name:,BCD 115
2020-10-14T04:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-8-19-inhibitor-bcd-115,Code name:,BCD-115
2020-10-14T04:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-8-19-inhibitor-bcd-115,Code name:,BCD115
2020-10-14T04:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-8-19-inhibitor-bcd-115,Synonym:,CDK8/19 inhibitor BCD 115
2020-10-14T04:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-inhibitor-pf-06873600,Code name:,PF 06873600
2020-10-14T04:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-inhibitor-pf-06873600,Code name:,PF-06873600
2020-10-14T04:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-inhibitor-pf-06873600,Synonym:,CDK inhibitor PF-06873600
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Chemical structure:,"10,11delta-amitriptyline hydrochloride1-propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)propyl(dimethyl)ammonium chloride"
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Code name:,FR2100873
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,cloben
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,Synonym:,Novo-Cycloprine
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Cycloflex
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexeril
2020-09-18T05:47:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride,US brand name:,Flexiban
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Code name:,CRLX101
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Code name:,IT-101
2020-09-18T05:48:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101,Synonym:,cyclodextrin-based polymer-camptothecin IT-101
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,ACP
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,ACPC
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,CL
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Abbreviation:,CYL
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Chemical structure:,1-aminocyclopentanecarboxylic acid
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Code name:,CB-1639
2020-09-18T05:48:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine,Synonym:,1-Aminocyclopentane
2020-09-18T05:48:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclopentenyl-cytosine,Abbreviation:,CPEC
2020-09-18T05:48:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclopentenyl-cytosine,Chemical structure:,"2(1H)-pyrimidinone, 4-amino-1-[4, 5-dihydroxy- 3-(hydroxymethyl)-2-cyclopenten-1-yl]-"
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Abbreviation:,CTX
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Code name:,WR-138719
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Carloxan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cicloxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,CYCLO-cell
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cycloblastin
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cycloblastine
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclophosphane
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclostin
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cyclostine
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Cytophosphan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Fosfaseron
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Genoxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Genuxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Foreign brand name:,Ledoxina
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,(-)-cyclophosphamide
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Ciclofosfamida
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Ciclofosfamide
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Claphene
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,CP monohydrate
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophospham
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphamid monohydrate
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphamidum
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cyclophosphanum
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Cytophosphane
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Genoxal
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Mitoxan
2020-09-18T05:48:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide,Synonym:,Syklofosfamid
2020-10-14T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide-epirubicin-vincristine-prednisone,Synonym:,Cyclophosphamide-Epirubicin-Oncovin-Prednisone regimen
2020-10-14T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide-epirubicin-vincristine-prednisone,Synonym:,Cyclophosphamide/Epirubicin/Vincristine/Prednisone
2020-10-14T04:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine,Chemical structure:,"(+)-4-Amino-3-isoxazolidinone3-Isoxazolidinone, 4-amino-, d-"
2020-10-14T04:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine,Synonym:,Oxamycin
2020-10-14T04:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine,Synonym:,Tisomycin
2020-10-14T04:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine,US brand name:,Seromycin
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CsA
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CYA
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Abbreviation:,CYSP
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Code name:,27-400
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Code name:,OL 27-400
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,ciclosporin
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,cyclosporin
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,Synonym:,cyclosporin A
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Gengraf
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Neoral
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Sandimmun
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,Sandimmune
2020-09-18T05:48:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine,US brand name:,SangCya
2020-09-18T05:48:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine-ophthalmic-emulsion,US brand name:,Restasis
2020-09-18T05:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyl-02-plasmid-dna,Synonym:,CYL-02
2020-10-14T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-208,Code name:,ODM 208
2020-10-14T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-208,Code name:,ODM-208
2020-10-14T04:50:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-208,Code name:,ODM208
2020-10-14T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-209,Code name:,ODM 209
2020-10-14T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-209,Code name:,ODM-209
2020-10-14T04:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-209,Code name:,ODM209
2020-09-18T05:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-androgen-receptor-inhibitor-odm-204,Code name:,ODM 204
2020-09-18T05:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-androgen-receptor-inhibitor-odm-204,Code name:,ODM-204
2020-10-14T04:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-cyp11b2-inhibitor-lae001,Code name:,CFG920
2020-09-18T05:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-inhibitor-cfg920,Code name:,CFG920
2020-09-18T05:49:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-lyase-inhibitor-asn001,Code name:,ASN001
2020-09-18T05:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproheptadine-hydrochloride,US brand name:,Periactin
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Abbreviation:,CPTR
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Abbreviation:,CyPat
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Code name:,SH 714
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Andro-Diane
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Androcur
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Cyprone
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Cyprostat
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Foreign brand name:,Dianette
2020-09-18T05:49:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate,Synonym:,cyproterone
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Code name:,IMN1207
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Foreign brand name:,Immunocal
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Synonym:,cysteine-rich protein formulation
2020-09-18T05:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207,Synonym:,Cysteine-Rich Whey-Derived Protein Formulation
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Chemical structure:,"4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1H)-one"
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Code name:,RX-3117
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Code name:,TV-1360
2020-09-18T05:49:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117,Synonym:,fluorocyclopentenylcytosine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Abbreviation:,ARA-C
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Chemical structure:,"1-.beta.-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone1.beta.-D-arabinofuranosylcytosine1-beta-D-arabinofuranosylcytosine2(1H)-pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone"
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,CHX-3311
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U 19920
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U-19920
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,U-29920A HCl
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Code name:,WR-28453
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Alexan
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,ARA-cell
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Arabine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Aracytin
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Aracytine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Cytarbel
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Cytosar
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Erpalfa
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Starasid
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Foreign brand name:,Udicil
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,.beta.-Cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,arabinofuranosylcytosine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,arabinosylcytosine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,aracytidine
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,beta-cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytarabine hydrochloride
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytarabinum
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine arabinosine hydrochloride
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,cytosine-.beta.-arabinoside
2020-09-18T05:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine,Synonym:,Tarabine PFS
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Code name:,DTC 101
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Foreign brand name:,DepoCyte
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Synonym:,DepoFoam-encapsulated cytarabine
2020-09-18T05:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome,Synonym:,liposomal cytarabine
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Chemical structure:,"(2R,4S)-4-amino-1-[5-O-[2-oxo-4-(4-pyridyl)-1,3,2-dioxaphosphorinan-2-yl]-beta-d-arabinofuranosyl]-2(1H)-pyrimidinone"
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Code name:,MB07133
2020-09-18T05:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133,Synonym:,cytarabine prodrug MB07133
2020-09-18T05:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytochlor,Abbreviation:,CldC
2020-10-14T04:50:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-based-biologic-agent-irx-2,NA,NA
2020-09-18T05:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells,Acronym:,CIK cells
2020-09-18T05:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells,Synonym:,autologous cytokine-induced killer cells
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,activated veto cells
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,activated veto T cells
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,veto CD8-positive T cells
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,veto cell
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,veto cells
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,veto-enhanced CTL
2020-10-14T04:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells,Synonym:,veto-enhanced cytotoxic T cell
2020-09-18T05:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-ie-1-specific-cytotoxic-t-lymphocytes,Abbreviation:,CMV IE-1-specific CTL
2020-09-18T05:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-pp65-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Chemical structure:,"(+)-4-Amino-3-isoxazolidinone3-Isoxazolidinone, 4-amino-, d-"
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Synonym:,Oxamycin
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,Synonym:,Tisomycin
2020-09-18T05:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine,US brand name:,Seromycin
2020-09-18T06:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-methionine-formulation-mrx-1024,Code name:,MRX-1024
2020-10-14T13:37:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-vitamin,Abbreviation:,VIT D
2020-10-14T13:37:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-vitamin,Synonym:,D vitamin
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Abbreviation:,D1/3 MAGE3 HIS
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,D1/3-Mage-3 Fusion Protein
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,D1/3-Mage-3 Fusion Protein (SB MAGE-3)
2020-09-18T05:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein,Synonym:,SB MAGE-3
2020-09-18T05:51:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dab389-epidermal-growth-factor,Acronym:,DAB389 EGF
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Chemical structure:,"beta-alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, methanesulfonate"
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Code name:,BIBR 1048 MS
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,Code name:,BIBR 1048MS
2020-09-18T05:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate,US brand name:,Pradaxa
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Code name:,GSK2118436 methane sulfate salt
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Synonym:,dabrafenib methanesulfonate
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,Synonym:,GSK2118436B
2020-09-18T05:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib,US brand name:,Tafinlar
2020-10-14T04:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate,Code name:,GSK2118436 methane sulfate salt
2020-10-14T04:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate,Synonym:,dabrafenib methanesulfonate
2020-10-14T04:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate,Synonym:,GSK2118436B
2020-10-14T04:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate,US brand name:,Tafinlar
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Abbreviation:,DIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Abbreviation:,DTIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Chemical structure:,"1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide5-(dimethyltriazeno)imidazole-4-carboxamide5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide"
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Code name:,WR-139007
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Asercit
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Dacatic
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Deticene
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Detimedac
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Foreign brand name:,Fauldetic
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Biocarbazine
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazina
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazina Almirall
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dacarbazine - DTIC
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dakarbazin
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl (triazeno) imidazolecarboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl Triazeno Imidazol Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Dimethyl Triazeno Imidazole Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Imidazole Carboxamide
2020-09-18T05:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine,Synonym:,Imidazole Carboxamide Dimethyltriazeno
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Code name:,huS2C6
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Code name:,SGN-40
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Synonym:,anti-huCD40 mAb
2020-09-18T05:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab,Synonym:,monoclonal antibody SGN-40
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Code name:,NC-4016
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Synonym:,DACH-Pt/m NC-4016
2020-09-18T05:51:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016,Synonym:,diaminocyclohexane platinum micelle NC-4016
2020-09-18T05:51:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-polymer-platinate-ap5346,Code name:,AP5346
2020-09-18T05:51:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclatasvir,Abbreviation:,DCV
2020-09-18T05:51:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclatasvir,Code name:,BMS-790052
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Abbreviation:,MOAB anti-Tac
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,anti-Tac
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,Anti-Tac Humanized Monoclonal Antibody
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,anti-Tac monoclonal antibody
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,Synonym:,Dacliximab
2020-09-18T05:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab,US brand name:,Zenapax
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Chemical structure:,(2E)-N-(4-((3-chloro-4-fluorophenyl)Amino)-7-methoxyquinazolin-6-yl)-4-piperidin-1-ylbut-2-enamide
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Code name:,PF-00299804
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Code name:,PF-00299804-03
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,Synonym:,EGFR inhibitor PF-00299804
2020-09-18T05:51:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib,US brand name:,Vizimpro
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Abbreviation:,DACT
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Chemical structure:,"2-bis[cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3"
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Foreign brand name:,Lyovac Cosmegen
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,ACT-D
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin C1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin D
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin I1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin IV
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin X 1
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,actinomycin-[thr-val-pro-sar-meval]
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,AD
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,dactinomycine
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,Synonym:,meractinomycin
2020-09-18T05:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin,US brand name:,Cosmegen
2020-10-14T13:05:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactolisib,Code name:,BEZ235
2020-10-14T13:05:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactolisib,Synonym:,NVP-BEZ235
2020-09-18T05:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dakins-solution,Synonym:,aqueous solution of sodium hypochlorite
2020-09-18T05:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dakins-solution,Synonym:,Dakin's fluid
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Code name:,ACE-041
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Synonym:,activin receptor-like kinase 1 inhibitor ACE-041
2020-09-18T05:52:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept,Synonym:,ALK1-Fc fusion protein ACE-041
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,Chemical structure:,"ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-α-D-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-α-D-mannopyranosyl-N15-methyl-"
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,Code name:,A-A-1
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,Code name:,BI397
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,Code name:,"MDL 63,397"
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,Code name:,VER001
2020-10-14T04:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin,US brand name:,Zeven
2020-09-18T05:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab,Code name:,MK-0646
2020-09-18T05:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab,Synonym:,anti-IGF-1R recombinant monoclonal antibody MK-0646
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,Code name:,ALFA 87-120
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Depo-Heparin
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin
2020-09-18T05:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium,US brand name:,Fragmin V
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Abbreviation:,DAN
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Chemical structure:,"(17alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol17alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol"
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Code name:,Win-17757
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Bonzol
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Chronogyn
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Cyclomen
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danol
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Danoval
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,Foreign brand name:,Ladogal
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Danocrine
2020-09-18T05:52:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol,US brand name:,Winobanin
2020-10-14T04:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danicopan,Code name:,ACH-0144471
2020-10-14T04:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danicopan,Code name:,ACH-4471
2020-10-14T04:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danicopan,Synonym:,FD inhibitor ACH-4471
2020-09-18T05:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daniquidone,Chemical structure:,"8-aminoisoindolo(1,2-b)quinazolin-12(10H)-one"
2020-09-18T05:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daniquidone,Synonym:,batracylin
2020-09-18T05:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danusertib,Synonym:,Aurora kinase inhibitor PHA-739358
2020-10-14T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen,Code name:,AZD9150
2020-10-14T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen,Code name:,ISIS 481464
2020-10-14T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen,Synonym:,STAT3 antisense oligonucleotide ISIS 481464
2020-10-14T04:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen,US brand name:,ISIS-STAT3rx
2020-10-14T04:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapagliflozin,Chemical structure:,"D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)"
2020-10-14T04:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapagliflozin,Code name:,BMS-512148-05
2020-10-14T05:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapatifagene-navolactibac,Abbreviation:,hTFF1-secreting Lactococcus lactis AG013
2020-10-14T05:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapatifagene-navolactibac,Code name:,AG013
2020-09-18T05:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daporinad,Code name:,APO866
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DADPS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Abbreviation:,DDS
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Chemical structure:,"4,4'-sulfonylbisbenzamine4,4'-sulfonylbisbenzeneamine4,4'-sulfonyldianilinebis(4-aminophenyl)sulfone"
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Code name:,1358F
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Eporal
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Foreign brand name:,Undolac
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,croysulfone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,diphenasone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,dumitone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,novophone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulfona-mae
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,Synonym:,sulphadione
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Aczone
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Avlosulfon
2020-09-18T01:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone,US brand name:,Disulone
2020-10-14T03:23:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel,US brand name:,Aczone Gel
2020-09-18T01:22:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel-5pct,US brand name:,Aczone Gel
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Chemical structure:,N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine epsilon1-lactone
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,Code name:,LY146032
2020-09-18T05:43:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin,US brand name:,Cubicin
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,anti-CD38 monoclonal antibody
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,Synonym:,JNJ-54767414
2020-09-18T05:53:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab,US brand name:,Darzalex
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,DARA co-formulated with rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,DARA/rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,daratumumab + rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,daratumumab with rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,daratumumab-rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,daratumumab/rHuPH20 co-formulation
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,darzalex/rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,HuMax-CD38-rHuPH20
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,Synonym:,recombinant human hyaluronidase mixed with daratumumab
2020-10-14T04:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj,US brand name:,Darzalex Faspro
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Abbreviation:,NESP
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Code name:,KRN321
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Foreign brand name:,Nespo
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,Synonym:,Novel Erythropoiesis Stimulating Protein
2020-09-18T03:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa,US brand name:,Aranesp
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Chemical structure:,S-dimethylarsino-glutathione
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Code name:,ZIO-101
2020-09-18T05:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin,Foreign brand name:,SP-02L
2020-10-14T12:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darleukin,Abbreviation:,L19-IL2
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Code name:,BAY 1841788
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Code name:,BAY-1841788
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Code name:,BAY1841788
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Code name:,ODM 201
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Code name:,ODM-201
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,Synonym:,antiandrogen ODM-201
2020-10-14T04:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide,US brand name:,Nubeqa
2020-10-14T04:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun,Synonym:,darleukin and fibromun
2020-10-14T04:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun,Synonym:,darleukin/fibromun
2020-10-14T04:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun,Synonym:,L19-IL2 and L19-TNF-alpha
2020-10-14T04:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun,Synonym:,L19-IL2/L19-TNF-alpha
2020-10-14T04:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun,Synonym:,L19IL2/L19TNF
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Chemical structure:,"methanesulfonamide, N-(6-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl)-2-naphthalenyl)-N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide"
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT 333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT-333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Code name:,ABT333
2020-09-18T05:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir,Foreign brand name:,EXVIERA
2020-09-18T05:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib,Code name:,BMS-354825
2020-09-18T05:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib,US brand name:,Sprycel
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,FI-6339
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Code name:,RP-13057
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Cerubidin
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastin
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Daunoblastina
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Ondena
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Foreign brand name:,Rubilem
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,cloridrato de daunorubicina
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunoblastine
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,daunomycin hydrochloride
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,Synonym:,rubidomycin hydrochloride
2020-09-18T05:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride,US brand name:,Cerubidine
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Code name:,CPX-351
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,cytarabine-daunorubicin liposome for injection
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal AraC-daunorubicin CPX-351
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal cytarabine-daunorubicin
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposomal cytarabine-daunorubicin CPX-351
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposome-encapsulated combination of daunorubicin and cytarabine
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,Synonym:,liposome-encapsulated daunorubicin-cytarabine
2020-09-18T05:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome,US brand name:,Vyxeos
2020-10-14T03:22:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dbve-pc-regimen,Synonym:,ABVE-PC
2020-10-14T03:22:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dbve-pc-regimen,Synonym:,Adriamycin-bleomycin-vincristine-etoposide-prednisone-cyclophosphamide regimen
2020-10-14T03:22:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dbve-pc-regimen,Synonym:,DBVE-PC
2020-10-14T03:22:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dbve-pc-regimen,Synonym:,DBVE-PC regimen
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Abbreviation:,DC-CHOL LIP
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Abbreviation:,DC-chol liposomes
2020-09-18T05:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome,Chemical structure:,dimethylaminoethane-carbamoyl-cholesterol liposomes
2020-09-18T05:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-ova-vaccine,Abbreviation:,DC-OVA
2020-09-18T05:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dcr-ligand-bearing-liposome-encapsulated-melanoma-antigens-vaccine,Foreign brand name:,Lipovaxin-MM
2020-09-18T05:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dcr-ligand-bearing-liposome-encapsulated-melanoma-antigens-vaccine,Synonym:,dendritic cell receptor ligand-bearing liposome-encapsulated melanoma antigens vaccine
2020-09-18T05:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dec-205-ny-eso-1-fusion-protein-cdx-1401,Code name:,CDX-1401
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,5AZA
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Abbreviation:,DAC
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Chemical structure:,"2'-deoxy-5-azacytidine4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one5-aza-2'-deoxycytidine5-aza-2-deoxycytidine5-azadeoxycytidine"
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,5-aza-dCyd
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,deoxyazacytidine
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,Synonym:,dezocitidine
2020-09-18T05:51:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine,US brand name:,Dacogen
2020-10-14T04:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine,Code name:,ASTX727
2020-10-14T04:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine,Synonym:,CDA inhibitor E7727/decitabine combination agent ASTX727
2020-10-14T04:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine,US brand name:,Inqovi
2020-09-18T05:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib,Code name:,PF-04554878
2020-09-18T05:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib,Code name:,VS-6063
2020-09-18T05:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,Code name:,ICL670
2020-09-18T05:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox,US brand name:,Exjade
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Abbreviation:,DFM
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,Synonym:,deferoxamine methanesulfonate
2020-09-18T05:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate,US brand name:,Desferal
2020-09-18T05:55:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defibrotide-sodium,US brand name:,Defitelio
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,ASP3550
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,Code name:,FE200486
2020-09-18T05:56:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix,US brand name:,Firmagon
2020-09-18T05:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,Synonym:,IgG-HD37-dgA/IgG-RFB4-dgA immunotoxins
2020-09-18T05:36:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins,US brand name:,Combotox
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,Abbreviation:,dHACM
2020-09-18T02:02:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane,US brand name:,AmnioFix
2020-09-18T05:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delanzomib,Code name:,CEP 18770
2020-09-18T05:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delanzomib,Synonym:,proteasome inhibitor CEP 18770
2020-09-18T05:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-8-tetrahydrocannabinol,Abbreviation:,delta-8-THC
2020-09-18T05:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-tocopherol,Chemical structure:,"[2R-[2R*(4R*,8R*)]]-3,4-dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol2,8-dimethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol"
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Code name:,OMP-21M18
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Synonym:,anti-delta-like 4 monoclonal antibody OMP-21M18
2020-09-18T05:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab,Synonym:,anti-DLL4 monoclonal antibody OMP-21M18
2020-09-18T05:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,Chemical structure:,"7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T05:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride,US brand name:,Declomycin
2020-09-18T05:57:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demineralized-bone-matrix,Acronym:,DBM
2020-10-14T12:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demplatin-pegraglumer,Code name:,NC-6004
2020-10-14T12:43:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demplatin-pegraglumer,Foreign brand name:,Nanoplatin
2020-09-18T05:57:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-autologous-lung-tumor-vaccine,Synonym:,DCVax-Lung
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,CEA peptide-pulsed DC vaccine
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,CEA peptide-pulsed dendritic cell vaccine
2020-09-18T05:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine,Synonym:,Dendritic cell-carcinoembryonic antigen peptide vaccine
2020-09-18T05:57:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-gp100-mart-1-antigen-vaccine,Abbreviation:,DC-gp100-MART-1
2020-09-18T05:57:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-gp100-mart-1-antigen-vaccine,Synonym:,gp100/Mart-1-transduced dendritic cell vaccine
2020-09-18T05:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-idiotype-keyhole-limpet-hemocyanin-vaccine,Abbreviation:,DC-Id-KLH vaccine
2020-09-18T05:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-mart-1-peptide-vaccine,Synonym:,MART-1 peptide-pulsed DC vaccine
2020-09-18T05:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-mart-1-peptide-vaccine,Synonym:,MART-1 peptide-pulsed dendritic cell vaccine
2020-09-18T05:57:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-precision-multiple-antigen-t-lymphocytes,Abbreviation:,DC-PMAT
2020-09-18T05:57:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-precision-multiple-antigen-t-lymphocytes,Synonym:,dendritic cell-precision multiple antigen T cells
2020-09-18T05:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305,Code name:,ID-LV305
2020-09-18T05:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305,Synonym:,DCvex-NY-ESO-1
2020-10-14T04:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendrobium-huoshanense-granules,Synonym:,Chinese herbal compound Dendrobium huoshanense
2020-10-14T04:51:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendrobium-huoshanense-granules,Synonym:,D. huoshanense granules
2020-09-18T05:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denenicokin,Abbreviation:,rhIL-21
2020-09-18T05:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denenicokin,Synonym:,recombinant human interleukin-21
2020-10-14T04:51:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv,Code name:,PV 001-DV
2020-10-14T04:51:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv,Code name:,PV-001-DV
2020-10-14T04:51:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv,Code name:,PV001-DV
2020-10-14T04:51:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv,Synonym:,dengue virus-1 PV-001-DV
2020-10-14T04:51:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv,Synonym:,PV-001-dengue virus
2020-09-18T05:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denibulin-hydrochloride,Code name:,MN-029
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389-IL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389IL-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Abbreviation:,DAB389IL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Code name:,LY335348
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB(389)-interleukin-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB389 interleukin-2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DAB389 interleukin-2 immunotoxin
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,Synonym:,DABIL2
2020-09-18T05:58:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox,US brand name:,Ontak
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,ADC SGN-19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,SGN-19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Code name:,SGN-CD19A
2020-09-18T05:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin,Synonym:,anti-CD19 antibody-drug conjugate SGN-CD19A
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,AMG 162
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,AMG-162
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Code name:,TK-006
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Foreign brand name:,Prolia
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,Synonym:,denosumab biosimilar TK-006
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,US brand name:,Prolia
2020-09-18T05:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab,US brand name:,Xgeva
2020-09-18T05:58:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deoxycytidine-analogue-tas-109,Code name:,TAS-109
2020-10-14T03:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab,Abbreviation:,anti-EGFR mAb ABT-806
2020-10-14T03:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab,Abbreviation:,anti-EGFR MoAb ABT-806
2020-10-14T03:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab,Code name:,ABT-806
2020-10-14T03:45:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab,Code name:,mAb-806
2020-10-14T04:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab-mafodotin,Code name:,ABT-414
2020-09-18T05:59:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depdc1-mphosh1-peptide-vaccine,NA,NA
2020-10-14T04:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derazantinib,Code name:,ARQ 087
2020-10-14T04:51:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derazantinib,Synonym:,pan FGFR inhibitor ARQ 087
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Abbreviation:,DMS topical cream
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Foreign brand name:,Fisiogel Cream
2020-09-18T06:00:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream,Foreign brand name:,Physiogel Cream
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,Chemical structure:,"Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-,(+-)-"
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,Code name:,I 653
2020-09-18T06:00:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane,US brand name:,Suprane
2020-09-18T06:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride,US brand name:,Norpramin
2020-09-18T06:00:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride,US brand name:,Pertofrane
2020-09-18T06:00:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deslorelin-acetate,Chemical structure:,5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide acetate6-D-tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (Swine) acetate
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Chemical structure:,1-(3-mercaptopropionic acid)-8-D-arginine vasopression monoacetate
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,Foreign brand name:,Octostim
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Concentraid
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,DDAVP
2020-09-18T05:37:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate,US brand name:,Stimate
2020-09-18T05:20:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestral,US brand name:,Cerazette
2020-10-14T04:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestrel,US brand name:,Cerazette
2020-09-18T06:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate,Chemical structure:,"butanedioic acid compound with 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol (1:1), monohydrate"
2020-09-18T06:00:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate,US brand name:,Pristiq
2020-09-18T06:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detorubicin,Chemical structure:,"14-DiethoxyacetoxydaunorubicinDiethoxy-,2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester,(2S-cis) Acetic Acid"
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Abbreviation:,DETOXB
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B SE Adjuvant
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,Synonym:,Detox-B Stable Emulsion
2020-09-18T06:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant,US brand name:,Enhanzyn
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,Detox PC
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,Detox PC adjuvant
2020-09-18T06:00:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc,Synonym:,DetoxPC adjuvant
2020-09-18T06:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-3-methylhistidine,Abbreviation:,D-3MH
2020-09-18T06:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-3-methylhistidine,Abbreviation:,deuterated 3MH
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Code name:,HC 1119
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Code name:,HC-1119
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Code name:,HC1119
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Synonym:,D3-ENT
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Synonym:,enzalutamide deuterated
2020-10-14T04:52:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide,Synonym:,N-trideuteromethyl enzalutamide
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Abbreviation:,[D10]Phe
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Synonym:,[D10] phenanthrene
2020-09-18T06:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene,Synonym:,phenanthrene-D10
2020-09-18T06:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterium-oxide,Synonym:,heavy water
2020-10-14T04:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/devimistat,Code name:,CPI 613
2020-10-14T04:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/devimistat,Code name:,CPI-613
2020-10-14T04:52:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/devimistat,Synonym:,alpha-lipoic acid analogue CPI-613
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Abbreviation:,DM
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Aacidexam
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Adexone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Aknichthol Dexa
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin Depot
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Alin Oftalmico
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Amplidermis
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Anemul mono
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Auricularum
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Auxiloson
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Baycuten
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Baycuten N
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Cortidexason
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Cortisumman
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decacort
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decalix
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Decameth
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dectancyl
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dekacort
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Deltafluorene
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Desameton
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Mamallet
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Rhinosan
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-Scheroson
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexa-sine
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexacortal
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexacortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexafarma
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexafluorene
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexalocal
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexamecortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexamonozon
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexapos
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexinoral
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dexone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Dinormon
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Fluorodelta
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Fortecortin
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Lokalison-F
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Loverine
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Millicorten
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Mymethasone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Orgadrone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Spersadex
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Foreign brand name:,Visumetazone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Desamethasone
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Dexamethasonum
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,disaimisong
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,DXM
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Hexadecadrol
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Maxidex
2020-09-18T06:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone,Synonym:,Methylfluorprednisolone
2020-09-18T06:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone-intravitreal-implant,US brand name:,Ozurdex
2020-09-18T06:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexanabinol,Code name:,HU-211
2020-09-18T06:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexmedetomidine-hydrochloride,US brand name:,Precedex
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Chemical structure:,"D-(+)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide"
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Code name:,302962
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Foreign brand name:,Bepanthenol
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,d-pantothenol
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,D-pantothenyl alcohol
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,dexpanthenol
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,motilyn
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,pantenyl
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,Synonym:,provitamin B5
2020-10-14T04:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol,US brand name:,Ilopan
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Chemical structure:,"D-(+)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide"
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Code name:,302962
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Foreign brand name:,Bepanthenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,d-pantothenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,D-pantothenyl alcohol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,dexpanthenol
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,motilyn
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,pantenyl
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,Synonym:,provitamin B5
2020-09-18T06:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream,US brand name:,Ilopan
2020-09-18T06:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-mouthwash,Synonym:,5% dexpanthenol mouthwash
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,Foreign brand name:,Cardioxane
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,Foreign brand name:,Savene
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,US brand name:,Totect
2020-09-18T06:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride,US brand name:,Zinecard
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Abbreviation:,SLI381
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,Synonym:,"D,L-amphetamine"
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall
2020-09-18T01:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine,US brand name:,Adderall XR
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Chemical structure:,"(+)-alpha-methylphenethylamine sulphate (2:1)(S)-alpha-methylbenzeneethanamine sulfatebenzeneethanamine, alpha-methyl-, (S)-, sulfate (2:1)d-alpha-methylphenethylamine sulfate"
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,Synonym:,d-amphetamine sulphate
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexampex
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dexedrine
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Dextrostat
2020-09-18T06:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate,US brand name:,Ferndex
2020-09-18T06:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextromethorphan-hydrobromide,Abbreviation:,DXM
2020-09-18T06:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextropropoxyphene-hydrochloride,NA,NA
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R verapamil
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R-verapamil
2020-09-18T06:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil,Synonym:,R-Verapamil Hydrochloride
2020-10-14T04:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab,Code name:,GSK 2398852
2020-10-14T04:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab,Code name:,GSK-2398852
2020-10-14T04:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab,Code name:,GSK2398852
2020-10-14T04:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab,Synonym:,anti-SAP mAb
2020-10-14T04:52:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab,Synonym:,anti-SAP monoclonal antibody
2020-10-14T13:04:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezapelisib,Code name:,INCB040093
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Abbreviation:,DHA-TAX
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Abbreviation:,TXP
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,Synonym:,Docosahexaenoic Acid-Paclitaxel conjugate
2020-09-18T06:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel,US brand name:,Taxoprexin
2020-09-18T06:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhap-regimen,Synonym:,Dexamethasone-High-dose-Ara-C-cis-Platin
2020-09-18T06:02:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhea-mustard,Synonym:,dehydroepiandrosterone mustard
2020-10-14T04:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2-vaccineas15-adjuvant,Synonym:,dHER2+AS15 antigen-specific cancer immunotherapeutic
2020-10-14T04:52:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2-vaccineas15-adjuvant,Synonym:,dHER2+AS15 ASCI
2020-09-18T06:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2as15-vaccine,Synonym:,dHER2+AS15 antigen-specific cancer immunotherapeutic
2020-09-18T06:03:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2as15-vaccine,Synonym:,dHER2+AS15 ASCI
2020-09-18T06:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine,Abbreviation:,DI-Leu16-IL-2
2020-09-18T06:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine,Synonym:,de-immunized anti-CD20-IL-2 immunocytokine DI-Leu16-IL-2
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Chemical structure:,"morphinan-3,6alpha-diol, 7,8-didehydro-4,5alpha-epoxy-17-methyl-, morphine, Diacetate (ester), hydrochloride"
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Synonym:,diamorphine hydrochloride
2020-09-18T06:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride,Synonym:,heroin hydrochloride
2020-09-18T06:03:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diammonium-glycyrrhizinate,NA,NA
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Abbreviation:,DAG
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Chemical structure:,"1,2,5,6 dianhydrogalactitol1,2:5, 6-diepoxydulcitol1,2:5,6 dianhydrogalactitol1,2:5,6-dianhydrodulcitolgalactitol, 1,2:5,6-dianhydro- (8CI 9CI)"
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,dianhydrodulcitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,diepoxydulcitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,diepoxygalactitol
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,dulcitol diepoxide
2020-09-18T06:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol,Synonym:,galactitol
2020-09-18T06:03:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazepinomicin,Code name:,ECO-4601
2020-09-18T06:03:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazepinomicin,Code name:,TLN-4601
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Abbreviation:,AZQ
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Code name:,CI-904
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,Aziridinyl Benzoquinone
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,aziridinylbenzoquinone
2020-09-18T06:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone,Synonym:,Aziridinylbenzoquinone carbamic acid
2020-09-18T06:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazooxonorleucine,Abbreviation:,DON
2020-09-18T06:03:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazooxonorleucine,Chemical structure:,6-diazo-5-oxo-L-norleucine
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,Chemical structure:,"3-methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide"
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,Code name:,SRG-95213
2020-09-18T06:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide,US brand name:,Proglycem
2020-10-14T13:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dibotermin-aalfa,Abbreviation:,rhBMP-2
2020-10-14T13:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dibotermin-aalfa,Abbreviation:,rhBMP2
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Abbreviation:,DCM
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Synonym:,dichloroamethopterin
2020-09-18T06:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate,Synonym:,"methotrexate, dichloro"
2020-09-18T06:04:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-epolamine-patch,US brand name:,Flector Patch
2020-09-18T06:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-sodium-gel,US brand name:,Solaraze
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Abbreviation:,ddI
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Chemical structure:,"2',3'-Dideoxyinosine"
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Synonym:,Didanosine EC
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,Synonym:,dideoxyinosine
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,US brand name:,Videx
2020-09-18T06:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine,US brand name:,Videx EC
2020-09-18T06:04:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didemnin-b,Synonym:,didemnin
2020-09-18T06:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dideoxyadenosine,Abbreviation:,ddA
2020-09-18T06:04:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dideoxyadenosine,Chemical structure:,"2',3'-Dideoxyadenosine6-Amino-9-(2''3'-dideoxy-beta-D-glycero-pentofuranosyl)purine"
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Chemical structure:,"17-hydroxy-3-oxo-19-nor-17.alpha.-pregna-4,9-diene-21-nitrile19-norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17.alpha.)-"
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,M 18575
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,STS 557
2020-09-18T06:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest,Code name:,ZK 37659
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DDTC
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DIECA
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Abbreviation:,DTC
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Foreign brand name:,Imuthiol
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,Diethylcarbamodithioic Acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,Diethyldione
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithiocarbamic acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithiocarbaminic acid
2020-09-18T06:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate,Synonym:,diethyldithione
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Abbreviation:,DES
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Chemical structure:,"(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol3,4-bis(p-hydroxyphenyl)-3-hexene4,4'-dihydroxy-alpha,beta-diethylstilbenealpha,alpha'-diethylstilbenedioltrans-bis-(hydroxy-4-phenyl)-3,4 hexene-3"
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Antigestil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Apstil
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Boestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Bufon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Distilbene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Estromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Grafestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Microest
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Oestromensyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Serral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sexocretin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Sibol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilboefral
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Foreign brand name:,Stilkap
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,diethylstilbestrolum
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,Sinestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,Synonym:,stilboestrol dipropionate
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Acnestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Cyren A
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Deladumone
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Diastyl
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Domestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrobene
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Estrosyn
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Fonatol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Makarol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Milestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Neo-Oestronol I
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestrogenine
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromenin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Oestromon
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Palestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilbetin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestroform
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Stilboestrol
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Synthoestrin
2020-09-18T01:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol,US brand name:,Vagestrol
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Chemical structure:,"(1,1'-biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-2',4'-difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid"
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Apo-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Flovacil
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Novo-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,Foreign brand name:,Nu-Diflunisal
2020-09-18T06:05:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal,US brand name:,Dolobid
2020-10-14T04:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digestible-starch,Abbreviation:,DS
2020-10-14T04:52:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digestible-starch,Synonym:,digestive starch
2020-09-18T06:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digoxin,US brand name:,Lanoxin
2020-09-18T06:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydro-5-azacytidine,Abbreviation:,DHAC
2020-09-18T06:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydro-5-azacytidine,Chemical structure:,"1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride5,6-dihydro-5-azacytidine HCl5,6-dihydro-5-azacytidine hydrochloride"
2020-09-18T06:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrolenperone,Chemical structure:,"1-butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]-"
2020-09-18T06:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrolenperone,Synonym:,Dihydro-lenperone
2020-10-14T04:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-ag-636,Code name:,AG 636
2020-10-14T04:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-ag-636,Code name:,AG-636
2020-10-14T04:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-ag-636,Code name:,AG636
2020-10-14T04:52:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-ag-636,Synonym:,DHODH inhibitor AG-636
2020-10-14T04:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-aslan003,Code name:,ASLAN 003
2020-10-14T04:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-aslan003,Code name:,ASLAN-003
2020-10-14T04:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-aslan003,Code name:,ASLAN003
2020-10-14T04:52:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-aslan003,Synonym:,DHODH inhibitor ASLAN003
2020-10-14T04:53:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-bay2402234,Code name:,BAY 2402234
2020-10-14T04:53:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-bay2402234,Code name:,BAY-2402234
2020-10-14T04:53:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-bay2402234,Code name:,BAY2402234
2020-10-14T04:53:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-bay2402234,Synonym:,DHODH inhibitor BAY2402234
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Abbreviation:,DHT
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Chemical structure:,"(5alpha,17beta)-17-hydroxyandrostan-3-one"
2020-09-18T06:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone,Synonym:,Androstanolone
2020-09-18T06:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane,Abbreviation:,DIM
2020-09-18T06:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane,Chemical structure:,"3,3'-diindoylmethane"
2020-10-14T04:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dilpacimab,Code name:,ABT-165
2020-10-14T04:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dilpacimab,Synonym:,DVD-Ig ABT-165
2020-09-18T05:07:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,Synonym:,diltiazem HCl
2020-09-18T05:07:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride,US brand name:,Cardizem
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Abbreviation:,DIM
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Chemical structure:,"2,2'-dithio-bis-ethanesulfonate, disodium salt"
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Code name:,BNP7787
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,Synonym:,mesna disulfide
2020-09-18T06:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna,US brand name:,Tavocept
2020-09-18T06:04:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethicone-containing-botanicals-based-lotion,US brand name:,Difinsa53
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Abbreviation:,DMF
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Chemical structure:,"(E)-2-butenedioic acid, dimethyl esterdimethyl (E)-butenedioate"
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Code name:,BG-00012
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Code name:,BG00012
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,Synonym:,"fumaric acid, dimethyl ester"
2020-09-18T06:06:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate,US brand name:,Tecfidera
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Abbreviation:,DMSO
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Chemical structure:,Sulfinylbismethane
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Code name:,SQ-9453
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Demasorb
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Demeso
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Domoso
2020-09-18T06:06:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide,Foreign brand name:,Dromisol
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Abbreviation:,DMB
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Abbreviation:,DMM
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethyl Myleran
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethyl-Myleran
2020-09-18T06:06:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan,Synonym:,Dimethylmyleran
2020-10-14T04:53:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran,Abbreviation:,DMB
2020-10-14T04:53:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran,Abbreviation:,DMM
2020-10-14T04:53:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran,Synonym:,Dimethyl Myleran
2020-10-14T04:53:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran,Synonym:,Dimethyl-Myleran
2020-10-14T04:53:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran,Synonym:,Dimethylmyleran
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Code name:,MK-7965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Code name:,SCH 727965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Synonym:,CDK inhibitor SCH 727965
2020-09-18T06:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib,Synonym:,cyclin-dependent kinase inhibitor SCH 727965
2020-09-18T06:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinitrophenyl,Abbreviation:,DNP
2020-10-14T04:54:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinitrophenyl-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine,Synonym:,dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
2020-09-18T06:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinoprost-tromethamine,NA,NA
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Abbreviation:,MOAB Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Foreign brand name:,Unituxin
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,MOAB Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,Synonym:,monoclonal antibody Ch14.18
2020-09-18T06:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab,US brand name:,Unituxin
2020-09-18T06:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3,Code name:,DNE3
2020-09-18T06:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3,Synonym:,Dioscorea nipponica extract with ethyl acetate
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,Abbreviation:,DPCP
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,Synonym:,diphenylcyclopropenone
2020-09-18T06:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone,US brand name:,Samcyprone
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Bendylate
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,Foreign brand name:,Eldadryl
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,Benadryl
2020-09-18T04:36:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride,US brand name:,SK-Diphenhydramine
2020-09-18T06:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride-dexamethasone-nystatin-magic-mouthwash,NA,NA
2020-09-18T06:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxin-fragment-interleukin-2-fusion-protein-e7777,Code name:,E7777
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Abbreviation:,DTaP
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,Synonym:,diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Adacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Daptacel
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Infanrix
2020-09-18T01:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed,US brand name:,Tripedia
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,DT
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,Abbreviation:,Td adsorbed
2020-09-18T05:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed,US brand name:,Decavac
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,Abbreviation:,DP
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,Chemical structure:,"2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol"
2020-09-18T06:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole,US brand name:,Persantine
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,Abbreviation:,DTP-GDP
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,Chemical structure:,N-acetylglucosaminyl-N-acetyhnuramyl-L-Ala-isoGlu-L-Ala-glycerol dipalmitate
2020-09-18T06:08:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl,US brand name:,ImmTher
2020-09-18T06:08:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/distilled-water,NA,NA
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,DS
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Abbreviation:,TTD
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Chemical structure:,bis(diethylthiocarbamoyl) disulfidetetraethylthioperoxydicarbonic diamidetetraethylthiuram disulfide
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,Synonym:,Teturamin
2020-09-18T02:03:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram,US brand name:,Antabuse
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Abbreviation:,DDTC
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Abbreviation:,DIECA
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Abbreviation:,DTC
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Foreign brand name:,Imuthiol
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Synonym:,Diethylcarbamodithioic Acid
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Synonym:,Diethyldione
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Synonym:,diethyldithiocarbamic acid
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Synonym:,diethyldithiocarbaminic acid
2020-10-14T04:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb,Synonym:,diethyldithione
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Chemical structure:,sodium hydrogen bis(2-propylpentanoate)
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Code name:,Abbott 50711
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,sodium divalproex
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,Synonym:,valproate semisodium
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depacon
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Depakote ER
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epilex
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Epival
2020-09-18T05:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium,US brand name:,Valparin
2020-09-18T06:08:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dj-927,Code name:,DJ927
2020-09-18T06:08:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dj-927,Synonym:,oral taxane derivative DJ-927
2020-09-18T06:08:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dkk1-neutralizing-monoclonal-antibody-dkn-01,Code name:,DKN-01
2020-09-18T06:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm-choc-pen,Chemical structure:,4-demethyl-4-cholestryloxycarbonylpenclomedine4-demethylcholesteryloxycarbonylpenclomedine
2020-09-18T06:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm4-conjugated-anti-cripto-monoclonal-antibody-biib015,Code name:,BIIB015
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Code name:,VX-984
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Code name:,VX984
2020-09-18T06:10:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984,Synonym:,DNA-PK inhibitor VX-984
2020-09-18T06:10:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-targeting-sidna-dt01,Code name:,DT01
2020-09-18T06:10:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-targeting-sidna-dt01,Synonym:,DNA-PK-targeting siDNA DT01
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Code name:,PNT2258
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,Synonym:,DNA interference drug PNT2258
2020-09-18T06:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258,US brand name:,DNAi® drug PNT2258
2020-09-18T06:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-pm060184,Code name:,PM060184
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,BN2629
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,NSC 694501
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,SG2000
2020-09-18T06:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000,Code name:,SJG-136
2020-10-14T04:53:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648,Chemical structure:,"7-methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one"
2020-10-14T04:53:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648,Code name:,AZD 7648
2020-10-14T04:53:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648,Code name:,AZD-7648
2020-10-14T04:53:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648,Code name:,AZD7648
2020-10-14T04:53:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648,Synonym:,DNA-dependent protein kinase inhibitor AZD7648
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Chemical structure:,"(S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol3-pyridazinemethanol, alpha-(2-Chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-"
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,M 3814
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,M-3814
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,M3814
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,MSC 2490484A
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,MSC-2490484A
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Code name:,MSC2490484A
2020-09-18T09:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a,Synonym:,DNA-PK inhibitor MSC2490484A
2020-10-14T04:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-pi3k-delta-inhibitor-br101801,Code name:,BR 101801
2020-10-14T04:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-pi3k-delta-inhibitor-br101801,Code name:,BR-101801
2020-10-14T04:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-pi3k-delta-inhibitor-br101801,Code name:,BR101801
2020-09-18T06:10:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-tor-kinase-inhibitor-cc-115,Code name:,CC-115
2020-09-18T06:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-encoding-interleukin-12-ino-9012,Code name:,INO-9012
2020-09-18T06:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-vector-ppra-psm-vaccine,NA,NA
2020-09-18T06:10:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016,Code name:,VB10.16
2020-09-18T06:10:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016,Synonym:,VB10.16 vaccine
2020-10-14T04:53:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vector-ppra-psm-vaccine,NA,NA
2020-10-14T04:53:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnajb1-prkaca-fusion-protein,Synonym:,DnaJ homolog subfamily B member 1/cAMP-dependent protein kinase catalytic subunit apha fusion protein
2020-10-14T04:53:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnajb1-prkaca-fusion-protein,Synonym:,HSP40/PKA C-alpha fusion protein
2020-10-14T04:53:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-inhibitor-ntx-301,Code name:,NTX 301
2020-10-14T04:53:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-inhibitor-ntx-301,Code name:,NTX-301
2020-10-14T04:53:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-inhibitor-ntx-301,Code name:,NTX301
2020-10-14T12:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-mixed-backbone-antisense-oligonucleotide-mg-98,Synonym:,MG-98 oligonucleotide
2020-09-18T06:10:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnp-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine,Synonym:,dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
2020-09-18T06:10:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnr-expressing-nasopharyngeal-carcinoma-specific-cytotoxic-t-lymphocytes,Abbreviation:,DNR NPC-specific CTL
2020-09-18T06:10:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dobutamine,NA,NA
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Abbreviation:,TXT
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Code name:,RP 56976
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,Foreign brand name:,Docecad
2020-09-18T06:10:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel,US brand name:,Taxotere
2020-09-18T06:11:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-emulsion-anx-514,Code name:,ANX-514
2020-09-18T06:11:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-formulation-ckd-810,Code name:,CKD-810
2020-09-18T06:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-lipid-microspheres,Abbreviation:,DT-LM
2020-09-18T06:11:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-lipid-microspheres,Synonym:,docetaxel lipid emulsion
2020-09-18T06:11:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-loaded-nanopharmaceutical-crlx301,Code name:,CRLX301
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Code name:,CPC 634
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Code name:,CPC-634
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Code name:,CPC634
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Foreign brand name:,CriPec® docetaxel
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Synonym:,docetaxel containing CriPec (R) nanoparticles
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Synonym:,docetaxel-containing CriPec (R) nanoparticles CPC634
2020-10-14T04:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634,Synonym:,nanoparticle-encapsulated docetaxel CPC634
2020-09-18T06:11:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-pnp,NA,NA
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Code name:,docetaxel-loaded PM
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Foreign brand name:,Nanoxel-M
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Foreign brand name:,NanoxelM
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Synonym:,docetaxel-loaded PMs
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Synonym:,docetaxel-loaded polymeric micelles
2020-10-14T04:54:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles,Synonym:,docetaxel-PM
2020-10-14T04:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-ritonavir,Synonym:,ModraDoc006/r
2020-10-14T04:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-ritonavir,Synonym:,oral docetaxel/ritonavir
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Abbreviation:,ODSH
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Code name:,CX 01
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Code name:,CX-01
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Code name:,CX01
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Code name:,PGX-100
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Code name:,PGX100
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Synonym:,O-desulfated heparin
2020-10-14T03:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium,Synonym:,PGX-ODSH
2020-09-18T06:11:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docosahexaenoic-acid,NA,NA
2020-09-18T06:11:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolasetron-mesylate,Code name:,"MDL 73,147EF"
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Chemical structure:,"L-Valinamide, N,N-dimethyl-L-valyl-N-[2-methoxy-4-[2-[1- methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-(1-methylpropyl)-4-oxobutyl]-N-methyl-, [2S-[1[1R*(R*),2S*],2R*[1S*,2S*,3(R*)]]]"
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Code name:,B720389K560
2020-09-18T06:11:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10,Synonym:,Dolastatin-10
2020-10-14T04:54:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolcanatide,Chemical structure:,"D-leucine, D-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-cysteinyl-L-alpha-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4->12),(7->15)-bis(disulfide)"
2020-10-14T04:54:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolcanatide,Code name:,SP 333
2020-10-14T04:54:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolcanatide,Code name:,SP-333
2020-10-14T04:54:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolcanatide,Code name:,SP333
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Abbreviation:,DTG
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Chemical structure:,"2H-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-"
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Code name:,GSK 1349572
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,Code name:,GSK-1349572
2020-09-18T06:12:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir,US brand name:,Tivicay
2020-10-14T04:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/domatinostat,Code name:,4SC-202
2020-10-14T04:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/domatinostat,Synonym:,HDAC Inhibitor 4SC-202
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Chemical structure:,"1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Hydrochloride"
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,Code name:,E-2020
2020-09-18T03:57:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride,US brand name:,Aricept
2020-10-14T04:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-cytokine-induced-memory-like-natural-killer-cells,Synonym:,allogeneic CIML NK cells
2020-10-14T04:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-cytokine-induced-memory-like-natural-killer-cells,Synonym:,allogeneic CIML NKs
2020-10-14T04:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-cytokine-induced-memory-like-natural-killer-cells,Synonym:,allogeneic cytokine-induced memory-like NK cell
2020-10-14T04:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-cytokine-induced-memory-like-natural-killer-cells,Synonym:,CIML-NK cells
2020-09-18T06:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-wt1-prame-ny-eso-1-survivin-specific-t-lymphocytes,Abbreviation:,multi-TAA-specific T cells
2020-09-18T06:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-lymphocytes,NA,NA
2020-09-18T06:12:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-regulatory-t-lymphocytes,Synonym:,donor CD4+CD25+FoxP3+ T cells
2020-09-18T06:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dopamine-somatostatin-chimeric-molecule-bim-23a760,Code name:,BIM-23A760
2020-09-18T06:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa,Synonym:,recombinant human deoxyribonuclease I
2020-09-18T06:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa,Synonym:,recombinanthuman deoxyribonuclease I
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Abbreviation:,rhDNase inhalation solution
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Foreign brand name:,Pulmozyme
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,Synonym:,recombinant human deoxyribonuclease I inhalation solution
2020-09-18T06:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution,US brand name:,Pulmozyme
2020-10-14T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab,Code name:,ANB011
2020-10-14T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab,Code name:,TSR 042
2020-10-14T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab,Code name:,TSR-042
2020-10-14T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab,Code name:,TSR042
2020-10-14T04:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab,Synonym:,"immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer"
2020-09-18T10:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dot1l-inhibitor-epz-5676,Code name:,EPZ-5676
2020-09-18T10:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dot1l-inhibitor-epz-5676,Synonym:,DOT1L inhibitor EPZ-5676
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:chol-Fus1
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1
2020-09-18T06:13:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1 liposome complex
2020-10-14T04:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapcholesterol-fus1-liposome-complex,Synonym:,DOTAP:chol-Fus1
2020-10-14T04:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapcholesterol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1
2020-10-14T04:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapcholesterol-fus1-liposome-complex,Synonym:,DOTAP:cholesterol-Fus1 liposome complex
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Code name:,CHIR-258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Code name:,TKI258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Synonym:,receptor tyrosine kinase inhibitor TKI258
2020-09-18T06:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate,Synonym:,RTK inhibitor TKI258
2020-09-18T05:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxazosin-mesylate,US brand name:,Cardura
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Adapin
2020-09-18T01:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride,US brand name:,Sinequan
2020-09-18T06:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol,Chemical structure:,"(1alpha,3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol1-alpha-hydroxyvitamin D2"
2020-09-18T06:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol,US brand name:,Hectorol
2020-09-18T06:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxifluridine,Abbreviation:,5-DFUR
2020-09-18T06:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxifluridine,Chemical structure:,5'-deoxy-5-fluorouridine
2020-09-18T06:14:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-eluting-beads,NA,NA
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Abbreviation:,P(GFLG)-ADR
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Code name:,PK1
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,doxorubicin-HPMA
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,doxorubicin-HPMA copolymer conjugate
2020-09-18T06:14:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate,Synonym:,HPMA-doxorubicin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,ADM
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,Adria
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Abbreviation:,DOX
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Code name:,FI-106
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriablastin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriacin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriblastina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adriblastine
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Adrimedac
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,DOXO-CELL
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Doxolem
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Doxorubin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Foreign brand name:,Farmiblastina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,ADR
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,adriamycin
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,adriamycin hydrochloride
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,Adriamycine
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,chloridrato de doxorrubicina
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,doxorubicin.HCl
2020-09-18T06:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride,Synonym:,hydroxydaunorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Abbreviation:,doxorubicin HCl liposome
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Chemical structure:,"(8S-cis)-8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride"
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Code name:,TLC D-99
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Caelyx
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Foreign brand name:,Doxilen
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,ATI-0918
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,doxorubicin hydrochloride liposome injection
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,duomeisu
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal adriamycin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposomal doxorubicin hydrochloride
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,liposome-encapsulated doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated doxorubicin HCl liposome
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Pegylated Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,pegylated liposomal doxorubicin hydrochloride
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,S-Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,Synonym:,Stealth Liposomal Doxorubicin
2020-09-18T06:14:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome,US brand name:,Doxil
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,doxorubicin-loaded EGFR-targeting nanocell
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR (vectibix sequence)-targeted EnGeneIC dream vectors containing doxorubicin
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR-targeted EnGeneIC dream vectors containing doxorubicin
2020-09-18T06:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells,Synonym:,EGFR(V)-EDV-Dox
2020-09-18T06:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-magnetic-targeted-carrier-complex,Abbreviation:,DOX-MTC
2020-09-18T06:14:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-magnetic-targeted-carrier-complex,Abbreviation:,MTC-DOX
2020-10-14T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-l-377202,Code name:,L-377202
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Code name:,SQ 3370
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Code name:,SQ-3370
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Code name:,SQ3370
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Code name:,SQL70-SQP33
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Code name:,SQL70/SQP33
2020-10-14T04:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370,Synonym:,doxorubicin prodrug SQP33/prodrug-activating biomaterial SQL70
2020-09-18T06:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-calcium,US brand name:,Vibramycin
2020-10-14T04:55:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-hyclate,NA,NA
2020-09-18T06:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-hyclate-injection,NA,NA
2020-09-18T06:15:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-bcg-measles-serratia-pneumococcus-vaccine,Synonym:,"diphtheria, pertussis, tetanus/Bacille Calmette-Guerin/measles/Serratia/pneumococcus vaccine"
2020-09-18T06:15:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-typhoid-staphylococcus-aureus-paratyphoid-a-paratyphoid-b-vaccine,Synonym:,"diphtheria, pertussis, tetanus/typhoid/Staphylococcus aureus/paratyphoid A/paratyphoid B vaccine"
2020-10-14T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine,Code name:,DPX E7
2020-10-14T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine,Code name:,DPX-E7
2020-10-14T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine,Synonym:,DPX-E7 vaccine
2020-10-14T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine,Synonym:,HPV16-E7 11-19 nanomer vaccine DPX-E7
2020-10-14T05:18:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine,Synonym:,HPV16-E7 11-19 vaccine
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Abbreviation:,THC
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Code name:,Abbott 40566
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Code name:,SP-104
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Synonym:,delta 9-tetrahydrocannabinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,Synonym:,tetrahydrocannabinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,US brand name:,Marinol
2020-09-18T06:15:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol,US brand name:,Syndros
2020-09-18T06:15:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/droperidol,US brand name:,Inapsine
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Code name:,SL-401
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,diphtheria toxin(388)-interleukin-3 fusion protein
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,DT(388)IL3 fusion protein SL-401
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,Synonym:,IL3R-targeting fusion protein SL-401
2020-09-18T06:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401,US brand name:,Elzonris
2020-09-18T06:15:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid,Code name:,DTA-H19
2020-09-18T06:15:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid,Synonym:,diphtheria toxin A-H19 plasmid
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD 009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD-009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Code name:,MGD009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,B7-H3 x CD3 DART protein
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,B7-H3 x CD3 dual-affinity re-targeting protein MGD009
2020-09-18T06:15:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009,Synonym:,DART protein MGD009
2020-10-14T05:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-igf-1r-insr-inhibitor-bms-754807,Code name:,BMS-754807
2020-09-18T06:15:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-pi3-kinase-mtor-inhibitor-gdc-0980,Code name:,GDC-0980
2020-09-18T06:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-variable-domain-immunoglobulin-abt-165,Code name:,ABT-165
2020-09-18T06:15:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-variable-domain-immunoglobulin-abt-165,Synonym:,DVD-Ig ABT-165
2020-10-14T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib,Chemical structure:,"2-((5-chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide"
2020-10-14T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib,Code name:,TP 0903
2020-10-14T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib,Code name:,TP-0903
2020-10-14T04:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib,Code name:,TP0903
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Chemical structure:,"5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride"
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,13-Hydroxydaunomycin
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunomycinol
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunomycinol HCl
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Daunorubicineal
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Duborimycin Hydrochloride
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,Duborimycine
2020-09-18T06:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin,Synonym:,"Duborimycine, Hydrochloride"
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Abbreviation:,RhApo2L/TRAIL
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Code name:,AMG 951
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Synonym:,recombinant human Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
2020-09-18T06:16:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin,Synonym:,recombinant TNF-related apoptosis-inducing ligand
2020-10-14T03:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duligotuzumab,Code name:,MEHD7945A
2020-10-14T03:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duligotuzumab,Synonym:,anti-erbB1/erbB3 monoclonal antibody MEHD7945A
2020-09-18T06:16:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duloxetine-hydrochloride,NA,NA
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,REGN 668
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,REGN-668
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,REGN668
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,SAR 231893
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,SAR-231893
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,Code name:,SAR231893
2020-10-14T04:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab,US brand name:,Dupixent
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Chemical structure:,"immunoglobulin G1, anti-(human protein B7-H1) (human monoclonal MEDI4736 heavy chain), disulfide with human monoclonal MEDI4736 kappa-chain, dimer"
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Code name:,MEDI-4736
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,Code name:,MEDI4736
2020-09-18T06:16:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab,US brand name:,Imfinzi
2020-10-14T03:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusigitumab,Code name:,MEDI-573
2020-10-14T03:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusigitumab,Synonym:,anti-insulin-like growth factor 1/2 monoclonal antibody MEDI-573
2020-10-14T05:24:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusquetide,Code name:,SGX942
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Chemical structure:,"alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidideAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide"
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,Code name:,GG 745
2020-09-18T04:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride,US brand name:,Avodart
2020-10-14T04:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-dpd-inhibitor-tas-114,Code name:,TAS-114
2020-09-18T06:16:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-inhibitor-tas-114,Code name:,TAS-114
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Chemical structure:,"1(2H)-isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one"
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,INK-1197
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,Code name:,IPI-145
2020-09-18T05:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib,US brand name:,Copiktra
2020-10-14T04:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvortuxizumab,Code name:,JNJ-64052781
2020-10-14T04:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvortuxizumab,Synonym:,CD19 x CD3 DART protein JNJ-64052781
2020-09-18T06:16:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dwj1319,NA,NA
2020-10-14T04:41:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride,Chemical structure:,"1-propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride"
2020-10-14T04:41:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride,US brand name:,Cepacol
2020-10-14T04:41:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride,US brand name:,Dyclone
2020-10-14T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone,Chemical structure:,"(9-beta,10-alpha)-pregna-4,6-diene-3,20-dioneretro-6-dehydroprogesterone"
2020-10-14T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone,Synonym:,didrogesterone
2020-10-14T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone,Synonym:,hydrogestrone
2020-10-14T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone,Synonym:,isopregnenone
2020-10-14T04:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone,US brand name:,Duphaston
2020-09-18T06:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-101-solution,Code name:,E-101
2020-09-18T06:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-coli-cd-expressing-genetically-modified-neural-stem-cells,Abbreviation:,HB1.F3.CD neural stem cells
2020-09-18T12:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-selectin-antagonist-gmi-1271,Code name:,GMI-1271
2020-09-18T12:42:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-selectin-antagonist-gmi-1271,Synonym:,E-selectin antagonist GMI-1271
2020-09-18T06:17:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e2f1-pathway-activator-arq-171,Code name:,ARQ 171
2020-09-18T06:17:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e7820,NA,NA
2020-10-14T04:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream,Code name:,SAN 007
2020-10-14T04:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream,Code name:,VIR 003
2020-10-14T04:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream,Code name:,VIR 007
2020-10-14T04:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream,Synonym:,EISO cream
2020-10-14T04:56:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream,Synonym:,Santalum album oil cream
2020-09-18T06:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-mouth-rinse,Synonym:,0.25% EISO mouth rinse
2020-09-18T06:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-mouth-rinse,Synonym:,EISO mouth rinse
2020-10-14T04:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebna-1-inhibitor-vk-2019,Code name:,VK 2019
2020-10-14T04:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebna-1-inhibitor-vk-2019,Code name:,VK-2019
2020-10-14T04:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebna-1-inhibitor-vk-2019,Code name:,VK2019
2020-10-14T04:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebna-1-inhibitor-vk-2019,Synonym:,Epstein-Barr nuclear antigen 1 inhibitor VK-2019
2020-09-18T06:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebselen-containing-oral-capsule-spi-1005,Code name:,SPI-1005
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Abbreviation:,EBViNT
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBV latent membrane protein-2a-specific Eutil autologous blood-derived T lymphocytes
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBV-induced natural T cells
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBV-induced T lymphocytes
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBV/LMP-2A-specific CD8 T cells
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBViNT cell
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,EBViNT cells
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,Epstein-Barr virus induced natural T cells
2020-10-14T04:56:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells,Synonym:,Eutil autologous T lymphocytes
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Chemical structure:,"N,N'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)"
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Code name:,BRN 0078671
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Code name:,SK 302B
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,bis-quinoline analogue
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,echinomycin A
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,levomycin
2020-09-18T06:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin,Synonym:,quinomycin A
2020-09-18T06:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ecromeximab,Synonym:,monoclonal antibody KW-2871
2020-10-14T05:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood,Code name:,ECT-001
2020-10-14T05:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood,Code name:,UM171
2020-10-14T05:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood,Synonym:,ECT-001 expanded UCB
2020-10-14T05:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood,Synonym:,ECT-001 expanded umbilical cord blood
2020-10-14T05:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood,Synonym:,UM171 expanded cord blood
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Code name:,EML 03
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Code name:,EML-03
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Code name:,EML03
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Foreign brand name:,Ectoin
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Synonym:,ectoine mouth wash
2020-10-14T04:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03,Synonym:,ectoine mouth wash EML03
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Abbreviation:,h5G1.1
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,Alexion
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar ABP 959
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar BCD-148
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,eculizumab biosimilar SB12
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,monoclonal antibody 5G1.1
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,Synonym:,monoclonal antibody anti-C5
2020-09-18T06:18:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab,US brand name:,Soliris
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Abbreviation:,10-EdAM
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Abbreviation:,EDAM
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Chemical structure:,"10-ethyl-10-deaza-aminopterinN-[4-[1-[(2,4-diamino-6-pteridinyl)-methyl]propyl]benzoyl]-L-glutamic acid"
2020-09-18T06:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate,Code name:,CGP-30694
2020-10-14T05:08:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edicotinib,Code name:,JNJ-40346527
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Abbreviation:,IL-12
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Code name:,Ro 24-7472
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Synonym:,cytotoxic lymphocyte maturation factor
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Synonym:,interleukin-12
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Synonym:,natural killer cell stimulatory factor
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Synonym:,NM-IL-12
2020-10-14T13:13:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa,Synonym:,recombinant human interleukin-12 (IL-12) cytokine
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Chemical structure:,"6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolol[3,4-c]-carbazole-5,7(6H)-dione"
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Code name:,J-107088
2020-09-18T06:18:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin,Synonym:,PHA-782615
2020-09-18T06:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edoxaban-tosylate,Chemical structure:,"N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N- dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2- carboxamido)cyclohexyl)oxamide, 4- methylbenzenesulfonate"
2020-09-18T06:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edoxaban-tosylate,Code name:,DU-176b
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Abbreviation:,MOAB 17-1A
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Foreign brand name:,Panorex
2020-09-18T06:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab,Synonym:,monoclonal antibody 17-1A
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Code name:,MAK 683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Code name:,MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,ectodermal embryonic development inhibitor MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,EED PPI inhibitor MAK683
2020-09-18T06:19:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683,Synonym:,EED protein-protein interaction inhibitor MAK683
2020-09-18T06:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ef5,Chemical structure:,"2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) Acetamide"
2020-09-18T06:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efalizumab,NA,NA
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Chemical structure:,"2-(4-(((3,5-dimethylanilino)Carbonyl)methyl)phenoxy)-2-methylpropionic acid"
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Code name:,RSR13
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Synonym:,2-dacmpp
2020-09-18T06:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral,Synonym:,Efaproxyn
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Chemical structure:,"2,4-thiazolidinedione, 5-((4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride (1:2)"
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Code name:,CS-7017
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Code name:,RS5444
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Synonym:,inolitazone dihydrochloride
2020-09-18T06:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride,Synonym:,PPAR-gamma agonist CS-7017
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Code name:,DMP-266
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Code name:,L743726
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,Foreign brand name:,Stocrin
2020-09-18T06:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz,US brand name:,Sustiva
2020-10-14T04:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa,Code name:,F-627
2020-10-14T04:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa,Code name:,F627
2020-10-14T04:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa,Synonym:,recombinant dimeric G-CSF fusion protein F627
2020-10-14T04:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa,Synonym:,rh G-CSF Fc fusion protein
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Code name:,GX-I7
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Code name:,NT-I7
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Code name:,TJ 107
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Code name:,TJ-107
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Code name:,TJ107
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Synonym:,Hyleukin-7
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Synonym:,Il-7 hybrid Fc
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Synonym:,IL-7-hyFc
2020-10-14T04:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa,Synonym:,rhIL-7-hyFc
2020-10-14T03:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efizonerimod,Code name:,MEDI6383
2020-10-14T04:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim,Abbreviation:,LAPS-GCSF
2020-10-14T04:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim,Code name:,HM10460A
2020-10-14T04:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim,Code name:,SPI-2012
2020-10-14T04:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim,Synonym:,long-acting granulocyte colony-stimulating factor receptor SPI-2012
2020-10-14T04:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim,US brand name:,Rolontis
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Chemical structure:,"2-(difluoromethyl)-dl-ornithine hydrochloride, monohydrate2-(difluoromethyl)-DL-ornithine hydrochloride, monohydrate"
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Code name:,MDL 71782
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Code name:,RMI-71782
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,2-difluoromethylornithine hydrochloride
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,alpha-difluoromethylornithine hydrochloride
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,Synonym:,eflornithine HCl
2020-09-18T06:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride,US brand name:,Vaniqa
2020-09-18T06:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride-ointment,Synonym:,DL-alpha-difluoromethylornitine hydrochloride ointment
2020-09-18T06:20:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efs-ada-lentiviral-vector-transduced-cd34-positive-autologous-lymphocytes,NA,NA
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Code name:,EDP-202
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Code name:,EOC-202
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Code name:,IMP-321
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Code name:,IMP321
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Foreign brand name:,ImmuFact IMP321
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Foreign brand name:,ImmuFact-IMP321
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Synonym:,Efti
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Synonym:,hLAG-31g
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Synonym:,LAG-3-Ig-fusion protein
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Synonym:,LAG-3Ig
2020-10-14T04:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha,Synonym:,sLAG-3-Ig
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Code name:,ABBV 621
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Code name:,ABBV-621
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Code name:,APG880
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Synonym:,HERA ligand ABBV-621
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Synonym:,hexavalent TRAIL receptor agonist ABBV-621
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Synonym:,TRAIL-Fc protein ABBV-621
2020-10-14T13:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa,Synonym:,TRAIL-receptor agonist fusion protein ABBV-621
2020-09-18T06:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-4sc-205,Code name:,4SC-205
2020-09-18T06:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-4sc-205,Synonym:,Eg5 kinesin inhibitor 4SC-205
2020-09-18T06:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-arq-621,Code name:,ARQ 621
2020-09-18T06:20:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-arq-621,Synonym:,Eg5 inhibitor ARQ 621
2020-10-14T13:35:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egaptivon-pegol,Code name:,ARC1779
2020-09-18T06:20:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egb761,Synonym:,ginkgo biloba
2020-10-14T04:58:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egf-vaccine-egf-pti,Synonym:,EGF pathway targeted immunization agent
2020-10-14T04:58:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egf-vaccine-egf-pti,Synonym:,EGF pathway targeted immunotherapy agent
2020-10-14T04:58:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egf-vaccine-egf-pti,Synonym:,EGF pathway-targeted immunotherapeutic
2020-10-14T04:58:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egf-vaccine-egf-pti,Synonym:,EGF-PTI
2020-09-18T06:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022,Code name:,Hemay022
2020-09-18T06:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022,Synonym:,EGFR inhibitor Hemay022
2020-09-18T06:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antisense-dna,NA,NA
2020-09-18T06:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes,Synonym:,CART-EGFR TCR zeta:CD1 27 cells
2020-10-14T04:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu,Code name:,WSD 0922-FU
2020-10-14T04:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu,Code name:,WSD-0922-FU
2020-10-14T04:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu,Code name:,WSD0922-FU
2020-10-14T04:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu,Synonym:,BBB penetrable EGFR/EGFRvIII inhibitor WSD0922-FU
2020-10-14T04:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu,Synonym:,EGFR mutant inhibitor WSD0922-FU
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Chemical structure:,"9H-purine-2,8-diamine, 9-(1-methylethyl)-N2-[4-(4-methyl-1-piperazinyl)phenyl]-N8-3-pyridinyl9-isopropyl-N2-(4-(4-methylpiperazin-1-yl)phenyl)-N8-(pyridin-3-yl)-9H-purine-2,8-diamine"
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB 1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB-1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Code name:,SKLB1028
2020-09-18T06:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028,Synonym:,multikinase inhibitor SKLB1028
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP 32788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP-32788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,AP32788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK 788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK-788
2020-09-18T06:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788,Code name:,TAK788
2020-09-18T06:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-av-412,Code name:,AV-412
2020-10-14T04:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-dzd9008,Code name:,DZD 9008
2020-10-14T04:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-dzd9008,Code name:,DZD-9008
2020-10-14T04:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-dzd9008,Code name:,DZD9008
2020-09-18T06:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-abt-414,Code name:,ABT-414
2020-09-18T06:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-asp8273,Code name:,ASP8273
2020-09-18T06:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-azd3759,Code name:,AZD3759
2020-10-14T04:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-bibx-1382,NA,NA
2020-10-14T04:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-dbpr112,Code name:,DBPR 112
2020-10-14T04:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-dbpr112,Code name:,DBPR-112
2020-10-14T04:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-dbpr112,Code name:,DBPR112
2020-09-18T06:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-egf816,Code name:,EGF816
2020-09-18T09:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-hm61713,Chemical structure:,"2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-"
2020-09-18T09:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-hm61713,Code name:,BI 1482694
2020-09-18T09:51:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-hm61713,Code name:,HM61713
2020-10-14T04:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-selective-inhibitor-tqb3804,Code name:,TQB 3804
2020-10-14T04:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-selective-inhibitor-tqb3804,Code name:,TQB-3804
2020-10-14T04:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-selective-inhibitor-tqb3804,Code name:,TQB3804
2020-10-14T04:57:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-selective-inhibitor-tqb3804,Synonym:,epidermal growth factor receptor inhibitor TQB3804
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK 101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK-101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,CK101
2020-09-18T06:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101,Code name:,RX-518
2020-10-14T04:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-d-0316,Code name:,D-0316
2020-10-14T04:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-d-0316,Code name:,D0316
2020-10-14T04:58:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-d-0316,Synonym:,D 0316
2020-10-14T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-zn-e4,Code name:,ZN e4
2020-10-14T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-zn-e4,Code name:,ZN-e4
2020-10-14T04:58:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-zn-e4,Code name:,ZNe4
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI 15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI-15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Code name:,BPI15086
2020-09-18T06:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086,Synonym:,EGFR T790M inhibitor BPI-15086
2020-10-14T04:58:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-inhibitor-hs-10296,Code name:,HS-10296
2020-09-18T06:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-inhibitor-pf-06747775,Code name:,PF-06747775
2020-09-18T06:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-tyrosine-kinase-inhibitor-hs-10296,Code name:,HS-10296
2020-10-14T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-vegfr-ret-inhibitor-ha121-28,Code name:,HA 121-28
2020-10-14T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-vegfr-ret-inhibitor-ha121-28,Code name:,HA-121 28
2020-10-14T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-vegfr-ret-inhibitor-ha121-28,Code name:,HA121-28
2020-09-18T06:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfrbi-armed-autologous-activated-t-cells,Synonym:,anti-CD3 OKT3/anti-EGFR bispecific antibody armed activated T lymphocytes
2020-10-14T04:57:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfrbi-armed-autologous-t-cells,Synonym:,anti-CD3 OKT3/anti-EGFR bispecific antibody armed activated T lymphocytes
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Abbreviation:,EPA
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Abbreviation:,IPA
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,"all cis-5,8,11,14,17-eicosapentaenoic acid"
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,icosapentaenoic acid
2020-09-18T06:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid,Synonym:,timnodonic acid
2020-09-18T06:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-enriched-nutritional-supplement,Synonym:,EPA-enriched nutritional supplement
2020-10-14T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-monoacylglyceride,Abbreviation:,MAG-EPA
2020-10-14T04:58:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-monoacylglyceride,Synonym:,monoglyceride eicosapentaenoic acid
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Code name:,ISIS 183750
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Code name:,LY2275796
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Synonym:,eIF4E inhibitor ISIS 183750
2020-09-18T06:23:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750,Synonym:,eIF4E modulator ISIS 183750
2020-10-14T04:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacestrant,Code name:,RAD1901
2020-10-14T04:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacestrant,Synonym:,selective estrogen receptor degrader/modulator RAD1901
2020-10-14T04:58:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacestrant,Synonym:,SERD/SERM RAD1901
2020-09-18T06:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacytarabine,Chemical structure:,"2(1H)-Pyrimidinone, 4-amino-1-[5-O-[(9E)-1-oxo-9-octadecenyl]-β-D-arabinofuranosyl]-4-amino-1-[5-O-[(9E)-octadec-9-enoyl]-β-D-arabinofuranosyl]pyrimidin-2(1H)-one"
2020-09-18T06:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacytarabine,Code name:,CP-4055
2020-10-14T04:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix,Chemical structure:,"butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-"
2020-10-14T04:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix,Code name:,ABT-620
2020-10-14T04:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix,Code name:,NBI 56418
2020-10-14T04:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix,Code name:,NBI-56418
2020-10-14T04:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix,US brand name:,Orilissa
2020-10-14T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir,Code name:,MK-8742/MK-5172
2020-10-14T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir,Synonym:,elbasvir-grazoprevir
2020-10-14T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir,Synonym:,grazoprevir-elbasvir
2020-10-14T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir,Synonym:,grazoprevir/elbasvir
2020-10-14T04:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir,US brand name:,Zepatier
2020-09-18T06:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrokinetically-modified-water,Abbreviation:,EMW
2020-09-18T06:23:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrokinetically-modified-water,Synonym:,electro-kinetically altered beverage
2020-09-18T06:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrolyte-free-parenteral-nutrition-emulsion,Foreign brand name:,SmofKabiven
2020-09-18T06:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol,Chemical structure:,"1-N'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-N'-methyl- oxopropanehydrazididepropanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide],"
2020-09-18T06:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol,Code name:,STA-4783
2020-09-18T06:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol-sodium,Chemical structure:,"propanedioic acid, bis[2-methyl-2-(phenylthioxomethyl)hydrazide], sodium salt"
2020-09-18T06:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol-sodium,Code name:,STA-4783
2020-10-14T03:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elgemtumab,Code name:,LJM716
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Code name:,PM02734
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Foreign brand name:,Irvalec
2020-09-18T06:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin,Synonym:,depsipeptide PM02734
2020-09-18T06:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ellagic-acid-annona-muricata-supplement,NA,NA
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,9-HME
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,HME
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Abbreviation:,NMHE
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,Chemical structure:,"9-hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium acetate (salt)9-hydroxy-2-methylellipticinium acetateN-2-methyl-9-hydroxyellipticinium acetate"
2020-09-18T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate,US brand name:,Celiptium
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,BMS-901608
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,HuLuc63
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL-063
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Code name:,PDL063
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,Synonym:,anti-CS1 monoclonal antibody HuLuc63
2020-09-18T06:25:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab,US brand name:,Empliciti
2020-10-14T13:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elpamotide,NA,NA
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Chemical structure:,"benzo(h)(1)benzopyrano(5,4,3-cde)(1)ebnzopyran-5,12-dione,10((2-O-(2-amino-2,6-dideoxy-3-O-methyl-alpha-D-galactopyranosyl)-6-deoxy-3-C-methyl-beta-D-galactopyranosyl)oxy)-6-hydroxy-1-methyl"
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BBM 2478A
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BMY-28090
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Code name:,BRN 5214813
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Synonym:,10-O-elsaminosylelsarosylchartarin
2020-09-18T06:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin,Synonym:,elsamicin A
2020-09-18T06:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsiglutide,Code name:,ZP1846
2020-10-14T13:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltanexor,Code name:,KPT-8602
2020-10-14T13:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltanexor,Synonym:,exportin 1 inhibitor KPT-8602
2020-10-14T13:39:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltanexor,Synonym:,selective inhibitor of nuclear export KPT-8602
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB 497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB-497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB-497115-GR
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,Code name:,SB497115
2020-09-18T06:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine,US brand name:,Promacta
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RG-7155
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RG7155
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RO-5509554
2020-09-18T06:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab,Code name:,RO5509554
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,Code name:,NI-0501
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,Synonym:,anti-IFN gamma monoclonal antibody NI-0501
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,Synonym:,anti-IFNg mAb NI-0501
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,Synonym:,anti-interferon gamma monoclonal antibody NI-0501
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,Synonym:,emapalumab
2020-10-14T04:59:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab,US brand name:,Gamifant
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Abbreviation:,BP1-7-KLH
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Abbreviation:,L-BLP25
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Code name:,BLP25
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Synonym:,liposomal BLP25 vaccine
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,Synonym:,tecemotide
2020-09-18T06:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s,US brand name:,Stimuvax
2020-10-14T03:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emibetuzumab,Code name:,LY2875358
2020-10-14T12:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/empesertib,Code name:,BAY116-1909
2020-10-14T12:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/empesertib,Code name:,BAY1161909
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Chemical structure:,"(-)-2'-deoxy-5-fluoro-3'-thiacytidine2(1H)-pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2R-cis)-"
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,coviracil
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,Synonym:,FTC
2020-09-18T06:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine,US brand name:,Emtriva
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,chimeric Ad11p/Ad3 oncolytic virus
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,ColoAd1
2020-09-18T06:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev,Synonym:,ColoAd1 oncolytic virus
2020-10-14T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a,Code name:,NG 350A
2020-10-14T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a,Code name:,NG-350A
2020-10-14T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a,Code name:,NG350A
2020-10-14T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a,Synonym:,oncolytic adenoviral vector expressing anti-CD40 antibody NG-350A
2020-10-14T04:59:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a,Synonym:,oncolytic adenoviral vector-expressing anti-CD40 agonistic antibody NG-350A
2020-10-14T04:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641,Code name:,NG 641
2020-10-14T04:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641,Code name:,NG-641
2020-10-14T04:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641,Code name:,NG641
2020-10-14T04:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641,Synonym:,oncolytic adenoviral vector expressing FAP/CD3 bispecific molecule NG-641
2020-10-14T04:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641,Synonym:,oncolytic adenoviral vector-expressing FAP/CD3 bispecific FAP-TAc NG-641
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,Foreign brand name:,Renitec
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Enacard
2020-09-18T06:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate,US brand name:,Vasotec
2020-10-14T03:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enapotamab-vedotin,Abbreviation:,HuMax-AXL-ADC
2020-10-14T03:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enapotamab-vedotin,Synonym:,anti-AXL/MMAE ADC
2020-10-14T03:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enapotamab-vedotin,Synonym:,anti-AXL/MMAE antibody-drug conjugate
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Code name:,CC-90007
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Synonym:,AG-221 mesylate
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,Synonym:,enasidenib methanesulfonate
2020-09-18T06:27:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate,US brand name:,Idhifa
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Code name:,PDL192
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Synonym:,anti-tumor necrosis factor-like weak inducer of apoptosis monoclonal antibody PDL192
2020-09-18T06:27:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab,Synonym:,anti-TWEAKR monoclonal antibody PDL192
2020-10-14T03:51:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab,Code name:,TSR 033
2020-10-14T03:51:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab,Code name:,TSR-033
2020-10-14T03:51:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab,Code name:,TSR033
2020-10-14T03:51:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab,Synonym:,anti-LAG-3 monoclonal antibody TSR-033
2020-10-14T03:51:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab,Synonym:,anti-lymphocyte activation gene 3 protein monoclonal antibody TSR-033
2020-10-14T13:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encequidar,Chemical structure:,"4-oxo-4H-chromene-2-carboxylic acid [2-(2-4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl]-amide"
2020-10-14T13:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encequidar,Code name:,HM30181A
2020-10-14T13:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encequidar,Code name:,HM30181AK
2020-10-14T13:03:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encequidar,Synonym:,Pgp inhibitor HM30181AK
2020-09-18T06:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enclomiphene-citrate,NA,NA
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Abbreviation:,CAMB
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Code name:,MAT2203
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,cochleate lipid-crystal nano-particles-containing amphotericin B
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,cochleate-amphotericin B
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,lipid-crystal nano-particle formulation of amphotericin B
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,lipid-crystal nanoparticle-based amphotericin B formulation
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,nano-cochleated-particles containing amphotericin B
2020-10-14T04:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b,Synonym:,oral encochleated amphotericin B
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX 818
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX-818
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,Code name:,LGX818
2020-09-18T04:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib,US brand name:,Braftovi
2020-09-18T06:27:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endothelin-b-receptor-agonist-spi-1620,Code name:,SPI-1620
2020-10-14T13:40:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endothelin-receptor-type-a-antagonist-ym598,NA,NA
2020-10-14T04:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin,Code name:,ASG-22CE
2020-10-14T04:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin,Synonym:,anti-nectin 4 ADC ASG-22CE
2020-10-14T04:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin,Synonym:,enfortumab vedotin
2020-10-14T04:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin,US brand name:,Padcev
2020-10-14T04:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205,Code name:,AB 205
2020-10-14T04:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205,Code name:,AB-205
2020-10-14T04:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205,Code name:,AB205
2020-10-14T04:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205,Synonym:,AB-205 cell product
2020-10-14T04:59:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205,Synonym:,engineered HUVEC AB-205
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Code name:,MT 5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Code name:,MT-5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Code name:,MT5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Synonym:,ETB targeting HER2 MT-5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Synonym:,HER2-targeted ETB MT-5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Synonym:,immunotoxin MT-5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Synonym:,recombinant fusion protein MT-5111
2020-10-14T04:59:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111,Synonym:,targeted engineered toxin body MT-5111
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Chemical structure:,"5-ethynyl-2,4(1H,3H)-pyrimidinedione"
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,776C85
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,ADH300004
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,GW776
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Code name:,GW776C85
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Synonym:,5-ethynyluracil
2020-09-18T06:28:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil,Synonym:,ethynyluracil
2020-09-18T06:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab,Code name:,MGA271
2020-09-18T06:28:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab,Synonym:,monoclonal antibody MGA271
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,Code name:,GTx-024
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,Synonym:,selective androgen receptor modulator GTx-024
2020-09-18T06:28:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm,US brand name:,Ostarine
2020-10-14T03:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoticumab,Code name:,REGN421
2020-10-14T03:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoticumab,Synonym:,anti-Delta-like 4 monoclonal antibody REGN421
2020-09-18T06:28:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoxaparin-sodium,US brand name:,Lovenox
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Code name:,X-396
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Synonym:,ALK inhibitor X-396
2020-09-18T06:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib,Synonym:,anaplastic lymphoma kinase inhibitor X-396
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Code name:,NPC-1C
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Synonym:,anti-CPAA monoclonal antibody NPC-1C
2020-09-18T06:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab,Synonym:,anti-pancreatic and colorectal carcinoma-associated antigen monoclonal antibody NPC-1C
2020-10-14T04:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entacapone,US brand name:,Comtan
2020-09-18T04:31:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,Abbreviation:,ETV
2020-09-18T04:31:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir,US brand name:,Baraclude
2020-09-18T06:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-trpm8-agonist-d-3263-hydrochloride,Synonym:,EC D-3263 HCl
2020-09-18T06:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101,Code name:,MER-101
2020-09-18T06:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101,US brand name:,Orazol
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Code name:,MRx 0518
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Code name:,MRx-0518
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Code name:,MRx0518
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Synonym:,E. gallinarum MRx0518
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Synonym:,gut microbiota-derived strain MRx0518
2020-10-14T05:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518,Synonym:,strain MRx0518
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Chemical structure:,"carbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3- pyridinylmethyl esterpyridin-3-ylmethyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate"
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Code name:,MS 275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Code name:,SNDX-275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Synonym:,HDAC inhibitor SNDX-275
2020-09-18T06:29:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat,Synonym:,KHK2375
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Code name:,CBLB502
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Synonym:,TLR5 agonist CBLB502
2020-09-18T06:29:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod,Synonym:,toll-like receptor 5 agonist CBLB502
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Chemical structure:,"6-(1H-indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine"
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Code name:,GS-9973
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,ENTO
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,spleen tyrosine kinase inhibitor GS-9973
2020-09-18T06:29:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib,Synonym:,SYK inhibitor GS-9973
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,Code name:,RXDX-101
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,Synonym:,TrkA/B/C/ROS1/ALK tyrosine kinase inhibitor RXDX-101
2020-09-18T06:29:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib,US brand name:,Rozlytrek
2020-10-14T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/envafolimab,Synonym:,anti-PD-L1 MoAb KN035
2020-10-14T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/envafolimab,Synonym:,KN 035
2020-10-14T03:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/envafolimab,Synonym:,KN035
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Chemical structure:,"benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-"
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Code name:,ASP9785
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Code name:,MDV3100
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,Synonym:,selective androgen receptor modulator MDV3100
2020-09-18T06:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide,US brand name:,Xtandi
2020-09-18T06:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzastaurin-hydrochloride,Chemical structure:,"3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione Dihydrochloride"
2020-09-18T06:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzastaurin-hydrochloride,Code name:,LY-317615
2020-09-18T06:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzymatically-hydrolyzed-whey-protein-based-nutritional-supplement,US brand name:,Peptamen
2020-10-14T05:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578,Code name:,BMS-986310
2020-10-14T05:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578,Code name:,ONO-4578
2020-10-14T05:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578,Synonym:,PGE2 receptor antagonist ONO-4578
2020-10-14T05:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578,Synonym:,prostaglandin E2 receptor antagonist ONO-4578
2020-10-14T05:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578,Synonym:,selective PGE2 receptor 4 antagonist ONO-4578
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Chemical structure:,"N-[[2,4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenylethylamino]carbonyl]-4-methyl-benzenesulfonamide"
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Code name:,AAT-007
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Code name:,"CJ-023,423"
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Code name:,RQ-00000007
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Code name:,RQ-07
2020-09-18T07:27:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007,Synonym:,EP4 receptor antagonist AAT-007
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Chemical structure:,"1,2,5-Oxadiazole-3-carboximidamide, 4-((2-((Aminosulfonyl)amino)ethyl)amino)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-, (C(Z))-"
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Code name:,INCB 024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Code name:,INCB024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Synonym:,IDO1 inhibitor INCB024360
2020-09-18T06:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat,Synonym:,"indoleamine-2,3-dioxygenase inhibitor INCB024360"
2020-09-18T06:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcam-specific-car-expressing-autologous-t-lymphocytes,Synonym:,EpCAM-specific CAR autologous T cells
2020-10-14T03:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab,Code name:,GEN 3013
2020-10-14T03:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab,Code name:,GEN-3013
2020-10-14T03:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab,Code name:,GEN3013
2020-10-14T03:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab,US brand name:,DuoBody-CD3xCD20
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Code name:,BT 5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Code name:,BT-5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,bicycle BT5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,bicycle toxin conjugate-targeting EphA2 BT5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,bicyclic peptide conjugate BT5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,BTC BT5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,EphA2-targeting BTC BT5528
2020-10-14T05:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528,Synonym:,EphA2-targeting-MMAE bicycle toxin BT5528
2020-09-18T06:30:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-dopc-encapsulated-sirna,Synonym:,siRNA-EphA2-DOPC
2020-09-18T06:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidermal-growth-factor-ointment,Synonym:,EGF ointment
2020-09-18T06:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidermal-growth-factor-ointment,Synonym:,sesal yeongo
2020-10-14T05:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidiferphane,Abbreviation:,EDP
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Abbreviation:,EGCG
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Chemical structure:,"(2R-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate"
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,(-)-epigallocatechin-3-gallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,"[(2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate"
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,epigallocatechin-3-gallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,epigallocatechingallate
2020-09-18T06:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate,Synonym:,tea catechin
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Code name:,IMI-28
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,Foreign brand name:,Pharmorubicin PFS
2020-09-18T06:24:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride,US brand name:,Ellence
2020-10-14T05:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epitinib-succinate,Code name:,HMPL 813
2020-10-14T05:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epitinib-succinate,Code name:,HMPL-813
2020-10-14T05:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epitinib-succinate,Code name:,HMPL813
2020-09-18T06:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone,Chemical structure:,"9,11alpha-epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester"
2020-09-18T06:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone,US brand name:,Inspra
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Abbreviation:,EPOCH-O
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,DA EPOCH-O
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted EPOCH-ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted etoposide-prednisone-vincristine-cyclophosphamide-ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone plus ofatumumab regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,EPOCH plus Arzerra
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,EPOCH plus ofatumumab
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin-ofatumumab regimen
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,O-EPOCH
2020-09-18T06:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen,Synonym:,O-EPOCH regimen
2020-10-14T13:14:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen,Synonym:,REPOCH regimen
2020-10-14T13:14:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen,Synonym:,rituximab-EPOCH regimen
2020-10-14T13:14:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen,Synonym:,rituximab-etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen
2020-10-14T13:14:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen,Synonym:,rituximab/etoposide/prednisone/vincristine/cyclophosphamide/doxorubicin regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Acronym:,CHEOP regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,CHEOP regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,DA-EPOCH
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone regimen
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,EPOCH
2020-09-18T06:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen,Synonym:,etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Abbreviation:,EPO
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Foreign brand name:,Eprex
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,erythropoietin
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,Synonym:,r-HuEPO
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Epogen
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Procrit
2020-09-18T06:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa,US brand name:,Retacrit
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,Acronym:,EPOB
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,Foreign brand name:,NeoRecormon
2020-09-18T06:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta,US brand name:,Recormon
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Code name:,SB309
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Foreign brand name:,Retacrit
2020-09-18T06:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta,Foreign brand name:,Silapo
2020-09-18T06:32:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-analog-utd1,Code name:,UTD1
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Chemical structure:,"(4S-(4R*,7S,8R*,9R*,13Z,16R*(E)))-4,8-Dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)oxacyclohexadec-13-ene-2,6-dione"
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Code name:,KOS 862
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Synonym:,"12,13-Deoxyepothilone B"
2020-09-18T06:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d,Synonym:,desoxyepothilone B
2020-09-18T06:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-kos-1584,Chemical structure:,"9,10-didehydroepothilone D"
2020-09-18T06:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-kos-1584,Code name:,KOS-1584
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Abbreviation:,hLL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Abbreviation:,MOAB LL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,AMG 412
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,Humanized Anti-CD22 Monoclonal Antibody IgG1
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,LL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,Synonym:,monoclonal antibody LL2
2020-09-18T06:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab,US brand name:,LymphoCide
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Code name:,ADCT 602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Code name:,ADCT-602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Code name:,ADCT602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,ADC ADCT-602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,anti-CD22/PBD ADC ADCT-602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,antibody-drug conjugate ADCT-602
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,epratuzumab-cys-SG3249
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,hLL2-cys-PBD
2020-10-14T05:00:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine,Synonym:,hLL2-cys-SG3249
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,Chemical structure:,"1,3-propanedisulfonic acid, disodium salt"
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,Code name:,NC 503
2020-09-18T06:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium,US brand name:,Kiacta
2020-10-14T05:00:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eps8-peptide-specific-dendritic-cells,Synonym:,EPS8 peptide-specific DCs
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Code name:,ARV 471
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Code name:,ARV-471
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Code name:,ARV471
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Synonym:,ER alpha PROTAC protein degrader ARV-471
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Synonym:,estrogen receptor alpha PROTAC protein degrader ARV-471
2020-10-14T05:00:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471,Synonym:,PROTAC protein degrader ARV-471
2020-09-18T06:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/era36-modulator-icaritin,Chemical structure:,"4H-1-benzopyran-4-one, 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-"
2020-09-18T06:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/era36-modulator-icaritin,Synonym:,icaritin
2020-09-18T06:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erastin-analogue-prlx-93936,Code name:,PRLX 93936
2020-09-18T06:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erb-38-immunotoxin,Synonym:,erb-38
2020-09-18T12:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380,Chemical structure:,"N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine"
2020-09-18T12:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380,Code name:,ARRY-380
2020-09-18T12:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380,Synonym:,irbinitinib
2020-09-18T12:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380,Synonym:,ONT-380
2020-09-18T12:38:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380,US brand name:,Tukysa
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Code name:,JNJ-42756493
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,Synonym:,pan-FGFR tyrosine kinase inhibitor JNJ-42756493
2020-09-18T04:31:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib,US brand name:,Balversa
2020-09-18T06:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ergocalciferol,Chemical structure:,"9,10-secoergosta-5,7,10(19),22-tetraen-3-beta-ol"
2020-09-18T06:33:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ergocalciferol,Synonym:,vitamin D2
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,B1939 mesylate
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,E7389
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Code name:,ER-086526
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,Synonym:,halichrondrin B analog
2020-09-18T06:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate,US brand name:,Halaven
2020-09-18T06:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eritoran-tetrasodium,Chemical structure:,"alpha-D-glucopyranose,3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono--D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-1-(dihydrogen phosphate), tetrasodium salt"
2020-09-18T06:34:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eritoran-tetrasodium,Code name:,E5564
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Code name:,ASTX 029
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Code name:,ASTX-029
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Code name:,ASTX029
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Synonym:,ERK inhibitor ASTX029
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor ASTX029
2020-10-14T05:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029,Synonym:,extracellular signal-regulated kinase inhibitor ASTX029
2020-09-18T12:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-bvd-523,Code name:,BVD-523
2020-09-18T12:40:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-bvd-523,Synonym:,ERK inhibitor BVD-523
2020-09-18T06:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-cc-90003,Code name:,CC-90003
2020-09-18T06:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-gdc-0994,Code name:,GDC-0994
2020-09-18T06:34:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-ltt462,Code name:,LTT 462
2020-09-18T06:34:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-ltt462,Code name:,LTT462
2020-10-14T05:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-jsi-1187,Code name:,JSI 1187
2020-10-14T05:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-jsi-1187,Code name:,JSI-1187
2020-10-14T05:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-jsi-1187,Synonym:,ERK Inhibitor JSI-1187
2020-10-14T05:01:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-jsi-1187,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor JSI-1187
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO 947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO-947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Code name:,KO947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Synonym:,ERK inhibitor KO-947
2020-09-18T06:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947,Synonym:,extracellular signal-regulated kinase 1/2 inhibitor KO-947
2020-09-18T06:34:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ly3214996,Code name:,LY 3214996
2020-09-18T06:34:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ly3214996,Code name:,LY3214996
2020-10-14T05:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-gemcitabine-regimen,NA,NA
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Chemical structure:,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride"
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,"CP-358,774"
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,CP358774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,OSI-774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,Code name:,OSI774
2020-09-18T06:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride,US brand name:,Tarceva
2020-09-18T06:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertapenem-sodium,US brand name:,Invanz
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Abbreviation:,CD3-HER2neu MOAB
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Synonym:,anti-CD3 x anti-HER-2-neu bispecific monoclonal antibody
2020-09-18T06:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab,Synonym:,MOAB anti-CD3 x anti-HER-2-neu
2020-09-18T06:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythrocyte-encapsulated-l-asparaginase-suspension,Synonym:,GRASPA
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,E-Mycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ery-Tab
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,ERYC
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Ilotycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,Robimycin
2020-09-18T06:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin,US brand name:,RP-Mycin
2020-09-18T06:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin-topical-cream,Foreign brand name:,Eritex
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,Chemical structure:,"5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)"
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,Code name:,Lu 26-054-0
2020-09-18T06:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate,US brand name:,Lexapro
2020-09-18T06:35:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esmolol,NA,NA
2020-09-18T06:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esomeprazole-magnesium,US brand name:,Nexium
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Chemical structure:,4'-deoxyadriamycin hydrochloride4'deoxydoxorubicin
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Code name:,IMI-58
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxyadriamycin
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxyadriamycin hydrochloride
2020-09-18T06:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin,Synonym:,deoxydoxorubicin
2020-09-18T06:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/essiac,Synonym:,Esiak
2020-09-18T01:21:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-norethindrone-acetate-tablet,US brand name:,Activella
2020-09-18T06:36:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-vaginal-ring,US brand name:,ESTRING
2020-09-18T06:36:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-valerate,NA,NA
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Chemical structure:,"estra-1,3,5(10)-triene-3,17-diol(17(beta))-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, monohydrateestramustine 17-(dihydrogenphosphate) disodium salt"
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Leo-299
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Code name:,Ro-21-8837/001
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Foreign brand name:,Estracyt
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine phosphate
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,Synonym:,estramustine sodium phosphate
2020-09-18T06:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium,US brand name:,Emcyt
2020-09-18T06:36:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estriol-vaginal-gel,Foreign brand name:,Blissel
2020-09-18T06:36:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estriol-vaginal-gel,Foreign brand name:,Gelistrol
2020-09-18T05:01:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,Code name:,GTx-758
2020-09-18T05:01:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758,US brand name:,Capesaris
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,Abbreviation:,EST
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,Code name:,Tag-39
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,Foreign brand name:,Conestron
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,Foreign brand name:,Sodestrin
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,US brand name:,Femest
2020-10-14T04:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated,US brand name:,Premarin
2020-09-18T06:37:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eszopiclone,US brand name:,Lunesta
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,ETN
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Abbreviation:,TNFR:Fc
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,Synonym:,Tumor Necrosis Factor Receptor IgG Chimera
2020-09-18T06:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept,US brand name:,Enbrel
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Chemical structure:,"1H-imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-2-nitroimidazole-1-acetamide, N-(2-hydroxyethyl)-"
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Code name:,SR-2508
2020-09-18T06:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole,Synonym:,2-nitro-imidazole derivative
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Code name:,MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,humanized monoclonal antibody MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,Synonym:,monoclonal antibody anti-alpha V beta 3 integrin MEDI-522
2020-09-18T01:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab,US brand name:,Abegrin
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Chemical structure:,N-acetyl-D-cysteinyl-S-(L-cysteine disulfide)-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-alanyl-D-argininamide
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,AMG 416
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI 4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI-4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Code name:,KAI4169
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,Synonym:,velcalcetide
2020-09-18T06:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide,US brand name:,Parsabiv
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Abbreviation:,EA
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,Chemical structure:,"[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid"
2020-09-18T06:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid,US brand name:,Edecrin
2020-09-18T06:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethambutol,NA,NA
2020-10-14T05:01:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethanol-containing-nasal-solution,Synonym:,Ethanol-based Intranasal Solution
2020-10-14T05:01:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethanol-containing-nasal-solution,Synonym:,Ethanol-based Nasal Sanitizer
2020-10-14T05:01:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethanol-containing-nasal-solution,US brand name:,Nozin
2020-09-18T06:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethaselen,Abbreviation:,BBSKE
2020-09-18T06:37:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethaselen,Chemical structure:,"1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]-ethane"
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Abbreviation:,EE
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Chemical structure:,"(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol"
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Diogyn E
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Eticylol
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Inestra
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,Foreign brand name:,Lynoral
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Estinyl
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Ethinoral
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Feminone
2020-09-18T06:36:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol,US brand name:,Orestralyn
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Alesse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Aviane
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Enpresse
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Lessina
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levlite
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Levora
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Microgynon
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Nordette
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Portia
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonale
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Seasonique
2020-09-18T01:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel,US brand name:,Trivora
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,Synonym:,Ortho-Novum 1/35
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Aranelle
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Balziva
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Brevicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Gencept
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Modicon
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norcept-E
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norethin
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Norinyl
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Nortrel
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ortho-Novum
2020-09-18T03:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone,US brand name:,Ovcon
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,Synonym:,Ethiodol
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,Synonym:,Iodized Oil
2020-09-18T06:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil,US brand name:,Lipiodol
2020-09-18T06:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide,Chemical structure:,"3-ethyl-3-methylpyrrolidine-2,5-dione"
2020-09-18T06:38:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide,US brand name:,Zarontin
2020-09-18T06:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-alcohol-mouthwash,Synonym:,ethyl alcohol mouth rinse
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Chemical structure:,"ethyl (all cis)-5,8,11,14,17-icosapentaenoate"
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Code name:,AMR 101
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Code name:,AMR101
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,Synonym:,icosapent ethyl
2020-09-18T06:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate,US brand name:,Vascepa
2020-09-18T06:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent,Synonym:,EVOH-based embolic agent
2020-09-18T06:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent,US brand name:,Onyx
2020-09-18T06:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etidronate-cytarabine-conjugate-mbc-11,Code name:,MBC-11
2020-09-18T06:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etidronate-cytarabine-conjugate-mbc-11,Synonym:,etidronate-ara-C conjugate MBC-11
2020-10-14T03:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etigilimab,Code name:,OMP 313M32
2020-10-14T03:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etigilimab,Code name:,OMP-313M32
2020-10-14T03:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etigilimab,Synonym:,anti-TIGIT (OMP-313M32)
2020-10-14T03:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etigilimab,Synonym:,anti-TIGIT OMP-313M32
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Abbreviation:,PEG-irinotecan
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Code name:,NKTR 102
2020-09-18T06:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol,Synonym:,pegylated irinotecan NKTR 102
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Chemical structure:,"1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic Acid"
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Synonym:,Etodolic Acid
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,Synonym:,Ultradol
2020-09-18T06:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac,US brand name:,Lodine
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Abbreviation:,EPEG
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Chemical structure:,"4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside9-[(4,6-O-Ethylidene-beta-D-glucopyranosyl]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one"
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Code name:,VP-16
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Code name:,VP-16-213
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Foreign brand name:,Lastet
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Synonym:,Demethyl Epipodophyllotoxin Ethylidine Glucoside
2020-09-18T06:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide,Synonym:,epipodophyllotoxin
2020-09-18T06:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,Abbreviation:,ETOP
2020-09-18T06:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate,US brand name:,Etopophos
2020-09-18T06:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-prodrug-cap71,Code name:,CAP7.1
2020-10-14T05:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-toniribate,Code name:,CAP7.1
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Chemical structure:,5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,L-791456
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,Code name:,MK-0663
2020-09-18T03:56:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib,US brand name:,Arcoxia
2020-09-18T06:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216,Code name:,TK-216
2020-09-18T06:39:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216,Code name:,TK216
2020-10-14T05:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eucerin,US brand name:,Eucerin
2020-09-18T06:39:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-cream,US brand name:,Evoskin cream
2020-09-18T06:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-topical-spray,Foreign brand name:,EVOZAC
2020-09-18T06:39:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-topical-spray,Synonym:,spring water/polysorbate 20/phenoxyethanol/zinc gluconate/caprylyl glycol/chlorphenesin topical spray
2020-09-18T06:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,Synonym:,Evaux thermal spring water/polyacrylate-16/chlorphenesin/xanthan gum/phenoxyethanol/caprylyl glycol/piroctone olamine solution
2020-09-18T06:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution,US brand name:,EvoNail
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Code name:,RAD001
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Certican
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Foreign brand name:,Votubia
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,Synonym:,42-O-(2-hydroxy)ethyl rapamycin
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Afinitor Disperz
2020-09-18T01:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus,US brand name:,Zortress
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,Afinitor/Aromasin
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,everolimus + exemestane
2020-09-18T06:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen,Synonym:,everolimus-exemestane
2020-09-18T01:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-tablets-for-oral-suspension,US brand name:,Afinitor Disperz
2020-10-14T05:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evlp-cmv-gb-pp65-plus-gm-csf-vbi-1901,Code name:,VBI 1901
2020-10-14T05:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evlp-cmv-gb-pp65-plus-gm-csf-vbi-1901,Code name:,VBI-1901
2020-10-14T05:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evlp-cmv-gb-pp65-plus-gm-csf-vbi-1901,Synonym:,enveloped virus-like particles CMV gB-pp65 plus GM-CSF VBI-1901
2020-10-14T05:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evlp-cmv-gb-pp65-plus-gm-csf-vbi-1901,Synonym:,VBI-1901 vaccine
2020-10-14T05:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evocalcet,Chemical structure:,"benzeneacetic acid, 4-((3S)-3-(((1R)-1-(1-naphthalenyl)ethyl)amino)-1-pyrrolidinyl)-"
2020-10-14T05:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evocalcet,Code name:,KHK7580
2020-10-14T05:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evocalcet,Code name:,MT-4580
2020-10-14T05:01:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evocalcet,Foreign brand name:,Orkedia
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Abbreviation:,HAP TH-302
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Chemical structure:,"phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester"
2020-09-18T06:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide,Code name:,TH-302
2020-09-18T06:40:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-activated-autologous-lymph-node-lymphocytes,Synonym:,X-ACT
2020-09-18T06:40:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-activated-autologous-lymph-node-lymphocytes,Synonym:,X-ACT autologous lymph node lymphocytes
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Code name:,IMA101
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,Synonym:,IMA101 T cells
2020-09-18T01:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101,US brand name:,ACTolog IMA101
2020-09-18T06:40:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-her2-specific-t-cells,NA,NA
2020-09-18T06:40:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate,Code name:,DX-8951f
2020-09-18T06:40:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate,Synonym:,exatecan mesylate hydrate
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Abbreviation:,PNU 155971
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Chemical structure:,"6-Methyleneandrosta-1,4-diene-3,17-dione"
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,Code name:,FCE-24304
2020-09-18T03:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane,US brand name:,Aromasin
2020-09-18T04:55:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exenatide,US brand name:,Byetta
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Chemical structure:,"exendin 3, 1-de-L-histidine-2-de-L-serine-3-de-L-aspartic acid-4-deglycine-5-de-L-threonine-6-de-L-phenylalanine-7-de-L-threonine-8-de-L-serine-LYS-ASN-GIY-GIY-PRO-SER-SER-GIY-ALA-PRO-PRO-PRO-SER-NH2"
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,9-39-exendin 4
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,ex(9-39)NH2
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,exendin (9-39)
2020-09-18T06:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39,Synonym:,exendin(9-39)amide
2020-10-14T13:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant,Code name:,CORT 125281
2020-10-14T13:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant,Code name:,CORT-125281
2020-10-14T13:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant,Code name:,CORT125281
2020-10-14T13:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant,Synonym:,glucocorticoid receptor antagonist CORT125281
2020-10-14T13:18:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant,Synonym:,selective GR antagonist CORT125134
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Chemical structure:,"(Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z)"
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Code name:,FGN-1
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,Synonym:,Sulindac Sulfone
2020-09-18T03:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind,US brand name:,Aptosyn
2020-10-14T05:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells,Synonym:,EAGD T cells
2020-10-14T05:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells,Synonym:,EAGD T lymphocytes
2020-10-14T05:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells,Synonym:,expanded and activated gamma delta T cells
2020-10-14T05:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells,Synonym:,expanded and activated gamma/delta T cells
2020-10-14T05:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells,Synonym:,expanded/activated gamma/delta T cells
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Code name:,HSC 835
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Code name:,HSC835
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Code name:,MGTA-456
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Code name:,MGTA456
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Synonym:,allogeneic UCB-derived HSPCs MGTA 456
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Synonym:,allogeneic umbilical cord blood-derived hematopoietic stem and progenitor cells MGTA-456
2020-09-18T11:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835,Synonym:,expanded umbilical cord blood product HSC835
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,ER bupivacaine HCl
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,extended release bupivacaine hydrochloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,SABER-bupivacaine chloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,Synonym:,sustained release bupivacaine hydrochloride
2020-09-18T06:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation,US brand name:,Posidur
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended release 5-FC
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended release 5-fluorocytosine
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended-release 5-FC
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,Synonym:,extended-release 5-fluorocytosine
2020-09-18T06:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine,US brand name:,Toca FC
2020-10-14T05:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide,Synonym:,ER galantamine hydrobromide
2020-10-14T05:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide,Synonym:,galantamine hydrobromide ER
2020-10-14T05:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide,Synonym:,galantamine hydrobromide extended release
2020-10-14T05:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide,US brand name:,Razadyne ER
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,ER granisetron injectable formulation
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,granisetron extended-release injection
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,Synonym:,granisetron extended-release polymer-based injectable formulation
2020-09-18T06:41:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation,US brand name:,Sustol
2020-10-14T05:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-microsphere-capsule-based-oxycodone,Synonym:,oxycodone ER microsphere capsule
2020-10-14T05:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-microsphere-capsule-based-oxycodone,US brand name:,Xtampza ER
2020-09-18T06:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-onapristone,Synonym:,ER onapristone
2020-09-18T06:42:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-onapristone,Synonym:,"onapristone, extended-release formulation"
2020-10-14T03:55:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezabenlimab,Code name:,BI 754091
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,Chemical structure:,"ethyl (2R)-[(4S)-4-amino-5-ethoxy-5-oxopentanoyl]-S-benzyl-L-cysteinyl-2- phenylglycinate hydrochlorideglycine, L-γ-glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenyl-, diethyl ester, monohydrochloride, (2R)-"
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,Code name:,TLK199
2020-09-18T06:42:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride,US brand name:,Telintra
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,Chemical structure:,1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,Synonym:,ezedoc
2020-09-18T06:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe,US brand name:,Zetia
2020-09-18T06:42:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe-simvastatin,US brand name:,Vytorin
2020-09-18T12:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-ds-3201,Chemical structure:,"1,3-benzodioxole-5-carboxamide, 7-chloro-N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-2-(trans-4-(dimethylamino)cyclohexyl)-2,4-dimethyl-, (2R)-, compd. with 4-methylbenzenesulfonate (1:1)"
2020-09-18T12:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-ds-3201,Code name:,DS 3201b
2020-09-18T12:45:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-ds-3201,Code name:,DS-3201 tosylate
2020-10-14T05:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-hh2853,Code name:,HH 2853
2020-10-14T05:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-hh2853,Code name:,HH-2853
2020-10-14T05:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-hh2853,Code name:,HH2853
2020-10-14T05:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-hh2853,Synonym:,EZH1 and EZH2 inhibitor HH2853
2020-10-14T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-0209,Code name:,CPI 0209
2020-10-14T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-0209,Code name:,CPI-0209
2020-10-14T05:02:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-0209,Code name:,CPI0209
2020-09-18T06:42:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-1205,Code name:,CPI-1205
2020-10-14T05:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-pf-06821497,Code name:,PF 06821497
2020-10-14T05:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-pf-06821497,Code name:,PF-06821497
2020-10-14T05:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-pf-06821497,Code name:,PF06821497
2020-10-14T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-shr2554,Code name:,SHR 2554
2020-10-14T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-shr2554,Code name:,SHR-2554
2020-10-14T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-shr2554,Code name:,SHR2554
2020-10-14T05:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-shr2554,Synonym:,enhancer of Zeste homolog 2 inhibitor SHR2554
2020-09-18T06:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-16-alpha-fluoroestradiol,Abbreviation:,F-18 FES
2020-09-18T06:43:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-16-alpha-fluoroestradiol,Synonym:,fluorine-18 16 alpha-fluoroestradiol
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Abbreviation:,FDGal
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,18-F-deoxy-galactose
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,18-F-deoxygalactose
2020-09-18T06:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose,Synonym:,fluorodeoxygalactose F-18
2020-09-18T06:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine,Abbreviation:,F-18 FET
2020-09-18T06:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine,Chemical structure:,O-(2-[F 18]fluoroethyl)-1-tyrosine
2020-09-18T01:07:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18hx4,NA,NA
2020-09-18T06:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f16-il2-fusion-protein,Synonym:,teleukin
2020-09-18T01:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f18vm4-037,NA,NA
2020-09-18T06:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fact-complex-targeting-curaxin-cbl0137,Code name:,CBL0137
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH 0145228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH 5228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH-0145228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH-5228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH0145228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ACH5228
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ALXN 2050
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ALXN-2050
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Code name:,ALXN2050
2020-10-14T05:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050,Synonym:,FD inhibitor ALXN2050
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Code name:,ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,FVII modified conjugate ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,FVII-targeting immunoconjugate protein ICON-1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,human immuno-conjugate 1
2020-09-18T06:43:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1,Synonym:,VII-Fc fusion protein ICON-1
2020-09-18T06:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-viia-inhibitor-pci-27483,Code name:,PCI-27483
2020-10-14T04:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadraciclib,Code name:,CYC065
2020-10-14T04:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadraciclib,Synonym:,cyclin dependent kinase inhibitor 2/5/9 CYC065
2020-09-18T06:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride,Code name:,CGS-16949A
2020-10-14T05:03:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-alk-ros1-inhibitor-apg-2449,Code name:,APG 2449
2020-10-14T05:03:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-alk-ros1-inhibitor-apg-2449,Code name:,APG-2449
2020-10-14T05:03:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-alk-ros1-inhibitor-apg-2449,Code name:,APG2449
2020-09-18T06:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098,Code name:,GSK2256098
2020-09-18T06:43:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098,Synonym:,focal adhesion kinase inhibitor GSK2256098
2020-09-18T06:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271,Code name:,PF-00562271
2020-09-18T06:44:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271,Synonym:,focal adhesion kinase inhibitor PF-00562271
2020-09-18T06:44:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-vs-4718,Code name:,VS-4718
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Abbreviation:,fCEA-MUC-1-TRI
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Synonym:,recombinant fowlpox-CEA-MUC-1-TRICOM vaccine
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,Synonym:,rfowlpox-CEA(D609)/MUC1(L93)/TRICOM vaccine
2020-09-18T06:44:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev,US brand name:,PANVAC-F
2020-09-18T06:44:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famitinib,NA,NA
2020-09-18T06:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine,US brand name:,Pepcid
2020-09-18T06:44:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine,US brand name:,Pepcid AC
2020-09-18T06:44:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fap-specific-cd8-positive-t-cells,NA,NA
2020-09-18T06:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab,Code name:,MORAb-003
2020-09-18T06:44:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab,Synonym:,anti-GP-3 monoclonal antibody
2020-09-18T06:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010,Code name:,APO010
2020-09-18T06:45:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010,Synonym:,mega-FasLigand
2020-09-18T06:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fasn-inhibitor-tvb-2640,Code name:,TVB-2640
2020-09-18T06:45:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion,Synonym:,intravenous fat emulsion
2020-09-18T06:45:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion,US brand name:,Intralipid
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Abbreviation:,Ara AC
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Abbreviation:,ARA-AC
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Chemical structure:,"1,3, 5-triazin-2(1H)-one, 4-Amino-1-beta-D- arabinofuranosyl- (9CI)1-beta-D-arabinofuranosyl-5-azacytosine"
2020-09-18T06:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine,Synonym:,Kymarabine
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Code name:,2141 V-11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Code name:,2141 V11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Code name:,2141-V11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Synonym:,anti-CD40 agonist antibody 2141-V11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Synonym:,anti-CD40 agonistic antibody 2141-V11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Synonym:,Fc-engineered anti-CD40 agonistic antibody 2141-V11
2020-10-14T05:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11,Synonym:,Fc-enhanced wnti-CD40 wntibody 2141-V11
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,Chemical structure:,2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,Code name:,TMX 67
2020-09-18T06:45:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat,US brand name:,Uloric
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CEF
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CEF regimen
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,CTX/EPI/5-FU
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,FEC
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,FEC 100
2020-09-18T06:45:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen,Synonym:,fluorouracil-epirubicin-cyclophosphamide regimen
2020-10-14T05:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule,Synonym:,fecal microbiota preparation delivery capsule
2020-10-14T05:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule,Synonym:,FMPCapDE
2020-10-14T05:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule,Synonym:,FMT Capsule DE
2020-10-14T05:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule,Synonym:,FMT capsule delivery
2020-10-14T05:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule,Synonym:,FMT DE capsule
2020-10-14T05:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fedratinib,Code name:,SAR302503a
2020-10-14T05:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fedratinib,Synonym:,fedratinib dihydrochloride monohydrate
2020-10-14T05:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fedratinib,US brand name:,Inrebic
2020-10-14T03:39:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/felzartamab,Code name:,MOR03087
2020-10-14T03:39:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/felzartamab,Code name:,MOR202
2020-10-14T03:39:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/felzartamab,Code name:,TJ202/MOR202
2020-10-14T04:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenebrutinib,Code name:,GDC-0853
2020-10-14T04:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenebrutinib,Synonym:,Bruton tyrosine kinase inhibitor GDC-0853
2020-09-18T06:46:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenofibrate,US brand name:,Tricor
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Abbreviation:,4-HPR
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Chemical structure:,4-(all-trans-retino-yl)aminophenol4-hydroxyphenylretinamideAll-trans-4'-hydroxyretinanilideall-trans-N-(4-hydroxyphenyl)retinamideall-trans-N-4'-hydroxyretinanilideN-(4-hydroxyphenyl)retinamide
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Code name:,McN-R-1967
2020-09-18T06:46:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide,Synonym:,fenretinimide
2020-09-18T06:46:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,Synonym:,fenretinide LXS
2020-09-18T06:46:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix,US brand name:,Fenretinide Lym-X-Sorb
2020-09-18T06:46:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-buccal-soluble-film,US brand name:,Onsolis
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Actiq
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Oralet
2020-09-18T01:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate,US brand name:,Sublimaze
2020-09-18T06:46:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,Synonym:,fentanyl buccal tablet
2020-09-18T06:46:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet,US brand name:,Fentora
2020-09-18T06:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-containing-nasal-spray,Foreign brand name:,Instanyl
2020-09-18T06:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-containing-nasal-spray,Synonym:,intranasal fentanyl spray
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,Foreign brand name:,Nasalfent
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,Foreign brand name:,PecFent
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,US brand name:,Lazanda
2020-09-18T06:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray,US brand name:,Nasalfent
2020-09-18T06:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-matrix-transdermal-patch,Foreign brand name:,Durogesic DTrans
2020-09-18T06:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-matrix-transdermal-patch,Synonym:,fentanyl matrix transdermal delivery system
2020-09-18T06:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-sublingual-spray,Abbreviation:,fentanyl SL spray
2020-09-18T06:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-sublingual-spray,Abbreviation:,FSS
2020-10-14T05:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-extract,Synonym:,fermented soy
2020-10-14T05:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-extract,Synonym:,fermented soy extract
2020-10-14T05:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-extract,US brand name:,Q-Can Plus
2020-09-18T06:47:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-protein-beverage,US brand name:,Haelan 951
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Acronym:,FWGE
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,Foreign brand name:,Avemar
2020-09-18T04:26:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract,US brand name:,Avemar
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Abbreviation:,FCM
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Foreign brand name:,Ferinject
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,Synonym:,ferric carboxymaltose injection
2020-09-18T06:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution,US brand name:,Injectafer
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Abbreviation:,Fe3O4
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Chemical structure:,iron oxidetriiron tetraoxide
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,black iron oxide
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,ferrosoferric oxide
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,iron black
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,magnetic black
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,magnetite
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,Synonym:,Sienna+
2020-10-14T05:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide,US brand name:,Feraheme
2020-09-18T06:48:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-fumarate,NA,NA
2020-09-18T06:48:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-sulfate,Synonym:,Iron(II) Sulfate
2020-09-18T06:47:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxides-injectable-solution,US brand name:,Feridex
2020-09-18T06:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension,US brand name:,GastroMARK
2020-09-18T06:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension,US brand name:,Lumirem
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Abbreviation:,USPIO
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,AMI-227
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Code name:,G-53425
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Foreign brand name:,Sinerem
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,Synonym:,Ultrasmall Particulate Iron Oxide
2020-09-18T05:36:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10,US brand name:,Combidex
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Abbreviation:,Fe3O4
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Chemical structure:,iron oxidetriiron tetraoxide
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,black iron oxide
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,ferrosoferric oxide
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,iron black
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetic black
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,magnetite
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,Synonym:,Sienna+
2020-09-18T06:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite,US brand name:,Feraheme
2020-09-18T06:48:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fesoterodine-fumarate,US brand name:,Toviaz
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,Synonym:,fexofenadine HCl
2020-09-18T01:49:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride,US brand name:,Allegra
2020-09-18T06:48:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-fgfr-pathway-inhibitor-e7090,Code name:,E7090
2020-10-14T05:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036,Code name:,FP-1039
2020-10-14T05:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036,Code name:,HGS1036
2020-10-14T05:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036,Synonym:,FGFR1 receptor antagonist FP-1039
2020-10-14T05:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036,Synonym:,GSK3052230
2020-09-18T06:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf401-inhibitor-fgf401,Code name:,FGF401
2020-09-18T06:48:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-asp5878,Code name:,ASP5878
2020-09-18T06:48:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-azd4547,Code name:,AZD4547
2020-10-14T05:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-cpl304110,Code name:,CPL 304110
2020-10-14T05:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-cpl304110,Code name:,CPL-304110
2020-10-14T05:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-cpl304110,Code name:,CPL304110
2020-10-14T05:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-cpl304110,Code name:,PG19
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Code name:,debio 1347
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Code name:,debio 1347-101
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,CH5183284
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,debiopharm 1347
2020-09-18T06:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347,Synonym:,FF284
2020-09-18T10:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-incb054828,Code name:,INCB054828
2020-09-18T10:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-incb054828,Synonym:,FGFR inhibitor INCB054828
2020-09-18T10:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-incb054828,US brand name:,Pemazyre
2020-09-18T07:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-tas-120,Code name:,TAS-120
2020-09-18T07:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-tas-120,Synonym:,FGFR inhibitor TAS-120
2020-10-14T05:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-2-3-inhibitor-hmpl-453,Code name:,HMPL 453
2020-10-14T05:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-2-3-inhibitor-hmpl-453,Code name:,HMPL-453
2020-10-14T05:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-2-3-inhibitor-hmpl-453,Synonym:,FGFR inhibitor HMPL-453
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Code name:,FP-1039
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Code name:,HGS1036
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Synonym:,FGFR1 receptor antagonist FP-1039
2020-09-18T06:49:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036,Synonym:,GSK3052230
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB 062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB-062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB062079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Code name:,INCB62079
2020-09-18T06:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079,Synonym:,fibroblast growth factor receptor 4 antagonist INCB062079
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Chemical structure:,"2-propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide"
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,BLU 554
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,BLU554
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,CS 3008
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Code name:,CS3008
2020-09-18T06:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554,Synonym:,fibroblast growth factor receptor 4 inhibitor BLU-554
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B 6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B-6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Code name:,H3B6527
2020-09-18T06:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527,Synonym:,fibroblast growth factor receptor 4 inhibitor H3B-6527
2020-10-14T05:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-icp-105,Code name:,ICP 105
2020-10-14T05:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-icp-105,Code name:,ICP-105
2020-10-14T05:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-icp-105,Code name:,ICP105
2020-10-14T05:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-icp-105,Synonym:,FGFR4 antagonist ICP-105
2020-10-14T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fianlimab,Code name:,REGN 3767
2020-10-14T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fianlimab,Code name:,REGN3767
2020-10-14T03:51:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fianlimab,Synonym:,anti-LAG-3 MoAb REGN3767
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,Foreign brand name:,Beriplast P
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,Fibrocaps
2020-09-18T06:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant,US brand name:,TISSEEL VH
2020-10-14T05:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibromun,Abbreviation:,L19-TNF-alpha
2020-10-14T05:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibromun,Abbreviation:,L19TNF alpha
2020-10-14T05:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibromun,Synonym:,recombinant human fusion protein L19TNFalpha
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Code name:,AV-299
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Code name:,SCH 900105
2020-09-18T06:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab,Synonym:,anti-HGF monoclonal antibody SCH900105
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Code name:,OPT-80
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Code name:,PAR-101
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,clostomicin B1
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,difimicin
2020-09-18T06:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin,Synonym:,lipiamycin A3
2020-09-18T06:50:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/figitumumab,Code name:,"CP-751,871"
2020-10-14T12:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filanesib,Code name:,ARRY-520
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Abbreviation:,G-CSF
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Abbreviation:,r-metHuG-CSF
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Grasin
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Nivestim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Foreign brand name:,Tevagrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,filgrastim XM02
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,filgrastim-sndz
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,G-CSF
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,granulocyte colony-stimulating factor
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,Recombinant Methionyl Human Granulocyte Colony Stimulating Factor
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,tbo-filgrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,Synonym:,Tbo-filgrastim
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Granix
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Neupogen
2020-09-18T06:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim,US brand name:,Zarxio
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Abbreviation:,filgrastim-primed PBPC
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Abbreviation:,GPBPCI
2020-09-18T06:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells,Synonym:,G-CSF-primed peripheral blood progenitor cells
2020-10-14T05:04:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimaporfin,Chemical structure:,"4,4'-(15,20-diphenyl-7,8(or 12,13 or 17,18)-dihydro-21H,23H-porphine-5,10-diyl)bisbenzenesulfonic acid, mixture of three isomers A, B and C (25%,50%,25%)"
2020-10-14T13:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimaporfin-a,Code name:,TPCS2a
2020-10-14T13:28:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimaporfin-a,Foreign brand name:,Amphinex
2020-10-14T13:04:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimepinostat,Code name:,CUDC-907
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Chemical structure:,"(5alpha,17beta)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide"
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Code name:,MK 906
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Chibro-Proscar
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Finastid
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Pro-Cure
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Prostide
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,Foreign brand name:,Uprosan
2020-09-18T06:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride,US brand name:,Proscar
2020-10-14T05:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/first-degree-perineal-laceration,Synonym:,cRGDY-PEG-Cy5.5-C dots
2020-10-14T13:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/firtecan-pegol,Abbreviation:,PEG-SN38
2020-10-14T13:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/firtecan-pegol,Code name:,EZN-2208
2020-09-18T06:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil,Synonym:,"oil, fish"
2020-09-18T06:50:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil,Synonym:,seafood oil
2020-09-18T06:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil-glycerol-egg-lecithin-based-emulsion,Foreign brand name:,Omegaven
2020-09-18T06:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil-glycerol-egg-lecithin-based-emulsion,Synonym:,omega-3 fatty acid infusion
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Chemical structure:,"2-propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide"
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Code name:,BLU 554
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Code name:,BLU554
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Code name:,CS 3008
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Code name:,CS3008
2020-10-14T05:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib,Synonym:,fibroblast growth factor receptor 4 inhibitor BLU-554
2020-09-18T06:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flanvotumab,Code name:,IMC-20D7S
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Abbreviation:,FAA
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Chemical structure:,"4H-1-benzopyran-8-acetic acid, 4-oxo-2-phenylflavone-8-acetic acid"
2020-09-18T06:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid,Code name:,LM 975
2020-09-18T06:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavonoid-tablet,NA,NA
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,linseed
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,lint bells
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,linum
2020-09-18T06:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed,Synonym:,Linum usitatissimum
2020-10-14T05:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed-lignan,Synonym:,flax lignan
2020-10-14T05:05:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flibanserin,NA,NA
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Code name:,MGD006
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Code name:,RES234
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Code name:,S80880
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Synonym:,anti-CD123/CD3 monoclonal antibody MGD006
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Synonym:,CD123 x CD3 DART bi-specific antibody MGD006
2020-10-14T05:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab,Synonym:,CD123 x CD3 dual affinity re-targeting bi-specific antibody MGD006
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,5-FUDR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FDUR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Abbreviation:,FUdR
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Chemical structure:,1-(2-deoxy-beta-D-ribofuranosyl)-5-fluorouracil2'-deoxy-5-fluorouridine5-fluoro-2'-deoxy-beta-uridine5-fluoro-2'-deoxyuridine5-fluorodeoxyuridine5-fluorouridine deoxyribose
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Code name:,WR-138720
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,FdUrD
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,floxuridin
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorodeoxyuridine
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluorouridine deoxyribose
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,Synonym:,fluoruridine deoxyribose
2020-09-18T06:52:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine,US brand name:,FUDF
2020-09-18T06:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-cdk4-6-inhibitor-flx925,Code name:,FLX925
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Code name:,MA Max 4
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Code name:,MAX 40279
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Code name:,MAX-40279
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Code name:,MAX-40279-01
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Code name:,MAX40279
2020-10-14T05:05:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279,Synonym:,FLT3/FGFR kinase inhibitor MAX-40279
2020-09-18T06:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate,Synonym:,FF-10101 succinate
2020-09-18T06:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate,Synonym:,FF10101 Succinate
2020-10-14T05:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-hm43239,Code name:,HM 43239
2020-10-14T05:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-hm43239,Code name:,HM-43239
2020-10-14T05:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-hm43239,Code name:,HM43239
2020-10-14T05:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-hm43239,Synonym:,FMS-like tyrosine kinase 3 inhibitor HM43239
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Code name:,G-801
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Code name:,SKI-G-801
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Synonym:,FLT3 kinase inhibitor SKI-G-801
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Synonym:,FLT3 tyrosine kinase inhibitor SKI-G-801
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Synonym:,G-749 HCl salt
2020-10-14T05:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801,Synonym:,G749 hydrochloride
2020-10-14T05:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-csf1r-inhibitor-nms-03592088,Code name:,NMS 03592088
2020-10-14T05:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-csf1r-inhibitor-nms-03592088,Code name:,NMS P088
2020-10-14T05:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-csf1r-inhibitor-nms-03592088,Code name:,NMS-03592088
2020-10-14T05:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-csf1r-inhibitor-nms-03592088,Code name:,NMS03592088
2020-09-18T06:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-kinase-inhibitor-akn-028,Code name:,AKN-028
2020-09-18T06:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-kinase-inhibitor-akn-028,Code name:,BVT-II
2020-10-14T05:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-mertk-inhibitor-mrx-2843,Code name:,MRX 2843
2020-10-14T05:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-mertk-inhibitor-mrx-2843,Code name:,MRX-2843
2020-10-14T05:05:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-mertk-inhibitor-mrx-2843,Code name:,MRX2843
2020-09-18T06:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flu-matrix-peptide-p58-66,NA,NA
2020-10-14T05:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclatide-f-18,Abbreviation:,18F-AH111585
2020-10-14T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18,Abbreviation:,[18F]FACBC
2020-10-14T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18,Synonym:,anti-1-amino-3-[18F ]fluorocyclobutane-1-carboxylic acid
2020-10-14T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18,Synonym:,fluciclovine (18F)
2020-10-14T04:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18,US brand name:,Axumin
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Abbreviation:,FCZ
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,Chemical structure:,"alpha-(2,4-difluorophenyl)-alpha- (1,2,4-triazol-1-ylmethyl)-1,2, 4- triazole-1-ethanol"
2020-09-18T06:04:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole,US brand name:,Diflucan
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Abbreviation:,5-FC
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Chemical structure:,4-amino-5-fluoro-2(1H)-pyrimidinone
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro 2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Code name:,Ro-2-9915
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Alcobon
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Foreign brand name:,Ancotil
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,Synonym:,5-fluorocytosine
2020-09-18T02:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine,US brand name:,Ancobon
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Abbreviation:,2-F-ara-AMP
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Chemical structure:,"9H-purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)fludarabine-5'-monophosphate"
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Code name:,SH T 586
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Foreign brand name:,Beneflur
2020-09-18T06:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate,Synonym:,fludarabine monophosphate
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Abbreviation:,18FDG
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Abbreviation:,FDG
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Chemical structure:,2-F18-fluoro-2-deoxy-D-glucose2-F18-fluoro-2-deoxyglucose
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Synonym:,Fluorine-18 2-Fluoro-2-deoxy-D-Glucose
2020-09-18T06:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18,Synonym:,fluorodeoxyglucose F 18
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,Florinef acetate
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,Synonym:,fludrocortisone
2020-09-18T06:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate,US brand name:,Florinef
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Chemical structure:,4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide Mesylate
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Code name:,HH-GV-678
2020-09-18T06:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate,Code name:,HH-GV678
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,Chemical structure:,"(6alpha,11beta,16alpha)-21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione"
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,Synonym:,fluocinonide
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,US brand name:,Lidex
2020-09-18T06:53:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream,US brand name:,Vanos
2020-10-14T05:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-conjugated-wisteria-floribunda-lectin,Synonym:,fluorescein-labeled WFA
2020-10-14T05:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-conjugated-wisteria-floribunda-lectin,Synonym:,fluorescein-labeled WFL
2020-10-14T05:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-conjugated-wisteria-floribunda-lectin,Synonym:,fluorescein-labeled Wisteria floribunda lectin
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Chemical structure:,"spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one, 3'6'-dihydroxy,disodium salt"
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,Synonym:,AK-FLUOR
2020-09-18T06:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection,US brand name:,Fluorescite
2020-09-18T06:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-emi-137,Code name:,EMI-137
2020-10-14T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-ic2000,Code name:,IC 2000
2020-10-14T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-ic2000,Code name:,IC2000
2020-10-14T05:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-ic2000,Synonym:,IC2000 fluorescence imaging agent
2020-09-18T06:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-antibody-sgm-101,Code name:,SGM-101
2020-09-18T06:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-antibody-sgm-101,Synonym:,anti-CEA fluorescent antibody SGM-101
2020-09-18T06:54:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-crgdy-peg-cy55-c-dots,Synonym:,cRGDY-PEG-Cy5.5-C dots
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Chemical structure:,cypate-cyclo (D-Cys-Gly-Arg--Asp-Ser-Pro-Cys)-Lys-OH
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS 301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS-301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Code name:,LS301
2020-09-18T06:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301,Synonym:,NIR fluorescent probe LS301
2020-10-14T05:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-agent-crgd-zw800-1,Abbreviation:,cRGD-ZW800-1
2020-10-14T05:05:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-agent-crgd-zw800-1,Synonym:,cyclo-(RGDyK)-ZW800-1
2020-09-18T06:54:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-ligand-otl38,Code name:,OTL38
2020-09-18T06:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-protease-activated-peptide-avb-620,Code name:,AVB-620
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,18F-fludarabine
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,2-[(18)F]fludarabine
2020-09-18T06:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine,Synonym:,fluorine 18 F fludarabine
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Abbreviation:,18F fluoroglutamine
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"(2S,4R)4-FGln"
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"[18F] 4-L-fluoroglutamine (2S,4R)"
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,F-glutamine
2020-09-18T06:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r,Synonym:,"fluorine F 18 4-L-fluoroglutamine (2S,4R)"
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Abbreviation:,[F-18]FdCyd
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Synonym:,[F-18]-5-fluoro-2'-deoxycytidine
2020-09-18T06:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine,Synonym:,fluorine F 18 5-fluoro-2-deoxycytidine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,[18F]-6F-DA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,18F-DA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Abbreviation:,6-[18F]FDA
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Chemical structure:,"1,2-benzenediol, 4-(2-aminoethyl)-5-(fluoro-18F)-"
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,18F-fluorodopamine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,18F]-6F-dopamine
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,"3,4-dihydroxy-6-fluorophenethylamine F-18"
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,6-fluorodopamine F-18
2020-09-18T06:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine,Synonym:,fluorine F 18 6-fluorodopamine
2020-10-14T05:06:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-active-site-inhibited-factor-viia,Abbreviation:,18F-ASIS
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,[18F]AlF-NOTA-neurotensin
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,"[18F]aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,18F-AlF-NOTA-neurotensin
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,18F-AlF-NOTA-NT
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,"18F-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-neurotensin"
2020-10-14T05:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin,Synonym:,fluorine F 18-Al-NOTA-neurotensin
2020-10-14T05:06:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-matbbn,Synonym:,18F-Al-NOTA-MATBBN
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Chemical structure:,"Al18F-1,4,7-triazacyclononane-1,4,7-triacetate-octreotide"
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Synonym:,18F-AlF-NOTA-octreotide
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Synonym:,18F-IMP-466
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Synonym:,Al18F-OC
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Synonym:,fluorine F 18-IMP-466
2020-10-14T05:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide,Synonym:,fluorine F 18-NOTA octreotide
2020-10-14T05:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alf-cys-variant-3-ph-low-insertion-peptides,Synonym:,[18F]AlF-cysVar3 pHLIP
2020-10-14T05:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alf-cys-variant-3-ph-low-insertion-peptides,Synonym:,18F-AlF-Var3 pHLIP
2020-10-14T05:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alf-cys-variant-3-ph-low-insertion-peptides,Synonym:,fluorine F 18-cys-Var3 pHLIP
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,(18)F-AlF-NOTA-E[PEG4-c(RGDfk)]2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-Al-NOTA-PRGD2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-AlF-NOTA-PRGD2
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,18F-Alfatide II
2020-09-18T06:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii,Synonym:,fluorine F 18 alfatide II
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Abbreviation:,18F-aVb6-BP
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,18F-alphaVbeta6-binding peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,18F-alphaVbeta6-binding-peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,fluorine F 18-alphaVbeta6-binding peptide
2020-09-18T06:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide,Synonym:,fluorine F 18-alphaVbeta6-binding-peptide
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Chemical structure:,2'-deoxy-2'-[18F]fluoro-9-beta-D-arabinofuranosylguanine
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,[18F]F-ara-G
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,18F-F-ara-G
2020-09-18T06:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g,Synonym:,fluorine F 18 ara-G
2020-09-18T06:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-av-133,Synonym:,18F-AV-133
2020-09-18T06:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-av-133,Synonym:,18F-FP-(+)-DTBZ
2020-10-14T05:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-azafol,Synonym:,[18F]-azafol
2020-10-14T05:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-azafol,Synonym:,3'-Aza-2'-[(18)F]fluorofolic acid
2020-10-14T05:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-azafol,Synonym:,fluorine F 18 azafol
2020-10-14T05:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-bms-986229,Synonym:,18F-BMS-986229
2020-10-14T05:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-bms-986229,Synonym:,fluorine F 18-labeled BMS-986229
2020-10-14T05:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-c-snat4,Synonym:,[18F]-C-SNAT4
2020-10-14T05:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-c-snat4,Synonym:,18F C SNAT4
2020-10-14T05:06:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-c-snat4,Synonym:,18F-C-SNAT4
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Abbreviation:,[18F]-choline
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Abbreviation:,18F-choline
2020-09-18T06:55:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline,Synonym:,18F-fluorocholine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Abbreviation:,18F-CA
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Chemical structure:,2-chloro-9-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)adenine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,[18F]-clofarabine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,18F-clofarabine
2020-09-18T06:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine,Synonym:,cl-18F-ara-A
2020-09-18T06:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-cp18-peptide,Synonym:,[F18]CP-18 peptide
2020-09-18T06:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-cp18-peptide,Synonym:,18F-CP18 peptide
2020-09-18T06:55:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-d-fmau,Chemical structure:,1-(2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl)thymine18F-2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil-clevudine2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil
2020-09-18T06:55:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dabrafenib,Synonym:,[F18]dabrafenib
2020-10-14T05:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dasa-23,Chemical structure:,1-((2-fluoro-6-[18F]fluorophenyl)sulfonyl)-4-((4-methoxyphenyl)sulfonyl)piperazine
2020-10-14T05:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dasa-23,Synonym:,18F-DASA-23
2020-10-14T05:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dasa-23,Synonym:,F18-labeled PKM2 inhibitor DASA-23
2020-10-14T05:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dasa-23,Synonym:,F18-labeled pyruvate kinase M2 inhibitor DASA-23
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Abbreviation:,[18]F-DCFBC
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Abbreviation:,18F-DCFBC
2020-09-18T06:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc,Chemical structure:,"N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine"
2020-09-18T06:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfpyl,Abbreviation:,18F-DCFPyL
2020-09-18T06:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfpyl,Chemical structure:,2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid
2020-09-18T06:55:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ef5,Abbreviation:,18F-EF5
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,(18)F-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,18F-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Abbreviation:,fluorine F 18 dihydrotestosterone
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F 18 16-beta-fluoro-5-alpha-dihydrotestosterone
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F 18-FDHT
2020-09-18T06:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht,Synonym:,fluorine F18-FDHT
2020-09-18T06:56:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-feqa,Abbreviation:,F-18 FEQA
2020-09-18T06:56:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-feqa,Chemical structure:,N-{4-[(3'- [F-18] fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Abbreviation:,[18F]FACBC
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,anti-1-amino-3-[18F ]fluorocyclobutane-1-carboxylic acid
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,Synonym:,fluciclovine (18F)
2020-09-18T04:28:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine,US brand name:,Axumin
2020-09-18T06:56:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-furanyl-norprogesterone,Abbreviation:,F18-FFNP
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Abbreviation:,[(18)F]F-PEG6-IPQA
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Abbreviation:,18F-fluoro-PEG6-IPQA
2020-09-18T06:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa,Chemical structure:,4-[(3-iodophenyl)amino]-7-{2-[2-{2-(2-[2-{2-([(18)F]fluoroethoxy)-ethoxy}-ethoxy]-ethoxy)-ethoxy}-ethoxy]-quinazoline-6-yl-acrylamide
2020-10-14T05:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroazomycin-arabinoside,Abbreviation:,18F-FAZA
2020-10-14T05:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroazomycin-arabinoside,Synonym:,18F-fluoroazomycin arabinoside
2020-09-18T06:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorobenzyl-triphenyl-phosphonium,Abbreviation:,(18)F-FBnTP
2020-09-18T06:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorobenzyl-triphenyl-phosphonium,Synonym:,18F-fluorobenzyl triphenyl phosphonium
2020-10-14T05:07:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorocholine,Synonym:,18F-fluoromethylcholine
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,(18)F-FDOPA
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-6- L-fluorodopa
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-DOPA
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Abbreviation:,18F-FDOPA
2020-09-18T06:56:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa,Chemical structure:,"3,4-dihydroxy-6-(18)F-fluoro-l-phenylalanineL-6-[ 18F]fluoro-3, 4-dihydroxyphenylalanine"
2020-09-18T06:56:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroethylcholine,Abbreviation:,18F-ethylcholine
2020-09-18T06:56:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoromethylcholine,Synonym:,18F-fluoromethylcholine
2020-09-18T06:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoropaclitaxel,Abbreviation:,18-F FPAC
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,18F-FLT
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,3'-deoxy-3'-(18F) fluorothymidine
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,3'-deoxy-3'-[18F]fluorothymidine
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,fluorothymidine F 18
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,fluorothymidine F-18
2020-09-18T06:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine,Synonym:,"Thymidine, 3'-deoxy-3'-(18F)fluoro-"
2020-09-18T06:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorthanatrace,Abbreviation:,[18F]FTT
2020-09-18T06:56:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorthanatrace,Synonym:,[18F]FluorThanatrace
2020-09-18T06:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fmdht,Chemical structure:,[7alpha-18F]fluoro-17alpha-methyl-5alpha-dihydrotestosterone
2020-09-18T06:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fmdht,Synonym:,18F FMDHT
2020-09-18T06:56:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fp-r01-mg-f2,Synonym:,[18F] FP-R01-MG-F2
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,[18F]Galacto-RGD
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,18F-Galacto-RGD
2020-09-18T06:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide,Synonym:,fluorine F 18 glycosylated RGD peptide
2020-10-14T05:02:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-hx4,NA,NA
2020-10-14T05:07:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-integrin-alpha-v-beta-6-targeted-peptide,Abbreviation:,18F-αvβ6-BP
2020-10-14T05:07:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-integrin-alpha-v-beta-6-targeted-peptide,Synonym:,18F-alphavbeta6-binding peptide
2020-10-14T05:07:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-integrin-alpha-v-beta-6-targeted-peptide,Synonym:,18F-aVb6-binding-peptide
2020-09-18T06:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-iso-1,Abbreviation:,[18F]ISO-1
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Chemical structure:,(4S)-4-(3-18F-fluoropropyl)-L-glutamate(S)-4-(3-18F-fluoropropyl)-L-glutamic acid
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Code name:,BAY94-9392
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Code name:,FSPG
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Synonym:,(4S)-(3-[F-18]fluoropropyl)-L-glutamic acid
2020-09-18T06:57:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392,Synonym:,18F-FSPG
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Abbreviation:,[(18)F]FPHCys
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Abbreviation:,18F-FPM
2020-09-18T06:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride,Synonym:,S-(3-[18F]fluoropropyl) homocysteine hydrochloride
2020-10-14T03:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ml-10,Chemical structure:,[18F]-2-(5-fluoro-pentyl)-2-methyl-malonic-acid
2020-10-14T03:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ml-10,Foreign brand name:,[18F]-ApoSense
2020-10-14T03:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ml-10,Synonym:,Fluorine F 18 ML-10
2020-10-14T05:07:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos,Synonym:,(18)F-NOS
2020-10-14T05:07:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos,Synonym:,[18F]NOS
2020-10-14T05:07:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos,Synonym:,18F NOS
2020-10-14T05:07:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos,Synonym:,18F-NOS
2020-10-14T05:07:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos,Synonym:,FNOS
2020-09-18T06:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ods2004436,Synonym:,[18F]-ODS2004436
2020-09-18T06:57:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ods2004436,Synonym:,18F-ODS2004436
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,[18F]PARP1-targeted probe
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,[18F]PARPi
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,[18F]PARPi imaging agent
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,18F fluorinated PARP1-targeted probe
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,18F-1(2H)phthalazinone-based PARPi imaging agent
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,18F-radiolabeled 1(2H)phthalazinone PARPi
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,fluorine F 18 PARPi
2020-10-14T05:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor,Synonym:,fluorine F 18 poly(ADP-ribose) polymerase inhibitor
2020-10-14T05:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007,Abbreviation:,18F-PSMA-1007
2020-10-14T05:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007,Abbreviation:,F-18-PSMA-1007
2020-10-14T05:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007,Synonym:,[18F]-PSMA-1007
2020-10-14T05:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007,Synonym:,18FPSMA-1007
2020-10-14T05:07:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007,Synonym:,fluorine-18 PSMA-1007
2020-09-18T06:57:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-based-integrin-peptide-polymer-ah111585,Abbreviation:,18F-AH111585
2020-09-18T06:57:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-k5,Abbreviation:,F18 RGD-K5
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Chemical structure:,[18F]-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Synonym:,[18F] SKI-249380
2020-09-18T06:57:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380,Synonym:,F-SKI249380
2020-09-18T06:57:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-sodium-fluoride,Abbreviation:,18 F-NaF
2020-09-18T06:57:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-sodium-fluoride,Abbreviation:,F-18 NaF
2020-10-14T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-tetrafluoroborate,Abbreviation:,18F-TFB
2020-10-14T05:07:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-tetrafluoroborate,Synonym:,18F-tetrafluoroborate
2020-10-14T05:02:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-vm4-037,NA,NA
2020-10-14T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodeoxygalactose-f-18,Abbreviation:,FDGal
2020-10-14T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodeoxygalactose-f-18,Synonym:,18-F-deoxy-galactose
2020-10-14T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodeoxygalactose-f-18,Synonym:,18-F-deoxygalactose
2020-10-14T05:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodeoxygalactose-f-18,Synonym:,fluorodeoxygalactose F-18
2020-10-14T05:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18,Abbreviation:,(18)F-FDOPA
2020-10-14T05:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18,Abbreviation:,18F-6- L-fluorodopa
2020-10-14T05:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18,Abbreviation:,18F-DOPA
2020-10-14T05:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18,Abbreviation:,18F-FDOPA
2020-10-14T05:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18,Chemical structure:,"3,4-dihydroxy-6-(18)F-fluoro-l-phenylalanineL-6-[ 18F]fluoro-3, 4-dihydroxyphenylalanine"
2020-10-14T05:07:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoropyrimidine,Synonym:,5-fluoropyrimidine
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,18F-FLT
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,3'-deoxy-3'-(18F) fluorothymidine
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,3'-deoxy-3'-[18F]fluorothymidine
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,fluorothymidine F 18
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,fluorothymidine F-18
2020-10-14T05:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18,Synonym:,"Thymidine, 3'-deoxy-3'-(18F)fluoro-"
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Abbreviation:,5-FU injection
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Abbreviation:,FU
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Chemical structure:,"2,4-dioxo-5-fluoropyrimidine5-fluoro-2,4(1H,3H)-pyrimidinedione"
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Code name:,Ro-2-9757
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,AccuSite
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,Flurablastin
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,Fluracedyl
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,Fluril
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,Fluroblastin
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Foreign brand name:,Ribofluor
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Synonym:,5-fluorouracil injection
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Synonym:,5-Fluracil
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Synonym:,fluouracil
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,Synonym:,Fluracil
2020-10-14T04:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil,US brand name:,Efudex
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Abbreviation:,5-FU-e TI
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,5-fluorouracil/epi
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,5-FU/epi gel
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,fluorouracil-epinephrine therapeutic implant
2020-09-18T07:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant,Synonym:,fluorouracil/epi
2020-09-18T07:00:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-implant,Foreign brand name:,Sinofuan
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,5-FU injection
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Abbreviation:,FU
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Chemical structure:,"2,4-dioxo-5-fluoropyrimidine5-fluoro-2,4(1H,3H)-pyrimidinedione"
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Code name:,Ro-2-9757
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,AccuSite
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Flurablastin
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluracedyl
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluril
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Fluroblastin
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Foreign brand name:,Ribofluor
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-fluorouracil injection
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,5-Fluracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,fluouracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,Synonym:,Fluracil
2020-09-18T06:20:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection,US brand name:,Efudex
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Abbreviation:,FXM
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Chemical structure:,"(11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone"
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Oratestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Stenox
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Foreign brand name:,Testoral
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androfluorene
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,Synonym:,Androsterolo
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Android-F
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halodrin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Halotestin
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ora-Testryl
2020-09-18T02:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone,US brand name:,Ultandren
2020-09-18T07:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride,US brand name:,Permitil
2020-09-18T07:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride,US brand name:,Prolixin
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Chemical structure:,"2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"BTS 18,322"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,E-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,MPC-7869
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,Code name:,"U-27,182"
2020-09-18T02:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen,US brand name:,Ansaid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Abbreviation:,FLUT
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Chemical structure:,"2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide4'-nitro-3'-trifluoromethylisobutyranilidealpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide"
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Code name:,Sch 13521
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Apimid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Cebatrol
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Chimax
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Cytomid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Drogenil
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Euflex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Eulexine
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flucinome
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fluken
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flulem
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fluta-Gry
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutabene
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutacan
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutamex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutamin
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutan
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Flutaplex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Fugerel
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Grisetin
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Oncosal
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Profamid
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostacur
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostadirex
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostica
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Prostogenat
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Tafenil
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Tecnoflut
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Foreign brand name:,Testotard
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Flucinom
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Flugerel
2020-09-18T07:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide,Synonym:,Niftolide
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Chemical structure:,"2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol"
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]flutemetamol
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]FPIB
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,[18F]GE-067
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,Synonym:,fluorine F 18 flutemetamol
2020-09-18T07:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18,US brand name:,Vizamyl
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,Chemical structure:,"(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester"
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flonase
2020-09-18T06:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate,US brand name:,Flovent
2020-09-18T07:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium,Chemical structure:,"(3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid"
2020-09-18T07:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium,US brand name:,Lescol
2020-09-18T07:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate,Synonym:,fluoxamine
2020-09-18T07:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate,US brand name:,Luvox
2020-09-18T07:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluzoparib,Code name:,SHR-3162
2020-09-18T07:01:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-inhibitor-jnj-40346527,Code name:,JNJ-40346527
2020-09-18T07:01:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486,Code name:,PLX7486
2020-10-14T05:08:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486-tosylate,Code name:,PLX7486
2020-09-18T07:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-e39-peptide-vaccine,Synonym:,E39 peptide vaccine
2020-09-18T07:01:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-e39-peptide-vaccine,Synonym:,FBP E39 peptide vaccine
2020-09-18T07:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-j65-peptide-vaccine,Synonym:,FBP J65 peptide vaccine
2020-09-18T07:01:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-j65-peptide-vaccine,Synonym:,J65 peptide vaccine
2020-09-18T07:01:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc,Code name:,EC17
2020-09-18T07:01:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc,Synonym:,folate fluorescein isothiocyanate conjugate
2020-09-18T07:01:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRalphaDC vaccine
2020-09-18T07:01:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRαDC vaccine
2020-09-18T07:01:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-epothilone-bms753493,Code name:,BMS753493
2020-09-18T07:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-technetium-tc-99m-ec20,Abbreviation:,99mTc-EC20
2020-09-18T07:01:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-technetium-tc-99m-ec20,Synonym:,technetium Tc 99m EC20
2020-09-18T07:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456,Code name:,EC1456
2020-09-18T07:01:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456,Synonym:,folate receptor-targeting folate-tubulysin conjugate EC1456
2020-09-18T07:01:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-ec0489,NA,NA
2020-09-18T07:01:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-mitomycin-c-ec0225,Code name:,EC0225
2020-09-18T07:02:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-bevacizumab-regimen,Synonym:,FOLFIRI-Avastin regimen
2020-09-18T07:02:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-bevacizumab-regimen,Synonym:,folinic acid-fluorouracil-irinotecan-bevacizumab regimen
2020-09-18T07:02:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-cetuximab-regimen,Synonym:,FOLFIRI-Erbitux regimen
2020-09-18T07:02:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-cetuximab-regimen,Synonym:,leucovorin-fluorouracil-irinotecan-cetuximab regimen
2020-09-18T07:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen,Abbreviation:,FOLFIRI
2020-09-18T07:02:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen,Synonym:,FOLinic acid-Fluorouracil-IRInotecan regimen
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,"fluorouracil with irinotecan hydrochloride, leucovorin calcium and oxaliplatin"
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,fluorouracil-leucovorin-irinotecan-oxaliplatin regimen
2020-09-18T07:02:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen,Synonym:,FOLFIRINOX protocol
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Abbreviation:,CF/5-FU/L-OHP
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Synonym:,fluorouracil/leucovorin calcium/oxaliplatin
2020-09-18T07:02:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen,Synonym:,FOLinic acid-Fluororuracil-OXaliplatin regimen
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Acronym:,FA
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Chemical structure:,"2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acidN-[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid"
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Synonym:,folicin
2020-09-18T07:02:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid,Synonym:,pteroylmonoglutamic acid
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,"5,10-MTHF"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Abbreviation:,MTHF
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Code name:,ANX-510
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10 methylenetetrahydrofolate"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,Synonym:,"5,10-methylenetetrahydrofolate"
2020-09-18T05:35:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin,US brand name:,CoFactor
2020-09-18T03:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium,US brand name:,Arixtra
2020-09-18T07:02:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib,Code name:,GSK1363089G
2020-09-18T07:02:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib,Code name:,XL880
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Abbreviation:,4-OHA
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Abbreviation:,4-OHAD
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Chemical structure:,"4-Hydroxyandrost-4-ene-3,17-dione"
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Code name:,CGP-32349
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Foreign brand name:,Lentaron
2020-09-18T07:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane,Synonym:,4-hydroxyandrostenedione
2020-09-18T07:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-oral,Code name:,APD209
2020-09-18T04:40:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-roxithromycin,US brand name:,BetaMarc
2020-09-18T07:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride,Code name:,BCX-1777
2020-09-18T07:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride,Synonym:,immucillin-H
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Abbreviation:,CA4PD
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Chemical structure:,"2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl disodium phosphate"
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin A4 Disodium Phosphate
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,Synonym:,Combretastatin A4 Prodrug
2020-09-18T07:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium,US brand name:,ZYBRESTAT
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,Abbreviation:,CA4P
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,Synonym:,combretastatin A4 phosphate
2020-09-18T07:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine,US brand name:,Zybrestat
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Chemical structure:,"(1R,2S)-(1,2-epoxypropyl)phosphonic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1)"
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Synonym:,fosfomycin compound with trometamol
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,Synonym:,fosfomycin trometamol salt
2020-09-18T07:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine,US brand name:,Monurol
2020-10-14T03:22:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide,Code name:,NUC 1031
2020-10-14T03:22:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide,Code name:,NUC-1031
2020-10-14T03:22:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide,Synonym:,gemcitabine ProTide
2020-10-14T03:22:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide,US brand name:,Acelarin
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Code name:,NUC 3373
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Code name:,NUC-3373
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Code name:,NUC3373
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Synonym:,5-FU analog prodrug NUC-3373
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Synonym:,nucleotide analog NUC-3373
2020-10-14T12:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide,Synonym:,phosphoramidate-FUDR-MP prodrug NUC-3373
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Chemical structure:,"4(1H)-quinolinone, 2-(3-fluorophenyl)-6-methoxy-5-(phosphonooxy)-"
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,CVM 1118
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,CVM-1118
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,CVM1118
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,TRX 818
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,TRX-818
2020-10-14T05:08:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib,Code name:,TRX818
2020-10-14T05:16:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosmanogepix,Code name:,APX001
2020-10-14T05:16:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosmanogepix,Code name:,E1211
2020-10-14T05:16:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosmanogepix,Synonym:,prodrug APX001
2020-10-14T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride,Abbreviation:,IV NEPA FDC
2020-10-14T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride,Synonym:,fosnetupitant-palonosetron HCl
2020-10-14T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride,Synonym:,fosnetupitant/palonosetron HCl combination
2020-10-14T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride,Synonym:,pro-netupitant/palonosetron HCl
2020-10-14T05:08:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride,Synonym:,pronetupitant/palonosetron HCl
2020-10-14T04:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosphenytoin-sodium,Chemical structure:,"2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt"
2020-10-14T04:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosphenytoin-sodium,Code name:,NPC-06
2020-10-14T04:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosphenytoin-sodium,US brand name:,Cerebyx
2020-09-18T07:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosquidone,Code name:,GR63178A
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Code name:,R788 sodium
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Code name:,R935788 sodium
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Synonym:,fostamatinib disodium hexahydrate
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,Synonym:,Syk kinase inhibitor R935788
2020-09-18T07:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium,US brand name:,Tavalisse
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Abbreviation:,FST
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Chemical structure:,"2H-pyran-2-one,5,6-dihydro-6-(3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11,-tridecatetraenyl)-,trans"
2020-09-18T07:04:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin,Synonym:,phosphotrienin
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Chemical structure:,[1-[[[(2-chloroethyl)nitrosamino]-carbonyl]amino]ethyl]phosphonic acid diethyl ester1-[N-(2-chloroethyl)-N-nitrosoureido]ethylphosphonic acid diethyl esterdiethyl[1-[3-(2-chloroethyl)-3-nitrosoureido]ethyl]phosphonate
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Code name:,S 10036
2020-09-18T07:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine,Foreign brand name:,Muphoran
2020-09-18T07:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-ny-eso-1-vaccine,Abbreviation:,rF-NY-ESO-1
2020-10-14T13:16:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-psa-tricom-vaccine,Synonym:,PROSTVAC-F
2020-10-14T13:16:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-psa-tricom-vaccine,Synonym:,recombinant fowlpox-PSA(L155)/TRICOM vaccine
2020-09-18T07:04:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-virus-vaccine-vector,Abbreviation:,FOWLVAC
2020-09-18T07:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/freeze-dried-black-raspberry-bioadhesive-gel,Abbreviation:,FBR gel
2020-09-18T07:04:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract,Abbreviation:,PYC
2020-09-18T07:04:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract,US brand name:,Pycnogenol
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Code name:,GC1008
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Synonym:,anti-TGF-beta monoclonal antibody GC1008
2020-09-18T07:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab,Synonym:,human anti-TGF-beta monoclonal antibody GC1008
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,FOS supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,fructo-oligosaccharide supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,fructo-oligosaccharides supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,oligofructan supplement
2020-09-18T07:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement,Synonym:,oligofructose supplement
2020-10-14T05:08:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extract,US brand name:,Juice Plus
2020-09-18T07:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extracts,US brand name:,Juice Plus
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Code name:,HMPL-013
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,Synonym:,VEGFR-1/2/3 inhibitor HMPL-013
2020-09-18T06:25:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib,US brand name:,Elunate
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,5FU/LV
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,de Gramont regimen
2020-09-18T07:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen,Synonym:,fluorouracil-leucovorin regimen
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Code name:,JNJ-42160443
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Synonym:,anti-nerve growth factor monoclonal antibody JNJ-42160443
2020-09-18T07:05:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab,Synonym:,Anti-NGF monoclonal antibody JNJ-42160443
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Chemical structure:,"7a-[9-[(4,4,5,5,5,-Pentafluoropentyl)sulphinyl]nonyl]-estra-1,3,5(10)-triene-3,17b-diol"
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,"ICI 182,780"
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,Code name:,ZD9238
2020-09-18T06:45:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant,US brand name:,Faslodex
2020-09-18T07:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fumagillin-derived-polymer-conjugate-xmt-1107,Code name:,XMT-1107
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,Abbreviation:,FRS
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,Code name:,LB-502
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,US brand name:,Lasix
2020-09-18T07:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide,US brand name:,SK-Furosemide
2020-10-14T05:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003,Code name:,CLS 003
2020-10-14T05:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003,Code name:,CLS-003
2020-10-14T05:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003,Code name:,CLS003
2020-10-14T05:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003,Synonym:,digoxin-furosemide topical gel CLS003
2020-10-14T05:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003,Synonym:,ICVT product CLS003
2020-10-14T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006,Code name:,CLS 006
2020-10-14T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006,Code name:,CLS-006
2020-10-14T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006,Code name:,CLS006
2020-10-14T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006,Synonym:,furosemide topical gel CLS 006
2020-10-14T05:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006,Synonym:,furosemide topical gel CLS-006
2020-09-18T07:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine,Abbreviation:,TTFD
2020-09-18T07:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine,Synonym:,thiamine tetrahydrofurfuryl disulfide
2020-09-18T07:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fusidic-acid-betamethasone-valerate-topical-cream,Foreign brand name:,Verutex B
2020-10-14T05:08:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futibatinib,Code name:,TAS-120
2020-10-14T05:08:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futibatinib,Synonym:,FGFR inhibitor TAS-120
2020-10-14T05:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab,Chemical structure:,"immunoglobulin G1, anti-(human epidermal growth factor receptor extracellular domain III) (human-Mus musculus monoclonal 992 DS heavy chain), disulfide with human-Mus musculus monoclonal 992 DS light chain, dimer"
2020-10-14T05:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab,Code name:,992 DS
2020-10-14T05:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab,Code name:,992-DS
2020-10-14T05:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab,Code name:,992DS
2020-10-14T03:45:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab-modotuximab-mixture,Code name:,sym004
2020-10-14T05:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-protein-coupled-estrogen-receptor-agonist-lns8801,Code name:,LNS 8801
2020-10-14T05:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-protein-coupled-estrogen-receptor-agonist-lns8801,Code name:,LNS-8801
2020-10-14T05:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-protein-coupled-estrogen-receptor-agonist-lns8801,Code name:,LNS8801
2020-10-14T05:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-protein-coupled-estrogen-receptor-agonist-lns8801,Synonym:,GPER agonist LNS8801
2020-09-18T07:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-quadruplex-stabilizer-bmvc,Chemical structure:,"3,6-bis (1-methyl-4-vinylpyridinium) carbazole diiodide3,6-bis[2-(1-methylpyridinium)vinyl]carbazole diiodide"
2020-09-18T07:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-quadruplex-stabilizer-bmvc,Code name:,BMVC
2020-09-18T07:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g2-checkpoint-inhibitor-cbp501,Code name:,CBP501
2020-09-18T07:07:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g207,Synonym:,oncolytic HSV-1 G207
2020-09-18T07:07:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g250-peptide-vaccine,NA,NA
2020-09-18T07:07:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ga-68-labeled-fab-2--trastuzumab,NA,NA
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,Chemical structure:,1-(aminomethyl)cyclohexaneacetic Acid
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,US brand name:,Gralise
2020-09-18T07:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin,US brand name:,Neurontin
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Abbreviation:,Gd-BOPTA
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Chemical structure:,"(4RS)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)] gadolinate(2-) dihydrogen compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)"
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,Synonym:,gadolinium benzyloxypropionictetraacetate
2020-09-18T07:07:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine,US brand name:,MultiHance
2020-09-18T07:07:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadavist
2020-09-18T07:07:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol,US brand name:,Gadovist
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Abbreviation:,Gd-DTPA-BMA
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Chemical structure:,"gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)-"
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Code name:,DV 7572
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Code name:,HSDB 7547
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,Synonym:,Gadolinium-DTPA-BMA
2020-09-18T07:07:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide,US brand name:,OmniScan
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS 325
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,Code name:,MS-325
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Ablavar
2020-09-18T01:15:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium,US brand name:,Vasovist
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P 03277
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P-03277
2020-09-18T07:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277,Code name:,P03277
2020-09-18T07:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-chelate,Synonym:,Gadolinium Coordination Complex
2020-09-18T07:07:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-chelate,Synonym:,Gadolinium-Chelant Complex
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,Abbreviation:,Gd-DTPA
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,Synonym:,gadolinium DTPA
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,US brand name:,Magnevist
2020-09-18T07:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine,US brand name:,MultiHance
2020-10-14T05:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopiclenol,Code name:,P 03277
2020-10-14T05:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopiclenol,Code name:,P-03277
2020-10-14T05:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopiclenol,Code name:,P03277
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Foreign brand name:,DOTAREM
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,Synonym:,Gd-DOTA
2020-09-18T06:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine,US brand name:,DOTAREM
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Abbreviation:,Gd-EOB-DTPA
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Chemical structure:,"(4S)-4-(4-ththoxylmethyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedoic acid, gadolinium complex, disodium salt"
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,EOB Primavist
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Foreign brand name:,Primovist
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,Synonym:,"gadoxetic acid, disodium"
2020-09-18T06:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium,US brand name:,Eovist
2020-09-18T07:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gag267-274-peptide-vaccine,Synonym:,ILGLNKIV
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Abbreviation:,GD
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,Synonym:,"1,4-beta-D-galactomannan"
2020-09-18T05:54:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative,US brand name:,DAVANAT
2020-09-18T07:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactose,NA,NA
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,Synonym:,lycoremine hydrobromide
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,Synonym:,Nivalin
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,US brand name:,Razadyne
2020-09-18T07:08:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide,US brand name:,Reminyl
2020-09-18T07:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008,Code name:,OTX008
2020-09-18T07:08:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008,Synonym:,Gal-1 inhibitor OTX008
2020-09-18T07:08:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-inhibitor-gr-md-02,Code name:,GR-MD-02
2020-09-18T07:08:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-inhibitor-gr-md-02,Synonym:,galactoarabino-rhamnogalacturonate
2020-09-18T07:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galeterone,Code name:,TOK-001
2020-09-18T07:08:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galeterone,Synonym:,SARM/LI TOK-001
2020-10-14T05:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galinpepimut-s,Code name:,SLS 001
2020-10-14T05:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galinpepimut-s,Code name:,SLS-001
2020-10-14T05:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galinpepimut-s,Code name:,SLS001
2020-10-14T05:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galinpepimut-s,Synonym:,WT-1 analog peptide vaccine SLS-001
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Abbreviation:,MOAB IDEC-114
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,anti-B7-1
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,anti-CD80
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,MOAB anti-CD80
2020-09-18T07:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab,Synonym:,monoclonal antibody anti-CD80
2020-10-14T05:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-based-bone-resorption-inhibitor-ap-002,Code name:,AP 002
2020-10-14T05:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-based-bone-resorption-inhibitor-ap-002,Code name:,AP-002
2020-10-14T05:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-based-bone-resorption-inhibitor-ap-002,Code name:,AP002
2020-09-18T07:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67,Chemical structure:,"1,2,3-Propanetricarboxylic Acid, 2-hydroxy-, Gallium-(sup 67)Ga(1:1) Salt"
2020-09-18T07:09:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67,US brand name:,Neoscan
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,(68)Ga-citrate
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,68Ga-citrate
2020-09-18T07:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate,Abbreviation:,gallium-68 citrate
2020-09-18T07:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-exendin-4,Synonym:,[Lys40(Ahx-DOTA-68Ga)NH2]-exendin-4
2020-09-18T07:09:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-exendin-4,Synonym:,68Ga-DOTA-exendin-4
2020-10-14T05:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-fapi-04,Synonym:,68Ga-DOTA-FAPI-04
2020-10-14T05:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-fapi-04,Synonym:,68Ga-FAPi-04
2020-10-14T05:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-fapi-04,Synonym:,gallium-68-FAPi-04
2020-09-18T07:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotanoc,Synonym:,Ga68-DOTANOC
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Abbreviation:,(68)Ga-DOTA-TATE
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Abbreviation:,68Ga-DOTATATE
2020-09-18T07:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate,Synonym:,"gallium-68 DOTA-DPhe1, Tyr3-octreotate"
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,68Ga-DOTA-d-Phe1-Tyr3-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,68Ga-DOTA-TOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68 DOTA0-Tyr3-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68 DOTATOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-[Tyr3]-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-DOTA-TOC
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,Ga-68-DOTA-tyr(3)-octreotide
2020-09-18T07:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide,Synonym:,gallium Ga 68-DOTATOC
2020-10-14T05:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-fab2-trastuzumab,NA,NA
2020-10-14T05:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-fapi-46,Synonym:,68Ga-FAPi-46
2020-10-14T05:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-fapi-46,Synonym:,gallium-68-FAPi-46
2020-10-14T05:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-aby-025,Abbreviation:,[68Ga]ABY-025
2020-10-14T05:09:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-aby-025,Synonym:,gallium Ga 68-maleimide-DOTA-Cys61-ZHER2:2891-Cys
2020-09-18T07:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-molecule-aby-025,Abbreviation:,[68Ga]ABY-025
2020-09-18T07:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-molecule-aby-025,Synonym:,gallium Ga 68-maleimide-DOTA-Cys61-ZHER2:2891-Cys
2020-09-18T07:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-bnota-prgd2,Synonym:,68Ga-BNOTA-PRGD2
2020-09-18T07:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-bnota-prgd2,Synonym:,68Ga-p-SCN-Bn-NOTA-PEG3-RGD2
2020-09-18T07:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dota-di-hsg-peptide-imp-288,Synonym:,Ga-68-IMP-288
2020-10-14T05:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dx600,Abbreviation:,(68)Ga-DX600
2020-10-14T05:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dx600,Abbreviation:,68Ga-DX600
2020-10-14T05:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dx600,Synonym:,gallium Ga 68-ACE2 inhibitor DX600
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Code name:,BAY 86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,(68)Ga-DOTA-4-amino-1-carboxymethylpiperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,[68Ga]-labeled bombesin analog BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,[68Ga]RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68-Ga RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-bombesin antagonist BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-DOTA RM2
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,68Ga-DOTA-bombesin analog BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,Ga-68-labeled bombesin antagonist BAY 86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,gallium Ga 68-labeled GRPR antagonist BAY86-7548
2020-09-18T07:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548,Synonym:,gallium Ga68-labeled GRPR antagonist RM2
2020-09-18T07:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-mln6907,Abbreviation:,[68Ga]MLN6907
2020-09-18T07:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-nodaga-mj9,Synonym:,Ga-68-NODAGA-MJ9
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga-labeled Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)Ga-PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,(68)gallium-PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,[68Ga] prostate-specific membrane antigen 11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,[68Ga]GaPSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-DKFZ-PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-HBED-CC-PSMA
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,68Ga-PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,Ga-68-labeled PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,gallium Ga 68 PSMA-11
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,gallium-68 PSMA ligand Glu-urea-Lys(Ahx)-HBED-CC
2020-09-18T07:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11,Synonym:,PSMA-HBED-CC GA-68
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Code name:,BAY 86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,(68)Ga-DOTA-4-amino-1-carboxymethylpiperidine-d-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,[68Ga]-labeled bombesin analog BAY86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,[68Ga]RM2
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,68-Ga RM2
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,68Ga-bombesin antagonist BAY86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,68Ga-DOTA RM2
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,68Ga-DOTA-bombesin analog BAY86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,Ga-68-labeled bombesin antagonist BAY 86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,gallium Ga 68-labeled GRPR antagonist BAY86-7548
2020-10-14T05:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2,Synonym:,gallium Ga68-labeled GRPR antagonist RM2
2020-09-18T07:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neb,Abbreviation:,68Ga-NEB
2020-09-18T07:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neb,Synonym:,68Ga-NOTA conjugated truncated form of Evans blue
2020-10-14T05:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob,Synonym:,[68Ga]-NeoB
2020-10-14T05:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob,Synonym:,68Ga-DOTA-NeoBOMB1
2020-10-14T05:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob,Synonym:,68Ga-NeoB
2020-10-14T05:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob,Synonym:,gallium Ga 68 NeoBOMB1
2020-10-14T05:10:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob,Synonym:,gallium-68 DOTA-NeoBOMB1
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,[68Ga]-labeled anti-EGFR affibody molecule Ac-Cys-ZEGFR:1907
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,68Ga-NODAGA-Ac-Cys-ZEGFR:1907
2020-09-18T07:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907,Synonym:,gallium Ga 68-NODAGA-Ac-Cys-Z(EGFR:1907)
2020-10-14T05:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-cbp8,Synonym:,[68Ga]CBP-8
2020-10-14T05:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-cbp8,Synonym:,[68Ga]CBP8
2020-10-14T05:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-cbp8,Synonym:,gallium-68 NODAGA-CBP8
2020-09-18T07:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ecrgdyk2,Synonym:,68Ga-NODAGA-E(c[RGDyK])2
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,[68Ga]-labeled anti-IGF-1R affibody molecule ZIGF-1R:4:40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4:40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4：40
2020-09-18T07:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440,Synonym:,68Ga-NODAGA-ZIGF-1R:4Z:40
2020-09-18T07:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-3ptate-rgd,Synonym:,68Ga-NOTA-3PTATE-RGD
2020-09-18T07:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14,Synonym:,68Ga-NOTA-Aca-BBN(7-14)
2020-09-18T07:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14,Synonym:,68gallium-labeled NOTA-Aca-BBN(7-14)
2020-09-18T07:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14,Synonym:,Gallium Ga 68-NOTA-Aca-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
2020-09-18T07:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14,Synonym:,gallium Ga 68-NOTA-aminocaproic acid-bombesin(7-14)
2020-09-18T07:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-ae105,Abbreviation:,68Ga-NOTA-AE105
2020-10-14T05:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1,Code name:,VHH1
2020-10-14T05:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1,Synonym:,68Ga-HER2-nanobody VHH1
2020-10-14T05:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1,Synonym:,68Ga-NOTA-2Rs15d
2020-10-14T05:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1,Synonym:,68Ga-NOTA-anti-HER2 VHH1
2020-10-14T05:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1,Synonym:,gallium Ga 68-NOTA-anti-HER2-VHH1
2020-10-14T05:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-mmr-vhh2-nanobody,Synonym:,68Ga-NOTA-MMR-VHH2 nanobody
2020-10-14T05:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-mmr-vhh2-nanobody,Synonym:,68GaNOTA-anti-MMR-VHH2
2020-09-18T07:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn-rgd,Abbreviation:,68Ga-NOTA-BBN-RGD
2020-09-18T07:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn-rgd,Synonym:,8Ga-NOTA-BBN(7-14)-RGD
2020-10-14T05:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn7-14-rgd,Abbreviation:,68Ga-NOTA-BBN-RGD
2020-10-14T05:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn7-14-rgd,Synonym:,8Ga-NOTA-BBN(7-14)-RGD
2020-10-14T05:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-hgzp,Synonym:,[68Ga]-NOTA-hGZP
2020-10-14T05:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-hgzp,Synonym:,68Ga-NOTA-hGZP
2020-10-14T05:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-mal-cys39-exendin-4,Synonym:,68 Ga-NOTA-MAL-Cys39-exendin-4
2020-09-18T07:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-nfb,Abbreviation:,68Ga-NOTA-NFB
2020-10-14T05:10:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-rm26,Synonym:,68Ga-NOTA-RM26
2020-10-14T05:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-sgc8,Abbreviation:,68Ga-Sgc8
2020-10-14T05:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-sgc8,Synonym:,[68Ga]-Sgc8
2020-10-14T05:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-sgc8,Synonym:,68Ga-labeled ssDNA aptamer Sgc8
2020-09-18T07:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-ops202,Synonym:,68Ga-OPS202
2020-09-18T07:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-ops202,Synonym:,gallium Ga 68 OPS202
2020-09-18T07:12:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-ops202,Synonym:,satoreotide trizoxetan gallium Ga-68
2020-09-18T07:12:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p15-041,Synonym:,[68Ga]P15-041
2020-09-18T07:12:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p15-041,Synonym:,gallium 68 P15 041
2020-09-18T07:12:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p15-041,Synonym:,gallium Ga 68 P15-041
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,[68Ga] HBED-CC-PHENOXY-PSMA
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,[68Ga]P16-093
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,Ga-68 P16-093
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,Ga-68 PSMA-093
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,Ga-68 PSMA-93
2020-10-14T05:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093,Synonym:,gallium-68-P16 093
2020-09-18T07:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor,Synonym:,[68Ga] pentixafor
2020-09-18T07:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor,Synonym:,68Ga pentixafor
2020-09-18T07:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor,Synonym:,Ga-68 pentixafor
2020-09-18T07:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor,Synonym:,Ga68 pentixafor
2020-09-18T07:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor,Synonym:,gallium Ga 68 pentixafor
2020-10-14T05:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-617,Synonym:,68Ga-PSMA-617
2020-10-14T05:11:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-617,Synonym:,gallium-68 PSMA-617
2020-10-14T05:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-r2,Synonym:,68Ga-PSMA-R2
2020-10-14T05:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-r2,Synonym:,68GaPSMA-R2
2020-10-14T05:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-r2,Synonym:,gallium Ga 68 PSMA-R2
2020-10-14T05:11:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-r2,Synonym:,gallium-68 PSMA-R2
2020-09-18T07:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-rgd,Synonym:,(68)Ga-RGD
2020-09-18T07:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-rgd,Synonym:,RGD (68Ga)
2020-10-14T05:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-thp-psma,Abbreviation:,68Ga-THP-PSMA
2020-10-14T05:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-thp-psma,Synonym:,gallium Ga 68-labeled THP-PSMA
2020-10-14T05:11:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-thp-psma,Synonym:,gallium Ga 68-tris(hydroxypyridinone)-prostate-specific membrane antigen
2020-10-14T05:11:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-labeled-psma-11-gadoxetate,Synonym:,68Ga-PSMA-11-gadoxetate
2020-09-18T07:12:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-maltolate,Abbreviation:,GaM
2020-09-18T07:12:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-maltolate,Synonym:,tris(3-hydroxy-2-methyl-4H-pyran-4-onato)gallium(III)
2020-09-18T07:12:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-nitrate,Abbreviation:,GaN
2020-09-18T07:12:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-nitrate,Code name:,WR-135675
2020-09-18T07:12:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-nitrate,US brand name:,Ganite
2020-09-18T07:13:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galnac-anti-c5-sirna-aln-cc5,Code name:,ALN-CC5
2020-09-18T07:13:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galnac-anti-c5-sirna-aln-cc5,Synonym:,CC5-targeting RNAi therapeutic ALN-CC5
2020-09-18T07:13:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galnac-anti-c5-sirna-aln-cc5,Synonym:,GalNAc-siRNA conjugate ALN-CC5
2020-09-18T07:13:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galunisertib,Chemical structure:,"4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide"
2020-09-18T07:13:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galunisertib,Code name:,LY-2157299
2020-09-18T07:13:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galunisertib,Code name:,LY2157299
2020-09-18T07:13:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamboge-resin-extract-tsb-9-w1,Code name:,TSB-9-W1
2020-10-14T05:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-d-glutamyl-l-tryptophan,Code name:,SCV-07
2020-10-14T05:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-d-glutamyl-l-tryptophan,Synonym:,gamma-D-glutamyl-L-tryptophan
2020-09-18T07:13:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-delta-tocotrienol,Abbreviation:,GDT
2020-09-18T07:13:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-delta-tocotrienol,Synonym:,gdT3
2020-09-18T09:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-pf-03084014,Code name:,PF-03084014
2020-09-18T09:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-pf-03084014,Synonym:,gamma secretase inhibitor PF-03084014
2020-10-14T05:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-ro4929097,Code name:,R4733
2020-10-14T05:11:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-ro4929097,Code name:,RO4929097
2020-09-18T07:13:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097,Code name:,R4733
2020-09-18T07:13:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097,Code name:,RO4929097
2020-09-18T07:13:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-tocopherol,Chemical structure:,"2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol"
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Abbreviation:,2'NDG
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Abbreviation:,BW-B759U
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Abbreviation:,DHPG
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Chemical structure:,"2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one2'-Nor-2'-deoxyguanosine9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine"
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Foreign brand name:,Cymevan
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Foreign brand name:,Virgan
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Synonym:,BW 759U
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Synonym:,BW-B759U
2020-09-18T07:13:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir,Synonym:,Nordeoxyguanosine
2020-09-18T07:14:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gandotinib,Code name:,LY 2784544
2020-09-18T07:14:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gandotinib,Code name:,LY2784544
2020-09-18T07:14:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganetespib,Code name:,STA-9090
2020-09-18T07:14:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganetespib,Synonym:,Hsp90 inhibitor STA-9090
2020-09-18T07:14:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganitumab,Code name:,AMG-479
2020-09-18T07:14:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganitumab,Synonym:,anti-IGF-1R fully human monoclonal antibody AMG-479
2020-09-18T07:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic,Synonym:,ajo
2020-09-18T07:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic,Synonym:,Allium sativum
2020-09-18T07:14:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic-extract,Code name:,CCRIS 7640
2020-09-18T07:14:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic-extract,Code name:,EINECS 232-371-1
2020-09-18T07:14:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic-extract,Synonym:,Allium sativum extract
2020-10-14T13:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-cholecystokinin-type-b-receptor-inhibitor-z-360,NA,NA
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Abbreviation:,G17-DT
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Abbreviation:,G17DT
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,anti-gastrin 17
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,anti-gastrin therapeutic vaccine
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,G17DT immunogen
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,neutralize hormone G17
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,neutralizing G17 hormone
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,Synonym:,PAS
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,US brand name:,Gastrimmune
2020-09-18T07:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin,US brand name:,Insegia
2020-09-18T07:15:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gataparsen-sodium,Code name:,LY2181308
2020-09-18T07:15:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gataparsen-sodium,Synonym:,antisurvivin antisense oligonucleotide LY2181308
2020-10-14T05:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gatipotuzumab,Synonym:,anti-TA-MUC1 monoclonal antibody PankoMab
2020-10-14T05:11:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gatipotuzumab,US brand name:,PankoMab-GEX
2020-09-18T07:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavilimomab,Abbreviation:,MOAB ABX-CBL
2020-09-18T07:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavilimomab,Synonym:,ABX-CBL
2020-09-18T07:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavilimomab,Synonym:,monoclonal antibody ABX-CBL
2020-09-18T07:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavinostat,Code name:,ITF2357
2020-09-18T07:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavinostat,Synonym:,HDAC inhibitor ITF2357
2020-09-18T07:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavinostat,Synonym:,histone deacetylase inhibitor ITF2357
2020-10-14T05:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gbm-antigens-and-alloantigens-immunotherapeutic-vaccine,US brand name:,V-Boost
2020-10-14T05:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gbm-antigens-and-alloantigens-immunotherapeutic-vaccine,US brand name:,V-Boost Immunitor
2020-09-18T07:15:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gd2-car-expressing-autologous-t-lymphocytes,Synonym:,tvs-CTL vaccine
2020-09-18T07:15:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gd2-lactone-gd3-lactone-klh-conjugate-bivalent-vaccine,NA,NA
2020-09-18T07:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gedatolisib,Code name:,PKI-587
2020-09-18T07:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gedatolisib,Synonym:,dual PI3 kinase/mTOR inhibitor PKI-587
2020-09-18T07:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gedatolisib,Synonym:,PF-05212384
2020-09-18T07:15:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib,Chemical structure:,"4-(3chloro-4-flurophenylamine)-7-methoxy-6(3-(4morpholinyl)quinazoline4-quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin] propoxy]N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin) propoxy]-4-quinazolinamine"
2020-09-18T07:15:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib,Code name:,ZD 1839
2020-09-18T07:15:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib,US brand name:,Iressa
2020-09-18T07:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gelonin,Abbreviation:,rGel
2020-09-18T07:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gelonin,Synonym:,"GEL protein, Gelonium multiflorum"
2020-09-18T07:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gelonin,Synonym:,ribosome-inactivating protein gelonin
2020-09-18T07:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gelonin,Synonym:,"ribosome-inactivating protein gelonin, Gelonium multiflorum"
2020-09-18T07:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-5-elaidic-acid-ester,Code name:,CO-1.01
2020-09-18T07:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-5-elaidic-acid-ester,Code name:,CP-4126
2020-09-18T07:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-5-elaidic-acid-ester,Synonym:,gemcitabine elaidate
2020-09-18T07:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-cisplatin-regimen,Synonym:,gemcitabine/cisplatin regimen
2020-10-14T05:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-elaidate,Code name:,CO-1.01
2020-10-14T05:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-elaidate,Code name:,CP-4126
2020-10-14T05:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-elaidate,Synonym:,gemcitabine elaidate
2020-09-18T07:16:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-erlotinib-regimen,NA,NA
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Abbreviation:,dFdCyd
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Chemical structure:,"1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose hydrochloride2'deoxy-2',2'-difluorocytidine hydrochloride2'-deoxy-2',2'-difluorocytidine hydrochloride"
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Code name:,FF 10832
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Code name:,LY-188011
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Code name:,LY188011
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,Synonym:,difluorodeoxycytidine hydrochloride
2020-09-18T07:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride,US brand name:,Gemzar
2020-09-18T07:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride-emulsion,Code name:,D07001-F4
2020-09-18T07:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride-emulsion,Synonym:,gemcitabine HCl oral
2020-09-18T07:16:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-oxaliplatin-regimen,Synonym:,GEM-OX regimen
2020-09-18T07:16:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-oxaliplatin-regimen,Synonym:,GEMOX regimen
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC 1031
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Code name:,NUC-1031
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,Synonym:,gemcitabine ProTide
2020-09-18T01:17:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031,US brand name:,Acelarin
2020-09-18T07:16:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-prodrug-ly2334737,Code name:,LY2334737
2020-10-14T05:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-releasing-intravesical-system,Code name:,TAR 200
2020-10-14T05:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-releasing-intravesical-system,Code name:,TAR-200
2020-10-14T05:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-releasing-intravesical-system,US brand name:,GemRIS
2020-09-18T07:16:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemfibrozil,US brand name:,Lopid
2020-09-18T07:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemigliptin,Chemical structure:,"1-((2S)-2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido(3,4-d)pyrimidin-7(6H)-yl)-4-oxobutyl-5,5-difluoropiperidin-2-one"
2020-09-18T07:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemigliptin,Code name:,LC15-0444
2020-09-18T07:16:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemigliptin,Foreign brand name:,Zemiglo
2020-10-14T05:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemox-regimen,Synonym:,GEM-OX regimen
2020-10-14T05:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemox-regimen,Synonym:,GEMOX regimen
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,Code name:,CDP-771
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,Code name:,CMA-676
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,Code name:,WAY-CMA-676
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,Synonym:,Calicheamicin-Conjugated Humanized Anti-CD33 Monoclonal Antibody
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,Synonym:,hP67.6-Calicheamicin
2020-09-18T07:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin,US brand name:,Mylotarg
2020-10-14T05:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gene-edited-autologous-neoantigen-targeted-neotcr-p1-t-cells,Synonym:,NeoTCR-P1
2020-10-14T05:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gene-edited-autologous-neoantigen-targeted-neotcr-p1-t-cells,Synonym:,NeoTCR-P1 T cells
2020-09-18T07:17:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-engineered-hsv-1-expressing-il-12,Code name:,M032
2020-09-18T07:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-modified-mage-a3-expressing-mg1-maraba-virus-vaccine,Synonym:,MG1 Maraba/MAGE-A3
2020-09-18T07:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-modified-mage-a3-expressing-mg1-maraba-virus-vaccine,Synonym:,MG1MA3
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Chemical structure:,"4',5,7-trihydroxyisoflavone5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one"
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,CI 75610
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,Genestein
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,genisteol
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,genisterin
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,prunetol
2020-09-18T07:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein,Synonym:,sophoricol
2020-10-14T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genolimzumab,Code name:,CBT 501
2020-10-14T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genolimzumab,Code name:,CBT-501
2020-10-14T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genolimzumab,Code name:,CBT501
2020-10-14T05:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genolimzumab,Code name:,GB-226
2020-10-14T05:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gentuximab,NA,NA
2020-10-14T05:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/geranylgeranyltransferase-i-inhibitor,Abbreviation:,GGTI-I
2020-10-14T05:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/geranylgeranyltransferase-i-inhibitor,Code name:,PTX-100
2020-10-14T05:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/geranylgeranyltransferase-i-inhibitor,Synonym:,GGTase-I inhibitor
2020-09-18T07:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ghrelin-peptide-analogue,NA,NA
2020-09-18T07:18:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gi-4000-vaccine,NA,NA
2020-10-14T03:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giloralimab,Code name:,ABBV-927
2020-10-14T03:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giloralimab,Synonym:,agonistic anti-CD40 monoclonal antibody ABBV-927
2020-10-14T03:40:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giloralimab,Synonym:,anti-CD40 monoclonal antibody ABBV-927
2020-09-18T07:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib,Code name:,ASP2215
2020-09-18T07:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib,Synonym:,FLT3/AXL/ALK kinase inhibitor ASP2215
2020-10-14T05:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate,Chemical structure:,"2-pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-, (2E)-2-butenedioate (2:1)"
2020-10-14T05:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate,Code name:,ASP2215 hemifumarate
2020-10-14T05:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate,Synonym:,gilteritinib hemifumarate
2020-10-14T05:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate,US brand name:,Xospata
2020-09-18T07:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimatecan,Chemical structure:,7-t-butoxyiminomethylcamptothecin
2020-09-18T07:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimatecan,Code name:,LBQ707
2020-09-18T07:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimatecan,Code name:,STI481
2020-09-18T07:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimeracil,Abbreviation:,CDHP
2020-09-18T07:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimeracil,Chemical structure:,"5-chloro-2,4-dihydroxypyridinediol"
2020-09-18T07:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimeracil,Synonym:,chlorodihydroxypyridine
2020-09-18T07:19:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginger-extract,NA,NA
2020-09-18T07:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-compound,NA,NA
2020-10-14T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-lingzhi-mushroom-cordyceps-sinensis-rose-oral-liquid,Synonym:,ginseng/lingzhi mushroom/Cordyceps sinensis/rose supplement
2020-10-14T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-lingzhi-mushroom-cordyceps-sinensis-rose-oral-liquid,Synonym:,Shen-Ling-Cao
2020-10-14T05:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-lingzhi-mushroom-cordyceps-sinensis-rose-oral-liquid,Synonym:,Shenlingcao oral liquid
2020-10-14T13:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giredestrant,Code name:,GDC-9545
2020-10-14T13:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giredestrant,Synonym:,selective estrogen receptor degrader GDC-9545
2020-10-14T13:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giredestrant,Synonym:,selective estrogen receptor downregulator GDC-9545
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,Abbreviation:,cG250
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,Abbreviation:,MOAB G250
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,Synonym:,chimeric monoclonal antibody cG250
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,Synonym:,monoclonal antibody G-250
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,Synonym:,WX-G250
2020-09-18T07:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab,US brand name:,Rencarex
2020-09-18T07:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873,Code name:,MEDI 1873
2020-09-18T07:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873,Code name:,MEDI1873
2020-09-18T07:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873,Synonym:,GITR stimulant MEDI1873
2020-09-18T07:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873,Synonym:,TNFRSF18 agonist MEDI1873
2020-09-18T07:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873,Synonym:,TNFRSF18 protein stimulant MEDI1873
2020-09-18T07:19:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Abbreviation:,GITRL RNA DC
2020-09-18T07:19:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,GITRL RNA-transfected autologous DC
2020-09-18T07:19:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitrl-rna-transfected-autologous-dendritic-cell-vaccine,Synonym:,GITRL RNA-transfected autologous dendritic cells
2020-10-14T05:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givinostat,Code name:,ITF2357
2020-10-14T05:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givinostat,Synonym:,HDAC inhibitor ITF2357
2020-10-14T05:11:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givinostat,Synonym:,histone deacetylase inhibitor ITF2357
2020-10-14T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran,Code name:,ALN AS1
2020-10-14T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran,Code name:,ALN-AS1
2020-10-14T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran,Synonym:,ESC-GalNAc-siRNA conjugate ALN-AS1
2020-10-14T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran,Synonym:,RNA interference therapeutic ALN-AS1
2020-10-14T05:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran,Synonym:,RNAi ALN-AS1
2020-10-14T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate,Chemical structure:,"1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate"
2020-10-14T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate,Code name:,PF-04449913 maleate
2020-10-14T04:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate,US brand name:,Daurismo
2020-10-14T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir,Abbreviation:,GLE/PIB
2020-10-14T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir,Code name:,ABT-493/ABT-530
2020-10-14T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir,Synonym:,glecaprevir and pibrentasvir
2020-10-14T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir,Synonym:,glecaprevir-pibrentasvir
2020-10-14T05:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir,US brand name:,Mavyret
2020-09-18T07:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glembatumumab-vedotin,Code name:,CDX-011
2020-09-18T07:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glembatumumab-vedotin,Synonym:,anti-glycoprotein NMB monoclonal antibody-monomethyl auristatin E conjugate CR011-vcMMAE
2020-09-18T07:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glembatumumab-vedotin,Synonym:,antibody-drug conjugate CR011-vcMMAE
2020-09-18T07:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glesatinib,Code name:,MGCD265
2020-09-18T07:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glesatinib,Synonym:,multitargeted tyrosine kinase inhibitor MGCD265
2020-09-18T07:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gliclazide,Chemical structure:,1-(3-azabicyclo(3.3.0)Oct-3-Yl)-3-(P-tolylsulfonyl)urea
2020-09-18T02:00:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glimepiride,US brand name:,Amaryl
2020-09-18T07:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-cancer-vaccine-erc1671,Code name:,ERC-1671
2020-09-18T07:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-cancer-vaccine-erc1671,Code name:,ERC1671
2020-09-18T07:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-cancer-vaccine-erc1671,Foreign brand name:,Gliovac
2020-09-18T07:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-multiforme-multipeptide-vaccine-ima950,Abbreviation:,GBM multi-antigen vaccine IMA950
2020-09-18T07:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-multiforme-multipeptide-vaccine-ima950,Synonym:,IMA950 vaccine
2020-09-18T07:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-associated-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine,Abbreviation:,GAA peptide-pulsed autologous dendritic cell vaccine
2020-09-18T07:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-associated-peptide-loaded-dendritic-cell-vaccine-sl-701,Code name:,SL-701
2020-09-18T07:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-lysate-vaccine-gbm6-ad,Code name:,GBM6-AD
2020-09-18T07:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-lysate-vaccine-gbm6-ad,Synonym:,GBM6-AD lysate protein vaccine
2020-09-18T07:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-lysate-vaccine-gbm6-ad,Synonym:,glioma cell lysate vaccine GBM6-AD
2020-09-18T07:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glipizide,US brand name:,Glucotrol
2020-09-18T07:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glisoxepide,NA,NA
2020-09-18T07:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-dt-vaccine-obi-833,Code name:,OBI-833
2020-09-18T07:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-dt-vaccine-obi-833,Synonym:,Globo H-CRM197 vaccine
2020-09-18T07:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-gm2-lewis-y-muc1-32aa-stnc-tfc-tnc-klh-conjugate-vaccine,Abbreviation:,GLO-GM2-LE-MUC1-sTN-TF-TN-KLH
2020-09-18T07:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globulin-component-macrophage-activating-factor,Abbreviation:,GC-MAF
2020-09-18T07:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globulin-component-macrophage-activating-factor,Abbreviation:,GcMAF
2020-09-18T07:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globulin-component-macrophage-activating-factor,Synonym:,GC protein-derived macrophage-activating factor
2020-10-14T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab,Code name:,RO 7082859
2020-10-14T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab,Code name:,RO7082859
2020-10-14T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody RO7082859
2020-10-14T05:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab,Synonym:,anti-CD20/CD3 bispecific monoclonal antibody RO7082859
2020-09-18T07:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase,Abbreviation:,CPDG2
2020-09-18T07:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase,Abbreviation:,CPG2
2020-09-18T07:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase,Synonym:,carboxypeptidase-G2
2020-09-18T07:21:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase,US brand name:,Voraxaze
2020-09-18T11:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-cort125134,Chemical structure:,"methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-"
2020-09-18T11:10:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-cort125134,Code name:,CORT125134
2020-10-14T05:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-oric-101,Code name:,ORIC 101
2020-10-14T05:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-oric-101,Code name:,ORIC-101
2020-10-14T05:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-oric-101,Code name:,ORIC101
2020-10-14T05:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-oric-101,Synonym:,GR antagonist ORIC-101
2020-09-18T07:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucosamine-sulfate-chondroitin-sulfate-tablet,NA,NA
2020-09-18T07:22:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucuronic-acid,NA,NA
2020-10-14T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glumetinib,Code name:,SCC 244
2020-10-14T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glumetinib,Code name:,SCC-244
2020-10-14T05:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glumetinib,Code name:,SCC244
2020-09-18T12:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-cb-839,Code name:,CB-839
2020-09-18T12:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-cb-839,Synonym:,glutaminase inhibitor CB-839
2020-10-14T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-ipn60090,Code name:,IPN 60090
2020-10-14T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-ipn60090,Code name:,IPN-60090
2020-10-14T05:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-ipn60090,Code name:,IPN60090
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Abbreviation:,Gln
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Glutacerebro
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Glutaven
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Foreign brand name:,Memoril
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,2-aminoglutaramic acid
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,glutamic acid 5-amide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,L-glutamine
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,levoglutamide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,Synonym:,Q. Levoglutamide
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Enterex Glutapak-10
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Glutapak-10
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,GlutaSolve
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Glutasolve Resource
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,NutreStore
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Sympt-X
2020-09-18T06:29:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine,US brand name:,Sympt-X G.I.
2020-09-18T07:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione,Abbreviation:,GSH
2020-09-18T07:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione,Chemical structure:,N-(N-L-gamma-glutamyl-L-cysteinyl)glycine
2020-09-18T07:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione,Foreign brand name:,TAD
2020-09-18T07:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione,Synonym:,reduced glutathione
2020-09-18T07:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione-disulfide-nov-002,Code name:,NOV-002
2020-09-18T07:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione-disulfide-nov-002,Foreign brand name:,Glutoxim
2020-09-18T07:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione-disulfide-nov-002,Synonym:,oxidized glutathione NOV-002
2020-09-18T07:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-compact-nutritional-supplement-drink,Foreign brand name:,Fortimel Compact
2020-09-18T07:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-dha-epa-gla-antioxidant-rich-nutritional-liquid,US brand name:,Oxepa
2020-09-18T07:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-fiber-enriched-compact-nutritional-supplement-drink,Foreign brand name:,Fortimel Compact Fibre
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,Synonym:,glibenclamide
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,US brand name:,Diabeta
2020-09-18T06:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide,US brand name:,Micronase
2020-09-18T07:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycerin-enema,NA,NA
2020-09-18T07:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycine,Abbreviation:,Gly
2020-09-18T07:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycine,Synonym:,aminoethanoic acid
2020-10-14T05:14:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyco-engineered-anti-cd20-monoclonal-antibody-cho-h01,Code name:,CHO H01
2020-10-14T05:14:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyco-engineered-anti-cd20-monoclonal-antibody-cho-h01,Code name:,CHO-H01
2020-09-18T07:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycooptimized-trastuzumab-gex,Synonym:,anti-HER2 monoclonal antibody GT-Mab 7.3-GEX
2020-09-18T07:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycooptimized-trastuzumab-gex,Synonym:,GT-Mab 7.3-GEX
2020-09-18T07:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycooptimized-trastuzumab-gex,US brand name:,TrasGEX
2020-09-18T07:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopeptide-antibiotic,NA,NA
2020-09-18T07:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopyrrolate,Chemical structure:,"pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide"
2020-09-18T07:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopyrrolate,Synonym:,glycopyrronium bromide
2020-09-18T07:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopyrrolate,US brand name:,Robinul
2020-10-14T05:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosaminoglycan,Foreign brand name:,Prisma
2020-10-14T05:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosaminoglycan,Synonym:,mesoglycan
2020-09-18T07:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-g-csf-avi-014,Abbreviation:,glycosylated rhG-CSF AVI014
2020-09-18T07:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-g-csf-avi-014,Code name:,AVI-014
2020-09-18T07:24:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-interleukin-7,Abbreviation:,glycosylated rhIL-7
2020-09-18T07:24:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-interleukin-7,Synonym:,CYT107
2020-09-18T07:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glymidine,Foreign brand name:,Gondafon
2020-09-18T07:24:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glymidine,Synonym:,glycodiazine
2020-09-18T07:24:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyt2-5ht2a-antagonist-vvz-149,Code name:,VVZ-149
2020-09-18T07:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-csf-encoding-oncolytic-adenovirus-cgtg-102,Abbreviation:,Ad5/3-D24-GMCSF
2020-09-18T07:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-csf-encoding-oncolytic-adenovirus-cgtg-102,Code name:,CGTG-102
2020-09-18T07:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-csf-encoding-oncolytic-adenovirus-cgtg-102,Synonym:,ONCOS-102
2020-09-18T07:24:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-k562-cell-vaccine,NA,NA
2020-09-18T07:24:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-gd2-gd3-lactone-klh-conjugate-trivalent-vaccine,Synonym:,GM2 lactone/GD2 lactone/GM3 lactone-KLH conjugate trivalent vaccine
2020-09-18T07:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-klh-vaccine,Abbreviation:,GM2-KLH
2020-09-18T07:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-klh-vaccine,Synonym:,GM2-KLH ganglioside
2020-09-18T07:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-klh-vaccine,Synonym:,KLH-conjugated GM2 Ganglioside Vaccine
2020-09-18T07:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gmcd40l-cell-vaccine,Abbreviation:,GM.CD40L
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,Synonym:,sodium aurothiomalate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Aurolate
2020-09-18T04:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate,US brand name:,Myochrysine
2020-09-18T07:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goldenrod,NA,NA
2020-09-18T07:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golimumab,Code name:,CNTO 148
2020-09-18T07:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golimumab,Synonym:,"immunoglobulin G1, anti-(human Tumor Necrosis Factor Alpha) (human monoclonal CNTO 148 gamma-1-chain), disulfide with human monoclonal CNTO 148 kappa-chain, dimer"
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Abbreviation:,Ad 5-TNF Alpha
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Abbreviation:,Ad5-TNFa
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Code name:,ADgv EGR.TNF.11D
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Synonym:,adenovirus 5-tumor necrosis factor alpha
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Synonym:,AdGV11-TNFalpha
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,Synonym:,tumor necrosis factor adenovirus 5 vector
2020-09-18T07:25:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec,US brand name:,TNFerade
2020-09-18T07:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golotimod,Code name:,SCV-07
2020-09-18T07:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golotimod,Synonym:,gamma-D-glutamyl-L-tryptophan
2020-09-18T07:25:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golvatinib,Code name:,E7050
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,AY-24031
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,D-His-6-Pro-8-NEt-LHRH
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,follicle stimulating hormone-releasing factor
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,GN-RH analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,GnRH analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,gonadoliberin
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,gonadorelin
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,gonadorelinum
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,Hoe- 471
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,LH-RF analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,LH-RH analogs
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,LH/FSH-RF analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,LH/FSH-RH analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,LHRH analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,luliberin
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,luteinising hormone-releasing factor analogue
2020-09-18T07:25:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue,Synonym:,luteinizing hormone-releasing hormone agonist
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,AY-24031
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,D-His-6-Pro-8-NEt-LHRH
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,follicle stimulating hormone-releasing factor
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,GN-RH analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,GnRH analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,gonadoliberin
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,gonadorelin
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,gonadorelinum
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,Hoe- 471
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,LH-RF analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,LH-RH analogs
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,LH/FSH-RF analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,LH/FSH-RH analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,LHRH analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,luliberin
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,luteinising hormone-releasing factor analogue
2020-10-14T05:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog,Synonym:,luteinizing hormone-releasing hormone agonist
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Code name:,ALX 0171
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Code name:,ALX-0171
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Code name:,ALX0171
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Synonym:,anti-RSV F nanobody ALX-0171
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Synonym:,anti-RSV protein F nanobody ALX-0171
2020-10-14T03:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab,Synonym:,RSV-specific nanobody ALX-0171
2020-09-18T07:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate,Abbreviation:,ZDX
2020-09-18T07:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate,Chemical structure:,D-Ser(bu(t))(6)azgly(10)-LHRH acetate
2020-09-18T07:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate,US brand name:,Zoladex
2020-10-14T05:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate-extended-release-microspheres-ly01005,Code name:,LY 01005
2020-10-14T05:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate-extended-release-microspheres-ly01005,Code name:,LY-01005
2020-10-14T05:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate-extended-release-microspheres-ly01005,Code name:,LY01005
2020-10-14T05:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate-extended-release-microspheres-ly01005,Synonym:,goserelin acetate extended-release microspheres
2020-09-18T07:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gossypol,Synonym:,Cottonseed Meal Toxin
2020-09-18T07:26:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gossypol,Synonym:,Gossypol (Racemic)
2020-09-18T07:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100-antigen,Synonym:,gp100
2020-09-18T07:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100-fowlpox-vaccine,NA,NA
2020-09-18T07:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100154-162-peptide-vaccine,NA,NA
2020-09-18T07:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100209-217210m-peptide-vaccine,Abbreviation:,G9 209-2M
2020-09-18T07:26:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100209-217210m-peptide-vaccine,Synonym:,gp100:209-217(210M)
2020-09-18T07:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100280-288288v-peptide-vaccine,NA,NA
2020-09-18T07:26:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp2-peptide-gm-csf-vaccine,NA,NA
2020-09-18T07:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp96-secreting-allogeneic-bladder-cancer-cell-vaccine-hs-410,Code name:,HS-410
2020-09-18T07:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gpi-0100,NA,NA
2020-09-18T07:26:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gpx-100,Synonym:,13-deoxydoxorubicin
2020-10-14T05:15:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron,Chemical structure:,1-methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide
2020-10-14T05:15:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron,US brand name:,Sancuso
2020-10-14T05:15:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron,US brand name:,Sustol
2020-09-18T07:27:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride,Abbreviation:,GRAN
2020-09-18T07:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride-nasal-spray,Abbreviation:,GNS
2020-09-18T07:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride-nasal-spray,Synonym:,granisetron HCl nasal spray
2020-09-18T07:27:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride-nasal-spray,Synonym:,intranasal granisetron hydrochloride
2020-10-14T05:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-patch,Synonym:,granisetron transdermal patch
2020-10-14T05:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-patch,US brand name:,Sancuso
2020-09-18T07:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-system,Synonym:,granisetron transdermal patch
2020-09-18T07:27:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-system,US brand name:,Sancuso
2020-09-18T07:27:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grape-seed-extract-supplement,Abbreviation:,GSE
2020-09-18T07:27:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grape-seed-extract-supplement,Synonym:,GSE supplement
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Chemical structure:,"N-[[2,4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenylethylamino]carbonyl]-4-methyl-benzenesulfonamide"
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Code name:,AAT-007
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Code name:,"CJ-023,423"
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Code name:,RQ-00000007
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Code name:,RQ-07
2020-10-14T05:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant,Synonym:,EP4 receptor antagonist AAT-007
2020-10-14T05:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-propolis-supplement,Synonym:,green propolis in oil supplement
2020-10-14T05:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-propolis-supplement,Synonym:,propolis supplement
2020-10-14T05:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-propolis-supplement,Synonym:,Taiwan green propolis supplement
2020-09-18T07:27:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea,NA,NA
2020-09-18T07:28:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract,Synonym:,green tea polyphenols
2020-09-18T07:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract-based-antioxidant-supplement,Synonym:,green tea polyphenols/epigallocatechin gallate antioxidant solution
2020-09-18T07:28:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract-based-antioxidant-supplement,US brand name:,Oncoxin
2020-10-14T05:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-licorice-extract-based-antioxidant-solution,Foreign brand name:,Ocoxin-Viusid
2020-10-14T05:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-licorice-extract-based-antioxidant-solution,Foreign brand name:,Ocoxin/Viusid
2020-10-14T05:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-licorice-extract-based-antioxidant-solution,Synonym:,Ocoxin and Viusid
2020-10-14T05:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-licorice-extract-based-antioxidant-solution,Synonym:,oral antioxidant solution
2020-09-18T07:28:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-lozenge,Foreign brand name:,Can-Tea
2020-10-14T05:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/growth-hormone-receptor-antisense-oligonucleotide-ionis-ghr-lrx,Synonym:,GHR antisense oligonucleotide IONIS-GHR-LRx
2020-10-14T05:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/growth-hormone-receptor-antisense-oligonucleotide-ionis-ghr-lrx,Synonym:,IONIS-GHR-LRx
2020-10-14T05:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/growth-hormone-receptor-antisense-oligonucleotide-ionis-ghr-lrx,Synonym:,LICA drug IONIS-GHR-LRx
2020-10-14T05:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/growth-hormone-receptor-antisense-oligonucleotide-ionis-ghr-lrx,Synonym:,ligand-conjugated antisense drug IONIS-GHR-LRx
2020-10-14T05:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al101,Code name:,AL 101
2020-10-14T05:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al101,Code name:,AL-101
2020-10-14T05:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al101,Code name:,AL101
2020-10-14T05:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al101,Code name:,BMS-906024
2020-09-18T07:28:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-906024,Code name:,AL 101
2020-09-18T07:28:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-906024,Code name:,AL-101
2020-09-18T07:28:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-906024,Code name:,AL101
2020-09-18T07:28:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-906024,Code name:,BMS-906024
2020-09-18T07:28:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-986115,Code name:,BMS-986115
2020-10-14T05:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gsk-3-inhibitor-9-ing-41,Code name:,9 ING 41
2020-10-14T05:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gsk-3-inhibitor-9-ing-41,Code name:,9-ING-41
2020-10-14T05:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gsk-3-inhibitor-9-ing-41,Code name:,9ING41
2020-10-14T05:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gsk-3-inhibitor-9-ing-41,Synonym:,glycogen synthase kinase-3 inhibitor 9-ING-41
2020-09-18T07:28:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gti-2040,NA,NA
2020-09-18T07:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guadecitabine,Abbreviation:,DNMT inhibitor SGI-110
2020-09-18T07:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guadecitabine,Code name:,S110
2020-09-18T07:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guadecitabine,Code name:,SGI-110
2020-09-18T07:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanabenz-acetate,Chemical structure:,"3-((2,6-dichlorophenyl)methylene)carbazamidine monoacetate"
2020-09-18T07:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanabenz-acetate,US brand name:,Wytensin
2020-09-18T07:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanazole,NA,NA
2020-09-18T07:29:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guarana-supplement,Synonym:,Paullinia cupana supplement
2020-10-14T05:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution,Synonym:,acacia gum solution
2020-10-14T05:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution,Synonym:,Acacia senegal
2020-10-14T05:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution,Synonym:,Acacia senegal solution
2020-10-14T05:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution,Synonym:,acacia solution
2020-10-14T05:15:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution,Synonym:,gum acacia solution
2020-10-14T05:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guselkumab,Code name:,CNTO 1959
2020-10-14T05:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guselkumab,US brand name:,Tremfya
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Abbreviation:,DSG
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Code name:,BMS-181173
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Code name:,BMY-42215-1
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Code name:,NKT-01
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Foreign brand name:,Spanidin
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Synonym:,deoxyspergualin
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Synonym:,Deoxyspergualin Hydrochloride
2020-09-18T07:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus,Synonym:,Gusperimus Trihydrochloride
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Abbreviation:,DSG
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Code name:,BMS-181173
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Code name:,BMY-42215-1
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Code name:,NKT-01
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Foreign brand name:,Spanidin
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Synonym:,deoxyspergualin
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Synonym:,Deoxyspergualin Hydrochloride
2020-10-14T05:16:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride,Synonym:,Gusperimus Trihydrochloride
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Code name:,CG8123V
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,autologous GVAX lung cancer vaccine
2020-09-18T04:17:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine,Synonym:,GVAX autologous lung cancer vaccine
2020-09-18T07:29:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-pancreatic-cancer-vaccine,Synonym:,GM-CSF gene transduced autologous pancreatic cancer vaccine
2020-10-14T05:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h-ras-antisense-oligodeoxynucleotide-isis-2503,Code name:,ISIS-2503
2020-10-14T05:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h-ras-antisense-oligodeoxynucleotide-isis-2503,Synonym:,H-RAS Antisense
2020-09-18T07:29:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h1299-tumor-cell-lysate-vaccine,Synonym:,H1299 lysate vaccine
2020-09-18T07:29:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h33k27m-specific-peptide-vaccine,Synonym:,H3.3K27M peptide vaccine
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Code name:,PAN 301-1
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Code name:,PAN-301-1
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Code name:,SNS 301
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Code name:,SNS-301
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Code name:,SNS301
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Synonym:,bacteriophage cancer vaccine SNS-301
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Synonym:,HAAH-1/2/3 lambda phage vaccine SNS-301
2020-10-14T05:16:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301,Synonym:,nanoparticle HAAH vaccine SNS-301
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b conjugate vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus b oligosaccharide conjugate vacccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,Synonym:,Hib TITER vaccine
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,ActHIB
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,HibTITER
2020-09-18T01:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine,US brand name:,PedvaxHIB
2020-09-18T07:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hafnium-oxide-containing-nanoparticles-nbtxr3,Code name:,NBTXR3
2020-10-14T05:16:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halichondrin-analogue-e7130,Code name:,E 7130
2020-10-14T05:16:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halichondrin-analogue-e7130,Code name:,E-7130
2020-10-14T05:16:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halichondrin-analogue-e7130,Code name:,E7130
2020-09-18T07:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide,Code name:,RU 19110
2020-09-18T07:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide,Synonym:,halofuginone IV (intravenous)
2020-09-18T07:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide,US brand name:,Tempostatin
2020-09-18T07:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol,Chemical structure:,4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
2020-09-18T07:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol,Code name:,McN-JR-1625
2020-09-18T07:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol,Code name:,R-1625
2020-09-18T07:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol,US brand name:,Haldol
2020-09-18T07:30:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hcv-dna-vaccine-ino-8000,Code name:,INO-8000
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG 146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG-146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG0146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG280146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Code name:,HG280146-P1
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Synonym:,class I/IIb HDACi HG146
2020-10-14T05:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146,Synonym:,HDAC I/IIb selective inhibitor HG146
2020-09-18T07:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-egfr-her2-inhibitor-cudc-101,Code name:,CUDC-101
2020-09-18T06:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-4sc-202,Code name:,4SC-202
2020-09-18T06:12:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-4sc-202,Synonym:,HDAC Inhibitor 4SC-202
2020-09-18T07:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-acy-241,Code name:,ACY-241
2020-09-18T07:31:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-acy-241,Synonym:,histone deacetylase inhibitor ACY-241
2020-09-18T07:31:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ar-42,Chemical structure:,(S)-N-hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide
2020-09-18T07:31:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ar-42,Code name:,AR-42
2020-09-18T07:31:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ar-42,Code name:,HDAC-42
2020-09-18T07:31:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ar-42,Code name:,OSU-HDAC42
2020-09-18T07:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cg200745,Abbreviation:,HDI CG200745
2020-09-18T07:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cg200745,Chemical structure:,(E)-N(1)-(3-(dimethylamino)propyl)-N(8)-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide
2020-09-18T07:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cg200745,Code name:,CG200745
2020-09-18T07:31:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-2845,Code name:,CHR-2845
2020-09-18T07:31:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-2845,Synonym:,histone deacetylase inhibitor CHR-2845
2020-09-18T07:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-3996,Code name:,CHR-3996
2020-09-18T07:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-3996,Code name:,VRx 3996
2020-09-18T07:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-3996,Code name:,VRx-3996
2020-09-18T07:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-3996,Code name:,VRx3996
2020-10-14T05:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ckd-581,Code name:,CKD 581
2020-10-14T05:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ckd-581,Code name:,CKD-581
2020-10-14T05:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ckd-581,Code name:,CKD581
2020-09-18T07:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cxd101,Code name:,AZD 9468
2020-09-18T07:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cxd101,Code name:,AZD9468
2020-09-18T07:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cxd101,Code name:,CXD101
2020-09-18T07:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cxd101,Synonym:,histone deacetylase inhibitor CXD101
2020-09-18T07:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-mpt0e028,Chemical structure:,"(E)-N-hydroxy-3-(1-(phenylsulfonyl)indolin-5-yl)acrylamide3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxy-acrylamide"
2020-09-18T07:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-mpt0e028,Code name:,MPT 0E028
2020-09-18T07:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-mpt0e028,Code name:,MPT-0E028
2020-09-18T07:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-mpt0e028,Code name:,MPT0E028
2020-09-18T07:31:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-obp-801,Code name:,OBP-801
2020-09-18T07:31:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-obp-801,Code name:,YM753
2020-09-18T07:31:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-obp-801,Synonym:,histone deacetylase inhibitor OBP-801
2020-09-18T07:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-shp-141,Code name:,SHP-141
2020-09-18T07:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac6-inhibitor-ka2507,Code name:,KA2507
2020-09-18T07:32:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac6-inhibitor-ka2507,Synonym:,HDAC6i KA2507
2020-09-18T11:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-hdm201,Code name:,HDM201
2020-09-18T11:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-hdm201,Synonym:,NVP-HDM 201
2020-09-18T07:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-mk-8242,Code name:,MK-8242
2020-09-18T07:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-mk-8242,Code name:,SCH 900242
2020-10-14T05:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101,Code name:,IMM 101
2020-10-14T05:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101,Code name:,IMM-101
2020-10-14T05:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101,Code name:,IMM101
2020-10-14T05:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101,Synonym:,heat-killed mycobacterial product IMM-101
2020-10-14T05:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101,Synonym:,heat-killed Mycobacterium obuense NCTC 13365 IMM-101
2020-09-18T07:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-varicella-zoster-virus-vaccine-v212,Code name:,V212
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,Chemical structure:,"1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate"
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,Code name:,PF-04449913 maleate
2020-09-18T05:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913,US brand name:,Daurismo
2020-10-14T05:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101,Code name:,IMX 101
2020-10-14T05:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101,Code name:,IMX-101
2020-10-14T05:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101,Code name:,IMX101
2020-10-14T05:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101,Synonym:,H. pylori therapeutic vaccine IMX101
2020-10-14T05:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101,Synonym:,IMX101 vaccine
2020-09-18T07:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hematoporphyrin-derivative,Abbreviation:,HPD
2020-10-14T05:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analog-e7974,Code name:,E7974
2020-10-14T05:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analog-e7974,Synonym:,hemiasterlin analog E7974
2020-09-18T07:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analogue-e7974,Code name:,E7974
2020-09-18T07:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analogue-e7974,Synonym:,hemiasterlin analog E7974
2020-10-14T05:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemoporfin,NA,NA
2020-09-18T07:33:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/henatinib-maleate,Chemical structure:,"(R,Z)-2-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl]-5-(2-hydroxy-3-morpholinopropyl)-3-methyl-5,6,7,8-tetrahydro-1H-pyrrolo[3,2-c] azepin-4-ketone maleate"
2020-09-18T07:33:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparan-sulfate-glycosaminoglycan-mimetic-m402,Code name:,M402
2020-09-18T07:33:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparan-sulfate-glycosaminoglycan-mimetic-m402,Synonym:,HSGAG mimetic M402
2020-09-18T07:33:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparan-sulfate-glycosaminoglycan-mimetic-nanopolymer-mouthwash,Foreign brand name:,MUCIPLIQ
2020-09-18T07:33:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-calcium,Synonym:,Calciparine
2020-09-18T07:33:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium,Synonym:,sodium heparin
2020-09-18T07:33:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium,US brand name:,Hep-Lock
2020-09-18T07:33:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium,US brand name:,Lipo-Hepin
2020-09-18T07:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-a-vaccine,US brand name:,Havrix
2020-09-18T07:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-a-vaccine,US brand name:,Vaqta
2020-10-14T04:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine,Foreign brand name:,Engerix-B
2020-10-14T04:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine,US brand name:,Engerix-B
2020-10-14T04:59:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine,US brand name:,Recombivax HB
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,Foreign brand name:,Engerix-B
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,US brand name:,Engerix-B
2020-09-18T06:27:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant,US brand name:,Recombivax HB
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Abbreviation:,HCIG
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,Synonym:,anti-HCV immunoglobulin
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Biotest-HCIG
2020-09-18T04:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous,US brand name:,Civacir
2020-10-14T05:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepcidin-mimetic-ptg-300,Code name:,PTG 300
2020-10-14T05:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepcidin-mimetic-ptg-300,Code name:,PTG-300
2020-10-14T05:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepcidin-mimetic-ptg-300,Code name:,PTG300
2020-10-14T05:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepcidin-mimetic-ptg-300,Synonym:,hepcidin agonist PTG-300
2020-09-18T07:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepsulfam,Chemical structure:,"1,7-heptanediyl ester sulfamic acid"
2020-09-18T07:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-cea-peptides-gm-csf-montanide-isa-51-vaccine,NA,NA
2020-09-18T07:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-intracellular-domain-protein,Synonym:,HER-2 ICD Peptide
2020-09-18T07:34:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-intracellular-domain-protein,Synonym:,HER-2/neu ICD Protein
2020-09-18T07:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-peptide-vaccine,Abbreviation:,HER-2
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Code name:,IMU-131
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Synonym:,HER-Vaxx
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Synonym:,HER-Vaxx peptide vaccine
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Synonym:,IMU-131 vaccine
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Synonym:,MU-131 HER2/Neu peptide vaccine
2020-09-18T07:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131,Synonym:,P467-CRM197/Montanide vaccine IMU-131
2020-09-18T07:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901,Code name:,AVX901
2020-09-18T07:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901,Synonym:,DUKE-002-VRP
2020-09-18T07:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901,Synonym:,HER2 ECDTM VRP
2020-09-18T07:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901,Synonym:,HER2 VRP
2020-09-18T07:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901,Synonym:,VRP-HER2 ECDTM
2020-10-14T04:48:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-cp-724714,NA,NA
2020-10-14T05:17:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-tas0728,Code name:,TAS 0728
2020-10-14T05:17:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-tas0728,Code name:,TAS-0728
2020-10-14T05:17:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-tas0728,Code name:,TAS0728
2020-10-14T05:17:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-tas0728,Code name:,TPC-107
2020-10-14T05:17:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-pulsed-autologous-type-1-polarized-dendritic-cell-vaccine,Synonym:,HER2-pulsed DC1 vaccine
2020-09-18T07:34:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-pulsed-type-1-polarized-autologous-dendritic-cell-vaccine,Synonym:,HER2-pulsed DC1 vaccine
2020-10-14T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-darpin-mp0274,Code name:,MP 0274
2020-10-14T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-darpin-mp0274,Code name:,MP0274
2020-10-14T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-darpin-mp0274,Synonym:,DARPin MP0274
2020-10-14T05:18:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-darpin-mp0274,Synonym:,HER2-targeting DARPin drug MP0274
2020-09-18T07:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-liposomal-doxorubicin-hydrochloride-mm-302,Code name:,MM-302
2020-09-18T07:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeting-antibody-fc-fragment-fs102,Code name:,FS102
2020-09-18T07:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeting-antibody-fc-fragment-fs102,Synonym:,anti-HER2 FCAB FS102
2020-09-18T07:35:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeting-antibody-fc-fragment-fs102,Synonym:,Fcab FS102
2020-10-14T05:18:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001,Code name:,DF 1001
2020-10-14T05:18:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001,Code name:,DF-1001
2020-10-14T05:18:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001,Synonym:,HER2 tri-specific NK cell engager DF1001
2020-10-14T05:18:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001,Synonym:,tri-specific natural killer cell engager DF1001
2020-10-14T05:18:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001,Synonym:,tri-specific NK cell engager DF1001
2020-09-18T07:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2bi-armed-activated-t-cells,Abbreviation:,HER2Bi-armed ATCs
2020-09-18T07:34:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2bi-armed-activated-t-cells,Synonym:,anti-CD3 x anti-Her2/neu bispecific antibody-armed activated T cells
2020-09-18T07:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herba-scutellaria-barbata,NA,NA
2020-09-18T07:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herbal-polysaccharide-saliva-substitute,Foreign brand name:,Saliva Natura
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Code name:,1437173A
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Code name:,GSK 1437173A
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Code name:,GSK1437173A
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Synonym:,herpes zoster subunit vaccine GSK 1437173A
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Synonym:,herpes zoster vaccine 1437173A
2020-09-18T07:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a,Synonym:,HZ/su vaccine GSK 1437173A
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,Abbreviation:,HES
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,Foreign brand name:,Hespan
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,Foreign brand name:,Volulyte
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,Synonym:,hydroxyethyl starch
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,Synonym:,venofundin
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,US brand name:,Hextend
2020-09-18T07:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch,US brand name:,Voluven
2020-09-18T07:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heterodimeric-interleukin-15,Abbreviation:,heterodimeric IL-15
2020-09-18T07:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heterodimeric-interleukin-15,Abbreviation:,hetIL-15
2020-09-18T07:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heterodimeric-interleukin-15,Synonym:,IL-15/sIL-15Ra
2020-10-14T05:18:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetrombopag-olamine,Chemical structure:,"(Z)-5-(2-hydroxy-3-(2- (3-methyl-5-oxo-1-(5,6,7,8-tetrahydronaphthalen- 2-yl)-1H-pyrazol-4(5H)-ylidene)hydrazinyl)phenyl) Furan-2-carboxylic acid diethanolamine"
2020-10-14T05:18:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetrombopag-olamine,Synonym:,SHR8735 olamine
2020-09-18T07:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexamethylene-bisacetamide,Abbreviation:,HMBA
2020-09-18T07:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexamethylene-bisacetamide,Chemical structure:,"acetamide, N,N'-1, 6-hexanediylbis-acetamide, N,N'-hexamethylenebis-N, N'-diacetylhexamethylenediamineN,N'-1,6-hexanediylbisacetamideN,N'-hexamethylenebisacetamide"
2020-09-18T07:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexamethylene-bisacetamide,Synonym:,hexamethylenebisacetamide
2020-09-18T07:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexamethylene-bisacetamide,Synonym:,hexamethylenediacetamide
2020-09-18T07:36:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate,Abbreviation:,HAL
2020-09-18T07:36:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate,Synonym:,hexyl 5-aminolevulinate
2020-09-18T07:36:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate,Synonym:,P-1206
2020-09-18T05:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride,Foreign brand name:,Hexvix
2020-09-18T05:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride,US brand name:,Cysview
2020-09-18T07:36:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-1alpha-inhibitor-px-478,Code name:,PX-478
2020-09-18T07:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2385,Code name:,PT2385
2020-09-18T07:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2977,Code name:,PT2977
2020-09-18T07:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2977,Synonym:,HIF-2a inhibitor PT2977
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Code name:,ARO HIF2
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Code name:,ARO-HIF2
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Code name:,AROHIF2
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Synonym:,RNA interference therapeutic ARO-HIF2
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Synonym:,targeted RNAi molecule ARO-HIF2
2020-10-14T05:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2,Synonym:,TRiM ARO-HIF2
2020-09-18T07:37:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-selenium-bakers-yeast,NA,NA
2020-09-18T07:37:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-selenium-brassica-juncea,Abbreviation:,BJ-Se
2020-09-18T07:37:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-titer-rsv-immune-globulin-ri-001,Code name:,RI-001
2020-09-18T07:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/highly-purified-staphylococcal-protein-a-prtx-100,Code name:,PRTX-100
2020-09-18T07:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/highly-purified-staphylococcal-protein-a-prtx-100,Synonym:,SpA PRTX-100
2020-09-18T07:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histone-lysine-n-methyltransferase-ezh2-inhibitor-gsk2816126,Code name:,GSK2816126
2020-09-18T07:37:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histone-lysine-n-methyltransferase-ezh2-inhibitor-gsk2816126,Synonym:,EZH2 inhibitor GSK2816126
2020-09-18T07:37:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histrelin-acetate,US brand name:,Supprelin
2020-09-18T07:37:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histrelin-acetate,US brand name:,Vantas
2020-09-18T07:37:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-tert572y-tert572-peptides-vaccine-vx-001,Code name:,Vx-001
2020-09-18T07:37:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-tert572y-tert572-peptides-vaccine-vx-001,Synonym:,HLA-A*0201 restricted telomerase-specific vaccine Vx-001
2020-09-18T07:37:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-trp2-gp100-epha2-her2-multipeptide-vaccine,NA,NA
2020-09-18T07:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-urlc10-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T07:38:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-vegfr1-peptide-vaccine,NA,NA
2020-09-18T07:38:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T07:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a1-a2-b35-restricted-survivin-peptides-montanide-isa-51-vaccine,Abbreviation:,SRV PEP VAC
2020-09-18T07:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a1-a2-b35-restricted-survivin-peptides-montanide-isa-51-vaccine,Synonym:,survivin peptide vaccine
2020-09-18T07:39:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-a3-restricted-fgf-5-peptides-montanide-isa-51-vaccine,Abbreviation:,HLA-A2A3-FGF5-ISA51
2020-09-18T07:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201,Code name:,GRN-1201
2020-09-18T07:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201,Synonym:,cancer vaccine GRN-1201
2020-09-18T07:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201,Synonym:,peptide cancer vaccine GRN-1201
2020-09-18T07:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201,Synonym:,peptide vaccine GRN-1201
2020-09-18T07:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-synthetic-glioma-antigen-peptides-vaccine,NA,NA
2020-09-18T07:38:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-cdca1-a24-56-peptide-vaccine,Synonym:,HLA-A*2402-restricted cell division cycle associated 1-A24-56 peptide vaccine
2020-09-18T07:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-cdca1-kif20a-multipeptide-vaccine,NA,NA
2020-09-18T07:38:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-koc1-ttk-co16-depdc1-mphosph1-multipeptide-vaccine,NA,NA
2020-09-18T07:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-multipeptide-vaccine-s-488410,Code name:,S-488410
2020-09-18T07:38:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-cdca1-kif20a-multipeptide-vaccine,NA,NA
2020-09-18T07:38:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-cdca1-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T07:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-koc1-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T07:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-peptides-vaccine,NA,NA
2020-09-18T07:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-ttk-koc1-multipeptide-vaccine,NA,NA
2020-09-18T07:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-ttk-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T07:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-vegfr1-2-multipeptide-vaccine,NA,NA
2020-09-18T07:39:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-vegfr1-peptide-vaccine,NA,NA
2020-09-18T07:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2404-restricted-rnf43-tomm34-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-10-14T13:07:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-matched-donor-mononuclear-cell-enriched-leukocytes-apocell,Foreign brand name:,ApoCell
2020-10-14T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7,Code name:,ALT-P7
2020-10-14T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7,Code name:,HER2ALT-P7
2020-10-14T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7,Synonym:,ADC ALT-P7
2020-10-14T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7,Synonym:,HM2-MMAE
2020-10-14T05:18:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7,Synonym:,HM2/MMAE ADC ALT-P7
2020-09-18T07:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ho-02-02,NA,NA
2020-09-18T07:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hodgkins-antigens-gm-csf-expressing-cell-vaccine,Synonym:,Hodgkin antigens-GM-CSF-expressing cell vaccine
2020-09-18T07:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hodgkins-antigens-gm-csf-expressing-cell-vaccine,Synonym:,KGEL vaccine
2020-09-18T07:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/honey,NA,NA
2020-09-18T07:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/honey-containing-mouthwash,Synonym:,honey mouthwash
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Abbreviation:,eATG
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Abbreviation:,hATG
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,anti-thymocyte globulin equine
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,antithymocyte globulin equine
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,ATG equine
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,equine ATG
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,horse ATG
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,Synonym:,"lymphocyte immune globulin, anti-thymocyte globulin equine"
2020-10-14T04:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin,US brand name:,Atgam
2020-09-18T07:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/host-dendritic-cell-vaccine-001-mssm-biir,Synonym:,MSSM/BIIR HDC Vax-001
2020-09-18T07:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hou-gu-mi-xi,Synonym:,TCM Hou Gu Mi Xi
2020-09-18T07:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hou-gu-mi-xi,Synonym:,traditional Chinese medicine Hou Gu Mi Xi
2020-09-18T07:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpph,Chemical structure:,2-(1-Hexyloxyethyl)-2-Devinyl Pyropheophorbide-a
2020-09-18T07:40:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpph,US brand name:,Photochlor
2020-09-18T07:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e6-peptides-vaccine-candida-albicans-extract,Synonym:,HPV 16 E6 peptides vaccine/Candin
2020-09-18T07:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-antigen-expressing-lactobacillis-casei-vaccine-bls-ilb-e710c,Code name:,BLS-ILB-E710c
2020-09-18T07:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-antigen-expressing-lactobacillis-casei-vaccine-bls-ilb-e710c,Synonym:,L. casei-E7 BLS_ILB_E710c
2020-09-18T07:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-antigen-expressing-lactobacillis-casei-vaccine-bls-ilb-e710c,Synonym:,L.casei-PgsA-E7
2020-09-18T07:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-antigen-expressing-lactobacillis-casei-vaccine-bls-ilb-e710c,Synonym:,LacE7 vaccine
2020-10-14T05:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-cells,Synonym:,HPV-16 E7 TCR expressing T cells
2020-10-14T05:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-cells,Synonym:,HPV-16 E7 TCR-expressing T cells
2020-10-14T05:19:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-cells,Synonym:,human papillomavirus type 16 E7 TCR expressing T cells
2020-09-18T07:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-lymphocytes,Synonym:,HPV-16 E7 TCR expressing T cells
2020-09-18T07:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-lymphocytes,Synonym:,HPV-16 E7 TCR-expressing T cells
2020-09-18T07:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-lymphocytes,Synonym:,human papillomavirus type 16 E7 TCR expressing T cells
2020-09-18T07:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e786-93-peptide-vaccine,Abbreviation:,E7(86-93)
2020-09-18T07:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e786-93-peptide-vaccine,Synonym:,E7(86-93) lipopeptide
2020-09-18T07:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e786-93-peptide-vaccine,Synonym:,HPV 16E7 86-93 Lipopeptide Vaccine
2020-09-18T07:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e786-93-peptide-vaccine,Synonym:,HPV-16E7 (86-93)
2020-09-18T07:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-6-targeting-immunotherapeutic-vaccine-ino-3106,Code name:,INO-3106
2020-09-18T07:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-6-targeting-immunotherapeutic-vaccine-ino-3106,Synonym:,HPV-6 E6/E7 DNA vaccine INO-3106
2020-09-18T07:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-6-targeting-immunotherapeutic-vaccine-ino-3106,Synonym:,HPV-6-targeting immunotherapeutic INO-3106
2020-09-18T07:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-dna-plasmids-therapeutic-vaccine-vgx-3100,Code name:,VGX-3100
2020-09-18T07:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e1-e2-interaction-inhibitor-gel-ap611074,Abbreviation:,PPI inhibitor AP611074
2020-09-18T07:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e1-e2-interaction-inhibitor-gel-ap611074,Code name:,AP611074
2020-09-18T07:41:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-dna-vaccine-gx-188e,Code name:,GX-188E
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Code name:,HB 201
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Code name:,HB-201
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Code name:,HB201
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Synonym:,arenavirus vector-based vaccine HB-201
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Synonym:,arenavirus vector-based vaccine-expressing HPV 16 E7E6 HB-201
2020-10-14T05:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201,Synonym:,HB-201 cancer vaccine
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Code name:,"SFVeE6,7"
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Code name:,Vvax-001
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Code name:,Vvax001
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Synonym:,HPV E6/7 Semliki Forest virus based cancer vaccine
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Synonym:,"rSFVeE6,7"
2020-10-14T05:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001,Synonym:,Vvax001 therapeutic cancer vaccine
2020-09-18T07:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-l1-vlp-vaccine-v504,Code name:,V504
2020-10-14T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e6-t27,Code name:,T27
2020-10-14T05:18:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e6-t27,Synonym:,HPV16-targeting TALEN T27
2020-10-14T05:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-specific-hla-a0201-restricted-igg1-fc-fusion-protein-cue-101,Code name:,CUE 101
2020-10-14T05:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-specific-hla-a0201-restricted-igg1-fc-fusion-protein-cue-101,Code name:,CUE-101
2020-10-14T05:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-specific-hla-a0201-restricted-igg1-fc-fusion-protein-cue-101,Code name:,CUE101
2020-10-14T05:18:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-specific-hla-a0201-restricted-igg1-fc-fusion-protein-cue-101,Synonym:,anti-HPV16 E7 fusion protein CUE-101
2020-10-14T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-t512,Code name:,T512
2020-10-14T05:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-t512,Synonym:,HPV16-targeting TALEN T512
2020-09-18T07:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7,Code name:,DPX E7
2020-09-18T07:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7,Code name:,DPX-E7
2020-09-18T07:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7,Synonym:,DPX-E7 vaccine
2020-09-18T07:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7,Synonym:,HPV16-E7 11-19 nanomer vaccine DPX-E7
2020-09-18T07:41:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7,Synonym:,HPV16-E7 11-19 vaccine
2020-09-18T07:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-l2-e6-e7-fusion-protein-vaccine-ta-cin,Code name:,TA-CIN
2020-09-18T07:41:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-l2-e6-e7-fusion-protein-vaccine-ta-cin,Synonym:,tissue antigen-cervical intraepithelial neoplasia vaccine
2020-10-14T05:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107,Code name:,INO 3107
2020-10-14T05:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107,Code name:,INO-3107
2020-10-14T05:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107,Code name:,INO3107
2020-10-14T05:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107,Synonym:,HPV-6/11-targeting immunotherapeutic vaccine INO-3107
2020-10-14T05:19:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107,Synonym:,HPV6/11-targeted DNA plasmid immunotherapeutic INO-3107
2020-09-18T07:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp70-peptide-tkd-il-2-activated-autologous-natural-killer-cells,Synonym:,Hsp70-peptide TKD/IL-2-activated autologous NK cells
2020-09-18T07:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-antagonist-kw-2478,NA,NA
2020-09-18T07:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-ab-010,Code name:,AB-010
2020-09-18T07:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-ab-010,Synonym:,heat shock protein 90 inhibitor AB-010
2020-09-18T07:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-at13387,Code name:,AT13387
2020-09-18T07:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-auy922,Code name:,AUY922
2020-10-14T05:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib021,Code name:,BIIB021
2020-10-14T05:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib021,Code name:,CNF2024
2020-10-14T05:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib021,Synonym:,Hsp90 antagonist CNF2024
2020-09-18T07:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib028,Code name:,BIIB028
2020-09-18T07:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-cnf2024,Code name:,BIIB021
2020-09-18T07:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-cnf2024,Code name:,CNF2024
2020-09-18T07:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-cnf2024,Synonym:,Hsp90 antagonist CNF2024
2020-09-18T07:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-debio-0932,Chemical structure:,"ristomycin A aglycone, 5,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-alpha-D-glucopyranuronosyl]-38-[[[3-(dimethylamino)propyl]amino]carbonyl]-42-O-alpha-D-mannopyranosyl-N15-methyl-"
2020-09-18T07:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-debio-0932,Code name:,debio 0932
2020-09-18T07:42:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-debio-0932,US brand name:,Zeven
2020-09-18T07:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-ds-2248,Code name:,DS-2248
2020-09-18T07:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-hsp990,Code name:,HSP990
2020-09-18T07:43:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-mpc-3100,Code name:,MPC-3100
2020-09-18T07:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-pu-h71,Code name:,PU-H71
2020-09-18T07:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-pu-h71,Code name:,PUH71
2020-09-18T07:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-2112,Code name:,PF 04928473
2020-09-18T07:43:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-2112,Code name:,SNX-2112
2020-09-18T07:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-5422-mesylate,Code name:,SNX-5422
2020-09-18T07:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-5422-mesylate,Code name:,SNX-5422 mesylate
2020-10-14T05:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-tqb3474,Code name:,TQB 3474
2020-10-14T05:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-tqb3474,Code name:,TQB-3474
2020-10-14T05:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-tqb3474,Code name:,TQB3474
2020-10-14T05:19:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-tqb3474,Synonym:,heat shock protein 90 inhibitor TQB3474
2020-09-18T07:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-xl888,Code name:,XL888
2020-10-14T05:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-photosensitizer-hs-201,Code name:,HS 201
2020-10-14T05:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-photosensitizer-hs-201,Code name:,HS-201
2020-10-14T05:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-photosensitizer-hs-201,Code name:,HS201
2020-10-14T05:20:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-photosensitizer-hs-201,Synonym:,Hsp90 inhibitor-linked verteporfin
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Code name:,PEN 866
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Code name:,PEN-866
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Code name:,PEN866
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Code name:,STA-12-8666
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Code name:,STA-8666
2020-10-14T05:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866,Synonym:,HDC SN-38
2020-09-18T07:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90alpha-beta-inhibitor-tas-116,Code name:,TAS-116
2020-09-18T07:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90alpha-beta-inhibitor-tas-116,Code name:,TAS116
2020-09-18T07:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90alpha-beta-inhibitor-tas-116,Synonym:,heat shock protein 90alpha/beta inhibitor TAS-116
2020-09-18T07:43:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90alpha-beta-inhibitor-tas-116,Synonym:,HSP90a/b inhibitor TAS-116
2020-09-18T07:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hspe7,Code name:,SGN-00101
2020-09-18T07:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hspe7,Synonym:,HPV 16 E7/HSP65 Vaccine
2020-09-18T07:43:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hspe7,Synonym:,HPV E7 Peptide Epitope Vaccine
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,HF10
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,Msc 2
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Code name:,TBI-1401
2020-09-18T04:59:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10,Synonym:,herpes simplex virus type 1 HF10
2020-09-18T07:43:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-tk-transduced-donor-lymphocytes,Synonym:,HSV-TK-engineered donor lymphocytes
2020-09-18T07:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-encoding-dna-vaccine-invac-1,Code name:,INVAC-1
2020-09-18T07:44:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-i540-r572y-d988y-multipeptide-vaccine,NA,NA
2020-10-14T05:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-mrna-survivin-peptide-double-loaded-autologous-dendritic-cell-vaccine,Foreign brand name:,Procure
2020-09-18T07:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-gx-301,Code name:,GX 301
2020-09-18T07:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-gx-301,Code name:,GX301
2020-10-14T05:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-vaccine-gx-301,Code name:,GX 301
2020-10-14T05:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-vaccine-gx-301,Code name:,GX301
2020-09-18T07:44:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-survivin-cmv-multipeptide-vaccine,NA,NA
2020-09-18T07:44:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-vaccine-v934-v935,Code name:,V934/V935
2020-09-18T07:44:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein,Abbreviation:,hu14.18-IL2
2020-09-18T07:44:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein,Code name:,EMD 273063
2020-10-14T05:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein-emd-273063,Abbreviation:,hu14.18-IL2
2020-10-14T05:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein-emd-273063,Code name:,EMD 273063
2020-09-18T07:44:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huachansu,NA,NA
2020-09-18T07:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huaier-extract-granule,Synonym:,Huaier granule
2020-09-18T07:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huaier-extract-granule,Synonym:,Trametes robiniophila murr extract granule
2020-09-18T07:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi,Synonym:,astragalus root
2020-09-18T07:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi,Synonym:,HuangQi
2020-09-18T07:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi,Synonym:,Milk Vetch Root
2020-09-18T07:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi,Synonym:,milkvetch root
2020-09-18T07:44:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi,Synonym:,Radix Astragali
2020-09-18T07:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hubc1-huil12-fusion-protein-as1409,Code name:,AS1409
2020-10-14T04:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix,Abbreviation:,hADM
2020-10-14T04:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix,Synonym:,D-ADM
2020-10-14T04:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix,Synonym:,human ADM
2020-10-14T04:52:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix,US brand name:,DermACELL
2020-10-14T05:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-anti-cd30-car-expressing-autologous-t-lymphocytes,Synonym:,human anti-CD30 CAR-expressing autologous T-cells
2020-10-14T05:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-anti-cd30-car-expressing-autologous-t-lymphocytes,Synonym:,human anti-CD30scFv CAR-expressing autologous T-lymphocytes
2020-09-18T07:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-combinatorial-antibody-library-based-antibody-vay736,Code name:,VAY736
2020-09-18T07:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-combinatorial-antibody-library-based-antibody-vay736,Synonym:,HuCAL-based antibody VAY736
2020-09-18T07:45:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-gp100-plasmid-dna-vaccine,Synonym:,gp100 Plasmid DNA
2020-09-18T07:45:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-lactoferrin-peptide-hlf1-11,Abbreviation:,hLF(1-11)
2020-10-14T05:20:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-lysozyme-containing-goat-milk,Synonym:,human lysozyme goat milk
2020-09-18T07:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-mhc-non-restricted-cytotoxic-t-cell-line-tall-104,Code name:,TALL-104
2020-09-18T07:45:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-monoclonal-antibody-216,Abbreviation:,MoAb 216
2020-09-18T07:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-monoclonal-antibody-b11-hcg-beta-fusion-protein-cdx-1307,Code name:,CDX-1307
2020-09-18T07:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-myeloid-progenitor-cells-clt-008,Abbreviation:,hMPC CLT-008
2020-09-18T07:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-myeloid-progenitor-cells-clt-008,Code name:,CLT-008
2020-10-14T05:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papilloma-virus-l1-virus-like-particle-v504-vaccine,Code name:,V504
2020-09-18T07:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papillomavirus-16-e7-peptide,Synonym:,HPV-16 E7
2020-09-18T07:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papillomavirus-16-e7-peptide,Synonym:,HPV16 E7
2020-09-18T07:46:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papillomavirus-vaccine-v503,Code name:,V503
2020-09-18T07:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-prostate-specific-membrane-antigen-plasmid-dna-vaccine,Abbreviation:,human PSMA DNA
2020-09-18T07:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-prostate-specific-membrane-antigen-plasmid-dna-vaccine,Synonym:,PSMA DNA vaccine
2020-09-18T07:46:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-trefoil-factor-1-secreting-lactococcus-lactis-ag013,Abbreviation:,hTFF1-secreting Lactococcus lactis AG013
2020-09-18T07:46:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-trefoil-factor-1-secreting-lactococcus-lactis-ag013,Code name:,AG013
2020-09-18T07:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin,Synonym:,human varicella-zoster immune globulin
2020-09-18T07:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin,Synonym:,varicella zoster immune globulin human
2020-09-18T07:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin,US brand name:,VariZIG
2020-09-18T07:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin,US brand name:,VariZIG vaccine
2020-09-18T09:34:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/humanized-monoclonal-antibody-3f8,Synonym:,hu3F8
2020-09-18T09:34:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/humanized-monoclonal-antibody-3f8,Synonym:,humanized anti-GD2 antibody 3F8
2020-09-18T09:34:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/humanized-monoclonal-antibody-3f8,Synonym:,humanized monoclonal antibody 3F8
2020-09-18T07:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid,Synonym:,hyaluronan
2020-09-18T07:46:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid,Synonym:,hyaluronate
2020-09-18T07:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-based-hydrating-vaginal-gel,US brand name:,Hyalo GYN
2020-09-18T07:47:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-containing-topical-cream,US brand name:,HylaCare™ cream
2020-10-14T13:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronidase-zzxf-pertuzumab-trastuzumab,Synonym:,hyaluronidase-zzxf/pertuzumab/trastuzumab
2020-10-14T13:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronidase-zzxf-pertuzumab-trastuzumab,Synonym:,pertuzumab/trastuzumab/hyaluronidase-zzxf
2020-10-14T13:03:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronidase-zzxf-pertuzumab-trastuzumab,US brand name:,Phesgo
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,Abbreviation:,HYC
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,Synonym:,Hycanthone mesylate
2020-09-18T06:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone,US brand name:,Etrenol
2020-09-18T07:47:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrated-sodium-calcium-aluminosilicate,Abbreviation:,HSCAS
2020-09-18T07:47:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrated-sodium-calcium-aluminosilicate,Code name:,ACCS100
2020-09-18T07:47:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrazine-sulfate,Foreign brand name:,Sehydrin
2020-09-18T07:47:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocodone-acetaminophen,US brand name:,Lorcet
2020-09-18T07:47:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocodone-acetaminophen,US brand name:,Vicodin
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Abbreviation:,HDC
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Chemical structure:,"(11beta)-21-(3-carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, monosodium salt"
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Buccalsone
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Corlan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Cortop
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Efcortelan
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Flebocortid
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hidroc Clora
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydro-Adreson
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Kinogen
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Nositrol
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Sinsurrene
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Foreign brand name:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,cortisol sodium succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hycorace
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone 21-Sodium Succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Hydrocortisone Na succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Nordicort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Sodium hydrocortisone succinate
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Cortef
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,Synonym:,Solu-Glyc
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,A-Hydrocort
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Emergent-EZ
2020-09-18T01:44:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate,US brand name:,Solu-Cortef
2020-10-14T05:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate-aluminum-phosphate-gel,Synonym:,hydrocortisone sodium succinate mixed with aluminum phosphate gel
2020-09-18T07:48:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrogen-peroxide-hyaluronic-acid-tumor-injectable-formulation,Synonym:,H2O2-HA tumor injectable formulation
2020-09-18T07:48:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrogen-peroxide-hyaluronic-acid-tumor-injectable-formulation,Synonym:,hydrogen peroxide-hyaluronic acid intratumoral injectable formulation
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dilaudid HP
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Dimorphone
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hydrostat
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Hymorphan
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Laudicon
2020-09-18T06:05:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride,US brand name:,Novolauden
2020-09-18T07:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxychloroquine,Abbreviation:,HCQ
2020-09-18T07:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxytyrosol,Abbreviation:,"3,4-DHPEA"
2020-09-18T07:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxytyrosol,Chemical structure:,"2-(3,4-dihydroxyphenyl)ethanol3,4-dihydroxyphenylethanol4-(2-hydroxyethyl)-1,2-benzenediol"
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Abbreviation:,HU
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,SQ 1089
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,SQ-1089
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Code name:,WR 83799
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Litalir
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Onco-Carbide
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Oxeron
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Foreign brand name:,Syrea
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,HYD
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,Hydroxycarbamide
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,Synonym:,Hydurea
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,US brand name:,Droxia
2020-09-18T06:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea,US brand name:,Hydrea
2020-09-18T07:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyper-cvad-regimen,Synonym:,HyperCVAD Regimen
2020-09-18T07:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyper-cvad-regimen,Synonym:,hyperfractionated cyclophosphamide-vincristine-adriamycin-dexamethasone regimen
2020-09-18T07:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperbaric-oxygen,NA,NA
2020-10-14T05:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypercvad-regimen,Synonym:,HyperCVAD Regimen
2020-10-14T05:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypercvad-regimen,Synonym:,hyperfractionated cyclophosphamide-vincristine-adriamycin-dexamethasone regimen
2020-09-18T07:49:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperimmune-bovine-colostrum,Synonym:,hyperimmune colostrum
2020-10-14T05:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-carbon-c-13-pyruvate,Synonym:,hyperpolarized 13C-pyruvate
2020-10-14T05:21:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-carbon-c-13-pyruvate,Synonym:,hyperpolarized pyruvate (13C)
2020-09-18T07:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-helium-3,Abbreviation:,HP3He
2020-09-18T07:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-helium-3,Synonym:,hyperpolarized He-3
2020-09-18T07:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-helium-3,Synonym:,hyperpolarized He3
2020-09-18T07:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-helium-3,Synonym:,hyperpolarized helium-3
2020-09-18T07:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-xenon-129,Abbreviation:,HP 129Xe
2020-09-18T07:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-xenon-129,Synonym:,hyperpolarized Xe-129
2020-09-18T07:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-xenon-129,Synonym:,hyperpolarized Xe129
2020-09-18T07:49:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-xenon-129,Synonym:,hyperpolarized xenon-129
2020-09-18T07:49:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypertonic-saline,Abbreviation:,HTS
2020-09-18T07:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000,Code name:,PR610
2020-09-18T07:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000,Code name:,TH-4000
2020-09-18T07:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000,US brand name:,Hypoxin
2020-09-18T07:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/i-131-monoclonal-antibody-cc49,Abbreviation:,131I-MOAB CC49
2020-09-18T07:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/i-131-monoclonal-antibody-cc49,Synonym:,I131 MOAB CC49
2020-09-18T07:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/i-131-monoclonal-antibody-cc49,Synonym:,iodine I 131 monoclonal antibody CC49
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,ORY 1001
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,ORY-1001
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,RG 6016
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,RG6016
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,RO 7051790
2020-10-14T12:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat,Code name:,RO7051790
2020-10-14T05:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ianalumab,Code name:,VAY736
2020-10-14T05:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ianalumab,Synonym:,HuCAL-based antibody VAY736
2020-09-18T07:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-at-406,Code name:,AT-406
2020-09-18T07:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-at-406,Code name:,SM-406
2020-09-18T07:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-at-406,Synonym:,"pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, n-((1,1'-biphenyl)-2-ylmethyl)decahydro-5-(((2s)-2-(methylamino)-1-oxopropyl)amino)-3-(3-methyl-1-oxobutyl)-6-oxo-, (5s,8s,10ar)"
2020-09-18T07:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-hgs1029,Code name:,AEG40826-2HCl
2020-09-18T07:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-hgs1029,Code name:,HGS1029
2020-09-18T07:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iapa-based-dendritic-cells-cytotoxic-t-lymphocytes,Abbreviation:,iAPA-DC/CTL
2020-09-18T07:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iapa-based-dendritic-cells-cytotoxic-t-lymphocytes,Synonym:,inhibition of antigen presentation attenuators-based dendritic cells/cytotoxic T lymphocytes
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,Foreign brand name:,Bondronate
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,Synonym:,ibandronate
2020-09-18T04:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium,US brand name:,Boniva
2020-10-14T05:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide,Code name:,CC 220
2020-10-14T05:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide,Code name:,CC-220
2020-10-14T05:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide,Synonym:,CRL4 cereblon E3 ubiquitin ligase modulator CC-220
2020-10-14T05:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide,Synonym:,CRL4(CRBN) E3 ubiquitin ligase modulator CC-220
2020-10-14T05:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide,Synonym:,CRL4CRBN E3 ubiquitin ligase modulator CC-220
2020-10-14T13:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iboctadekin,Abbreviation:,IL-18
2020-10-14T13:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iboctadekin,Code name:,SB-485232
2020-10-14T13:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iboctadekin,Synonym:,IFN-gamma-inducing factor
2020-10-14T13:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iboctadekin,Synonym:,interferon-gamma-inducing factor
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Abbreviation:,IBX
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,MK 3118
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,MK-3118
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,MK3118
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,SCY 078
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,SCY-078
2020-10-14T05:21:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp,Code name:,SCY078
2020-09-18T07:50:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibritumomab-tiuxetan,US brand name:,Zevalin
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,Chemical structure:,"2-propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-"
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,Code name:,CRA-032765
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,Code name:,PCI-32765
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,Synonym:,Bruton's tyrosine kinase inhibitor PCI-32765
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,Synonym:,BTK inhibitor PCI-32765
2020-09-18T07:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib,US brand name:,Imbruvica
2020-10-14T05:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibudilast,Abbreviation:,IBD
2020-10-14T05:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibudilast,Chemical structure:,"3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine"
2020-10-14T05:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibudilast,Code name:,MN-166
2020-09-18T07:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen,Chemical structure:,"benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-p-isobutylhydratropic acid"
2020-09-18T07:50:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen,US brand name:,Motrin
2020-10-14T04:33:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-injection,US brand name:,Caldolor
2020-09-18T04:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-intravenous,US brand name:,Caldolor
2020-10-14T05:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells,Synonym:,GD2-CAR NKT cells
2020-10-14T05:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells,Synonym:,GD2-CAR-expressing autologous natural killer T cells
2020-10-14T05:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells,Synonym:,GINAKIT cells
2020-10-14T05:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells,Synonym:,GINAKIT-cells
2020-10-14T05:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells,Synonym:,iC9-GD2.CD28.OX40.zeta natural killer T cells
2020-09-18T07:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-cd28-ox40-expressing-t-lymphocytes,Synonym:,iC9-GD2 T lymphocytes
2020-09-18T07:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen,Abbreviation:,CBDCA/IFF/VP-16
2020-09-18T07:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen,Acronym:,ICE
2020-09-18T07:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen,Synonym:,carboplatin/etoposide/ifosfamide
2020-09-18T07:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen,Synonym:,iosfamide-carboplatin-etoposide regimen
2020-09-18T07:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icodextrin-solution,NA,NA
2020-10-14T05:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent,Abbreviation:,EPA-FFA
2020-10-14T05:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent,Synonym:,eicosapentaenoic acid-free fatty acid
2020-10-14T05:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl,Chemical structure:,"ethyl (all cis)-5,8,11,14,17-icosapentaenoate"
2020-10-14T05:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl,Code name:,AMR 101
2020-10-14T05:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl,Code name:,AMR101
2020-10-14T05:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl,Synonym:,icosapent ethyl
2020-10-14T05:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl,US brand name:,Vascepa
2020-09-18T07:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icotinib-hydrochloride,Code name:,BPI-2009
2020-09-18T07:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icotinib-hydrochloride,Foreign brand name:,Conmana
2020-09-18T07:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icrucumab,Code name:,IMC-18F1
2020-09-18T07:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icrucumab,Synonym:,anti-vascular endothelial growth factor receptor-1 monoclonal antibody IMC-18F1
2020-09-18T07:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icrucumab,Synonym:,anti-VEGFR-1 monoclonal antibody IMC-18F1
2020-09-18T07:51:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-eluting-beads,NA,NA
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Abbreviation:,4-DMDR
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Abbreviation:,IDA
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Code name:,IMI-30
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Code name:,SC-33428
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Foreign brand name:,Zavedos
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Synonym:,4-demethoxydaunomycin
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Synonym:,4-demethoxydaunorubicin
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Synonym:,DMDR
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,Synonym:,idarubicin HCl
2020-09-18T07:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride,US brand name:,Idamycin PFS
2020-09-18T07:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idasanutlin,Code name:,RG7388
2020-09-18T07:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idasanutlin,Code name:,RO 5503781
2020-09-18T07:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idasanutlin,Synonym:,MDM2 antagonist RO5503781
2020-10-14T04:27:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idecabtagene-vicleucel,Code name:,bb2121
2020-10-14T04:27:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idecabtagene-vicleucel,Synonym:,anti-BCMA-CAR T cells
2020-10-14T04:27:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idecabtagene-vicleucel,Synonym:,anti-BCMA-CAR-transduced T cells
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,Chemical structure:,5-fluoro-3-phenyl-2-([S)]-1-[9H-purin-6-ylamino]-propyl)-3H-quinazolin-4-one
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,Code name:,CAL-101
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,Code name:,GS-1101
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,Synonym:,phosphoinositide-3 kinase delta inhibitor CAL-101
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,Synonym:,PI3K delta inhibitor CAL-101
2020-09-18T07:52:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib,US brand name:,Zydelig
2020-10-14T03:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed,Chemical structure:,"N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid"
2020-10-14T03:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed,Code name:,ONX 0801
2020-10-14T03:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed,Code name:,ONX-0801
2020-10-14T03:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed,Synonym:,BGC 945
2020-09-18T12:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh-mutant-inhibitor-ag-881,Code name:,AG 881
2020-09-18T12:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh-mutant-inhibitor-ag-881,Code name:,AG-881
2020-09-18T08:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1-inhibitor-ag-120,Code name:,AG-120
2020-09-18T08:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1-inhibitor-ag-120,Synonym:,IDH1 inhibitor AG-120
2020-09-18T08:17:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1-inhibitor-ag-120,US brand name:,Tibsovo
2020-09-18T07:52:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132-inhibitor-idh305,Code name:,IDH305
2020-09-18T07:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132h-mutation-targeting-idh1-peptide-vaccine,Synonym:,IDH1R132H-specific peptide vaccine
2020-09-18T07:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132h-specific-peptide-vaccine-pepidh1m,Code name:,PEPIDH1M
2020-09-18T07:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132h-specific-peptide-vaccine-pepidh1m,Synonym:,PEPIDH1M vaccine
2020-09-18T07:52:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idiotype-pulsed-autologous-dendritic-cell-vaccine-apc8020,Code name:,APC8020
2020-09-18T07:52:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idiotype-pulsed-autologous-dendritic-cell-vaccine-apc8020,US brand name:,Mylovenge
2020-10-14T05:22:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-ly3381916,Code name:,LY3381916
2020-09-18T07:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-pf-06840003,Chemical structure:,"indoleamine 2,3-dioxygenase inhibitor PF-06840003"
2020-09-18T07:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-pf-06840003,Code name:,PF 06840003
2020-09-18T07:53:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-pf-06840003,Code name:,PF-06840003
2020-09-18T07:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-inhibitor-nlg919,Code name:,NLG919
2020-09-18T07:52:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-inhibitor-nlg919,Synonym:,NLG-919
2020-10-14T05:22:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-tdo-inhibitor-hti-1090,Code name:,HTI-1090
2020-10-14T05:22:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-tdo-inhibitor-hti-1090,Code name:,SHR9146
2020-10-14T05:22:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-tdo-inhibitor-hti-1090,Synonym:,HTI 1090
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Chemical structure:,"(R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propenamide"
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Code name:,BMS 986205
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Code name:,BMS-986205
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Code name:,BMS986205
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Code name:,ONO-7701
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Synonym:,IDO-1 inhibitor BMS-986205
2020-09-18T07:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205,Synonym:,"indoleamine-pyrrole 2,3-dioxygenase inhibitor BMS-986205"
2020-09-18T07:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-khk2455,Code name:,KHK 2455
2020-09-18T07:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-khk2455,Code name:,KHK2455
2020-09-18T07:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-khk2455,Synonym:,IDO-1 inhibitor KHK2455
2020-10-14T05:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-pf-06840003,Chemical structure:,"indoleamine 2,3-dioxygenase inhibitor PF-06840003"
2020-10-14T05:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-pf-06840003,Code name:,PF 06840003
2020-10-14T05:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-pf-06840003,Code name:,PF-06840003
2020-10-14T05:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112,Code name:,M 4112
2020-10-14T05:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112,Code name:,M-4112
2020-10-14T05:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112,Code name:,M4112
2020-10-14T05:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112,Code name:,MS201408-0005
2020-10-14T05:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112,Synonym:,"indoleamine 2,3-dioxygenase-1/tryptophan 2,3-dioxygenase 2 inhibitor M4112"
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IDUR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IdURD
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Abbreviation:,IUdR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Chemical structure:,1-(2-deoxy-beta-D-ribofuranosyl)-5-iodouracil2'-deoxy-5-iodouridine5-iodo-2'-deoxyuridine
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Code name:,SKF 14287
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idexur
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idoxene
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Idulea
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Iduridin
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Kerecid
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Foreign brand name:,Virudox
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,1beta-D-2'-Deoxyribofuranosyl-5-iodouracil
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,2'-deoxy-5-iodouridine
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,5-iododeoxyuridine
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,5-IUdR
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,IDU
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,"uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-"
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,Synonym:,"uridine, 2'-deoxy-5-iodo-"
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Dendrid
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Herplex
2020-09-18T05:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine,US brand name:,Stoxil
2020-09-18T07:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil,Chemical structure:,3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
2020-09-18T07:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil,Code name:,NV-06
2020-09-18T07:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil,Synonym:,phenoxodiol
2020-09-18T07:53:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil-suppository-nox66,Code name:,NOX66
2020-10-14T03:51:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ieramilimab,Code name:,LAG525
2020-10-14T03:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifabotuzumab,Abbreviation:,anti-EphA3 mAb KB004
2020-10-14T03:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifabotuzumab,Code name:,KB004
2020-10-14T05:22:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifetroban-sodium,NA,NA
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Abbreviation:,IFF
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Abbreviation:,IFO
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Abbreviation:,IFX
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Abbreviation:,IPP
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Chemical structure:,"2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxideN,3-bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide"
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Code name:,Asta Z-4942
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Code name:,MJF-9325
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Code name:,Z-4942
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Holoxan
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Holoxane
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,IFO-Cell
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Ifolem
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Ifomida
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Ifoxan
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Mitoxana
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Foreign brand name:,Tronoxal
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,Ifomide
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,Iphosphamid
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,iphosphamide
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,Iso-Endoxan
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,Isoendoxan
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,isophosphamide
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,Synonym:,Naxamide
2020-09-18T07:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide,US brand name:,Ifex
2020-09-18T07:53:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-antagonist-bms-754807,Code name:,BMS-754807
2020-09-18T07:53:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-antisense-oligodeoxynucleotide-treated-autologous-glioma-cells,Synonym:,IGF-1R/AS ODN-treated autologous glioma cells
2020-09-18T07:54:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-inhibitor-pl225b,Code name:,PL225B
2020-09-18T07:54:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-ir-inhibitor-kw-2450,NA,NA
2020-09-18T07:54:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-methotrexate-conjugate,Abbreviation:,765IGF-MTX
2020-10-14T05:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins,Synonym:,IgM-enriched immunoglobulin
2020-10-14T05:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins,Synonym:,immunoglobulin GMA
2020-10-14T05:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins,Synonym:,immunoglobulin M-enriched immunoglobulins
2020-10-14T05:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins,Synonym:,ivIgGMA
2020-10-14T05:22:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins,Synonym:,pentaglobin
2020-09-18T01:21:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ih636-grape-seed-proanthocyanidin-extract,US brand name:,ActiVin
2020-09-18T07:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-10-immunomodulator-mk-1966,Code name:,MK 1966
2020-09-18T07:54:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-10-immunomodulator-mk-1966,Code name:,MK-1966
2020-10-14T05:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-12-expressing-hsv-1-nsc-733972,Code name:,M032
2020-09-18T07:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-12-expressing-mesenchymal-stem-cell-vaccine-gx-051,Abbreviation:,MSCs/IL-12M
2020-09-18T07:54:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-12-expressing-mesenchymal-stem-cell-vaccine-gx-051,Code name:,GX-051
2020-10-14T05:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-9-15-gamma-chain-receptor-inhibitor-bnz-1,Code name:,BNZ-1
2020-10-14T05:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-9-15-gamma-chain-receptor-inhibitor-bnz-1,Code name:,BNZ132-1-40
2020-09-18T07:55:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-lptn-gene-modified-allogeneic-neuroblastoma-tumor-cell-vaccine,Synonym:,interleukin-2/lymphotactin gene-modified allogeneic neuroblastoma tumor cell vaccine
2020-09-18T07:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex,Code name:,VCL-1102
2020-09-18T07:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex,Synonym:,IL-2 plasmid DNA/DMRIE/DOPE lipid complex
2020-09-18T07:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex,Synonym:,interleukin-2 DNA/lipid complex
2020-09-18T07:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex,Synonym:,plasmid DNA IL-2 lipid complex
2020-09-18T07:54:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex,US brand name:,Leuvectin
2020-09-18T07:54:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-recombinant-fusion-protein-alt-801,Code name:,ALT-801
2020-09-18T07:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55,Abbreviation:,IL4-PE
2020-09-18T07:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55,Code name:,MDNA55
2020-09-18T07:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55,Code name:,PRX321
2020-09-18T07:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55,Synonym:,IL4-Pseudomonas exotoxin fusion protein PRX321
2020-09-18T07:55:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55,US brand name:,INxin
2020-09-18T07:55:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilaprazole,Foreign brand name:,Noltec
2020-10-14T05:28:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilginatinib,Code name:,NS-018
2020-09-18T07:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost,Chemical structure:,"(E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(sup 2(1H),delta)-pentalenevaleric Acidpentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)"
2020-09-18T07:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost,Code name:,ZK 36374
2020-09-18T07:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost,Synonym:,Ciloprost
2020-09-18T07:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost,Synonym:,iloprost clathrate
2020-09-18T07:55:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost,US brand name:,Ventavis
2020-09-18T07:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilorasertib,Chemical structure:,"1-(4-(4-amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea"
2020-09-18T07:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilorasertib,Code name:,A-968660.0
2020-09-18T07:55:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilorasertib,Code name:,ABT-348
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Chemical structure:,Gln-Arg-His-Lys-Pro-Arg-Glu-Gly-Gly-Gly-Ser-Lys(Cy5)-NH2
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Code name:,QRH-882260
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Synonym:,fluorescence peptide QRH-882260
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Synonym:,fluorescently-labeled peptide QRH-882260
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Synonym:,QRH-882260 Cy-5-labeled heptapeptide
2020-10-14T05:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide,Synonym:,QRHKPRE-GGGSK-(Cy5)-NH2
2020-09-18T07:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab,Code name:,BAX-69
2020-09-18T07:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab,Code name:,BAX069
2020-09-18T07:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab,Code name:,BAX69
2020-09-18T07:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab,Synonym:,"immunoglobulin G1-kappa, anti-(Homo sapiens MIF (macrophage migration inhibitory factor, glycosylation-inhibiting factor, GlIF, GIF)), Homo sapiens monoclonal antibody"
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,Chemical structure:,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,Code name:,CGP 57148
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,Code name:,CGP57148B
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,Code name:,STI-571
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,Foreign brand name:,Glivec
2020-09-18T07:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate,US brand name:,Gleevec
2020-09-18T07:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imetelstat-sodium,Chemical structure:,"DNA, d(3'-amino-3'-deoxy-P-thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-[O-[2-hydroxy-3- [(1-oxohexadecyl)amino]propyl] hydrogen phosphorothioate], sodium salt (1:13)"
2020-09-18T07:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imetelstat-sodium,Code name:,GRN163L
2020-09-18T07:56:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imetelstat-sodium,Code name:,"GRN163L, sodium salt"
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,Chemical structure:,"4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one"
2020-09-18T02:04:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon,US brand name:,Amplimexon
2020-10-14T03:45:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imgatuzumab,Synonym:,anti-epidermal growth factor receptor GFR monoclonal antibody RO5083945
2020-09-18T07:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazole-mustard,Abbreviation:,BIC
2020-09-18T07:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazole-mustard,Chemical structure:,"5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide"
2020-09-18T07:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazole-mustard,Synonym:,HN2
2020-09-18T07:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazole-mustard,Synonym:,TIC mustard
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Chemical structure:,6-(2-(1H-Imidazol-4-yl)ethylamino)-5-oxohexanoic acid
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Code name:,Myelo 001
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Code name:,Myelo001
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Foreign brand name:,Ingavirin
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Foreign brand name:,Vitaglutam
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Synonym:,Dicarbamin
2020-09-18T07:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid,Synonym:,pentanedioic acid imidazolyl ethanamide
2020-09-18T07:56:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imipenem,Code name:,MK-0787
2020-09-18T07:56:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imipenem,Synonym:,imipemide
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Abbreviation:,IMQ
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Chemical structure:,"1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline"
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,R 837
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,Code name:,S 26308
2020-09-18T01:46:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod,US brand name:,Aldara
2020-09-18T07:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imisopasem-manganese,Chemical structure:,"Manganese, dichloro[(4aR,13aR,17aR,21aR)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-eicosahydro-11,7-nitrilo-7Hdibenzo[b,h][1,4,7,10]tetraazacycloheptadecine-κN5,κN13,κN18,κN21,κN22]-, (PB-7-11-2344'3')-"
2020-09-18T07:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imisopasem-manganese,Code name:,GC4419
2020-09-18T07:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imisopasem-manganese,Code name:,M40403
2020-09-18T07:56:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imisopasem-manganese,Code name:,SC-72325
2020-09-18T07:57:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-afuresertib,Synonym:,GSK2110183 IR tablet
2020-09-18T07:57:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-afuresertib,Synonym:,IR afuresertib
2020-10-14T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-bupropion,Synonym:,bupropion immediate release
2020-10-14T05:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-bupropion,Synonym:,IR bupropion
2020-09-18T07:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-onapristone,Synonym:,IR onapristone
2020-09-18T07:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-onapristone,Synonym:,"onapristone, immediate-release formulation"
2020-10-14T05:23:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-tablet-afuresertib,Synonym:,GSK2110183 IR tablet
2020-10-14T05:23:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-tablet-afuresertib,Synonym:,IR afuresertib
2020-09-18T07:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immune-checkpoint-inhibitor-asp8374,Code name:,ASP 8374
2020-09-18T07:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immune-checkpoint-inhibitor-asp8374,Code name:,ASP-8374
2020-09-18T07:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immune-checkpoint-inhibitor-asp8374,Code name:,ASP8374
2020-09-18T07:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunoadjuvant-qs-dg,Code name:,QS-DG
2020-09-18T07:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunoconjugate-ro5479599,Code name:,RO5479599
2020-09-18T07:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il12,Code name:,NHS-IL12
2020-09-18T07:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il2-lt,Code name:,EMD 521873
2020-09-18T07:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il2-lt,Foreign brand name:,Selectkine
2020-09-18T07:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunological-adjuvant-opt-821,Code name:,OPT-821
2020-10-14T05:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-lam-003,Code name:,LAM 003
2020-10-14T05:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-lam-003,Code name:,LAM-003
2020-10-14T05:23:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-lam-003,Code name:,LAM003
2020-09-18T07:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-ohr-avr118,Code name:,AVR118
2020-09-18T07:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-ohr-avr118,Synonym:,Product R
2020-09-18T07:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-ohr-avr118,Synonym:,Reticulose
2020-09-18T07:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulatory-agent-cc-11006,Code name:,CC-11006
2020-09-18T07:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulatory-agent-cc-11006,Code name:,CC-11006-MDS-001
2020-09-18T07:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305,Code name:,CMB 305
2020-09-18T07:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305,Code name:,CMB305
2020-09-18T07:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305,Synonym:,ID-CMB305
2020-09-18T07:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305,Synonym:,LV 305 plus G 305
2020-09-18T07:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305,Synonym:,LV305 plus G305
2020-09-18T07:58:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-gsk1572932a,Code name:,GSK1572932A
2020-09-18T07:58:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapy-regimen-mkc-1106-mt,Code name:,MKC-1106-MT
2020-09-18T07:58:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-cmd-193,Code name:,CMD-193
2020-09-18T07:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-d2c7-scdsfv-pe38kdel,Abbreviation:,D2C7-IT
2020-09-18T07:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-d2c7-scdsfv-pe38kdel,Synonym:,D2C7-(scdsFv)-PE38KDEL
2020-09-18T07:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-d2c7-scdsfv-pe38kdel,Synonym:,D2C7-(scdsFv)-PE38KDEL immunotoxin
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,EDP-202
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,EOC-202
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,IMP-321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Code name:,IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Foreign brand name:,ImmuFact IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Foreign brand name:,ImmuFact-IMP321
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,Efti
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,hLAG-31g
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,LAG-3-Ig-fusion protein
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,LAG-3Ig
2020-09-18T06:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321,Synonym:,sLAG-3-Ig
2020-09-18T07:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imt-1012-immunotherapeutic-vaccine,Code name:,IMT-1012
2020-09-18T07:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imt-1012-immunotherapeutic-vaccine,Synonym:,OCPM immunotherapeutic vaccine
2020-09-18T07:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inactivated-poliovirus-vaccine,Acronym:,IPV
2020-09-18T07:59:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inactivated-poliovirus-vaccine,US brand name:,IPOL
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,Abbreviation:,vCEA-MUC-1-TRI
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,Synonym:,recombinant vaccinia-CEA-MUC1-TRICOM vaccine
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,Synonym:,recombinant vaccinia-CEA(D609)/MUC1(L93)/TRICOM vaccine
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,Synonym:,rVaccinia-CEA(D609)/MUC1(L93)/TRICOM vaccine
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,Synonym:,vaccinia-CEA-MUC-1-TRICOM vaccine
2020-09-18T07:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev,US brand name:,PANVAC-V
2020-09-18T08:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incomplete-freunds-adjuvant,Abbreviation:,IFA
2020-09-18T08:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incomplete-freunds-adjuvant,Code name:,ISA-51
2020-09-18T08:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incomplete-freunds-adjuvant,Synonym:,Montanide ISA 51
2020-09-18T08:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide,Chemical structure:,"4-dimethlyamino sancycline4-dimethlyaminosancycline6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline"
2020-09-18T08:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide,Code name:,CMT-3
2020-09-18T08:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide,Code name:,COL 3
2020-09-18T08:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide,US brand name:,Metastat
2020-10-14T03:53:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indatuximab-ravtansine,Code name:,BT-062
2020-10-14T03:53:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indatuximab-ravtansine,Synonym:,maytansinoid-conjugated anti-myeloma monoclonal antibody BT-062
2020-09-18T08:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indibulin,Chemical structure:,(N-(pyridin-4-yl)-[1-(4-chlorbenzyl)-indol-3-yl]-glyoxyl-amid)
2020-09-18T08:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indibulin,Code name:,D 24851
2020-09-18T08:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indibulin,Code name:,D-24851
2020-09-18T08:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indibulin,Code name:,ZIO-301
2020-09-18T08:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indicine-n-oxide,Abbreviation:,INDI
2020-09-18T05:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate,Abbreviation:,IDV
2020-09-18T05:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate,US brand name:,Crixivan
2020-09-18T08:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-cd45-monoclonal-antibody-bc8,Synonym:,In 111 MOAB BC8
2020-09-18T08:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-cd45-monoclonal-antibody-bc8,Synonym:,In 111 monoclonal antibody BC8
2020-09-18T08:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-cd45-monoclonal-antibody-bc8,Synonym:,In111 MOAB BC8
2020-09-18T08:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-cd45-monoclonal-antibody-bc8,Synonym:,indium In 111 MOAB BC8
2020-09-18T08:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,111-Indium-ABT806
2020-09-18T08:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-egfr-monoclonal-antibody-abt-806,Abbreviation:,ABT-806i
2020-09-18T08:00:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-egfr-monoclonal-antibody-abt-806,Synonym:,Indium In 111 ABT-806
2020-10-14T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-autologous-cmv-pp65-lamp-mrna-loaded-dendritic-cells,Synonym:,111In-labeled autologous CMV-pp65-LAMP mRNA loaded dendritic cells
2020-10-14T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-autologous-cmv-pp65-lamp-mrna-loaded-dendritic-cells,Synonym:,111In-labeled pp65-LAMP mRNA-loaded mature autologous DCs
2020-10-14T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-autologous-cmv-pp65-lamp-mrna-loaded-dendritic-cells,Synonym:,indium In 111-CMV pp65-LAMP mRNA-pulsed autologous DCs
2020-10-14T05:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-autologous-cmv-pp65-lamp-mrna-loaded-dendritic-cells,Synonym:,indium In 111-labeled CMV pp65 peptide-pulsed autologous DCs
2020-09-18T08:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-bevacizumab,Synonym:,111-indium labeled bevacizumab
2020-09-18T08:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-capromab-pendetide,Synonym:,111-In capromab pendetide
2020-09-18T08:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-capromab-pendetide,US brand name:,Indium 111 ProstaScint
2020-09-18T08:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-chimeric-monoclonal-antibody-806,Abbreviation:,111-Indium-ch806
2020-09-18T08:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-chx-a-dtpa-trastuzumab,NA,NA
2020-09-18T08:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-cmd-193,Synonym:,In 111 CMD-193
2020-09-18T08:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-biotin,Synonym:,In 111-DOTA-Biotin
2020-09-18T08:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-di-hsg-peptide-imp-288,NA,NA
2020-09-18T08:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-exendin-4,Synonym:,[Lys40(Ahx-DOTA-111In)NH2]-exendin-4
2020-09-18T08:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-exendin-4,Synonym:,111In-DOTA-exendin-4
2020-09-18T08:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-girentuximab,Synonym:,111-indium labeled chimeric monoclonal antibody G250
2020-09-18T08:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-girentuximab,Synonym:,indium In 111 chimeric monoclonal antibody G250
2020-10-14T05:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-h11b6,Synonym:,111In-DOTA-h11B6
2020-10-14T05:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-h11b6,Synonym:,indium-111 radiolabeled h11B6
2020-10-14T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-fpi-1547,Code name:,[111In]-FPI-1547
2020-10-14T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-fpi-1547,Synonym:,indium In 111-FPI-1397-FPI-1175
2020-10-14T05:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-fpi-1547,Synonym:,indium In 111-labeled FPI-1547
2020-10-14T05:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-girentuximab,Synonym:,111-indium labeled chimeric monoclonal antibody G250
2020-10-14T05:23:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-girentuximab,Synonym:,indium In 111 chimeric monoclonal antibody G250
2020-09-18T08:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-ibritumomab-tiuxetan,Code name:,IDEC-In2B8
2020-09-18T08:02:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-labeled-autologous-peripheral-blood-mononuclear-cells,Abbreviation:,indium In 111-labeled autologous PBMCs
2020-09-18T08:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-labeled-autologous-polymorphonuclear-leukocytes,Abbreviation:,indium In 111-labeled autologous PMNLs
2020-10-14T05:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-minigastrin-analog-cp04,Code name:,PPF11
2020-10-14T05:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-minigastrin-analog-cp04,Synonym:,111-indium CP04
2020-10-14T05:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-minigastrin-analog-cp04,Synonym:,111In-CP04
2020-10-14T05:24:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-minigastrin-analog-cp04,Synonym:,indium In 111 CP04
2020-09-18T08:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-bre-3,Abbreviation:,In 111 MOAB BrE-3
2020-09-18T08:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-bre-3,Synonym:,In 111 monoclonal antibody BrE-3
2020-10-14T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-huj591,Synonym:,111In-HuJ591
2020-10-14T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-huj591,Synonym:,111In-J591
2020-10-14T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-huj591,Synonym:,In111-J591
2020-09-18T08:01:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-hupam4,Synonym:,111 In- labeled humanized PAM4 IgG
2020-09-18T08:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetate,Foreign brand name:,DRAXIMAGE INDIUM DTPA
2020-09-18T08:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetate,Synonym:,indium In 111 diethylenetriamine pentaacetate
2020-09-18T08:01:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetate,Synonym:,indium In 111 DTPA
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium In 111-Pentetreotide
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium In-111 Pentetreotide
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium-111 Octreotide DTPA
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium-111-DTPA-D-Phe-1-octreotide
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium-In 111 Pentetreotide
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,Synonym:,Indium-In-111-Pentetreotide
2020-09-18T08:01:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide,US brand name:,Octreoscan
2020-09-18T08:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pertuzumab,Abbreviation:,111In-pertuzumab
2020-09-18T08:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pertuzumab,Abbreviation:,111In-PmAb
2020-09-18T08:02:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-albumin-solution,NA,NA
2020-10-14T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100,Code name:,ONM 100
2020-10-14T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100,Code name:,ONM-100
2020-10-14T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100,Code name:,ONM100
2020-10-14T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100,Synonym:,ICG-labeled polymeric micelles ONM-100
2020-10-14T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100,Synonym:,pH-activated ICG tracer ONM-100
2020-09-18T07:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-solution,Abbreviation:,ICG solution
2020-09-18T07:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-solution,US brand name:,IC-GREEN
2020-09-18T08:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indole-3-carbinol,Abbreviation:,I3C
2020-09-18T08:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indole-3-carbinol,Synonym:,3-hydroxymethylindole
2020-09-18T08:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indole-3-carbinol,Synonym:,indole-3-methanol
2020-09-18T08:03:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoleamine-23-dioxygenase-peptide-vaccine,Abbreviation:,IDO peptide vaccine
2020-09-18T07:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin,Abbreviation:,INDO
2020-09-18T07:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin,Chemical structure:,1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid
2020-09-18T07:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin,Synonym:,Indometacin
2020-09-18T07:19:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin,US brand name:,Indocin
2020-09-18T08:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod,Abbreviation:,1-MT
2020-09-18T08:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod,Synonym:,1-methyl-d-tryptophan
2020-09-18T08:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod,Synonym:,D-(+)-1-methyltryptophan
2020-09-18T08:03:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod,Synonym:,D-1MT
2020-10-14T05:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod-prodrug-nlg802,Code name:,NLG 802
2020-10-14T05:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod-prodrug-nlg802,Code name:,NLG-802
2020-10-14T05:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod-prodrug-nlg802,Code name:,NLG802
2020-10-14T05:24:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod-prodrug-nlg802,Synonym:,IDO1 inhibitor NLG802
2020-09-18T08:03:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inducible-cd4cd25-regulatory-t-cells,Synonym:,iTregs
2020-10-14T03:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indusatumab-vedotin,Code name:,MLN0264
2020-10-14T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inebilizumab,Code name:,MEDI-551
2020-10-14T05:24:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inebilizumab,Synonym:,anti-CD19 monoclonal antibody MEDI-551
2020-09-18T08:03:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inecalcitol,Abbreviation:,ICC
2020-09-18T08:03:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inecalcitol,Chemical structure:,"(7E)-19-nor-9,10-seco-14beta-cholesta-5,7-dien-23-yne-1alpha,3beta,25-triol"
2020-10-14T05:24:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infigratinib,Code name:,BGJ398
2020-10-14T05:24:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infigratinib,Synonym:,pan FGFR kinase inhibitor BGJ398
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,Abbreviation:,INF
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,Code name:,cA2
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,Foreign brand name:,Remsima
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,Synonym:,Avakine
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,Synonym:,INFLIX
2020-09-18T08:03:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab,US brand name:,Remicade
2020-09-18T08:04:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-derivative-leo-43204-gel,Code name:,LEO 43204
2020-10-14T05:24:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-disoxate,Code name:,LEO 43204
2020-09-18T08:04:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate,Abbreviation:,I3A
2020-09-18T08:04:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate,Synonym:,3-ingenyl angelate
2020-09-18T08:04:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate,US brand name:,Picato
2020-09-18T08:04:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel,Synonym:,3-angel oyl ingenol gel
2020-09-18T08:04:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel,Synonym:,ingenol-3-angelate gel
2020-09-18T08:04:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel,Synonym:,PEP-005 topical gel
2020-09-18T08:04:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel,Synonym:,PEP005 gel
2020-09-18T08:04:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel,US brand name:,Picato
2020-09-18T08:04:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iniparib,Chemical structure:,"4-iodo-3-nitrobenzamideBenzamide, 4-iodo-3-nitro-"
2020-09-18T08:04:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iniparib,Code name:,BSI-201
2020-09-18T08:04:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-astragalus-membranaceus-polysaccharide,Abbreviation:,injectable APS
2020-09-18T08:04:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-astragalus-membranaceus-polysaccharide,Synonym:,injectable PG2
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Acronym:,VLI
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,Synonym:,vinorelbine liposomes injection
2020-09-18T01:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine,US brand name:,Alocrest
2020-10-14T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inkt-cell-agonist-abx196,Code name:,ABX 196
2020-10-14T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inkt-cell-agonist-abx196,Code name:,ABX-196
2020-10-14T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inkt-cell-agonist-abx196,Code name:,ABX196
2020-10-14T05:24:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inkt-cell-agonist-abx196,Synonym:,invariant NKT cell agonist ABX196
2020-09-18T08:04:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/innate-defense-regulator-sgx942,Code name:,SGX942
2020-09-18T08:04:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/innate-immunostimulator-rbbx-01,Code name:,rBBX-01
2020-09-18T08:05:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ino-1001,NA,NA
2020-10-14T05:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid,Code name:,BC 819
2020-10-14T05:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid,Code name:,BC-819
2020-10-14T05:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid,Code name:,BC819
2020-10-14T05:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid,Synonym:,diphtheria-toxin-A-H19
2020-10-14T05:25:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid,Synonym:,dT-A-H19
2020-10-14T04:02:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inos-dimerization-inhibitor-asp9853,NA,NA
2020-09-18T08:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5--monophosphate-dehydrogenase-inhibitor-ff-10501-01,Code name:,FF-10501
2020-09-18T08:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5--monophosphate-dehydrogenase-inhibitor-ff-10501-01,Code name:,FF-10501-01
2020-09-18T08:05:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5--monophosphate-dehydrogenase-inhibitor-ff-10501-01,Synonym:,IMPDH inhibitor FF-10501
2020-10-14T05:25:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5-monophosphate-dehydrogenase-inhibitor-ff-10501-01,Code name:,FF-10501
2020-10-14T05:25:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5-monophosphate-dehydrogenase-inhibitor-ff-10501-01,Code name:,FF-10501-01
2020-10-14T05:25:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5-monophosphate-dehydrogenase-inhibitor-ff-10501-01,Synonym:,IMPDH inhibitor FF-10501
2020-09-18T08:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-dialdehyde,Abbreviation:,IdA
2020-09-18T08:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-dialdehyde,Code name:,Wy-5321
2020-09-18T08:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-dialdehyde,Synonym:,diglycoaldehyde
2020-09-18T08:05:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-dialdehyde,Synonym:,INOX
2020-10-14T04:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-monophosphate-dehydrogenase-inhibitor-avn944,NA,NA
2020-09-18T08:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inositol,Chemical structure:,"cis-1,2,3,5-trans-4,6-cyclohexanehexolcyclohexanehexol"
2020-09-18T08:05:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inositol,Synonym:,myo-inositol
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,CMC-544
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,Way 207294
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,Code name:,WAY-207294
2020-09-18T04:37:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin,US brand name:,Besponsa
2020-09-18T07:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-lispro,US brand name:,Humalog
2020-09-18T07:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-nph,US brand name:,Humulin N
2020-09-18T07:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-nph,US brand name:,Novolin N
2020-09-18T07:46:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-regular,US brand name:,Humulin R Insulin
2020-09-18T07:46:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-regular,US brand name:,Regular Novolin R
2020-10-14T04:56:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/integrin-alpha-2-inhibitor-e7820,NA,NA
2020-09-18T08:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/integrin-receptor-antagonist-glpg0187,Code name:,GLPG0187
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Abbreviation:,CIFN
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Abbreviation:,r-metHuIFN-Con1
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Foreign brand name:,Advaferon
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,consensus interferon
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,IFN alfacon-1
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,"interferon consensus, methionyl"
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,methionyl interferon consensus
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,methionyl-interferon-consensus
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,recombinant consensus interferon
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,Synonym:,recombinant methionyl human consensus interferon
2020-09-18T08:03:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1,US brand name:,Infergen
2020-09-18T08:06:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-beta-secreting-mesenchymal-stem-cells,Abbreviation:,IFNb-MSC
2020-09-18T08:06:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-beta-secreting-mesenchymal-stem-cells,Abbreviation:,IFNbeta-MSC
2020-09-18T08:06:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-beta-secreting-mesenchymal-stem-cells,Abbreviation:,MSC-IFN beta
2020-09-18T08:06:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-beta-secreting-mesenchymal-stem-cells,Synonym:,IFNb-secreting MSCs
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,N(sup 2)-L-methionyl-1-139-interferon G
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,Synonym:,recombinant interferon gamma-1b
2020-09-18T01:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b,US brand name:,Actimmune
2020-09-18T08:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-expressing-adenovirus-vaccine-asn-002,Abbreviation:,Ad-IFNg
2020-09-18T08:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-expressing-adenovirus-vaccine-asn-002,Code name:,ASN-002
2020-09-18T08:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-expressing-adenovirus-vaccine-asn-002,Code name:,TG1042
2020-09-18T08:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-expressing-adenovirus-vaccine-asn-002,Synonym:,INFg-expressing Ad vaccine ASN-002
2020-10-14T05:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-fc-fusion-protein-df6002,Code name:,DF 6002
2020-10-14T05:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-fc-fusion-protein-df6002,Code name:,DF-6002
2020-10-14T05:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-fc-fusion-protein-df6002,Code name:,DF6002
2020-10-14T05:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-fc-fusion-protein-df6002,Synonym:,IL12-Fc fusion protein DF6002
2020-09-18T08:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-gene,Abbreviation:,IL-12 gene
2020-09-18T08:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-gene,Abbreviation:,pIL-12
2020-09-18T08:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-gene,Synonym:,plasmid DNA encoding human interleukin-12
2020-09-18T08:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-gene,Synonym:,plasmid IL-12
2020-09-18T08:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-gene,Synonym:,IL-2 gene
2020-10-14T12:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-liposome,Abbreviation:,IL-2 LIPO
2020-10-14T12:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-liposome,Synonym:,interleukin-2 liposome
2020-10-14T12:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-liposome,Synonym:,liposome encapsulated interleukin-2
2020-10-14T13:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/internalized-arginylglycylaspartic-acid-cyclic-peptide,Synonym:,iRGD
2020-09-18T08:07:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intetumumab,Code name:,CNTO 95
2020-09-18T08:07:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intetumumab,Synonym:,human anti-alpha-v integrin monoclonal antibody
2020-09-18T08:07:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intranasal-ketamine,Code name:,PMI-150
2020-09-18T08:07:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inulin,NA,NA
2020-10-14T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-124,Abbreviation:,124I-metaiodobenzylguanidine
2020-10-14T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-124,Abbreviation:,124I-MIBG
2020-10-14T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-124,Synonym:,iobenguane I-124
2020-10-14T05:25:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-124,Synonym:,iodine I 124 metaiodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,(131)I-MIBG
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,131I-MIBG
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,I 131 metaiodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,I-131 meta-iodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,iodine I 131 metaiodobenzylguanidine
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,Synonym:,MIBG I-131
2020-09-18T04:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131,US brand name:,Azedra
2020-10-14T05:25:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-sulfate-i-123,Abbreviation:,I-123 MIBG
2020-09-18T08:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobitridol,Chemical structure:,"N,N'-Bis(2,3-dihydroxypropyl)-5-(2-(hydroxymethyl)hydracrylamido)-2,4,6-tri=iodo-N,N'-dimethylisophthalamide"
2020-09-18T08:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobitridol,Foreign brand name:,Xenetix
2020-10-14T05:25:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-contrast-agent,Synonym:,"contrast dye, iodinated"
2020-09-18T08:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-contrast-dye,Synonym:,"contrast dye, iodinated"
2020-10-14T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker,Synonym:,PEG-based hydrogel tissue marker
2020-10-14T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker,Synonym:,radiopaque polymer hydrogel imaging agent
2020-10-14T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker,US brand name:,TraceIT
2020-10-14T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker,US brand name:,TraceIT Hydrogel
2020-10-14T05:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker,US brand name:,TraceIT Tissue Marker
2020-09-18T08:12:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-123-metaiodobenzylguanidine,Abbreviation:,I-123 MIBG
2020-09-18T08:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-131-6-beta-iodomethyl-19-norcholesterol,Synonym:,iodine-131 NP-59
2020-09-18T08:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123,Synonym:,I-123
2020-09-18T08:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123,Synonym:,iodine 123
2020-09-18T08:08:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-adam,Synonym:,I-123 ADAM
2020-09-18T08:08:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-adam,Synonym:,iodine-123-labeled 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine
2020-09-18T08:08:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-anti-cea-recombinant-diabody-t8466,NA,NA
2020-09-18T08:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-iodobenzamide,Abbreviation:,123I-IBZM
2020-09-18T08:08:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-iodometomidate,NA,NA
2020-10-14T03:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-mip-1095,Chemical structure:,2-(3-{l-carboxy-5-[3-(4-iodo-phenyl)-ureido]-pentyl}-ureido)-pentanedioic acid
2020-10-14T03:20:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-mip-1095,Synonym:,iodine I 123 IMP-1095
2020-09-18T08:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124,Synonym:,I-124
2020-09-18T08:08:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124,Synonym:,iodine 124
2020-10-14T05:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-anti-phosphatidylserine-monoclonal-antibody-pgn650,Abbreviation:,I-124 anti-PS MoAb PNG650
2020-10-14T05:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-anti-phosphatidylserine-monoclonal-antibody-pgn650,Abbreviation:,I-124 PGN650
2020-10-14T05:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-anti-phosphatidylserine-monoclonal-antibody-pgn650,Synonym:,I-124 anti-PS MoAb PNG650
2020-09-18T08:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-cpd-1028,Abbreviation:,[I-124]-CPD-1028
2020-09-18T08:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-fiau,Abbreviation:,124I-FIAU
2020-09-18T08:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-fiau,Chemical structure:,2'-fluoro-2'-deoxy-5'-[124I]iodo-1β-d-arabinofuranosyluracil
2020-09-18T08:12:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-girentuximab,NA,NA
2020-09-18T08:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iobenguane,Abbreviation:,124I-metaiodobenzylguanidine
2020-09-18T08:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iobenguane,Abbreviation:,124I-MIBG
2020-09-18T08:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iobenguane,Synonym:,iobenguane I-124
2020-09-18T08:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iobenguane,Synonym:,iodine I 124 metaiodobenzylguanidine
2020-09-18T08:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iodo-azomycin-galactopyranoside,Abbreviation:,I-124 IAZGP
2020-09-18T08:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iododeoxyuridine,Synonym:,I-124 iododeoxyuridine
2020-09-18T08:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-phosphatidylserine-monoclonal-antibody-pgn650,Abbreviation:,I-124 anti-PS MoAb PNG650
2020-09-18T08:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-phosphatidylserine-monoclonal-antibody-pgn650,Abbreviation:,I-124 PGN650
2020-09-18T08:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-phosphatidylserine-monoclonal-antibody-pgn650,Synonym:,I-124 anti-PS MoAb PNG650
2020-09-18T08:09:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-psca-a11-minibody,Synonym:,124I-A11 PSCA minibody
2020-09-18T08:09:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-psca-a11-minibody,Synonym:,iodine I 124-labeled anti-PSCA affinity matured antibody fragment A11
2020-09-18T08:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-hsp90-inhibitor-puh71,Abbreviation:,iodine I 124 PUH71
2020-09-18T08:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-hsp90-inhibitor-puh71,Synonym:,124I-PUH71
2020-09-18T08:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-3f8,Abbreviation:,124I-hu3F8
2020-09-18T08:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-3f8,Abbreviation:,I 124 mAb 3F8
2020-09-18T08:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-3f8,Synonym:,124I-humanized 3F8
2020-09-18T08:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-3f8,Synonym:,I 124 monoclonal antibody 3F8
2020-09-18T08:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-8h9,Abbreviation:,124I-8H9
2020-09-18T08:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-8h9,Synonym:,iodine I 124 MOAB 8H9
2020-09-18T08:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-a33,Synonym:,I 124 Monoclonal Antibody A33
2020-09-18T08:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-a33,Synonym:,iodine I 124 MOAB A33
2020-10-14T05:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-m5a,Synonym:,124I-M5A
2020-10-14T05:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-m5a,Synonym:,iodine I 124 anti-CEA monoclonal antibody M5A
2020-09-18T08:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-nm404,Synonym:,[(124)I]NM404
2020-09-18T08:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-nm404,Synonym:,124I-NM404
2020-09-18T08:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-phospholipid-ether-analogue-clr1404,Abbreviation:,I-124-CLR1404
2020-09-18T08:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-phospholipid-ether-analogue-clr1404,Synonym:,I-124 PLE analogue CLR1404
2020-09-18T08:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-phospholipid-ether-analogue-clr1404,Synonym:,I-124-NM404; 18-(p-[I-124]iodophenyl) octadecyl phosphocholine
2020-09-18T08:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-pu-ad,Abbreviation:,[124I]-PU-AD
2020-09-18T08:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-pu-ad,Synonym:,124I-PU-AD
2020-09-18T08:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125,Synonym:,125-Iodine
2020-09-18T08:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125,Synonym:,I-125
2020-09-18T08:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125-anti-egfr-425-monoclonal-antibody,Synonym:,iodine 125-labeled anti-EGFR-425 monoclonal antibody
2020-09-18T08:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125-anti-egfr-425-monoclonal-antibody,Synonym:,iodine 125-labeled anti-epidermal growth factor receptor-425 monoclonal antibody
2020-09-18T08:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131,Abbreviation:,I 131
2020-09-18T08:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131,Foreign brand name:,Iodotrope
2020-09-18T08:10:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131,US brand name:,Iodotope
2020-10-14T05:25:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-6-beta-iodomethyl-19-norcholesterol,Synonym:,iodine-131 NP-59
2020-09-18T08:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-anti-fibronectin-antibody-fragment-l19-sip,Abbreviation:,I-131 L19-SIP
2020-09-18T08:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-anti-fibronectin-antibody-fragment-l19-sip,Code name:,L19-SIP
2020-09-18T08:10:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-anti-fibronectin-antibody-fragment-l19-sip,Synonym:,I-131 antibody L19-SIP
2020-10-14T05:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-apamistamab,Abbreviation:,I 131 MOAB BC8
2020-10-14T05:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-apamistamab,Synonym:,I 131 Monoclonal Antibody BC8
2020-10-14T05:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-apamistamab,Synonym:,iodine I 131 MOAB BC8
2020-10-14T05:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-apamistamab,Synonym:,iomab-B
2020-09-18T08:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-chimeric-monoclonal-antibody-g-250,Abbreviation:,iodine I 131 MOAB G250
2020-09-18T08:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-chimeric-monoclonal-antibody-g-250,Synonym:,I 131 Monoclonal Antibody G-250
2020-09-18T08:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-chimeric-monoclonal-antibody-g-250,Synonym:,iodine I 131 MOAB G-250
2020-09-18T08:10:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-chimeric-monoclonal-antibody-g-250,Synonym:,iodine I 131 monoclonal antibody G-250
2020-10-14T04:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-derlotuximab-biotin,Abbreviation:,I 131 MOAB TNT-1/B
2020-10-14T04:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-derlotuximab-biotin,Synonym:,iodine I 131 MOAB TNT-1/B
2020-10-14T04:48:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-derlotuximab-biotin,US brand name:,Cotara
2020-09-18T08:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-ethiodized-oil,US brand name:,Iodine I 131 Lipiodol
2020-09-18T08:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol,Synonym:,"cholest-5-en-3-ol, 19(iodo-(sup 131)I)-, (3beta)-"
2020-09-18T08:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol,Synonym:,I-131 iodocholesterol
2020-09-18T08:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol,Synonym:,iodine 131 iodocholesterol
2020-09-18T08:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol,Synonym:,iodocholesterol (131 I)
2020-09-18T08:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol,Synonym:,iodocholesterol I 131
2020-09-18T08:11:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-labeled-anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2,Abbreviation:,131I-TF2
2020-09-18T08:10:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095,Chemical structure:,((S)-2-(3-((S)-1-carboxy-5-(3-(4-[(131)I]iodophenyl)ureido)pentyl)ureido)pentanedioic acid
2020-09-18T08:10:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095,Synonym:,(131) I-MIP-1095
2020-09-18T08:10:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095,Synonym:,131I-MIP-1095
2020-09-18T08:10:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095,Synonym:,I-131 MIP-1095
2020-09-18T08:10:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095,Synonym:,MIP-1095 I-131
2020-09-18T08:10:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-3f8,Synonym:,I 131 Monoclonal Antibody 3F8
2020-09-18T08:10:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-3f8,Synonym:,I131-MOAB-3F8
2020-09-18T08:10:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-3f8,Synonym:,iodine I 131 MOAB 3F8
2020-09-18T08:11:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-81c6,Synonym:,I 131 Monoclonal Antibody 81C6
2020-09-18T08:11:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-81c6,Synonym:,iodine I 131 MOAB 81C6
2020-09-18T08:11:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-81c6,US brand name:,Neuradiab
2020-09-18T08:12:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-8h9,Synonym:,iodine I 131 MOAB 8H9
2020-09-18T08:12:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-8h9,Synonym:,Iodine I 131 Monoclonal Antibody 8H9
2020-09-18T08:11:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-bc8,Abbreviation:,I 131 MOAB BC8
2020-09-18T08:11:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-bc8,Synonym:,I 131 Monoclonal Antibody BC8
2020-09-18T08:11:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-bc8,Synonym:,iodine I 131 MOAB BC8
2020-09-18T08:11:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-bc8,Synonym:,iomab-B
2020-09-18T08:11:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-cc49-deltach2,Abbreviation:,131I-HuCC49-deltaCH2
2020-09-18T08:11:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-cc49-deltach2,Abbreviation:,131I-MOAB CC49-deltaCH2
2020-09-18T08:11:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-f16sip,Code name:,F16SIP
2020-09-18T08:11:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-f16sip,Synonym:,(131I) monoclonal antibody F16SIP
2020-09-18T08:11:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-f16sip,Synonym:,I-131 monoclonal antibody F16SIP
2020-10-14T05:26:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-g-250,Abbreviation:,iodine I 131 MOAB G250
2020-10-14T05:26:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-g-250,Synonym:,I 131 Monoclonal Antibody G-250
2020-10-14T05:26:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-g-250,Synonym:,iodine I 131 MOAB G-250
2020-10-14T05:26:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-g-250,Synonym:,iodine I 131 monoclonal antibody G-250
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,Abbreviation:,I 131 MOAB TNT-1/B
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,Synonym:,iodine I 131 MOAB TNT-1/B
2020-09-18T05:42:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b,US brand name:,Cotara
2020-09-18T08:11:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-nm404,Synonym:,[(131)I]NM404
2020-09-18T08:11:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-nm404,Synonym:,131I-NM404
2020-10-14T05:26:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-omburtamab,Synonym:,iodine I 131 MOAB 8H9
2020-10-14T05:26:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-omburtamab,Synonym:,Iodine I 131 Monoclonal Antibody 8H9
2020-09-18T08:11:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-rituximab,Synonym:,(131)I-rituximab
2020-09-18T08:11:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-rituximab,Synonym:,131I-Rituxan
2020-09-18T08:11:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-rituximab,Synonym:,131I-rituximab
2020-09-18T08:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-sgmib-anti-her2-vhh1,Synonym:,[131I]-SGMIB anti-HER2 VHH1
2020-09-18T08:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-sgmib-anti-her2-vhh1,Synonym:,iodine I 131 N-succinimidyl 4-guanidinomethyl-3-iodobenzoate-anti-HER2 VHH1
2020-09-18T08:11:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tenatumomab,Synonym:,131I-tenatumomab
2020-09-18T08:11:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601,Synonym:,131I-chlorotoxin
2020-09-18T08:11:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601,Synonym:,131I-TM-601
2020-09-18T08:11:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601,Synonym:,131I-TM601
2020-09-18T08:11:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601,Synonym:,I 131 TM-601
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Abbreviation:,I131-MOAB-B1
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,131-I-anti-B1 monoclonal antibody
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,I 131 monoclonal antibody anti-B1
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,I 131 tositumomab
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,iodine I 131 MOAB anti-B1
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,iodine I 131 monoclonal antibody anti-B1
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,iodine-131 anti-B1 antibody
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,iodine-131 anti-CD20 monoclonal antibody
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,iodine-131 tositumomab
2020-09-18T08:11:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab,Synonym:,tositumomab I-131
2020-09-18T08:12:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol,Chemical structure:,"5,5'-((2-hydroxytrimethylene)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)"
2020-09-18T08:12:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol,Code name:,2-5410-3A
2020-09-18T08:12:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol,US brand name:,OptiPrep
2020-09-18T08:12:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol,US brand name:,Visipaque
2020-09-18T08:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ioflubenzamide-i-131,Chemical structure:,"N-(4-(2-(diethylamino)ethylcarbamoyl)-2-iodo-5-methoxyphenyl)benzo[d][1,3]dioxole-5 carboxamide; N-(2-diethylamino-ethyl)-4-(4-F-benzamido)-5-iodo-2-methoxy-benzamide"
2020-09-18T08:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ioflubenzamide-i-131,Synonym:,131-I-MIP-1145
2020-09-18T08:12:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ioflubenzamide-i-131,Synonym:,iodine I 131 MIP-1145
2020-09-18T08:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iofolastat-i123,Synonym:,123-I-MIP-1072
2020-09-18T08:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iofolastat-i123,Synonym:,iodine I 123 MIP-1072
2020-09-18T08:12:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iohexol,US brand name:,Omnipaque
2020-09-18T08:12:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iopromide,US brand name:,Ultravist
2020-09-18T08:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipafricept,Code name:,Fzd8-Fc
2020-09-18T08:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipafricept,Code name:,OMP-54F28
2020-09-18T08:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipafricept,Synonym:,Fzd8 fusion protein OMP-54F28
2020-09-18T08:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipamorelin,NA,NA
2020-09-18T08:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib,Chemical structure:,"(2S)-2-(4-chlorophenyl)-1-(4-((5r,7r)-7-hydroxy-5-methyl-6,7-dihydro-5h-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl(-3-((propan-2-yl)amino)propan-1-one"
2020-09-18T08:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib,Code name:,GDC-0068
2020-09-18T08:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib,Code name:,RG-7440
2020-09-18T08:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib,Synonym:,Akt inhibitor GDC-0068
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Abbreviation:,MDX-CTLA-4
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Code name:,BMS-734016
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Code name:,IBI310
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Code name:,MDX-010
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Synonym:,anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Synonym:,MOAB CTLA-4
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,Synonym:,monoclonal antibody CTLA-4
2020-09-18T08:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab,US brand name:,Yervoy
2020-09-18T08:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipomeanol,Chemical structure:,1-(3-furanyl)-4-hydroxy-1-pentanone
2020-09-18T08:13:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipomeanol,Synonym:,4-ipomeanol
2020-09-18T08:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iproplatin,Abbreviation:,CHIP
2020-09-18T08:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iproplatin,Chemical structure:,(OC-6-33)-dichlorodihydroxybis(2-propanamine)platinum
2020-09-18T08:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iproplatin,Code name:,JM-9
2020-10-14T05:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-expressing-natural-killer-cells-ft516,NA,NA
2020-10-14T05:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596,Code name:,FT 596
2020-10-14T05:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596,Code name:,FT-596
2020-10-14T05:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596,Code name:,FT596
2020-10-14T05:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596,Synonym:,induced pluripotent stem cell-derived CD16/IL-15RF-expressing anti-CD19 CAR-NK cells FT596
2020-10-14T05:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596,Synonym:,iPSC-derived CD16/IL-15RF-expressing anti-CD19 CAR-natural killer cells FT596
2020-10-14T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iptacopan,Code name:,LNP 023
2020-10-14T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iptacopan,Code name:,LNP-023
2020-10-14T05:03:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iptacopan,Code name:,LNP023
2020-10-14T05:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irak4-inhibitor-ca-4948,Code name:,AU 4948
2020-10-14T05:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irak4-inhibitor-ca-4948,Code name:,CA 4948
2020-10-14T05:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irak4-inhibitor-ca-4948,Code name:,CA-4948
2020-10-14T05:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irak4-inhibitor-ca-4948,Synonym:,interleukin-1 receptor-associated kinase 4 inhibitor CA-4948
2020-09-18T08:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iratumumab,Synonym:,MDX-060
2020-09-18T08:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iratumumab,Synonym:,monoclonal antibody MDX-060
2020-10-14T05:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g,Code name:,919288G
2020-10-14T05:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g,Synonym:,IRDye800-labeled KSP/QRH dimer
2020-10-14T05:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g,Synonym:,KSP-QRH-E3-IRDye800
2020-10-14T05:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g,Synonym:,KSP/QRH peptide dimer
2020-10-14T05:26:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g,Synonym:,peptide 919288G
2020-10-14T05:26:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800cw-labeled-heptapeptide-ksp-910638g,Code name:,KSP-910638G
2020-10-14T05:26:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800cw-labeled-heptapeptide-ksp-910638g,Synonym:,KSP heptapeptide
2020-10-14T05:26:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800cw-labeled-heptapeptide-ksp-910638g,Synonym:,KSP-910638G heptapeptide
2020-10-14T05:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iridium-ir-192,Abbreviation:,Ir-192
2020-10-14T05:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iridium-ir-192,Synonym:,iridium-192
2020-09-18T08:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iriduim-ir-192,Abbreviation:,Ir-192
2020-09-18T08:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iriduim-ir-192,Synonym:,iridium-192
2020-09-18T08:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-eluting-beads,Code name:,CM-BC2
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Code name:,CPT-11
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Code name:,U-101440E
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Foreign brand name:,Campto
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Foreign brand name:,Irinomedac
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,camptothecin-11
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,irinotecan
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,Synonym:,irinotecan HCl
2020-09-18T04:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride,US brand name:,Camptosar
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Code name:,BAX2398
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Code name:,PEP02
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Synonym:,liposomal irinotecan hydrochloride
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Synonym:,liposome-encapsulated irinotecan hydrochloride PEP02
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Synonym:,MM-398
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,Synonym:,nal-IRI
2020-09-18T08:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome,US brand name:,Onivyde
2020-09-18T08:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-p-glycoprotein-inhibitor-hm30181ak-combination-tablet,Foreign brand name:,Oratecan
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Code name:,BAX2398
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Code name:,PEP02
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Synonym:,liposomal irinotecan hydrochloride
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Synonym:,liposome-encapsulated irinotecan hydrochloride PEP02
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Synonym:,MM-398
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,Synonym:,nal-IRI
2020-10-14T05:27:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate,US brand name:,Onivyde
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Abbreviation:,HMAF
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Chemical structure:,"(R)-6'-hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one"
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Code name:,MGI 114
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Code name:,MGI-114
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Synonym:,6-hydroxymethylacylfulvene
2020-09-18T08:14:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven,Synonym:,hydroxymethylacylfulvene
2020-09-18T08:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron,Abbreviation:,Fe
2020-09-18T08:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron,US brand name:,Niferex
2020-09-18T08:14:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-dextran-complex,Synonym:,Iron Dextran Injection
2020-09-18T08:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-isomaltoside-1000,US brand name:,Monofer
2020-09-18T08:15:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-sucrose-injection,US brand name:,Venofer
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Abbreviation:,rPF4
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Acronym:,rhPF4
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Synonym:,CXC-chemokine PF-4
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Synonym:,CXCL4
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Synonym:,platelet factor 4
2020-10-14T13:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact,Synonym:,recombinant human platelet factor 4
2020-10-14T13:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irosustat,Abbreviation:,STS inhibitor BN 83495
2020-10-14T13:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irosustat,Code name:,BN 83495
2020-10-14T13:22:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irosustat,Code name:,STX 64
2020-09-18T05:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irx-2,NA,NA
2020-09-18T08:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab,Code name:,SAR650984
2020-09-18T08:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab,Synonym:,anti-CD38 monoclonal antibody SAR650984
2020-09-18T08:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab,Synonym:,isatuximab
2020-09-18T08:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab,US brand name:,Sarclisa
2020-09-18T08:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isavuconazole,Code name:,BAL8557
2020-09-18T08:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-2503,Code name:,ISIS-2503
2020-09-18T08:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-2503,Synonym:,H-RAS Antisense
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,CGP 64128A
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Code name:,LY900003
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,Synonym:,"DNA, d(P-thio)(GTTCTCGCTGGTGAGTTTCA)"
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitac
2020-09-18T01:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521,US brand name:,Affinitak
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Code name:,CGP 69846A
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Code name:,CGP69846A
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Code name:,ISIS-5132
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Synonym:,c-RAF Antisense
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Synonym:,ISIS 5132/CGP69846A
2020-09-18T08:15:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132,Synonym:,RAF-IK Antisense ODN
2020-09-18T08:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iso-fludelone,Chemical structure:,"17-iso-oxazole-26-F3-9,10-dehydro-12,13-desoxy-epothilone B"
2020-09-18T08:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iso-fludelone,Code name:,KOS-1803
2020-09-18T08:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iso-fludelone,Synonym:,17-iso-oxazole-fludelone
2020-10-14T12:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isocoumarin-nm-3,NA,NA
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,Chemical structure:,"1-chloro-2,2,2-trifluoroethyl difluoromethyl ether (SN); 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane"
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Aerrane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Forane
2020-09-18T01:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane,US brand name:,Isoflo
2020-09-18T07:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoniazid,Abbreviation:,INH
2020-09-18T07:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoniazid,Chemical structure:,isonicotinic acid hydrazideisonicotinyl hydrazine
2020-10-14T05:27:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isopropyl-alcohol,Chemical structure:,2-propanol
2020-10-14T05:27:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isopropyl-alcohol,Synonym:,isopropanol
2020-09-18T08:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoquercetin,Synonym:,quercetin-3-O-glucoside
2020-09-18T08:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isosulfan-blue,Synonym:,"N-[4-[4-(diethylamino)phenyl] (2,5-disulfophenyl) Methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide"
2020-09-18T08:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isosulfan-blue,US brand name:,Lymphazurin
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Abbreviation:,13-CRA
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Chemical structure:,"3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)2cis-4-trans-6-trans-8-trans-nonatetraenoic Acid"
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Code name:,Ro 4-3780
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Accure
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrex
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Isotrexin
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Oratane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roaccutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Foreign brand name:,Roacutan
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,13-cis-vitamin A acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,cis-retinoic acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,isotretinoinum
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,neovitamin A
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,Synonym:,Neovitamin A Acid
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Accutane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Amnesteem
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Cistane
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Claravis
2020-09-18T01:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin,US brand name:,Sotret
2020-09-18T08:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ispinesib,Code name:,CK0238273
2020-09-18T08:16:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ispinesib,Code name:,SB-715992
2020-09-18T08:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iss-1018-cpg-oligodeoxynucleotide,NA,NA
2020-10-14T03:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/istiratumab,Code name:,MM-141
2020-09-18T08:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib,Synonym:,INCB-039110 adipate
2020-09-18T08:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib,Synonym:,INCB039110 adipate
2020-10-14T05:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib-adipate,Synonym:,INCB-039110 adipate
2020-10-14T05:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib-adipate,Synonym:,INCB039110 adipate
2020-10-14T05:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itk-inhibitor-cpi-818,Code name:,CPI 818
2020-10-14T05:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itk-inhibitor-cpi-818,Code name:,CPI-818
2020-10-14T05:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itk-inhibitor-cpi-818,Code name:,CPI818
2020-10-14T05:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itk-inhibitor-cpi-818,Synonym:,interleukin-2 inducible T-cell kinase inhibitor CPI-818
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,Abbreviation:,ICZ
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,Code name:,"R 51,211"
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,Foreign brand name:,Lozanoc
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,Synonym:,oriconazole
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,US brand name:,Lozanoc
2020-09-18T08:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole,US brand name:,Sporanox
2020-09-18T08:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole-dispersion-in-polymer-matrix,Synonym:,SUBA-itraconazole
2020-10-14T04:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivabradine-hydrochloride,Code name:,S-16257
2020-10-14T04:47:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivabradine-hydrochloride,US brand name:,Corlanor
2020-09-18T08:16:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivac-mutanome-vaccine,NA,NA
2020-10-14T05:16:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivaltinostat,Abbreviation:,HDI CG200745
2020-10-14T05:16:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivaltinostat,Chemical structure:,(E)-N(1)-(3-(dimethylamino)propyl)-N(8)-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide
2020-10-14T05:16:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivaltinostat,Code name:,CG200745
2020-10-14T05:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib,Code name:,AG-120
2020-10-14T05:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib,Synonym:,IDH1 inhibitor AG-120
2020-10-14T05:27:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib,US brand name:,Tibsovo
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,Chemical structure:,"(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione"
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,Code name:,BMS-247550
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,Synonym:,Azaepothilone B
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,Synonym:,epothilone B lactam
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,Synonym:,Epothilone-B BMS 247550
2020-09-18T08:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone,US brand name:,Ixempra
2020-09-18T08:17:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone-oral,Synonym:,oral ixabepilone
2020-09-18T08:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate,Code name:,MLN9708
2020-09-18T08:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate,Synonym:,proteasome inhibitor MLN9708
2020-09-18T08:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate,US brand name:,Ninlaro
2020-09-18T08:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak-inhibitor-incb047986,Code name:,INCB 047986
2020-09-18T08:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak-inhibitor-incb047986,Code name:,INCB-047986
2020-09-18T08:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak-inhibitor-incb047986,Code name:,INCB047986
2020-10-14T05:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-azd4205,Code name:,AZD 4205
2020-10-14T05:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-azd4205,Code name:,AZD-4205
2020-10-14T05:27:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-azd4205,Code name:,AZD4205
2020-09-18T08:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-incb052793,Code name:,INCB052793
2020-09-18T08:17:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-azd1480,Code name:,AZD1480
2020-09-18T08:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-bms-911543,Code name:,BMS-911543
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,Code name:,SAR302503a
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,Synonym:,fedratinib dihydrochloride monohydrate
2020-09-18T06:45:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348,US brand name:,Inrebic
2020-09-18T08:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-wp1066,Chemical structure:,(E)-3(6-bromopyridin-2-yl)-2-cyano-N-((S0-1-phenylethyl)acrylamide
2020-09-18T08:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-wp1066,Code name:,WP1066
2020-09-18T08:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-xl019,Code name:,XL019
2020-09-18T08:18:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-src-inhibitor-ns-018,Code name:,NS-018
2020-10-14T05:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jarlsberg-cheese,Synonym:,vitamin K2-rich cheese
2020-09-18T08:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jeb-regimen,Synonym:,carboplatin-etoposide-bleomycin regimen
2020-09-18T08:18:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jeb-regimen,Synonym:,JM8-etoposide-bleomycin regimen
2020-09-18T08:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jin-fu-kang,NA,NA
2020-10-14T04:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jnk-inhibitor-cc-401,NA,NA
2020-09-18T08:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/juven,NA,NA
2020-09-18T08:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite,Abbreviation:,KLT
2020-09-18T08:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite,Synonym:,coicis semen oil
2020-09-18T08:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite,Synonym:,coix seed extract
2020-09-18T08:19:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite,Synonym:,Kanglaite Injection
2020-10-14T05:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanitinib,Code name:,CX 1003
2020-10-14T05:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanitinib,Code name:,CX-1003
2020-10-14T05:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanitinib,Code name:,CX1003
2020-09-18T08:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karenitecin,Code name:,BNP1350
2020-10-14T05:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karonudib,Code name:,TH1579
2020-10-14T05:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karonudib,Synonym:,Karolinska MTH1 inhibitor TH1579
2020-10-14T05:28:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karonudib,Synonym:,Karolinska NUDT1 inhibitor TH1579
2020-09-18T08:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kava-based-supplement,Synonym:,Kavalactones-based supplement
2020-09-18T06:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-amitriptyline-np-h-cream,US brand name:,EpiCept NP-1
2020-09-18T08:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-hydrochloride,US brand name:,Ketalar
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Abbreviation:,KCZ
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Chemical structure:,"cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine"
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Code name:,R-41400
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Fungarest
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Fungoral
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Ketoderm
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Ketoisdin
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Orifungal M
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,Foreign brand name:,Panfungol
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,US brand name:,Nizoral
2020-09-18T08:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole,US brand name:,Xolegel
2020-09-18T08:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen,Chemical structure:,"benzeneacetic Acid, 3-benzoyl-alpha-methyl-propionic scid, 2-(3-benzoylphenyl)-"
2020-09-18T08:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen,Synonym:,capisten
2020-09-18T08:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen,Synonym:,dexketoprofen
2020-09-18T08:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen,US brand name:,Orudis
2020-09-18T08:20:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen,US brand name:,Oruvail
2020-09-18T08:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac,NA,NA
2020-09-18T08:20:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac-tromethamine,US brand name:,Toradol
2020-09-18T08:20:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/keyhole-limpet-hemocyanin,Acronym:,KLH
2020-09-18T10:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618,Chemical structure:,"1-N'-[2,5-difluoro-4-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxyphenyl]-1-N'-phenylcyclopropane-1,1-dicarboxamide"
2020-09-18T10:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618,Code name:,DCC-2618
2020-09-18T10:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618,Code name:,DCC2618
2020-09-18T10:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618,Synonym:,KIT/PDGFR inhibitor DCC-2618
2020-09-18T10:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618,US brand name:,Qinlock
2020-09-18T08:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/klh-fitc,Code name:,EC90
2020-09-18T08:21:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/klh-fitc,Synonym:,keyhole-limpet hemocyanin fluorescein isothiocyanate conjugate
2020-10-14T05:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-ly3499446,Code name:,LY 3499446
2020-10-14T05:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-ly3499446,Code name:,LY-3499446
2020-10-14T05:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-ly3499446,Code name:,LY3499446
2020-10-14T05:29:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-ly3499446,Synonym:,KRAS-G12C inhibitor LY3499446
2020-10-14T12:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-mrtx849,Code name:,MRTX 849
2020-10-14T12:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-mrtx849,Code name:,MRTX-849
2020-10-14T12:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-mrtx849,Code name:,MRTX849
2020-10-14T12:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-mapk-signaling-pathway-inhibitor-jab-3312,Code name:,JAB 3312
2020-10-14T12:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-mapk-signaling-pathway-inhibitor-jab-3312,Code name:,JAB-3312
2020-10-14T12:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-mapk-signaling-pathway-inhibitor-jab-3312,Code name:,JAB3312
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,ARS 3248
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,ARS-3248
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,ARS3248
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,JNJ 74699157
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,JNJ-74699157
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Code name:,JNJ74699157
2020-10-14T05:28:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157,Synonym:,G12C mutant KRAS protein inhibitor JNJ-74699157
2020-09-18T08:21:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krn5500,Chemical structure:,"(6-[4-deoxy-4-(2E, 4E)-tetradecadienoylglycyl] amino-L-glycero - beta-L-mannoheptopyranosyl] amino-9H-purine)"
2020-09-18T08:21:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-arry-520,Code name:,ARRY-520
2020-09-18T08:22:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-azd4877,Code name:,AZD4877
2020-10-14T13:18:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-sb-743921,NA,NA
2020-09-18T08:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-vegf-sirnas-aln-vsp02,Code name:,ALN-VSP02
2020-09-18T08:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment,Synonym:,sinecatechins ointment
2020-09-18T08:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment,US brand name:,Polyphenon E Ointment
2020-09-18T08:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment,US brand name:,Veregen
2020-09-18T08:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kw-2149,Chemical structure:,7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C
2020-09-18T08:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kw-2149,Code name:,KT6149
2020-09-18T08:22:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kw-2149,Code name:,KW 2149
2020-09-18T08:22:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-377202,Code name:,L-377202
2020-09-18T08:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-alanosine,Chemical structure:,3-(hydroxynitrosoamino)-L-alanineL-2-amino-3-(hydroxynitrosoamino)propionic acidL-2-amino-3-[(N-nitroso)hydroxylamino]propionic acid
2020-09-18T08:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-alanosine,Code name:,SDX-102
2020-09-18T08:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-alanosine,Synonym:,alanosine
2020-09-18T08:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-alanosine,Synonym:,L-alanosine sodium
2020-09-18T03:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng--gingko-biloba-damiana-based-supplement,US brand name:,ArginMax
2020-10-14T04:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng-ginkgo-biloba-damiana-based-supplement,US brand name:,ArginMax
2020-09-18T08:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate,Abbreviation:,LCLT
2020-09-18T08:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate,Foreign brand name:,L-Carnipure L-Carnitine L-Tartrate
2020-09-18T08:26:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate,US brand name:,L-Carnipure L-Carnitine L-Tartrate
2020-09-18T08:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-citrulline,Chemical structure:,2-amino-5-(carbamoylamino)pentanoic acid
2020-09-18T08:27:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-citrulline,Synonym:,citrulline
2020-09-18T08:31:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-gossypol,NA,NA
2020-09-18T08:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-leucyl-l-leucine-methyl-ester,Abbreviation:,LLME
2020-09-18T08:39:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-leucyl-l-leucine-methyl-ester,Synonym:,LeuLeuOMe
2020-09-18T08:39:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine,Chemical structure:,"L-alpha,epsilon-diaminocaproic acid"
2020-09-18T08:39:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine,Synonym:,L-lysine monohydrate
2020-09-18T08:39:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine,Synonym:,lysine monohydrate
2020-10-14T12:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid,Synonym:,amino acid renal protectant solution
2020-10-14T12:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid,Synonym:,amino acid solution-containing L-lysine and L-arginine
2020-10-14T12:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid,Synonym:,intravenous L-lysine/L-arginine-containing amino acid solution
2020-10-14T12:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid,Synonym:,L-lysine/L-arginine AA solution
2020-10-14T12:36:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid,Synonym:,radioprotective amino acid solution
2020-09-18T08:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-menthol-preparation-npo-11,Code name:,NPO-11
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Abbreviation:,5-MTHF
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Chemical structure:,5-methyltetrahydrofolateL-methyltetrahydrofolate
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,Synonym:,5-methyl terahydrofolic acid
2020-09-18T05:59:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate,US brand name:,Deplin
2020-09-18T08:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l19-il2-monoclonal-antibody-cytokine-fusion-protein,Abbreviation:,L19-IL2
2020-10-14T12:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-govitecan,Abbreviation:,ADC IMMU-130
2020-10-14T12:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-govitecan,Synonym:,hMN14-SN38
2020-09-18T08:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-sn-38-immunoconjugate-immu-130,Abbreviation:,ADC IMMU-130
2020-09-18T08:22:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-sn-38-immunoconjugate-immu-130,Synonym:,hMN14-SN38
2020-10-14T04:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labradimil,Code name:,DRG-0182
2020-10-14T04:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labradimil,Synonym:,RMP-7
2020-10-14T04:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labradimil,US brand name:,Cereport
2020-10-14T03:52:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacnotuzumab,Code name:,MCS110
2020-09-18T08:23:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacosamide,NA,NA
2020-10-14T13:08:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus,Synonym:,Lactobacillus acidophilus
2020-09-18T08:23:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus-estriol-vaginal-tablet,Foreign brand name:,Gynoflor
2020-09-18T08:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-based-probiotic-capsule,Synonym:,Lactobacillus-based capsule
2020-09-18T08:23:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-brevis-cd2-lozenge,NA,NA
2020-09-18T08:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-fermented-extract,Foreign brand name:,Seigen
2020-09-18T08:23:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-fermented-extract,US brand name:,Seigen
2020-09-18T08:23:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299,Code name:,DSM 6595
2020-09-18T08:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299v,Abbreviation:,Lp 299v
2020-09-18T08:23:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299v,Code name:,DSM 9843
2020-10-14T12:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6,Code name:,BSL PS6
2020-10-14T12:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6,Code name:,BSL_PS6
2020-10-14T12:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6,Code name:,BSLPS6
2020-10-14T12:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6,Synonym:,Lactobacillus supplement BSL_PS6
2020-10-14T12:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6,Synonym:,Lactobacillus-based probiotic BSL_PS6
2020-10-14T12:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-reuteri-probiotic-tablet,Synonym:,L. reuteri probiotic
2020-10-14T12:33:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-reuteri-probiotic-tablet,Synonym:,Lactobacillus reuteri probiotic
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,Foreign brand name:,Gefilus
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,Foreign brand name:,LGG
2020-09-18T05:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg,US brand name:,Culturelle
2020-09-18T08:24:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-l-jensenii-l-crispatus-l-gasseri-oral-supplement,Abbreviation:,L. rhamnosus/L. jensenii/L. crispatus/L. gasseri oral supplement
2020-10-14T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-lactobacillus-reuteri-probiotic-supplement,Synonym:,L. rhamnosus and L. reuteri probiotic supplement
2020-10-14T12:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-lactobacillus-reuteri-probiotic-supplement,US brand name:,RepHresh Pro-B
2020-09-18T08:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactoferrin-derived-lytic-peptide-ltx-315,Code name:,LTX-315
2020-09-18T08:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactoferrin-derived-lytic-peptide-ltx-315,Foreign brand name:,Oncopore
2020-09-18T08:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactoferrin-derived-lytic-peptide-ltx-315,Synonym:,lactoferrin pharmacophore LTX-315
2020-10-14T03:51:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacutamab,Code name:,IPH4102
2020-10-14T03:51:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacutamab,Synonym:,anti-KIR3DL2 mAb IPH4102
2020-10-14T12:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ladiratuzumab-vedotin,Code name:,SGN-LIV1A
2020-10-14T12:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ladiratuzumab-vedotin,Synonym:,anti-LIV-1 antibody-drug conjugate SGN-LIV1A
2020-10-14T12:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ladiratuzumab-vedotin,Synonym:,anti-LIV-1 monoclonal antibody-MMAE conjugate SGN-LIV1A
2020-09-18T08:24:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laetrile,Synonym:,Laetrille
2020-10-14T12:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lair-2-fusion-protein-nc410,Code name:,NC 410
2020-10-14T12:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lair-2-fusion-protein-nc410,Code name:,NC-410
2020-10-14T12:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lair-2-fusion-protein-nc410,Code name:,NC410
2020-10-14T12:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lair-2-fusion-protein-nc410,Synonym:,leukocyte-associated immunoglobulin-like receptor-2 fusion protein NC410
2020-09-18T08:24:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611,Code name:,LMS-611
2020-09-18T08:24:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611,Code name:,OXB/1-20
2020-09-18T08:24:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611,Synonym:,RIX-LMS-611x-20
2020-09-18T08:24:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611,US brand name:,Visco-ease
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,Abbreviation:,3TC
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,Abbreviation:,LAM
2020-09-18T06:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine,US brand name:,Epivir
2020-09-18T08:24:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamotrigine,US brand name:,Lamictal
2020-09-18T08:25:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate,Chemical structure:,"L-threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, acetate"
2020-09-18T08:25:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate,Code name:,AT-1001
2020-09-18T08:25:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate,US brand name:,Somatuline Depot
2020-09-18T08:25:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate-copolymer-microparticles,Foreign brand name:,Somatuline LA
2020-09-18T08:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-long-acting-aqueous-gel,Foreign brand name:,Somatuline Autogel
2020-09-18T08:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-long-acting-aqueous-gel,Synonym:,lanreotide (long-acting aqueous preparation)
2020-09-18T08:25:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-long-acting-aqueous-gel,US brand name:,Lanreotide Autogel
2020-10-14T04:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone,Chemical structure:,"3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione"
2020-10-14T04:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone,Code name:,ARQ 501
2020-10-14T04:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone,Code name:,ARQ501
2020-10-14T04:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone,Synonym:,b-lapachone
2020-10-14T04:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone,Synonym:,β-lapachone
2020-09-18T08:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate,Code name:,GSK572016
2020-09-18T08:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate,Code name:,GW-572016
2020-09-18T08:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate,Code name:,GW2016
2020-09-18T08:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate,Synonym:,Lapatinib
2020-09-18T08:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate,US brand name:,Tykerb
2020-10-14T03:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laprituximab-emtansine,Code name:,IMGN289
2020-10-14T03:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laprituximab-emtansine,Synonym:,anti-EGFR-SMCC-DM1
2020-09-18T08:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t,Code name:,APC 8024
2020-09-18T08:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t,Code name:,APC8024
2020-09-18T08:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t,Code name:,DN24-02
2020-09-18T08:25:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t,US brand name:,Neuvenge
2020-09-18T08:25:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/largetrifoliolious-bugbane-rhizome-supplement,Foreign brand name:,Ximingting
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,Chemical structure:,"1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine2'-(2-chloroethyl)-N-methyl-1',2'-bis(methylsulfonyl)carbamohydrazidemethanesulfonic acid, 1-(2-chloroethyl)-2-[(methylamino)carbonyl]-2- (methylsulfonyl)hydrazide"
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,Code name:,VNP40101M
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,US brand name:,Cloretazine
2020-09-18T05:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine,US brand name:,Onrigin
2020-09-18T08:26:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel,Code name:,RPR 109881
2020-09-18T08:26:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel,Code name:,RPR 109881A
2020-09-18T08:26:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel,Code name:,XRP9881
2020-09-18T08:26:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel,Synonym:,RPR 109881
2020-09-18T08:26:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel,Synonym:,RPR 109881A
2020-10-14T12:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotinib-mesylate,Code name:,Z 650
2020-10-14T12:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotinib-mesylate,Code name:,Z-650
2020-10-14T12:33:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotinib-mesylate,Code name:,Z650
2020-09-18T08:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib,Code name:,LOXO-101
2020-09-18T08:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib,Synonym:,Trk inhibitor LOXO-101
2020-09-18T08:26:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib,US brand name:,Vitrakvi
2020-10-14T12:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib,Chemical structure:,N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
2020-10-14T12:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib,Code name:,GNS-1480
2020-10-14T12:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib,Code name:,YH 25448
2020-10-14T12:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib,Code name:,YH-25448
2020-10-14T12:33:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib,Code name:,YH25448
2020-09-18T08:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lead-pb-212-tcmc-trastuzumab,Synonym:,[212]Pb TCMC-Herceptin
2020-09-18T08:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lead-pb-212-tcmc-trastuzumab,Synonym:,[212]Pb TCMC-trastuzumab
2020-09-18T08:27:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lead-pb-212-tcmc-trastuzumab,Synonym:,lead Pb 212 TCMC-Herceptin
2020-09-18T08:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir,Code name:,GS 5885
2020-09-18T08:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir,Code name:,GS-5885
2020-09-18T08:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir,Code name:,GS5885
2020-09-18T08:27:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir,Code name:,WHO 9796
2020-10-14T05:16:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir,Synonym:,ledipasvir and sofosbuvir
2020-10-14T05:16:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir,Synonym:,ledipasvir-sofosbuvir
2020-10-14T05:16:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir,Synonym:,ledipasvir/sofosbuvir
2020-10-14T05:16:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir,Synonym:,ledipasvir/sofosbuvir tablet
2020-10-14T05:16:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir,US brand name:,Harvoni
2020-10-14T13:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lefitolimod,Code name:,MGN1703
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Chemical structure:,"4-isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-"
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,Code name:,SU101
2020-09-18T03:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide,US brand name:,Arava
2020-09-18T08:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide,Code name:,CC-5013
2020-09-18T08:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide,Code name:,CDC 501
2020-09-18T08:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide,Synonym:,IMiD-1
2020-09-18T08:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide,US brand name:,Revlimid
2020-09-18T08:27:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenapenem,Chemical structure:,"(+)-(4R,5S,6S)-6-((R)-1-hydroxyethyl)-3-(((3S,5S)-5-((R)-1-hydroxy-3-(methylamino)propyl)-3-pyrrolidinyl)thio)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid"
2020-09-18T08:27:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenapenem,Synonym:,carbapenem
2020-09-18T07:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim,Synonym:,Glycosylated Recombinant G-CSF
2020-09-18T07:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim,Synonym:,Glycosylated Recombinant Granulocyte Colony Stimulating Factor
2020-09-18T07:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim,US brand name:,Granocyte
2020-09-18T08:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenti-d-abcd1-transduced-autologous-hematopoietic-stem-cells,NA,NA
2020-09-18T08:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenvatinib-mesylate,Code name:,E7080
2020-09-18T08:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenvatinib-mesylate,US brand name:,Lenvima
2020-09-18T08:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenzilumab,Code name:,KB 003
2020-09-18T08:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenzilumab,Code name:,KB003
2020-09-18T08:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenzilumab,Synonym:,"immunoglobulin G1-kappa, anti-(homo sapiens CSF2 (colony stimulating factor 2 (granulocyte-macrophage), granulocyte macrophage colony stimulating factor, GM-CSF)), homo sapiens monoclonal antibody"
2020-09-18T08:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lepirudin,Synonym:,Recombinant Hirudin
2020-09-18T08:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lepirudin,US brand name:,Refludan
2020-09-18T08:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leridistim,Abbreviation:,MPO
2020-09-18T08:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leridistim,Code name:,SC-70935
2020-09-18T08:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leridistim,Synonym:,Myelopoietin
2020-09-18T08:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lerisetron,Chemical structure:,1-phenyl-methyl-2-piperazinyl-1H-benzimidazole hydrochloride
2020-10-14T04:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lerociclib,Code name:,G1T38
2020-10-14T12:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leronlimab,Code name:,PRO 140
2020-10-14T12:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leronlimab,Code name:,PRO140
2020-10-14T12:33:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leronlimab,Synonym:,anti-CCR5 monoclonal antibody PRO 140
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Chemical structure:,"9,12-epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-"
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Code name:,CEP 701
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Code name:,CEP-701
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Code name:,CEP701
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Code name:,KT-5555
2020-09-18T08:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib,Code name:,SPM-924
2020-09-18T08:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letermovir,Code name:,AIC246
2020-09-18T08:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letermovir,Code name:,MK-8228
2020-10-14T03:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letolizumab,Code name:,BMS-986004
2020-10-14T03:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letolizumab,Code name:,BMS986004
2020-10-14T03:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letolizumab,Synonym:,Fc-fusion protein BMS986004
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Abbreviation:,LTZ
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Chemical structure:,"4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile"
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,Code name:,CGS 20267
2020-09-18T06:46:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole,US brand name:,Femara
2020-09-18T08:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen,Synonym:,Femara/Ibrance
2020-09-18T08:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen,Synonym:,letrozole + palbociclib
2020-09-18T08:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen,Synonym:,letrozole-palbociclib
2020-09-18T08:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen,Synonym:,letrozole/palbociclib
2020-09-18T08:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen,Synonym:,palbociclib + letrozole
2020-10-14T12:33:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leu15-gastrin-17,Code name:,GAST 17
2020-10-14T12:33:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leu15-gastrin-17,Code name:,GAST-17
2020-10-14T12:33:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leu15-gastrin-17,Code name:,GAST17
2020-09-18T08:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucine-enhanced-essential-amino-acid-dietary-supplement,NA,NA
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Adinepar
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Calcifolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Calfolex
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Calinat
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Cehafolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Citofolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Citrec
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Cromatonbic Folinico
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Dalisol
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Disintox
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Divical
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Ecofol
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Emovis
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Flynoken A
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folaren
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folaxin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,FOLI-cell
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Foliben
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folidan
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folidar
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folinac
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folinoral
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folinvit
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Foliplus
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Folix
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Imo
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Lederfolat
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Lederfolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Leucosar
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Rescufolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Rescuvolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Foreign brand name:,Tonofolin
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,calcium (6S)-folinate
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,calcium folinate
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,citrovorum factor
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,"factor, citrovorum"
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,folinate calcium
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,folinic acid
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,folinic acid calcium salt pentahydrate
2020-09-18T08:29:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium,Synonym:,leucovorin
2020-09-18T08:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leukemic-apoptotic-corpse-pulsed-autologous-dendritic-cells,Synonym:,autologous dendritic cells pulsed with leukemic apoptotic corpse
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Abbreviation:,LEUP
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Chemical structure:,6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide luteinizing hormone-releasing factor (pig) monoacetate6-D-leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (pig) monoacetate
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,A-43818
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,Abbott 43818
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,DWJ108J
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Code name:,TAP-144
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Carcinil
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Depo-Eligard
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enanton
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Enantone-Gyn
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Ginecrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Leuplin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lucrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lucrin Depot
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Lutrate
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Procren
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Procrin
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Prostap
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Trenantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Foreign brand name:,Uno-Enantone
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,Synonym:,leuprorelin acetate
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Eligard
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Lupron
2020-09-18T06:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate,US brand name:,Lupron Depot
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Abbreviation:,LEV
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Chemical structure:,"(-)-( S)-2,3,5, 6-tetrahydro-6-phenylimidazo [2,1-b] thiazole monohydrochloride"
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,ICI-59623
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,R 12564
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Code name:,RP-20605
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ascaridil
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Decaris
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ergamisole
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Ketrax
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Foreign brand name:,Solaskil
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,Synonym:,l-tetramisole hydrochloride
2020-09-18T06:33:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride,US brand name:,Ergamisol
2020-09-18T08:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levetiracetam,Chemical structure:,"(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide1-pyrrolidineacetamide, alpha-ethyl-2-oxo-,(S)-"
2020-09-18T08:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levetiracetam,US brand name:,Keppra
2020-09-18T05:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levobupivacaine-hydrochloride,US brand name:,Chirocaine
2020-09-18T05:08:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine,Synonym:,L-carnitine
2020-09-18T05:08:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine,US brand name:,Carnitor
2020-10-14T12:34:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine,US brand name:,Xyzal
2020-09-18T08:30:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine-dihydrochloride,US brand name:,Xyzal
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Chemical structure:,"(--)-2amino-3-)3,4-dihydroxyphenyl)propanoic acid(--)-3-(3,4-dihydroxyphenyl)-L-alanine3-hydroxy-L-tyrosinebeta-(3,4-dihydroxyphenyl)-L-alanine"
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Cidandopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Deadopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaflex
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaidan
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopal
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopalina
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparkine
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doparl
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopasol
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopaston
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Dopastral
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Doprin
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopal
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eldopatec
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Eurodopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Ledopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Maipedopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Parda
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Foreign brand name:,Veldopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,Synonym:,L-dopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Bendopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Dopar
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Eldopar
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Laradopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Larodopa
2020-09-18T04:36:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa,US brand name:,Levopa
2020-09-18T08:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levofloxacin,US brand name:,Levaquin
2020-09-18T08:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levofloxacin,US brand name:,Quixin
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Chemical structure:,"ethanone, 1-(4-(4-(((2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)-"
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Code name:,COR-003
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Code name:,COR003
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Synonym:,"(-)-(2S,4R)-ketoconazole"
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Synonym:,"2S,4R ketoconazole"
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Synonym:,"2S,4R-ketoconazole"
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,Synonym:,"ketoconazole, (2S,4R)-"
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,US brand name:,NormoCort
2020-09-18T08:30:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole,US brand name:,Recorlev
2020-09-18T07:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium,Synonym:,calcium levoleucovorin
2020-09-18T07:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium,US brand name:,Fusilev
2020-09-18T08:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonantradol,Synonym:,Levonantradol HCl
2020-09-18T08:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel,Chemical structure:,"(17Alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one"
2020-09-18T08:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel,Synonym:,18-Methylnorethisterone
2020-09-18T08:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel,Synonym:,D-(-)-Norgestrel
2020-09-18T08:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel,US brand name:,Norplant
2020-09-18T08:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel,US brand name:,Plan B
2020-09-18T08:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel-releasing-intrauterine-system,Acronym:,LNG-IUS
2020-09-18T08:31:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel-releasing-intrauterine-system,US brand name:,Mirena
2020-09-18T08:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium,Synonym:,Therapeutic Levothyroxine
2020-09-18T08:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium,US brand name:,Levoxyl
2020-09-18T08:31:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium,US brand name:,Synthroid
2020-10-14T13:01:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexaptepid-pegol,Code name:,NOX-H94
2020-09-18T08:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexatumumab,Code name:,HGS-ETR2
2020-09-18T08:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexatumumab,Synonym:,anti-TRAIL receptor 2 monoclonal antibody HGS-ETR2
2020-09-18T08:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexatumumab,Synonym:,monoclonal antibody HGS-ETR2
2020-09-18T08:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexibulin,Code name:,CYT997
2020-09-18T08:31:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexibulin,Synonym:,vascular disrupting agent CYT997
2020-09-18T08:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liarozole-fumarate,Chemical structure:,"(+-)-5-(m-chloro-alpha-imidazol-1-ylbenzyl)benzimidazole fumarate (2:3)1H-benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (+-)-, (E)-2-butenedioate (2:3)"
2020-09-18T08:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liarozole-fumarate,Code name:,R85246
2020-09-18T08:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin,Synonym:,(131)I-labeled HAb18 F(ab')(2)
2020-09-18T08:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin,Synonym:,[131I] mAb HAb18G/CD147
2020-09-18T08:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin,Synonym:,iodine I 131 metuximab
2020-09-18T08:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin,Synonym:,iodine[131I] metuximab
2020-10-14T12:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licochalcone-a,Chemical structure:,"2-propen-1-one, 3-(5-(1,1-dimethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)-, (E)-3-dimethylallyl-4,4'-dihydroxy-6-methoxychalcone"
2020-10-14T12:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licogliflozin,Code name:,LIK 066
2020-10-14T12:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licogliflozin,Code name:,LIK-066
2020-10-14T12:34:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licogliflozin,Code name:,LIK066
2020-10-14T12:34:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licorice,Synonym:,Glycyrrhiza glabra root
2020-09-18T08:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licorice-root-extract,Synonym:,Glycyrrhiza glabra root
2020-09-18T08:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride,Chemical structure:,"2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide monohydrochloride"
2020-09-18T08:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride,Foreign brand name:,Xylotox
2020-09-18T08:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride,US brand name:,Xylocaine
2020-09-18T08:32:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride,US brand name:,Xylocitin
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,Synonym:,lidocaine HCl ophthalmic gel
2020-09-18T01:45:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel,US brand name:,Akten
2020-10-14T12:34:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-mixture-with-tribenoside,Chemical structure:,"D-glucofuranoside, ethyl 3,5,6-tris-O-(phenylmethyl)-, mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide"
2020-10-14T12:34:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-mixture-with-tribenoside,US brand name:,Procto-glyvenol
2020-10-14T12:34:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch,US brand name:,Lidoderm
2020-09-18T08:32:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch-5pct,US brand name:,Lidoderm
2020-10-14T12:34:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-topical,NA,NA
2020-10-14T03:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifastuzumab-vedotin,Code name:,DNIB0600A
2020-10-14T03:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifastuzumab-vedotin,Synonym:,ADC DNIB0600A
2020-10-14T04:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel,Code name:,LN-144
2020-10-14T04:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel,Synonym:,autologous TIL LN-144
2020-10-14T04:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel,US brand name:,Contego
2020-10-14T04:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifirafenib,Code name:,BGB-283
2020-09-18T08:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011,Code name:,AU-011
2020-09-18T08:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011,Synonym:,HPV-NP AU-011
2020-09-18T08:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011,Synonym:,human papillomavirus virus-like particles conjugated with IR700 dye AU-011
2020-09-18T08:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011,Synonym:,viral nanoparticle conjugates AU-011
2020-09-18T08:33:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011,Synonym:,VNC AU-011
2020-09-18T08:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-emitting-oncolytic-vaccinia-virus-gl-onc1,Code name:,GL-ONC1
2020-09-18T08:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-emitting-oncolytic-vaccinia-virus-gl-onc1,Code name:,GLV-1h68
2020-10-14T12:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lilotomab,Code name:,HH1
2020-10-14T12:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lilotomab,Synonym:,anti-CD37 monoclonal antibody HH1
2020-09-18T08:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/limonene,Chemical structure:,1-methyl-4-prop-1-en-2-yl-cyclohexene4R)-1-methyl-4-prop-1-en-2-yl-cyclohexene
2020-09-18T08:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate,Chemical structure:,"L-tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1→6),(2→10),(5→13)-tris(disulfide), monoacetate (salt)"
2020-09-18T08:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate,Code name:,MD-1100 Acetate
2020-09-18T08:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate,Code name:,MM-416775
2020-09-18T08:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate,US brand name:,Linzess
2020-10-14T12:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linagliptin,Code name:,BI 1356 BS
2020-10-14T12:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linagliptin,Code name:,BI-1356
2020-10-14T12:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linagliptin,US brand name:,Tradjenta
2020-09-18T08:33:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linezolid,US brand name:,Zyvox
2020-09-18T08:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linifanib,Chemical structure:,N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl) urea
2020-09-18T08:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linifanib,Code name:,ABT-869
2020-09-18T08:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linifanib,Synonym:,multitargeted receptor tyrosine kinase inhibitor ABT-869
2020-09-18T08:33:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linoleyl-carbonate-paclitaxel,Synonym:,2-linoleyl carbonate-paclitaxel
2020-09-18T08:33:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linoleyl-carbonate-paclitaxel,Synonym:,LOC-paclitaxel
2020-10-14T13:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib,Code name:,YY 20394
2020-10-14T13:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib,Code name:,YY-20394
2020-10-14T13:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib,Code name:,YY20394
2020-10-14T13:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib,Synonym:,PI3Kdelta inhibitor YY-20394
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Chemical structure:,"(R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propenamide"
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Code name:,BMS 986205
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Code name:,BMS-986205
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Code name:,BMS986205
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Code name:,ONO-7701
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Synonym:,IDO-1 inhibitor BMS-986205
2020-10-14T05:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat,Synonym:,"indoleamine-pyrrole 2,3-dioxygenase inhibitor BMS-986205"
2020-09-18T08:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linsitinib,Code name:,OSI-906
2020-09-18T08:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab,Abbreviation:,MOAB HuG1-M195
2020-09-18T08:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab,Abbreviation:,MOAB HuM195
2020-09-18T08:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab,Synonym:,Hu-M195 monoclonal antibody
2020-09-18T08:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab,Synonym:,HuG1-M195
2020-09-18T08:34:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab,Synonym:,HuG1-M195 monoclonal antibody
2020-10-14T05:14:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linzagolix,Code name:,OBE2109
2020-10-14T05:14:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linzagolix,Synonym:,GnRH receptor antagonist OBE2109
2020-10-14T13:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine,Abbreviation:,Therapeutic T3
2020-10-14T13:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine,Synonym:,L-Triiodothyronine
2020-10-14T13:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine,Synonym:,Liothyronine
2020-10-14T13:29:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine,Synonym:,Triiodothyronine
2020-09-18T05:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium,US brand name:,Cytomel
2020-09-18T05:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium,US brand name:,Triostat
2020-09-18T08:34:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipegfilgrastim,Code name:,XM22
2020-09-18T08:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipid-nanoparticle-encapsulated-ox40l-mrna-2416,Code name:,mRNA 2416
2020-09-18T08:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipid-nanoparticle-encapsulated-ox40l-mrna-2416,Code name:,mRNA-2416
2020-09-18T08:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipid-nanoparticle-encapsulated-ox40l-mrna-2416,Synonym:,lipid nanoparticle encapsulated mRNA encoding human OX40L
2020-09-18T08:35:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipopolysaccharide,Abbreviation:,LPS
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Code name:,RGI 2001
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Code name:,RGI-2001
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Code name:,RGI2001
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Synonym:,liposomal alpha-GalCer
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Synonym:,liposomal KRN-7000
2020-10-14T12:35:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide,Synonym:,liposomal RGI-7000
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Acronym:,L-AMB
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,Synonym:,amphotericin B-lipid complex
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,Abelcet
2020-09-18T01:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b,US brand name:,AmBisome
2020-09-18T08:35:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-annamycin,Synonym:,annamycin liposomal
2020-09-18T08:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-belotecan,Code name:,S-CKD602
2020-10-14T04:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-bupivacaine,Synonym:,bupivacaine liposome injectable suspension
2020-10-14T04:32:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-bupivacaine,US brand name:,Exparel
2020-09-18T08:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-c-raf-antisense-oligonucleotide,Synonym:,c-raf antisense oligodeoxynucleotide liposome
2020-09-18T08:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-c-raf-antisense-oligonucleotide,Synonym:,LErafAON
2020-09-18T08:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-c-raf-antisense-oligonucleotide,Synonym:,liposome-encapsulated c-raf antisense oligodeoxynucleotide
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Code name:,SPI-077
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Code name:,SPI-77
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Synonym:,"Cisplatin, Liposomal"
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Synonym:,STEALTH Cisplatin
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Synonym:,STEALTH Liposomal Cisplatin
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Synonym:,STEALTH Liposomal Encapsulated Cisplatin
2020-09-18T08:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin,Synonym:,STEALTH Liposome Cisplatin
2020-09-18T08:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-curcumin,Synonym:,curcumin liposome
2020-10-14T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cytarabine,Code name:,DTC 101
2020-10-14T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cytarabine,Foreign brand name:,DepoCyte
2020-10-14T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cytarabine,Synonym:,DepoFoam-encapsulated cytarabine
2020-10-14T04:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cytarabine,Synonym:,liposomal cytarabine
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,Synonym:,daunorubicin liposomal
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,Synonym:,liposomal daunorubicin
2020-09-18T05:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate,US brand name:,DaunoXome
2020-09-18T08:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel,Abbreviation:,LE-DT
2020-09-18T08:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel,Synonym:,docetaxel liposome
2020-09-18T08:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel,Synonym:,liposomal-encapsulated docetaxel
2020-09-18T08:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel,Synonym:,liposome entrapped docetaxel
2020-09-18T08:35:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-eribulin-mesylate,Abbreviation:,E7389-LF
2020-09-18T08:35:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-eribulin-mesylate,Synonym:,E7389 liposomal formulation
2020-09-18T08:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-hpv-16-e6-e7-multipeptide-vaccine-pds0101,Code name:,PDS0101
2020-09-18T08:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-hpv-16-e6-e7-multipeptide-vaccine-pds0101,Synonym:,immunoMAPK-RDOTAP /HPV-16 E6/E7 peptide antigen vaccine
2020-09-18T08:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-interleukin-2,Abbreviation:,IL-2 LIPO
2020-09-18T08:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-interleukin-2,Synonym:,interleukin-2 liposome
2020-09-18T08:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-interleukin-2,Synonym:,liposome encapsulated interleukin-2
2020-09-18T08:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-lurtotecan,Abbreviation:,NX211
2020-09-18T08:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-lurtotecan,Synonym:,lurtotecan liposome
2020-09-18T08:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-lurtotecan,Synonym:,NX 211
2020-09-18T08:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-lurtotecan,Synonym:,OSI-211
2020-09-18T08:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-mitoxantrone-hydrochloride,Synonym:,mitoxantrone hydrochloride liposome
2020-10-14T12:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-mnsod-plasmid,Abbreviation:,MnSOD-PL
2020-10-14T12:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-mnsod-plasmid,Synonym:,manganese superoxide dismutase plasmid liposomes
2020-09-18T08:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-muc1-pet-lipid-a-vaccine,Code name:,ONT-10
2020-10-14T12:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-muc1-pet-lipid-a-vaccine-ont-10,Code name:,ONT-10
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Abbreviation:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Chemical structure:,"liposome-entrapped cis-bis-neodecanoate-trans-R,R-1,2-diaminocyclohexane platinum (II)"
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,L-NDDP
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,Synonym:,liposomal neodecanoic acid platinum complex
2020-09-18T03:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp,US brand name:,Aroplatin
2020-09-18T08:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-oxaliplatin,Foreign brand name:,Lipoxal
2020-09-18T08:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel,Abbreviation:,PNU-93914
2020-09-18T08:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel,Synonym:,LEP
2020-09-18T08:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel,Synonym:,liposome-encapsulated paclitaxel
2020-09-18T08:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel,Synonym:,paclitaxel liposome
2020-09-18T08:28:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel,US brand name:,LEP-ETU
2020-09-18T08:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-rhenium-re-186,Synonym:,(186)Re-liposomes
2020-09-18T08:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-rhenium-re-186,Synonym:,liposomal rhenium-186
2020-09-18T08:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-rhenium-re-186,Synonym:,rhenium-186 liposome
2020-09-18T08:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-sn-38,Code name:,LE-SN38
2020-09-18T08:36:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-sn-38,Synonym:,SN-38 liposome
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,bacteriophage T4 endonuclease V in liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,T4 endonuclease V liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,Synonym:,T4N5 liposomal lotion
2020-09-18T06:06:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion,US brand name:,Dimericine
2020-10-14T12:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-ff-10850,Code name:,FF 10850
2020-10-14T12:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-ff-10850,Code name:,FF-10850
2020-10-14T12:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-ff-10850,Code name:,FF10850
2020-09-18T04:49:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride,Synonym:,topotecan hydrochloride liposomes
2020-09-18T04:49:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride,US brand name:,Brakiva
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Abbreviation:,L-ATRA
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Code name:,AR-623
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,All-trans-retinoic acid liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposomal
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoin liposome
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,Synonym:,tretinoinLF
2020-09-18T04:02:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin,US brand name:,Atragen
2020-10-14T03:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine,Acronym:,VLI
2020-10-14T03:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine,Synonym:,vinorelbine liposomes injection
2020-10-14T03:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine,US brand name:,Alocrest
2020-09-18T08:37:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine-tartrate,Code name:,TLC-178
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Code name:,CPX-351
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,cytarabine-daunorubicin liposome for injection
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,liposomal AraC-daunorubicin CPX-351
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,liposomal cytarabine-daunorubicin
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,liposomal cytarabine-daunorubicin CPX-351
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,liposome-encapsulated combination of daunorubicin and cytarabine
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,Synonym:,liposome-encapsulated daunorubicin-cytarabine
2020-10-14T04:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine,US brand name:,Vyxeos
2020-09-18T08:37:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-doxorubicin-citrate,Foreign brand name:,Myocet
2020-09-18T08:37:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-mir-34-mimic-mrx34,Code name:,MRX34
2020-10-14T12:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-osi-7904,Code name:,GS7904L
2020-10-14T12:56:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-osi-7904,Synonym:,OSI-7904 liposomal
2020-09-18T08:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-rb94-plasmid-dna-gene-therapy-agent-sgt-94,Code name:,SGT-94
2020-09-18T08:37:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-rb94-plasmid-dna-gene-therapy-agent-sgt-94,Synonym:,TfRscFv/Lip/RB94
2020-09-18T08:37:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-recombinant-human-enzyme-cu-zn-superoxide-dismutase,Code name:,APN201
2020-09-18T08:37:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-recombinant-human-enzyme-cu-zn-superoxide-dismutase,Foreign brand name:,Lipoxysan
2020-09-18T08:37:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-recombinant-human-enzyme-cu-zn-superoxide-dismutase,Synonym:,liposome-encapsulated recombinant human enzyme Cu/Zn SOD
2020-10-14T12:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1,Code name:,BNT-115
2020-10-14T12:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1,Code name:,W_ova1
2020-10-14T12:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1,Synonym:,liposome-formulated mRNA vaccine W_ova1
2020-10-14T12:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1,Synonym:,mRNA vaccine W_ova1
2020-10-14T12:35:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1,Synonym:,W_ova1 vaccine
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Abbreviation:,L-Grb-2
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Abbreviation:,L-Grb2
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Code name:,BP-100-1.01
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Code name:,BP1001
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Synonym:,grb2 mRNA
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Synonym:,liposomal Grb-2
2020-09-18T08:37:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide,Synonym:,liposomal Grb2 AS ODN
2020-09-18T08:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liraglutide,Code name:,NN2211
2020-09-18T08:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liraglutide,Synonym:,N26-(hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
2020-09-18T08:38:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liraglutide,US brand name:,Victoza
2020-09-18T08:38:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirilumab,Code name:,BMS-986015
2020-09-18T08:38:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirilumab,Code name:,IPH2102
2020-09-18T08:38:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirilumab,Synonym:,anti-KIR monoclonal antibody IPH2102
2020-10-14T12:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisavanbulin,Code name:,BAL101553
2020-09-18T08:38:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisdexamfetamine-dimesylate,US brand name:,Vyvanse
2020-09-18T08:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril,US brand name:,Prinivil
2020-09-18T08:38:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril,US brand name:,Zestril
2020-10-14T12:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisocabtagene-maraleucel,Code name:,JCAR017
2020-10-14T12:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisocabtagene-maraleucel,Synonym:,anti-CD19-CAR genetically engineered autologous T lymphocytes JCAR017
2020-10-14T12:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisocabtagene-maraleucel,Synonym:,autologous anti-CD19-EGFRt-4-1BB-zeta-modified CAR CD8+ and CD4+ T lymphocytes JCAR017
2020-10-14T12:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisocabtagene-maraleucel,Synonym:,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes JCAR017
2020-10-14T03:31:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lissencephaly,Abbreviation:,ACCS
2020-09-18T08:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/listeria-monocytogenes-llo-psa-adxs31-142,Code name:,ADXS-PSA
2020-09-18T08:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/listeria-monocytogenes-llo-psa-adxs31-142,Code name:,ADXS31-142
2020-09-18T08:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/listeria-monocytogenes-llo-psa-adxs31-142,Synonym:,Lm-LLO-PSA
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,Synonym:,Lithium
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Eskalith
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithane
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithobid
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithonate
2020-09-18T06:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate,US brand name:,Lithotabs
2020-09-18T08:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/litronesib,Chemical structure:,"Propanamide, N-[4-(2,2-dimethyl-1-oxopropyl)-5-[[[[2-(ethylamino)ethyl]sulfonyl] amino]methyl]-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-, (-)-"
2020-09-18T08:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/litronesib,Code name:,LY2523355
2020-09-18T08:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/litronesib,Synonym:,Eg5 Kinesin-Related Motor Protein Inhibitor LY2523355
2020-09-18T08:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-double-deleted-listeria-monocytogenes-bacteria-jnj-64041809,Code name:,ADU-741
2020-09-18T08:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-double-deleted-listeria-monocytogenes-bacteria-jnj-64041809,Code name:,JNJ-64041809
2020-09-18T08:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-double-deleted-listeria-monocytogenes-bacteria-jnj-64041809,Code name:,JNJ-809
2020-09-18T08:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-double-deleted-listeria-monocytogenes-bacteria-jnj-64041809,Synonym:,LADD Listeria monocytogenes bacteria JNJ-64041809
2020-09-18T08:39:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-encoding-human-mesothelin-vaccine-crs-207,Code name:,CRS-207
2020-09-18T08:39:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-encoding-human-mesothelin-vaccine-crs-207,Synonym:,LADD Listeria monocytogenes CRS-207
2020-09-18T08:39:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001,Code name:,ADXS11-001
2020-09-18T08:39:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001,Code name:,Lm-LLO-E7
2020-09-18T08:39:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001,Synonym:,attenuated live Listeria encoding HPV 16 E7 vaccine ADXS11-001
2020-09-18T08:39:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001,US brand name:,Lovaxin C
2020-09-18T08:39:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-measles-virus-vaccine,NA,NA
2020-09-18T08:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-freeze-dried-lactic-acid-bacteria-probiotic,Synonym:,VSL3
2020-09-18T08:39:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-freeze-dried-lactic-acid-bacteria-probiotic,US brand name:,VSL#3
2020-09-18T08:39:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liver-x-receptor-beta-agonist-rgx-104,Code name:,RGX 104
2020-09-18T08:39:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liver-x-receptor-beta-agonist-rgx-104,Code name:,RGX-104
2020-09-18T08:39:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liver-x-receptor-beta-agonist-rgx-104,Code name:,RGX104
2020-09-18T08:39:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liver-x-receptor-beta-agonist-rgx-104,Synonym:,LXR-b agonist RGX-104
2020-10-14T12:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lm-tllo-neoantigens-vaccine-adxs-neo,Code name:,ADXS NEO
2020-10-14T12:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lm-tllo-neoantigens-vaccine-adxs-neo,Code name:,ADXS-NEO
2020-10-14T12:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lm-tllo-neoantigens-vaccine-adxs-neo,Synonym:,neoepitope-based Immunotherapeutic ADXS-NEO
2020-09-18T08:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-1-immunotoxin,Abbreviation:,LMB-1
2020-09-18T08:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-1-immunotoxin,Synonym:,B3-NLysPE38
2020-09-18T08:40:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-1-immunotoxin,Synonym:,immunotoxin LMB-1
2020-09-18T08:40:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin,Abbreviation:,LMB-2
2020-09-18T08:40:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin,Synonym:,Anti-Tac(Fv)-PE38
2020-09-18T08:40:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin,Synonym:,humanized antiTac toxin|
2020-09-18T08:40:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin,Synonym:,LMB-2 (anti-TAC(FV)-PE-38)
2020-09-18T08:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin,Synonym:,B3(Fv)-PE38
2020-09-18T08:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin,Synonym:,B3(Fv)-PE38 Immunotoxin
2020-09-18T08:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin,Synonym:,HB21(Fv)PE40
2020-09-18T08:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin,Synonym:,immunotoxin LMB-7
2020-09-18T08:40:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin,Synonym:,LMB-7 (Single-Chain Immunotoxin)
2020-09-18T08:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-9-immunotoxin,Synonym:,B3 (dsFv)-PE38
2020-09-18T08:40:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-9-immunotoxin,Synonym:,LMB-9
2020-09-18T08:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-2340-349-peptide-vaccine,NA,NA
2020-09-18T08:41:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-2419-427-peptide-vaccine,NA,NA
2020-09-18T08:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-barf1--ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/ EBNA1-specific CTLs
2020-09-18T08:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-barf1--ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/EBNA-1 MABEL CTLs
2020-09-18T08:40:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-barf1--ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/EBNA-1 minimum anticipated biological effect level cytotoxic T lymphocytes
2020-10-14T12:36:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-barf1-ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/ EBNA1-specific CTLs
2020-10-14T12:36:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-barf1-ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/EBNA-1 MABEL CTLs
2020-10-14T12:36:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-barf1-ebna1-specific-cytotoxic-t-lymphocytes,Synonym:,LMP1/BARF1/EBNA-1 minimum anticipated biological effect level cytotoxic T lymphocytes
2020-09-18T08:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-specific-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,anti-LMP1 CAR T cells
2020-09-18T08:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-specific-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,LMP1-CAR-CTLs
2020-09-18T08:40:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-specific-chimeric-antigen-receptor-expressing-t-lymphocytes,Synonym:,LMP1-CAR-T cells
2020-10-14T12:36:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp2-specific-t-cell-receptor-transduced-autologous-t-lymphocytes,Synonym:,LMP2 antigen-specific TCR T cells
2020-09-18T08:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp2a-specific-cytotoxic-t-lymphocytes,Abbreviation:,LMP2A CTL
2020-10-14T12:36:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp7-inhibitor-m3258,Code name:,M 3258
2020-10-14T12:36:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp7-inhibitor-m3258,Code name:,M-3258
2020-10-14T12:36:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp7-inhibitor-m3258,Code name:,M3258
2020-10-14T12:36:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp7-inhibitor-m3258,Synonym:,immunoproteasome inhibitor M3258
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Code name:,MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,anti-miR-155 oligonucleotide MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,LNA antimiR-155 MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,LNA-based antimiR-155 MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,microRNA-155 antagonist MRG-106
2020-09-18T05:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106,Synonym:,MiR-155 antagonist MRG-106
2020-09-18T08:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobaplatin,Chemical structure:,"1,2-diammino-methy lcyclobutane-platinum (II) lactate"
2020-09-18T08:41:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobaplatin,Code name:,D-19466
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,Code name:,DRG-0182
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,Synonym:,RMP-7
2020-09-18T05:20:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil,US brand name:,Cereport
2020-09-18T08:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lometrexol,Abbreviation:,(6R)-DDATHF
2020-09-18T08:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lometrexol,Abbreviation:,LMTX
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Abbreviation:,CCNU
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Acronym:,CCNU
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Chemical structure:,"1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-chloroethylcyclo-hexylnitrosoureaN-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea"
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Code name:,RB-1509
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Code name:,WR-139017
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Belustin
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Belustine
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Cecenu
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Citostal
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Lomeblastin
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Lucostin
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Lucostine
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Foreign brand name:,Prava
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,Synonym:,Lomustinum
2020-09-18T07:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine,US brand name:,Gleostine
2020-09-18T08:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib,Chemical structure:,"4-[2-[4-(3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide"
2020-09-18T08:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib,Code name:,SCH 66336
2020-09-18T08:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib,Code name:,SCH-66336
2020-09-18T08:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib,Code name:,SCH66336
2020-09-18T08:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib,US brand name:,Sarasar
2020-09-18T08:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonaprisan,Chemical structure:,"11β-(4-acetylphenyl)-20,20,21,21,21-pentafluro-17-hydroxy-19-nor-17α-pregna-4,9- dien-3-one19-norpregna-4,9-dien-3-one, 11-(4-acetylphenyl)-20,20,21,21,21-pentafluro-17- hydroxy-, (11β,17α)-"
2020-09-18T08:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonaprisan,Code name:,ZK 230211
2020-09-18T08:42:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonaprisan,Synonym:,progesterone receptor antagonist ZK 230211
2020-10-14T12:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine,Code name:,ADC ADCT-402
2020-10-14T12:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine,Code name:,ADCT-402
2020-10-14T12:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine,Synonym:,anti-CD19 PBD-conjugate ADCT-402
2020-10-14T12:36:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine,Synonym:,antibody-drug conjugate ADCT-402
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Abbreviation:,LAPS-GCSF
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Code name:,HM10460A
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Code name:,SPI-2012
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,Synonym:,long-acting granulocyte colony-stimulating factor receptor SPI-2012
2020-09-18T06:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012,US brand name:,Rolontis
2020-09-18T08:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-release-pasireotide,Abbreviation:,SOM230 LAR
2020-09-18T08:42:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-release-pasireotide,Synonym:,LAR pasireotide
2020-09-18T08:42:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-peptide-vaccine-7,Abbreviation:,LPV7
2020-10-14T12:55:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lontucirev,Code name:,CI-1042
2020-10-14T12:55:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lontucirev,Synonym:,E1B 55kDa mutant adenovirus dl1520
2020-09-18T07:59:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loperamide-hydrochloride,US brand name:,Imodium A-D
2020-09-18T08:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lopinavir,Code name:,ABT-378/r
2020-09-18T05:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine,Chemical structure:,"1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, Ethyl Ester"
2020-09-18T05:30:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine,US brand name:,Claritin
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,Chemical structure:,"7-chloro-5-(2-chlorophenyl)-1, 3-dihydro-3-Hydroxy-1,4- benzodiazepin-2-one"
2020-09-18T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam,US brand name:,Ativan
2020-09-18T08:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib,Code name:,PF-06463922
2020-09-18T08:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib,Synonym:,ALK/ROS1 inhibitor PF-06463922
2020-09-18T08:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib,US brand name:,Lorbrena
2020-09-18T08:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorvotuzumab-mertansine,Code name:,BB-10901
2020-09-18T08:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorvotuzumab-mertansine,Synonym:,huN901-DM1
2020-09-18T08:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorvotuzumab-mertansine,Synonym:,IMGN901
2020-09-18T05:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium,Chemical structure:,"2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt"
2020-09-18T05:43:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium,US brand name:,Cozaar
2020-10-14T03:21:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losatuxizumab-vedotin,NA,NA
2020-09-18T08:43:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin,Chemical structure:,"(2S)-2-methylbutanoic acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester"
2020-09-18T08:43:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin,Synonym:,Lovastatin Sodium
2020-09-18T08:43:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin,Synonym:,Mevinolin
2020-09-18T08:43:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin,Synonym:,Monacolin K
2020-09-18T08:43:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin,US brand name:,Mevacor
2020-10-14T12:37:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loxl2-inhibitor-pat-1251,Code name:,PAT 1251
2020-10-14T12:37:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loxl2-inhibitor-pat-1251,Code name:,PAT1251
2020-10-14T12:37:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loxl2-inhibitor-pat-1251,Synonym:,Lysyl Oxidase-like Protein 2 Inhibitor PAT-1251
2020-09-18T08:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp-1-targeted-peptide-drug-conjugate-grn1005,Code name:,ANG1005
2020-09-18T08:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp-1-targeted-peptide-drug-conjugate-grn1005,Code name:,GRN1005
2020-10-14T12:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp5-6-antagonist-bi-905677,Code name:,BI 905677
2020-10-14T12:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp5-6-antagonist-bi-905677,Code name:,BI-905677
2020-10-14T12:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp5-6-antagonist-bi-905677,Code name:,BI905677
2020-10-14T12:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp5-6-antagonist-bi-905677,Synonym:,anti-LRP5/6 nanobody BI 905677
2020-09-18T08:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-cc-90011,Code name:,CC 90011
2020-09-18T08:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-cc-90011,Code name:,CC-90011
2020-09-18T08:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-cc-90011,Code name:,CC90011
2020-09-18T08:44:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-cc-90011,Synonym:,lysine-specific demethylase 1 inhibitor CC-90011
2020-09-18T08:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-gsk2879552,Code name:,GSK2879552
2020-09-18T08:44:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-gsk2879552,Synonym:,lysine specific demethylase 1 inhibitor GSK2879552
2020-09-18T08:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-img-7289,Code name:,IMG 7289
2020-09-18T08:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-img-7289,Code name:,IMG-7289
2020-09-18T08:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-img-7289,Synonym:,LSD-1 inhibitor IMG-7289
2020-09-18T08:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-img-7289,Synonym:,lysine-specific demethylase 1 inhibitor IMG-7289
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,ORY 1001
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,ORY-1001
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,RG 6016
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,RG6016
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,RO 7051790
2020-09-18T08:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790,Code name:,RO7051790
2020-10-14T12:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-syha1807,Code name:,SYHA 1807
2020-10-14T12:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-syha1807,Code name:,SYHA-1807
2020-10-14T12:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-syha1807,Code name:,SYHA1807
2020-10-14T12:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-syha1807,Synonym:,lysine-specific demethylase 1 inhibitor SYHA1807
2020-09-18T02:02:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lubiprostone,US brand name:,Amitiza
2020-09-18T08:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucanthone,NA,NA
2020-09-18T08:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab,Abbreviation:,MOAB CHIR-12.12
2020-09-18T08:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab,Chemical structure:,"immunoglobulin G1, anti-(human CD40 (antigen)) (human monoclonal CHIR-12.12 heavy chain), disulfide with human monoclonal CHIR-12.12 light chain, dimer"
2020-09-18T08:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab,Code name:,CHIR-12.12
2020-09-18T08:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab,Code name:,HCD-122
2020-09-18T08:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab,Synonym:,monoclonal antibody CHIR-12.12
2020-09-18T08:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib,Chemical structure:,"1-naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl-"
2020-09-18T08:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib,Code name:,AL3810
2020-09-18T08:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib,Code name:,E-3810
2020-09-18T08:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib,Synonym:,VEGFR/FGFR dual kinase inhibitor E-3810
2020-09-18T08:45:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lugols-solution,Synonym:,Lugol's iodine
2020-10-14T05:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luminespib,Code name:,AUY922
2020-10-14T03:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-cancer-pt2b-tnm-finding-v8,Code name:,AGEN 2034
2020-10-14T03:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-cancer-pt2b-tnm-finding-v8,Code name:,AGEN2034
2020-09-18T08:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-targeted-immunomodulator-qbkpn,Code name:,QBKPN
2020-09-18T08:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-targeted-immunomodulator-qbkpn,Synonym:,site-specific immunomodulator QBKPN
2020-09-18T08:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-targeted-immunomodulator-qbkpn,Synonym:,SSI QBKPN
2020-09-18T08:45:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-tumor-associated-antigen,Synonym:,Lung TAA
2020-09-18T08:45:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-tumor-associated-antigen,Synonym:,"tumor-associated antigen, lung"
2020-10-14T03:34:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lupartumab-amadotin,Abbreviation:,anti-C4.4a ADC BAY1129980
2020-10-14T03:34:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lupartumab-amadotin,Code name:,BAY112-9980
2020-10-14T03:34:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lupartumab-amadotin,Code name:,BAY1129980
2020-09-18T08:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin,Code name:,PM01183
2020-09-18T08:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin,Synonym:,DNA minor groove-binding agent PM01183
2020-09-18T08:46:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin,US brand name:,Zepzelca
2020-09-18T08:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan,Code name:,GG 211
2020-09-18T08:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan,Code name:,GI-147211
2020-09-18T08:46:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan,Code name:,GI147211C
2020-10-14T12:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan-liposome,Abbreviation:,NX211
2020-10-14T12:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan-liposome,Synonym:,lurtotecan liposome
2020-10-14T12:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan-liposome,Synonym:,NX 211
2020-10-14T12:35:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan-liposome,Synonym:,OSI-211
2020-09-18T08:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept,Code name:,ACE-536
2020-09-18T08:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept,Synonym:,luspatercept
2020-09-18T08:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept,Synonym:,transforming growth factor-beta superfamily inhibitor ACE-536
2020-09-18T08:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept,US brand name:,Reblozyl
2020-10-14T12:38:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luteolin,NA,NA
2020-09-18T08:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-anti-ca19-9-monoclonal-antibody-5b1,Code name:,MVT-1075
2020-09-18T08:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-anti-ca19-9-monoclonal-antibody-5b1,Synonym:,177Lu human monoclonal antibody 5B1
2020-09-18T08:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-anti-ca19-9-monoclonal-antibody-5b1,Synonym:,177Lu-CHX-A''-DTPA-HuMab-5B1
2020-09-18T08:46:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-anti-ca19-9-monoclonal-antibody-5b1,Synonym:,Lu 177 anti-CA19-9 monoclonal antibody 5B1
2020-09-18T08:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-capromab,Code name:,CYT-500
2020-09-18T08:47:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-capromab,Synonym:,177Lu-meO-DOTA-7E11
2020-09-18T08:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-biotin,Synonym:,[177Lu]DOTA-biotin
2020-09-18T08:46:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-biotin,Synonym:,177Lu-ST2210
2020-09-18T08:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-di-hsg-peptide-imp-288,Synonym:,Lu-177-labeled di-histamine-succinyl-glycine-DOTA peptide IMP-288
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,177 Lu-DOTA-EB-TATE
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,177Lu-DOTA-EB-TATE
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,177Lu-DOTA0-EB-Tyr3-octreotate
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,lutetium Lu 177 DOTA(0)-EB-Tyr(3)-octreotate
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,lutetium Lu 177-DOTA-EB-Tyr3-octreotate
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,"lutetium-177-1, 4, 7, 10-tetra-azacyclododecane-1, 4, 7, 10-tetraacetic acid-Evans blue-octreotate"
2020-10-14T12:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate,Synonym:,lutetium-177-DOTA-EB-TATE
2020-10-14T12:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087,Synonym:,177Lu-3BP-227
2020-10-14T12:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087,Synonym:,177Lu-DOTA-3BP-227
2020-10-14T12:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087,Synonym:,177Lu-DOTA-IPN01087
2020-10-14T12:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087,Synonym:,177Lu-IPN01087
2020-10-14T12:38:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087,Synonym:,lutetium Lu 177 DOTA-3BP-227
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Foreign brand name:,SOMther
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,177Lu-DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH2]
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,177Lu-DOTA-Cpa-c[d-Cys-Aph(Hor)-d-Aph(Cbm)-Lys-Thr-Cys]-d-Tyr-NH2
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,177Lu-DOTA-JR11
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,177Lu-satoreotide tetraxetan
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,Lu-177 OPS-201
2020-09-18T08:47:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11,Synonym:,satoreotide tetraxetan lutetium-177
2020-10-14T12:38:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-n3-ctt1403,Synonym:,177Lu-DOTA-azide-CTT1403
2020-10-14T12:38:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-n3-ctt1403,Synonym:,177Lu-DOTA-N3-CTT1403
2020-10-14T12:38:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-n3-ctt1403,Synonym:,lutetium Lu 177 DOTA-azide-CTT1403
2020-09-18T08:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-octreotate,Abbreviation:,177 Lu-DOTA-octreotate
2020-09-18T08:47:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-octreotate,Abbreviation:,Lu-177-DOTA-octreotide
2020-09-18T08:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate,Abbreviation:,177 Lu-DOTA-TATE
2020-09-18T08:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate,Synonym:,177 Lu-DOTA-Tyr3-octreotate
2020-09-18T08:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate,Synonym:,lutetium oxodotreotide LU-177
2020-09-18T08:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate,US brand name:,Lutathera
2020-09-18T08:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tetulomab,Foreign brand name:,Betalutin
2020-09-18T08:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tetulomab,Synonym:,177Lu-DOTA-HH1
2020-09-18T08:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tetulomab,Synonym:,177Lu-Dota-tetulomab
2020-09-18T08:46:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tetulomab,Synonym:,177Lu-HH1
2020-10-14T12:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate,Abbreviation:,177 Lu-DOTA-octreotate
2020-10-14T12:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate,Abbreviation:,Lu-177-DOTA-octreotide
2020-10-14T12:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dtpa-omburtamab,Synonym:,177Lu-DTPA-omburtamab
2020-09-18T08:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-edotreotide,Abbreviation:,[177LuDOTA]-TOC
2020-09-18T08:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-edotreotide,Synonym:,177Lu-DOTA-Tyr3-octreotide
2020-09-18T08:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-edotreotide,Synonym:,lutetium Lu 177 DOTA-tyr3-octreotide
2020-09-18T08:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-edotreotide,Synonym:,lutetium Lu 177-DOTA-edotreotide
2020-09-18T08:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-girentuximab,Abbreviation:,177Lu-DOTA-cG250
2020-09-18T08:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-girentuximab,Synonym:,lutetium Lu-177-DOTA-chimeric monoclonal antibody cG250
2020-09-18T08:47:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-monoclonal-antibody-j591,Abbreviation:,Lu 177 MOAB J591
2020-10-14T12:38:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-neob,Synonym:,[177Lu]-NeoB
2020-10-14T12:38:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-neob,Synonym:,177Lu-NeoB
2020-10-14T12:38:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-neob,Synonym:,lutetium 177-NeoB
2020-10-14T12:38:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-neob,Synonym:,lutetium Lu 177 DOTA-NeoBOMB1
2020-09-18T08:47:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-pp-f11n,Synonym:,177Lu-PP-F11N
2020-10-14T12:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-617,Synonym:,177Lu-PSMA-617
2020-10-14T12:38:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-r2,Synonym:,177Lu-PSMA-R2
2020-10-14T12:38:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-r2,Synonym:,177LuPSMA-R2
2020-10-14T12:38:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-r2,Synonym:,Lu177-PSMA-R2
2020-10-14T12:38:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-r2,Synonym:,lutetium-177 PSMA-R2
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Foreign brand name:,SOMther
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,177Lu-DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH2]
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,177Lu-DOTA-Cpa-c[d-Cys-Aph(Hor)-d-Aph(Cbm)-Lys-Thr-Cys]-d-Tyr-NH2
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,177Lu-DOTA-JR11
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,177Lu-satoreotide tetraxetan
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,Lu-177 OPS-201
2020-10-14T12:38:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan,Synonym:,satoreotide tetraxetan lutetium-177
2020-09-18T08:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine,Code name:,RFUSIN2-AML1
2020-09-18T08:48:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine,Synonym:,lentivirus-transduced AML blasts expressing B7.1 and IL-2
2020-10-14T12:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine-rfusin2-aml1,Code name:,RFUSIN2-AML1
2020-10-14T12:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine-rfusin2-aml1,Synonym:,lentivirus-transduced AML blasts expressing B7.1 and IL-2
2020-09-18T08:48:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ly6k-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T08:48:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene,Abbreviation:,LYCO
2020-09-18T08:48:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene,Synonym:,all-trans-Lycopene
2020-09-18T08:48:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene,Synonym:,"psi,psi-Carotene"
2020-09-18T08:48:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene,US brand name:,Lyc-O-Mato
2020-09-18T08:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphokine-activated-killer-cells,Abbreviation:,LAK
2020-09-18T08:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphokine-activated-killer-cells,Abbreviation:,LAK cells
2020-09-18T08:49:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphokine-activated-killer-cells,Synonym:,therapeutic lymphokine-activated killer cells
2020-09-18T08:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphoma-taa-specific-cytotoxic-t-lymphocytes,Abbreviation:,TAA CTL
2020-09-18T08:49:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphoma-taa-specific-cytotoxic-t-lymphocytes,Abbreviation:,TAA-specific CTL
2020-09-18T08:49:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyophilized-black-raspberry-lozenge,Synonym:,LBR lozenge
2020-09-18T08:49:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyophilized-black-raspberry-saliva-substitute,Synonym:,LBR saliva substitute
2020-09-18T08:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lysine-specific-demethylase-1-inhibitor-incb059872,Code name:,INCB059872
2020-09-18T08:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lysine-specific-demethylase-1-inhibitor-incb059872,Code name:,INCB59872
2020-09-18T08:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lysine-specific-demethylase-1-inhibitor-incb059872,Synonym:,LSD1 inhibitor INCB059872
2020-09-18T08:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposomal-doxorubicin,Synonym:,heat-activated liposomal doxorubicin hydrochloride
2020-09-18T08:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposomal-doxorubicin,Synonym:,lyso-thermosensitive liposome doxorubicin
2020-09-18T08:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposomal-doxorubicin,US brand name:,ThermoDox
2020-10-14T12:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin,Synonym:,heat-activated liposomal doxorubicin hydrochloride
2020-10-14T12:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin,Synonym:,lyso-thermosensitive liposome doxorubicin
2020-10-14T12:39:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin,US brand name:,ThermoDox
2020-09-18T08:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/m-azidopyrimethamine,Abbreviation:,MZP
2020-09-18T08:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/m87o-transduced-cd34-peripheral-blood-stem-cells,Synonym:,M87o-transduced CD34+ PBSC
2020-09-18T08:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/m87o-transduced-cd34-peripheral-blood-stem-cells,Synonym:,therapeutic gamma-retroviral vector M87o-transduced CD34+ peripheral blood stem cells
2020-09-18T08:50:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ma-zi-ren-wan,Abbreviation:,MZRW
2020-09-18T08:50:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ma-zi-ren-wan,Synonym:,hemp seed formula
2020-09-18T08:50:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ma-zi-ren-wan,Synonym:,MaZiRenWan
2020-10-14T12:39:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maackia-amurensis-seed-lectin,Abbreviation:,MASL
2020-09-18T08:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin,Chemical structure:,N-(2-Amino-2-Methylpropanoyl-N1-((1R)-1-Formamido-2-(1H-Indol-3-yl)Ethyl)-D-Tryptophanamide
2020-09-18T08:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin,Code name:,AEZS-130
2020-09-18T08:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin,Code name:,EP 1572
2020-09-18T08:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin,Code name:,JMV 1843
2020-09-18T08:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macitentan,Chemical structure:,N-[5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)-pyrimidin-4-yl]-N'-propylaminosulfonamide
2020-09-18T08:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macitentan,Code name:,ACT-064992
2020-09-18T08:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macitentan,Foreign brand name:,Actelion-1
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Code name:,E 7766
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Code name:,E-7766
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Code name:,E7766
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Code name:,MBSA E7766
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Synonym:,stimulator of interferon genes agonist E7766
2020-10-14T12:39:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766,Synonym:,Sting agonist E7766
2020-10-14T12:39:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrogol-3350-based-iso-osmotic-laxative,Foreign brand name:,Colonlytely
2020-09-18T08:50:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrogol-3350-based-oral-osmotic-laxative,Foreign brand name:,Colonlytely
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Abbreviation:,MMDT
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Synonym:,Bakumondo-to
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Synonym:,Maekgeuron granules
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Synonym:,Mai-men-dong-tang
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Synonym:,Ophiopogonis tuber/Pinelliae tuber/Glycyrrhizae radix/Zizyphi fructus/Ginseng radix/oryzae semen herbal formulation
2020-10-14T12:39:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang,Synonym:,TJ-29
2020-09-18T08:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mafosfamide,NA,NA
2020-09-18T08:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mag-tn3-as15-vaccine,Synonym:,MAG-TN3 plus AS15 vaccine
2020-09-18T08:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mag-tn3-as15-vaccine,Synonym:,MAG-Tn3/AS15
2020-09-18T08:50:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-10a2,NA,NA
2020-09-18T08:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-3a1-peptide-vaccine,Synonym:,HLA-A1-restricted MAGE-3 peptide vaccine
2020-09-18T08:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-3a1-peptide-vaccine,Synonym:,MAGE-3.A1
2020-10-14T12:39:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-her-2-neu-fbp-peptides-cancer-vaccine,NA,NA
2020-09-18T08:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-her-2-neu-fbp-peptides-ovarian-cancer-vaccine,NA,NA
2020-09-18T08:51:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-mage-a3-ny-eso-1-peptides-vaccine,NA,NA
2020-10-14T12:39:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type-5-vaccine,Abbreviation:,Ad-MAGE-A3
2020-10-14T12:39:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type-5-vaccine,Abbreviation:,AdMA3
2020-10-14T12:39:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type-5-vaccine,Synonym:,adenovirus/MAGE-A3
2020-09-18T08:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type5-vaccine,Abbreviation:,Ad-MAGE-A3
2020-09-18T08:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type5-vaccine,Abbreviation:,AdMA3
2020-09-18T08:51:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type5-vaccine,Synonym:,adenovirus/MAGE-A3
2020-09-18T08:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-hpv-16-peptide-vaccine,NA,NA
2020-09-18T08:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-peptide-vaccine,Abbreviation:,MAGE-A3
2020-09-18T08:51:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-peptide-vaccine,Code name:,GL-0817
2020-09-18T08:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-reactive-t-cell-receptor-transduced-autologous-t-cells,Synonym:,MAGE-A3 T cell receptor-transduced autologous T cells
2020-09-18T08:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-reactive-t-cell-receptor-transduced-autologous-t-cells,Synonym:,MAGE-A3 TCR-transduced autologous T cells
2020-10-14T12:39:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a4-specific-tcr-gene-transduced-autologous-t-lymphocytes-tbi-1201,Code name:,TBI-1201
2020-09-18T08:51:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a4-specific-tcr-gene-transduced-t-lymphocytes-tbi-1201,Code name:,TBI-1201
2020-10-14T12:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-based-bone-void-filler,Synonym:,magnesium-based BVF
2020-10-14T12:39:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-based-bone-void-filler,US brand name:,Osteocrete
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,Foreign brand name:,Citramag
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,Synonym:,citrate of magnesia
2020-09-18T05:30:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate,US brand name:,Citroma
2020-10-14T12:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-glycinate,NA,NA
2020-09-18T08:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide,US brand name:,Milk of Magnesia
2020-09-18T08:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide,Synonym:,aluminum hydroxide/magnesium hydroxide
2020-09-18T08:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide,US brand name:,Maalox
2020-09-18T08:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide,US brand name:,Mylanta
2020-09-18T08:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-isoglycyrrhizinate,Synonym:,tianqingganmei
2020-09-18T08:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-l-threonate,Chemical structure:,"magnesium, bis((2R,3S)-2,3,4-trihydroxybutanoato-kappaO,kappaO')-, (T-4)-"
2020-09-18T08:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-oxide,NA,NA
2020-10-14T12:40:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-rich-mineral-water,Foreign brand name:,Rozana
2020-09-18T08:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-valproate,NA,NA
2020-10-14T12:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magrolimab,Code name:,Hu5F9-G4
2020-10-14T12:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magrolimab,Code name:,ONO-7913
2020-10-14T12:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magrolimab,Synonym:,anti-CD47 monoclonal antibody Hu5F9-G4
2020-09-18T08:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong,Synonym:,Mai Men Dong
2020-09-18T08:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong,Synonym:,Maidong
2020-09-18T08:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong,Synonym:,ophiopogon
2020-09-18T08:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong,Synonym:,Radix Ophiopogonis
2020-09-18T08:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maitake-mushroom-extract,Synonym:,Grifola frondosa extract
2020-09-18T08:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malignant-glioma-tumor-lysate-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-10-14T12:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malt1-inhibitor-jnj-67856633,Code name:,JNJ 67856633
2020-10-14T12:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malt1-inhibitor-jnj-67856633,Code name:,JNJ-67856633
2020-10-14T12:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malt1-inhibitor-jnj-67856633,Code name:,JNJ67856633
2020-10-14T12:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malt1-inhibitor-jnj-67856633,Synonym:,mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitor JNJ-67856633
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Dextri-Maltose
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Glucidex
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Glucodry
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Maldex
2020-09-18T06:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin,US brand name:,Maldrin
2020-09-18T08:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltose,NA,NA
2020-09-18T08:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malva-sylvestris-alcea-digitata-herbal-compound,Synonym:,M. sylvestris/A. digitata herbal compound
2020-09-18T08:53:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malva-sylvestris-alcea-digitata-herbal-compound,Synonym:,traditional persian medicine preparation M. sylvestris/A. digitata
2020-09-18T08:53:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mammaglobin-a-dna-vaccine,Abbreviation:,mam-A DNA vaccine
2020-10-14T03:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manelimab,Code name:,BCD 135
2020-10-14T03:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manelimab,Code name:,BCD-135
2020-10-14T03:56:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manelimab,Code name:,BCD135
2020-09-18T08:53:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mangafodipir-trisodium,NA,NA
2020-10-14T12:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-chloride,Chemical structure:,MnCl2
2020-10-14T12:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-chloride,Synonym:,manganese chloride tetrahydrate
2020-10-14T12:40:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-chloride,Synonym:,manganum muriaticum
2020-10-14T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation,Code name:,CMC 001
2020-10-14T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation,Code name:,CMC-001
2020-10-14T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation,Code name:,CMC001
2020-10-14T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation,Synonym:,manganese-based contrast agent CMC 001
2020-10-14T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation,US brand name:,Mangoral
2020-09-18T08:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol,Synonym:,D-mannitol
2020-09-18T08:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol,US brand name:,Osmitrol
2020-09-18T08:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol,US brand name:,Resectisol
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Abbreviation:,MBL
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Abbreviation:,MBP
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Acronym:,rhMBL
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Synonym:,mannan-binding lectin
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Synonym:,mannose-binding lectin
2020-10-14T13:13:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin,Synonym:,mannose-binding protein
2020-09-18T08:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manuka-honey,US brand name:,Medihoney™
2020-09-18T08:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mapatumumab,Abbreviation:,TRM-1 mAb
2020-09-18T08:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mapatumumab,Code name:,HGS-ETR1
2020-09-18T08:54:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mapatumumab,Synonym:,Anti-TRAIL R1-mAb
2020-10-14T12:37:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maprotiline-hydrochloride,Chemical structure:,"1-(3-methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride9-(gamma-methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride"
2020-10-14T12:37:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maprotiline-hydrochloride,US brand name:,Ludiomil
2020-10-14T12:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7,Synonym:,MG1-E6/E7
2020-10-14T12:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7,Synonym:,MG1-E6E7
2020-10-14T12:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7,Synonym:,MG1-expressing mutant HPV E6/E7
2020-10-14T12:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7,Synonym:,oncolytic MG1 virus-encoding E6E7
2020-10-14T12:40:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7,Synonym:,oncolytic virus MG1-E6E7
2020-09-18T08:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraviroc,Foreign brand name:,Celsentri
2020-09-18T08:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraviroc,US brand name:,Selzentry
2020-09-18T08:54:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marcellomycin,Synonym:,Rhodirubin E
2020-09-18T08:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/margetuximab,Abbreviation:,anti-HER2 mAb MGAH22
2020-09-18T08:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/margetuximab,Code name:,MGAH22
2020-09-18T08:54:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/margetuximab,Synonym:,anti-HER2 monoclonal antibody MGAH22
2020-09-18T08:54:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marijuana,Synonym:,cannabis
2020-09-18T08:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marimastat,Chemical structure:,"(2S,3R)-3-(((1S)-2,2-dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic Acid(2S,3R)-3-{(S)-[2,2-dimethyl-1-(methylcarbamoyl) propyl]carbamoyl}-2-hydroxy-5-methylhexanohydroxamic acid"
2020-09-18T08:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marimastat,Code name:,BB-2516
2020-09-18T08:54:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marimastat,Code name:,TA-2516
2020-09-18T08:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marizomib,Code name:,NPI-0052
2020-09-18T08:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marizomib,Synonym:,salinosporamide A
2020-09-18T08:55:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marizomib,Synonym:,salinosporin A
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,antigen LB39-AA
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,antigen SK29-AA
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,MART-1
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,MART-1 tumor antigen
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,MART1
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,Melan A
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,Melan-A
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,Melan-A protein
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,melanoma antigen recognized by T Cells 1
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,MLANA
2020-09-18T08:55:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen,Synonym:,MLANA protein
2020-09-18T08:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-lymphocytes,Synonym:,MART 1-reactive PBL
2020-09-18T08:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-lymphocytes,Synonym:,MART-1 reactive CD8-positive T lymphocytes
2020-10-14T12:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-t-lymphocytes,Synonym:,MART 1-reactive PBL
2020-10-14T12:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-t-lymphocytes,Synonym:,MART-1 reactive CD8-positive T lymphocytes
2020-09-18T08:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-126-3527l-peptide-vaccine,NA,NA
2020-09-18T08:55:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-127-35-peptide-vaccine,NA,NA
2020-09-18T08:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masitinib-mesylate,Chemical structure:,"4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide mesylate"
2020-09-18T08:55:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masitinib-mesylate,Code name:,AB1010
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Abbreviation:,NDGA
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Chemical structure:,"4,4'-(2,3-Dimethyl-1,4-butanediyl)bis[1,2-benzenediol]"
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,Synonym:,nordihydroguaiaretic acid
2020-09-18T01:19:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol,US brand name:,Actinex
2020-09-18T08:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mast-cell-stabilizer-tf002,NA,NA
2020-10-14T12:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mat2a-inhibitor-ag-270,Code name:,AG 270
2020-10-14T12:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mat2a-inhibitor-ag-270,Code name:,AG-270
2020-10-14T12:40:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mat2a-inhibitor-ag-270,Code name:,AG270
2020-09-18T08:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-gel,Synonym:,Chamomilla recutita gel
2020-09-18T08:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-gel,Synonym:,German chamomile gel
2020-09-18T08:55:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-gel,Synonym:,Matricaria chamomilla L. gel
2020-09-18T08:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-topical-infusion,Synonym:,Chamomilla recutita infuse
2020-09-18T08:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-topical-infusion,Synonym:,German chamomile infuse
2020-09-18T08:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-topical-infusion,Synonym:,Matricaria chamomilla L. topical infusion
2020-09-18T08:56:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matuzumab,Code name:,EMD 72000
2020-10-14T04:58:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavelertinib,Code name:,PF-06747775
2020-10-14T12:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor,Chemical structure:,"(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine"
2020-10-14T12:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor,Code name:,AMD-070
2020-10-14T12:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor,Code name:,AMD-11070
2020-10-14T12:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor,Code name:,X4P 001
2020-10-14T12:41:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor,Code name:,X4P001
2020-09-18T08:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maytansine,Synonym:,maitansine
2020-09-18T08:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maytansine,Synonym:,Maysanine
2020-09-18T08:56:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maytansine,Synonym:,Maytansin
2020-10-14T12:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-abbv-467,Code name:,ABBV 467
2020-10-14T12:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-abbv-467,Code name:,ABBV-467
2020-10-14T12:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-abbv-467,Code name:,ABBV467
2020-10-14T12:41:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-abbv-467,Synonym:,myeloid cell leukemia-1 inhibitor ABBV-467
2020-09-18T08:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-amg-176,Code name:,AMG 176
2020-09-18T08:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-azd5991,Code name:,AZD-5991
2020-09-18T08:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-azd5991,Code name:,AZD5991
2020-09-18T08:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-azd5991,Synonym:,MCL1 inhibitor AZD5991
2020-09-18T08:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665,Code name:,MIK 665
2020-09-18T08:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665,Code name:,MIK-665
2020-09-18T08:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665,Code name:,MIK665
2020-09-18T08:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665,Code name:,S 64315
2020-09-18T08:57:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcpyv-tag-specific-polyclonal-autologous-cd8-positive-t-cell-vaccine,Synonym:,MCPyV TAg-specific polyclonal autologous CD8-positive T cells
2020-10-14T12:41:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcpyv-tag-specific-polyclonal-autologous-cd8-positive-t-cells,Synonym:,MCPyV TAg-specific polyclonal autologous CD8-positive T cells
2020-10-14T12:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-acid-lipid-emulsion,Foreign brand name:,Lipoplus
2020-10-14T12:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-acid-lipid-emulsion,Synonym:,medium chain triglyceride/long chain triglyceride/ fish oil omega-3 fatty acid triglyceride lipid emulsion
2020-09-18T08:57:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-triglyceride-lipid-emulsion,Foreign brand name:,Lipoplus
2020-09-18T08:57:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-triglyceride-lipid-emulsion,Synonym:,medium chain triglyceride/long chain triglyceride/ fish oil omega-3 fatty acid triglyceride lipid emulsion
2020-09-18T08:57:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-lipid-emulsion,Foreign brand name:,Lipofundin
2020-09-18T08:57:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-lipid-emulsion,Synonym:,medium chain triglyceride/long chain triglyceride lipid emulsion
2020-10-14T12:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-astx295,Code name:,ASTX 295
2020-10-14T12:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-astx295,Code name:,ASTX-295
2020-10-14T12:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-astx295,Code name:,ASTX295
2020-10-14T12:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-astx295,Synonym:,MDM2 inhibitor ASTX295
2020-09-18T08:57:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro5045337,Code name:,R7112
2020-09-18T08:57:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro5045337,Code name:,RO5045337
2020-09-18T08:57:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro6839921,Code name:,RO6839921
2020-09-18T08:58:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232,Code name:,AMG 232
2020-09-18T08:58:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232,Code name:,AMG-232
2020-09-18T08:58:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232,Code name:,KRT 232
2020-09-18T08:58:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232,Code name:,KRT232
2020-09-18T08:58:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232,Synonym:,"(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-((1S)-2-methyl-1-(((1-methylethyl)sulfonyl)methyl)propyl)-2-oxo-3-piperidineacetic acid"
2020-10-14T12:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-bi-907828,Code name:,BI 907828
2020-10-14T12:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-bi-907828,Code name:,BI-907828
2020-10-14T12:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-bi-907828,Code name:,BI907828
2020-09-18T09:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-ds-3032b,Code name:,DS-3032b
2020-09-18T09:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-ds-3032b,Synonym:,HDM2 inhibitor DS-3032b
2020-09-18T09:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-ds-3032b,Synonym:,MDM2 inhibitor DS-3032b
2020-10-14T12:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232,Code name:,AMG 232
2020-10-14T12:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232,Code name:,AMG-232
2020-10-14T12:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232,Code name:,KRT 232
2020-10-14T12:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232,Code name:,KRT232
2020-10-14T12:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232,Synonym:,"(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-((1S)-2-methyl-1-(((1-methylethyl)sulfonyl)methyl)propyl)-2-oxo-3-piperidineacetic acid"
2020-09-18T08:58:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-mdmx-inhibitor-alrn-6924,Code name:,ALRN-6924
2020-09-18T05:10:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdr-modulator-cbt-1,US brand name:,CBT-1
2020-09-18T08:58:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine,Abbreviation:,M-M-R II
2020-09-18T08:58:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine,Abbreviation:,MMR vaccine
2020-09-18T08:58:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine,Synonym:,measles mumps rubella vaccine
2020-09-18T08:58:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine,Synonym:,"measles, mumps and rubella virus vaccine, live"
2020-09-18T08:58:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine,Synonym:,"measles, mumps, and rubella vaccine"
2020-09-18T08:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole,Chemical structure:,(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl esterMethyl 5-benzoyl benzimidazole-2-carbamate
2020-09-18T08:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole,Code name:,R 17635
2020-09-18T08:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole,Foreign brand name:,Ovex
2020-09-18T08:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole,US brand name:,Vermox
2020-10-14T12:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mecapegfilgrastim,NA,NA
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Chemical structure:,"bis(2-chloroethyl)methylamine hydrochlorideethanamine,2-chloro-N-(2-chloroethyl)-N-methyl hydrochloridemethylbis(beta-chloroethyl)amine hydrochloride"
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Code name:,WR-147650
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Foreign brand name:,Caryolysine
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Foreign brand name:,Cloramin
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Foreign brand name:,Erasol
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Foreign brand name:,Mustine Hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Foreign brand name:,Onco-Cloramin
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,chlorethamine HCl
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,chlorethamine hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,chlorethazine hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,chlormethine hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,chloromethine HCl
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,HN 2 hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,mechlorethamine HCl
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,mustargen HCl
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,mustargen hydrochloride
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,mustine
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,Synonym:,N-Lost
2020-09-18T08:58:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride,US brand name:,Mustargen
2020-09-18T08:58:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride-gel,Synonym:,mechlorethamine HCl gel
2020-09-18T08:58:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride-gel,US brand name:,Valchlor
2020-09-18T08:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclocycline-sulfosalicylate,Chemical structure:,"(4S,4aR,5S,5aR,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide Mono(5-sulfosalicylate)(Salt)"
2020-09-18T08:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclocycline-sulfosalicylate,Synonym:,Mecloderm
2020-09-18T08:58:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclocycline-sulfosalicylate,US brand name:,Meclan
2020-09-18T08:58:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclofenamate-sodium,Chemical structure:,"benzoic Acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium saltsodium 2-((2,6-dichloro-3-methylphenyl)amino)benzoate"
2020-09-18T08:58:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclofenamate-sodium,Synonym:,meclonax
2020-09-18T08:58:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclofenamate-sodium,US brand name:,Meclomen
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Abbreviation:,MPA
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Chemical structure:,"(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione17-(acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione17alpha-acetoxy-6alpha-methylprogesterone17-hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate6-alpha-methyl-17alpha-acetoxyprogesterone"
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Aragest
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Ciclotal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinofem
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Depo-Clinovir
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,G-Farlutal
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Gestapuran
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Hysron
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Lutoral
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Perlutex
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Prodasone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Sodelut G
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Foreign brand name:,Veramix
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,depot-medroxyprogestereone acetate
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,Synonym:,metipregnone
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Amen
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Depo-Provera
2020-09-18T02:00:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate,US brand name:,Provera
2020-09-18T08:59:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mefloquine,NA,NA
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Code name:,BDH 1298
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Code name:,BDH-1298
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Code name:,SC-10363
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Foreign brand name:,Maygace
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Foreign brand name:,Megestat
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Foreign brand name:,Megestil
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Foreign brand name:,Niagestin
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Synonym:,ovaban
2020-09-18T08:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate,Synonym:,pallace
2020-09-18T08:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-as703988-msc2015103b,Code name:,AS703988
2020-09-18T08:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-as703988-msc2015103b,Code name:,AS703988/MSC2015103B
2020-09-18T08:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-as703988-msc2015103b,Code name:,MSC2015103B
2020-10-14T12:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-fcn-159,Code name:,FCN 159
2020-10-14T12:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-fcn-159,Code name:,FCN-159
2020-10-14T12:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-fcn-159,Code name:,FCN159
2020-10-14T12:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-fcn-159,Synonym:,MEK inhibitor FCN-159
2020-09-18T09:00:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-mekk-1-inhibitor-e6201,Code name:,E6201
2020-09-18T09:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-aurora-kinase-dual-inhibitor-bi-847325,Code name:,BI 847325
2020-10-14T12:42:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-aurora-kinase-inhibitor-bi-847325,Code name:,BI 847325
2020-09-18T08:59:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-azd8330,Code name:,ARRY-424704
2020-10-14T12:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-cs3006,Code name:,CS 3006
2020-10-14T12:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-cs3006,Code name:,CS-3006
2020-10-14T12:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-cs3006,Code name:,CS3006
2020-10-14T12:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-cs3006,Synonym:,MAPK kinase inhibitor CS3006
2020-09-18T08:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-gdc-0623,Code name:,GDC-0623
2020-10-14T12:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-hl-085,Code name:,HL 085
2020-10-14T12:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-hl-085,Code name:,HL-085
2020-10-14T12:42:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-hl-085,Code name:,HL085
2020-10-14T12:59:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-pd0325901,Code name:,PD-0325901
2020-10-14T12:59:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-pd0325901,Synonym:,MEK inhibitor PD0325901
2020-09-18T08:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-ro4987655,Code name:,RO4987655
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Code name:,SHR 7390
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Code name:,SHR-7390
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Code name:,SHR7390
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Synonym:,MAP2K inhibitor SHR 7390
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Synonym:,MAPK kinase inhibitor SHR 7390
2020-10-14T12:42:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390,Synonym:,MEKi SHR 7390
2020-09-18T09:00:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-tak-733,Code name:,TAK-733
2020-09-18T09:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-wx-554,Code name:,WX-554
2020-09-18T09:00:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melan-a-mage-3dp4-peptide-vaccine,NA,NA
2020-09-18T09:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melan-a-vlp-vaccine,NA,NA
2020-09-18T09:00:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melanoma-helper-peptide-vaccine,Abbreviation:,MHP VAC
2020-09-18T09:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melanoma-trp2-ctl-epitope-vaccine-scib1,Code name:,SCIB1
2020-09-18T09:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melanoma-trp2-ctl-epitope-vaccine-scib1,Synonym:,human IgG1/murine IgG2a double-expression vector encoding TRP2 CTL epitope vaccine SCIB1
2020-09-18T09:01:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melitac-121-peptide-vaccine,Code name:,MELITAC 12.1
2020-09-18T09:01:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melk-inhibitor-ots167,Code name:,OTS167
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,Chemical structure:,"4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide"
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,US brand name:,Mobec
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,US brand name:,Mobic
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,US brand name:,Mobicox
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,US brand name:,Movalis
2020-09-18T09:01:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam,US brand name:,Movatec
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Abbreviation:,L-PAM
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Chemical structure:,4-[bis(2-chloroethyl)amino]-L-phenylalaninep-di(chloroethyl)amino-L-phenylalanine
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,CB-3025
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Code name:,WR-19813
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Melphalanum
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Foreign brand name:,Sarkolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,alanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysin phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,L-sarcolysine
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,phenylalanine nitrogen mustard
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,Synonym:,sarcoclorin
2020-09-18T01:49:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan,US brand name:,Alkeran
2020-10-14T12:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide,Code name:,J1
2020-10-14T12:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide,Synonym:,L-melphalanyl-p-L-fluorophenylalanine ethyl ester
2020-10-14T12:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide,Synonym:,mel-flufen
2020-10-14T12:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide,Synonym:,melflufen
2020-09-18T09:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide-prodrug,Code name:,J1
2020-09-18T09:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide-prodrug,Synonym:,L-melphalanyl-p-L-fluorophenylalanine ethyl ester
2020-09-18T09:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide-prodrug,Synonym:,mel-flufen
2020-09-18T09:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide-prodrug,Synonym:,melflufen
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,Chemical structure:,"3-(p-(bis(2-chloroethyl)amino)phenyl)-L-alanine, hydrochloride"
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,Foreign brand name:,Alkerana
2020-09-18T06:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride,US brand name:,Evomela
2020-09-18T05:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride-sulfobutyl-ether-beta-cyclodextrin-complex,US brand name:,Captisol-enabled Melphalan IV
2020-09-18T09:01:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/memantine-hydrochloride,Chemical structure:,"1-amino-3,5-dimethyladamantane Hydrochloride"
2020-09-18T09:01:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/memantine-hydrochloride,Synonym:,Ebixia
2020-09-18T09:01:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/memantine-hydrochloride,US brand name:,Namenda
2020-09-18T09:01:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-bound-interleukin-21-expanded-haploidentical-natural-killer-cells,Synonym:,(mbIL21)-expanded haploidentical NK Cells
2020-09-18T09:01:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-bound-interleukin-21-expanded-haploidentical-natural-killer-cells,Synonym:,mbIL21-expanded haploidentical NK cells
2020-09-18T09:01:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-disrupting-peptide-ep-100,Abbreviation:,MDP EP-100
2020-09-18T09:01:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-disrupting-peptide-ep-100,Code name:,EP-100
2020-09-18T09:01:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menadione-topical-lotion,NA,NA
2020-09-18T09:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menatetrenone,Code name:,E0167
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Code name:,KO 539
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Code name:,KO-539
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Code name:,KO539
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Synonym:,menin-KMT2A inhibitor KO 539
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Synonym:,menin-mixed lineage leukemia protein-protein interaction inhibitor KO 539
2020-10-14T12:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539,Synonym:,menin-MLL inhibitor KO-539
2020-10-14T12:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613,Code name:,SNDX 5613
2020-10-14T12:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613,Code name:,SNDX-5613
2020-10-14T12:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613,Code name:,SNDX5613
2020-10-14T12:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613,Synonym:,menin-mixed lineage leukemia protein-protein interaction inhibitor SNDX-5613
2020-10-14T12:42:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613,Synonym:,menin-MLL inhibitor SNDX-5613
2020-09-18T09:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril,Abbreviation:,7-OMEN
2020-09-18T09:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril,Abbreviation:,MEN
2020-09-18T09:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril,Abbreviation:,TUT-7
2020-09-18T09:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril,Code name:,U-52047
2020-09-18T09:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril,US brand name:,Menogarol
2020-09-18T05:56:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride,Synonym:,meperidine
2020-09-18T05:56:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride,US brand name:,Demerol
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,Chemical structure:,"1-methyl-2',6'-pipecoloxylidide hydrochloride (SY), (1-methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride"
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,US brand name:,Carbocaine
2020-09-18T05:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride,US brand name:,Polocaine
2020-10-14T12:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab,Code name:,SB 240563
2020-10-14T12:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab,Code name:,SB-240563
2020-10-14T12:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab,Code name:,SB240563
2020-10-14T12:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab,Foreign brand name:,Bosatria
2020-10-14T12:42:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab,US brand name:,Nucala
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Abbreviation:,6-MP
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Abbreviation:,MP
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Chemical structure:,"1,7 dihydro-6H-purine-6-thione monohydrate1,7-Dihydro-6H-purine-6-thione3H purine-6-thiol6H-purine-6-thione, 1,7-dihydro- (9CI)7-mercapto-1,3,4,6-tetrazaindeneMercapto-6-purinepurine-6-thiol (8CI)purine-6-thiol Monohydratepurine-6-thiol, monohydrate"
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Code name:,BW 57-323H
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Code name:,U-4748
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Code name:,WR-2785
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Alti-Mercaptopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Flocofil
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Ismipur
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Leukerin
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Mercaleukim
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Mercaptina
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Puri-Nethol
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Purinethiol
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Foreign brand name:,Xaluprine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6 thiohypoxanthine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6 thiopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6-mercaptopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6-mercaptopurine monohydrate
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6-purinethiol
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6-thiopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,6-thioxopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,Azathiopurine
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,Leupurin
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,Mercapurin
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,Mern
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,Synonym:,Purimethol
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,US brand name:,Purinethol
2020-09-18T09:02:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine,US brand name:,Purixan
2020-09-18T09:02:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-oral-suspension,Foreign brand name:,Xaluprine
2020-09-18T09:02:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-oral-suspension,Synonym:,6-MP oral suspension
2020-09-18T09:02:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-oral-suspension,US brand name:,Purixan
2020-09-18T09:02:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-tablet,Foreign brand name:,Puri-Nethol
2020-09-18T09:02:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-tablet,Foreign brand name:,Purinethol
2020-09-18T09:02:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-tablet,Synonym:,mercaptopurine anhydrous
2020-09-18T09:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/merestinib,Chemical structure:,"3-pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-"
2020-09-18T09:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/merestinib,Code name:,LY2801653
2020-09-18T09:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/merestinib,Synonym:,c-Met inhibitor LY2801653
2020-09-18T09:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meropenem,Code name:,SM-7338
2020-09-18T09:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meropenem,Synonym:,meropenem trihydrate
2020-09-18T09:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meropenem,US brand name:,Merrem I.V.
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Abbreviation:,5-ASA
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Chemical structure:,5-amino-2-hydroxybenzoic acid5-aminosalicylic acid
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,Synonym:,mesalazine
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Apriso
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Asacol
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Lialda
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Pentasa
2020-09-18T03:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine,US brand name:,Rowasa
2020-10-14T12:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12d-sirna,Synonym:,KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes
2020-10-14T12:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12d-sirna,Synonym:,MSC-derived exosomes with KrasG12D siRNA
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Abbreviation:,MSA
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Chemical structure:,"2-mercaptoethanesulfonic acid, sodium saltsodium 2-mercaptoethane sulfonate"
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Code name:,D-7093
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Code name:,UCB 3983
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Ausobronc
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Filesna
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mesnil
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mexan
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mistabron
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mistabronco
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mitexan
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mucofluid
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Mucolene
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Uromitexan
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Foreign brand name:,Ziken
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Synonym:,mercaptoethane sulfonate
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,Synonym:,Mesnum
2020-09-18T09:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna,US brand name:,Mesnex
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Code name:,HPN 536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Code name:,HPN-536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Code name:,HPN536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Code name:,MSLN-specific TriTAC HPN536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Synonym:,mesothelin-targeting T-cell engager HPN536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Synonym:,mesothelin/CD3e-specific TriTAC HPN536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Synonym:,MSLN/CD3e TriTAC HPN536
2020-10-14T12:42:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536,Synonym:,TriTAC HPN536
2020-09-18T09:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelioma-tumor-lysate-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-10-14T12:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-kinase-inhibitor-omo-1,Code name:,JNJ-38877618
2020-10-14T12:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-kinase-inhibitor-omo-1,Code name:,OMO-1
2020-10-14T12:43:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-kinase-inhibitor-omo-1,Code name:,OMO1
2020-09-18T09:03:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-receptor-tyrosine-kinase-inhibitor-sgx523,Code name:,SGX523
2020-09-18T09:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-bms-777607,Code name:,ASLAN002
2020-09-18T09:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-bms-777607,Code name:,BMS-777607
2020-09-18T09:04:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-emd-1204831,Code name:,EMD 1204831
2020-09-18T09:04:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-pf-04217903,Code name:,PF-04217903
2020-09-18T09:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-sar125844,Code name:,SAR125844
2020-10-14T12:43:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-sgx523,Code name:,SGX523
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Code name:,REGN 5093
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Code name:,REGN-5093
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Code name:,REGN5093
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Synonym:,anti-c-Met bispecific antibody REGN5093
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Synonym:,METxMET antibody REGN5093
2020-10-14T12:43:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093,Synonym:,METxMET bispecific antibody REGN5093
2020-09-18T09:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meta-fluorine-f-18-fluorobenzylguanidine,Abbreviation:,[(18)F]-MFBG
2020-09-18T09:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meta-fluorine-f-18-fluorobenzylguanidine,Abbreviation:,18F-MFBG
2020-09-18T09:04:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meta-fluorine-f-18-fluorobenzylguanidine,Synonym:,meta-[(18)F]-fluorobenzylguanidine
2020-09-18T09:04:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metahexamide,NA,NA
2020-10-14T12:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-apl-1202,Code name:,APL 1202
2020-10-14T12:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-apl-1202,Code name:,APL-1202
2020-10-14T12:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-apl-1202,Code name:,APL1202
2020-10-14T12:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-apl-1202,Synonym:,methionine aminopeptidase type II inhibitor APL-1202
2020-09-18T09:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-sdx-7320,Code name:,SDX-7320
2020-09-18T09:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-sdx-7320,Synonym:,methionine aminopeptidase type II inhibitor SDX-7320
2020-10-14T12:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metarrestin,Chemical structure:,"trans-4-(7-benzyl-4-imino-5,6-diphenylpyrrolo[2,3-d]pyrimidin-3-yl)cyclohexan-1-ol"
2020-10-14T12:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metarrestin,Code name:,ML 246
2020-10-14T12:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metarrestin,Code name:,ML-246
2020-10-14T12:43:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metarrestin,Code name:,ML246
2020-09-18T09:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metatinib-tromethamine,Code name:,BL001
2020-09-18T09:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metatinib-tromethamine,Synonym:,BCR-ABL tyrosine kinase inhibitor BL001
2020-09-18T09:05:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metatinib-tromethamine,Synonym:,metatinib
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,Synonym:,metformide HCl/pioglitazone HCl ER tablet
2020-09-18T01:22:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet,US brand name:,ACTOplus Met XR
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Chemical structure:,"1,1-dimethylbiguanide hydrochlorideN,N-dimethylimidodicarbonimidic diamide monohydrochloride"
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Cidophage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Dimefor
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Glifage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Glucoformin
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Foreign brand name:,Siofor
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,Synonym:,Metformin HCl
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Fortamet
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glucophage
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glucophage XR
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Glumetza
2020-09-18T07:03:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride,US brand name:,Riomet
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Adanon
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Althose
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Dolophine
2020-09-18T01:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride,US brand name:,Methadose
2020-09-18T09:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methanol-extraction-residue-of-bcg,Acronym:,MER
2020-09-18T09:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methanol-extraction-residue-of-bcg,Acronym:,MER-BCG
2020-09-18T09:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methanol-extraction-residue-of-bcg,Synonym:,MER of BCG
2020-09-18T09:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methanol-extraction-residue-of-bcg,Synonym:,methanol extraction residue of bacillus Calmette-Guerin
2020-09-18T09:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methazolamide,US brand name:,Neptazane
2020-09-18T09:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-aminopeptidase-2-inhibitor-m8891,Code name:,M8891
2020-09-18T09:05:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-aminopeptidase-2-inhibitor-m8891,Synonym:,MetAP2 inhibitor M8891
2020-10-14T13:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-aminopeptidase-2-inhibitor-ppi-2458,NA,NA
2020-09-18T09:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-c-11,Abbreviation:,11C-MET
2020-09-18T09:05:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-c-11,Synonym:,11C-methionine
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Abbreviation:,MTX
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Chemical structure:,"4-amino-10-methylfolic acid4-amino-4-deoxy-10-methylpteroyl-L-glutamic acidN-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid"
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Code name:,CL-14377
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Code name:,WR-19039
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Brimexate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Emtexate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Emthexat
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Emthexate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Farmitrexat
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Fauldexato
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Lantarel
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Ledertrexate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Lumexon
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Maxtrex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Medsatrexate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Metex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Methoblastin
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Metrotex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Novatrex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Texate
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Tremetex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Trexeron
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Foreign brand name:,Trixilem
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,alpha-methopterin
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,amethopterin
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,methotrexate methylaminopterin
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,Methotrexatum
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,methylaminopterin
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,Synonym:,Metotrexato
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,US brand name:,Rheumatrex
2020-09-18T09:05:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate,US brand name:,Trexall
2020-09-18T09:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-e-therapeutic-implant,Abbreviation:,MTX-e TI
2020-09-18T09:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-e-therapeutic-implant,Synonym:,methotrexate-epinephrine therapeutic implant
2020-09-18T09:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-e-therapeutic-implant,Synonym:,methotrexate/epi
2020-09-18T09:05:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-e-therapeutic-implant,Synonym:,MTX/epi gel
2020-09-18T09:05:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-encapsulating-autologous-tumor-derived-microparticles,Abbreviation:,MTX-ATMP
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Abbreviation:,8-MOP
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Chemical structure:,"9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one"
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Deltasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Dermox
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Geroxalen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinina
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Meladinine
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Metoxaleno
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Mopsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Puvasoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Foreign brand name:,Ultramop
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,8-methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,Synonym:,Methoxypsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Ammoidin
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Oxsoralen-Ultra
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Uvadex
2020-09-18T02:02:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen,US brand name:,Xanthotoxin
2020-09-18T09:05:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxy-polyethylene-glycol-epoetin-beta,Code name:,Ro 50-3821
2020-09-18T09:05:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxy-polyethylene-glycol-epoetin-beta,Foreign brand name:,Mircera
2020-09-18T09:05:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxy-polyethylene-glycol-epoetin-beta,US brand name:,Mircera
2020-09-18T09:06:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyamine,Code name:,TRC102
2020-09-18T09:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyflurane,Chemical structure:,"2,2-dichloro-1,1-difluoro-1-methoxyethane"
2020-09-18T09:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyflurane,Foreign brand name:,Penthrox
2020-09-18T09:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyflurane,Synonym:,analgizer
2020-09-18T09:06:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyflurane,Synonym:,methoflurane
2020-09-18T09:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream,Abbreviation:,MAL cream
2020-09-18T09:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream,Foreign brand name:,Metvix cream
2020-09-18T09:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream,Foreign brand name:,Metvixia cream
2020-09-18T09:06:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream,US brand name:,Metvixia cream
2020-10-14T12:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylcantharidimide,Abbreviation:,NMC
2020-10-14T12:43:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylcantharidimide,Synonym:,N-methylcantharidimide
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Abbreviation:,MB
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Acronym:,MB
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Code name:,CI-52015
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Foreign brand name:,Azul Metile
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Foreign brand name:,Collubleu
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Foreign brand name:,Desmoidpillen
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Foreign brand name:,Vitableu
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Azul de Metileno
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Blu di Metilene
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,CI Basic Blue 9
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Colour Index No. 52015
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Methylenum Caeruleum
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Methylthioninii Chloridum
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Methylthioninium Chloride
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Schultz No. 1038
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,Synonym:,Tetramethylthionine Chloride Trihydrate
2020-09-18T09:06:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue,US brand name:,Urolene Blue
2020-09-18T09:06:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-dimethane-sulfonate,Abbreviation:,MDMS
2020-09-18T09:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside,Abbreviation:,6-MMPR
2020-09-18T09:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside,Abbreviation:,MMPR
2020-09-18T09:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside,Code name:,NCI-C04784
2020-09-18T09:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside,Code name:,SQ 21977
2020-09-18T09:06:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside,Synonym:,methylthioinosine
2020-09-18T09:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone,Abbreviation:,MNTX
2020-09-18T09:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone,Chemical structure:,"17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium"
2020-09-18T09:06:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone,Synonym:,N-methylnaltrexone bromide
2020-09-18T09:06:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone-bromide,US brand name:,Relistor
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,Chemical structure:,alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,Synonym:,d-methylphenidate
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Concerta
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Quillivant XR
2020-09-18T05:38:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride,US brand name:,Ritalin
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Chemical structure:,"11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate"
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,D-Med
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,Depo-Medrate
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Foreign brand name:,Depo-Medrone
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Synonym:,D-Med
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,Synonym:,Depo-Medrone
2020-09-18T05:59:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate,US brand name:,Depo-Medrol
2020-09-18T09:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine,Abbreviation:,MSC
2020-09-18T09:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine,Abbreviation:,SeMSC
2020-09-18T09:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine,Synonym:,3-(methylseleno)-l-alanine
2020-09-18T09:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine,Synonym:,l-se-methylselenocysteine
2020-09-18T09:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine,Synonym:,selenium-methylselenocystine
2020-09-18T09:07:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoclopramide-hydrochloride,US brand name:,Reglan
2020-09-18T09:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprine,Abbreviation:,DDMP
2020-09-18T09:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprine,Code name:,BW 197U
2020-09-18T09:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprolol,NA,NA
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,Code name:,SC 32642
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,US brand name:,Flagyl
2020-09-18T06:50:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride,US brand name:,Satric
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Code name:,L-588357-0
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Code name:,MK-781
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,Alpha-methyl-p-tyrosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,methyl-tyrosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,Synonym:,Metirosine
2020-09-18T05:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine,US brand name:,DEMSER
2020-10-14T04:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mevociclib,Code name:,SY 1365
2020-10-14T04:40:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mevociclib,Code name:,SY-1365
2020-10-14T03:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezagitamab,Code name:,TAK 079
2020-10-14T03:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezagitamab,Code name:,TAK-079
2020-10-14T03:38:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezagitamab,Synonym:,anti-CD38 MAb TAK-079
2020-09-18T09:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mg-98,Synonym:,MG-98 oligonucleotide
2020-09-18T09:07:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micafungin,Code name:,FK463
2020-09-18T09:07:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micafungin,Synonym:,FK463
2020-09-18T09:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-cisplatin-nc-6004,Code name:,NC-6004
2020-09-18T09:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-cisplatin-nc-6004,Foreign brand name:,Nanoplatin
2020-09-18T09:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin,Code name:,K-912
2020-09-18T09:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin,Code name:,NC-6300
2020-09-18T09:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin,Synonym:,epirubicin-conjugated polymer micelles
2020-09-18T09:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin,Synonym:,epirubicin-incorporating micelle
2020-09-18T09:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin,Synonym:,nanoparticle epirubicin
2020-10-14T12:43:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/michelia-alba-leaf-oil,Synonym:,MA leaf oil
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Abbreviation:,MNA-D
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,doxorubicin-coated patches
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,doxorubicin-loaded patches
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,micro-needle array doxorubicin
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,microneedle applicator-doxorubicin
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,microneedle array doxorubicin
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,MNA-D patches
2020-10-14T12:44:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin,Synonym:,MNA-doxorubicin
2020-10-14T12:43:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbial-ecosystem-therapeutics-4,Code name:,MET 4
2020-10-14T12:43:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbial-ecosystem-therapeutics-4,Code name:,MET-4
2020-10-14T12:43:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbial-ecosystem-therapeutics-4,Code name:,MET4
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Code name:,EO 2401
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Code name:,EO-2401
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Code name:,EO2401
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Synonym:,cancer vaccine EO2401
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Synonym:,microbial-derived peptide vaccine EO2401
2020-10-14T12:43:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401,Synonym:,microbiome-derived therapeutic cancer vaccine EO2401
2020-10-14T12:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-gen-001,Code name:,GEN 001
2020-10-14T12:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-gen-001,Code name:,GEN-001
2020-10-14T12:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-gen-001,Code name:,GEN001
2020-10-14T12:44:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-gen-001,Synonym:,microbiome-based therapeutic GEN-001
2020-10-14T12:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-ser-401,Code name:,SER 401
2020-10-14T12:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-ser-401,Code name:,SER-401
2020-10-14T12:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-ser-401,Code name:,SER401
2020-10-14T12:44:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-ser-401,Synonym:,microbiome-based therapeutic SER-401
2020-09-18T09:08:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micronutrient-fortified-probiotic-yogurt,NA,NA
2020-10-14T13:42:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microparticle-encapsulated-cyp1b1-encoding-dna-vaccine-zyc300,NA,NA
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Chemical structure:,"6-methoxy-3-(3',4',5'-trimethoxybenzoyl) Indole"
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,BPR 0L075
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,DBPR104
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,SB 01
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,SB01
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,SCB 01A
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,SCB-01A
2020-09-18T09:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a,Code name:,SCB01A
2020-09-18T09:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-targeted-agent-bal101553,Code name:,BAL101553
2020-09-18T09:09:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-containing-buccal-liquid,Foreign brand name:,Epistatus
2020-09-18T09:09:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-containing-buccal-liquid,Synonym:,midazolam maleate buccal liquid
2020-09-18T09:09:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-containing-buccal-liquid,Synonym:,midazolam maleate oromucosal solution
2020-09-18T09:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-hydrochloride,Chemical structure:,"8-Chloro-6-(2-fluorophenyl)-1-Methyl- 4H- Imidazo(1,5a)(1,4)Benzodiazepine"
2020-09-18T09:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-hydrochloride,Synonym:,midazolam
2020-09-18T09:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-hydrochloride,US brand name:,Versed
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Code name:,CGP 41251
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Code name:,CGP41251
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Code name:,PKC 412
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Code name:,PKC412
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Synonym:,N-benzoyl-staurosporine
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,Synonym:,N-benzoylstaurosporine
2020-09-18T09:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin,US brand name:,Rydapt
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,Abbreviation:,L-MTP-PE
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,Abbreviation:,MTP-PE Liposome
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,Foreign brand name:,MEPACT
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,Synonym:,CGP 19835A Lipid
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,Synonym:,muramyl tripeptide phosphatidylethanolamine liposome
2020-09-18T08:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide,US brand name:,JUNOVAN
2020-09-18T09:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone,Code name:,RU 486
2020-09-18T09:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone,Code name:,RU-38486
2020-09-18T09:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone,Foreign brand name:,Mifegyne
2020-09-18T09:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone,US brand name:,Mifeprex
2020-09-18T07:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miglitol,US brand name:,Glyset
2020-09-18T09:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miha-loaded-pd-l1-l2-silenced-dendritic-cell-vaccine,Synonym:,MiHA-loaded PD-L-silenced DC vaccine
2020-10-14T12:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milademetan-tosylate,Code name:,DS-3032b
2020-10-14T12:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milademetan-tosylate,Synonym:,HDM2 inhibitor DS-3032b
2020-10-14T12:44:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milademetan-tosylate,Synonym:,MDM2 inhibitor DS-3032b
2020-10-14T12:55:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milataxel,Code name:,TL139
2020-09-18T09:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab,Code name:,hLL1
2020-09-18T09:09:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab,Synonym:,humanized anti-CD74 monoclonal antibody hLL1
2020-09-18T09:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate,Code name:,IMMU-110
2020-09-18T09:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate,Synonym:,hLL1-DOX
2020-10-14T12:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate-immu-110,Code name:,IMMU-110
2020-10-14T12:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate-immu-110,Synonym:,hLL1-DOX
2020-10-14T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milciclib-maleate,Chemical structure:,"N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide"
2020-10-14T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milciclib-maleate,Code name:,PHA-848125 AC
2020-10-14T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milciclib-maleate,Synonym:,CDK2/TRKA inhibitor PHA-848125 AC
2020-09-18T09:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milk-protein-based-energy-drink,Foreign brand name:,Fresubin Protein Energy Drink
2020-09-18T09:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milk-thistle,NA,NA
2020-10-14T12:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milled-seed-mix,Synonym:,milled flax/sesame/pumpkin seed mix
2020-10-14T12:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milled-seed-mix,Synonym:,milled mix of flax/sesame/pumpkin seeds in sour milk
2020-10-14T12:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milled-seed-mix,Synonym:,milled sesame/pumpkin/flax seed mixture
2020-09-18T09:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim,Code name:,PIXY321
2020-09-18T09:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim,Synonym:,GM-CSF/IL-3 Fusion Protein
2020-09-18T09:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim,Synonym:,GM-CSF/IL3 Fusion Protein
2020-09-18T09:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim,Synonym:,Granulocyte-Macrophage Colony Stimulating Factor/Interleukin-3 Fusion Protein
2020-09-18T09:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim,Synonym:,pixykine
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Abbreviation:,HDPC
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Chemical structure:,"2-[[(Hexadecycloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium Inner SaltHexadecyl 2-(N,N,N-trimethylamino)ethyl Phosphaten-Hexadecylphosphorylcholine"
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Code name:,D-18506
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Foreign brand name:,Miltex
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Synonym:,"Choline Phosphate Hexadecyl Ester, Hydroxide, Inner Salt"
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Synonym:,hexadecylphosphocholine
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Synonym:,Miltefosin
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Synonym:,Miltefosina
2020-09-18T09:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine,Synonym:,Miltefosinum
2020-09-18T09:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mimotope-p10s-padre-peptide-vaccine,Synonym:,P10s-PADRE
2020-09-18T09:10:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mimotope-p10s-padre-peptide-vaccine,Synonym:,P10s-PADRE Vaccine
2020-09-18T09:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-edta,Abbreviation:,M-EDTA
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Chemical structure:,"4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride"
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Minomax
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Minomycin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,Synonym:,Tri-minocycline
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Dynacin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Minocin
2020-09-18T06:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride,US brand name:,Vectrin
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Abbreviation:,MAb CC49
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Abbreviation:,MOAB CC49
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Synonym:,"antibody CC49, monoclonal"
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Synonym:,CC-49 Monoclonal Antibody
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Synonym:,CC49
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Synonym:,MOAB CC-49/TAG72 (DW)
2020-10-14T12:46:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab,Synonym:,monoclonal antibody CC-49
2020-09-18T09:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mipsagargin,Code name:,G-202
2020-09-18T09:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mipsagargin,Synonym:,thapsigargin prodrug G-202
2020-09-18T09:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron,Chemical structure:,"2-(2-aminothiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl] acetamide4-thiazoleacetamide, 2-amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)"
2020-09-18T09:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron,Code name:,YM 178
2020-09-18T09:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron,Code name:,YM178
2020-09-18T09:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron,Foreign brand name:,Betanis
2020-09-18T09:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron,US brand name:,Myrbetriq
2020-10-14T03:26:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miransertib,Code name:,ARQ 092
2020-09-18T09:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirasol-treated-allogeneic-platelets,Synonym:,allogeneic MIR PLTs
2020-09-18T09:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirasol-treated-allogeneic-platelets,Synonym:,allogeneic Mirasol platelets
2020-09-18T09:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirasol-treated-allogeneic-platelets,Synonym:,allogeneic Mirasol PRT-treated platelets
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Abbreviation:,CPHPC
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Chemical structure:,(2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Code name:,CPHPC
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Code name:,GSK 2315698
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Code name:,GSK-2315698
2020-10-14T12:44:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap,Code name:,GSK2315698
2020-09-18T09:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirtazapine,US brand name:,Remeron
2020-09-18T09:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine,Code name:,IMGN853
2020-09-18T09:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine,Synonym:,anti-FOLR1 monoclonal antibody-maytansinoid conjugate IMGN853
2020-09-18T09:11:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine,Synonym:,M9346A-sulfo-SPDB-DM4
2020-10-14T03:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirzotamab-clezutoclax,Code name:,ABBV 155
2020-10-14T03:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirzotamab-clezutoclax,Code name:,ABBV-155
2020-10-14T03:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirzotamab-clezutoclax,Code name:,ABBV155
2020-10-14T03:34:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirzotamab-clezutoclax,Synonym:,ADC ABBV-155
2020-09-18T09:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/misonidazole,Chemical structure:,1-(alpha-methoxymethyl ethanol)-2-Nitroimidazole
2020-09-18T09:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/misonidazole,Code name:,Ro-07-0582
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,ABNOBAviscum
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Apotheker Bauer's Misteltinktur
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Cefalektin
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Eurixor
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Helixor
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Iscador
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Isorel
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Isugran
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Lektinol
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Mistel Curarina
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Mistel- Krautertabletten
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Mistelol-Kapseln
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Plenosol N
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Viscysat
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Foreign brand name:,Vysorel
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Synonym:,Viscum
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,Synonym:,Viscum album Loranthacea
2020-09-18T08:15:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract,US brand name:,Iscar
2020-10-14T13:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat,Code name:,AG 348
2020-10-14T13:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat,Code name:,AG-348
2020-10-14T13:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat,Code name:,AG348
2020-10-14T13:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat,Synonym:,PK-R activator AG-348
2020-10-14T13:05:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat,Synonym:,red cell pyruvate kinase activator AG-348
2020-10-14T03:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitazalimab,Code name:,ADC-1013
2020-10-14T04:03:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitochondrial-oxidative-phosphorylation-inhibitor-atr-101,NA,NA
2020-10-14T05:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoflaxone,Abbreviation:,FAA
2020-10-14T05:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoflaxone,Chemical structure:,"4H-1-benzopyran-8-acetic acid, 4-oxo-2-phenylflavone-8-acetic acid"
2020-10-14T05:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoflaxone,Code name:,LM 975
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Abbreviation:,MeGAG
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Abbreviation:,methyl-G
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Abbreviation:,methyl-GAG
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Abbreviation:,MGBG
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Abbreviation:,MGGH
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Chemical structure:,"1,1'-[(methylethanediylidene)dinitrilo)diguanidine2,2""-(methyl-1,2-ethanediylidene)bis[hydrazinecarboximidamide]methylglyoxal bis(amidinohydrazone)"
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Code name:,DRG-0223
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Code name:,NSC 32946
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Foreign brand name:,Zyrkamine
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Synonym:,methylglyoxal bisguanylhydrazone
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Synonym:,mitoguazone dihydrochloride
2020-09-18T09:12:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone,Synonym:,pyruvaldehyde bis(amidinohydrazone)
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Abbreviation:,DBD
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Chemical structure:,6-dibromodideoxydulcitol6-dibromodulcitol
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Foreign brand name:,Elobromol
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Foreign brand name:,Mitolac
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Synonym:,Dibromdicil
2020-09-18T09:12:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol,Synonym:,dibromodulcitol
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Abbreviation:,MITC
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Abbreviation:,MITO
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Abbreviation:,MITO-C
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Abbreviation:,MTC
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Code name:,NCI-C04706
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Foreign brand name:,Ametycine
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Foreign brand name:,Mito-Medac
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Foreign brand name:,Mitocin-C
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Foreign brand name:,Mitolem
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Foreign brand name:,Mutamycine
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Synonym:,mitomycin C
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Synonym:,mitomycin-X
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,Synonym:,mitomycine C
2020-10-14T05:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin,US brand name:,Jelmyto
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Abbreviation:,MITC
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Abbreviation:,MITO
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Abbreviation:,MITO-C
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Abbreviation:,MTC
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Code name:,NCI-C04706
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Foreign brand name:,Ametycine
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Foreign brand name:,Mito-Medac
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Foreign brand name:,Mitocin-C
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Foreign brand name:,Mitolem
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Foreign brand name:,Mutamycine
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Synonym:,mitomycin C
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Synonym:,mitomycin-X
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,Synonym:,mitomycine C
2020-09-18T08:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c,US brand name:,Jelmyto
2020-10-14T12:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c-analog-kw-2149,Chemical structure:,7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C
2020-10-14T12:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c-analog-kw-2149,Code name:,KT6149
2020-10-14T12:32:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c-analog-kw-2149,Code name:,KW 2149
2020-09-18T09:12:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-angiogenesis-inhibitor-r1530,Abbreviation:,MAI R1530
2020-09-18T09:12:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-angiogenesis-inhibitor-r1530,Code name:,R1530
2020-10-14T12:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-inhibitor-t-1101-tosylate,Synonym:,T 1101 tosylate
2020-10-14T12:45:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-inhibitor-t-1101-tosylate,Synonym:,T1101 tosylate
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Abbreviation:,DDD
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Abbreviation:,"o,p' - DDD"
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Abbreviation:,"o,p'-DDD"
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Code name:,CB-313
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Code name:,WR-13045
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Foreign brand name:,Lisodren
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,Chloditan
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,Chlodithane
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,Khloditan
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,Mytotan
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,"o,p'-DDD"
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,Synonym:,"Ortho,para-DDD"
2020-09-18T08:49:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane,US brand name:,Lysodren
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Abbreviation:,DHAD
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Abbreviation:,DHAQ
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Chemical structure:,"1,3-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthroquinonedihydroxyanthracenedione"
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Code name:,CL 232315
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Foreign brand name:,Mitroxone
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Foreign brand name:,Neotalem
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Foreign brand name:,Onkotrone
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Foreign brand name:,Pralifan
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Synonym:,dihydroxyanthracenedione
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Synonym:,dihydroxyanthracenedione dihydrochloride
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Synonym:,mitoxantrone dihydrochloride
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Synonym:,mitoxantrone HCl
2020-09-18T09:12:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride,Synonym:,mitozantrone
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Code name:,TAK-659
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Code name:,TAK659
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Synonym:,syk inhibitor TAK-659
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Synonym:,syk inhibitor TAK659
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Synonym:,syk-inhibitor TAK-659
2020-10-14T13:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib,Synonym:,syk-Inhibitor TAK659
2020-10-14T04:31:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivebresib,Code name:,ABBV-075
2020-09-18T09:12:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivobulin-isethionate,Code name:,CI-980
2020-09-18T09:13:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mixed-bacteria-vaccine,Acronym:,MBV
2020-09-18T09:13:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mixed-bacteria-vaccine,Synonym:,Coley's toxins
2020-09-18T09:13:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mk0731,NA,NA
2020-09-18T09:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mkc-1,Code name:,R440
2020-09-18T09:13:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mkc-1,Code name:,Ro 31-7453
2020-09-18T09:13:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mknk1-inhibitor-bay-1143269,Code name:,BAY 1143269
2020-09-18T09:13:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mln2704,Code name:,MLN591DM1
2020-09-18T09:13:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mln2704,Synonym:,DM1-conjugated monoclonal antibody MLN591
2020-09-18T09:13:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mln2704,Synonym:,maytansinoid -1 conjugated with MLN591 monoclonal antibody
2020-10-14T13:17:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mmp-inhibitor-s-3304,NA,NA
2020-09-18T12:24:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-eft508,Code name:,eFT508
2020-09-18T12:24:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-eft508,Synonym:,MNK1/2 inhibitor eFT508
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC 1907206
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC 206
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC-1907206
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC-206
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC1907206
2020-10-14T12:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206,Code name:,ETC206
2020-09-18T09:13:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-mimetic-bmx-001,Code name:,BMX-001
2020-09-18T09:13:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-mimetic-bmx-001,Synonym:,manganese (III) ortho N-butoxyethylpyridylporphyrin
2020-09-18T09:13:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-mimetic-bmx-001,Synonym:,mitochondrial manganese superoxide dismutatse mimetic BMX-001
2020-09-18T09:13:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-plasmid-liposomes,Abbreviation:,MnSOD-PL
2020-09-18T09:13:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-plasmid-liposomes,Synonym:,manganese superoxide dismutase plasmid liposomes
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,AP 32788
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,AP-32788
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,AP32788
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,TAK 788
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,TAK-788
2020-10-14T04:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib,Code name:,TAK788
2020-09-18T09:14:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mocetinostat,Chemical structure:,"benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide"
2020-09-18T09:14:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mocetinostat,Code name:,MGCD0103
2020-09-18T09:14:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modafinil,US brand name:,Provigil
2020-10-14T03:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa,Code name:,TAK-573
2020-10-14T03:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa,Code name:,TEV-48573
2020-10-14T03:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa,Synonym:,anti-CD38-targeted IgG4-attenuated interferon alpha TAK-573
2020-10-14T03:39:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa,Synonym:,CD38-targeted IgG4 fused with attenuated IFNa
2020-09-18T09:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-citrus-pectin-supplement,US brand name:,PectaSol-C
2020-09-18T09:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-release-calcifediol-capsule,Code name:,CTAP101
2020-09-18T09:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-release-calcifediol-capsule,US brand name:,Rayaldee
2020-09-18T09:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-ankara-bavarian-nordic-her2-vaccine,Foreign brand name:,MVA-BN Breast
2020-09-18T09:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-ankara-bavarian-nordic-her2-vaccine,Synonym:,MVA-BN-HER2 vaccine
2020-09-18T09:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53,Abbreviation:,MVA-p53 vaccine
2020-09-18T09:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53,Abbreviation:,MVAp53 vaccine
2020-09-18T09:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53,Synonym:,MVAp53
2020-09-18T09:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53,Synonym:,p53MVA
2020-09-18T09:14:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53,Synonym:,p53MVA vaccine
2020-09-18T09:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vitamin-d-binding-protein-macrophage-activator-ef-022,Code name:,EF-022
2020-09-18T09:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vitamin-d-binding-protein-macrophage-activator-ef-022,Synonym:,modified VDBP-macrophage activator EF-022
2020-09-18T09:14:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vitamin-d-binding-protein-macrophage-activator-ef-022,Synonym:,MVDP-macrophage activator
2020-10-14T12:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modotuximab,Code name:,1024 DS
2020-10-14T12:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modotuximab,Code name:,1024-DS
2020-10-14T12:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modotuximab,Synonym:,zatuximab
2020-10-14T12:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mof-compound-rimo-301,Code name:,RiMO-301
2020-09-18T09:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab,Code name:,KW-0761
2020-09-18T09:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab,Synonym:,Anti-CCR4 monoclonal antibody KW-0761
2020-09-18T09:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab,Synonym:,mogamulizumab
2020-09-18T09:15:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab,US brand name:,Poteligeo
2020-10-14T12:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moisturizing-cream-wo2085,Code name:,WO 2085
2020-10-14T12:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moisturizing-cream-wo2085,Code name:,WO-2085
2020-10-14T12:45:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moisturizing-cream-wo2085,Code name:,WO2085
2020-10-14T12:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/molibresib-besylate,Chemical structure:,"2-((4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-4-yl)-N-ethylacetamide monobenzenesulfonate salt"
2020-10-14T12:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/molibresib-besylate,Code name:,GSK525762C
2020-09-18T09:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/molybdenum,Abbreviation:,Mo
2020-09-18T09:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/momelotinib,Code name:,CYT387
2020-09-18T09:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/momelotinib,Code name:,GS-0387
2020-09-18T09:15:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/momelotinib,Synonym:,JAK1/2 inhibitor CYT387
2020-09-18T06:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate,Chemical structure:,"(11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione"
2020-09-18T06:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate,US brand name:,Elocon
2020-09-18T09:15:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monalizumab,Code name:,IPH2201
2020-09-18T09:15:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monalizumab,Synonym:,anti-NKG2A monoclonal antibody IPH2201
2020-09-18T09:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoacetyldiglyceride-ec-18,Chemical structure:,"1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol9,12-octadecadienoic acid (9Z,12Z)-, 1-((acetyloxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl ester"
2020-09-18T09:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoacetyldiglyceride-ec-18,Code name:,EC-18
2020-09-18T09:20:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoacetyldiglyceride-ec-18,Synonym:,monoacetyldiglyceride EC-18
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,Abbreviation:,MBEH
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,Synonym:,monobenzyl ether of hydroquinone
2020-09-18T04:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone,US brand name:,Benoquin
2020-09-18T09:15:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monocarboxylate-transporter-1-inhibitor-azd3965,Code name:,AZD3965
2020-09-18T09:15:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monocarboxylate-transporter-1-inhibitor-azd3965,Synonym:,MCT1 inhibitor AZD3965
2020-09-18T09:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-105ad7-anti-idiotype-vaccine,Abbreviation:,MOAB 105AD7
2020-09-18T09:16:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-105ad7-anti-idiotype-vaccine,Synonym:,105AD7
2020-09-18T09:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine,Abbreviation:,MOAB 11D10 VAC
2020-09-18T09:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine,Synonym:,11D10 anti-idiotype vaccine
2020-09-18T09:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine,Synonym:,TriAb anti-idiotype antibody
2020-09-18T09:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine,Synonym:,"vaccine, MOAB 11D10 anti-idiotype"
2020-09-18T09:16:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine,US brand name:,TriAb
2020-09-18T09:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-14g2a,Abbreviation:,MOAB 14G2A
2020-09-18T09:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-14g2a,Synonym:,14G2A
2020-09-18T09:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-14g2a,Synonym:,"14G2A, monoclonal antibody"
2020-09-18T09:16:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-14g2a,Synonym:,"antibody 14G2A, monoclonal"
2020-09-18T09:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3f8,Abbreviation:,MOAB 3F8
2020-09-18T09:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3f8,Synonym:,3F8
2020-09-18T09:16:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3f8,Synonym:,anti-Ganglioside (GD2) Monoclonal Antibody 3F8
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Abbreviation:,MOAB 3H1
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,3H1 anti-idiotype vaccine
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,CEA-Vac
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,Synonym:,MOAB 3H1 anti-idiotype vaccine
2020-09-18T05:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine,US brand name:,CeaVac
2020-09-18T09:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-4b5-anti-idiotype-vaccine,Abbreviation:,MOAB 4B5
2020-09-18T09:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-4b5-anti-idiotype-vaccine,Synonym:,4B5 monoclonal antibody anti-idiotype vaccine
2020-09-18T09:16:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-4b5-anti-idiotype-vaccine,Synonym:,MOAB 4B5 anti-idiotype vaccine
2020-09-18T09:16:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a2715,Abbreviation:,MOAB A27.15
2020-09-18T09:16:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a2715,Synonym:,A27.15
2020-09-18T09:16:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a2715,Synonym:,ANTI-TRANSFERRIN MOAB 27.15
2020-09-18T09:16:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a33,Abbreviation:,MOAB A33
2020-09-18T09:16:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a33,Synonym:,A33
2020-09-18T09:16:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a33,Synonym:,A33 monoclonal antibody
2020-09-18T09:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-abgn-7,Abbreviation:,AbGn-7
2020-09-18T09:16:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-ak002,Code name:,AK 002
2020-09-18T09:16:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-ak002,Code name:,AK002
2020-09-18T09:16:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-ak002,Synonym:,monoclonal antibody AK 002
2020-09-18T09:17:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cal,Abbreviation:,MOAB CAL
2020-09-18T09:17:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cal,Synonym:,CAL
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Abbreviation:,MAb CC49
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Abbreviation:,MOAB CC49
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Synonym:,"antibody CC49, monoclonal"
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Synonym:,CC-49 Monoclonal Antibody
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Synonym:,CC49
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Synonym:,MOAB CC-49/TAG72 (DW)
2020-09-18T09:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49,Synonym:,monoclonal antibody CC-49
2020-09-18T09:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49-delta-ch2,Abbreviation:,MOAB CC49-deltaCH2
2020-09-18T09:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49-delta-ch2,Synonym:,MOAB HCC49DCH2
2020-09-18T09:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49-delta-ch2,Synonym:,MoAb HuCC49DeltaCH2
2020-09-18T09:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49-delta-ch2,Synonym:,Monoclonal Antibody HCC49DCH2
2020-09-18T09:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cep-37250-khk2804,Code name:,CEP-37250/KHK2804
2020-09-18T09:17:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-e23,Abbreviation:,MOAB E2.3
2020-09-18T09:17:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-e23,Synonym:,Anti-Transferrin MOAB E2.3
2020-09-18T09:17:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-e23,Synonym:,E2.3
2020-09-18T09:17:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-gd2-anti-idiotype-vaccine,NA,NA
2020-09-18T09:17:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hefi-1,Abbreviation:,MOAB HeFi-1
2020-09-18T09:17:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hefi-1,Synonym:,HeFi-1
2020-09-18T09:17:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hu3s193,Abbreviation:,MOAB Hu3S193
2020-09-18T09:17:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hu3s193,Synonym:,Hu3S193
2020-09-18T09:17:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huafp31,Abbreviation:,MOAB HuAFP31
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Abbreviation:,HuHMFG1
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Abbreviation:,MOAB HuHMFG1
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Code name:,AS1402
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Code name:,R1550
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Foreign brand name:,Therex
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Synonym:,humanized human milk fat globule-1 monoclonal antibody
2020-09-18T09:17:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1,Synonym:,humanized IgG1 monoclonal antibody HMFG-1
2020-09-18T09:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hupam4,Abbreviation:,MOAB HuPAM4
2020-09-18T09:18:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-l6,Abbreviation:,MOAB L6
2020-09-18T09:18:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-l6,Synonym:,L6
2020-09-18T09:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-lym-1,Abbreviation:,MOAB Lym-1
2020-09-18T09:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-lym-1,Synonym:,IgG2a murine monoclonal antibody Lym-1
2020-09-18T09:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-lym-1,Synonym:,Lym-1
2020-09-18T09:18:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-lym-1,Synonym:,"monoclonal antibody Lym-1, IgG2a murine"
2020-09-18T09:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-m170,NA,NA
2020-09-18T09:18:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-me1-14-fab2,Abbreviation:,MOAB Me1-14 F(ab')2
2020-09-18T09:18:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-me1-14-fab2,Synonym:,Me1-14 F(ab')2
2020-09-18T09:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-mik-beta-1,Abbreviation:,MOAB Mik-beta-1
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Code name:,NEO 201
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Code name:,NEO-201
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Code name:,NEO201
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Synonym:,h16C3
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Synonym:,h16C3 antibody
2020-10-14T12:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201,Synonym:,neoantigen-targeting antibody NEO-201
2020-09-18T09:18:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-r24,Abbreviation:,MOAB R24
2020-09-18T09:18:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-r24,Synonym:,R24
2020-09-18T09:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-rav12,Abbreviation:,anti-RAAG12 MOAB
2020-09-18T09:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-rav12,Synonym:,anti-RAAG12 monoclonal antibody
2020-09-18T09:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-rav12,Synonym:,RAV12
2020-09-18T09:18:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-sgn-30,Code name:,SGN-30
2020-09-18T09:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-trk-950,Code name:,TRK 950
2020-09-18T09:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-trk-950,Code name:,TRK-950
2020-10-14T12:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-microbial-edp1503,Code name:,EDP 1503
2020-10-14T12:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-microbial-edp1503,Code name:,EDP-1503
2020-10-14T12:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-microbial-edp1503,Code name:,EDP1503
2020-09-18T09:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-t-cell-receptor-anti-cd3-scfv-fusion-protein-imcgp100,Code name:,IMCgp100
2020-09-18T09:18:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-t-cell-receptor-anti-cd3-scfv-fusion-protein-imcgp100,Synonym:,ImmTAC-gp100
2020-09-18T09:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monophosphoryl-lipid-a,Abbreviation:,MPL
2020-09-18T09:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monophosphoryl-lipid-a,Abbreviation:,MPLA
2020-09-18T09:19:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monophosphoryl-lipid-a,Chemical structure:,3-deacylated monophosphoryl lipid A3-O-desacyl-4'-monophosphoryl lipid A
2020-09-18T09:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside,Abbreviation:,GM-1
2020-09-18T09:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside,Abbreviation:,GM1
2020-09-18T09:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside,Synonym:,ganglioside GM1
2020-09-18T09:19:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside,Synonym:,monosialoanglioside GM1
2020-09-18T09:19:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-51-vg,NA,NA
2020-09-18T09:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-720,Synonym:,ISA 720
2020-09-18T09:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montelukast-sodium,US brand name:,Singulair
2020-09-18T09:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mopp-regimen,Acronym:,MOPP
2020-09-18T09:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mopp-regimen,Synonym:,mechlorethamine/prednisone/procarbazine/vincristine regimen
2020-09-18T09:19:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mopp-regimen,Synonym:,Mustargen-Oncovin-procarbazine-prednisone regimen
2020-09-18T09:19:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morinda-citrifolia-fruit-extract,Synonym:,noni fruit juice
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,Abbreviation:,MORPH
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Avinza
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Infumorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Kadian
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MS Contin
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,MSir
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Oramorph SR
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Roxanol
2020-09-18T04:26:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate,US brand name:,Statex SR
2020-09-18T09:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate-sustained-release-tablet,NA,NA
2020-10-14T12:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosedipimod,Chemical structure:,"1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol9,12-octadecadienoic acid (9Z,12Z)-, 1-((acetyloxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl ester"
2020-10-14T12:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosedipimod,Code name:,EC-18
2020-10-14T12:46:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosedipimod,Synonym:,monoacetyldiglyceride EC-18
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Code name:,BTCT 4465A
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Code name:,BTCT-4465A
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Code name:,RG 7828
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Code name:,RG7828
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody BTCT4465A
2020-10-14T12:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab,Synonym:,CD20/CD3 BiMAb BTCT4465A
2020-09-18T09:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motesanib-diphosphate,Chemical structure:,"3-pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4- pyridinylmethyl)amino]-N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4- ylmethyl)amino]pyridine-3-carboxamide"
2020-09-18T09:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motesanib-diphosphate,Code name:,AMG 706
2020-09-18T09:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium,Abbreviation:,Gd-Tex
2020-09-18T09:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium,Code name:,PCI-0120
2020-09-18T09:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium,Synonym:,gadolinium texaphyrin
2020-09-18T09:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium,Synonym:,Gd (III) Texaphryin
2020-09-18T09:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium,US brand name:,Xcytrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Code name:,PCI-0123
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,Synonym:,lutetium texaphyrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Antrin
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutex
2020-09-18T03:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium,US brand name:,Lutrin
2020-10-14T04:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide,Code name:,BKT140
2020-10-14T04:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide,Code name:,BL-8040
2020-10-14T04:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide,Synonym:,CXCR4 antagonist BKT140
2020-10-14T04:49:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide,Synonym:,CXCR4 chemokine receptor antagonist BKT140
2020-10-14T13:30:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motolimod,Code name:,VTX-2337
2020-10-14T13:30:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motolimod,Synonym:,Toll-like receptor 8 agonist VTX-2337
2020-09-18T09:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-gp100-plasmid-dna-vaccine,NA,NA
2020-09-18T09:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-prostate-specific-membrane-antigen-plasmid-dna-vaccine,Abbreviation:,mouse PSMA DNA
2020-09-18T09:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-prostate-specific-membrane-antigen-plasmid-dna-vaccine,Synonym:,mouse PSMA DNA Vaccine
2020-09-18T09:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-renal-adenocarcinoma-cell-encapsulated-agarose-agarose-macrobeads,Acronym:,RENCA Macrobead
2020-09-18T09:21:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov-gamma-chimeric-receptor-gene,Synonym:,MOv-gamma
2020-10-14T12:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov19-car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Synonym:,allogeneic MOv19 CAR-CD3zeta-4-1BB-expressing T lymphocytes
2020-10-14T12:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov19-car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Synonym:,anti-folate receptor alpha-CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes
2020-10-14T12:46:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov19-car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes,Synonym:,MOv19-CAR-CD3zeta-4-1BB-expressing allogeneic T cells
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Code name:,CAT-8015
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Code name:,GCR-8015
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Code name:,HA22
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Synonym:,anti-CD22 immunotoxin CAT-8015
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Synonym:,immunotoxin CAT-8015
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,Synonym:,moxetumomab pasudotox
2020-09-18T08:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox,US brand name:,Lumoxiti
2020-10-14T12:46:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxidectin,NA,NA
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Abbreviation:,MOXI
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,Code name:,BAY 128039
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Avelox
2020-09-18T04:26:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride,US brand name:,Viagmox
2020-09-18T09:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mp-35491,Code name:,MNK-010
2020-09-18T09:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mp-35491,Code name:,MP-3549-1
2020-09-18T09:21:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mp-35491,Synonym:,pegylated liposomal docetaxel prodrug MNK-010
2020-09-18T09:21:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bay-1217389,Code name:,BAY 1217389
2020-10-14T12:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bos172722,Code name:,BOS 172722
2020-10-14T12:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bos172722,Code name:,BOS172722
2020-10-14T12:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bos172722,Synonym:,monopolar spindle 1 inhibitor BOS172722
2020-10-14T12:46:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bos172722,Synonym:,TTK inhibitor BOS172722
2020-09-18T09:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-kinase-inhibitor-bay1161909,Code name:,BAY116-1909
2020-09-18T09:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-kinase-inhibitor-bay1161909,Code name:,BAY1161909
2020-10-14T12:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-personalized-cancer-vaccine-mrna-4157,Code name:,mRNA 4157
2020-10-14T12:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-personalized-cancer-vaccine-mrna-4157,Code name:,mRNA-4157
2020-10-14T12:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-personalized-cancer-vaccine-mrna-4157,Synonym:,mRNA-based PCV mRNA-4157
2020-10-14T12:47:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-personalized-cancer-vaccine-mrna-4157,Synonym:,PCV mRNA-4157
2020-10-14T12:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-trimix-melanoma-vaccine-eci-006,Code name:,ECI 006
2020-10-14T12:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-trimix-melanoma-vaccine-eci-006,Code name:,ECI-006
2020-10-14T12:47:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-trimix-melanoma-vaccine-eci-006,Code name:,ECI006
2020-10-14T12:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902,Code name:,GRT R902
2020-10-14T12:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902,Code name:,GRT-R902
2020-10-14T12:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902,Code name:,GRTR902
2020-10-14T12:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902,Synonym:,boosting cancer vaccine GRT-R902
2020-10-14T12:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902,Synonym:,mRNA-based TSNA boosting vaccine GRT-R902
2020-10-14T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941,Code name:,V 941
2020-10-14T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941,Code name:,V941
2020-10-14T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941,Synonym:,mRNA 5671
2020-10-14T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941,Synonym:,mRNA-5671
2020-10-14T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941,Synonym:,mRNA-5671 vaccine
2020-10-14T12:47:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-bi-1361849,Code name:,BI 1361849
2020-10-14T12:47:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-bi-1361849,Code name:,CV9202
2020-09-18T09:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-cv9202,Code name:,BI 1361849
2020-09-18T09:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-cv9202,Code name:,CV9202
2020-09-18T09:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9103,Code name:,CV9103
2020-09-18T09:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9103,Synonym:,messenger RNA-derived prostate cancer vaccine CV9103
2020-09-18T09:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9104,Code name:,CV9104
2020-09-18T09:22:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9104,Synonym:,RNActive®-derived prostate cancer vaccine CV9104
2020-09-18T09:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl,Chemical structure:,"2-(6-fluoro-2-methyl-1H-indol-3-yl)-1H-imidazo[4,5-f][1,10]phenanthroline hydrochloride"
2020-09-18T09:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl,Code name:,APTO-253 HCl
2020-09-18T09:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl,Code name:,LOR-253 HCl
2020-09-18T09:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl,Code name:,LT-253 HCl
2020-09-18T09:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl,Synonym:,MTF-1 inhibitor LOR-253 HCl
2020-09-18T09:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-inhibitor-gdc-0349,Chemical structure:,"(S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea"
2020-09-18T09:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-inhibitor-gdc-0349,Code name:,GDC-0349
2020-09-18T09:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-inhibitor-gdc-0349,Code name:,GDC0349
2020-09-18T09:23:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-inhibitor-gdc-0349,Code name:,RG7603
2020-09-18T09:23:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-azd8055,Code name:,AZD8055
2020-09-18T12:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223,Code name:,ATG-008
2020-09-18T12:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223,Code name:,CC-223
2020-09-18T12:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223,Synonym:,mTOR kinase inhibitor CC-223
2020-09-18T12:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223,US brand name:,TORKi
2020-09-18T09:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-osi-027,Code name:,OSI-027
2020-09-18T09:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-osi-027,Synonym:,mammalian target of rapamycin kinase inhibitor OSI-027
2020-09-18T09:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor1-2-kinase-inhibitor-me-344,Code name:,ME-344
2020-10-14T12:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc-1-2-inhibitor-lxi-15029,Code name:,LXI-15029
2020-10-14T12:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc-1-2-inhibitor-lxi-15029,Code name:,LXI15029
2020-10-14T12:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc-1-2-inhibitor-lxi-15029,Code name:,SCC-31
2020-09-18T09:23:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc1-2-kinase-inhibitor-bi-860585,Code name:,BI 860585
2020-09-18T09:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc1-mtorc2-dhfr-inhibitor-abtl0812,Code name:,ABTL0812
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,CA15-3 antigen
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,cancer antigen 15-3
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,DF3 antigen
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,episialin
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,glycosylated MUC-1
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,ImMucin
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,MUC-1
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,Muc1 Mucin
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,Mucin Peptide MUC-1
2020-10-14T12:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen,Synonym:,Polymorphic Epithelial Mucin
2020-10-14T12:47:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-peptide-vaccine,NA,NA
2020-10-14T12:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-wt1-peptide-primed-autologous-dendritic-cells,Synonym:,MUC-1/WT1 peptide-loaded autologous dendritic cells
2020-10-14T12:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-wt1-peptide-primed-autologous-dendritic-cells,Synonym:,MUC-1/WT1 peptide-primed autologous DCs
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,CA15-3 antigen
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,cancer antigen 15-3
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,DF3 antigen
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,episialin
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,glycosylated MUC-1
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,ImMucin
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,MUC-1
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,Muc1 Mucin
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,Mucin Peptide MUC-1
2020-09-18T09:23:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen,Synonym:,Polymorphic Epithelial Mucin
2020-09-18T09:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-klh-conjugate-vaccine,Abbreviation:,MUC1-KLH VAC
2020-09-18T09:24:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-klh-conjugate-vaccine,Synonym:,MUC-1-KLH vaccine
2020-09-18T09:24:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-klh-vaccine-qs21,NA,NA
2020-09-18T09:23:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-poly-iclc-adjuvant-vaccine,NA,NA
2020-10-14T12:47:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-poly-iclc-vaccine,NA,NA
2020-09-18T09:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-vaccine,NA,NA
2020-09-18T09:24:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-targeted-peptide-go-2-03-2c,Code name:,GO-203-2C
2020-10-14T12:47:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-targeted-peptide-go-203-2c,Code name:,GO-203-2C
2020-09-18T09:23:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc16-targeted-antibody-drug-conjugate-dmuc5754a,Code name:,DMUC5754A
2020-09-18T09:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-hydrogel-gargle,Foreign brand name:,FORRAD
2020-09-18T09:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-hydrogel-gargle,Synonym:,oral ulder gargle
2020-09-18T09:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-hydrogel-gargle,Synonym:,oral viscous mucoadhesive hydrogel gargle
2020-09-18T09:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-oral-wound-rinse,Synonym:,oral mucoadhesive protectant rinse
2020-09-18T09:24:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-oral-wound-rinse,US brand name:,MuGard
2020-09-18T09:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-paclitaxel-formulation,Code name:,DHP107
2020-09-18T09:24:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-agc-kinase-inhibitor-at13148,Code name:,AT13148
2020-10-14T12:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002,Code name:,NEXI 002
2020-10-14T12:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002,Code name:,NEXI002
2020-10-14T12:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002,Synonym:,autologous MM-associated antigens specific T cells NEXI-002
2020-10-14T12:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002,Synonym:,NEXI-002 T cells
2020-10-14T12:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002,Synonym:,TAA primed antigen-specific CD8+ T cells NEXI-002
2020-09-18T09:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200,Code name:,TPIV 200
2020-09-18T09:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200,Code name:,TPIV-200
2020-09-18T09:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200,Code name:,TPIV200
2020-09-18T09:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200,Synonym:,TPIV 200 vaccine
2020-09-18T09:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200,Synonym:,TPIV200/huFR-1
2020-10-14T05:08:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRalphaDC vaccine
2020-10-14T05:08:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-loaded-dendritic-cell-vaccine,Abbreviation:,FRαDC vaccine
2020-09-18T09:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-peptide-vaccine,Abbreviation:,HuFR-1
2020-09-18T09:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-peptide-vaccine,Synonym:,FR alpha peptide vaccine
2020-09-18T09:24:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-peptide-vaccine,Synonym:,FRα peptide vaccine
2020-10-14T12:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-h2nvac,Code name:,H2NVAC
2020-10-14T12:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-h2nvac,Synonym:,HER2 peptide vaccine H2NVAC
2020-10-14T12:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-h2nvac,Synonym:,HER2 specific helper T-cell epitope vaccine H2NVAC
2020-10-14T12:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100,Code name:,TPIV 100
2020-10-14T12:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100,Code name:,TPIV-100
2020-10-14T12:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100,Code name:,TPIV100
2020-10-14T12:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100,Synonym:,HER2/Neu peptide vaccine TPIV100
2020-10-14T12:48:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100,Synonym:,peptide vaccine TPIV100
2020-09-18T09:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-melanoma-peptide-vaccine,Abbreviation:,MULTI-EP MP VAC
2020-10-14T12:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,ME T-cell receptor gamma alternate reading frame protein peptide-pulsed autologous DC vaccine
2020-10-14T12:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,multi-epitope TARP peptide-pulsed autologous dendritic cell vaccine
2020-10-14T12:48:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,multi-epitope TARP-pulsed autologous DC vaccine
2020-10-14T12:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022,Code name:,TPX 0022
2020-10-14T12:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022,Code name:,TPX-0022
2020-10-14T12:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022,Code name:,TPX0022
2020-10-14T12:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022,Synonym:,MET/Src/CSF1R tyrosine kinase inhibitor TPX-0022
2020-10-14T12:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022,Synonym:,multikinase inhibitor TPX-0022
2020-10-14T12:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-xl092,Code name:,XL 092
2020-10-14T12:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-xl092,Code name:,XL-092
2020-10-14T12:48:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-xl092,Code name:,XL092
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Chemical structure:,"urea, N-[4-[4-amino-6-(methoxymethyl)-7-(4-morpholinylmethyl)pyrrolo[2,1-f][1,2,4]triazin-5-yl]-2-fluorophenyl]-N'-[2-fluoro-5-(trifluoromethyl)phenyl]-"
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Code name:,ACTB-1003
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Code name:,EDP317
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Code name:,EOC 317
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Code name:,EOC-317
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Code name:,EOC317
2020-10-14T12:48:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317,Synonym:,MMKI EOC317
2020-10-14T12:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-neo-epitope-vaccine-ose-2101,Code name:,EP-2101
2020-10-14T12:56:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-neo-epitope-vaccine-ose-2101,Foreign brand name:,Tedopi
2020-09-18T09:26:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-peptide-cmv-modified-vaccinia-ankara-vaccine,Synonym:,CMV-MVA triplex vaccine
2020-10-14T12:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-subtype-natural-human-leukocyte-interferon-alpha,Synonym:,multisubtype natural human interferon alpha
2020-10-14T12:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-subtype-natural-human-leukocyte-interferon-alpha,US brand name:,Multiferon
2020-09-18T09:24:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multicarotenoid-supplement-mcs-8,Code name:,MCS-8
2020-09-18T09:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiepitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,ME T-cell receptor gamma alternate reading frame protein peptide-pulsed autologous DC vaccine
2020-09-18T09:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiepitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,multi-epitope TARP peptide-pulsed autologous dendritic cell vaccine
2020-09-18T09:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiepitope-tarp-pulsed-autologous-dendritic-cell-vaccine,Synonym:,multi-epitope TARP-pulsed autologous DC vaccine
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Code name:,OMN54
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,Synonym:,MFMT OMN54
2020-09-18T02:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54,US brand name:,Aneustat
2020-09-18T09:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-4sc-203,Code name:,4SC-203
2020-10-14T03:25:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-aee788,NA,NA
2020-09-18T09:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-at9283,Code name:,AT9283
2020-09-18T09:25:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-sar103168,Code name:,SAR103168
2020-09-18T09:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multipeptide-vaccine-s-588210,Code name:,S-588210
2020-09-18T09:26:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multipeptide-vaccine-s-588210,Synonym:,S-488210/S-488211
2020-09-18T09:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiple-taa-loaded-dendritic-cell-vaccine,Abbreviation:,MASCT-I
2020-09-18T09:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,antigen-pulsed DCs MASCT-I
2020-09-18T09:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,multiple TAA-loaded DC vaccine
2020-09-18T09:26:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,multiple target antigen-stimulating cells-I
2020-09-18T09:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multisubtype-natural-human-leukocyte-interferon-alpha,Synonym:,multisubtype natural human interferon alpha
2020-09-18T09:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multisubtype-natural-human-leukocyte-interferon-alpha,US brand name:,Multiferon
2020-09-18T09:26:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multitargeted-tyrosine-kinase-inhibitor-jnj-26483327,Code name:,JNJ-26483327
2020-09-18T09:26:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multivitamin,Abbreviation:,MULTIVIT
2020-10-14T13:05:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muparfostat,Synonym:,heparanase inhibitor PI-88
2020-09-18T09:26:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mureletecan,Code name:,PNU 166148
2020-09-18T09:26:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murine-tyrp2-plasmid-dna-vaccine,NA,NA
2020-10-14T12:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murizatoclax,Code name:,AMG 397
2020-10-14T12:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murizatoclax,Code name:,AMG-397
2020-10-14T12:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murizatoclax,Code name:,AMG397
2020-10-14T12:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murizatoclax,Synonym:,myeloid cell leukemia 1 inhibitor AMG 397
2020-10-14T03:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab,Code name:,3C23K
2020-10-14T03:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab,Code name:,GM102
2020-10-14T03:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab,Code name:,GM10II
2020-10-14T03:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab,Synonym:,anti-AMHR2 monoclonal antibody GM10II
2020-10-14T03:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab,Synonym:,GM102 antibody
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,Abbreviation:,MOAB OKT3
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,Synonym:,Anti-CD3 monoclonal antibody OKT3
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,Synonym:,MOAB OKT3
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,Synonym:,monoclonal antibody OKT3
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,Synonym:,OKT3
2020-09-18T09:27:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3,US brand name:,Orthoclone OKT3
2020-09-18T09:27:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract,Abbreviation:,MSKE
2020-09-18T09:27:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract,US brand name:,Muscadine Plus
2020-09-18T09:27:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract,US brand name:,Vinetra
2020-09-18T09:27:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscarinic-agonist-apd515,Code name:,APD515
2020-10-14T12:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-idh1-inhibitor-ds-1001,Code name:,DS 1001
2020-10-14T12:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-idh1-inhibitor-ds-1001,Code name:,DS-1001
2020-10-14T12:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-idh1-inhibitor-ds-1001,Code name:,DS-1001b
2020-10-14T12:48:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-idh1-inhibitor-ds-1001,Synonym:,mutant isocitrate dehydrogenase type 1 inhibitor DS-1001
2020-09-18T09:27:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-activator-coti-2,Code name:,COTI-2
2020-09-18T09:27:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-activator-coti-2,Code name:,COTI2
2020-09-18T09:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-peptide-pulsed-dendritic-cell-vaccine,Abbreviation:,p53 DEN
2020-09-18T09:27:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-peptide-pulsed-dendritic-cell-vaccine,Synonym:,mutant p53 peptide pulsed DC vaccine
2020-09-18T09:27:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-selective-egfr-inhibitor-pf-06459988,Code name:,PF-06459988
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,Foreign brand name:,Imvanex
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,Synonym:,modified vaccinia Ankara - Bavarian Nordic smallpox vaccine
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,Synonym:,modified vaccinia Ankara smallpox vaccine
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,Synonym:,MVA smallpox vaccine
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,US brand name:,Imvamune
2020-10-14T05:23:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine,US brand name:,Jynneos
2020-09-18T09:28:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-ebna1-lmp2-vaccine,NA,NA
2020-09-18T09:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-fcu1-tg4023,Code name:,TG4023
2020-09-18T09:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-fcu1-tg4023,Synonym:,modified Ankara virus-mediated suicide gene delivery vector TG4023
2020-09-18T09:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-muc1-il2-vaccine,Abbreviation:,MVA-MUC1-IL2
2020-09-18T09:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-muc1-il2-vaccine,Code name:,TG4010
2020-09-18T09:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-muc1-il2-vaccine,Synonym:,modified vaccinia ankara encoding human MUC-1 antigen and interleukin-2 suspension
2020-09-18T09:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-psa-pap-prostate-cancer-vaccine,Synonym:,modified vaccinia Ankara (Bavarian Nordic) prostate cancer vaccine
2020-09-18T09:28:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-psa-pap-prostate-cancer-vaccine,Synonym:,MVA-BN-PRO
2020-10-14T12:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-tumor-specific-neoantigen-boosting-vaccine-mva-209-fsp,Code name:,MVA-209-FSP
2020-10-14T12:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-tumor-specific-neoantigen-boosting-vaccine-mva-209-fsp,Synonym:,Modified Vaccinia Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP
2020-10-14T12:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-tumor-specific-neoantigen-boosting-vaccine-mva-209-fsp,Synonym:,Modified Vaccinia Virus Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP
2020-09-18T09:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvac-regimen,Synonym:,M-VAC regimen
2020-09-18T09:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvac-regimen,Synonym:,methotrexate-vinblastine sulfate-doxorubicin hydrochloride-cisplatin regimen
2020-09-18T09:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvac-regimen,Synonym:,methotrexate-vinblastine-adriamycin-cisplatin regimen
2020-09-18T09:27:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvac-regimen,Synonym:,methotrexate-vinblastine-doxorubicin-cisplatin regimen
2020-09-18T09:28:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvf-her-2597-626-mvf-her-2-266-296-peptide-vaccine,NA,NA
2020-09-18T09:28:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvx-1-loaded-macrocapsule-autologous-tumor-cell-vaccine-mvx-onco-1,Code name:,MVX-ONCO-1
2020-09-18T09:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/myc-targeting-sirna-dcr-myc,Code name:,DCR-M1711
2020-09-18T09:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/myc-targeting-sirna-dcr-myc,Code name:,DCR-MYC
2020-09-18T09:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterial-cell-wall-dna-complex,Abbreviation:,MCC
2020-09-18T09:29:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterium-tuberculosis-arabinomannan-z-100,Code name:,Z-100
2020-09-18T09:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterium-w,NA,NA
2020-09-18T05:19:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil,Abbreviation:,MMF
2020-09-18T05:19:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil,US brand name:,Cellcept
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Abbreviation:,MPA
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Chemical structure:,"4-hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-4-hexenoic acid, 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-, (E)-"
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Code name:,Lilly-68618
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Code name:,Ly 68618
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Synonym:,acide mycophenolique
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Synonym:,acido micofenolico
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,Synonym:,acidum mycophenolicum
2020-09-18T09:29:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid,US brand name:,Myfortic
2020-09-18T09:30:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-acetylcysteine-simethicone-solution,NA,NA
2020-10-14T12:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-dihydrogalactochitosan,Code name:,IP 001
2020-10-14T12:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-dihydrogalactochitosan,Code name:,IP-001
2020-10-14T12:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-dihydrogalactochitosan,Code name:,IP001
2020-10-14T12:50:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-dihydrogalactochitosan,Synonym:,1% N-dihydro-galacto-chitosan
2020-09-18T09:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide,Abbreviation:,NMF
2020-09-18T09:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide,Code name:,EK 7011
2020-09-18T09:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide,Code name:,X 188
2020-09-18T09:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide,Synonym:,formylmethylamine
2020-09-18T09:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide,Synonym:,monomethylformamide
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Chemical structure:,N-oleyl-phosphatidylethanolamine/epigallocatechin gallate
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,N-oleoyl-PE/EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,NOPE plus EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,NOPE-EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,NOPE/EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,OEA-PE/EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,Synonym:,oleoyl ethanolamine-phosphatidylethanolamine plus EGCG
2020-10-14T12:52:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement,US brand name:,PhosphoLean
2020-09-18T09:30:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na-17-mage-3a2-ny-eso-1-peptide-vaccine,NA,NA
2020-09-18T09:30:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na17-a-antigen,Synonym:,NA17-A
2020-09-18T09:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na17a2-peptide-vaccine,Synonym:,NA17.A2
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Code name:,ABI-007
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,albumin-bound paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,Albumin-Stabilized Nanoparticle Paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,nab paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,nab-paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,nanoparticle albumin-bound paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,Nanoparticle Paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,Synonym:,protein-bound paclitaxel
2020-10-14T03:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel,US brand name:,Abraxane
2020-09-18T09:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160,Code name:,AR160
2020-09-18T09:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160,Synonym:,Abraxane coated with rituximab
2020-09-18T09:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160,Synonym:,Abraxane Coated with rituximab 160nm nanoparticle
2020-09-18T09:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160,Synonym:,Abraxane/Rituxan 160 complex
2020-09-18T09:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160,Synonym:,nab-paclitaxel-rituximab complex
2020-09-18T09:30:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabilone,Foreign brand name:,Cesamet
2020-09-18T09:30:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabilone,Synonym:,Cpd 109514
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Code name:,GW-1000
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Code name:,GW-1000-02
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Foreign brand name:,Sativex
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Synonym:,cannabidiol mixture with tetrahydrocannabinol
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Synonym:,cannabis-based oromucosal spray GW-1000-02
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,Synonym:,THC and CBD mixture
2020-09-18T09:30:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols,US brand name:,Sativex
2020-10-14T12:49:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec,Abbreviation:,rAd-IFN SCH 721015
2020-10-14T12:49:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec,Code name:,SCH 721015
2020-10-14T12:49:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec,Synonym:,recombinant adenovirus-interferon SCH 721015
2020-10-14T13:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec-syn3,Foreign brand name:,Instiladrin
2020-10-14T13:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec-syn3,Synonym:,rAd-IFN/Syn3
2020-10-14T13:12:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec-syn3,Synonym:,recombinant adenovirus-interferon with Syn3
2020-09-18T05:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadolol,US brand name:,Corgard
2020-09-18T09:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadroparin-calcium,Foreign brand name:,Fraxiparine
2020-09-18T09:30:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadroparin-calcium,Synonym:,nadroparin
2020-09-18T09:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nafoxidine-hydrochloride,Chemical structure:,"1-[2-[4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]pyrrolidine Hydrochloride"
2020-09-18T09:31:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nafoxidine-hydrochloride,Code name:,U 11100A
2020-10-14T13:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nagrestipen,Abbreviation:,eMIP
2020-10-14T13:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nagrestipen,Code name:,ECI301
2020-10-14T12:49:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nalbuphine,NA,NA
2020-09-18T09:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol,Chemical structure:,"morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)- 17-(2-propenyl)-, (5alpha,6alpha)-"
2020-09-18T09:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol,Code name:,AZ13337019
2020-09-18T09:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol,Code name:,NKTR-118
2020-09-18T09:21:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol,US brand name:,Movantik
2020-09-18T09:31:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxone-hydrochloride,US brand name:,Narcan
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,Chemical structure:,"(5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride"
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,US brand name:,Depade
2020-09-18T05:58:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride,US brand name:,Revia
2020-10-14T03:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson,Abbreviation:,Cl-IB-MECA
2020-10-14T03:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson,Chemical structure:,2-chloro-N6-(3-iodobenzyl)-9-[5-(methylcarbamoyl)--D-ribofuranosyl]adenine
2020-10-14T03:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson,Code name:,CF102
2020-10-14T03:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson,Synonym:,A3AR agonist CF102
2020-10-14T12:49:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82,Code name:,OT 82
2020-10-14T12:49:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82,Code name:,OT-82
2020-10-14T12:49:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82,Code name:,OT82
2020-10-14T12:49:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82,Synonym:,NAMPTi OT-82
2020-10-14T12:49:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82,Synonym:,nicotinamide phosphoribosyl transferase inhibitor OT-82
2020-10-14T05:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanatinostat,Code name:,CHR-3996
2020-10-14T05:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanatinostat,Code name:,VRx 3996
2020-10-14T05:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanatinostat,Code name:,VRx-3996
2020-10-14T05:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanatinostat,Code name:,VRx3996
2020-09-18T09:31:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nandrolone-decanoate,Synonym:,Deca-Durabolin
2020-09-18T09:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanocell-encapsulated-mir-16-based-microrna-mimic,Foreign brand name:,TargomiRs
2020-10-14T12:49:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel,Abbreviation:,nab-docetaxel
2020-10-14T12:49:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel,Code name:,ABI-008
2020-09-18T09:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel-abi-008,Abbreviation:,nab-docetaxel
2020-09-18T09:31:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel-abi-008,Code name:,ABI-008
2020-09-18T09:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-rapamycin,Code name:,ABI-009
2020-09-18T09:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-rapamycin,Synonym:,nab-rapamycin
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,Code name:,SN132D
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,Synonym:,manganese-based macromolecular contrast agent SN132D
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,Synonym:,manganese-containing nanoparticle contrast agent SN132D
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,Synonym:,MRI contrast agent SN132D
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,Synonym:,nanoparticle-based contrast agent with manganese SN132D
2020-10-14T12:49:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d,US brand name:,SpagoPix
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC 634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC-634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Code name:,CPC634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Foreign brand name:,CriPec® docetaxel
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,docetaxel containing CriPec (R) nanoparticles
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,docetaxel-containing CriPec (R) nanoparticles CPC634
2020-09-18T06:11:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel,Synonym:,nanoparticle-encapsulated docetaxel CPC634
2020-09-18T09:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-doxorubicin-hydrochloride,Code name:,BA-003
2020-09-18T09:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-doxorubicin-hydrochloride,Foreign brand name:,doxorubicin Transdrug
2020-09-18T09:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-doxorubicin-hydrochloride,Foreign brand name:,Livatag
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Code name:,SOR007
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Synonym:,nanopac ointment
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Synonym:,nanoparticle paclitaxel SOR007
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Synonym:,SOR007 ointment
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Synonym:,topical manoparticle paclitaxel ointment
2020-10-14T12:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007,Synonym:,uncoated nanoparticle paclitaxel ointment
2020-10-14T12:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-sn-38-encapsulated-micelle-formulation-it-141,Code name:,IT-141
2020-10-14T12:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-sn-38-encapsulated-micelle-formulation-it-141,Code name:,IT141
2020-10-14T12:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-sn-38-encapsulated-micelle-formulation-it-141,Synonym:,nanoparticle SN-38 formulation IT141
2020-10-14T12:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoscale-coordination-polymer-nanoparticles-cpi-100,Code name:,CPI 100
2020-10-14T12:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoscale-coordination-polymer-nanoparticles-cpi-100,Code name:,CPI-100
2020-10-14T12:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoscale-coordination-polymer-nanoparticles-cpi-100,Code name:,CPI100
2020-10-14T12:50:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoscale-coordination-polymer-nanoparticles-cpi-100,Synonym:,NCP nanoparticles CPI-100
2020-09-18T09:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanosomal-docetaxel-lipid-suspension,Abbreviation:,DTX-LNS
2020-09-18T09:32:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanosomal-docetaxel-lipid-suspension,Abbreviation:,NDLS
2020-09-18T09:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/napabucasin,Code name:,BBI608
2020-09-18T09:32:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/napabucasin,Synonym:,cancer stemness inhibitor BBI608
2020-09-18T09:32:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naphthalimide-analogue-unbs5162,Chemical structure:,"1-(2-(2-(dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea"
2020-09-18T09:32:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naphthalimide-analogue-unbs5162,Code name:,UNBS5162
2020-09-18T09:32:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naproxen,Chemical structure:,6-Methoxy-alpha-methyl-2-naphthaleneacetic Acidd-2-(6-Methoxy-2-naphthyl)propionic Acid
2020-09-18T09:32:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naproxen,Code name:,RS-3540
2020-09-18T09:32:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naproxen,US brand name:,Naprosyn
2020-09-18T09:32:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naptumomab-estafenatox,Code name:,ABR-217620
2020-10-14T04:57:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naquotinib,Code name:,ASP8273
2020-09-18T09:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narnatumab,Code name:,IMC RON8
2020-09-18T09:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narnatumab,Code name:,IMC-RON8
2020-09-18T09:33:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narnatumab,Synonym:,anti-RON monoclonal antibody IMC-RON8
2020-10-14T03:52:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narsoplimab,Code name:,OMS721
2020-09-18T09:33:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nasal-saline-irrigation-solution,Synonym:,nasal saline rinse
2020-09-18T09:33:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nasal-saline-irrigation-solution,Synonym:,nasal saline wash
2020-09-18T09:33:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natalizumab,US brand name:,Tysabri
2020-09-18T09:33:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nateglinide,US brand name:,Starlix
2020-09-18T09:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-human-interferon-alpha-opc-18,Code name:,OPC-18
2020-09-18T09:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-human-interferon-alpha-opc-18,Foreign brand name:,Alfaferone
2020-09-18T09:33:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-human-interferon-alpha-opc-18,Synonym:,natural interferon alfa
2020-10-14T12:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-ifn-alpha-opc-18,Code name:,OPC-18
2020-10-14T12:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-ifn-alpha-opc-18,Foreign brand name:,Alfaferone
2020-10-14T12:50:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-ifn-alpha-opc-18,Synonym:,natural interferon alfa
2020-09-18T09:33:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-killer-cells-zrx101,Synonym:,NK cells ZRx101
2020-10-14T03:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navicixizumab,Code name:,OMP-305B83
2020-09-18T09:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navitoclax,Code name:,A-855071.0
2020-09-18T09:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navitoclax,Code name:,ABT-263
2020-09-18T09:34:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navitoclax,Synonym:,BcI-2 family protein inhibitor ABT-263
2020-10-14T05:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navoximod,Code name:,NLG919
2020-10-14T05:22:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navoximod,Synonym:,NLG-919
2020-09-18T09:34:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navy-bean-powder,NA,NA
2020-10-14T12:50:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naxitamab,Synonym:,hu3F8
2020-10-14T12:50:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naxitamab,Synonym:,humanized anti-GD2 antibody 3F8
2020-10-14T12:50:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naxitamab,Synonym:,humanized monoclonal antibody 3F8
2020-10-14T04:57:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nazartinib,Code name:,EGF816
2020-09-18T09:34:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ncmtrna-oligonucleotide-andes-1537,Code name:,Andes-1537
2020-10-14T12:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196,Code name:,HS 196
2020-10-14T12:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196,Code name:,HS-196
2020-10-14T12:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196,Code name:,HS196
2020-10-14T12:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196,Synonym:,HSP90 inhibitor-linked NIR probe HS-196
2020-10-14T12:50:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196,Synonym:,NIR-tethered Hsp90 inhibitor HS-196
2020-09-18T09:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab,Code name:,IMC-11F8
2020-09-18T09:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab,Synonym:,anti-EGFR monoclonal antibody IMC-11F8
2020-09-18T09:34:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab,US brand name:,Portrazza
2020-09-18T09:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedaplatin,Chemical structure:,"platinum, diammine(hydroxy-kappaO)acetato(2-)-kappaO)-, (SP-4-3)-"
2020-09-18T09:34:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedaplatin,Synonym:,nedaplat
2020-09-18T09:34:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedd8-activating-enzyme-e1-inhibitor-tas4464,Code name:,TAS4464
2020-09-18T09:34:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedd8-activating-enzyme-e1-inhibitor-tas4464,Synonym:,NAE inhibitor TAS4464
2020-09-18T09:35:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nefopam-hydrochloride,Chemical structure:,"1-ethyl-3-hydroxy-1-methylpyrrolidinium .alpha.-cyclopentylphenylacetate3,4,5,6-tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine hydrochloride"
2020-09-18T09:35:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neihulizumab,Code name:,AbGn 168H
2020-09-18T09:35:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neihulizumab,Code name:,AbGn-168
2020-09-18T09:35:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neihulizumab,Code name:,AbGn-168H
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Chemical structure:,2-amino-6-methoxypurine arabinoside2-amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,Code name:,GW506U78
2020-09-18T03:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine,US brand name:,Arranon
2020-09-18T09:35:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelfinavir-mesylate,US brand name:,Viracept
2020-09-18T09:35:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine,Synonym:,E75 Plus GM-CSF
2020-09-18T09:35:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine,Synonym:,E75 vaccine plus GM-CSF
2020-09-18T09:35:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine,Synonym:,HLA A2/A3–restricted HER-2/neu peptide vaccine plus GM-CSF
2020-09-18T09:35:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine,Synonym:,nelipepimut-S plus sargramostim
2020-09-18T09:35:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine,Synonym:,NeuVax Plus GM-CSF
2020-10-14T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neo-multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,neo-MASCT
2020-10-14T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neo-multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,neo-multiple TAA-loaded DC vaccine
2020-10-14T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neo-multiple-taa-loaded-dendritic-cell-vaccine,Synonym:,neoantigen-loaded dendritic cell vaccine
2020-09-18T09:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-glioblastoma-vaccine,Synonym:,NeoVax (TM) glioblastoma vaccine
2020-09-18T09:35:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-glioblastoma-vaccine,Synonym:,personalized neoantigen glioblastoma vaccine
2020-09-18T09:35:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-melanoma-poly-iclc-vaccine,Synonym:,NeoVax melanoma vaccine
2020-10-14T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-renal-cell-carcinoma-poly-iclc-vaccine,Synonym:,NeoVax RCC vaccine
2020-10-14T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-renal-cell-carcinoma-poly-iclc-vaccine,Synonym:,NeoVax renal cell carcinoma vaccine
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Code name:,GRT C903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Code name:,GRT-C903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Code name:,GRTC903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Synonym:,priming cancer vaccine GRT-C903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Synonym:,priming vaccine GRT-C903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Synonym:,shared neoantigen cancer vaccine prime GRT-C903
2020-10-14T12:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903,Synonym:,shared neoantigen priming cancer vaccine GRT-C903
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Code name:,GRT R904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Code name:,GRT-R904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Code name:,GRTR904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Synonym:,boosting cancer vaccine GRT-R904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Synonym:,boosting vaccine GRT-R904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Synonym:,Shared Neoantigen Boosting Cancer Vaccine GRT-R904
2020-10-14T12:50:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904,Synonym:,shared neoantigen cancer vaccine boost GRT-R904
2020-09-18T09:35:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-dna-based-pancreatic-cancer-vaccine,Synonym:,neoantigen DNA pancreatic cancer vaccine
2020-09-18T09:35:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-dna-based-pancreatic-cancer-vaccine,Synonym:,personalized neoantigen DNA pancreatic cancer vaccine
2020-10-14T12:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-encoding-personalized-virus-2,Synonym:,PSV-2
2020-10-14T12:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-encoding-personalized-virus-2,Synonym:,PSV2
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Code name:,AGEN 2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Code name:,AGEN-2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Code name:,AGEN2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Synonym:,ASV AGEN2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Synonym:,autologous cancer vaccine AGEN2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Synonym:,AutoSynVax AGEN2017
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Synonym:,AutoSynVax vaccine
2020-09-18T09:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine,Synonym:,neoantigen vaccine AGEN2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Code name:,AGEN 2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Code name:,AGEN-2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Code name:,AGEN2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Synonym:,ASV AGEN2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Synonym:,autologous cancer vaccine AGEN2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Synonym:,AutoSynVax AGEN2017
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Synonym:,AutoSynVax vaccine
2020-10-14T12:51:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017,Synonym:,neoantigen vaccine AGEN2017
2020-09-18T09:36:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-loaded-autologous-dendritic-cell-vaccine,Synonym:,autologous tumor peptide-loaded mature DC vaccine
2020-10-14T12:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-peptide-vaccine,NA,NA
2020-09-18T09:36:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neomycin,Synonym:,neomycin complex
2020-10-14T13:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nepidermin,Abbreviation:,rhEGF
2020-10-14T13:12:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nepidermin,Foreign brand name:,EASYEF
2020-10-14T12:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib,Chemical structure:,"2-butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1)"
2020-10-14T12:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib,Code name:,HKI-272 maleate
2020-10-14T12:51:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib,US brand name:,Nerlynx
2020-09-18T09:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib-maleate,Chemical structure:,"2-butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1)"
2020-09-18T09:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib-maleate,Code name:,HKI-272 maleate
2020-09-18T09:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib-maleate,US brand name:,Nerlynx
2020-09-18T09:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide,Synonym:,Human Brain Natriuretic Factor-32
2020-09-18T09:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide,Synonym:,Natriuretic factor-32
2020-09-18T09:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide,Synonym:,Natriuretic Peptide Type-B
2020-09-18T09:33:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide,US brand name:,Natrecor
2020-09-18T09:37:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab,Code name:,REGN910
2020-09-18T09:37:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab,Code name:,SAR307746
2020-09-18T09:37:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab,Synonym:,anti-ANG2 MoAb REGN910
2020-09-18T09:37:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab,Synonym:,anti-ANG2 monoclonal antibody REGN910
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Chemical structure:,"1-((3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-3-(3-(methylamino)phenyl)urea"
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Code name:,YF-476
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Code name:,YF476
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Synonym:,CCK-B/gastrin receptor antagonist YF476
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Synonym:,cholecystokin 2 (CCK(2)) receptor antagonist YF476
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Synonym:,cholecystokinin B receptor antagonist YF476
2020-09-18T09:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide,Synonym:,sograzepide
2020-09-18T09:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant,Code name:,CHEBI:441603
2020-09-18T09:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant,Code name:,CID6451149
2020-09-18T09:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant,Code name:,D05152
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,Synonym:,netupitant/palonosetron hydrochloride
2020-09-18T01:45:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride,US brand name:,Akynzeo
2020-10-14T03:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-palonosetron-hydrochloride,Synonym:,netupitant/palonosetron hydrochloride
2020-10-14T03:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-palonosetron-hydrochloride,US brand name:,Akynzeo
2020-09-18T09:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7,Synonym:,CRAd-S-pk7 loaded NSCs
2020-09-18T09:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7,Synonym:,NSC-CRAd-S-pk7
2020-09-18T09:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7,Synonym:,NSC-CRAd-S-pk7 virotherapeutic
2020-09-18T09:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7,Synonym:,NSC-CRAd-Survivin-pk7
2020-09-18T09:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7,Synonym:,NSCs loaded with CRAd-S-pk7
2020-09-18T09:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neutrophil-activation-probe-imaging-agent,Abbreviation:,NAP
2020-09-18T09:38:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neutrophil-activation-probe-imaging-agent,Synonym:,NAP imaging agent
2020-09-18T09:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine,Abbreviation:,NVP
2020-09-18T09:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine,Chemical structure:,"11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one"
2020-09-18T09:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine,Code name:,BIRG 0587
2020-09-18T09:38:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine,US brand name:,Viramune
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Abbreviation:,L-NMMA
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Abbreviation:,NMA
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Synonym:,N-methylarginine
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Synonym:,N5-(methylamidino)-L-ornithine
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Synonym:,NG-monomethyl-L-arginine
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Synonym:,omega-N-monomethylarginine
2020-09-18T12:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine,Synonym:,targinine
2020-09-18T09:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-nitro-l-arginine,Abbreviation:,L-NNA
2020-09-18T09:38:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-nitro-l-arginine,Abbreviation:,NOLA
2020-09-18T09:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacin,Chemical structure:,3-Pyridinecarboxylic Acid
2020-09-18T09:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacin,Synonym:,nicotinic acid
2020-09-18T09:38:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacin,Synonym:,Vitamin B3
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Foreign brand name:,Nicamid
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Foreign brand name:,Nicosedine
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,3-Pyridinecarboxamide
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,nicotinamide
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,Nicotinamidum
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,Nicotinic Acid Amide
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,Nicotylamide
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,Pellagra-Preventing Factor
2020-09-18T09:38:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide,Synonym:,Vitamin PP
2020-09-18T09:39:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicardipine,NA,NA
2020-09-18T09:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niclosamide,Chemical structure:,"benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-salicylanilide, 2',5-dichloro-4'-nitro-"
2020-09-18T09:39:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niclosamide,Foreign brand name:,Yomesan
2020-09-18T09:39:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicorandil,NA,NA
2020-10-14T12:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotinamide-riboside,Abbreviation:,NR
2020-10-14T12:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotinamide-riboside,US brand name:,Niagen
2020-09-18T09:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine,Abbreviation:,NIC
2020-09-18T09:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine,Chemical structure:,(S)-3-(1-methyl-2-pyrrolidinyl)pyridine1-methyl-2-(3-pyridyl)pyrrolidinebeta-pyridyl-alpha-N-methylpyrrolidine
2020-09-18T09:39:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-gum,Synonym:,nicotine polacrilex
2020-09-18T09:39:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-gum,US brand name:,Nicorette
2020-09-18T05:37:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-lozenge,US brand name:,Commit
2020-09-18T09:39:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-nasal-spray,US brand name:,Nicotrol NS
2020-09-18T09:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch,Synonym:,nicotine skin patch
2020-09-18T09:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch,Synonym:,nicotine transdermal patch
2020-09-18T09:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch,Synonym:,nicotine transdermal system patch
2020-09-18T09:39:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch,US brand name:,NicoDerm CQ
2020-10-14T12:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nidanilimab,Code name:,CAN 04
2020-10-14T12:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nidanilimab,Code name:,CAN-04
2020-10-14T12:51:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nidanilimab,Code name:,CAN04
2020-09-18T09:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nifurtimox,Foreign brand name:,Lampit
2020-09-18T09:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib,Chemical structure:,4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide
2020-09-18T09:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib,Synonym:,AMN 107
2020-09-18T09:40:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib,US brand name:,Tasigna
2020-10-14T12:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate,Chemical structure:,4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide
2020-10-14T12:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate,Synonym:,AMN 107
2020-10-14T12:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate,US brand name:,Tasigna
2020-09-18T09:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide,Abbreviation:,ANAN
2020-09-18T09:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide,Chemical structure:,"1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione5,5-Dimethyl-3-[4-nitro-3-(trifluoro-methyl)phenyl]-2,4-imidazolidinedione"
2020-09-18T09:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide,Code name:,RU-23908
2020-09-18T09:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide,Foreign brand name:,Anandron
2020-09-18T09:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide,US brand name:,Nilandron
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Code name:,CA 102N
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Code name:,CA102N
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Synonym:,HA-Nim Conjugate CA102N
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Synonym:,HA-Nimesulide
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Synonym:,Hyaluronic Acid Nimesulide-NH2 Bioconjugate
2020-10-14T12:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n,Synonym:,Nim-HA Conjugate
2020-09-18T09:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimodipine,Abbreviation:,NIMO
2020-09-18T09:40:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimodipine,US brand name:,Nimotop
2020-09-18T09:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab,Foreign brand name:,BIOMAb EGFR
2020-09-18T09:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab,Foreign brand name:,Taixinsheng
2020-09-18T09:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab,Foreign brand name:,Theraloc
2020-09-18T09:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab,Synonym:,Thera-CIM-hr3
2020-09-18T09:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab,Synonym:,TheraCim hR3
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Abbreviation:,ACNU
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Chemical structure:,N'-[4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Foreign brand name:,Nidran
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,Nimustine Hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,Synonym:,pimustine hydrochloride
2020-09-18T01:19:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine,US brand name:,ACNU 50
2020-10-14T12:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ningetinib-tosylate,Code name:,CT-053-PTSA
2020-10-14T12:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ningetinib-tosylate,Code name:,CT053PTSA
2020-10-14T12:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ningetinib-tosylate,Synonym:,CT-053 tosylate
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Chemical structure:,"methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylidene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate"
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Code name:,BIBF 1120
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Code name:,BIBF-1120
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Synonym:,intedanib
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Synonym:,multitargeted tyrosine kinase inhibitor BIBF 1120
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,Synonym:,Tyrosine Kinase Inhibitor BIBF 1120
2020-09-18T09:41:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib,US brand name:,Vargatef
2020-10-14T12:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nipocalimab,Code name:,M 281
2020-10-14T12:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nipocalimab,Code name:,M-281
2020-10-14T12:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nipocalimab,Code name:,M281
2020-09-18T09:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nir-fluorochrome-vm110,Code name:,VM110
2020-09-18T09:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nir-fluorochrome-vm110,Synonym:,NIRF imaging agent VM110
2020-09-18T09:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nir-fluorochrome-vm110,Synonym:,prosense VM110
2020-09-18T09:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niraparib-tosylate-monohydrate,Chemical structure:,"2H-indazole-7-carboxamide, 2-(4-(3S)-3-piperidinylphenyl)-, 4-methylbenzenesulfonate, hydrate (1:1:1)"
2020-09-18T09:41:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niraparib-tosylate-monohydrate,US brand name:,Zejula
2020-10-14T12:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nirogacestat,Code name:,PF-03084014
2020-10-14T12:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nirogacestat,Synonym:,gamma secretase inhibitor PF-03084014
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,Chemical structure:,"benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-salicylamide, N-(5-nitro-2-thiazolyl)-, acetate(ester)"
2020-09-18T01:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide,US brand name:,Alinia
2020-09-18T09:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitric-oxide-releasing-acetylsalicylic-acid-derivative,Chemical structure:,"benzoic acid, 2-(acetyl-oxy)-3-[(nitrooxy)methyl]phenyl ester"
2020-09-18T09:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitric-oxide-releasing-acetylsalicylic-acid-derivative,Code name:,NCX 4016
2020-09-18T09:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitric-oxide-releasing-acetylsalicylic-acid-derivative,Synonym:,nitric oxide-releasing aspirin derivative
2020-09-18T09:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitric-oxide-releasing-acetylsalicylic-acid-derivative,Synonym:,nitroaspirin
2020-10-14T13:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitrogen-mustard-prodrug-pr-104,Synonym:,PR104
2020-09-18T09:41:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin,NA,NA
2020-09-18T09:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-sodium-citrate-ethanol-solution,Abbreviation:,NiCE
2020-09-18T09:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-sodium-citrate-ethanol-solution,Synonym:,glyceryl trinitrate-citrate-ethanol
2020-09-18T09:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-sodium-citrate-ethanol-solution,Synonym:,GTN-citrate-ethanol
2020-09-18T09:42:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-sodium-citrate-ethanol-solution,Synonym:,nitroglycerin-citrate-ethanol
2020-09-18T07:28:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-transdermal-patch,Synonym:,glyceryl trinitrate transdermal patch
2020-09-18T07:28:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-transdermal-patch,US brand name:,GTN transdermal patch
2020-09-18T09:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi,Synonym:,Achyranthes root
2020-09-18T09:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi,Synonym:,Huai Niu Xi
2020-09-18T09:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi,Synonym:,Niuxi
2020-09-18T09:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi,Synonym:,ox-knee root
2020-09-18T09:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi,Synonym:,Radix Achyranthis bidentatae
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,Abbreviation:,NIVO
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,Code name:,BMS-936558
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,Code name:,MDX-1106
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,Code name:,ONO-4538
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,Synonym:,anti-PD-1 human monoclonal antibody MDX-1106
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,US brand name:,Opdivo
2020-09-18T09:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab,US brand name:,Opdivo Injection
2020-10-14T12:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nlrp3-agonist-bms-986299,Code name:,BMS 986299
2020-10-14T12:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nlrp3-agonist-bms-986299,Code name:,BMS-986299
2020-10-14T12:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nlrp3-agonist-bms-986299,Code name:,BMS986299
2020-10-14T12:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nlrp3-agonist-bms-986299,Synonym:,NLR family pyrin-domain-containing 3 agonist BMS-986299
2020-09-18T09:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nm-3,NA,NA
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Abbreviation:,IL-15N72D/IL-15Ra-Fc
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Code name:,ALT 803
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Code name:,ALT803
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Code name:,N 803
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Code name:,N-803
2020-10-14T13:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa,Synonym:,IL-15N72D:IL-15RaSu/Fc fusion complex
2020-09-18T09:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride,Chemical structure:,"3,4-dihydro-2-amino-6-methyl-4-oxy-5-(4-pyridylthio)-quinazoline Dihydrochloride"
2020-09-18T09:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride,Code name:,AG337
2020-09-18T09:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride,Synonym:,Nolatrexed
2020-09-18T09:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride,Synonym:,nolatrexed hydrochloride
2020-09-18T09:42:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride,US brand name:,Thymitaq
2020-09-18T09:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-adjuvanted-ah1n1-influenza-vaccine,NA,NA
2020-09-18T09:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-small-cell-lung-cancer-mrna-derived-vaccine-cv9201,Code name:,CV9201
2020-09-18T09:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine,Chemical structure:,"(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol"
2020-09-18T09:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine,Synonym:,Arterenol
2020-09-18T09:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine,Synonym:,Noradrenaline
2020-10-14T12:52:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine-dl-,Chemical structure:,"(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol"
2020-10-14T12:52:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine-dl-,Synonym:,Arterenol
2020-10-14T12:52:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine-dl-,Synonym:,Noradrenaline
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Foreign brand name:,Ortho Micronor
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Synonym:,nor-Q.D.
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,Synonym:,norethisterone acetate
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,US brand name:,Aygestin
2020-09-18T04:28:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate,US brand name:,Norlutate
2020-09-18T09:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel,Chemical structure:,"(+/-)-13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one"
2020-09-18T09:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel,Code name:,Wy-3707
2020-09-18T09:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel,US brand name:,Neogest
2020-09-18T09:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel,US brand name:,Ovrette
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Code name:,AFX-2
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Code name:,CVT-E002
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,Synonym:,Panax quinquefolius Extract AFX-2
2020-09-18T05:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2,US brand name:,COLD-fX
2020-09-18T09:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/noscapine-hydrochloride,Chemical structure:,"6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3- dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-isobenzofuranone, [S-(R*,S*)] hydrochloride monohydrate"
2020-09-18T09:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/noscapine-hydrochloride,Synonym:,narcosine hydrochloride
2020-09-18T09:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/noscapine-hydrochloride,Synonym:,narcotine hydrochloride
2020-09-18T09:44:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/notch-signaling-pathway-inhibitor-mk0752,NA,NA
2020-09-18T09:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nrf2-activator-rta-408,Chemical structure:,"propanamide, N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-"
2020-09-18T09:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nrf2-activator-rta-408,Code name:,RTA 408
2020-09-18T09:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nrf2-activator-rta-408,Code name:,RTA-408
2020-09-18T09:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ns5b-polymerase-inhibitor-bms-791325,Code name:,BMS-791325
2020-10-14T12:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-antigen-loaded-dendritic-cell-derived-exosomes,Abbreviation:,NSCLC tumor Ag-loaded Dex
2020-10-14T12:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-antigen-loaded-dendritic-cell-derived-exosomes,Abbreviation:,NSCLC tumor antigen-loaded Dex
2020-10-14T12:52:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-antigen-loaded-dendritic-cell-derived-exosomes,Synonym:,non-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
2020-10-14T12:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-specific-marrow-infiltrating-lymphocytes,Synonym:,Marrow Infiltrating Lymphocytes-Non-Small Cell Lung Cancer
2020-10-14T12:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-specific-marrow-infiltrating-lymphocytes,Synonym:,MILs-NSCLC
2020-10-14T12:52:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-specific-marrow-infiltrating-lymphocytes,Synonym:,NSCLC-specific MILs
2020-09-18T09:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ntrk-ros1-inhibitor-ds-6051b,Code name:,AB-106
2020-09-18T09:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ntrk-ros1-inhibitor-ds-6051b,Code name:,DS-6051
2020-09-18T09:45:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ntrk-ros1-inhibitor-ds-6051b,Code name:,DS-6051b
2020-09-18T09:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleoside-analog-dfp-10917,Chemical structure:,2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine
2020-09-18T09:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleoside-analog-dfp-10917,Code name:,DFP-10917
2020-09-18T09:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleoside-analog-dfp-10917,Synonym:,CNDAC
2020-09-18T09:46:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleotide-analogue-gs-9219,Code name:,GS 9219
2020-09-18T09:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutraceutical-tbl-12,Code name:,TBL-12
2020-09-18T09:46:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutraceutical-tbl-12,Synonym:,immune modulator TBL-12
2020-09-18T09:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutrient-rich-whole-wheat-flour-supplement,Synonym:,IAtta
2020-09-18T09:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutrient-rich-whole-wheat-flour-supplement,Synonym:,Improved Atta
2020-09-18T09:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutrient-rich-whole-wheat-flour-supplement,Synonym:,nutrient-rich bread mix IAtta
2020-09-18T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Boost
2020-09-18T04:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink,US brand name:,Ensure
2020-09-18T09:46:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink-pediatric,US brand name:,PediaSure
2020-10-14T12:53:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel,US brand name:,Nutri-jelly
2020-10-14T12:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel-with-phenethyl-isothiocyanate,Synonym:,semisolid food gel with PEITC
2020-10-14T12:53:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel-with-phenethyl-isothiocyanate,US brand name:,Nutri-jelly with PEITC
2020-09-18T09:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-gla-se-vaccine-id-g305,Code name:,ID-G305
2020-09-18T09:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-gla-se-vaccine-id-g305,Code name:,IDC-G305
2020-09-18T09:47:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-lage-1-hla-class-i-ii-peptide-vaccine,NA,NA
2020-10-14T12:53:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-lage-1-peptide-vaccine,NA,NA
2020-09-18T09:48:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-mart-1-peptide-pulsed-dendritic-cell-vaccine,Synonym:,NY-ESO-1/MART-1 peptide-pulsed DC vaccine
2020-09-18T09:47:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-peptide-vaccine,Synonym:,ESO-1 Peptide Vaccine
2020-09-18T09:47:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine,Code name:,pPJV7611
2020-09-18T09:47:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine,Synonym:,pPJV7611 vaccine
2020-10-14T12:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine-ppjv7611,Code name:,pPJV7611
2020-10-14T12:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine-ppjv7611,Synonym:,pPJV7611 vaccine
2020-09-18T09:48:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-prame-mage-a3-wt-1-peptide-vaccine,Synonym:,NPMW peptide vaccine
2020-09-18T09:47:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-protein-microparticle-mdp-bacterial-dna-containing-mis416-vaccine,Synonym:,NY-ESO-1 protein/MIS416 vaccine
2020-09-18T09:47:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-protein-vaccine-plus-montanide-isa-51-vg,Synonym:,NY-ESO-1 protein vaccine emulsified In Montanide ISA-51 VG
2020-09-18T09:47:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-reactive-tcr-retroviral-vector-transduced-autologous-pbl,Synonym:,anti-NY-ESO-1 TCR gene-engineered lymphocytes
2020-09-18T09:47:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-reactive-tcr-retroviral-vector-transduced-autologous-pbl,Synonym:,anti-NY-ESO-1 TCR retroviral vector-transduced lymphocytes
2020-09-18T09:48:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-cd4-positive-t-lymphocytes,Synonym:,CD4+ NY-ESO-1-specific T cells
2020-09-18T09:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-tcr-gene-transduced-t-lymphocytes-tbi-1301,Code name:,TBI-1301
2020-09-18T09:48:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-tcr-gene-transduced-t-lymphocytes-tbi-1301,Synonym:,NY-ESO-1-specific TCR gene-transduced T lymphocytes
2020-09-18T09:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1157-165-peptide-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T09:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1b-peptide-vaccine,NA,NA
2020-09-18T09:48:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-b,NA,NA
2020-10-14T13:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o-chloroacetylcarbamoylfumagillol,Code name:,AGM-1470
2020-09-18T09:48:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o6-benzylguanine,Abbreviation:,BG
2020-09-18T09:48:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oat-biscuit,NA,NA
2020-09-18T09:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obatoclax-mesylate,Chemical structure:,"1H-indole, 2-[2-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-3-methoxy-2H-pyrrol-5-yl, monomethanesulfonate2-[2-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-3-methoxy-2H-pyrrol-5-yl]-1H-indole monomethanesulfonate"
2020-09-18T09:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obatoclax-mesylate,Code name:,GX15-070MS
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Code name:,GA-101
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Code name:,GA101
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Code name:,R7159
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Code name:,RO5072759
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Foreign brand name:,Gazyvaro
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Synonym:,afutuzumab
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,Synonym:,anti-CD20 monoclonal antibody R7159
2020-09-18T07:15:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab,US brand name:,Gazyva
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Code name:,G3139
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,antidode G3139
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,augmerosen
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,bcl-2 antisense oligodeoxynucleotide G3139
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,BCL-2 antisense/G3139
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,G3139 antisense oligonucleotide
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,G3139 bcl-2 antisense oligo
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,G3139 bcl-2 antisense oligodeoxynucleotide
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,Synonym:,G3139 bcl-2 antisense oligonucleotide
2020-09-18T07:17:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium,US brand name:,Genasense
2020-09-18T09:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocaratuzumab,Code name:,AME-133v
2020-09-18T09:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocaratuzumab,Code name:,LY 2469298
2020-09-18T09:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocaratuzumab,Synonym:,anti-CD20 monoclonal antibody AME-133v
2020-09-18T09:49:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocrelizumab,Code name:,RO4964913
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Chemical structure:,"D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide acetate"
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Code name:,SMS 201-995
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Foreign brand name:,Longastatina
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Foreign brand name:,Samilstin
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Foreign brand name:,Sandostatina
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Foreign brand name:,Sandostatine
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,Synonym:,Longastatin
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,US brand name:,Sandostatin
2020-09-18T09:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate,US brand name:,Sandostatin Lar Depot
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,Code name:,SMS 201-995 pa
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,Code name:,SMS 201-995 pa LAR
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,Synonym:,octreotide pamoate LAR(SMS 201-995)
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,Synonym:,OP LAR
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,US brand name:,OncoLAR
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,US brand name:,Sandostatin pamoate
2020-09-18T09:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate,US brand name:,Sandostatin pamoate LAR
2020-09-18T09:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odanacatib,Code name:,MK0822
2020-09-18T09:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odanacatib,Synonym:,cathepsin K inhibitor MK0822
2020-10-14T03:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odronextamab,Code name:,REGN1979
2020-10-14T03:36:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odronextamab,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody REGN1979
2020-09-18T09:49:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oepa-regimen,Synonym:,GPOH-HD 95 regimen
2020-09-18T09:49:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oepa-regimen,Synonym:,OEPA
2020-09-18T09:49:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oepa-regimen,Synonym:,Oncovin-Etoposide-Prednisone-Adriamycin Regimen
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,2F2
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Code name:,GSK1841157
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,Foreign brand name:,HuMax-CD20
2020-09-18T03:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab,US brand name:,Arzerra
2020-09-18T09:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/off-regimen,Synonym:,fluorouracil/leucovorin/oxaliplatin regimen
2020-09-18T09:49:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/off-regimen,Synonym:,oxaliplatin-folinic acid-fluorouracil regimen
2020-09-18T09:49:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofloxacin,NA,NA
2020-10-14T12:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofranergene-obadenovec,Code name:,GT-111
2020-10-14T12:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofranergene-obadenovec,Code name:,VB-111
2020-10-14T12:53:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofranergene-obadenovec,Synonym:,angiogenesis inhibitor GT-111
2020-09-18T09:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oglufanide-disodium,Code name:,IM 862
2020-09-18T09:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine,Chemical structure:,"2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine"
2020-09-18T09:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine,Code name:,LY 170053
2020-09-18T09:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine,Synonym:,Zydis
2020-09-18T09:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine,US brand name:,Zyprexa
2020-09-18T08:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib,Code name:,AZD2281
2020-09-18T08:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib,Code name:,KU-0059436
2020-09-18T08:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib,Synonym:,PARP inhibitor AZD2281
2020-09-18T08:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib,US brand name:,Lynparza
2020-10-14T12:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaptesed-pegol,Code name:,NOX-A12
2020-10-14T12:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaptesed-pegol,Synonym:,CXCL12-targeted agent NOX-A12
2020-10-14T12:53:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaptesed-pegol,Synonym:,SDF-1-targeted agent NOX-A12
2020-09-18T09:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab,Code name:,IMC-3G3
2020-09-18T09:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab,Code name:,LY3012207
2020-09-18T09:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab,Synonym:,anti-PDGFR alpha monoclonal antibody IMC-3G3
2020-09-18T09:50:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab,Synonym:,anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3
2020-09-18T09:50:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleandrin,Code name:,PBI-05204
2020-10-14T12:54:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleclumab,Code name:,MEDI9447
2020-10-14T12:54:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleclumab,Synonym:,anti-CD73 monoclonal antibody MEDI9447
2020-10-14T03:50:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olendalizumab,Code name:,ALXN 1007
2020-10-14T03:50:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olendalizumab,Code name:,ALXN-1007
2020-10-14T03:50:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olendalizumab,Code name:,ALXN1007
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,Foreign brand name:,Beneo Synergy 1
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,Synonym:,Synergy 1
2020-09-18T04:36:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin,US brand name:,Beneo Synergy 1
2020-09-18T09:51:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex,Acronym:,OPC
2020-09-18T09:51:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex,Synonym:,oligomeric flavanols
2020-09-18T09:51:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex,Synonym:,oligomeric proanthocyanidins
2020-09-18T09:51:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex,Synonym:,OPC supplement
2020-09-18T09:51:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex,Synonym:,pligomeric procyanidolic complex
2020-09-18T09:51:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligonucleotide-spc2996,NA,NA
2020-10-14T13:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat,Code name:,IW 1701
2020-10-14T13:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat,Code name:,IW-1701
2020-10-14T13:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat,Code name:,IW1701
2020-10-14T13:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat,Synonym:,sGC stimulator IW-1701
2020-10-14T13:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat,Synonym:,stimulator of soluble guanylate cyclase IW-1701
2020-10-14T13:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinvacimab,Code name:,TTAC-0001
2020-09-18T09:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-extract-curcumin-based-capsule,Synonym:,PhytoMed medical food supplement
2020-09-18T05:31:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-soya-oil-egg-lecithin-based-emulsion,US brand name:,ClinOleic
2020-10-14T12:54:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olmutinib,Chemical structure:,"2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-"
2020-10-14T12:54:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olmutinib,Code name:,BI 1482694
2020-10-14T12:54:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olmutinib,Code name:,HM61713
2020-10-14T12:54:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib,Chemical structure:,"2-pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-"
2020-10-14T12:54:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib,Code name:,FT-2102
2020-10-14T12:54:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib,Code name:,FT2102
2020-10-14T12:54:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib,Synonym:,IDH1-R132 inhibitor FT-2102
2020-10-14T12:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olvimulogene-nanivacirepvec,Code name:,GL-ONC1
2020-10-14T12:34:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olvimulogene-nanivacirepvec,Code name:,GLV-1h68
2020-09-18T09:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate,Abbreviation:,HHT
2020-09-18T09:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate,Code name:,CGX-635
2020-09-18T09:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate,Synonym:,homoharringtonine
2020-09-18T09:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate,US brand name:,Synribo
2020-09-18T09:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab,Abbreviation:,rhuMAb-E25
2020-09-18T09:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab,Code name:,IGE 025
2020-09-18T09:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab,Synonym:,anti-IgE monoclonal antibody E25
2020-09-18T09:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab,Synonym:,olizumab
2020-09-18T09:51:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab,US brand name:,Xolair
2020-10-14T12:54:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omaveloxolone,Chemical structure:,"propanamide, N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-"
2020-10-14T12:54:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omaveloxolone,Code name:,RTA 408
2020-10-14T12:54:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omaveloxolone,Code name:,RTA-408
2020-09-18T09:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombitasvir-paritaprevir-ritonavir,Abbreviation:,OBV/PTV/r
2020-09-18T09:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombitasvir-paritaprevir-ritonavir,Foreign brand name:,VIEKIRAX
2020-09-18T09:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombrabulin,Chemical structure:,"(2S)-2-amino-3-hydroxy-N-{2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl}propanamide"
2020-09-18T09:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombrabulin,Code name:,AC7700
2020-09-18T09:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombrabulin,Code name:,AVE8062
2020-09-18T09:52:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombrabulin,Synonym:,combretastatin A4 analogue AVE8062
2020-10-14T12:37:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-acid-ethyl-esters,US brand name:,Lovaza
2020-09-18T09:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-fatty-acid,Synonym:,n-3 fatty acid
2020-09-18T09:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-fatty-acid,Synonym:,omega-3 polyunsaturated fatty acid
2020-09-18T09:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-fatty-acid,Synonym:,omega-3 PUFA
2020-09-18T09:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole,Abbreviation:,OMEP
2020-09-18T09:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole,Chemical structure:,"5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole"
2020-09-18T09:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole,Code name:,H168/68
2020-09-18T09:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole,Foreign brand name:,Losec
2020-09-18T09:52:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole,US brand name:,Prilosec
2020-10-14T12:54:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omidubicel,Foreign brand name:,NiCord
2020-10-14T12:54:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omidubicel,Synonym:,ex vivo-expanded umbilical cord blood-derived hematopoietic CD34-positive progenitor cells
2020-10-14T12:54:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omidubicel,Synonym:,UCB-derived CD34+ HPCs
2020-09-18T09:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omiganan-pentahydrochloride,Code name:,CLS001
2020-09-18T09:52:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omiganan-pentahydrochloride,Code name:,MBI 226
2020-10-14T13:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omipalisib,Chemical structure:,"2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamid"
2020-10-14T13:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omipalisib,Code name:,GSK2126458
2020-10-14T05:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onalespib,Code name:,AT13387
2020-09-18T09:52:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onartuzumab,Code name:,MetMAb
2020-09-18T09:52:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onartuzumab,Code name:,RO5490258
2020-09-18T09:52:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onartuzumab,Synonym:,anti-MET monoclonal antibody MetMAb
2020-10-14T13:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib,Code name:,ATG-008
2020-10-14T13:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib,Code name:,CC-223
2020-10-14T13:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib,Synonym:,mTOR kinase inhibitor CC-223
2020-10-14T13:32:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib,US brand name:,TORKi
2020-09-18T09:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-ad5-dnx-2401,Code name:,DNX-2401
2020-09-18T09:53:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-ad5-dnx-2401,Synonym:,DNX2401
2020-10-14T12:54:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-cadvec,Synonym:,CAd-VEC
2020-10-14T12:54:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-cadvec,Synonym:,CAdVEC
2020-09-18T09:53:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-encoding-gm-csf,Code name:,CG0070
2020-09-18T09:53:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-icovir5-infected-autologous-mesenchymal-stem-cells,Foreign brand name:,Celyvir
2020-10-14T12:54:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-orca-010,Code name:,ORCA 010
2020-10-14T12:54:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-orca-010,Code name:,ORCA-010
2020-10-14T12:54:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-orca-010,Code name:,ORCA010
2020-10-14T12:54:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-orca-010,Synonym:,modified Ad5 ORCA-010
2020-09-18T09:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-herpes-simplex-virus-encoding-gm-csf,Abbreviation:,HSV-encoding GM-CSF
2020-09-18T09:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-herpes-simplex-virus-encoding-gm-csf,Foreign brand name:,OrienX010
2020-09-18T09:53:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-herpes-simplex-virus-encoding-gm-csf,Synonym:,recombinant hGM-CSF
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Code name:,C 134
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Code name:,C-134
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Code name:,C134
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Synonym:,C134-HSV-1
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Synonym:,IRS-1 HSV C134
2020-10-14T12:54:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134,Synonym:,oHSV C134
2020-10-14T05:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-g207,Synonym:,oncolytic HSV-1 G207
2020-09-18T09:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rqnestin345v2,Synonym:,genetically engineered HSV-1 virus rQNestin34.5v.2
2020-09-18T09:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rqnestin345v2,Synonym:,oncolytic rQNestin34.5v.2
2020-09-18T09:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rqnestin345v2,Synonym:,oncolytic rQNestin34.5v.2 HSV virus
2020-09-18T09:53:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rqnestin345v2,Synonym:,rQNestin34.5v.2
2020-09-18T09:53:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rrp450,Code name:,rRp450
2020-09-18T09:53:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rrp450,Synonym:,oncolytic herpes virus mutant rRp450
2020-09-18T09:53:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1716,Synonym:,herpes simplex virus 1716
2020-10-14T12:54:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv1716,Synonym:,herpes simplex virus 1716
2020-09-18T09:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-measles-virus-encoding-thyroidal-sodium-iodide-symporter,Abbreviation:,MV-NIS
2020-09-18T09:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus,Abbreviation:,oncolytic NDV
2020-09-18T09:54:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus,Code name:,MTH-68H
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Code name:,MEDI 5395
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Code name:,MEDI-5395
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Code name:,MEDI5395
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Synonym:,oncolytic NDV MEDI5395
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Synonym:,recNDV(GM-CSF)
2020-10-14T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395,Synonym:,recombinant NDV expressing GM-CSF
2020-10-14T12:54:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-mth-68h,Abbreviation:,oncolytic NDV
2020-10-14T12:54:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-mth-68h,Code name:,MTH-68H
2020-10-14T13:10:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-strain-pv701,NA,NA
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Code name:,T601
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Code name:,TG 6002
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Code name:,TG-6002
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Code name:,TG6002
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Synonym:,oncolytic FCU1-expressing TK-RR-deleted vaccinia virus TG6002
2020-10-14T12:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002,Synonym:,vaccinia virus TG6002
2020-10-14T12:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-asp9801,Code name:,ASP 9801
2020-10-14T12:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-asp9801,Code name:,ASP-9801
2020-10-14T12:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-asp9801,Code name:,ASP9801
2020-10-14T12:55:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1,Abbreviation:,RP1
2020-10-14T12:55:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1,Synonym:,genetically-modified HSV-1 oncolytic immunotherapeutic RP1
2020-10-14T12:55:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1,Synonym:,HSV-1 engineered RP1
2020-10-14T12:55:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1,Synonym:,HSV-1 oncolytic viral strain RP1
2020-10-14T12:55:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1,Synonym:,HSV-1 RP1
2020-09-18T09:55:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron,US brand name:,Zofran
2020-09-18T09:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride,Code name:,GR 38032F
2020-09-18T09:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride,Code name:,GR-C507/75
2020-09-18T09:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride,Code name:,SN-307
2020-09-18T09:55:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride,US brand name:,Zofran
2020-10-14T13:20:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontorpacept,Code name:,TTI 621
2020-10-14T13:20:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontorpacept,Code name:,TTI-621
2020-10-14T13:20:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontorpacept,Synonym:,SIRPaFc
2020-10-14T03:45:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontuxizumab,Code name:,MORAb-004
2020-10-14T12:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib,Code name:,PCM 075
2020-10-14T12:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib,Code name:,PCM-075
2020-10-14T12:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib,Synonym:,PLK-1 inhibitor PCM-075
2020-10-14T12:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib,Synonym:,PLK1 inhibitor PCM-075
2020-10-14T12:55:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib,Synonym:,Polo-like kinase 1 inhibitor PCM-075
2020-10-14T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvatilimab,Code name:,JNJ 61610588
2020-10-14T04:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvatilimab,Code name:,JNJ-61610588
2020-09-18T09:56:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onyx-015,Code name:,CI-1042
2020-09-18T09:56:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onyx-015,Synonym:,E1B 55kDa mutant adenovirus dl1520
2020-10-14T12:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib,Abbreviation:,SK2 inhibitor ABC294640
2020-10-14T12:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib,Code name:,ABC294640
2020-10-14T12:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib,Foreign brand name:,Yeliva
2020-10-14T12:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib,Synonym:,sphingosine kinase-2 inhibitor ABC294640
2020-09-18T09:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opebacan,Abbreviation:,rBPI 21
2020-09-18T09:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opebacan,Foreign brand name:,Neuprex
2020-09-18T09:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opebacan,Synonym:,recombinant BPI 21 fragment
2020-09-18T09:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1001,Chemical structure:,trimebutine 3-thiocarbamoylbenzenesulfonate
2020-09-18T09:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1001,Code name:,GIC-1001
2020-09-18T09:56:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1001,Code name:,TB-905-02
2020-09-18T09:56:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1002,Code name:,GIC-1002
2020-09-18T09:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-growth-factor,Abbreviation:,OGF
2020-09-18T09:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-growth-factor,Code name:,INNO-105
2020-09-18T09:56:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-growth-factor,Synonym:,[Met5]-enkephalin
2020-09-18T09:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opium-tincture,Synonym:,Laudanum
2020-09-18T09:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox,Code name:,VB4-845
2020-09-18T09:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox,Foreign brand name:,Proxinium
2020-09-18T09:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox,Foreign brand name:,Vicinium
2020-09-18T09:57:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox,Synonym:,anti-EpCAM antibody fragment -Pseudomonas exotoxin fusion protein
2020-09-18T09:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oppa-regimen,Synonym:,GPOH-HD 95 regimen
2020-09-18T09:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oppa-regimen,Synonym:,Oncovin-prednisone-procarbazine-Adriamycin regimen
2020-09-18T09:57:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oppa-regimen,Synonym:,OPPA
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Abbreviation:,rhIL-11
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Foreign brand name:,Baijieyi
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Synonym:,adipogenesis inhibitory factor
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Synonym:,IL-11
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Synonym:,interleukin 11
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Synonym:,recombinant human interleukin-11
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,Synonym:,therapeutic interleukin-11
2020-09-18T09:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin,US brand name:,Neumega
2020-09-18T09:57:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprozomib,Code name:,ONX 0912
2020-10-14T03:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opucolimab,Code name:,HLX 20
2020-10-14T03:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opucolimab,Code name:,HLX-20
2020-10-14T03:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opucolimab,Code name:,HLX20
2020-10-14T03:57:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opucolimab,Synonym:,PD-L1-targeting Monoclonal Antibody HLX20
2020-09-18T09:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-aminolevulinic-acid-hydrochloride,Abbreviation:,oral 5-ALA
2020-09-18T09:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-aminolevulinic-acid-hydrochloride,Foreign brand name:,Gliolan
2020-09-18T09:57:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-aminolevulinic-acid-hydrochloride,Synonym:,"5-aminolevulinic acid hydrochloride, oral"
2020-09-18T09:58:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-azacitidine,Abbreviation:,oral AZA
2020-09-18T09:58:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-azacitidine,Code name:,CC-486
2020-09-18T09:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel,Code name:,ModraDoc001
2020-09-18T09:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel,Code name:,ModraDoc006/r
2020-09-18T09:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel,Synonym:,docetaxel-P-glycoprotein inhibitor
2020-09-18T09:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel,Synonym:,docetaxel-P-gp inhibitor
2020-09-18T09:57:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel,US brand name:,Oradoxel
2020-09-18T09:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-fludarabine-phosphate,Code name:,SH T 586
2020-09-18T09:58:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-fludarabine-phosphate,Foreign brand name:,Fludara Oral
2020-09-18T09:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-hsp90-inhibitor-ipi-493,Code name:,IPI-493
2020-09-18T09:58:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-hsp90-inhibitor-ipi-493,Synonym:,heat shock protein 90 inhibitor IPI-493
2020-10-14T05:27:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-ixabepilone,Synonym:,oral ixabepilone
2020-09-18T04:43:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane,Abbreviation:,BR-DIM
2020-09-18T04:43:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane,US brand name:,BioResponse DIM
2020-09-18T09:58:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-milataxel,Code name:,TL139
2020-10-14T12:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-moisturizing-jelly,Abbreviation:,OMJ
2020-10-14T12:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-moisturizing-jelly,Synonym:,gel-based artificial saliva
2020-10-14T12:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-myoma-vaccine-v3-myoma,Synonym:,V3 myoma
2020-10-14T12:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-myoma-vaccine-v3-myoma,Synonym:,V3 myoma vaccine
2020-10-14T12:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-myoma-vaccine-v3-myoma,Synonym:,V3-myoma
2020-10-14T12:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-myoma-vaccine-v3-myoma,Synonym:,V3-myoma vaccine
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Code name:,V3 P
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Code name:,V3-P
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Code name:,V3P
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Synonym:,cancer vaccine V3-P
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Synonym:,oral tableted therapeutic vaccine V3-P
2020-10-14T12:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p,Synonym:,V3-P cancer vaccine
2020-09-18T09:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-picoplatin,NA,NA
2020-09-18T09:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution,Abbreviation:,ORS
2020-09-18T09:58:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution,Code name:,OS1
2020-10-14T12:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution-os-1,Abbreviation:,ORS
2020-10-14T12:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution-os-1,Code name:,OS1
2020-09-18T09:58:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-sodium-phenylbutyrate,NA,NA
2020-10-14T12:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-therapeutic-vaccine-v3-x,Code name:,V 3X
2020-10-14T12:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-therapeutic-vaccine-v3-x,Code name:,V3-X
2020-10-14T12:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-therapeutic-vaccine-v3-x,Synonym:,CA19-9 oral vaccine V3-X
2020-10-14T12:56:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-therapeutic-vaccine-v3-x,Synonym:,V3-X vaccine
2020-09-18T07:47:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-topotecan-hydrochloride,Chemical structure:,"S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7] indolizino [1,2-b]quinoline-3,14-(4H,12H)-dione monohydrochloride"
2020-09-18T07:47:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-topotecan-hydrochloride,US brand name:,Hycamtin Capsules
2020-09-18T09:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib,Chemical structure:,"3-(2,4-dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid"
2020-09-18T09:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib,Code name:,SU006668
2020-09-18T09:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib,Code name:,SU6668
2020-09-18T09:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib,Code name:,Sugen SU6668
2020-09-18T09:59:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib,Code name:,TSU 68
2020-09-18T09:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oraxol,Synonym:,paclitaxel-HM30181 methanesulfonate monohydrate
2020-09-18T09:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oraxol,Synonym:,paclitaxel/HM30181A
2020-09-18T09:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab,Abbreviation:,MOAB B43.13
2020-09-18T09:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab,Synonym:,B43.13
2020-09-18T09:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab,Synonym:,monoclonal antibody B43.13
2020-09-18T09:59:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab,US brand name:,OvaRex
2020-10-14T03:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orilanolimab,Code name:,SYNT 001
2020-10-14T03:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orilanolimab,Code name:,SYNT001
2020-09-18T10:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ormaplatin,Chemical structure:,"tetrachloro(1,2-cyclohexanediamine-N,N')-, (OC-6-22-(trans))platinum"
2020-09-18T10:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ormaplatin,Synonym:,tetraplatin
2020-09-18T09:43:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orphenadrine-citrate,US brand name:,Norflex
2020-09-18T10:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ortataxel,Code name:,BAY 59-8862
2020-09-18T10:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ortataxel,Code name:,IDN5109
2020-09-18T10:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ortataxel,Code name:,SB-T-101131
2020-09-18T10:00:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orteronel,Code name:,TAK-700
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Code name:,JCARH 125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Code name:,JCARH-125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Code name:,JCARH125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Synonym:,autologous anti-BCMA CAR-T cells JCARH 125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Synonym:,autologous BCMA 41BBz CAR-T cells JCARH-125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Synonym:,autologous BCMA-specific CAR-T cells JCARH125
2020-10-14T04:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel,Synonym:,autologous BCMA-specific CAR4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH 125
2020-09-18T10:00:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ose-2101,Code name:,EP-2101
2020-09-18T10:00:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ose-2101,Foreign brand name:,Tedopi
2020-09-18T10:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oseltamivir-phosphate,US brand name:,Tamiflu
2020-09-18T10:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osi-7904l,Code name:,GS7904L
2020-09-18T10:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osi-7904l,Synonym:,OSI-7904 liposomal
2020-09-18T10:01:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osilodrostat,Chemical structure:,"(R)-4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile"
2020-09-18T10:01:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osilodrostat,Code name:,LCI 699
2020-09-18T10:01:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osilodrostat,Code name:,LCI-699
2020-09-18T10:01:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osilodrostat,Code name:,LCI699
2020-09-18T10:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib,Chemical structure:,"2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-"
2020-09-18T10:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib,Code name:,AZD9291
2020-09-18T10:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib,Synonym:,EGFR inhibitor AZD9291
2020-09-18T10:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib,Synonym:,mereletinib
2020-09-18T10:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib,US brand name:,Tagrisso
2020-09-18T10:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/otlertuzumab,Code name:,TRU-016
2020-09-18T10:01:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/otlertuzumab,Synonym:,anti-CD37 single-chain polypeptide TRU-016
2020-09-18T10:01:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovapuldencel-t,Synonym:,autologous dendritic cells loaded with irradiated autologous tumor cells in GM-CSF
2020-09-18T10:01:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovarian-cancer-peptide-vaccine,Abbreviation:,OC-PEP-VAC
2020-09-18T10:02:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovarian-tumor-antigen-activated-autologous-dendritic-cell-vaccine,Synonym:,DCVAC/OvCa
2020-10-14T12:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ox40l-expressing-oncolytic-adenovirus-dnx-2440,Code name:,DNX 2440
2020-10-14T12:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ox40l-expressing-oncolytic-adenovirus-dnx-2440,Code name:,DNX-2440
2020-10-14T12:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ox40l-expressing-oncolytic-adenovirus-dnx-2440,Code name:,DNX2440
2020-10-14T12:56:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ox40l-expressing-oncolytic-adenovirus-dnx-2440,Synonym:,oncolytic adenovirus armed with OX40L DNX-2440
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Abbreviation:,1-OHP
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Abbreviation:,L-OHP
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,JM-83
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,RP-54780
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Code name:,SR-96669
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Dacotin
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Dacplat
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Foreign brand name:,Eloxatine
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,Ai Heng
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,Aiheng
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,diaminocyclohexane oxalatoplatinum
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxalatoplatin
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxalatoplatinum
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,Synonym:,oxaliplatine
2020-09-18T06:25:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin,US brand name:,Eloxatin
2020-10-14T12:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin-eluting-beads,Synonym:,CalliSpheres drug-eluting beads with oxaliplatin
2020-10-14T12:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin-eluting-beads,Synonym:,DEB with oxaliplatin
2020-10-14T12:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin-eluting-beads,Synonym:,deboxa
2020-10-14T12:56:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin-eluting-beads,Synonym:,drug-eluting beads with oxaliplatin
2020-09-18T10:02:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxandrolone,US brand name:,Oxandrin
2020-09-18T10:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxcarbazepine,Chemical structure:,"10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide"
2020-09-18T10:02:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxcarbazepine,US brand name:,Trileptal
2020-09-18T10:03:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-iacs-010759,Code name:,IACS-010759
2020-09-18T10:03:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-iacs-010759,Synonym:,OXPHOS inhibitor IACS-010759
2020-10-14T12:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156,Code name:,IM 156
2020-10-14T12:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156,Code name:,IM-156
2020-10-14T12:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156,Code name:,IM156
2020-10-14T12:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156,Synonym:,mitochondrial oxidative phosphorylation inhibitor IM156
2020-10-14T12:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156,Synonym:,OxPhos inhibitor IM156
2020-09-18T10:03:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidized-avidin,Foreign brand name:,AvidinOX®
2020-09-18T10:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxitriptan,Abbreviation:,5-HTP
2020-09-18T10:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxitriptan,Chemical structure:,2-Amino-3-(5-hydroxy-1-H-indol-3-yl)propionic Acid
2020-09-18T10:03:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxitriptan,Synonym:,5-hydroxytryptophan
2020-09-18T10:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxphos-inhibitor-vlx600,Chemical structure:,"1-(2-pyridinyl)ethanone(6-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)hydrazone"
2020-09-18T10:03:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxphos-inhibitor-vlx600,Code name:,VLX600
2020-09-18T10:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-acetaminophen,US brand name:,Percocet
2020-09-18T10:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride,Chemical structure:,"4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride"
2020-09-18T10:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride,Foreign brand name:,OxyNorm
2020-09-18T10:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride,US brand name:,Oxecta
2020-09-18T10:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride,US brand name:,OxyContin
2020-09-18T10:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride,US brand name:,Roxicodone
2020-09-18T10:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride-naloxone-hydrochloride-prolonged-release-tablet,Foreign brand name:,Targin®
2020-09-18T10:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride-naloxone-hydrochloride-prolonged-release-tablet,Foreign brand name:,Targinact™
2020-09-18T09:46:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride,Chemical structure:,"4,5-alpha-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one hydrochloride"
2020-09-18T09:46:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride,US brand name:,Numorphan
2020-09-18T09:46:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride,US brand name:,Opana
2020-09-18T10:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ozarelix,Code name:,D 63153
2020-09-18T10:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ozarelix,Code name:,D-63 153
2020-09-18T10:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ozarelix,Code name:,SPI-153
2020-09-18T10:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ozarelix,Synonym:,LHRH antagonist SPI-153
2020-09-18T10:14:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-antagonist-pf-03732010,Code name:,PF-03732010
2020-09-18T10:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-inhibitor-pca062,Code name:,PCA062
2020-09-18T10:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-inhibitor-pca062,Synonym:,P-CAD inhibitor PCA062
2020-09-18T10:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-targeting-agent-pf-06671008,Code name:,PF-06671008
2020-09-18T10:24:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-glycoprotein-inhibitor-hm30181ak,Chemical structure:,"4-oxo-4H-chromene-2-carboxylic acid [2-(2-4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl]-amide"
2020-09-18T10:24:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-glycoprotein-inhibitor-hm30181ak,Code name:,HM30181A
2020-09-18T10:24:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-glycoprotein-inhibitor-hm30181ak,Code name:,HM30181AK
2020-09-18T10:24:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-glycoprotein-inhibitor-hm30181ak,Synonym:,Pgp inhibitor HM30181AK
2020-09-18T10:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-p68-inhibitor-rx-5902,Code name:,RX-5902
2020-09-18T10:42:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-p68-inhibitor-rx-5902,US brand name:,supinoxin
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,CAL-120
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Code name:,GS-9820
2020-09-18T01:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820,Synonym:,p110beta/delta PI3K Inhibitor GS-9820
2020-10-14T12:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p300-cbp-bromodomain-inhibitor-ccs1477,Code name:,CCS 1477
2020-10-14T12:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p300-cbp-bromodomain-inhibitor-ccs1477,Code name:,CCS-1477
2020-10-14T12:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p300-cbp-bromodomain-inhibitor-ccs1477,Code name:,CCS1477
2020-10-14T12:56:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p300-cbp-bromodomain-inhibitor-ccs1477,Synonym:,p300 HAT/CREB binding protein inhibitor CCS1477
2020-09-18T10:04:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-mapk-inhibitor-ly2228820-dimesylate,Abbreviation:,p38 mitogen-activated protein kinase inhibitor LY2228820 dimesylate
2020-09-18T10:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-mapk-inhibitor-ly3007113,Code name:,LY3007113
2020-09-18T10:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-mapk-inhibitor-ly3007113,Synonym:,p38 mitogen-activated protein kinase inhibitor LY3007113
2020-09-18T10:04:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-tie2-kinase-inhibitor-arry-614,Code name:,Arry-614
2020-09-18T10:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-cgm097,Code name:,CGM097
2020-09-18T10:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-cgm097,Synonym:,HDM2/p53 inhibitor CGM097
2020-10-14T12:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-mi-773,Code name:,MI-773
2020-10-14T12:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-mi-773,Code name:,SAR405838
2020-10-14T12:57:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-mi-773,Synonym:,p53-MDM2 interaction inhibitor MI-773
2020-09-18T10:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-apg-115,Code name:,APG 115
2020-09-18T10:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-apg-115,Code name:,APG-115
2020-09-18T10:05:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-apg-115,Synonym:,MDM2-p53 inhibitor APG-115
2020-09-18T10:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-mi-773,Code name:,MI-773
2020-09-18T10:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-mi-773,Code name:,SAR405838
2020-09-18T10:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-mi-773,Synonym:,p53-MDM2 interaction inhibitor MI-773
2020-09-18T10:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine,Code name:,MPS-128
2020-09-18T10:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine,Code name:,PR-147
2020-09-18T10:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine,Synonym:,p53:264-272 peptide
2020-10-14T12:57:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine-mps-128,Code name:,MPS-128
2020-10-14T12:57:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine-mps-128,Code name:,PR-147
2020-10-14T12:57:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine-mps-128,Synonym:,p53:264-272 peptide
2020-09-18T10:04:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-synthetic-long-peptide-70-251-vaccine,Abbreviation:,p53-SLP vaccine
2020-10-14T12:57:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-synthetic-long-peptides-vaccine,Abbreviation:,p53-SLP vaccine
2020-09-18T10:05:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-akt-inhibitor-msc2363318a,Code name:,MSC2363318A
2020-09-18T10:05:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-inhibitor-ly2584702,Code name:,LY2584702
2020-09-18T10:05:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5083,Code name:,CB-5083
2020-10-14T12:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339,Code name:,CB 5339
2020-10-14T12:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339,Code name:,CB-5339
2020-10-14T12:57:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339,Code name:,CB5339
2020-10-14T12:57:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339-tosylate,Synonym:,CB 5339 tosylate
2020-10-14T12:57:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339-tosylate,Synonym:,CB-5339 tosylate
2020-10-14T12:57:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339-tosylate,Synonym:,CB5339 tosylate
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Abbreviation:,TAX
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Foreign brand name:,Anzatax
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Foreign brand name:,Asotax
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Foreign brand name:,Bristaxol
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Foreign brand name:,Praxel
2020-09-18T10:05:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel,Foreign brand name:,Taxol Konzentrat
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Code name:,ABI-007
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Albumin-Stabilized Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nab-paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,nanoparticle albumin-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,Nanoparticle Paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,Synonym:,protein-bound paclitaxel
2020-09-18T01:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation,US brand name:,Abraxane
2020-09-18T10:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-injection-concentrate-for-nanodispersion,Abbreviation:,PICN
2020-10-14T12:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome,Abbreviation:,PNU-93914
2020-10-14T12:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome,Synonym:,LEP
2020-10-14T12:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome,Synonym:,liposome-encapsulated paclitaxel
2020-10-14T12:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome,Synonym:,paclitaxel liposome
2020-10-14T12:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome,US brand name:,LEP-ETU
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,IG-001
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT 008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT-008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Code name:,NANT008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,micellar nanoparticle-encapsulated NANT-008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,nant-paclitaxel
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,Synonym:,paclitaxel-loaded micellar diblock copolymer NANT-008
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,US brand name:,Cynviloq™
2020-09-18T05:48:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle,US brand name:,Genexol-PM
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Abbreviation:,PG-TXL
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Code name:,CT-2103
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Synonym:,paclitaxel-polyglutamate polymer
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Synonym:,Poly-L-Glutamic acid-Paclitaxel Conjugate
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Synonym:,polyglutamate paclitaxel
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,Synonym:,polyglutamic acid paclitaxel
2020-09-18T10:05:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex,US brand name:,Xyotax
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Code name:,IG-001
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Code name:,NANT 008
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Code name:,NANT-008
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Code name:,NANT008
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Synonym:,micellar nanoparticle-encapsulated NANT-008
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Synonym:,nant-paclitaxel
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,Synonym:,paclitaxel-loaded micellar diblock copolymer NANT-008
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,US brand name:,Cynviloq™
2020-10-14T04:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008,US brand name:,Genexol-PM
2020-10-14T12:37:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-trevatide,Code name:,ANG1005
2020-10-14T12:37:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-trevatide,Code name:,GRN1005
2020-10-14T12:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion,Code name:,S-8184
2020-10-14T12:57:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion,US brand name:,Tocosol Paclitaxel
2020-09-18T10:06:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion-formulation,Code name:,S-8184
2020-09-18T10:06:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion-formulation,US brand name:,Tocosol Paclitaxel
2020-10-14T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab,Code name:,CX 072
2020-10-14T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab,Code name:,CX-072
2020-10-14T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab,Synonym:,PD-L1 probody therapeutic CX-072
2020-10-14T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab,Synonym:,probody CX-072
2020-09-18T10:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacritinib,Code name:,SB1518
2020-09-18T10:06:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacritinib,Synonym:,oral JAK2 inhibitor SB1518
2020-09-18T10:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pad-regimen,Abbreviation:,PAD
2020-09-18T10:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pad-regimen,Synonym:,bortezomib-doxorubicin-dexamethasone regimen
2020-09-18T10:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pad-regimen,Synonym:,bortezomib/doxorubicin/dexamethasone regimen
2020-09-18T10:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pad-regimen,Synonym:,Velcade/adriamycin/dexamethasone regimen
2020-09-18T10:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin,Chemical structure:,"(SP-4-2)-[(7S,8S,17R,18R)-13-acetyl-18-ethyl-5-(2-methoxy-2-oxoethyl)-2,8,12,17-tetramethyl-3-[[(2-sulfoethyl)amino]carbonyl]-21H,23H-porphine-7-propanoato(4-)-kN21,kN22,kN23,kN24]palladate(2-)"
2020-09-18T10:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin,Code name:,WST11
2020-09-18T10:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin,Foreign brand name:,Stakel
2020-09-18T10:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin,Synonym:,palladium-bacteriochlorophyll derivative WST11
2020-09-18T10:06:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin,US brand name:,Stakel
2020-10-14T12:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padoporfin,Code name:,WST09
2020-10-14T12:57:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padoporfin,Foreign brand name:,Tookad
2020-09-18T10:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-96510,Code name:,PADRE 96510
2020-09-18T10:06:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-96510,Synonym:,15 Amino Acid Helper Peptide
2020-09-18T10:06:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-cmv-fusion-peptide-vaccine,NA,NA
2020-09-18T10:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-inhibitor-pf-03758309,Code name:,PF-03758309
2020-09-18T10:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-inhibitor-pf-03758309,Synonym:,p21-activated kinase 4 inhibitor PF-03758309
2020-09-18T10:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-nampt-inhibitor-kpt-9274,Code name:,KPT-9274
2020-09-18T07:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib,Chemical structure:,"6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one"
2020-09-18T07:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib,Code name:,PD-0332991
2020-09-18T07:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib,Code name:,PD-332991
2020-09-18T07:50:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib,US brand name:,Ibrance
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,Abbreviation:,rhKGF
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,Synonym:,"growth factor, recombinant human keratinocyte"
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,Synonym:,"keratinocyte growth factor, recombinant human"
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,Synonym:,recombinant human keratinocyte growth factor
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,Synonym:,rhu keratinocyte growth factor
2020-09-18T08:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin,US brand name:,Kepivance
2020-09-18T10:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide,Abbreviation:,IPM-lysine
2020-09-18T10:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide,Chemical structure:,"N,N'-bis(2-chloroethyl)phosphorodiamidic acidphosphorodiamidic acid, N,N'-bis(2-chloroethyl)-"
2020-09-18T10:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide,Code name:,ZIO-201
2020-09-18T10:06:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide,Synonym:,isophosphoramide mustard-lysine
2020-09-18T10:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide-tromethamine,Synonym:,palifosfamide tris
2020-09-18T10:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-bacteriopheophorbide,Code name:,WST09
2020-09-18T10:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-bacteriopheophorbide,Foreign brand name:,Tookad
2020-09-18T10:07:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-pd-103,Abbreviation:,Pd 103
2020-09-18T10:07:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-pd-103,Synonym:,Palladium 103
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Chemical structure:,"1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride,(3aS)-"
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,Code name:,RS 25259-197
2020-09-18T01:56:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride,US brand name:,Aloxi
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Code name:,GCP-23339A
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,Foreign brand name:,Aminomux
2020-09-18T03:56:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium,US brand name:,Aredia
2020-10-14T12:57:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamiparib,Code name:,BGB-290
2020-10-14T12:57:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamiparib,Synonym:,PARP inhibitor BGB-290
2020-10-14T12:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamrevlumab,Abbreviation:,anti-CTGF hmAb FG-3019
2020-10-14T12:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamrevlumab,Code name:,FG-3019
2020-10-14T12:57:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamrevlumab,Synonym:,anti-connective tissue growth factor monoclonal antibody FG-3019
2020-09-18T10:07:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq-751,Code name:,ARQ 751
2020-09-18T10:07:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq-751,Code name:,ARQ751
2020-09-18T10:07:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq-751,Synonym:,AKT inhibitor ARQ751
2020-10-14T12:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq751,Code name:,ARQ 751
2020-10-14T12:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq751,Code name:,ARQ751
2020-10-14T12:57:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq751,Synonym:,AKT inhibitor ARQ751
2020-09-18T10:07:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-kinase-inhibitor-gsk690693,Code name:,GSK690693
2020-09-18T05:59:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-arq-087,Code name:,ARQ 087
2020-09-18T05:59:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-arq-087,Synonym:,pan FGFR inhibitor ARQ 087
2020-09-18T10:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-ly2874455,Code name:,LY2874455
2020-09-18T10:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-ly2874455,Synonym:,pan FGFR inhibitor LY2874455
2020-09-18T10:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-ly2874455,Synonym:,pan fibroblast growth factor receptor inhibitor LY2874455
2020-09-18T08:03:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-kinase-inhibitor-bgj398,Code name:,BGJ398
2020-09-18T08:03:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-kinase-inhibitor-bgj398,Synonym:,pan FGFR kinase inhibitor BGJ398
2020-09-18T10:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-tyrosine-kinase-inhibitor-bay1163877,Code name:,BAY1163877
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Code name:,CG 806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Code name:,CG-026806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Code name:,CG-806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Code name:,CG’806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Code name:,CG806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Synonym:,FLT3/BTK inhibitor CG 806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Synonym:,pan-FLT3/BTK multi-kinase inhibitor CG 806
2020-10-14T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806,Synonym:,pan-FLT3/pan-BTK inhibitor CG-806
2020-09-18T10:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-kinase-inhibitor-ac480,Code name:,AC480
2020-09-18T10:08:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-kinase-inhibitor-ac480,Code name:,BMS-599626
2020-09-18T10:08:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-vegfr2-receptor-tyrosine-kinase-inhibitor-bms-690514,Code name:,BMS-690514
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Code name:,BI 1701963
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Code name:,BI-1701963
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Code name:,BI1701963
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Synonym:,PPI Inhibitor BI 1701963
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Synonym:,protein-protein interaction inhibitor BI 1701963
2020-10-14T12:58:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963,Synonym:,SOS1:KRAS interaction inhibitor BI 1701963
2020-10-14T12:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032,Chemical structure:,"3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid"
2020-10-14T12:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032,Code name:,BAY 1436032
2020-10-14T12:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032,Code name:,BAY-1436032
2020-10-14T12:58:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032,Code name:,BAY1436032
2020-09-18T10:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay1436032,Chemical structure:,"3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid"
2020-09-18T10:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay1436032,Code name:,BAY 1436032
2020-09-18T10:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay1436032,Code name:,BAY-1436032
2020-09-18T10:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay1436032,Code name:,BAY1436032
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,CLN 081
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,CLN-081
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,CLN081
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,TAS 6417
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,TAS-6417
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Code name:,TAS6417
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Synonym:,EGFR mutant-specific inhibitor CLN-081
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Synonym:,mutation-specific EGFR TKI TAS6417
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Synonym:,pan- EGFR inhibitor CLN-081
2020-10-14T12:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081,Synonym:,pan-mutation-selective EGFR tyrosine kinase Inhibitor CLN-081
2020-09-18T10:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-inhibitor-clr457,Code name:,CLR457
2020-09-18T10:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-pqr309,Code name:,PQR-309
2020-09-18T10:09:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-pqr309,Code name:,PQR309
2020-09-18T10:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-sf1126,Code name:,SF1126
2020-09-18T10:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-inhibitor-incb053914,Code name:,INCB 053914
2020-09-18T10:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-inhibitor-incb053914,Code name:,INCB053914
2020-09-18T10:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-inhibitor-incb053914,Code name:,INCB53914
2020-09-18T10:09:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-kinase-inhibitor-azd1208,Code name:,AZD1208
2020-09-18T10:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-lxh254,Code name:,LXH 254
2020-09-18T10:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-lxh254,Code name:,LXH-254
2020-09-18T10:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-lxh254,Code name:,LXH254
2020-09-18T10:09:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-lxh254,Synonym:,Raf family kinase inhibitor LXH254
2020-09-18T10:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-ly3009120,Code name:,DP-4978
2020-09-18T10:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-ly3009120,Code name:,LY3009120
2020-09-18T10:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-cct3833,Code name:,BAL3833
2020-09-18T10:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-cct3833,Code name:,CCT3833
2020-09-18T10:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-tak-580,Code name:,BIIB-024
2020-09-18T10:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-tak-580,Code name:,MLN-2480
2020-09-18T10:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-tak-580,Code name:,MLN2480
2020-09-18T10:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-tak-580,Code name:,TAK-580
2020-09-18T10:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-selectin-antagonist-gmi-1070,Code name:,GMI-1070
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Code name:,CHC 2014
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Code name:,CHC-2014
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Code name:,NOV 1601
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Code name:,NOV-1601
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Code name:,NOV1601
2020-10-14T12:58:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601,Synonym:,TRK inhibitor NOV1601
2020-09-18T10:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579,Code name:,ONO 7579
2020-09-18T10:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579,Code name:,ONO-7579
2020-09-18T10:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579,Code name:,ONO7579
2020-09-18T10:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579,Synonym:,TRK inhibitor ONO-7579
2020-09-18T10:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-vegfr-tie2-tyrosine-kinase-inhibitor-cep-11981,Code name:,CEP-11981
2020-09-18T10:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-vegfr-tie2-tyrosine-kinase-inhibitor-cep-11981,Code name:,ESK981
2020-10-14T13:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancreatic-proteolytic-enzymes,NA,NA
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Creon
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Pancrease
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Ultresa
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Viokace
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Zenpep
2020-09-18T05:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase,US brand name:,Zymase
2020-09-18T10:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab,Abbreviation:,MOAB ABX-EGF
2020-09-18T10:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab,Code name:,ABX-EGF
2020-09-18T10:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab,Synonym:,clone E7.6.3
2020-09-18T10:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab,Synonym:,monoclonal antibody ABX-EGF
2020-09-18T10:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab,US brand name:,Vectibix
2020-09-18T10:08:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab-irdye800,Synonym:,IRDye800-panitumumab conjugate
2020-09-18T10:08:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab-irdye800,Synonym:,panitumumab IRDye 800
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Code name:,LBH589
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Foreign brand name:,Faridak
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Synonym:,HDAC inhibitor LBH589
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,Synonym:,histone deacetylase inhibitor LBH589
2020-09-18T06:44:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat,US brand name:,Farydak
2020-10-14T12:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat-nanoparticle-formulation-mtx110,Code name:,MTX 110
2020-10-14T12:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat-nanoparticle-formulation-mtx110,Code name:,MTX-110
2020-10-14T12:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat-nanoparticle-formulation-mtx110,Code name:,MTX110
2020-09-18T10:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pantoprazole-sodium,US brand name:,Protonix
2020-10-14T13:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panulisib,Code name:,P7170
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Abbreviation:,Pap-H
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Foreign brand name:,Cerebid
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,Foreign brand name:,Pavacap
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Cerespan
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Pavabid
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Therapav
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vasal
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vaso-Pav
2020-09-18T05:20:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride,US brand name:,Vasospan
2020-10-14T12:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide,Abbreviation:,PTS
2020-10-14T12:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide,Code name:,PTS 100
2020-10-14T12:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide,Code name:,PTS-100
2020-10-14T12:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide,Code name:,PTS100
2020-10-14T12:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide,Synonym:,p-toluenesulfonamide
2020-09-18T10:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parathyroid-hormone-related-protein-1-36,Abbreviation:,PTHrP (1-36)
2020-09-18T10:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parecoxib-sodium,Chemical structure:,"propanamide, N-((4-(5-methyl-3-phenyl-4- isoxazolyl)phenyl)sulfonyl)-, sodium salt"
2020-09-18T10:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parecoxib-sodium,Foreign brand name:,Dynastat
2020-09-18T10:11:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paricalcitol,US brand name:,Zemplar
2020-09-18T07:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate,Chemical structure:,"D-Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-beta-D-ribofuranosyl-(1->5))-2-deoxy-, Sulfate(salt)"
2020-09-18T07:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate,Synonym:,aminosidine sulfate
2020-09-18T07:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate,Synonym:,humycin sulfate
2020-09-18T07:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate,Synonym:,paramomycin sulfate
2020-09-18T07:46:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate,US brand name:,Humatin
2020-09-18T10:11:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paroxetine-hydrochloride,US brand name:,Paxil
2020-09-18T10:12:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-abt-767,Code name:,ABT-767
2020-09-18T10:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-e7449,Code name:,E7449
2020-09-18T10:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-e7449,Synonym:,PARP/TNKS inhibitor 2X-121
2020-10-14T12:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-imp4297,Code name:,IMP 4297
2020-10-14T12:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-imp4297,Code name:,IMP-4297
2020-10-14T12:59:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-imp4297,Code name:,IMP4297
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,IDX 1197
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,IDX-1197
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,IDX1197
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,NOV 1401
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,NOV-1401
2020-10-14T12:59:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401,Code name:,NOV1401
2020-09-18T10:07:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-bgb-290,Code name:,BGB-290
2020-09-18T10:07:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-bgb-290,Synonym:,PARP inhibitor BGB-290
2020-09-18T10:11:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-cep-9722,Code name:,CEP-9722
2020-09-18T10:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-e7016,Code name:,E7016
2020-10-14T12:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-nms-03305293,Code name:,NMS 03305293
2020-10-14T12:59:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-nms-03305293,Code name:,NMS03305293
2020-10-14T12:59:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-tankyrase-inhibitor-2x-121,Code name:,E7449
2020-10-14T12:59:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-tankyrase-inhibitor-2x-121,Synonym:,PARP/TNKS inhibitor 2X-121
2020-10-14T12:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp7-inhibitor-rbn-2397,Code name:,RBN 2397
2020-10-14T12:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp7-inhibitor-rbn-2397,Code name:,RBN-2397
2020-10-14T12:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp7-inhibitor-rbn-2397,Code name:,RBN2397
2020-10-14T13:04:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parsaclisib,Code name:,INCB050465
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Code name:,TregGraft
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Code name:,TRGFT 201
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Code name:,TRGFT-201
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Code name:,TRGFT201
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Synonym:,partially engineered and enriched Treg donor graft TRGFT-201
2020-10-14T12:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201,Synonym:,T-cell-depleted graft with additional infusion of conventional T cells and regulatory T cells
2020-10-14T12:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes,Synonym:,allogeneic HLA-matched virus-specific T cell lines
2020-10-14T12:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes,Synonym:,allogeneic HLA-matched VSTs
2020-10-14T12:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes,Synonym:,allogeneic partially HLA-matched AdV/CMV/EBV-specific T cells
2020-10-14T12:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes,Synonym:,partially HLA-matched adenovirus/cytomegalovirus/Epstein-Barr virus-specific allogeneic cytotoxic T lymphocytes
2020-10-14T12:59:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes,Synonym:,partially HLA-matched AdV/CMV/EBV-specific allogeneic T cells
2020-09-18T10:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parvovirus-h-1,Abbreviation:,H-1PV
2020-09-18T10:12:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parvovirus-h-1,US brand name:,ParvOryx
2020-09-18T10:12:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pasireotide,Code name:,SOM230
2020-10-14T03:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pasotuxizumab,Code name:,BAY2010112
2020-10-14T03:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pasotuxizumab,Code name:,MT112
2020-09-18T10:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patent-blue-v-dye,Synonym:,"dye, patent blue V"
2020-09-18T10:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patent-blue-v-dye,Synonym:,"dye, patent blue violet"
2020-09-18T10:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patent-blue-v-dye,Synonym:,patent blue violet dye
2020-09-18T10:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib,Code name:,IPI-926
2020-09-18T10:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib,Synonym:,Hedgehog pathway inhibitor IPI-926
2020-09-18T10:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib,Synonym:,saridegib
2020-09-18T10:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib,Synonym:,Smoothened Antagonist IPI-926
2020-10-14T04:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Abbreviation:,TAA-T
2020-10-14T04:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Abbreviation:,TAATs
2020-10-14T04:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Synonym:,autologous tumor antigen-associated cytotoxic T lymphocytes
2020-10-14T04:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Synonym:,patient-derived multi-antigen associated cytotoxic T lymphocytes
2020-10-14T04:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Synonym:,patient-derived WT1/PRAME/survivin-specific T lymphocytes
2020-09-18T10:13:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-specific-follicular-lymphoma-derived-anti-idiotype-vaccine,NA,NA
2020-10-14T04:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran,Code name:,ALN-TTR02
2020-10-14T04:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran,Synonym:,RNAi therapeutic-targeting transthyretin ALN-TTR02
2020-10-14T04:00:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran,US brand name:,Patisiran
2020-09-18T10:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab,Code name:,AMG 888
2020-09-18T10:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab,Code name:,U3-1287
2020-09-18T10:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab,Synonym:,anti-HER3 monoclonal antibody U3-1287
2020-10-14T03:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan,Code name:,U3 1402
2020-10-14T03:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan,Code name:,U3-1402
2020-10-14T03:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan,Code name:,U3-1402a
2020-10-14T03:49:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan,Synonym:,ADC U3 1402
2020-09-18T10:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone,Chemical structure:,"(1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione"
2020-09-18T10:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone,Code name:,EPO906
2020-09-18T10:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone,Synonym:,(-)-Epothilone B
2020-09-18T10:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone,Synonym:,epothilone B
2020-10-14T13:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paxalisib,Code name:,GDC-0084
2020-10-14T13:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paxalisib,Code name:,GDC0084
2020-10-14T13:04:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paxalisib,Code name:,RG7666
2020-09-18T10:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride,Chemical structure:,"5-((4-((2,3-dimethyl-2h-indazol-6-Yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride"
2020-09-18T10:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride,Code name:,GW786034B
2020-09-18T10:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride,US brand name:,Votrient
2020-09-18T10:13:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbcar3-phosphopeptide-tetanus-peptide-vaccine,Synonym:,pBCAR3-phosphopeptide plus Tet vaccine
2020-09-18T10:13:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbcar3-pirs2-phosphopeptide-tetanus-peptide-vaccine,Synonym:,2-MpP phosphopeptide-tetanus peptide vaccine
2020-09-18T10:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbi-shrna-stmn1-lipoplex,Synonym:,pbi-shRNA STMN1 LP
2020-09-18T10:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007,Chemical structure:,"2,4-disulfophenyl-tert-butylnitrone"
2020-09-18T10:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007,Code name:,NXY-059
2020-09-18T10:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007,Code name:,OKN-007
2020-09-18T10:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007,Code name:,OKN007
2020-09-18T10:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007,Synonym:,"2,4-disulfonyl PBN"
2020-09-18T10:14:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbtl-cd19car-28-zeta,NA,NA
2020-09-18T10:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pcv-regimen,Synonym:,matulane-CCNU-oncovin regimen
2020-09-18T10:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pcv-regimen,Synonym:,PCV
2020-09-18T10:14:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pcv-regimen,Synonym:,procarbazine-lomustine-vincristine regimen
2020-10-14T12:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-directed-probody-cx-188,Code name:,CX 188
2020-10-14T12:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-directed-probody-cx-188,Code name:,CX-188
2020-10-14T12:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-directed-probody-cx-188,Code name:,CX188
2020-10-14T12:59:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-directed-probody-cx-188,Synonym:,anti-PD-1 probody CX-188
2020-09-18T10:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-autologous-t-lymphocytes,Synonym:,PD-1 knockout autologous T cells
2020-09-18T10:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-autologous-t-lymphocytes,Synonym:,PD-1-disrupted autologous T lymphocytes
2020-09-18T10:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-autologous-t-lymphocytes,Synonym:,PDCD1 gene knockout autologous T cells
2020-10-14T13:00:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-ebv-specific-cytotoxic-t-lymphocytes,Synonym:,PD-1 knockout EBV-CTLs
2020-10-14T13:00:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-ebv-specific-cytotoxic-t-lymphocytes,Synonym:,PD-1 knockout EBV-reactive CTLs
2020-10-14T13:00:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-ebv-specific-cytotoxic-t-lymphocytes,Synonym:,PD-1 knockout Epstein-Barr virus-cytotoxic T lymphocytes
2020-10-14T13:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-ido-peptide-vaccine,Synonym:,IO103/IO102 peptide vaccine
2020-10-14T13:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-ido-peptide-vaccine,Synonym:,PD-L1/IDO peptide
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB 086550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB 86550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB-086550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB-86550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB086550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Code name:,INCB86550
2020-10-14T13:00:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550,Synonym:,PD-1 ligand 1 inhibitor INCB086550
2020-10-14T13:00:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-peptide-montanide-vaccine,Synonym:,PD-L1/PD-L2 peptide plus Montanide ISA-51 vaccine
2020-10-14T13:00:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-peptide-montanide-vaccine,Synonym:,PD-L1/PD-L2 peptide plus Montanide vaccine
2020-09-18T10:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-vista-antagonist-ca-170,Code name:,AUPM 170
2020-09-18T10:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-vista-antagonist-ca-170,Code name:,CA-170
2020-09-18T10:15:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-vista-antagonist-ca-170,Synonym:,PD-L1/PD-L2/VISTA checkpoint antagonist CA-170
2020-10-14T13:00:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-peptide-vaccine,Synonym:,PD-L1 peptide
2020-10-14T13:00:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l2-peptide-montanide-vaccine,Synonym:,PD-L2 peptide plus Montanide ISA-51 vaccine
2020-10-14T13:00:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l2-peptide-montanide-vaccine,Synonym:,PD-L2 peptide plus Montanide vaccine
2020-10-14T13:00:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l2-peptide-montanide-vaccine,Synonym:,programmed death ligand 2 peptide vaccine
2020-09-18T10:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd0325901,Code name:,PD-0325901
2020-09-18T10:14:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd0325901,Synonym:,MEK inhibitor PD0325901
2020-10-14T13:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdcd-1-knockout-autologous-t-lymphocytes,Synonym:,PD-1 knockout autologous T cells
2020-10-14T13:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdcd-1-knockout-autologous-t-lymphocytes,Synonym:,PD-1-disrupted autologous T lymphocytes
2020-10-14T13:00:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdcd-1-knockout-autologous-t-lymphocytes,Synonym:,PDCD1 gene knockout autologous T cells
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Code name:,BLU-285
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,Synonym:,PDGFR alpha/KIT mutant-specific inhibitor BLU-285
2020-09-18T04:26:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285,US brand name:,Ayvakit
2020-09-18T10:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdk1-inhibitor-ar-12,Chemical structure:,2-amino-N-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide
2020-09-18T10:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdk1-inhibitor-ar-12,Code name:,AR-12
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Code name:,IFx-Hu2.0
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Foreign brand name:,ImmuneFx
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Synonym:,autologous cancer cell-transfected with plasmid DNA encoding for Emm55 Streptococcal antigen IFx-Hu2.0
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Synonym:,pDNA autologous cancer cell vaccine IFx-Hu2.0
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Synonym:,plasmid DNA autologous cancer vaccine IFx-Hu2.0
2020-10-14T13:00:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20,Synonym:,plasmid DNA vaccine encoding S. pyogenes Emm55 protein
2020-09-18T10:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdom-wt1-126-dna-vaccine,NA,NA
2020-09-18T10:04:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdom-wt1-37-dna-vaccine,NA,NA
2020-10-14T13:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1,Code name:,TVGV-1
2020-10-14T13:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1,Synonym:,PE-E7-KDEL/GPI-0100 TVGV-1
2020-10-14T13:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1,Synonym:,PEK fusion protein/GPI-0100 vaccine
2020-10-14T13:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1,Synonym:,TVGV-1 vaccine
2020-09-18T10:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-tvgv-1,Code name:,TVGV-1
2020-09-18T10:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-tvgv-1,Synonym:,PE-E7-KDEL/GPI-0100 TVGV-1
2020-09-18T10:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-tvgv-1,Synonym:,PEK fusion protein/GPI-0100 vaccine
2020-09-18T10:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-tvgv-1,Synonym:,TVGV-1 vaccine
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Abbreviation:,PEB
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Synonym:,cisplatin-etoposide-bleomycin regimen
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Synonym:,cisplatin/etoposide/bleomycin
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Synonym:,pediatric BEP regimen
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Synonym:,pediatric PEB
2020-09-18T10:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen,Synonym:,platinol-etoposide-bleomycin regimen
2020-10-14T12:53:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pediatric-nutritional-supplement-drink,US brand name:,PediaSure
2020-09-18T10:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-based-laxative-ner1006,Code name:,NER1006
2020-10-14T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262,Code name:,NKTR 262
2020-10-14T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262,Code name:,NKTR262
2020-10-14T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262,Synonym:,TLR 7/8 agonist NKTR-262
2020-10-14T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262,Synonym:,TLR7/TLR8 agonist NKTR-262
2020-10-14T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262,Synonym:,Toll-like receptor 7/8 agonist NKTR-262
2020-09-18T10:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a,Abbreviation:,PEG-IFNA2a
2020-09-18T10:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a,Synonym:,peginterferon alfa-2a
2020-09-18T10:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a,Synonym:,pegylated interferon alfa-2a
2020-09-18T10:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a,US brand name:,PEGASYS
2020-09-18T10:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interleukin-2,Abbreviation:,PEG-IL-2
2020-09-18T10:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interleukin-2,Synonym:,polyethylene glycol-modified recombinant interleukin-2
2020-09-18T10:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-linked-l-rna-oligonucleotide-hepcidin-targeting-agent-nox-h94,Code name:,NOX-H94
2020-09-18T10:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1,Code name:,EGEN-001
2020-09-18T10:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1,Code name:,GEN-1
2020-09-18T10:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1,Synonym:,IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer
2020-09-18T10:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1,Synonym:,nanoparticle-encased IL-12 DNA plasmid vector
2020-09-18T10:17:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1,Synonym:,phIL-12-005/PPC
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Code name:,AOP2014
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Code name:,P1101
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,PEG interferon alpha-2b
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,PEG intron
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,PEG-P-IFN-alfa-2b
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,PEG-P-IFN-alpha-2b
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,pegylated interferon alfa-2b
2020-09-18T10:17:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b,Synonym:,pegylated interferon alpha-2b
2020-10-14T13:01:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegargiminase,Abbreviation:,ADI-PEG
2020-10-14T13:01:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegargiminase,Abbreviation:,ADI-PEG 20
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Abbreviation:,PEG-ASP
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Abbreviation:,PEGLA
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Chemical structure:,(monomethoxypolyethylene glycol succinimidyl)74-L-asparaginase
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Synonym:,L-asparaginase with polyethylene glycol
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Synonym:,PEG-asparaginase
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Synonym:,PEG-L-asparaginase
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Synonym:,PEG-L-asparaginase(K-H)
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,Synonym:,polyethylene glycol-L-asparaginase
2020-09-18T09:52:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase,US brand name:,Oncaspar
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Code name:,CT-322
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,Synonym:,VEGFR-2 inhibitor peptide CT-322
2020-09-18T02:07:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib,US brand name:,Angiocept
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Abbreviation:,GCSF-SD01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Code name:,HSP-130
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Foreign brand name:,Jinyouli
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Foreign brand name:,Neulastim
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,Filgrastim SD-01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,PEG-rhG-CSF
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,pegfilgrastim biosimilar pegcyte
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,SD-01
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,Synonym:,SD-01 sustained duration G-CSF
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,US brand name:,Fulphila
2020-09-18T07:05:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim,US brand name:,Neulasta
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,PEG G-CSF ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,Synonym:,pegfilgrastim ANF
2020-09-18T02:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor,US brand name:,ANF-Rho
2020-09-18T10:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-biosimilar-la-ep2006,Code name:,LA-EP2006
2020-10-14T13:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegilodecakin,Abbreviation:,PEG-rHuIL-10 AM0010
2020-10-14T13:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegilodecakin,Code name:,AM0010
2020-10-14T05:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginesatide,US brand name:,Hematide
2020-10-14T13:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a,Abbreviation:,PEG-IFNA2a
2020-10-14T13:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a,Synonym:,peginterferon alfa-2a
2020-10-14T13:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a,Synonym:,pegylated interferon alfa-2a
2020-10-14T13:00:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a,US brand name:,PEGASYS
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Abbreviation:,PEG-IFN-a 2b
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Synonym:,PEG-IFN alfa-2b
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Synonym:,pegylated interferon alfa-2b
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Synonym:,polyethylene glycol IFN-A2b
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Synonym:,polyethylene glycol interferon alfa-2b
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,Synonym:,SCH 54031
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,US brand name:,PEG-Intron
2020-09-18T10:16:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b,US brand name:,Sylatron
2020-09-18T10:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide,Code name:,EPO 018B
2020-09-18T10:17:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide,Code name:,EPO-018B
2020-10-14T13:01:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide-injection,Code name:,EPO 018B
2020-10-14T13:01:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide-injection,Code name:,EPO-018B
2020-09-18T10:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegteograstim,Foreign brand name:,Neurapeg
2020-09-18T10:17:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvisomant,US brand name:,Somavert
2020-10-14T13:01:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvorhyaluronidase-alfa,Abbreviation:,PEGPH20
2020-10-14T13:01:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvorhyaluronidase-alfa,Abbreviation:,pegylated rHuPH20
2020-09-18T10:17:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-anti-gfr-antibody-fragment,Code name:,CDP 791
2020-09-18T10:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-arginine-deiminase,Abbreviation:,ADI-PEG
2020-09-18T10:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-arginine-deiminase,Abbreviation:,ADI-PEG 20
2020-10-14T13:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927,Code name:,DFP 14927
2020-10-14T13:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927,Code name:,DFP-14927
2020-10-14T13:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927,Code name:,DFP14927
2020-10-14T13:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927,Synonym:,PEGylated DFP-10917
2020-10-14T13:01:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927,Synonym:,polymeric nucleoside analogue DFP-14927
2020-09-18T10:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-granulocyte-colony-stimulating-factor-maxy-g34,Abbreviation:,PEG-CSF MAXY-G34
2020-09-18T10:17:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-granulocyte-colony-stimulating-factor-maxy-g34,Code name:,MAXY-G34
2020-09-18T10:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102,Code name:,AEB1102
2020-09-18T10:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102,Synonym:,Co-ArgI-PEG AEB1102
2020-09-18T10:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102,Synonym:,co-ArgI-PEG modified human arginase I AEB1102
2020-09-18T10:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102,Synonym:,pegylated human recombinant arginase AEB1102
2020-09-18T10:18:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102,Synonym:,pegylated recombinant arginase AEB1102
2020-09-18T10:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-interferon-alfa,Abbreviation:,PEG-IFN-a
2020-09-18T10:18:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-interferon-alfa,Synonym:,PEG-interferon alfa
2020-10-14T12:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-belotecan,Code name:,S-CKD602
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Abbreviation:,doxorubicin HCl liposome
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Chemical structure:,"(8S-cis)-8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride"
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Code name:,TLC D-99
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Foreign brand name:,Caelyx
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Foreign brand name:,Doxilen
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,ATI-0918
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,doxorubicin hydrochloride liposome injection
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,duomeisu
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,liposomal adriamycin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,liposomal doxorubicin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,liposomal doxorubicin hydrochloride
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,liposome-encapsulated doxorubicin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,pegylated doxorubicin HCl liposome
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,Pegylated Liposomal Doxorubicin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,pegylated liposomal doxorubicin hydrochloride
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,S-Liposomal Doxorubicin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,Synonym:,Stealth Liposomal Doxorubicin
2020-10-14T04:54:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride,US brand name:,Doxil
2020-09-18T10:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-irinotecan,Code name:,IHL-305
2020-09-18T10:18:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-mitomycin-c-lipid-based-prodrug,Abbreviation:,PL-MLP
2020-09-18T10:18:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-mitomycin-c-lipid-based-prodrug,Foreign brand name:,Promitil
2020-09-18T10:18:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-mitoxantrone-hydrochloride,Code name:,PLM60
2020-10-14T12:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-nanoparticle-based-docetaxel-prodrug-mnk-010,Code name:,MNK-010
2020-10-14T12:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-nanoparticle-based-docetaxel-prodrug-mnk-010,Code name:,MP-3549-1
2020-10-14T12:46:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-nanoparticle-based-docetaxel-prodrug-mnk-010,Synonym:,pegylated liposomal docetaxel prodrug MNK-010
2020-09-18T10:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-arginase-i-bct-100,Code name:,PEG-BCT-100
2020-09-18T10:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-arginase-i-bct-100,Synonym:,rhArgIpeg5000
2020-09-18T10:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-hyaluronidase-ph20,Abbreviation:,PEGPH20
2020-09-18T10:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-hyaluronidase-ph20,Abbreviation:,pegylated rHuPH20
2020-09-18T10:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-interleukin-10-am0010,Abbreviation:,PEG-rHuIL-10 AM0010
2020-09-18T10:18:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-interleukin-10-am0010,Code name:,AM0010
2020-10-14T13:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707,Code name:,THOR 707
2020-10-14T13:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707,Code name:,THOR-707
2020-10-14T13:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707,Code name:,THOR707
2020-10-14T13:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707,Synonym:,IL-2 variant THOR-707
2020-10-14T13:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707,Synonym:,pegylated recombinant IL-2 variant THOR-707
2020-09-18T10:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-l-asparaginase-erwinia-chrysanthemi,Foreign brand name:,Asparec
2020-09-18T10:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-l-asparaginase-erwinia-chrysanthemi,Synonym:,mPEG-R-crisantaspase
2020-10-14T13:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-sn-38-conjugate-plx038,Code name:,PLX 038
2020-10-14T13:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-sn-38-conjugate-plx038,Code name:,PLX-038
2020-10-14T13:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-sn-38-conjugate-plx038,Code name:,PLX038
2020-10-14T13:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-sn-38-conjugate-plx038,Synonym:,pegylated SN-38 PLX038
2020-10-14T13:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase,Code name:,AEB1102
2020-10-14T13:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase,Synonym:,Co-ArgI-PEG AEB1102
2020-10-14T13:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase,Synonym:,co-ArgI-PEG modified human arginase I AEB1102
2020-10-14T13:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase,Synonym:,pegylated human recombinant arginase AEB1102
2020-10-14T13:02:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase,Synonym:,pegylated recombinant arginase AEB1102
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,Code name:,PO BB0209
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,Code name:,PO-BB0209
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,Foreign brand name:,Reolysin
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,Synonym:,reovirus serotype 3
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,Synonym:,wild-type reovirus
2020-10-14T13:02:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep,US brand name:,Reolysin
2020-10-14T04:26:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelcitoclax,Code name:,APG 1252
2020-10-14T04:26:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelcitoclax,Code name:,APG-1252
2020-09-18T10:19:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelitinib,Code name:,EKB-569
2020-09-18T10:19:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelitrexol,Code name:,AG2037
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,Code name:,MK-3475
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,Code name:,SCH 900475
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,Synonym:,anti-PD-1 monoclonal antibody MK-3475
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,Synonym:,humanized mouse monoclonal (228-L-proline(H10-S>P))gamma 4 heavy chain (134-218')-disulfide with humanized mouse monoclonal kappa light chain dimer (226-226'':229-229'')-bisdisulfide
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,Synonym:,"immunoglobulin G4, anti-(human programmed cell death 1)"
2020-09-18T08:20:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab,US brand name:,Keytruda
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Abbreviation:,MTA
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Chemical structure:,"L-glutamic acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt"
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Code name:,LY231514
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,Synonym:,multitargeted antifolate
2020-09-18T01:47:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium,US brand name:,Alimta
2020-10-14T13:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib,Code name:,INCB054828
2020-10-14T13:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib,Synonym:,FGFR inhibitor INCB054828
2020-10-14T13:02:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib,US brand name:,Pemazyre
2020-10-14T12:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac,Code name:,ADU-214
2020-10-14T12:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac,Code name:,JNJ-64041757
2020-10-14T12:36:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac,Synonym:,LADD Listeria monocytogenes JNJ-64041757
2020-09-18T10:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penclomedine,Abbreviation:,PEN
2020-09-18T10:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penclomedine,Chemical structure:,"3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl) pyridine"
2020-09-18T10:19:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penclomedine,Code name:,CRC 88-04
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Chemical structure:,"3-mercapto-D-valinealpha-amino-beta-methyl-beta-mercaptobutyric acidbeta,beta-dimethylcysteinebeta-thiovaline"
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Atamir
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Cupripen
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Distamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Kelatin
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Mercaptyl
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Metalcaptase
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Pendramine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Foreign brand name:,Trolovol
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-mercaptovaline
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,D-Penicillamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,Synonym:,Depamine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprenil
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Cuprimine
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Depen
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Perdolat
2020-09-18T05:45:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine,US brand name:,Sufortan
2020-09-18T10:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillin-v-potassium,US brand name:,Pen-Vee
2020-09-18T10:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamethylmelamine,Abbreviation:,PMM
2020-09-18T10:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamethylmelamine,Chemical structure:,"N,N,N',N',N""-pentamethyl-1,3,5-triazine"
2020-09-18T10:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine,Synonym:,Aerosolized Pentamadine
2020-09-18T09:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate,Foreign brand name:,Pentacarinat
2020-09-18T09:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate,US brand name:,NebuPent
2020-09-18T09:34:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate,US brand name:,Pentam
2020-09-18T10:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentavalent-klh-conjugate-vaccine,NA,NA
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Abbreviation:,Ca-DTPA
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Foreign brand name:,Ditripentat-Heyl
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Synonym:,calcium DTPA
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Synonym:,Calcium Trisodium DTPA
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Synonym:,Calcium Trisodium Pentetate
2020-09-18T10:20:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium,Synonym:,Trisodium Calcium Diethylenetriaminepentaacetate
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Acronym:,PPS
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Code name:,SP-54
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Fibrezym
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Fibrocid
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Hemoclar
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,HOE/BAY 946
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,Foreign brand name:,Tavan SP-54
2020-09-18T06:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium,US brand name:,Elmiron
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Abbreviation:,DCF
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Chemical structure:,"(R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol"
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Code name:,CI-825
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Code name:,PD-81565
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Synonym:,2'-deoxycoformycin
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Synonym:,co-vidarabine
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Synonym:,deoxycoformycin
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,Synonym:,pentostatine
2020-09-18T09:41:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin,US brand name:,Nipent
2020-09-18T10:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline,Abbreviation:,PTX
2020-09-18T10:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline,Chemical structure:,"3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione"
2020-09-18T10:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline,Synonym:,oxpentifylline
2020-09-18T10:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline,Synonym:,Pentoxyphylline
2020-09-18T10:20:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline,US brand name:,Trental
2020-09-18T10:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-3-klh-conjugate-vaccine,Abbreviation:,PEP-3-KLH
2020-09-18T10:20:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-3-klh-conjugate-vaccine,Synonym:,PEPvIII-KLH conjugate vaccine
2020-09-18T10:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-cmv-vaccine,NA,NA
2020-09-18T10:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peplomycin,Abbreviation:,PEP
2020-09-18T10:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peplomycin,Chemical structure:,(S)-n1-[3-[(1-phenylethyl)amino]propyl]bleomycinamiden1-[3[[(S)-alpha-methylbenzyl]amino]propyl]bleomycinamide
2020-09-18T10:21:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peplomycin,Synonym:,pepleomycin
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Chemical structure:,"(S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol3-pyridazinemethanol, alpha-(2-Chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-"
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,M 3814
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,M-3814
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,M3814
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,MSC 2490484A
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,MSC-2490484A
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Code name:,MSC2490484A
2020-10-14T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib,Synonym:,DNA-PK inhibitor MSC2490484A
2020-10-14T13:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptide-dye-conjugate-alm-488,Code name:,ALM 488
2020-10-14T13:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptide-dye-conjugate-alm-488,Code name:,ALM-488
2020-10-14T13:02:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptide-dye-conjugate-alm-488,Code name:,ALM488
2020-10-14T13:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptidoglycan-complex-of-spirulina-k-001,Code name:,K 001
2020-10-14T13:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptidoglycan-complex-of-spirulina-k-001,Code name:,K-001
2020-10-14T13:02:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptidoglycan-complex-of-spirulina-k-001,Code name:,K001
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,Chemical structure:,"3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-onebenzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl(2,3'-bipyridin)-5'-yl)-"
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,Code name:,E2007
2020-09-18T07:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel,US brand name:,Fycompa
2020-09-18T10:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peretinoin,Chemical structure:,"(2E,4e,6E,10e)-3,7,11,15-tetramethylhexadeca-2,4,6,10,14-pentaenoic acid"
2020-09-18T10:21:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peretinoin,Code name:,NIK-333
2020-09-18T10:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflenapent-emulsion,Code name:,NVX-108
2020-09-18T10:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflenapent-emulsion,Synonym:,DDFP liquid emulsion
2020-09-18T10:21:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflenapent-emulsion,Synonym:,dodecafluoropentane emulsion
2020-09-18T07:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflubron,Abbreviation:,PFOB
2020-09-18T07:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflubron,Synonym:,perfluorooctylbromide
2020-09-18T07:55:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflubron,US brand name:,Imagent
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Abbreviation:,PFP
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,freon 218
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,octafluoropropane
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,Synonym:,perfluoropropane
2020-09-18T05:55:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren,US brand name:,Definity
2020-09-18T05:55:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-lipid-microspheres,US brand name:,Definity
2020-09-18T09:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-protein-type-a-microspheres,US brand name:,Optison
2020-09-18T10:22:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perfosfamide,Abbreviation:,4-HC
2020-09-18T10:22:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perfosfamide,Synonym:,hydroperoxycyclophosphamide
2020-09-18T10:22:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perfosfamide,US brand name:,Pergamid
2020-09-18T10:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perifosine,Chemical structure:,"4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethylpiperidinium, inner saltoctadecyl-(N,N-dimethylpiperidino-4-yl)phosphate"
2020-09-18T10:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perifosine,Code name:,D21266
2020-09-18T10:22:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perifosine,Synonym:,octadecylphosphopiperidine
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Abbreviation:,POH
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Chemical structure:,"(S)-(-)-perillyl alcohol1-cyclohexene-1-methanol4-(1-methylethenyl)-1-cyclohexene-1-methanol4-isopropenylcyclohex-1-ene-1-methanolp-mentha-1,8-dien-7-ol"
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Code name:,NEO100
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Synonym:,dihydrocuminyl alcohol
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Synonym:,perilla alcohol
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Synonym:,perillic alcohol
2020-09-18T10:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol,Synonym:,perillol
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Chemical structure:,"1H-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-methyl-2-propanamine(1:1)"
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,MCN-A-2833-109
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Code name:,S-9490-3
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Foreign brand name:,Coversyl
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,Synonym:,perindopril tert-butylamine
2020-09-18T01:17:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine,US brand name:,Aceon
2020-09-18T10:23:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-cancer-vaccine-ro7198457,Code name:,RO7198457
2020-09-18T10:23:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-cancer-vaccine-ro7198457,Synonym:,PCV RO7198457
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Code name:,PGV 001
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Code name:,PGV-001
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Code name:,PGV001
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Synonym:,multi-peptide therapeutic vaccine 001
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Synonym:,personalized peptide vaccine 001
2020-09-18T10:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001,Synonym:,personalized peptides plus Poly-ICLC vaccine 001
2020-09-18T10:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-live-attenuated-double-deleted-listeria-monocytogenes,Abbreviation:,pLADD
2020-09-18T10:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-live-attenuated-double-deleted-listeria-monocytogenes,Synonym:,patient-specific LADD
2020-09-18T10:23:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-live-attenuated-double-deleted-listeria-monocytogenes,Synonym:,personalized LADD
2020-10-14T13:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoantigen-dna-vaccine-gnos-pvo2,Code name:,GNOS-PVO2
2020-10-14T13:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoantigen-dna-vaccine-gnos-pvo2,Synonym:,neoantigen vaccine GNOS-PVO2
2020-10-14T13:02:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoantigen-peptide-vaccine-ineo-vac-p01,Code name:,iNeo-Vac-P01
2020-10-14T13:02:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoepitope-yeast-vaccine-ye-neo-001,Code name:,YE-NEO-001
2020-09-18T10:23:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-polyepitope-plasmid-dna-breast-cancer-vaccine,NA,NA
2020-09-18T10:23:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-breast-cancer-vaccine,NA,NA
2020-10-14T13:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-vaccine,Synonym:,TSMA-based SLP vaccine
2020-10-14T13:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-vaccine,Synonym:,TSMA-based synthetic long peptide vaccine
2020-10-14T13:03:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-vaccine,Synonym:,tumor specific mutant antigen-based synthetic long peptide vaccine
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Abbreviation:,MOAB 2C4
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Code name:,RO4368451
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Synonym:,2C4
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Synonym:,2C4 antibody
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Synonym:,monoclonal antibody 2C4
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Synonym:,rhuMAb-2C4
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,Synonym:,rhuMAb2C4
2020-09-18T10:22:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab,US brand name:,Perjeta
2020-09-18T03:55:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment,US brand name:,Aquaphor
2020-09-18T10:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat,Chemical structure:,"((1S,2S,4R)-4-(4-((1S)-2,3-Dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate"
2020-09-18T10:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat,Code name:,MLN4924
2020-09-18T10:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat,Synonym:,NAE inhibitor MLN4924
2020-09-18T10:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat,Synonym:,Nedd8-activating enzyme inhibitor MLN4924
2020-09-18T10:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexastimogene-devacirepvec,Code name:,JX-594
2020-09-18T10:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexastimogene-devacirepvec,Foreign brand name:,PexaVec
2020-09-18T10:24:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexastimogene-devacirepvec,Synonym:,thymidine kinase-deleted vaccinia-hGM-CSF JX-594
2020-09-18T10:24:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib,Chemical structure:,"(5-(5-chloro-1H-pyrrolo(2,3-b)pyridin-3-ylmethyl)-pyridin-2-yl)-(6-trifluoromethyl-pyridin-3-ylmethyl)-amine hydrochloride salt5[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)pyridin-3yl]methyl}pyridin-2-amine monohydrochloride"
2020-09-18T10:24:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib,Synonym:,PLX3397 HCl
2020-09-18T10:24:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib,Synonym:,PLX3397 hydrochloride
2020-09-18T10:24:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib,US brand name:,Turalio
2020-10-14T12:57:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexmetinib,Code name:,Arry-614
2020-09-18T07:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgg-beta-glucan,Chemical structure:,poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose beta-glucan
2020-09-18T07:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgg-beta-glucan,US brand name:,Imprime PGG
2020-09-18T09:52:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgla-peg-copolymer-based-paclitaxel,US brand name:,OncoGel
2020-09-18T10:24:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ph20-hyaluronidase-expressing-adenovirus-vcn-01,Code name:,VCN-01
2020-09-18T10:24:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ph20-hyaluronidase-expressing-adenovirus-vcn-01,Synonym:,genetically modified adenovirus-encoding human PH20 hyaluronidase VCN-01
2020-09-18T10:24:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phaleria-macrocarpa-extract-dlbs-1425,Code name:,DLBS-1425
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,ascorbate injection
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,ascorbic acid injection
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,HD ascorbate
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,HD P-AscH-
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,high-dose ascorbate
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,high-dose ascorbic acid
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,high-dose parenteral ascorbate
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,high-dose vitamin C
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,intravenous ascorbate
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,intravenous high-dose ascorbate
2020-10-14T13:03:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate,Synonym:,IV ascorbate
2020-09-18T09:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phellodendron-amurense-bark-extract,US brand name:,Nexrutine
2020-09-18T09:33:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenelzine-sulfate,Chemical structure:,2-phenylethylhydrazine hydrogen sulphate2-phenylethylhydrazine sulphate
2020-09-18T09:33:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenelzine-sulfate,US brand name:,Nardil
2020-09-18T10:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenethyl-isothiocyanate,Chemical structure:,(2-Isothiocyanatoethyl)benzene2-phenylethyl isothiocyanate
2020-09-18T10:25:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenethyl-isothiocyanate,Synonym:,PEITC
2020-09-18T10:25:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenethyl-isothiocyanate-containing-watercress-juice,NA,NA
2020-09-18T10:25:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenformin-hydrochloride,NA,NA
2020-09-18T10:25:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenobarbital,Abbreviation:,PHENO
2020-09-18T10:25:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenobarbital,Chemical structure:,"5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione"
2020-09-18T06:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride,Chemical structure:,N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine
2020-09-18T06:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride,US brand name:,Dibenzyline
2020-09-18T08:37:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenprocoumon,Chemical structure:,"2H-1-benzopyran-2-one, 4-hydroxy-3-(1-phenylpropyl)-3-(alpha-phenylpropyl)-4-hydroxycoumarin"
2020-09-18T08:37:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenprocoumon,US brand name:,Liquamar
2020-09-18T10:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phentolamine-mesylate,Chemical structure:,2-[N-p'-tolyl-N-(m'-hydroxyphenyl)aminomethyl]imidazoline monomethanesulfonate
2020-09-18T10:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phentolamine-mesylate,US brand name:,Regitine
2020-09-18T10:26:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphatidylcholine-bound-silybin,US brand name:,Silybin-Phytosome
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Abbreviation:,I-131 PLE analogue CLR1404
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Code name:,CLR 131
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Synonym:,[131I]-CLR1404
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Synonym:,CLR 1404 I-131
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Synonym:,I-131-CLR1404
2020-09-18T10:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131,Synonym:,PDC CLR 131
2020-09-18T10:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorodiamidate-morpholino-oligomer-avi-4126,Abbreviation:,PMO AVI-4126
2020-09-18T10:26:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorodiamidate-morpholino-oligomer-avi-4126,Code name:,AVI-4126
2020-10-14T13:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p-32,Abbreviation:,32-P
2020-10-14T13:03:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p-32,Abbreviation:,P32
2020-09-18T10:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p32,Abbreviation:,32-P
2020-09-18T10:26:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p32,Abbreviation:,P32
2020-09-18T10:26:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photocyanine,NA,NA
2020-10-14T13:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photodynamic-compound-tld-1433,Code name:,TLD 1433
2020-10-14T13:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photodynamic-compound-tld-1433,Code name:,TLD-1433
2020-10-14T13:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photodynamic-compound-tld-1433,Code name:,TLD1433
2020-10-14T13:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photodynamic-compound-tld-1433,Synonym:,PDC TLD-1433
2020-09-18T10:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photosensitizer-luz-11,Code name:,LUZ 11
2020-09-18T10:27:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochemical,Synonym:,Phytonutrients
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,Chemical structure:,chlorin e6-polyvinylpyrrolidone
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,Code name:,BLC-1013
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,Foreign brand name:,Fotolon
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,Synonym:,chlorin E6-PVP
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,Synonym:,chlorin e6/PVP
2020-09-18T10:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex,US brand name:,Photolon
2020-09-18T10:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytonadione,Synonym:,phylloquinone
2020-09-18T10:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytonadione,Synonym:,vitamin K1
2020-09-18T10:30:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi-88,Synonym:,heparanase inhibitor PI-88
2020-09-18T10:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-beta-inhibitor-bay1082439,Code name:,BAY1082439
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Chemical structure:,"5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine"
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,CH 5132799
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,CH-5132799
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,MEN 1611
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,MEN-1611
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,MEN1611
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,PA 799
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,PA-799
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Code name:,PA799
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Synonym:,alpha-selective PI3K inhibitor MEN1611
2020-10-14T13:03:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611,Synonym:,PI3Kalpha inhibitor MEN1611
2020-09-18T10:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-mln1117,Code name:,INK1117
2020-09-18T10:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-mln1117,Code name:,MLN1117
2020-09-18T10:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-mln1117,Code name:,TAK-117
2020-09-18T10:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-mtor-inhibitor-pwt33597-mesylate,Code name:,PWT33597 mesylate
2020-09-18T10:29:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-gsk2636771,Code name:,GSK2636771
2020-09-18T10:29:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-gsk2636771,Synonym:,PI3Kα inhibitor GSK2636771
2020-09-18T10:30:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-sar260301,Chemical structure:,(S)-2-(2-(2-methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one
2020-09-18T10:30:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-sar260301,Code name:,SAR 260301
2020-09-18T10:30:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-sar260301,Code name:,SAR-260301
2020-09-18T10:30:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-sar260301,Code name:,SAR260301
2020-09-18T12:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-gamma-inhibitor-rp6530,Code name:,RP 6530
2020-09-18T12:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-gamma-inhibitor-rp6530,Code name:,RP-6530
2020-09-18T12:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-gamma-inhibitor-rp6530,Code name:,RP6530
2020-09-18T12:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-gamma-inhibitor-rp6530,Synonym:,PI3K delta/gamma inhibitor RP6530
2020-09-18T10:30:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-amg-319,Code name:,AMG 319
2020-10-14T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-hmpl-689,Code name:,HMPL 689
2020-10-14T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-hmpl-689,Code name:,HMPL-689
2020-10-14T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-hmpl-689,Code name:,HMPL689
2020-10-14T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-hmpl-689,Synonym:,PI3K-d inhibitor HMPL 689
2020-09-18T10:30:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-incb050465,Code name:,INCB050465
2020-09-18T10:27:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-me-401,Code name:,ME-401
2020-09-18T10:27:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-me-401,Code name:,PWT-143
2020-09-18T10:27:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-me-401,Code name:,PWT143
2020-10-14T13:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-shc014748m,Code name:,SHC 014748M
2020-10-14T13:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-shc014748m,Code name:,SHC-014748M
2020-10-14T13:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-shc014748m,Code name:,SHC014748M
2020-10-14T13:04:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-shc014748m,Synonym:,PI3Kd Inhibitor SHC014748M
2020-09-18T12:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202,Chemical structure:,"2-((1S)-1-(4-amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one"
2020-09-18T12:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202,Code name:,RP-5264
2020-09-18T12:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202,Code name:,RP5264
2020-09-18T12:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202,Code name:,TGR-1202
2020-09-18T12:41:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202,Synonym:,PI3K-delta inhibitor TGR-1202
2020-09-18T10:30:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-gamma-inhibitor-ipi-549,Code name:,IPI 549
2020-09-18T10:30:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-gamma-inhibitor-ipi-549,Code name:,IPI-549
2020-09-18T10:28:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-hdac-inhibitor-cudc-907,Code name:,CUDC-907
2020-09-18T10:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-acp-319,Code name:,ACP-319
2020-09-18T10:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-bgt226,Code name:,BGT226
2020-09-18T10:27:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-bgt226,Synonym:,phospatidylinositol 3'-kinase inhibitor BGT226
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,GDC 0077
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,GDC-0077
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,GDC0077
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,RG 6114
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,RG-6114
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,RG6114
2020-09-18T10:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077,Code name:,RO 7113755
2020-09-18T10:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0084,Code name:,GDC-0084
2020-09-18T10:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0084,Code name:,GDC0084
2020-09-18T10:28:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0084,Code name:,RG7666
2020-09-18T10:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0941-bismesylate,Chemical structure:,"2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1- ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, bimesylate salt"
2020-09-18T10:28:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0941-bismesylate,Code name:,GDC-0941 bismesylate
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,GDC 0077
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,GDC-0077
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,GDC0077
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,RG 6114
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,RG-6114
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,RG6114
2020-10-14T13:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077,Code name:,RO 7113755
2020-09-18T10:28:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gsk1059615,Code name:,GSK1059615
2020-09-18T10:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gsk2126458,Chemical structure:,"2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamid"
2020-09-18T10:28:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gsk2126458,Code name:,GSK2126458
2020-09-18T10:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-px-866,Chemical structure:,"acetic acid (1S,4E,10R,11R,13S,14R)-[4-diallylaminomethylene-6-hydroxy-1-methoxymethyl-10,13-dimethyl-3,7,17-trioxo-1,3,4,7,10,11,12,13,14,15,16,17-dodecahydro-2-oxa-cyclopenta[a]phenanthren-11-yl ester"
2020-09-18T10:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-px-866,Code name:,PX-866
2020-09-18T10:28:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-wx-037,Code name:,WX-037
2020-09-18T10:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-zstk474,Code name:,ZSTK474
2020-09-18T10:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-zstk474,Synonym:,phosphatidylinositol 3-kinase inhibitor ZSTK474
2020-09-18T10:29:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-alk-1-dna-pk-inhibitor-p7170,Code name:,P7170
2020-09-18T10:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-dual-kinase-inhibitor-xl765,Code name:,SAR245409
2020-09-18T10:28:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-dual-kinase-inhibitor-xl765,Code name:,XL765
2020-09-18T10:28:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-inhibitor-ly3023414,Code name:,LY 3023414
2020-09-18T10:28:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-inhibitor-ly3023414,Code name:,LY-3023414
2020-09-18T10:28:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-inhibitor-ly3023414,Code name:,LY3023414
2020-09-18T10:29:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-bez235,Code name:,BEZ235
2020-09-18T10:29:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-bez235,Synonym:,NVP-BEZ235
2020-09-18T10:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-ds-7423,Code name:,DS-7423
2020-09-18T10:29:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-ds-7423,Synonym:,dual PI3 kinase/mTOR inhibitor DS-7423
2020-09-18T10:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-pf-04691502,Code name:,PF-04691502
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Chemical structure:,"2-pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-Yl]-2-pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-Yl]-2- pyrimidinamine"
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,SB 2343
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,SB-2343
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,SB2343
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,VS 5584
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,VS-5584
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Code name:,VS5584
2020-09-18T10:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584,Synonym:,PI3K/mTOR inhibitor VS-5584
2020-09-18T10:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtorc1-mtorc2-inhibitor-dcbci0901,Code name:,DCBCI0901
2020-09-18T10:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-p110beta-delta-inhibitor-ka2237,Code name:,KA 2237
2020-09-18T10:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-p110beta-delta-inhibitor-ka2237,Code name:,KA2237
2020-09-18T10:28:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-p110beta-delta-inhibitor-ka2237,Synonym:,PI3 kinase b/d inhibitor KA2237
2020-09-18T10:29:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3ka-mtor-inhibitor-pki-179,Code name:,PKI-179
2020-09-18T10:29:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kalpha-inhibitor-azd8835,Code name:,AZD8835
2020-09-18T10:29:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kbeta-inhibitor-azd8186,Code name:,AZD-8186
2020-09-18T10:29:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kbeta-inhibitor-azd8186,Code name:,AZD8186
2020-09-18T10:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kdelta-inhibitor-incb040093,Code name:,INCB040093
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Chemical structure:,"phenol, 4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)-, trihydrochloridephenol, p-[5-[5-(4-methyl-1-piperazinyl)-2-benzimidazolyl]-2- benzimidazolyl]-, trihydrochloride"
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Code name:,HOE 33258
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Code name:,Hoechst 33258
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Synonym:,bisbenzimidazole
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Synonym:,Hoechst dye 33258
2020-09-18T10:30:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol,Synonym:,pibenzimol hydrochloride
2020-09-18T10:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibrozelesin,Chemical structure:,"Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methy-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7,-trimethoxy-1H-indol-2-yl)carbonyl)-, Methyl Ester (S)"
2020-09-18T10:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibrozelesin,Code name:,KW 2189
2020-09-18T10:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibrozelesin,Code name:,KW-2189
2020-09-18T10:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibrozelesin,Synonym:,Duocamycin B2 Analog
2020-09-18T10:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picibanil,Code name:,OK-432
2020-09-18T10:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picoplatin,Chemical structure:,"Cis-Amminedichloro (2-Methylpyridine) PlatinumPlatinum, Amminedichloro(2-methylpyridine)-, (SP-4-3)"
2020-09-18T10:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picoplatin,Code name:,AMD473
2020-09-18T10:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picoplatin,Code name:,NX 473
2020-09-18T10:31:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picoplatin,Code name:,ZD0473
2020-09-18T10:31:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picropodophyllin,Code name:,AXL1717
2020-10-14T13:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pictilisib-bismesylate,Chemical structure:,"2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1- ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine, bimesylate salt"
2020-10-14T13:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pictilisib-bismesylate,Code name:,GDC-0941 bismesylate
2020-09-18T10:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pidilizumab,Code name:,CT-011
2020-09-18T10:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pidilizumab,Code name:,MDV9300
2020-10-14T04:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilaralisib,Code name:,XL147
2020-10-14T04:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilaralisib,Synonym:,PI3K inhibitor XL147
2020-10-14T04:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilaralisib,Synonym:,SAR245408
2020-10-14T13:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine,Synonym:,pilocarpine
2020-10-14T13:05:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine,US brand name:,Salagen
2020-09-18T10:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine-hydrochloride,Synonym:,pilocarpine
2020-09-18T10:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine-hydrochloride,US brand name:,Salagen
2020-09-18T10:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24,Code name:,SEL 24
2020-09-18T10:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24,Code name:,SEL24
2020-09-18T10:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24,Code name:,SEL24-B489
2020-09-18T10:31:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24,Synonym:,dual PIM/FLT3 kinase inhibitor
2020-09-18T10:31:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-lgh447,Code name:,LGH447
2020-09-18T10:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-sgi-1776,Code name:,SGI-1776
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Chemical structure:,"2-((1R,4R)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol"
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,SGI 9481
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,SGI-9481
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,SGI9481
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,TP 3654
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,TP-3654
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Code name:,TP3654
2020-10-14T13:05:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654,Synonym:,PIM inhibitor TP-3654
2020-09-18T10:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib,Chemical structure:,"N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4- iodophenyl)= amino]isonicotinamide hydrochloride"
2020-09-18T10:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib,Code name:,AS703026
2020-09-18T10:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib,Code name:,MSC1936369B
2020-09-18T10:31:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib,Synonym:,MEK inhibitor AS703026
2020-10-14T04:58:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus,US brand name:,Elidel
2020-09-18T06:24:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus-cream,US brand name:,Elidel
2020-10-14T05:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib,Code name:,TAS-116
2020-10-14T05:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib,Code name:,TAS116
2020-10-14T05:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib,Synonym:,heat shock protein 90alpha/beta inhibitor TAS-116
2020-10-14T05:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib,Synonym:,HSP90a/b inhibitor TAS-116
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,JNJ 63623872
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,JNJ-63623872
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,JNJ63623872
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,VX 787
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,VX-787
2020-10-14T13:05:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir,Code name:,VX787
2020-09-18T10:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimonidazole,Code name:,Ro 03-8799
2020-09-18T10:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimonidazole,Synonym:,ro 03-8799
2020-10-14T03:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimurutamab,Code name:,HLX 07
2020-10-14T03:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimurutamab,Code name:,HLX-07
2020-10-14T03:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimurutamab,Code name:,HLX07
2020-10-14T03:45:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimurutamab,Synonym:,cetuximab biobetter HLX07
2020-10-14T03:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinatuzumab-vedotin,Code name:,DCDT2980S
2020-10-14T03:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinatuzumab-vedotin,Synonym:,ADC DCDT2980S
2020-10-14T03:37:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinatuzumab-vedotin,Synonym:,antibody-drug conjugate DCDT2980S
2020-09-18T10:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinaverium-bromide,Chemical structure:,"morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide"
2020-09-18T10:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinaverium-bromide,Foreign brand name:,Pinverin
2020-10-14T13:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinometostat,Code name:,EPZ-5676
2020-10-14T13:05:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinometostat,Synonym:,DOT1L inhibitor EPZ-5676
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,Synonym:,pioglitazone HCl
2020-09-18T01:22:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride,US brand name:,Actos
2020-09-18T10:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium,Chemical structure:,"sodium (2S,5R,6R)-6-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate"
2020-09-18T10:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium,Code name:,"CL 227,193"
2020-09-18T10:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium,Code name:,T-1220
2020-09-18T10:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium,US brand name:,Pipracil
2020-09-18T10:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperazinedione,Abbreviation:,PZD
2020-09-18T10:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperazinedione,Code name:,593A
2020-09-18T10:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperazinedione,Synonym:,compound 593A
2020-09-18T10:32:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperazinedione,Synonym:,Merck Compound 593A;
2020-09-18T04:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized,Abbreviation:,PIPE
2020-09-18T04:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized,US brand name:,Bioperine
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Abbreviation:,THP-ADM
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Abbreviation:,THP-DOX
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Code name:,1609RB
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Foreign brand name:,Pinorubicin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Foreign brand name:,Theprubicine
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Foreign brand name:,Therarubicin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,Tepirubicin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,Tetrahydropyranyl-Doxorubicin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,theprubicin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,THP
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,THP-Adriamycin
2020-09-18T10:32:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin,Synonym:,THP-Doxorubicin
2020-09-18T10:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirfenidone,Synonym:,Deskar
2020-09-18T10:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritramide,Chemical structure:,"(1,4'-bipiperidine)-4'-carboxamide, 1'-(3-cyano-3,3-diphenylpropyl)-1'-(3-cyano-3,3-diphenylpropyl)-(1,4'-bipiperidine)-4'-carboxamide"
2020-09-18T10:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritramide,Code name:,R 3365
2020-09-18T10:32:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritramide,Foreign brand name:,Dipidolor
2020-09-18T10:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritrexim,Chemical structure:,"2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine6-((2,5-dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine"
2020-09-18T10:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritrexim,Code name:,BW-301U
2020-09-18T10:32:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritrexim,Synonym:,Piritrexim Isethionate
2020-09-18T10:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirotinib,Code name:,KBP-5209
2020-09-18T10:33:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirotinib,Code name:,KBP5209
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Chemical structure:,"Anthra(1,9-cd)pyrazol-6(2H)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)"
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Code name:,CI-942
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Code name:,PD-111815
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Synonym:,oxanthrazole
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Synonym:,oxantrazole
2020-09-18T10:33:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone,Synonym:,Piroxantrone HCl
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,Abbreviation:,PXM
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,Chemical structure:,"4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide"
2020-09-18T06:46:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam,US brand name:,Feldene
2020-09-18T10:33:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirs2-phosphopeptide-tetanus-peptide-vaccine,Synonym:,pIRS2-phosphopeptide plus Tet vaccine
2020-09-18T10:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixantrone-dimaleate,Chemical structure:,"6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione dimaleatebenz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2-butenedioate (1:2)"
2020-09-18T10:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixantrone-dimaleate,Code name:,BBR 2778
2020-09-18T10:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixantrone-dimaleate,Synonym:,pixantrone maleate
2020-10-14T03:32:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixatimod,Code name:,PG545
2020-10-14T13:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pkc-beta-inhibitor-ms-553,Code name:,MS 553
2020-10-14T13:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pkc-beta-inhibitor-ms-553,Code name:,MS-553
2020-10-14T13:05:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pkc-beta-inhibitor-ms-553,Synonym:,PKC-b inhibitor MS-553
2020-09-18T10:33:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/placebo,Abbreviation:,PLCB
2020-09-18T10:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pladienolide-derivative-e7107,Code name:,E7107
2020-10-14T03:37:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plamotamab,Code name:,XmAb13676
2020-10-14T03:37:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plamotamab,Synonym:,anti-CD20 x anti-CD3 bispecific monoclonal antibody XmAb13676
2020-09-18T10:33:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plant-derived-hematopoiesis-enhancer-pg2,Code name:,PG2
2020-09-18T10:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmacytoid-dendritic-cell-vaccine,Abbreviation:,pDC vaccine
2020-09-18T10:34:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmid-encoding-antiangiogenic-metargidin-peptide,Foreign brand name:,AMEP
2020-09-18T10:34:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmid-encoding-antiangiogenic-metargidin-peptide,Synonym:,peptide AMEP
2020-10-14T13:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmodium-vivax-infected-red-blood-cell,Synonym:,P. vivax-infected RBCs
2020-10-14T13:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmodium-vivax-infected-red-blood-cell,Synonym:,P. vivax-infected red blood cells
2020-10-14T13:06:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmodium-vivax-infected-red-blood-cell,Synonym:,Plasmodium vivax RBC immunotherapy agent
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Code name:,NPt
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Code name:,NPt-Ca
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,NPt nanomaterial
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,NPt nanoparticles
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,platinum acetylacetonate nanomaterial
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,platinum-titania nanoparticles
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,Pt(acac)2/F-TiO2
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,Pt(acac)2/F-TiO2 nanoparticles
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,Pt(acac)2/titanium dioxide
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,sol-gel NPt nanomaterial
2020-10-14T13:06:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles,Synonym:,sol-gel NPt nanoparticles
2020-09-18T10:34:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pled-based-mnsod-mimetic,Code name:,PP-095
2020-09-18T10:34:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pled-based-mnsod-mimetic,Foreign brand name:,PLEDOx
2020-09-18T10:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pleiotropic-pathway-modifier-cc-122-hydrochloride,Code name:,CC-122 hydrochloride
2020-09-18T09:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor,Chemical structure:,"1,1'-[1,4-phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecanebis(tetraazacyclotetradecane) derivative"
2020-09-18T09:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor,Code name:,AMD 3100
2020-09-18T09:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor,Code name:,LM-3100
2020-09-18T09:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor,US brand name:,Mozobil
2020-09-18T10:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plevitrexed,Chemical structure:,"(2S)-2-[[4-[[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methy](prop-2-ynyl)amino]-2-fluorobenzoyl]amino]-4-(1H-tetrazol-5-yl)butanoic acid"
2020-09-18T10:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plevitrexed,Code name:,BGC 9331
2020-09-18T10:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plevitrexed,Code name:,ZD9331
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Abbreviation:,MTH
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Code name:,A-2371
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Code name:,PA-144
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Foreign brand name:,Mithracine
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Synonym:,aureolic acid
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,Synonym:,mithramycin
2020-09-18T09:12:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin,US brand name:,Mithracin
2020-09-18T10:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plinabulin,Code name:,NPI-2358
2020-09-18T10:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plinabulin,Synonym:,vascular-disrupting agent NPI-2358
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,APLD
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Abbreviation:,DDB
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Chemical structure:,"N-[1-(1,2-dioxopropyl)-L-prolyl]didemnin A"
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,aplidine
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,Synonym:,dehydrodidemnin B
2020-09-18T03:54:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin,US brand name:,Aplidin
2020-10-14T04:29:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-bi-2536,NA,NA
2020-10-14T13:06:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140,Code name:,CYC 140
2020-10-14T13:06:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140,Code name:,CYC-140
2020-10-14T13:06:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140,Code name:,CYC140
2020-10-14T13:06:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140,Synonym:,PLK-1 inhibitor CYC140
2020-10-14T13:06:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140,Synonym:,polo-like kinase 1 inhibitor CYC140
2020-09-18T10:35:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-tak-960,Synonym:,Polo-like kinase 1 inhibitor TAK-960
2020-10-14T04:53:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plocabulin,Code name:,PM060184
2020-09-18T10:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plozalizumab,Code name:,MLN1202
2020-09-18T10:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plozalizumab,Synonym:,anti-CCR2 Monoclonal Antibody MLN1202
2020-09-18T10:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pm00104,US brand name:,Zalypsis
2020-09-18T10:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-13-valent-conjugate-vaccine,Abbreviation:,PCV 13
2020-09-18T10:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-13-valent-conjugate-vaccine,Synonym:,PCV13 vaccine
2020-09-18T10:35:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-13-valent-conjugate-vaccine,US brand name:,Prevnar 13
2020-09-18T10:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-7-valent-conjugate-vaccine,Abbreviation:,PCV7
2020-09-18T10:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-7-valent-conjugate-vaccine,Synonym:,pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)
2020-09-18T10:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-7-valent-conjugate-vaccine,US brand name:,Prevnar
2020-09-18T10:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-polyvalent-vaccine,US brand name:,Pneumovax 23
2020-09-18T10:35:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-polyvalent-vaccine,US brand name:,Pnu-Imune 23
2020-09-18T10:35:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl3-hicd-vaccine,NA,NA
2020-09-18T10:36:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl4a-crt-e7detox-dna-vaccine,NA,NA
2020-09-18T10:36:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl4a-sig-e7detox-hsp70-dna-vaccine,NA,NA
2020-09-18T10:36:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pnp-expressing-ovine-atadenovirus-fp253,Code name:,FP253
2020-09-18T10:36:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pol-i-inhibitor-cx5461,Code name:,CX-5461
2020-09-18T10:36:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pol-i-inhibitor-cx5461,Code name:,CX5461
2020-09-18T10:36:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pol-i-inhibitor-cx5461,Synonym:,RNA Pol I inhibitor CX5461
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Chemical structure:,"catena-poly[zinc-μ-[β-alanyl-L-histidinato(2)-N,NN,O:Nτ]]zinc, (beta-alanyl-kappaN-L-histidinato(2-)-kappaN,kappaO)-"
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Code name:,Z-103
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Synonym:,aprozinate
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Synonym:,carnosine zinc complex
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Synonym:,CAZ
2020-09-18T10:36:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,Synonym:,zinc L-carnosine
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,Code name:,DCDS4501A
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,Synonym:,ADC DCDS4501A
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,Synonym:,anti-CD79B monoclonal antibody-MMAE conjugate DCDS4501A
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,Synonym:,antibody-drug conjugate DCDS4501A
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,Synonym:,polatuzumab vedotin
2020-09-18T10:36:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin,US brand name:,Polivy
2020-10-14T04:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol,Synonym:,aethoxysklerol
2020-10-14T04:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol,Synonym:,dodecylnonaoxyethylene glycol monoether
2020-10-14T04:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol,Synonym:,Laureth-9
2020-10-14T04:02:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol,US brand name:,Asclera
2020-10-14T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poliglusam,Synonym:,chitosan
2020-10-14T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poliglusam,Synonym:,deacetylchitin
2020-09-18T10:36:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polihexanide-solution,Synonym:,PHMB solution
2020-09-18T10:36:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polihexanide-solution,Synonym:,polyhexamethylenebiguanide solution
2020-10-14T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pollen-extract-pcc-100,Code name:,PCC 100
2020-10-14T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pollen-extract-pcc-100,Code name:,PCC-100
2020-10-14T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pollen-extract-pcc-100,Code name:,PCC100
2020-09-18T10:37:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk-461364,Abbreviation:,PLK-1 inhibitor GSK-461364
2020-09-18T10:37:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk-461364,Code name:,GSK-461364
2020-10-14T13:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk461364,Abbreviation:,PLK-1 inhibitor GSK-461364
2020-10-14T13:06:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk461364,Code name:,GSK-461364
2020-09-18T10:37:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-mk1496,Code name:,MK1496
2020-09-18T10:37:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-nms-1286937,Code name:,NMS-1286937
2020-09-18T10:37:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-4-inhibitor-cfi-400945-fumarate,Abbreviation:,PLK4 inhibitor CFI-400945 fumarate
2020-09-18T10:37:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-4-inhibitor-cfi-400945-fumarate,Code name:,CFI-400945 fumarate
2020-09-18T10:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-alendronate-dextran-guanidine-conjugate,Abbreviation:,ODX
2020-09-18T10:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-alendronate-dextran-guanidine-conjugate,Foreign brand name:,Osteodex
2020-09-18T10:37:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-alendronate-dextran-guanidine-conjugate,Synonym:,dextran/alendronate/guanidine-containing polybisphosphonate
2020-09-18T10:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-au,Synonym:,poly A:U
2020-09-18T10:37:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-au,Synonym:,Polyadenylic Polyuridylic Acid
2020-09-18T10:38:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-gamma-glutamic-acid,Synonym:,gamma-PGA
2020-09-18T10:38:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-gamma-glutamic-acid,Synonym:,gamma-polyglutamic Acid
2020-09-18T10:38:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-gamma-glutamic-acid,Synonym:,poly-gamma-glutamate
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,"5'-inosinic Acid, homopolymer complex with 5'-cytidylic acid homopolymer"
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,poly I-poly C
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,poly I:C
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,polyinosate-polycytidylate
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,polyinosinic acid-polycytidylic acid
2020-09-18T10:37:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic,Synonym:,polyinosinic-polycytidylic acid
2020-09-18T07:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc,Synonym:,poly I:poly C with poly-1-lysine stabilizer
2020-09-18T07:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc,Synonym:,Polyinosinic-Polycytidylic Acid Stabilized with Polylysine and Carboxymethylcellulose
2020-09-18T07:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc,Synonym:,Polyriboinosinic-Polyribocytidylic Acid-Polylysine Carboxymethylcellulose
2020-09-18T07:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc,Synonym:,stabilized polyriboinosinic/polyribocytidylic acid
2020-09-18T07:37:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc,US brand name:,Hiltonol
2020-09-18T10:40:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-tlr-agonist-polyantigenic-vaccine-cadi-05,Code name:,CADI-05
2020-09-18T04:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel,Foreign brand name:,Aquamid
2020-09-18T04:53:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel,US brand name:,Bulkamid
2020-09-18T10:38:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-pg11047,Chemical structure:,"((1)N,(12)N)bis(ethyl)-6,7-dehydrospermine(N(1),N(12))bis(ethyl)-6,7-dehydrospermine"
2020-09-18T10:38:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-pg11047,Code name:,CGC-11047
2020-09-18T10:38:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-pg11047,Code name:,PG11047
2020-09-18T10:38:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-pg11047,Code name:,SL-11047
2020-09-18T10:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-sbp-101,Code name:,SBP 101
2020-09-18T10:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-sbp-101,Code name:,SBP-101
2020-09-18T10:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-sbp-101,Synonym:,diethyl dihydroxyhomospermine
2020-09-18T10:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-sbp-101,Synonym:,HO2-DEHSPM
2020-10-14T13:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-transport-inhibitor-amxt-1501-dicaprate,Synonym:,AMX513 dicaprate
2020-10-14T13:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-transport-inhibitor-amxt-1501-dicaprate,Synonym:,AMXT 1501 dicaprate
2020-10-14T13:06:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-transport-inhibitor-amxt-1501-dicaprate,Synonym:,AMXT-1501 dicaprate
2020-09-18T10:38:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-1000-cetyl-ether-cream,Abbreviation:,PEG 1000 cetyl ether cream
2020-09-18T10:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008,Code name:,NER1008
2020-09-18T10:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008,Foreign brand name:,Movidra
2020-09-18T10:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008,Synonym:,NER1008 enema
2020-09-18T10:38:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008,Synonym:,PEG3350-containing enema NER1008
2020-09-18T10:38:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-hydrogel,Synonym:,PEG hydrogel
2020-09-18T10:38:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-recombinant-endostatin,Synonym:,M2ES
2020-09-18T10:38:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin,Abbreviation:,PEG-SN38
2020-09-18T10:38:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin,Code name:,EZN-2208
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Code name:,DFP-13318
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Code name:,PEG SN38 DFP-13318
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Code name:,PL 0264
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Code name:,PL-0264
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Code name:,PLX-0264
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Synonym:,polyethyleneglycol-7-ethyl-10-hydroxycamptothecin
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Synonym:,ultra-long acting PEG-SN38
2020-09-18T10:38:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318,Synonym:,ultra-long-acting-PEG-SN-38
2020-09-18T10:39:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyglutamate-camptothecin,Abbreviation:,PG-CPT
2020-09-18T10:39:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyglutamate-camptothecin,Code name:,CT-2106
2020-10-14T13:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyinosinic-polycytidylic-acid-inactivated-rabies-virus-vaccine-ys-on-001,Code name:,YS ON 001
2020-10-14T13:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyinosinic-polycytidylic-acid-inactivated-rabies-virus-vaccine-ys-on-001,Code name:,YS-ON-001
2020-10-14T13:06:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyinosinic-polycytidylic-acid-inactivated-rabies-virus-vaccine-ys-on-001,Synonym:,poly IC/inactivated RV-V YS-ON-001
2020-10-14T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255,Code name:,NKTR 255
2020-10-14T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255,Code name:,NKTR-255
2020-10-14T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255,Code name:,NKTR255
2020-10-14T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255,Synonym:,IL-15 receptor agonist NKTR-255
2020-10-14T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255,Synonym:,long-acting polymer-engineered IL-15 conjugate NKTR-255
2020-10-14T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-encapsulated-luteolin-nanoparticle,Chemical structure:,"3',4',5,7-tetrahydroxyflavone-encapsulated polymer nanoparticles"
2020-10-14T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-encapsulated-luteolin-nanoparticle,Synonym:,nano-luteolin
2020-10-14T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-encapsulated-luteolin-nanoparticle,Synonym:,nanoluteolin
2020-10-14T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-encapsulated-luteolin-nanoparticle,Synonym:,nanoparticle-based luteolin
2020-09-18T10:39:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymeric-camptothecin-prodrug-xmt-1001,Code name:,XMT-1001
2020-09-18T10:39:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b,NA,NA
2020-09-18T10:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b-immobilized-fiber-pmx-20r,Code name:,PMX-20R
2020-09-18T10:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b-immobilized-fiber-pmx-20r,Synonym:,PMX cartridge
2020-09-18T10:39:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b-immobilized-fiber-pmx-20r,US brand name:,Toraymyxin
2020-09-18T10:39:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polypodium-leucotomos-extract,Abbreviation:,PLE
2020-09-18T10:39:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polypodium-leucotomos-extract,Foreign brand name:,Fernblock
2020-09-18T10:39:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polypodium-leucotomos-extract,Synonym:,PL extract
2020-09-18T10:39:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysaccharide-k,Abbreviation:,PSK
2020-09-18T10:39:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysaccharide-k,Foreign brand name:,Krestin
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Foreign brand name:,AGuIX
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,AGuIX-NP
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,gadolinium-based nanoparticle
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,Gd-based NPs
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,polysiloxane gadolinium-chelates-based nanoparticles
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,polysiloxane matrix-gadolinium chelates-based nanoparticles
2020-09-18T10:39:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles,Synonym:,polysiloxane/gadolinium-DOTA chelates-based nanoparticles
2020-09-18T10:40:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyunsaturated-fatty-acid,Abbreviation:,PUFA
2020-09-18T10:40:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvalent-antigen-klh-conjugate-vaccine,NA,NA
2020-09-18T10:40:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvalent-melanoma-vaccine,Abbreviation:,PMCV
2020-09-18T10:40:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvalent-melanoma-vaccine,Synonym:,polyvalent melanoma cell vaccine
2020-09-18T07:15:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvinylpyrrolidone-sodium-hyaluronate-gel,US brand name:,Gelclair
2020-09-18T10:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide,Chemical structure:,"1H-Isoindole-1,3(2H)-dione, 4-amino-2-(2,6-dioxo-3-piperidinyl)-4-amino-2-[(3RS)-2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione"
2020-09-18T10:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide,Code name:,CC-4047
2020-09-18T10:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide,Foreign brand name:,Imnovid
2020-09-18T10:40:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide,US brand name:,Pomalyst
2020-09-18T10:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-extract-pill,US brand name:,POMx
2020-09-18T10:40:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-juice,NA,NA
2020-09-18T10:40:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-liquid-extract,NA,NA
2020-09-18T07:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride,Code name:,AP24534
2020-09-18T07:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride,Synonym:,multitargeted tyrosine kinase inhibitor AP24534
2020-09-18T07:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride,US brand name:,Iclusig
2020-09-18T10:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponesimod,Chemical structure:,"(2Z,5Z)-5-(3-chloro-4-((2R)-2,3-dihydroxypropoxy)phenylmethylidene)-3-(2-methylphenyl)-2-(propylimino)-1,3-thiazolidin-4-one"
2020-10-14T13:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pooled-mutant-kras-targeted-long-peptide-vaccine,Synonym:,KRAS peptide vaccine
2020-10-14T13:07:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pooled-mutant-kras-targeted-long-peptide-vaccine,Synonym:,pooled mutant KRAS peptide vaccine
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Code name:,CGX 1321
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Code name:,CGX-1321
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Code name:,CGX1321
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Synonym:,PORCN inhibitor CGX1321
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Synonym:,WNT inhibitor CGX1321
2020-10-14T13:07:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321,Synonym:,Wnt signaling inhibitor CGX1321
2020-09-18T10:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-etc-1922159,Code name:,ETC-159
2020-09-18T10:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-etc-1922159,Code name:,ETC-1922159
2020-09-18T10:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-etc-1922159,Synonym:,PORCN inhibitor ETC-1922159
2020-10-14T13:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-rxc004,Code name:,RXC 004
2020-10-14T13:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-rxc004,Code name:,RXC-004
2020-10-14T13:07:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-rxc004,Code name:,RXC004
2020-09-18T10:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974,Chemical structure:,"2-(2,3-dimethyl-[2,4-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide"
2020-09-18T10:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974,Code name:,WNT974
2020-09-18T10:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974,Synonym:,LGK974
2020-09-18T10:41:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974,Synonym:,PORCN inhibitor LGK974
2020-10-14T13:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-xnw7201,Code name:,XNW 7201
2020-10-14T13:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-xnw7201,Code name:,XNW-7201
2020-10-14T13:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-xnw7201,Code name:,XNW7201
2020-10-14T13:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-xnw7201,Synonym:,PORCN inhibitor XNW7201
2020-09-18T10:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium,Abbreviation:,DHE
2020-09-18T10:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium,Code name:,CL-184116
2020-09-18T10:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium,Synonym:,dihematoporphyrin ester
2020-09-18T10:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium,Synonym:,dihematoporphyrin ether
2020-09-18T10:41:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium,Synonym:,photofrin II
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Chemical structure:,"[1aS-(1a alpha,8beta,8a alpha,8b alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dioneN-methylmitomycin C"
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Code name:,ENT-50825
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Code name:,U-14743
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Synonym:,methyl mitomycin
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Synonym:,methyl mitomycin C
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Synonym:,Methylmitomycin
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Synonym:,porfiromycine
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,Synonym:,porphyromycin
2020-09-18T10:41:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin,US brand name:,Promycin
2020-09-18T09:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/posaconazole,Code name:,SCH 56592
2020-09-18T09:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/posaconazole,US brand name:,Noxafil
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,Abbreviation:,PVP iodine
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,Foreign brand name:,Betaisodona
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,Synonym:,Betadine topical
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,Synonym:,iodine povidone topical
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,Synonym:,iodopovidone solution
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,Betadine
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,Betadine Solution
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,E-Z Prep
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,E-Z Scrub
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,Traumasept
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,Ultradine
2020-10-14T04:28:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine,US brand name:,Videne
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Abbreviation:,PVP iodine
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Foreign brand name:,Betaisodona
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,Betadine topical
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodine povidone topical
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,Synonym:,iodopovidone solution
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Betadine Solution
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Prep
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,E-Z Scrub
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Traumasept
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Ultradine
2020-09-18T04:39:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution,US brand name:,Videne
2020-10-14T13:00:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement,Synonym:,powdered berry extracts
2020-10-14T13:00:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement,Synonym:,powdered berry extracts blend
2020-10-14T13:00:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement,Synonym:,powdered natural berry extracts
2020-10-14T13:00:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement,Synonym:,powdered NBE
2020-10-14T13:00:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement,US brand name:,PediaBerry
2020-10-14T13:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pozelimab,Code name:,REGN 3918
2020-10-14T13:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pozelimab,Code name:,REGN-3918
2020-10-14T13:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pozelimab,Code name:,REGN3918
2020-10-14T13:07:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pozelimab,Synonym:,WHO 10945
2020-09-18T10:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poziotinib,Code name:,HM781-36B
2020-09-18T10:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poziotinib,Code name:,NOV120101
2020-09-18T10:42:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poziotinib,Synonym:,pan-HER kinase inhibitor HM781-36B
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Code name:,TPST 1120
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Code name:,TPST-1120
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Code name:,TPST1120
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Synonym:,peroxisome proliferator activated receptor alpha antagonist TPST-1120
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Synonym:,PPARA antagonist TPST-1120
2020-10-14T13:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120,Synonym:,PPARalpha antagonist TPST-1120
2020-09-18T10:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppe-expressing-replication-defective-hsv-1-vector-np2,Code name:,NP2
2020-09-18T10:42:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppe-expressing-replication-defective-hsv-1-vector-np2,Synonym:,preproenkephalin-expressing replication-defective herpes simplex virus-1 vector NP2
2020-09-18T10:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppi-2458,NA,NA
2020-09-18T10:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pr-104,Synonym:,PR104
2020-09-18T10:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pr1-leukemia-peptide-vaccine,Abbreviation:,PR1 vac
2020-09-18T10:43:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pr1-leukemia-peptide-vaccine,Synonym:,proteinase 3 PR1 peptide
2020-09-18T10:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pracinostat,Code name:,SB939
2020-09-18T10:43:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pracinostat,Synonym:,HDAC inhibitor SB939
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,Chemical structure:,"(2S)-2-[[4-[(1RS)-1-[(2, 4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid10-propargyl-10-deazaaminopterin"
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,Code name:,PDX
2020-09-18T07:02:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate,US brand name:,Folotyn
2020-10-14T05:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib,Chemical structure:,(cis)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)cyclohexanecarboxamide
2020-10-14T05:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib,Code name:,BLU-667
2020-10-14T05:11:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib,US brand name:,Gavreto
2020-10-14T03:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine,Code name:,CX-2009
2020-10-14T03:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine,Synonym:,ADC CX-2009
2020-10-14T03:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine,Synonym:,anti-CD166-DM4 CX-2009
2020-10-14T03:35:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine,Synonym:,PDC CX-2009
2020-09-18T10:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-iinducible-caspase-9-bpx-701,Code name:,BPX-701
2020-09-18T10:43:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-iinducible-caspase-9-bpx-701,Synonym:,caspaCID-based PRAME-TCR allogeneic T lymphocytes BPX-701
2020-10-14T13:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-inducible-caspase-9-bpx-701,Code name:,BPX-701
2020-10-14T13:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-inducible-caspase-9-bpx-701,Synonym:,caspaCID-based PRAME-TCR allogeneic T lymphocytes BPX-701
2020-09-18T09:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pramipexole-dihydrochloride,US brand name:,Mirapex
2020-10-14T13:08:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pramlintide,Synonym:,triproamylin
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Abbreviation:,DHEA
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Chemical structure:,3beta-Hydroxyandrost-5-en-17-one
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Code name:,GL701
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Synonym:,Dehydroisoandrosterone
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,Synonym:,therapeutic dehydroepiandrosterone
2020-09-18T06:50:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone,US brand name:,Fidelin
2020-09-18T10:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pravastatin-sodium,Abbreviation:,PRAV
2020-09-18T10:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pravastatin-sodium,US brand name:,Pravachol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Abbreviation:,PRDL
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Chemical structure:,"(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione1,2-dehydrohydrocortisone"
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Adnisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Aprednislon
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Capsoid
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Cortisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dacortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decaprednil
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Decortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta- Cortef
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Diona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Delta-Phoricol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltacortril
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltasolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Deltidrosol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dhasolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Di-Adreson-F
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Dontisolon D
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Estilsona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Fisopred
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Frisolona
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Gupisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Hostacortin H
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Klismacort
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Kuhlprednon
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lenisolone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Lepi-Cortinolo
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H N
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Linola-H-Fett N
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Longiprednil
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Meticortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Opredsone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Panafcortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Precortisyl
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Pred-Clysma
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predeltilone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Coelin
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Predni-Helvacort
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prednicortelone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Foreign brand name:,Prenilone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta(1)hydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,delta1-dehydro-hydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,deltahydrocortisone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,Synonym:,metacortandralone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Cortalone
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Delta-Cortef
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltra
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Hydeltrasol
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Meti-derm
2020-09-18T05:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone,US brand name:,Prelone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Abbreviation:,PRED
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Chemical structure:,"1, 2-dehydrocortisone1;2-dehydrocortisone17,21-dihydroxypregna-1,4-diene-3,11,20-trione"
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Adasone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Cortancyl
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Dacortin
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,DeCortin
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Decortisyl
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Decorton
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Deltacortene
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Deltison
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Deltra
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Econosone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Meprosona-F
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Ofisolona
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Panafcort
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Panasol-S
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Paracort
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Predeltin
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Predicor
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Predicorten
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Prednicort
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Prednidib
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Prednilonga
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Predniment
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Prednitone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Promifen
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Foreign brand name:,Servisone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,delta 1-cortisone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,Delta(1)-Cortisone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,deltacortisone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,deltadehydrocortisone
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,metacortandracin
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,PRD
2020-09-18T10:44:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone,Synonym:,Prednisonum
2020-09-18T08:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin,Chemical structure:,3-(aminomethyl)-5-methyl-hexanoic acid
2020-09-18T08:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin,Code name:,CI-1008
2020-09-18T08:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin,Code name:,PD-144723
2020-09-18T08:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin,Synonym:,3-Isobutyl GABA
2020-09-18T08:49:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin,US brand name:,Lyrica
2020-09-18T10:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/preimplantation-factor-pif-1,Abbreviation:,PIF-1
2020-09-18T10:44:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/preimplantation-factor-pif-1,Synonym:,PIF-1 peptide
2020-10-14T13:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/presatovir,Synonym:,GS-5806
2020-10-14T13:17:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/presatovir,Synonym:,respiratory syncytial virus fusion inhibitor GS-5806
2020-09-18T10:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexasertib,Abbreviation:,chk1 inhibitor LY2606368
2020-09-18T10:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexasertib,Code name:,LY2606368
2020-09-18T10:45:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexasertib,Synonym:,checkpoint kinase 1 inhibitor LY2606368
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Abbreviation:,L-Grb-2
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Abbreviation:,L-Grb2
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Code name:,BP-100-1.01
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Code name:,BP1001
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Synonym:,grb2 mRNA
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Synonym:,liposomal Grb-2
2020-10-14T12:36:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen,Synonym:,liposomal Grb2 AS ODN
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,Chemical structure:,2-(propylamino)-o-propionotoluidide hydrochloride
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,Code name:,L-67
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,US brand name:,Citanest
2020-09-18T05:29:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride,US brand name:,Xylonest
2020-09-18T10:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prima-1-analog-apr-246,Code name:,APR-246
2020-09-18T10:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prima-1-analog-apr-246,Synonym:,p53 activator APR-246
2020-09-18T10:45:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prima-1-analog-apr-246,Synonym:,PRIMA-1MET
2020-09-18T10:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prime-cancer-vaccine-mva-bn-cv301,Synonym:,modified vaccinia Ankara-Bavarian Nordic vaccine CV301
2020-09-18T10:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prime-cancer-vaccine-mva-bn-cv301,Synonym:,MVA-BN vaccine CV301
2020-09-18T10:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prime-cancer-vaccine-mva-bn-cv301,Synonym:,MVA-BN-CV301
2020-09-18T10:45:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prime-cancer-vaccine-mva-bn-cv301,Synonym:,prime vaccine CV301
2020-09-18T10:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prinomastat,Chemical structure:,"(3S)-N-hydroxy-2,2-dimethyl-4-{{4-(4-piridinyloxy)phenyl}sulfonyl}-3-thiomorpholinecarboxamide"
2020-09-18T10:45:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prinomastat,Code name:,AG3340
2020-09-18T10:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritelivir,Code name:,AIC-316
2020-09-18T10:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritelivir,Code name:,AIC316
2020-09-18T10:45:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritelivir,Code name:,BAY 57-1293
2020-10-14T13:08:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritumumab,Code name:,ACA-11
2020-10-14T13:08:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritumumab,Code name:,CLNH11
2020-10-14T13:08:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritumumab,Synonym:,CLN-IgG
2020-10-14T13:08:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritumumab,Synonym:,"immunoglobulin G, anti-(human vimentin) (human monoclonal CLN G11 gamma1-chain), disulfide with human monoclonal CLN G11 kappa-chain, dimer"
2020-10-14T13:08:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor,Synonym:,histone-arginine N-methyltransferase PRMT1 inhibitor
2020-10-14T13:08:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor,Synonym:,interferon receptor 1-bound protein 4 inhibitor
2020-10-14T13:08:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor,Synonym:,protein arginine N-methyltransferase 1 inhibitor
2020-10-14T13:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor-gsk3368715,Code name:,GSK 3368715
2020-10-14T13:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor-gsk3368715,Code name:,GSK-3368715
2020-10-14T13:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor-gsk3368715,Code name:,GSK3368715
2020-10-14T13:08:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor-gsk3368715,Synonym:,protein arginine methyltransferase 1 inhibitor GSK3368715
2020-10-14T13:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-jnj-64619178,Code name:,JNJ 64619178
2020-10-14T13:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-jnj-64619178,Code name:,JNJ-64619178
2020-10-14T13:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-jnj-64619178,Code name:,JNJ64619178
2020-10-14T13:08:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-jnj-64619178,Synonym:,protein arginine methyltransferase 5 inhibitor JNJ-64619178
2020-10-14T13:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-prt811,Code name:,PRT 811
2020-10-14T13:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-prt811,Code name:,PRT-811
2020-10-14T13:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-prt811,Code name:,PRT811
2020-10-14T13:08:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-prt811,Synonym:,protein arginine methyltransferase 5 inhibitor PRT811
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Chemical structure:,"1H-indene-3-acetamide, 5-fluoro-2-methyl-N-(phenylmethyl)-1-(4-pyridinylmethylene)-, monohydrochloride, (1Z)-"
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Code name:,CEL 031
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Code name:,CP 461
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Code name:,CP-461
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Code name:,OSI 461
2020-09-18T10:46:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461,Synonym:,CP461
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,Abbreviation:,PROB
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,US brand name:,Benemid
2020-09-18T04:36:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid,US brand name:,SK-Probenecid
2020-09-18T10:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probiotic-acidophilus,Synonym:,Lactobacillus acidophilus
2020-10-14T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probiotic-supplement-weileshu,Synonym:,probiotic WeiLeShu
2020-10-14T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probiotic-supplement-weileshu,Synonym:,WeiLeShu
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Abbreviation:,PCB
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Abbreviation:,PCZ
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Code name:,NCI-C01810
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Code name:,Ro 4-6467/1
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Foreign brand name:,Natulan
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Foreign brand name:,Natulanar
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Synonym:,ibenzmethyzin hydrochloride
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Synonym:,MIH hydrochloride
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Synonym:,PCB hydrochloride
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,Synonym:,PCZ
2020-09-18T08:56:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride,US brand name:,Matulane
2020-09-18T10:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procaspase-activating-compound-1-vo-100,Abbreviation:,PAC-1
2020-09-18T10:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procaspase-activating-compound-1-vo-100,Code name:,VO-100
2020-09-18T10:46:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procaspase-activating-compound-1-vo-100,Synonym:,PAC-1 VO-100
2020-09-18T10:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine,Synonym:,Compazine
2020-09-18T10:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine,Synonym:,prochlorperazine dimaleate
2020-10-14T13:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine-maleate,Synonym:,Compazine
2020-10-14T13:09:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine-maleate,Synonym:,prochlorperazine dimaleate
2020-09-18T10:47:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proflavine-hemisulfate,Chemical structure:,"acridine, 3,6-diamino-, sulfate (2:1)"
2020-09-18T10:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progenipoietin,Abbreviation:,ProGP
2020-09-18T10:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progenipoietin,Code name:,SD-9427
2020-09-18T10:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progenipoietin,Synonym:,filgrastim-fetal liver tyrosine kinase-3 fusion protein
2020-09-18T10:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progenipoietin,Synonym:,Flt-3 ligand/G-CSF fusion protein
2020-09-18T06:27:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progesterone-vaginal-insert,US brand name:,Endometrin
2020-09-18T10:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prohibitin-targeting-peptide-1,Abbreviation:,prohibitin TP01
2020-09-18T10:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prohibitin-targeting-peptide-1,Abbreviation:,prohibitin-TP01
2020-09-18T10:48:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prohibitin-targeting-peptide-1,Code name:,TP01
2020-10-14T03:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prolgolimab,Code name:,BCD 100
2020-10-14T03:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prolgolimab,Code name:,BCD-100
2020-10-14T03:55:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prolgolimab,Code name:,BCD100
2020-10-14T13:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promestriene,NA,NA
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Chemical structure:,"N,N-dimethyl- 1-(10H-phenothiazin-10-yl) propan-2-amine"
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Foreign brand name:,Anergan
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Synonym:,phenazine
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Synonym:,Phencen
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Synonym:,prometh
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,Synonym:,V-Gan
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,US brand name:,Phenergan
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,US brand name:,Prorex
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,US brand name:,Provigan
2020-09-18T10:25:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride,US brand name:,Zipan
2020-09-18T10:49:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pronase-oral-solution,Synonym:,pronase solution
2020-09-18T10:49:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propacetamol,NA,NA
2020-09-18T06:08:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propofol,US brand name:,Diprivan
2020-09-18T07:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride,Chemical structure:,2-Propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) Hydrochloride
2020-09-18T07:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride,Foreign brand name:,Dociton
2020-09-18T07:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride,US brand name:,Hemangeol
2020-09-18T07:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride,US brand name:,Inderal
2020-09-18T10:49:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propylthiouracil,Synonym:,6-Propyl-2-Thiouracil
2020-09-18T10:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-cancer-vaccine-ony-p1,Code name:,ONY-P1
2020-09-18T10:49:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-cancer-vaccine-ony-p1,Foreign brand name:,Onyvax-P
2020-10-14T04:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-health-cocktail-dietary-supplement,US brand name:,PHC
2020-10-14T04:43:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-health-cocktail-dietary-supplement,US brand name:,Prostate Health Cocktail
2020-09-18T10:50:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-tumor-antigen-activated-autologous-dendritic-cell-vaccine,Synonym:,DCVAC/PCa
2020-09-18T10:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein,Code name:,PA2024
2020-09-18T10:50:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein,Synonym:,PA2024
2020-10-14T13:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein-pa2024,Code name:,PA2024
2020-10-14T13:09:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein-pa2024,Synonym:,PA2024
2020-09-18T10:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-activated-anti-pd-l1-antibody-prodrug-cx-072,Code name:,CX 072
2020-09-18T10:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-activated-anti-pd-l1-antibody-prodrug-cx-072,Code name:,CX-072
2020-09-18T10:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-activated-anti-pd-l1-antibody-prodrug-cx-072,Synonym:,PD-L1 probody therapeutic CX-072
2020-09-18T10:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-activated-anti-pd-l1-antibody-prodrug-cx-072,Synonym:,probody CX-072
2020-09-18T10:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-inhibitor-formulation-lb1148,Code name:,LB-1148
2020-09-18T10:50:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-inhibitor-formulation-lb1148,Code name:,LB1148
2020-09-18T10:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-gsk3326595,Code name:,GSK-3326595
2020-09-18T10:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-gsk3326595,Code name:,GSK3326595
2020-09-18T10:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-gsk3326595,Synonym:,EPZ015938
2020-09-18T10:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-gsk3326595,Synonym:,PRMT5 inhibitor GSK3326595
2020-10-14T13:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-pf-06939999,Code name:,PF 06939999
2020-10-14T13:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-pf-06939999,Code name:,PF-06939999
2020-10-14T13:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-pf-06939999,Code name:,PF06939999
2020-10-14T13:09:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-pf-06939999,Synonym:,PRMT5 inhibitor PF-06939999
2020-10-14T13:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-prt543,Code name:,PRT 543
2020-10-14T13:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-prt543,Code name:,PRT-543
2020-10-14T13:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-prt543,Code name:,PRT543
2020-10-14T13:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-prt543,Synonym:,PRMT5 inhibitor PRT543
2020-10-14T05:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-e7-human-papillomavirus-type-16,Synonym:,HPV-16 E7
2020-10-14T05:21:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-e7-human-papillomavirus-type-16,Synonym:,HPV16 E7
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Code name:,IDE 196
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Code name:,IDE-196
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Code name:,IDE196
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Code name:,LXS196
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Synonym:,PKC inhibitor IDE196
2020-10-14T13:09:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196,Synonym:,protein kinase C inhibitor LXS196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Code name:,IDE 196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Code name:,IDE-196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Code name:,IDE196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Code name:,LXS196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Synonym:,PKC inhibitor IDE196
2020-09-18T10:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196,Synonym:,protein kinase C inhibitor LXS196
2020-09-18T10:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-phosphatase-2a-inhibitor-lb-100,Abbreviation:,PP2A inhibitor LB-100
2020-09-18T10:50:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-phosphatase-2a-inhibitor-lb-100,Code name:,LB-100
2020-09-18T10:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-stabilized-liposomal-docetaxel-nanoparticles,Code name:,ATI-1123
2020-09-18T10:50:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-stabilized-liposomal-docetaxel-nanoparticles,Synonym:,protein-stabilized nanoparticle-bound docetaxel ATI-1123
2020-09-18T10:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proteolytic-enzymes,NA,NA
2020-10-14T13:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protopine-nuciferine-supplement,Foreign brand name:,Protoves M1
2020-10-14T13:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protopine-nuciferine-supplement,Synonym:,protopine and nuciferine supplement
2020-10-14T13:09:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protopine-nuciferine-supplement,Synonym:,protopine/nuciferine
2020-09-18T10:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proxalutamide,Code name:,GT-0918
2020-09-18T10:51:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proxalutamide,Code name:,GT0918
2020-09-18T10:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-il-2-gm-csf-vaccine,Synonym:,proscavax
2020-09-18T10:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-il-2-gm-csf-vaccine,Synonym:,prostatac
2020-09-18T10:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-pap-klh-pulsed-autologous-dendritic-cell-vaccine,Foreign brand name:,CreaVax-PC
2020-09-18T10:52:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-pap-klh-pulsed-autologous-dendritic-cell-vaccine,Synonym:,prostate cancer antigen/KLH-pulsed autologous dendritic cell vaccine
2020-09-18T09:54:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-prostate-cancer-vaccine,US brand name:,OncoVax-PR
2020-09-18T10:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-psma-dna-plasmid-ino-5150,Code name:,INO 5150
2020-09-18T10:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-psma-dna-plasmid-ino-5150,Code name:,INO-5150
2020-09-18T10:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-psma-dna-plasmid-ino-5150,Synonym:,PSA/PSMA synthetic DNA vaccine INO-5150
2020-09-18T10:52:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-psma-dna-plasmid-ino-5150,Synonym:,PSA/PSMA-encoding DNA plasmid INO-5150
2020-09-18T10:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-rna-pulsed-dendritic-cell-vaccine,NA,NA
2020-09-18T10:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa154-163155l-peptide-vaccine,Abbreviation:,PSA PEP VAC
2020-09-18T10:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa154-163155l-peptide-vaccine,Synonym:,PSA-3A
2020-09-18T10:52:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pseudomonas-aeruginosa-preparation,NA,NA
2020-09-18T10:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psilocybine,Chemical structure:,"4-phosphoryloxy-N,N-dimethyl-tryptamine"
2020-09-18T10:52:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psilocybine,Synonym:,psilocybin
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Code name:,HPN 424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Code name:,HPN-424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Code name:,HPN424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Synonym:,anti-PSMA/CD3 TriTAC HPN424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Synonym:,PSMA/CD3 TriTAC HPN424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Synonym:,PSMA/CD3-specific TriTAC HPN424
2020-10-14T13:10:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424,Synonym:,TriTAC HPN424
2020-09-18T10:52:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-docetaxel-nanoparticles-bind-014,Code name:,BIND-014
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Code name:,18F-CTT1057
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Synonym:,18F-CTT-1057
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Synonym:,CTT 1057 18F
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Synonym:,CTT 1057 F18
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Synonym:,fluorine F 18 CTT1057
2020-09-18T10:52:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057,Synonym:,fluorine-18-CTT 1057
2020-09-18T10:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-tubulysin-b-containing-conjugate-ec1169,Code name:,EC1169
2020-09-18T10:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-tubulysin-b-containing-conjugate-ec1169,Code name:,EC1719
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Code name:,EC 0652
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Code name:,EC0652
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Synonym:,99mTc-EC0652
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Synonym:,DUPA-99mTc
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Synonym:,DUPA-99mTc EC0652
2020-09-18T10:52:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652,Synonym:,radiodiagnostic EC0652
2020-09-18T10:52:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-tarp-peptide-vaccine,NA,NA
2020-10-14T13:10:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pterostilbene,Chemical structure:,"3',5'-dimethoxy-4-stilbenol (SY); 3,5-dimethoxy-4'-hydroxystilbenephenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (E)-trans-3,5-dimethoxy-4-hydroxystilbene"
2020-09-18T10:53:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ptvg-hp-plasmid-dna-vaccine,NA,NA
2020-09-18T10:53:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-higfbp-2-multi-epitope-plasmid-dna-vaccine,NA,NA
2020-09-18T10:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-igfbp2-her2-igf1r-plasmid-dna-vaccine,Synonym:,pUMVC3-IGFBP2-HER2-IGF1R
2020-09-18T10:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-igfbp2-her2-igf1r-plasmid-dna-vaccine,Synonym:,pUMVC3-IGFBP2-HER2-IGF1R vaccine
2020-09-18T10:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-igfbp2-her2-igf1r-plasmid-dna-vaccine,Synonym:,WOKVAC
2020-09-18T10:53:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-igfbp2-her2-igf1r-plasmid-dna-vaccine,Synonym:,WOKVAC vaccine
2020-09-18T10:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/purple-grape-juice,Abbreviation:,PGJ
2020-09-18T10:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv-10,Synonym:,rose bengal disodium 10%
2020-09-18T10:51:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv-10,US brand name:,Provecta
2020-09-18T10:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv701,NA,NA
2020-09-18T04:34:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres,US brand name:,Bead Block Compressible Microspheres
2020-09-18T10:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres-doxorubicin-hydrochloride,Synonym:,HepaSphere microspheres/doxorubicin hydrochloride
2020-09-18T10:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres-doxorubicin-hydrochloride,Synonym:,QuadraSphere microspheres/doxorubicin hydrochloride
2020-10-14T13:10:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvaxrcpsav53l-dna-vaccine,Synonym:,pVAXrcPSAv53l (DNA encoding rhesus PSA)
2020-09-18T10:54:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvaxrcpsav53l-vaccine,Synonym:,pVAXrcPSAv53l (DNA encoding rhesus PSA)
2020-09-18T10:54:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvdf-sirolimus-topical,Synonym:,topical PVDF/rapamycin
2020-09-18T10:54:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazinamide,NA,NA
2020-09-18T10:54:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazine-diazohydroxide,Abbreviation:,PZDH
2020-09-18T10:54:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazine-diazohydroxide,Chemical structure:,pyrazine-2-diazohydroxide
2020-09-18T10:54:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazine-diazohydroxide,Synonym:,"pyrazinamine, N-nitroso-, sodium salt"
2020-09-18T10:54:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazine-diazohydroxide,Synonym:,"pyrazineamine, N-nitroso-, sodium salt"
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Chemical structure:,"4-hydroxy-3-beta-D-ribofuranosylpyrazole-5-carboxamidepyrazole, -3-carboxamide, 4-Hydroxy-5-beta-L-ribofuranosyl"
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Code name:,47599
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Synonym:,beta-pyrazomycin
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Synonym:,compound 47599
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Synonym:,pirazofurin
2020-09-18T10:54:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin,Synonym:,pyrazomycin
2020-09-18T10:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazoloacridine,Abbreviation:,PZA
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,Chemical structure:,"5-hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride"
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,Synonym:,vitamin B6 hydrochloride
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,US brand name:,Beesix
2020-09-18T04:34:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride,US brand name:,Hexa-Betalin
2020-09-18T05:53:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrimethamine,US brand name:,Daraprim
2020-09-18T10:55:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrotinib,NA,NA
2020-09-18T10:55:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyroxamide,Chemical structure:,Suberoyl-3-aminopyridineamide Hydroxamic Acid
2020-09-18T10:55:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b,Code name:,SGN CD19B
2020-09-18T10:55:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b,Code name:,SGN-CD19B
2020-09-18T10:55:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,ADC SGN-CD19B
2020-09-18T10:55:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,PBD-based anti-CD19 ADC SGN-CD19B
2020-09-18T10:55:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b,Synonym:,PBD-based anti-CD19 antibody-drug conjugate SGN-CD19B
2020-09-18T10:55:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyruvate-kinase-inhibitor-tln-232,Code name:,CAP-232
2020-09-18T10:55:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyruvate-kinase-inhibitor-tln-232,Code name:,TLN-232
2020-10-14T13:10:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrvinium-pamoate,NA,NA
2020-10-14T13:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qilisheng-immunoregulatory-oral-solution,Synonym:,qilisheng
2020-10-14T13:10:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qilisheng-immunoregulatory-oral-solution,Synonym:,qilisheng solution
2020-09-18T10:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qs21,Code name:,NIAID VEU 016
2020-09-18T10:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qs21,Code name:,QS-21
2020-09-18T10:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qs21,Synonym:,QS-21 Adjuvant
2020-09-18T10:55:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qs21,Synonym:,Stimulon QS-21 Adjuvant
2020-10-14T05:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-human-papillomavirus-types-6-11-16-18-recombinant-vaccine,Synonym:,"quadrivalent HPV (type 6, 11, 16 and 18) L1 virus-like particle vaccine"
2020-10-14T05:11:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-human-papillomavirus-types-6-11-16-18-recombinant-vaccine,US brand name:,Gardasil
2020-09-18T10:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-inactivated-influenza-vaccine,Abbreviation:,QIV
2020-09-18T10:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-inactivated-influenza-vaccine,Synonym:,Fluzone Quadrivalent
2020-09-18T10:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-inactivated-influenza-vaccine,Synonym:,Fluzone Quadrivalent Influenza Vaccine
2020-09-18T10:56:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-inactivated-influenza-vaccine,Synonym:,quadrivalent influenza vaccine
2020-09-18T10:56:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quarfloxacin,Code name:,CX-3543
2020-10-14T13:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quarfloxin,Code name:,CX-3543
2020-09-18T10:56:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quaternary-ammonium-polyethylenimine-nanoparticles,Abbreviation:,QA-PEI nanoparticles
2020-09-18T10:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quercetin,Chemical structure:,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one3,3',4',5,7-pentahydroxyflavone"
2020-09-18T10:56:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quercetin,Synonym:,C.I. natural yellow 10
2020-09-18T10:56:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-dihydrochloride,Chemical structure:,6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine dihydrochloride
2020-09-18T10:56:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-dihydrochloride,Code name:,SN 390
2020-09-18T10:56:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-dihydrochloride,Synonym:,atabrine dihydrochloride
2020-09-18T10:56:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-dihydrochloride,Synonym:,mepacrine dihydrochoride
2020-10-14T13:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride,Chemical structure:,6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine dihydrochloride
2020-10-14T13:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride,Code name:,SN 390
2020-10-14T13:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride,Synonym:,atabrine dihydrochloride
2020-10-14T13:11:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride,Synonym:,mepacrine dihydrochoride
2020-09-18T10:56:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinidine,NA,NA
2020-09-18T10:56:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinine,Abbreviation:,QUIN
2020-09-18T10:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quisinostat,Code name:,JNJ-26481585
2020-09-18T10:56:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quisinostat,Synonym:,HDAC inhibitor JNJ-26481585
2020-09-18T10:57:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r---gossypol-acetic-acid,Code name:,AT-101
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Abbreviation:,CTX/DOX/MOAB IDEC-C2B8/PRED/VCR
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Synonym:,cyclophosphamide/doxorubicin/prednisone/rituximab/vincristine
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Synonym:,R-CHOP
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Synonym:,Rituxan/CHOP
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Synonym:,rituximab-cyclophosphamide-hydroxydaunorubicin-Oncovin-prednisone regimen
2020-09-18T11:00:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen,Synonym:,rituximab/cyclophosphamide/doxorubicin/prednisone/vincristine
2020-09-18T11:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-cvp-regimen,Synonym:,rituximab-cyclophosphamide-vincristine-prednisone regimen
2020-09-18T11:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-epoch-regimen,Synonym:,REPOCH regimen
2020-09-18T11:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-epoch-regimen,Synonym:,rituximab-EPOCH regimen
2020-09-18T11:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-epoch-regimen,Synonym:,rituximab-etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen
2020-09-18T11:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-epoch-regimen,Synonym:,rituximab/etoposide/prednisone/vincristine/cyclophosphamide/doxorubicin regimen
2020-09-18T11:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-ice-regimen,Synonym:,RICE regimen
2020-09-18T11:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-ice-regimen,Synonym:,rituximab-ifosfamide-carboplatin-etoposide regimen
2020-09-18T10:57:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r1-cooling-gel-plus-r2-moisturizing-sun-protecting-lotion,Synonym:,R1/R2 waterjel
2020-10-14T13:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin,Abbreviation:,rATG
2020-10-14T13:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin,Synonym:,anti-thymocyte globulin rabbit
2020-10-14T13:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin,Synonym:,rabbit antithymocyte globulin
2020-10-14T13:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin,Synonym:,rabbit ATG
2020-10-14T13:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin,Synonym:,thymoglobulin
2020-10-14T03:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole,Foreign brand name:,Pariet
2020-10-14T03:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole,Foreign brand name:,Rablet
2020-10-14T03:22:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole,US brand name:,Aciphex
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Pariet
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,Foreign brand name:,Rablet
2020-09-18T01:18:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium,US brand name:,Aciphex
2020-09-18T10:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabusertib,Code name:,LY2603618
2020-09-18T10:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabusertib,Synonym:,checkpoint kinase 2 inhibitor LY2603618
2020-09-18T10:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabusertib,Synonym:,CHK2 inhibitor LY2603618
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Code name:,SM-88
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Synonym:,racemetyrosine/methoxsalen/phenytoin/sirolimus combination SM88
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Synonym:,SM-88 used with methoxsalen/phenytoin/sirolimus
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Synonym:,SM-88 used with MPS
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Synonym:,SM-88/methoxsalen/phenytoin/sirolimus
2020-10-14T13:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88,Synonym:,tyrosine isomers/phenytoin/methoxsalen/sirolimus
2020-09-18T10:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemic-xk469,NA,NA
2020-09-18T10:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racotumomab,Abbreviation:,anti-P3 Ab idiotype mAB1E10
2020-09-18T10:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racotumomab,Code name:,MoAb 1E10
2020-09-18T10:57:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racotumomab,Synonym:,anti-P3 antibody idiotype monoclonal antibody 1E10
2020-09-18T10:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad-p53,Foreign brand name:,Gendicine
2020-09-18T10:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad-p53,Foreign brand name:,Genkaxin
2020-09-18T10:58:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad-p53,Synonym:,recombinant adenovirus encoding p53
2020-10-14T13:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad51-inhibitor-cyt-0851,Code name:,CYT 0851
2020-10-14T13:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad51-inhibitor-cyt-0851,Code name:,CYT-0851
2020-10-14T13:11:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad51-inhibitor-cyt-0851,Code name:,CYT0851
2020-09-18T10:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radiosensitizer-rrx-001,Code name:,RRx-001
2020-10-14T13:11:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-bromatum,NA,NA
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,Code name:,BAY 88-8223
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,Code name:,BAY88-8223
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,Synonym:,alpharadin
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,Synonym:,radium 223 dichloride
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,Synonym:,radium-223 dichloride
2020-09-18T10:58:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride,US brand name:,Xofigo
2020-09-18T10:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radix-angelicae-sinensis-radix-astragali-herbal-supplement,Abbreviation:,DB1
2020-09-18T10:58:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radix-angelicae-sinensis-radix-astragali-herbal-supplement,Synonym:,Danggui Buxue Decoction No.1
2020-10-14T13:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib,Chemical structure:,4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide hydrochloride
2020-10-14T13:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib,Code name:,IY5511HCl
2020-10-14T13:11:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib,US brand name:,Supect
2020-09-18T10:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib-hydrochloride,Chemical structure:,4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide hydrochloride
2020-09-18T10:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib-hydrochloride,Code name:,IY5511HCl
2020-09-18T10:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib-hydrochloride,US brand name:,Supect
2020-09-18T10:58:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-kinase-inhibitor-hm95573,Code name:,HM95573
2020-09-18T10:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-kinase-inhibitor-xl281,Code name:,XL281
2020-09-18T10:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-mek-dual-kinase-inhibitor-ro5126766,Code name:,RO5126766
2020-10-14T13:12:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-mek-serine-threonine-kinase-inhibitor-ro5126766,Code name:,RO5126766
2020-10-14T03:47:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ragifilimab,Code name:,INCAGN01876
2020-10-14T03:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralaniten-acetate,Code name:,EPI-506
2020-10-14T03:32:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralaniten-acetate,Synonym:,AR inhibitor EPI-506
2020-10-14T12:56:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralimetinib-mesylate,Abbreviation:,p38 mitogen-activated protein kinase inhibitor LY2228820 dimesylate
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Chemical structure:,[6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Code name:,LY-139481
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Foreign brand name:,Optruma
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,Synonym:,Raloxifene HCl
2020-09-18T06:39:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride,US brand name:,Evista
2020-09-18T08:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltegravir-potassium,Chemical structure:,"N-[ (4-Fluorophenyl)methyl]-1,6-dihydro5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4pyrimidinecarboxamide monopotassium salt"
2020-09-18T08:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltegravir-potassium,US brand name:,Isentress
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,Abbreviation:,TDX
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,Chemical structure:,"N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acidN-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid"
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,Code name:,D1694
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,Code name:,ICI-D1694
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,Code name:,ZD1694
2020-09-18T10:58:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed,US brand name:,Tomudex
2020-09-18T10:59:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramelteon,US brand name:,Rozerem
2020-09-18T01:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramipril,US brand name:,Altace
2020-09-18T10:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramosetron-hydrochloride,Abbreviation:,RAM
2020-09-18T10:59:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramosetron-hydrochloride,Foreign brand name:,Nasea
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Code name:,IMC-1121B
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Code name:,LY3009806
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,Synonym:,anti-VEGFR-2 fully human monoclonal antibody IMC-1121B
2020-09-18T05:49:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab,US brand name:,Cyramza
2020-09-18T08:44:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranibizumab,US brand name:,Lucentis
2020-09-18T10:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine,Abbreviation:,MCNU
2020-09-18T10:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine,Foreign brand name:,Cymer
2020-09-18T10:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine,Foreign brand name:,Cymerin
2020-09-18T10:59:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine,Synonym:,Ranomustine
2020-09-18T10:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranolazine,Chemical structure:,"1-piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy- 3-(2-methoxyphenoxy)propyl)-"
2020-09-18T10:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranolazine,US brand name:,Ranexa
2020-09-18T09:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranpirnase,Synonym:,P-30
2020-09-18T09:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranpirnase,Synonym:,P-30 protein
2020-09-18T09:54:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranpirnase,US brand name:,Onconase
2020-09-18T10:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rapamycin-polarized-th1-tc1-autologous-t-lymphocytes,Synonym:,"ex vivo anti-CD3/CD28 costimulated, rapamycin-polarized Th1/Tc1 autologous T lymphocytes"
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Abbreviation:,RARa agonist IRX5183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,AGN 195183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,AGN-195183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,IRX 5183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,IRX5183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,NRX 195183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,NRX195183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,VTP 195183
2020-09-18T11:00:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183,Code name:,VTP-195183
2020-09-18T11:00:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ras-peptide-cancer-vaccine,Abbreviation:,ras pep vac
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Code name:,NK-631
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Code name:,SR-29142
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Synonym:,recombinant urate oxidase
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,Synonym:,Urate Oxidase
2020-09-18T06:24:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase,US brand name:,Elitek
2020-09-18T11:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravuconazole,Code name:,BMS-207147
2020-09-18T11:00:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravuconazole,Synonym:,ER-30346
2020-10-14T13:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab,Code name:,ALXN 1210
2020-10-14T13:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab,Code name:,ALXN1210
2020-10-14T13:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab,Synonym:,complement C5 inhibitor ALXN1210
2020-10-14T13:12:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab,US brand name:,Ultomiris
2020-09-18T11:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/razoxane,Code name:,ICI 59118
2020-09-18T11:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/razoxane,Code name:,ICRF-159
2020-09-18T11:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/razoxane,Foreign brand name:,Razoxin
2020-09-18T11:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/re-186-hydroxyethylidene-diphosphonate,Abbreviation:,rhenium-186 HEDP
2020-09-18T11:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/re-186-hydroxyethylidene-diphosphonate,Synonym:,186Re-etidronate
2020-09-18T11:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/re-186-hydroxyethylidene-diphosphonate,Synonym:,rhenium Re 186 etidronate
2020-09-18T11:01:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/re-186-hydroxyethylidene-diphosphonate,Synonym:,rhenium-186 hydroxyethylidene diphosphonate
2020-09-18T11:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/realgar-indigo-naturalis-formulation,Abbreviation:,RIF formula
2020-09-18T11:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebamipide,Chemical structure:,"alpha-[(4-xhlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid"
2020-09-18T11:01:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebamipide,Code name:,OPC 12759
2020-09-18T11:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebastinib-tosylate,Code name:,DCC-2036
2020-09-18T11:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebastinib-tosylate,Synonym:,multitargeted tyrosine kinase inhibitor DCC-2036
2020-09-18T11:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebimastat,Chemical structure:,"N-((2S)-2-Mercapto-1-oxo-4-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-L-valinamide"
2020-09-18T11:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebimastat,Code name:,BMS-275291
2020-09-18T11:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebimastat,Code name:,D2163
2020-10-14T12:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/receptor-tyrosine-kinase-inhibitor-r1530,Abbreviation:,MAI R1530
2020-10-14T12:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/receptor-tyrosine-kinase-inhibitor-r1530,Code name:,R1530
2020-09-18T11:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-70-kd-heat-shock-protein,Abbreviation:,HSP70
2020-09-18T11:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-70-kd-heat-shock-protein,Synonym:,70-kD Heat-Shock Protein
2020-09-18T11:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-70-kd-heat-shock-protein,Synonym:,Heat Shock Protein 70
2020-10-14T13:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-encoding-p53,Foreign brand name:,Gendicine
2020-10-14T13:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-encoding-p53,Foreign brand name:,Genkaxin
2020-10-14T13:11:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-encoding-p53,Synonym:,recombinant adenovirus encoding p53
2020-09-18T11:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-hifn-beta,Code name:,BG00001
2020-09-18T11:01:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-hifn-beta,Synonym:,Ad-hIFN-beta
2020-09-18T09:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-sch-721015,Abbreviation:,rAd-IFN SCH 721015
2020-09-18T09:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-sch-721015,Code name:,SCH 721015
2020-09-18T09:30:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-sch-721015,Synonym:,recombinant adenovirus-interferon SCH 721015
2020-09-18T11:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-syn3,Foreign brand name:,Instiladrin
2020-09-18T11:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-syn3,Synonym:,rAd-IFN/Syn3
2020-09-18T11:01:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-syn3,Synonym:,recombinant adenovirus-interferon with Syn3
2020-09-18T11:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-l523s-vaccine,Abbreviation:,Ad/L523S
2020-09-18T11:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-p53-sch-58500,Abbreviation:,rAd/p53
2020-09-18T11:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-p53-sch-58500,Code name:,SCH-58500
2020-09-18T11:02:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-attenuated-salmonella-typhimurium-expressing-il-2,NA,NA
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Code name:,VAX 014
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Code name:,VAX-014
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Code name:,VAX-IP
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Code name:,VAX014
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Synonym:,rBMCs VAX014
2020-10-14T13:12:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014,Synonym:,VAX-IP minicells
2020-09-18T11:02:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bispecific-single-chain-antibody-rm28,NA,NA
2020-10-14T13:12:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bovine-basic-fibroblast-growth-factor,Abbreviation:,rb-bFGF
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Abbreviation:,CD40L
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Abbreviation:,rhu CD40L
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,CD154 antigen
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,gp39
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,T-BAM
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,T-cell antigen gp39
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,TNF-related activation protein
2020-09-18T11:02:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand,Synonym:,TRAP ligand
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Code name:,DAS181
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Code name:,DAS181-F02
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,Synonym:,273-666-neuraminidase [273-methionine] (actinomyces viscosus clone DAS181) fusion protein with 125-145-preproamphiregulin (human)
2020-09-18T06:53:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181,US brand name:,Fludase
2020-09-18T11:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-dher2-vaccine,NA,NA
2020-09-18T11:02:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-dna-l523s-vaccine,Synonym:,pVAX/L523S
2020-09-18T11:02:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-ephb4-hsa-fusion-protein,Abbreviation:,sEphB4-HSA
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Code name:,JZP 458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Code name:,JZP-458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Code name:,JZP458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Code name:,PF743
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Synonym:,crisantaspase biobetter JZP-458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Synonym:,RC-P JZP-458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Synonym:,recombinant Asparaginase erwinia chrysanthemi JZP-458
2020-10-14T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458,Synonym:,recombinant crisantaspase JZP-458
2020-09-18T09:14:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand,Abbreviation:,rFlt3L
2020-09-18T09:14:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand,Code name:,CDX-301
2020-09-18T09:14:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand,Synonym:,flt3 ligand
2020-09-18T09:14:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand,Synonym:,rhuFlt3L
2020-09-18T09:14:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand,US brand name:,Mobista
2020-09-18T11:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-b71-vaccine,Abbreviation:,rF-B7.1
2020-09-18T11:03:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-b71-vaccine,Abbreviation:,rF-B7.1 vaccine
2020-09-18T11:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-cea6d-tricom-vaccine,Synonym:,fowlpox-CEA-B7-1/ICAM-1/LFA-3
2020-09-18T11:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-cea6d-tricom-vaccine,Synonym:,rF-CEA(6D)TRICOM
2020-09-18T11:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-gm-csf-vaccine-adjuvant,Abbreviation:,rf-GM-CSF
2020-09-18T11:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-gm-csf-vaccine-adjuvant,Synonym:,fowlpox-GM-CSF
2020-09-18T11:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-gm-csf-vaccine-adjuvant,Synonym:,fowlpox-sargramostim
2020-09-18T11:03:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-gm-csf-vaccine-adjuvant,Synonym:,rf-sargramostim
2020-09-18T11:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-prostate-specific-antigen-vaccine,Abbreviation:,rF-PSA
2020-09-18T11:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-prostate-specific-antigen-vaccine,Synonym:,fowlpox-PSA vaccine
2020-09-18T11:03:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-prostate-specific-antigen-vaccine,Synonym:,recombinant fowlpox-PSA vaccine
2020-09-18T11:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-psal-155tricom-vaccine,Synonym:,PROSTVAC-F
2020-09-18T11:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-psal-155tricom-vaccine,Synonym:,recombinant fowlpox-PSA(L155)/TRICOM vaccine
2020-09-18T11:03:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-tricom-vaccine,Synonym:,rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox)
2020-09-18T11:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-tyrosinase-vaccine,Abbreviation:,rF-TYR Vaccine
2020-09-18T11:03:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-tyrosinase-vaccine,Synonym:,rF-TYR vaccine (Tyrosinase-Fowl Pox)
2020-10-14T05:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-globulin-component-macrophage-activating-factor,Abbreviation:,GC-MAF
2020-10-14T05:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-globulin-component-macrophage-activating-factor,Abbreviation:,GcMAF
2020-10-14T05:13:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-globulin-component-macrophage-activating-factor,Synonym:,GC protein-derived macrophage-activating factor
2020-10-14T13:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-granulocyte-colony-stimulating-factor,Acronym:,rhG-CSF
2020-10-14T13:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein,Abbreviation:,fusion protein rHSA/GCSF
2020-10-14T13:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein,Abbreviation:,rHSA/G-CSF
2020-10-14T13:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein,Synonym:,human serum albumin GCSF
2020-10-14T13:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein,Synonym:,recombinant human serum albumin/granulocyte colony-stimulating factor fusion protein
2020-10-14T13:12:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein,Synonym:,rHSA/GCSF fusion protein
2020-09-18T11:03:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsp110-gp100-chaperone-complex-vaccine,NA,NA
2020-09-18T11:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-6ckine,Acronym:,rhSLC
2020-09-18T11:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-6ckine,Synonym:,recombinant human Exodus-2
2020-09-18T11:03:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-6ckine,Synonym:,recombinant human secondary lymphoid chemokine
2020-09-18T11:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-adenovirus-type-5-h101,Abbreviation:,rAd5 H101
2020-09-18T11:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-adenovirus-type-5-h101,Code name:,H101
2020-09-18T11:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-adenovirus-type-5-h101,Foreign brand name:,Oncorine
2020-09-18T09:37:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-albumin-human-granulocyte-colony-stimulating-factor,Code name:,GW003
2020-09-18T09:37:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-albumin-human-granulocyte-colony-stimulating-factor,US brand name:,Neugranin
2020-09-18T11:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-angiotensin-converting-enzyme-2-apn01,Acronym:,rhACE2 APN01
2020-09-18T11:04:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-angiotensin-converting-enzyme-2-apn01,Code name:,APN01
2020-09-18T11:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-2,Abbreviation:,rhBMP-2
2020-09-18T11:04:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-2,Abbreviation:,rhBMP2
2020-09-18T11:04:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-4,Code name:,hrBM-4
2020-09-18T11:04:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-4,Code name:,hrBMP4
2020-09-18T11:04:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-4,Synonym:,recombinant human BMP4
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Abbreviation:,rhCG
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Code name:,LDI-200
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,Synonym:,human chorionic gonadotropin
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Follutein
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Novarel
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Pregnyl
2020-09-18T07:02:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin,US brand name:,Profasi
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Abbreviation:,Cimavax
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Abbreviation:,CimaVax
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,Center of Molecular Immunology (CIMA) epidermal growth factor (EGF) vaccine
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,Center of Molecular Immunology epidermal growth factor vaccine
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,CIMAvax EGF
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,CIMAvax epidermal growth factor vaccine
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,CIMAvax-EGF
2020-09-18T11:04:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine,Synonym:,recombinant human EGF-P64K/Montanide vaccine
2020-09-18T11:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-endostatin,Foreign brand name:,Endostar
2020-09-18T11:04:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-endostatin,US brand name:,rhEndostatin
2020-09-18T11:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-epidermal-growth-factor,Abbreviation:,rhEGF
2020-09-18T11:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-epidermal-growth-factor,Foreign brand name:,EASYEF
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Abbreviation:,L19-TNF-alpha
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Abbreviation:,L19TNF alpha
2020-09-18T06:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha,Synonym:,recombinant human fusion protein L19TNFalpha
2020-09-18T11:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-granulocyte-colony-stimulating-factor,Acronym:,rhG-CSF
2020-10-14T13:12:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hsp110-gp100-chaperone-complex-vaccine,NA,NA
2020-09-18T05:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase,Abbreviation:,rHuPH20
2020-09-18T05:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase,US brand name:,Chemophase
2020-09-18T11:05:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-15,Abbreviation:,IL15
2020-09-18T11:05:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-15,Abbreviation:,rIL15
2020-09-18T11:05:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-15,Synonym:,interleukin 15
2020-09-18T11:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-22-igg2-fc,Code name:,F-652
2020-09-18T11:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-22-igg2-fc,Synonym:,IL-22 dimer F-652
2020-09-18T11:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-22-igg2-fc,Synonym:,IL-22 IgG2-Fc
2020-09-18T11:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-22-igg2-fc,Synonym:,recombinant human IL-22 IgG2-Fc
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Abbreviation:,MBL
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Abbreviation:,MBP
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Acronym:,rhMBL
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Synonym:,mannan-binding lectin
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Synonym:,mannose-binding lectin
2020-09-18T11:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin,Synonym:,mannose-binding protein
2020-10-14T13:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-11-valent-vaccine,Synonym:,11-valent recombinant HPV vaccine
2020-10-14T13:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-11-valent-vaccine,Synonym:,11-valent recombinant human papillomavirus vaccine
2020-10-14T13:13:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-11-valent-vaccine,Synonym:,11-valent recombinant human papillomavirus vaccine (Hansenula polymorpha)
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Abbreviation:,HPV 16/18 L1 VLP/AS04 VAC
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Code name:,GSK-580299
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Foreign brand name:,Cervarix
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,Synonym:,human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
2020-09-18T05:21:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine,US brand name:,Cervarix
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Code name:,V503
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Synonym:,nonavalent HPV recombinant vaccine
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Synonym:,nonavalent HPV VLP vaccine
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Synonym:,nonavalent human papillomavirus recombinant vaccine
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Synonym:,recombinant HPV nonavalent vaccine
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,Synonym:,recombinant human papillomavirus 9-valent vaccine
2020-09-18T07:14:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine,US brand name:,Gardasil 9
2020-09-18T07:14:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-quadrivalent-vaccine,Synonym:,"quadrivalent HPV (type 6, 11, 16 and 18) L1 virus-like particle vaccine"
2020-09-18T07:14:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-quadrivalent-vaccine,US brand name:,Gardasil
2020-09-18T11:05:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-serum-amyloid-p-pentraxin-2,Code name:,PRM-151
2020-09-18T11:05:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-serum-amyloid-p-pentraxin-2,Synonym:,pentraxin 2
2020-09-18T11:05:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-serum-amyloid-p-pentraxin-2,Synonym:,PRM-151/PTX2
2020-09-18T11:05:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-serum-amyloid-p-pentraxin-2,Synonym:,recombinant human PTX2
2020-09-18T11:05:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-stem-cell-factor,Synonym:,c-kit ligand
2020-09-18T11:05:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-stem-cell-factor,Synonym:,mast-cell growth factor
2020-09-18T11:05:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-stem-cell-factor,Synonym:,steel factor
2020-09-18T11:05:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon,Abbreviation:,rIFN
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,alpha interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,leukocyte interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblast interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,Synonym:,lymphoblastoid interferon
2020-09-18T01:47:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa,US brand name:,Alferon
2020-10-14T13:13:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-1b,NA,NA
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Abbreviation:,rHuIFN-a 2a
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Foreign brand name:,Laroferon
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Foreign brand name:,Roceron-A
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,alpha 2 interferon
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,IFN alpha-2A
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,IFN-alpha 2
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,interferon alfa 2a
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,interferon alfa-2a
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,Synonym:,recombinant interferon alfa-2a
2020-10-14T13:13:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a,US brand name:,Roferon-A
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Code name:,Sch 30500
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Foreign brand name:,Alfatronol
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Foreign brand name:,Glucoferon
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Foreign brand name:,Heberon Alfa
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Foreign brand name:,Urifron
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Foreign brand name:,Viraferon
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Synonym:,IFN alpha-2B
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Synonym:,interferon alfa-2B
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,Synonym:,interferon alpha-2b
2020-09-18T08:07:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b,US brand name:,Intron A
2020-09-18T11:06:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-1b,NA,NA
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Abbreviation:,rHuIFN-a 2a
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Foreign brand name:,Laroferon
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Foreign brand name:,Roceron-A
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,alpha 2 interferon
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,IFN alpha-2A
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,IFN-alpha 2
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,interferon alfa 2a
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,interferon alfa-2a
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,Synonym:,recombinant interferon alfa-2a
2020-09-18T11:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a,US brand name:,Roferon-A
2020-09-18T11:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2b-like-protein,Foreign brand name:,Novaferon
2020-09-18T11:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2b-like-protein,Synonym:,recombinant IFN Alfa-2b-like protein
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Foreign brand name:,Betantrone
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Foreign brand name:,Feron
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Foreign brand name:,Naferon
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,beta interferon
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,human interferon beta
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,interferon beta
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,interferon-B
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,interferon-beta
2020-09-18T11:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta,Synonym:,"interferon, beta"
2020-09-18T11:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-gamma,Abbreviation:,IFN-G
2020-09-18T11:06:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-gamma,Synonym:,gamma interferon
2020-09-18T11:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-1-alpha,Synonym:,interleukin-1-alpha
2020-09-18T11:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-1-beta,Abbreviation:,IL-1-b
2020-09-18T11:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-1-beta,Synonym:,interleukin-1-beta
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Abbreviation:,IL-12
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Code name:,Ro 24-7472
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Synonym:,cytotoxic lymphocyte maturation factor
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Synonym:,interleukin-12
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Synonym:,natural killer cell stimulatory factor
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Synonym:,NM-IL-12
2020-09-18T11:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12,Synonym:,recombinant human interleukin-12 (IL-12) cytokine
2020-09-18T11:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-18,Abbreviation:,IL-18
2020-09-18T11:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-18,Code name:,SB-485232
2020-09-18T11:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-18,Synonym:,IFN-gamma-inducing factor
2020-09-18T11:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-18,Synonym:,interferon-gamma-inducing factor
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Abbreviation:,IL-3
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Abbreviation:,MCGF
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Code name:,ILE-964
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Synonym:,eosinophil-mast cell growth factor
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Synonym:,erythrocyte burst-promoting factor
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Synonym:,interleukin-3
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Synonym:,mast cell colony-stimulating factor
2020-09-18T11:06:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3,Synonym:,multipotential colony-stimulating factor
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Abbreviation:,BCGF
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Abbreviation:,BCSF 1
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Abbreviation:,IL-4
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Abbreviation:,MCGF 2
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Abbreviation:,rhIL-4
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,B Cell Proliferating Factor
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,B-Cell Growth Factor
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,B-Cell Stimulating Factor
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,B-Cell Stimulatory Factor 1
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,Mast Cell Growth Factor-2
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,recombinant human IL-4
2020-09-18T11:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4,Synonym:,T-Cell Growth Factor 2
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Abbreviation:,HPGF
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Abbreviation:,HSF
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Abbreviation:,IL-6
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,B-cell differentiation factor-2
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,B-cell stimulatory factor-2
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,hepatocyte-stimulating factor
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,hybridoma growth factor
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,IFN beta 2
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,interleukin-6
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,myeloid differentiation inducing protein
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,Synonym:,plasmacytoma growth factor
2020-09-18T11:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6,US brand name:,Sigosix
2020-09-18T11:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-7,Abbreviation:,IL-7
2020-09-18T11:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-7,Code name:,CYT 99 007
2020-09-18T11:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-7,Synonym:,lymphopoietin-1
2020-09-18T11:07:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-7,Synonym:,recombinant human interleukin-7
2020-09-18T09:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin,Abbreviation:,BC-IL
2020-09-18T09:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin,Abbreviation:,BC-LI
2020-09-18T09:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin,Synonym:,buffy coat interleukin
2020-09-18T09:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin,Synonym:,"leukocyte interleukin, Inj."
2020-09-18T09:26:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin,US brand name:,Multikine
2020-09-18T11:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-macrophage-colony-stimulating-factor,Abbreviation:,rM-CSF
2020-09-18T11:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-macrophage-colony-stimulating-factor,Synonym:,colony stimulating factor 1
2020-09-18T11:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-macrophage-colony-stimulating-factor,Synonym:,recombinant colony-stimulating factor 1
2020-09-18T11:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mage-31-antigen,Synonym:,MAGE-3
2020-09-18T11:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mage-31-antigen,Synonym:,MAGE-3.1
2020-09-18T11:07:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mage-31-antigen,Synonym:,MAGEA3
2020-09-18T11:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mip1-alpha-variant-eci301,Abbreviation:,eMIP
2020-09-18T11:07:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mip1-alpha-variant-eci301,Code name:,ECI301
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,Abbreviation:,rV-5T4 VAC
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,Foreign brand name:,TroVax
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,Synonym:,recombinant MVA-5T4 vaccine
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,Synonym:,recombinant pox virus encoding 5T4 vaccine
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,Synonym:,vaccinia-5T4 antigen vaccine
2020-09-18T11:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine,US brand name:,TroVax
2020-09-18T11:07:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-nematode-anticoagulant-protein-c2,Acronym:,rNAPc2
2020-09-18T11:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oncolytic-poliovirus-pvs-ripo,Code name:,PVS-RIPO
2020-09-18T11:07:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oncolytic-poliovirus-pvs-ripo,Code name:,PVSRIPO
2020-09-18T10:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin,Synonym:,oxytocin
2020-09-18T10:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin,US brand name:,Pitocin
2020-09-18T10:33:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin,US brand name:,Syntocinon
2020-09-18T11:07:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-parathyroid-hormone,Abbreviation:,rPTH
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Abbreviation:,rPF4
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Acronym:,rhPF4
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Synonym:,CXC-chemokine PF-4
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Synonym:,CXCL4
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Synonym:,platelet factor 4
2020-09-18T11:07:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4,Synonym:,recombinant human platelet factor 4
2020-09-18T11:08:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-prame-protein-plus-as15-adjuvant-gsk2302025a,Code name:,GSK2302025A
2020-10-14T13:13:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-saccharomyces-cerevisia-cea610d-expressing-vaccine-gi-6207,Code name:,GI-6207
2020-09-18T11:08:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-saccharomyces-cerevisia-cea610d-vaccine-gi-6207,Code name:,GI-6207
2020-09-18T11:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-soluble-human-cd4-protein,Abbreviation:,rCD4
2020-09-18T11:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-super-compound-interferon,Synonym:,recombinant super compound interferon
2020-09-18T11:08:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-super-compound-interferon,Synonym:,rSIFN-co
2020-09-18T11:08:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thymosin,Synonym:,thymosin
2020-09-18T11:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone,Abbreviation:,Recombinant TSH
2020-09-18T11:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone,Synonym:,recombinant thyroid-stimulating hormone biosimilar GX-30
2020-09-18T11:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone,Synonym:,Thyroid Stimulating Hormone
2020-09-18T11:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone,Synonym:,Thyrotropin
2020-09-18T11:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone,US brand name:,Thytropar
2020-09-18T11:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyrotropin-alfa,US brand name:,Thyrogen
2020-09-18T11:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-transforming-growth-factor-beta-2,Abbreviation:,rTGF-beta-2
2020-09-18T11:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-transforming-growth-factor-beta-2,Acronym:,TGF-beta 2
2020-09-18T11:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-transforming-growth-factor-beta-2,Synonym:,glioblastoma-derived T-cell suppressor factor
2020-09-18T11:08:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-transforming-growth-factor-beta-2,Synonym:,transforming growth factor-beta 2
2020-09-18T11:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tumor-necrosis-factor-family-protein,Acronym:,TNF
2020-09-18T11:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tumor-necrosis-factor-family-protein,Synonym:,tumor necrosis factor
2020-09-18T11:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tumor-necrosis-factor-family-protein,Synonym:,Tumor Necrosis Factor Family Protein
2020-10-14T13:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-1,Abbreviation:,TRP-1
2020-10-14T13:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-1,Synonym:,gp75 antigen
2020-10-14T13:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-1,Synonym:,tyrosinase related protein-1
2020-10-14T13:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-1,Synonym:,tyrosinase-related protein 1
2020-09-18T11:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-2,Abbreviation:,TRP-2
2020-09-18T11:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-2,Synonym:,Tyrosinase-Related Protein-2
2020-09-18T11:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-b71-vaccine,Abbreviation:,rV-B7.1
2020-09-18T11:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-b71-vaccine,Abbreviation:,rV-B7.1 vaccine
2020-09-18T11:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-b71-vaccine,Synonym:,Recombinant Vaccinia-B7.1
2020-09-18T11:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-b71-vaccine,Synonym:,rV-B7 (Recomb Vaccinia/B7)
2020-09-18T11:09:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-cea6d-tricom-vaccine,Synonym:,rV-CEA(6D)-TRICOM
2020-10-14T13:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc-1-vaccine,Abbreviation:,rV-MUC-1
2020-10-14T13:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc-1-vaccine,Synonym:,recombinant vaccinia-MUC-1 vaccine
2020-10-14T13:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc-1-vaccine,Synonym:,rV-MUC-1 vaccine
2020-10-14T13:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc-1-vaccine,Synonym:,vaccinia-MUC-1 vaccine
2020-09-18T11:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc1-vaccine,Abbreviation:,rV-MUC-1
2020-09-18T11:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc1-vaccine,Synonym:,recombinant vaccinia-MUC-1 vaccine
2020-09-18T11:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc1-vaccine,Synonym:,rV-MUC-1 vaccine
2020-09-18T11:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc1-vaccine,Synonym:,vaccinia-MUC-1 vaccine
2020-09-18T11:09:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-multiepitope-melanoma-peptides-b71-b72-vaccine,NA,NA
2020-09-18T11:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-ny-eso-1-vaccine,Abbreviation:,rV-NY-ESO-1
2020-09-18T11:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-ny-eso-1-vaccine,Synonym:,vaccinia-NY-ESO-1 vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Abbreviation:,VPSA
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,Prostate Specific Antigen Expressing Vaccinia Virus Vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,rV-PSA
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,RV-PSA (RECOMB VACCINIA/PSA-CV-1)
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,rV-PSA vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,vaccinia prostate-specific antigen vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,Vaccinia PSA Vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,vaccinia-prostate-specific antigen vaccine
2020-09-18T11:08:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine,Synonym:,Vaccinia-PSA Vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Abbreviation:,VPSA
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,Prostate Specific Antigen Expressing Vaccinia Virus Vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,rV-PSA
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,RV-PSA (RECOMB VACCINIA/PSA-CV-1)
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,rV-PSA vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,vaccinia prostate-specific antigen vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,Vaccinia PSA Vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,vaccinia-prostate-specific antigen vaccine
2020-10-14T13:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine,Synonym:,Vaccinia-PSA Vaccine
2020-09-18T11:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-tricom-vaccine,Synonym:,rV-TRICOM
2020-09-18T11:09:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-tricom-vaccine,Synonym:,Vaccinia-TRICOM
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,R3484
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,RG3484
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,RO5217790
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,TG 4001
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,TG-4001
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Code name:,TG4001
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Synonym:,HPV16 E6/E7-encoding MVA vaccine TG4001
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Synonym:,MVA-HPV-IL2
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Synonym:,MVA-HPV16E6/E7-IL2
2020-09-18T09:28:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790,Synonym:,recombinant vaccinia viral vector RO5217790
2020-09-18T11:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vesicular-stomatitis-virus-expressing-interferon-beta,Abbreviation:,VSV-hIFN-b
2020-09-18T11:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vesicular-stomatitis-virus-expressing-interferon-beta,Synonym:,recombinant VSV-IFN-beta
2020-09-18T11:09:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/red-tomato-juice,NA,NA
2020-10-14T13:03:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/redaporfin,Code name:,LUZ 11
2020-09-18T11:00:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reduced-glutathione-l-cysteine-anthocyanins-gel,US brand name:,RayGel
2020-09-18T11:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib,Code name:,BAY 869766
2020-09-18T11:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib,Code name:,BAY86-9766
2020-09-18T11:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib,Code name:,RDEA119
2020-09-18T11:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib,Synonym:,MEK inhibitor RDEA119
2020-09-18T08:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regadenoson,Chemical structure:,"adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-"
2020-09-18T08:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regadenoson,Code name:,CVT-3146
2020-09-18T08:31:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regadenoson,US brand name:,Lexiscan
2020-09-18T11:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib,Code name:,BAY 73-4506
2020-09-18T11:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib,Synonym:,multikinase inhibitor BAY 73-4506
2020-09-18T11:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib,US brand name:,Stivarga
2020-10-14T13:14:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relacorilant,Chemical structure:,"methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-"
2020-10-14T13:14:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relacorilant,Code name:,CORT125134
2020-10-14T13:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/related-donor-adenovirus-specific-cytotoxic-t-cells,Synonym:,related donor Ad-specific CTLs
2020-10-14T13:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relatlimab,Code name:,BMS-986016
2020-10-14T13:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relatlimab,Code name:,BMS986016
2020-10-14T13:14:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relatlimab,Synonym:,anti-LAG-3 monoclonal antibody BMS-986016
2020-09-18T11:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relugolix,Chemical structure:,"urea, N-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-"
2020-09-18T11:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relugolix,Code name:,TAK-385
2020-09-18T11:11:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relugolix,Synonym:,GnRH antagonist TAK-385
2020-09-18T10:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remestemcel-l,Abbreviation:,allogeneic adults MSCs
2020-09-18T10:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remestemcel-l,Synonym:,allogeneic adult mesenchymal stem cells
2020-09-18T10:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remestemcel-l,US brand name:,Prochymal
2020-10-14T05:16:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remetinostat,Code name:,SHP-141
2020-09-18T11:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remifentanil-hydrochloride,Chemical structure:,"1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride"
2020-09-18T11:11:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remifentanil-hydrochloride,US brand name:,Ultiva
2020-09-18T11:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/renal-cell-carcinoma-peptides-vaccine-ima901,Code name:,IMA901
2020-09-18T10:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repaglinide,Chemical structure:,"(+)-2-ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acidbenzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-,(S)-"
2020-09-18T10:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repaglinide,Code name:,AG-EE 623 ZW
2020-09-18T10:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repaglinide,US brand name:,Prandin
2020-09-18T11:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reparixin,Chemical structure:,2-(4-isobutylphenyl)propionylmethanesulfonamide
2020-09-18T11:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reparixin,Code name:,DF 1681Y
2020-10-14T13:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib,Code name:,TPX-0005
2020-10-14T13:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib,Synonym:,ALK/ROS1/NTRK/SRC multi-kinase inhibitor TPX-0005
2020-10-14T13:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib,Synonym:,ALK/ROS1/NTRK/SRC/FAK multikinase inhibitor TPX-0005
2020-10-14T13:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib,Synonym:,multi-kinase inhibitor TPX-0005
2020-10-14T13:14:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib,Synonym:,multikinase inhibitor TPX-0005
2020-09-18T11:12:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiniferatoxin,Abbreviation:,RTX
2020-09-18T11:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod,Chemical structure:,"4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol"
2020-09-18T11:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod,Code name:,R 848
2020-09-18T11:12:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod,Code name:,S 28463
2020-10-14T13:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-gel-cd11301,Code name:,CD 11301
2020-10-14T13:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-gel-cd11301,Code name:,CD11301
2020-10-14T13:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-gel-cd11301,Synonym:,CD11301 topical gel
2020-09-18T11:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-topical-gel,Synonym:,R848 gel
2020-09-18T11:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resistant-starch,Abbreviation:,RS
2020-09-18T11:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resminostat,Code name:,4SC-201
2020-09-18T11:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resminostat,Synonym:,HDAC Inhibitor 4SC-201
2020-09-18T11:13:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resminostat,Synonym:,histone deacetylase inhibitor 4SC-201
2020-09-18T11:13:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol,Chemical structure:,"(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol3,4',5-stilbenetriol"
2020-09-18T11:13:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol-formulation-srt501,Code name:,SRT501
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,AC 013773
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,CEP-32496
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,CEP32496
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,RXDX 105
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,RXDX-105
2020-10-14T03:25:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105,Code name:,RXDX105
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,BOS 172738
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,BOS-172738
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,BOS172738
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,DS 5010
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,DS-5010
2020-10-14T13:15:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010,Code name:,DS5010
2020-09-18T11:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292,Code name:,LOXO-292
2020-09-18T11:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292,Synonym:,RET inhibitor LOXO-292
2020-09-18T11:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292,Synonym:,RET kinase inhibitor LOXO-292
2020-09-18T11:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292,US brand name:,Retevmo
2020-09-18T07:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-mutation-fusion-inhibitor-blu-667,Chemical structure:,(cis)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)cyclohexanecarboxamide
2020-09-18T07:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-mutation-fusion-inhibitor-blu-667,Code name:,BLU-667
2020-09-18T07:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-mutation-fusion-inhibitor-blu-667,US brand name:,Gavreto
2020-10-14T13:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-src-inhibitor-tpx-0046,Code name:,TPX 0046
2020-10-14T13:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-src-inhibitor-tpx-0046,Code name:,TPX0046
2020-10-14T13:15:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-src-inhibitor-tpx-0046,Synonym:,RET/SRC tyrosine kinase inhibitor TPX-0046
2020-09-18T11:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retaspimycin-hydrochloride,Code name:,IPI-504
2020-10-14T13:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab,Code name:,INCMGA 0012
2020-10-14T13:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab,Code name:,INCMGA-0012
2020-10-14T13:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab,Code name:,INCMGA00012
2020-10-14T13:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab,Code name:,MGA 012
2020-10-14T13:15:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab,Code name:,MGA012
2020-09-18T11:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-9cuab30,NA,NA
2020-09-18T11:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204,Code name:,AGN194204
2020-09-18T11:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204,Code name:,IRX 4204
2020-09-18T11:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204,Code name:,IRX-4204
2020-09-18T11:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204,Code name:,IRX4204
2020-09-18T11:14:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204,Synonym:,RXR agonist IRX4204
2020-09-18T11:14:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinol,Chemical structure:,"3,7-dimethyl-9-(2,6, 6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraen-1-ol"
2020-09-18T11:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinyl-acetate,Synonym:,retinol acetate
2020-09-18T11:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinyl-acetate,Synonym:,vitamin A acetate
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,Synonym:,Mx-dnG1 retroviral vector
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,Synonym:,retroviral expression vector bearing anti-cyclin G1 gene construct
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,US brand name:,DeltaRex-G
2020-09-18T05:56:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1,US brand name:,REXIN-G
2020-10-14T03:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab,Code name:,ABBV 368
2020-10-14T03:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab,Code name:,ABBV-368
2020-10-14T03:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab,Code name:,ABBV368
2020-10-14T03:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab,Synonym:,agonistic anti-OX40 monoclonal antibody ABBV-368
2020-10-14T03:53:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab,Synonym:,anti-OX40 agonistic monoclonal antibody ABBV-368
2020-09-18T11:14:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revm10-gene,NA,NA
2020-10-14T13:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx-194204,Code name:,AGN194204
2020-10-14T13:15:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx-194204,Code name:,NRX194204
2020-09-18T11:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx194204,Code name:,AGN194204
2020-09-18T11:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx194204,Code name:,NRX194204
2020-10-14T04:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rezivertinib,Code name:,BPI 7711
2020-10-14T04:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rezivertinib,Code name:,BPI-7711
2020-10-14T04:57:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rezivertinib,Code name:,BPI7711
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Code name:,4SCAR20
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,4S-CD20-CAR-T cell
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,4SCAR20 T cells
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,anti-CD20 CAR-T cells 4SCAR20
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,anti-CD20-CD28-CD137-CD27-CD3z-iCasp9 CAR T-cells 4SCAR20
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,CD20-4SCAR-expressing T lymphocytes
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,CD20-scFv/CD28/CD137/CD27/CD3z-iCasp9 T cells
2020-10-14T04:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene,Synonym:,CD20-specific 4th generation chimeric antigen receptor-modified T cells
2020-09-18T11:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin,Abbreviation:,IgG-RFT5-dgA
2020-09-18T11:15:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin,Synonym:,anti-CD25 immunotoxin IMTOX25
2020-10-14T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin-imtox25,Abbreviation:,IgG-RFT5-dgA
2020-10-14T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin-imtox25,Synonym:,anti-CD25 immunotoxin IMTOX25
2020-10-14T13:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-186-hydroxyethylidene-diphosphonate,Abbreviation:,rhenium-186 HEDP
2020-10-14T13:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-186-hydroxyethylidene-diphosphonate,Synonym:,186Re-etidronate
2020-10-14T13:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-186-hydroxyethylidene-diphosphonate,Synonym:,rhenium Re 186 etidronate
2020-10-14T13:12:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-186-hydroxyethylidene-diphosphonate,Synonym:,rhenium-186 hydroxyethylidene diphosphonate
2020-10-14T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-labeled-liposomes,Synonym:,(188) Re-BMEDA-liposomes
2020-10-14T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-labeled-liposomes,Synonym:,188Re-BMEDA-liposome
2020-10-14T13:15:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-labeled-liposomes,Synonym:,"188Re-N,N-bis (2-mercaptoethyl)-N',N'-diethylethylenediamine-labeled liposomes"
2020-09-18T11:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-liposome,Synonym:,(188) Re-BMEDA-liposomes
2020-09-18T11:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-liposome,Synonym:,188Re-BMEDA-liposome
2020-09-18T11:15:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-liposome,Synonym:,"188Re-N,N-bis (2-mercaptoethyl)-N',N'-diethylethylenediamine-labeled liposomes"
2020-09-18T11:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-ethiodized-oil,Synonym:,188Re-SSS lipiodol
2020-09-18T11:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-ethiodized-oil,Synonym:,rhenium Re 188 lipiodol
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,188Re-etidronate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,188Re-HEDP
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re 188 etidronic acid
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re 188 hydroxyethylidene diphosphonate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re-188 etidronate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re-188 HEDP
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re-188 hydroxyethylidene diphosphonate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,Re-188etidronate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,rhenium Re 188-HEDP
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,rhenium Re-188 hydroxyethylidene diphosphonate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,rhenium-188 etidronate
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,rhenium-188 HEDP
2020-10-14T13:15:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate,Synonym:,rhenium-188-HEDP
2020-09-18T11:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhizoxin,Code name:,WF-1360
2020-10-14T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhoc-peptide-vaccine-rv001v,Code name:,RV 001
2020-10-14T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhoc-peptide-vaccine-rv001v,Code name:,RV 001V
2020-10-14T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhoc-peptide-vaccine-rv001v,Code name:,RV001V
2020-10-14T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhoc-peptide-vaccine-rv001v,Synonym:,RV001 vaccine
2020-09-18T11:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhubarb-licorice-herbal-supplement,Synonym:,Da Huang Gan Cao Tang herbal medicine
2020-09-18T11:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhubarb-licorice-herbal-supplement,Synonym:,Da Huang GanTsao Tang Chinese herbal medicine
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,Abbreviation:,RIBA
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,Abbreviation:,RTCA
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,Chemical structure:,"1-beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide"
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,Code name:,ICN-1229
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,Synonym:,Viramide
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,US brand name:,Rebetol
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,US brand name:,Virazid
2020-09-18T11:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin,US brand name:,Virazole
2020-09-18T08:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib,Chemical structure:,"7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide"
2020-09-18T08:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib,Code name:,LEE-011
2020-09-18T08:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib,Code name:,LEE011
2020-09-18T08:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib,Synonym:,CDK4/6 inhibitor LEE011
2020-09-18T08:21:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib,US brand name:,Kisqali
2020-09-18T11:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riboflavin,Chemical structure:,"6,7-Dimethyl-9-D-ribitylisoalloxazine"
2020-09-18T11:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riboflavin,Synonym:,Lactoflavin
2020-09-18T11:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riboflavin,Synonym:,riboflavine
2020-09-18T11:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riboflavin,Synonym:,Vitamin B2
2020-09-18T11:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribonuclease-qbi-139,Abbreviation:,RNase QBI-139
2020-09-18T11:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribonuclease-qbi-139,Code name:,QBI-139
2020-09-18T11:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribosome-inactivating-protein-cy503,NA,NA
2020-10-14T03:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribozyme-rpi4610,Code name:,RPI.4610
2020-10-14T03:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribozyme-rpi4610,Foreign brand name:,Angiozyme
2020-10-14T03:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribozyme-rpi4610,US brand name:,Angiozyme
2020-09-18T11:16:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rice-bran,NA,NA
2020-09-18T11:16:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ricolinostat,Code name:,ACY-1215
2020-09-18T11:16:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ricolinostat,Synonym:,HDAC6 inhibitor ACY-1215
2020-09-18T11:16:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ricolinostat,Synonym:,histone deacetylase 6 inhibitorACY-1215
2020-09-18T11:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ridaforolimus,Code name:,AP23573
2020-09-18T11:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ridaforolimus,Code name:,MK8669
2020-09-18T11:17:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ridaforolimus,Synonym:,deforolimus
2020-09-18T09:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifabutin,US brand name:,Mycobutin
2020-09-18T11:17:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifaximin,US brand name:,Xifaxan
2020-10-14T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rig-i-selective-ligand-rgt100,Code name:,MK-4621
2020-10-14T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rig-i-selective-ligand-rgt100,Code name:,RGT 100
2020-10-14T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rig-i-selective-ligand-rgt100,Code name:,RGT-100
2020-10-14T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rig-i-selective-ligand-rgt100,Code name:,RGT100
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Code name:,ON 01910.Na
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Code name:,SyB L-1101
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,Synonym:,PI-3 kinase inhibitor ON 01910.Na
2020-09-18T06:36:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium,US brand name:,Estybon
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Code name:,JNJ 53718678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Code name:,JNJ-53718678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Code name:,JNJ-678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Code name:,JNJ-8678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Code name:,JNJ53718678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Synonym:,respiratory syncytial virus fusion protein inhibitor JNJ-53718678
2020-10-14T13:17:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir,Synonym:,RSV F protein inhibitor JNJ-53718678
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Abbreviation:,vPSA-TRI
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Synonym:,PROSTVAC-V
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Synonym:,PROSTVAC-V/TRICOM
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Synonym:,recombinant vaccinia-PSA(L155)/TRICOM vaccine
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Synonym:,rvaccinia-prostate-specific antigen-TRICOM vaccine
2020-09-18T11:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec,Synonym:,rvaccinia-PSA-TRICOM vaccine
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,Synonym:,PROSTVAC-V-PROSTVAC-F
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,Synonym:,PROSTVAC-V/F
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,Synonym:,PROSTVAC-VF-TRICOM
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,Synonym:,PROSTVAC-VF/TRICOM
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,Synonym:,recombinant vaccinia-fowlpox-prostate-specific antigen-TRICOM vaccine
2020-09-18T10:50:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec,US brand name:,PROSTVAC
2020-09-18T11:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilotumumab,Code name:,AMG 102
2020-09-18T11:17:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilotumumab,Synonym:,anti-HGF monoclonal antibody AMG 102
2020-09-18T11:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riluzole,Chemical structure:,2-amino-6-(trifluoromethoxy)benzothiazole
2020-09-18T11:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riluzole,US brand name:,Rilutek
2020-09-18T11:18:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rimiducid,Code name:,AP1903
2020-09-18T11:18:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rimiducid,Synonym:,dimerizer AP1903
2020-09-18T11:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rindopepimut,Code name:,CDX-110
2020-09-18T11:18:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rindopepimut,Synonym:,anti-EGFRvIII vaccine CDX-110
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Abbreviation:,poly(I):poly(C12U) RNA
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Chemical structure:,"poly(inosinic acid) poly(cytidylic(12), uridylic)acid"
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,Synonym:,atvogen
2020-09-18T02:04:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod,US brand name:,Ampligen
2020-10-14T03:37:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripertamab,Code name:,SCT400
2020-10-14T13:16:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripk1-inhibitor-gsk3145095,Code name:,GSK 3145095
2020-10-14T13:16:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripk1-inhibitor-gsk3145095,Code name:,GSK-3145095
2020-10-14T13:16:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripk1-inhibitor-gsk3145095,Code name:,GSK3145095
2020-10-14T13:16:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripk1-inhibitor-gsk3145095,Synonym:,receptor-interacting serine/threonine-protein kinase 1 inhibitor GSK3145095
2020-10-14T13:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib,Chemical structure:,"1-N'-[2,5-difluoro-4-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxyphenyl]-1-N'-phenylcyclopropane-1,1-dicarboxamide"
2020-10-14T13:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib,Code name:,DCC-2618
2020-10-14T13:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib,Code name:,DCC2618
2020-10-14T13:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib,Synonym:,KIT/PDGFR inhibitor DCC-2618
2020-10-14T13:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib,US brand name:,Qinlock
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Abbreviation:,RISE
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Chemical structure:,monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate hemipentahydrate
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Code name:,NE-58095
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,Synonym:,Risedronate
2020-09-18T01:22:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium,US brand name:,Actonel
2020-09-18T11:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risperidone-formulation-in-rumenic-acid,Code name:,VAL-401
2020-09-18T11:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risperidone-formulation-in-rumenic-acid,Code name:,VAL401
2020-09-18T11:18:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risperidone-formulation-in-rumenic-acid,Synonym:,risperidone lipid formulation VAL401
2020-10-14T05:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritlecitinib,Code name:,PF 06651600
2020-10-14T05:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritlecitinib,Code name:,PF-06651600
2020-10-14T05:28:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritlecitinib,Code name:,PF06651600
2020-09-18T09:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritonavir,Abbreviation:,RIT
2020-09-18T09:44:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritonavir,US brand name:,Norvir
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Abbreviation:,MOAB IDEC-C2B8
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Code name:,IDEC-102
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Code name:,IDEC-C2B8
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Code name:,PF-05280586
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Code name:,RTXM83
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Foreign brand name:,Mabthera
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Foreign brand name:,Reditux
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,BI 695500
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,C2B8 Monoclonal Antibody
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,CT-P10
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,IDEC-C2B8 monoclonal antibody
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar ABP 798
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar BI 695500
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar DRL_RI
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar GB241
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar HLX01
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar HS006
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar IBI301
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar JHL1101
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar PF-05280586
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar Reditux
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar RTXM83
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar SAIT101
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab biosimilar TQB2303
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,Synonym:,rituximab-pvvr
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,US brand name:,Rituxan
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,US brand name:,Ruxience
2020-09-18T11:18:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab,US brand name:,Truxima
2020-09-18T11:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human,Synonym:,rituximab plus hyaluronidase
2020-09-18T11:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human,Synonym:,rituximab/hyaluronidase
2020-09-18T11:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human,Synonym:,rituximab/hyaluronidase human
2020-09-18T11:18:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human,US brand name:,Rituxan Hycela
2020-10-14T04:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-conjugate-con-4619,Code name:,CON-4619
2020-10-14T04:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-conjugate-con-4619,Synonym:,aurixim antibody conjugate
2020-10-14T04:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-conjugate-con-4619,US brand name:,Aurixim
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Abbreviation:,R-IVAC
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Abbreviation:,RIVAC
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Synonym:,R-IVAC regimen
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Synonym:,rituximab + ifosfamide + cytarabine + etoposide
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Synonym:,rituximab-ifosfamide-cytarabine-etoposide
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Synonym:,rituximab/ifosfamide/cytarabine/etoposide
2020-10-14T13:16:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen,Synonym:,rituximab/ifosphamide/VP-16/ARA-C
2020-09-18T11:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivaroxaban,Chemical structure:,"5-chloro-N-[[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide"
2020-09-18T11:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivaroxaban,Code name:,BAY 59-7939
2020-09-18T11:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivaroxaban,US brand name:,Xarelto
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,Chemical structure:,"carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1)"
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,Code name:,SDZ-ENA 713
2020-09-18T06:40:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate,US brand name:,Exelon
2020-10-14T04:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riviciclib,Code name:,P276
2020-10-14T04:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riviciclib,Code name:,P276-00
2020-10-14T04:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riviciclib,Synonym:,cyclin-dependent kinase inhibitor P276
2020-10-14T12:58:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivipansel,Code name:,GMI-1070
2020-10-14T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate,Code name:,YN968D1
2020-10-14T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate,Foreign brand name:,Aitan
2020-10-14T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate,Foreign brand name:,Rivoceranib
2020-10-14T04:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate,Synonym:,ATAN
2020-10-14T13:16:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivogenlecleucel,Code name:,BPX-501
2020-10-14T13:16:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivogenlecleucel,Synonym:,allogeneic T lymphocytes BPX-501
2020-09-18T08:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate,Chemical structure:,"1H-indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate"
2020-09-18T08:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate,Code name:,"L 705,126"
2020-09-18T08:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate,Code name:,MK 0482
2020-09-18T08:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate,Code name:,MK-0482
2020-09-18T08:56:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate,US brand name:,Maxalt
2020-09-18T11:19:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rk-0202,NA,NA
2020-09-18T11:19:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rnr-inhibitor-coh29,Chemical structure:,"N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamide"
2020-09-18T11:19:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rnr-inhibitor-coh29,Code name:,COH29
2020-09-18T11:19:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rnr-inhibitor-coh29,Synonym:,ribonucleotide reductase holoenzyme inhibitor COH29
2020-09-18T11:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robatumumab,Chemical structure:,"immunoglobulin G1, anti-(human insulin-like growth factor I receptor) (human monoclonal SCH 717454 heavy chain), disulfide with human monoclonal SCH 717454 light chain, dimer"
2020-09-18T11:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robatumumab,Code name:,SCH 717454
2020-09-18T11:19:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robatumumab,Synonym:,anti-IGF-1R recombinant monoclonal antibody SCH 717454
2020-10-14T05:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roblitinib,Code name:,FGF401
2020-10-14T13:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robo1-targeted-bicar-nkt-cells,Synonym:,anti-ROBO1 BiCAR-NK/T cells
2020-10-14T13:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robo1-targeted-bicar-nkt-cells,Synonym:,ROBO1 CAR-NK/T cells
2020-10-14T13:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robo1-targeted-bicar-nkt-cells,Synonym:,ROBO1-targeted Bi-CAR-NK/T cells
2020-10-14T04:53:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocakinogene-sifuplasmid,Code name:,INO-9012
2020-10-14T13:14:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocapuldencel-t,Code name:,AGS-003
2020-09-18T11:20:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rociletinib,Code name:,CO-1686
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Chemical structure:,2-[3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy]-N-(1-methylethyl)-acetamide
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,KD 025
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,KD-025
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,KD025
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,SLx 2119
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,SLx-2119
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Code name:,SLx2119
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Synonym:,rho-associated coiled-coil kinase 2 inhibitor KD025
2020-09-18T11:20:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025,Synonym:,ROCK-II inhibitor KD025
2020-09-18T11:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocuronium-bromide,Chemical structure:,"pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide"
2020-09-18T11:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocuronium-bromide,Code name:,ORG 9426
2020-09-18T11:20:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocuronium-bromide,US brand name:,Zemuron
2020-10-14T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine,Chemical structure:,"4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1H)-one"
2020-10-14T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine,Code name:,RX-3117
2020-10-14T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine,Code name:,TV-1360
2020-10-14T04:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine,Synonym:,fluorocyclopentenylcytosine
2020-09-18T11:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rofecoxib,Chemical structure:,4-[4'-(Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
2020-09-18T11:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rofecoxib,Code name:,MK 966
2020-09-18T11:20:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rofecoxib,US brand name:,Vioxx
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Chemical structure:,"3-cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide"
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,B9302-107
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,BY21
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,Code name:,BYK20869
2020-09-18T05:52:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast,US brand name:,Daliresp
2020-10-14T12:58:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rogaratinib,Code name:,BAY1163877
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,Chemical structure:,"1,7-diazaspiro(4.5)decan-2-one, 8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, monohydrochloride, monohydrate, (5S,8S)-"
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,Code name:,SCH-619734
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,Code name:,SCH619734
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,Synonym:,rolapitant hydrochloride monohydrate
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,Synonym:,rolapitant monohydrochloride monohydrate
2020-09-18T11:21:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride,US brand name:,Varubi
2020-10-14T03:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine,Code name:,ABBV 176
2020-10-14T03:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine,Code name:,ABBV-176
2020-10-14T03:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine,Code name:,ABBV176
2020-10-14T03:34:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine,Synonym:,ADC ABBV-176
2020-09-18T08:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin,Code name:,FK228
2020-09-18T08:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin,Code name:,FR901228
2020-09-18T08:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin,Code name:,NSC 630176
2020-09-18T08:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin,Synonym:,depsipeptide
2020-09-18T08:16:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin,US brand name:,Istodax
2020-09-18T09:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim,Chemical structure:,"methionyl, 227 amino acid C-terminal immunoglobulin G1 (human Fc fragment) fusion protein with 41 amino acid peptide, dimer"
2020-09-18T09:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim,Code name:,AMG 531
2020-09-18T09:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim,Synonym:,Amgen megakaryopoiesis protein 2
2020-09-18T09:45:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim,US brand name:,Nplate
2020-10-14T05:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romyelocel-l,Abbreviation:,hMPC CLT-008
2020-10-14T05:20:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romyelocel-l,Code name:,CLT-008
2020-09-18T11:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roniciclib,Code name:,BAY1000394
2020-09-18T11:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roniciclib,Synonym:,pan-CDK inhibitor BAY1000394
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Code name:,AOP2014
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Code name:,P1101
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,PEG interferon alpha-2b
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,PEG intron
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,PEG-P-IFN-alfa-2b
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,PEG-P-IFN-alpha-2b
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,pegylated interferon alfa-2b
2020-10-14T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b,Synonym:,pegylated interferon alpha-2b
2020-09-18T11:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropidoxuridine,Chemical structure:,"2(1H)-pyrimidinone, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-iodo-5-iodo-2-pyrimidinone 2' deoxyribonucleoside5-iodo-2-pyrimidinone-2'-deoxyribose"
2020-09-18T11:21:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropidoxuridine,Synonym:,IPdR
2020-09-18T11:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride,Chemical structure:,"2(H)-indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride"
2020-09-18T11:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride,Code name:,SK&F 101468-A
2020-09-18T11:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride,Synonym:,4-(2-(dipropylamino)ethyl)-2-indolinone monohydrochloride
2020-09-18T11:12:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride,US brand name:,Requip
2020-09-18T09:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropivacaine-hydrochloride,Synonym:,ropivacaine hydrochloride monohydrate
2020-09-18T09:33:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropivacaine-hydrochloride,US brand name:,Naropin
2020-09-18T08:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex,Chemical structure:,"1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-3-quinolinecarboxanilide1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamideN-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide"
2020-09-18T08:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex,Code name:,FCF 89
2020-09-18T08:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex,Code name:,LS 2616
2020-09-18T08:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex,US brand name:,Linomide
2020-09-18T11:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ror1-car-specific-autologous-t-lymphocytes,Abbreviation:,ROR1-CAR-T
2020-09-18T11:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ror1-car-specific-autologous-t-lymphocytes,Synonym:,autologous ROR1-CAR-T cells
2020-09-18T11:21:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ror1-car-specific-autologous-t-lymphocytes,Synonym:,chimeric anti-ROR1 T-cell receptor-expressing autologous T lymphocytes
2020-09-18T11:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rorgamma-agonist-lyc-55716,Code name:,LYC-55716
2020-09-18T11:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rorgamma-agonist-lyc-55716,Code name:,LYC55716
2020-09-18T11:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rorgamma-agonist-lyc-55716,Synonym:,RORg agonist LYC-55716
2020-10-14T13:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rose-bengal-solution-pv-10,Synonym:,rose bengal disodium 10%
2020-10-14T13:10:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rose-bengal-solution-pv-10,US brand name:,Provecta
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Abbreviation:,ROS
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Chemical structure:,"(+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1)"
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,Code name:,BRL49653
2020-09-18T04:26:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate,US brand name:,Avandia
2020-10-14T03:58:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosmantuzumab,Code name:,OMP-131R10
2020-09-18T10:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin,Abbreviation:,SnET2
2020-09-18T10:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin,Chemical structure:,"tin, (ethyl tetramethyl-20-phorbinecarboxylato(2-)-N23,N24,N25,N26)-, (SP-4-2)"
2020-09-18T10:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin,Synonym:,tin ethyl etiopurpurin
2020-09-18T10:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin,Synonym:,tin etiopurpurin
2020-09-18T10:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin,US brand name:,Purlytin
2020-09-18T05:44:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosuvastatin-calcium,US brand name:,Crestor
2020-09-18T11:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rotavirus-vaccine,Synonym:,"rotavirus vaccine, live, oral"
2020-09-18T11:22:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rotavirus-vaccine,US brand name:,Rotarix
2020-09-18T11:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rou-cong-rong,Synonym:,Herba Cistanche
2020-09-18T11:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rou-cong-rong,Synonym:,Rou Cong-Rong
2020-09-18T11:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rou-cong-rong,Synonym:,RouCongRong
2020-09-18T11:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine,Code name:,SC16LD6.5
2020-09-18T11:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine,Synonym:,anti-SC16 ADC SC16LD6.5
2020-09-18T11:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine,Synonym:,antibody-drug conjugate SC16LD6.5
2020-09-18T11:22:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine,Synonym:,Rova-T
2020-09-18T11:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roxadustat,Chemical structure:,(((4-hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl)amino)acetic acid
2020-09-18T11:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roxadustat,Code name:,ASP 1517
2020-09-18T11:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roxadustat,Code name:,FG 4592
2020-09-18T11:22:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roxadustat,Code name:,FG-4592
2020-10-14T13:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsk1-4-inhibitor-pmd-026,Code name:,PMD 026
2020-10-14T13:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsk1-4-inhibitor-pmd-026,Code name:,PMD-026
2020-10-14T13:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsk1-4-inhibitor-pmd-026,Code name:,PMD026
2020-10-14T13:17:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsk1-4-inhibitor-pmd-026,Synonym:,RSK inhibitor PMD-026
2020-09-18T11:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsv-fusion-inhibitor-gs-5806,Synonym:,GS-5806
2020-09-18T11:23:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsv-fusion-inhibitor-gs-5806,Synonym:,respiratory syncytial virus fusion inhibitor GS-5806
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Abbreviation:,9-NC
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Chemical structure:,9-nitro-20 (S-)camptothecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Code name:,RFS 2000
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,9-nitro-CPT
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,9-nitrocamptothecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,Synonym:,nitrocamptothecin
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,US brand name:,Camptogen
2020-09-18T04:58:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan,US brand name:,Orathecin
2020-09-18T11:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate,Code name:,CO-338
2020-09-18T11:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate,Code name:,PF-1367338-BW
2020-09-18T11:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate,US brand name:,Rubraca
2020-09-18T11:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate,Code name:,AG014699
2020-09-18T11:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate,Code name:,PF-01367338
2020-09-18T11:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate,Synonym:,PARP-1 inhibitor AG014699
2020-09-18T11:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate,Synonym:,PARP1 inhibitor PF-01367338
2020-10-14T13:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-photosensitizer-tld1411,Code name:,TLD 1411
2020-10-14T13:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-photosensitizer-tld1411,Code name:,TLD-1411
2020-10-14T13:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-photosensitizer-tld1411,Code name:,TLD1411
2020-10-14T13:17:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-photosensitizer-tld1411,Synonym:,PS TLD1411
2020-10-14T13:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-small-molecule-therapeutic-bold-100,Code name:,BOLD 100
2020-10-14T13:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-small-molecule-therapeutic-bold-100,Code name:,BOLD-100
2020-10-14T13:17:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-small-molecule-therapeutic-bold-100,Code name:,BOLD100
2020-09-18T11:24:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-transferrin-targeting-agent-nkp-1339,Code name:,NKP-1339
2020-09-18T11:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-ru-106,Abbreviation:,Ru-106
2020-09-18T11:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-ru-106,Synonym:,Ruthenium 106
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,Chemical structure:,"(3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile phosphate (1:1)1H-pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-, phosphate (1:1)"
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,Code name:,INCB18424
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,Synonym:,INCB-18424 phosphate
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,Synonym:,oral JAK inhibitor INCB18424
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,Synonym:,oral Janus-associated kinase inhibitor INCB18424
2020-09-18T08:18:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate,US brand name:,Jakafi
2020-10-14T12:33:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxotemitide,Code name:,LTX-315
2020-10-14T12:33:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxotemitide,Foreign brand name:,Oncopore
2020-10-14T12:33:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxotemitide,Synonym:,lactoferrin pharmacophore LTX-315
2020-09-18T10:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxk469,Chemical structure:,"2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acidpropanoic acid, 2-[4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}-, (+ )-(R)-"
2020-09-18T10:57:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxk469,Synonym:,XK469
2020-10-14T03:21:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm,Abbreviation:,AMP
2020-10-14T03:21:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm,Synonym:,AMP hemostatic powder
2020-10-14T03:21:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm,Synonym:,Endo-Clot
2020-10-14T03:21:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm,US brand name:,EndoClot
2020-09-18T11:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-3304,NA,NA
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Abbreviation:,SAMe disulfate p-toluene-sulfonate
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Chemical structure:,"(3S)-5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxyadenosine, disulfate-methylbenzenesulfonate"
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Synonym:,S-adenosyl-L-methionine disulfate p-toluenesulfonate
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Synonym:,S-adenosyl-L-methionine disulfate tosilate
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Synonym:,S-adenosyl-L-methionine disulfate tosylate
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,Synonym:,S-adenosylmethionine tosylate disulfate
2020-09-18T11:25:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate,US brand name:,SAM-e Complete
2020-09-18T11:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosylmethionine,Chemical structure:,"5'-[(3-Amino-3-carboxypropyl)methylsulfonio]-5'-deoxyadenosine Hydroxide, Inner SaltS-Adenosyl-l-methionine 1,4-Butanedisulfonate"
2020-09-18T11:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosylmethionine,Synonym:,active methionine
2020-09-18T11:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosylmethionine,Synonym:,S-Adenosyl-l-methionine
2020-09-18T11:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosylmethionine,Synonym:,S-Adenosyl-methionine
2020-09-18T11:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-equol,Chemical structure:,"(3S)-3,4-dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol2H-1-benzopyran-7-ol, 3,4-dihydro-3-(4-hydroxyphenyl)-, (3S)-"
2020-09-18T11:32:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-equol,Synonym:,(−)-equol
2020-09-18T11:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s1p-receptor-agonist-krp203,Chemical structure:,2-amino-2-propanediol hydrochloride
2020-09-18T11:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s1p-receptor-agonist-krp203,Code name:,KRP203
2020-09-18T11:24:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s1p-receptor-agonist-krp203,Synonym:,KRP-203
2020-09-18T11:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sabarubicin,Code name:,BMS-195615
2020-09-18T11:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sabarubicin,Code name:,MEN-10755
2020-09-18T11:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saccharomyces-boulardii-probiotic-supplement,Foreign brand name:,Floratil
2020-09-18T11:24:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saccharomyces-boulardii-probiotic-supplement,Synonym:,S. boulardii probiotic
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,Abbreviation:,RS7-SN38
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,Code name:,IMMU-132
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,Synonym:,anti-TROP-2 antigen antibody-drug conjugate IMMU-132
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,Synonym:,hRS7-SN38 antibody-drug conjugate
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,Synonym:,sacituzumab govitecan
2020-09-18T11:24:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan,US brand name:,Trodelvy
2020-10-14T05:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril,Chemical structure:,"(2R,4S)-5-(biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid ethyl ester"
2020-10-14T05:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril,Code name:,AHU 377
2020-10-14T05:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril,Code name:,AHU-377
2020-10-14T05:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril,Code name:,AHU377
2020-10-14T05:00:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril,US brand name:,Entresto
2020-09-18T08:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol,Chemical structure:,"2-amino-1,3-dihydroxyoctadecaneL-threo-dihydrosphingosine"
2020-09-18T08:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol,Synonym:,sphinganine
2020-09-18T08:22:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol,US brand name:,Kynacyte
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Abbreviation:,ZK-EPO
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Chemical structure:,"(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-(prop-2-enyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dione"
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Code name:,DE-03757
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Code name:,SH-Y03757A
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Code name:,ZK-219477
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Synonym:,Epothilone ZK219477
2020-09-18T11:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone,Synonym:,ZK-Epothilone
2020-10-14T12:50:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saline,Synonym:,nasal saline rinse
2020-10-14T12:50:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saline,Synonym:,nasal saline wash
2020-09-18T11:25:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salirasib,Chemical structure:,"s-trans, trans-farnesylthiosalicylic acid"
2020-09-18T11:25:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salmonella-vnp20009,Code name:,VNP20009
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,Chemical structure:,"benzoic Acid, 2-hydroxy-, 2-carboxyphenyl ester"
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,Synonym:,o-salicylsalicylic acid
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,Synonym:,salicylsalicylic scid
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,US brand name:,Disalcid
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,US brand name:,Mono-Gesic
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,US brand name:,Salflex
2020-10-14T04:53:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate,US brand name:,Salsitab
2020-09-18T11:25:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-hispanica-seed,Synonym:,chia
2020-09-18T11:25:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-hispanica-seed,Synonym:,chia seed
2020-09-18T11:25:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-hispanica-seed,Synonym:,SH seed
2020-10-14T13:17:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-officinalis-extract,Synonym:,common sage extract tablet
2020-09-18T11:26:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-officinalis-extract-tablet,Synonym:,common sage extract tablet
2020-09-18T11:26:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sam68-modulator-cwp232291,Code name:,CWP232291
2020-09-18T11:26:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samalizumab,Code name:,ALXN6000
2020-09-18T11:26:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samalizumab,Synonym:,anti-CD200 monoclonal antibody ALXN6000
2020-09-18T11:26:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samalizumab,Synonym:,"immunoglobulin, anti-(CD200 (antigen)) (human-mouse monoclonal ALXN6000 heavy chain), disulfide with human-mouse monoclonal ALXN6000 kappa-chain, dimer"
2020-10-14T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp,Chemical structure:,"Sm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylene)phosphonic acidSm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayltetrakis(methylene)tetrakisphosphonic acid"
2020-10-14T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp,Synonym:,153 Sm-DOTMP
2020-10-14T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp,Synonym:,153Sm-DOTMP
2020-10-14T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp,Synonym:,Sm-153-DOTMP
2020-10-14T04:49:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp,US brand name:,CycloSam
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,Abbreviation:,153Sm-EDTMP
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,Abbreviation:,Sm-153 EDTMP
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,Synonym:,samarium Sm 153 lexidronam
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,Synonym:,Samarium-153 EDTMP
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,Synonym:,Sm 153 lexidronam pentasodium
2020-09-18T10:56:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium,US brand name:,Quadramet
2020-10-14T13:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samotolisib,Code name:,LY 3023414
2020-10-14T13:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samotolisib,Code name:,LY-3023414
2020-10-14T13:05:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samotolisib,Code name:,LY3023414
2020-10-14T04:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib,Code name:,CT 7001
2020-10-14T04:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib,Code name:,CT-7001
2020-10-14T04:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib,Code name:,CT7001
2020-10-14T04:40:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib,Code name:,ICEC0942
2020-09-18T11:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapacitabine,Chemical structure:,"N-[1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide"
2020-09-18T11:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapacitabine,Code name:,CS-682
2020-09-18T11:27:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapacitabine,Code name:,CYC682
2020-09-18T11:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib,Code name:,INK0128
2020-09-18T11:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib,Code name:,INK128
2020-09-18T11:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib,Code name:,MLN0128
2020-09-18T11:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib,Code name:,TAK-228
2020-09-18T11:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib,Synonym:,TORC1/2 Inhibitor INK128
2020-09-18T11:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapitinib,Code name:,AZD8931
2020-09-18T11:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapitinib,Synonym:,ErbB kinase inhibitor AZD8931
2020-09-18T11:27:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-based-immunoadjuvant-obi-821,Code name:,OBI-821
2020-09-18T11:27:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-based-immunoadjuvant-obi-821,Code name:,OPT-821
2020-09-18T08:15:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-cholesterol-phospholipid-adjuvant,US brand name:,Iscomatrix
2020-09-18T08:07:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saquinavir-mesylate,US brand name:,Invirase
2020-09-18T11:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saracatinib,Chemical structure:,"4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1- piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-[(tetrahydro- 2H-pyran-4-yl)oxy]quinazolin-4-amine"
2020-09-18T11:28:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saracatinib,Code name:,AZD0530
2020-09-18T11:28:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sarcnu,Chemical structure:,2-chloroethyl-3-sarcosinamide-1-nitrosourea
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Abbreviation:,GM CSF
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Abbreviation:,GM-CSF
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Abbreviation:,rhu GM-CFS
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Code name:,DRG-0012
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,23-L-leucine colony-stimulating factor 2
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,colony stimulating factor 2
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,CSF-2
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,GM-CSF
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,granulocyte macrophage colony-stimulating factor
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,Synonym:,sargramostatin
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,US brand name:,Leukine
2020-09-18T08:29:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim,US brand name:,Prokine
2020-09-18T11:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-hepatocellular-carcinoma-vaccine-adjuvant,Abbreviation:,phGM-CSF HCC
2020-09-18T11:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-hepatocellular-carcinoma-vaccine-adjuvant,Synonym:,GM-CSF plasmid DNA hepatocellular carcinoma vaccine adjuvant
2020-09-18T11:28:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-melanoma-vaccine-adjuvant,Synonym:,GM-CSF plasmid DNA melanoma vaccine adjuvant
2020-09-18T11:28:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-pancreatic-tumor-cell-vaccine,Synonym:,GM-CSF plasmid DNA pancreatic tumor cell vaccine
2020-10-14T13:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sasanlimab,Code name:,PF-06801591
2020-10-14T13:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sasanlimab,Synonym:,anti-PD-1 PF-06801591
2020-10-14T13:17:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sasanlimab,Synonym:,WHO 11161
2020-09-18T10:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin,Chemical structure:,"(OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(OC-6-43)-bis(acetato-O)amminedichloro(cyclohexanamine)platinumplatinum,bis(acetato-O)amminedichloro(cyclohexanamine)-,(OC-6-43)"
2020-09-18T10:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin,Code name:,BMS-182751
2020-09-18T10:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin,Code name:,BMY-45594
2020-09-18T10:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin,Code name:,JM216
2020-09-18T10:00:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin,US brand name:,Orplatna
2020-10-14T13:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/savolitinib,Code name:,HMPL-504
2020-10-14T13:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/savolitinib,Synonym:,AZD6094
2020-10-14T13:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/savolitinib,Synonym:,volitinib
2020-09-18T11:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saw-palmetto-berry-extract-supplement,Synonym:,saw palmetto
2020-09-18T11:29:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saw-palmetto-berry-extract-supplement,Synonym:,Saw Palmetto Berry Extract
2020-09-18T11:29:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saxagliptin-hydrochloride,NA,NA
2020-09-18T11:29:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-743921,NA,NA
2020-09-18T11:29:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-as02b-adjuvant,Abbreviation:,SB AS02B
2020-09-18T11:29:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-as15-adjuvant,Code name:,SB AS15
2020-09-18T09:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sdf-1-targeted-agent-nox-a12,Code name:,NOX-A12
2020-09-18T09:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sdf-1-targeted-agent-nox-a12,Synonym:,CXCL12-targeted agent NOX-A12
2020-09-18T09:50:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sdf-1-targeted-agent-nox-a12,Synonym:,SDF-1-targeted agent NOX-A12
2020-10-14T13:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seclidemstat,Code name:,SP 2577
2020-10-14T13:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seclidemstat,Code name:,SP-2577
2020-10-14T13:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seclidemstat,Code name:,SP2577
2020-10-14T13:18:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seclidemstat,Synonym:,LSD1 inhibitor SP-2577
2020-10-14T04:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human,Abbreviation:,SHS
2020-10-14T04:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human,Code name:,RG1068
2020-10-14T04:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human,Synonym:,secretin human
2020-10-14T04:43:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human,US brand name:,ChiRhoStim
2020-09-18T11:29:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sedoxantrone-trihydrochloride,Code name:,CI-958
2020-09-18T11:29:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selatinib-ditosilate,NA,NA
2020-09-18T11:30:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selected-vegetables-suns-soup,Synonym:,Sun's soup
2020-09-18T11:30:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473,Chemical structure:,"Isopropyl N-[(2S)-7-cyano-4-(2-pyridylmethyl)-2,3-dihydro-1H-cyclopenta[b]indol-2-yl]carbamate"
2020-09-18T11:30:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473,Code name:,LY2452473
2020-09-18T11:30:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473,Synonym:,LY SARM
2020-09-18T11:30:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473,Synonym:,SARM LY2452473
2020-09-18T11:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140,Code name:,RAD 140
2020-09-18T11:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140,Code name:,RAD-140
2020-09-18T11:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140,Code name:,RAD140
2020-09-18T11:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140,Synonym:,SARM RAD140
2020-09-18T11:30:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140,US brand name:,Testolone
2020-10-14T04:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-cytokine-inhibitory-drug-cc-1088,NA,NA
2020-10-14T13:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-covalent-antagonist-h3b-6545,Code name:,H3B 6545
2020-10-14T13:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-covalent-antagonist-h3b-6545,Code name:,H3B-6545
2020-10-14T13:18:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-covalent-antagonist-h3b-6545,Synonym:,SERCA H3B-6545
2020-09-18T11:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-arn-810,Code name:,ARN-810
2020-09-18T11:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-arn-810,Code name:,GDC-0810
2020-09-18T11:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-arn-810,Code name:,RG6046
2020-09-18T11:30:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-arn-810,Synonym:,SERD ARN-810
2020-09-18T11:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496,Chemical structure:,"(E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic acid"
2020-09-18T11:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496,Code name:,AZD 9496
2020-09-18T11:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496,Code name:,AZD-9496
2020-09-18T11:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496,Code name:,AZD9496
2020-09-18T11:30:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496,Synonym:,SERD AZD9496
2020-10-14T13:18:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9833,Code name:,AZD 9833
2020-10-14T13:18:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9833,Code name:,AZD9833
2020-10-14T13:18:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9833,Synonym:,SERD AZD9833
2020-10-14T13:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102,Code name:,LSZ 102
2020-10-14T13:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102,Code name:,LSZ102
2020-10-14T13:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102,Synonym:,SERD LSZ 102
2020-10-14T13:18:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102,Synonym:,SERD LSZ102
2020-10-14T13:18:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lx-039,Code name:,LX 039
2020-10-14T13:18:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lx-039,Code name:,LX-039
2020-10-14T13:18:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lx-039,Code name:,LX039
2020-10-14T13:18:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lx-039,Synonym:,SERD LX-039
2020-10-14T13:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-ly3484356,Code name:,LY 3484356
2020-10-14T13:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-ly3484356,Code name:,LY3484356
2020-10-14T13:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-ly3484356,Synonym:,SERD LY3484356
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Code name:,RAD1901
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Synonym:,selective estrogen receptor degrader/modulator RAD1901
2020-09-18T06:23:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901,Synonym:,SERD/SERM RAD1901
2020-09-18T11:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-srn-927,Code name:,SRN-927
2020-09-18T11:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-srn-927,Synonym:,SERD SRN-927
2020-09-18T11:30:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degraderlsz102,Code name:,LSZ 102
2020-09-18T11:30:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degraderlsz102,Code name:,LSZ102
2020-09-18T11:30:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degraderlsz102,Synonym:,SERD LSZ 102
2020-09-18T11:30:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degraderlsz102,Synonym:,SERD LSZ102
2020-10-14T04:37:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator-cc-8490,Code name:,SPC8490
2020-10-14T13:26:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator-tas-108,Chemical structure:,"(7)-21-[4-[(diethylamino)methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol 2-hydroxy-1,2,3-propanetricarboxylate"
2020-10-14T13:26:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator-tas-108,Code name:,SR16234
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Chemical structure:,3-(4-fluorophenyl)-2-(4-hydroxyphenoxy)benzo[b]thiophen-6-ol
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Code name:,TTC 352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Code name:,TTC-352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Synonym:,ERa partial agonist TTC-352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Synonym:,selective estrogen mimic TTC-352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Synonym:,selective estrogen modulator TTC-352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Synonym:,SEM TTC-352
2020-10-14T13:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352,Synonym:,ShERPA TTC-352
2020-09-18T11:31:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selenium,Abbreviation:,Se
2020-09-18T11:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seliciclib,Chemical structure:,2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
2020-09-18T11:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seliciclib,Code name:,CYC202
2020-09-18T11:31:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seliciclib,Synonym:,R-roscovitine
2020-10-14T13:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selicrelumab,Code name:,RO7009789
2020-10-14T13:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selicrelumab,Synonym:,CD40 agonist monoclonal antibody RO7009789
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,Abbreviation:,SINE KPT-330
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,Code name:,ATG-010
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,Code name:,KPT-330
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,Synonym:,CRM1 nuclear export inhibitor KPT-330
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,Synonym:,selective inhibitor of nuclear export KPT-330
2020-09-18T11:31:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor,US brand name:,Xpovio
2020-10-14T13:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selitrectinib,Chemical structure:,"(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one"
2020-10-14T13:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selitrectinib,Code name:,LOXO 195
2020-10-14T13:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selitrectinib,Code name:,LOXO-195
2020-10-14T13:33:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selitrectinib,Code name:,LOXO195
2020-10-14T04:02:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selonsertib,Code name:,GS-4997
2020-10-14T13:15:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib,Code name:,LOXO-292
2020-10-14T13:15:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib,Synonym:,RET inhibitor LOXO-292
2020-10-14T13:15:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib,Synonym:,RET kinase inhibitor LOXO-292
2020-10-14T13:15:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib,US brand name:,Retevmo
2020-09-18T08:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib,Code name:,AZD6244 hydrogen sulfate
2020-09-18T08:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib,Code name:,AZD6244 hydrogen sulphate
2020-09-18T08:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib,Synonym:,selumetinib sulphate
2020-09-18T08:21:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib,US brand name:,Koselugo
2020-10-14T05:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate,Code name:,AZD6244 hydrogen sulfate
2020-10-14T05:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate,Code name:,AZD6244 hydrogen sulphate
2020-10-14T05:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate,Synonym:,selumetinib sulphate
2020-10-14T05:28:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate,US brand name:,Koselugo
2020-09-18T11:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semaxanib,Chemical structure:,"3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-indolin-2-oneH-indol-2-one, 3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)-1,3-dihydro-"
2020-09-18T11:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semaxanib,Code name:,SU5416
2020-09-18T11:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semaxanib,Code name:,Sugen 5416
2020-09-18T11:31:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semaxanib,Synonym:,semoxind
2020-09-18T11:31:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semuloparin,Abbreviation:,ULMW heparin AVE5026
2020-09-18T11:31:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semuloparin,Code name:,AVE5026
2020-09-18T11:31:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semuloparin,Synonym:,ultralow-molecular-weight heparin AVE5026
2020-09-18T11:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine,Abbreviation:,MeCCNU
2020-09-18T11:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine,Synonym:,"CCNU, methyl-"
2020-09-18T11:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine,Synonym:,MCCNU
2020-09-18T11:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine,Synonym:,methyl CCNU
2020-09-18T11:32:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine,Synonym:,methyl-CCNU
2020-09-18T11:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seneca-valley-virus-001,Code name:,NTX-010
2020-09-18T11:32:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seneca-valley-virus-001,Code name:,SVV-001
2020-09-18T11:32:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/senna-extract,Synonym:,senna
2020-09-18T11:32:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/senna-fruit,NA,NA
2020-09-18T11:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sepantronium-bromide,Code name:,YM155
2020-09-18T11:32:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sepantronium-bromide,Synonym:,survivin inhibitor YM155
2020-10-14T13:03:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serabelisib,Code name:,INK1117
2020-10-14T13:03:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serabelisib,Code name:,MLN1117
2020-10-14T13:03:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serabelisib,Code name:,TAK-117
2020-10-14T03:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine,Code name:,ABBV 321
2020-10-14T03:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine,Code name:,ABBV-321
2020-10-14T03:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine,Code name:,ABBV321
2020-10-14T03:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine,Synonym:,ADC ABBV-321
2020-10-14T03:45:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine,Synonym:,anti-EGFR/PBD ADC ABBV-321
2020-10-14T13:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-g1t48,Code name:,G1T48
2020-10-14T13:19:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-g1t48,Synonym:,selective estrogen receptor downregulator G1T48
2020-10-14T13:19:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-sar439859,Code name:,SAR 439859
2020-10-14T13:19:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-sar439859,Code name:,SAR-439859
2020-10-14T13:19:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-sar439859,Synonym:,selective estrogen receptor degrader SAR439859
2020-10-14T13:19:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-sar439859,Synonym:,selective estrogen receptor downregulator SAR439859
2020-10-14T13:19:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549,Code name:,SHR 9549
2020-10-14T13:19:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549,Code name:,SHR-9549
2020-10-14T13:19:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549,Code name:,SHR9549
2020-10-14T13:19:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549,Synonym:,selective estrogen receptor degrader SHR9549
2020-10-14T13:19:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549,Synonym:,selective estrogen receptor downregulator SHR9549
2020-09-18T11:33:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serdemetan,Code name:,JNJ-26854165
2020-09-18T11:33:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serdemetan,Synonym:,HDM2 antagonist JNJ-26854165
2020-09-18T11:33:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seribantumab,Code name:,MM-121
2020-10-14T13:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-hydrolase-monoacylglycerol-lipase-inhibitor-abx-1431,Code name:,ABX-1431
2020-10-14T13:19:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-hydrolase-monoacylglycerol-lipase-inhibitor-abx-1431,Synonym:,MGLL inhibitor ABX-1431
2020-09-18T11:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-protease-inhibitor-wx-671,Chemical structure:,"N-α-(2,4,6-triisopropylphenyl-sulfonyl)-3-hydroxyamidino-(L )-phenylalanine-4-ethoxycarbonylpiperazide"
2020-09-18T11:33:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-protease-inhibitor-wx-671,Code name:,WX-671
2020-10-14T05:09:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-threonine-kinase-inhibitor-cbp501,Code name:,CBP501
2020-09-18T11:33:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-threonine-kinase-inhibitor-xl418,Code name:,XL418
2020-10-14T13:19:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serplulimab,Code name:,HLX 10
2020-10-14T13:19:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serplulimab,Code name:,HLX10
2020-09-18T11:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sertraline-hydrochloride,US brand name:,Zoloft
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,Abbreviation:,SBI
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,Synonym:,serum bovine immunoglobulin
2020-09-18T06:29:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate,US brand name:,EnteraGam
2020-09-18T11:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevacizumab,NA,NA
2020-09-18T11:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seviteronel,Code name:,VT-464
2020-09-18T11:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seviteronel,Synonym:,CYP17 inhibitor VT-464
2020-09-18T11:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevoflurane,Chemical structure:,"1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propaneEther, Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-"
2020-09-18T11:34:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevoflurane,US brand name:,Ultane
2020-09-18T04:36:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Benefin
2020-09-18T04:36:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage,US brand name:,Cartilade
2020-09-18T09:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941,Code name:,AE-941
2020-09-18T09:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941,Foreign brand name:,Neovastat
2020-09-18T09:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941,Synonym:,Neovastat/AE-941
2020-09-18T09:36:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941,US brand name:,Neovastat
2020-09-18T11:34:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheddase-inhibitor-incb007839,Code name:,INCB007839
2020-09-18T11:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-di-huang,Synonym:,Radix Rehmanniae Glutinosae
2020-09-18T11:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-di-huang,Synonym:,Rehmannia glutinosa
2020-09-18T11:34:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-di-huang,Synonym:,ShengDiHuang
2020-09-18T11:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-mai-san,Synonym:,Panax ginseng/Ophiopogon japonicus/Schisandra chinensis herbal supplement
2020-09-18T11:34:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-mai-san,Synonym:,Shengmai San
2020-09-18T11:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-yu-tang,Synonym:,Chinese medicine Sheng-Yu-Tang
2020-09-18T11:34:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-yu-tang,Synonym:,sagacious cure decoction
2020-09-18T11:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction,Synonym:,Shi Pi decoction
2020-09-18T11:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction,Synonym:,Shi Pi TCM herbal decoction
2020-09-18T11:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction,Synonym:,Shi Pi traditional Chinese medicine herbal decoction
2020-09-18T11:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction,Synonym:,Shi Pi Yin
2020-09-18T11:34:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction,Synonym:,Shi-pi-yin
2020-09-18T11:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/short-chain-fatty-acid-hqk-1004,Abbreviation:,SCFA HQK-1004
2020-09-18T11:35:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/short-chain-fatty-acid-hqk-1004,Code name:,HQK-1004
2020-10-14T13:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43,Chemical structure:,1-[4-chloro-3(trifluoromethyl)phenyl-3-[3-(4-cyanophenoxy)] urea
2020-10-14T13:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43,Code name:,SC 43
2020-10-14T13:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43,Code name:,SC-43
2020-10-14T13:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43,Code name:,SC43
2020-10-14T13:19:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43,Synonym:,SC-43 oral solution
2020-10-14T13:20:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-jab-3068,Code name:,JAB 3068
2020-10-14T13:20:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-jab-3068,Code name:,JAB-3068
2020-10-14T13:20:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-jab-3068,Code name:,JAB3068
2020-10-14T13:20:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-jab-3068,Synonym:,PTPN11 inhibitor JAB-3068
2020-10-14T13:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-rmc-4630,Code name:,RMC 4630
2020-10-14T13:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-rmc-4630,Code name:,RMC4630
2020-10-14T13:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-rmc-4630,Synonym:,PTPN11 inhibitor RMC-4630
2020-10-14T13:20:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-rmc-4630,Synonym:,SAR442720
2020-09-18T11:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-tno155,Code name:,TNO155
2020-09-18T11:35:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-tno155,Synonym:,PTPN11 inhibitor TNO155
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,cooked rehmannia root
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,processed Rehmannia Glutinosa Libosch root
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,processed Rehmannia root
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,Radix Rehmanniae Preparata
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,ShuDiHuang
2020-09-18T11:35:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang,Synonym:,steamed Chinese foxglove root
2020-09-18T11:35:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sialyl-lewis-keyhole-limpet-hemocyanin-conjugate-vaccine,NA,NA
2020-09-18T11:35:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sig12d-loder,NA,NA
2020-09-18T11:35:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silatecan-ar-67,Chemical structure:,7-tert-butyldimethylsilyl-10-hydroxycamptothecin
2020-09-18T11:35:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sildenafil-citrate,US brand name:,Viagra
2020-09-18T11:35:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silicon-phthalocyanine-4,Abbreviation:,Pc 4
2020-09-18T11:35:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silicon-phthalocyanine-4,Synonym:,Pc-4 (Silicone phthalocyanine)
2020-09-18T11:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib,Chemical structure:,"5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic acid sodium salt"
2020-09-18T11:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib,Code name:,CX-4945 sodium
2020-09-18T11:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib,Synonym:,CK inhibitor CX-4945
2020-09-18T11:36:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib,Synonym:,CX 4945 sodium
2020-10-14T13:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium,Chemical structure:,"5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic acid sodium salt"
2020-10-14T13:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium,Code name:,CX-4945 sodium
2020-10-14T13:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium,Synonym:,CK inhibitor CX-4945
2020-10-14T13:20:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium,Synonym:,CX 4945 sodium
2020-09-18T10:59:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silodosin,US brand name:,Rapaflo
2020-09-18T11:36:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siltuximab,Code name:,cCLB8
2020-09-18T11:36:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siltuximab,Code name:,CNTO 328
2020-09-18T11:36:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siltuximab,US brand name:,Sylvant
2020-09-18T11:31:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-nitrate,NA,NA
2020-09-18T11:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine,Foreign brand name:,Flamazine
2020-09-18T11:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine,Synonym:,sulfadiazine silver
2020-09-18T11:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine,US brand name:,Silvadene
2020-09-18T11:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine,US brand name:,SSD
2020-09-18T11:36:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine,US brand name:,Thermazene
2020-09-18T11:36:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silymarin,NA,NA
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,Chemical structure:,"N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide"
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,Code name:,HSDB 8227
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,Code name:,TMC 435
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,Code name:,TMC-435
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,Code name:,TMC435
2020-09-18T09:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir,US brand name:,Olysio
2020-09-18T11:36:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simethicone,NA,NA
2020-09-18T11:36:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmiparib,Code name:,SMOCL-9112
2020-09-18T11:36:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmitecan-hydrochloride,NA,NA
2020-10-14T13:20:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmitinib,Code name:,SOMCL-15-290
2020-09-18T11:37:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simo-decoction,Abbreviation:,SMD
2020-10-14T03:51:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simtuzumab,Code name:,AB0024
2020-10-14T03:51:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simtuzumab,Code name:,GS-6624
2020-10-14T04:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simurosertib,Code name:,TAK-931
2020-10-14T04:39:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simurosertib,Synonym:,cell division cycle 7 inhibitor TAK-931
2020-09-18T11:37:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simvastatin,US brand name:,Zocor
2020-10-14T13:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab,Code name:,IBI 308
2020-10-14T13:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab,Code name:,IBI308
2020-10-14T13:20:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab,Synonym:,anti-PDCD1 monoclonal antibody IBI308
2020-09-18T11:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipjeondaebo-tang,Abbreviation:,SJDBT
2020-09-18T11:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipjeondaebo-tang,Synonym:,deciten granule
2020-09-18T11:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipjeondaebo-tang,Synonym:,juzen-taiho-to
2020-09-18T11:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipjeondaebo-tang,Synonym:,shi-quan-da-bu-tang
2020-09-18T11:37:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siplizumab,Abbreviation:,MEDI-507
2020-09-18T11:37:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siplizumab,Code name:,MEDI-507
2020-09-18T11:37:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siplizumab,Synonym:,anti-CD2 monoclonal antibody
2020-09-18T10:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipuleucel-t,Code name:,APC 8015
2020-09-18T10:51:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipuleucel-t,US brand name:,Provenge
2020-10-14T13:20:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siremadlin,Code name:,HDM201
2020-10-14T13:20:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siremadlin,Synonym:,NVP-HDM 201
2020-10-14T13:20:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-expressing-sv40,NA,NA
2020-09-18T11:38:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-expressing-sv40-vector,NA,NA
2020-09-18T11:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-transfected-peripheral-blood-mononuclear-cells-apn401,Code name:,APN401
2020-09-18T11:38:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-transfected-peripheral-blood-mononuclear-cells-apn401,Synonym:,siRNA-transfected PBMC APN401
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Abbreviation:,RAPA
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Abbreviation:,SLM
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Code name:,AY 22989
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Code name:,SILA 9268A
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Code name:,WY-090217
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,Synonym:,rapamycin
2020-09-18T10:46:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus,US brand name:,Rapamune
2020-10-14T13:20:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154,Code name:,SL 172154
2020-10-14T13:20:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154,Code name:,SL-172154
2020-10-14T13:20:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154,Code name:,SL172154
2020-10-14T13:20:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154,Synonym:,CD172a-Fc-CD40L chimeric protein SL-172154
2020-10-14T13:20:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154,Synonym:,SIRPα-Fc-CD40L SL-172154
2020-09-18T11:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-fusion-protein-tti-621,Code name:,TTI 621
2020-09-18T11:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-fusion-protein-tti-621,Code name:,TTI-621
2020-09-18T11:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-fusion-protein-tti-621,Synonym:,SIRPaFc
2020-10-14T13:20:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622,Code name:,TTI 622
2020-10-14T13:20:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622,Code name:,TTI-622
2020-10-14T13:20:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622,Code name:,TTI622
2020-10-14T13:20:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622,Synonym:,SIRPa-IgG4 Fc
2020-10-14T13:20:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622,Synonym:,SIRPa-IgG4 Fc TTI-622
2020-10-14T13:20:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sisunatovir,Code name:,RV 521
2020-10-14T13:20:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sisunatovir,Code name:,RV-521
2020-10-14T13:20:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sisunatovir,Code name:,RV521
2020-09-18T11:38:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sitravatinib,Code name:,MGCD516
2020-09-18T11:38:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sitravatinib,Synonym:,multitargeted kinase inhibitor MGCD516
2020-10-14T13:21:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene,Chemical structure:,"4,4'-[[2-(2,4-dinitrophenyl)hydrazinylidene]methylene]diphenol4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazonemethanone, bis(4-hydroxyphenyl)-, (2,4-dinitrophenyl)hydrazone"
2020-10-14T13:21:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene,Code name:,A-007
2020-09-18T11:38:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene-gel,Chemical structure:,"4,4'-[[2-(2,4-dinitrophenyl)hydrazinylidene]methylene]diphenol4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazonemethanone, bis(4-hydroxyphenyl)-, (2,4-dinitrophenyl)hydrazone"
2020-09-18T11:38:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene-gel,Code name:,A-007
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,Chemical structure:,poly(3-(O-beta-D-glucopyranosyl-(1-3)-O-(beta-D-glucopyranosyl-(1-6))-O-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl)-1)
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,Synonym:,schizophyllan
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,Synonym:,schizophyllane
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,Synonym:,sonifilan
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,US brand name:,MC-Glucan
2020-09-18T08:56:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran,US brand name:,Sixofilan
2020-10-14T13:21:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slc6a8-inhibitor-rgx-202,Code name:,RGX 202
2020-10-14T13:21:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slc6a8-inhibitor-rgx-202,Code name:,RGX-202
2020-10-14T13:21:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slc6a8-inhibitor-rgx-202,Code name:,RGX-202-01
2020-10-14T13:21:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slc6a8-inhibitor-rgx-202,Code name:,RGX202
2020-10-14T13:21:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slct-inhibitor-gns561,Code name:,GNS 561
2020-10-14T13:21:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slct-inhibitor-gns561,Code name:,GNS-561
2020-10-14T13:21:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slct-inhibitor-gns561,Code name:,GNS561
2020-10-14T13:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-bi-891065,Code name:,BI 891065
2020-09-18T11:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-cudc-427,Code name:,GDC-0917
2020-09-18T11:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-cudc-427,Synonym:,IAP Antagonist GDC-0917
2020-09-18T11:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-cudc-427,Synonym:,IAP inhibitor CUDC-427
2020-09-18T11:39:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-cudc-427,Synonym:,SMAC/DIABLO mimetic GDC-0917IAP Antagonist GDC-0917 (SY)
2020-10-14T05:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-debio-1143,Code name:,AT-406
2020-10-14T05:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-debio-1143,Code name:,SM-406
2020-10-14T05:21:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-debio-1143,Synonym:,"pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, n-((1,1'-biphenyl)-2-ylmethyl)decahydro-5-(((2s)-2-(methylamino)-1-oxopropyl)amino)-3-(3-methyl-1-oxobutyl)-6-oxo-, (5s,8s,10ar)"
2020-09-18T11:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0152,Code name:,GDC-0152
2020-09-18T11:39:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0152,Synonym:,IAP antagonist GDC-0152
2020-10-14T13:21:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0917,Code name:,GDC-0917
2020-10-14T13:21:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0917,Synonym:,IAP Antagonist GDC-0917
2020-10-14T13:21:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0917,Synonym:,IAP inhibitor CUDC-427
2020-10-14T13:21:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0917,Synonym:,SMAC/DIABLO mimetic GDC-0917IAP Antagonist GDC-0917 (SY)
2020-09-18T11:39:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-lcl161,Code name:,LCL161
2020-09-18T11:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smo-antagonist-bms-833923,Code name:,BMS 833923
2020-09-18T11:39:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smo-antagonist-bms-833923,Code name:,XL139
2020-09-18T11:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum,Synonym:,black plum
2020-09-18T11:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum,Synonym:,Chinese plum
2020-09-18T11:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum,Synonym:,Japanese apricot
2020-09-18T11:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum,Synonym:,mume fruit
2020-09-18T11:40:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum,Synonym:,Wu Mei
2020-09-18T11:40:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smokeless-tobacco,NA,NA
2020-10-14T13:21:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-bms-833923,Code name:,BMS 833923
2020-10-14T13:21:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-bms-833923,Code name:,XL139
2020-09-18T11:40:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-lde225-topical,NA,NA
2020-09-18T11:40:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-leq506,Code name:,LEQ506
2020-09-18T11:40:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sn-38-loaded-polymeric-micelles-nk012,Code name:,NK012
2020-09-18T11:40:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sns01-t-nanoparticles,NA,NA
2020-09-18T11:40:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soblidotin,Code name:,TZT-1027
2020-09-18T11:40:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sod1-inhibitor-atn-224,Code name:,ATN-224
2020-09-18T11:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-alginate-microspheres,Abbreviation:,KMG
2020-09-18T11:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-alginate-microspheres,Foreign brand name:,KMG microspheres
2020-09-18T11:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate,Chemical structure:,NaHCO3sodium hydrogen carbonate
2020-09-18T11:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate,Synonym:,baking soda
2020-09-18T11:40:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate,Synonym:,bicarbonate of soda
2020-09-18T01:48:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-potassium-bicarbonate-anhydrous-citric-acid,US brand name:,Alka Seltzer Gold
2020-09-18T11:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-solution,Synonym:,baking soda solution
2020-09-18T06:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative,Foreign brand name:,Fleet Phospho-soda
2020-09-18T06:51:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative,US brand name:,Fleet Phospho-soda
2020-09-18T11:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-borocaptate,Abbreviation:,BSH
2020-09-18T11:41:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-borocaptate,Foreign brand name:,Borocarpin
2020-09-18T03:55:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-carboxymethylcellulose-dressing,US brand name:,Aquacel Dressing
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,Synonym:,Albright's Solution
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,Synonym:,Modified Shohl's Solution
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,US brand name:,Bicitra
2020-09-18T04:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate,US brand name:,Oracit
2020-09-18T11:41:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-dichloroacetate,Abbreviation:,DCA
2020-09-18T06:47:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-ferric-gluconate-complex-in-sucrose,US brand name:,Ferrlecit
2020-09-18T11:41:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-fluoride,Abbreviation:,NaF
2020-09-18T11:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-glycididazole,Acronym:,SG
2020-09-18T11:41:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-glycididazole,Foreign brand name:,CMNa
2020-09-18T10:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-hyaluronate-topical-hydrogel,Synonym:,gelronate
2020-09-18T10:57:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-hyaluronate-topical-hydrogel,US brand name:,RadiaPlex Rx Gel
2020-09-18T11:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131,Synonym:,(131-I)sodium iodide
2020-09-18T11:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131,Synonym:,iodotope I-131
2020-09-18T11:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131,Synonym:,natrium radio-iodatum(131 I)
2020-09-18T11:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131,Synonym:,oriodide
2020-09-18T11:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131,Synonym:,radiocaps-131
2020-09-18T11:41:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-metaarsenite,Code name:,KML-001
2020-09-18T11:41:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-nitrate-supplement,Synonym:,dietary supplement sodium nitrate
2020-09-18T04:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate,Synonym:,sodium 4-phenylbutyrate
2020-09-18T04:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate,US brand name:,Buphenyl
2020-09-18T10:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate,US brand name:,Phosphoral
2020-10-14T05:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate-sodium-biphosphate-laxative,Foreign brand name:,Fleet Phospho-soda
2020-10-14T05:04:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate-sodium-biphosphate-laxative,US brand name:,Fleet Phospho-soda
2020-10-14T13:21:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-picosulfate-magnesium-oxide-citric-acid-laxative,Foreign brand name:,Picoprep
2020-09-18T11:42:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-picosulfate-magnesium-oxide-citric-acid-oral-laxative,Foreign brand name:,Picoprep
2020-10-14T13:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108,Code name:,RX 108
2020-10-14T13:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108,Code name:,RX-108
2020-10-14T13:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108,Code name:,RX108
2020-10-14T13:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108,Synonym:,Na+/K+-ATPase inhibitor RX108
2020-10-14T13:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108,Synonym:,sodium-potassium pump inhibitor RX108
2020-09-18T11:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-salicylate,Chemical structure:,"benzoic acid, 2-hydroxy-, monosodium salt"
2020-09-18T11:42:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-salicylate,Synonym:,"salicylate, sodium"
2020-09-18T11:42:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-selenite,NA,NA
2020-09-18T11:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-stibogluconate,Abbreviation:,SSG
2020-09-18T11:42:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-stibogluconate,Foreign brand name:,Pentostam
2020-09-18T11:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-sulfate-potassium-sulfate-magnesium-sulfate-based-laxative,Synonym:,trisulfate bowel cleansing solution
2020-09-18T11:42:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-sulfate-potassium-sulfate-magnesium-sulfate-based-laxative,US brand name:,Suprep®
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,Abbreviation:,STS
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,Foreign brand name:,S-Hydril
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,Synonym:,disodium thiosulfate
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,Synonym:,Sodium Hyposulfate
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,Synonym:,sodium thiosulfate pentahydrate
2020-09-18T11:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate,US brand name:,Sodothiol
2020-10-14T12:47:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofituzumab-vedotin,Code name:,DMUC5754A
2020-09-18T11:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofosbuvir,Code name:,GS-7977
2020-09-18T11:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofosbuvir,Code name:,PSI-7977
2020-09-18T11:42:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofosbuvir,Synonym:,nucleotide NS5B inhibitor GS-7977
2020-09-18T11:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/solitomab,Code name:,MT110
2020-09-18T11:43:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/solitomab,Synonym:,anti-EpCAM/anti-CD3 recombinant bispecific monoclonal antibody MT110
2020-09-18T07:18:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatotropin,Acronym:,rhGH
2020-09-18T07:18:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatotropin,Synonym:,recombinant human growth hormone
2020-09-18T07:18:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatotropin,US brand name:,Genotropin
2020-10-14T05:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatropin,Acronym:,rhGH
2020-10-14T05:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatropin,Synonym:,recombinant human growth hormone
2020-10-14T05:13:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatropin,US brand name:,Genotropin
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,Code name:,LT1009
2020-09-18T03:59:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab,US brand name:,ASONEP
2020-09-18T09:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib,Code name:,LDE-225
2020-09-18T09:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib,Code name:,LDE225
2020-09-18T09:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib,Synonym:,erismodegib
2020-09-18T09:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib,Synonym:,smoothened antagonist LDE225
2020-09-18T09:49:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib,US brand name:,Odomzo
2020-10-14T13:05:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonolisib,Chemical structure:,"acetic acid (1S,4E,10R,11R,13S,14R)-[4-diallylaminomethylene-6-hydroxy-1-methoxymethyl-10,13-dimethyl-3,7,17-trioxo-1,3,4,7,10,11,12,13,14,15,16,17-dodecahydro-2-oxa-cyclopenta[a]phenanthren-11-yl ester"
2020-10-14T13:05:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonolisib,Code name:,PX-866
2020-09-18T09:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate,Chemical structure:,4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate tosylate
2020-09-18T09:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate,Code name:,BAY 43-9006 tosylate
2020-09-18T09:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate,Code name:,BAY 54-9085
2020-09-18T09:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate,Synonym:,sorafenib
2020-09-18T09:38:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate,US brand name:,Nexavar
2020-09-18T11:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorghum-bicolor-supplement,Foreign brand name:,Jobelyn
2020-09-18T11:44:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorghum-bicolor-supplement,Synonym:,sorghum bicolor extract
2020-09-18T11:44:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotagliflozin,Chemical structure:,"beta-l-xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, (5S)-"
2020-09-18T11:44:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotagliflozin,Code name:,LX4211
2020-09-18T11:44:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotagliflozin,Synonym:,LP 802034
2020-09-18T11:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotatercept,Code name:,ACE-011
2020-09-18T11:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotatercept,Synonym:,decoy activin receptor ACE-011
2020-09-18T11:44:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotatercept,Synonym:,soluble activin receptor Type IIa IgG-Fc fusion protein ACE-011
2020-10-14T13:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotorasib,Code name:,AMG 510
2020-10-14T13:21:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotorasib,Code name:,AMG510
2020-09-18T11:44:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotrastaurin-acetate,Chemical structure:,"3-(1H-indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4- yl)-1H-pyrrole-2,5-dione acetate"
2020-09-18T11:44:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotrastaurin-acetate,Code name:,AEB 071
2020-09-18T11:44:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotrastaurin-acetate,Code name:,AEB071
2020-10-14T04:59:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sovateltide,Code name:,SPI-1620
2020-09-18T09:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-isoflavones,Synonym:,soy phytoestrogens
2020-09-18T09:44:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-isoflavones,US brand name:,NovaSoy
2020-09-18T11:44:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-lecithin-glycerol-dioleate-based-oral-spray,Foreign brand name:,Episil
2020-09-18T11:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate,Synonym:,Isolated Soy Protein
2020-09-18T11:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate,Synonym:,Soybean Protein Isolate
2020-09-18T11:14:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate,US brand name:,Revival
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Code name:,HSC 835
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Code name:,HSC835
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Code name:,MGTA-456
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Code name:,MGTA456
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Synonym:,allogeneic UCB-derived HSPCs MGTA 456
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Synonym:,allogeneic umbilical cord blood-derived hematopoietic stem and progenitor cells MGTA-456
2020-10-14T13:22:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel,Synonym:,expanded umbilical cord blood product HSC835
2020-09-18T11:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sparfosic-acid,Abbreviation:,PALA
2020-09-18T11:45:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sparfosic-acid,Synonym:,sparfosate
2020-09-18T11:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spartalizumab,Code name:,PDR001
2020-09-18T11:45:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spartalizumab,Synonym:,anti-PD-1 monoclonal antibody PDR001
2020-10-14T04:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib,Code name:,AVL-292
2020-10-14T04:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib,Code name:,CC-292
2020-10-14T04:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib,Synonym:,Bruton's tyrosine kinase inhibitor AVL-292
2020-10-14T04:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib,Synonym:,Bruton's tyrosine kinase inhibitor CC-292
2020-10-14T04:32:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib,Synonym:,BTK inhibitor AVL-292
2020-10-14T12:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/specific-gravity,Foreign brand name:,Puri-Nethol
2020-10-14T12:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/specific-gravity,Foreign brand name:,Purinethol
2020-10-14T12:42:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/specific-gravity,Synonym:,mercaptopurine anhydrous
2020-09-18T11:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spherical-nucleic-acid-nanoparticle-nu-0129,Code name:,NU-0129
2020-09-18T11:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spherical-nucleic-acid-nanoparticle-nu-0129,Synonym:,SNA gold nanoparticle NU-0129
2020-09-18T11:45:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spherical-nucleic-acid-nanoparticle-nu-0129,Synonym:,SNA NU-0129
2020-09-18T09:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sphingosine-kinase-2-inhibitor-abc294640,Abbreviation:,SK2 inhibitor ABC294640
2020-09-18T09:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sphingosine-kinase-2-inhibitor-abc294640,Code name:,ABC294640
2020-09-18T09:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sphingosine-kinase-2-inhibitor-abc294640,Foreign brand name:,Yeliva
2020-09-18T09:56:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sphingosine-kinase-2-inhibitor-abc294640,Synonym:,sphingosine kinase-2 inhibitor ABC294640
2020-09-18T11:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium,Abbreviation:,SPG
2020-09-18T11:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium,Abbreviation:,Spiro-32
2020-09-18T11:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium,Chemical structure:,"2-[3-(dimethyl-amino)propyl]-8,8-diethyl-2-aza-8-germaspiro[4,5]decane8,8-diethyl-N,N-dimethyl-3-aza-8-germaspiro[4,5]decane-2-propanamine"
2020-09-18T11:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium,Code name:,S 99 A
2020-09-18T11:45:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium,Synonym:,Spirogermanium Compound
2020-09-18T11:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiromustine,Abbreviation:,SHM
2020-09-18T11:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiromustine,Chemical structure:,"1,3-diazaspiro(4,5)decane-2,4-dione,3-(2-(bis-chloroethyl)amino)ethyl"
2020-09-18T11:45:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiromustine,Synonym:,spirohydantoin mustard
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Abbreviation:,SPL
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Chemical structure:,"17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate"
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Code name:,SC 9420
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,Foreign brand name:,Spiroctan
2020-09-18T01:46:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone,US brand name:,Aldactone
2020-09-18T11:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiroplatin,Chemical structure:,"Cis-1,1-diamino-methylcyclohexane sulfato-platinum"
2020-09-18T11:45:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiroplatin,Code name:,TNO-6
2020-10-14T13:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirulina-based-dietary-supplement,Synonym:,blue-green algae supplement
2020-10-14T13:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirulina-based-dietary-supplement,Synonym:,spirulina-based supplement
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Code name:,TAK-659
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Code name:,TAK659
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Synonym:,syk inhibitor TAK-659
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Synonym:,syk inhibitor TAK659
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Synonym:,syk-inhibitor TAK-659
2020-09-18T11:45:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659,Synonym:,syk-Inhibitor TAK659
2020-09-18T11:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800,Code name:,H3B 8800
2020-09-18T11:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800,Code name:,H3B-8800
2020-09-18T11:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800,Synonym:,SF3B1 inhibitor H3B-8800
2020-09-18T11:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800,Synonym:,splicing factor inhibitor H3B-8800
2020-09-18T11:45:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800,Synonym:,splicing modulator H3B-8800
2020-10-14T13:22:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr-bp1-hsi-inhibitor-sr31747a,NA,NA
2020-09-18T11:46:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr-t100-gel,Code name:,SR-T100
2020-09-18T11:46:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr31747a,NA,NA
2020-09-18T11:46:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-abl-kinase-inhibitor-azd0424,Code name:,AZD0424
2020-09-18T11:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391,Code name:,KX01
2020-09-18T11:46:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391,Code name:,KX2-391
2020-09-18T11:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391-ointment,Code name:,KX2-391 ointment
2020-09-18T11:46:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391-ointment,Synonym:,KX2 391 ointment
2020-09-18T11:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-tubulin-inhibitor-kx02,Code name:,KX2-361
2020-09-18T11:46:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-tubulin-inhibitor-kx02,Synonym:,KX02
2020-09-18T11:46:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ss1dsfv-pe38-immunotoxin,Abbreviation:,SS1(dsFv) PE38
2020-10-14T13:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102,Code name:,CV 8102
2020-10-14T13:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102,Code name:,CV-8102
2020-10-14T13:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102,Code name:,CV8102
2020-10-14T13:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102,Synonym:,RNA-based adjuvant CV8102
2020-10-14T13:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102,US brand name:,RNAdjuvant
2020-09-18T11:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221,Code name:,BTP-277
2020-09-18T11:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221,Code name:,PEN 221
2020-09-18T11:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221,Code name:,PEN-221
2020-09-18T11:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221,Code name:,PEN221
2020-09-18T11:47:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221,Synonym:,SSTR2PEN-221
2020-09-18T11:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/st-johns-wort,Synonym:,Hypericum perforatum extract
2020-09-18T11:47:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/st-johns-wort,Synonym:,St. John's wort extract
2020-09-18T11:47:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stabilized-sulphur-hexafluoride-microbubble-based-contrast-agent,Foreign brand name:,SonoVue
2020-09-18T11:47:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/standardized-freeze-dried-table-grape-powder,NA,NA
2020-09-18T11:47:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stanford-v-regimen,Synonym:,Stanford V
2020-09-18T11:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/staphylococcus-aureus-protein-a,Synonym:,S. aureus protein A
2020-09-18T11:47:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/staphylococcus-aureus-protein-a,Synonym:,Staph. Protein A
2020-10-14T13:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stapuldencel-t,Synonym:,DCVAC/PCa
2020-10-14T04:47:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/starch-corn,Synonym:,"starch, corn"
2020-09-18T11:47:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat-inhibitor-opb-111077,Code name:,OPB-111077
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Code name:,AZD9150
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Code name:,ISIS 481464
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,Synonym:,STAT3 antisense oligonucleotide ISIS 481464
2020-09-18T05:52:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464,US brand name:,ISIS-STAT3rx
2020-09-18T11:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-decoy-oligonucleotide,Abbreviation:,STAT3 decoy
2020-09-18T11:47:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-decoy-oligonucleotide,Abbreviation:,STAT3 decoy ODN
2020-10-14T13:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-dsp-0337,Code name:,DSP 0337
2020-10-14T13:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-dsp-0337,Code name:,DSP-0337
2020-10-14T13:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-dsp-0337,Synonym:,cancer stemness inhibitor DSP-0337
2020-10-14T13:22:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-dsp-0337,Synonym:,napabucasin prodrug DSP-0337
2020-09-18T11:48:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-31121,Code name:,OPB-31121
2020-09-18T11:48:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-51602,Code name:,OPB-51602
2020-10-14T13:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-tti-101,Code name:,C188-9
2020-10-14T13:22:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-tti-101,Synonym:,STAT3 inhibitor XIII
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,Abbreviation:,d4T
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,Chemical structure:,"1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine2',3'-didehydro-3'-deoxythymidine3'-deoxy-2'-thymidinene"
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,Code name:,BMY-27857
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,Synonym:,didehydrodeoxythymidine
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,Synonym:,dideoxydidehydrothymidine
2020-09-18T11:48:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine,US brand name:,Zerit
2020-09-18T11:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/steroid-sulfatase-inhibitor-bn-83495,Abbreviation:,STS inhibitor BN 83495
2020-09-18T11:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/steroid-sulfatase-inhibitor-bn-83495,Code name:,BN 83495
2020-09-18T11:48:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/steroid-sulfatase-inhibitor-bn-83495,Code name:,STX 64
2020-09-18T11:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-adu-s100,Code name:,ADU-S100
2020-09-18T11:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-adu-s100,Code name:,MIW815
2020-09-18T11:49:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-adu-s100,Synonym:,CDN agonist ADU-S100
2020-10-14T13:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-miw815,Code name:,ADU-S100
2020-10-14T13:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-miw815,Code name:,MIW815
2020-10-14T13:23:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-miw815,Synonym:,CDN agonist ADU-S100
2020-10-14T13:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-bms-986301,Code name:,BMS 986301
2020-10-14T13:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-bms-986301,Code name:,BMS-986301
2020-10-14T13:23:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-bms-986301,Code name:,BMS986301
2020-10-14T13:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-gsk3745417,Code name:,GSK 3745417
2020-10-14T13:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-gsk3745417,Code name:,GSK-3745417
2020-10-14T13:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-gsk3745417,Code name:,GSK3745417
2020-10-14T13:23:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-gsk3745417,Synonym:,stimulator of interferon genes agonist GSK3745417
2020-10-14T13:23:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-imsa101,Code name:,IMSA 101
2020-10-14T13:23:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-imsa101,Code name:,IMSA-101
2020-10-14T13:23:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-imsa101,Code name:,IMSA101
2020-09-18T11:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-mk-1454,Code name:,MK 1454
2020-09-18T11:49:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-mk-1454,Code name:,MK-1454
2020-10-14T13:23:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-sb-11285,Code name:,SB 11285 (CN); SB-11285 (CN); SB11285
2020-10-14T13:23:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-sb-11285,Code name:,SB-11285
2020-10-14T13:23:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-sb-11285,Code name:,SB11285
2020-10-14T13:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-tak-676,Code name:,TAK 676
2020-10-14T13:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-tak-676,Code name:,TAK-676
2020-10-14T13:23:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-tak-676,Code name:,TAK676
2020-10-14T13:23:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-expressing-e-coli-synb1891,Code name:,SYNB 1891
2020-10-14T13:23:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-expressing-e-coli-synb1891,Code name:,SYNB-1891
2020-10-14T13:23:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-expressing-e-coli-synb1891,Code name:,SYNB1891
2020-10-14T13:23:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-expressing-e-coli-synb1891,Synonym:,STING-expressing Escherichia coli strain SYNB1891
2020-09-18T11:50:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strawberry-blackberry-black-raspberry-blueberry-berry-mixture,NA,NA
2020-10-14T13:23:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strawberry-blackberry-black-raspberry-blueberry-mixture,NA,NA
2020-09-18T11:50:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptavidin,NA,NA
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Abbreviation:,STN
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Chemical structure:,"5-Amino-6-(70-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic Acid5-Amino-6-(7-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methyl-2-pyridinecarboxylic Acid"
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Code name:,BA-163
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Code name:,PC-501
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Synonym:,Bruneomycin
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Synonym:,nigrin
2020-09-18T11:50:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin,Synonym:,Rufocromomycin
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Abbreviation:,STZ
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Abbreviation:,SZC
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Abbreviation:,SZN
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Chemical structure:,2-deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose2-deoxy-2-[[(methylnitrosamino)-carbonyl]amino]-D-glucopyranose
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Code name:,U-9889
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,Synonym:,streptozotocin
2020-09-18T11:50:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin,US brand name:,Zanosar
2020-09-18T09:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strontium-chloride-sr-89,Abbreviation:,Sr89
2020-09-18T09:04:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strontium-chloride-sr-89,US brand name:,Metastron
2020-09-18T11:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/su014813,NA,NA
2020-10-14T12:49:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension,Synonym:,sterile nanoparticle-based paclitaxel suspension
2020-10-14T12:49:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension,Synonym:,sterile nanoparticulate paclitaxel
2020-10-14T12:49:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension,Synonym:,submicron particle paclitaxel
2020-10-14T12:49:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension,Synonym:,submicron particle paclitaxel formulation
2020-10-14T12:49:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension,US brand name:,Nanopac
2020-09-18T11:50:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/substance-p-saporin,Abbreviation:,SP-SAP
2020-10-14T04:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer,Abbreviation:,DMSA
2020-10-14T04:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer,Chemical structure:,"Butanedioic Acid, 2,3-Dimercapto-, (2R,3S)-rel-"
2020-10-14T04:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer,Synonym:,"Meso 2, 3-Dimercaptosuccinic Acid"
2020-10-14T04:42:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer,US brand name:,Chemet
2020-10-14T03:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride,Chemical structure:,"Ethanaminium, 2,2'-((1,4-Dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-)"
2020-10-14T03:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride,Synonym:,Suxamethonium Chloride
2020-10-14T03:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride,US brand name:,Anectine
2020-10-14T03:32:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride,US brand name:,Quelicin
2020-09-18T11:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-citrate,Synonym:,Fentatienil
2020-09-18T11:51:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-citrate,US brand name:,Sufenta
2020-09-18T11:51:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-transdermal-system,Foreign brand name:,Sufentanil TDS
2020-09-18T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium,Code name:,Org 25969
2020-09-18T04:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium,US brand name:,Bridion
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,CS 1001
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,CS-1001
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,CS1001
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,WBP 3155
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,WBP-3155
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Code name:,WPB3155
2020-10-14T03:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab,Synonym:,anti-PD-L1 monoclonal antibody WBP 3155
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Chemical structure:,2-hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic acid
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Synonym:,salazosulfapyridine
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,Synonym:,sulphasalazine
2020-09-18T04:29:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine,US brand name:,Azulfidine
2020-10-14T04:30:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfate-based-laxative-bli850,NA,NA
2020-09-18T11:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfatinib,Code name:,HMPL-012
2020-09-18T11:51:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfatinib,Synonym:,surufatinib
2020-09-18T11:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane,Chemical structure:,1-Isothiocyanato-4-(methylsulfinyl)butane
2020-09-18T11:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane,Synonym:,(+/-)-sulforaphane
2020-09-18T11:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane,Synonym:,sulfaforaphane
2020-09-18T11:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane,Synonym:,sulforafan
2020-09-18T11:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane,Synonym:,sulphoraphane
2020-09-18T11:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01,Code name:,SFX-01
2020-09-18T11:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01,Foreign brand name:,Sulforadex
2020-09-18T11:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01,Synonym:,stabilized sulforaphane
2020-09-18T11:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01,Synonym:,sulforaphane-cyclodextrin complex
2020-09-18T11:51:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01,US brand name:,Sulforadex
2020-10-14T13:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex,Code name:,SFX-01
2020-10-14T13:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex,Foreign brand name:,Sulforadex
2020-10-14T13:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex,Synonym:,stabilized sulforaphane
2020-10-14T13:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex,Synonym:,sulforaphane-cyclodextrin complex
2020-10-14T13:23:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex,US brand name:,Sulforadex
2020-09-18T11:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride,Abbreviation:,SF6
2020-09-18T11:52:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride,Synonym:,hexafluorosulfur
2020-10-14T12:37:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride-lipid-microspheres,Synonym:,SF6 lipid microspheres
2020-10-14T12:37:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride-lipid-microspheres,Synonym:,sulfur hexafluoride lipid-type A microspheres
2020-10-14T12:37:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride-lipid-microspheres,US brand name:,Lumason
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Abbreviation:,SULIN
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Chemical structure:,(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acidcis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Code name:,MK-231
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Algocetil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Apo-Sulin
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Arthrocine
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Artribid
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Citireuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Clisundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Imbaral
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Novo-Sundac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumofil
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Reumyl
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sudac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulinol
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Foreign brand name:,Sulreuma
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,Synonym:,Sulindac Sulfoxide
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Aflodac
2020-09-18T01:43:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac,US brand name:,Clinoril
2020-09-18T11:52:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulofenur,Code name:,LY186641
2020-09-18T11:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumac-black-cumin-powder,Synonym:,persumac
2020-09-18T11:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumac-black-cumin-powder,Synonym:,persumac powder
2020-09-18T11:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumac-black-cumin-powder,Synonym:,Rhus coriaria L./Bunium persicum Boiss powder
2020-09-18T11:52:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumac-black-cumin-powder,Synonym:,sumac/black zira powder
2020-09-18T07:56:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumatriptan-succinate,US brand name:,Imitrex
2020-10-14T13:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumoylation-inhibitor-tak-981,Code name:,TAK 981
2020-10-14T13:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumoylation-inhibitor-tak-981,Code name:,TAK-981
2020-10-14T13:24:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumoylation-inhibitor-tak-981,Code name:,TAK981
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,Abbreviation:,SU11248
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,Chemical structure:,"5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)"
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,Code name:,SU011248
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,Code name:,SU11248
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,Synonym:,sunitinib
2020-09-18T11:52:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate,US brand name:,Sutent
2020-10-14T13:18:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suns-soup,Synonym:,Sun's soup
2020-09-18T11:52:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunscreen,NA,NA
2020-10-14T13:24:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/super-enhancer-inhibitor-gz17-602,Code name:,GZ17 6.02
2020-10-14T13:24:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/super-enhancer-inhibitor-gz17-602,Code name:,GZ17-6.02
2020-10-14T13:24:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/super-enhancer-inhibitor-gz17-602,Code name:,GZ176.02
2020-10-14T13:24:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/super-enhancer-inhibitor-gz17-602,Synonym:,synthetic Arum palaestinum derivative GZ17-6.02
2020-10-14T13:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/superoxide-dismutase-mimetic-gc4711,Code name:,GC 4711
2020-10-14T13:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/superoxide-dismutase-mimetic-gc4711,Code name:,GC-4711
2020-10-14T13:24:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/superoxide-dismutase-mimetic-gc4711,Synonym:,SOD mimetic GC4711
2020-09-18T05:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse,Foreign brand name:,Caphosol
2020-09-18T05:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse,US brand name:,Caphosol
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Chemical structure:,"8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-1,3,5-naphthalenetrisulfonic Acid hexasodium Salt"
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Code name:,CI-1003
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,309 F
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Belganyl
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Fourneau 309
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Germanin
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Moranyl
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Naganin
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Naganinum
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Naganol
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Foreign brand name:,Naphuride
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Synonym:,Antrypol
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Synonym:,sodium suramin
2020-09-18T11:53:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium,Synonym:,suramin hexasodium
2020-09-18T11:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-antigen,Abbreviation:,SRV
2020-09-18T11:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-antigen,Synonym:,survivin
2020-09-18T11:53:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-antigen-vaccine-dpx-survivac,Code name:,DPX-Survivac
2020-10-14T13:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-expressing-cvd908ssb-txsvn-vaccine,Code name:,CVD908ssb-TXSVN
2020-10-14T13:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-expressing-cvd908ssb-txsvn-vaccine,Code name:,TXSVN
2020-10-14T13:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-expressing-cvd908ssb-txsvn-vaccine,Synonym:,Salmonella-based survivin vaccine CVD908ssb-TXSVN
2020-09-18T11:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-mrna-antagonist-ezn-3042,Code name:,EZN-3042
2020-09-18T11:54:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-mrna-antagonist-ezn-3042,Synonym:,LNA-RNA antagonist EZN-3042
2020-09-18T11:54:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-p53-her2-antigen-loaded-autologous-dendritic-cell-vaccine,Synonym:,survivin/p53/HER2 antigen-loaded autologous DC vaccine
2020-09-18T11:54:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-sur1m2-peptide-vaccine,NA,NA
2020-09-18T11:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-exposure-dexamethasone-formulation-oto-104,Code name:,OTO-104
2020-09-18T11:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-exposure-dexamethasone-formulation-oto-104,Synonym:,dexamethasone sustained-exposure formulation OTO-104
2020-09-18T11:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-exposure-dexamethasone-formulation-oto-104,Synonym:,SR DXM formulation OTO-104
2020-09-18T11:54:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-exposure-dexamethasone-formulation-oto-104,Synonym:,sustained release dexamethasone formulation OTO-104
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Code name:,MP77-08
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Code name:,UGN-101
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Synonym:,RTgel with mitomycin C
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Synonym:,RTgel with MMC
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Synonym:,SR mitomycin C
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,Synonym:,sustained-release mitomycin C gel formulation
2020-09-18T09:12:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation,US brand name:,MitoGel
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Code name:,MP77-08
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Code name:,UGN-101
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Synonym:,RTgel with mitomycin C
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Synonym:,RTgel with MMC
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Synonym:,SR mitomycin C
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,Synonym:,sustained-release mitomycin C gel formulation
2020-10-14T12:44:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101,US brand name:,MitoGel
2020-09-18T11:54:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/svn53-67-m57-klh-peptide-vaccine,Synonym:,SurVaxM
2020-09-18T11:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-inhibitor-hmpl-523,Code name:,HMPL-523
2020-09-18T11:54:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-inhibitor-hmpl-523,Synonym:,spleen tyrosine kinase inhibitor HMPL-523
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Code name:,PRT062070
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Synonym:,Syk-JAK inhibitor PRT062070
2020-09-18T05:20:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070,Synonym:,Syk/JAK inhibitor PRT062070
2020-09-18T11:55:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synbiotic-supplement,Synonym:,prebiotic/probiotic supplement
2020-10-14T13:06:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-alkaloid-pm00104,US brand name:,Zalypsis
2020-09-18T11:55:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-brain-tumor-peptides-pulsed-autologous-dendritic-cell-vaccine,NA,NA
2020-09-18T11:55:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-breast-cancer-peptides-tetanus-toxoid-montanide-isa-51-vaccine,NA,NA
2020-09-18T11:55:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-breast-cancer-peptides-tetanus-toxoid-poly-iclc-vaccine,NA,NA
2020-09-18T11:55:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-colorectal-tumor-associated-peptides-vaccine-ima910,Code name:,IMA910
2020-09-18T11:56:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-glioblastoma-tumor-associated-peptides-vaccine-therapy-apvac1,Code name:,APVAC1
2020-09-18T11:56:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1400,Code name:,INO-1400
2020-10-14T13:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1401,Code name:,INO-1401
2020-10-14T13:25:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1401,Code name:,SynCon TERT
2020-09-18T11:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-papillomavirus-16-e6-peptide,Synonym:,HPV-16 E6
2020-09-18T11:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-papillomavirus-16-e6-peptide,Synonym:,HPV-16 E6 peptide
2020-09-18T11:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-papillomavirus-16-e6-peptide,Synonym:,HPV16 E6
2020-09-18T11:56:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-papillomavirus-16-e6-peptide,Synonym:,human papillomavirus 16 E6 peptide
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Abbreviation:,SHS
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Code name:,RG1068
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,Synonym:,secretin human
2020-09-18T05:24:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin,US brand name:,ChiRhoStim
2020-09-18T11:56:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-hypericin,Synonym:,topical SGX301
2020-09-18T11:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-e6-e7-peptides-vaccine-hpv-01,Code name:,ISA-HPV-01
2020-09-18T11:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-e6-e7-peptides-vaccine-hpv-01,Code name:,ISA101
2020-09-18T11:56:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-e6-e7-peptides-vaccine-hpv-01,Foreign brand name:,SLP-HPV-01
2020-10-14T13:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-hpv16-e6-e7-peptides-vaccine-isa101b,Code name:,ISA 101b
2020-10-14T13:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-hpv16-e6-e7-peptides-vaccine-isa101b,Code name:,ISA-101b
2020-10-14T13:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-hpv16-e6-e7-peptides-vaccine-isa101b,Code name:,ISA101b
2020-10-14T13:25:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-hpv16-e6-e7-peptides-vaccine-isa101b,Synonym:,HPV16 E6/E7-SLP ISA101b
2020-09-18T11:56:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-melanoma-associated-antigens-vaccine,NA,NA
2020-09-18T07:32:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-peptide-based-erythropoiesis-stimulating-agent,US brand name:,Hematide
2020-09-18T11:57:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-peptides-e-pra-and-e-psm-vaccine,Code name:,MKC-1106-PP
2020-10-14T13:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-plumbagin-pcur-101,Code name:,PCUR 101
2020-10-14T13:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-plumbagin-pcur-101,Code name:,PCUR-101
2020-10-14T13:25:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-plumbagin-pcur-101,Code name:,PCUR101
2020-09-18T11:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-tert-dna-vaccine-ino-1401,Code name:,INO-1401
2020-09-18T11:57:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-tert-dna-vaccine-ino-1401,Code name:,SynCon TERT
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Abbreviation:,SVP-R
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Code name:,SEL 110
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Code name:,SEL-110
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Code name:,SEL110
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Synonym:,SVP-rapa
2020-10-14T13:25:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin,Synonym:,SVP-rapamycin
2020-09-18T11:57:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t1e28z-car-expressing-autologous-cd4-positive-t-lymphocytes,Synonym:,4ab T1E28-positive T-cells
2020-10-14T04:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion,Synonym:,bacteriophage T4 endonuclease V in liposomal lotion
2020-10-14T04:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion,Synonym:,T4 endonuclease V liposomal lotion
2020-10-14T04:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion,Synonym:,T4N5 liposomal lotion
2020-10-14T04:53:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion,US brand name:,Dimericine
2020-09-18T11:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t900607,Synonym:,T607
2020-09-18T11:57:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t900607,Synonym:,T900607 sodium
2020-09-18T11:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabalumab,Code name:,LY2127399
2020-09-18T11:57:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabalumab,Synonym:,anti-BAFF monoclonal antibody LY2127399
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Abbreviation:,EBV-CTLs
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Code name:,ATA 129
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Code name:,ATA129
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Synonym:,allogeneic EBV-specific CTLs ATA129
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Synonym:,allogeneic EBV-specific cytotoxic T lymphocytes
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,Synonym:,CTLs ATA129
2020-10-14T13:25:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel,US brand name:,Tab-cel
2020-09-18T11:58:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tac-regimen,Synonym:,TAC
2020-09-18T11:58:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tac-regimen,Synonym:,Taxotere-Adriamycin-Cytoxan regimen
2020-09-18T11:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacedinaline,Chemical structure:,4-acetamido-N-(2-aminophenyl)benzamide
2020-09-18T11:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacedinaline,Code name:,CI-994
2020-09-18T11:58:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacedinaline,Synonym:,acetyldinaline
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,Chemical structure:,"hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone"
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,Code name:,FK 506
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,Foreign brand name:,Advagraf
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,Synonym:,fujimycin
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,US brand name:,Hecoria
2020-09-18T07:32:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus,US brand name:,Prograf
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,Chemical structure:,"(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione"
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,Code name:,Ic351
2020-09-18T05:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil,US brand name:,Cialis
2020-09-18T11:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafamidis-meglumine,Chemical structure:,"D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)D-gluco-2,3,4,5,6-pentahydroxy-N-methylhexan-1-aminium 2-(3,5-dichlorophenyl)benzoxazole-6-carboxylate"
2020-09-18T11:58:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafamidis-meglumine,Code name:,FX-1006A
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Code name:,MOR 00208
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Code name:,MOR-00208
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Code name:,MOR00208
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Code name:,XmAb5574
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Synonym:,"immunoglobulin, anti-(human Cd19 antigen) (human-mus musculus monoclonal MOR00208 heavy chain), disulfide with human-mus musculus monoclonal MOR00208 .kappa.-chain, dimer"
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,Synonym:,tafasitamab
2020-10-14T12:45:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab,US brand name:,Monjuvi
2020-10-14T13:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tag7-gene-modified-vaccine,Abbreviation:,GMV
2020-10-14T13:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tag7-gene-modified-vaccine,Synonym:,Tag-7 gene-modified inactivated tumor cell vaccine
2020-10-14T13:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tag7-gene-modified-vaccine,Synonym:,Tag-7 GMV
2020-10-14T13:25:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tag7-gene-modified-vaccine,Synonym:,Tag7 gene-modified inactivated tumor cell vaccine
2020-10-14T04:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs,Code name:,SL-401
2020-10-14T04:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs,Synonym:,diphtheria toxin(388)-interleukin-3 fusion protein
2020-10-14T04:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs,Synonym:,DT(388)IL3 fusion protein SL-401
2020-10-14T04:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs,Synonym:,IL3R-targeting fusion protein SL-401
2020-10-14T04:59:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs,US brand name:,Elzonris
2020-09-18T11:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talabostat-mesylate,Abbreviation:,Val-boro-Pro
2020-09-18T11:59:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talabostat-mesylate,Chemical structure:,[(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid methanesulfonate
2020-09-18T11:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talacotuzumab,Code name:,CSL362
2020-09-18T11:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talacotuzumab,Code name:,JNJ-56022473
2020-09-18T11:59:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talacotuzumab,Synonym:,anti-IL-3 receptor alpha monoclonal antibody CSL362
2020-09-18T11:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin,Abbreviation:,oral rhLF
2020-09-18T11:59:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin,Synonym:,oral recombinant human lactoferrin
2020-10-14T13:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin-alfa,Abbreviation:,oral rhLF
2020-10-14T13:25:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin-alfa,Synonym:,oral recombinant human lactoferrin
2020-09-18T11:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taladegib,Chemical structure:,4-Fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide
2020-09-18T11:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taladegib,Code name:,LY2940680
2020-09-18T11:59:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taladegib,Synonym:,Smo receptor-specific Hh signaling inhibitor LY2940680
2020-09-18T11:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talampanel,Code name:,GYKI-53773
2020-09-18T11:59:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talampanel,Synonym:,LY 300164
2020-09-18T11:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium,Abbreviation:,NPe6
2020-09-18T11:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium,Chemical structure:,mono-L-aspartyl chlorin e6
2020-09-18T11:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium,Code name:,LS11
2020-09-18T11:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium,Code name:,ME2906
2020-09-18T11:59:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium,Foreign brand name:,Laserphyrin
2020-09-18T11:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib,Code name:,BMN 673
2020-09-18T11:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib,Code name:,BMN-673
2020-09-18T11:59:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib,US brand name:,Talzenna
2020-10-14T13:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate,Code name:,BMN 673
2020-10-14T13:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate,Code name:,BMN-673
2020-10-14T13:25:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate,US brand name:,Talzenna
2020-09-18T11:29:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc,US brand name:,Sclerosol Intrapleural Aerosol
2020-09-18T11:29:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc,US brand name:,Sterile Talc Powder
2020-09-18T11:29:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc,US brand name:,Steritalc
2020-10-14T13:26:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid,Synonym:,plasmid HPV16/18 E6E7-targeting TALEN
2020-10-14T13:26:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid,Synonym:,TALEN-HPV16 E6/E7;TALEN-HPV18 E6/E7
2020-10-14T13:26:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid,Synonym:,TALEN-HPV16 E6/E7/TALEN-HPV18 E6/E7
2020-10-14T13:26:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid,Synonym:,TALEN-HPV16 E6/E7/TALEN-HPV18 E6/E7 plasmid
2020-10-14T13:26:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid,Synonym:,TALEN-mediated HPV16/18 E6/7 editing
2020-10-14T12:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taletrectinib,Code name:,AB-106
2020-10-14T12:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taletrectinib,Code name:,DS-6051
2020-10-14T12:52:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taletrectinib,Code name:,DS-6051b
2020-09-18T07:56:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec,Abbreviation:,T-VEC
2020-09-18T07:56:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec,Synonym:,GM-CSF-encoding oncolytic herpes simplex virus
2020-09-18T07:56:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec,US brand name:,Imlygic
2020-09-18T12:00:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talmapimod,Code name:,SCIO-469
2020-09-18T12:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talotrexin-ammonium,Chemical structure:,"2-(((4S)-4-carboxy-4-((4-(((2,4-diaminopteridin-6-yl)methyl)amino)benzoyl)amino)butyl)carbamoyl)benzoic acid monoammonium salt"
2020-09-18T12:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talotrexin-ammonium,Code name:,PT-523
2020-09-18T12:00:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talotrexin-ammonium,Code name:,PT523
2020-09-18T12:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taltirelin-hydrate,Chemical structure:,"(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide"
2020-09-18T12:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taltirelin-hydrate,Foreign brand name:,Ceredist
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Chemical structure:,"N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(4-fluorophenyl)-2,4-dioxo-1-propan-2-ylpyrimidine-5-carboxamide"
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,CEP 40783
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,CEP-40783
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,CEP40783
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,RXDX 106
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,RXDX-106
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Code name:,RXDX106
2020-10-14T13:26:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106,Synonym:,TYRO3/AXL/MER/c-Met inhibitor RXDX-106
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Chemical structure:,"4 [(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid"
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Code name:,Am-80
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Code name:,SY-1425
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Foreign brand name:,Amnoid
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Foreign brand name:,AMNOLAKE
2020-09-18T12:00:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene,Synonym:,retinobenzoic acid
2020-10-14T03:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taminadenant,Code name:,PBF-509
2020-10-14T03:23:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taminadenant,Synonym:,A2AR antagonist PBF-509
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Abbreviation:,TAM
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Chemical structure:,"(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-hydroxy-1,2,3-propanetricarboxylate (1:1)(Z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene"
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Code name:,"ICI 46,474"
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Code name:,ICI-46474
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Apo-Tamox
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Clonoxifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Dignotamoxi
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Ebefen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Emblon
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Estroxyn
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Fentamox
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Gen-Tamoxifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Genox
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Jenoxifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Kessar
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Ledertam
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Lesporene
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Nolgen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Noltam
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Nolvadex-D
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Nourytam
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Novo-Tamoxifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Novofen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Oestrifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Oncotam
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,PMS-Tamoxifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Soltamox
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamax
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamaxin
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamifen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamizam
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamofen
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Tamoxasta
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Foreign brand name:,Zemide
2020-09-18T12:00:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate,Synonym:,tamoxifeni citras
2020-10-14T03:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine,Code name:,SC 003
2020-10-14T03:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine,Code name:,SC-003
2020-10-14T03:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine,Code name:,SC003
2020-10-14T03:34:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine,Synonym:,ADC SC-003
2020-09-18T06:51:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamsulosin-hydrochloride,US brand name:,Flomax
2020-09-18T12:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tandutinib,Chemical structure:,"1-piperazinecarboxamide, 4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-"
2020-09-18T12:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tandutinib,Code name:,CT53518
2020-09-18T12:00:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tandutinib,Code name:,MLN518
2020-09-18T08:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin,Abbreviation:,17-AAG
2020-09-18T08:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin,Chemical structure:,17-allylamino-17-demethoxy-geldanamycin17-allyl-aminogeldanamycin17-demethoxy-17-(2-propenylamino)geldanamycin
2020-09-18T08:21:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin,US brand name:,KOS-953
2020-09-18T12:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanezumab,Code name:,RN624
2020-09-18T12:01:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanezumab,Synonym:,anti-NGF monoclonal antibody RN624
2020-09-18T12:01:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tangerine-tomato-juice,NA,NA
2020-09-18T12:01:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanibirumab,Code name:,TTAC-0001
2020-09-18T12:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanomastat,Chemical structure:,(S)-3-[(4'-chloro-4-biphenylyl)carbonyl]-2-[(phenylthio)methyl]propionic acid4-[4-(chlorophenyl)phenyl]-4-oxo-2S-(phenylthiomethyl) butanoic acid
2020-09-18T12:01:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanomastat,Code name:,BAY 12-9566
2020-10-14T13:26:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapentadol-hydrochloride,Code name:,CG5503 ER
2020-09-18T12:01:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapentadol-hydrochloride-er,Code name:,CG5503 ER
2020-10-14T12:41:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapotoclax,Code name:,AMG 176
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Chemical structure:,"(R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid"
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Code name:,E-7869
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Code name:,MPC-7869
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,Synonym:,R-flurbiprofen
2020-09-18T07:00:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil,US brand name:,Flurizan
2020-09-18T12:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarextumab,Code name:,OMP-59R5
2020-09-18T12:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarextumab,Synonym:,anti-notch receptor monoclonal antibody OMP-59R5
2020-09-18T12:01:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarextumab,Synonym:,MoAb OMP-59R5
2020-09-18T12:02:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tariquidar,Code name:,XR9576
2020-09-18T12:02:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarp-27-35-peptide-vaccine,NA,NA
2020-09-18T12:02:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarp-29-37-9v-peptide-vaccine,NA,NA
2020-09-18T12:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tas-108,Chemical structure:,"(7)-21-[4-[(diethylamino)methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol 2-hydroxy-1,2,3-propanetricarboxylate"
2020-09-18T12:02:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tas-108,Code name:,SR16234
2020-10-14T12:54:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasadenoturev,Code name:,DNX-2401
2020-10-14T12:54:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasadenoturev,Synonym:,DNX2401
2020-09-18T12:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taselisib,Code name:,GDC-0032
2020-09-18T12:02:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taselisib,Synonym:,PI3 kinase inhibitor GDC-0032
2020-09-18T12:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasisulam-sodium,Chemical structure:,"benzamide, N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-, sodium salt"
2020-09-18T12:02:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasisulam-sodium,Code name:,LY573636-sodium
2020-09-18T12:02:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasquinimod,Code name:,ABR-215050
2020-09-18T12:02:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurolidine,Chemical structure:,"Bis(1,1-dioxoperhydro-1,2,4-thiadiazinyl-4)-methane"
2020-09-18T12:02:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurolidine,Foreign brand name:,Taurolin
2020-10-14T13:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurultam-analogue-gp-2250,Code name:,GP 2250
2020-10-14T13:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurultam-analogue-gp-2250,Code name:,GP-2250
2020-10-14T13:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurultam-analogue-gp-2250,Code name:,GP2250
2020-10-14T13:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurultam-analogue-gp-2250,Synonym:,substance 2250
2020-10-14T13:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavokinogene-telseplasmid,Synonym:,IT-Tavo-EP
2020-10-14T13:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavokinogene-telseplasmid,Synonym:,plasmid IL-12 pUMVC3-hIL-12-NGVL3
2020-10-14T13:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavokinogene-telseplasmid,Synonym:,tavo
2020-10-14T03:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavolimab,Code name:,MEDI-0562
2020-10-14T03:54:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavolimab,Code name:,MEDI0562
2020-10-14T13:32:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taxane-analogue-tpi-287,NA,NA
2020-09-18T12:03:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taxol-analogue-sid-530,Code name:,SID 530
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Chemical structure:,"6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl EsterEthyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate"
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Code name:,AGN-190168
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Retisol-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Stieva-A Forte
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,Foreign brand name:,Vitinoin
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Avage
2020-09-18T04:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene,US brand name:,Tazorac
2020-09-18T12:03:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazemetostat,US brand name:,Tazverik
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Abbreviation:,Tc-99m MIBI
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Synonym:,technetium 99m sestamibi
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,Synonym:,technetium Tc 99m sestamibi
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,US brand name:,Cardiolite
2020-09-18T05:07:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi,US brand name:,Miraluma
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,"allogeneic alpha, beta TCR/CD19-depleted HPCs"
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,allogeneic TCRab/CD19-depleted hematopoietic stem cells
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCR alpha/beta/CD19-depleted HPCs
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCR alpha/beta+/CD19+ depleted ematopoietic progenitor cells
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCR alpha/beta+/CD19+ depleted HPCs
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCRab-/CD19-depleted allogeneic hematopoietic progenitor cells
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCRab-/CD19-depleted hematopoietic progenitor cells
2020-10-14T13:26:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells,Synonym:,TCRab+/CD19+-depleted haploidentical donor HPCs
2020-09-18T12:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-specific-alpha-fetoprotein-enhanced-autologous-t-lymphocytes,Abbreviation:,AFP-C332 T cells
2020-09-18T12:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-specific-alpha-fetoprotein-enhanced-autologous-t-lymphocytes,Synonym:,AFP-C332 CTLs
2020-09-18T12:04:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-specific-alpha-fetoprotein-enhanced-autologous-t-lymphocytes,Synonym:,anti-AFP TCR-expressing autologous CTLs
2020-10-14T12:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tebentafusp,Code name:,IMCgp100
2020-10-14T12:46:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tebentafusp,Synonym:,ImmTAC-gp100
2020-09-18T12:04:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-94m-sestamibi,NA,NA
2020-09-18T12:04:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99-hydrazinonicotinamide-tricine-linked-interleukin-2,Synonym:,99mTc-HYNIC-IL2
2020-09-18T12:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m,Synonym:,Tc 99m
2020-09-18T12:06:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m,Synonym:,technetium 99m
2020-09-18T12:05:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-3prgd2,Abbreviation:,99mTc-3PRGD2
2020-09-18T12:05:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-3prgd2,Synonym:,((99m)Tc-3PRGD2)
2020-09-18T12:05:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-3prgd2,Synonym:,(99m)Tc-PEG(4)-E[PEG(4)-c(RGDfK)](2)
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Abbreviation:,(99m)Tc-labeled MAA
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Abbreviation:,Tc 99m-labeled MAA
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Synonym:,(99m)Tc-labeled macroaggregated albumin
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Synonym:,Tc 99m-labeled macroaggregated albumin
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Synonym:,technetium Tc-99m albumin aggregated
2020-10-14T13:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated,Synonym:,technetium-99m-labeled albumin macroaggregates
2020-10-14T13:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-anti-her2-affibody,Synonym:,99mTc-ABH2
2020-10-14T13:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-anti-her2-affibody,Synonym:,HER2-targeting 99mTc-labeled affibody
2020-09-18T12:04:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-demobesin-4,Synonym:,99mTc demobesin-4
2020-09-18T12:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-dtpa,Abbreviation:,Tc-99m-DTPA
2020-09-18T12:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-dtpa,Abbreviation:,Tc-DTPA
2020-09-18T12:04:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-dtpa,Synonym:,99m-technetium diethylenetriaminepentaacetic acid
2020-09-18T12:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-ethylenedicysteine-deoxyglucose,Abbreviation:,99mTc-EC-DG
2020-09-18T12:05:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-ethylenedicysteine-deoxyglucose,Synonym:,99mTc-ethylenedicysteine-deoxyglucose
2020-09-18T12:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-galactosyl-human-serum-albumin,Synonym:,99MTc-GSA
2020-09-18T12:05:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-galactosyl-human-serum-albumin,Synonym:,Tc-99m GSA
2020-09-18T12:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-glycopeptide,Abbreviation:,99mTc-GP
2020-09-18T12:05:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-glycopeptide,Synonym:,99mTc-glycopeptide
2020-09-18T12:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid,Foreign brand name:,Nanocoll
2020-09-18T12:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid,Synonym:,99mTc-colloidal albumin
2020-09-18T12:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid,Synonym:,99mTc-labeled albumin nanocolloid
2020-09-18T12:05:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid,Synonym:,Tc-99m-labeled nanocolloid human serum albumin
2020-09-18T12:05:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-hydroxydiphosphonate,Abbreviation:,99mTc HDP
2020-09-18T12:05:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-hydroxydiphosphonate,Abbreviation:,Tc-99m hydroxydiphosphonate
2020-09-18T12:05:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-albumin-microspheres,Synonym:,(99m)Tc-labeled albumin microspheres
2020-09-18T12:05:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-albumin-microspheres,Synonym:,99mTc-labeled albumin microspheres
2020-09-18T12:05:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-albumin-microspheres,Synonym:,technetium-99m-labeled albumin microspheres
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Abbreviation:,(99m)Tc-labeled MAA
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Abbreviation:,Tc 99m-labeled MAA
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Synonym:,(99m)Tc-labeled macroaggregated albumin
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Synonym:,Tc 99m-labeled macroaggregated albumin
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Synonym:,technetium Tc-99m albumin aggregated
2020-09-18T12:05:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin,Synonym:,technetium-99m-labeled albumin macroaggregates
2020-09-18T12:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-rhenium-sulfide-nanocolloid,Foreign brand name:,Nanocis
2020-09-18T12:06:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-rhenium-sulfide-nanocolloid,Synonym:,99mTc-labeled rhenium sulfide nanocolloid
2020-09-18T08:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-tilmanocept,Synonym:,99mTc-diethylenetriamine pentaacetic acid-mannosyl-dextran
2020-09-18T08:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-tilmanocept,Synonym:,99mTc-DTPA-mannosyl-dextran
2020-09-18T08:49:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-tilmanocept,US brand name:,Lymphoseek
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,Abbreviation:,Tc 99m MEB
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,Abbreviation:,Tc 99m mebrofenin
2020-09-18T05:26:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin,US brand name:,Choletec
2020-10-14T13:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate,Abbreviation:,99mTc-MDP
2020-10-14T13:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate,Synonym:,technetium Tc 99m medronate
2020-10-14T13:27:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate,US brand name:,TechneScan MDP
2020-09-18T12:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-methylene-diphosphonate,Abbreviation:,99mTc-MDP
2020-09-18T12:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-methylene-diphosphonate,Synonym:,technetium Tc 99m medronate
2020-09-18T12:04:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-methylene-diphosphonate,US brand name:,TechneScan MDP
2020-09-18T12:06:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-nc100692,Synonym:,Tc-99m-NC100692
2020-10-14T04:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi,Abbreviation:,Tc-99m MIBI
2020-10-14T04:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi,Synonym:,technetium 99m sestamibi
2020-10-14T04:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi,Synonym:,technetium Tc 99m sestamibi
2020-10-14T04:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi,US brand name:,Cardiolite
2020-10-14T04:36:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi,US brand name:,Miraluma
2020-09-18T12:05:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sulfur-colloid,Abbreviation:,Tc-99m SC
2020-09-18T12:05:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sulfur-colloid,Synonym:,Tc 99m Sulfur Colloid
2020-09-18T12:06:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-tetrofosmin,Synonym:,technetium Tc 99m Tetrofosmin
2020-10-14T03:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab,Code name:,JNJ 64007957
2020-10-14T03:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab,Code name:,JNJ64007957
2020-10-14T03:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab,Synonym:,BCMA x CD3 bispecific antibody JNJ-64007957
2020-10-14T03:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab,Synonym:,BCMA x CD3 duobody antibody JNJ-64007957
2020-10-14T03:39:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab,Synonym:,humanized BCMA/CD3 duobody antibody JNJ-64007957
2020-09-18T12:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tecogalan-sodium,Abbreviation:,SP-PG
2020-09-18T12:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tecogalan-sodium,Code name:,DS-4152
2020-09-18T12:06:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tecogalan-sodium,Synonym:,Sulfated Polysaccharide Tecogalan DS-4152
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Abbreviation:,FT
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Chemical structure:,"5-fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione5-fluoro-1-(tetrahydro-2-furyl)-uracilN1-(2'-furanidyl)-5-fluorouracil"
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,FT-207
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,MJF-12264
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Code name:,WR-220066
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Citofur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Coparogin
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Exonal
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fental
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,ftorafur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoral
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Ftoralon
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulaid
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Fulfeel
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furafluor
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Furofutran
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Futraful
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lamar
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Lifril
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Neberk
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Nitobanil
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Riol
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sinoflurol
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Sunfural
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Tefsiel
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,Foreign brand name:,Utefos
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Florafur
2020-09-18T06:52:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur,US brand name:,Fluorofur
2020-09-18T12:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium,Foreign brand name:,Teysuno
2020-09-18T12:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium,Synonym:,S-1
2020-09-18T12:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium,US brand name:,TS-1
2020-09-18T12:06:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium,US brand name:,TS-ONE
2020-09-18T12:06:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium-leucovorin-calcium-oral-formulation,Code name:,TAS-118
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Abbreviation:,UFT
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Foreign brand name:,Uftoral
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Synonym:,oral fluorouracil-uracil
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Synonym:,Uracil and Ftorafur
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Synonym:,Uracil and Tegafur
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Synonym:,Uracil and Tetrahydrofuranyl-5-Fluorouracil
2020-09-18T12:07:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,Synonym:,Uracil/Tegafur (UFT)
2020-10-14T13:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint,Chemical structure:,"9,10-anthracenedione, 2,7-bis(((3R,5S)-3,5-dimethyl-1-piperidinyl)sulfonyl)-, 9,10-dioxime, rel-"
2020-10-14T13:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint,Code name:,BC 2059
2020-10-14T13:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint,Code name:,BC-2059
2020-10-14T13:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint,Code name:,BC2059
2020-10-14T13:27:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint,Synonym:,tegatrabetan
2020-09-18T12:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teglarinad-chloride,Code name:,GMX1777
2020-09-18T12:07:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teglarinad-chloride,Synonym:,apoptosis inducer GMX1777
2020-09-18T12:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teicoplanin,Synonym:,Teichomycin
2020-09-18T12:01:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teicoplanin,US brand name:,Targocid
2020-10-14T13:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaglenastat,Code name:,CB-839
2020-10-14T13:27:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaglenastat,Synonym:,glutaminase inhibitor CB-839
2020-09-18T07:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir,Code name:,LY-570310
2020-09-18T07:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir,Code name:,MP-424
2020-09-18T07:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir,Code name:,VRT-111950
2020-09-18T07:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir,Code name:,VX-950
2020-09-18T07:59:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir,US brand name:,Incivek
2020-09-18T10:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate,Chemical structure:,"(8S,11R,13S,14S,17R)-11-(4-(dimethylamino)phenyl)-17-(2-methoxyacetyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate"
2020-09-18T10:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate,Code name:,CDB-4124
2020-09-18T10:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate,Synonym:,progesterone receptor inhibitor CDB-4124
2020-09-18T10:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate,US brand name:,Proellex
2020-09-18T10:47:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate,US brand name:,Progenta
2020-09-18T12:07:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telatinib-mesylate,Chemical structure:,17-demethoxy-17-allylaminogeldanamycin mesylate
2020-09-18T12:07:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telavancin-hydrochloride,Code name:,TD-6424
2020-09-18T12:07:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telavancin-hydrochloride,Synonym:,"vancomycin, N(sup 3'')-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)-, monohydrochloride"
2020-09-18T12:07:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telavancin-hydrochloride,US brand name:,Vibativ
2020-09-18T12:07:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telbivudine,US brand name:,Tyzeka
2020-10-14T03:42:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab,Code name:,ABT-700
2020-10-14T13:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin,Code name:,ABBV 399
2020-10-14T13:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin,Code name:,ABBV-399
2020-10-14T13:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin,Code name:,ABT 399
2020-10-14T13:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin,Code name:,ABT-399
2020-10-14T13:27:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin,Synonym:,ABT-700-VCMMAE
2020-09-18T12:08:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-540-548-peptide-vaccine,Abbreviation:,TEL540-548
2020-09-18T12:08:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-540-548-peptide-vaccine,Synonym:,Telomerase:540-548 Peptide
2020-09-18T12:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-specific-type-5-adenovirus-obp-301,Code name:,OBP-301
2020-09-18T12:08:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-specific-type-5-adenovirus-obp-301,US brand name:,Telomelysin
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Code name:,LX1032
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Code name:,LX1606
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Synonym:,telotristat ethyl
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Synonym:,TPH inhibitor LX1606
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Synonym:,TPHI inhibitor LX1032
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,Synonym:,tryptophan hydroxylase inhibitor LX1032
2020-09-18T12:08:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate,US brand name:,Xermelo
2020-10-14T13:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochloride,Chemical structure:,"anthra(1,9-cd)pyrazol-6(2H)-one,7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino) dihydrochloride"
2020-10-14T13:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochloride,Code name:,CI-937
2020-10-14T13:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochloride,Code name:,DUP 937
2020-10-14T13:27:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochloride,Synonym:,moxantrazole hydrochloride
2020-09-18T12:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochoride,Chemical structure:,"anthra(1,9-cd)pyrazol-6(2H)-one,7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino) dihydrochloride"
2020-09-18T12:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochoride,Code name:,CI-937
2020-09-18T12:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochoride,Code name:,DUP 937
2020-09-18T12:08:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochoride,Synonym:,moxantrazole hydrochloride
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Code name:,3M 052
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Code name:,3M-052
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Code name:,MEDI 9197
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Code name:,MEDI9197
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Synonym:,TLR7/TLR8 dual agonist MEDI9197
2020-10-14T13:30:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod,Synonym:,Toll-like receptor 7/8 agonist MEDI9197
2020-09-18T12:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temoporfin,Abbreviation:,mTHPC
2020-09-18T12:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temoporfin,Chemical structure:,"5,10,15,20-tetra-(m-hydroxyphenyl)chlorinmeta-tetrahydroxyphenyl chlorinmeta-tetrahydroxyphenylchlorin"
2020-09-18T12:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temoporfin,Foreign brand name:,Foscan
2020-09-18T12:08:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temoporfin,Synonym:,m-tetrahydroxyphenyl-chlorin
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Abbreviation:,TMZ
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Chemical structure:,"3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-oneimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-"
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Code name:,CCRG-81045
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Code name:,M & B 39831
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Code name:,RP-46161
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Code name:,SCH 52365
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Foreign brand name:,Temcad
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Foreign brand name:,Temodal
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,Foreign brand name:,Temomedac
2020-09-18T12:08:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide,US brand name:,Temodar
2020-09-18T12:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus,Chemical structure:,42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin
2020-09-18T12:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus,Code name:,CCI-779
2020-09-18T12:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus,Synonym:,cell cycle inhibitor 779
2020-09-18T12:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus,Synonym:,rapamycin analog CCI-779
2020-09-18T12:09:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus,US brand name:,Torisel
2020-10-14T13:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib,Code name:,RP 6530
2020-10-14T13:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib,Code name:,RP-6530
2020-10-14T13:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib,Code name:,RP6530
2020-10-14T13:27:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib,Synonym:,PI3K delta/gamma inhibitor RP6530
2020-09-18T12:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenifatecan,Code name:,SN2310
2020-09-18T12:09:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenifatecan,Synonym:,tocopherol-conjugated camptothecin derivative SN2310
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Abbreviation:,EPT
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Abbreviation:,PTG
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Code name:,VM-26
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Foreign brand name:,Vehem
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Synonym:,Thenvlidene-Lignan-P
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Synonym:,Thenylidene-Lignan-P
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,Synonym:,VM26
2020-09-18T12:09:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide,US brand name:,Vumon
2020-09-18T12:09:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir,NA,NA
2020-09-18T12:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate,Abbreviation:,TDF
2020-09-18T12:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate,Chemical structure:,"9-((R)-2-((bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine, fumarate"
2020-09-18T12:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate,Synonym:,PMPA prodrug
2020-09-18T12:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate,Synonym:,tenofovir DF
2020-09-18T12:09:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate,US brand name:,Viread
2020-10-14T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab,Code name:,MCLA 117
2020-10-14T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab,Code name:,MCLA-117
2020-10-14T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab,Code name:,MCLA117
2020-10-14T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab,Synonym:,anti-CLEC12A x CD3 bispecific antibody MCLA117
2020-10-14T03:42:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab,Synonym:,bispecific antibody MCLA-117
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Code name:,R1507
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Code name:,RG1507
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Code name:,RO4858696-000
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Code name:,RV001
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Synonym:,anti-IGF-1 receptor human monoclonal antibody R1507
2020-09-18T12:09:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab,Synonym:,"immunoglobulin G1, anti-(human insulin-like growth factor I receptor)(human monoclonal heavy chain), disulfide with human monoclonal light chain, dimer"
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Abbreviation:,M4N
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Abbreviation:,tetra-O-methyl-NDGA
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Abbreviation:,TMNDGA
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Chemical structure:,"1,1'-(2,3-dimethyl-1,4-butanediyl)bis(3,4-dimethoxybenzene)"
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Code name:,EM-1421
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Synonym:,tetra-O-methyl nordihydroguaiaretic acid
2020-09-18T12:09:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol,Synonym:,tetramethylnordihydroguaiaretic acid
2020-09-18T12:09:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terephthalamidine,Chemical structure:,"1,4-Benzenedicarboximidamide"
2020-10-14T03:30:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tergenpumatucel-l,US brand name:,HyperAcute-Lung Cancer Vaccine
2020-10-14T13:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terlipressin,Synonym:,Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 disulfide)
2020-10-14T13:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terlipressin,Synonym:,N-(N-(N-glycylglycyl)glycyl)-8-L-lysinevasopressin
2020-10-14T13:27:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terlipressin,Synonym:,terlipressinum
2020-09-18T12:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teroxirone,Chemical structure:,"alpha-1,3,5-triglycidyl-s-triazinetrionealpha-TGIalpha-triglycidyl isocyanurate"
2020-09-18T12:10:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teroxirone,Synonym:,Henkel's Compound
2020-09-18T12:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tertomotide,Code name:,GV 1001
2020-09-18T12:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tertomotide,Code name:,GV-1001
2020-09-18T12:10:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tertomotide,Code name:,GV1001
2020-09-18T12:10:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesetaxel,Code name:,DJ-927
2020-09-18T12:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesevatinib,Code name:,KD019
2020-09-18T12:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesevatinib,Code name:,XL647
2020-09-18T12:10:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesevatinib,Synonym:,receptor tyrosine kinase inhibitor XL647
2020-09-18T12:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone,Abbreviation:,TL
2020-09-18T12:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone,Code name:,SQ-9538
2020-09-18T12:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone,Synonym:,Fludestrin
2020-09-18T12:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone,Synonym:,therapeutic testolactone
2020-09-18T12:10:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone,US brand name:,Teslac
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Chemical structure:,17beta-cyclopentanepropionate
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Depovirin
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,Foreign brand name:,Pertestis
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,depAndro
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depo-Testosterone
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Depotest
2020-09-18T05:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate,US brand name:,Virilon
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,Foreign brand name:,Androtardyl
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,Foreign brand name:,Testinon
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,Foreign brand name:,Testo-Enant
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,US brand name:,Andro LA
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,US brand name:,Delatestryl
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,US brand name:,Everone
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,US brand name:,Primosteston
2020-10-14T03:32:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate,US brand name:,Testate
2020-09-18T02:05:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-gel,US brand name:,AndroGel
2020-09-18T12:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate,Foreign brand name:,Andriol
2020-09-18T12:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate,Foreign brand name:,Pantestone
2020-09-18T12:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate,Foreign brand name:,Restandol
2020-09-18T12:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate,Synonym:,injectable testosterone undecanoate
2020-09-18T12:10:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate,Synonym:,testosterone 17beta-undecylate
2020-09-18T12:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-vaginal-cream,NA,NA
2020-09-18T12:11:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-cmv-fusion-peptide-vaccine,NA,NA
2020-09-18T12:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-peptide-melanoma-vaccine,Abbreviation:,Tet p
2020-09-18T12:11:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid,Abbreviation:,TETTOX
2020-09-18T12:11:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid-helper-peptide,Abbreviation:,TET TOX PEP VAC
2020-10-14T13:28:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid-vaccine,Abbreviation:,TETTOX
2020-10-14T13:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetmyb-dna-vaccine,Abbreviation:,TetMYB
2020-10-14T13:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetmyb-dna-vaccine,Synonym:,DNA vaccine TetMYB
2020-10-14T13:28:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetmyb-dna-vaccine,Synonym:,DNA-based TetMYB vaccine
2020-09-18T12:11:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-antibiotic,Synonym:,Tetracycline Antibiotics
2020-09-18T12:11:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-antibiotic,Synonym:,Tetracyclines
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,Chemical structure:,"(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride"
2020-09-18T01:18:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride,US brand name:,Achromycin
2020-09-18T12:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate,Abbreviation:,PMA
2020-09-18T12:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate,Abbreviation:,TPA
2020-09-18T12:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate,Chemical structure:,12-O-tetradecanoylphorbol-13-acetate
2020-09-18T12:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate,Synonym:,Lonomycin
2020-09-18T12:11:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate,Synonym:,Phorbol Myristate Acetate
2020-09-18T12:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrahydrouridine,Abbreviation:,THU
2020-09-18T12:12:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrahydrouridine,Chemical structure:,"2(1H)-pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl-"
2020-09-18T12:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetraphenyl-chlorin-disulfonate,Code name:,TPCS2a
2020-09-18T12:12:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetraphenyl-chlorin-disulfonate,Foreign brand name:,Amphinex
2020-09-18T12:12:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetravalent-rna-lipoplex-cancer-vaccine,Code name:,RB_0003-01
2020-09-18T12:12:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetravalent-rna-lipoplex-cancer-vaccine,Synonym:,Lipo-MERIT
2020-09-18T12:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrodotoxin,Abbreviation:,TTX
2020-09-18T12:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrodotoxin,Foreign brand name:,Tectin
2020-09-18T12:06:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrodotoxin,US brand name:,Tectin
2020-09-18T12:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tezacitabine,Abbreviation:,FMdC
2020-09-18T12:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tezacitabine,Chemical structure:,(E)-2'-deoxy-2'-(fluoromethylene)cytidine
2020-09-18T12:12:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tezacitabine,Code name:,"MDL 101,731"
2020-10-14T13:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-sh3051,Code name:,SH 3051
2020-10-14T13:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-sh3051,Code name:,SH-3051
2020-10-14T13:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-sh3051,Code name:,SH3051
2020-10-14T13:28:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-sh3051,Synonym:,TGFbR1 inhibitor SH3051
2020-10-14T13:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-yl-13027,Code name:,YL 13027
2020-10-14T13:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-yl-13027,Code name:,YL-13027
2020-10-14T13:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-yl-13027,Code name:,YL13027
2020-10-14T13:28:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-yl-13027,Synonym:,YTGFbR1 inhibitor YL-13027
2020-09-18T12:13:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-resistant-lmp-specific-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,Abbreviation:,TP-38
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,Synonym:,TP-38
2020-09-18T05:21:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin,US brand name:,Cervene
2020-09-18T12:12:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbdnrii-transduced-autologous-tumor-infiltrating-lymphocytes,Synonym:,TGFbDNRII-transduced autologous TILs
2020-09-18T12:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-inhibitor-ly3200882,Code name:,LY 3200882
2020-09-18T12:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-inhibitor-ly3200882,Code name:,LY3200882
2020-09-18T12:12:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-inhibitor-ly3200882,Synonym:,TGFb inhibitor LY 3200882
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Code name:,AVID 200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Code name:,AVID-200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Code name:,AVID200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Synonym:,TGF-beta 1/3 inhibitor AVID200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Synonym:,TGFb inhibitor AVID200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Synonym:,TGFbeta ligand trap AVID200
2020-10-14T13:28:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200,Synonym:,TGFbeta-neutralizing agent AVID200
2020-09-18T12:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalicarpine,Synonym:,taliblastine
2020-09-18T12:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalicarpine,Synonym:,thaliblastine
2020-09-18T12:13:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalicarpine,Synonym:,thalicarpin
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Abbreviation:,THAL
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Chemical structure:,"2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione2,6-dioxo-3-phthalimidopiperidine3-phthalimidoglutarimideN-(2,6-dioxo-3-piperidyl)phthalimide"
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Contergan
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Distaval
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Kevadon
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Neurosedyn
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Pantosediv
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Sedoval K-17
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Softenon
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Foreign brand name:,Talimol
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Synonym:,alpha-phthalimidoglutarimide
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Synonym:,N-phthaloylglutamimide
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,Synonym:,N-phthalylglutamic acid imide
2020-09-18T12:13:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide,US brand name:,Thalomid
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Chemical structure:,"1,3-dimethylxanthine monohydrate3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrate"
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,Synonym:,theophylline monohydrate
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Constant-T
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Elixophyllin
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,LaBID
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Respbid
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-bid
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Slo-Phyllin
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-CRT
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Somophyllin-T
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,T-Phyl
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theo-24
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theobid Duracap
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Theochron
2020-09-18T05:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline,US brand name:,Uniphyl
2020-09-18T12:13:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-allogeneic-cytotoxic-t-lymphocytes,Abbreviation:,therapeutic allogeneic CTLs
2020-09-18T12:13:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-allogeneic-lymphocytes,Abbreviation:,ALLOLYMPH
2020-09-18T12:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-angiotensin-1-7,Abbreviation:,therapeutic Ang-(1-7)
2020-09-18T12:14:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-angiotensin-1-7,Code name:,TXA127
2020-09-18T12:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-dendritic-cells,Abbreviation:,ADC
2020-09-18T12:14:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-dendritic-cells,Synonym:,autologous dendritic cells
2020-09-18T12:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-lymphocytes,Abbreviation:,AL
2020-09-18T12:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-lymphocytes,Synonym:,Autologous Lymphocytes
2020-09-18T12:14:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-lymphocytes,Synonym:,autologous T cells
2020-09-18T12:14:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-breast-ovarian-prostate-cancer-vaccine-dpx-0907,Code name:,DPX-0907
2020-10-14T13:28:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-breast-ovarian-prostate-peptide-cancer-vaccine-dpx-0907,Code name:,DPX-0907
2020-10-14T13:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-cancer-vaccine-atp128,Code name:,ATP 128
2020-10-14T13:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-cancer-vaccine-atp128,Code name:,ATP-128
2020-10-14T13:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-cancer-vaccine-atp128,Code name:,ATP128
2020-10-14T13:28:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-cancer-vaccine-atp128,Synonym:,Z12-multiE/TLR agonist domain ATP128
2020-09-18T12:14:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-dendritic-cells-cytokine-induced-killer-cells,Abbreviation:,DC-CIK
2020-09-18T12:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-epinephrine,Abbreviation:,epi
2020-09-18T12:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-epinephrine,Synonym:,adrenaline
2020-09-18T12:14:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-epinephrine,Synonym:,epinephrine
2020-09-18T12:14:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estetrol,Code name:,therapeutic E4
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Abbreviation:,ESDL
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Chemical structure:,"(17beta)-estra-1,3,5(10)-triene-3,17-diol"
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Dimenformon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogyn
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Diogynets
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Ovocylin
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Foreign brand name:,Progynon
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,17 beta-estradiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,Synonym:,Estraldine
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Aquadiol
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Estrace
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vagifem
2020-09-18T03:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol,US brand name:,Vivelle
2020-10-14T13:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-expanded-allogeneic-gamma-delta-t-cells,Foreign brand name:,OmnImmune
2020-10-14T13:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-expanded-allogeneic-gamma-delta-t-cells,Synonym:,ex-vivo expanded allogeneic gd T lymphocytes
2020-10-14T13:28:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-expanded-allogeneic-gamma-delta-t-cells,Synonym:,"therapeutic ex vivo-expanded allogeneic gamma, delta T cells"
2020-10-14T13:28:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-treated-autologous-central-memory-t-cells,Synonym:,autologous Tcm cells
2020-09-18T12:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-gamma-delta-t-lymphocytes,Synonym:,gammadelta T cells
2020-09-18T12:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-gamma-delta-t-lymphocytes,Synonym:,gd T cells
2020-09-18T12:14:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-gamma-delta-t-lymphocytes,Synonym:,γδ T cells
2020-09-18T10:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hemin,US brand name:,Panhematin
2020-10-14T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin,Abbreviation:,HCIG
2020-10-14T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin,Synonym:,anti-HCV immunoglobulin
2020-10-14T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin,US brand name:,Biotest-HCIG
2020-10-14T04:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin,US brand name:,Civacir
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Abbreviation:,ATIII
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Synonym:,antithrombin
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Synonym:,antithrombin III
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Synonym:,antithrombin-III
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Synonym:,AT-III (human)
2020-09-18T12:15:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii,Synonym:,human AT-III
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Abbreviation:,HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Chemical structure:,"(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione"
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Barseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Cortifan
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,cortisol
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Domolene
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,Synonym:,Komed-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Aeroseb-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Barseb HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cetacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cort-Dome
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortef
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortenema
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortispray
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Cortril
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Dermacort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Domolene-HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Eldecort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hydrocortone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Hytone
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Komed HC
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Nutracort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Proctocort
2020-09-18T01:41:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone,US brand name:,Rectoid
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Abbreviation:,IG
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Abbreviation:,IgIV
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,immune globulin intravenous
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,immune globulin IV
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,Synonym:,therapeutic immunoglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,BayGam
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gamimune N
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gammagard S/D
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Gammar-P
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Iveegam EN
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Panglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Polygam S/D
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Sandoglobulin
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Venoglobulin-I
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,Venoglobulin-S
2020-09-18T04:32:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin,US brand name:,WinRho SDF
2020-09-18T12:15:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-insulin,NA,NA
2020-10-14T13:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-invariant-natural-killer-t-cells,Synonym:,therapeutic iNK T cells
2020-10-14T13:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-invariant-natural-killer-t-cells,Synonym:,therapeutic iNKT
2020-10-14T13:29:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-invariant-natural-killer-t-cells,Synonym:,therapeutic iNKT cells
2020-10-14T13:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-liver-cancer-peptide-vaccine-ima970a,Code name:,IMA970A
2020-10-14T13:29:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-liver-cancer-peptide-vaccine-ima970a,Synonym:,HCC vaccine IMA970A
2020-09-18T06:39:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-lotion,US brand name:,Eucerin
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,Abbreviation:,MLT
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,Foreign brand name:,melaxen
2020-09-18T05:28:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin,US brand name:,Circadin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Abbreviation:,PRG
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Chemical structure:,"delta4-pregnene-3,20-dione"
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Corlutina
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Corluvite
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Cyclogest
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Gestiron
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Gestone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocyclin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocylin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutocylin M
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutogyl
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Lutromone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestasert
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progesterol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestogel
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progestol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Progeston
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Prolidon
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Syngesterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Foreign brand name:,Utrogestan
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,Synonym:,progesterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Colprosterone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Gesterol 100
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Lipo-Lutin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Lucorteum Sol
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Luteohormone
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Progestin
2020-09-18T05:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone,US brand name:,Prolutin
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,Chemical structure:,(17beta)-17-hydroxyandrost-4-en-3-onedelta4-androsten-17beta-ol-3-one
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,Foreign brand name:,Mertestate
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,Foreign brand name:,Virosterone
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,Synonym:,Testosterone
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,Synonym:,trans-testosterone
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,US brand name:,Testoderm
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,US brand name:,Testolin
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,US brand name:,Testostroval
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,US brand name:,Testostroval-PA
2020-09-18T12:10:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone,US brand name:,Testro AQ
2020-09-18T12:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-triiodothyronine,Abbreviation:,Therapeutic T3
2020-09-18T12:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-triiodothyronine,Synonym:,L-Triiodothyronine
2020-09-18T12:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-triiodothyronine,Synonym:,Liothyronine
2020-09-18T12:15:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-triiodothyronine,Synonym:,Triiodothyronine
2020-09-18T12:16:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-tumor-infiltrating-lymphocytes,Synonym:,tumor infiltrating lymphocytes
2020-09-18T09:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole,Abbreviation:,TBZ
2020-09-18T09:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole,Code name:,MK-360
2020-09-18T09:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole,US brand name:,Mintezol
2020-09-18T09:11:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole,US brand name:,Thibenzole
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Abbreviation:,vit B1
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Chemical structure:,"2-[3-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-1-thia-3-azoniacyclopenta-2,4-dien-5-yl]ethanol"
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Synonym:,aneurin
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Synonym:,B1 vitamin
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Synonym:,thiamin
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Synonym:,vitamin B1
2020-09-18T12:16:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine,Synonym:,vitamin-B1
2020-09-18T12:16:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiarabine,Chemical structure:,4′-thio-ara-C4′-thio-beta-D-arabinofuranosylcytosine
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Abbreviation:,6-TG
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Abbreviation:,TG
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Code name:,BW 5071
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Code name:,Wellcome U3B
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Code name:,WR-1141
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Code name:,X 27
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Foreign brand name:,Lanvis
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Synonym:,tioguanin
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,Synonym:,tioguanine
2020-09-18T11:58:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine,US brand name:,Tabloid
2020-09-18T12:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioredoxin-1-inhibitor-px-12,Chemical structure:,1-methylpropyl 2-imidazolyl disulfide
2020-09-18T12:16:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioredoxin-1-inhibitor-px-12,Code name:,PX-12
2020-09-18T09:01:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioridazine-hydrochloride,US brand name:,Mellaril
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Abbreviation:,TSPA
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Chemical structure:,"1,1',1""-phosphinothioylidynetrisaziridine1,1',1''-phosphinothioyldynetrisaziridineN,N',N''-triethylenethiophosphoramidetris(1-aziridinyl)phosphine sulfide"
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Code name:,WR 45312
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Foreign brand name:,tepadina
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Synonym:,thiofosfamide
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Synonym:,thiophosphamide
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Synonym:,thiophosphoramide
2020-09-18T12:16:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa,Synonym:,triethylene thiophosphoramide
2020-09-18T08:20:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioureidobutyronitrile,US brand name:,Kevetrin
2020-09-18T12:17:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thl-p,NA,NA
2020-10-14T13:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab,Code name:,BAY 2287411
2020-10-14T13:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab,Code name:,BAY2287411
2020-10-14T13:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab,Synonym:,thorium Th 227-antibody-chelator conjugate BAY2287411
2020-10-14T13:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab,Synonym:,thorium-227-labeled anetumab
2020-10-14T13:29:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab,Synonym:,thorium-227-labeled antibody-chelator conjugate BAY2287411
2020-09-18T12:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/threonine-tyrosine-kinase-inhibitor-cfi-402257,Chemical structure:,"N-cyclopropyl-4-(7-((((1s,3s)-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(pyridin-2-yloxy)pyrazolo[1,5-a]pyridin-3-yl)-2-methylbenzamide"
2020-09-18T12:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/threonine-tyrosine-kinase-inhibitor-cfi-402257,Code name:,CFI-402257
2020-09-18T12:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/threonine-tyrosine-kinase-inhibitor-cfi-402257,Synonym:,MPS1 inhibitor CFI-402257
2020-09-18T12:17:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/threonine-tyrosine-kinase-inhibitor-cfi-402257,Synonym:,TTK inhibitor CFI-402257
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Abbreviation:,Tma
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Code name:,ART 123
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Code name:,ART-123
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Synonym:,1-498-thrombomodulin (human clone TMP26/TMJ1 protein moiety reduced)
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Synonym:,recomodulin
2020-09-18T12:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa,Synonym:,thrombomodulin (human 498-amino acid fragment)
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Abbreviation:,dT
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Abbreviation:,DThyd
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Abbreviation:,TDR
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Synonym:,2'-deoxythymidine
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Synonym:,thymidin
2020-09-18T12:17:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine,Synonym:,thymidine deoxyriboside
2020-10-14T13:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106,Code name:,CX 1106
2020-10-14T13:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106,Code name:,CX-1106
2020-10-14T13:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106,Code name:,CX1106
2020-10-14T13:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106,Synonym:,TS inhibitor CX1106
2020-10-14T13:29:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106,Synonym:,TSI CX1106
2020-09-18T12:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-dfp-11207,Code name:,DFP-11207
2020-09-18T12:17:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-dfp-11207,Synonym:,TS inhibitor DFP-11207
2020-09-18T07:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin,Chemical structure:,N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-tyrosine
2020-09-18T07:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin,Foreign brand name:,Mepentil
2020-09-18T07:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin,Foreign brand name:,Sintomodulina
2020-09-18T07:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin,Foreign brand name:,Timunox
2020-09-18T07:58:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin,US brand name:,Immunox
2020-09-18T12:18:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thyroxine,Synonym:,T4
2020-09-18T11:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiazofurin,Abbreviation:,TCAR
2020-09-18T11:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiazofurin,Chemical structure:,2-beta-D-ribofuranosyl-4-thiazolecarboxamide2-beta-D-ribofuranosylthiazole-4-carboxamide
2020-09-18T11:16:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiazofurin,US brand name:,Riboxamide
2020-09-18T12:18:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tibolone,Foreign brand name:,Livial
2020-09-18T12:18:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tibolone,Foreign brand name:,Xyvion
2020-10-14T03:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tidutamab,Code name:,XmAb 18087
2020-10-14T03:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tidutamab,Code name:,XmAb-18087
2020-10-14T03:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tidutamab,Code name:,XmAb18087
2020-10-14T03:59:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tidutamab,Synonym:,anti-SSTR2 x anti-CD3 monoclonal antibody XmAb18087
2020-09-18T12:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigapotide,Code name:,PCK3145
2020-09-18T12:18:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigapotide,Synonym:,prostate-secretory protein-94-derived synthetic peptide PCK3145
2020-09-18T12:18:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigatuzumab,Code name:,CS-1008
2020-09-18T12:18:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigatuzumab,Synonym:,Anti-DR5 MoAb
2020-09-18T12:18:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigatuzumab,Synonym:,Anti-TRAIL-R2 MoAb
2020-09-18T12:19:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigecycline,US brand name:,Tygacil
2020-09-18T12:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684,Code name:,MK 7684
2020-09-18T12:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684,Code name:,MK-7684
2020-09-18T12:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684,Code name:,MK7684
2020-09-18T12:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684,Synonym:,T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif inhibitor MK-7684
2020-09-18T12:19:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684,Synonym:,TIGIT inhibitor MK-7684
2020-09-18T12:19:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/til-1383i-t-cell-receptor-transduced-autologous-t-cells,Synonym:,TIL 1383I TCR transduced autologous T cells
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Abbreviation:,L-NMMA
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Abbreviation:,NMA
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Synonym:,N-methylarginine
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Synonym:,N5-(methylamidino)-L-ornithine
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Synonym:,NG-monomethyl-L-arginine
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Synonym:,omega-N-monomethylarginine
2020-10-14T13:29:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine,Synonym:,targinine
2020-10-14T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab,Chemical structure:,immunoglobulin G1 anti-(human interleukin-23) humanized mouse monoclonal gamma1 heavy chain (219-214')-disulfide with humanized mouse monoclonal kappa light chain dimer (225-225'':228-228'')-bisdisulfide
2020-10-14T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab,Code name:,MK-3222
2020-10-14T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab,Synonym:,"immunoglobulin G1, anti-(human interleukin 23) (human-Mus musculus monoclonal heavy chain), disulfide with human-Mus musculus monoclonal light chain, dimer"
2020-10-14T05:23:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab,US brand name:,Iluyma
2020-10-14T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab,Code name:,GEN 1029
2020-10-14T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab,Code name:,GEN1029
2020-10-14T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab,Synonym:,HexaBody-DR5-01/DR5-05
2020-10-14T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab,Synonym:,HexaBody-DR5/DR5
2020-10-14T04:55:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab,Synonym:,Hx-DR5-01/05
2020-10-14T13:31:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium,Code name:,IMO 2125
2020-10-14T13:31:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium,Code name:,IMO-2125
2020-10-14T13:31:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium,Synonym:,TLR9 agonist IMO-2125
2020-09-18T12:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timolol-maleate-gel-forming-solution,Chemical structure:,"(-)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate (1:1) (salt)"
2020-09-18T12:19:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timolol-maleate-gel-forming-solution,US brand name:,Timoptic-XE
2020-09-18T12:19:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timonacic,Chemical structure:,"1,3-thiazolidine-4-carboxylic acid"
2020-10-14T13:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin,Abbreviation:,SnET2
2020-10-14T13:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin,Chemical structure:,"tin, (ethyl tetramethyl-20-phorbinecarboxylato(2-)-N23,N24,N25,N26)-, (SP-4-2)"
2020-10-14T13:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin,Synonym:,tin ethyl etiopurpurin
2020-10-14T13:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin,Synonym:,tin etiopurpurin
2020-10-14T13:10:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin,US brand name:,Purlytin
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,Abbreviation:,TDZ
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,Foreign brand name:,Simplotan
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,US brand name:,Fasigyn
2020-09-18T06:45:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole,US brand name:,Tindamax
2020-10-14T13:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine,Chemical structure:,7-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)-N-hydroxyheptanamide
2020-10-14T13:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine,Code name:,EDO-S 101
2020-10-14T13:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine,Code name:,EDO-S-101
2020-10-14T13:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine,Code name:,EDO-S101
2020-10-14T13:29:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine,Synonym:,bendamustine-vorinostat fusion molecule EDO-S101
2020-09-18T08:05:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinzaparin-sodium,US brand name:,Innohep
2020-09-18T12:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium,Abbreviation:,ammonium TM
2020-09-18T12:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium,Abbreviation:,ATM
2020-09-18T12:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium,Abbreviation:,ATTM
2020-09-18T12:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium,Synonym:,ammonium tetrathiomolybdate
2020-09-18T12:20:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium,Synonym:,tetrathiomolybdate
2020-09-18T11:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiotropium-bromide-monohydrate,Chemical structure:,"1,4-Dihydro-3,5-Diiodo-1-Methyl-4-Oxopyridine-2,6-Dicarboxylic Acid6.Beta.,7.Beta.-Epoxy-3.Beta.-Hydroxy-8-Methyl-1.Alpha.H,5.Alpha.H-Tropanium Bromide, Di-2-Thienylglycolate Monohydrate"
2020-09-18T11:45:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiotropium-bromide-monohydrate,US brand name:,Spiriva
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,R3484
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,RG3484
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,RO5217790
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,TG 4001
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,TG-4001
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Code name:,TG4001
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Synonym:,HPV16 E6/E7-encoding MVA vaccine TG4001
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Synonym:,MVA-HPV-IL2
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Synonym:,MVA-HPV16E6/E7-IL2
2020-10-14T12:49:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec,Synonym:,recombinant vaccinia viral vector RO5217790
2020-09-18T12:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib,Chemical structure:,(+)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone
2020-09-18T12:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib,Code name:,R115777
2020-09-18T12:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib,US brand name:,Zarnestra
2020-09-18T12:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirabrutinib,Code name:,ONO-4059
2020-09-18T12:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirabrutinib,Synonym:,Bruton's tyrosine kinase inhibitor ONO-4059
2020-09-18T12:20:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirabrutinib,Synonym:,BTK inhibitor ONO-4059
2020-09-18T12:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine,Chemical structure:,"3-amino-1,2,4-benzotriazine-1,4-dioxide"
2020-09-18T12:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine,Code name:,SR 4233
2020-09-18T12:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine,Code name:,WIN 59075
2020-09-18T12:20:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine,US brand name:,Tirazone
2020-10-14T13:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirbanibulin,Code name:,KX01
2020-10-14T13:22:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirbanibulin,Code name:,KX2-391
2020-09-18T08:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel,Synonym:,autologous CART-19 TCR:4-1BB cells
2020-09-18T08:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel,Synonym:,CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes
2020-09-18T08:22:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel,US brand name:,Kymriah
2020-10-14T13:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tislelizumab,Code name:,BGB-A317
2020-10-14T13:29:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tislelizumab,Synonym:,anti-PD-1 monoclonal antibody BGB-A317
2020-10-14T13:29:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisotumab-vedotin,Foreign brand name:,HuMax-TF-ADC
2020-10-14T13:29:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisotumab-vedotin,Synonym:,anti-TF monoclonal antibody-MMAE conjugate
2020-10-14T13:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen,US brand name:,Vanicream Sunscreen SPF 60
2020-09-18T12:20:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen-cream-spf-60,US brand name:,Vanicream Sunscreen SPF 60
2020-09-18T12:21:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivantinib,Code name:,ARQ 197
2020-09-18T12:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivozanib,Code name:,AV-951
2020-09-18T12:21:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivozanib,Synonym:,oral VEGF receptor tyrosine kinase inhibitor AV-951
2020-09-18T12:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tizanidine-hydrochloride,Chemical structure:,"2,1,3-benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, monohydrochloride5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole hydrochloride"
2020-09-18T12:21:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tizanidine-hydrochloride,US brand name:,Zanaflex
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Code name:,PUL 042
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Code name:,PUL-042
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,inhalation solution PUL-042
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,Pam2/M362
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,Pam2/M362 combination
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,Pam2CSK4 acetate/ODN M362
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,Pam2CSK4 acetate/ODN M362 combination
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,solution PUL-042
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,TLR agonist PUL-042
2020-09-18T12:21:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042,Synonym:,Toll-like receptor agonist PUL-042
2020-10-14T13:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bdb001,Code name:,BDB 001
2020-10-14T13:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bdb001,Code name:,BDB-001
2020-10-14T13:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bdb001,Code name:,BDB001
2020-10-14T13:30:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bdb001,Synonym:,Toll-like receptor agonist BDB001
2020-10-14T13:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bsg-001,Code name:,BSG 001
2020-10-14T13:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bsg-001,Code name:,BSG-001
2020-10-14T13:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bsg-001,Code name:,BSG001
2020-10-14T13:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bsg-001,Synonym:,syngenon
2020-10-14T13:07:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-cadi-05,Code name:,CADI-05
2020-09-18T12:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-directed-cationic-lipid-dna-complex-jvrs-100,Code name:,JVRS-100
2020-09-18T12:22:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-directed-cationic-lipid-dna-complex-jvrs-100,Synonym:,Toll-like receptor-directed cationic lipid-DNA complex JVRS-10
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Code name:,G100
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,GLA-SE
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,glucopyranosyl lipid A stable emulsion
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,glucopyranosyl lipid adjuvant–stable emulsion
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,TLR-4 agonist G100
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,TLR-4 agonist GLA-SE
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,Toll-like receptor 4 agonist G100
2020-09-18T12:21:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100,Synonym:,Toll-like receptor 4 agonist GLA-SE
2020-09-18T12:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-gsk1795091,Code name:,GSK1795091
2020-09-18T12:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-gsk1795091,Synonym:,TLR 4 agonist GSK1795091
2020-09-18T12:21:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-gsk1795091,Synonym:,Toll-like receptor 4 agonist GSK1795091
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Code name:,3M 052
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Code name:,3M-052
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Code name:,MEDI 9197
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Code name:,MEDI9197
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Synonym:,TLR7/TLR8 dual agonist MEDI9197
2020-09-18T12:22:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197,Synonym:,Toll-like receptor 7/8 agonist MEDI9197
2020-10-14T03:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-852a,Synonym:,TLR7 agonist 852A
2020-10-14T03:21:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-852a,Synonym:,Toll-like receptor agonist 852A
2020-09-18T12:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-ana773-tosylate,Code name:,ANA773 tosylate
2020-09-18T12:21:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-ana773-tosylate,Synonym:,Toll-like receptor 7 agonist ANA773 tosylate
2020-10-14T13:30:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-bnt411,Code name:,BNT 411
2020-10-14T13:30:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-bnt411,Code name:,BNT-411
2020-10-14T13:30:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-bnt411,Code name:,BNT411
2020-10-14T13:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-lhc165,Code name:,LHC 165
2020-10-14T13:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-lhc165,Code name:,LHC-165
2020-10-14T13:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-lhc165,Code name:,LHC165
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN 1508052
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN A1
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN-1508052
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN-A1
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN1508052
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DN1508052-01
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Code name:,DNA1
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Synonym:,TLR8 agonist DN-A1
2020-10-14T13:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052,Synonym:,TLR8 agonist DN1508052-01
2020-09-18T12:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-vtx-2337,Code name:,VTX-2337
2020-09-18T12:22:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-vtx-2337,Synonym:,Toll-like receptor 8 agonist VTX-2337
2020-10-14T13:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008,Code name:,AST 008
2020-10-14T13:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008,Code name:,AST-008
2020-10-14T13:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008,Code name:,AST008
2020-10-14T13:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008,Synonym:,SNA AST-008
2020-10-14T13:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008,Synonym:,toll-like receptor 9 activator AST-008
2020-09-18T12:22:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-duk-cpg-001,Code name:,DUK-CPG-001
2020-09-18T12:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-emd-1201081,Code name:,EMD 1201081
2020-09-18T12:22:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-emd-1201081,Synonym:,Toll-like receptor 9 agonist EMD 1201081
2020-09-18T12:22:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-imo-2055,Code name:,IMO-2055
2020-09-18T12:22:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-mgn1703,Code name:,MGN1703
2020-09-18T12:22:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-sd-101,Abbreviation:,ISS-ODN SD-101
2020-09-18T12:22:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-sd-101,Code name:,SD-101
2020-10-14T13:30:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tm4sf1-car-epcam-car-expressing-autologous-t-cells,Synonym:,autologous CART-TM4SF1 cells/CART-EpCAM cells
2020-10-14T13:30:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tm4sf1-car-epcam-car-expressing-autologous-t-cells,Synonym:,autologous TM4SF1-targeting CAR T cells and EpCAM-targeting CAR T cells
2020-10-14T13:30:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tm4sf1-car-epcam-car-expressing-autologous-t-cells,Synonym:,TM4SF1-CAR autologous T cells/EpCAM-CAR autologous T cells
2020-10-14T13:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124,Code name:,SLN 124
2020-10-14T13:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124,Code name:,SLN-124
2020-10-14T13:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124,Code name:,SLN124
2020-10-14T13:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124,Synonym:,GalNAc-anti-TMPRSS6 siRNA conjugate SLN124
2020-10-14T13:31:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124,Synonym:,RNA interference therapeutic SLN124
2020-09-18T12:23:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tnp-470,Code name:,AGM-1470
2020-09-18T12:23:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tobramycin-sulfate,US brand name:,Tobrex
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Abbreviation:,MRA
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Code name:,R-1569
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Foreign brand name:,RoActemra
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,Synonym:,"immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa chain dimer"
2020-09-18T01:19:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab,US brand name:,Actemra
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Abbreviation:,8-Cl-cAMP
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Abbreviation:,c-AMP
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Abbreviation:,cAMP
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Chemical structure:,"8-chloroadenosine 3',5' monophosphate8-chloroadenosine cyclic 3':5'-monophosphate8-chloro-cyclic adnenosine monophosphate"
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Synonym:,8-chloro cyclic AMP
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Synonym:,adenazole
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Synonym:,cAMP
2020-09-18T12:23:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine,Synonym:,ICN-1256
2020-09-18T12:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocophersolan,Abbreviation:,vitamin E PEG-1000-succinate
2020-09-18T12:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocophersolan,Acronym:,TPGS
2020-09-18T12:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocophersolan,Synonym:,d-alpha tocopheryl polyethylene glycol 1000 succinate
2020-09-18T12:23:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocophersolan,Synonym:,d-alpha-tocopheryl polyethylene glycol 1000 succinate
2020-09-18T12:23:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocotrienol,NA,NA
2020-09-18T12:23:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocotrienol-rich-fraction,Abbreviation:,TRF
2020-09-18T12:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tofacitinib,Chemical structure:,"3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-D)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile"
2020-09-18T12:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tofacitinib,Code name:,"CP-690,550 free base"
2020-09-18T12:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tofacitinib,Code name:,CP-690550
2020-09-18T12:23:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tofacitinib,Synonym:,tasocitinib
2020-09-18T09:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide,Chemical structure:,"1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide"
2020-09-18T09:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide,Code name:,U-17835
2020-09-18T09:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide,US brand name:,Norglycin
2020-09-18T09:43:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide,US brand name:,Tolinase
2020-09-18T12:24:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolbutamide,NA,NA
2020-09-18T12:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolcapone,Synonym:,"3,4-dihydroxy-4'-methyl-5-nitrobenzophenone"
2020-09-18T12:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolcapone,Synonym:,"Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-"
2020-09-18T12:02:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolcapone,US brand name:,Tasmar
2020-10-14T04:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolebrutinib,Code name:,SAR 442168
2020-10-14T04:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolebrutinib,Code name:,SAR-442168
2020-10-14T04:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolebrutinib,Code name:,SAR442168
2020-10-14T04:32:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolebrutinib,Synonym:,Bruton's tyrosine kinase inhibitor SAR442168
2020-09-18T12:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolfenamic-acid,Chemical structure:,2-((3-chloro-2-methylphenyl)amino)benzoic acid
2020-09-18T12:24:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolfenamic-acid,Synonym:,N-(3-chloro-O-Tolyl)anthranilic
2020-10-14T13:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-7-agonist-dsp-0509,Code name:,DSP 0509
2020-10-14T13:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-7-agonist-dsp-0509,Code name:,DSP-0509
2020-10-14T13:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-7-agonist-dsp-0509,Code name:,DSP0509
2020-10-14T13:31:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-7-agonist-dsp-0509,Synonym:,TLR7 agonist DSP-0509
2020-09-18T12:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-9-agonist-imo-2125,Code name:,IMO 2125
2020-09-18T12:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-9-agonist-imo-2125,Code name:,IMO-2125
2020-09-18T12:24:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-9-agonist-imo-2125,Synonym:,TLR9 agonist IMO-2125
2020-10-14T04:00:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomaralimab,Code name:,OPN-305
2020-09-18T12:24:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomato-soy-juice,NA,NA
2020-10-14T13:31:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomivosertib,Code name:,eFT508
2020-10-14T13:31:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomivosertib,Synonym:,MNK1/2 inhibitor eFT508
2020-10-14T13:31:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomuzotuximab,NA,NA
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,Synonym:,ammonia oxidizing bacteria-containing probiotic Mist
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,Synonym:,AO bacteria-containing mist
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,Synonym:,AOB-based probiotic sprayt
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,Synonym:,topical probiotic solution
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,Synonym:,topical probiotic spray
2020-10-14T04:01:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution,US brand name:,AO+ Mist
2020-09-18T12:25:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-betulinic-acid,Synonym:,topical ALS-357
2020-09-18T12:25:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-calcitriol,Code name:,topical compound 31543
2020-10-14T13:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution,Foreign brand name:,Cantharone
2020-10-14T13:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution,Synonym:,cantharidin
2020-10-14T13:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution,Synonym:,topical cantharidin
2020-10-14T13:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution,Synonym:,topical cantharidine
2020-10-14T13:31:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution,Synonym:,VP-102
2020-10-14T13:31:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-celecoxib,Code name:,DFD-07
2020-10-14T13:31:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-celecoxib,Code name:,DFD07
2020-10-14T13:31:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-celecoxib,Synonym:,celecoxib cream
2020-10-14T13:31:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-celecoxib,Synonym:,celecoxib topical
2020-09-18T12:25:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cocaine-hydrochloride,Chemical structure:,"methyl 3-beta-hydroxy-1-alpha-H,5-alpha-H-tropan-2-beta-carboxylate, benzoate (ester) HCl"
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Code name:,CAM 101
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Code name:,CAM-101
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Code name:,CAM101
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Synonym:,FD hPL CAM-101
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Synonym:,ophthalmic fibrinogen-depleted allogeneic standardized human platelet lysate
2020-10-14T13:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101,Synonym:,topical fibrinogen-depleted human platelet lysate
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Abbreviation:,5-FU topical
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Actino-Hermal
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Arumel
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Cytosafe
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Efurix
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Fiverocil
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Foreign brand name:,Flurox
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,Timazin
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,Synonym:,topical 5-fluorouracil
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Carac
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Efudex
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Fluoroplex
2020-09-18T05:02:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil,US brand name:,Tolak
2020-09-18T12:25:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-gemcitabine-hydrochloride,NA,NA
2020-09-18T08:20:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-keratin,US brand name:,KeraStat
2020-09-18T12:26:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-menthol,NA,NA
2020-10-14T13:31:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-menthol-cream,NA,NA
2020-09-18T12:26:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-myristyl-nicotinate-cream,NA,NA
2020-09-18T12:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-naloxone-hydrochloride,Code name:,E-0316
2020-09-18T12:26:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-naloxone-hydrochloride,Synonym:,naloxone hydrochloride dehydrate lotion
2020-09-18T12:26:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-phenylephrine-solution,NA,NA
2020-09-18T12:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-piperidine-nitroxide-mts-01,Chemical structure:,"4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl"
2020-09-18T12:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-piperidine-nitroxide-mts-01,Code name:,MTS-01
2020-09-18T12:09:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-piperidine-nitroxide-mts-01,US brand name:,Tempol
2020-10-14T13:32:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-potassium-dobesilate,Code name:,AM-001
2020-10-14T13:10:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-pvdf-sirolimus,Synonym:,topical PVDF/rapamycin
2020-09-18T12:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-sirolimus,Code name:,NPC-12G gel
2020-09-18T12:26:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-sirolimus,Synonym:,Rapamune topical formulation
2020-10-14T13:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vbp-926-solution,Code name:,VBP 926
2020-10-14T13:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vbp-926-solution,Code name:,VBP-926
2020-10-14T13:32:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vbp-926-solution,Synonym:,VBP-926 solution
2020-09-18T12:26:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vitamin-e,NA,NA
2020-09-18T12:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-wound-spray-hp802-247,Code name:,HP802-247
2020-09-18T12:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-wound-spray-hp802-247,Code name:,HP802247
2020-09-18T12:26:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-wound-spray-hp802-247,Synonym:,allogeneic keratinocyte/fibroblast topical spray HP802-247
2020-09-18T12:25:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topiramate,Chemical structure:,"beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate"
2020-09-18T12:25:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topiramate,US brand name:,Topamax
2020-09-18T12:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-ii-inhibitor-nev-801,Code name:,NEV-801
2020-09-18T12:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-ii-inhibitor-nev-801,Code name:,NEV801
2020-09-18T12:27:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-ii-inhibitor-nev-801,Synonym:,TopI/II NEV-801
2020-09-18T12:27:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-genz-644282,Code name:,Genz-644282
2020-09-18T12:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp400,Code name:,LMP400
2020-09-18T12:27:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp400,Synonym:,Top1 inhibitor 400
2020-09-18T12:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp776,Code name:,LMP776
2020-09-18T12:27:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp776,Synonym:,Top1 inhibitor LMP776
2020-10-14T13:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-ii-beta-inhibitor-racemic-xk469,Chemical structure:,"2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acidpropanoic acid, 2-[4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}-, (+ )-(R)-"
2020-10-14T13:17:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-ii-beta-inhibitor-racemic-xk469,Synonym:,XK469
2020-10-14T13:11:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-ii-inhibitor-racemic-xk469,NA,NA
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,Abbreviation:,TOPO
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,Chemical structure:,"(S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4'; 6,7] indolizino[1,2-b] quinoline-3,14-(4H,12H)-dione monohydrochloride"
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,Code name:,SKF S-104864-A
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,Synonym:,hycamptamine
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,Synonym:,topotecan HCl
2020-09-18T07:47:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride,US brand name:,Hycamtin
2020-10-14T04:31:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride-liposomes,Synonym:,topotecan hydrochloride liposomes
2020-10-14T04:31:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride-liposomes,US brand name:,Brakiva
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,episcleral topotecan
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,SR topotecan episcleral plaque
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,sustained-release episcleral topotecan
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,sustained-release topotecan episcleral plaque
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,topotecan SR episcleral plaque
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,Synonym:,transscleral topotecan
2020-10-14T04:43:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque,US brand name:,Chemoplaque
2020-09-18T12:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topsalysin,Chemical structure:,PSA-PAH1
2020-09-18T12:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topsalysin,Code name:,PRX302
2020-09-18T12:27:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topsalysin,Foreign brand name:,PORxin 302
2020-09-18T12:27:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/torc1-2-kinase-inhibitor-ds-3078a,Code name:,DS-3078a
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Chemical structure:,"(Z)-2-[4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)- N,N-dimethylethylamine citrate (1:1)"
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Code name:,FC-1157a
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,Code name:,GTx-006
2020-09-18T06:44:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate,US brand name:,Fareston
2020-10-14T13:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab,Code name:,JS001
2020-10-14T13:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab,Synonym:,anti-PD-1 monoclonal antibody JS001
2020-10-14T13:32:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab,Synonym:,TAB-001
2020-09-18T12:28:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tosedostat,Code name:,CHR-2797
2020-09-18T12:28:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tosedostat,Synonym:,aminopeptidase inhibitor CHR-2797
2020-09-18T12:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab,Abbreviation:,MOAB anti-B1
2020-09-18T12:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab,Synonym:,anti-B1
2020-09-18T12:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab,Synonym:,anti-B1 monoclonal antibody
2020-09-18T12:28:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab,Synonym:,Anti-CD20 Antibody
2020-09-18T04:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab,Synonym:,Bexxar therapeutic regimen
2020-09-18T04:40:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab,US brand name:,Bexxar
2020-09-18T12:28:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/total-tumor-rna-loaded-dendritic-cell-vaccine,Synonym:,TTRNA-loaded DC vaccine
2020-10-14T03:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovetumab,Code name:,MEDI-575
2020-10-14T03:56:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovetumab,Synonym:,anti-platelet-derived growth factor receptor alpha monoclonal antibody MEDI-575
2020-09-18T12:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozasertib-lactate,Code name:,MK-0457
2020-09-18T12:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozasertib-lactate,Code name:,VX-680
2020-09-18T12:28:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozasertib-lactate,Synonym:,Aurora kinase inhibitor MK-0457
2020-10-14T04:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozuleristide,Code name:,BLZ-100
2020-10-14T04:43:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozuleristide,Code name:,CyTP 007
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Abbreviation:,DCF
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Abbreviation:,TPF
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Synonym:,DCF regimen
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Synonym:,docetaxel-cisplatin-5-FU regimen
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Synonym:,docetaxel-cisplatin-fluorouracil regimen
2020-09-18T12:29:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen,Synonym:,Taxotere-Platinol-fluorouracil regimen
2020-09-18T12:29:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpi-287,NA,NA
2020-09-18T12:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpo-receptor-agonist-ono-7746,Code name:,ONO-7746
2020-09-18T12:29:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpo-receptor-agonist-ono-7746,Synonym:,NIP-022
2020-09-18T12:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin,Abbreviation:,ET 743
2020-09-18T12:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin,Foreign brand name:,Yondelis
2020-09-18T12:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin,Synonym:,ecteinascidin
2020-09-18T12:29:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin,US brand name:,Yondelis
2020-09-18T12:29:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabedersen,Code name:,AP 12009
2020-09-18T09:00:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib,Chemical structure:,"N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
2020-09-18T09:00:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib,Code name:,GSK1120212
2020-09-18T09:00:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib,Code name:,JTP-74057
2020-09-18T09:00:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib,Code name:,TMT212
2020-09-18T09:00:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib,US brand name:,Mekinist
2020-09-18T05:48:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranexamic-acid,US brand name:,Cyklokapron
2020-09-18T12:30:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trans-sodium-crocetinate,Acronym:,TSC
2020-09-18T12:30:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-17beta-estradiol-gel-bhr-200,Code name:,BHR-200
2020-09-18T12:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-4-hydroxytestosterone,Synonym:,transdermal 4-OHT
2020-09-18T12:30:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-4-hydroxytestosterone,Synonym:,transdermal CR1447
2020-09-18T06:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-estrogen,US brand name:,EstroGel
2020-09-18T12:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107,Code name:,HN-66000
2020-09-18T12:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107,Synonym:,Tf-CRM107
2020-09-18T12:30:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107,US brand name:,TransMID
2020-09-18T12:30:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-anti-rrm2-sirna-calaa-01,Code name:,CALAA-01
2020-09-18T12:30:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-liposomal-p53-cdna,Code name:,SGT-53
2020-09-18T12:30:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transgenic-lymphocyte-immunization-vaccine,Synonym:,TLI vaccine
2020-09-18T12:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transthyretin-antisense-oligonucleotide-isis-ttr-rx,Code name:,ISIS-TTR Rx
2020-09-18T12:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transthyretin-antisense-oligonucleotide-isis-ttr-rx,Code name:,ISIS-TTRRx
2020-09-18T12:30:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transthyretin-antisense-oligonucleotide-isis-ttr-rx,Synonym:,TTR ASO ISIS-TTR Rx
2020-09-18T10:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranylcypromine-sulfate,Chemical structure:,(+-)-trans-2-phenylcyclopropylamine sulfate (2:1)1-amino-2-phenylcyclopropane sulfate
2020-09-18T10:11:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranylcypromine-sulfate,US brand name:,Parnate
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Abbreviation:,MOAB HER2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Abbreviation:,rhuMAb HER2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Code name:,ABP 980
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Code name:,PF-05280014
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Code name:,RO0452317
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-c-erB-2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-c-erbB2 monoclonal antibody
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-ERB-2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-erbB-2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-erbB2 monoclonal antibody
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-HER2/c-erbB2 monoclonal antibody
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,anti-p185-HER2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,Herceptin biosimilar PF-05280014
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,Herceptin trastuzumab biosimilar PF-05280014
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,MOAB HER2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,monoclonal antibody c-erb-2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,monoclonal antibody HER2
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar ABP 980
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar ALT02
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar EG12014
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar GB221
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar HLX02
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar PF-05280014
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab biosimilar SB3
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab-anns
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab-dttb
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,Synonym:,trastuzumab-qyyp
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Herceptin
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Herzuma
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Kanjinti
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Ogivri
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Ontruzant
2020-09-18T07:35:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab,US brand name:,Trazimera
2020-10-14T13:32:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-conjugate-bi-con-02,Code name:,BI-CON-02
2020-10-14T04:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan,Code name:,DS-8201
2020-10-14T04:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan,Code name:,DS-8201a
2020-10-14T04:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan,Code name:,WHO 10516
2020-10-14T04:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan,Synonym:,trastuzumab deruxtecan
2020-10-14T04:59:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan,US brand name:,Enhertu
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Code name:,SYD985
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Code name:,UNII-XCR2BZ80N7
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Synonym:,ADC SYD985
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Synonym:,antibody-drug conjugate SYD985
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Synonym:,trastuzumab vc-seco-DUBA
2020-09-18T12:31:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine,Synonym:,trastuzumab-drug conjugate SYD985
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Abbreviation:,T-DM1
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Code name:,PRO132365
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Code name:,RO5304020
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Synonym:,trastuzumab emtansine
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Synonym:,trastuzumab-DM1
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 antibody-drug conjugate
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,Synonym:,trastuzumab-MCC-DM1 immunoconjugate
2020-10-14T03:24:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine,US brand name:,Kadcyla
2020-10-14T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk,Synonym:,trastuzumab and hyaluronidase
2020-10-14T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk,Synonym:,trastuzumab and recombinant human hyaluronidase PH20
2020-10-14T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk,Synonym:,trastuzumab and rHuPH20
2020-10-14T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk,Synonym:,trastuzumab-hyaluronidase-oysk
2020-10-14T05:18:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk,US brand name:,Herceptin Hylecta
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Code name:,FS 1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Code name:,FS-1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Code name:,FS1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Synonym:,ADC FS-1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Synonym:,anti-HER2 ADC FS-1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Synonym:,antibody-drug conjugate FS-1502
2020-10-14T13:32:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f,Synonym:,trastuzumab MMAF
2020-09-18T12:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502,Code name:,ADCT 502
2020-09-18T12:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502,Code name:,ADCT-502
2020-09-18T12:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502,Code name:,ADCT50
2020-09-18T12:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502,Synonym:,ADC ADCT-502
2020-09-18T12:31:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502,Synonym:,anti-HER2/PBD ADC ADCT 502
2020-09-18T12:32:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/traumeel-s,Abbreviation:,TRS
2020-09-18T12:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trebananib,Code name:,AMG 386
2020-09-18T12:32:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trebananib,Code name:,AMG386
2020-09-18T12:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab,Chemical structure:,"immunoglobulin G2, anti-(human CTLA-4 (antigen)) (human monoclonal CP-675206 clone 11.2.1 heavy chain) disulfide with human monoclonal CP-675206 clone 11.2.1 light chain, dimer"
2020-09-18T12:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab,Code name:,CP-675
2020-09-18T12:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab,Code name:,"CP-675,206"
2020-09-18T12:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab,Synonym:,"anti-CTLA4 human monoclonal antibody CP-675,206"
2020-09-18T12:32:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab,Synonym:,ticilimumab
2020-09-18T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan,Chemical structure:,"(S-(R*,R*))-1,2,3,4-butanetetrol,1,4-dimethanesulfonateL-threitol 1,4-dimethanesulfonate"
2020-09-18T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan,Foreign brand name:,Ovastat
2020-09-18T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan,Synonym:,dihydroxybusulfan
2020-09-18T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan,Synonym:,treosulphan
2020-09-18T12:32:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan,Synonym:,tresulfon
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Abbreviation:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,ATRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Acronym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Chemical structure:,"(All-E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid"
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Code name:,Ro 5488
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Airol
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Cordes Vas
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Dermairol
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Epi-Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Eudyna
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Retisol-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Stieva-A Forte
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Foreign brand name:,Vitinoin
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,all-trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,beta-retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,TRA
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans retinoic acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,trans vitamin A acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,tretinoinum
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,Synonym:,Vitamin A Acid
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aberel
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Aknoten
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Avita
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Renova
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Retin-A MICRO
2020-09-18T01:15:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin,US brand name:,Vesanoid
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Abbreviation:,L-ATRA
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Code name:,AR-623
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Synonym:,All-trans-retinoic acid liposomal
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Synonym:,tretinoin liposomal
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Synonym:,tretinoin liposome
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,Synonym:,tretinoinLF
2020-10-14T04:03:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome,US brand name:,Atragen
2020-09-18T12:35:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tri-virus-gd2-specific-allogeneic-cytotoxic-t-lymphocytes,NA,NA
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,Chemical structure:,"(11beta,16alpha)-9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione"
2020-09-18T03:57:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone,US brand name:,Aristocort
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,Chemical structure:,"9-alpha-fluoro-11-beta,21-dihydroxy-16-alpha-isopropylidenedioxy-1,4-pregnadiene,3,20-dione"
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,AllerNaze
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Aristocort A
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Kenalog
2020-09-18T01:49:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide,US brand name:,Nasacort
2020-10-14T13:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131,Code name:,SUN 131
2020-10-14T13:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131,Code name:,SUN-131
2020-10-14T13:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131,Code name:,SUN131
2020-10-14T13:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131,Synonym:,SUN-131 TDS
2020-10-14T13:32:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131,Synonym:,triamcinolone acetonide transdermal patch SUN-131
2020-09-18T12:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine,Abbreviation:,3-Apct
2020-09-18T12:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine,Chemical structure:,3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2020-09-18T12:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine,Code name:,OCX-191
2020-09-18T12:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine,Synonym:,3-AP
2020-10-14T04:36:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazene-derivative-cb10-277,Chemical structure:,"1-p-carboxy-3,3-dimethylphenyltriazine"
2020-10-14T13:33:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazene-derivative-trin2755,Code name:,TriN2755
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Abbreviation:,BAF
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Abbreviation:,TZT
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Synonym:,Baker's antifol
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Synonym:,Baker's Antifolate
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Synonym:,Bakers antifolate
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Synonym:,ethanesulfonic acid compound
2020-09-18T12:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate,Synonym:,soluble Baker's antifol
2020-09-18T12:33:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazine-derivative-trin2755,Code name:,TriN2755
2020-09-18T12:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tributyrin,Abbreviation:,TB
2020-09-18T12:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tributyrin,Chemical structure:,"1,2,3-propanetriyl butanoate1,2,3-tributyrylglycerolbutanoic acid 1,2,3-propanetriyl ester"
2020-09-18T12:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tributyrin,Synonym:,butyryl triglyceride
2020-09-18T12:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tributyrin,Synonym:,glyceryl tributyrate
2020-10-14T13:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tricaprin,Synonym:,glycerol tricaprin
2020-10-14T13:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tricaprin,Synonym:,glycerol tridecanoate
2020-10-14T13:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tricaprin,Synonym:,tricapric glyceride
2020-10-14T13:33:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tricaprin,Synonym:,tridecanoin
2020-10-14T13:33:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trichostatin-a,Chemical structure:,"(2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide"
2020-09-18T12:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate,Abbreviation:,TCN-P
2020-09-18T12:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate,Chemical structure:,"1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amine3-amino-1, 5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)"
2020-09-18T12:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate,Synonym:,tricyclic nucleoside 5'-phosphate
2020-09-18T12:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate,Synonym:,tricycloside phosphate
2020-10-14T13:33:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triclosan-copolymer-fluoride-toothpaste,Synonym:,triclosan/copolymer/fluoride dentifrice
2020-09-18T11:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride,Abbreviation:,TETA
2020-09-18T11:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride,Abbreviation:,trien
2020-09-18T11:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride,Chemical structure:,"N,N'-bis(2-aminoethyl)ethane-1,2-diamine"
2020-09-18T11:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride,Synonym:,triethylenetetramine dihydrochloride
2020-09-18T11:46:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride,US brand name:,spyrine
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,Chemical structure:,10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,Code name:,SKF 5019
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,Foreign brand name:,Eskazine
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,Foreign brand name:,Jatroneural
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,Foreign brand name:,Terfluzine
2020-09-18T11:48:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride,US brand name:,Stelazine
2020-09-18T12:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine,Abbreviation:,F3TdR
2020-09-18T12:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine,Chemical structure:,2'-Deoxy-5-trifluoromethyluridine
2020-09-18T12:34:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine,Synonym:,triflorothymidine
2020-09-18T08:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride,Code name:,TAS-102
2020-09-18T08:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride,Synonym:,trifluridine and tipiracil
2020-09-18T08:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride,Synonym:,trifluridine/tipiracil hydrochloride
2020-09-18T08:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride,Synonym:,trifluridine/tipiracil hydrochloride combination agent TAS-102
2020-09-18T08:42:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride,US brand name:,Lonsurf
2020-09-18T12:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trigriluzole,Chemical structure:,"glycinamide, glycylglycyl-N2-methyl-N-(6-(trifluoromethoxy)-2-benzothiazolyl)-"
2020-09-18T12:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trigriluzole,Code name:,BHV 4157
2020-09-18T12:34:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trigriluzole,Code name:,BHV-4157
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,Chemical structure:,"(4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile"
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,Code name:,"WIN 24,540"
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,Code name:,WIN 24540
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,Foreign brand name:,Desopan
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,Foreign brand name:,Modrenal
2020-09-18T09:14:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane,US brand name:,Modrastane
2020-10-14T12:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimebutine-3-thiocarbamoylbenzenesulfonate,Chemical structure:,trimebutine 3-thiocarbamoylbenzenesulfonate
2020-10-14T12:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimebutine-3-thiocarbamoylbenzenesulfonate,Code name:,GIC-1001
2020-10-14T12:55:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimebutine-3-thiocarbamoylbenzenesulfonate,Code name:,TB-905-02
2020-09-18T12:34:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimeric-gitrl-fc-omp-336b11,Code name:,OMP 336B11
2020-09-18T12:34:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimeric-gitrl-fc-omp-336b11,Code name:,OMP-336B11
2020-09-18T12:34:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimeric-gitrl-fc-omp-336b11,Synonym:,GITRL-Fc
2020-09-18T12:34:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimeric-gitrl-fc-omp-336b11,Synonym:,GITRL-Fc trimer
2020-10-14T13:33:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetazidine,US brand name:,Vastarel MR
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,SMZ-TMP
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Abbreviation:,TMP-SMX
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,cotrimoxazole
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,Eslectin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,insozalin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimedin
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,Synonym:,trimezole
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Bactrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Cotrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Septra
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfamethoprim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulfatrim
2020-09-18T04:30:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole,US brand name:,Sulmeprim
2020-09-18T12:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethylcolchicinic-acid,Abbreviation:,TMCA
2020-09-18T12:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethylcolchicinic-acid,Synonym:,desacetyl colchicine D-tartrate
2020-09-18T12:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethylcolchicinic-acid,Synonym:,methyl ether
2020-09-18T12:34:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethylcolchicinic-acid,Synonym:,trimethylcolchicinic acid methyl ether d-tartrate
2020-09-18T09:38:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetrexate-glucuronate,Chemical structure:,"2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline mono-D-glucuronate"
2020-09-18T09:38:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetrexate-glucuronate,US brand name:,Neutrexin
2020-10-14T12:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analog,US brand name:,Minnelide
2020-09-18T09:10:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analogue,US brand name:,Minnelide
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Abbreviation:,TRIP
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Code name:,AY-25650
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Code name:,"CL-118,532"
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Foreign brand name:,Decapeptyl
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Synonym:,6-D-Tryptophan-LH-RH
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Synonym:,6-D-Tryptophanluteinizing Hormone-releasing Factor
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Synonym:,D-TRP-6-LHRH
2020-09-18T12:35:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin,Synonym:,Detryptoreline
2020-09-18T12:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate,Chemical structure:,"6-D-Tryptophan-, 4,4'Mmethylenebis(3-hydroxy-2-naphthalenecarboxylate) (Salt)"
2020-09-18T12:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate,Foreign brand name:,Diphereline
2020-09-18T12:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate,Synonym:,Pamorelin
2020-09-18T12:32:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate,US brand name:,Trelstar Depot
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,Abbreviation:,TAGM
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,Synonym:,trisacryl gelatin microspheres
2020-09-18T06:25:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres,US brand name:,Embospheres
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,Influenza Vaccine
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,"influenza virus vaccine, trivalent, types A and B"
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,Synonym:,TIV
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Agriflu
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluarix
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flublok
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,FluLaval
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Flushield
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluvirin
2020-09-18T01:44:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine,US brand name:,Fluzone
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,Foreign brand name:,Fluenz
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,Synonym:,"trivalent intranasal influenza vaccine, live"
2020-09-18T06:53:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine,US brand name:,FluMist
2020-09-18T12:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-loxo-195,Chemical structure:,"(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one"
2020-09-18T12:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-loxo-195,Code name:,LOXO 195
2020-09-18T12:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-loxo-195,Code name:,LOXO-195
2020-09-18T12:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-loxo-195,Code name:,LOXO195
2020-10-14T13:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-tqb3558,Code name:,TQB 3558
2020-10-14T13:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-tqb3558,Code name:,TQB-3558
2020-10-14T13:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-tqb3558,Code name:,TQB3558
2020-10-14T13:33:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-tqb3558,Synonym:,tropomyosin receptor kinase inhibitor TQB3558
2020-10-14T13:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trka-inhibitor-vmd-928,Code name:,VMD 928
2020-10-14T13:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trka-inhibitor-vmd-928,Code name:,VMD-928
2020-10-14T13:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trka-inhibitor-vmd-928,Code name:,VMD928
2020-10-14T13:33:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trka-inhibitor-vmd-928,Synonym:,NTRK1 inhibitor VMD-928
2020-09-18T12:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trodusquemine,Chemical structure:,"(24R)-3beta-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-7alpha-hydroxy-5alpha-cholestan-24-yl hydrogen sulfatecholestane-7,24-diol, 3-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-, 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-"
2020-09-18T12:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trodusquemine,Code name:,MSI-1436C
2020-09-18T12:36:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trodusquemine,Synonym:,MSI-1436
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,Abbreviation:,TFF
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,Chemical structure:,"2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorine 2-oxideN,N,3-tris(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxideN,N,N'-tris(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide"
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,Code name:,A-4828
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,Foreign brand name:,Genoxal Trofosfamida
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,Synonym:,trofosfamid
2020-09-18T08:17:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide,US brand name:,Ixoten
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,Chemical structure:,"5-[[4-[4(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl\-2,4-thiazolidinedione5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione"
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,Code name:,CI-991
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,Code name:,CS-045
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,US brand name:,Prelay
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,US brand name:,Rezulin
2020-09-18T10:44:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone,US brand name:,Romozin
2020-09-18T12:36:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron,Code name:,ICS 205-930
2020-09-18T12:36:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron,Foreign brand name:,Navoban
2020-09-18T09:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron-hydrochloride,Chemical structure:,"1alpha-H,5alpha-H-tropan-3alpha-yl Indole-3-carboxylate hydrochloride1H-indole-3-carboxylic acid, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, monohydrochloride"
2020-09-18T09:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron-hydrochloride,Code name:,SDZ-ICS 930
2020-09-18T09:44:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron-hydrochloride,US brand name:,Novaban
2020-09-18T12:36:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropomysin-receptor-kinase-inhibitor-azd7451,Code name:,AZD7451
2020-09-18T12:36:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropomysin-receptor-kinase-inhibitor-azd7451,Synonym:,TRK Inhibitor AZD7451
2020-10-14T13:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troriluzole,Chemical structure:,"glycinamide, glycylglycyl-N2-methyl-N-(6-(trifluoromethoxy)-2-benzothiazolyl)-"
2020-10-14T13:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troriluzole,Code name:,BHV 4157
2020-10-14T13:33:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troriluzole,Code name:,BHV-4157
2020-09-18T12:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine,Chemical structure:,"2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-"
2020-09-18T12:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine,Code name:,BCH-4556
2020-09-18T12:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine,Code name:,L-Oddc
2020-09-18T12:36:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine,US brand name:,Troxatyl
2020-10-14T13:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine-nucleotide-prodrug-miv-818,Code name:,MIV 818
2020-10-14T13:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine-nucleotide-prodrug-miv-818,Code name:,MIV-818
2020-10-14T13:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine-nucleotide-prodrug-miv-818,Code name:,MIV818
2020-10-14T13:33:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine-nucleotide-prodrug-miv-818,Synonym:,troxacitabine prodrug MIV-818
2020-09-18T12:37:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trp2-mrna-electroporated-autologous-langerhans-type-dendritic-cell-vaccine,Synonym:,autologous Langerhans-type mRNA-electroporated dendritic cell vaccine
2020-09-18T12:37:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trpv6-calcium-channel-inhibitor-sor-c13,Code name:,SOR-C13
2020-09-18T12:37:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/truncated-tissue-factor-ngr-peptide,Abbreviation:,tTF-NGR
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,L-tryptophanase
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,TDO2
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,TPH2
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,TRPO
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,"Tryptamin 2,3-Dioxygenase"
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,"Tryptophan 2,3-Dioxygenase"
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,Tryptophan Oxygenase
2020-10-14T13:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase,Synonym:,Tryptophan Pyrrolase
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,L-tryptophanase
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,TDO2
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,TPH2
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,TRPO
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,"Tryptamin 2,3-Dioxygenase"
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,"Tryptophan 2,3-Dioxygenase"
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,Tryptophan Oxygenase
2020-09-18T12:37:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase,Synonym:,Tryptophan Pyrrolase
2020-10-14T03:22:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-abt-510,NA,NA
2020-09-18T12:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-fusion-protein-cvx-045,Code name:,CVX-045
2020-09-18T12:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-fusion-protein-cvx-045,Synonym:,thrombospondin-1 mimetic fusion protein CVX-045
2020-09-18T12:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tti-237,Synonym:,TTI 237
2020-09-18T12:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubercidin,Abbreviation:,TBC
2020-09-18T12:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubercidin,Chemical structure:,"4-amino-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine7-deazaadenosine"
2020-09-18T12:37:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubercidin,Code name:,U-10071
2020-09-18T12:38:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-binding-agent-ssr97225,Code name:,SSR97225
2020-10-14T13:34:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-binding-agent-tti-237,Synonym:,TTI 237
2020-10-14T13:34:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-inhibitor-alb-109564-dihydrochloride,Code name:,ALB 109564(a)
2020-09-18T12:37:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-inhibitor-alb-109564a,Code name:,ALB 109564(a)
2020-09-18T12:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-ckd-516,Chemical structure:,"(S)-N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide hydrochloride"
2020-09-18T12:37:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-ckd-516,Code name:,CKD-516
2020-10-14T13:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-veru-111,Code name:,VERU 111
2020-10-14T13:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-veru-111,Code name:,VERU-111
2020-10-14T13:34:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-veru-111,Code name:,VERU111
2020-10-14T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib,Chemical structure:,"N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine"
2020-10-14T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib,Code name:,ARRY-380
2020-10-14T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib,Synonym:,irbinitinib
2020-10-14T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib,Synonym:,ONT-380
2020-10-14T13:34:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib,US brand name:,Tukysa
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Chemical structure:,N-(2-amino-5-fluorine benzyl)-4-[N-(pyridine-3-acrylyl) ammonia methyl] benzamideN-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]-benzamide
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Code name:,CS055
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Code name:,HBI-8000
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Synonym:,chidamide
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Synonym:,epidaza
2020-09-18T12:38:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat,Synonym:,histone deacetylase inhibitor HBI-8000
2020-09-18T12:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucotuzumab-celmoleukin,Code name:,EMD 273066
2020-09-18T12:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucotuzumab-celmoleukin,Synonym:,huKS-IL2 fusion protein
2020-09-18T12:38:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucotuzumab-celmoleukin,Synonym:,KSA-Interleukin-2 Fusion Protein
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV 001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Code name:,DPV001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,allogeneic DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribble cancer vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRibble vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,dribbles vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,DRiPs and SLiPs-containing blebs vaccine DPV-001
2020-09-18T01:50:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine,Synonym:,vaccine DPV-001
2020-09-18T12:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cells-apoptosis-factor-hormone-peptide,Abbreviation:,TCApF
2020-09-18T12:38:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cells-apoptosis-factor-hormone-peptide,Foreign brand name:,Nerofe
2020-09-18T12:38:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-homing-peptide-irgd,Synonym:,iRGD
2020-09-18T12:38:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-peptide-loaded-myeloid-dendritic-cells,Synonym:,tumor peptide-loaded myDC vaccine
2020-09-18T12:39:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/typhoid-vaccine,NA,NA
2020-09-18T12:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyroserleutide,Abbreviation:,YSL
2020-09-18T12:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyroserleutide,Code name:,CMS 024
2020-09-18T12:39:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-peptide,Abbreviation:,TYRP
2020-09-18T12:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-related-protein-1,Abbreviation:,TRP-1
2020-09-18T12:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-related-protein-1,Synonym:,gp75 antigen
2020-09-18T12:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-related-protein-1,Synonym:,tyrosinase related protein-1
2020-09-18T12:39:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-related-protein-1,Synonym:,tyrosinase-related protein 1
2020-09-18T12:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-osi-930,Code name:,OSI-930
2020-10-14T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-tl-895,Code name:,TL 895
2020-10-14T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-tl-895,Code name:,TL895
2020-10-14T13:34:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-tl-895,Synonym:,TKI TL-895
2020-09-18T12:39:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-xl228,Code name:,XL228
2020-09-18T12:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-mln7243,Code name:,AOB87172
2020-09-18T12:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-mln7243,Code name:,MLN7243
2020-09-18T12:39:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-mln7243,Code name:,TAK-243
2020-10-14T13:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-tak-243,Code name:,AOB87172
2020-10-14T13:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-tak-243,Code name:,MLN7243
2020-10-14T13:34:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-tak-243,Code name:,TAK-243
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Code name:,API 31510
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Code name:,BPM 31510
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Code name:,BPM-31510
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Code name:,BPM31510
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Synonym:,BPM31510 nanosuspension injection
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Synonym:,coenzyme Q10 injectable nanosuspension
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Synonym:,ubidecarenone injectable nanosuspension
2020-09-18T12:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510,Synonym:,ubiquinone injectable nanosuspension
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Code name:,API 31510
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Code name:,BPM 31510
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Code name:,BPM-31510
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Code name:,BPM31510
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Synonym:,BPM31510 nanosuspension injection
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Synonym:,coenzyme Q10 injectable nanosuspension
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Synonym:,ubidecarenone injectable nanosuspension
2020-10-14T13:34:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n,Synonym:,ubiquinone injectable nanosuspension
2020-09-18T12:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab,Code name:,LFB-R603
2020-09-18T12:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab,Code name:,TG-1101
2020-09-18T12:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab,Code name:,TG-20
2020-09-18T12:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab,Code name:,TGTX-1101
2020-09-18T12:40:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab,Synonym:,anti-CD20 monoclonal antibody LFB-R603
2020-09-18T12:40:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/udenafil,Foreign brand name:,Zydena
2020-09-18T12:40:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulimorelin-hydrochloride,Code name:,TZP-101
2020-09-18T12:40:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulinastatin,Abbreviation:,UTI
2020-09-18T12:40:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulinastatin,Synonym:,urinary trypsin inhibitor
2020-10-14T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal,Code name:,CDB-2914
2020-10-14T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal,Code name:,PGL-4001
2020-10-14T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal,Code name:,RTI-3021-012
2020-10-14T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal,Code name:,VA-2914
2020-10-14T13:35:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal,Foreign brand name:,Esmya
2020-09-18T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate,Code name:,CDB-2914
2020-09-18T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate,Code name:,PGL-4001
2020-09-18T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate,Code name:,RTI-3021-012
2020-09-18T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate,Code name:,VA-2914
2020-09-18T12:40:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate,Foreign brand name:,Esmya
2020-10-14T13:35:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulixertinib,Code name:,BVD-523
2020-10-14T13:35:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulixertinib,Synonym:,ERK inhibitor BVD-523
2020-09-18T12:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab,Code name:,BMS 936564
2020-09-18T12:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab,Code name:,BMS-936564
2020-09-18T12:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab,Code name:,MDX-1338
2020-09-18T12:40:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab,Synonym:,anti-CXCR4 monoclonal antibody MDX-1338
2020-09-18T12:41:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulvwf-multimer-targeting-agent-arc1779,Code name:,ARC1779
2020-10-14T13:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-cd4-cd25-t-regulatory-cells-ck0801,Code name:,CK 0801
2020-10-14T13:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-cd4-cd25-t-regulatory-cells-ck0801,Code name:,CK-0801
2020-10-14T13:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-cd4-cd25-t-regulatory-cells-ck0801,Code name:,CK0801
2020-10-14T13:35:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-cd4-cd25-t-regulatory-cells-ck0801,Synonym:,UCB-derived CD4+CD25+ Tregs CK0801
2020-09-18T12:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-hematopoietic-cd34-positive-progenitor-cells,Foreign brand name:,NiCord
2020-09-18T12:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-hematopoietic-cd34-positive-progenitor-cells,Synonym:,ex vivo expanded umbilical cord blood-derived hematopoietic CD34-positive progenitor cells
2020-09-18T12:41:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-hematopoietic-cd34-positive-progenitor-cells,Synonym:,UCB-derived CD34+ HPCs
2020-09-18T12:41:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-mesenchymal-stem-cells,Abbreviation:,umbilical cord blood-derived MSCs
2020-09-18T12:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-natural-killer-cells,Synonym:,cord blood NK cells
2020-09-18T12:41:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-natural-killer-cells,Synonym:,umbilical cord blood-derived NK cells
2020-10-14T13:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib,Chemical structure:,"2-((1S)-1-(4-amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one"
2020-10-14T13:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib,Code name:,RP-5264
2020-10-14T13:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib,Code name:,RP5264
2020-10-14T13:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib,Code name:,TGR-1202
2020-10-14T13:35:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib,Synonym:,PI3K-delta inhibitor TGR-1202
2020-09-18T12:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uncaria-tomentosa-extract,Synonym:,cat's claw herbal extract
2020-09-18T12:41:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uncaria-tomentosa-extract,Synonym:,Uncaria tomentosa
2020-10-14T13:35:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cfructose,Synonym:,[U-13C]fructose
2020-10-14T13:35:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cfructose,Synonym:,U-13C-fructose
2020-10-14T13:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglucose,Synonym:,[U-13C] glucose
2020-10-14T13:35:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglucose,Synonym:,U-13C-glucose
2020-10-14T13:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglutamine,Synonym:,[U-13C]glutamine
2020-10-14T13:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglutamine,Synonym:,U-13C-Gln
2020-10-14T13:35:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglutamine,Synonym:,U-13C-glutamine
2020-10-14T13:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13clactate,Synonym:,[U-13C]lactate
2020-10-14T13:35:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13clactate,Synonym:,U-13C-lactate
2020-09-18T12:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-u-13c-glucose,Synonym:,[U-13C] glucose
2020-09-18T12:42:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-u-13c-glucose,Synonym:,U-13C-glucose
2020-10-14T13:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upamostat,Chemical structure:,"N-α-(2,4,6-triisopropylphenyl-sulfonyl)-3-hydroxyamidino-(L )-phenylalanine-4-ethoxycarbonylpiperazide"
2020-10-14T13:19:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upamostat,Code name:,WX-671
2020-10-14T03:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab,Code name:,XMT 1535
2020-10-14T03:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab,Code name:,XMT-1535
2020-10-14T03:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab,Code name:,XMT1535
2020-10-14T03:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab,Synonym:,anti-NaPi2b MoAb XMT-1535
2020-10-14T03:53:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab,Synonym:,MoAb XMT-1535
2020-10-14T13:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uproleselan,Code name:,GMI-1271
2020-10-14T13:35:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uproleselan,Synonym:,E-selectin antagonist GMI-1271
2020-10-14T03:26:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uprosertib,Code name:,GSK2141795
2020-10-14T03:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urabrelimab,Code name:,SRF 231
2020-10-14T03:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urabrelimab,Code name:,SRF-231
2020-10-14T03:40:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urabrelimab,Code name:,SRF231
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Chemical structure:,"2,4(1H,3H)-pyrimidinedione"
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Code name:,BMS-205603-01
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Code name:,SQ-6201
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Synonym:,2-hydroxy-4-(1H)-pyrimidione
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Synonym:,2-hydroxy-4-(3H)-pyrimidione
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Synonym:,"2,4-dioxopyrimidine"
2020-09-18T12:42:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil,Synonym:,"2,4-pyrimidinediol"
2020-09-18T12:42:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil-ointment,NA,NA
2020-09-18T12:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urelumab,Code name:,BMS-663513
2020-09-18T12:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urelumab,Synonym:,anti-4-1BB monoclonal antibody
2020-09-18T12:42:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urelumab,Synonym:,anti-CD137 monoclonal antibody
2020-09-18T12:42:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine,Abbreviation:,UR
2020-09-18T12:42:53Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine,Abbreviation:,Urd
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Abbreviation:,TAU
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Code name:,PN401
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Code name:,RG2133
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Synonym:,tri-O-acetyluridine
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Synonym:,triacetyluridine
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,Synonym:,vistonuridine
2020-09-18T12:42:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate,US brand name:,Vistogard
2020-09-18T12:43:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-peptide-montanide-isa51-vaccine,NA,NA
2020-10-14T13:36:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-peptide-vaccine,NA,NA
2020-09-18T12:43:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-ttk-koc1-vegfr1-vegfr2-multipeptide-vaccine,NA,NA
2020-09-18T12:43:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urokinase-derived-peptide-a6,Abbreviation:,A6
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Abbreviation:,UDCA
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Chemical structure:,"(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-oic acid"
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Foreign brand name:,Deursil
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,Synonym:,ursodeoxycholic acid
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,Actigall
2020-09-18T01:19:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol,US brand name:,URSO
2020-10-14T13:36:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursolic-acid,Chemical structure:,(3beta)-3-hydroxyurs-12-en-28-oic acid
2020-09-18T12:43:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/usp14-uchl5-inhibitor-vlx1570,Code name:,VLX1570
2020-09-18T11:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab,Code name:,CNTO 1275
2020-09-18T11:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab,Code name:,CNTO1275
2020-09-18T11:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab,Synonym:,anti-IL12 beta monoclonal antibody CNTO1275
2020-09-18T11:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab,Synonym:,"immunoglobulin G1, anti-(human interleukin-12 subunit beta (IL-12B, CLMF p40, NKSF2)) (human monoclonal CNTO 1275 gamma1-chain), disulfide with human monoclonal CNTO 1275 kappa-chain, dimer"
2020-09-18T11:48:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab,US brand name:,Stelara
2020-09-18T12:43:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uv1-telomerase-peptide-vaccine,Synonym:,UV1/hTERT peptide vaccine
2020-10-14T12:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uzansertib,Code name:,INCB 053914
2020-10-14T12:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uzansertib,Code name:,INCB053914
2020-10-14T12:58:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uzansertib,Code name:,INCB53914
2020-09-18T12:43:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/v930-vaccine,NA,NA
2020-09-18T12:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen,Abbreviation:,VAC
2020-09-18T12:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen,Acronym:,CTX/DACT/VCR
2020-09-18T12:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen,Synonym:,cyclophosphamide/dactinomycin/vincristine
2020-09-18T12:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen,Synonym:,vincristine/actinomycin-D/cyclophosphamide
2020-09-18T12:43:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen,Synonym:,vincristine/dactinomycin/cyclophosphamide
2020-09-18T12:44:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccine-sensitized-draining-lymph-node-cells,Abbreviation:,vDLN cells
2020-09-18T12:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-tyrosinase-vaccine,Synonym:,rV-TYR Vaccine
2020-09-18T12:44:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-tyrosinase-vaccine,Synonym:,VACTYROS
2020-10-14T13:36:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-virus-dd-cdsr,Code name:,JX-929
2020-09-18T12:44:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-virus-vvdd-cdsr,Code name:,JX-929
2020-10-14T13:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vactosertib,Code name:,TEW-7197
2020-10-14T13:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vactosertib,Code name:,TEW7197
2020-10-14T13:36:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vactosertib,Synonym:,TGFBR1 inhibitor TEW-7197
2020-10-14T03:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadacabtagene-leraleucel,Code name:,JCAR 015
2020-10-14T03:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadacabtagene-leraleucel,Code name:,JCAR 15
2020-10-14T03:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadacabtagene-leraleucel,Code name:,JCAR015
2020-10-14T03:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadacabtagene-leraleucel,Synonym:,anti-CD19/CD28/zeta modified CAR CD3+ T lymphocytes JCAR015
2020-09-18T12:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadastuximab-talirine,Code name:,33A
2020-09-18T12:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadastuximab-talirine,Code name:,SGN-CD33A
2020-09-18T12:44:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadastuximab-talirine,Synonym:,anti-CD33 antibody-drug conjugate SGN-CD33A
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Abbreviation:,"5,6-MexXAA"
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Abbreviation:,DMXAA
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Chemical structure:,"5,6-Dimethylxanthenone-4-Acetic Acid"
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Code name:,AS1404
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Code name:,ASA404
2020-09-18T12:44:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan,Synonym:,Dimethyloxoxanthene Acetic Acid
2020-09-18T12:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride,Chemical structure:,L-valine ester with 9-((2-hydroxyethoxy)methyl)guanine hydrochloride
2020-09-18T12:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride,Code name:,256U87 hydrochloride
2020-09-18T12:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride,Code name:,BW-256U87
2020-09-18T12:44:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride,US brand name:,Valtrex
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,Chemical structure:,4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,Code name:,SC 65872
2020-09-18T04:40:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib,US brand name:,Bextra
2020-10-14T13:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valemetostat-tosylate,Chemical structure:,"1,3-benzodioxole-5-carboxamide, 7-chloro-N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-2-(trans-4-(dimethylamino)cyclohexyl)-2,4-dimethyl-, (2R)-, compd. with 4-methylbenzenesulfonate (1:1)"
2020-10-14T13:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valemetostat-tosylate,Code name:,DS 3201b
2020-10-14T13:36:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valemetostat-tosylate,Code name:,DS-3201 tosylate
2020-10-14T13:36:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valerian,Synonym:,valerian
2020-09-18T12:45:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valeriana-officinalis-extract,Synonym:,valerian
2020-09-18T12:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valganciclovir,Abbreviation:,VGCV
2020-09-18T12:44:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valganciclovir,US brand name:,Valcyte
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Abbreviation:,VA
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Chemical structure:,2-Propylpentanoic Acid2-Propylvaleric AcidDi-n-propylacetic Acid
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Alti-Valproic
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Ergenyl
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Foreign brand name:,Novo-Valproic
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Stavzor
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,Synonym:,Valproate Sodium
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depacon
2020-09-18T05:58:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid,US brand name:,Depakene
2020-10-14T13:36:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid-expanded-umbilical-cord-blood-derived-cd34-positive-cells,Synonym:,VPA-expanded cord blood stem cells
2020-10-14T13:36:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid-expanded-umbilical-cord-blood-derived-cd34-positive-cells,Synonym:,VPA-expanded UCB stem cells
2020-10-14T13:36:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid-expanded-umbilical-cord-blood-derived-cd34-positive-cells,Synonym:,VPA-expanded UCB-derived CD34-positive cells
2020-09-18T12:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin,Chemical structure:,N-trifluoroacetyladriamycin-14-valerate
2020-09-18T12:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin,Code name:,AD 32
2020-09-18T12:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin,Foreign brand name:,Valtaxin
2020-09-18T12:45:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin,US brand name:,Valstar
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,Chemical structure:,"L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine"
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,Code name:,CGP 48933
2020-09-18T06:07:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan,US brand name:,Diovan
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Chemical structure:,"6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]cyclosporin Dcyclo((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-me"
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,Code name:,PSC 833
2020-09-18T02:00:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar,US brand name:,Amdray
2020-09-18T12:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vamp-regimen,Synonym:,VAMP
2020-09-18T12:45:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vamp-regimen,Synonym:,vincristine-Adriamycin-methotrexate-prednisone regimen
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,Code name:,AZD6474
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,Code name:,ZD6474
2020-09-18T05:01:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib,US brand name:,Caprelsa
2020-10-14T13:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814,Acronym:,VERB
2020-10-14T13:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814,Code name:,BTG-002814
2020-10-14T13:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814,Synonym:,vandetanib-eluting radiopaque embolic beads
2020-10-14T13:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814,Synonym:,VERB BTG-002814
2020-10-14T13:36:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814,Synonym:,VTB-loaded beads
2020-09-18T12:46:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vantictumab,Code name:,OMP-18R5
2020-09-18T12:46:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vantictumab,Synonym:,anti-Wnt signaling pathway monoclonal antibody OMP-18R5
2020-09-18T08:30:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride,US brand name:,Levitra
2020-10-14T12:34:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride-trihydrate,US brand name:,Levitra
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Chemical structure:,"6,10-methano-6H-pyrazino[2,3-h][3]benzazeprine, 7,8,9,10-tetrahydro, (2R,3R)-2,3-dihydroxybutanedioate (1:1)7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutqanedioate"
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Code name:,CP-526555
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,Foreign brand name:,Champix
2020-09-18T05:22:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline,US brand name:,Chantix
2020-09-18T12:47:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-vaccine,Synonym:,varicella virus vaccine live
2020-09-18T12:47:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-vaccine,US brand name:,Varivax
2020-09-18T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen,Synonym:,human herpesvirus 3 live (attenuated) antigen
2020-09-18T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen,Synonym:,varicella-zoster virus live
2020-09-18T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen,Synonym:,zoster vaccine live
2020-09-18T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen,US brand name:,Varivax
2020-09-18T12:47:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen,US brand name:,Zostavax
2020-09-18T12:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab,Code name:,CDX 1127
2020-09-18T12:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab,Code name:,CDX-1127
2020-09-18T12:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab,Synonym:,anti-CD27 monoclonal antibody CDX-1127
2020-09-18T12:47:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab,Synonym:,"immunoglobulin G1, anti-(human CD antigen CD27) (human monoclonal CDX1127 clone 1f5 heavy chain), disulfide with human monoclonal CDX-1127 clone 1f5 kappa chain, dimer"
2020-09-18T12:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlitinib,Code name:,ARRY-334543
2020-09-18T12:47:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlitinib,Synonym:,ASLAN001
2020-09-18T12:48:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-disrupting-agent-bnc105p,Code name:,BNC105P
2020-10-14T13:40:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-disrupting-agent-zd6126,Chemical structure:,"N-[(5S)-6,7-dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo[a,c]cyclohepten-5-yl]acetamideN-acetylcochinol-O-phosphate"
2020-10-14T13:40:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-disrupting-agent-zd6126,Code name:,ANG453
2020-09-18T12:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-endothelial-growth-factor-antisense-oligonucleotide,Abbreviation:,VEGF-AS
2020-09-18T12:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-endothelial-growth-factor-antisense-oligonucleotide,Synonym:,VEGF antisense oligonucleotide
2020-09-18T12:48:19Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-endothelial-growth-factor-antisense-oligonucleotide,US brand name:,Veglin
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Chemical structure:,"1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, butanedioate (1:1)"
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Code name:,CGP-79787
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Code name:,PTK787
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Code name:,ZK 222584
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Synonym:,CGP79787D
2020-09-18T12:48:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib,Synonym:,PTK787/ZK 222584
2020-09-18T12:49:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vcl-cb01-vaccine,NA,NA
2020-10-14T13:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-110,Code name:,VDA-1102
2020-10-14T13:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-110,Synonym:,VDA-1102 ointment
2020-10-14T13:37:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-110,Synonym:,VDA-1102 topical dermal ointment
2020-09-18T12:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-1102,Code name:,VDA-1102
2020-09-18T12:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-1102,Synonym:,VDA-1102 ointment
2020-09-18T12:49:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-1102,Synonym:,VDA-1102 topical dermal ointment
2020-10-14T13:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib,Code name:,SNS 062
2020-10-14T13:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib,Code name:,SNS-062
2020-10-14T13:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib,Code name:,SNS062
2020-10-14T13:37:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib,Synonym:,BTK inhibitor SNS-062
2020-09-18T09:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecuronium-bromide,Chemical structure:,"piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromide"
2020-09-18T09:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecuronium-bromide,Code name:,NC-45
2020-09-18T09:43:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecuronium-bromide,US brand name:,Norcuron
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,LDP02
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,MLN0002
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Code name:,MLN02
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,Synonym:,"immunoglobulin G1, anti-(human integrin LPAM-1 (lymphocyte Peyer's patch adhesion molecule 1)) (human-Mus musculus heavy chain), disulfide with human-Mus musculus kappa-chain, dimer"
2020-09-18T06:30:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab,US brand name:,Entyvio
2020-09-18T12:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-hgf-targeting-darpin-mp0250,Code name:,MP0250
2020-09-18T12:49:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-hgf-targeting-darpin-mp0250,Synonym:,bispecific VEGF/HGF-targeting Darpin
2020-09-18T12:49:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-inhibitor-ptc299,Code name:,PTC299
2020-09-18T12:50:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-2-dna-vaccine-vxm01,Code name:,VXM01
2020-09-18T12:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-fgfr-inhibitor-odm-203,Code name:,ODM 203
2020-09-18T12:49:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-fgfr-inhibitor-odm-203,Code name:,ODM-203
2020-09-18T12:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-inhibitor-krn951,Chemical structure:,"N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate"
2020-09-18T12:49:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-inhibitor-krn951,Code name:,KRN951
2020-09-18T12:49:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-tak-593,Code name:,TAK-593
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Chemical structure:,"(S,Z)-N-(1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide"
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Code name:,CM 082
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Code name:,CM-082
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Code name:,CM082
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Code name:,X 82
2020-09-18T12:59:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82,Code name:,X-82
2020-10-14T13:37:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-tyrosine-kinase-inhibitor-tak-593,Code name:,TAK-593
2020-09-18T12:50:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr1-1084-peptide-vaccine,NA,NA
2020-09-18T12:50:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-169-peptide-vaccine,NA,NA
2020-10-14T13:23:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-pdgfr-c-kit-flt-3-inhibitor-su014813,NA,NA
2020-09-18T12:50:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-targeted-contrast-agent-br55,Code name:,BR55
2020-09-18T12:50:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-tyrosine-kinase-inhibitor-pf-00337210,Code name:,PF-00337210
2020-09-18T12:50:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veip-regimen,Synonym:,Velban-ifosfamide-cisplatin regimen
2020-09-18T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velafermin,Acronym:,rhFGF-20
2020-09-18T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velafermin,Code name:,CG53135-05
2020-09-18T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velafermin,Synonym:,recombinant human fibroblast growth factor-20
2020-09-18T12:50:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velafermin,Synonym:,rhFGF-20
2020-10-14T13:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veledimex,Chemical structure:,"benzoic acid, 2-ethyl-3-methoxy-, 2-(3,5-dimethylbenzoyl)-2-((1R)-1-(1,1-dimethylethyl)butyl)hydrazide"
2020-10-14T13:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veledimex,Code name:,INXN-1001
2020-10-14T13:37:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veledimex,Code name:,RG-115932
2020-09-18T12:50:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veliparib,Code name:,ABT-888
2020-10-14T13:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velpatasvir,Code name:,GS 5816
2020-10-14T13:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velpatasvir,Code name:,GS-5816
2020-10-14T13:37:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velpatasvir,Code name:,GS5816
2020-09-18T12:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veltuzumab,Abbreviation:,MOAB hA20
2020-09-18T12:51:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veltuzumab,Synonym:,monoclonal antibody hA20
2020-09-18T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib,Code name:,PLX4032
2020-09-18T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib,Code name:,RG7204
2020-09-18T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib,Code name:,RO5185426
2020-09-18T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib,Synonym:,BRAF(V600E) kinase inhibitor RO5185426
2020-09-18T12:51:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib,US brand name:,Zelboraf
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Code name:,ABT-0199
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Code name:,ABT-199
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Code name:,ABT199
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Code name:,GDC-0199
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Synonym:,Bcl-2 inhibitor GDC-0199
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,Synonym:,RG7601
2020-09-18T12:51:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax,US brand name:,Venclexta
2020-09-18T06:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine,Abbreviation:,VNF
2020-09-18T06:19:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine,US brand name:,Effexor
2020-10-14T04:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine-hydrochloride-extended-release,Synonym:,Venlafaxine HCl ER
2020-10-14T04:56:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine-hydrochloride-extended-release,US brand name:,Effexor XR
2020-09-18T12:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vepoloxamer,Code name:,MST-188
2020-09-18T12:52:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vepoloxamer,Synonym:,purified poloxamer 188
2020-09-18T12:52:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verapamil,Chemical structure:,"alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile"
2020-09-18T12:52:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verapamil,US brand name:,Verapamil SR
2020-10-14T05:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verpasep-caltespen,Code name:,SGN-00101
2020-10-14T05:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verpasep-caltespen,Synonym:,HPV 16 E7/HSP65 Vaccine
2020-10-14T05:20:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verpasep-caltespen,Synonym:,HPV E7 Peptide Epitope Vaccine
2020-09-18T12:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verteporfin,Abbreviation:,BPD-MA
2020-09-18T12:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verteporfin,Synonym:,Benzoporphyrin Derivative Monoacid Ring A
2020-09-18T12:52:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verteporfin,US brand name:,Visudyne
2020-09-18T04:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride,Code name:,MPC-6827
2020-09-18T04:29:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride,US brand name:,Azixa
2020-10-14T03:53:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vesencumab,Code name:,MNRP1685A
2020-10-14T05:14:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vesigenurtucel-l,Code name:,HS-410
2020-10-14T13:39:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vgefr-c-kit-pdgfr-tyrosine-kinase-inhibitor-xl820,Synonym:,XL820-001
2020-09-18T12:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l,Code name:,HS-110
2020-09-18T12:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l,Code name:,HS110
2020-09-18T12:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l,Synonym:,AD100-gp96-Ig-HLA A1
2020-09-18T12:52:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l,Synonym:,gp96-Ig-secreting allogeneic tumor-cell vaccine HS110
2020-10-14T03:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vibecotamab,Code name:,XmAb14045
2020-10-14T03:35:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vibecotamab,Synonym:,anti-CD123/anti-CD3 bispecific antibody XmAb1404
2020-10-14T13:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vicriviroc,Code name:,MK-7690
2020-10-14T13:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vicriviroc,Code name:,SCH 417690
2020-10-14T13:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vicriviroc,Code name:,SCH-D
2020-10-14T13:37:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vicriviroc,Code name:,SCH417690
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Abbreviation:,ARA-A
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Chemical structure:,9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate9-Beta-D-arabinofuranosyladenine Monohydrate
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Code name:,CI-673
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Foreign brand name:,Arasena-A
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Synonym:,adenine arabinoside
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Synonym:,araadenosine
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Synonym:,Arabinosyladenine
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Synonym:,Beta Ara-A
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,Synonym:,Spongoadenosine
2020-09-18T12:53:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine,US brand name:,Vira-A
2020-10-14T13:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vilaprisan,Chemical structure:,"(8S,11R,13S,14S,17S)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one"
2020-10-14T13:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vilaprisan,Code name:,BAY 1002670
2020-10-14T13:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vilaprisan,Code name:,BAY-1002670
2020-10-14T13:37:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vilaprisan,Code name:,BAY1002670
2020-09-18T12:54:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vildagliptin,NA,NA
2020-09-18T12:54:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinblastine-sulfate,Code name:,29060-LE
2020-09-18T12:54:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinblastine-sulfate,Foreign brand name:,Exal
2020-09-18T12:54:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinblastine-sulfate,Foreign brand name:,Velbe
2020-09-18T12:54:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate,Foreign brand name:,Kyocristine
2020-09-18T12:54:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate,Synonym:,leurocristine sulfate
2020-09-18T08:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome,Synonym:,liposomal vincristine sulfate
2020-09-18T08:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome,Synonym:,vincristine liposomal
2020-09-18T08:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome,Synonym:,vincristine sulfate liposome injection
2020-09-18T08:55:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome,US brand name:,Marqibo
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Code name:,LY-099094
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Eldisin
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Enison
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Foreign brand name:,Gesidine
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,desacetyl vinblastine amide sulfate
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,vindesine sulphate
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,Synonym:,vindesini sulfas
2020-09-18T06:23:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate,US brand name:,Eldisine
2020-09-18T12:54:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinflunine,Chemical structure:,"4'-Deoxy-20',20'-difluoro-C'-norvincaleukoblastine"
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Abbreviation:,NVB
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Code name:,KW-2307
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Foreign brand name:,Biovelbin
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Foreign brand name:,Eunades
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Foreign brand name:,Navelbine
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Synonym:,navelbine ditartrate
2020-09-18T12:54:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate,Synonym:,vinorelbine ditartrate
2020-09-18T12:54:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate-emulsion,Code name:,ANX-530
2020-09-18T12:55:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate-oral,Foreign brand name:,Navelbine Oral
2020-09-18T12:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vintafolide,Code name:,EC145
2020-09-18T12:55:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vintafolide,Synonym:,folate-vinca alkaloid conjugate EC145
2020-09-18T12:55:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vip-regimen,Abbreviation:,VIP
2020-09-18T12:55:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vip-regimen,Synonym:,etoposide-ifosfamide-cisplatin regimen
2020-09-18T12:55:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vip-regimen,Synonym:,VePesid-ifosfamide-Platinol regimen
2020-09-18T12:55:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vip-regimen,Synonym:,VP16-ifosfamide-Platinol regimen
2020-09-18T12:56:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/virulizin,Abbreviation:,VIRU
2020-09-18T09:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/visilizumab,Code name:,HuM291
2020-09-18T09:47:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/visilizumab,US brand name:,Nuvion
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Chemical structure:,2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Code name:,GDC-0449
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,Synonym:,Hedgehog antagonist GDC-0449
2020-09-18T06:34:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib,US brand name:,Erivedge
2020-09-18T12:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vistusertib,Code name:,AZD2014
2020-09-18T12:56:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vistusertib,Synonym:,mTOR kinase inhibitor AZD2014
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Chemical structure:,"3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol"
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,A 313
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Arovit
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Avibon
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Avitol
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Axerol
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Biovit-A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Ido A 50
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Idrurto A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Ledovit A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Micelle A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Mulsal A Megadosis
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Rinocusi Vitaminico
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Vitaminoftalmina
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Foreign brand name:,Vogan
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,anti-infective vitamin
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,antixerophthalmic vitamin
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Axerophthol
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Axerophtholum
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Biosterol
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Lard-Factor
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Oleovitamin A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Ophthalamin
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,vitamin A alcohol
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,vitamin A USP
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,vitamin A1
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,Synonym:,Vitaminum A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,US brand name:,Aquasol A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,US brand name:,Del-Vi-A
2020-10-14T04:01:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound,US brand name:,Pedi-Vit-A
2020-09-18T12:57:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-d,Abbreviation:,VIT D
2020-09-18T12:57:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-d,Synonym:,D vitamin
2020-09-18T12:57:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-e,Abbreviation:,VIT E
2020-10-14T13:37:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-e-compound,Abbreviation:,VIT E
2020-09-18T12:57:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-k,Synonym:,"2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione"
2020-09-18T12:57:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-k1-containing-urea-skin-cream,Foreign brand name:,Reconval K1
2020-10-14T13:26:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamins-minerals-proteins-based-synthetic-meal-replacement,US brand name:,Tality
2020-09-18T09:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen,Code name:,HSPPC-96
2020-09-18T09:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen,Synonym:,autologous gp96 heat shock protein peptide complex vaccine
2020-09-18T09:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen,Synonym:,gp96 HSP-peptide complex
2020-09-18T09:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen,Synonym:,heat shock protein peptide complex-96
2020-09-18T09:54:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen,US brand name:,Oncophage
2020-09-18T12:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vlp-encapsulated-tlr9-agonist-cmp-001,Code name:,ARB-1598
2020-09-18T12:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vlp-encapsulated-tlr9-agonist-cmp-001,Code name:,CMP-001
2020-09-18T12:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vlp-encapsulated-tlr9-agonist-cmp-001,Code name:,CYT 003
2020-09-18T12:58:03Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vlp-encapsulated-tlr9-agonist-cmp-001,Code name:,CYT-003
2020-09-18T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vocimagene-amiretrorepvec,Code name:,Toca 511
2020-09-18T12:58:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vocimagene-amiretrorepvec,Synonym:,retroviral virus vector encoding cytosine deaminase
2020-10-14T13:38:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vofatamab,Code name:,B-701
2020-10-14T13:38:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vofatamab,Synonym:,anti-FGFR3 monoclonal antibody B-701
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Chemical structure:,"3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositolN-(1,3-dihydroxy-2-propyl)valiolamine"
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Code name:,A-71100
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,Code name:,AO-128
2020-09-18T04:31:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose,US brand name:,Basen
2020-09-18T12:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volasertib,Abbreviation:,PLK-1 inhibitor BI 6727
2020-09-18T12:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volasertib,Code name:,BI 6727
2020-09-18T12:58:24Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volasertib,Synonym:,Polo-like kinase 1 inhibitor BI 6727
2020-09-18T11:29:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volitinib,Code name:,HMPL-504
2020-09-18T11:29:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volitinib,Synonym:,AZD6094
2020-09-18T11:29:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volitinib,Synonym:,volitinib
2020-09-18T12:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab,Abbreviation:,anti-α5β1 integrin MOAB
2020-09-18T12:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab,Code name:,M200
2020-09-18T12:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab,Synonym:,anti-alpha 5 beta 1 integrin monoclonal antibody
2020-09-18T12:58:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab,Synonym:,anti-α5β1 integrin
2020-09-18T12:58:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/von-hippel-lindau-peptide-vaccine,Synonym:,VHL peptide vaccine
2020-09-18T12:58:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/von-hippel-lindau-peptide-vaccine,Synonym:,VHL Peptides
2020-10-14T13:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vonoprazan-fumarate,Chemical structure:,"1H-pyrrole-3-methanamine, 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1)"
2020-10-14T13:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vonoprazan-fumarate,Code name:,TAK-438
2020-10-14T13:25:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vonoprazan-fumarate,US brand name:,Takecab
2020-10-14T13:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vopratelimab,Code name:,JTX-2011
2020-10-14T13:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vopratelimab,Synonym:,anti-ICOS agonist MAb JTX-2011
2020-10-14T13:38:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vopratelimab,Synonym:,ICOS agonist monoclonal antibody JTX-2011
2020-10-14T13:38:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib,Code name:,AG 881
2020-10-14T13:38:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib,Code name:,AG-881
2020-09-18T12:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voriconazole,Abbreviation:,VCZ
2020-09-18T12:52:42Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voriconazole,US brand name:,Vfend
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,Abbreviation:,SAHA
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,Chemical structure:,N-hydroxy-N'-phenyloctanediamide
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,Code name:,L-001079038
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,Code name:,MSK390
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,Synonym:,suberoylanilide hydroxamic acid
2020-09-18T12:59:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat,US brand name:,Zolinza
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Chemical structure:,"(S,Z)-N-(1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide"
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Code name:,CM 082
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Code name:,CM-082
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Code name:,CM082
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Code name:,X 82
2020-10-14T13:38:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib,Code name:,X-82
2020-09-18T12:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetuzumab-mafodotin,Code name:,SGN-75
2020-09-18T12:59:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetuzumab-mafodotin,Synonym:,anti-CD70 monoclonal antibody SGN-75
2020-10-14T13:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetzumab-mafodotin,Code name:,SGN-75
2020-10-14T13:38:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetzumab-mafodotin,Synonym:,anti-CD70 monoclonal antibody SGN-75
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,Chemical structure:,"1-(2-((2,4-dimethylphenyl)sulfanyl)phenyl)piperazine monohydrobromidepiperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-, hydrobromide (1:1)"
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,Foreign brand name:,Trintellix
2020-09-18T04:50:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide,US brand name:,Brintellix
2020-09-18T12:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin,Chemical structure:,"1,4-dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid"
2020-09-18T12:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin,Code name:,AG-7352
2020-09-18T12:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin,Code name:,SNS-595
2020-09-18T12:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin,Code name:,SPC 595
2020-09-18T12:59:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin,Synonym:,voreloxin
2020-10-14T13:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm,Code name:,RAD 140
2020-10-14T13:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm,Code name:,RAD-140
2020-10-14T13:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm,Code name:,RAD140
2020-10-14T13:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm,Synonym:,SARM RAD140
2020-10-14T13:18:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm,US brand name:,Testolone
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Chemical structure:,"2-hydroxy-6-((2-(1-(propan-2-yl)-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehydebenzaldehyde, 2-hydroxy-6-((2-(1-(1-methylethyl)-1H-pyrazol-5-yl)-3-pyridinyl)methoxy)-"
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Code name:,GBT 440
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Code name:,GBT-440
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Code name:,GBT440
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Code name:,GTx 011
2020-10-14T13:38:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor,Code name:,GTx-011
2020-10-14T13:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxilaprevir,Code name:,GS 9857
2020-10-14T13:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxilaprevir,Code name:,GS-9857
2020-10-14T13:38:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxilaprevir,Code name:,GS9857
2020-10-14T13:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxtalisib,Code name:,SAR245409
2020-10-14T13:05:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxtalisib,Code name:,XL765
2020-10-14T13:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vt30-topical-gel,Code name:,VT 30
2020-10-14T13:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vt30-topical-gel,Code name:,VT-30
2020-10-14T13:38:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vt30-topical-gel,Code name:,VT30
2020-10-14T04:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vulinacimab,Code name:,HLX 06
2020-10-14T04:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vulinacimab,Code name:,HLX-06
2020-10-14T04:00:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vulinacimab,Code name:,HLX06
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Marevan
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Waran
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Foreign brand name:,Warfilone
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Synonym:,prothromadin
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,Synonym:,tintorane
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,US brand name:,Coumadin
2020-09-18T05:42:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium,US brand name:,Panwarfin
2020-09-18T13:00:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-based-vaginal-lubricant,NA,NA
2020-09-18T13:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-o-15,Abbreviation:,[15O]-H2O
2020-09-18T13:00:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-o-15,Synonym:,[15O] water
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Chemical structure:,"2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one"
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,AZD1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK-1775
2020-09-18T01:24:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775,Code name:,MK1775
2020-10-14T13:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-kinase-inhibitor-debio-0123,Code name:,Debio 0123
2020-10-14T13:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-kinase-inhibitor-debio-0123,Code name:,Debio-0123
2020-10-14T13:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-kinase-inhibitor-debio-0123,Code name:,Debio0123
2020-10-14T13:38:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-kinase-inhibitor-debio-0123,Synonym:,Wee1 inhibitor Debio 0123
2020-09-18T13:01:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wheatgrass-juice,Synonym:,wheat germ juice
2020-09-18T07:57:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate,Synonym:,milk serum protein isolate
2020-09-18T07:57:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate,Synonym:,undenatured bioactive whey protein derivative
2020-09-18T07:57:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate,US brand name:,Immunocal
2020-10-14T04:30:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate-based-nutritional-supplement,US brand name:,Boost Breeze
2020-09-18T13:01:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-button-mushroom-extract,Abbreviation:,WBM extract
2020-09-18T13:01:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-carrot,NA,NA
2020-09-18T13:01:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-wine,NA,NA
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,Code name:,PO BB0209
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,Code name:,PO-BB0209
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,Foreign brand name:,Reolysin
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,Synonym:,reovirus serotype 3
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,Synonym:,wild-type reovirus
2020-09-18T10:19:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus,US brand name:,Reolysin
2020-09-18T13:01:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-5a-mimic-hexapeptide-foxy-5,Code name:,foxy-5
2020-09-18T13:01:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-signaling-pathway-inhibitor-sm08502,Code name:,SM 08502
2020-09-18T13:01:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-signaling-pathway-inhibitor-sm08502,Code name:,SM-08502
2020-09-18T13:01:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-signaling-pathway-inhibitor-sm08502,Code name:,SM08502
2020-09-18T13:02:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt-1-analogue-peptide-vaccine,Synonym:,WT-1 vax
2020-09-18T13:01:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-124-138-peptide-vaccine,NA,NA
2020-09-18T13:01:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-126-134-peptide-vaccine,NA,NA
2020-09-18T13:02:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-235-243-peptide-vaccine,NA,NA
2020-09-18T13:02:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-247-261-peptide-vaccine,NA,NA
2020-09-18T13:02:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-a10-as01b-immunotherapeutic-gsk2130579a,Code name:,GSK2130579A
2020-10-14T13:39:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-analog-peptide-vaccine,Synonym:,WT-1 vax
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Code name:,ASP 7517
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Code name:,ASP-7517
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Code name:,ASP7517
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Synonym:,WT1-loaded aAVC immunotherapeutic ASP7517
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Synonym:,WT1-loaded aAVCs ASP7517
2020-10-14T13:39:06Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517,Synonym:,WT1-loaded artificial adjuvant vector cells ASP7517
2020-09-18T13:02:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-mrna-electroporated-autologous-dendritic-cell-vaccine,Synonym:,Wilms tumor 1 mRNA-electroporated autologous dendritic cell vaccine
2020-09-18T13:02:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-ocv-501,Code name:,OCV-501
2020-09-18T13:02:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-wt2725,Code name:,WT2725
2020-10-14T13:39:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-prame-survivin-specific-cytotoxic-t-lymphocytes,Synonym:,WT1/PRAME/survivin-specific CTLs
2020-09-18T13:02:36Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-protein-derived-peptide-vaccine-dsp-7888,Code name:,DSP-7888
2020-10-14T13:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-psma-htert-encoding-plasmid-dna-ino-5401,Code name:,INO 5401
2020-10-14T13:39:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-psma-htert-encoding-plasmid-dna-ino-5401,Code name:,INO5401
2020-10-14T13:39:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-sensitized-allogeneic-t-lymphocytes,NA,NA
2020-09-18T13:03:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-sensitized-t-cells,NA,NA
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Abbreviation:,WLS
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,Hoelen five herb formula
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,Poria five powder
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,powder of five drugs with Poria
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,WLS formula
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,wu ling pian
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,wu ling san
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,wu ling wan
2020-09-18T13:03:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san,Synonym:,wuling san
2020-09-18T13:03:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xaliproden-hydrochloride,Code name:,SR 57746A
2020-09-18T13:03:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xanthohumol,Chemical structure:,"3'-[3,3-dimethyl allyl]-2',4',4-trihydroxy-6'-methoxychalcone"
2020-09-18T13:03:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xbp1-us-xbp1-sp-cd138-cs1-multipeptide-vaccine-pvx-410,Code name:,PVX-410
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,capecitabine-irinotecan regimen
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,capecitabine/irinotecan regimen
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,Capiri
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,CAPIRI
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,Xeloda-Camptosar regimen
2020-09-18T13:03:50Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen,Synonym:,Xeloda/Camptosar regimen
2020-09-18T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xelox-regimen,Synonym:,capecitabine-oxaliplatin regimen
2020-09-18T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xelox-regimen,Synonym:,Xeloda-oxaliplatin regimen
2020-09-18T13:04:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xelox-regimen,Synonym:,XELOX
2020-09-18T13:04:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xenogeneic-tyrosinase-dna-vaccine,NA,NA
2020-09-18T13:04:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xenon,Abbreviation:,Xe
2020-09-18T13:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xentuzumab,Code name:,BI 836845
2020-09-18T13:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xentuzumab,Synonym:,IGF ligand neutralizing antibody BI 836845
2020-09-18T13:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao,Abbreviation:,XLGB
2020-09-18T13:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao,Synonym:,xian ling gu bao
2020-09-18T13:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao,Synonym:,xian-ling-gu-bao
2020-09-18T13:04:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao,Synonym:,xianlinggubao
2020-10-14T13:39:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiaoai-jiedu-decoction,Synonym:,Xiaoai Jiedu recipe
2020-10-14T03:25:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-antisense-oligonucleotide-aeg35156,US brand name:,GEM640
2020-09-18T13:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-ciap1-antagonist-astx660,Code name:,ASTX 660
2020-09-18T13:04:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-ciap1-antagonist-astx660,Code name:,ASTX660
2020-10-14T13:39:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xinmailong,Abbreviation:,XML
2020-09-18T13:05:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xl820,Synonym:,XL820-001
2020-09-18T13:05:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xl844,NA,NA
2020-09-18T13:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xpo1-inhibitor-kpt-8602,Code name:,KPT-8602
2020-09-18T13:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xpo1-inhibitor-kpt-8602,Synonym:,exportin 1 inhibitor KPT-8602
2020-09-18T13:05:45Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xpo1-inhibitor-kpt-8602,Synonym:,selective inhibitor of nuclear export KPT-8602
2020-09-18T13:07:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/y-shape-branched-pegylated-filgrastim,Abbreviation:,YPEG-filgrastim
2020-09-18T13:07:35Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/y-shape-branched-pegylated-filgrastim,Abbreviation:,YPEG-rhG-CSF
2020-09-18T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fang,Synonym:,TCM Yang Yin Fang
2020-09-18T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fang,Synonym:,traditional Chinese medicine Yang Yin Fang
2020-09-18T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fang,Synonym:,Yang-Yin-Fang
2020-09-18T13:06:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fang,Synonym:,YangYinFang
2020-09-18T13:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fu-zheng,Synonym:,Fu Zheng Yang Yin
2020-09-18T13:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fu-zheng,Synonym:,Fu Zheng Yang Yin decoction
2020-09-18T13:06:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fu-zheng,Synonym:,TCM Yang Yin Fu Zheng
2020-09-18T13:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang,Synonym:,TCM YiQiFang
2020-09-18T13:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang,Synonym:,traditional Chinese medicine Yi Qi Fang
2020-09-18T13:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang,Synonym:,traditional Chinese medicine YiQiFang
2020-09-18T13:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang,Synonym:,Yi-Qi-Fang
2020-09-18T13:06:58Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang,Synonym:,YiQiFang
2020-09-18T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-yang-yin-fang,Synonym:,TCM Yi-qi-yang-yin Fang
2020-09-18T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-yang-yin-fang,Synonym:,traditional Chinese medicine Yi-qi-yang-yin Fang
2020-09-18T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-yang-yin-fang,Synonym:,Yi-qi-yang-yin Fang
2020-09-18T13:07:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-yang-yin-fang,Synonym:,YiQiYangYinFang
2020-09-18T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yiqi-yangyin-jiedu-herbal-decoction,Abbreviation:,YYJD
2020-09-18T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yiqi-yangyin-jiedu-herbal-decoction,Synonym:,TCM yiqi-yangyin-jiedu decoction
2020-09-18T13:07:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yiqi-yangyin-jiedu-herbal-decoction,Synonym:,yiqi yangyin jiedu decoction
2020-09-18T13:07:14Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ym598,NA,NA
2020-09-18T13:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yoshi-864,Code name:,NCI-C01547
2020-09-18T13:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yoshi-864,Code name:,Yoshi 864
2020-09-18T13:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yoshi-864,Synonym:,Compound 864
2020-09-18T13:07:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yoshi-864,Synonym:,IPD Hydrochloride
2020-10-14T13:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/young-autologous-tumor-infiltrating-lymphocytes,Synonym:,therapeutic young autologous TILs
2020-10-14T13:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/young-autologous-tumor-infiltrating-lymphocytes,Synonym:,young autologous TIL
2020-10-14T13:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/young-autologous-tumor-infiltrating-lymphocytes,Synonym:,young autologous TILs
2020-10-14T13:40:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/young-autologous-tumor-infiltrating-lymphocytes,Synonym:,young autologous tumor infiltrating lymphocytes
2020-09-18T13:09:52Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-90-polycarbonate-brachytherapy-plaque,NA,NA
2020-09-18T13:07:40Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd19-monoclonal-antibody-bu12,NA,NA
2020-09-18T13:07:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd45-monoclonal-antibody-ahn-12,Abbreviation:,Y 90 AHN-12
2020-09-18T13:07:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd45-monoclonal-antibody-bc8,Abbreviation:,90Y anti-CD45 MAb BC8
2020-09-18T13:07:51Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd45-monoclonal-antibody-bc8,Abbreviation:,90Y anti-CD45 MoAb BC8
2020-09-18T13:07:56Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd66-monoclonal-antibody-bw-250-183,NA,NA
2020-09-18T13:08:01Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cdh3-monoclonal-antibody-ff-21101,Abbreviation:,FF-21101(90Y)
2020-09-18T13:08:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cea-monoclonal-antibody-ct8466,NA,NA
2020-10-14T13:40:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-basiliximab,Synonym:,90Y basiliximab
2020-09-18T13:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan,Abbreviation:,Y90 DOTA MOAB HuPAM4
2020-09-18T13:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan,Code name:,IMMU-107
2020-09-18T13:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan,Synonym:,90Y-hPAM4
2020-09-18T13:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan,Synonym:,hPAM4-DOTA
2020-09-18T13:08:12Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan,Synonym:,yttrium Y 90 DOTA monoclonal antibody HuPAM4
2020-09-18T13:08:17Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-colloid,Synonym:,90Y colloid
2020-09-18T13:08:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-daclizumab,Synonym:,Y90 daclizumab
2020-09-18T13:08:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-daclizumab,Synonym:,Y90 MOAB anti-Tac
2020-09-18T13:08:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-anti-cea-monoclonal-antibody-m5a,NA,NA
2020-09-18T13:08:33Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-biotin,Abbreviation:,90Y-DOTA-biotin
2020-09-18T13:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-di-hsg-peptide-imp-288,Abbreviation:,90-Y-IMP-288
2020-09-18T13:09:26Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-di-hsg-peptide-imp-288,Abbreviation:,90Y-IMP288
2020-09-18T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-girentuximab,Abbreviation:,90Y-DOTA-cG250
2020-09-18T13:09:31Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-girentuximab,Synonym:,yttrium Y 90 DOTA chimeric monoclonal antibody cG250
2020-09-18T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide,Synonym:,Y90-DOTA-tyr3-octreotide
2020-09-18T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide,Synonym:,yttrium Y 90 -DOTATOC
2020-09-18T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide,Synonym:,yttrium Y 90 SMT 487
2020-09-18T13:06:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide,US brand name:,Y-90 OctreoTher
2020-09-18T13:08:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab,Synonym:,Y 90 Humanized Monoclonal Antibody LL2
2020-09-18T13:08:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab,Synonym:,Yttrium Y 90 Humanized Monoclonal Antibody LL2
2020-10-14T13:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab-tetraxetan,Synonym:,Y 90 Humanized Monoclonal Antibody LL2
2020-10-14T13:40:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab-tetraxetan,Synonym:,Yttrium Y 90 Humanized Monoclonal Antibody LL2
2020-09-18T12:16:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-glass-microspheres,US brand name:,TheraSphere
2020-09-18T13:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan,Code name:,IDEC Y2B8
2020-09-18T13:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan,Synonym:,90Y ibritumomab tiuxetan
2020-09-18T13:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan,Synonym:,IDEC-Y2B8 monoclonal antibody
2020-09-18T13:08:49Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan,Synonym:,Y90 Zevalin
2020-09-18T13:09:41Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-labeled-anti-fzd10-monoclonal-antibody-otsa101,Abbreviation:,OTSA101-DTPA-90Y
2020-09-18T13:09:46Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-labeled-basiliximab,Synonym:,90Y basiliximab
2020-09-18T13:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-b3,Abbreviation:,Y90-B3
2020-09-18T13:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-b3,Synonym:,90 Y-B3
2020-09-18T13:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-b3,Synonym:,"MOAB B3, yttrium Y 90"
2020-09-18T13:08:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-b3,Synonym:,Y 90 monoclonal antibody B3
2020-09-18T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-bre-3,Abbreviation:,Y90 MOAB BrE-3
2020-09-18T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-bre-3,Synonym:,"BrE-3 monoclonal antibody, yttrium Y 90"
2020-09-18T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-bre-3,Synonym:,"MOAB BrE-3, yttrium Y 90"
2020-09-18T13:08:59Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-bre-3,Synonym:,Y90 monoclonal antibody BrE-3
2020-09-18T13:09:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-hu3s193,Synonym:,Y90 MOAB Hu3S193
2020-09-18T13:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-mn-14,Abbreviation:,Y 90 MoAb MN-14
2020-09-18T13:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-mn-14,Synonym:,Y 90 Monoclonal Antibody MN-14
2020-09-18T13:09:10Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-mn-14,Synonym:,yttrium Y 90 MOAB MN-14
2020-09-18T13:09:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-resin-microspheres,NA,NA
2020-10-14T13:40:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-tabituximab-barzuxetan,Abbreviation:,OTSA101-DTPA-90Y
2020-09-18T13:09:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-tacatuzumab-tetraxetan,Abbreviation:,Y90 DOTA MOAB HuAFP31
2020-09-18T13:09:57Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-360,NA,NA
2020-09-18T13:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-endoxifen-hydrochloride,Chemical structure:,4-hydroxy-N-desmethyltamoxifen hydrochloride
2020-09-18T13:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-endoxifen-hydrochloride,Synonym:,(Z)-endoxifen
2020-09-18T13:11:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-endoxifen-hydrochloride,Synonym:,Z-endoxifen HCl
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,Chemical structure:,"carbamic Acid,(3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl estercyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate"
2020-09-18T01:17:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast,US brand name:,Accolate
2020-09-18T07:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine,Abbreviation:,ddC
2020-09-18T07:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine,Chemical structure:,"2',3'-dideoxycytidine"
2020-09-18T07:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine,Synonym:,dideoxycytidine
2020-09-18T07:37:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine,US brand name:,Hivid
2020-10-14T03:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalifrelimab,Code name:,AGEN-1884
2020-10-14T03:43:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalifrelimab,Code name:,AGEN1884
2020-09-18T13:10:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalutumumab,Foreign brand name:,HuMax-EGFr
2020-09-18T11:11:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanamivir,US brand name:,Relenza
2020-10-14T13:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zandelisib,Code name:,ME-401
2020-10-14T13:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zandelisib,Code name:,PWT-143
2020-10-14T13:04:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zandelisib,Code name:,PWT143
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Code name:,HuMax-CD4
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Code name:,MDX-016
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Synonym:,anti-CD4 monoclonal antibody HuMax
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Synonym:,HuMax-CD4 monoclonal antibody
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Synonym:,MOAB HuMax-CD4
2020-09-18T13:10:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab,Synonym:,monoclonal antibody HuMax-CD4
2020-10-14T04:32:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib,Chemical structure:,"(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide"
2020-10-14T04:32:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib,Code name:,BGB-3111
2020-10-14T04:32:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib,Synonym:,BTK-InhB
2020-10-14T04:32:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib,US brand name:,Brukinsa
2020-09-18T13:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zd6126,Chemical structure:,"N-[(5S)-6,7-dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo[a,c]cyclohepten-5-yl]acetamideN-acetylcochinol-O-phosphate"
2020-09-18T13:11:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zd6126,Code name:,ANG453
2020-09-18T13:12:34Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zhongyao-fufang,Synonym:,zhongyaofufang
2020-09-18T13:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zibotentan,Chemical structure:,"3-pyridinesulfonamide, N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2- yl)phenyl]-N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pridine-3- sulfonamide"
2020-09-18T13:12:39Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zibotentan,Code name:,ZD4054
2020-09-18T10:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziconotide,Code name:,SNX-111
2020-09-18T10:45:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziconotide,US brand name:,Prialt
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Abbreviation:,AZT
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Abbreviation:,ZDV
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Chemical structure:,3'-azido-3'-deoxythymidine
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Code name:,BW-A509U
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Foreign brand name:,Aztec
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,Synonym:,azidothymidine
2020-09-18T11:14:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine,US brand name:,Retrovir
2020-09-18T13:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zileuton,Abbreviation:,ZLT
2020-09-18T13:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zileuton,Chemical structure:,(+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-ureaN-(1-Benzo[b]thien-2-ylethyl)-N-hydroxyurea
2020-09-18T13:12:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zileuton,US brand name:,Zyflo
2020-10-14T13:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilucoplan,Code name:,RA 101495
2020-10-14T13:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilucoplan,Code name:,RA101495
2020-10-14T13:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilucoplan,Synonym:,C5 inhibitor RA101495
2020-10-14T13:40:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilucoplan,Synonym:,complement C5 inhibitor RA101495
2020-09-18T13:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-603,Code name:,ZFN-603
2020-09-18T13:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-603,Code name:,ZFN603
2020-09-18T13:13:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-603,Synonym:,ZFN ZFN-603
2020-09-18T13:13:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-758,Code name:,ZFN-758
2020-09-18T13:13:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-758,Code name:,ZFN758
2020-09-18T13:13:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-758,Synonym:,ZFN ZFN-758
2020-09-18T13:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-gluconate,Chemical structure:,"bis(D-gluconato-O1,O2) zinc"
2020-09-18T13:13:22Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-gluconate,Synonym:,zinc D-gluconate (1:2)
2020-09-18T13:13:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-sulfate,NA,NA
2020-09-18T13:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinostatin,Abbreviation:,NCS
2020-09-18T13:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinostatin,Synonym:,neocarzinostatin
2020-09-18T13:13:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinostatin,Synonym:,vinostatin
2020-10-14T13:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-cd8-antibody-zed88082a,Code name:,ZED88082A
2020-10-14T13:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-cd8-antibody-zed88082a,Synonym:,89Zr anti-CD8 antibody ZED88082A
2020-10-14T13:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-cd8-antibody-zed88082a,Synonym:,zirconium Zr 89-labeled anti-CD8 imaging agent ZED88082A
2020-10-14T13:40:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-cd8-antibody-zed88082a,Synonym:,Zr-89 anti-CD8 antibody ZED88082A
2020-10-14T13:41:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-egfr-monoclonal-antibody-abt-806,Synonym:,89Zr-ABT806
2020-10-14T13:41:00Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-egfr-monoclonal-antibody-abt-806,Synonym:,89Zr-labeled ABT-806
2020-09-18T13:14:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-bevacizumab,Abbreviation:,89Zr-bevacizumab
2020-09-18T13:14:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-bevacizumab,Synonym:,zirconium Zr 89 bevacizumab
2020-09-18T13:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-cetuximab,Abbreviation:,cetuximab-Zr-89
2020-09-18T13:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-cetuximab,Synonym:,cetuximab-zirconium-89
2020-09-18T13:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-cetuximab,Synonym:,zirconium Zr 89 cetuximab
2020-09-18T13:14:15Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-cetuximab,Synonym:,zirconium-89-labeled cetuximab
2020-09-18T13:14:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-desferrioxamine-b-monoclonal-antibody-huj591,Abbreviation:,89Zr-DFO-J591
2020-09-18T13:14:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-desferrioxamine-b-monoclonal-antibody-huj591,Synonym:,89Zr-DFO-huJ591
2020-09-18T13:14:20Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-desferrioxamine-b-monoclonal-antibody-huj591,Synonym:,zirconium Zr 89 desferrioxamine B monoclonal antibody huJ591
2020-09-18T13:14:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab22m2c,Synonym:,89Zr-desferrioxamine-IAB22M2C
2020-09-18T13:14:25Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab22m2c,Synonym:,89Zr-Df-IAB22M2C
2020-09-18T13:14:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab2m,Synonym:,[89Zr]Df-IAB2M
2020-09-18T13:14:30Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab2m,Synonym:,zirconium Zr 89 Df-IAB2M
2020-10-14T13:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots,Synonym:,89Zr-cRGDY
2020-10-14T13:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dot nanoparticles
2020-10-14T13:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles
2020-10-14T13:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots,Synonym:,89Zr-DFO-cRGDY-PEG-Cy5-C' dots
2020-10-14T13:41:05Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots,Synonym:,Zr 89-DFO-cRGDY PEG-Cy5-C' dots
2020-10-14T13:41:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-daratumumab,Synonym:,(89)Zr-daratumumab
2020-10-14T13:41:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-daratumumab,Synonym:,89Zr-DFO-daratumumab
2020-10-14T13:41:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-daratumumab,Synonym:,zirconium Zr 89 DFO-daratumumab
2020-10-14T13:41:11Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-daratumumab,Synonym:,Zr 89-DFO-daratumumab
2020-10-14T13:41:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-mstp2109a,Synonym:,89Zr-DFO-MSTP2109A
2020-10-14T13:41:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-mstp2109a,Synonym:,89Zr-DFO-vandortuzumab vedotin
2020-10-14T13:41:27Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-mstp2109a,Synonym:,zirconium Zr 89 DFO-MSTP2109A
2020-10-14T13:41:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-pertuzumab,Synonym:,(89)Zr-pertuzumab
2020-10-14T13:41:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-pertuzumab,Synonym:,89Zr-DFO-pertuzumab
2020-10-14T13:41:43Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-pertuzumab,Synonym:,Zr 89-DFO-pertuzumab
2020-10-14T13:41:16Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-regn3504,Code name:,89Zr˗DFO˗REGN3504
2020-10-14T13:41:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-sc1656,Synonym:,89Zr-DFO-SC16.56
2020-09-18T13:15:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-anti-ca19-9-monoclonal-antibody-5b1,Code name:,MVT-2163
2020-09-18T13:15:02Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-anti-ca19-9-monoclonal-antibody-5b1,Synonym:,89Zr-DFO-HuMab-5B1
2020-09-18T13:15:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-anti-pigf-monoclonal-antibody-ro5323441,Abbreviation:,89Zr-RO5323441
2020-09-18T13:15:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-atezolizumab,Synonym:,89Zr-MPDL3280A
2020-09-18T13:15:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-atezolizumab,Synonym:,zirconium Zr 89-labeled MPDL3280A
2020-09-18T13:15:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-monoclonal-antibody-mmot0530a,Abbreviation:,89Zr-MMOT
2020-09-18T13:15:18Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-monoclonal-antibody-mmot0530a,Synonym:,89Zr-MMOT0530A
2020-09-18T13:15:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-ro5479599,Synonym:,89Zr-labeled RG7116
2020-09-18T13:15:23Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-ro5479599,Synonym:,89Zr-labeled RO5479599
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89-zirconium-Nanocoll
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89Zr nanocolloidal albumin
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89Zr-colloidal albumin
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89Zr-labeled albumin nanocolloid
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89Zr-labeled nanocolloid human serum albumin
2020-09-18T13:15:28Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin,Synonym:,89Zr-nanocoll
2020-10-14T13:41:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-panitumumab,Synonym:,89Zr-labeled panitumumab
2020-10-14T13:41:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-panitumumab,Synonym:,89Zr-panitumumab
2020-10-14T13:41:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-panitumumab,Synonym:,zirconium Zr 89 panitumumab
2020-10-14T13:41:32Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-panitumumab,Synonym:,Zr 89-panitumumab
2020-10-14T13:41:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pembrolizumab,Synonym:,89Zr-labeled pembrolizumab
2020-10-14T13:41:38Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pembrolizumab,Synonym:,89Zr-pembrolizumab
2020-09-18T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pertuzumab,Synonym:,(89)Zr-pertuzumab
2020-09-18T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pertuzumab,Synonym:,89Zr-DFO-pertuzumab
2020-09-18T13:15:44Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pertuzumab,Synonym:,Zr 89-DFO-pertuzumab
2020-10-14T13:41:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-tak-164,Synonym:,89Zr-labeled TAK-164
2020-10-14T13:41:48Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-tak-164,Synonym:,89Zr-TAK-164
2020-09-18T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab,Abbreviation:,89Zr-trastuzumab
2020-09-18T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab,Synonym:,89Zr-DFO-trastuzumab
2020-09-18T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab,Synonym:,89Zr-Trastuzumab
2020-09-18T13:15:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab,Synonym:,zirconium Zr 89 trastuzumab
2020-09-18T13:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept,Synonym:,aflibercept
2020-09-18T13:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept,Synonym:,vascular endothelial growth factor trap
2020-09-18T13:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept,Synonym:,VEGF Trap
2020-09-18T13:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept,Synonym:,VEGF Trap R1R2
2020-09-18T13:10:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept,US brand name:,Zaltrap
2020-10-14T13:41:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab,Code name:,iMAB362
2020-10-14T13:41:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab,Synonym:,claudiximab
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Chemical structure:,[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Code name:,CGP 42446
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Code name:,CGP42446A
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Code name:,ZOL 446
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Synonym:,NDC-zoledronate
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,Synonym:,zoledronate
2020-09-18T13:16:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid,US brand name:,Zometa
2020-09-18T13:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolmitriptan,Chemical structure:,"2-oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-,(S)-"
2020-09-18T13:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolmitriptan,Code name:,311C90
2020-09-18T13:16:47Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolmitriptan,US brand name:,Zomig
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,Abbreviation:,ZPD
2020-09-18T02:00:21Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate,US brand name:,Ambien
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Chemical structure:,"1-piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazine"
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Code name:,RP 27267
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,Synonym:,(+-)-zopiclone
2020-09-18T02:03:09Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone,US brand name:,Amoban
2020-09-18T13:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoptarelin-doxorubicin,Code name:,AEZS-108
2020-09-18T13:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoptarelin-doxorubicin,Synonym:,doxorubicin-GNRH agonist conjugate AEZS-108
2020-09-18T13:17:08Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoptarelin-doxorubicin,Synonym:,doxorubicin-LHRH agonist conjugate AEZS-108
2020-10-14T04:57:37Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorifertinib,Code name:,AZD3759
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Abbreviation:,RBZ
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Chemical structure:,"(2S-cis)-benzoic acid[1-[4-[3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3-naphthacenyl]ethylidene]hydrazidebenzoic acid hydrazide 3-hydrazone with daunorubicin"
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Code name:,RP-22050
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Foreign brand name:,Zorubicine
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Synonym:,benzoyl hydrazone daunorubicin
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Synonym:,daunorubicin benzoylhydrazone hydrochloride
2020-09-18T13:17:13Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride,Synonym:,rubidazone
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Code name:,1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Code name:,GSK 1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Code name:,GSK1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Synonym:,herpes zoster subunit vaccine GSK 1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Synonym:,herpes zoster vaccine 1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,Synonym:,HZ/su vaccine GSK 1437173A
2020-10-14T13:19:54Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted,US brand name:,Shingrix
2020-09-18T13:17:29Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zosuquidar-trihydrochloride,Code name:,LY335979
2020-10-14T13:42:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotatifin,Chemical structure:,"4-((5aR,6S,7S,8R,8aS)-7-((dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile"
2020-10-14T13:42:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotatifin,Code name:,eFT 226
2020-10-14T13:42:04Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotatifin,Code name:,eFT-226
2020-10-14T04:41:07Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotiraciclib-citrate,Code name:,TG02 citrate
2020-09-18T13:17:55Z,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zyc300,NA,NA
